{"NCT_id": "NCT03661307", "json": [{"cohort": "frontline", "disease_state": "untreated", "histology_inclusion": "Acute Myeloid Leukemia (AML) excluding acute promyelocytic leukemia (APL) or Myelodysplastic Syndrome (MDS) with > 10% blasts", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "frontline", "disease_state": "untreated", "histology_inclusion": "newly diagnosed AML with poor risk complex karyotype and/or TP53 deletions/mutations", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "relapsed", "disease_state": "relapsed/refractory", "histology_inclusion": "Acute Myeloid Leukemia (AML) excluding acute promyelocytic leukemia (APL) or Myelodysplastic Syndrome (MDS) with > 10% blasts", "biomarker_inclusion": [], "histology_exclusion": ["uncontrolled Central Nervous System (CNS) leukemia"], "biomarker_exclusion": ["prior quizartinib use"]}], "json_norm": [{"cohort": "frontline", "histology_inclusion": "Acute Promyelocytic Leukemia with PML-RARA"}, {"cohort": "frontline", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "frontline", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "frontline", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "relapsed", "histology_inclusion": "Acute Promyelocytic Leukemia with PML-RARA"}, {"cohort": "relapsed", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "relapsed", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}]}
{"NCT_id": "NCT04546009", "json": [{"cohort": "", "disease_state": "Locally Advanced or Metastatic", "histology_inclusion": "Adenocarcinoma of the breast", "biomarker_inclusion": ["ER-positive", "HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}]}
{"NCT_id": "NCT05001828", "json": [{"cohort": "Lead In and Cohort 1", "disease_state": "Previously treated AML", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["Favorable risk AML per ELN 2017 criteria"]}, {"cohort": "Cohort 2", "disease_state": "Untreated AML with high risk features", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["Favorable risk AML per ELN 2017 criteria"]}], "json_norm": [{"cohort": "Lead In and Cohort 1", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "Cohort 2", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}]}
{"NCT_id": "NCT05001880", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "malignant peritoneal mesothelioma", "biomarker_inclusion": [], "histology_exclusion": ["well-differentiated papillary mesothelioma", "multicystic mesothelioma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Peritoneal Malignant Mesothelioma", "histology_exclusion": ["Mesothelioma"]}]}
{"NCT_id": "NCT04415853", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "squamous cell carcinoma of the esophagus", "biomarker_inclusion": ["EGFR high expression"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR targeted drugs", "Irinotecan", "Tegafur", "central nervous system metastasis"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Esophageal Squamous Cell Carcinoma", "biomarker_inclusion": [["EGFR-High", "EGFR-High", "expression"]]}]}
{"NCT_id": "NCT04546074", "json": [{"cohort": "", "disease_state": "unresectable or metastatic melanoma", "histology_inclusion": "melanoma", "biomarker_inclusion": ["KIT mutations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["KIT Mutation", "KIT-Mutation", "gene"]]}]}
{"NCT_id": "NCT04741438", "json": [{"cohort": "", "disease_state": "metastatic or unresectable advanced", "histology_inclusion": "Angiosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable advanced", "histology_inclusion": "Alveolar Soft Part Sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable advanced", "histology_inclusion": "Clear Cell Sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable advanced", "histology_inclusion": "Desmoplastic Small Round Cell Tumour", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable advanced", "histology_inclusion": "Sclerosing Epithelioid Fibrosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable advanced", "histology_inclusion": "Perivascular Epithelioid Cell Tumour", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable advanced", "histology_inclusion": "Intimal sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable advanced", "histology_inclusion": "Extraskeletal Myxoid Chondrosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable advanced", "histology_inclusion": "Solitary Fibrous Tumour", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable advanced", "histology_inclusion": "Epithelioid HemangioEndothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable advanced", "histology_inclusion": "Inflammatory Myofibroblastic Tumour", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable advanced", "histology_inclusion": "Epithelioid sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable advanced", "histology_inclusion": "FibroSarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable advanced", "histology_inclusion": "SMARCA-4 deficient sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable advanced", "histology_inclusion": "Malign Peripheral Nerve Sheath Tumours", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable advanced", "histology_inclusion": "Chordoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Angiosarcoma"}, {"cohort": "", "histology_inclusion": "Alveolar Soft Part Sarcoma"}, {"cohort": "", "histology_inclusion": "Clear Cell Sarcoma of Soft Tissue"}, {"cohort": "", "histology_inclusion": "Desmoplastic Small Round Cell Tumor"}, {"cohort": "", "histology_inclusion": "Sclerosing Epithelioid Fibrosarcoma"}, {"cohort": "", "histology_inclusion": "PEComa"}, {"cohort": "", "histology_inclusion": "Intimal Sarcoma"}, {"cohort": "", "histology_inclusion": "Extraskeletal Myxoid Chondrosarcoma"}, {"cohort": "", "histology_inclusion": "Solitary Fibrous Tumor"}, {"cohort": "", "histology_inclusion": "Epithelioid Hemangioendothelioma"}, {"cohort": "", "histology_inclusion": "Inflammatory Myofibroblastic Tumor"}, {"cohort": "", "histology_inclusion": "Epithelioid Sarcoma"}, {"cohort": "", "histology_inclusion": "Fibrosarcoma"}, {"cohort": "", "histology_inclusion": "Sarcoma", "biomarker_inclusion": [["SMARCA4-Low", "SMARCA4-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Nerve Sheath Neoplasm"}, {"cohort": "", "histology_inclusion": "Chordoma"}]}
{"NCT_id": "NCT03922100", "json": [{"cohort": "Phase I", "disease_state": "relapsed/refractory", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [], "histology_exclusion": ["acute promyelocytic leukemia", "BCR-ABL-positive leukemia", "CNS leukemia involvement"], "biomarker_exclusion": []}, {"cohort": "Phase I", "disease_state": "relapsed/refractory", "histology_inclusion": "Chronic Myelomonocytic Leukemia (CMML)", "biomarker_inclusion": [], "histology_exclusion": ["acute promyelocytic leukemia", "BCR-ABL-positive leukemia", "CNS leukemia involvement"], "biomarker_exclusion": []}, {"cohort": "Cohort 1 (FLT3 mut AML)", "disease_state": "refractory/relapsed/unsuitable for standard therapy", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": ["FLT3-ITD (\u226510% allelic frequency)", "FLT3-TKD point mutations"], "histology_exclusion": ["acute promyelocytic leukemia", "BCR-ABL-positive leukemia", "CNS leukemia involvement"], "biomarker_exclusion": []}, {"cohort": "Cohort 2 (CMML)", "disease_state": "failed previous therapies/unsuitable for standard therapy", "histology_inclusion": "Chronic Myelomonocytic Leukemia (CMML)", "biomarker_inclusion": [], "histology_exclusion": ["acute promyelocytic leukemia", "BCR-ABL-positive leukemia", "CNS leukemia involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase I", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Central Nervous System Leukemia"], "biomarker_exclusion": [["BCR - MTTP", "BCR - MTTP", "coordinate"], ["BCR - ABL1", "BCR - ABL1", "coordinate"], ["MTTP-High", "MTTP-High", "expression"]]}, {"cohort": "Phase I", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Central Nervous System Leukemia"], "biomarker_exclusion": [["BCR - MTTP", "BCR - MTTP", "coordinate"], ["BCR - ABL1", "BCR - ABL1", "coordinate"], ["MTTP-High", "MTTP-High", "expression"]]}, {"cohort": "Cohort 1 (FLT3 mut AML)", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Central Nervous System Leukemia"], "biomarker_exclusion": [["BCR - MTTP", "BCR - MTTP", "coordinate"], ["BCR - ABL1", "BCR - ABL1", "coordinate"], ["MTTP-High", "MTTP-High", "expression"]]}, {"cohort": "Cohort 2 (CMML)", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Central Nervous System Leukemia"], "biomarker_exclusion": [["BCR - MTTP", "BCR - MTTP", "coordinate"], ["BCR - ABL1", "BCR - ABL1", "coordinate"], ["MTTP-High", "MTTP-High", "expression"]]}]}
{"NCT_id": "NCT03987217", "json": [{"cohort": "", "disease_state": "Metastatic", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma"}]}
{"NCT_id": "NCT04182516", "json": [{"cohort": "Dose Escalation Part", "disease_state": "locally advanced/metastatic", "histology_inclusion": "HER2 negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Escalation Part", "disease_state": "locally advanced/metastatic", "histology_inclusion": "epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Escalation Part", "disease_state": "locally advanced/metastatic", "histology_inclusion": "castration-resistant prostate cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Escalation Part", "disease_state": "locally advanced/metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Part - Epithelial Ovarian Cancer", "disease_state": "locally advanced/metastatic", "histology_inclusion": "epithelial ovarian cancer", "biomarker_inclusion": ["gBRCA mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Part - Pretreated HER 2 Neg. Breast Cancer", "disease_state": "locally advanced/metastatic", "histology_inclusion": "HER2 negative breast cancer", "biomarker_inclusion": ["gBRCA mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior PARP inhibitor"]}, {"cohort": "Dose Expansion Part - No Pretreated HER 2 Neg. Breast Cancer", "disease_state": "locally advanced/metastatic", "histology_inclusion": "HER2 negative breast cancer", "biomarker_inclusion": ["gBRCA mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Part - CRPC", "disease_state": "locally advanced/metastatic", "histology_inclusion": "castration-resistant prostate cancer", "biomarker_inclusion": ["gBRCA mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Part - Pancreatic Cancer", "disease_state": "locally advanced/metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["gBRCA mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior PARP inhibitor"]}], "json_norm": [{"cohort": "Dose Escalation Part", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Dose Escalation Part", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Dose Escalation Part", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Dose Escalation Part", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Dose Escalation Part", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "Dose Expansion Part - Epithelial Ovarian Cancer", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Dose Expansion Part - Pretreated HER 2 Neg. Breast Cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Dose Expansion Part - No Pretreated HER 2 Neg. Breast Cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Dose Expansion Part - CRPC", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Dose Expansion Part - CRPC", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Dose Expansion Part - Pancreatic Cancer", "histology_inclusion": "Pancreatic Carcinoma"}]}
{"NCT_id": "NCT04481113", "json": [{"cohort": "", "disease_state": "Clinical T1-T3, any N, M0", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": ["ER >= 1%", "PR >= 1%", "HER2 non-amplified"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Clinical T1-T3, any N, M0", "histology_inclusion": "Hormone Receptor Positive Breast Adenocarcinoma", "biomarker_inclusion": ["ER >= 1%", "PR >= 1%", "HER2 non-amplified"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Clinical T1-T3, any N, M0", "histology_inclusion": "HER2 Negative Breast Adenocarcinoma", "biomarker_inclusion": ["ER >= 1%", "PR >= 1%", "HER2 non-amplified"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Clinical T1-T3, any N, M0", "histology_inclusion": "Multifocal Breast Carcinoma", "biomarker_inclusion": ["ER >= 1%", "PR >= 1%", "HER2 non-amplified"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT05002127", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "gastric adenocarcinoma", "biomarker_inclusion": ["HER2-overexpressing"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "gastroesophageal junction adenocarcinoma", "biomarker_inclusion": ["HER2-overexpressing"], "histology_exclusion": ["CNS metastases", "leptomeningeal disease"], "biomarker_exclusion": ["anti-CD47", "anti-SIRP\u03b1", "ramucirumab"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT05002140", "json": [{"cohort": "", "disease_state": "metastatic, locally advanced, or recurrent cancer", "histology_inclusion": "cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}]}
{"NCT_id": "NCT05067283", "json": [{"cohort": "MK-1084", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "solid-tumor malignancy", "biomarker_inclusion": ["KRASG12C mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Pembrolizumab plus MK-1084", "disease_state": "untreated metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["KRASG12C mutation", "tumor proportion score (TPS) \u22651%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastases", "carcinomatous meningitis", "Kaposi's sarcoma", "Multicentric Castleman's Disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "MK-1084", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "Pembrolizumab plus MK-1084", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "", "histology_exclusion": ["Sarcoma"]}]}
{"NCT_id": "NCT05002270", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT05262608", "json": [{"cohort": "", "disease_state": "metastatic castration-resistant prostate cancer", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["BRCA1", "BRCA2", "ATM", "BARD1", "BRIP1", "CDK12", "CHEK1", "CHEK2", "FANCL", "PALB2", "RAD51B", "RAD51C", "RAD51D", "RAD54L"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT05392686", "json": [{"cohort": "", "disease_state": "stage IIIA, IIIB, IIIc", "histology_inclusion": "Non-small Cell Lung Cancer (Lung Squamous Cell Carcinoma)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Squamous Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT02945033", "json": [{"cohort": "", "disease_state": "stage III or II high risk", "histology_inclusion": "colonic adenocarcinoma", "biomarker_inclusion": ["PI3K mutation, exon 9 or 20"], "histology_exclusion": ["rectal cancer"], "biomarker_exclusion": ["MSS"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Rectal Carcinoma"], "biomarker_exclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT03922555", "json": [{"cohort": "", "disease_state": "recurrent/progressive non-enhancing", "histology_inclusion": "IDH mutant glioma", "biomarker_inclusion": ["IDH1 gene-mutation", "IDH2 gene-mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"], ["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04546620", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma, not otherwise specified (NOS)", "biomarker_inclusion": ["CD20 positive"], "histology_exclusion": ["primary mediastinal lymphoma", "primary Central Nervous System lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "T-cell/histiocyte-rich large B-cell lymphoma", "biomarker_inclusion": ["CD20 positive"], "histology_exclusion": ["primary mediastinal lymphoma", "primary Central Nervous System lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Epstein-Barr virus positive Diffuse Large B-Cell Lymphoma, not otherwise specified (NOS)", "biomarker_inclusion": ["CD20 positive"], "histology_exclusion": ["primary mediastinal lymphoma", "primary Central Nervous System lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "ALK-positive large B-cell lymphoma", "biomarker_inclusion": ["CD20 positive"], "histology_exclusion": ["primary mediastinal lymphoma", "primary Central Nervous System lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "HHV8-positive Diffuse Large B-Cell Lymphoma, not otherwise specified (NOS)", "biomarker_inclusion": ["CD20 positive"], "histology_exclusion": ["primary mediastinal lymphoma", "primary Central Nervous System lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements (double-hit or triple-hit lymphoma)", "biomarker_inclusion": ["CD20 positive"], "histology_exclusion": ["primary mediastinal lymphoma", "primary Central Nervous System lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "High-grade B-cell lymphoma, not otherwise specified (NOS)", "biomarker_inclusion": ["CD20 positive"], "histology_exclusion": ["primary mediastinal lymphoma", "primary Central Nervous System lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma, Not Otherwise Specified", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma", "Mediastinal Lymphoma"]}, {"cohort": "", "histology_inclusion": "T-Cell/Histiocyte-Rich Large B-Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma", "Mediastinal Lymphoma"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma, Not Otherwise Specified", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"], ["CR2-High", "CR2-High", "expression"]], "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma", "Mediastinal Lymphoma"]}, {"cohort": "", "histology_inclusion": "ALK-Positive Large B-Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"], ["ALK-High", "ALK-High", "expression"]], "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma", "Mediastinal Lymphoma"]}, {"cohort": "", "histology_inclusion": "HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma", "Mediastinal Lymphoma"]}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"], ["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Mediastinal Lymphoma", "Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}, {"cohort": "", "histology_inclusion": "High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"], ["BCL6 Fusion", "BCL6", "fusion"]], "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma", "Mediastinal Lymphoma"]}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma, Not Otherwise Specified", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma", "Mediastinal Lymphoma"]}]}
{"NCT_id": "NCT04741997", "json": [{"cohort": "", "disease_state": "Stage III (B/C/D) or Stage IV (AJCC 8th edition)", "histology_inclusion": "Melanoma", "biomarker_inclusion": ["BRAFV600 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma"}]}
{"NCT_id": "NCT05002569", "json": [{"cohort": "", "disease_state": "Stage IIIA (> 1 mm tumor in lymph node)/B/C/D or Stage IV", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": ["Ocular Melanoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "histology_exclusion": ["Ocular Melanoma"]}]}
{"NCT_id": "NCT05132738", "json": [{"cohort": "Ripretinib treatment group", "disease_state": "locally advanced or recurrent metastatic gastrointestinal stromal tumors", "histology_inclusion": "gastrointestinal stromal tumors", "biomarker_inclusion": ["CD117 positive", "DOG-1 positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Ripretinib treatment group", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["ANO1-High", "ANO1-High", "expression"], ["KIT-High", "KIT-High", "expression"]]}]}
{"NCT_id": "NCT01351103", "json": [{"cohort": "Single Agent Dose escalation part", "disease_state": "locally advanced or metastatic", "histology_inclusion": "B-RAF mutant colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Single Agent Dose escalation part", "disease_state": "locally advanced or metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Single Agent Dose expansion part", "disease_state": "locally advanced or metastatic", "histology_inclusion": "B-RAF mutant colorectal cancer", "biomarker_inclusion": ["RNF43 mutation", "RSPO fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Single Agent Dose expansion part", "disease_state": "locally advanced or metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": ["RNF43 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "LGK974 with PDR001: Dose escalation", "disease_state": "primary refractory", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "LGK974 with PDR001: Dose escalation", "disease_state": "primary refractory", "histology_inclusion": "lung squamous cell cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "LGK974 with PDR001: Dose escalation", "disease_state": "primary refractory", "histology_inclusion": "head and neck squamous cell cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "LGK974 with PDR001: Dose escalation", "disease_state": "primary refractory or na\u00efve", "histology_inclusion": "esophageal squamous cell cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "LGK974 with PDR001: Dose escalation", "disease_state": "primary refractory or na\u00efve", "histology_inclusion": "cervical squamous cell cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "LGK974 with PDR001: Dose escalation", "disease_state": "primary refractory or na\u00efve", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "LGK974 with PDR001: Dose expansion", "disease_state": "primary refractory", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["BRAF V600-mutant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "LGK974 with PDR001: Dose expansion", "disease_state": "acquired resistance", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["BRAF V600-mutant"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Single Agent Dose escalation part", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "Single Agent Dose escalation part", "histology_inclusion": "Pancreatic Adenocarcinoma"}, {"cohort": "Single Agent Dose expansion part", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["RNF43 Mutation", "RNF43-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "Single Agent Dose expansion part", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": [["RNF43 Mutation", "RNF43-Mutation", "gene"]]}, {"cohort": "LGK974 with PDR001: Dose escalation", "histology_inclusion": "Melanoma"}, {"cohort": "LGK974 with PDR001: Dose escalation", "histology_inclusion": "Squamous Cell Lung Carcinoma"}, {"cohort": "LGK974 with PDR001: Dose escalation", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "LGK974 with PDR001: Dose escalation", "histology_inclusion": "Esophageal Squamous Cell Carcinoma"}, {"cohort": "LGK974 with PDR001: Dose escalation", "histology_inclusion": "Cervical Squamous Cell Carcinoma, Not Otherwise Specified"}, {"cohort": "LGK974 with PDR001: Dose escalation", "histology_inclusion": "Cervical Squamous Cell Carcinoma"}, {"cohort": "LGK974 with PDR001: Dose escalation", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "LGK974 with PDR001: Dose expansion", "histology_inclusion": "Cutaneous Melanoma"}, {"cohort": "LGK974 with PDR001: Dose expansion", "histology_inclusion": "Cutaneous Melanoma"}]}
{"NCT_id": "NCT03531736", "json": [{"cohort": "Patients with Myeloid Malignancies & Aplastic Anemia", "disease_state": "Acute Myeloid Leukemia (AML) in CR1 with intermediate or high risk features", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["FLT3 mutation", "RUNX1 mutation", "TP53 mutation", "ASXL1 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Patients with Myeloid Malignancies & Aplastic Anemia", "disease_state": "AML in \u2265 2nd remission", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Patients with Myeloid Malignancies & Aplastic Anemia", "disease_state": "Myelodysplastic syndrome, myeloproliferative neoplasms, or MDS/MPN overlap syndrome", "histology_inclusion": "Myelodysplastic syndrome", "biomarker_inclusion": ["TP53 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Patients with Myeloid Malignancies & Aplastic Anemia", "disease_state": "Chronic myelomonocytic leukemia (CMML)", "histology_inclusion": "Chronic myelomonocytic leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Patients with Myeloid Malignancies & Aplastic Anemia", "disease_state": "Chronic myeloid leukemia (CML) with high risk features", "histology_inclusion": "Chronic myeloid leukemia", "biomarker_inclusion": ["BCR-ABL mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Patients with Myeloid Malignancies & Aplastic Anemia", "disease_state": "Severe aplastic anemia", "histology_inclusion": "Aplastic anemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Patients with Myeloid Malignancies & Aplastic Anemia", "disease_state": "Chronic lymphocytic leukemia (CLL) with high risk disease", "histology_inclusion": "Chronic lymphocytic leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Patients with Myeloid Malignancies & Aplastic Anemia", "disease_state": "Non-Hodgkin lymphoma", "histology_inclusion": "Non-Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Patients with Myeloid Malignancies & Aplastic Anemia", "disease_state": "Multiple Myeloma", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": ["complex karyotype", "del17p", "t4;14", "t14;16", "del13"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Patients with Myeloid Malignancies & Aplastic Anemia", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["ASXL1 Mutation", "ASXL1-Mutation", "gene"], ["RUNX1 Mutation", "RUNX1-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["FLT3 Mutation", "FLT3-Mutation", "gene"]]}, {"cohort": "Patients with Myeloid Malignancies & Aplastic Anemia", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "Patients with Myeloid Malignancies & Aplastic Anemia", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Patients with Myeloid Malignancies & Aplastic Anemia", "histology_inclusion": "Chronic Myelomonocytic Leukemia"}, {"cohort": "Patients with Myeloid Malignancies & Aplastic Anemia", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "biomarker_inclusion": [["BCR - MTTP", "BCR - MTTP", "coordinate"], ["BCR - ABL1", "BCR - ABL1", "coordinate"]]}, {"cohort": "Patients with Myeloid Malignancies & Aplastic Anemia"}, {"cohort": "Patients with Myeloid Malignancies & Aplastic Anemia", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "Patients with Myeloid Malignancies & Aplastic Anemia", "histology_inclusion": "Non-Hodgkin Lymphoma"}, {"cohort": "Patients with Myeloid Malignancies & Aplastic Anemia", "histology_inclusion": "Plasma Cell Myeloma"}]}
{"NCT_id": "NCT03662126", "json": [{"cohort": "", "disease_state": "Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF)", "histology_inclusion": "Myelofibrosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Myelofibrosis"}]}
{"NCT_id": "NCT04117945", "json": [{"cohort": "", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["KRAS wild type", "NRAS wild type", "BRAF v600E wildtype"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04117958", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced unresectable", "histology_inclusion": "gastric adenocarcinoma", "biomarker_inclusion": ["MUC17"], "histology_exclusion": [], "biomarker_exclusion": ["MSI H", "dMMR"]}, {"cohort": "", "disease_state": "metastatic or locally advanced unresectable", "histology_inclusion": "gastroesophageal junction adenocarcinoma", "biomarker_inclusion": ["MUC17"], "histology_exclusion": [], "biomarker_exclusion": ["MSI H", "dMMR"]}, {"cohort": "", "disease_state": "metastatic or locally advanced unresectable", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["MUC17"], "histology_exclusion": [], "biomarker_exclusion": ["MSI H", "dMMR", "KRAS", "NRAS", "BRAF wild type"]}, {"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "pancreatic ductal adenocarcinoma", "biomarker_inclusion": ["MUC17"], "histology_exclusion": ["CNS metastases", "leptomeningeal", "spinal cord compression"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma"}]}
{"NCT_id": "NCT03075696", "json": [{"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "B-Cell Non-Hodgkin's Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["chronic lymphocytic leukemia", "Burkitt lymphoma", "lymphoplasmacytic lymphoma", "central nervous system lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Chronic Lymphocytic Leukemia", "Burkitt Lymphoma", "Lymphoplasmacytic Lymphoma", "Primary Central Nervous System Lymphoma"]}]}
{"NCT_id": "NCT03336333", "json": [{"cohort": "Cohort 1, Arm A: Zanubrutinib", "disease_state": "Previously untreated CLL or SLL", "histology_inclusion": "CD20-positive CLL or SLL", "biomarker_inclusion": [], "histology_exclusion": ["prolymphocytic leukemia", "Richter's transformation", "central nervous system involvement by leukemia or lymphoma"], "biomarker_exclusion": []}, {"cohort": "Cohort 1, Arm B: B+R", "disease_state": "Previously untreated CLL or SLL", "histology_inclusion": "CD20-positive CLL or SLL", "biomarker_inclusion": [], "histology_exclusion": ["prolymphocytic leukemia", "Richter's transformation", "central nervous system involvement by leukemia or lymphoma"], "biomarker_exclusion": []}, {"cohort": "Cohort 1a, Arm A (China only): Zanubrutinib", "disease_state": "Previously untreated CLL or SLL", "histology_inclusion": "CD20-positive CLL or SLL", "biomarker_inclusion": [], "histology_exclusion": ["prolymphocytic leukemia", "Richter's transformation", "central nervous system involvement by leukemia or lymphoma"], "biomarker_exclusion": []}, {"cohort": "Cohort 1a, Arm B (China only): B + R", "disease_state": "Previously untreated CLL or SLL", "histology_inclusion": "CD20-positive CLL or SLL", "biomarker_inclusion": [], "histology_exclusion": ["prolymphocytic leukemia", "Richter's transformation", "central nervous system involvement by leukemia or lymphoma"], "biomarker_exclusion": []}, {"cohort": "Cohort 2, Arm C: Zanubrutinib", "disease_state": "Previously untreated CLL or SLL", "histology_inclusion": "CD20-positive CLL or SLL", "biomarker_inclusion": [], "histology_exclusion": ["prolymphocytic leukemia", "Richter's transformation", "central nervous system involvement by leukemia or lymphoma"], "biomarker_exclusion": []}, {"cohort": "Cohort 3, Arm D: Venetoclax + zanubrutinib", "disease_state": "Previously untreated CLL or SLL", "histology_inclusion": "CD20-positive CLL or SLL", "biomarker_inclusion": ["del17p", "TP53 mutation"], "histology_exclusion": ["prolymphocytic leukemia", "Richter's transformation", "central nervous system involvement by leukemia or lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1, Arm A: Zanubrutinib", "histology_inclusion": "Small Lymphocytic Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Prolymphocytic Leukemia", "Richter Syndrome"]}, {"cohort": "Cohort 1, Arm A: Zanubrutinib", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Richter Syndrome", "Prolymphocytic Leukemia"]}, {"cohort": "Cohort 1, Arm B: B+R", "histology_inclusion": "Small Lymphocytic Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Prolymphocytic Leukemia", "Richter Syndrome"]}, {"cohort": "Cohort 1, Arm B: B+R", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Richter Syndrome", "Prolymphocytic Leukemia"]}, {"cohort": "Cohort 1a, Arm A (China only): Zanubrutinib", "histology_inclusion": "Small Lymphocytic Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Prolymphocytic Leukemia", "Richter Syndrome"]}, {"cohort": "Cohort 1a, Arm A (China only): Zanubrutinib", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Richter Syndrome", "Prolymphocytic Leukemia"]}, {"cohort": "Cohort 1a, Arm B (China only): B + R", "histology_inclusion": "Small Lymphocytic Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Prolymphocytic Leukemia", "Richter Syndrome"]}, {"cohort": "Cohort 1a, Arm B (China only): B + R", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Richter Syndrome", "Prolymphocytic Leukemia"]}, {"cohort": "Cohort 2, Arm C: Zanubrutinib", "histology_inclusion": "Small Lymphocytic Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Prolymphocytic Leukemia", "Richter Syndrome"]}, {"cohort": "Cohort 2, Arm C: Zanubrutinib", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Richter Syndrome", "Prolymphocytic Leukemia"]}, {"cohort": "Cohort 3, Arm D: Venetoclax + zanubrutinib", "histology_inclusion": "Small Lymphocytic Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"], ["TP53 Mutation", "TP53-Mutation", "gene"]], "histology_exclusion": ["Prolymphocytic Leukemia", "Richter Syndrome"]}, {"cohort": "Cohort 3, Arm D: Venetoclax + zanubrutinib", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"], ["TP53 Mutation", "TP53-Mutation", "gene"]], "histology_exclusion": ["Richter Syndrome", "Prolymphocytic Leukemia"]}]}
{"NCT_id": "NCT05002816", "json": [{"cohort": "Belantamab Mafodotin and Elotuzumab Arm", "disease_state": "relapsed or refractory", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Belantamab Mafodotin and Elotuzumab Arm", "histology_inclusion": "Plasma Cell Myeloma"}]}
{"NCT_id": "NCT05328102", "json": [{"cohort": "", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Diffuse Large B-Cell Lymphoma (DLBCL), NOS, including DLBCL arising from low grade lymphoma", "biomarker_inclusion": ["CD20+", "CD19+"], "histology_exclusion": ["High-grade B-cell lymphoma, including those with MYC and BCL2 and/or BCL6 rearrangements", "Primary mediastinal (thymic) large B cell (PMBL)", "Burkitt lymphoma", "CLL (Richter's Transformation)", "Primary central nervous system (CNS) lymphoma"], "biomarker_exclusion": ["Anti-CD20 \u00d7 anti-CD3 bsAb treatment", "CD19-targeted therapy (unless current biopsy is CD19+)"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"], ["CD19-High", "CD19-High", "expression"]], "histology_exclusion": ["Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Chronic Lymphocytic Leukemia", "Richter Syndrome", "Burkitt Lymphoma", "High Grade B-Cell Lymphoma"], "biomarker_exclusion": [["BCL6 Fusion", "BCL6", "fusion"]]}]}
{"NCT_id": "NCT05393258", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "IDH-mutant gliomas", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "IDH-mutant astrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "IDH-mutant oligodendroglioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}, {"cohort": "", "histology_inclusion": "Astrocytoma"}, {"cohort": "", "histology_inclusion": "Oligodendroglioma"}]}
{"NCT_id": "NCT03271255", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["vermiform appendix cancer", "anal canal cancer", "brain metastases", "brain tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "histology_exclusion": ["Primary Brain Neoplasm", "Malignant Brain Neoplasm", "Brain Tumor", "Appendix Carcinoma"]}]}
{"NCT_id": "NCT03662412", "json": [{"cohort": "Advanced Pancreatic Cancer", "disease_state": "Chemo-resistant, Recurrent or Metastatic", "histology_inclusion": "Pancreatic Cancer", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System metastases", "neoplastic meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Advanced Pancreatic Cancer", "histology_inclusion": "Pancreatic Carcinoma"}]}
{"NCT_id": "NCT04351555", "json": [{"cohort": "", "disease_state": "Stage II - IIIB N2", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": ["EGFR Ex19del", "EGFR L858R"], "histology_exclusion": ["mixed small cell and NSCLC"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]], "histology_exclusion": ["Non-Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT05002868", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["HER2 positive breast cancer"], "biomarker_exclusion": []}, {"cohort": "dose-expansion phase", "disease_state": "locally advanced or metastatic", "histology_inclusion": "extensive-stage small cell lung cancer", "biomarker_inclusion": ["deleterious HRR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "dose-expansion phase", "disease_state": "locally advanced or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["deleterious HRR mutation"], "histology_exclusion": ["HER2 positive breast cancer"], "biomarker_exclusion": []}, {"cohort": "dose-expansion phase", "disease_state": "locally advanced or metastatic", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["deleterious HRR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "dose-expansion phase", "disease_state": "locally advanced or metastatic", "histology_inclusion": "fallopian tube carcinoma", "biomarker_inclusion": ["deleterious HRR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "dose-expansion phase", "disease_state": "locally advanced or metastatic", "histology_inclusion": "peritoneal cancer", "biomarker_inclusion": ["deleterious HRR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Breast Carcinoma"], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "dose-expansion phase", "histology_inclusion": "Small Cell Lung Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "dose-expansion phase", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]], "histology_exclusion": ["Breast Carcinoma"], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "dose-expansion phase", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "dose-expansion phase", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "dose-expansion phase", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "dose-expansion phase", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}]}
{"NCT_id": "NCT05067972", "json": [{"cohort": "Part 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "HR+ HER2- breast cancer", "biomarker_inclusion": ["high B7-H4 expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2B", "disease_state": "locally advanced or metastatic", "histology_inclusion": "HR+ HER2- breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2B", "disease_state": "locally advanced or metastatic", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2C", "disease_state": "locally advanced or metastatic", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": ["high B7-H4 expression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 1", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "Part 1", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "Part 1", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Part 1", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "Part 2A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["VTCN1-High", "VTCN1-High", "expression"]]}, {"cohort": "Part 2A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["VTCN1-High", "VTCN1-High", "expression"]]}, {"cohort": "Part 2A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["VTCN1-High", "VTCN1-High", "expression"]]}, {"cohort": "Part 2A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-Low", "HR-Low", "expression"], ["HR-High", "HR-High", "expression"], ["VTCN1-High", "VTCN1-High", "expression"]]}, {"cohort": "Part 2B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Part 2B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Part 2B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Part 2B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Part 2B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Part 2C", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["VTCN1-High", "VTCN1-High", "expression"]]}]}
{"NCT_id": "NCT05068024", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic NSCLC (Stage IIIB/IIIC or IV)", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutation", "HER2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic NSCLC (Stage IIIB/IIIC or IV)", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR in-frame exon 20 insertion"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT05523440", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["ARID1A mutation"], "histology_exclusion": [], "biomarker_exclusion": ["PARP inhibitor treatment"]}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["ARID1A mutation"], "histology_exclusion": [], "biomarker_exclusion": ["PARP inhibitor treatment"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["ARID1A Mutation", "ARID1A-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["ARID1A Mutation", "ARID1A-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["ARID1A Mutation", "ARID1A-Mutation", "gene"]]}]}
{"NCT_id": "NCT02945631", "json": [{"cohort": "", "disease_state": "Stage 3 or 4", "histology_inclusion": "squamous cell carcinoma of the oropharynx, hypopharynx, supraglottic larynx, nasal cavity, unknown primary, or nasopharynx", "biomarker_inclusion": ["p16 positive", "HPV positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}]}
{"NCT_id": "NCT04547101", "json": [{"cohort": "", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["MSI-H", "dMMR"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04742556", "json": [{"cohort": "", "disease_state": "Advanced, Unresectable or Metastatic Refractory", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": ["NRAS Mutation", "KRAS Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT05068206", "json": [{"cohort": "", "disease_state": "Unresectable Metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma"}]}
{"NCT_id": "NCT05588609", "json": [{"cohort": "Group A", "disease_state": "locally advanced, unresectable, or metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["NRG1 gene fusion"], "histology_exclusion": [], "biomarker_exclusion": ["anti-HER3-directed therapies"]}, {"cohort": "Group B", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the prostate without neuroendocrine differentiation or small cell features", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["more than 2 lines of a second-generation hormonal agent for metastatic disease", "more than 2 lines of systemic chemotherapy for metastatic disease"]}], "json_norm": [{"cohort": "Group A", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["NRG1 Fusion", "NRG1", "fusion"]]}, {"cohort": "Group B", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT02478099", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["unstable brain metastases", "unstable leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT03727724", "json": [{"cohort": "Afatinib plus cetuximab", "disease_state": "stage IV", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR exon 20 insertion mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Afatinib plus cetuximab", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT03727763", "json": [{"cohort": "FIVC group", "disease_state": "advanced or recurrent", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["BRAF V600E", "KRAS WT"], "histology_exclusion": [], "biomarker_exclusion": ["KRAS/NRAS mutation", "brain metastases"]}], "json_norm": [{"cohort": "FIVC group", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"]], "biomarker_exclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04053322", "json": [{"cohort": "Study Arm", "disease_state": "Metastatic or Locally Advanced", "histology_inclusion": "ER-positive (\u226510%), HER2-negative Breast Cancer", "biomarker_inclusion": ["BRCA1 germline alteration", "BRCA2 germline alteration", "ATM alteration", "BARD1 alteration", "BRCA1 alteration", "BRCA2 alteration", "BRIP1 alteration", "CDK12 alteration", "CHEK1 alteration", "CHEK2 alteration", "FANCA alteration", "FAND2 alteration", "FANCL alteration", "MRE11A alteration", "NBN alteration", "PALB2 alteration", "PPP2R2A alteration", "RAD51B alteration", "RAD51C alteration", "RAD51D alteration", "RAD54L alteration", "MSI status alteration"], "histology_exclusion": ["Primary Central Nervous System Tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Study Arm", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["ATM Mutation", "ATM-Mutation", "gene"], ["BARD1 Mutation", "BARD1-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRIP1 Mutation", "BRIP1-Mutation", "gene"], ["CDK12 Mutation", "CDK12-Mutation", "gene"], ["CHEK1 Mutation", "CHEK1-Mutation", "gene"], ["CHEK2 Mutation", "CHEK2-Mutation", "gene"], ["FANCA Mutation", "FANCA-Mutation", "gene"], ["FANCL Mutation", "FANCL-Mutation", "gene"], ["MRE11 Mutation", "MRE11-Mutation", "gene"], ["ARTN Mutation", "ARTN-Mutation", "gene"], ["NBN Mutation", "NBN-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["PPP2R2A Mutation", "PPP2R2A-Mutation", "gene"], ["RAD51B Mutation", "RAD51B-Mutation", "gene"], ["RAD51C Mutation", "RAD51C-Mutation", "gene"], ["RAD51D Mutation", "RAD51D-Mutation", "gene"], ["RAD54L Mutation", "RAD54L-Mutation", "gene"], ["MSI", "MSI", "coordinate"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "Study Arm", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["RAD51C Mutation", "RAD51C-Mutation", "gene"], ["BARD1 Mutation", "BARD1-Mutation", "gene"], ["BRIP1 Mutation", "BRIP1-Mutation", "gene"], ["EREG-High", "EREG-High", "expression"], ["CHEK2 Mutation", "CHEK2-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["RAD51D Mutation", "RAD51D-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["PPP2R2A Mutation", "PPP2R2A-Mutation", "gene"], ["RAD51B Mutation", "RAD51B-Mutation", "gene"], ["MSI", "MSI", "coordinate"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["CHEK1 Mutation", "CHEK1-Mutation", "gene"], ["CDK12 Mutation", "CDK12-Mutation", "gene"], ["RAD54L Mutation", "RAD54L-Mutation", "gene"], ["ARTN Mutation", "ARTN-Mutation", "gene"], ["MRE11 Mutation", "MRE11-Mutation", "gene"], ["NBN Mutation", "NBN-Mutation", "gene"], ["FANCA Mutation", "FANCA-Mutation", "gene"], ["FANCL Mutation", "FANCL-Mutation", "gene"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT04677595", "json": [{"cohort": "Cohort 1", "disease_state": "stage IIIB, IIIC or IV", "histology_inclusion": "Non-Small Cell Lung Cancer (NSCLC)", "biomarker_inclusion": ["EGFR wt", "ALK rearrangement negative", "MET Exon 14 Skipping Mutation"], "histology_exclusion": [], "biomarker_exclusion": ["ROS1 translocation", "BRAF mutation"]}, {"cohort": "Cohort 2", "disease_state": "stage IIIB, IIIC or IV", "histology_inclusion": "Non-Small Cell Lung Cancer (NSCLC)", "biomarker_inclusion": ["EGFR wt", "ALK rearrangement negative", "MET Exon 14 Skipping Mutation"], "histology_exclusion": [], "biomarker_exclusion": ["ROS1 translocation", "BRAF mutation"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["ALK-Low", "ALK-Low", "expression"], ["MET exon 14 del", "exon 14 del", "exon"], ["ALK Fusion", "ALK", "fusion"]], "biomarker_exclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["ALK-Low", "ALK-Low", "expression"], ["MET exon 14 del", "exon 14 del", "exon"], ["ALK Fusion", "ALK", "fusion"]], "biomarker_exclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"]]}]}
{"NCT_id": "NCT04807777", "json": [{"cohort": "", "disease_state": "metastatic advanced", "histology_inclusion": "cutaneous squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Skin Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT05653869", "json": [{"cohort": "", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["RET mutations", "RET fusions"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"], ["RET Fusion", "RET", "fusion"]]}]}
{"NCT_id": "NCT05395052", "json": [{"cohort": "A/AA", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "A/AA", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "A/AA", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "A/AA", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Ovarian Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "A/AA", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Pancreatic Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "B/BB", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": ["PD-L1 expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "C/CC", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": ["PD-L1 expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "D/DD", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["HER2+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "E/EE", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Squamous Non Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "E/EE", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Head and Neck Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "E/EE", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["KRAS wild-type", "NRAS wild-type"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "F/FF", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR driver mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "F/FF", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": ["MET exon 14 skipping mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "F/FF", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": ["MET amplification"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "A/AA", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "A/AA", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "A/AA", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "A/AA", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "A/AA", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "A/AA", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "B/BB", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "C/CC", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "D/DD", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "E/EE", "histology_inclusion": "Squamous Cell Lung Carcinoma"}, {"cohort": "E/EE", "histology_inclusion": "Malignant Head and Neck Neoplasm"}, {"cohort": "E/EE", "histology_inclusion": "Head and Neck Carcinoma"}, {"cohort": "E/EE", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}, {"cohort": "F/FF", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "F/FF", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]]}, {"cohort": "F/FF", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}]}
{"NCT_id": "NCT05655260", "json": [{"cohort": "p53 abn subtype and nonendometrioid carcinomas", "disease_state": "Stage I-II molecular integrated high-intermediate or high-risk", "histology_inclusion": "Endometrial Adenocarcinoma", "biomarker_inclusion": ["p53 abn"], "histology_exclusion": ["Uterine sarcoma"], "biomarker_exclusion": []}, {"cohort": "MMR-D molecular subgroup", "disease_state": "Stage I-II molecular integrated high-intermediate or high-risk", "histology_inclusion": "Endometrial Adenocarcinoma", "biomarker_inclusion": ["MMR-D"], "histology_exclusion": ["Uterine sarcoma"], "biomarker_exclusion": []}, {"cohort": "NSMP molecular subgroup", "disease_state": "Stage I-II molecular integrated high-intermediate or high-risk", "histology_inclusion": "Endometrial Adenocarcinoma", "biomarker_inclusion": ["NSMP"], "histology_exclusion": ["Uterine sarcoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "p53 abn subtype and nonendometrioid carcinomas", "histology_inclusion": "Endometrial Adenocarcinoma", "histology_exclusion": ["Uterine Corpus Sarcoma"]}, {"cohort": "MMR-D molecular subgroup", "histology_inclusion": "Endometrial Adenocarcinoma", "histology_exclusion": ["Uterine Corpus Sarcoma"]}, {"cohort": "NSMP molecular subgroup", "histology_inclusion": "Endometrial Adenocarcinoma", "histology_exclusion": ["Uterine Corpus Sarcoma"]}]}
{"NCT_id": "NCT02675829", "json": [{"cohort": "Cohort 1: Lung cancers, HER2 mutant", "disease_state": "advanced", "histology_inclusion": "lung cancer", "biomarker_inclusion": ["HER2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2: Lung cancers, HER2 amplified", "disease_state": "advanced", "histology_inclusion": "lung cancer", "biomarker_inclusion": ["HER2 amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3: Colorectal cancers", "disease_state": "advanced", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["HER2 amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 4: Endometrial cancers", "disease_state": "advanced", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["HER2 amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 5: Salivary gland cancers", "disease_state": "advanced", "histology_inclusion": "salivary gland cancer", "biomarker_inclusion": ["HER2 amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 6: Other solid cancers", "disease_state": "advanced", "histology_inclusion": "solid tumor cancers", "biomarker_inclusion": ["HER2 amplification"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1: Lung cancers, HER2 mutant", "histology_inclusion": "Lung Carcinoma", "biomarker_inclusion": [["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "Cohort 2: Lung cancers, HER2 amplified", "histology_inclusion": "Lung Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort 3: Colorectal cancers", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort 4: Endometrial cancers", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort 5: Salivary gland cancers", "histology_inclusion": "Malignant Salivary Gland Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort 5: Salivary gland cancers", "histology_inclusion": "Salivary Gland Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort 6: Other solid cancers", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT03533946", "json": [{"cohort": "", "disease_state": "nonmetastatic, hormone-sensitive", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["BARD1 alteration", "BRCA1 alteration", "BRCA2 alteration", "BRIP1 alteration", "CHEK1 alteration", "CHEK2 alteration", "FANCA alteration", "NBN alteration", "PALB2 alteration", "RAD51C alteration", "RAD51D alteration", "RAD51 alteration", "RAD51B alteration"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["CHEK2 Mutation", "CHEK2-Mutation", "gene"], ["RAD51C Mutation", "RAD51C-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["ARTN Mutation", "ARTN-Mutation", "gene"], ["RAD51B Mutation", "RAD51B-Mutation", "gene"], ["NBN Mutation", "NBN-Mutation", "gene"], ["BARD1 Mutation", "BARD1-Mutation", "gene"], ["FANCA Mutation", "FANCA-Mutation", "gene"], ["RAD51 Mutation", "RAD51-Mutation", "gene"], ["BRIP1 Mutation", "BRIP1-Mutation", "gene"], ["RAD51D Mutation", "RAD51D-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["CHEK1 Mutation", "CHEK1-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04418661", "json": [{"cohort": "Part 1", "disease_state": "advanced", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["KRAS mutations", "KRAS amplifications", "BRAF Class 3 mutations", "NF1 LOF mutations"], "histology_exclusion": ["primary central nervous system (CNS) tumors"], "biomarker_exclusion": []}, {"cohort": "Part 3A and 3B", "disease_state": "advanced", "histology_inclusion": "KRAS G12C NSCLC", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": ["primary central nervous system (CNS) tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["NF1 Mutation", "NF1-Mutation", "gene"], ["KRAS-High", "KRAS-High", "expression"], ["BRAF Class 3", "BRAF Class 3", "coordinate"]]}, {"cohort": "Part 3A and 3B", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT04809467", "json": [{"cohort": "Cohort 1: R/R DLBCL", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary or secondary CNS lymphoma"], "biomarker_exclusion": []}, {"cohort": "Cohort 2: R/R MCL", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["Cyclin D1 overexpression", "t(11;14)"], "histology_exclusion": ["Primary or secondary CNS lymphoma"], "biomarker_exclusion": []}, {"cohort": "Cohort 3: R/R FL", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Follicular Lymphoma Grade 1, 2, 3a", "biomarker_inclusion": [], "histology_exclusion": ["Primary or secondary CNS lymphoma"], "biomarker_exclusion": []}, {"cohort": "Cohort 4: R/R MZL", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Marginal Zone Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary or secondary CNS lymphoma"], "biomarker_exclusion": []}, {"cohort": "Cohort 5: R/R CLL/SLL", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary or secondary CNS lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1: R/R DLBCL", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}, {"cohort": "Cohort 2: R/R MCL", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["CCND1-High", "CCND1-High", "expression"]], "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}, {"cohort": "Cohort 3: R/R FL", "histology_inclusion": "Follicular Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}, {"cohort": "Cohort 4: R/R MZL", "histology_inclusion": "Marginal Zone Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}, {"cohort": "Cohort 5: R/R CLL/SLL", "histology_inclusion": "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}, {"cohort": "Cohort 5: R/R CLL/SLL", "histology_inclusion": "Small Lymphocytic Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}]}
{"NCT_id": "NCT05069935", "json": [{"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "head and neck squamous cell cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "microsatellite instability-high/mismatch repair deficient cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "gastric cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "esophageal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "cervical cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "merkel cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "endometrial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "tumor mutation burden-high", "biomarker_inclusion": ["TMB \u2265 10 mutations/megabase"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "cutaneous squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "triple-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "relapsed or progressed", "histology_inclusion": "HER2+ breast cancer", "biomarker_inclusion": ["HER2 \u22652+ IHC", "HER2 copy number \u22654 signals per cell"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "relapsed or progressed", "histology_inclusion": "HER2+ gastric cancer", "biomarker_inclusion": ["HER2 \u22652+ IHC", "HER2 copy number \u22654 signals per cell"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "progressed", "histology_inclusion": "HER2+ solid tumor", "biomarker_inclusion": ["HER2 \u22652+ IHC", "HER2 copy number \u22654 signals per cell"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort C", "disease_state": "progressed", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["KRAS mutation", "NRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort C", "disease_state": "progressed", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Cutaneous Melanoma"}, {"cohort": "Cohort A", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort A", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Cohort A", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "Cohort A", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Cohort A", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort A", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort A", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "Cohort A", "histology_inclusion": "Esophageal Carcinoma"}, {"cohort": "Cohort A", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "Cohort A", "histology_inclusion": "Merkel Cell Carcinoma"}, {"cohort": "Cohort A", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "Cohort A", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"], ["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Cohort A", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Cohort A", "histology_inclusion": "Skin Squamous Cell Carcinoma"}, {"cohort": "Cohort A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Cohort B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort B", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort B", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort C", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"]]}, {"cohort": "Cohort C", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT02675946", "json": [{"cohort": "Phase 1 Single Agent CGX1321 Dose Escalation phase", "disease_state": "locally advanced or metastatic solid tumors", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1 Single Agent CGX1321 Dose Expansion phase", "disease_state": "advanced GI tumors", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["Rspo2 fusion", "Rspo3 fusion", "loss-of-function mutations in RNF43"], "histology_exclusion": [], "biomarker_exclusion": ["APC", "CTNNB1", "Axin1"]}, {"cohort": "Phase 1 Single Agent CGX1321 Dose Expansion phase", "disease_state": "advanced GI tumors", "histology_inclusion": "gastric adenocarcinoma", "biomarker_inclusion": ["Rspo2 fusion", "Rspo3 fusion", "loss-of-function mutations in RNF43"], "histology_exclusion": [], "biomarker_exclusion": ["APC", "CTNNB1", "Axin1"]}, {"cohort": "Phase 1 Single Agent CGX1321 Dose Expansion phase", "disease_state": "advanced GI tumors", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": ["Rspo2 fusion", "Rspo3 fusion", "loss-of-function mutations in RNF43"], "histology_exclusion": [], "biomarker_exclusion": ["APC", "CTNNB1", "Axin1"]}, {"cohort": "Phase 1 Single Agent CGX1321 Dose Expansion phase", "disease_state": "advanced GI tumors", "histology_inclusion": "bile duct carcinoma", "biomarker_inclusion": ["Rspo2 fusion", "Rspo3 fusion", "loss-of-function mutations in RNF43"], "histology_exclusion": [], "biomarker_exclusion": ["APC", "CTNNB1", "Axin1"]}, {"cohort": "Phase 1 Single Agent CGX1321 Dose Expansion phase", "disease_state": "advanced GI tumors", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": ["Rspo2 fusion", "Rspo3 fusion", "loss-of-function mutations in RNF43"], "histology_exclusion": [], "biomarker_exclusion": ["APC", "CTNNB1", "Axin1"]}, {"cohort": "Phase 1 Single Agent CGX1321 Dose Expansion phase", "disease_state": "advanced GI tumors", "histology_inclusion": "esophageal carcinoma", "biomarker_inclusion": ["Rspo2 fusion", "Rspo3 fusion", "loss-of-function mutations in RNF43"], "histology_exclusion": [], "biomarker_exclusion": ["APC", "CTNNB1", "Axin1"]}, {"cohort": "Phase 1b or Roll-over Cohort CGX1321 in combination with pembrolizumab", "disease_state": "advanced colorectal tumors", "histology_inclusion": "colorectal tumors", "biomarker_inclusion": ["mismatch repair-proficient", "MSS", "Rspo2 fusion", "Rspo3 fusion", "loss-of-function mutations in RNF43"], "histology_exclusion": [], "biomarker_exclusion": ["APC", "CTNNB1", "Axin1"]}, {"cohort": "Phase 1b Cohort CGX1321 in Combination with Encorafenib + Cetuximab", "disease_state": "advanced colorectal tumors", "histology_inclusion": "colorectal tumors", "biomarker_inclusion": ["BRAF V600E mutation", "Rspo2 fusion", "Rspo3 fusion", "loss-of-function mutations in RNF43"], "histology_exclusion": [], "biomarker_exclusion": ["APC", "CTNNB1", "Axin1"]}], "json_norm": [{"cohort": "Phase 1 Single Agent CGX1321 Dose Escalation phase", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase 1 Single Agent CGX1321 Dose Expansion phase", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["RNF43 Mutation", "RNF43-Mutation", "gene"], ["RSPO3 Fusion", "RSPO3", "fusion"], ["RSPO2 Fusion", "RSPO2", "fusion"]]}, {"cohort": "Phase 1 Single Agent CGX1321 Dose Expansion phase", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["RNF43 Mutation", "RNF43-Mutation", "gene"], ["RSPO3 Fusion", "RSPO3", "fusion"], ["RSPO2 Fusion", "RSPO2", "fusion"]]}, {"cohort": "Phase 1 Single Agent CGX1321 Dose Expansion phase", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": [["RNF43 Mutation", "RNF43-Mutation", "gene"], ["RSPO3 Fusion", "RSPO3", "fusion"], ["RSPO2 Fusion", "RSPO2", "fusion"]]}, {"cohort": "Phase 1 Single Agent CGX1321 Dose Expansion phase", "histology_inclusion": "Bile Duct Neoplasm", "biomarker_inclusion": [["RNF43 Mutation", "RNF43-Mutation", "gene"], ["RSPO3 Fusion", "RSPO3", "fusion"], ["RSPO2 Fusion", "RSPO2", "fusion"]]}, {"cohort": "Phase 1 Single Agent CGX1321 Dose Expansion phase", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [["RNF43 Mutation", "RNF43-Mutation", "gene"], ["RSPO3 Fusion", "RSPO3", "fusion"], ["RSPO2 Fusion", "RSPO2", "fusion"]]}, {"cohort": "Phase 1 Single Agent CGX1321 Dose Expansion phase", "histology_inclusion": "Esophageal Carcinoma", "biomarker_inclusion": [["RNF43 Mutation", "RNF43-Mutation", "gene"], ["RSPO3 Fusion", "RSPO3", "fusion"], ["RSPO2 Fusion", "RSPO2", "fusion"]]}, {"cohort": "Phase 1b or Roll-over Cohort CGX1321 in combination with pembrolizumab", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["RNF43 Mutation", "RNF43-Mutation", "gene"], ["RSPO3 Fusion", "RSPO3", "fusion"], ["RSPO2 Fusion", "RSPO2", "fusion"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Phase 1b Cohort CGX1321 in Combination with Encorafenib + Cetuximab", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["RNF43 Mutation", "RNF43-Mutation", "gene"], ["BRAF V600E", "V600E", "coordinate"], ["RSPO3 Fusion", "RSPO3", "fusion"], ["RSPO2 Fusion", "RSPO2", "fusion"]]}]}
{"NCT_id": "NCT04120246", "json": [{"cohort": "", "disease_state": "Refractory HER2+ Metastatic Breast Cancer", "histology_inclusion": "HER2 Positive Breast Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04250545", "json": [{"cohort": "", "disease_state": "stage IV or recurrent/metastatic NSCLC", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose expansion", "disease_state": "stage IV or recurrent/metastatic NSCLC", "histology_inclusion": "Lung Squamous Cell Carcinoma", "biomarker_inclusion": ["NFE2L2 mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose expansion", "disease_state": "stage IV or recurrent/metastatic NSCLC", "histology_inclusion": "Lung Squamous Cell Carcinoma", "biomarker_inclusion": ["KEAP1 mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose expansion", "disease_state": "stage IV or recurrent/metastatic NSCLC", "histology_inclusion": "Non-squamous Non-small Cell Lung Cancer", "biomarker_inclusion": ["KRAS/KEAP1 co-mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose expansion", "disease_state": "stage IV or recurrent/metastatic NSCLC", "histology_inclusion": "Non-squamous Non-small Cell Lung Cancer", "biomarker_inclusion": ["KRAS/NFE2L2 co-mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose expansion", "disease_state": "stage IV or recurrent/metastatic NSCLC", "histology_inclusion": "Lung Squamous Cell Carcinoma", "biomarker_inclusion": ["WT for NFE2L2 or KEAP1"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Dose expansion", "histology_inclusion": "Squamous Cell Lung Carcinoma", "biomarker_inclusion": [["NFE2L2 Mutation", "NFE2L2-Mutation", "gene"]]}, {"cohort": "Dose expansion", "histology_inclusion": "Squamous Cell Lung Carcinoma", "biomarker_inclusion": [["KEAP1 Mutation", "KEAP1-Mutation", "gene"]]}, {"cohort": "Dose expansion", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["KEAP1 Mutation", "KEAP1-Mutation", "gene"]]}, {"cohort": "Dose expansion", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["NFE2L2 Mutation", "NFE2L2-Mutation", "gene"]]}, {"cohort": "Dose expansion", "histology_inclusion": "Squamous Cell Lung Carcinoma", "biomarker_inclusion": [["NFE2L2 NFE2L2-wild_type", "NFE2L2-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT05200143", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Cutaneous Melanoma"}]}
{"NCT_id": "NCT05460481", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR wild type", "ALK wild type", "ROS1 wild type"], "histology_exclusion": ["Small Cell Lung Cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["ALK ALK-wild_type", "ALK-wild_type", "wild_type"], ["ROS 1 ROS 1-wild_type", "ROS 1-wild_type", "wild_type"], ["ROS1 ROS1-wild_type", "ROS1-wild_type", "wild_type"]], "histology_exclusion": ["Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT03469011", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Papillary Thyroid Cancer", "biomarker_inclusion": ["Radioiodine-refractory"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Thyroid Gland Papillary Carcinoma"}]}
{"NCT_id": "NCT04120454", "json": [{"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "non-small cell carcinoma of the lung", "biomarker_inclusion": ["EGFR mutations"], "histology_exclusion": ["small cell or mixed (small cell/non-small cell) lung cancer"], "biomarker_exclusion": ["Exon 20 resistance mutations", "prior exposure to PD/PD-L1 inhibitors"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "histology_exclusion": ["Lung Carcinoma"]}]}
{"NCT_id": "NCT04250597", "json": [{"cohort": "", "disease_state": "advanced, unresectable, metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, unresectable, metastatic", "histology_inclusion": "hepatocellular cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, unresectable, metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, unresectable, metastatic", "histology_inclusion": "gastric cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, unresectable, metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, unresectable, metastatic", "histology_inclusion": "bladder cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, unresectable, metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, unresectable, metastatic", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, unresectable, metastatic", "histology_inclusion": "acral melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, unresectable, metastatic", "histology_inclusion": "mucosal melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, unresectable, metastatic", "histology_inclusion": "esophageal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, unresectable, metastatic", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, unresectable, metastatic", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, unresectable, metastatic", "histology_inclusion": "cervical cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, unresectable, metastatic", "histology_inclusion": "epithelial uterine cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "", "histology_inclusion": "Cutaneous Melanoma"}, {"cohort": "", "histology_inclusion": "Acral Lentiginous Melanoma"}, {"cohort": "", "histology_inclusion": "Mucosal Melanoma"}, {"cohort": "", "histology_inclusion": "Esophageal Carcinoma"}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "", "histology_inclusion": "Malignant Uterine Neoplasm"}]}
{"NCT_id": "NCT04809766", "json": [{"cohort": "Cohorts I, II, III, and IV", "disease_state": "metastatic", "histology_inclusion": "pancreatic ductal adenocarcinoma", "biomarker_inclusion": ["mesothelin (MSLN) expression", "HLA-A*02:01"], "histology_exclusion": [], "biomarker_exclusion": ["HLA B*1302"]}], "json_norm": [{"cohort": "Cohorts I, II, III, and IV", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma"}]}
{"NCT_id": "NCT04940052", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "differentiated thyroid cancer", "biomarker_inclusion": ["BRAFV600E mutation"], "histology_exclusion": ["anaplastic carcinoma of the thyroid", "medullary carcinoma of the thyroid"], "biomarker_exclusion": ["RET fusion positive"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Differentiated Thyroid Gland Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]], "histology_exclusion": ["Thyroid Gland Medullary Carcinoma", "Thyroid Gland Undifferentiated (Anaplastic) Carcinoma"], "biomarker_exclusion": [["RET Fusion", "RET", "fusion"], ["RET-High", "RET-High", "expression"]]}]}
{"NCT_id": "NCT05005182", "json": [{"cohort": "Cohort A", "disease_state": "Refractory or unlikely to respond", "histology_inclusion": "Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "Refractory or unlikely to respond", "histology_inclusion": "Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable", "biomarker_inclusion": [">= 15% Ring Sideroblasts"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis"}, {"cohort": "Cohort A", "histology_inclusion": "Myelodysplastic/Myeloproliferative Disease"}]}
{"NCT_id": "NCT05200442", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT03860207", "json": [{"cohort": "Phase I", "disease_state": "relapsed/refractory", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System tumor"], "biomarker_exclusion": []}, {"cohort": "Phase I", "disease_state": "relapsed/refractory", "histology_inclusion": "Osteosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System tumor"], "biomarker_exclusion": []}, {"cohort": "Phase I", "disease_state": "relapsed/refractory", "histology_inclusion": "GD2-expressing solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System tumor"], "biomarker_exclusion": []}, {"cohort": "Phase II Group 1", "disease_state": "chemorefractory/relapsed high-risk Neuroblastoma", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System tumor"], "biomarker_exclusion": []}, {"cohort": "Phase II Group 2", "disease_state": "relapsed/refractory", "histology_inclusion": "Osteosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase I", "histology_inclusion": "Neuroblastoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Phase I", "histology_inclusion": "Osteosarcoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Phase I", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Phase II Group 1", "histology_inclusion": "Neuroblastoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Phase II Group 2", "histology_inclusion": "Osteosarcoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT03925350", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["ARID1A", "ARID1B", "ARID2", "ATM", "ATR", "ATRX", "BARD1", "BRCA1", "BRCA2", "BAP1", "BRIP1", "CHEK2", "FANCD2", "MRN11A", "PALB2", "RAD50", "RAD51", "RAD54B"], "histology_exclusion": [], "biomarker_exclusion": ["PARP inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma"}]}
{"NCT_id": "NCT03990454", "json": [{"cohort": "", "disease_state": "advanced and/or metastatic or unresectable", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior use of any AXL inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04185831", "json": [{"cohort": "NF1/MAP2K1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["CNS malignancy"], "biomarker_exclusion": []}, {"cohort": "MTOR/TSC1/TSC2", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["CNS malignancy"], "biomarker_exclusion": []}, {"cohort": "Mutation burden", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["CNS malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "NF1/MAP2K1", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "MTOR/TSC1/TSC2", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Mutation burden", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT04250922", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "glioblastoma WHO Grade IV", "biomarker_inclusion": ["IDH1 wildtype"], "histology_exclusion": ["diffuse midline gliomas", "multifocal GBM"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "histology_exclusion": ["Glioblastoma"]}]}
{"NCT_id": "NCT04614636", "json": [{"cohort": "FT538 Monotherapy", "disease_state": "Primary refractory AML or Relapsed AML", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "FT538 in Combination with Daratumumab", "disease_state": "Relapsed or progressed MM after at least two lines of therapies", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": ["Plasma cell leukemia", "Leptomeningeal involvement of MM"], "biomarker_exclusion": []}, {"cohort": "FT538 in Combination with Elotuzumab", "disease_state": "Relapsed or progressed MM after proteasome inhibitor therapy and immunomodulatory therapy", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": ["Plasma cell leukemia", "Leptomeningeal involvement of MM"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "FT538 Monotherapy", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "FT538 in Combination with Daratumumab", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Plasma Cell Leukemia"]}, {"cohort": "FT538 in Combination with Elotuzumab", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Plasma Cell Leukemia"]}]}
{"NCT_id": "NCT04744831", "json": [{"cohort": "", "disease_state": "unresectable, recurrent, or metastatic colorectal adenocarcinoma", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["HER2-overexpressing", "BRAF wild-type", "RAS wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-high", "dMMR", "TMB-high"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]], "biomarker_exclusion": [["TMB", "TMB", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}]}
{"NCT_id": "NCT04940299", "json": [{"cohort": "Cohort 1", "disease_state": "Stage III (unresectable) or Stage IV", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": ["Uveal Melanoma", "Mucosal Melanoma"], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Locally Advanced or Metastatic", "histology_inclusion": "Transitional Cell Carcinoma of the Urothelium", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "Locally Advanced or Metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Melanoma", "histology_exclusion": ["Mucosal Melanoma", "Intraocular Melanoma"]}, {"cohort": "Cohort 2", "histology_inclusion": "Transitional Cell Carcinoma"}, {"cohort": "Cohort 3", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT02611024", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Soft Tissue Sarcoma (Excluding GIST)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Epithelial Ovarian Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Mesothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Gastroenteropancreatic Neuroendocrine Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Small Cell Lung Cancer (SCLC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Neuroendocrine Tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Soft Tissue Sarcoma"}, {"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor"}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Mesothelioma"}, {"cohort": "", "histology_inclusion": "Digestive System Neuroendocrine Tumor"}, {"cohort": "", "histology_inclusion": "Digestive System Neuroendocrine Neoplasm"}, {"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "", "histology_inclusion": "Neuroendocrine Carcinoma"}, {"cohort": "", "histology_inclusion": "Lung Neuroendocrine Neoplasm"}, {"cohort": "", "histology_inclusion": "Neuroendocrine Tumor"}]}
{"NCT_id": "NCT03404193", "json": [{"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Acute Promyelocytic Leukemia"], "biomarker_exclusion": ["t(15;17)"]}, {"cohort": "", "disease_state": "Relapsed", "histology_inclusion": "High-Risk Myelodysplastic Syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Blastic Plasmacytoid Dendritic Cell Neoplasm", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Mixed Phenotype Acute Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Newly Diagnosed", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["Poor risk complex karyotype", "TP53 deletions/mutations"], "histology_exclusion": ["Acute Promyelocytic Leukemia"], "biomarker_exclusion": ["t(15;17)"]}, {"cohort": "", "disease_state": "Newly Diagnosed", "histology_inclusion": "High-Risk Myelodysplastic Syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Newly Diagnosed", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": ["Bone marrow blasts >= 10%"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Blastic Plasmacytoid Dendritic Cell Neoplasm"}, {"cohort": "", "histology_inclusion": "Mixed Phenotype Acute Leukemia"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia"}]}
{"NCT_id": "NCT03599752", "json": [{"cohort": "", "disease_state": "Stage IV, Stage IVA, Stage IVB, Stage IVC", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma"}]}
{"NCT_id": "NCT04185883", "json": [{"cohort": "", "disease_state": "locally-advanced or metastatic", "histology_inclusion": "advanced solid tumors", "biomarker_inclusion": ["KRAS p.G12C mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]], "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT04316182", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Fibrolamellar carcinoma", "mixed hepatocellular cholangiocarcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma", "histology_exclusion": ["Fibrolamellar Carcinoma", "Combined Hepatocellular Carcinoma and Cholangiocarcinoma"]}]}
{"NCT_id": "NCT04614740", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic solid tumors", "histology_inclusion": "salivary gland cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic solid tumors", "histology_inclusion": "thyroid cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic solid tumors", "histology_inclusion": "soft tissue sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic solid tumors", "histology_inclusion": "liposarcoma", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Salivary Gland Neoplasm", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_inclusion": "Salivary Gland Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_inclusion": "Thyroid Gland Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_inclusion": "Soft Tissue Sarcoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_inclusion": "Liposarcoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT05656248", "json": [{"cohort": "", "disease_state": "Secondary Myeloid Neoplasms", "histology_inclusion": "Treatment-related MDS/AML", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Secondary Myeloid Neoplasms", "histology_inclusion": "Secondary MDS/AML", "biomarker_inclusion": ["GATA2", "RUNX1", "SAMD9", "SAMD9L", "ERCC6L2", "NF1", "ETV6", "ANKRD26", "ERCC6L2", "TP53", "CEBPA"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Secondary Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}]}
{"NCT_id": "NCT03990896", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["somatic BRCA 1 mutation", "somatic BRCA 2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["germline BRCA 1 mutation", "germline BRCA 2 mutation", "VUS", "non-functional BRCA mutation"]}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": ["somatic BRCA 1 mutation", "somatic BRCA 2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["germline BRCA 1 mutation", "germline BRCA 2 mutation", "VUS", "non-functional BRCA mutation"]}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "hormone receptor positive, HER2 negative breast cancer", "biomarker_inclusion": ["somatic BRCA 1 mutation", "somatic BRCA 2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["germline BRCA 1 mutation", "germline BRCA 2 mutation", "VUS", "non-functional BRCA mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]], "biomarker_exclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]], "biomarker_exclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]], "biomarker_exclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]], "biomarker_exclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["PGR-High", "PGR-High", "expression"], ["ESR1-High", "ESR1-High", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]], "biomarker_exclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04940637", "json": [{"cohort": "", "disease_state": "advanced (stage IV)", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["PD-L1 expression (TPS \u2265 1%)", "germline or somatic HRd status"], "histology_exclusion": ["known EGFR-sensitizing mutation", "ALK/ROS1 rearrangements", "symptomatic brain or leptomeningeal metastases"], "biomarker_exclusion": ["prior treatment with a PARP inhibitor"]}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "malignant pleural mesothelioma", "biomarker_inclusion": ["PD-L1 expression (TPS \u2265 1%)", "germline or somatic HRd status"], "histology_exclusion": ["symptomatic brain or leptomeningeal metastases"], "biomarker_exclusion": ["prior treatment with a PARP inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Pleural Malignant Mesothelioma"}]}
{"NCT_id": "NCT05005728", "json": [{"cohort": "Cohort A - AVPCa", "disease_state": "metastatic castration-resistant prostate cancer", "histology_inclusion": "carcinoma of the prostate", "biomarker_inclusion": ["Aggressive variant prostate cancer"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B - HRD/CDK12 PARP - Progressors", "disease_state": "metastatic castration-resistant prostate cancer", "histology_inclusion": "carcinoma of the prostate", "biomarker_inclusion": ["Homologous recombination deficient (HRD) tumor"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort C - HRD/CDK12 PARP Na\u00efve", "disease_state": "metastatic castration-resistant prostate cancer", "histology_inclusion": "carcinoma of the prostate", "biomarker_inclusion": ["Homologous recombination deficient (HRD) tumor"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort D - MSI-H, MMRD or TMB-H", "disease_state": "metastatic castration-resistant prostate cancer", "histology_inclusion": "carcinoma of the prostate", "biomarker_inclusion": ["Microsatellite instability-high (MSI-H)", "mismatch repair deficient (MMRD) tumors", "TMB-H (\u2265 10 mut/Mb)"], "histology_exclusion": [], "biomarker_exclusion": ["Grade 4 immune-mediated adverse events related to prior immunotherapy"]}, {"cohort": "Cohort E - No Targetable Mutations", "disease_state": "metastatic castration-resistant prostate cancer", "histology_inclusion": "carcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A - AVPCa", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Cohort A - AVPCa", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Cohort B - HRD/CDK12 PARP - Progressors", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Cohort B - HRD/CDK12 PARP - Progressors", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Cohort C - HRD/CDK12 PARP Na\u00efve", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Cohort C - HRD/CDK12 PARP Na\u00efve", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Cohort D - MSI-H, MMRD or TMB-H", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Cohort D - MSI-H, MMRD or TMB-H", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Cohort E - No Targetable Mutations", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Cohort E - No Targetable Mutations", "histology_inclusion": "Prostate Carcinoma"}]}
{"NCT_id": "NCT05005845", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Neurofibromatosis 1", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Cutaneous Neurofibroma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}, {"cohort": "", "histology_inclusion": "Neurofibroma"}]}
{"NCT_id": "NCT05135975", "json": [{"cohort": "Stratum 1: Neuroblastoma", "disease_state": "", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 2: Central nervous system (CNS) tumors", "disease_state": "", "histology_inclusion": "Atypical teratoid rhabdoid tumors (ATRT)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 2: Central nervous system (CNS) tumors", "disease_state": "", "histology_inclusion": "Diffuse intrinsic pontine glioma (DIPG)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 2: Central nervous system (CNS) tumors", "disease_state": "", "histology_inclusion": "Diffuse midline gliomas (DMG)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 2: Central nervous system (CNS) tumors", "disease_state": "", "histology_inclusion": "High grade gliomas (HGG, WHO Grade 3 or 4 astrocytomas)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 2: Central nervous system (CNS) tumors", "disease_state": "", "histology_inclusion": "Medulloblastoma", "biomarker_inclusion": ["MYC/MYCN amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 2: Central nervous system (CNS) tumors", "disease_state": "", "histology_inclusion": "Medulloblastoma", "biomarker_inclusion": ["SHH molecular subtype", "TP53 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 2: Central nervous system (CNS) tumors", "disease_state": "", "histology_inclusion": "Germ Cell tumor of the CNS", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 3: Sarcomas and other solid tumors", "disease_state": "", "histology_inclusion": "Malignant rhabdoid Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 3: Sarcomas and other solid tumors", "disease_state": "", "histology_inclusion": "Osteosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 3: Sarcomas and other solid tumors", "disease_state": "", "histology_inclusion": "Ewing sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 3: Sarcomas and other solid tumors", "disease_state": "", "histology_inclusion": "Rhabdomyosarcoma", "biomarker_inclusion": ["alveolar subtype", "fusion-positive subtype"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 3: Sarcomas and other solid tumors", "disease_state": "", "histology_inclusion": "Rhabdomyosarcoma", "biomarker_inclusion": ["embryonal subtype"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 3: Sarcomas and other solid tumors", "disease_state": "", "histology_inclusion": "Desmoplastic small round blue cell tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 3: Sarcomas and other solid tumors", "disease_state": "", "histology_inclusion": "Germ cell tumors outside the CNS", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 3: Sarcomas and other solid tumors", "disease_state": "", "histology_inclusion": "Wilms tumor", "biomarker_inclusion": ["diffuse anaplasia histology"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 3: Sarcomas and other solid tumors", "disease_state": "", "histology_inclusion": "Wilms tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Stratum 1: Neuroblastoma", "histology_inclusion": "Neuroblastoma"}, {"cohort": "Stratum 2: Central nervous system (CNS) tumors", "histology_inclusion": "Rhabdoid Tumor"}, {"cohort": "Stratum 2: Central nervous system (CNS) tumors", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma"}, {"cohort": "Stratum 2: Central nervous system (CNS) tumors"}, {"cohort": "Stratum 2: Central nervous system (CNS) tumors"}, {"cohort": "Stratum 2: Central nervous system (CNS) tumors", "histology_inclusion": "Medulloblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]]}, {"cohort": "Stratum 2: Central nervous system (CNS) tumors", "histology_inclusion": "Medulloblastoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Stratum 2: Central nervous system (CNS) tumors", "histology_inclusion": "Central Nervous System Germ Cell Tumor"}, {"cohort": "Stratum 3: Sarcomas and other solid tumors", "histology_inclusion": "Rhabdoid Tumor"}, {"cohort": "Stratum 3: Sarcomas and other solid tumors", "histology_inclusion": "Osteosarcoma"}, {"cohort": "Stratum 3: Sarcomas and other solid tumors", "histology_inclusion": "Ewing Sarcoma"}, {"cohort": "Stratum 3: Sarcomas and other solid tumors", "histology_inclusion": "Rhabdomyosarcoma"}, {"cohort": "Stratum 3: Sarcomas and other solid tumors", "histology_inclusion": "Rhabdomyosarcoma"}, {"cohort": "Stratum 3: Sarcomas and other solid tumors"}, {"cohort": "Stratum 3: Sarcomas and other solid tumors", "histology_inclusion": "Germ Cell Tumor"}, {"cohort": "Stratum 3: Sarcomas and other solid tumors", "histology_inclusion": "Wilms Tumor"}, {"cohort": "Stratum 3: Sarcomas and other solid tumors", "histology_inclusion": "Wilms Tumor"}]}
{"NCT_id": "NCT05461261", "json": [{"cohort": "", "disease_state": "Metastatic Hormone-sensitive", "histology_inclusion": "Prostate Cancer", "biomarker_inclusion": ["ATM", "BARD1", "BRCA1", "BRCA2", "BRIP1", "CDK12", "CHEK1", "CHEK2", "FANCL", "PALB2", "RAD51B", "RAD51C", "RAD51D", "RAD54L", "EPCAM", "MLH1", "MSH2", "MSH6", "PMS2"], "histology_exclusion": ["Neuroendocrine", "Small Cell", "Signet Ring Cell"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma"}]}
{"NCT_id": "NCT01434316", "json": [{"cohort": "", "disease_state": "Advanced", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": [], "histology_exclusion": ["CNS Metastases", "Brain Metastases"], "biomarker_exclusion": []}, {"cohort": "BRCA-deficient", "disease_state": "Advanced", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": ["BRCA1 germline mutation", "BRCA2 germline mutation", "somatic BRCA mutation"], "histology_exclusion": ["CNS Metastases", "Brain Metastases"], "biomarker_exclusion": ["SCH727965"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "BRCA-deficient", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04251533", "json": [{"cohort": "Part A", "disease_state": "advanced (loco-regionally recurrent and not amenable to curative therapy, or metastatic (stage IV))", "histology_inclusion": "Triple Negative Breast Cancer", "biomarker_inclusion": ["PIK3CA mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with any PI3K, mTOR or AKT inhibitor"]}, {"cohort": "Part B1", "disease_state": "advanced (loco-regionally recurrent and not amenable to curative therapy, or metastatic (stage IV))", "histology_inclusion": "Triple Negative Breast Cancer", "biomarker_inclusion": ["PTEN loss"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with any PI3K, mTOR or AKT inhibitor"]}, {"cohort": "Part B2", "disease_state": "advanced (loco-regionally recurrent and not amenable to curative therapy, or metastatic (stage IV))", "histology_inclusion": "Triple Negative Breast Cancer", "biomarker_inclusion": ["PTEN loss", "no PIK3CA mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with any PI3K, mTOR or AKT inhibitor"]}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "Part B1", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["PTEN-Low", "PTEN-Low", "expression"]]}, {"cohort": "Part B2", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["PTEN-Low", "PTEN-Low", "expression"]]}]}
{"NCT_id": "NCT04354727", "json": [{"cohort": "", "disease_state": "intermediate-2 or high-risk myelofibrosis by IPSS scoring system; intermediate-1 myelofibrosis with palpable splenomegaly \u2265 5 cm below left costal margin; chronic phase (CP) or accelerated phase (AP)", "histology_inclusion": "myelofibrosis", "biomarker_inclusion": ["JAK2 wild type", "JAK2V617F mutated"], "histology_exclusion": ["metastatic carcinoma", "lymphoma", "myelodysplasia", "hairy cell leukemia", "mast cell disease", "acute leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Myelofibrosis", "biomarker_inclusion": [["JAK2 JAK2-wild_type", "JAK2-wild_type", "wild_type"], ["JAK2 V617F", "V617F", "coordinate"]], "histology_exclusion": ["Mastocytosis", "Lymphoma", "Hairy Cell Leukemia", "Acute Leukemia"]}]}
{"NCT_id": "NCT04615312", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "digestive system tumor", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Digestive System Neoplasm", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Digestive System Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT05071183", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT05071209", "json": [{"cohort": "Part A", "disease_state": "recurrent or refractory", "histology_inclusion": "Alveolar Rhabdomyosarcoma", "biomarker_inclusion": ["PAX3-FOXO1 fusion"], "histology_exclusion": ["CNS primary"], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "recurrent or refractory", "histology_inclusion": "non-CNS primary solid tumor including lymphoma", "biomarker_inclusion": ["ATM", "ATRX", "BRCA1", "BRCA2", "CDK12", "CHEK1", "CHEK2", "FANCA", "MSH2", "MRE11", "PALB2", "PARP1", "POLD1", "RAD51", "XRCC2"], "histology_exclusion": ["CNS primary"], "biomarker_exclusion": []}, {"cohort": "Part B1", "disease_state": "recurrent or refractory", "histology_inclusion": "Ewing Sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS primary"], "biomarker_exclusion": []}, {"cohort": "Part B2", "disease_state": "recurrent or refractory", "histology_inclusion": "Alveolar Rhabdomyosarcoma", "biomarker_inclusion": ["PAX3-FOXO1 fusion"], "histology_exclusion": ["CNS primary"], "biomarker_exclusion": []}, {"cohort": "Part B3", "disease_state": "recurrent or refractory", "histology_inclusion": "non-CNS primary solid tumor including lymphoma", "biomarker_inclusion": ["ATM", "ATRX", "BRCA1", "BRCA2", "CDK12", "CHEK1", "CHEK2", "FANCA", "MSH2", "MRE11", "PALB2", "PARP1", "POLD1", "RAD51", "XRCC2"], "histology_exclusion": ["CNS primary"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Alveolar Rhabdomyosarcoma", "biomarker_inclusion": [["PAX3 - FOXO1", "PAX3 - FOXO1", "coordinate"], ["PAX3 Fusion", "PAX3", "fusion"], ["FOXO1 Fusion", "FOXO1", "fusion"]]}, {"cohort": "Part A", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part B1", "histology_inclusion": "Ewing Sarcoma"}, {"cohort": "Part B2", "histology_inclusion": "Alveolar Rhabdomyosarcoma", "biomarker_inclusion": [["PAX3 - FOXO1", "PAX3 - FOXO1", "coordinate"], ["PAX3 Fusion", "PAX3", "fusion"], ["FOXO1 Fusion", "FOXO1", "fusion"]]}, {"cohort": "Part B3", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT05136196", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally recurrent or metastatic", "histology_inclusion": "squamous cell carcinoma of the head and neck (HNSCC)", "biomarker_inclusion": [], "histology_exclusion": ["nasopharynx", "unknown primary tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT05201183", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["extramedullary disease"], "biomarker_exclusion": ["duration of first CR < 6 months", "poor risk karyotype", "circulating peripheral blood blasts"]}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Acute Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["primary refractory or first relapse", "bone marrow blasts > 25%", "age > 40 years"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "Myelodysplasia", "biomarker_inclusion": ["IPSS-R > 4.5"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "accelerated phase", "histology_inclusion": "Chronic Myelogenous Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["10-19% blasts in peripheral blood white cells or bone marrow", "peripheral blood basophils at least 20%", "persistent thrombocytopenia", "persistent thrombocytosis unresponsive to therapy", "cytogenetic evidence of clonal evolution"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive"}]}
{"NCT_id": "NCT03209401", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": ["ARID1A mutation", "ATM mutation", "ATRX mutation", "MRE11A mutation", "NBN mutation", "PTEN mutation", "RAD50 mutation", "RAD51 mutation", "RAD51B mutation", "BARD1 mutation", "BLM mutation", "BRCA1 mutation", "BRCA2 mutation", "BRIP1 mutation", "FANCA mutation", "FANCC mutation", "FANCD2 mutation", "FANCE mutation", "FANCF mutation", "FANCG mutation", "FANCL mutation", "PALB2 mutation", "WRN mutation", "CHEK2 mutation", "CHEK1 mutation", "BAP1 mutation", "FAM175A mutation", "SLX4 mutation", "MLL2 mutation", "XRCC mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior disease progression while receiving platinum chemotherapy", "platinum chemotherapy within the last 6 months", "prior PARP inhibitor-based therapy"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["RAD50 Mutation", "RAD50-Mutation", "gene"], ["WRN Mutation", "WRN-Mutation", "gene"], ["BARD1 Mutation", "BARD1-Mutation", "gene"], ["BRIP1 Mutation", "BRIP1-Mutation", "gene"], ["FANCD2 Mutation", "FANCD2-Mutation", "gene"], ["MAGI1 Mutation", "MAGI1-Mutation", "gene"], ["KMT2D Mutation", "KMT2D-Mutation", "gene"], ["CHEK2 Mutation", "CHEK2-Mutation", "gene"], ["ABRAXAS1 Mutation", "ABRAXAS1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BLM Mutation", "BLM-Mutation", "gene"], ["KMT2B Mutation", "KMT2B-Mutation", "gene"], ["RAD51 Mutation", "RAD51-Mutation", "gene"], ["FANCE Mutation", "FANCE-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["FANCC Mutation", "FANCC-Mutation", "gene"], ["SLX4 Mutation", "SLX4-Mutation", "gene"], ["RAD51B Mutation", "RAD51B-Mutation", "gene"], ["RNF2 Mutation", "RNF2-Mutation", "gene"], ["FANCF Mutation", "FANCF-Mutation", "gene"], ["ARID1A Mutation", "ARID1A-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["CHEK1 Mutation", "CHEK1-Mutation", "gene"], ["ATRX Mutation", "ATRX-Mutation", "gene"], ["ARTN Mutation", "ARTN-Mutation", "gene"], ["MRE11 Mutation", "MRE11-Mutation", "gene"], ["NBN Mutation", "NBN-Mutation", "gene"], ["FANCA Mutation", "FANCA-Mutation", "gene"], ["FANCL Mutation", "FANCL-Mutation", "gene"], ["BAP1 Mutation", "BAP1-Mutation", "gene"], ["FANCG Mutation", "FANCG-Mutation", "gene"]]}]}
{"NCT_id": "NCT04121455", "json": [{"cohort": "Dose Escalation Cohorts", "disease_state": "", "histology_inclusion": "Newly diagnosed, histologically confirmed, supratentorial WHO grade IV glioblastoma", "biomarker_inclusion": ["Unmethylated MGMT promoter status"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Group", "disease_state": "", "histology_inclusion": "Newly diagnosed, histologically confirmed, supratentorial WHO grade IV glioblastoma", "biomarker_inclusion": ["Unmethylated MGMT promoter status"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Escalation Cohorts", "histology_inclusion": "Glioblastoma"}, {"cohort": "Expansion Group", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT04186637", "json": [{"cohort": "Part A (Dose Escalation)", "disease_state": "locally advanced or metastatic unresectable solid tumor", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": []}, {"cohort": "Part B (Dose Expansion)", "disease_state": "metastatic cutaneous melanoma", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": []}, {"cohort": "Part B (Dose Expansion)", "disease_state": "PD-L1-positive cancers (other than cutaneous melanoma or renal cell carcinoma)", "histology_inclusion": "", "biomarker_inclusion": ["PD-L1-positive"], "histology_exclusion": ["cutaneous melanoma", "renal cell carcinoma", "central nervous system metastases"], "biomarker_exclusion": []}, {"cohort": "Part B (Dose Expansion)", "disease_state": "metastatic renal cell carcinoma", "histology_inclusion": "renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A (Dose Escalation)", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part B (Dose Expansion)", "histology_inclusion": "Cutaneous Melanoma"}, {"cohort": "Part B (Dose Expansion)", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"]], "histology_exclusion": ["Renal Cell Carcinoma", "Cutaneous Melanoma"]}, {"cohort": "Part B (Dose Expansion)", "histology_inclusion": "Renal Cell Carcinoma"}]}
{"NCT_id": "NCT03730948", "json": [{"cohort": "All subjects", "disease_state": "stage I and II", "histology_inclusion": "hypermutated colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "All subjects", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["TMB-High", "TMB-High", "coordinate"]]}]}
{"NCT_id": "NCT02611973", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Essential Thrombocythemia", "biomarker_inclusion": ["JAK2V617F"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Essential Thrombocythemia", "biomarker_inclusion": [["JAK2 V617F", "V617F", "coordinate"]]}]}
{"NCT_id": "NCT03600701", "json": [{"cohort": "Cohort 1", "disease_state": "Metastatic, Recurrent, or Refractory", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR sensitizing alteration", "ALK sensitizing alteration", "ROS1 sensitizing alteration"]}, {"cohort": "Cohort 2", "disease_state": "Metastatic, Recurrent, or Refractory", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["KRAS wild type"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR sensitizing alteration", "ALK sensitizing alteration", "ROS1 sensitizing alteration"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]], "biomarker_exclusion": [["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"]], "biomarker_exclusion": [["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"]]}]}
{"NCT_id": "NCT04121676", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Specific Melanoma Criteria", "disease_state": "Progression on or within 24 weeks of stopping treatment with a PD-1/PD-L1", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["BRAF V600-positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Specific Melanoma Criteria", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["BRAF-High", "BRAF-High", "expression"]]}]}
{"NCT_id": "NCT04317105", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "malignancy", "biomarker_inclusion": ["PIK3CA hotspot (E542, E545, or H1047)", "PTEN"], "histology_exclusion": [], "biomarker_exclusion": ["PD-1/PD-L1/PI3K inhibitors"]}], "json_norm": [{"cohort": ""}]}
{"NCT_id": "NCT04550494", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["DNA damage response (DDR) gene aberrations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Ovarian Cancer", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["platinum-sensitive", "gBRCAm"], "histology_exclusion": ["platinum-refractory"], "biomarker_exclusion": []}, {"cohort": "Pancreatic Cancer", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["prior platinum-containing therapy"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Breast Cancer", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "HER2+ breast cancer", "biomarker_inclusion": ["2 prior systemic lines of therapy in metastatic setting", "anti-HER2 therapy"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Gastric Cancer", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "HER2+ gastric cancer", "biomarker_inclusion": ["anti-HER2 therapy in metastatic setting"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Prostate Cancer", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["castration resistant", "castrate levels of testosterone (< 50 ng/dL [1.74 nmol/L])"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "Ovarian Cancer", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Ovarian Cancer", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "Pancreatic Cancer", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "Breast Cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Gastric Cancer", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Prostate Cancer", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Prostate Cancer", "histology_inclusion": "Prostate Carcinoma"}]}
{"NCT_id": "NCT04811001", "json": [{"cohort": "", "disease_state": "stage IIIB/IV", "histology_inclusion": "Non Small-Cell Lung Cancer", "biomarker_inclusion": ["EGFR exon 19 deletion", "EGFR exon 21 L858R", "EGFR exon 21 L861Q", "EGFR exon 18 G719S", "EGFR exon 18 G719A", "EGFR exon 18 G719C", "EGFR exon 20 S768I", "EGFR exon 20 V769L"], "histology_exclusion": [], "biomarker_exclusion": ["KRAS mutations", "HER2 mutations", "ALK rearrangements", "ROS1 rearrangements", "MET mutations", "BRAF mutations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR V769L", "V769L", "coordinate"], ["EGFR G719A", "G719A", "coordinate"], ["EGFR L861Q", "L861Q", "coordinate"], ["EGFR G719C", "G719C", "coordinate"], ["EGFR G719S", "G719S", "coordinate"], ["EGFR L858R", "L858R", "coordinate"], ["EGFR S768I", "S768I", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]], "biomarker_exclusion": [["MET Mutation", "MET-Mutation", "gene"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["SLTM Mutation", "SLTM-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"]]}]}
{"NCT_id": "NCT04811027", "json": [{"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "HNSCC of the oral cavity, oropharynx, hypopharynx, or larynx", "biomarker_inclusion": ["PD-L1 positive (CPS \u22651)"], "histology_exclusion": ["HNSCC of unknown primary", "squamous cell carcinoma originating from skin", "non-squamous histologies (e.g. nasopharynx, salivary gland or mucosal melanoma)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "HNSCC of the oral cavity, oropharynx, hypopharynx, or larynx", "biomarker_inclusion": ["PD-L1 negative (CPS <1)"], "histology_exclusion": ["HNSCC of unknown primary", "squamous cell carcinoma originating from skin", "non-squamous histologies (e.g. nasopharynx, salivary gland or mucosal melanoma)"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"]], "histology_exclusion": ["Head and Neck Squamous Cell Carcinoma", "Mucosal Melanoma", "Squamous Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["CD274-Low", "CD274-Low", "expression"]], "histology_exclusion": ["Head and Neck Squamous Cell Carcinoma", "Mucosal Melanoma", "Squamous Cell Carcinoma"]}]}
{"NCT_id": "NCT05396859", "json": [{"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["TP53 mutation"], "histology_exclusion": ["Acute promyelocytic leukemia (M3)", "isolated myeloid sarcoma", "active central nervous system (CNS) involvement by AML"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Myeloid Sarcoma", "Acute Myeloid Leukemia (AML)"]}]}
{"NCT_id": "NCT03600883", "json": [{"cohort": "", "disease_state": "locally-advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["KRAS p.G12C mutation"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT03796273", "json": [{"cohort": "primary cohort", "disease_state": "", "histology_inclusion": "primary breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["ependymoma"], "biomarker_exclusion": []}, {"cohort": "exploratory cohort", "disease_state": "recurrent or progressive", "histology_inclusion": "astrocytoma", "biomarker_inclusion": [], "histology_exclusion": ["ependymoma"], "biomarker_exclusion": []}, {"cohort": "exploratory cohort", "disease_state": "recurrent or progressive", "histology_inclusion": "oligodendroglioma", "biomarker_inclusion": [], "histology_exclusion": ["ependymoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "primary cohort", "histology_inclusion": "Breast Carcinoma", "histology_exclusion": ["Ependymoma"]}, {"cohort": "exploratory cohort", "histology_inclusion": "Astrocytoma", "histology_exclusion": ["Ependymoma"]}, {"cohort": "exploratory cohort", "histology_inclusion": "Oligodendroglioma", "histology_exclusion": ["Ependymoma"]}]}
{"NCT_id": "NCT05527184", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": ["endometrioid", "clear cell", "mucinous", "sarcomatous histology", "mixed tumors containing any of the above histologies", "low-grade/borderline ovarian tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "high-grade serous epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["endometrioid", "clear cell", "mucinous", "sarcomatous histology", "mixed tumors containing any of the above histologies", "low-grade/borderline ovarian tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": ["endometrioid", "clear cell", "mucinous", "sarcomatous histology", "mixed tumors containing any of the above histologies", "low-grade/borderline ovarian tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": ["endometrioid", "clear cell", "mucinous", "sarcomatous histology", "mixed tumors containing any of the above histologies", "low-grade/borderline ovarian tumor"], "biomarker_exclusion": []}, {"cohort": "Expansion Phase", "disease_state": "recurrent", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": ["endometrioid", "clear cell", "mucinous", "sarcomatous histology", "mixed tumors containing any of the above histologies", "low-grade/borderline ovarian tumor"], "biomarker_exclusion": []}, {"cohort": "Expansion Phase", "disease_state": "platinum-resistant", "histology_inclusion": "high-grade serous epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["endometrioid", "clear cell", "mucinous", "sarcomatous histology", "mixed tumors containing any of the above histologies", "low-grade/borderline ovarian tumor"], "biomarker_exclusion": []}, {"cohort": "Expansion Phase", "disease_state": "platinum-resistant", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": ["endometrioid", "clear cell", "mucinous", "sarcomatous histology", "mixed tumors containing any of the above histologies", "low-grade/borderline ovarian tumor"], "biomarker_exclusion": []}, {"cohort": "Expansion Phase", "disease_state": "platinum-resistant", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": ["endometrioid", "clear cell", "mucinous", "sarcomatous histology", "mixed tumors containing any of the above histologies", "low-grade/borderline ovarian tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm"]}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm"]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm"]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm"]}, {"cohort": "Expansion Phase", "histology_inclusion": "Endometrial Carcinoma", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm"]}, {"cohort": "Expansion Phase", "histology_inclusion": "Ovarian Epithelial Cancer", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm"]}, {"cohort": "Expansion Phase", "histology_inclusion": "Primary Peritoneal Carcinoma", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm"]}, {"cohort": "Expansion Phase", "histology_inclusion": "Fallopian Tube Carcinoma", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm"]}]}
{"NCT_id": "NCT03144765", "json": [{"cohort": "taTME", "disease_state": "cT1 (high-risk), T2, or T3, cN0, N1, N2", "histology_inclusion": "adenocarcinoma of the rectal", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["cT4"]}], "json_norm": [{"cohort": "taTME", "histology_inclusion": "Rectal Adenocarcinoma"}]}
{"NCT_id": "NCT03926624", "json": [{"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "Acute Myelogenous Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT03991819", "json": [{"cohort": "", "disease_state": "metastatic or advanced NSCLC (stage IV or incurable stage III)", "histology_inclusion": "non-small cell lung carcinoma", "biomarker_inclusion": ["PDL-1 TPS\u226550%", "EGFR wild-type", "ALK-rearrangement negative"], "histology_exclusion": ["neuroendocrine (carcinoid) carcinoma", "small cell carcinoma", "mixed small cell and non-small cell carcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["ALK-Low", "ALK-Low", "expression"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["ALK Fusion", "ALK", "fusion"]], "histology_exclusion": ["Small Cell Carcinoma"]}]}
{"NCT_id": "NCT03991832", "json": [{"cohort": "Cohort A", "disease_state": "", "histology_inclusion": "diffuse astrocytic and oligodendroglial tumors", "biomarker_inclusion": ["IDH mutant"], "histology_exclusion": ["glioma", "central nervous system (CNS) metastases"], "biomarker_exclusion": ["PARP inhibitor", "PD-1/PD-L1 inhibitors"]}, {"cohort": "Cohort B", "disease_state": "", "histology_inclusion": "adenocarcinoma of the biliary tract", "biomarker_inclusion": ["IDH mutant"], "histology_exclusion": ["central nervous system (CNS) metastases"], "biomarker_exclusion": ["PARP inhibitor", "PD-1/PD-L1 inhibitors"]}], "json_norm": [{"cohort": "Cohort A", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]], "histology_exclusion": ["Glioma"]}, {"cohort": "Cohort B", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04056910", "json": [{"cohort": "", "disease_state": "advanced solid tumor", "histology_inclusion": "", "biomarker_inclusion": ["IDH1 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior IDH inhibitor"]}, {"cohort": "", "disease_state": "glioma", "histology_inclusion": "contrast enhancing disease", "biomarker_inclusion": ["IDH1 mutation", "WHO 2016 grade II"], "histology_exclusion": [], "biomarker_exclusion": ["prior IDH inhibitor"]}, {"cohort": "", "disease_state": "solid tumor", "histology_inclusion": "", "biomarker_inclusion": ["IDH1 mutation"], "histology_exclusion": ["symptomatic brain metastases"], "biomarker_exclusion": ["prior IDH inhibitor"]}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04187105", "json": [{"cohort": "", "disease_state": "relapsed or refractory acute leukemia", "histology_inclusion": "acute leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "poor-risk AML in first remission", "histology_inclusion": "AML", "biomarker_inclusion": ["FLT3 internal tandem duplication mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "poor-risk ALL in first remission", "histology_inclusion": "ALL", "biomarker_inclusion": ["Philadelphia Chromosome", "t(4;11)", "KMT2A translocation", "t(8;14)", "complex karyotype", "low hypodiploidy", "near triploidy", "Philadelphia-like ALL"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Myelodysplastic syndromes (MDS) with poor-risk features", "histology_inclusion": "MDS", "biomarker_inclusion": ["7/7q minus", "complex cytogenetics", "IPSS score of INT-2 or greater", "treatment-related MDS", "secondary MDS", "MDS diagnosed before age 21 years", "lack of response to standard DNA-methyltransferase inhibitor therapy", "life-threatening cytopenias", "BCOR mutation", "ASXL1 mutation", "p53 mutation", "RUNX1 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "mixed lineage and biphenotypic leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Leukemia"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["KMT2A Fusion", "KMT2A", "fusion"]]}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["ASXL1 Mutation", "ASXL1-Mutation", "gene"], ["RUNX1 Mutation", "RUNX1-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["BCOR Mutation", "BCOR-Mutation", "gene"]]}, {"cohort": ""}]}
{"NCT_id": "NCT04681105", "json": [{"cohort": "Cohort A", "disease_state": "relapsed or refractory", "histology_inclusion": "Acute lymphoblastic leukemia (B-cell phenotype)", "biomarker_inclusion": ["CD123-positive", "failed or ineligible for CD19-based targeted therapy"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "relapsed or refractory", "histology_inclusion": "Acute lymphoblastic leukemia (T-cell phenotype)", "biomarker_inclusion": ["CD123-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "failed standard regimens", "histology_inclusion": "Blastic plasmacytoid dendritic cell neoplasm (BPDCN)", "biomarker_inclusion": ["CD123-positive"], "histology_exclusion": ["acute myeloid leukemia", "myelodysplastic syndrome"], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "failed standard regimens", "histology_inclusion": "Chronic myelocytic leukemia (CML)", "biomarker_inclusion": ["CD123-positive", "failed or relapsed or ineligible for third generation tyrosine kinase inhibitor (ponatinib)"], "histology_exclusion": ["acute myeloid leukemia", "myelodysplastic syndrome"], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "failed standard regimens", "histology_inclusion": "Hairy cell leukemia", "biomarker_inclusion": ["CD123-positive", "failed or progressed shortly after purine analogs or failed 2 cycles of purine analog"], "histology_exclusion": ["acute myeloid leukemia", "myelodysplastic syndrome"], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "failed standard regimens", "histology_inclusion": "Systemic mastocytosis", "biomarker_inclusion": ["CD123-positive", "failed or progressed on midostaurin"], "histology_exclusion": ["acute myeloid leukemia", "myelodysplastic syndrome"], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "failed standard regimens", "histology_inclusion": "Hodgkin lymphoma", "biomarker_inclusion": ["CD123-positive", "failed or relapsed after PD-1/PD-L1- inhibitors and brentuximab vedotin"], "histology_exclusion": ["acute myeloid leukemia", "myelodysplastic syndrome"], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "failed standard regimens", "histology_inclusion": "Advanced acute leukemia with ambiguous lineage or biphenotypic leukemia", "biomarker_inclusion": ["CD123-positive", "failed 2 lines of prior regimens"], "histology_exclusion": ["acute myeloid leukemia", "myelodysplastic syndrome"], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "failed standard regimens", "histology_inclusion": "Other advanced CD123+ hematological malignancy", "biomarker_inclusion": ["CD123-positive", "failed standard therapy per the treating physician's judgement"], "histology_exclusion": ["acute myeloid leukemia", "myelodysplastic syndrome"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["IL3RA-High", "IL3RA-High", "expression"]]}, {"cohort": "Cohort A", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["IL3RA-High", "IL3RA-High", "expression"]]}, {"cohort": "Cohort B", "histology_inclusion": "Blastic Plasmacytoid Dendritic Cell Neoplasm", "biomarker_inclusion": [["IL3RA-High", "IL3RA-High", "expression"]], "histology_exclusion": ["Myelodysplastic Syndrome", "Acute Myeloid Leukemia (AML)"]}, {"cohort": "Cohort B", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "biomarker_inclusion": [["IL3RA-High", "IL3RA-High", "expression"]], "histology_exclusion": ["Myelodysplastic Syndrome", "Acute Myeloid Leukemia (AML)"]}, {"cohort": "Cohort B", "histology_inclusion": "Hairy Cell Leukemia", "biomarker_inclusion": [["IL3RA-High", "IL3RA-High", "expression"]], "histology_exclusion": ["Myelodysplastic Syndrome", "Acute Myeloid Leukemia (AML)"]}, {"cohort": "Cohort B", "histology_inclusion": "Systemic Mastocytosis", "biomarker_inclusion": [["IL3RA-High", "IL3RA-High", "expression"]], "histology_exclusion": ["Acute Myeloid Leukemia (AML)", "Myelodysplastic Syndrome"]}, {"cohort": "Cohort B", "histology_inclusion": "Primary Systemic Mastocytosis", "biomarker_inclusion": [["IL3RA-High", "IL3RA-High", "expression"]], "histology_exclusion": ["Myelodysplastic Syndrome", "Acute Myeloid Leukemia (AML)"]}, {"cohort": "Cohort B", "histology_inclusion": "Hodgkin Lymphoma", "biomarker_inclusion": [["CD274-Low", "CD274-Low", "expression"], ["PDCD1-Low", "PDCD1-Low", "expression"], ["IL3RA-High", "IL3RA-High", "expression"]], "histology_exclusion": ["Myelodysplastic Syndrome", "Acute Myeloid Leukemia (AML)"]}, {"cohort": "Cohort B", "histology_inclusion": "Acute Leukemia", "biomarker_inclusion": [["IL3RA-High", "IL3RA-High", "expression"]], "histology_exclusion": ["Myelodysplastic Syndrome", "Acute Myeloid Leukemia (AML)"]}, {"cohort": "Cohort B", "histology_inclusion": "Hematopoietic and Lymphoid Cell Neoplasm", "biomarker_inclusion": [["IL3RA-High", "IL3RA-High", "expression"]], "histology_exclusion": ["Myelodysplastic Syndrome", "Acute Myeloid Leukemia (AML)"]}]}
{"NCT_id": "NCT05397093", "json": [{"cohort": "Phase 1a Dose Escalation", "disease_state": "advanced (metastatic and/or unresectable)", "histology_inclusion": "High-grade serous epithelial carcinoma of the ovary, fallopian tube, or peritoneum", "biomarker_inclusion": [], "histology_exclusion": ["low-grade", "endometrioid", "clear cell", "mucinous", "sarcomatous", "mixed"], "biomarker_exclusion": []}, {"cohort": "Phase 1a Dose Escalation", "disease_state": "advanced (metastatic and/or unresectable)", "histology_inclusion": "adenocarcinoma of the lung", "biomarker_inclusion": [], "histology_exclusion": ["squamous", "neuroendocrine differentiation"], "biomarker_exclusion": []}, {"cohort": "Phase 1a Dose Escalation", "disease_state": "advanced (metastatic and/or unresectable)", "histology_inclusion": "clear-cell renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["nonclear-cell RCC"], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort 1", "disease_state": "advanced (metastatic and/or unresectable)", "histology_inclusion": "High grade serous, endometrioid, or clear cell epithelial carcinoma of the ovary, fallopian tube, or peritoneum", "biomarker_inclusion": [], "histology_exclusion": ["mucinous", "sarcomatous", "low-grade"], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort 2", "disease_state": "advanced (metastatic and/or unresectable)", "histology_inclusion": "Squamous-cell carcinoma or adenocarcinoma of the lung", "biomarker_inclusion": [], "histology_exclusion": ["small cell lung cancer", "neuroendocrine differentiation"], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort 3", "disease_state": "advanced (metastatic and/or unresectable)", "histology_inclusion": "Clear cell or papillary RCC", "biomarker_inclusion": [], "histology_exclusion": ["nonclear-cell RCC"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1a Dose Escalation", "histology_inclusion": "Epithelial Neoplasm"}, {"cohort": "Phase 1a Dose Escalation", "histology_inclusion": "Lung Adenocarcinoma"}, {"cohort": "Phase 1a Dose Escalation", "histology_inclusion": "Clear Cell Renal Cell Carcinoma", "histology_exclusion": ["Renal Cell Carcinoma", "Refractory Cytopenia of Childhood"]}, {"cohort": "Phase 1b Cohort 1", "histology_inclusion": "Epithelial Neoplasm"}, {"cohort": "Phase 1b Cohort 2", "histology_inclusion": "Squamous Cell Carcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma"]}, {"cohort": "Phase 1b Cohort 2", "histology_inclusion": "Lung Adenocarcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma"]}, {"cohort": "Phase 1b Cohort 3", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Renal Cell Carcinoma", "Refractory Cytopenia of Childhood"]}, {"cohort": "Phase 1b Cohort 3", "histology_inclusion": "Refractory Cytopenia of Childhood", "histology_exclusion": ["Renal Cell Carcinoma", "Refractory Cytopenia of Childhood"]}]}
{"NCT_id": "NCT03601078", "json": [{"cohort": "Cohort 1", "disease_state": "Relapsed and Refractory Multiple Myeloma", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": ["Plasma cell leukemia", "Waldenstrom's macroglobulinemia", "POEMS syndrome", "clinically significant amyloidosis"], "biomarker_exclusion": []}, {"cohort": "Cohort 2a", "disease_state": "High-Risk Multiple Myeloma", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": ["Plasma cell leukemia", "Waldenstrom's macroglobulinemia", "POEMS syndrome", "clinically significant amyloidosis"], "biomarker_exclusion": []}, {"cohort": "Cohort 2b", "disease_state": "High-Risk Multiple Myeloma", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": ["Plasma cell leukemia", "Waldenstrom's macroglobulinemia", "POEMS syndrome", "clinically significant amyloidosis"], "biomarker_exclusion": []}, {"cohort": "Cohort 2c", "disease_state": "High-Risk Multiple Myeloma", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": ["Plasma cell leukemia", "Waldenstrom's macroglobulinemia", "POEMS syndrome", "clinically significant amyloidosis"], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "Newly Diagnosed Multiple Myeloma", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": ["Plasma cell leukemia", "Waldenstrom's macroglobulinemia", "POEMS syndrome", "clinically significant amyloidosis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Plasma Cell Leukemia", "Amyloidosis", "Waldenstrom Macroglobulinemia"]}, {"cohort": "Cohort 2a", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Plasma Cell Leukemia", "Amyloidosis", "Waldenstrom Macroglobulinemia"]}, {"cohort": "Cohort 2b", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Plasma Cell Leukemia", "Amyloidosis", "Waldenstrom Macroglobulinemia"]}, {"cohort": "Cohort 2c", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Plasma Cell Leukemia", "Amyloidosis", "Waldenstrom Macroglobulinemia"]}, {"cohort": "Cohort 3", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Plasma Cell Leukemia", "Amyloidosis", "Waldenstrom Macroglobulinemia"]}]}
{"NCT_id": "NCT04941716", "json": [{"cohort": "", "disease_state": "Refractory or Recurrent", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Prolymphocytic Leukemia", "Richter's Transformation"], "biomarker_exclusion": ["Prior disease progression on BTK inhibitor", "Prior disease progression on venetoclax"]}, {"cohort": "", "disease_state": "Refractory or Recurrent", "histology_inclusion": "Small Lymphocytic Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Prolymphocytic Leukemia", "Richter's Transformation"], "biomarker_exclusion": ["Prior disease progression on BTK inhibitor", "Prior disease progression on venetoclax"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia", "histology_exclusion": ["Richter Syndrome", "Prolymphocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "Small Lymphocytic Lymphoma", "histology_exclusion": ["Richter Syndrome", "Prolymphocytic Leukemia"]}]}
{"NCT_id": "NCT05071937", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "ovarian carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["ovarian carcinosarcoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "fallopian tube carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "primary peritoneal carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "histology_exclusion": ["Ovarian Carcinosarcoma"]}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm", "histology_exclusion": ["Ovarian Carcinosarcoma"]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma"}]}
{"NCT_id": "NCT05267106", "json": [{"cohort": "Cohort A: IDH-wild-type GBM", "disease_state": "recurrent", "histology_inclusion": "WHO Grade 4, IDH-wild-type GBM OR molecular diagnosis of IDH-wild-type, diffuse astrocytic glioma with molecular features of Grade 4 GBM", "biomarker_inclusion": ["FGFR1-3 fusions", "FGFR1-3 rearrangements", "FGFR1-3 activating mutation", "FGFR1-3 in-frame deletion"], "histology_exclusion": ["Primary Central Nervous System Tumors"], "biomarker_exclusion": ["FGFR inhibitor"]}, {"cohort": "Cohort B: Other gliomas other than GBM", "disease_state": "recurrent", "histology_inclusion": "gliomas other than GBM, circumscribed astrocytic gliomas, and glioneuronal and neuronal tumors", "biomarker_inclusion": ["FGFR1-3 fusions", "FGFR1-3 rearrangements", "FGFR1-3 activating mutation", "FGFR1-3 in-frame deletion"], "histology_exclusion": ["Primary Central Nervous System Tumors"], "biomarker_exclusion": ["FGFR inhibitor"]}], "json_norm": [{"cohort": "Cohort A: IDH-wild-type GBM", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"], ["FGFR1 Fusion", "FGFR1", "fusion"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"], ["FGFR1 Fusion", "FGFR1", "fusion"], ["FGFR1 Mutation", "FGFR1-Mutation", "gene"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "Cohort A: IDH-wild-type GBM", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"], ["FGFR1 Fusion", "FGFR1", "fusion"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"], ["FGFR1 Fusion", "FGFR1", "fusion"], ["FGFR1 Mutation", "FGFR1-Mutation", "gene"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "Cohort A: IDH-wild-type GBM", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"], ["FGFR1 Fusion", "FGFR1", "fusion"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"], ["FGFR1 Fusion", "FGFR1", "fusion"], ["FGFR1 Mutation", "FGFR1-Mutation", "gene"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "Cohort A: IDH-wild-type GBM", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"], ["FGFR1 Fusion", "FGFR1", "fusion"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"], ["FGFR1 Fusion", "FGFR1", "fusion"], ["FGFR1 Mutation", "FGFR1-Mutation", "gene"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "Cohort A: IDH-wild-type GBM", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"], ["FGFR1 Fusion", "FGFR1", "fusion"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"], ["FGFR1 Fusion", "FGFR1", "fusion"], ["FGFR1 Mutation", "FGFR1-Mutation", "gene"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "Cohort A: IDH-wild-type GBM", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR1 Fusion", "FGFR1", "fusion"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["FGFR3 Fusion", "FGFR3", "fusion"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "Cohort B: Other gliomas other than GBM", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"], ["FGFR1 Fusion", "FGFR1", "fusion"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT03340506", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Rare Cancers", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "High Grade Glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Malignant Glioma"}]}
{"NCT_id": "NCT04616183", "json": [{"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["KRAS wild-type", "NRAS wild-type", "EGFR wild-type", "BRAF wild-type", "MEK1 wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["KRAS mutated", "NRAS mutated", "EGFR mutated", "BRAF mutated", "MEK1 mutated", "symptomatic brain metastasis", "leptomeningeal disease"]}, {"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["left-sided primary tumor"], "histology_exclusion": ["right-sided or transverse colonic primary tumor"], "biomarker_exclusion": ["symptomatic brain metastasis", "leptomeningeal disease"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["MAP2K1 MAP2K1-wild_type", "MAP2K1-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]], "biomarker_exclusion": [["MAP2K1 Mutation", "MAP2K1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Colon Adenocarcinoma"}]}
{"NCT_id": "NCT04616209", "json": [{"cohort": "", "disease_state": "stage IIIB-IV or recurrent", "histology_inclusion": "non-small-cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases", "leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04811560", "json": [{"cohort": "", "disease_state": "relapsed or refractory acute leukemia", "histology_inclusion": "acute leukemia", "biomarker_inclusion": ["KMT2A alterations", "NPM1 alterations"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Leukemia", "biomarker_inclusion": [["NPM1 Mutation", "NPM1-Mutation", "gene"], ["KMT2A Mutation", "KMT2A-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT05267288", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "nonsquamous non-small cell lung cancer", "biomarker_inclusion": ["EGFR Exon G719X", "EGFR Exon S768I", "EGFR Exon L861Q"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR S768I", "S768I", "coordinate"], ["EGFR L861Q", "L861Q", "coordinate"]]}]}
{"NCT_id": "NCT05592626", "json": [{"cohort": "Phase 1", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["TMB-H"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["MSI-H", "dMMR"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "virally associated tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["TMB-H"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["MSI-H", "dMMR"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "virally associated tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "metastatic", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "relapsed and refractory", "histology_inclusion": "epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "metastatic", "histology_inclusion": "castration-resistance prostate cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["K-Ras wild type"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["K-Ras mutant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "primary stage IV or recurrent", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Phase 1"}, {"cohort": "Phase 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Phase 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Phase 2"}, {"cohort": "Phase 2", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Phase 2", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Phase 2", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Phase 2", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Phase 2", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Phase 2", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Phase 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT03079999", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Vestibular Schwannoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acoustic Schwannoma"}]}
{"NCT_id": "NCT03666559", "json": [{"cohort": "", "disease_state": "Recurrent", "histology_inclusion": "Glioma grade II or III", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04420884", "json": [{"cohort": "Part 1A", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1B", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2A", "disease_state": "untreated metastatic or recurrent, unresectable", "histology_inclusion": "squamous cell carcinoma of head and neck", "biomarker_inclusion": ["CPS \u22651"], "histology_exclusion": ["nasopharyngeal cancer", "salivary gland tumors"], "biomarker_exclusion": []}, {"cohort": "Part 2B", "disease_state": "untreated metastatic or recurrent, unresectable", "histology_inclusion": "squamous cell carcinoma of head and neck", "biomarker_inclusion": [], "histology_exclusion": ["nasopharyngeal cancer", "salivary gland tumors"], "biomarker_exclusion": []}, {"cohort": "Part 3A", "disease_state": "third-line or later recurrent locally advanced or metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["MSI-H", "dMMR"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 3B", "disease_state": "third-line recurrent locally advanced or metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["MSS", "pMMR"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 1A", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part 1B", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part 2A", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Nasopharyngeal Carcinoma", "Malignant Salivary Gland Neoplasm", "Salivary Gland Carcinoma"]}, {"cohort": "Part 2B", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Nasopharyngeal Carcinoma", "Malignant Salivary Gland Neoplasm", "Salivary Gland Carcinoma"]}, {"cohort": "Part 3A", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Part 3B", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT04681469", "json": [{"cohort": "", "disease_state": "locally advanced", "histology_inclusion": "p16 negative squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx or larynx", "biomarker_inclusion": [], "histology_exclusion": ["p16/HPV positive HNSCC", "sinonasal, nasal cavity or nasopharyngeal cancer", "SCC on neck disease with unknown primary tumor site"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-Low", "H3P10-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]], "histology_exclusion": ["Head and Neck Squamous Cell Carcinoma", "Nasopharyngeal Carcinoma", "Squamous Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-Low", "H3P10-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]], "histology_exclusion": ["Head and Neck Squamous Cell Carcinoma", "Nasopharyngeal Carcinoma", "Squamous Cell Carcinoma"]}]}
{"NCT_id": "NCT05137275", "json": [{"cohort": "Cohort 1", "disease_state": "Non-small cell lung cancer with disease progression or intolerance after at least two systemic therapies", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Breast cancer, treated with at least one systemic chemotherapy agent", "histology_inclusion": "Breast cancer", "biomarker_inclusion": ["PR negative", "ER negative", "HER2 negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "Colorectal cancer with disease progression or intolerance after at least two systemic therapies", "histology_inclusion": "Colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 4", "disease_state": "Mesothelioma with disease progression or intolerance after at least two systemic therapies", "histology_inclusion": "Mesothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 5", "disease_state": "Other tumors with high expression of antigen 5T4", "histology_inclusion": "", "biomarker_inclusion": ["High expression of antigen 5T4"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"], ["TMEM37-Low", "TMEM37-Low", "expression"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Cohort 4", "histology_inclusion": "Mesothelioma"}, {"cohort": "Cohort 5"}]}
{"NCT_id": "NCT05202236", "json": [{"cohort": "", "disease_state": "advanced metastatic", "histology_inclusion": "gastric adenocarcinoma", "biomarker_inclusion": ["FGFR1 alterations", "FGFR2 alterations", "FGFR3 alterations"], "histology_exclusion": [], "biomarker_exclusion": ["selective FGFR inhibitors"]}, {"cohort": "", "disease_state": "advanced metastatic", "histology_inclusion": "adenocarcinoma of the gastroesophageal junction", "biomarker_inclusion": ["FGFR1 alterations", "FGFR2 alterations", "FGFR3 alterations"], "histology_exclusion": [], "biomarker_exclusion": ["selective FGFR inhibitors"]}, {"cohort": "", "disease_state": "advanced metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["FGFR1 alterations", "FGFR2 alterations", "FGFR3 alterations"], "histology_exclusion": [], "biomarker_exclusion": ["selective FGFR inhibitors"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04355858", "json": [{"cohort": "", "disease_state": "locally advanced breast cancer or recurrent metastatic breast cancer", "histology_inclusion": "HR+/HER2- invasive breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT04942054", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "ER+/HER2- adenocarcinoma of the breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 3a", "disease_state": "advanced/metastatic", "histology_inclusion": "HR+ve, HER2- MBC", "biomarker_inclusion": ["ESR1 mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 3b", "disease_state": "advanced/metastatic", "histology_inclusion": "HR+ve HER2- MBC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 3c", "disease_state": "advanced/metastatic", "histology_inclusion": "HR+ve HER2- MBC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 3d", "disease_state": "advanced/metastatic", "histology_inclusion": "ER+ve HER-ve Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 3a", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["ESR1 Mutation", "ESR1-Mutation", "gene"]]}, {"cohort": "Part 3a", "biomarker_inclusion": [["ESR1 Mutation", "ESR1-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Part 3b", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Part 3b", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Part 3c", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Part 3c", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Part 3d", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["EREG-High", "EREG-High", "expression"]]}]}
{"NCT_id": "NCT04942067", "json": [{"cohort": "Arm A and Arm B", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": ["Plasma Cell Leukemia", "Waldenstr\u00f6m's Macroglobulinemia", "POEMS Syndrome"], "biomarker_exclusion": []}, {"cohort": "Arm C", "disease_state": "AL Amyloidosis", "histology_inclusion": "AL Amyloidosis", "biomarker_inclusion": [], "histology_exclusion": ["Clinically Overt Multiple Myeloma", "Plasma Cell Leukemia", "Waldenstr\u00f6m's Macroglobulinemia", "POEMS Syndrome"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm A and Arm B", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Plasma Cell Leukemia"]}, {"cohort": "Arm C", "histology_inclusion": "Amyloidosis", "histology_exclusion": ["Plasma Cell Myeloma", "Plasma Cell Leukemia"]}]}
{"NCT_id": "NCT05267470", "json": [{"cohort": "", "disease_state": "unresectable, locally advanced or metastatic", "histology_inclusion": "squamous cell lung carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["mixed small-cell lung cancer", "mixed non-small cell lung cancer"], "biomarker_exclusion": []}, {"cohort": "Part 2, 3 and 4", "disease_state": "unresectable, locally advanced or metastatic", "histology_inclusion": "squamous cell lung carcinoma", "biomarker_inclusion": ["FGFR2b overexpression"], "histology_exclusion": ["mixed small-cell lung cancer", "mixed non-small cell lung cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Squamous Cell Lung Carcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma", "Non-Small Cell Lung Carcinoma"]}, {"cohort": "Part 2, 3 and 4", "histology_inclusion": "Squamous Cell Lung Carcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma", "Non-Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT05462717", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer (NSCLC)", "biomarker_inclusion": ["KRASG12C"], "histology_exclusion": ["Primary central nervous system (CNS) tumors", "Active brain metastases"], "biomarker_exclusion": ["KRASG12C (ON) inhibitor"]}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Colorectal Cancer (CRC)", "biomarker_inclusion": ["KRASG12C"], "histology_exclusion": ["Primary central nervous system (CNS) tumors", "Active brain metastases"], "biomarker_exclusion": ["KRASG12C (ON) inhibitor"]}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": ["KRASG12C"], "histology_exclusion": ["Primary central nervous system (CNS) tumors", "Active brain metastases"], "biomarker_exclusion": ["KRASG12C (ON) inhibitor"]}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Advanced Solid Tumor", "biomarker_inclusion": ["KRASG12C"], "histology_exclusion": ["Primary central nervous system (CNS) tumors", "Active brain metastases"], "biomarker_exclusion": ["KRASG12C (ON) inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT03471260", "json": [{"cohort": "", "disease_state": "Relapsed/refractory AML, or treatment-naive patients with AML who are not eligible for standard induction chemotherapy", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH1-R132 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "High-risk myelodysplastic syndrome (MDS) or myeloproliferative neoplasm (MPN) (defined as >= 10% bone marrow blasts, or intermediate or high risk by International Prostate Symptom Score [IPSS], Revised [R]-IPSS or Dynamic [D]-IPSS)", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": ["IDH1-R132 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "High-risk myelodysplastic syndrome (MDS) or myeloproliferative neoplasm (MPN) (defined as >= 10% bone marrow blasts, or intermediate or high risk by International Prostate Symptom Score [IPSS], Revised [R]-IPSS or Dynamic [D]-IPSS)", "histology_inclusion": "Myeloproliferative Neoplasm", "biomarker_inclusion": ["IDH1-R132 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Myeloproliferative Neoplasm"}, {"cohort": "", "histology_inclusion": "Myelodysplastic/Myeloproliferative Disease"}]}
{"NCT_id": "NCT03862157", "json": [{"cohort": "AML Cohort", "disease_state": "Newly Diagnosed", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Acute Promyelocytic Leukemia"], "biomarker_exclusion": []}, {"cohort": "Newly Diagnosed MDS/CMML Cohort", "disease_state": "Intermediate-2 or High-Risk", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Newly Diagnosed MDS/CMML Cohort", "disease_state": "Intermediate-2 or High-Risk", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "MDS/CMML Post-HMA Failure Cohort", "disease_state": "Intermediate-1, Intermediate-2, or High-Risk", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["Venetoclax", "Pevonedistat"]}, {"cohort": "MDS/CMML Post-HMA Failure Cohort", "disease_state": "Intermediate-1, Intermediate-2, or High-Risk", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["Venetoclax", "Pevonedistat"]}], "json_norm": [{"cohort": "AML Cohort", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Newly Diagnosed MDS/CMML Cohort", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "Newly Diagnosed MDS/CMML Cohort", "histology_inclusion": "Chronic Myelomonocytic Leukemia"}, {"cohort": "MDS/CMML Post-HMA Failure Cohort", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "MDS/CMML Post-HMA Failure Cohort", "histology_inclusion": "Chronic Myelomonocytic Leukemia"}]}
{"NCT_id": "NCT04486352", "json": [{"cohort": "Atezolizumab and Ipatasertib Cohort", "disease_state": "Recurrent or persistent endometrial carcinoma", "histology_inclusion": "Endometrial carcinoma", "biomarker_inclusion": ["PIK3CA", "AKT1", "PTEN-altered"], "histology_exclusion": ["Squamous carcinomas", "Sarcomas"], "biomarker_exclusion": []}, {"cohort": "Atezolizumab and Talazoparib Cohort", "disease_state": "Recurrent or persistent endometrial carcinoma", "histology_inclusion": "Endometrial carcinoma", "biomarker_inclusion": ["\u226516% genomic loss of heterozygosity (LOH)"], "histology_exclusion": ["Squamous carcinomas", "Sarcomas"], "biomarker_exclusion": []}, {"cohort": "Atezolizumab and Trastuzumab emtansine (TDM-1) Cohort", "disease_state": "Recurrent or persistent endometrial carcinoma", "histology_inclusion": "Endometrial carcinoma", "biomarker_inclusion": ["ERBB2/HER2 amplification"], "histology_exclusion": ["Squamous carcinomas", "Sarcomas"], "biomarker_exclusion": []}, {"cohort": "Atezolizumab and Tiragolumab Cohort", "disease_state": "Recurrent or persistent endometrial carcinoma", "histology_inclusion": "Endometrial carcinoma", "biomarker_inclusion": ["MSI-H", "tTMB >=10 mut/mb"], "histology_exclusion": ["Squamous carcinomas", "Sarcomas"], "biomarker_exclusion": []}, {"cohort": "Inavolisib and Letrozole Cohort", "disease_state": "Recurrent or persistent endometrial carcinoma", "histology_inclusion": "Endometrial carcinoma", "biomarker_inclusion": ["PIK3CA activating mutations", "No PTEN loss-of-function alterations", "No AKT1 activating mutations"], "histology_exclusion": ["Squamous carcinomas", "Sarcomas"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Atezolizumab and Ipatasertib Cohort", "histology_inclusion": "Endometrial Carcinoma", "histology_exclusion": ["Sarcoma"]}, {"cohort": "Atezolizumab and Talazoparib Cohort", "histology_inclusion": "Endometrial Carcinoma", "histology_exclusion": ["Sarcoma"]}, {"cohort": "Atezolizumab and Trastuzumab emtansine (TDM-1) Cohort", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "histology_exclusion": ["Sarcoma"]}, {"cohort": "Atezolizumab and Tiragolumab Cohort", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]], "histology_exclusion": ["Sarcoma"]}, {"cohort": "Inavolisib and Letrozole Cohort", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["PTEN-Low", "PTEN-Low", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Sarcoma"]}]}
{"NCT_id": "NCT04551495", "json": [{"cohort": "Single Arm", "disease_state": "stages 1 to 3", "histology_inclusion": "invasive lobular breast adenocarcinoma", "biomarker_inclusion": ["ER+", "HER2-"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Single Arm", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}]}
{"NCT_id": "NCT04681677", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "glioblastoma multiforme", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "giant cell glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype"}, {"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Gliosarcoma"}, {"cohort": "", "histology_inclusion": "Giant Cell Glioblastoma"}]}
{"NCT_id": "NCT05202561", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["KRAS G12C", "KRAS G12D", "KRAS G12V"], "histology_exclusion": ["central nervous system metastasis"], "biomarker_exclusion": ["HLA-A11:01", "HLA-C08:02"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12V", "G12V", "coordinate"], ["KRAS G12D", "G12D", "coordinate"], ["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT03210714", "json": [{"cohort": "", "disease_state": "relapsed or refractory advanced", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["FGFR mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "non-Hodgkin lymphoma", "biomarker_inclusion": ["FGFR mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "histiocytic disorders", "biomarker_inclusion": ["FGFR mutations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Non-Hodgkin Lymphoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}, {"cohort": "", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04187833", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRCA1", "BRCA2", "ATM", "CHEK1", "CHEK2", "PALB2", "RAD50", "RAD51", "NBN", "BLM", "BRIP1", "ATR", "PARP1", "MDC1", "DSS1", "ERCC3", "MRE11", "HDAC2", "FANCA", "MLH3", "MLH1", "EMSY", "BAP1", "LIG4", "LIG3", "PRKDC", "XRCC6"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with a PARP inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma"}]}
{"NCT_id": "NCT04551521", "json": [{"cohort": "BRAF V600E/K", "disease_state": "metastatic or locally advanced", "histology_inclusion": "", "biomarker_inclusion": ["BRAF V600E", "BRAF V600K"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "ERBB2", "disease_state": "metastatic or locally advanced", "histology_inclusion": "", "biomarker_inclusion": ["ERBB2 amplification", "ERBB2 overexpression", "activating ERBB2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "ALK", "disease_state": "metastatic or locally advanced", "histology_inclusion": "", "biomarker_inclusion": ["ALK rearrangement", "activating ALK mutation", "ALK-ATI", "RET-fusions"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "AKT/PTEN", "disease_state": "metastatic or locally advanced", "histology_inclusion": "", "biomarker_inclusion": ["activating AKT1 mutation", "activating AKT2 mutation", "activating AKT3 mutation", "AKT1 amplification", "AKT2 amplification", "AKT3 amplification", "PTEN loss"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "PI3K", "disease_state": "metastatic or locally advanced", "histology_inclusion": "", "biomarker_inclusion": ["activating PIK3CA mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "MAPK", "disease_state": "metastatic or locally advanced", "histology_inclusion": "", "biomarker_inclusion": ["increased RAF-MEK-ERK pathway activity"], "histology_exclusion": [], "biomarker_exclusion": ["BRAF V600E", "BRAF V600K"]}, {"cohort": "Immune evasion", "disease_state": "metastatic or locally advanced", "histology_inclusion": "", "biomarker_inclusion": ["high tumor mutational burden", "DNA mismatch repair deficiency", "PDL1 amplification", "PDL1 overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "BRAF V600E/K", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}, {"cohort": "ERBB2", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "ALK", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"], ["ALK Mutation", "ALK-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "AKT/PTEN", "biomarker_inclusion": [["AKT1 Mutation", "AKT1-Mutation", "gene"], ["AKT3 Mutation", "AKT3-Mutation", "gene"], ["AKT2 Mutation", "AKT2-Mutation", "gene"], ["AKT2-High", "AKT2-High", "expression"], ["PTEN-Low", "PTEN-Low", "expression"], ["AKT3-High", "AKT3-High", "expression"], ["AKT1-High", "AKT1-High", "expression"]]}, {"cohort": "PI3K", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "MAPK", "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}, {"cohort": "Immune evasion", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"], ["CD274-High", "CD274-High", "expression"]]}]}
{"NCT_id": "NCT02286687", "json": [{"cohort": "", "disease_state": "advanced, metastatic, recurrent, refractory", "histology_inclusion": "", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "ATM", "disease_state": "advanced, metastatic, recurrent, refractory", "histology_inclusion": "", "biomarker_inclusion": ["ATM mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "PALB2", "disease_state": "advanced, metastatic, recurrent, refractory", "histology_inclusion": "", "biomarker_inclusion": ["PALB2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "other genes", "disease_state": "advanced, metastatic, recurrent, refractory", "histology_inclusion": "", "biomarker_inclusion": ["Fanconi Anemia genes", "ARID1A", "MER11", "RAD50", "NBS1", "ATR"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "EMSY", "disease_state": "advanced, metastatic, recurrent, refractory", "histology_inclusion": "", "biomarker_inclusion": ["EMSY amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "germline BRCA1/2", "disease_state": "advanced, metastatic, recurrent, refractory", "histology_inclusion": "", "biomarker_inclusion": ["germline BRCA1 mutation", "germline BRCA2 mutation"], "histology_exclusion": ["breast cancer", "ovarian cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "ATM", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"]]}, {"cohort": "PALB2", "biomarker_inclusion": [["PALB2 Mutation", "PALB2-Mutation", "gene"]]}, {"cohort": "other genes"}, {"cohort": "EMSY", "biomarker_inclusion": [["EMSY-High", "EMSY-High", "expression"]]}, {"cohort": "germline BRCA1/2", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]], "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Breast Carcinoma"]}]}
{"NCT_id": "NCT03406208", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Neurofibromatosis 1", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Neurofibromatosis 2", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Schwannomatosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}, {"cohort": ""}, {"cohort": ""}]}
{"NCT_id": "NCT03536728", "json": [{"cohort": "", "disease_state": "unresectable, locally advanced, or metastatic solid tumor", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory or progressive DIPG", "histology_inclusion": "DIPG", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high-grade gliomas", "histology_inclusion": "anaplastic astrocytoma", "biomarker_inclusion": ["H3K27M mutant DMG"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high-grade gliomas", "histology_inclusion": "glioblastoma", "biomarker_inclusion": ["H3K27M mutant DMG"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma"}, {"cohort": "", "histology_inclusion": "Anaplastic Astrocytoma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}]}
{"NCT_id": "NCT03601923", "json": [{"cohort": "", "disease_state": "advanced pancreatic adenocarcinoma", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": ["germline deleterious BRCA1 mutation", "germline deleterious BRCA2 mutation", "germline deleterious PALB2 mutation", "germline deleterious CHEK2 mutation", "germline deleterious ATM mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced pancreatic adenocarcinoma", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": ["somatic BRCA1 mutation", "somatic BRCA2 mutation", "somatic PALB2 mutation", "somatic CHEK2 mutation", "somatic ATM mutation"], "histology_exclusion": [], "biomarker_exclusion": ["progression on oxaliplatin-containing regimen", "previous treatment with PARP inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["CHEK2 Mutation", "CHEK2-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["CHEK2 Mutation", "CHEK2-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT05007652", "json": [{"cohort": "multiple myeloma cohort", "disease_state": "CR, sCR, VGPR, PR", "histology_inclusion": "multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "malignant lymphoma cohort", "disease_state": "first or second CR or PR", "histology_inclusion": "malignant lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "multiple myeloma cohort", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "malignant lymphoma cohort", "histology_inclusion": "Lymphoma"}]}
{"NCT_id": "NCT03667170", "json": [{"cohort": "Subjects with MSI-H/dMMR", "disease_state": "locally advanced or metastatic", "histology_inclusion": "colorectal carcinoma", "biomarker_inclusion": ["dMMR", "MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Subjects with MSI-H/dMMR", "disease_state": "locally advanced or metastatic", "histology_inclusion": "other malignant solid tumors", "biomarker_inclusion": ["dMMR", "MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Subjects with MSI-H/dMMR", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Subjects with MSI-H/dMMR", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT03797391", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "Phase II", "disease_state": "advanced/metastatic", "histology_inclusion": "non-small-cell lung cancer", "biomarker_inclusion": ["EGFR mutant", "cMET aberration"], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase II", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT03080766", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["Complex Karyotype", "Monosomal Karyotype"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}]}
{"NCT_id": "NCT04253561", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "adenocarcinoma of the breast", "biomarker_inclusion": ["HER2-positive", "PIK3CA mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}]}
{"NCT_id": "NCT04487080", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR Exon 19 deletion", "EGFR Exon 21 L858R substitution"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT04487106", "json": [{"cohort": "Cohort A (frontline)", "disease_state": "Newly diagnosed AML", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B (relapsed/refractory)", "disease_state": "Relapsed/refractory AML", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["KIT mutation", "HRAS mutation", "NRAS mutation", "KRAS mutation", "BRAF mutation", "CBL mutation", "PTPN11 mutation", "NF1 loss of function mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B (relapsed/refractory)", "disease_state": "Relapsed/refractory MDS", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": ["KIT mutation", "HRAS mutation", "NRAS mutation", "KRAS mutation", "BRAF mutation", "CBL mutation", "PTPN11 mutation", "NF1 loss of function mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B (relapsed/refractory)", "disease_state": "Relapsed/refractory CMML", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": ["KIT mutation", "HRAS mutation", "NRAS mutation", "KRAS mutation", "BRAF mutation", "CBL mutation", "PTPN11 mutation", "NF1 loss of function mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A (frontline)", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "Cohort B (relapsed/refractory)", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["NF1 Mutation", "NF1-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["NF1-Low", "NF1-Low", "expression"], ["PTPN11 Mutation", "PTPN11-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["CBL Mutation", "CBL-Mutation", "gene"], ["KIT Mutation", "KIT-Mutation", "gene"]]}, {"cohort": "Cohort B (relapsed/refractory)", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["NF1 Mutation", "NF1-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["NF1-Low", "NF1-Low", "expression"], ["PTPN11 Mutation", "PTPN11-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["CBL Mutation", "CBL-Mutation", "gene"], ["KIT Mutation", "KIT-Mutation", "gene"]]}, {"cohort": "Cohort B (relapsed/refractory)", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": [["NF1 Mutation", "NF1-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["NF1-Low", "NF1-Low", "expression"], ["PTPN11 Mutation", "PTPN11-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["CBL Mutation", "CBL-Mutation", "gene"], ["KIT Mutation", "KIT-Mutation", "gene"]]}]}
{"NCT_id": "NCT04552288", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Solid Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Solid Tumor, Adult", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Hematologic Malignancy", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Hematopoietic and Lymphoid Cell Neoplasm"}]}
{"NCT_id": "NCT04617314", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["c-Met positive"], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}]}
{"NCT_id": "NCT04682431", "json": [{"cohort": "Part A", "disease_state": "locally advanced (unresectable) and/or metastatic solid tumors", "histology_inclusion": "head and neck", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["EGFR", "VEGF", "ALK", "ROS-1", "NTRK", "MET", "RET", "BRAF V600E", "HER2"]}, {"cohort": "Part A", "disease_state": "locally advanced (unresectable) and/or metastatic solid tumors", "histology_inclusion": "gynecologic", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["EGFR", "VEGF", "ALK", "ROS-1", "NTRK", "MET", "RET", "BRAF V600E", "HER2"]}, {"cohort": "Part A", "disease_state": "locally advanced (unresectable) and/or metastatic solid tumors", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["EGFR", "VEGF", "ALK", "ROS-1", "NTRK", "MET", "RET", "BRAF V600E", "HER2"]}, {"cohort": "Part A", "disease_state": "locally advanced (unresectable) and/or metastatic solid tumors", "histology_inclusion": "lung adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["EGFR", "VEGF", "ALK", "ROS-1", "NTRK", "MET", "RET", "BRAF V600E", "HER2"]}, {"cohort": "Part A", "disease_state": "locally advanced (unresectable) and/or metastatic solid tumors", "histology_inclusion": "lung squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["EGFR", "VEGF", "ALK", "ROS-1", "NTRK", "MET", "RET", "BRAF V600E", "HER2"]}, {"cohort": "Part A", "disease_state": "locally advanced (unresectable) and/or metastatic solid tumors", "histology_inclusion": "gastric and esophagogastric junction adenocarcinomas", "biomarker_inclusion": ["MSI low", "CPI refractory MSI high"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["EGFR", "VEGF", "ALK", "ROS-1", "NTRK", "MET", "RET", "BRAF V600E", "HER2"]}, {"cohort": "Part A", "disease_state": "locally advanced (unresectable) and/or metastatic solid tumors", "histology_inclusion": "breast TNBC", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["EGFR", "VEGF", "ALK", "ROS-1", "NTRK", "MET", "RET", "BRAF V600E", "HER2"]}, {"cohort": "Part A", "disease_state": "locally advanced (unresectable) and/or metastatic solid tumors", "histology_inclusion": "breast HR+", "biomarker_inclusion": ["HER2-"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["EGFR", "VEGF", "ALK", "ROS-1", "NTRK", "MET", "RET", "BRAF V600E", "HER2"]}], "json_norm": [{"cohort": "Part A", "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "Part A", "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "Part A", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "Part A", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "Part A", "histology_inclusion": "Squamous Cell Lung Carcinoma", "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "Part A", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]], "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "Part A", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]], "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "Part A", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]], "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT04812808", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": ["IL-6 (GP130/STAT3)-pathway activity > 5%"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma"}]}
{"NCT_id": "NCT03211416", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "hepatocellular carcinoma (HCC)", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["PD1 blocker", "sorafenib"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma"}]}
{"NCT_id": "NCT03667716", "json": [{"cohort": "P1a Arm A (Monotherapy Expansion)", "disease_state": "advanced", "histology_inclusion": "triple-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "P1a Arm A (Monotherapy Expansion)", "disease_state": "locally advanced or metastatic", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "P1a Arm A (Monotherapy Expansion)", "disease_state": "recurrent or progressive", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "P1a Arm A (Monotherapy Expansion)", "disease_state": "stage IIIB or IV or recurrent", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "P1b (Combination Cohort Dose Expansion)", "disease_state": "advanced", "histology_inclusion": "triple-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "P1b (Combination Cohort Dose Expansion)", "disease_state": "locally advanced or metastatic", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "P1b (Combination Cohort Dose Expansion)", "disease_state": "recurrent or progressive", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "P1b (Combination Cohort Dose Expansion)", "disease_state": "microsatellite stable", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "P1a Arm A (Monotherapy Expansion)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "P1a Arm A (Monotherapy Expansion)", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "P1a Arm A (Monotherapy Expansion)", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "P1a Arm A (Monotherapy Expansion)", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "P1a Arm A (Monotherapy Expansion)", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "P1b (Combination Cohort Dose Expansion)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "P1b (Combination Cohort Dose Expansion)", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "P1b (Combination Cohort Dose Expansion)", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "P1b (Combination Cohort Dose Expansion)", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "P1b (Combination Cohort Dose Expansion)", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT05203445", "json": [{"cohort": "", "disease_state": "Stage T1c-3N0-3", "histology_inclusion": "Triple Negative Breast Cancer (TNBC)", "biomarker_inclusion": ["BRCA1", "BRCA2", "PALB2", "RAD51C", "RAD51D"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage T1c-3N0-3", "histology_inclusion": "Hormone Receptor-positive HER2-negative Breast Cancer", "biomarker_inclusion": ["BRCA1", "BRCA2", "PALB2", "RAD51C", "RAD51D"], "histology_exclusion": ["Stage IV (metastatic) breast cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ESR1-High", "ESR1-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ESR1-High", "ESR1-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ESR1-High", "ESR1-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ESR1-High", "ESR1-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}]}
{"NCT_id": "NCT02287428", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "glioblastoma with oligodendroglial features", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "giant cell glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "astrocytoma with molecular features of glioblastoma", "biomarker_inclusion": ["IDH-mutated"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Gliosarcoma"}, {"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Giant Cell Glioblastoma"}, {"cohort": "", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT02885753", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma"}]}
{"NCT_id": "NCT03667820", "json": [{"cohort": "", "disease_state": "Advanced", "histology_inclusion": "Non-small Cell Lung Cancer (NSCLC)", "biomarker_inclusion": ["EGFR exon 19", "EGFR exon 21"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT03798106", "json": [{"cohort": "durvalumab+pazopanib", "disease_state": "metastatic", "histology_inclusion": "Soft Tissue Sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "durvalumab+pazopanib", "histology_inclusion": "Soft Tissue Sarcoma"}]}
{"NCT_id": "NCT04318938", "json": [{"cohort": "", "disease_state": "locally advanced (stage III) and not suitable for curative treatment, metastatic (stage IV)", "histology_inclusion": "ALK+ NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"]]}]}
{"NCT_id": "NCT04318964", "json": [{"cohort": "TAEST16001 cells treat tumor antigen NY-ESO-1", "disease_state": "Advanced", "histology_inclusion": "Soft Tissue Sarcoma", "biomarker_inclusion": ["HLA-A * 02:01", "NY-ESO-1 positive: immunohistochemistry positive cells \u2265 20%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "TAEST16001 cells treat tumor antigen NY-ESO-1", "disease_state": "Advanced", "histology_inclusion": "Primary Liver Cancer", "biomarker_inclusion": ["HLA-A * 02:01", "NY-ESO-1 positive: immunohistochemistry positive cells \u2265 20%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "TAEST16001 cells treat tumor antigen NY-ESO-1", "disease_state": "Advanced", "histology_inclusion": "Ovarian Cancer", "biomarker_inclusion": ["HLA-A * 02:01", "NY-ESO-1 positive: immunohistochemistry positive cells \u2265 20%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "TAEST16001 cells treat tumor antigen NY-ESO-1", "disease_state": "Advanced", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["HLA-A * 02:01", "NY-ESO-1 positive: immunohistochemistry positive cells \u2265 20%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "TAEST16001 cells treat tumor antigen NY-ESO-1", "disease_state": "Advanced", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["HLA-A * 02:01", "NY-ESO-1 positive: immunohistochemistry positive cells \u2265 20%"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "TAEST16001 cells treat tumor antigen NY-ESO-1", "histology_inclusion": "Soft Tissue Sarcoma", "biomarker_inclusion": [["CTAG1B-High", "CTAG1B-High", "expression"]]}, {"cohort": "TAEST16001 cells treat tumor antigen NY-ESO-1", "histology_inclusion": "Liver Cancer", "biomarker_inclusion": [["CTAG1B-High", "CTAG1B-High", "expression"]]}, {"cohort": "TAEST16001 cells treat tumor antigen NY-ESO-1", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["CTAG1B-High", "CTAG1B-High", "expression"]]}, {"cohort": "TAEST16001 cells treat tumor antigen NY-ESO-1", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["CTAG1B-High", "CTAG1B-High", "expression"]]}, {"cohort": "TAEST16001 cells treat tumor antigen NY-ESO-1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["CTAG1B-High", "CTAG1B-High", "expression"]]}, {"cohort": "TAEST16001 cells treat tumor antigen NY-ESO-1", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["CTAG1B-High", "CTAG1B-High", "expression"]]}]}
{"NCT_id": "NCT05463848", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "glioblastoma", "biomarker_inclusion": ["IDH wildtype"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT02157051", "json": [{"cohort": "", "disease_state": "Stage III-IV", "histology_inclusion": "HER2-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT03146637", "json": [{"cohort": "Activated CIK armed with bispecific antibody treatment group", "disease_state": "Advanced Liver Cancer", "histology_inclusion": "Liver Cancer", "biomarker_inclusion": ["MUC1", "CEA", "EpCAM", "GPC3"], "histology_exclusion": [], "biomarker_exclusion": ["HIV antibody"]}], "json_norm": [{"cohort": "Activated CIK armed with bispecific antibody treatment group", "histology_inclusion": "Liver Cancer"}]}
{"NCT_id": "NCT04058756", "json": [{"cohort": "", "disease_state": "Advanced", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04552613", "json": [{"cohort": "", "disease_state": "Advanced", "histology_inclusion": "Non-small-cell lung cancer (NSCLC)", "biomarker_inclusion": ["EGFR positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Advanced", "histology_inclusion": "Non-small-cell lung cancer (NSCLC)", "biomarker_inclusion": ["T790M", "TP53", "RB1", "PTEN", "CDKN", "PIK3A", "DDR", "KRAS"], "histology_exclusion": ["brain metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT05529069", "json": [{"cohort": "", "disease_state": "Relapsed or Refractory MCL", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["Cyclin D1 positive", "CD20 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed or Refractory MCL", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["Cyclin D1 negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed High Risk MCL", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["Blastoid/pleomorphic histology", "High Ki-67 (\u226550%)", "TP53 mutated", "del17p by FISH", "NSD2", "NOTCH2", "CDKN2A mutated", "MYC positive by FISH", "MYC, Bcl2 amplification", "complex karyotype", "high risk biologic MIPI score"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System involvement by lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"], ["CCND1-High", "CCND1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["CCND1-Low", "CCND1-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["CDKN2A Mutation", "CDKN2A-Mutation", "gene"], ["BCL2-High", "BCL2-High", "expression"], ["MKI67-High", "MKI67-High", "expression"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["MYC-High", "MYC-High", "expression"]]}, {"cohort": ""}]}
{"NCT_id": "NCT04189055", "json": [{"cohort": "Cohort #1", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["RAS mutant (either KRAS or NRAS tumor gene mutation)"], "histology_exclusion": [], "biomarker_exclusion": ["BRAF mutant"]}, {"cohort": "Cohort #2", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["RAS mutant (either KRAS or NRAS tumor gene mutation)"], "histology_exclusion": [], "biomarker_exclusion": ["BRAF mutant"]}], "json_norm": [{"cohort": "Cohort #1", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]], "biomarker_exclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "Cohort #2", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]], "biomarker_exclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"]]}]}
{"NCT_id": "NCT04552769", "json": [{"cohort": "", "disease_state": "Metastatic or Locally Advanced", "histology_inclusion": "Anaplastic Thyroid Cancer", "biomarker_inclusion": ["BRAF V600E positive (with prior FDA approved therapy and progressed or intolerant)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Metastatic or Locally Advanced", "histology_inclusion": "Undifferentiated Thyroid Cancer", "biomarker_inclusion": ["BRAF V600E positive (with prior FDA approved therapy and progressed or intolerant)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Thyroid Gland Undifferentiated (Anaplastic) Carcinoma", "biomarker_inclusion": [["BRAF-High", "BRAF-High", "expression"], ["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Thyroid Gland Undifferentiated (Anaplastic) Carcinoma", "biomarker_inclusion": [["BRAF-High", "BRAF-High", "expression"], ["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT04943536", "json": [{"cohort": "Biolen+Radiation Therapy", "disease_state": "localized", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Biolen+Radiation Therapy", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT01028716", "json": [{"cohort": "", "disease_state": "remission", "histology_inclusion": "Acute Biphenotypic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "remission", "histology_inclusion": "Acute Erythroid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "remission", "histology_inclusion": "Acute Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "remission", "histology_inclusion": "Acute Lymphoblastic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Acute Myeloid Leukaemia With Prior Myelodysplastic Syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "remission", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["FLT3/ITD Mutation", "Inv(3)(Q21Q26.2); RPN1-EVI1", "t(6;9)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Acute Myeloid Leukemia With Multilineage Dysplasia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Acute Undifferentiated Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "complete remission", "histology_inclusion": "Adult Acute Lymphoblastic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "B Acute Lymphoblastic Leukemia", "biomarker_inclusion": ["T(1;19)(Q23;P13.3); E2A-PBX1 (TCF3-PBX1)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Ph+ ALL", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Burkitt Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "complete remission", "histology_inclusion": "Childhood Acute Lymphoblastic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "DS Stage II Plasma Cell Myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "DS Stage III Plasma Cell Myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Anaplastic Large Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Blasts Under 5 Percent of Bone Marrow Nucleated Cells", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Follicular Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Hodgkin Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Marginal Zone Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Plasma Cell Myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory", "histology_inclusion": "Plasma Cell Myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Secondary Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "T Lymphoblastic Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Hematopoietic Cell Transplant Recipient", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Infant Acute Biphenotypic Leukemia"}, {"cohort": "", "histology_inclusion": "Acute Biphenotypic Leukemia"}, {"cohort": "", "histology_inclusion": "Acute Erythroid Leukemia"}, {"cohort": "", "histology_inclusion": "Acute Leukemia"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["PSMD2 - MECOM", "PSMD2 - MECOM", "coordinate"], ["RPN1 - MECOM", "RPN1 - MECOM", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Undifferentiated Leukemia"}, {"cohort": "", "histology_inclusion": "Infant Acute Undifferentiated Leukemia"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "B Acute Lymphoblastic Leukemia", "biomarker_inclusion": [["TCF7L1 - PBX1", "TCF7L1 - PBX1", "coordinate"], ["TCF3 - PBX1", "TCF3 - PBX1", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["PAH-High", "PAH-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Burkitt Lymphoma"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Anaplastic Large Cell Lymphoma"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "", "histology_inclusion": "Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Marginal Zone Lymphoma"}, {"cohort": "", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "", "histology_inclusion": "Secondary Acute Myeloid Leukemia"}, {"cohort": "", "histology_inclusion": "Lymphoblastic Lymphoma"}, {"cohort": ""}]}
{"NCT_id": "NCT03993873", "json": [{"cohort": "Cohort I", "disease_state": "advanced/metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["MET\u0394ex14"], "histology_exclusion": ["CNS tumors", "brain metastases"], "biomarker_exclusion": ["ALK", "ROS1", "KRAS", "EGFR"]}, {"cohort": "Cohort II", "disease_state": "advanced/metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["MET\u0394ex14"], "histology_exclusion": ["CNS tumors", "brain metastases"], "biomarker_exclusion": ["ALK", "ROS1", "KRAS", "EGFR"]}, {"cohort": "Cohort III", "disease_state": "advanced/metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["MET amplified", "GCN\u226510"], "histology_exclusion": ["CNS tumors", "brain metastases"], "biomarker_exclusion": []}, {"cohort": "Cohort IV", "disease_state": "advanced/metastatic", "histology_inclusion": "GI cancer", "biomarker_inclusion": ["MET amplified", "GCN\u226510"], "histology_exclusion": ["CNS tumors", "brain metastases"], "biomarker_exclusion": ["HCC with MET alterations and liver dysfunction greater than Child-Pugh Class A"]}, {"cohort": "Cohort V", "disease_state": "advanced/metastatic", "histology_inclusion": "NSCLC or GI", "biomarker_inclusion": ["MET amplified", "GCN\u22655", "GCN<10"], "histology_exclusion": ["CNS tumors", "brain metastases"], "biomarker_exclusion": []}, {"cohort": "Cohort VI", "disease_state": "advanced/metastatic", "histology_inclusion": "Solid tumors", "biomarker_inclusion": ["MET fusions", "oncogenic MET mutations", "MET amplified"], "histology_exclusion": ["CNS tumors", "brain metastases", "GI", "NSCLC"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort I", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Cohort II", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Cohort III", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]], "histology_exclusion": ["Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Cohort IV", "histology_inclusion": "Digestive System Neoplasm", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]], "histology_exclusion": ["Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"], "biomarker_exclusion": [["FAM126A Mutation", "FAM126A-Mutation", "gene"], ["MET Mutation", "MET-Mutation", "gene"], ["SLTM Mutation", "SLTM-Mutation", "gene"]]}, {"cohort": "Cohort V", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]], "histology_exclusion": ["Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Cohort VI", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["MET Mutation", "MET-Mutation", "gene"], ["SLTM Fusion", "SLTM", "fusion"], ["SLTM Mutation", "SLTM-Mutation", "gene"], ["MET Fusion", "MET", "fusion"]], "histology_exclusion": ["Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Non-Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT04943627", "json": [{"cohort": "", "disease_state": "recurrent or metastatic cervical cancer", "histology_inclusion": "squamous cell carcinoma (SCC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or metastatic cervical cancer", "histology_inclusion": "adenocarcinoma (AC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or metastatic cervical cancer", "histology_inclusion": "adenosquamous carcinoma (ASC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Cervical Adenosquamous Carcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Adenosquamous Carcinoma"}]}
{"NCT_id": "NCT04943718", "json": [{"cohort": "personalized vaccine", "disease_state": "recurrent", "histology_inclusion": "malignant glioma", "biomarker_inclusion": [">10 TMB", "genetically unstable", "at least 10 neoantigens"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "personalized vaccine", "histology_inclusion": "Malignant Glioma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"]]}]}
{"NCT_id": "NCT03146962", "json": [{"cohort": "A", "disease_state": "early stage or locally advanced", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "A", "disease_state": "early stage or locally advanced", "histology_inclusion": "lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "A", "disease_state": "early stage or locally advanced", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "B", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["extended RAS (e.g. KRAS or NRAS)", "BRAF mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "B", "disease_state": "metastatic", "histology_inclusion": "lung cancer", "biomarker_inclusion": ["extended RAS (e.g. KRAS or NRAS)", "BRAF mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "B", "disease_state": "metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["extended RAS (e.g. KRAS or NRAS)", "BRAF mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "C", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["extended RAS (e.g. KRAS or NRAS)", "BRAF mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "A", "histology_inclusion": "Colorectal Adenocarcinoma"}, {"cohort": "A", "histology_inclusion": "Lung Carcinoma"}, {"cohort": "A", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "B", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "B", "histology_inclusion": "Lung Carcinoma", "biomarker_inclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "B", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "C", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"]]}]}
{"NCT_id": "NCT03668340", "json": [{"cohort": "Part A and C", "disease_state": "recurrent or persistent", "histology_inclusion": "uterine serous carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases", "CNS disease"], "biomarker_exclusion": ["MSI-high", "MMR-deficient"]}, {"cohort": "Part B", "disease_state": "recurrent", "histology_inclusion": "uterine carcinosarcoma", "biomarker_inclusion": ["p53 alteration"], "histology_exclusion": ["brain metastases", "CNS disease"], "biomarker_exclusion": ["MSI-high", "MMR-deficient"]}], "json_norm": [{"cohort": "Part A and C", "histology_inclusion": "Endometrial Serous Adenocarcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Part B", "histology_inclusion": "Uterine Corpus Carcinosarcoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Part B", "histology_inclusion": "Uterine Carcinosarcoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04357587", "json": [{"cohort": "", "disease_state": "stage II (T3-4, N0), stage III (T1-4, N+), or oligometastatic locally advanced stage IV", "histology_inclusion": "rectal adenocarcinoma", "biomarker_inclusion": ["dMMR", "MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Rectal Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04943848", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "Diffuse Midline Glioma, H3 K27M-Mutant", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma"}, {"cohort": "", "histology_inclusion": "Diffuse Midline Glioma, H3 K27M-Mutant", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}]}
{"NCT_id": "NCT03668431", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["BRAF V600E", "KRAS wild-type", "NRAS wild-type"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04189445", "json": [{"cohort": "Cohort A", "disease_state": "locally-advanced, advanced, or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["FGFR1 rearrangement", "FGFR2 rearrangement", "FGFR3 rearrangement", "FGFR4 rearrangement"], "histology_exclusion": ["primary brain tumors", "intrahepatic cholangiocarcinoma"], "biomarker_exclusion": ["prior treatment with FGFR inhibitor", "untreated or unstable brain metastases"]}, {"cohort": "Cohort B", "disease_state": "locally-advanced, advanced, or metastatic", "histology_inclusion": "gastric or gastroesophageal junction cancer", "biomarker_inclusion": ["FGFR2 amplification"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with FGFR inhibitor", "untreated or unstable brain metastases"]}, {"cohort": "Cohort C", "disease_state": "", "histology_inclusion": "myeloid or lymphoid neoplasms", "biomarker_inclusion": ["FGFR1 rearrangement"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with FGFR inhibitor", "untreated or unstable brain metastases"]}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"], ["FGFR4 Fusion", "FGFR4", "fusion"], ["FGFR1 Fusion", "FGFR1", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm", "Intrahepatic Cholangiocarcinoma"]}, {"cohort": "Cohort B", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["FGFR2-High", "FGFR2-High", "expression"]]}, {"cohort": "Cohort C", "histology_inclusion": "Lymphoma", "biomarker_inclusion": [["FGFR1 Fusion", "FGFR1", "fusion"]]}, {"cohort": "Cohort C", "histology_inclusion": "Lymphocytic Neoplasm", "biomarker_inclusion": [["FGFR1 Fusion", "FGFR1", "fusion"]]}]}
{"NCT_id": "NCT04488003", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Advanced Solid Tumor", "biomarker_inclusion": ["MEK alteration", "atypical BRAF alteration"], "histology_exclusion": [], "biomarker_exclusion": ["ERK inhibitor (e.g. LY3214996, LTT462)", "BRAF and/or MEK inhibitor (e.g. encorafenib, dabrafenib, vemurafenib, binimetinib, trametinib, cobimetinib)"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"]]}]}
{"NCT_id": "NCT04553133", "json": [{"cohort": "HR-positive HER2-negative advanced or metastatic breast cancer", "disease_state": "advanced or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["HR-positive", "HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "locally recurrent/advanced or metastatic TNBC", "disease_state": "locally recurrent/advanced or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["TNBC"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "advanced platinum resistant epithelial ovarian cancer (EOC)/fallopian tube cancer/primary peritoneal cancer (PPC)", "disease_state": "advanced", "histology_inclusion": "epithelial ovarian cancer", "biomarker_inclusion": ["platinum resistant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "advanced platinum resistant fallopian tube cancer", "disease_state": "advanced", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": ["platinum resistant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "advanced platinum resistant primary peritoneal cancer (PPC)", "disease_state": "advanced", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": ["platinum resistant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "advanced/metastatic SCLC", "disease_state": "advanced/metastatic", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "advanced/metastatic NSCLC", "disease_state": "advanced/metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "HR-positive HER2-negative advanced or metastatic breast cancer (second line plus setting)", "disease_state": "advanced or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["HR-positive", "HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "HR-positive HER2-negative advanced or metastatic breast cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "locally recurrent/advanced or metastatic TNBC", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "advanced platinum resistant epithelial ovarian cancer (EOC)/fallopian tube cancer/primary peritoneal cancer (PPC)", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "advanced platinum resistant fallopian tube cancer", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "advanced platinum resistant primary peritoneal cancer (PPC)", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "advanced/metastatic SCLC", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "advanced/metastatic NSCLC", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "HR-positive HER2-negative advanced or metastatic breast cancer (second line plus setting)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT04683354", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04943900", "json": [{"cohort": "", "disease_state": "locally advanced unresectable, metastatic, or recurrent", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced unresectable, metastatic, or recurrent", "histology_inclusion": "Urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced unresectable, metastatic, or recurrent", "histology_inclusion": "Squamous cell carcinoma of the head and neck", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced unresectable, metastatic, or recurrent", "histology_inclusion": "Hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced unresectable, metastatic, or recurrent", "histology_inclusion": "Microsatellite-stable colorectal carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced unresectable, metastatic, or recurrent", "histology_inclusion": "Pancreatic ductal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma"}]}
{"NCT_id": "NCT03212404", "json": [{"cohort": "", "disease_state": "unresectable recurrent or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["microsatellite instability-high (MSI-H)", "mismatch repair deficient (dMMR)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, recurrent or metastatic", "histology_inclusion": "endometrial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "cutaneous squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable", "histology_inclusion": "malignant pleural or peritoneal mesothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable Stage III or metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": ["uveal or ocular melanoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "Merkel cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "renal cell carcinoma", "biomarker_inclusion": ["clear cell component"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "transitional cell carcinoma of the urothelium", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "classical Hodgkin's lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "non-Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "", "histology_inclusion": "Skin Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Peritoneal Malignant Mesothelioma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Melanoma", "histology_exclusion": ["Ocular Melanoma"]}, {"cohort": "", "histology_inclusion": "Merkel Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Transitional Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Classic Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Non-Hodgkin Lymphoma"}]}
{"NCT_id": "NCT03864042", "json": [{"cohort": "", "disease_state": "locally advanced, unresectable or metastatic cutaneous melanoma or unknown primary melanoma AJCC Stage IIIB, IIIC or IV", "histology_inclusion": "cutaneous melanoma or unknown primary melanoma", "biomarker_inclusion": ["BRAF V600E", "BRAF V600K"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "BRAF V600-mutant advanced solid tumors", "histology_inclusion": "advanced solid tumors", "biomarker_inclusion": ["BRAF V600E", "BRAF V600K"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}]}
{"NCT_id": "NCT04319757", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["HER2 IHC 2+ or above"], "histology_exclusion": ["untreated central nervous system (CNS) metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04423029", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "head and neck squamous cell", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "urothelial", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "gastric", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "esophageal", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "cervical", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "hepatocellular", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "merkel cell", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "cutaneous squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "renal cell", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "endometrial", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "triple-negative breast", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "ovarian", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "prostate", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": ""}, {"cohort": ""}, {"cohort": ""}, {"cohort": ""}, {"cohort": ""}, {"cohort": ""}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Skin Squamous Cell Carcinoma"}, {"cohort": ""}, {"cohort": ""}, {"cohort": "", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": ""}, {"cohort": ""}]}
{"NCT_id": "NCT05269381", "json": [{"cohort": "Cohort 1", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "solid malignancies", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "head and neck squamous cell cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "microsatellite instability-high tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "gastric or gastroesophageal junction adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "cervical cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "merkel cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "endometrial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "tumor mutational burden-high cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "cutaneous squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "triple-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1"}, {"cohort": "Cohort 2", "histology_inclusion": "Melanoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "Cohort 2", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort 2", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Merkel Cell Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "Cohort 2", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Cohort 2", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Skin Squamous Cell Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}]}
{"NCT_id": "NCT02810743", "json": [{"cohort": "", "disease_state": "stage III", "histology_inclusion": "adenocarcinoma of the breast", "biomarker_inclusion": ["HER2-negative", "homologous recombination deficiency (HRD)"], "histology_exclusion": [], "biomarker_exclusion": ["PARP-inhibitor treatment"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT04189757", "json": [{"cohort": "Ibrutinib-Intolerant Mantle Cell Lymphoma", "disease_state": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["CD20 positivity", "chromosome translocation t(11;14) (q13;q32)", "overexpress cyclin D1"], "histology_exclusion": ["Central Nervous System involvement with Mantle Cell Lymphoma", "suspected or confirmed progressive multifocal leukoencephalopathy"], "biomarker_exclusion": ["BTK mutations conferring resistance to BTK inhibitors (e.g. BTK C481S, C481R mutations)", "progressive disease while on ibrutinib therapy", "drug-specific hypersensitivity or anaphylaxis to ibrutinib"]}], "json_norm": [{"cohort": "Ibrutinib-Intolerant Mantle Cell Lymphoma", "histology_inclusion": "Mantle Cell Lymphoma", "histology_exclusion": ["Mantle Cell Lymphoma"]}]}
{"NCT_id": "NCT05009329", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT05659914", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the pancreas", "biomarker_inclusion": ["DDR genes alterations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}]}
{"NCT_id": "NCT03994484", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["metastatic brain/meningeal tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT03734198", "json": [{"cohort": "Relapsed or Refractory Chronic Lymphocytic Leukemia with p53 Dysfunction", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": ["17p deletion", "TP53 mutation"], "histology_exclusion": ["Richter's transformation", "Central Nervous System involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Relapsed or Refractory Chronic Lymphocytic Leukemia with p53 Dysfunction", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]], "histology_exclusion": ["Richter Syndrome"]}]}
{"NCT_id": "NCT04358185", "json": [{"cohort": "Advanced Hepatocellular Carcinoma", "disease_state": "advanced", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Advanced Hepatocellular Carcinoma", "histology_inclusion": "Hepatocellular Carcinoma"}]}
{"NCT_id": "NCT04879368", "json": [{"cohort": "", "disease_state": "metastatic or locally recurrent", "histology_inclusion": "adenocarcinoma or undifferentiated carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or locally recurrent", "histology_inclusion": "HER2-positive", "biomarker_inclusion": ["trastuzumab"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Undifferentiated Carcinoma"}, {"cohort": "", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT03603951", "json": [{"cohort": "", "disease_state": "Relapsed or Refractory Mature Lymphoid Neoplasms", "histology_inclusion": "Mature lymphoid neoplasms", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed or Refractory Mature Lymphoid Neoplasms", "histology_inclusion": "Peripheral T cell lymphomas", "biomarker_inclusion": [], "histology_exclusion": ["FL 3b", "transformed FL", "central nerves invasion"], "biomarker_exclusion": ["EZH2 inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Lymphoma"}, {"cohort": "", "histology_inclusion": "Lymphocytic Neoplasm"}, {"cohort": ""}]}
{"NCT_id": "NCT03929666", "json": [{"cohort": "Part 1 - GEA", "disease_state": "Unresectable, locally advanced, recurrent or metastatic", "histology_inclusion": "Gastroesophageal Adenocarcinoma", "biomarker_inclusion": ["HER2-expressing (IHC 3+ or 2+ with or without gene amplification)"], "histology_exclusion": [], "biomarker_exclusion": ["Prior treatment with a HER2-targeted agent"]}, {"cohort": "Part 1 - BTC", "disease_state": "Unresectable, locally advanced, recurrent or metastatic", "histology_inclusion": "Biliary Tract Cancer (including Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, or Gallbladder Cancer)", "biomarker_inclusion": ["HER2-expressing (IHC 3+ with or without gene amplification; or IHC 0, 1+ or 2+ with gene amplification)"], "histology_exclusion": [], "biomarker_exclusion": ["Prior treatment with a HER2-targeted agent", "More than one cycle of any standard gemcitabine-based chemotherapy regimen"]}, {"cohort": "Part 1 - CRC", "disease_state": "Unresectable, locally advanced, recurrent or metastatic", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["HER2-expressing (IHC 3+ with or without gene amplification; or IHC 0, 1+ or 2+ with gene amplification)", "Extended RAS (KRAS and NRAS) and BRAF wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["Prior treatment with a HER2-targeted agent", "More than one cycle of 5-FU-based chemotherapy (< 1 month of therapy)"]}, {"cohort": "Part 2 - GEA", "disease_state": "Unresectable, locally advanced, recurrent or metastatic", "histology_inclusion": "Gastroesophageal Adenocarcinoma", "biomarker_inclusion": ["HER2-expressing (IHC 3+, or IHC 2+ and FISH+)"], "histology_exclusion": [], "biomarker_exclusion": ["Prior treatment with a HER2-targeted agent"]}, {"cohort": "Part 2 - BTC", "disease_state": "Unresectable, locally advanced, recurrent or metastatic", "histology_inclusion": "Biliary Tract Cancer (including Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, or Gallbladder Cancer)", "biomarker_inclusion": ["HER2-expressing (IHC 3+ with or without gene amplification; or IHC 0, 1+ or 2+ with gene amplification)"], "histology_exclusion": [], "biomarker_exclusion": ["Prior treatment with a HER2-targeted agent", "More than one cycle of any standard gemcitabine-based chemotherapy regimen"]}, {"cohort": "Part 2 - CRC", "disease_state": "Unresectable, locally advanced, recurrent or metastatic", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["HER2-expressing (IHC 3+ with or without gene amplification; or IHC 0, 1+ or 2+ with gene amplification)", "Extended RAS (KRAS and NRAS) and BRAF wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["Prior treatment with a HER2-targeted agent", "More than one cycle of 5-FU-based chemotherapy (< 1 month of therapy)"]}], "json_norm": [{"cohort": "Part 1 - GEA", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part 1 - BTC", "histology_inclusion": "Liver Cancer", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part 1 - BTC", "histology_inclusion": "Biliary Tract Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part 1 - BTC", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part 1 - BTC", "histology_inclusion": "Gallbladder Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part 1 - BTC", "histology_inclusion": "Intrahepatic Cholangiocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part 1 - CRC", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]]}, {"cohort": "Part 2 - GEA", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["SH3PXD2A-High", "SH3PXD2A-High", "expression"]]}, {"cohort": "Part 2 - BTC", "histology_inclusion": "Liver Cancer", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part 2 - BTC", "histology_inclusion": "Biliary Tract Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part 2 - BTC", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part 2 - BTC", "histology_inclusion": "Gallbladder Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part 2 - BTC", "histology_inclusion": "Intrahepatic Cholangiocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part 2 - CRC", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT05074810", "json": [{"cohort": "", "disease_state": "Stage 3B-C or 4", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["G12C KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT01296178", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Acute Myeloblastic Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["promyelocytic leukemia", "AML secondary to chronic myeloproliferative syndrome"], "biomarker_exclusion": ["t (15, 17)", "PML-RARa rearrangement"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Secondary Acute Myeloid Leukemia", "Acute Promyelocytic Leukemia with PML-RARA"], "biomarker_exclusion": [["PML Fusion", "PML", "fusion"], ["RARA Fusion", "RARA", "fusion"], ["PML - RARA", "PML - RARA", "coordinate"]]}]}
{"NCT_id": "NCT04492488", "json": [{"cohort": "Solid Tumors", "disease_state": "metastatic, unresectable", "histology_inclusion": "HER2-positive advanced solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastases"], "biomarker_exclusion": []}, {"cohort": "Locally Advanced or Metastatic Gastric/GEJ Cancer", "disease_state": "locally advanced or metastatic", "histology_inclusion": "gastric/gastroesophageal junction (GEJ) cancer", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": ["central nervous system (CNS) metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Solid Tumors", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Locally Advanced or Metastatic Gastric/GEJ Cancer", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT05078671", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "high grade serious epithelial ovarian cancer", "biomarker_inclusion": ["BRCA-mutated"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": ["BRCA-mutated"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "peritoneal cancer", "biomarker_inclusion": ["BRCA-mutated"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["germline BRCA1/2-mutated", "HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic castration-resistant", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["BRCA1/2-mutated"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT05338970", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": ["EGFR exon 19 deletion", "EGFR L858R"], "histology_exclusion": ["small cell", "combined small cell/non-small cell", "squamous NSCLC"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]], "histology_exclusion": ["Squamous Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT02162563", "json": [{"cohort": "", "disease_state": "unresectable liver-only metastases", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["RAS mutation", "BRAF mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable liver-only metastases", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["RAS wildtype", "BRAF wildtype"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04194359", "json": [{"cohort": "Sintilimab (IBI308) plus Bevacizumab, Oxaliplatin and Capecitabine", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["RAS gene mutation", "BRAF wild-type", "microsatellite stable"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Sintilimab (IBI308) plus Bevacizumab, Oxaliplatin and Capecitabine", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04259450", "json": [{"cohort": "Phase 1", "disease_state": "advanced or metastatic", "histology_inclusion": "solid malignancies", "biomarker_inclusion": ["EGFR"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2a - Colorectal Cancer, KRAS-wildtype", "disease_state": "advanced or metastatic", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["EGFR", "KRAS-wildtype"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2a - ccRCC", "disease_state": "advanced or metastatic", "histology_inclusion": "ccRCC", "biomarker_inclusion": ["EGFR"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2a - metastatic NSCLC, EGFRmut", "disease_state": "metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["EGFRmut"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1"}, {"cohort": "Phase 2a - Colorectal Cancer, KRAS-wildtype", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"]]}, {"cohort": "Phase 2a - ccRCC", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}, {"cohort": "Phase 2a - metastatic NSCLC, EGFRmut", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT03282396", "json": [{"cohort": "", "disease_state": "High risk smoldering MCL", "histology_inclusion": "Mantle Cell Lymphoma with CD20 and cyclin D1 positivity or cyclin D1 negative MCL classic histology", "biomarker_inclusion": ["Ki-67 of 15-30%", "WBC 15-30k", "Lymph node size 3-5 cm in diameter", "Complex karyotype", "TP53 mutated or wild type and/or del17p (FISH% 10-50%)", "MYC positive MCL", "Presence of either or KMT2D, BIRC3, NOTCH2, NSD2 or more than one mutation in the initial NGS panel testing"], "histology_exclusion": ["Blastoid variant histology", "Pleomorphic variant histology", "Central nervous system (CNS) involvement at diagnosis"], "biomarker_exclusion": ["Ki-67 > 30%", "Prior exposure to BTK inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["CCND1-Low", "CCND1-Low", "expression"], ["CLEC4D-Low", "CLEC4D-Low", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SH3PXD2A Mutation", "SH3PXD2A-Mutation", "gene"], ["CLEC4D-High", "CLEC4D-High", "expression"], ["MYC-High", "MYC-High", "expression"], ["KMT2D Mutation", "KMT2D-Mutation", "gene"], ["BIRC3 Mutation", "BIRC3-Mutation", "gene"], ["NSD2 Mutation", "NSD2-Mutation", "gene"], ["NOTCH2 Mutation", "NOTCH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["KMT2D Mutation", "KMT2D-Mutation", "gene"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["CLEC4D-High", "CLEC4D-High", "expression"], ["NSD2 Mutation", "NSD2-Mutation", "gene"], ["NOTCH2 Mutation", "NOTCH2-Mutation", "gene"], ["SH3PXD2A Mutation", "SH3PXD2A-Mutation", "gene"], ["BIRC3 Mutation", "BIRC3-Mutation", "gene"], ["CCND1-Low", "CCND1-Low", "expression"], ["CLEC4D-Low", "CLEC4D-Low", "expression"], ["MYC-High", "MYC-High", "expression"]]}]}
{"NCT_id": "NCT03543306", "json": [{"cohort": "", "disease_state": "unresectable stage IIIB/IV", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": ["symptomatic central nervous system (CNS) metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT03803761", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) metastatic breast cancer", "biomarker_inclusion": ["PIK3CA mutation", "PTEN mutation"], "histology_exclusion": ["brain metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PTEN Mutation", "PTEN-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}]}
{"NCT_id": "NCT04194554", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT04362839", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of colon or rectal", "biomarker_inclusion": ["pMMR", "MSS"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04493060", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "pancreatic ductal adenocarcinoma", "biomarker_inclusion": ["germline deleterious mutation in BRCA1/2", "germline deleterious mutation in PALB2", "germline deleterious mutation in BARD1", "germline deleterious mutation in RAD51c", "germline deleterious mutation in RAD51d", "somatic deleterious mutation in BRCA1/2", "somatic deleterious mutation in PALB2", "somatic deleterious mutation in BARD1", "somatic deleterious mutation in RAD51c", "somatic deleterious mutation in RAD51d"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": [["RAD51C Mutation", "RAD51C-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BARD1 Mutation", "BARD1-Mutation", "gene"], ["RAD51D Mutation", "RAD51D-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT05404516", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Core Binding Factor Acute Myeloid Leukemia", "biomarker_inclusion": ["RUNX1/RUNX1T1", "CBFB/MYH11"], "histology_exclusion": ["Central nervous system involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}]}
{"NCT_id": "NCT03152318", "json": [{"cohort": "", "disease_state": "recurrent or progressive", "histology_inclusion": "Malignant Glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or progressive", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": ["IDH wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["IDH1 R132H mutation", "alternative mutation of IDH1 or 2"]}, {"cohort": "", "disease_state": "recurrent or progressive", "histology_inclusion": "Malignant Astrocytoma", "biomarker_inclusion": ["IDH wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["IDH1 R132H mutation", "alternative mutation of IDH1 or 2"]}, {"cohort": "", "disease_state": "recurrent or progressive", "histology_inclusion": "Oligodendroglioma", "biomarker_inclusion": ["IDH wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["IDH1 R132H mutation", "alternative mutation of IDH1 or 2"]}, {"cohort": "", "disease_state": "recurrent or progressive", "histology_inclusion": "Anaplastic Oligodendroglioma", "biomarker_inclusion": ["IDH wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["IDH1 R132H mutation", "alternative mutation of IDH1 or 2"]}, {"cohort": "", "disease_state": "recurrent or progressive", "histology_inclusion": "Mixed Oligo-Astrocytoma", "biomarker_inclusion": ["IDH wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["IDH1 R132H mutation", "alternative mutation of IDH1 or 2"]}, {"cohort": "", "disease_state": "recurrent or progressive", "histology_inclusion": "Ependymoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or progressive", "histology_inclusion": "Ganglioglioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or progressive", "histology_inclusion": "Pylocytic/Pylomyxoid Astrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or progressive", "histology_inclusion": "Glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or progressive", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["IDH wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["IDH1 R132H mutation", "alternative mutation of IDH1 or 2"]}, {"cohort": "", "disease_state": "recurrent or progressive", "histology_inclusion": "Glioblastoma Multiforme", "biomarker_inclusion": ["IDH wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["IDH1 R132H mutation", "alternative mutation of IDH1 or 2"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Glioma"}, {"cohort": "", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH1 R132H", "R132H", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Anaplastic Astrocytoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH1 R132H", "R132H", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Oligodendroglioma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH1 R132H", "R132H", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Anaplastic Oligodendroglioma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH1 R132H", "R132H", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Oligoastrocytoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH1 R132H", "R132H", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Ependymoma"}, {"cohort": "", "histology_inclusion": "Ganglioglioma"}, {"cohort": "", "histology_inclusion": "Astrocytoma"}, {"cohort": "", "histology_inclusion": "Glioma"}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH1 R132H", "R132H", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "biomarker_exclusion": [["IDH1 R132H", "R132H", "coordinate"], ["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH1 R132H", "R132H", "coordinate"]]}]}
{"NCT_id": "NCT04129502", "json": [{"cohort": "", "disease_state": "locally advanced not suitable for definitive therapy, recurrent, or metastatic (Stage IV)", "histology_inclusion": "nonsquamous cell non-small cell lung cancer", "biomarker_inclusion": ["EGFR exon 20 insertion mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR exon 19 del", "EGFR L858R", "EGFR T790M", "EGFR L861Q", "EGFR G719X", "EGFR S768I"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR L861Q", "L861Q", "coordinate"], ["EGFR L858R", "L858R", "coordinate"], ["EGFR S768I", "S768I", "coordinate"], ["EGFR T790M", "T790M", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT04493138", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": ["FLT3-ITD mutation", "CBL exon 8 or 9 deletions", "CBL exon 8 or 9 point mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Myelodysplastic/Myeloproliferative Neoplasm", "biomarker_inclusion": ["FLT3-ITD mutation", "CBL exon 8 or 9 deletions", "CBL exon 8 or 9 point mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": ["FLT3-ITD mutation", "CBL exon 8 or 9 deletions", "CBL exon 8 or 9 point mutations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["CBL Mutation", "CBL-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Myelodysplastic/Myeloproliferative Disease", "biomarker_inclusion": [["CBL Mutation", "CBL-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": [["CBL Mutation", "CBL-Mutation", "gene"]]}]}
{"NCT_id": "NCT04493164", "json": [{"cohort": "", "disease_state": "treatment naive or relapsed/refractory AML", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": ["IDH1-R132 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high-risk MDS or MPN", "histology_inclusion": "myelodysplastic syndrome", "biomarker_inclusion": ["IDH1-R132 mutation"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high-risk MDS or MPN", "histology_inclusion": "myeloproliferative neoplasm", "biomarker_inclusion": ["IDH1-R132 mutation"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "histology_inclusion": "Myeloproliferative Neoplasm", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "histology_inclusion": "Myelodysplastic/Myeloproliferative Disease", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT04688658", "json": [{"cohort": "", "disease_state": "unresectable stage IIIB, stage IIIC, stage IIID or stage IV melanoma", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": [], "histology_exclusion": ["uveal melanoma", "mucosal melanoma", "CNS metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Cutaneous Melanoma", "histology_exclusion": ["Mucosal Melanoma", "Intraocular Melanoma"]}]}
{"NCT_id": "NCT04949113", "json": [{"cohort": "", "disease_state": "Stage III", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": [], "histology_exclusion": ["uveal/ocular melanoma", "mucosal melanoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III", "histology_inclusion": "unknown primary melanoma", "biomarker_inclusion": [], "histology_exclusion": ["uveal/ocular melanoma", "mucosal melanoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Cutaneous Melanoma", "histology_exclusion": ["Mucosal Melanoma", "Ocular Melanoma"]}, {"cohort": "", "histology_inclusion": "Melanoma", "histology_exclusion": ["Mucosal Melanoma", "Ocular Melanoma"]}]}
{"NCT_id": "NCT04949191", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "malignancies", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}]}
{"NCT_id": "NCT03608631", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "pancreatic ductal adenocarcinoma", "biomarker_inclusion": ["KrasG12D mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma"}]}
{"NCT_id": "NCT05014360", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Familial Adenomatous Polyposis", "biomarker_inclusion": ["APC germline mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["APC Mutation", "APC-Mutation", "gene"]]}]}
{"NCT_id": "NCT05469893", "json": [{"cohort": "", "disease_state": "High-risk Smoldering Multiple Myeloma", "histology_inclusion": "Smoldering Multiple Myeloma", "biomarker_inclusion": ["t(4,14)", "t(14,16)", "1q gain", "del13q", "t(4;14)", "t(14;16)", "t(14;20)", "17p deletion", "TP53 mutation", "1q21 gain"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Smoldering Plasma Cell Myeloma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT05599984", "json": [{"cohort": "Part 1", "disease_state": "Advanced recurrent or refractory", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["high-grade central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "Advanced recurrent or refractory", "histology_inclusion": "high-grade central nervous system tumors", "biomarker_inclusion": ["glioblastoma", "IDH-wildtype Grade 4", "oligodendroglioma", "IDH-mutant", "1p/19q-codeleted Grade 3", "astrocytoma", "IDH-mutant Grade 3 or Grade 4"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "Advanced recurrent or refractory", "histology_inclusion": "neuroendocrine prostate cancer", "biomarker_inclusion": [], "histology_exclusion": ["high-grade central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "Advanced recurrent or refractory", "histology_inclusion": "high-grade poorly differentiated gastroenteropancreatic neuroendocrine carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["high-grade central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "Advanced recurrent or refractory", "histology_inclusion": "large cell neuroendocrine carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["high-grade central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "Advanced recurrent or refractory", "histology_inclusion": "small cell lung cancer transformed from epidermal growth factor receptor mutant non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["high-grade central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "Advanced recurrent or refractory", "histology_inclusion": "atypical lung carcinoids", "biomarker_inclusion": [], "histology_exclusion": ["high-grade central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "Advanced recurrent or refractory", "histology_inclusion": "other high-grade poorly differentiated neuroendocrine carcinomas", "biomarker_inclusion": [], "histology_exclusion": ["high-grade central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "relapsed or refractory", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["high-grade central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part 3a", "disease_state": "relapsed or refractory", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["high-grade central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part 3a", "disease_state": "relapsed or refractory", "histology_inclusion": "poorly differentiated neuroendocrine carcinomas", "biomarker_inclusion": ["neuroendocrine prostate cancer", "gastroenteropancreatic neuroendocrine carcinomas", "large cell neuroendocrine carcinoma", "small cell lung cancer transformed from epidermal growth factor receptor mutant non-small cell lung cancer", "atypical lung carcinoids"], "histology_exclusion": ["high-grade central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part 3b", "disease_state": "relapsed or refractory", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["high-grade central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part 3b", "disease_state": "relapsed or refractory", "histology_inclusion": "neuroendocrine carcinomas", "biomarker_inclusion": ["neuroendocrine prostate cancer", "gastroenteropancreatic neuroendocrine carcinomas", "large cell neuroendocrine carcinoma", "small cell lung cancer transformed from epidermal growth factor receptor mutant non-small cell lung cancer", "atypical lung carcinoids"], "histology_exclusion": ["high-grade central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part 4a", "disease_state": "relapsed or refractory", "histology_inclusion": "high-grade central nervous system tumors", "biomarker_inclusion": ["glioblastoma", "IDH-wildtype Grade 4", "oligodendroglioma", "IDH-mutant", "1p/19q-codeleted Grade 3", "astrocytoma", "IDH-mutant Grade 3 or Grade 4"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 4b", "disease_state": "relapsed or refractory", "histology_inclusion": "neuroendocrine tumors", "biomarker_inclusion": ["neuroendocrine prostate cancer", "gastroenteropancreatic neuroendocrine carcinomas", "large cell neuroendocrine carcinoma", "small cell lung cancer transformed from epidermal growth factor receptor mutant non-small cell lung cancer", "atypical lung carcinoids"], "histology_exclusion": ["high-grade central nervous system tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 1", "histology_inclusion": "Small Cell Lung Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Part 1", "histology_inclusion": "Primary Central Nervous System Neoplasm", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Part 1", "histology_inclusion": "Malignant Central Nervous System Neoplasm", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Part 1", "histology_inclusion": "Central Nervous System Neoplasm", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Part 1", "histology_inclusion": "Prostate Neoplasm", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Part 1", "histology_inclusion": "Prostate Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Part 1", "histology_inclusion": "Digestive System Neuroendocrine Tumor", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Part 1", "histology_inclusion": "Digestive System Neuroendocrine Neoplasm", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Part 1", "histology_inclusion": "Large Cell Neuroendocrine Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Part 1", "histology_inclusion": "Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Part 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Part 1", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Part 1", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Part 2", "histology_inclusion": "Small Cell Lung Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Part 3a", "histology_inclusion": "Small Cell Lung Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Part 3a", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Part 3b", "histology_inclusion": "Small Cell Lung Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Part 3b", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Part 4a", "histology_inclusion": "Primary Central Nervous System Neoplasm", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Part 4a", "histology_inclusion": "Malignant Central Nervous System Neoplasm", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Part 4a", "histology_inclusion": "Central Nervous System Neoplasm", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Part 4b", "histology_inclusion": "Neuroendocrine Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Part 4b", "histology_inclusion": "Lung Neuroendocrine Neoplasm", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Part 4b", "histology_inclusion": "Neuroendocrine Tumor", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT04194944", "json": [{"cohort": "", "disease_state": "Stage IIIB-IIIC or Stage IV", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["RET fusion-positive"], "histology_exclusion": [], "biomarker_exclusion": ["Additional validated oncogenic drivers in NSCLC"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"], ["RET-High", "RET-High", "expression"]]}]}
{"NCT_id": "NCT04363242", "json": [{"cohort": "Part A", "disease_state": "recurrent or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "", "histology_inclusion": "epithelial cancers", "biomarker_inclusion": ["EGFR expressions"], "histology_exclusion": ["central nervous system metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part B", "histology_inclusion": "Epithelial Neoplasm"}]}
{"NCT_id": "NCT04819100", "json": [{"cohort": "", "disease_state": "Stage IB, II, or IIIA", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["RET gene fusion"], "histology_exclusion": ["Small Cell Lung Cancer"], "biomarker_exclusion": ["Additional oncogenic drivers in NSCLC"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"]], "histology_exclusion": ["Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT04949425", "json": [{"cohort": "Patients with advanced solid tumours", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumour", "biomarker_inclusion": [], "histology_exclusion": ["lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Patients with advanced solid tumours", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Lymphoma"]}]}
{"NCT_id": "NCT05144698", "json": [{"cohort": "", "disease_state": "Advanced metastatic, recurrent, and unresectable solid tumor", "histology_inclusion": "Small cell and non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Advanced metastatic, recurrent, and unresectable solid tumor", "histology_inclusion": "Breast cancer (triple-negative sub-type or relapse after ovarian ablation/suppression)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Advanced metastatic, recurrent, and unresectable solid tumor", "histology_inclusion": "Gastric cancer (esophageal and esophageal-gastric-junction adenocarcinoma; gastric adenocarcinoma; esophageal squamous cell carcinoma)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Advanced metastatic, recurrent, and unresectable solid tumor", "histology_inclusion": "Head and neck cancer (squamous cell carcinoma of oral cavity, larynx, nasopharynx, and other sites)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Advanced metastatic, recurrent, and unresectable solid tumor", "histology_inclusion": "Carcinoma of unknown primary", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Advanced metastatic, recurrent, and unresectable solid tumor", "histology_inclusion": "Bladder cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Advanced metastatic, recurrent, and unresectable solid tumor", "histology_inclusion": "Malignant melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["SGCG-Low", "SGCG-Low", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["SGCG-Low", "SGCG-Low", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Esophageal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Malignant Head and Neck Neoplasm"}, {"cohort": "", "histology_inclusion": "Head and Neck Carcinoma"}, {"cohort": "", "histology_inclusion": "Carcinoma of Unknown Primary Origin"}, {"cohort": "", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": "", "histology_inclusion": "Melanoma"}]}
{"NCT_id": "NCT01639508", "json": [{"cohort": "Group A", "disease_state": "metastatic or unresectable", "histology_inclusion": "non-small cell lung carcinoma", "biomarker_inclusion": ["KIF5B/RET fusion", "related variant RET fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group B", "disease_state": "metastatic or unresectable", "histology_inclusion": "non-small cell lung carcinoma", "biomarker_inclusion": ["NTRK fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group B", "disease_state": "metastatic or unresectable", "histology_inclusion": "non-small cell lung carcinoma", "biomarker_inclusion": ["MET overexpression", "MET amplification", "MET mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group B", "disease_state": "metastatic or unresectable", "histology_inclusion": "non-small cell lung carcinoma", "biomarker_inclusion": ["AXL overexpression", "AXL amplification", "AXL mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group C", "disease_state": "metastatic or unresectable", "histology_inclusion": "non-small cell lung carcinoma", "biomarker_inclusion": ["ROS1 fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group D", "disease_state": "metastatic or unresectable", "histology_inclusion": "non-small cell lung carcinoma", "biomarker_inclusion": ["RET fusion"], "histology_exclusion": [], "biomarker_exclusion": ["post-progression on selective RET inhibitor"]}], "json_norm": [{"cohort": "Group A", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"]]}, {"cohort": "Group B", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}, {"cohort": "Group B", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MET Mutation", "MET-Mutation", "gene"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["SLTM Mutation", "SLTM-Mutation", "gene"]]}, {"cohort": "Group B", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["AXL-High", "AXL-High", "expression"], ["AXL Mutation", "AXL-Mutation", "gene"]]}, {"cohort": "Group C", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"]]}, {"cohort": "Group D", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"]]}]}
{"NCT_id": "NCT03478514", "json": [{"cohort": "Mantle Cell Lymphoma", "disease_state": "Previously Treated", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["t(11;14)", "Cyclin D1 positive"], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": ["BTK inhibitor", "CDK4/6 inhibitor"]}], "json_norm": [{"cohort": "Mantle Cell Lymphoma", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["CCND1-High", "CCND1-High", "expression"]]}]}
{"NCT_id": "NCT04493619", "json": [{"cohort": "PLX2853 Phase 2a Monotherapy", "disease_state": "advanced", "histology_inclusion": "gynecological malignancy", "biomarker_inclusion": ["ARID1A mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "PLX2853 + Carboplatin Phase 1b/2a Combination Therapy", "disease_state": "platinum-resistant", "histology_inclusion": "epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases", "leptomeningeal metastases"], "biomarker_exclusion": ["prior exposure to a bromodomain inhibitor"]}, {"cohort": "PLX2853 + Carboplatin Phase 1b/2a Combination Therapy", "disease_state": "platinum-resistant", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases", "leptomeningeal metastases"], "biomarker_exclusion": ["prior exposure to a bromodomain inhibitor"]}, {"cohort": "PLX2853 + Carboplatin Phase 1b/2a Combination Therapy", "disease_state": "platinum-resistant", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases", "leptomeningeal metastases"], "biomarker_exclusion": ["prior exposure to a bromodomain inhibitor"]}], "json_norm": [{"cohort": "PLX2853 Phase 2a Monotherapy", "biomarker_inclusion": [["ARID1A Mutation", "ARID1A-Mutation", "gene"]]}, {"cohort": "PLX2853 + Carboplatin Phase 1b/2a Combination Therapy", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "PLX2853 + Carboplatin Phase 1b/2a Combination Therapy", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "PLX2853 + Carboplatin Phase 1b/2a Combination Therapy", "histology_inclusion": "Primary Peritoneal Carcinoma"}]}
{"NCT_id": "NCT04623801", "json": [{"cohort": "Participants with papillary microcarcinoma (PTMC)", "disease_state": "", "histology_inclusion": "Papillary thyroid cancer", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": ["non papillary thyroid cancer (PTC)"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Participants with papillary microcarcinoma (PTMC)", "histology_inclusion": "Thyroid Gland Papillary Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]], "histology_exclusion": ["Thyroid Gland Papillary Carcinoma"]}]}
{"NCT_id": "NCT03543969", "json": [{"cohort": "", "disease_state": "AJCC stage IV", "histology_inclusion": "unresectable melanoma", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "AJCC stage IIIC or IIID with unresectable nodal/locoregional involvement", "histology_inclusion": "unresectable melanoma", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT03739372", "json": [{"cohort": "Newly diagnosed HGG (Stratum A)", "disease_state": "newly diagnosed", "histology_inclusion": "High-grade glioma", "biomarker_inclusion": ["H3K27M mutation"], "histology_exclusion": ["Diffuse Intrinsic Pontine Glioma"], "biomarker_exclusion": []}, {"cohort": "Diffuse midline HGG (Stratum B)", "disease_state": "diffuse midline", "histology_inclusion": "High-grade glioma", "biomarker_inclusion": ["H3K27M mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Newly diagnosed HGG (Stratum A)", "histology_inclusion": "Malignant Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]], "histology_exclusion": ["Diffuse Intrinsic Pontine Glioma"]}, {"cohort": "Diffuse midline HGG (Stratum B)", "histology_inclusion": "Malignant Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}]}
{"NCT_id": "NCT04623931", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Diffuse Astrocytoma, IDH-Wildtype", "biomarker_inclusion": [], "histology_exclusion": ["Gliosarcoma", "Pilocytic Astrocytoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Anaplastic Astrocytoma, IDH-Wildtype", "biomarker_inclusion": [], "histology_exclusion": ["Gliosarcoma", "Pilocytic Astrocytoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Oligodendroglioma", "biomarker_inclusion": [], "histology_exclusion": ["Gliosarcoma", "Pilocytic Astrocytoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Anaplastic Oligodendroglioma", "biomarker_inclusion": [], "histology_exclusion": ["Gliosarcoma", "Pilocytic Astrocytoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Oligoastrocytoma", "biomarker_inclusion": [], "histology_exclusion": ["Gliosarcoma", "Pilocytic Astrocytoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Anaplastic Oligoastrocytoma", "biomarker_inclusion": [], "histology_exclusion": ["Gliosarcoma", "Pilocytic Astrocytoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "IDH Wildtype Gliomas (Molecularly Defined High Grade Glioma or Molecularly Defined Glioblastoma)", "biomarker_inclusion": [], "histology_exclusion": ["Gliosarcoma", "Pilocytic Astrocytoma", "Multicentric Glioblastoma", "Leptomeningeal Disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Astrocytoma", "histology_exclusion": ["Pilocytic Astrocytoma", "Gliosarcoma"]}, {"cohort": "", "histology_inclusion": "Anaplastic Astrocytoma", "histology_exclusion": ["Pilocytic Astrocytoma", "Gliosarcoma"]}, {"cohort": "", "histology_inclusion": "Oligodendroglioma", "histology_exclusion": ["Pilocytic Astrocytoma", "Gliosarcoma"]}, {"cohort": "", "histology_inclusion": "Anaplastic Oligodendroglioma", "histology_exclusion": ["Pilocytic Astrocytoma", "Gliosarcoma"]}, {"cohort": "", "histology_inclusion": "Oligoastrocytoma", "histology_exclusion": ["Pilocytic Astrocytoma", "Gliosarcoma"]}, {"cohort": "", "histology_inclusion": "Anaplastic Oligoastrocytoma", "histology_exclusion": ["Pilocytic Astrocytoma", "Gliosarcoma"]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "histology_exclusion": ["Gliosarcoma", "Pilocytic Astrocytoma", "Pilocytic Astrocytoma", "Pilocytic Astrocytoma", "Glioblastoma", "Glioblastoma", "Glioblastoma"]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "histology_exclusion": ["Gliosarcoma", "Pilocytic Astrocytoma", "Pilocytic Astrocytoma", "Pilocytic Astrocytoma", "Glioblastoma", "Glioblastoma", "Glioblastoma"]}, {"cohort": "", "histology_inclusion": "Malignant Glioma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "histology_exclusion": ["Gliosarcoma", "Pilocytic Astrocytoma", "Pilocytic Astrocytoma", "Pilocytic Astrocytoma", "Glioblastoma", "Glioblastoma", "Glioblastoma"]}, {"cohort": "", "histology_inclusion": "Malignant Glioma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "histology_exclusion": ["Pilocytic Astrocytoma", "Gliosarcoma", "Glioblastoma"]}]}
{"NCT_id": "NCT02755272", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["ER > 5%", "PR > 5%", "HER2 3+ or amplification ratio \u2265 2.0"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT03874026", "json": [{"cohort": "Folfiri/Cetuximab", "disease_state": "stage IV", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["KRAS wild-type", "NRAS wild-type", "BRAF wild-type", "Fc\u03b3RIIIaV/V genotype"], "histology_exclusion": [], "biomarker_exclusion": ["brain metastases"]}], "json_norm": [{"cohort": "Folfiri/Cetuximab", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT02962063", "json": [{"cohort": "Esophageal Cancer", "disease_state": "TanyN+M0 or T3-4NanyM0", "histology_inclusion": "adenocarcinoma of the esophagus or gastroesophageal junction (GEJ)", "biomarker_inclusion": ["Her2 positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Esophageal Cancer", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT05279690", "json": [{"cohort": "Cohort 1", "disease_state": "metastatic or recurrent", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastases"], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "post-radical surgery for high-risk clinically localized", "histology_inclusion": "urothelial cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Cohort 2", "histology_inclusion": "Urothelial Carcinoma"}]}
{"NCT_id": "NCT03092518", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "gastric adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "gastroesophageal junction (Siewert I-III) adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastric Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Adenocarcinoma"}]}
{"NCT_id": "NCT04759248", "json": [{"cohort": "", "disease_state": "Advanced/Metastatic", "histology_inclusion": "adenocarcinoma of the breast", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT05410145", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["KRAS p.G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT05540275", "json": [{"cohort": "Cohort 1", "disease_state": "Recurrent", "histology_inclusion": "Glioma", "biomarker_inclusion": ["PTEN gene mutation", "TERT gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Recurrent", "histology_inclusion": "Glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PTEN gene mutation", "TERT gene mutation"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Glioma", "biomarker_inclusion": [["TERT Mutation", "TERT-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Glioma", "biomarker_exclusion": [["TERT Mutation", "TERT-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"]]}]}
{"NCT_id": "NCT05019794", "json": [{"cohort": "Cohort 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "gastric cancer or gastroesophageal junction adenocarcinoma", "biomarker_inclusion": ["FGFR2 amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumors other than CHOL and UC", "biomarker_inclusion": ["FGFR1 fusions/rearrangements/mutations"], "histology_exclusion": ["gastric cancer", "gastroesophageal junction adenocarcinoma", "CHOL", "UC"], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumors other than CHOL and UC", "biomarker_inclusion": ["FGFR2 fusions/rearrangements/mutations"], "histology_exclusion": ["gastric cancer", "gastroesophageal junction adenocarcinoma", "CHOL", "UC"], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumors other than CHOL and UC", "biomarker_inclusion": ["FGFR3 fusions/rearrangements/mutations"], "histology_exclusion": ["gastric cancer", "gastroesophageal junction adenocarcinoma", "CHOL", "UC"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["FGFR2-High", "FGFR2-High", "expression"]]}, {"cohort": "Cohort 1", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["FGFR2-High", "FGFR2-High", "expression"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGFR1 Fusion", "FGFR1", "fusion"]], "histology_exclusion": ["Gastroesophageal Junction Adenocarcinoma", "Gastric Carcinoma"]}, {"cohort": "Cohort 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGFR2 Fusion", "FGFR2", "fusion"]], "histology_exclusion": ["Gastroesophageal Junction Adenocarcinoma", "Gastric Carcinoma"]}, {"cohort": "Cohort 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGFR3 Fusion", "FGFR3", "fusion"]], "histology_exclusion": ["Gastroesophageal Junction Adenocarcinoma", "Gastric Carcinoma"]}]}
{"NCT_id": "NCT04005144", "json": [{"cohort": "", "disease_state": "stage IIIB/IV", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["ALK-rearrangement", "ROS1-rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT04564027", "json": [{"cohort": "Cohort A", "disease_state": "advanced/metastatic", "histology_inclusion": "AST (excluding NSCLC)", "biomarker_inclusion": ["deleterious or suspected deleterious ATM mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "metastatic castrate resistant", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["deleterious or suspected deleterious ATM mutation"], "histology_exclusion": ["symptomatic and/or uncontrolled brain metastases"], "biomarker_exclusion": ["previous therapy with an telangiectasia and rad3 related protein inhibitor"]}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"]]}, {"cohort": "Cohort B", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"]]}, {"cohort": "Cohort B", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"]]}]}
{"NCT_id": "NCT03940131", "json": [{"cohort": "Single Arm", "disease_state": "Metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["KRAS wild", "RAS wild"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-high", "HER2-positive"]}], "json_norm": [{"cohort": "Single Arm", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04266249", "json": [{"cohort": "", "disease_state": "Stage II-IIIa", "histology_inclusion": "HER2-positive primary invasive breast carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT01646034", "json": [{"cohort": "", "disease_state": "oligometastatic", "histology_inclusion": "infiltrating breast cancer", "biomarker_inclusion": ["homologous recombination deficiency", "deleterious germline BRCA1 mutation", "deleterious germline BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["HER2-positive"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04695223", "json": [{"cohort": "", "disease_state": "refractory", "histology_inclusion": "malignant solid tumors", "biomarker_inclusion": ["TP53 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT02757222", "json": [{"cohort": "LH", "disease_state": "Stage III or IV a/b", "histology_inclusion": "squamous cell cancer of the larynx or hypopharynx", "biomarker_inclusion": [], "histology_exclusion": ["metastatic carcinoma"], "biomarker_exclusion": []}, {"cohort": "OPC", "disease_state": "HPV (p16) negative: TNM Stage T2-T4, any N stage, M0 disease", "histology_inclusion": "squamous cell cancer of the oropharynx", "biomarker_inclusion": ["HPV (p16) negative"], "histology_exclusion": ["metastatic carcinoma", "locally advanced LH or OPC tumours where organ preservation is unrealistic"], "biomarker_exclusion": ["HPV p16 positive T1-2 with N0-N2a disease or less than 10 pack year history"]}, {"cohort": "OPC", "disease_state": "HPV (p16) Positive: more than 10 pack year history and N2b or N3 disease", "histology_inclusion": "squamous cell cancer of the oropharynx", "biomarker_inclusion": ["HPV (p16) positive", "more than 10 pack year history"], "histology_exclusion": ["metastatic carcinoma", "locally advanced LH or OPC tumours where organ preservation is unrealistic"], "biomarker_exclusion": ["HPV p16 positive T1-2 with N0-N2a disease or less than 10 pack year history"]}], "json_norm": [{"cohort": "LH", "histology_inclusion": "Laryngeal Squamous Cell Carcinoma"}, {"cohort": "OPC", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-Low", "H3P10-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]], "biomarker_exclusion": [["TRAPPC9-High", "TRAPPC9-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"], ["H3P10-High", "H3P10-High", "expression"], ["CD5-High", "CD5-High", "expression"], ["IL1RL1-High", "IL1RL1-High", "expression"], ["SLC25A4-High", "SLC25A4-High", "expression"]]}, {"cohort": "OPC", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]], "biomarker_exclusion": [["TRAPPC9-High", "TRAPPC9-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"], ["H3P10-High", "H3P10-High", "expression"], ["CD5-High", "CD5-High", "expression"], ["IL1RL1-High", "IL1RL1-High", "expression"], ["SLC25A4-High", "SLC25A4-High", "expression"]]}]}
{"NCT_id": "NCT04499924", "json": [{"cohort": "", "disease_state": "locally-advanced unresectable or metastatic", "histology_inclusion": "HER2+ gastric or gastroesophageal junction adenocarcinoma", "biomarker_inclusion": ["HER2 amplification in blood-based NGS assay", "HER2 overexpression/amplification by IHC and ISH (IHC3+ or IHC2+/ISH+)"], "histology_exclusion": ["squamous cell GEC", "undifferentiated GEC"], "biomarker_exclusion": []}, {"cohort": "Cohort 2A", "disease_state": "locally-advanced unresectable or metastatic", "histology_inclusion": "HER2+ gastric or gastroesophageal junction adenocarcinoma", "biomarker_inclusion": ["HER2 amplification in blood-based NGS assay"], "histology_exclusion": ["squamous cell GEC", "undifferentiated GEC"], "biomarker_exclusion": []}, {"cohort": "Cohort 2B", "disease_state": "locally-advanced unresectable or metastatic", "histology_inclusion": "HER2+ gastric or gastroesophageal junction adenocarcinoma", "biomarker_inclusion": ["HER2 overexpression/amplification by IHC and ISH (IHC3+ or IHC2+/ISH+)"], "histology_exclusion": ["squamous cell GEC", "undifferentiated GEC"], "biomarker_exclusion": ["HER2 amplification in blood-based NGS assay"]}, {"cohort": "Phase 3", "disease_state": "locally-advanced unresectable or metastatic", "histology_inclusion": "HER2+ gastric or gastroesophageal junction adenocarcinoma", "biomarker_inclusion": ["HER2 amplification in blood-based NGS assay"], "histology_exclusion": ["squamous cell GEC", "undifferentiated GEC"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort 2A", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort 2B", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Phase 3", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT03810872", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": ["non-squamous non-small cell lung cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "", "biomarker_inclusion": ["HER2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "", "biomarker_inclusion": ["HER3 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "histology_exclusion": ["Non-Squamous Non-Small Cell Lung Carcinoma"]}, {"cohort": "", "biomarker_inclusion": [["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "", "biomarker_inclusion": [["ERBB3 Mutation", "ERBB3-Mutation", "gene"]]}]}
{"NCT_id": "NCT04006262", "json": [{"cohort": "Experimental arm", "disease_state": "localized", "histology_inclusion": "oeso-gastric adenocarcinoma", "biomarker_inclusion": ["dMMR", "MSI"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Experimental arm", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04565275", "json": [{"cohort": "Phase I", "disease_state": "unresectable or metastatic advanced malignant solid tumors", "histology_inclusion": "advanced solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["selective pan-FGFR molecular inhibitors or antibody drugs"]}, {"cohort": "Phase II", "disease_state": "unresectable or metastatic urothelial carcinoma or cholangiocarcinoma", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": ["FGFR gene alteration"], "histology_exclusion": [], "biomarker_exclusion": ["selective pan-FGFR molecular inhibitors or antibody drugs"]}, {"cohort": "Phase II", "disease_state": "unresectable or metastatic urothelial carcinoma or cholangiocarcinoma", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": ["FGFR gene alteration"], "histology_exclusion": [], "biomarker_exclusion": ["selective pan-FGFR molecular inhibitors or antibody drugs"]}], "json_norm": [{"cohort": "Phase I", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase II", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}, {"cohort": "Phase II", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04695470", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["MSS", "MSI-low", "TMB\u22655 mutations/Mb"], "histology_exclusion": ["MSI-H colorectal adenocarcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["RAS wild", "left side"], "histology_exclusion": ["MSI-H colorectal adenocarcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["TMB-High", "TMB-High", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"], ["TMB", "TMB", "coordinate"], ["MSI", "MSI", "coordinate"], ["MB Mutation", "MB-Mutation", "gene"]], "histology_exclusion": ["Colorectal Adenocarcinoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "histology_exclusion": ["Colorectal Adenocarcinoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04956042", "json": [{"cohort": "Cohort 1 - Fosciclopirox only", "disease_state": "relapsed/refractory", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["acute promyelocytic leukemia", "Ph+ AML"], "biomarker_exclusion": []}, {"cohort": "Cohort 2 - Fosciclopirox + Cytarabine", "disease_state": "relapsed/refractory", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["acute promyelocytic leukemia", "Ph+ AML"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1 - Fosciclopirox only", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Acute Myeloid Leukemia (AML)"], "biomarker_exclusion": [["PAH-High", "PAH-High", "expression"]]}, {"cohort": "Cohort 2 - Fosciclopirox + Cytarabine", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Acute Myeloid Leukemia (AML)"], "biomarker_exclusion": [["PAH-High", "PAH-High", "expression"]]}]}
{"NCT_id": "NCT02365597", "json": [{"cohort": "", "disease_state": "metastatic or surgically unresectable", "histology_inclusion": "urothelial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Urothelial Carcinoma"}]}
{"NCT_id": "NCT05216432", "json": [{"cohort": "RLY-2608 Single Agent Arm", "disease_state": "unresectable or metastatic solid tumor", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["PIK3CA mutation"], "histology_exclusion": ["primary CNS tumor"], "biomarker_exclusion": ["prior treatment with PI3K\u03b1 inhibitors", "hypersensitivity to PI3K inhibitors"]}, {"cohort": "RLY-2608 Single Agent Arm", "disease_state": "unresectable or metastatic solid tumor", "histology_inclusion": "clear cell ovarian cancer", "biomarker_inclusion": ["PIK3CA mutation"], "histology_exclusion": ["primary CNS tumor"], "biomarker_exclusion": ["prior treatment with PI3K\u03b1 inhibitors", "hypersensitivity to PI3K inhibitors"]}, {"cohort": "RLY-2608 Single Agent Arm", "disease_state": "unresectable or metastatic solid tumor", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": ["PIK3CA mutation"], "histology_exclusion": ["primary CNS tumor"], "biomarker_exclusion": ["prior treatment with PI3K\u03b1 inhibitors", "hypersensitivity to PI3K inhibitors"]}, {"cohort": "RLY-2608 Single Agent Arm", "disease_state": "unresectable or metastatic solid tumor", "histology_inclusion": "cervical cancer", "biomarker_inclusion": ["PIK3CA mutation"], "histology_exclusion": ["primary CNS tumor"], "biomarker_exclusion": ["prior treatment with PI3K\u03b1 inhibitors", "hypersensitivity to PI3K inhibitors"]}, {"cohort": "RLY-2608 Single Agent Arm", "disease_state": "unresectable or metastatic solid tumor", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["PIK3CA double mutations"], "histology_exclusion": ["colorectal cancer", "clear cell ovarian cancer", "head and neck squamous cell carcinoma", "cervical cancer", "primary CNS tumor"], "biomarker_exclusion": ["prior treatment with PI3K\u03b1 inhibitors", "hypersensitivity to PI3K inhibitors"]}, {"cohort": "RLY-2608 + Fulvestrant Arm", "disease_state": "HR+ HER2- unresectable or metastatic breast cancer", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["HR+", "HER2-", "PIK3CA mutation"], "histology_exclusion": ["primary CNS tumor"], "biomarker_exclusion": ["prior treatment with PI3K\u03b1 inhibitors (except for Part 2, Group 2)", "hypersensitivity to PI3K inhibitors"]}], "json_norm": [{"cohort": "RLY-2608 Single Agent Arm", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "RLY-2608 Single Agent Arm", "histology_inclusion": "Ovarian Clear Cell Tumor", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "RLY-2608 Single Agent Arm", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "RLY-2608 Single Agent Arm", "histology_inclusion": "Cervical Carcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "RLY-2608 Single Agent Arm", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Ovarian Clear Cell Tumor", "Head and Neck Squamous Cell Carcinoma", "Primary Brain Neoplasm", "Cervical Carcinoma", "Colorectal Carcinoma"]}, {"cohort": "RLY-2608 + Fulvestrant Arm", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT05541822", "json": [{"cohort": "Cohort 1", "disease_state": "advanced, recurrent, or metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["MET exon 14 skipping"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutations", "ALK rearrangements", "KRAS mutation", "ROS1 translocation", "BRAF mutation", "RET alteration", "NTRK fusion"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]], "biomarker_exclusion": [["RET Mutation", "RET-Mutation", "gene"], ["NTRK1 Fusion", "NTRK1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}]}
{"NCT_id": "NCT04201756", "json": [{"cohort": "", "disease_state": "Stage III", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": ["EGFR sensitive mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04891198", "json": [{"cohort": "Subjects with TMB-H/TMB-L", "disease_state": "unresectable or metastatic advanced solid tumors", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": ["TMB\u226512 Mut/Mb"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Subjects with TMB-H/TMB-L", "disease_state": "unresectable or metastatic advanced solid tumors", "histology_inclusion": "cervical cancer", "biomarker_inclusion": ["TMB\u226512 Mut/Mb"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Subjects with TMB-H/TMB-L", "disease_state": "unresectable or metastatic advanced solid tumors", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["TMB\u226512 Mut/Mb"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Subjects with TMB-H/TMB-L", "disease_state": "unresectable or metastatic advanced solid tumors", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["TMB\u226512 Mut/Mb"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Subjects with TMB-H/TMB-L", "disease_state": "unresectable or metastatic advanced solid tumors", "histology_inclusion": "vulvar cancer", "biomarker_inclusion": ["TMB\u226512 Mut/Mb"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Subjects with TMB-H/TMB-L", "disease_state": "unresectable or metastatic advanced solid tumors", "histology_inclusion": "neuroendocrine tumors", "biomarker_inclusion": ["TMB\u226512 Mut/Mb"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Subjects with TMB-H/TMB-L", "disease_state": "unresectable or metastatic advanced solid tumors", "histology_inclusion": "salivary gland cancer", "biomarker_inclusion": ["TMB\u226512 Mut/Mb"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Subjects with TMB-H/TMB-L", "disease_state": "unresectable or metastatic advanced solid tumors", "histology_inclusion": "thyroid papillary or follicular cancer", "biomarker_inclusion": ["TMB\u226512 Mut/Mb"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Subjects with TMB-H/TMB-L", "disease_state": "unresectable or metastatic advanced solid tumors", "histology_inclusion": "skin squamous cell carcinoma", "biomarker_inclusion": ["TMB\u226512 Mut/Mb"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Subjects with TMB-H/TMB-L", "disease_state": "unresectable or metastatic advanced solid tumors", "histology_inclusion": "skin malignant melanoma", "biomarker_inclusion": ["TMB\u226512 Mut/Mb"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Subjects with TMB-H/TMB-L", "disease_state": "unresectable or metastatic advanced solid tumors", "histology_inclusion": "Merkel cell tumor", "biomarker_inclusion": ["TMB\u226512 Mut/Mb"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Subjects with TMB-H/TMB-L", "disease_state": "unresectable or metastatic advanced solid tumors", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": ["TMB\u226512 Mut/Mb"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Subjects with TMB-H/TMB-L", "disease_state": "unresectable or metastatic advanced solid tumors", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["TMB\u226512 Mut/Mb"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Subjects with TMB-H/TMB-L", "disease_state": "unresectable or metastatic advanced solid tumors", "histology_inclusion": "gastric cancer", "biomarker_inclusion": ["TMB\u226512 Mut/Mb"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Subjects with TMB-H/TMB-L", "disease_state": "unresectable or metastatic advanced solid tumors", "histology_inclusion": "bladder cancer", "biomarker_inclusion": ["TMB\u226512 Mut/Mb"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Subjects with TMB-H/TMB-L", "disease_state": "unresectable or metastatic advanced solid tumors", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": ["TMB\u226512 Mut/Mb"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Small Cell Lung Carcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Cervical Carcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Vulvar Carcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Vulvar Neoplasm", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Neuroendocrine Carcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Lung Neuroendocrine Neoplasm", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Neuroendocrine Tumor", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Malignant Salivary Gland Neoplasm", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Salivary Gland Carcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Thyroid Gland Follicular Carcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Skin Squamous Cell Carcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Merkel Cell Carcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Bladder Carcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Bladder Neoplasm", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Subjects with TMB-H/TMB-L", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}]}
{"NCT_id": "NCT04956302", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": ["Waldenstrom macroglobulinemia", "primary amyloid light-chain (AL) amyloidosis", "primary plasma cell leukemia", "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome"], "biomarker_exclusion": ["active (untreated or relapsed) central nervous system (CNS) metastasis of myeloma", "secondary plasma cell leukemia"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Plasma Cell Leukemia", "Amyloidosis", "Waldenstrom Macroglobulinemia"]}]}
{"NCT_id": "NCT03879798", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT05155124", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colon or rectal adenocarcinoma", "biomarker_inclusion": ["RAS wild-type"], "histology_exclusion": ["appendiceal cancer", "anal canal cancer", "brain metastases"], "biomarker_exclusion": ["BARF mutations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Rectal Adenocarcinoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]], "histology_exclusion": ["Appendix Carcinoma"]}]}
{"NCT_id": "NCT02369458", "json": [{"cohort": "Arm 1: p16+ OPSCC", "disease_state": "incurable", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": ["p16 Positive"], "histology_exclusion": ["Central Nervous System metastases"], "biomarker_exclusion": []}, {"cohort": "Arm 2: p16- HNSCC", "disease_state": "incurable", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["p16 Negative"], "histology_exclusion": ["Central Nervous System metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm 1: p16+ OPSCC", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "Arm 2: p16- HNSCC", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-Low", "H3P10-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]]}]}
{"NCT_id": "NCT04270591", "json": [{"cohort": "", "disease_state": "stage IIIb or IIIc (not candidates for definitive surgical resection or concurrent chemoradiation) or stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["METex14 skipping mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutation", "ALK rearrangement", "ROS1 rearrangement", "BRAF mutation", "NTRK fusion"]}, {"cohort": "Phase Ib", "disease_state": "", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["MET amplification GCN \u2265 4", "MET/CEP7 ratio \u2265 2"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase Ib", "disease_state": "", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["MET over-expression (IHC2+)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}, {"cohort": "Phase Ib", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}, {"cohort": "Phase Ib", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}]}
{"NCT_id": "NCT04764474", "json": [{"cohort": "", "disease_state": "advanced relapsed, refractory, or resistant hematological malignancies", "histology_inclusion": "", "biomarker_inclusion": ["IDH mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "refractory to or intolerant of established therapies", "histology_inclusion": "", "biomarker_inclusion": ["IDH mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "MDS with IPSS-R score > 4.5 (high and very high risk)", "histology_inclusion": "MDS", "biomarker_inclusion": ["IDH1 (R132C) mutation", "IDH1 (R132H) mutation", "IDH (R140Q) mutation", "IDH2 (R172K) mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "relapsed AML unsuitable for intensive chemotherapy or venetoclax-based regimen or target agents", "histology_inclusion": "AML", "biomarker_inclusion": ["IDH1 (R132C) mutation", "IDH1 (R132H) mutation", "IDH (R140Q) mutation", "IDH2 (R172K) mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "primary refractory AML unsuitable for intensive chemotherapy or venetoclax-based regimen or target agents", "histology_inclusion": "AML", "biomarker_inclusion": ["IDH1 (R132C) mutation", "IDH1 (R132H) mutation", "IDH (R140Q) mutation", "IDH2 (R172K) mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "relapsed/refractory AML/HR-MDS/AITL", "histology_inclusion": "AML", "biomarker_inclusion": ["IDH1 (R132C) mutation", "IDH1 (R132H) mutation", "IDH (R140Q) mutation", "IDH2 (R172K) mutation"], "histology_exclusion": [], "biomarker_exclusion": ["progressed on prior IDH treatment unless isoform switching of the IDH mutation"]}, {"cohort": "Part 2", "disease_state": "relapsed/refractory AML/HR-MDS/AITL", "histology_inclusion": "HR-MDS", "biomarker_inclusion": ["IDH1 (R132C) mutation", "IDH1 (R132H) mutation", "IDH (R140Q) mutation", "IDH2 (R172K) mutation"], "histology_exclusion": [], "biomarker_exclusion": ["progressed on prior IDH treatment unless isoform switching of the IDH mutation"]}, {"cohort": "Part 2", "disease_state": "relapsed/refractory AML/HR-MDS/AITL", "histology_inclusion": "AITL", "biomarker_inclusion": ["IDH1 (R132C) mutation", "IDH1 (R132H) mutation", "IDH (R140Q) mutation", "IDH2 (R172K) mutation"], "histology_exclusion": [], "biomarker_exclusion": ["progressed on prior IDH treatment unless isoform switching of the IDH mutation"]}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Part 1", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Part 2", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["IDH1 R132H", "R132H", "coordinate"], ["IDH1 R132C", "R132C", "coordinate"], ["IDH2 R172K", "R172K", "coordinate"]]}, {"cohort": "Part 2", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH1 R132H", "R132H", "coordinate"], ["IDH1 R132C", "R132C", "coordinate"], ["IDH2 R172K", "R172K", "coordinate"]]}, {"cohort": "Part 2", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH1 R132H", "R132H", "coordinate"], ["IDH1 R132C", "R132C", "coordinate"], ["IDH2 R172K", "R172K", "coordinate"]]}, {"cohort": "Part 2", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH1 R132H", "R132H", "coordinate"], ["IDH1 R132C", "R132C", "coordinate"], ["IDH2 R172K", "R172K", "coordinate"]]}, {"cohort": "Part 2", "biomarker_inclusion": [["HR - PAFAH1B1", "HR - PAFAH1B1", "coordinate"], ["IDH1 R132H", "R132H", "coordinate"], ["IDH1 R132C", "R132C", "coordinate"], ["IDH2 R172K", "R172K", "coordinate"]]}, {"cohort": "Part 2", "biomarker_inclusion": [["IDH1 R132H", "R132H", "coordinate"], ["IDH1 R132C", "R132C", "coordinate"], ["IDH2 R172K", "R172K", "coordinate"]]}]}
{"NCT_id": "NCT04959903", "json": [{"cohort": "Group A (adults)", "disease_state": "High risk AML in CR1; Chemo-refractory relapse (MRD+); \u2265 CR2", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group A (adults)", "disease_state": "Chemo-refractory relapse (MRD+); High risk ALL in CR1; Philadelphia (like) or any poor risk feature; \u2265 CR2", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group A (adults)", "disease_state": "\u2265 CR1 with a minimal residual disease (MRD) <5%", "histology_inclusion": "Acute leukemia of ambiguous lineage", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group A (adults)", "disease_state": "Revised International Prognostic Scoring System risk score of intermediate or higher at the time of transplant evaluation; Life-threatening cytopenia; Karyotype or genomic changes that indicate high risk for progression to acute myelogenous leukemia, including abnormalities of chromosome 7 or 3, mutations of TP53, or complex or monosomal karyotype; Therapy related disease or disease evolving from other malignant processes", "histology_inclusion": "Myelodysplastic Syndrome (MDS)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group B (pediatrics)", "disease_state": "High risk AML in CR1; Chemo-refractory relapse (MRD+); \u2265 CR2", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group B (pediatrics)", "disease_state": "Chemo-refractory relapse (MRD+); High risk ALL in CR1; Philadelphia (like) or any poor risk feature; \u2265 CR2", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group B (pediatrics)", "disease_state": "\u2265 CR1 with a minimal residual disease (MRD) <5%", "histology_inclusion": "Acute leukemia of ambiguous lineage", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Group A (adults)", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "Group A (adults)", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "Group A (adults)", "histology_inclusion": "Acute Leukemia of Ambiguous Lineage"}, {"cohort": "Group A (adults)", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "Group B (pediatrics)", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "Group B (pediatrics)", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "Group B (pediatrics)", "histology_inclusion": "Acute Leukemia of Ambiguous Lineage"}]}
{"NCT_id": "NCT04959981", "json": [{"cohort": "Part 1 and Part 4: ERAS-007 plus osimertinib", "disease_state": "advanced", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation(s) sensitive to EGFR inhibitors"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2, Part 5, Part 3, and Part 6: ERAS-007 plus sotorasib and ERAS-601 plus sotorasib", "disease_state": "advanced", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 1 and Part 4: ERAS-007 plus osimertinib", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Part 2, Part 5, Part 3, and Part 6: ERAS-007 plus sotorasib and ERAS-601 plus sotorasib", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT05025085", "json": [{"cohort": "", "disease_state": "advanced, metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT05155254", "json": [{"cohort": "", "disease_state": "unresectable stage III or stage IV", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": ["BRAFV600-positive with rapidly progressing disease and/or received standard first-line therapy with BRAF and/or MEK inhibitor for unresectable or metastatic disease"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma"}]}
{"NCT_id": "NCT04140487", "json": [{"cohort": "Phase I cohort", "disease_state": "relapsed/refractory", "histology_inclusion": "FLT3-mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm", "biomarker_inclusion": ["FLT3-ITD", "FLT3 D835 mutations"], "histology_exclusion": ["active central nervous system leukemia"], "biomarker_exclusion": []}, {"cohort": "Phase II cohort A", "disease_state": "newly diagnosed", "histology_inclusion": "FLT3-mutated Acute Myeloid Leukemia", "biomarker_inclusion": ["FLT3-ITD", "FLT3 D835 mutations"], "histology_exclusion": ["active central nervous system leukemia"], "biomarker_exclusion": []}, {"cohort": "Phase II cohort B", "disease_state": "relapsed/refractory", "histology_inclusion": "FLT3-mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm", "biomarker_inclusion": ["FLT3-ITD", "FLT3 D835 mutations"], "histology_exclusion": ["active central nervous system leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase I cohort", "histology_inclusion": "Myeloproliferative Neoplasm", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]], "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "Phase I cohort", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]], "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "Phase I cohort", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]], "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "Phase I cohort", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]], "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "Phase I cohort", "histology_inclusion": "Myelodysplastic/Myeloproliferative Disease", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]], "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "Phase II cohort A", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]], "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "Phase II cohort B", "histology_inclusion": "Myeloproliferative Neoplasm", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]], "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "Phase II cohort B", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]], "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "Phase II cohort B", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]], "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "Phase II cohort B", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]], "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "Phase II cohort B", "histology_inclusion": "Myelodysplastic/Myeloproliferative Disease", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]], "histology_exclusion": ["Central Nervous System Leukemia"]}]}
{"NCT_id": "NCT04140526", "json": [{"cohort": "Part A", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "advanced/metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "advanced/metastatic", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "advanced/metastatic", "histology_inclusion": "non small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "advanced/metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "advanced/metastatic", "histology_inclusion": "head and neck cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "advanced/metastatic", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "advanced/metastatic", "histology_inclusion": "other solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part D", "disease_state": "recurrent/metastatic", "histology_inclusion": "adenoid cystic carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part B", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part C", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "Part C", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Part C", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part C", "histology_inclusion": "Melanoma"}, {"cohort": "Part C", "histology_inclusion": "Malignant Head and Neck Neoplasm"}, {"cohort": "Part C", "histology_inclusion": "Head and Neck Carcinoma"}, {"cohort": "Part C", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Part C", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "Part C", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part D", "histology_inclusion": "Adenoid Cystic Carcinoma"}]}
{"NCT_id": "NCT05090215", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}]}
{"NCT_id": "NCT04634552", "json": [{"cohort": "Cohort A", "disease_state": "relapsed or refractory", "histology_inclusion": "multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "relapsed or refractory", "histology_inclusion": "multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort C", "disease_state": "relapsed or refractory", "histology_inclusion": "multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "Cohort B", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "Cohort C", "histology_inclusion": "Plasma Cell Myeloma"}]}
{"NCT_id": "NCT04699773", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "high-grade glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Glioma"}]}
{"NCT_id": "NCT04205968", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced unresectable", "histology_inclusion": "small bowel adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["ampullary adenocarcinoma"], "biomarker_exclusion": ["dMMR", "MSI-H"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Small Intestinal Adenocarcinoma", "histology_exclusion": ["Ampulla of Vater Adenocarcinoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04960618", "json": [{"cohort": "Participants with confirmed mycosis fungoides/Sezary syndrome", "disease_state": "stage IB or higher", "histology_inclusion": "Mycosis Fungoides", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1", "anti-PD-L2", "CTLA-4", "OX 40", "CD137"]}, {"cohort": "Participants with confirmed mycosis fungoides/Sezary syndrome", "disease_state": "stage IB or higher", "histology_inclusion": "Sezary Syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1", "anti-PD-L2", "CTLA-4", "OX 40", "CD137"]}], "json_norm": [{"cohort": "Participants with confirmed mycosis fungoides/Sezary syndrome", "histology_inclusion": "Mycosis Fungoides"}, {"cohort": "Participants with confirmed mycosis fungoides/Sezary syndrome", "histology_inclusion": "Sezary Syndrome"}]}
{"NCT_id": "NCT05025735", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "HR+ HER2- breast cancer", "biomarker_inclusion": ["PIK3CA activating mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-Low", "HR-Low", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT05546268", "json": [{"cohort": "Phase 1", "disease_state": "advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system involvement", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "Phase 1", "disease_state": "advanced", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system involvement", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "Phase 1", "disease_state": "advanced", "histology_inclusion": "high-grade neuroendocrine cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system involvement", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "Phase 1", "disease_state": "advanced", "histology_inclusion": "diffuse large B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system involvement", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "Phase 1", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["L-MYC amplification", "N-MYC amplification"], "histology_exclusion": ["central nervous system involvement", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["L-MYC amplification", "N-MYC amplification"], "histology_exclusion": ["central nervous system involvement", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["L-MYC mRNA expression", "N-MYC mRNA expression"], "histology_exclusion": ["central nervous system involvement", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "advanced", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": ["L-MYC mRNA expression", "N-MYC mRNA expression"], "histology_exclusion": ["central nervous system involvement", "carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Phase 1", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Phase 1", "histology_inclusion": "Neuroendocrine Carcinoma"}, {"cohort": "Phase 1", "histology_inclusion": "Neuroendocrine Tumor"}, {"cohort": "Phase 1", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"], ["MYC-High", "MYC-High", "expression"]]}, {"cohort": "Phase 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"], ["MYC-High", "MYC-High", "expression"]]}, {"cohort": "Phase 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Phase 2", "histology_inclusion": "Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT03229200", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Lymphoma, B-Cell", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Lymphoma, Non-Hodgkin", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Leukemia, B-cell", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Graft Vs Host Disease", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Non-Hodgkin Lymphoma"}, {"cohort": ""}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT03620201", "json": [{"cohort": "", "disease_state": "Stage II-III", "histology_inclusion": "HER2 Positive Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": ["Inflammatory breast cancer"], "biomarker_exclusion": ["PD-1 inhibitor treatment", "PD-L1 inhibitor treatment", "CTLA-4 inhibitor treatment"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "histology_exclusion": ["Inflammatory Breast Carcinoma"]}]}
{"NCT_id": "NCT03685331", "json": [{"cohort": "", "disease_state": "Metastatic or locally advanced unresectable breast cancer", "histology_inclusion": "ER and/or PR positive (>1%) and HER2 nonamplified breast cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["PRH2-High", "PRH2-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["TMEM37-High", "TMEM37-High", "expression"]]}]}
{"NCT_id": "NCT04504916", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "triple-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["malignancy involving the central nervous system"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "non-TNBC HER2-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["malignancy involving the central nervous system"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "non-squamous non-small-cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["malignancy involving the central nervous system"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "gastric cancer", "biomarker_inclusion": [], "histology_exclusion": ["malignancy involving the central nervous system"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": ["malignancy involving the central nervous system"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "platinum-resistant ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["malignancy involving the central nervous system"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm"}]}
{"NCT_id": "NCT04895709", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Cervical Cancer", "biomarker_inclusion": [], "histology_exclusion": ["Primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Gastric/Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Microsatellite Stable Colorectal Cancer", "biomarker_inclusion": [], "histology_exclusion": ["Primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Non-Small-Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["Primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Squamous Cell Carcinoma of Head and Neck", "biomarker_inclusion": [], "histology_exclusion": ["Primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Carcinoma, Renal Cell", "biomarker_inclusion": [], "histology_exclusion": ["Primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Ovarian Neoplasms", "biomarker_inclusion": [], "histology_exclusion": ["Primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Triple Negative Breast Neoplasms", "biomarker_inclusion": [], "histology_exclusion": ["Primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Kidney Cancer"}, {"cohort": "", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Melanoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}]}
{"NCT_id": "NCT04895761", "json": [{"cohort": "", "disease_state": "stage I to III", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["HR+", "HER2-", "Ki67>10%"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT05351294", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system", "leukemia", "primary central nervous system cancers"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system", "leukemia", "primary central nervous system cancers"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system", "leukemia", "primary central nervous system cancers"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Leukemia"]}, {"cohort": "", "histology_inclusion": "Lymphoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Leukemia"]}, {"cohort": "", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Leukemia"]}]}
{"NCT_id": "NCT04830813", "json": [{"cohort": "", "disease_state": "progressed or relapsed", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT05156268", "json": [{"cohort": "", "disease_state": "persistent/recurrent", "histology_inclusion": "Serous endometrial cancer", "biomarker_inclusion": ["aberrant p53 expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "persistent/recurrent", "histology_inclusion": "Carcinosarcoma of the endometrium", "biomarker_inclusion": ["aberrant p53 expression", "retained MMR expression"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H", "POLE hotspot mutations"]}, {"cohort": "", "disease_state": "persistent/recurrent", "histology_inclusion": "Grade 3 Endometrioid and/or undifferentiated carcinoma", "biomarker_inclusion": ["aberrant p53 expression", "retained MMR expression"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H", "POLE hotspot mutations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Carcinosarcoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["POLE Mutation", "POLE-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Undifferentiated Carcinoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["POLE Mutation", "POLE-Mutation", "gene"]]}]}
{"NCT_id": "NCT05221320", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "esophageal adenocarcinoma", "biomarker_inclusion": ["MAPK-mutated", "KRAS", "NRAS", "HRAS", "BRAF non-V600", "MEK 1/2 (MAP2K1/2)", "ERK 1/2 (MAPK3/1)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "esophageal squamous cell carcinoma", "biomarker_inclusion": ["MAPK-mutated", "KRAS", "NRAS", "HRAS", "BRAF non-V600", "MEK 1/2 (MAP2K1/2)", "ERK 1/2 (MAPK3/1)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "GEJ adenocarcinoma", "biomarker_inclusion": ["MAPK-mutated", "KRAS", "NRAS", "HRAS", "BRAF non-V600", "MEK 1/2 (MAP2K1/2)", "ERK 1/2 (MAPK3/1)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "gastric adenocarcinoma", "biomarker_inclusion": ["MAPK-mutated", "KRAS", "NRAS", "HRAS", "BRAF non-V600", "MEK 1/2 (MAP2K1/2)", "ERK 1/2 (MAPK3/1)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": ["MAPK-mutated", "KRAS", "NRAS", "HRAS", "BRAF non-V600", "MEK 1/2 (MAP2K1/2)", "ERK 1/2 (MAPK3/1)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "intrahepatic cholangiocarcinoma", "biomarker_inclusion": ["MAPK-mutated", "KRAS", "NRAS", "HRAS", "BRAF non-V600", "MEK 1/2 (MAP2K1/2)", "ERK 1/2 (MAPK3/1)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "perihilar cholangiocarcinoma", "biomarker_inclusion": ["MAPK-mutated", "KRAS", "NRAS", "HRAS", "BRAF non-V600", "MEK 1/2 (MAP2K1/2)", "ERK 1/2 (MAPK3/1)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "extrahepatic cholangiocarcinoma", "biomarker_inclusion": ["MAPK-mutated", "KRAS", "NRAS", "HRAS", "BRAF non-V600", "MEK 1/2 (MAP2K1/2)", "ERK 1/2 (MAPK3/1)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["MAPK-mutated", "KRAS", "NRAS", "HRAS", "BRAF non-V600", "MEK 1/2 (MAP2K1/2)", "ERK 1/2 (MAPK3/1)"], "histology_exclusion": [], "biomarker_exclusion": ["dMMR/MSI-H"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Esophageal Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Esophageal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Intrahepatic Cholangiocarcinoma"}, {"cohort": "", "histology_inclusion": "Cholangiocarcinoma"}, {"cohort": "", "histology_inclusion": "Cholangiocarcinoma"}, {"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT03620578", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "High-grade B-cell lymphoma", "biomarker_inclusion": ["MYC rearrangement", "BCL2 rearrangement", "BCL6 rearrangement"], "histology_exclusion": [], "biomarker_exclusion": ["HIV positive"]}], "json_norm": [{"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma", "biomarker_inclusion": [["MYC Fusion", "MYC", "fusion"], ["BCL6 Fusion", "BCL6", "fusion"], ["BCL2 Fusion", "BCL2", "fusion"]]}]}
{"NCT_id": "NCT04011293", "json": [{"cohort": "A", "disease_state": "Relapsed or Refractory", "histology_inclusion": "B-cell lineage acute lymphoblastic leukemia (B-ALL)", "biomarker_inclusion": ["CD19"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "A", "disease_state": "Relapsed or Refractory", "histology_inclusion": "B-cell non-Hodgkin's lymphoma (NHL)", "biomarker_inclusion": ["CD19"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "A", "disease_state": "Relapsed or Refractory", "histology_inclusion": "chronic lymphocytic leukemia (CLL)", "biomarker_inclusion": ["CD19"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "A", "histology_inclusion": "B Acute Lymphoblastic Leukemia", "biomarker_inclusion": [["PPIB - BCR", "PPIB - BCR", "coordinate"]]}, {"cohort": "A", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["PPIB - BCR", "PPIB - BCR", "coordinate"]]}, {"cohort": "A", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma"}, {"cohort": "A", "histology_inclusion": "Non-Hodgkin Lymphoma"}, {"cohort": "A", "histology_inclusion": "Chronic Lymphocytic Leukemia"}]}
{"NCT_id": "NCT04271800", "json": [{"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "B Cell Leukemia", "biomarker_inclusion": ["CD19+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "Lymphoma", "biomarker_inclusion": ["CD19+"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["CD19-High", "CD19-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Lymphoma", "biomarker_inclusion": [["CD19-High", "CD19-High", "expression"]]}]}
{"NCT_id": "NCT04272034", "json": [{"cohort": "Cohort 1", "disease_state": "Advanced", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": [], "histology_exclusion": ["Brain or CNS metastases"], "biomarker_exclusion": ["Prior receipt of an anti-PD-L1 therapy"]}, {"cohort": "Cohort 2", "disease_state": "Advanced", "histology_inclusion": "MSI-H/dMMR Tumors", "biomarker_inclusion": [], "histology_exclusion": ["Brain or CNS metastases"], "biomarker_exclusion": ["Prior receipt of an anti-PD-L1 therapy"]}, {"cohort": "Cohort 3", "disease_state": "Advanced", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": ["Progression after anti-PD-1 monoclonal antibody therapy"], "histology_exclusion": ["Brain or CNS metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Cohort 2", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort 2", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT02501551", "json": [{"cohort": "", "disease_state": "metastatic or unresectable stage III", "histology_inclusion": "melanoma", "biomarker_inclusion": ["c-kit mutations"], "histology_exclusion": [], "biomarker_exclusion": ["BRAF mutation", "NRAS mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["KIT Mutation", "KIT-Mutation", "gene"]], "biomarker_exclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT03816345", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "adjuvant setting", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "adjuvant setting", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "adjuvant setting", "histology_inclusion": "renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "adjuvant setting", "histology_inclusion": "cervical cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "adjuvant setting", "histology_inclusion": "bladder cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "any solid tumor", "biomarker_inclusion": ["microsatellite instability-high status"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Melanoma"}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT03555877", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "HER2-/HR+ invasive breast carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system lesions"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT03686202", "json": [{"cohort": "All Cohorts", "disease_state": "locally-advanced or metastatic", "histology_inclusion": "solid malignancy", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "All Cohorts"}]}
{"NCT_id": "NCT04375527", "json": [{"cohort": "", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["V600BRAF wildtype"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Cutaneous Melanoma"}]}
{"NCT_id": "NCT03686345", "json": [{"cohort": "Core binding factor acute myeloid leukemia (CBF-AML)", "disease_state": "", "histology_inclusion": "Core Binding Factor Acute Myeloid Leukemia (CBF-AML)", "biomarker_inclusion": ["AML1-ETO", "CBFB-MYH11"], "histology_exclusion": ["Central nervous system involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Core binding factor acute myeloid leukemia (CBF-AML)", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["CBFB - MYH11", "CBFB - MYH11", "coordinate"], ["RUNX1 - RUNX1T1", "RUNX1 - RUNX1T1", "coordinate"]]}]}
{"NCT_id": "NCT03946878", "json": [{"cohort": "", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["CD5+", "CD23-", "CD20+", "t(11;14)(q13;q32)", "Cyclin D1 overexpression"], "histology_exclusion": ["Central Nervous System disease"], "biomarker_exclusion": ["Refractory to prior ibrutinib", "BTK mutation", "Previous exposure to ibrutinib"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["FCER2-Low", "FCER2-Low", "expression"], ["MS4A1-High", "MS4A1-High", "expression"], ["CCND1-High", "CCND1-High", "expression"], ["CD5-High", "CD5-High", "expression"]], "biomarker_exclusion": [["BTK Mutation", "BTK-Mutation", "gene"]]}]}
{"NCT_id": "NCT04077099", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": ["MET-exon14 gene mutation", "MET gene amplification", "elevated MET protein expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "expansion cohorts (except cohort 1A)", "disease_state": "advanced", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": ["MET-exon14 gene mutation", "MET gene amplification", "elevated MET protein expression"], "histology_exclusion": ["primary brain tumor", "CNS metastases", "leptomeningeal disease", "spinal cord compression"], "biomarker_exclusion": ["MET-targeted biologic therapy (function-blocking antibodies or ADCs)", "MET-targeted agent (small molecule tyrosine kinase inhibitors eg, crizotinib, capmatinib, tepotinib)"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM Mutation", "SLTM-Mutation", "gene"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["MET Mutation", "MET-Mutation", "gene"]]}, {"cohort": "expansion cohorts (except cohort 1A)", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM Mutation", "SLTM-Mutation", "gene"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["MET Mutation", "MET-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT04505826", "json": [{"cohort": "", "disease_state": "Advanced and/or Metastatic", "histology_inclusion": "Hormone Receptor Positive Breast Carcinoma", "biomarker_inclusion": ["HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}]}
{"NCT_id": "NCT04701281", "json": [{"cohort": "", "disease_state": "liver metastases", "histology_inclusion": "adenocarcinoma of the colon/rectal", "biomarker_inclusion": ["RAS mutant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "liver-dominant pre-treated or refractory", "histology_inclusion": "adenocarcinoma of the colon/rectal", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Colon Adenocarcinoma"}]}
{"NCT_id": "NCT05352178", "json": [{"cohort": "", "disease_state": "oligorecurrent hormone sensitive prostate cancer", "histology_inclusion": "prostate adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["active malignancy other than prostate cancer"], "biomarker_exclusion": ["serum testosterone level at castration level", "PSA rise while on active treatment"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "histology_exclusion": ["Prostate Neoplasm", "Prostate Carcinoma"]}]}
{"NCT_id": "NCT03556228", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": ["TrkA protein overexpression"], "histology_exclusion": ["lymphoma"], "biomarker_exclusion": ["negative TrkA IHC assay"]}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": ["NTRK1 gene fusion"], "histology_exclusion": ["lymphoma"], "biomarker_exclusion": ["negative TrkA IHC assay"]}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": ["NTRK1 mutation"], "histology_exclusion": ["lymphoma"], "biomarker_exclusion": ["negative TrkA IHC assay"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK1-High", "NTRK1-High", "expression"]], "histology_exclusion": ["Lymphoma"], "biomarker_exclusion": [["NTRK1-Low", "NTRK1-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"]], "histology_exclusion": ["Lymphoma"], "biomarker_exclusion": [["NTRK1-Low", "NTRK1-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK1 Mutation", "NTRK1-Mutation", "gene"]], "histology_exclusion": ["Lymphoma"], "biomarker_exclusion": [["NTRK1-Low", "NTRK1-Low", "expression"]]}]}
{"NCT_id": "NCT04375683", "json": [{"cohort": "Ph-positive ALLs", "disease_state": "", "histology_inclusion": "Ph positive ALL", "biomarker_inclusion": ["BCR-ABL1 Fusion Protein Expression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Ph-positive ALLs", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["ABL1 Fusion", "ABL1", "fusion"], ["BCR Fusion", "BCR", "fusion"], ["BCR - ABL1", "BCR - ABL1", "coordinate"], ["PAH-High", "PAH-High", "expression"]]}]}
{"NCT_id": "NCT05026983", "json": [{"cohort": "A", "disease_state": "metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAFV600 mutation"], "histology_exclusion": ["central nervous system tumor"], "biomarker_exclusion": []}, {"cohort": "B", "disease_state": "metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAFV600 mutation"], "histology_exclusion": ["central nervous system tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "A", "histology_inclusion": "Melanoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "B", "histology_inclusion": "Melanoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT03230318", "json": [{"cohort": "", "disease_state": "inoperable or advanced", "histology_inclusion": "intrahepatic cholangiocarcinoma", "biomarker_inclusion": ["FGFR2 gene fusion", "FGFR2 gene mutation", "FGFR2 gene amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "inoperable or advanced", "histology_inclusion": "combined hepatocellular-cholangiocarcinoma", "biomarker_inclusion": ["FGFR2 gene fusion", "FGFR2 gene mutation", "FGFR2 gene amplification"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Intrahepatic Cholangiocarcinoma", "biomarker_inclusion": [["FGFR2-High", "FGFR2-High", "expression"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}, {"cohort": "", "biomarker_inclusion": [["FGFR2-High", "FGFR2-High", "expression"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04077307", "json": [{"cohort": "", "disease_state": "refractory or relapsed", "histology_inclusion": "AML", "biomarker_inclusion": [], "histology_exclusion": ["Acute promyelocytic leukemia (AML M3)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory or relapsed", "histology_inclusion": "ALL", "biomarker_inclusion": [], "histology_exclusion": ["Acute promyelocytic leukemia (AML M3)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory or relapsed", "histology_inclusion": "DLBCL", "biomarker_inclusion": [], "histology_exclusion": ["Acute promyelocytic leukemia (AML M3)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory or relapsed", "histology_inclusion": "Burkitt lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Acute promyelocytic leukemia (AML M3)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory or relapsed", "histology_inclusion": "multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": ["Acute promyelocytic leukemia (AML M3)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory or relapsed", "histology_inclusion": "high-risk MDS", "biomarker_inclusion": [], "histology_exclusion": ["Acute promyelocytic leukemia (AML M3)"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Acute Myeloid Leukemia (AML)"]}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Acute Myeloid Leukemia (AML)"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Acute Myeloid Leukemia (AML)"]}, {"cohort": "", "histology_inclusion": "Burkitt Lymphoma", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Acute Myeloid Leukemia (AML)"]}, {"cohort": "", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Acute Myeloid Leukemia (AML)"]}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Acute Myeloid Leukemia (AML)"]}]}
{"NCT_id": "NCT04440943", "json": [{"cohort": "", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["glioblastoma multiforme", "prostate cancer", "pancreatic cancer", "mucosal melanoma", "ocular melanoma"], "biomarker_exclusion": ["MSI-low colorectal cancer"]}, {"cohort": "", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": ["glioblastoma multiforme", "prostate cancer", "pancreatic cancer", "mucosal melanoma", "ocular melanoma"], "biomarker_exclusion": ["MSI-low colorectal cancer"]}, {"cohort": "", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "Gastric Cancer", "biomarker_inclusion": [], "histology_exclusion": ["glioblastoma multiforme", "prostate cancer", "pancreatic cancer", "mucosal melanoma", "ocular melanoma"], "biomarker_exclusion": ["MSI-low colorectal cancer"]}, {"cohort": "", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["glioblastoma multiforme", "prostate cancer", "pancreatic cancer", "mucosal melanoma", "ocular melanoma"], "biomarker_exclusion": ["MSI-low colorectal cancer"]}, {"cohort": "", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "Ovarian Cancer", "biomarker_inclusion": [], "histology_exclusion": ["glioblastoma multiforme", "prostate cancer", "pancreatic cancer", "mucosal melanoma", "ocular melanoma"], "biomarker_exclusion": ["MSI-low colorectal cancer"]}, {"cohort": "", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["glioblastoma multiforme", "prostate cancer", "pancreatic cancer", "mucosal melanoma", "ocular melanoma"], "biomarker_exclusion": ["MSI-low colorectal cancer"]}, {"cohort": "", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "Fallopian Tube Cancer", "biomarker_inclusion": [], "histology_exclusion": ["glioblastoma multiforme", "prostate cancer", "pancreatic cancer", "mucosal melanoma", "ocular melanoma"], "biomarker_exclusion": ["MSI-low colorectal cancer"]}, {"cohort": "", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["glioblastoma multiforme", "prostate cancer", "pancreatic cancer", "mucosal melanoma", "ocular melanoma"], "biomarker_exclusion": ["MSI-low colorectal cancer"]}, {"cohort": "", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "Bladder Urothelial Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["glioblastoma multiforme", "prostate cancer", "pancreatic cancer", "mucosal melanoma", "ocular melanoma"], "biomarker_exclusion": ["MSI-low colorectal cancer"]}, {"cohort": "", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "MSI-H Colorectal Cancer", "biomarker_inclusion": [], "histology_exclusion": ["glioblastoma multiforme", "prostate cancer", "pancreatic cancer", "mucosal melanoma", "ocular melanoma"], "biomarker_exclusion": ["MSI-low colorectal cancer"]}, {"cohort": "", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "Esophageal Cancer", "biomarker_inclusion": [], "histology_exclusion": ["glioblastoma multiforme", "prostate cancer", "pancreatic cancer", "mucosal melanoma", "ocular melanoma"], "biomarker_exclusion": ["MSI-low colorectal cancer"]}, {"cohort": "", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "Hepatic Cancer", "biomarker_inclusion": [], "histology_exclusion": ["glioblastoma multiforme", "prostate cancer", "pancreatic cancer", "mucosal melanoma", "ocular melanoma"], "biomarker_exclusion": ["MSI-low colorectal cancer"]}, {"cohort": "", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "Head and Neck Cancer", "biomarker_inclusion": [], "histology_exclusion": ["glioblastoma multiforme", "prostate cancer", "pancreatic cancer", "mucosal melanoma", "ocular melanoma"], "biomarker_exclusion": ["MSI-low colorectal cancer"]}, {"cohort": "", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "Other Solid Tumors", "biomarker_inclusion": [], "histology_exclusion": ["glioblastoma multiforme", "prostate cancer", "pancreatic cancer", "mucosal melanoma", "ocular melanoma"], "biomarker_exclusion": ["MSI-low colorectal cancer"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Mucosal Melanoma", "Glioblastoma, IDH-Wildtype", "Prostate Neoplasm", "Glioblastoma", "Ocular Melanoma", "Prostate Carcinoma", "Pancreatic Carcinoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "histology_exclusion": ["Mucosal Melanoma", "Glioblastoma, IDH-Wildtype", "Prostate Neoplasm", "Glioblastoma", "Ocular Melanoma", "Prostate Carcinoma", "Pancreatic Carcinoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma", "histology_exclusion": ["Mucosal Melanoma", "Glioblastoma, IDH-Wildtype", "Prostate Neoplasm", "Glioblastoma", "Ocular Melanoma", "Prostate Carcinoma", "Pancreatic Carcinoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Mucosal Melanoma", "Glioblastoma, IDH-Wildtype", "Prostate Neoplasm", "Glioblastoma", "Ocular Melanoma", "Prostate Carcinoma", "Pancreatic Carcinoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "histology_exclusion": ["Glioblastoma, IDH-Wildtype", "Glioblastoma", "Prostate Neoplasm", "Prostate Carcinoma", "Pancreatic Carcinoma", "Mucosal Melanoma", "Ocular Melanoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm", "histology_exclusion": ["Mucosal Melanoma", "Glioblastoma, IDH-Wildtype", "Prostate Neoplasm", "Glioblastoma", "Ocular Melanoma", "Prostate Carcinoma", "Pancreatic Carcinoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "histology_exclusion": ["Mucosal Melanoma", "Glioblastoma, IDH-Wildtype", "Prostate Neoplasm", "Glioblastoma", "Ocular Melanoma", "Prostate Carcinoma", "Pancreatic Carcinoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "histology_exclusion": ["Mucosal Melanoma", "Glioblastoma, IDH-Wildtype", "Prostate Neoplasm", "Glioblastoma", "Ocular Melanoma", "Prostate Carcinoma", "Pancreatic Carcinoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Cholangiocarcinoma", "histology_exclusion": ["Mucosal Melanoma", "Glioblastoma, IDH-Wildtype", "Prostate Neoplasm", "Glioblastoma", "Ocular Melanoma", "Prostate Carcinoma", "Pancreatic Carcinoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Bladder Urothelial Carcinoma", "histology_exclusion": ["Mucosal Melanoma", "Glioblastoma, IDH-Wildtype", "Prostate Neoplasm", "Glioblastoma", "Ocular Melanoma", "Prostate Carcinoma", "Pancreatic Carcinoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Glioblastoma, IDH-Wildtype", "Glioblastoma", "Prostate Neoplasm", "Prostate Carcinoma", "Pancreatic Carcinoma", "Mucosal Melanoma", "Ocular Melanoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Mucosal Melanoma", "Glioblastoma, IDH-Wildtype", "Prostate Neoplasm", "Glioblastoma", "Ocular Melanoma", "Prostate Carcinoma", "Pancreatic Carcinoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Esophageal Carcinoma", "histology_exclusion": ["Mucosal Melanoma", "Glioblastoma, IDH-Wildtype", "Prostate Neoplasm", "Glioblastoma", "Ocular Melanoma", "Prostate Carcinoma", "Pancreatic Carcinoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "", "histology_exclusion": ["Mucosal Melanoma", "Glioblastoma, IDH-Wildtype", "Prostate Neoplasm", "Glioblastoma", "Ocular Melanoma", "Prostate Carcinoma", "Pancreatic Carcinoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Malignant Head and Neck Neoplasm", "histology_exclusion": ["Glioblastoma, IDH-Wildtype", "Glioblastoma", "Prostate Neoplasm", "Prostate Carcinoma", "Pancreatic Carcinoma", "Mucosal Melanoma", "Ocular Melanoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Head and Neck Carcinoma", "histology_exclusion": ["Mucosal Melanoma", "Glioblastoma, IDH-Wildtype", "Prostate Neoplasm", "Glioblastoma", "Ocular Melanoma", "Prostate Carcinoma", "Pancreatic Carcinoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Mucosal Melanoma", "Glioblastoma, IDH-Wildtype", "Prostate Neoplasm", "Glioblastoma", "Ocular Melanoma", "Prostate Carcinoma", "Pancreatic Carcinoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT01783535", "json": [{"cohort": "", "disease_state": "intraocular retinoblastoma", "histology_inclusion": "retinoblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Retinoblastoma"}]}
{"NCT_id": "NCT03556384", "json": [{"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "SDH-mutant/deficient GIST", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["SDHB-Low", "SDHB-Low", "expression"], ["SDS Mutation", "SDS-Mutation", "gene"], ["SDHB Mutation", "SDHB-Mutation", "gene"], ["SDS-Low", "SDS-Low", "expression"], ["SARDH-Low", "SARDH-Low", "expression"], ["SARDH Mutation", "SARDH-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["SDHB-Low", "SDHB-Low", "expression"], ["SDS Mutation", "SDS-Mutation", "gene"], ["SDHB Mutation", "SDHB-Mutation", "gene"], ["SDS-Low", "SDS-Low", "expression"], ["SARDH-Low", "SARDH-Low", "expression"], ["SARDH Mutation", "SARDH-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["SDHB-Low", "SDHB-Low", "expression"], ["SDS Mutation", "SDS-Mutation", "gene"], ["SDHB Mutation", "SDHB-Mutation", "gene"], ["SDS-Low", "SDS-Low", "expression"], ["SARDH-Low", "SARDH-Low", "expression"], ["SARDH Mutation", "SARDH-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["SDHB-Low", "SDHB-Low", "expression"], ["SDS Mutation", "SDS-Mutation", "gene"], ["SDHB Mutation", "SDHB-Mutation", "gene"], ["SDS-Low", "SDS-Low", "expression"], ["SARDH-Low", "SARDH-Low", "expression"], ["SARDH Mutation", "SARDH-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["SDHB-Low", "SDHB-Low", "expression"], ["SDS Mutation", "SDS-Mutation", "gene"], ["SDHB Mutation", "SDHB-Mutation", "gene"], ["SDS-Low", "SDS-Low", "expression"], ["SARDH-Low", "SARDH-Low", "expression"], ["SARDH Mutation", "SARDH-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["SDHB-Low", "SDHB-Low", "expression"], ["SDS Mutation", "SDS-Mutation", "gene"], ["SDHB Mutation", "SDHB-Mutation", "gene"], ["SDS-Low", "SDS-Low", "expression"], ["SARDH-Low", "SARDH-Low", "expression"], ["SARDH Mutation", "SARDH-Mutation", "gene"]]}]}
{"NCT_id": "NCT05092360", "json": [{"cohort": "", "disease_state": "platinum-resistant/refractory", "histology_inclusion": "Epithelial Ovarian Cancer (high-grade serous, endometrioid of any grade, clear cell)", "biomarker_inclusion": [], "histology_exclusion": ["EOC with mucinous or carcinosarcoma subtype", "nonepithelial tumor", "ovarian tumor with low malignant potential (borderline or low-grade serous tumor)"], "biomarker_exclusion": ["prior exposure to any anti-PD1/PD-L1 therapy"]}, {"cohort": "", "disease_state": "platinum-resistant/refractory", "histology_inclusion": "Fallopian Tube Cancer", "biomarker_inclusion": [], "histology_exclusion": ["EOC with mucinous or carcinosarcoma subtype", "nonepithelial tumor", "ovarian tumor with low malignant potential (borderline or low-grade serous tumor)"], "biomarker_exclusion": ["prior exposure to any anti-PD1/PD-L1 therapy"]}, {"cohort": "", "disease_state": "platinum-resistant/refractory", "histology_inclusion": "Primary Peritoneal Cancer", "biomarker_inclusion": [], "histology_exclusion": ["EOC with mucinous or carcinosarcoma subtype", "nonepithelial tumor", "ovarian tumor with low malignant potential (borderline or low-grade serous tumor)"], "biomarker_exclusion": ["prior exposure to any anti-PD1/PD-L1 therapy"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "histology_exclusion": ["Carcinosarcoma", "Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Ovarian Serous Adenocarcinoma"]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "histology_exclusion": ["Carcinosarcoma", "Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Ovarian Serous Adenocarcinoma"]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "histology_exclusion": ["Carcinosarcoma", "Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Ovarian Serous Adenocarcinoma"]}]}
{"NCT_id": "NCT05613036", "json": [{"cohort": "", "disease_state": "advanced, unresectable and/or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["brain metastasis", "leptomeningeal disease"], "biomarker_exclusion": ["known TP53 mutant tumors"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT04833114", "json": [{"cohort": "", "disease_state": "primary refractory or relapsed", "histology_inclusion": "diffuse large B-cell lymphoma not otherwise specified", "biomarker_inclusion": [], "histology_exclusion": ["primary or secondary central nervous system lymphoma", "Richter's transformation", "chronic lymphocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "primary refractory or relapsed", "histology_inclusion": "T-cell/histiocyte-rich large B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["primary or secondary central nervous system lymphoma", "Richter's transformation", "chronic lymphocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "primary refractory or relapsed", "histology_inclusion": "primary cutaneous diffuse large B-cell lymphoma, leg type", "biomarker_inclusion": [], "histology_exclusion": ["primary or secondary central nervous system lymphoma", "Richter's transformation", "chronic lymphocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "primary refractory or relapsed", "histology_inclusion": "Epstein-Barr virus-positive diffuse large B-cell lymphoma, not otherwise specified", "biomarker_inclusion": [], "histology_exclusion": ["primary or secondary central nervous system lymphoma", "Richter's transformation", "chronic lymphocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "primary refractory or relapsed", "histology_inclusion": "diffuse large B-cell lymphoma associated with chronic inflammation", "biomarker_inclusion": [], "histology_exclusion": ["primary or secondary central nervous system lymphoma", "Richter's transformation", "chronic lymphocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "primary refractory or relapsed", "histology_inclusion": "primary mediastinal (thymic) large B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["primary or secondary central nervous system lymphoma", "Richter's transformation", "chronic lymphocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "primary refractory or relapsed", "histology_inclusion": "high-grade B-cell lymphoma, with MYC and BCL2 and/or BCL6 rearrangements", "biomarker_inclusion": [], "histology_exclusion": ["primary or secondary central nervous system lymphoma", "Richter's transformation", "chronic lymphocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "primary refractory or relapsed", "histology_inclusion": "high-grade B-cell lymphoma, not otherwise specified", "biomarker_inclusion": [], "histology_exclusion": ["primary or secondary central nervous system lymphoma", "Richter's transformation", "chronic lymphocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Richter Syndrome", "Primary Central Nervous System Lymphoma", "Chronic Lymphocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "T-Cell/Histiocyte-Rich Large B-Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Richter Syndrome", "Primary Central Nervous System Lymphoma", "Chronic Lymphocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "histology_exclusion": ["Central Nervous System Lymphoma", "Richter Syndrome", "Primary Central Nervous System Lymphoma", "Chronic Lymphocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma, Not Otherwise Specified", "biomarker_inclusion": [["CR2-High", "CR2-High", "expression"]], "histology_exclusion": ["Central Nervous System Lymphoma", "Richter Syndrome", "Primary Central Nervous System Lymphoma", "Chronic Lymphocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation", "histology_exclusion": ["Central Nervous System Lymphoma", "Richter Syndrome", "Primary Central Nervous System Lymphoma", "Chronic Lymphocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Richter Syndrome", "Primary Central Nervous System Lymphoma", "Chronic Lymphocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"]], "histology_exclusion": ["Central Nervous System Lymphoma", "Richter Syndrome", "Primary Central Nervous System Lymphoma", "Chronic Lymphocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma, Not Otherwise Specified", "histology_exclusion": ["Central Nervous System Lymphoma", "Richter Syndrome", "Primary Central Nervous System Lymphoma", "Chronic Lymphocytic Leukemia"]}]}
{"NCT_id": "NCT05223673", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of metastatic colorectal cancer", "biomarker_inclusion": ["KRAS Wild Type", "NRAS Wild Type", "BRAF V600E Wild Type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"], ["BRAF V600E", "V600E", "coordinate"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["BRAF V600E", "V600E", "coordinate"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT05223699", "json": [{"cohort": "", "disease_state": "R/R AML or MDS-EB", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["CD117+"], "histology_exclusion": ["Acute promyelocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "R/R AML or MDS-EB", "histology_inclusion": "Myelodysplasia-Excess Blasts", "biomarker_inclusion": ["CD117+"], "histology_exclusion": ["Acute promyelocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["KIT-High", "KIT-High", "expression"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "biomarker_inclusion": [["KIT-High", "KIT-High", "expression"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT05028751", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": ["FLT3-mutated"], "histology_exclusion": ["central nervous system involvement with leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]]}]}
{"NCT_id": "NCT03493048", "json": [{"cohort": "", "disease_state": "Initially unresectable colorectal liver metastasis", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["RAS wild-type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04638309", "json": [{"cohort": "Cohort 1", "disease_state": "relapsed/refractory or previously untreated MDS", "histology_inclusion": "TP53-mutant MDS", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "relapsed/refractory or previously untreated MDS", "histology_inclusion": "TP53-mutant MDS", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "relapsed/refractory or previously untreated MDS", "histology_inclusion": "TP53-mutant MDS", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["PAFAH1B1 Mutation", "PAFAH1B1-Mutation", "gene"]]}, {"cohort": "Cohort 1", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["PAFAH1B1 Mutation", "PAFAH1B1-Mutation", "gene"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["PAFAH1B1 Mutation", "PAFAH1B1-Mutation", "gene"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["PAFAH1B1 Mutation", "PAFAH1B1-Mutation", "gene"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["PAFAH1B1 Mutation", "PAFAH1B1-Mutation", "gene"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["PAFAH1B1 Mutation", "PAFAH1B1-Mutation", "gene"]]}]}
{"NCT_id": "NCT05484622", "json": [{"cohort": "", "disease_state": "recurrent or progressive", "histology_inclusion": "Grade 2 or Grade 3 astrocytoma", "biomarker_inclusion": ["IDH1-R132H gene mutation"], "histology_exclusion": [], "biomarker_exclusion": ["1p19q co-deletion"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Anaplastic Astrocytoma", "biomarker_inclusion": [["IDH1 R132H", "R132H", "coordinate"]]}]}
{"NCT_id": "NCT05614739", "json": [{"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor cancer", "biomarker_inclusion": ["FGFR3 alteration"], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "Cohorts B1, B2, B3", "disease_state": "locally advanced or metastatic", "histology_inclusion": "urothelial cancer", "biomarker_inclusion": ["prespecified activating FGFR3 alteration"], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "Cohort C", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-urothelial solid tumor malignancy", "biomarker_inclusion": ["prespecified activating FGFR3 alteration"], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGFR3 Mutation", "FGFR3-Mutation", "gene"]]}, {"cohort": "Cohorts B1, B2, B3", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["FGFR3 Mutation", "FGFR3-Mutation", "gene"]]}, {"cohort": "Cohort C", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGFR3 Mutation", "FGFR3-Mutation", "gene"]]}]}
{"NCT_id": "NCT04209595", "json": [{"cohort": "Phase I", "disease_state": "progressed on or after standard first-line systemic chemotherapy", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II", "disease_state": "progressed on or after standard first-line systemic chemotherapy", "histology_inclusion": "SCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II", "disease_state": "progressed on or after standard first-line systemic chemotherapy", "histology_inclusion": "extra-pulmonary small cell carcinomas", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase I", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase II", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Phase II"}]}
{"NCT_id": "NCT04508140", "json": [{"cohort": "Cohort A", "disease_state": "advanced/metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases", "carcinomatosis meningitis"], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "advanced/metastatic", "histology_inclusion": "gastric/gastro-oesophageal junction cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases", "carcinomatosis meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Cohort B", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}]}
{"NCT_id": "NCT05289466", "json": [{"cohort": "", "disease_state": "Early Stage Breast Cancer", "histology_inclusion": "in situ and invasive ductal or lobular breast recurrence", "biomarker_inclusion": [], "histology_exclusion": ["Paget's disease of the nipple"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_exclusion": ["Nipple Paget Disease"]}]}
{"NCT_id": "NCT04768868", "json": [{"cohort": "Advanced Solid Tumors", "disease_state": "refractory/intolerant", "histology_inclusion": "advanced solid tumor", "biomarker_inclusion": ["MSI-H", "dMMR"], "histology_exclusion": ["CNS metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Advanced Solid Tumors", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT05159518", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "sarcoma with documented gene fusion", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS malignancies", "uncontrolled CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "castrate resistant", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS malignancies", "uncontrolled CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "hormone receptor positive (HR+), HER2 negative (HER2-) breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS malignancies", "uncontrolled CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "non-small cell lung cancer (NSCLC)", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS malignancies", "uncontrolled CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["MYC amplification"], "histology_exclusion": ["primary CNS malignancies", "uncontrolled CNS metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Sarcoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["HR-High", "HR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["HR-High", "HR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["HR-High", "HR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["HR-High", "HR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MYC-High", "MYC-High", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT05419817", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["dMMR"], "histology_exclusion": ["sarcoma", "carcinosarcoma"], "biomarker_exclusion": ["pMMR"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["dMMR"], "histology_exclusion": ["sarcoma", "carcinosarcoma"], "biomarker_exclusion": ["pMMR"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Carcinosarcoma", "Sarcoma"]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Carcinosarcoma", "Sarcoma"]}]}
{"NCT_id": "NCT03819387", "json": [{"cohort": "Part A", "disease_state": "progressive or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "progressive or metastatic", "histology_inclusion": "Pancreatic Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "progressive or metastatic", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A - Dose Level 5", "disease_state": "progressive or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS-mutant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "progressive or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS-mutant"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part A", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "Part A", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Part A - Dose Level 5", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "Part B", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04964505", "json": [{"cohort": "", "disease_state": "treatment naive", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT04145115", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "glioblastoma IDH-wildtype CNS WHO grade 4", "biomarker_inclusion": ["TMB >= 10"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "diffuse astrocytic glioma IDH-wildtype", "biomarker_inclusion": ["TMB >= 10", "TERT promoter mutation", "EGFR gene amplification", "+7/-10 chromosome copy-number changes"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "astrocytoma IDH-mutant CNS WHO grade 4", "biomarker_inclusion": ["TMB >= 10", "ATRX mutation", "TP53 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "diffuse astrocytic glioma IDH-mutant", "biomarker_inclusion": ["TMB >= 10", "homozygous deletion of CDKN2A", "homozygous deletion of CDKN2B"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"], ["TERT-Promoter", "TERT-Promoter", "coordinate"], ["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["TMB-High", "TMB-High", "coordinate"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["TMB", "TMB", "coordinate"], ["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["TERT-Promoter", "TERT-Promoter", "coordinate"], ["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"], ["ATRX Mutation", "ATRX-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}]}
{"NCT_id": "NCT04769388", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": ["EGFRm (exon 19 deletion)", "EGFRm (exon 21 L858R)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT02635672", "json": [{"cohort": "Part 2 (Global), Part 3 (US Only), and Part 4 (US Only)", "disease_state": "refractory to or have exhausted all available therapies", "histology_inclusion": "solid tumor or aggressive non-hodgkin's lymphoma", "biomarker_inclusion": ["MYC expression", "C-MYC amplification/alterations"], "histology_exclusion": ["brain or meningeal or spinal metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 2 (Global), Part 3 (US Only), and Part 4 (US Only)", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MYC Mutation", "MYC-Mutation", "gene"], ["MYC-High", "MYC-High", "expression"]]}, {"cohort": "Part 2 (Global), Part 3 (US Only), and Part 4 (US Only)", "histology_inclusion": "Aggressive Non-Hodgkin Lymphoma", "biomarker_inclusion": [["MYC Mutation", "MYC-Mutation", "gene"], ["MYC-High", "MYC-High", "expression"]]}]}
{"NCT_id": "NCT04015778", "json": [{"cohort": "Nivolumab Mono", "disease_state": "Early stage IB-IIIA", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["PD-L1 expression level \u226550%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Nivolumab Plus Chemo", "disease_state": "Early stage IB-IIIA", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["PD-L1 expression level <1%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Nivolumab Plus Chemo", "disease_state": "Early stage IB-IIIA", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["PD-L1 expression level 1%-49%"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Nivolumab Mono", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Nivolumab Plus Chemo", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Nivolumab Plus Chemo", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT05099549", "json": [{"cohort": "Phase 1/Dose Escalation", "disease_state": "advanced or metastatic", "histology_inclusion": "EGFR-positive malignancy", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2a/Expansion Cohort 1 - Metastatic colorectal cancer (EXP-1: mCRC)", "disease_state": "advanced or metastatic", "histology_inclusion": "mCRC", "biomarker_inclusion": ["EGFR positive", "MSI low", "DNA mismatch repair proficient"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2a/Expansion Cohort 2 - Head and Neck Squamous Cell Carcinoma (EXP-2: SCCHN)", "disease_state": "advanced or metastatic", "histology_inclusion": "SCCHN", "biomarker_inclusion": ["EGFR positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2a/Expansion Cohort 3 - Non-small cell lung cancer (EXP-3: NSCLC)", "disease_state": "advanced or metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["EGFR positive", "EGFR WT"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1/Dose Escalation", "biomarker_inclusion": [["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "Phase 2a/Expansion Cohort 1 - Metastatic colorectal cancer (EXP-1: mCRC)", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["EGFR-High", "EGFR-High", "expression"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Phase 2a/Expansion Cohort 2 - Head and Neck Squamous Cell Carcinoma (EXP-2: SCCHN)", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "Phase 2a/Expansion Cohort 3 - Non-small cell lung cancer (EXP-3: NSCLC)", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["EGFR-High", "EGFR-High", "expression"]]}]}
{"NCT_id": "NCT05489926", "json": [{"cohort": "", "disease_state": "relapsed", "histology_inclusion": "non-mucinous epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": ["untreated and/or active brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma"}]}
{"NCT_id": "NCT04084717", "json": [{"cohort": "ROS1 Rearrangement", "disease_state": "Stage IV or incurable", "histology_inclusion": "Non-squamous Non-small-cell Lung Cancer", "biomarker_inclusion": ["ROS1 rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "MET-activating Mutation (exon 14)", "disease_state": "Stage IV or incurable", "histology_inclusion": "Non-squamous Non-small-cell Lung Cancer", "biomarker_inclusion": ["MET-activating mutation (exon 14)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "MET-amplification", "disease_state": "Stage IV or incurable", "histology_inclusion": "Non-squamous Non-small-cell Lung Cancer", "biomarker_inclusion": ["MET-amplification"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "ROS1 Rearrangement", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"]]}, {"cohort": "MET-activating Mutation (exon 14)", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MET Mutation", "MET-Mutation", "gene"], ["SLTM Mutation", "SLTM-Mutation", "gene"]]}, {"cohort": "MET-amplification", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}]}
{"NCT_id": "NCT04215003", "json": [{"cohort": "CL1", "disease_state": "", "histology_inclusion": "invasive ductal carcinoma of breast", "biomarker_inclusion": ["HR+", "HER2-", "PI3K-AKT pathway mutation negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "CL2", "disease_state": "", "histology_inclusion": "invasive ductal carcinoma of breast", "biomarker_inclusion": ["HR+", "HER2-", "PI3K-AKT pathway mutation positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "CLH1", "disease_state": "", "histology_inclusion": "invasive ductal carcinoma of breast", "biomarker_inclusion": ["HR+", "HER2+", "PI3K-AKT pathway mutation negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "CLH2", "disease_state": "", "histology_inclusion": "invasive ductal carcinoma of breast", "biomarker_inclusion": ["HR+", "HER2+", "PI3K-AKT pathway mutation positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "CH1", "disease_state": "", "histology_inclusion": "invasive ductal carcinoma of breast", "biomarker_inclusion": ["HR-", "HER2+", "PI3K-AKT pathway mutation negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "CH2", "disease_state": "", "histology_inclusion": "invasive ductal carcinoma of breast", "biomarker_inclusion": ["HR-", "HER2+", "PI3K-AKT pathway mutation positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "CT1", "disease_state": "", "histology_inclusion": "invasive ductal carcinoma of breast", "biomarker_inclusion": ["HR-", "HER2-", "LAR subtype"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "CL1", "histology_inclusion": "Invasive Ductal Carcinoma, Not Otherwise Specified", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["PIK3CA - AKT1", "PIK3CA - AKT1", "coordinate"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "CL2", "histology_inclusion": "Invasive Ductal Carcinoma, Not Otherwise Specified", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["PIK3CA - AKT1", "PIK3CA - AKT1", "coordinate"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "CLH1", "histology_inclusion": "Invasive Ductal Carcinoma, Not Otherwise Specified", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["PIK3CA - AKT1", "PIK3CA - AKT1", "coordinate"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "CLH2", "histology_inclusion": "Invasive Ductal Carcinoma, Not Otherwise Specified", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["PIK3CA - AKT1", "PIK3CA - AKT1", "coordinate"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "CH1", "histology_inclusion": "Invasive Ductal Carcinoma, Not Otherwise Specified", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["PIK3CA - AKT1", "PIK3CA - AKT1", "coordinate"]]}, {"cohort": "CH2", "histology_inclusion": "Invasive Ductal Carcinoma, Not Otherwise Specified", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["PIK3CA - AKT1", "PIK3CA - AKT1", "coordinate"]]}, {"cohort": "CT1", "histology_inclusion": "Invasive Ductal Carcinoma, Not Otherwise Specified", "biomarker_inclusion": [["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT05359861", "json": [{"cohort": "", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["fibrolamellar HCC", "sarcomatoid HCC", "mixed cholangiocarcinoma and HCC"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma", "histology_exclusion": ["Cholangiocarcinoma", "Hepatocellular Carcinoma"]}]}
{"NCT_id": "NCT04280848", "json": [{"cohort": "Cohort A", "disease_state": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["unmethylated MGMT status"], "histology_exclusion": [], "biomarker_exclusion": ["IDH1 mutation"]}, {"cohort": "Cohort B", "disease_state": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["methylated MGMT status"], "histology_exclusion": [], "biomarker_exclusion": ["IDH1 mutation"]}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Glioblastoma", "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "Cohort B", "histology_inclusion": "Glioblastoma", "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}]}
{"NCT_id": "NCT05035381", "json": [{"cohort": "Experiment Group", "disease_state": "unresectable recurrent or metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Experiment Group", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT05035407", "json": [{"cohort": "", "disease_state": "metastatic or refractory/recurrent", "histology_inclusion": "KK-LC-1 positive epithelial cancer", "biomarker_inclusion": ["HLA-A 01:01"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Epithelial Neoplasm", "biomarker_inclusion": [["CT83-High", "CT83-High", "expression"]]}]}
{"NCT_id": "NCT05295589", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "High grade serous ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Endometrioid grade 3 ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Ovarian cancer with BRCA1 and/or BRCA2 deleterious mutation", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Fallopian tube cancer with BRCA1 and/or BRCA2 deleterious mutation", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Primary peritoneal cancer with BRCA1 and/or BRCA2 deleterious mutation", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Serous Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT02314481", "json": [{"cohort": "Arm 1", "disease_state": "relapsed", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["actionable mutation"]}, {"cohort": "Arm 2", "disease_state": "relapsed", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["BRAFV600 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["sensitising EGFR mutation"]}, {"cohort": "Arm 3", "disease_state": "relapsed", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["ALK/RET gene fusion", "ALK IHC+", "RET FISH"], "histology_exclusion": [], "biomarker_exclusion": ["sensitising EGFR mutation"]}, {"cohort": "Arm 4", "disease_state": "relapsed", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["HER2 amplification", "HER2 IHC 3+"], "histology_exclusion": [], "biomarker_exclusion": ["sensitising EGFR mutation"]}], "json_norm": [{"cohort": "Arm 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Arm 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Arm 3", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"], ["ALK-High", "ALK-High", "expression"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Arm 4", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT02912949", "json": [{"cohort": "", "disease_state": "locally-advanced unresectable or metastatic", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": ["NRG1 gene fusion"], "histology_exclusion": ["brain metastases", "leptomeningeal metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NRG1 Fusion", "NRG1", "fusion"]]}]}
{"NCT_id": "NCT03434262", "json": [{"cohort": "Stratum A", "disease_state": "refractory or recurrent", "histology_inclusion": "medulloblastoma (Group 3/4)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum A", "disease_state": "refractory or recurrent", "histology_inclusion": "ependymoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum B", "disease_state": "refractory or recurrent", "histology_inclusion": "medulloblastoma (SHH- or WNT-activated)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum B", "disease_state": "refractory or recurrent", "histology_inclusion": "high grade glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum B", "disease_state": "refractory or recurrent", "histology_inclusion": "select CNS embryonal tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum C", "disease_state": "refractory or recurrent", "histology_inclusion": "medulloblastoma (SHH-activated)", "biomarker_inclusion": ["9q loss", "PTCH1 mutant"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Stratum A", "histology_inclusion": "Medulloblastoma"}, {"cohort": "Stratum A", "histology_inclusion": "Ependymoma"}, {"cohort": "Stratum B", "histology_inclusion": "Medulloblastoma", "biomarker_inclusion": [["SHH-Low", "SHH-Low", "expression"]]}, {"cohort": "Stratum B", "histology_inclusion": "Malignant Glioma"}, {"cohort": "Stratum B", "histology_inclusion": "Central Nervous System Embryonal Tumor"}, {"cohort": "Stratum C", "histology_inclusion": "Medulloblastoma", "biomarker_inclusion": [["PTCH1 Mutation", "PTCH1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04514419", "json": [{"cohort": "", "disease_state": "early-stage (T2-3, N0-1, M0), locally advanced (T2-3, N2-3,M0 or T4a-c, any N, M0), or inflammatory (T4d, any N,M0)", "histology_inclusion": "invasive breast carcinoma", "biomarker_inclusion": ["HER2 positive (HER2+++ by IHC or ISH+)"], "histology_exclusion": [], "biomarker_exclusion": ["Stage IV metastatic", "HIV antibody positive", "HCV antibody positive and HCV RNA positive", "HBcAb or HBsAg positive, and HBV DNA positive"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04774952", "json": [{"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04840186", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "adenocarcinoma in colon or rectal", "biomarker_inclusion": [], "histology_exclusion": ["bone metastatic disease", "CNS metastatic disease"], "biomarker_exclusion": ["KRAS mutant primary tumour", "BRAF mutant primary tumour"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Adenocarcinoma", "biomarker_exclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}]}
{"NCT_id": "NCT05425940", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["RAS mutant", "RAS wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-high", "dMMR"]}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["MSS", "MSI-low"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT02706626", "json": [{"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["ALK rearrangement"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with brigatinib"]}, {"cohort": "Cohort B", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["ALK rearrangement", "progressive disease on first-line therapy with alectinib"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort C", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["ALK rearrangement", "previous treatment with brigatinib at 180 mg daily for \u22654 weeks without > grade 2 drug-related toxicities", "radiographic evidence of progressive disease"], "histology_exclusion": [], "biomarker_exclusion": ["intervening systemic therapies such as chemotherapy, immunotherapy or another ALK inhibitor"]}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Cohort B", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Cohort C", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT03434418", "json": [{"cohort": "", "disease_state": "Stage 4", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR exon 18 G719X", "EGFR exon 20 S768I", "EGFR exon 21 L861Q"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR exon 20 T790M", "EGFR exon 19 deletion", "EGFR exon 21 L858R", "EGFR exon 20 insertion"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR S768I", "S768I", "coordinate"], ["EGFR L861Q", "L861Q", "coordinate"]], "biomarker_exclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR T790M", "T790M", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT02978495", "json": [{"cohort": "", "disease_state": "Stage II or III", "histology_inclusion": "Triple Negative Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}]}
{"NCT_id": "NCT04281498", "json": [{"cohort": "Patients with MPN", "disease_state": "Accelerated-phase or Blast-phase Myeloproliferative Neoplasm", "histology_inclusion": "Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia", "biomarker_inclusion": ["IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Patients with MPN", "disease_state": "Chronic-phase Myelofibrosis", "histology_inclusion": "Myelofibrosis", "biomarker_inclusion": ["IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Patients with MPN", "histology_inclusion": "Essential Thrombocythemia", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Patients with MPN", "histology_inclusion": "Myelofibrosis", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Patients with MPN", "histology_inclusion": "Polycythemia Vera", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Patients with MPN", "histology_inclusion": "Myelofibrosis", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04449874", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT04905810", "json": [{"cohort": "", "disease_state": "treatment naive or relapsed", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT05036005", "json": [{"cohort": "", "disease_state": "early", "histology_inclusion": "HER2-positive breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04905914", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["DDR mutations"], "histology_exclusion": ["leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]], "histology_exclusion": ["Leukemia"]}]}
{"NCT_id": "NCT04970992", "json": [{"cohort": "", "disease_state": "advanced, unresectable, or metastatic", "histology_inclusion": "solid malignant tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, unresectable, or metastatic", "histology_inclusion": "lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Neoplasm"}, {"cohort": "", "histology_inclusion": "Lymphoma"}]}
{"NCT_id": "NCT05361395", "json": [{"cohort": "", "disease_state": "Extensive Stage Small Cell Lung Cancer", "histology_inclusion": "Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04906031", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": ["p53 mutation: Q136P", "p53 mutation: Y234H", "p53 mutation: V272M", "p53 mutation: F270V", "p53 mutation: P278A", "p53 mutation: R213L", "p53 mutation: Y126H", "p53 mutation: T253N", "p53 mutation: T253I", "p53 mutation: R158L", "p53 mutation: Q136E", "p53 mutation: P142F", "p53 mutation: A129D", "p53 mutation: L194R", "p53 mutation: R110P", "p53 mutation: V172G", "p53 mutation: C176F", "p53 mutation: I254N", "p53 mutation: K305R", "p53 mutation: E285D", "p53 mutation: T155P", "p53 mutation: H296D", "p53 mutation: E258G", "p53 mutation: G279V", "p53 mutation: T211A", "p53 mutation: R213P", "p53 mutation: C229Y", "p53 mutation: I232F", "p53 mutation: E294K", "p53 mutation: P152R", "p53 mutation: R196P", "p53 mutation: M160T", "p53 mutation: N131S", "p53 mutation: N131H", "p53 mutation: K139N", "p53 mutation: L330H", "p53 mutation: Y220N", "p53 mutation: E298Q", "p53 mutation: D148E", "p53 mutation: L264R", "p53 mutation: E224D", "p53 mutation: H168P", "p53 mutation: N263H", "p53 mutation: K320N", "p53 mutation: S227C", "p53 mutation: E286D", "p53 mutation: K292T", "p53 mutation: V203A", "p53 mutation: M237R", "p53 mutation: F212L", "p53 mutation: K132Q", "p53 mutation: Y236S", "p53 mutation: Y126S", "p53 mutation: Q136H", "p53 mutation: E221A", "p53 mutation: I232S", "p53 mutation: Y163H", "p53 mutation: P190T", "p53 mutation: C182Y", "p53 mutation: P142L", "p53 mutation: Y163S", "p53 mutation: V218E", "p53 mutation: I195S", "p53 mutation: V272A", "p53 mutation: S106R"], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["p53 mutation: Q136P", "p53 mutation: Y234H", "p53 mutation: V272M", "p53 mutation: F270V", "p53 mutation: P278A", "p53 mutation: R213L", "p53 mutation: Y126H", "p53 mutation: T253N", "p53 mutation: T253I", "p53 mutation: R158L", "p53 mutation: Q136E", "p53 mutation: P142F", "p53 mutation: A129D", "p53 mutation: L194R", "p53 mutation: R110P", "p53 mutation: V172G", "p53 mutation: C176F", "p53 mutation: I254N", "p53 mutation: K305R", "p53 mutation: E285D", "p53 mutation: T155P", "p53 mutation: H296D", "p53 mutation: E258G", "p53 mutation: G279V", "p53 mutation: T211A", "p53 mutation: R213P", "p53 mutation: C229Y", "p53 mutation: I232F", "p53 mutation: E294K", "p53 mutation: P152R", "p53 mutation: R196P", "p53 mutation: M160T", "p53 mutation: N131S", "p53 mutation: N131H", "p53 mutation: K139N", "p53 mutation: L330H", "p53 mutation: Y220N", "p53 mutation: E298Q", "p53 mutation: D148E", "p53 mutation: L264R", "p53 mutation: E224D", "p53 mutation: H168P", "p53 mutation: N263H", "p53 mutation: K320N", "p53 mutation: S227C", "p53 mutation: E286D", "p53 mutation: K292T", "p53 mutation: V203A", "p53 mutation: M237R", "p53 mutation: F212L", "p53 mutation: K132Q", "p53 mutation: Y236S", "p53 mutation: Y126S", "p53 mutation: Q136H", "p53 mutation: E221A", "p53 mutation: I232S", "p53 mutation: Y163H", "p53 mutation: P190T", "p53 mutation: C182Y", "p53 mutation: P142L", "p53 mutation: Y163S", "p53 mutation: V218E", "p53 mutation: I195S", "p53 mutation: V272A", "p53 mutation: S106R"], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["TP53 L264R", "L264R", "coordinate"], ["TP53 I232S", "I232S", "coordinate"], ["TP53 P190T", "P190T", "coordinate"], ["TP53 E224D", "E224D", "coordinate"], ["TP53 R213L", "R213L", "coordinate"], ["TP53 T211A", "T211A", "coordinate"], ["TP53 I232F", "I232F", "coordinate"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["TP53 S106R", "S106R", "coordinate"], ["TP53 E258G", "E258G", "coordinate"], ["TP53 K139N", "K139N", "coordinate"], ["TP53 I254N", "I254N", "coordinate"], ["TP53 Q136E", "Q136E", "coordinate"], ["TP53 Y163H", "Y163H", "coordinate"], ["TP53 R158L", "R158L", "coordinate"], ["TP53 V172G", "V172G", "coordinate"], ["TP53 H168P", "H168P", "coordinate"], ["TP53 Y163S", "Y163S", "coordinate"], ["TP53 I195S", "I195S", "coordinate"], ["TP53 V272A", "V272A", "coordinate"], ["TP53 T155P", "T155P", "coordinate"], ["TP53 K320N", "K320N", "coordinate"], ["TP53 R213P", "R213P", "coordinate"], ["TP53 P152R", "P152R", "coordinate"], ["TP53 Y126H", "Y126H", "coordinate"], ["TP53 T253I", "T253I", "coordinate"], ["TP53 Y220N", "Y220N", "coordinate"], ["TP53 V272M", "V272M", "coordinate"], ["TP53 Y234H", "Y234H", "coordinate"], ["TP53 P278A", "P278A", "coordinate"], ["TP53 Y236S", "Y236S", "coordinate"], ["TP53 N131S", "N131S", "coordinate"], ["TP53 L194R", "L194R", "coordinate"], ["TP53 Y126S", "Y126S", "coordinate"], ["TP53 C176F", "C176F", "coordinate"], ["TP53 K132Q", "K132Q", "coordinate"], ["TP53 S227C", "S227C", "coordinate"], ["TP53 E294K", "E294K", "coordinate"], ["TP53 P142L", "P142L", "coordinate"], ["TP53 R196P", "R196P", "coordinate"], ["TP53 R110P", "R110P", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["TP53 L264R", "L264R", "coordinate"], ["TP53 I232S", "I232S", "coordinate"], ["TP53 P190T", "P190T", "coordinate"], ["TP53 E224D", "E224D", "coordinate"], ["TP53 R213L", "R213L", "coordinate"], ["TP53 T211A", "T211A", "coordinate"], ["TP53 I232F", "I232F", "coordinate"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["TP53 S106R", "S106R", "coordinate"], ["TP53 E258G", "E258G", "coordinate"], ["TP53 K139N", "K139N", "coordinate"], ["TP53 I254N", "I254N", "coordinate"], ["TP53 Q136E", "Q136E", "coordinate"], ["TP53 Y163H", "Y163H", "coordinate"], ["TP53 R158L", "R158L", "coordinate"], ["TP53 V172G", "V172G", "coordinate"], ["TP53 H168P", "H168P", "coordinate"], ["TP53 Y163S", "Y163S", "coordinate"], ["TP53 I195S", "I195S", "coordinate"], ["TP53 V272A", "V272A", "coordinate"], ["TP53 T155P", "T155P", "coordinate"], ["TP53 K320N", "K320N", "coordinate"], ["TP53 R213P", "R213P", "coordinate"], ["TP53 P152R", "P152R", "coordinate"], ["TP53 Y126H", "Y126H", "coordinate"], ["TP53 T253I", "T253I", "coordinate"], ["TP53 Y220N", "Y220N", "coordinate"], ["TP53 V272M", "V272M", "coordinate"], ["TP53 Y234H", "Y234H", "coordinate"], ["TP53 P278A", "P278A", "coordinate"], ["TP53 Y236S", "Y236S", "coordinate"], ["TP53 N131S", "N131S", "coordinate"], ["TP53 L194R", "L194R", "coordinate"], ["TP53 Y126S", "Y126S", "coordinate"], ["TP53 C176F", "C176F", "coordinate"], ["TP53 K132Q", "K132Q", "coordinate"], ["TP53 S227C", "S227C", "coordinate"], ["TP53 E294K", "E294K", "coordinate"], ["TP53 P142L", "P142L", "coordinate"], ["TP53 R196P", "R196P", "coordinate"], ["TP53 R110P", "R110P", "coordinate"]]}]}
{"NCT_id": "NCT05036291", "json": [{"cohort": "NB004", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "NB004", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04775862", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["RAS wildtype", "BRAF wildtype"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT03761108", "json": [{"cohort": "Phase 1 Dose Escalation", "disease_state": "relapsed or refractory", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": ["plasma cell leukemia", "primary systemic light-chain amyloidosis", "Waldenstr\u00f6m macroglobulinemia (lymphoplasmacytic lymphoma)", "POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes)", "MM brain lesions", "meningeal involvement"], "biomarker_exclusion": ["BCMA-directed immunotherapies", "BCMA bispecific antibodies", "BiTEs", "BCMA CAR T cells"]}, {"cohort": "Phase 2", "disease_state": "triple-refractory", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": ["plasma cell leukemia", "primary systemic light-chain amyloidosis", "Waldenstr\u00f6m macroglobulinemia (lymphoplasmacytic lymphoma)", "POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes)", "MM brain lesions", "meningeal involvement"], "biomarker_exclusion": ["BCMA-directed immunotherapies", "BCMA bispecific antibodies", "BiTEs", "BCMA CAR T cells"]}], "json_norm": [{"cohort": "Phase 1 Dose Escalation", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Plasma Cell Leukemia", "Amyloidosis", "Lymphoplasmacytic Lymphoma", "Waldenstrom Macroglobulinemia"]}, {"cohort": "Phase 2", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Plasma Cell Leukemia", "Amyloidosis", "Lymphoplasmacytic Lymphoma", "Waldenstrom Macroglobulinemia"]}]}
{"NCT_id": "NCT04645797", "json": [{"cohort": "APR003 Dose Escalation", "disease_state": "Advanced", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "APR003 Dose Escalation", "histology_inclusion": "Colorectal Carcinoma"}]}
{"NCT_id": "NCT05166616", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR Ex19del", "EGFR L858R"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT05557045", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["MAPK pathway alteration"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MAPK/ERK pathway", null, "pathway"]]}]}
{"NCT_id": "NCT05687266", "json": [{"cohort": "", "disease_state": "Stage IIIB, IIIC, or IV", "histology_inclusion": "NSCLC", "biomarker_inclusion": [], "histology_exclusion": ["Mixed small-cell lung cancer and NSCLC", "sarcomatoid variant of NSCLC"], "biomarker_exclusion": ["sensitising EGFR tumour tissue mutation", "ALK rearrangement", "ROS1 rearrangement", "NTRK genomic alteration", "BRAF genomic alteration", "RET genomic alteration", "MET genomic alteration"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma", "Non-Small Cell Lung Carcinoma"], "biomarker_exclusion": [["RET Mutation", "RET-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["MET Mutation", "MET-Mutation", "gene"], ["NTRK3 Mutation", "NTRK3-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"], ["NTRK2 Mutation", "NTRK2-Mutation", "gene"], ["NTRK1 Mutation", "NTRK1-Mutation", "gene"], ["SLTM Mutation", "SLTM-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"]]}]}
{"NCT_id": "NCT03891615", "json": [{"cohort": "", "disease_state": "stage IV (AJCC 8th ed.)", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior PARP inhibitor therapy"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT03891784", "json": [{"cohort": "", "disease_state": "advanced, refractory, unresectable", "histology_inclusion": "GEP NET", "biomarker_inclusion": [], "histology_exclusion": ["poorly differentiated neuroendocrine carcinoma", "mixed adenoneuroendocrine carcinomas"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory, unresectable", "histology_inclusion": "foregut neuroendocrine tumor", "biomarker_inclusion": [], "histology_exclusion": ["poorly differentiated neuroendocrine carcinoma", "mixed adenoneuroendocrine carcinomas"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory, unresectable", "histology_inclusion": "midgut neuroendocrine tumor", "biomarker_inclusion": [], "histology_exclusion": ["poorly differentiated neuroendocrine carcinoma", "mixed adenoneuroendocrine carcinomas"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory, unresectable", "histology_inclusion": "hindgut neuroendocrine tumor", "biomarker_inclusion": [], "histology_exclusion": ["poorly differentiated neuroendocrine carcinoma", "mixed adenoneuroendocrine carcinomas"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory, unresectable", "histology_inclusion": "pancreatic neuroendocrine tumor", "biomarker_inclusion": [], "histology_exclusion": ["poorly differentiated neuroendocrine carcinoma", "mixed adenoneuroendocrine carcinomas"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Digestive System Neuroendocrine Tumor", "histology_exclusion": ["Pancreatic Neuroendocrine Carcinoma"]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Carcinoma", "histology_exclusion": ["Pancreatic Neuroendocrine Carcinoma"]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Tumor", "histology_exclusion": ["Pancreatic Neuroendocrine Carcinoma"]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Carcinoma", "histology_exclusion": ["Pancreatic Neuroendocrine Carcinoma"]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Tumor", "histology_exclusion": ["Pancreatic Neuroendocrine Carcinoma"]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Carcinoma", "histology_exclusion": ["Pancreatic Neuroendocrine Carcinoma"]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Tumor", "histology_exclusion": ["Pancreatic Neuroendocrine Carcinoma"]}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Neoplasm", "histology_exclusion": ["Pancreatic Neuroendocrine Carcinoma"]}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Carcinoma", "histology_exclusion": ["Pancreatic Neuroendocrine Carcinoma"]}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Tumor", "histology_exclusion": ["Pancreatic Neuroendocrine Carcinoma"]}]}
{"NCT_id": "NCT04450732", "json": [{"cohort": "", "disease_state": "relapsed or refractory to standard therapy or for which there is no standard therapy and progressed", "histology_inclusion": "HER2-positive advanced/unresectable or metastatic breast cancer", "biomarker_inclusion": ["HER2 IHC 3+", "HER2 IHC 2+ and ISH+"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory to standard therapy or for which there is no standard therapy and progressed", "histology_inclusion": "HER2-positive advanced/unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma", "biomarker_inclusion": ["HER2 IHC 3+", "HER2 IHC 2+ and ISH+"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory to standard therapy or for which there is no standard therapy and progressed", "histology_inclusion": "other HER2-positive advanced/unresectable or metastatic solid malignant tumor", "biomarker_inclusion": ["HER2 IHC", "HER2 ISH", "HER2 Next Generation Sequencing"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Malignant Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT05362409", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Astrocytoma, WHO grade 3 and 4 (including subtypes)", "biomarker_inclusion": [], "histology_exclusion": ["Primary infratentorial or brainstem tumors", "Primary spinal cord tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Oligodendroglioma WHO grade 3 (including subtypes)", "biomarker_inclusion": [], "histology_exclusion": ["Primary infratentorial or brainstem tumors", "Primary spinal cord tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Astrocytoma", "histology_exclusion": ["Spinal Cord Neoplasm"]}, {"cohort": "", "histology_inclusion": "Oligodendroglioma", "histology_exclusion": ["Spinal Cord Neoplasm"]}]}
{"NCT_id": "NCT04975698", "json": [{"cohort": "HST-NEETs", "disease_state": "primary refractory or recurrent", "histology_inclusion": "diffuse large B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": ["HIV subtype other than B", "raltegravir or protease inhibitor resistance"]}, {"cohort": "HST-NEETs", "disease_state": "primary refractory or recurrent", "histology_inclusion": "immunoblastic lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": ["HIV subtype other than B", "raltegravir or protease inhibitor resistance"]}, {"cohort": "HST-NEETs", "disease_state": "primary refractory or recurrent", "histology_inclusion": "plasmablastic lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": ["HIV subtype other than B", "raltegravir or protease inhibitor resistance"]}, {"cohort": "HST-NEETs", "disease_state": "primary refractory or recurrent", "histology_inclusion": "high grade B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": ["HIV subtype other than B", "raltegravir or protease inhibitor resistance"]}, {"cohort": "HST-NEETs", "disease_state": "primary refractory or recurrent", "histology_inclusion": "Burkitt lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": ["HIV subtype other than B", "raltegravir or protease inhibitor resistance"]}, {"cohort": "HST-NEETs", "disease_state": "primary refractory or recurrent", "histology_inclusion": "primary effusion lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": ["HIV subtype other than B", "raltegravir or protease inhibitor resistance"]}, {"cohort": "HST-NEETs", "disease_state": "primary refractory or recurrent", "histology_inclusion": "classical Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": ["HIV subtype other than B", "raltegravir or protease inhibitor resistance"]}], "json_norm": [{"cohort": "HST-NEETs", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "HST-NEETs"}, {"cohort": "HST-NEETs", "histology_inclusion": "Plasmablastic Lymphoma"}, {"cohort": "HST-NEETs", "histology_inclusion": "High Grade B-Cell Lymphoma"}, {"cohort": "HST-NEETs", "histology_inclusion": "Burkitt Lymphoma"}, {"cohort": "HST-NEETs", "histology_inclusion": "Primary Effusion Lymphoma"}, {"cohort": "HST-NEETs", "histology_inclusion": "Classic Hodgkin Lymphoma"}]}
{"NCT_id": "NCT03439735", "json": [{"cohort": "Cohort A: Participants with untreated metastatic disease receiving ET and a CDK 4/6", "disease_state": "Metastatic (stage IV) or locally advanced breast cancer", "histology_inclusion": "Estrogen Receptor (ER) and/or Progesterone Receptor (PR) positive, HER2- negative", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B: Participants initiating a CDK 4/6 i after progression on ET", "disease_state": "Metastatic (stage IV) or locally advanced breast cancer", "histology_inclusion": "Estrogen Receptor (ER) and/or Progesterone Receptor (PR) positive, HER2- negative", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A: Participants with untreated metastatic disease receiving ET and a CDK 4/6", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "Cohort A: Participants with untreated metastatic disease receiving ET and a CDK 4/6", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "Cohort A: Participants with untreated metastatic disease receiving ET and a CDK 4/6", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "Cohort A: Participants with untreated metastatic disease receiving ET and a CDK 4/6", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "Cohort B: Participants initiating a CDK 4/6 i after progression on ET", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "Cohort B: Participants initiating a CDK 4/6 i after progression on ET", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "Cohort B: Participants initiating a CDK 4/6 i after progression on ET", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "Cohort B: Participants initiating a CDK 4/6 i after progression on ET", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}]}
{"NCT_id": "NCT04389632", "json": [{"cohort": "", "disease_state": "metastatic or unresectable solid malignancy, relapsed or refractory or intolerant to standard-of-care therapies", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable solid malignancy, relapsed or refractory or intolerant to standard-of-care therapies", "histology_inclusion": "Head and neck squamous cell cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable solid malignancy, relapsed or refractory or intolerant to standard-of-care therapies", "histology_inclusion": "Advanced HER2-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable solid malignancy, relapsed or refractory or intolerant to standard-of-care therapies", "histology_inclusion": "Esophageal squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable solid malignancy, relapsed or refractory or intolerant to standard-of-care therapies", "histology_inclusion": "Esophageal/Gastro-esophageal junction adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable solid malignancy, relapsed or refractory or intolerant to standard-of-care therapies", "histology_inclusion": "Cutaneous squamous cell cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable solid malignancy, relapsed or refractory or intolerant to standard-of-care therapies", "histology_inclusion": "Exocrine pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable solid malignancy, relapsed or refractory or intolerant to standard-of-care therapies", "histology_inclusion": "Bladder cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable solid malignancy, relapsed or refractory or intolerant to standard-of-care therapies", "histology_inclusion": "Cervical cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable solid malignancy, relapsed or refractory or intolerant to standard-of-care therapies", "histology_inclusion": "Gastric cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable solid malignancy, relapsed or refractory or intolerant to standard-of-care therapies", "histology_inclusion": "High grade serous ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Esophageal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Skin Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": "", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Serous Adenocarcinoma"}]}
{"NCT_id": "NCT04585035", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["KRasG12C mutation"], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["KRasG12C mutation"], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "CRC", "biomarker_inclusion": ["KRasG12C mutation"], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}]}
{"NCT_id": "NCT04910685", "json": [{"cohort": "Part 1 and Part 2", "disease_state": "Indolent Systemic Mastocytosis", "histology_inclusion": "Indolent Systemic Mastocytosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part M", "disease_state": "Monoclonal Mast Cell Activation Syndrome", "histology_inclusion": "Monoclonal Mast Cell Activation Syndrome", "biomarker_inclusion": ["KIT D816V", "CD25+ Mast cells"], "histology_exclusion": [], "biomarker_exclusion": ["tryptase \u2265 20 ng/mL"]}, {"cohort": "All Patients", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": ["cutaneous mastocytosis only", "smoldering Systemic Mastocytosis", "Systemic Mastocytosis with associated hematologic neoplasm", "aggressive Systemic Mastocytosis", "mast cell leukemia", "mast cell sarcoma"], "biomarker_exclusion": ["targeted KIT inhibitors"]}], "json_norm": [{"cohort": "Part 1 and Part 2", "histology_inclusion": "Indolent Systemic Mastocytosis"}, {"cohort": "Part M", "biomarker_inclusion": [["ISG20-High", "ISG20-High", "expression"], ["SPG21-High", "SPG21-High", "expression"], ["IL2RA-High", "IL2RA-High", "expression"], ["SPACA9-High", "SPACA9-High", "expression"], ["KIT D816V", "D816V", "coordinate"]]}, {"cohort": "All Patients", "histology_exclusion": ["Systemic Mastocytosis", "Mast Cell Sarcoma", "Smoldering Systemic Mastocytosis", "Mast Cell Leukemia", "Aggressive Systemic Mastocytosis", "Cutaneous Mastocytosis", "Hematopoietic and Lymphoid Cell Neoplasm", "Primary Systemic Mastocytosis"]}]}
{"NCT_id": "NCT04975919", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["acute promyelocytic leukemia (French-American-British [FAB] class M3-AML)", "symptomatic CNS leukemia", "poorly controlled CNS leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Acute Biphenotypic Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["acute promyelocytic leukemia (French-American-British [FAB] class M3-AML)", "symptomatic CNS leukemia", "poorly controlled CNS leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Bilineage Leukemia with a myeloid component", "biomarker_inclusion": [], "histology_exclusion": ["acute promyelocytic leukemia (French-American-British [FAB] class M3-AML)", "symptomatic CNS leukemia", "poorly controlled CNS leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Central Nervous System Leukemia"]}, {"cohort": "", "histology_inclusion": "Infant Acute Biphenotypic Leukemia", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Central Nervous System Leukemia", "Central Nervous System Leukemia"]}, {"cohort": "", "histology_inclusion": "Acute Biphenotypic Leukemia", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Central Nervous System Leukemia"]}, {"cohort": "", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Central Nervous System Leukemia"]}]}
{"NCT_id": "NCT02712112", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "Gastrointestinal Stromal Tumors (GISTs)", "biomarker_inclusion": ["CD117", "KIT mutation", "PDGFR\u03b1 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["KIT Mutation", "KIT-Mutation", "gene"]]}]}
{"NCT_id": "NCT04780568", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR exon 19 deletion", "EGFR L858R", "EGFR G719X", "EGFR S768I", "EGFR L861Q", "EGFR T790M"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with an EGFR TKI"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L861Q", "L861Q", "coordinate"], ["EGFR L858R", "L858R", "coordinate"], ["EGFR S768I", "S768I", "coordinate"], ["EGFR T790M", "T790M", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT04975958", "json": [{"cohort": "", "disease_state": "locally advanced and nonresectable, or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT03830918", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid malignancy", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "extensive-stage", "histology_inclusion": "small cell lung carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases", "leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}, {"cohort": "Phase 2", "histology_inclusion": "Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT03895970", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "hepatobiliary malignant tumors", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Neoplasm"}]}
{"NCT_id": "NCT04650451", "json": [{"cohort": "", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "HER2+ solid tumor malignancy", "biomarker_inclusion": ["HER2 amplification", "HER2 overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "HER2-positive Gastric Cancer", "biomarker_inclusion": ["HER2 amplification", "HER2 overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "HER2-positive Breast Cancer", "biomarker_inclusion": ["HER2 amplification", "HER2 overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT03765918", "json": [{"cohort": "", "disease_state": "Stage III-IVA", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["HPV positive oropharyngeal primary (T4, N0-2, M0)", "HPV negative oropharyngeal", "larynx primary", "hypopharynx primary", "oral cavity primary"], "histology_exclusion": [], "biomarker_exclusion": ["Stage T4B", "N3", "distant metastases", "cancer outside of the oropharynx, larynx, and hypopharynx or oral cavity", "central nervous system metastases", "carcinomatous meningitis"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT04585477", "json": [{"cohort": "Cohort 1 minimal residue disease positive(MRD+)", "disease_state": "Stage IA2 to IIIC", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["Tumors with any component of small cell lung cancer"], "biomarker_exclusion": ["EGFR TKI sensitizing mutation (Exon 19 deletion or L858R mutation)", "ALK/ ROS1 rearrangement"]}, {"cohort": "Cohort 1 minimal residue disease positive(MRD+)", "disease_state": "Stage IA2 to IIIC", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutant NSCLC with PD-L1 expression of 1% or higher"], "histology_exclusion": ["Tumors with any component of small cell lung cancer"], "biomarker_exclusion": ["ALK/ ROS1 rearrangement"]}], "json_norm": [{"cohort": "Cohort 1 minimal residue disease positive(MRD+)", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma"], "biomarker_exclusion": [["EGFR L858R", "L858R", "coordinate"], ["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}, {"cohort": "Cohort 1 minimal residue disease positive(MRD+)", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["CD274 Mutation", "CD274-Mutation", "gene"]], "histology_exclusion": ["Small Cell Lung Carcinoma"], "biomarker_exclusion": [["ROS1 Fusion", "ROS1", "fusion"]]}]}
{"NCT_id": "NCT04976218", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "EGFR-positive solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases", "active central nervous system (CNS)"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["EGFR-High", "EGFR-High", "expression"]]}]}
{"NCT_id": "NCT02647099", "json": [{"cohort": "", "disease_state": "stage II-III", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["PIK3CA mutation", "PIK3R1 mutation", "PTEN mutation"], "histology_exclusion": ["familial colonic polyposis", "Lynch syndrome", "Crohn's disease", "ulcerative colitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["PIK3R1 Mutation", "PIK3R1-Mutation", "gene"]], "histology_exclusion": ["Lynch Syndrome"]}]}
{"NCT_id": "NCT03114319", "json": [{"cohort": "TNO155", "disease_state": "Advanced", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutant", "KRAS G12-mutant"], "histology_exclusion": [], "biomarker_exclusion": ["activating KRAS", "NRAS", "HRAS", "BRAF", "PTPN11 (SHP2)"]}, {"cohort": "TNO155", "disease_state": "Advanced", "histology_inclusion": "Esophageal Squamous Cell Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["activating KRAS", "NRAS", "HRAS", "BRAF", "PTPN11 (SHP2)"]}, {"cohort": "TNO155", "disease_state": "Advanced", "histology_inclusion": "Head and Neck Squamous Cell Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["activating KRAS", "NRAS", "HRAS", "BRAF", "PTPN11 (SHP2)"]}, {"cohort": "TNO155", "disease_state": "Advanced", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["activating KRAS", "NRAS", "HRAS", "BRAF", "PTPN11 (SHP2)"]}, {"cohort": "TNO155 in combination with EGF816 (nazartinib)", "disease_state": "Advanced", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutant"], "histology_exclusion": [], "biomarker_exclusion": ["activating KRAS", "NRAS", "HRAS", "BRAF", "PTPN11 (SHP2)"]}], "json_norm": [{"cohort": "TNO155", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "TNO155", "histology_inclusion": "Esophageal Squamous Cell Carcinoma"}, {"cohort": "TNO155", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "TNO155", "histology_inclusion": "Melanoma"}, {"cohort": "TNO155 in combination with EGF816 (nazartinib)", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT03570619", "json": [{"cohort": "Metastatic CRPC", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the prostate without small cell histology", "biomarker_inclusion": ["CDK12 aberration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Solid Tumors (non-prostate)", "disease_state": "metastatic", "histology_inclusion": "metastatic carcinoma", "biomarker_inclusion": ["CDK12 aberration"], "histology_exclusion": ["adenocarcinoma of the prostate without small cell histology"], "biomarker_exclusion": []}, {"cohort": "Metastatic CRPC with Monotherapy", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the prostate without small cell histology", "biomarker_inclusion": ["CDK12 aberration"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Metastatic CRPC", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["CDK12 Mutation", "CDK12-Mutation", "gene"]]}, {"cohort": "Solid Tumors (non-prostate)", "biomarker_inclusion": [["CDK12 Mutation", "CDK12-Mutation", "gene"]], "histology_exclusion": ["Prostate Adenocarcinoma"]}, {"cohort": "Metastatic CRPC with Monotherapy", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["CDK12 Mutation", "CDK12-Mutation", "gene"]]}]}
{"NCT_id": "NCT04390243", "json": [{"cohort": "", "disease_state": "Locally Advanced, Metastatic, Recurrent, Stage III, Stage IV", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": [], "biomarker_exclusion": ["BRAF non-V600E mutation", "BRAF fusion"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]], "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF Fusion", "BRAF", "fusion"]]}]}
{"NCT_id": "NCT03635892", "json": [{"cohort": "Cohort 1: Unclassified, papillary, and HL RCC", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Unclassified Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain or spinal cord malignancies", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Cohort 1: Unclassified, papillary, and HL RCC", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Papillary Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain or spinal cord malignancies", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Cohort 2: Chromophobe RCC", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Chromophobe Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain or spinal cord malignancies", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Cohort 3: Unclassified, papillary, and HL RCC", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Unclassified Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain or spinal cord malignancies", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Cohort 3: Unclassified, papillary, and HL RCC", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Papillary Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain or spinal cord malignancies", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Cohort 4: Unclassified, papillary, and HL RCC", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Unclassified Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain or spinal cord malignancies", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Cohort 4: Unclassified, papillary, and HL RCC", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Papillary Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain or spinal cord malignancies", "leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1: Unclassified, papillary, and HL RCC", "histology_inclusion": "Unclassified Renal Cell Carcinoma", "histology_exclusion": ["Spinal Cord Neoplasm"]}, {"cohort": "Cohort 1: Unclassified, papillary, and HL RCC", "histology_inclusion": "Papillary Renal Cell Carcinoma", "histology_exclusion": ["Spinal Cord Neoplasm"]}, {"cohort": "Cohort 2: Chromophobe RCC", "histology_inclusion": "Chromophobe Renal Cell Carcinoma", "histology_exclusion": ["Spinal Cord Neoplasm"]}, {"cohort": "Cohort 3: Unclassified, papillary, and HL RCC", "histology_inclusion": "Unclassified Renal Cell Carcinoma", "histology_exclusion": ["Spinal Cord Neoplasm"]}, {"cohort": "Cohort 3: Unclassified, papillary, and HL RCC", "histology_inclusion": "Papillary Renal Cell Carcinoma", "histology_exclusion": ["Spinal Cord Neoplasm"]}, {"cohort": "Cohort 4: Unclassified, papillary, and HL RCC", "histology_inclusion": "Unclassified Renal Cell Carcinoma", "histology_exclusion": ["Spinal Cord Neoplasm"]}, {"cohort": "Cohort 4: Unclassified, papillary, and HL RCC", "histology_inclusion": "Papillary Renal Cell Carcinoma", "histology_exclusion": ["Spinal Cord Neoplasm"]}]}
{"NCT_id": "NCT04585750", "json": [{"cohort": "Phase 2 Dose Expansion, Cohort A", "disease_state": "Advanced Solid Tumor, Metastatic Cancer, Metastatic Solid Tumor", "histology_inclusion": "Advanced Malignant Neoplasm", "biomarker_inclusion": ["TP53 Y220C mutation"], "histology_exclusion": ["Primary CNS tumor"], "biomarker_exclusion": []}, {"cohort": "Phase 2 Dose Expansion, Cohort B", "disease_state": "Advanced Solid Tumor, Metastatic Cancer, Metastatic Solid Tumor", "histology_inclusion": "Advanced Malignant Neoplasm", "biomarker_inclusion": ["TP53 Y220C mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 2 Dose Expansion, Cohort A", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TP53 Y220C", "Y220C", "coordinate"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 2 Dose Expansion, Cohort B", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TP53 Y220C", "Y220C", "coordinate"]]}]}
{"NCT_id": "NCT05171660", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["RAS mutation"], "histology_exclusion": ["central nervous system (CNS) metastasis", "cancerous meningitis"], "biomarker_exclusion": ["RAS wild type"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]], "biomarker_exclusion": [["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT03440450", "json": [{"cohort": "", "disease_state": "metastatic solid tumor, relapsed or refractory to standard therapy", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort", "disease_state": "metastatic or unresectable", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort", "disease_state": "metastatic or unresectable", "histology_inclusion": "gall bladder carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort", "disease_state": "metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Expansion Cohort", "histology_inclusion": "Cholangiocarcinoma"}, {"cohort": "Expansion Cohort", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "Expansion Cohort", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": "Expansion Cohort", "histology_inclusion": "Pancreatic Adenocarcinoma"}]}
{"NCT_id": "NCT03570892", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Diffuse Large B-cell Lymphoma (DLBCL), NOS", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-CD19 therapy", "T cell therapy", "gene therapy product"]}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Follicular Lymphoma (FL) grade 3B", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-CD19 therapy", "T cell therapy", "gene therapy product"]}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Primary Mediastinal Large B-cell Lymphoma (PMBCL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-CD19 therapy", "T cell therapy", "gene therapy product"]}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "T cell rich/histiocyte rich large B-cell Lymphoma (T/HRBCL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-CD19 therapy", "T cell therapy", "gene therapy product"]}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "DLBCL associated with chronic inflammation", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-CD19 therapy", "T cell therapy", "gene therapy product"]}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Intravascular large B-cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-CD19 therapy", "T cell therapy", "gene therapy product"]}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "ALK+ large B-cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-CD19 therapy", "T cell therapy", "gene therapy product"]}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "B-cell Lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin's Lymphoma (HL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-CD19 therapy", "T cell therapy", "gene therapy product"]}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "High grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 rearrangements", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-CD19 therapy", "T cell therapy", "gene therapy product"]}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "High-grade B-cell Lymphoma, NOS", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-CD19 therapy", "T cell therapy", "gene therapy product"]}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "HHV8+ DLBCL, NOS", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-CD19 therapy", "T cell therapy", "gene therapy product"]}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "DLBCL transforming from Follicular Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-CD19 therapy", "T cell therapy", "gene therapy product"]}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "DLBCL transforming from Marginal Zone Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-CD19 therapy", "T cell therapy", "gene therapy product"]}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "DLBCL, leg type", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-CD19 therapy", "T cell therapy", "gene therapy product"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "", "histology_inclusion": "Grade 3b Follicular Lymphoma"}, {"cohort": "", "histology_inclusion": "Primary Mediastinal (Thymic) Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "T-Cell/Histiocyte-Rich Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation"}, {"cohort": "", "histology_inclusion": "Intravascular Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Classic Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"]]}, {"cohort": "", "histology_inclusion": "High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"]]}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma, Not Otherwise Specified"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Marginal Zone Lymphoma"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}]}
{"NCT_id": "NCT04520711", "json": [{"cohort": "CDX-1140 + TCR-T + Pembro", "disease_state": "metastatic or locoregionally advanced", "histology_inclusion": "epithelial cancers", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "CDX-1140 + TCR-T + Pembro", "histology_inclusion": "Epithelial Neoplasm"}]}
{"NCT_id": "NCT04585815", "json": [{"cohort": "Sub-Study A", "disease_state": "locally advanced/metastatic (Stage IIIB-IV) NSCLC", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["BRAFV600E mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutation", "ALK fusion oncogene", "ROS1 rearrangement"]}, {"cohort": "Sub-Study B", "disease_state": "locally advanced/metastatic (Stage IIIB-IV) NSCLC", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["PD-L1 TPS \u22651%"], "histology_exclusion": [], "biomarker_exclusion": ["BRAF", "EGFR", "ALK"]}], "json_norm": [{"cohort": "Sub-Study A", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]], "biomarker_exclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Sub-Study B", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04781270", "json": [{"cohort": "", "disease_state": "unresectable liver-limited metastases", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["RAS mutation", "BRAF V600E wild-type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["BRAF V600E", "V600E", "coordinate"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT05236972", "json": [{"cohort": "", "disease_state": "Stage III", "histology_inclusion": "adenocarcinoma of the colon", "biomarker_inclusion": ["dMMR", "MSI-H"], "histology_exclusion": ["rectal tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Rectal Carcinoma"]}]}
{"NCT_id": "NCT03570983", "json": [{"cohort": "", "disease_state": "new diagnosis", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": ["amyloidosis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Amyloidosis"]}]}
{"NCT_id": "NCT04222309", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Glioblastoma Multiforme (GBM)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype"}, {"cohort": "", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT04092179", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": ["IDH2 R140 mutation", "IDH2 R172 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}]}
{"NCT_id": "NCT04222335", "json": [{"cohort": "", "disease_state": "non operable and / or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR activating mutation (exons 18, 19, 21)"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR exon 20 mutation", "EGFR resistance mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT03311126", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System involvement", "leptomeningeal involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma"}]}
{"NCT_id": "NCT04223596", "json": [{"cohort": "", "disease_state": "Stage IIIB or IV", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["EML4-ALK rearrangement"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutation", "STK-1 Ligand alteration", "MDM2 amplification", "ROS1 translocations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EML4 Fusion", "EML4", "fusion"], ["EML4 - ALK", "EML4 - ALK", "coordinate"], ["ALK Fusion", "ALK", "fusion"]], "biomarker_exclusion": [["MDM2-High", "MDM2-High", "expression"], ["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT01996098", "json": [{"cohort": "", "disease_state": "Stage IIA-IIIA", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR activating mutation in exon 19", "EGFR activating mutation in exon 21"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04029922", "json": [{"cohort": "Part A", "disease_state": "unresectable, locally advanced or metastatic", "histology_inclusion": "HER2-positive solid cancers", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "unresectable, locally advanced or metastatic", "histology_inclusion": "HER2-positive breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "unresectable, locally advanced or metastatic", "histology_inclusion": "gastric or gastroesophageal adenocarcinomas (GEA)", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": ["histologically distinct tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part B", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": ""}, {"cohort": ""}]}
{"NCT_id": "NCT04853017", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": ["KRAS G12D", "KRAS G12R", "NRAS G12D", "NRAS G12R"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["KRAS G12D", "KRAS G12R", "NRAS G12D", "NRAS G12R"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["KRAS G12D", "KRAS G12R", "NRAS G12D", "NRAS G12R"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Ovarian Cancer", "biomarker_inclusion": ["KRAS G12D", "KRAS G12R", "NRAS G12D", "NRAS G12R"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": ["KRAS G12D", "KRAS G12R", "NRAS G12D", "NRAS G12R"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Bile Duct Cancer", "biomarker_inclusion": ["KRAS G12D", "KRAS G12R", "NRAS G12D", "NRAS G12R"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Gallbladder Carcinoma", "biomarker_inclusion": ["KRAS G12D", "KRAS G12R", "NRAS G12D", "NRAS G12R"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": [["NRAS G12R", "G12R", "coordinate"], ["KRAS G12D", "G12D", "coordinate"], ["KRAS G12R", "G12R", "coordinate"], ["NRAS G12D", "G12D", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["NRAS G12R", "G12R", "coordinate"], ["KRAS G12D", "G12D", "coordinate"], ["KRAS G12R", "G12R", "coordinate"], ["NRAS G12D", "G12D", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["NRAS G12R", "G12R", "coordinate"], ["KRAS G12D", "G12D", "coordinate"], ["KRAS G12R", "G12R", "coordinate"], ["NRAS G12D", "G12D", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"], ["KRAS G12R", "G12R", "coordinate"], ["NRAS G12D", "G12D", "coordinate"], ["NRAS G12R", "G12R", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["NRAS G12R", "G12R", "coordinate"], ["KRAS G12D", "G12D", "coordinate"], ["KRAS G12R", "G12R", "coordinate"], ["NRAS G12D", "G12D", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["NRAS G12R", "G12R", "coordinate"], ["KRAS G12D", "G12D", "coordinate"], ["KRAS G12R", "G12R", "coordinate"], ["NRAS G12D", "G12D", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Bile Duct Neoplasm", "biomarker_inclusion": [["NRAS G12R", "G12R", "coordinate"], ["KRAS G12D", "G12D", "coordinate"], ["KRAS G12R", "G12R", "coordinate"], ["NRAS G12D", "G12D", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Gallbladder Carcinoma", "biomarker_inclusion": [["NRAS G12R", "G12R", "coordinate"], ["KRAS G12D", "G12D", "coordinate"], ["KRAS G12R", "G12R", "coordinate"], ["NRAS G12D", "G12D", "coordinate"]]}]}
{"NCT_id": "NCT04853043", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["APC mutation", "TP53 mutation", "KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": ["wild type KRAS", "wild type APC", "wild type TP53"]}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["APC mutation", "TP53 mutation", "NRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": ["wild type KRAS", "wild type APC", "wild type TP53"]}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["APC mutation", "TP53 mutation", "HRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": ["wild type KRAS", "wild type APC", "wild type TP53"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["APC Mutation", "APC-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"]], "biomarker_exclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["APC APC-wild_type", "APC-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["APC Mutation", "APC-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"]], "biomarker_exclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["APC APC-wild_type", "APC-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["APC Mutation", "APC-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"]], "biomarker_exclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["APC APC-wild_type", "APC-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04592653", "json": [{"cohort": "Cohort 1: Tumor Microenvironment (TME) Nemvaleukin and Pembrolizumab", "disease_state": "advanced", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1: Tumor Microenvironment (TME) Nemvaleukin and Pembrolizumab", "disease_state": "advanced", "histology_inclusion": "renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1: Tumor Microenvironment (TME) Nemvaleukin and Pembrolizumab", "disease_state": "advanced", "histology_inclusion": "triple-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1: Tumor Microenvironment (TME) Nemvaleukin and Pembrolizumab", "disease_state": "advanced", "histology_inclusion": "microsatellite stable colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1: Tumor Microenvironment (TME) Nemvaleukin and Pembrolizumab", "disease_state": "advanced", "histology_inclusion": "microsatellite instability-high solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1: Tumor Microenvironment (TME) Nemvaleukin and Pembrolizumab", "disease_state": "advanced", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "metastatic or advanced", "histology_inclusion": "epithelial tumor of the fallopian tube, peritoneum, or ovaries", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": ["prior IL-2-based or IL-15-based soluble protein therapy"]}, {"cohort": "Cohort 2", "disease_state": "metastatic or advanced", "histology_inclusion": "cervical cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": ["prior IL-2-based or IL-15-based soluble protein therapy"]}, {"cohort": "Cohort 2", "disease_state": "metastatic or advanced", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": ["prior IL-2-based or IL-15-based soluble protein therapy"]}, {"cohort": "Cohort 2", "disease_state": "metastatic or advanced", "histology_inclusion": "non-small cell lung adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": ["prior IL-2-based or IL-15-based soluble protein therapy"]}, {"cohort": "Cohort 2", "disease_state": "metastatic or advanced", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": ["prior IL-2-based or IL-15-based soluble protein therapy"]}, {"cohort": "Cohort 2", "disease_state": "metastatic or advanced", "histology_inclusion": "gastric and gastroesophageal junction adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": ["prior IL-2-based or IL-15-based soluble protein therapy"]}, {"cohort": "Cohort 2", "disease_state": "metastatic or advanced", "histology_inclusion": "esophageal cancer (squamous and adeno cell type)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": ["prior IL-2-based or IL-15-based soluble protein therapy"]}, {"cohort": "Cohort 2", "disease_state": "metastatic or advanced", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": ["prior IL-2-based or IL-15-based soluble protein therapy"]}, {"cohort": "Cohort 2", "disease_state": "metastatic or advanced", "histology_inclusion": "biliary tract tumor (including intra- and extrahepatic cholangiocarcinoma, gall bladder, ampullary type)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": ["prior IL-2-based or IL-15-based soluble protein therapy"]}, {"cohort": "Cohort 2", "disease_state": "metastatic or advanced", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": ["prior IL-2-based or IL-15-based soluble protein therapy"]}, {"cohort": "Cohort 2", "disease_state": "metastatic or advanced", "histology_inclusion": "mucosal melanoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": ["prior IL-2-based or IL-15-based soluble protein therapy"]}, {"cohort": "Cohort 2", "disease_state": "metastatic or advanced", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": ["prior IL-2-based or IL-15-based soluble protein therapy"]}, {"cohort": "Cohort 2", "disease_state": "metastatic or advanced", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": ["prior IL-2-based or IL-15-based soluble protein therapy"]}], "json_norm": [{"cohort": "Cohort 1: Tumor Microenvironment (TME) Nemvaleukin and Pembrolizumab", "histology_inclusion": "Cutaneous Melanoma"}, {"cohort": "Cohort 1: Tumor Microenvironment (TME) Nemvaleukin and Pembrolizumab", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "Cohort 1: Tumor Microenvironment (TME) Nemvaleukin and Pembrolizumab", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Cohort 1: Tumor Microenvironment (TME) Nemvaleukin and Pembrolizumab", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Cohort 1: Tumor Microenvironment (TME) Nemvaleukin and Pembrolizumab", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort 1: Tumor Microenvironment (TME) Nemvaleukin and Pembrolizumab", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort 1: Tumor Microenvironment (TME) Nemvaleukin and Pembrolizumab", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Cohort 1: Tumor Microenvironment (TME) Nemvaleukin and Pembrolizumab", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "Cohort 2", "histology_inclusion": "Epithelial Neoplasm"}, {"cohort": "Cohort 2", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Lung Adenocarcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Esophageal Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Cholangiocarcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Liver Cancer"}, {"cohort": "Cohort 2", "histology_inclusion": "Biliary Tract Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Cutaneous Melanoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Mucosal Melanoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Breast Carcinoma"}]}
{"NCT_id": "NCT04918186", "json": [{"cohort": "", "disease_state": "platinum resistant", "histology_inclusion": "high grade serous carcinoma of ovarian, fallopian tube or peritoneal origin", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Serous Tumor"}, {"cohort": "", "histology_inclusion": "Ovarian Serous Adenocarcinoma"}]}
{"NCT_id": "NCT04983407", "json": [{"cohort": "", "disease_state": "locally advanced, recurrent, or metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["islet-cell neoplasms"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma", "histology_exclusion": ["Pancreatic Neuroendocrine Carcinoma", "Pancreatic Neuroendocrine Tumor"]}]}
{"NCT_id": "NCT05243641", "json": [{"cohort": "Phase Ib/II", "disease_state": "metastatic or inflammatory breast cancer", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["abnormal HER-family signaling activity", "abnormal c-Met signaling activity"], "histology_exclusion": [], "biomarker_exclusion": ["HER2-positive"]}], "json_norm": [{"cohort": "Phase Ib/II", "histology_inclusion": "Breast Carcinoma", "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04294160", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "BRAF V600 colorectal cancer", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}]}
{"NCT_id": "NCT04462471", "json": [{"cohort": "Participants with thyroid cancer", "disease_state": "RAIR", "histology_inclusion": "thyroid carcinoma of follicular origin (including papillary, follicular, and poorly differentiated subtypes and their respective variants)", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Participants with thyroid cancer", "histology_inclusion": "Thyroid Gland Follicular Carcinoma"}]}
{"NCT_id": "NCT04294264", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Colon Cancer", "biomarker_inclusion": ["RAS mutation", "Mismatch Repair Deficiency (MMR)"], "histology_exclusion": ["Central Nervous System (CNS) metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT05048797", "json": [{"cohort": "", "disease_state": "locally advanced not amenable to curative therapy, or metastatic", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": ["HER2 mutation in exons 19 or 20"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR targetable alterations", "ALK targetable alterations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ERBB2 Mutation", "ERBB2-Mutation", "gene"]], "biomarker_exclusion": [["ALK Mutation", "ALK-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT05178888", "json": [{"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT04165772", "json": [{"cohort": "Cohort 1", "disease_state": "Stage II, Stage III", "histology_inclusion": "Locally Advanced Solid Tumor", "biomarker_inclusion": ["dMMR", "MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": ["MSI"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"]]}]}
{"NCT_id": "NCT04296019", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "left-sided colon cancer with RAS mutation", "biomarker_inclusion": [], "histology_exclusion": ["brain metastasis", "leptomeningeal metastasis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "right-sided colon cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastasis", "leptomeningeal metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Colon Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Colon Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Colon Carcinoma"}]}
{"NCT_id": "NCT04659629", "json": [{"cohort": "Part 1", "disease_state": "relapsed or refractory advanced solid tumor", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["prostate cancer"], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "failed at least 1 line of systemic therapy", "histology_inclusion": "kidney cancer", "biomarker_inclusion": [], "histology_exclusion": ["prostate cancer"], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "failed at least 1 line of systemic therapy", "histology_inclusion": "skin cancer", "biomarker_inclusion": [], "histology_exclusion": ["prostate cancer"], "biomarker_exclusion": []}, {"cohort": "Part 3", "disease_state": "received \u2265 1 prior line of therapy for advanced or metastatic disease", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["prostate cancer"], "biomarker_exclusion": []}, {"cohort": "Part 4", "disease_state": "diagnosed target disease OR previously received pembrolizumab", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["prostate cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 1", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Prostate Neoplasm", "Prostate Carcinoma"]}, {"cohort": "Part 2", "histology_inclusion": "Kidney Cancer", "histology_exclusion": ["Prostate Neoplasm", "Prostate Carcinoma"]}, {"cohort": "Part 2", "histology_inclusion": "Malignant Skin Neoplasm", "histology_exclusion": ["Prostate Neoplasm", "Prostate Carcinoma"]}, {"cohort": "Part 2", "histology_inclusion": "Skin Carcinoma", "histology_exclusion": ["Prostate Neoplasm", "Prostate Carcinoma"]}, {"cohort": "Part 3", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Prostate Neoplasm", "Prostate Carcinoma"]}, {"cohort": "Part 4", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Prostate Neoplasm", "Prostate Carcinoma"]}]}
{"NCT_id": "NCT03058289", "json": [{"cohort": "EC2, EC3, DEC2, FEC", "disease_state": "advanced or metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor", "metastatic brain tumor"], "biomarker_exclusion": []}, {"cohort": "EC2, EC3, DEC2, FEC", "disease_state": "advanced or metastatic", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor", "metastatic brain tumor"], "biomarker_exclusion": []}, {"cohort": "EC2, EC3, DEC2, FEC", "disease_state": "advanced or metastatic", "histology_inclusion": "non-MSI-H and/or MMR proficient colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor", "metastatic brain tumor"], "biomarker_exclusion": []}, {"cohort": "EC2, EC3, DEC2, FEC", "disease_state": "advanced or metastatic", "histology_inclusion": "squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor", "metastatic brain tumor"], "biomarker_exclusion": []}, {"cohort": "EC2, EC3, DEC2, FEC", "disease_state": "advanced or metastatic", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor", "metastatic brain tumor"], "biomarker_exclusion": []}, {"cohort": "EC2, EC3, DEC2, FEC", "disease_state": "advanced or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor", "metastatic brain tumor"], "biomarker_exclusion": []}, {"cohort": "EC2, EC3, DEC2, FEC", "disease_state": "advanced or metastatic", "histology_inclusion": "soft tissue sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor", "metastatic brain tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "EC2, EC3, DEC2, FEC", "histology_inclusion": "Pancreatic Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "EC2, EC3, DEC2, FEC", "histology_inclusion": "Cholangiocarcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "EC2, EC3, DEC2, FEC", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "EC2, EC3, DEC2, FEC", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "EC2, EC3, DEC2, FEC", "histology_inclusion": "Squamous Cell Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "EC2, EC3, DEC2, FEC", "histology_inclusion": "Hepatocellular Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "EC2, EC3, DEC2, FEC", "histology_inclusion": "Breast Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "EC2, EC3, DEC2, FEC", "histology_inclusion": "Soft Tissue Sarcoma", "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT03318939", "json": [{"cohort": "Cohort 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR exon 20 insertion mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["HER2 exon 20 insertion mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR exon 20 insertion mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 4", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["HER2 exon 20 insertion mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 5", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR exon 20 insertion mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 5", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["HER2 exon 20 insertion mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 6", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["acquired EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 7", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR activating mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 7", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["HER2 activating mutations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 3", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 4", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 5", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 5", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 6", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Cohort 7", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Cohort 7", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}]}
{"NCT_id": "NCT03449381", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["known TP53 mutant tumor"]}, {"cohort": "Phase Ib - Cohort 1", "disease_state": "advanced or metastatic", "histology_inclusion": "MDM2-amplified sarcoma", "biomarker_inclusion": ["TP53 wt"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase Ib - Cohort 2", "disease_state": "advanced or metastatic", "histology_inclusion": "MDM2-amplified NSCLC", "biomarker_inclusion": ["TP53 wt"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase Ib - Cohort 2", "disease_state": "advanced or metastatic", "histology_inclusion": "MDM2-amplified urothelial", "biomarker_inclusion": ["TP53 wt"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase Ib - Cohort 2", "disease_state": "advanced or metastatic", "histology_inclusion": "MDM2-amplified gastric", "biomarker_inclusion": ["TP53 wt"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase Ib - Cohort 2", "disease_state": "advanced or metastatic", "histology_inclusion": "MDM2-amplified biliary tract", "biomarker_inclusion": ["TP53 wt"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase Ib - Cohort 2", "disease_state": "advanced or metastatic", "histology_inclusion": "MDM2-amplified pancreatic solid PDAC tumors", "biomarker_inclusion": ["TP53 wt"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Phase Ib - Cohort 1", "histology_inclusion": "Sarcoma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Phase Ib - Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Phase Ib - Cohort 2", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Phase Ib - Cohort 2", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Phase Ib - Cohort 2", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Phase Ib - Cohort 2", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT05115630", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Acute myeloid leukemia (AML)", "biomarker_inclusion": ["FLT3 mutations", "internal tandem duplication", "t(6;9)(p23;q34.1); DEK-NUP214", "t(v;11q23.3); KMT2A rearranged", "t(9;22)(q34.1;q11.2); BCR-ABL1", "inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2,MECOM(EVI1)", "-5 or del(5q)", "-7", "-17/abn(17p)", "Complex karyotype", "monosomal karyotype", "Wild-type NPM1 and FLT3-ITDhigh", "Mutated RUNX1", "Mutated ASXL1"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Myelodysplastic syndromes (MDS)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Chronic myeloid leukemia (CML)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["ASXL1 Mutation", "ASXL1-Mutation", "gene"], ["BCR - ABL1", "BCR - ABL1", "coordinate"], ["FLT3 Mutation", "FLT3-Mutation", "gene"], ["NPM1 NPM1-wild_type", "NPM1-wild_type", "wild_type"], ["RUNX1 Mutation", "RUNX1-Mutation", "gene"], ["DEK - NUP214", "DEK - NUP214", "coordinate"], ["FLT3-High", "FLT3-High", "expression"], ["NPM1-High", "NPM1-High", "expression"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive"}]}
{"NCT_id": "NCT05180695", "json": [{"cohort": "Soft-tissue sarcomas with MDM2 amplification", "disease_state": "Advanced/Metastatic", "histology_inclusion": "Soft Tissue Sarcoma", "biomarker_inclusion": ["p53 wild-type", "MDM2 amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Soft-tissue sarcomas with no MDM2 amplification", "disease_state": "Advanced/Metastatic", "histology_inclusion": "Soft Tissue Sarcoma", "biomarker_inclusion": ["p53 wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["MDM2 amplification"]}], "json_norm": [{"cohort": "Soft-tissue sarcomas with MDM2 amplification", "histology_inclusion": "Soft Tissue Sarcoma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "Soft-tissue sarcomas with no MDM2 amplification", "histology_inclusion": "Soft Tissue Sarcoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]], "biomarker_exclusion": [["MDM2-High", "MDM2-High", "expression"]]}]}
{"NCT_id": "NCT05440942", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["pure neuroendocrine neoplasms of the pancreas"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenosquamous carcinoma of the pancreas", "biomarker_inclusion": [], "histology_exclusion": ["pure neuroendocrine neoplasms of the pancreas"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "mixed adenocarcinoma/neuroendocrine carcinoma (MANEC) of the pancreas", "biomarker_inclusion": [], "histology_exclusion": ["pure neuroendocrine neoplasms of the pancreas"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma", "histology_exclusion": ["Neuroendocrine Carcinoma", "Neuroendocrine Tumor"]}, {"cohort": "", "histology_inclusion": "Pancreatic Adenosquamous Carcinoma", "histology_exclusion": ["Neuroendocrine Carcinoma", "Neuroendocrine Tumor"]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Carcinoma", "histology_exclusion": ["Neuroendocrine Carcinoma", "Neuroendocrine Tumor"]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "histology_exclusion": ["Neuroendocrine Carcinoma", "Neuroendocrine Tumor"]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Tumor", "histology_exclusion": ["Neuroendocrine Carcinoma", "Neuroendocrine Tumor"]}]}
{"NCT_id": "NCT02264678", "json": [{"cohort": "Module 2 Part B1", "disease_state": "advanced", "histology_inclusion": "gastric adenocarcinoma (including GEJ)", "biomarker_inclusion": ["ATM deficient"], "histology_exclusion": [], "biomarker_exclusion": ["previous treatment with PARP inhibitor"]}, {"cohort": "Module 2 Part B2", "disease_state": "advanced", "histology_inclusion": "gastric adenocarcinoma (including GEJ)", "biomarker_inclusion": ["ATM proficient"], "histology_exclusion": [], "biomarker_exclusion": ["previous treatment with PARP inhibitor"]}, {"cohort": "Module 2 Part B3", "disease_state": "second or third line", "histology_inclusion": "HER2 negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["previous treatment with PARP inhibitor"]}, {"cohort": "Module 2 Part B4", "disease_state": "second or third line", "histology_inclusion": "triple negative breast cancer (TNBC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["previous treatment with PARP inhibitor"]}, {"cohort": "Module 2 Part B5", "disease_state": "Platinum Sensitive Relapsed", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["BRCAm", "RAD51C/Dm", "PALB2m", "HRD positive status"], "histology_exclusion": [], "biomarker_exclusion": ["previous progression on a licensed PARPi"]}, {"cohort": "Module 3", "disease_state": "advanced recurrent or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["previous treatment with durvalumab"]}, {"cohort": "Module 3", "disease_state": "advanced recurrent or metastatic", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["previous treatment with durvalumab"]}, {"cohort": "Module 5 Part B", "disease_state": "platinum-sensitive relapsed", "histology_inclusion": "ovarian, fallopian tube, or primary peritoneal cancer", "biomarker_inclusion": ["BRCA mutation", "PALB2 mutation", "RAD51CD mutation"], "histology_exclusion": [], "biomarker_exclusion": ["known hypersensitivity to PARP including AZD5305"]}], "json_norm": [{"cohort": "Module 2 Part B1", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["ATM-Low", "ATM-Low", "expression"]]}, {"cohort": "Module 2 Part B2", "histology_inclusion": "Gastric Adenocarcinoma"}, {"cohort": "Module 2 Part B3", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Module 2 Part B4", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Module 2 Part B5", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["TBCE-High", "TBCE-High", "expression"]]}, {"cohort": "Module 2 Part B5", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["TBCE-High", "TBCE-High", "expression"]]}, {"cohort": "Module 3", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Module 3", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Module 5 Part B", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [["PALB2 Mutation", "PALB2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04985604", "json": [{"cohort": "", "disease_state": "recurrent or progressive", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["MAPK pathway alteration"], "histology_exclusion": [], "biomarker_exclusion": ["concurrent activating mutation"]}, {"cohort": "Substudy A", "disease_state": "recurrent or progressive", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["MAPK pathway alteration"], "histology_exclusion": [], "biomarker_exclusion": ["concurrent activating mutation", "prior RAS- RAF-, MEK-, or ERK-directed inhibitor therapy"]}, {"cohort": "Substudy B", "disease_state": "recurrent or progressive", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["MAPK pathway alteration"], "histology_exclusion": [], "biomarker_exclusion": ["concurrent activating mutation", "prior Type-II pan-RAF inhibitor therapy"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MAPK/ERK pathway", null, "pathway"]]}, {"cohort": "Substudy A", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MAPK/ERK pathway", null, "pathway"]]}, {"cohort": "Substudy B", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MAPK/ERK pathway", null, "pathway"]]}]}
{"NCT_id": "NCT05180799", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "Solid Tumor, Adult", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Gastric Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Cervical Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "", "histology_inclusion": "Melanoma"}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma"}]}
{"NCT_id": "NCT05180825", "json": [{"cohort": "Pediatric and AYA patients", "disease_state": "", "histology_inclusion": "Grade 1 Glioma", "biomarker_inclusion": ["BRAF Wild Type", "Negative BRAFv600 mutation", "No 7q34 duplication", "No FGFR1 abnormalities", "No MYB/MYBL1 abnormalities", "No histone H3 mutations", "No IDH1 mutation"], "histology_exclusion": ["Diffuse intrinsic pontine glioma (DIPG)", "Subependymal giant astrocytoma (SEGA)"], "biomarker_exclusion": []}, {"cohort": "Pediatric and AYA patients", "disease_state": "", "histology_inclusion": "Mixed Glio-neuronal Tumors", "biomarker_inclusion": ["BRAF Wild Type", "Negative BRAFv600 mutation", "No 7q34 duplication", "No FGFR1 abnormalities", "No MYB/MYBL1 abnormalities", "No histone H3 mutations", "No IDH1 mutation"], "histology_exclusion": ["Diffuse intrinsic pontine glioma (DIPG)", "Subependymal giant astrocytoma (SEGA)"], "biomarker_exclusion": []}, {"cohort": "Pediatric and AYA patients", "disease_state": "", "histology_inclusion": "Pleomorphic Xanthoastrocytoma (PXA)", "biomarker_inclusion": ["BRAF Wild Type", "Negative BRAFv600 mutation", "No 7q34 duplication", "No FGFR1 abnormalities", "No MYB/MYBL1 abnormalities", "No histone H3 mutations", "No IDH1 mutation"], "histology_exclusion": ["Diffuse intrinsic pontine glioma (DIPG)", "Subependymal giant astrocytoma (SEGA)"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Pediatric and AYA patients", "histology_inclusion": "Glioma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]], "histology_exclusion": ["Astrocytoma", "Diffuse Intrinsic Pontine Glioma"]}, {"cohort": "Pediatric and AYA patients", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]], "histology_exclusion": ["Astrocytoma", "Diffuse Intrinsic Pontine Glioma"]}, {"cohort": "Pediatric and AYA patients", "histology_inclusion": "Pleomorphic Xanthoastrocytoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]], "histology_exclusion": ["Astrocytoma", "Diffuse Intrinsic Pontine Glioma"]}]}
{"NCT_id": "NCT04296305", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Hematopoietic and Lymphoid Cell Neoplasm", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Hematopoietic and Lymphoid Cell Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04296370", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "HER2-negative breast cancer", "biomarker_inclusion": ["Germline BRCA1 mutation", "Germline BRCA2 mutation"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["Prior treatment with PARP inhibitor", "Prior treatment with Apatinib"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04529772", "json": [{"cohort": "", "disease_state": "Stage II to IV", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS lymphoma", "leptomeningeal disease", "primary mediastinal lymphoma", "High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements", "indolent lymphoma", "CLL"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "Chronic Lymphocytic Leukemia", "High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "Primary Central Nervous System Lymphoma", "Mediastinal Lymphoma", "Indolent Non-Hodgkin Lymphoma"], "biomarker_exclusion": [["BCL6 Fusion", "BCL6", "fusion"]]}]}
{"NCT_id": "NCT04920617", "json": [{"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary CNS lymphoma", "secondary CNS involvement", "lymphomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}]}
{"NCT_id": "NCT04985721", "json": [{"cohort": "Cohort A", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": ["ATM", "CDK12", "PALB2", "ARID1A", "ATRX", "BLM", "BARD1", "BRIP1", "CHEK1", "CHEK2", "FANCA", "FANCF", "FANCG", "FANCI", "FANCL", "FANCM", "MSH2", "NBN", "RAD50", "RAD51C", "RAD51D", "WRN", "somatic BRCA1", "somatic BRCA2", "mutational signature 3", "positive HRD status"], "histology_exclusion": ["high grade serous ovarian cancer", "TNBC", "prostate cancer"], "biomarker_exclusion": ["previous treatment with a PARP inhibitor"]}, {"cohort": "Cohort B", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": ["pathogenic germline BRCA1", "pathogenic germline BRCA2"], "histology_exclusion": [], "biomarker_exclusion": ["previous treatment with a PARP inhibitor"]}], "json_norm": [{"cohort": "Cohort A", "biomarker_inclusion": [["TBCE-High", "TBCE-High", "expression"]], "histology_exclusion": ["Prostate Neoplasm", "Prostate Carcinoma", "Ovarian Serous Adenocarcinoma"], "biomarker_exclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Cohort B"}]}
{"NCT_id": "NCT04166318", "json": [{"cohort": "", "disease_state": "T1-2N0M0", "histology_inclusion": "anal canal squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "T1-2N0M0", "histology_inclusion": "anal margin squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "T1-2N0M0", "histology_inclusion": "anal basaloid carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "T1-2N0M0", "histology_inclusion": "anal canal cloacogenic carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "T1-2N0M0", "histology_inclusion": "anal canal transitional cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Anal Canal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Anal Margin Squamous Cell Carcinoma"}, {"cohort": ""}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Transitional Cell Carcinoma"}]}
{"NCT_id": "NCT01872975", "json": [{"cohort": "", "disease_state": "Stage IB Breast Cancer", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II Breast Cancer", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma"}]}
{"NCT_id": "NCT04231448", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Diffuse Large B-cell Lymphoma", "biomarker_inclusion": ["CD20-positive", "Myc\u226540%", "Bcl-2\u226550%"], "histology_exclusion": ["primary DLBCL of the central nervous system (CNS)", "secondary lymphoma of the central nervous system", "Primary mediastinal (thymic) large B-cell lymphoma", "Primary effusion lymphoma", "B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma", "Primary cutaneous DLBCL, leg type", "indolent lymphoma", "Burkitt lymphoma", "EBV-positive mucocutaneous ulcer", "DLBCL associated with chronic inflammation", "Lymphomatoid granulomatosis", "Intravascular large B-cell lymphoma", "ALK-positive large B-cell lymphoma", "Plasmablastic lymphoma", "HHV8-positive DLBCL, NOS", "primary testicular DLBCL"], "biomarker_exclusion": ["double (BCL-2 and c-MYC gene rearrangement)", "triple (BCL-2, BCL-6, and c-MYC gene rearrangement)"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Primary Effusion Lymphoma", "Lymphomatoid Granulomatosis", "Central Nervous System Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma", "Plasmablastic Lymphoma", "Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation", "Diffuse Large B-Cell Lymphoma", "Intravascular Large B-Cell Lymphoma", "HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified", "Burkitt Lymphoma", "ALK-Positive Large B-Cell Lymphoma", "Epstein-Barr Virus-Positive Mucocutaneous Ulcer", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "Indolent Non-Hodgkin Lymphoma"], "biomarker_exclusion": [["ALK-High", "ALK-High", "expression"]]}]}
{"NCT_id": "NCT05116189", "json": [{"cohort": "", "disease_state": "platinum-resistant", "histology_inclusion": "epithelial ovarian carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["nonepithelial cancers", "borderline tumors", "mucinous", "seromucinous that is predominantly mucinous", "malignant Brenner's tumor", "undifferentiated carcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "platinum-resistant", "histology_inclusion": "fallopian tube carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["nonepithelial cancers", "borderline tumors", "mucinous", "seromucinous that is predominantly mucinous", "malignant Brenner's tumor", "undifferentiated carcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "platinum-resistant", "histology_inclusion": "primary peritoneal carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["nonepithelial cancers", "borderline tumors", "mucinous", "seromucinous that is predominantly mucinous", "malignant Brenner's tumor", "undifferentiated carcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "histology_exclusion": ["Pancreatic Undifferentiated Carcinoma", "Brenner Tumor"]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "histology_exclusion": ["Pancreatic Undifferentiated Carcinoma", "Brenner Tumor"]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "histology_exclusion": ["Pancreatic Undifferentiated Carcinoma", "Brenner Tumor"]}]}
{"NCT_id": "NCT05441475", "json": [{"cohort": "Part A", "disease_state": "advanced or unresectable", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastasis", "meningeal metastasis"], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "advanced or unresectable", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastasis", "meningeal metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "Part B", "histology_inclusion": "Hepatocellular Carcinoma"}]}
{"NCT_id": "NCT05441514", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": ["IDH2 mutation (R140 or R172)", "RAS-pathway mutation (NRAS, KRAS, PTPN11, CBL, or NF1)"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["NF1 Mutation", "NF1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["PTPN11 Mutation", "PTPN11-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["MAPK/ERK pathway", null, "pathway"], ["CBL Mutation", "CBL-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT03580421", "json": [{"cohort": "", "disease_state": "Stage I or II", "histology_inclusion": "Endometrial Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Endometrial Carcinoma"}]}
{"NCT_id": "NCT03840967", "json": [{"cohort": "Niraparib", "disease_state": "metastatic", "histology_inclusion": "esophageal adenocarcinoma", "biomarker_inclusion": ["high LOH", "HR mutation", "germline mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior therapy with a PARP inhibitor", "platinum refractory"]}, {"cohort": "Niraparib", "disease_state": "metastatic", "histology_inclusion": "gastroesophageal junction adenocarcinoma", "biomarker_inclusion": ["high LOH", "HR mutation", "germline mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior therapy with a PARP inhibitor", "platinum refractory"]}, {"cohort": "Niraparib", "disease_state": "metastatic", "histology_inclusion": "proximal gastric adenocarcinoma", "biomarker_inclusion": ["high LOH", "HR mutation", "germline mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior therapy with a PARP inhibitor", "platinum refractory"]}], "json_norm": [{"cohort": "Niraparib", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_inclusion": [["HR Mutation", "HR-Mutation", "gene"]]}, {"cohort": "Niraparib", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["HR Mutation", "HR-Mutation", "gene"]]}, {"cohort": "Niraparib", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["HR Mutation", "HR-Mutation", "gene"]]}]}
{"NCT_id": "NCT03906071", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutation", "ROS1 mutation", "ALK mutation", "ALK fusion"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"], ["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04790708", "json": [{"cohort": "Midgut NETs", "disease_state": "", "histology_inclusion": "non-functional and functional NETs arising from: stomach, duodenum, jejunum, ileum, colon and rectal", "biomarker_inclusion": ["high expression of somatostatin receptors"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Pancreatic NETs", "disease_state": "", "histology_inclusion": "non-functional and functional NETs arising from Pancreas", "biomarker_inclusion": ["high expression of somatostatin receptors"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Bronchial NETs", "disease_state": "", "histology_inclusion": "non-functional and functional Bronchial NETs", "biomarker_inclusion": ["high expression of somatostatin receptors"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Sympathetic-Adrenergic axis NEts", "disease_state": "", "histology_inclusion": "non-functional and functional: Pheochromocytoma, Paraganglioma and Neuroblastoma", "biomarker_inclusion": ["high expression of somatostatin receptors"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Other Nets", "disease_state": "", "histology_inclusion": "non-functional and functional NETs arising from Skin, Thyroid (medullary thyroid and anaplastic cancer) and Parathyroids", "biomarker_inclusion": ["high expression of somatostatin receptors"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cancers of Unknown Primary Origin (CUP) NETs", "disease_state": "", "histology_inclusion": "non-functional and functional unknown primary NETs", "biomarker_inclusion": ["high expression of somatostatin receptors"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Midgut NETs"}, {"cohort": "Pancreatic NETs"}, {"cohort": "Bronchial NETs"}, {"cohort": "Sympathetic-Adrenergic axis NEts", "histology_inclusion": "Neuroblastoma"}, {"cohort": "Sympathetic-Adrenergic axis NEts", "histology_inclusion": "Paraganglioma"}, {"cohort": "Other Nets"}, {"cohort": "Cancers of Unknown Primary Origin (CUP) NETs"}]}
{"NCT_id": "NCT04855929", "json": [{"cohort": "Advanced Solid Tumor", "disease_state": "relapsed/refractory advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": []}, {"cohort": "Multiple Myeloma", "disease_state": "relapsed/refractory", "histology_inclusion": "multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Advanced Solid Tumor", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Multiple Myeloma", "histology_inclusion": "Plasma Cell Myeloma"}]}
{"NCT_id": "NCT03384914", "json": [{"cohort": "", "disease_state": "stage I-III", "histology_inclusion": "HER2 positive breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT03841110", "json": [{"cohort": "Regimen A: FT500 Monotherapy (Dose Escalation)", "disease_state": "advanced", "histology_inclusion": "solid tumor malignancy, including lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Regimen B and BB (Dose Escalation): FT500 (+ IL-2, Regimen BB only) + ICI", "disease_state": "advanced", "histology_inclusion": "solid tumor malignancy, including lymphomas", "biomarker_inclusion": ["progressed on treatment with at least one ICI (ie, nivolumab, pembrolizumab or atezolizumab)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Regimen B(Dose Expansion): FT500 (+ IL-2, Regimen BB only) + ICI", "disease_state": "advanced", "histology_inclusion": "solid tumor malignancy or lymphoma", "biomarker_inclusion": ["disease relapse or progression on an ICI (nivolumab, pembrolizumab, or atezolizumab)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Regimen A: FT500 Monotherapy (Dose Escalation)", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Regimen B and BB (Dose Escalation): FT500 (+ IL-2, Regimen BB only) + ICI", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Regimen B(Dose Expansion): FT500 (+ IL-2, Regimen BB only) + ICI", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04036461", "json": [{"cohort": "", "disease_state": "relapsed and/or refractory", "histology_inclusion": "multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Plasma Cell Myeloma"}]}
{"NCT_id": "NCT04334863", "json": [{"cohort": "", "disease_state": "progressive or recurrent", "histology_inclusion": "medulloblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "progressive or recurrent", "histology_inclusion": "malignant glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "progressive or recurrent", "histology_inclusion": "malignant brain tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "post-radiation", "histology_inclusion": "DIPG", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "post-radiation", "histology_inclusion": "DMG", "biomarker_inclusion": ["H3K27M"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Medulloblastoma"}, {"cohort": "", "histology_inclusion": "Malignant Glioma"}, {"cohort": "", "histology_inclusion": "Malignant Brain Neoplasm"}, {"cohort": "", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma"}, {"cohort": "", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}]}
{"NCT_id": "NCT04334941", "json": [{"cohort": "", "disease_state": "Extensive Stage", "histology_inclusion": "Small Cell Lung Cancer", "biomarker_inclusion": ["SLFN11 Positive"], "histology_exclusion": ["Non-Small Cell Lung Cancer", "SCLC with mixed histology"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLFN11-High", "SLFN11-High", "expression"]], "histology_exclusion": ["Small Cell Lung Carcinoma", "Non-Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT04595565", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "HER2-negative Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Triple Negative Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}]}
{"NCT_id": "NCT04660760", "json": [{"cohort": "", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "adenocarcinoma of the stomach or gastroesophageal junction", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastric Adenocarcinoma"}]}
{"NCT_id": "NCT05181592", "json": [{"cohort": "", "disease_state": "lower-risk MDS", "histology_inclusion": "MDS-RS", "biomarker_inclusion": ["SF3B1 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["PAFAH1B1 - REG1CP", "PAFAH1B1 - REG1CP", "coordinate"], ["PAFAH1B1 - RS1", "PAFAH1B1 - RS1", "coordinate"], ["PAFAH1B1 - PITX2", "PAFAH1B1 - PITX2", "coordinate"], ["SF3B2 Mutation", "SF3B2-Mutation", "gene"], ["SF3B1 Mutation", "SF3B1-Mutation", "gene"]]}, {"cohort": "", "biomarker_inclusion": [["PAFAH1B1 - REG1CP", "PAFAH1B1 - REG1CP", "coordinate"], ["PAFAH1B1 - RS1", "PAFAH1B1 - RS1", "coordinate"], ["PAFAH1B1 - PITX2", "PAFAH1B1 - PITX2", "coordinate"], ["SF3B2 Mutation", "SF3B2-Mutation", "gene"], ["SF3B1 Mutation", "SF3B1-Mutation", "gene"]]}, {"cohort": "", "biomarker_inclusion": [["SF3B2 Mutation", "SF3B2-Mutation", "gene"], ["PAFAH1B1 - RS1", "PAFAH1B1 - RS1", "coordinate"], ["PAFAH1B1 - REG1CP", "PAFAH1B1 - REG1CP", "coordinate"], ["PAFAH1B1 - PITX2", "PAFAH1B1 - PITX2", "coordinate"], ["SF3B1 Mutation", "SF3B1-Mutation", "gene"]]}]}
{"NCT_id": "NCT05376800", "json": [{"cohort": "Phase 0", "disease_state": "newly diagnosed", "histology_inclusion": "glioblastoma", "biomarker_inclusion": [], "histology_exclusion": ["TP53 mutant glioblastoma", "IDH mutant grade IV astrocytoma"], "biomarker_exclusion": []}, {"cohort": "Phase Ia", "disease_state": "newly diagnosed", "histology_inclusion": "glioblastoma", "biomarker_inclusion": ["TP53 wild type", "unmethylated MGMT promoters", "IDH wild type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 0", "histology_inclusion": "Glioblastoma", "histology_exclusion": ["Astrocytoma", "Glioblastoma"], "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Phase Ia", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT05571969", "json": [{"cohort": "Advanced Solid Tumors", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Advanced Solid Tumors", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT02722668", "json": [{"cohort": "", "disease_state": "in remission", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "in remission", "histology_inclusion": "Acute Lymphoblastic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "in remission", "histology_inclusion": "Biphenotypic/Undifferentiated/Prolymphocytic Leukemias", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "in remission", "histology_inclusion": "Chronic Myelogenous Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "in remission", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "in remission", "histology_inclusion": "MRD Positive Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "in remission", "histology_inclusion": "Leukemia or MDS in Aplasia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "in remission", "histology_inclusion": "Relapsed T-Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "in remission", "histology_inclusion": "Relapsed Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "in remission", "histology_inclusion": "Plasma Cell Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "T-Cell Non-Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "", "histology_inclusion": "Plasma Cell Leukemia"}]}
{"NCT_id": "NCT03645928", "json": [{"cohort": "Cohort 1A", "disease_state": "Stage IIIC to IV unresectable or metastatic melanoma", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": ["Melanoma of uveal/ocular origin"], "biomarker_exclusion": []}, {"cohort": "Cohort 1B", "disease_state": "Stage IIIC or Stage IV unresectable or metastatic melanoma", "histology_inclusion": "Melanoma", "biomarker_inclusion": ["PD-1 blocking antibody"], "histology_exclusion": ["Melanoma of uveal/ocular origin"], "biomarker_exclusion": []}, {"cohort": "Cohort 1C", "disease_state": "Stage IIIC or Stage IV unresectable or metastatic melanoma", "histology_inclusion": "Melanoma", "biomarker_inclusion": ["PD-1 blocking antibody"], "histology_exclusion": ["Melanoma of uveal/ocular origin"], "biomarker_exclusion": []}, {"cohort": "Cohort 2A", "disease_state": "Advanced, recurrent or metastatic HNSCC", "histology_inclusion": "Squamous Cell Carcinoma of the Head and Neck", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3A", "disease_state": "Stage III or Stage IV non-small cell lung cancer", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3B", "disease_state": "Stage III or Stage IV non-small cell lung cancer", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["CPI"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3C", "disease_state": "Stage III or Stage IV non-small cell lung cancer", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["CPI monotherapy"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1A", "histology_inclusion": "Melanoma", "histology_exclusion": ["Intraocular Melanoma"]}, {"cohort": "Cohort 1B", "histology_inclusion": "Melanoma", "histology_exclusion": ["Intraocular Melanoma"]}, {"cohort": "Cohort 1C", "histology_inclusion": "Melanoma", "histology_exclusion": ["Intraocular Melanoma"]}, {"cohort": "Cohort 2A", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Cohort 3A", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 3B", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 3C", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT03711058", "json": [{"cohort": "Phase I/II", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Microsatellite Stable (MSS) Solid Tumor", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System (CNS) metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "Phase I/II", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Microsatellite Stable (MSS) Colon Cancer", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System (CNS) metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase I/II", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Phase I/II", "histology_inclusion": "Colon Carcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT02069730", "json": [{"cohort": "Phase 1, Molecular Profiling", "disease_state": "recurrent or metastatic", "histology_inclusion": "malignant salivary gland tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2, Treatment", "disease_state": "advanced recurrent or metastatic", "histology_inclusion": "salivary gland cancer", "biomarker_inclusion": [], "histology_exclusion": ["other active malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1, Molecular Profiling", "histology_inclusion": "Malignant Salivary Gland Neoplasm"}, {"cohort": "Phase 2, Treatment", "histology_inclusion": "Malignant Salivary Gland Neoplasm"}, {"cohort": "Phase 2, Treatment", "histology_inclusion": "Salivary Gland Carcinoma"}]}
{"NCT_id": "NCT04660929", "json": [{"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "HER2-positive solid tumors", "biomarker_inclusion": ["HER2 overexpression"], "histology_exclusion": ["central nervous system metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "HER2-positive breast cancer", "biomarker_inclusion": ["HER2 overexpression"], "histology_exclusion": ["central nervous system metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "HER2-positive gastric cancer", "biomarker_inclusion": ["HER2 overexpression"], "histology_exclusion": ["central nervous system metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "HER2-positive gastroesophageal junction cancers", "biomarker_inclusion": ["HER2 overexpression"], "histology_exclusion": ["central nervous system metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT02929290", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["c-Met protein expression", "MET exon 14 skipping alterations"], "histology_exclusion": ["Brain/meninges metastases"], "biomarker_exclusion": ["ALK rearrangement", "ROS1 rearrangement"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]], "biomarker_exclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT03255070", "json": [{"cohort": "Phase 1a", "disease_state": "advanced", "histology_inclusion": "HER2 expressing cancer", "biomarker_inclusion": ["HER2 IHC 3+", "HER2 ISH positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort 8", "disease_state": "advanced", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["HER2 IHC 3+", "HER2 IHC 2+/ISH+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort 9", "disease_state": "advanced", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["HER2 IHC 2+/ISH-"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort 10", "disease_state": "advanced", "histology_inclusion": "gastric cancer", "biomarker_inclusion": ["HER2 IHC 3+", "HER2 IHC 2+/ISH+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort 10", "disease_state": "advanced", "histology_inclusion": "gastroesophageal junction adenocarcinoma", "biomarker_inclusion": ["HER2 IHC 3+", "HER2 IHC 2+/ISH+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort 11", "disease_state": "advanced", "histology_inclusion": "other solid tumor cancers", "biomarker_inclusion": ["HER2 IHC 3+", "HER2 IHC 2+/ISH+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort 12", "disease_state": "advanced", "histology_inclusion": "solid tumor cancers", "biomarker_inclusion": ["HER2 activating mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1a", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Phase 1b Cohort 8", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "Phase 1b Cohort 9", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "Phase 1b Cohort 10", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "Phase 1b Cohort 10", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "Phase 1b Cohort 11", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase 1b Cohort 12", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04661150", "json": [{"cohort": "", "disease_state": "locally advanced resectable", "histology_inclusion": "gastric cancer", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced resectable", "histology_inclusion": "adenocarcinoma of gastroesophageal junction", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT03059823", "json": [{"cohort": "Expansion Cohort", "disease_state": "locally advanced unresectable or metastatic solid tumors", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["MSI-H", "dMMR"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Expansion Cohort", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04726332", "json": [{"cohort": "Cohort A", "disease_state": "unresectable or metastatic solid tumor", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B, F, H", "disease_state": "inoperable locally advanced or metastatic hormone receptor-positive breast cancer", "histology_inclusion": "hormone receptor-positive breast cancer", "biomarker_inclusion": ["ER+", "PR+", "HER-2-"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort C, G, I", "disease_state": "metastatic castration-resistant prostate cancer", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort D", "disease_state": "inoperable locally advanced or metastatic triple negative breast cancer", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": ["HER-2-", "ER-", "PR-"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort E", "disease_state": "platinum-resistant epithelial ovarian cancer", "histology_inclusion": "epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["ovarian borderline epithelial tumors"], "biomarker_exclusion": []}, {"cohort": "Cohort E", "disease_state": "platinum-resistant primary peritoneal cancer", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": ["ovarian borderline epithelial tumors"], "biomarker_exclusion": []}, {"cohort": "Cohort E", "disease_state": "platinum-resistant fallopian tube cancer", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": ["ovarian borderline epithelial tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Cohort B, F, H", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["EREG-High", "EREG-High", "expression"], ["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Cohort B, F, H", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["PRH2-High", "PRH2-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["ESR1-High", "ESR1-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Cohort C, G, I", "histology_inclusion": "Prostate Adenocarcinoma"}, {"cohort": "Cohort D", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["PRH2-Low", "PRH2-Low", "expression"], ["TMEM37-Low", "TMEM37-Low", "expression"]]}, {"cohort": "Cohort E", "histology_inclusion": "Ovarian Epithelial Cancer", "histology_exclusion": ["Epithelial Neoplasm"]}, {"cohort": "Cohort E", "histology_inclusion": "Primary Peritoneal Carcinoma", "histology_exclusion": ["Epithelial Neoplasm"]}, {"cohort": "Cohort E", "histology_inclusion": "Fallopian Tube Carcinoma", "histology_exclusion": ["Epithelial Neoplasm"]}]}
{"NCT_id": "NCT05182112", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the pancreas", "biomarker_inclusion": ["BRCA1", "BRCA2", "PALB2", "ATM", "BAP1", "BARD1", "BLM", "BRIP1", "CHEK2", "FAM175A", "FANCA", "FANCC", "NBN", "RAD50", "RAD51", "RAD51C", "RTEL1"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma"}]}
{"NCT_id": "NCT03450850", "json": [{"cohort": "NOVOTTF-200A", "disease_state": "Recurrent Grade III", "histology_inclusion": "Malignant Astrocytoma", "biomarker_inclusion": [], "histology_exclusion": ["Anaplastic Oligodendroglioma"], "biomarker_exclusion": ["1p19q LOH"]}], "json_norm": [{"cohort": "NOVOTTF-200A", "histology_inclusion": "Anaplastic Astrocytoma", "histology_exclusion": ["Anaplastic Oligodendroglioma"]}]}
{"NCT_id": "NCT04335669", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Triple Negative Breast Neoplasms", "biomarker_inclusion": ["ER-negative", "HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT04987112", "json": [{"cohort": "CAN1012 single agent", "disease_state": "metastatic or locally advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["untreated or uncontrolled central nervous system (CNS) involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "CAN1012 single agent", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT05312398", "json": [{"cohort": "single arm", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["RAS wild-type", "BRAF wild-type"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "single arm", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT05507606", "json": [{"cohort": "", "disease_state": "Stage IIIB/IIIC/IV", "histology_inclusion": "non-squamous Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR 19del", "EGFR L858R", "EGFR T790M", "EGFR G719X", "EGFR L861Q", "EGFR S768I", "EGFR 20 A763-Y764ins", "TP53"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutations without TP53"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR T790M", "T790M", "coordinate"], ["EGFR S768I", "S768I", "coordinate"], ["EGFR L861Q", "L861Q", "coordinate"]]}]}
{"NCT_id": "NCT03581487", "json": [{"cohort": "", "disease_state": "Stage IV or Recurrent", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04401059", "json": [{"cohort": "", "disease_state": "advanced non-small cell lung adenocarcinoma (stage IIIB~IV)", "histology_inclusion": "non-small cell lung adenocarcinoma", "biomarker_inclusion": ["EGFR exon 19 deletions", "EGFR L858R exon 21"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutations other than 19DEL or 21L858R"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT04466254", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["KRAS wild-type", "NRAS wild-type", "BRAF wild-type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04298008", "json": [{"cohort": "AZD6738 + Durvalumab Cohort", "disease_state": "refractory", "histology_inclusion": "biliary tract cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "AZD6738 + Durvalumab Cohort", "disease_state": "refractory", "histology_inclusion": "intrahepatic cholangiocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "AZD6738 + Durvalumab Cohort", "disease_state": "refractory", "histology_inclusion": "extrahepatic bile duct cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "AZD6738 + Durvalumab Cohort", "disease_state": "refractory", "histology_inclusion": "gallbladder cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "AZD6738 + Durvalumab Cohort", "disease_state": "refractory", "histology_inclusion": "ampulla of vater cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "AZD6738 + Durvalumab Cohort", "histology_inclusion": "Liver Cancer"}, {"cohort": "AZD6738 + Durvalumab Cohort", "histology_inclusion": "Biliary Tract Carcinoma"}, {"cohort": "AZD6738 + Durvalumab Cohort", "histology_inclusion": "Intrahepatic Cholangiocarcinoma"}, {"cohort": "AZD6738 + Durvalumab Cohort", "histology_inclusion": "Bile Duct Neoplasm"}, {"cohort": "AZD6738 + Durvalumab Cohort", "histology_inclusion": "Gallbladder Carcinoma"}, {"cohort": "AZD6738 + Durvalumab Cohort", "histology_inclusion": "Ampulla of Vater Carcinoma"}]}
{"NCT_id": "NCT05768139", "json": [{"cohort": "Cohort A0", "disease_state": "advanced or refractory solid tumor malignancy that is metastatic or locally advanced and unresectable", "histology_inclusion": "HR+/HER2- breast cancer", "biomarker_inclusion": ["PI3K\u03b1 H1047X mutations", "PI3K\u03b1 other kinase domain mutations"], "histology_exclusion": [], "biomarker_exclusion": ["PTEN mutations/deletions", "AKT activating mutations", "mTOR activating mutations"]}, {"cohort": "Cohort A1", "disease_state": "advanced or refractory solid tumor malignancy that is metastatic or locally advanced and unresectable", "histology_inclusion": "Gynecologic cancers", "biomarker_inclusion": ["PI3K\u03b1 H1047X mutations", "PI3K\u03b1 other kinase domain mutations"], "histology_exclusion": [], "biomarker_exclusion": ["PTEN mutations/deletions", "AKT activating mutations", "mTOR activating mutations"]}, {"cohort": "Cohort A2", "disease_state": "advanced or refractory solid tumor malignancy that is metastatic or locally advanced and unresectable", "histology_inclusion": "HNSCC", "biomarker_inclusion": ["PI3K\u03b1 H1047X mutations", "PI3K\u03b1 other kinase domain mutations"], "histology_exclusion": [], "biomarker_exclusion": ["PTEN mutations/deletions", "AKT activating mutations", "mTOR activating mutations"]}, {"cohort": "Cohort A3", "disease_state": "advanced or refractory solid tumor malignancy that is metastatic or locally advanced and unresectable", "histology_inclusion": "Other solid tumors not included in Cohorts A0, A1, or A2", "biomarker_inclusion": ["PI3K\u03b1 H1047X mutations", "PI3K\u03b1 other kinase domain mutations"], "histology_exclusion": [], "biomarker_exclusion": ["PTEN mutations/deletions", "AKT activating mutations", "mTOR activating mutations"]}, {"cohort": "Cohort A4", "disease_state": "advanced or refractory solid tumor malignancy that is metastatic or locally advanced and unresectable", "histology_inclusion": "Solid tumors", "biomarker_inclusion": ["PI3K\u03b1 helical domain mutations (E542/E545)"], "histology_exclusion": [], "biomarker_exclusion": ["PTEN mutations/deletions", "AKT activating mutations", "mTOR activating mutations"]}, {"cohort": "Cohort B", "disease_state": "advanced or refractory solid tumor malignancy that is metastatic or locally advanced and unresectable", "histology_inclusion": "HR+/HER2- breast cancer", "biomarker_inclusion": ["PI3K\u03b1 H1047X mutations", "PI3K\u03b1 other kinase domain mutations"], "histology_exclusion": [], "biomarker_exclusion": ["PTEN mutations/deletions", "AKT activating mutations", "mTOR activating mutations"]}], "json_norm": [{"cohort": "Cohort A0", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "biomarker_exclusion": [["PTEN Mutation", "PTEN-Mutation", "gene"], ["AKT1 Mutation", "AKT1-Mutation", "gene"], ["MTOR Mutation", "MTOR-Mutation", "gene"]]}, {"cohort": "Cohort A0", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]], "biomarker_exclusion": [["AKT1 Mutation", "AKT1-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["MTOR Mutation", "MTOR-Mutation", "gene"]]}, {"cohort": "Cohort A1", "histology_inclusion": "Malignant Female Reproductive System Neoplasm", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "biomarker_exclusion": [["AKT1 Mutation", "AKT1-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["MTOR Mutation", "MTOR-Mutation", "gene"]]}, {"cohort": "Cohort A2", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "biomarker_exclusion": [["AKT1 Mutation", "AKT1-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["MTOR Mutation", "MTOR-Mutation", "gene"]]}, {"cohort": "Cohort A3", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "biomarker_exclusion": [["AKT1 Mutation", "AKT1-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["MTOR Mutation", "MTOR-Mutation", "gene"]]}, {"cohort": "Cohort A4", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "biomarker_exclusion": [["AKT1 Mutation", "AKT1-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["MTOR Mutation", "MTOR-Mutation", "gene"]]}, {"cohort": "Cohort B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "biomarker_exclusion": [["PTEN Mutation", "PTEN-Mutation", "gene"], ["AKT1 Mutation", "AKT1-Mutation", "gene"], ["MTOR Mutation", "MTOR-Mutation", "gene"]]}, {"cohort": "Cohort B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]], "biomarker_exclusion": [["AKT1 Mutation", "AKT1-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["MTOR Mutation", "MTOR-Mutation", "gene"]]}]}
{"NCT_id": "NCT03907527", "json": [{"cohort": "", "disease_state": "recurrent, advanced, platinum resistant", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent, advanced, platinum resistant", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent, advanced, platinum resistant", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma"}]}
{"NCT_id": "NCT04233021", "json": [{"cohort": "Cohort 1", "disease_state": "stage IV", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR L858R", "EGFR exon 19 deletions", "EGFR exon 19 insertions", "EGFR L861Q", "EGFR G719X"], "histology_exclusion": ["Small Cell Lung Cancer"], "biomarker_exclusion": ["EGFR T790M"]}, {"cohort": "Cohort 2", "disease_state": "stage IV", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR L858R", "EGFR exon 19 deletions", "EGFR exon 19 insertions", "EGFR L861Q", "EGFR G719X"], "histology_exclusion": ["Small Cell Lung Cancer"], "biomarker_exclusion": ["EGFR T790M", "EGFR TKI"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR L861Q", "L861Q", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]], "histology_exclusion": ["Small Cell Lung Carcinoma"], "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR L861Q", "L861Q", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]], "histology_exclusion": ["Small Cell Lung Carcinoma"], "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"]]}]}
{"NCT_id": "NCT04661852", "json": [{"cohort": "Cabozantinib with Topotecan-Cyclophosphamide", "disease_state": "relapsed or refractory", "histology_inclusion": "Ewing sarcoma", "biomarker_inclusion": ["EWSR1 or FUS translocation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cabozantinib with Topotecan-Cyclophosphamide", "disease_state": "relapsed or refractory", "histology_inclusion": "osteosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["low-grade osteosarcoma", "parosteal osteosarcoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cabozantinib with Topotecan-Cyclophosphamide", "histology_inclusion": "Ewing Sarcoma", "biomarker_inclusion": [["FUS Fusion", "FUS", "fusion"]]}, {"cohort": "Cabozantinib with Topotecan-Cyclophosphamide", "histology_inclusion": "Osteosarcoma", "histology_exclusion": ["Parosteal Osteosarcoma", "Osteosarcoma"]}]}
{"NCT_id": "NCT05443126", "json": [{"cohort": "RET fusion-positive NSCLC", "disease_state": "advanced", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["RET fusion-positive"], "histology_exclusion": [], "biomarker_exclusion": ["major driver gene alterations other than RET"]}, {"cohort": "RET mutation-positive MTC", "disease_state": "advanced", "histology_inclusion": "Medullary Thyroid Carcinoma", "biomarker_inclusion": ["RET mutation-positive"], "histology_exclusion": [], "biomarker_exclusion": ["major driver gene alterations other than RET"]}, {"cohort": "Other RET-altered solid tumours", "disease_state": "advanced", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": ["RET-altered"], "histology_exclusion": [], "biomarker_exclusion": ["major driver gene alterations other than RET"]}, {"cohort": "RET fusion-positive NSCLC (no prior SRI therapy)", "disease_state": "advanced", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["RET fusion-positive"], "histology_exclusion": [], "biomarker_exclusion": ["major driver gene alterations other than RET"]}, {"cohort": "RET mutation-positive MTC (no prior SRI therapy)", "disease_state": "advanced", "histology_inclusion": "Medullary Thyroid Carcinoma", "biomarker_inclusion": ["RET mutation-positive"], "histology_exclusion": [], "biomarker_exclusion": ["major driver gene alterations other than RET"]}, {"cohort": "Other RET-altered solid tumours (no prior SRI therapy)", "disease_state": "advanced", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": ["RET-altered"], "histology_exclusion": [], "biomarker_exclusion": ["major driver gene alterations other than RET"]}], "json_norm": [{"cohort": "RET fusion-positive NSCLC", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"], ["RET-High", "RET-High", "expression"]]}, {"cohort": "RET mutation-positive MTC", "histology_inclusion": "Thyroid Gland Medullary Carcinoma", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "Other RET-altered solid tumours", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "RET fusion-positive NSCLC (no prior SRI therapy)", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"], ["RET-High", "RET-High", "expression"]]}, {"cohort": "RET mutation-positive MTC (no prior SRI therapy)", "histology_inclusion": "Thyroid Gland Medullary Carcinoma", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "Other RET-altered solid tumours (no prior SRI therapy)", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT01743950", "json": [{"cohort": "Bevacizumab-na\u00efve with recurrent IDH wildtype high grade glioma", "disease_state": "recurrent", "histology_inclusion": "Grade 3 or 4 glioma, IDH wildtype", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Bevacizumab-exposed with refractory recurrent IDH wildtype high grade glioma", "disease_state": "refractory recurrent", "histology_inclusion": "Grade 3 or 4 glioma, IDH wildtype", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Bevacizumab-na\u00efve with recurrent IDH mutant glioma", "disease_state": "recurrent", "histology_inclusion": "Grade 3 or 4 glioma, IDH mutant", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Bevacizumab-exposed with recurrent IDH mutant glioma", "disease_state": "recurrent", "histology_inclusion": "Grade 3 or 4 glioma, IDH mutant", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Bevacizumab-na\u00efve with recurrent IDH wildtype high grade glioma", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Bevacizumab-na\u00efve with recurrent IDH wildtype high grade glioma", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Bevacizumab-exposed with refractory recurrent IDH wildtype high grade glioma", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Bevacizumab-exposed with refractory recurrent IDH wildtype high grade glioma", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Bevacizumab-na\u00efve with recurrent IDH mutant glioma", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Bevacizumab-na\u00efve with recurrent IDH mutant glioma", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Bevacizumab-exposed with recurrent IDH mutant glioma", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Bevacizumab-exposed with recurrent IDH mutant glioma", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04727151", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "HER2-positive solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT05313009", "json": [{"cohort": "STAGE 1: SAFETY LEAD IN", "disease_state": "unresectable or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": ["KRAS", "ALK", "ROS1", "RET", "BRAF", "NTRK1/2/3", "MET", "EGFR"]}, {"cohort": "STAGE 2: EFFICACY", "disease_state": "unresectable or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": ["KRAS", "ALK", "ROS1", "RET", "BRAF", "NTRK1/2/3", "MET", "EGFR"]}], "json_norm": [{"cohort": "STAGE 1: SAFETY LEAD IN", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "STAGE 2: EFFICACY", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT05117931", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "esophagogastric cancer", "biomarker_inclusion": ["EGFR amplification", "MET amplification"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Esophagogastric Cancer", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["EGFR-High", "EGFR-High", "expression"]]}]}
{"NCT_id": "NCT03907852", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "Malignant Pleural/Peritoneal Mesothelioma", "biomarker_inclusion": ["MSLN expression >= 50% of tumor cells that are 2+ and/or 3+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Serous Ovarian Adenocarcinoma", "biomarker_inclusion": ["MSLN expression >= 30% of tumor cells that are 1+, 2+, and/or 3+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": ["MSLN expression >= 30% of tumor cells that are 1+, 2+, and/or 3+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["MSLN expression >= 30% of tumor cells that are 1+, 2+, and/or 3+"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Peritoneal Malignant Mesothelioma"}, {"cohort": "", "histology_inclusion": "Ovarian Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Cholangiocarcinoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04466891", "json": [{"cohort": "ZW25 (Zanidatamab) Monotherapy", "disease_state": "advanced or metastatic", "histology_inclusion": "Biliary Tract Cancers", "biomarker_inclusion": ["HER2-amplified"], "histology_exclusion": [], "biomarker_exclusion": ["HER2-targeted agents"]}], "json_norm": [{"cohort": "ZW25 (Zanidatamab) Monotherapy", "histology_inclusion": "Liver Cancer", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "ZW25 (Zanidatamab) Monotherapy", "histology_inclusion": "Biliary Tract Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04987996", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT03712605", "json": [{"cohort": "", "disease_state": "Stage I-IIIb", "histology_inclusion": "Merkel cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Merkel Cell Carcinoma"}]}
{"NCT_id": "NCT03973151", "json": [{"cohort": "", "disease_state": "unresectable Stage III or Stage IV", "histology_inclusion": "melanoma", "biomarker_inclusion": ["NRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04988074", "json": [{"cohort": "", "disease_state": "AJCC 7th edition: Stage III, IV without bulky N2b/c disease (defined as N3 equivalent volume) and without bulky T4 (\u226430cc). AJCC 8th edition: Stage II or III, or stage I with N1 or N2 nodes (>3cm or multiple), without bulky nodal disease (defined as N3 equivalent volume) and without bulky T4 disease (defined as 30cc tumor volume)", "histology_inclusion": "HPV-positive head and neck squamous cell carcinoma of the oropharynx", "biomarker_inclusion": ["p16 IHC positivity", "HPV16 type"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "AJCC 7th edition: Stage III, IV without bulky N2b/c disease (defined as N3 equivalent volume) and without bulky T4 (\u226430cc). AJCC 8th edition: Stage II or III, or stage I with N1 or N2 nodes (>3cm or multiple), without bulky nodal disease (defined as N3 equivalent volume) and without bulky T4 disease (defined as 30cc tumor volume)", "histology_inclusion": "HPV-positive head and neck squamous cell carcinoma of other subsites", "biomarker_inclusion": ["p16 IHC positivity", "HPV16 type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT02201992", "json": [{"cohort": "", "disease_state": "Stage IB (>= 4 cm), II, IIIA", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["ALK Fusion Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT04402008", "json": [{"cohort": "Phase 2: Cohort 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR exon 20 insertion mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2: Cohort 2", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["HER2 exon 20 insertion mutations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 2: Cohort 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Phase 2: Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04923126", "json": [{"cohort": "", "disease_state": "low-grade glioma, recurrent low-grade glioma, progressive low-grade glioma", "histology_inclusion": "low-grade glioma/astrocytic tumor/glioneuronal tumor/neuroepithelial tumor, not otherwise specified (NOS) or not elsewhere classified (NEC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "low-grade glioma, recurrent low-grade glioma, progressive low-grade glioma", "histology_inclusion": "pilocytic astrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "low-grade glioma, recurrent low-grade glioma, progressive low-grade glioma", "histology_inclusion": "pilomyxoid astrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "low-grade glioma, recurrent low-grade glioma, progressive low-grade glioma", "histology_inclusion": "pleomorphic xanthroastrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "low-grade glioma, recurrent low-grade glioma, progressive low-grade glioma", "histology_inclusion": "ganglioglioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "low-grade glioma, recurrent low-grade glioma, progressive low-grade glioma", "histology_inclusion": "gangliocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "low-grade glioma, recurrent low-grade glioma, progressive low-grade glioma", "histology_inclusion": "diffuse glioma, diffuse astrocytoma, oligodendroglioma, or oligoastrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "low-grade glioma, recurrent low-grade glioma, progressive low-grade glioma", "histology_inclusion": "papillary glioneuronal tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "low-grade glioma, recurrent low-grade glioma, progressive low-grade glioma", "histology_inclusion": "rosette-forming glioneuronal tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "low-grade glioma, recurrent low-grade glioma, progressive low-grade glioma", "histology_inclusion": "diffuse leptomeningeal glioneuronal tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "low-grade glioma, recurrent low-grade glioma, progressive low-grade glioma", "histology_inclusion": "central neurocytoma, extraventricular neurocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "low-grade glioma, recurrent low-grade glioma, progressive low-grade glioma", "histology_inclusion": "angiocentric glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "low-grade glioma, recurrent low-grade glioma, progressive low-grade glioma", "histology_inclusion": "dysembryoplastic neuroepithelial tumor (DNET), septal DNET, myxoid glioneuronal tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "low-grade glioma, recurrent low-grade glioma, progressive low-grade glioma", "histology_inclusion": "tectal glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "low-grade glioma, recurrent low-grade glioma, progressive low-grade glioma", "histology_inclusion": "desmoplastic infantile astrocytoma / ganglioglioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "low-grade glioma, recurrent low-grade glioma, progressive low-grade glioma", "histology_inclusion": "polymorphous low-grade neuroepithelial tumor of the young", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Neuroendocrine Carcinoma"}, {"cohort": "", "histology_inclusion": "Low Grade Glioma"}, {"cohort": "", "histology_inclusion": "Neuroepithelial Neoplasm"}, {"cohort": "", "histology_inclusion": "Pilocytic Astrocytoma"}, {"cohort": "", "histology_inclusion": "Pilomyxoid Astrocytoma"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Ganglioglioma"}, {"cohort": "", "histology_inclusion": "Gangliocytoma"}, {"cohort": "", "histology_inclusion": "Diffuse Astrocytoma"}, {"cohort": "", "histology_inclusion": "Oligoastrocytoma"}, {"cohort": "", "histology_inclusion": "Diffuse Glioma"}, {"cohort": "", "histology_inclusion": "Oligodendroglioma"}, {"cohort": "", "histology_inclusion": "Papillary Glioneuronal Tumor"}, {"cohort": ""}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Central Neurocytoma"}, {"cohort": "", "histology_inclusion": "Extraventricular Neurocytoma"}, {"cohort": "", "histology_inclusion": "Angiocentric Glioma"}, {"cohort": "", "histology_inclusion": "Dysembryoplastic Neuroepithelial Tumor"}, {"cohort": "", "histology_inclusion": "Glioma"}, {"cohort": "", "histology_inclusion": "Ganglioglioma"}, {"cohort": "", "histology_inclusion": "Desmoplastic Infantile Astrocytoma"}, {"cohort": "", "histology_inclusion": "Neuroepithelial Neoplasm"}]}
{"NCT_id": "NCT05768919", "json": [{"cohort": "Newly Diagnosed High-Grade Gliomas", "disease_state": "", "histology_inclusion": "High-Grade Gliomas (WHO grade III or IV, including GBM, astrocytoma, gliosarcoma, H3K27M mutant diffuse midline glioma)", "biomarker_inclusion": ["MGMT promoter methylated", "MGMT promoter unmethylated", "IDH WT", "IDH mutant"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Newly Diagnosed High-Grade Gliomas", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"], ["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Newly Diagnosed High-Grade Gliomas", "histology_inclusion": "Gliosarcoma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"], ["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Newly Diagnosed High-Grade Gliomas", "histology_inclusion": "Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"], ["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Newly Diagnosed High-Grade Gliomas", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"], ["H3-3A K28M", "K28M", "coordinate"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT03647800", "json": [{"cohort": "Part 1: Dose Escalation Phase", "disease_state": "relapsed or refractory", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [], "histology_exclusion": ["Acute promyelocytic leukemia", "CNS (cerebral/meningeal) disease related to underlying malignancy"], "biomarker_exclusion": ["Prior anti-CD123 therapy"]}, {"cohort": "Part 1: Dose Escalation Phase", "disease_state": "relapsed or refractory", "histology_inclusion": "High-Grade Myelodysplastic Syndrome (MDS)", "biomarker_inclusion": [], "histology_exclusion": ["CNS (cerebral/meningeal) disease related to underlying malignancy"], "biomarker_exclusion": ["Prior anti-CD123 therapy"]}], "json_norm": [{"cohort": "Part 1: Dose Escalation Phase", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Part 1: Dose Escalation Phase", "histology_inclusion": "Myelodysplastic Syndrome"}]}
{"NCT_id": "NCT04233866", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the pancreas", "biomarker_inclusion": [], "histology_exclusion": ["acinar cell", "adenosquamous carcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma", "histology_exclusion": ["Cervical Adenosquamous Carcinoma", "Pancreatic Adenosquamous Carcinoma"]}]}
{"NCT_id": "NCT04336943", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["Biallelic CDK12 inactivating mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["MMRd/MSI-high"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["Loss of function mutations in homologous recombination genes"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["CDK12 Mutation", "CDK12-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}]}
{"NCT_id": "NCT04402138", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["t(11;14)", "cyclin D1 expression"], "histology_exclusion": [], "biomarker_exclusion": ["known mutations that confer resistance to a BTK inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma"}]}
{"NCT_id": "NCT04988295", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["EGFR Exon 19del", "EGFR Exon 21 L858R"], "histology_exclusion": ["small cell transformation"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT05378763", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["HER2 exon 20 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR", "ALK"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT02724579", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "WNT-driven medulloblastoma", "biomarker_inclusion": ["Positive nuclear beta-catenin", "Positive for CTNNB1 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["MYC", "MYCN"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Medulloblastoma", "biomarker_inclusion": [["CTNNB1 Mutation", "CTNNB1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04234113", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "thyroid", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "small-cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "bladder cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "Merkel cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "skin squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "microsatellite instability high", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "mesothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "thymic cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "cervical cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "biliary tract cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "gastric cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "anal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": "", "histology_inclusion": "Melanoma"}, {"cohort": "", "histology_inclusion": "Merkel Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Skin Squamous Cell Carcinoma"}, {"cohort": "", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Mesothelioma"}, {"cohort": "", "histology_inclusion": "Thymus Neoplasm"}, {"cohort": "", "histology_inclusion": "Thymic Carcinoma"}, {"cohort": "", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "", "histology_inclusion": "Liver Cancer"}, {"cohort": "", "histology_inclusion": "Biliary Tract Carcinoma"}, {"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Anal Neoplasm"}, {"cohort": "", "histology_inclusion": "Anal Carcinoma"}]}
{"NCT_id": "NCT04467515", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "HER2-positive breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["leptomeningeal disease", "symptomatic brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "HER2-positive gastric cancer", "biomarker_inclusion": [], "histology_exclusion": ["leptomeningeal disease", "symptomatic brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "HER2-positive gastroesophageal junction cancer", "biomarker_inclusion": [], "histology_exclusion": ["leptomeningeal disease", "symptomatic brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04858334", "json": [{"cohort": "", "disease_state": "Resected", "histology_inclusion": "Pancreatic Acinar Cell Carcinoma", "biomarker_inclusion": ["BRCA1", "BRCA2", "PALB2"], "histology_exclusion": ["Neuroendocrine Tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Resected", "histology_inclusion": "Pancreatic Adenosquamous Carcinoma", "biomarker_inclusion": ["BRCA1", "BRCA2", "PALB2"], "histology_exclusion": ["Neuroendocrine Tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Resected", "histology_inclusion": "Pancreatic Squamous Cell Carcinoma", "biomarker_inclusion": ["BRCA1", "BRCA2", "PALB2"], "histology_exclusion": ["Neuroendocrine Tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Resected", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": ["BRCA1", "BRCA2", "PALB2"], "histology_exclusion": ["Neuroendocrine Tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Acinar Cell Cancer", "histology_exclusion": ["Neuroendocrine Carcinoma", "Lung Neuroendocrine Neoplasm", "Neuroendocrine Tumor"]}, {"cohort": "", "histology_inclusion": "Pancreatic Adenosquamous Carcinoma", "histology_exclusion": ["Neuroendocrine Carcinoma", "Lung Neuroendocrine Neoplasm", "Neuroendocrine Tumor"]}, {"cohort": "", "histology_inclusion": "Pancreatic Squamous Cell Carcinoma", "histology_exclusion": ["Neuroendocrine Carcinoma", "Lung Neuroendocrine Neoplasm", "Neuroendocrine Tumor"]}, {"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma", "histology_exclusion": ["Neuroendocrine Carcinoma", "Lung Neuroendocrine Neoplasm", "Neuroendocrine Tumor"]}]}
{"NCT_id": "NCT04988555", "json": [{"cohort": "Phase 1", "disease_state": "relapsed or refractory", "histology_inclusion": "AML, ALL, or acute leukemia of ambiguous lineage", "biomarker_inclusion": [], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": ["menin-MLL inhibitors"]}, {"cohort": "Phase 2 Arm A", "disease_state": "relapsed or refractory", "histology_inclusion": "AML", "biomarker_inclusion": ["KMT2A (MLL)-fusion"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": ["menin-MLL inhibitors"]}, {"cohort": "Phase 2 Arm B", "disease_state": "relapsed or refractory", "histology_inclusion": "AML", "biomarker_inclusion": ["NPM1c mutations"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": ["menin-MLL inhibitors"]}], "json_norm": [{"cohort": "Phase 1", "histology_inclusion": "Acute Leukemia of Ambiguous Lineage", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Phase 1", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Phase 1", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Phase 2 Arm A", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Phase 2 Arm B", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT05118789", "json": [{"cohort": "Phase 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["ROS1 rearrangement"], "histology_exclusion": [], "biomarker_exclusion": ["oncogenic driver alteration other than ROS1"]}, {"cohort": "Cohorts 2a, 2b, 2c, 2d", "disease_state": "locally advanced or metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["ROS1 rearrangement"], "histology_exclusion": [], "biomarker_exclusion": ["oncogenic driver alteration other than ROS1"]}, {"cohort": "Cohort 2e", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor (other than NSCLC)", "biomarker_inclusion": ["ROS1 rearrangement"], "histology_exclusion": [], "biomarker_exclusion": ["oncogenic driver alteration other than ROS1"]}], "json_norm": [{"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"]]}, {"cohort": "Cohorts 2a, 2b, 2c, 2d", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"]]}, {"cohort": "Cohort 2e", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"]]}, {"cohort": "Cohort 2e", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"]]}]}
{"NCT_id": "NCT04169074", "json": [{"cohort": "", "disease_state": "Clinical stage I-IVa", "histology_inclusion": "Squamous cell carcinoma of the oral cavity, p16-negative oropharynx, hypopharynx, or larynx", "biomarker_inclusion": ["HPV-negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-Low", "H3P10-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-Low", "H3P10-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]]}]}
{"NCT_id": "NCT04169178", "json": [{"cohort": "dose finding stage", "disease_state": "advanced or metastatic solid tumors", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "dose expansion stage", "disease_state": "advanced or metastatic solid tumors", "histology_inclusion": "", "biomarker_inclusion": ["c-MET mutations (MET exon 14 mutations)", "c-MET amplifications (MET/CEP7 ratio \u2265 2.0 or MET \u2265 5.0 copies)", "c-MET over-expression (IHC score \u2265 2+)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "dose expansion stage, gastric cancer", "disease_state": "advanced or metastatic gastric cancer", "histology_inclusion": "gastric cancer", "biomarker_inclusion": ["c-MET mutations (MET exon 14 mutations)", "c-MET amplifications (MET/CEP7 ratio \u2265 2.0 or MET \u2265 5.0 copies)", "c-MET over-expression (IHC score \u2265 2+)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "dose expansion stage, NSCLC", "disease_state": "advanced or metastatic non-small cell lung cancer", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["c-MET mutations (MET exon 14 mutations)", "c-MET amplifications (MET/CEP7 ratio \u2265 2.0 or MET \u2265 5.0 copies)", "c-MET over-expression (IHC score \u2265 2+)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "dose expansion stage, colorectal cancer", "disease_state": "advanced or metastatic colorectal cancer", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["c-MET mutations (MET exon 14 mutations)", "c-MET amplifications (MET/CEP7 ratio \u2265 2.0 or MET \u2265 5.0 copies)", "c-MET over-expression (IHC score \u2265 2+)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "dose expansion stage, other solid cancer", "disease_state": "advanced or metastatic other solid cancer", "histology_inclusion": "other solid cancer", "biomarker_inclusion": ["c-MET mutations (MET exon 14 mutations)", "c-MET amplifications (MET/CEP7 ratio \u2265 2.0 or MET \u2265 5.0 copies)", "c-MET over-expression (IHC score \u2265 2+)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "dose finding stage"}, {"cohort": "dose expansion stage", "biomarker_inclusion": [["MET Mutation", "MET-Mutation", "gene"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["SLTM Mutation", "SLTM-Mutation", "gene"]]}, {"cohort": "dose expansion stage, gastric cancer", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["MET Mutation", "MET-Mutation", "gene"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["SLTM Mutation", "SLTM-Mutation", "gene"]]}, {"cohort": "dose expansion stage, NSCLC", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MET Mutation", "MET-Mutation", "gene"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["SLTM Mutation", "SLTM-Mutation", "gene"]]}, {"cohort": "dose expansion stage, colorectal cancer", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MET Mutation", "MET-Mutation", "gene"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["SLTM Mutation", "SLTM-Mutation", "gene"]]}, {"cohort": "dose expansion stage, other solid cancer", "biomarker_inclusion": [["MET Mutation", "MET-Mutation", "gene"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["SLTM Mutation", "SLTM-Mutation", "gene"]]}]}
{"NCT_id": "NCT04598009", "json": [{"cohort": "", "disease_state": "Unresectable Stage III or Stage IV", "histology_inclusion": "Melanoma", "biomarker_inclusion": ["KIT-mutant"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["KIT Mutation", "KIT-Mutation", "gene"]]}]}
{"NCT_id": "NCT03583086", "json": [{"cohort": "Checkpoint Inhibitor Na\u00efve Non-Small Cell Lung Cancer", "disease_state": "refractory", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR", "ALK", "ROS1", "BRAF", "PD1", "PD-L1", "oral VEGF TKI"]}, {"cohort": "Progressed on Checkpoint Inhibitor Non-Small Cell Lung Cancer", "disease_state": "refractory", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["oral VEGF TKI"]}, {"cohort": "EGFR, ALK, ROS1 and BRAF NSCLC", "disease_state": "refractory", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR", "ALK", "ROS1", "BRAF"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Small Cell Lung Cancer", "disease_state": "refractory", "histology_inclusion": "Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["oral VEGF TKI"]}], "json_norm": [{"cohort": "Checkpoint Inhibitor Na\u00efve Non-Small Cell Lung Cancer", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Progressed on Checkpoint Inhibitor Non-Small Cell Lung Cancer", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "EGFR, ALK, ROS1 and BRAF NSCLC", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Small Cell Lung Cancer", "histology_inclusion": "Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT05119036", "json": [{"cohort": "", "disease_state": "T1 or T2, N0, N1 or N2", "histology_inclusion": "Squamous Cell Carcinoma of the Oropharynx", "biomarker_inclusion": ["HPV+ tumor"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT01810588", "json": [{"cohort": "All Patients", "disease_state": "Relapsed or refractory acute leukemia (myeloid or lymphoid)", "histology_inclusion": "Acute leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "All Patients", "disease_state": "Acute leukemia in first remission at high-risk for recurrence", "histology_inclusion": "Acute leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "All Patients", "disease_state": "Chronic myelogenous leukemia in chronic, accelerated phase or blast-crisis", "histology_inclusion": "Chronic myelogenous leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "All Patients", "disease_state": "Recurrent or refractory malignant lymphoma or Hodgkin lymphoma", "histology_inclusion": "Malignant lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "All Patients", "disease_state": "Recurrent or refractory malignant lymphoma or Hodgkin lymphoma", "histology_inclusion": "Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "All Patients", "disease_state": "Chronic lymphocytic leukemia, relapsed or with poor prognostic features", "histology_inclusion": "Chronic lymphocytic leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "All Patients", "disease_state": "Multiple myeloma", "histology_inclusion": "Multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "All Patients", "disease_state": "Myelodysplastic syndrome", "histology_inclusion": "Myelodysplastic syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "All Patients", "disease_state": "Chronic myeloproliferative disease", "histology_inclusion": "Chronic myeloproliferative disease", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "All Patients", "disease_state": "Aplastic anemia", "histology_inclusion": "Aplastic anemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "All Patients", "disease_state": "Other hematological disorder in need of allogeneic transplant (e.g. blastoid dendritic cell neoplasm)", "histology_inclusion": "Blastoid dendritic cell neoplasm", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "All Patients", "histology_inclusion": "Acute Leukemia"}, {"cohort": "All Patients", "histology_inclusion": "Acute Leukemia"}, {"cohort": "All Patients", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive"}, {"cohort": "All Patients", "histology_inclusion": "Lymphoma"}, {"cohort": "All Patients", "histology_inclusion": "Hodgkin Lymphoma"}, {"cohort": "All Patients", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "All Patients", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "All Patients", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "All Patients", "histology_inclusion": "Myeloproliferative Neoplasm"}, {"cohort": "All Patients"}, {"cohort": "All Patients"}]}
{"NCT_id": "NCT04169347", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["RAS wild-type", "KRAS exon 2 (codons 12/13)", "KRAS exon 3 (codons 59/61)", "KRAS exon 4 (codons 117/146)", "NRAS exon 2 (codons 12/13)", "NRAS exon 3 (codons 59/61)", "NRAS exon 4 (codons 117/146)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT03974217", "json": [{"cohort": "", "disease_state": "Secondary AML, Relapsed or refractory AML, MDS with a minimum history of at least 4 cycles of decitabine or 6 cycles of azacitidine", "histology_inclusion": "AML, MDS", "biomarker_inclusion": ["Cohesin complex mutation (STAG2, SMC1A, RAD21, PDS5B, or SMC3) with VAF \u2265 5%"], "histology_exclusion": ["CNS leukemia"], "biomarker_exclusion": ["Active HIV", "Active HCV", "Active HBV"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["RAD21 Mutation", "RAD21-Mutation", "gene"], ["SMC3 Mutation", "SMC3-Mutation", "gene"], ["PDS5B Mutation", "PDS5B-Mutation", "gene"], ["STAG2 Mutation", "STAG2-Mutation", "gene"], ["SMC1A Mutation", "SMC1A-Mutation", "gene"]], "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["RAD21 Mutation", "RAD21-Mutation", "gene"], ["SMC3 Mutation", "SMC3-Mutation", "gene"], ["PDS5B Mutation", "PDS5B-Mutation", "gene"], ["STAG2 Mutation", "STAG2-Mutation", "gene"], ["SMC1A Mutation", "SMC1A-Mutation", "gene"]], "histology_exclusion": ["Central Nervous System Leukemia"]}]}
{"NCT_id": "NCT04923932", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Gastric Cancer", "biomarker_inclusion": ["MET gene amplifications"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Esophagogastric junction adenocarcinoma", "biomarker_inclusion": ["MET gene amplifications"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}]}
{"NCT_id": "NCT05639751", "json": [{"cohort": "", "disease_state": "advanced, recurrent, or metastatic", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": ["SMARCA4 truncating mutation", "SMARCA4 deletion"], "histology_exclusion": [], "biomarker_exclusion": ["SMARCA2 mutation", "SMARCA2 loss of protein expression"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["SMARCA4 Mutation", "SMARCA4-Mutation", "gene"]], "biomarker_exclusion": [["SMARCA2 Mutation", "SMARCA2-Mutation", "gene"], ["SMARCA2-Low", "SMARCA2-Low", "expression"]]}]}
{"NCT_id": "NCT02268253", "json": [{"cohort": "Myelofibrosis", "disease_state": "resistant/refractory or intolerant to approved JAK therapy (JAK1/JAK2 or JAK2)", "histology_inclusion": "Myelofibrosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "CMML (refractory/resistant/intolerant to HMAs, HU, or intensive chemotherapy)", "disease_state": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia (CMML-1 or CMML-2)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "CMML (high-risk based on morphological features and molecularly-integrated prognostic systems)", "disease_state": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia (CMML-1 or CMML-2)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Myelofibrosis", "histology_inclusion": "Myelofibrosis"}, {"cohort": "CMML (refractory/resistant/intolerant to HMAs, HU, or intensive chemotherapy)", "histology_inclusion": "Chronic Myelomonocytic Leukemia-1"}, {"cohort": "CMML (refractory/resistant/intolerant to HMAs, HU, or intensive chemotherapy)", "histology_inclusion": "Chronic Myelomonocytic Leukemia-2"}, {"cohort": "CMML (refractory/resistant/intolerant to HMAs, HU, or intensive chemotherapy)", "histology_inclusion": "Chronic Myelomonocytic Leukemia"}, {"cohort": "CMML (high-risk based on morphological features and molecularly-integrated prognostic systems)", "histology_inclusion": "Chronic Myelomonocytic Leukemia-1"}, {"cohort": "CMML (high-risk based on morphological features and molecularly-integrated prognostic systems)", "histology_inclusion": "Chronic Myelomonocytic Leukemia-2"}, {"cohort": "CMML (high-risk based on morphological features and molecularly-integrated prognostic systems)", "histology_inclusion": "Chronic Myelomonocytic Leukemia"}]}
{"NCT_id": "NCT03127215", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["defective DNA repair via HR"], "histology_exclusion": ["hematological malignancies", "primary brain tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]], "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm", "Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT03844048", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Non-Hodgkin's Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Acute Lymphoblastic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "", "histology_inclusion": "Non-Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": ""}]}
{"NCT_id": "NCT04924075", "json": [{"cohort": "Cohort A1: Pheochromocytoma/Paraganglioma (PPGL)", "disease_state": "locally advanced or metastatic", "histology_inclusion": "pheochromocytoma or paraganglioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A2: Pancreatic Neuroendocrine Tumor (pNET)", "disease_state": "locally advanced or metastatic", "histology_inclusion": "well-differentiated, low, or intermediate grade (G1 or G2 pNET per 2017 World Health Organization (WHO) classification and grading) pNET", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B1: von Hippel-Lindau (VHL) Disease-Associated Tumors", "disease_state": "", "histology_inclusion": "VHL disease-associated tumors", "biomarker_inclusion": ["documented germline VHL gene alteration"], "histology_exclusion": ["pheochromocytoma >5 cm", "paraganglioma >4 cm", "Metastatic or locally advanced, unresectable PPGL", "lesion(s) located in the head of the pancreas >2 cm", "lesion(s) located in the body or tail of the pancreas >3 cm", "locally advanced, unresectable or metastatic pNET", "lesion(s) >3 cm", "metastatic RCC"], "biomarker_exclusion": []}, {"cohort": "Cohort C: Gastrointestinal Stromal Tumor (wt GIST)", "disease_state": "advanced", "histology_inclusion": "GIST", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A1: Pheochromocytoma/Paraganglioma (PPGL)", "histology_inclusion": "Paraganglioma"}, {"cohort": "Cohort A2: Pancreatic Neuroendocrine Tumor (pNET)", "histology_inclusion": "Primitive Neuroectodermal Tumor"}, {"cohort": "Cohort B1: von Hippel-Lindau (VHL) Disease-Associated Tumors", "biomarker_inclusion": [["VHL Mutation", "VHL-Mutation", "gene"]], "histology_exclusion": ["Paraganglioma"]}, {"cohort": "Cohort C: Gastrointestinal Stromal Tumor (wt GIST)", "histology_inclusion": "Gastrointestinal Stromal Tumor"}]}
{"NCT_id": "NCT04989218", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "intrahepatic cholangiocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["ampullary cancer", "extrahepatic cholangiocarcinoma", "gall bladder cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["ampullary cancer", "extrahepatic cholangiocarcinoma", "gall bladder cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "mixed histology with adenocarcinoma/hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["ampullary cancer", "extrahepatic cholangiocarcinoma", "gall bladder cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Intrahepatic Cholangiocarcinoma", "histology_exclusion": ["Ampulla of Vater Carcinoma", "Cholangiocarcinoma", "Bladder Carcinoma", "Bladder Neoplasm"]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "histology_exclusion": ["Ampulla of Vater Carcinoma", "Cholangiocarcinoma", "Bladder Carcinoma", "Bladder Neoplasm"]}, {"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma", "histology_exclusion": ["Ampulla of Vater Carcinoma", "Cholangiocarcinoma", "Bladder Carcinoma", "Bladder Neoplasm"]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "histology_exclusion": ["Ampulla of Vater Carcinoma", "Cholangiocarcinoma", "Bladder Carcinoma", "Bladder Neoplasm"]}]}
{"NCT_id": "NCT05054348", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["symptomatic CNS spread of tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04169841", "json": [{"cohort": "Metastatic breast cancer", "disease_state": "metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["mutation in homologous repair gene"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Metastatic lung cancer", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["mutation in homologous repair gene"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Metastatic head and Neck cancer", "disease_state": "metastatic", "histology_inclusion": "head and neck cancer", "biomarker_inclusion": ["mutation in homologous repair gene"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Metastatic endometrial cancer", "disease_state": "metastatic", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["mutation in homologous repair gene"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Metastatic clear cell renal cancer", "disease_state": "metastatic", "histology_inclusion": "clear cell renal cancer", "biomarker_inclusion": ["mutation in homologous repair gene"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Metastatic pancreatic cancer", "disease_state": "metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["mutation in homologous repair gene"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Locally advanced or metastatic ovarian cancer", "disease_state": "locally advanced or metastatic", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["mutation in homologous repair gene"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Metastatic urothelial cancer", "disease_state": "metastatic", "histology_inclusion": "urothelial cancer", "biomarker_inclusion": ["mutation in homologous repair gene"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Metastatic prostate cancer", "disease_state": "metastatic castration resistant", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["mutation in homologous repair gene"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Metastatic breast cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Metastatic lung cancer", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Metastatic head and Neck cancer", "histology_inclusion": "Malignant Head and Neck Neoplasm", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Metastatic head and Neck cancer", "histology_inclusion": "Head and Neck Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Metastatic endometrial cancer", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Metastatic clear cell renal cancer", "histology_inclusion": "Kidney Cancer", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Metastatic pancreatic cancer", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Locally advanced or metastatic ovarian cancer", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Locally advanced or metastatic ovarian cancer", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Metastatic urothelial cancer", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Metastatic prostate cancer", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Metastatic prostate cancer", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}]}
{"NCT_id": "NCT04728893", "json": [{"cohort": "Part 2 Cohort A", "disease_state": "CLL/SLL participants who are relapsed or refractory to prior therapy with a covalent, irreversible Bruton's tyrosine kinase inhibitor (BTKi), and a B-cell lymphoma 2 inhibitor (BCL2i)", "histology_inclusion": "chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)", "biomarker_inclusion": [], "histology_exclusion": ["active central nervous system (CNS) disease"], "biomarker_exclusion": []}, {"cohort": "Part 2 Cohort B", "disease_state": "CLL/SLL participants who are relapsed or refractory following at least 1 line of prior therapy and are BTKi treatment naive", "histology_inclusion": "chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)", "biomarker_inclusion": [], "histology_exclusion": ["active central nervous system (CNS) disease"], "biomarker_exclusion": []}, {"cohort": "Part 2 Cohort C", "disease_state": "CLL/SLL participants with 17p deletion or tumor protein p53 (TP53) mutation who are relapsed or refractory following at least 1 line of prior therapy", "histology_inclusion": "chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)", "biomarker_inclusion": ["17p deletion", "TP53 mutation"], "histology_exclusion": ["active central nervous system (CNS) disease"], "biomarker_exclusion": []}, {"cohort": "Part 2 Cohort D", "disease_state": "Richter's transformation participants who are relapsed or refractory following at least 1 line of prior therapy", "histology_inclusion": "Richter's transformation", "biomarker_inclusion": [], "histology_exclusion": ["active central nervous system (CNS) disease"], "biomarker_exclusion": []}, {"cohort": "Part 2 Cohort E", "disease_state": "Mantle cell lymphoma participants who are relapsed or are refractory to chemoimmunotherapy and a covalent irreversible BTKi", "histology_inclusion": "mantle cell lymphoma", "biomarker_inclusion": ["cyclin D1 overexpression", "t(11;14)"], "histology_exclusion": ["active central nervous system (CNS) disease"], "biomarker_exclusion": []}, {"cohort": "Part 2 Cohort F", "disease_state": "Marginal zone lymphoma participants who are relapsed or refractory to chemoimmunotherapy and a covalent irreversible BTKi", "histology_inclusion": "marginal zone lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["active central nervous system (CNS) disease"], "biomarker_exclusion": []}, {"cohort": "Part 2 Cohort G", "disease_state": "Follicular lymphoma participants who are relapsed or refractory to chemoimmunotherapy, immunomodulatory agents (i.e. lenalidomide plus rituximab)", "histology_inclusion": "follicular lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["active central nervous system (CNS) disease"], "biomarker_exclusion": []}, {"cohort": "Part 2 Cohort H", "disease_state": "Waldenstr\u00f6m's macroglobulinemia participants who are relapsed or refractory to standard therapies for WM including chemoimmunotherapy and a covalent irreversible BTKi", "histology_inclusion": "Waldenstr\u00f6m's macroglobulinemia", "biomarker_inclusion": [], "histology_exclusion": ["active central nervous system (CNS) disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 2 Cohort A", "histology_inclusion": "Small Lymphocytic Lymphoma"}, {"cohort": "Part 2 Cohort A", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "Part 2 Cohort B", "histology_inclusion": "Small Lymphocytic Lymphoma"}, {"cohort": "Part 2 Cohort B", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "Part 2 Cohort C", "histology_inclusion": "Small Lymphocytic Lymphoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Part 2 Cohort C", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Part 2 Cohort D", "histology_inclusion": "Richter Syndrome"}, {"cohort": "Part 2 Cohort E", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["CCND1-High", "CCND1-High", "expression"]]}, {"cohort": "Part 2 Cohort F", "histology_inclusion": "Marginal Zone Lymphoma"}, {"cohort": "Part 2 Cohort G", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "Part 2 Cohort H"}]}
{"NCT_id": "NCT04793958", "json": [{"cohort": "", "disease_state": "Advanced Colorectal Cancer, Metastatic Colorectal Cancer", "histology_inclusion": "colorectal carcinoma", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": ["Prior treatment with a therapy targeting KRAS G12C mutation (e.g., AMG 510)", "Prior treatment with an anti-EGFR antibody (e.g., cetuximab or panitumumab)"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT05379985", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "Non-small Cell Lung Cancer (NSCLC)", "biomarker_inclusion": ["KRAS p.G12A", "KRAS p.G12D", "KRAS p.G12R", "KRAS p.G12S", "KRAS p.G12V"], "histology_exclusion": ["Primary central nervous system (CNS) tumors"], "biomarker_exclusion": ["KRAS p.G12C"]}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Colorectal Cancer (CRC)", "biomarker_inclusion": ["KRAS p.G12A", "KRAS p.G12D", "KRAS p.G12R", "KRAS p.G12S", "KRAS p.G12V"], "histology_exclusion": ["Primary central nervous system (CNS) tumors"], "biomarker_exclusion": ["KRAS p.G12C"]}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma (PDAC)", "biomarker_inclusion": ["KRAS p.G12A", "KRAS p.G12D", "KRAS p.G12R", "KRAS p.G12S", "KRAS p.G12V"], "histology_exclusion": ["Primary central nervous system (CNS) tumors"], "biomarker_exclusion": ["KRAS p.G12C"]}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Advanced Solid Tumors", "biomarker_inclusion": ["KRAS p.G12A", "KRAS p.G12D", "KRAS p.G12R", "KRAS p.G12S", "KRAS p.G12V"], "histology_exclusion": ["Primary central nervous system (CNS) tumors"], "biomarker_exclusion": ["KRAS p.G12C"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"], ["KRAS G12A", "G12A", "coordinate"], ["KRAS G12V", "G12V", "coordinate"], ["KRAS G12R", "G12R", "coordinate"], ["KRAS G12S", "G12S", "coordinate"]], "biomarker_exclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"], ["KRAS G12A", "G12A", "coordinate"], ["KRAS G12V", "G12V", "coordinate"], ["KRAS G12R", "G12R", "coordinate"], ["KRAS G12S", "G12S", "coordinate"]], "biomarker_exclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"], ["KRAS G12A", "G12A", "coordinate"], ["KRAS G12V", "G12V", "coordinate"], ["KRAS G12R", "G12R", "coordinate"], ["KRAS G12S", "G12S", "coordinate"]], "biomarker_exclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"], ["KRAS G12A", "G12A", "coordinate"], ["KRAS G12V", "G12V", "coordinate"], ["KRAS G12R", "G12R", "coordinate"], ["KRAS G12S", "G12S", "coordinate"]], "biomarker_exclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT05054725", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRASG12C"], "histology_exclusion": ["Primary central nervous system (CNS) tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT03714334", "json": [{"cohort": "Recurrent Glioblastoma", "disease_state": "first or second recurrence", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Recurrent Glioblastoma", "disease_state": "first or second recurrence", "histology_inclusion": "Gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Recurrent Glioblastoma", "disease_state": "first or second recurrence", "histology_inclusion": "Giant cell Glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Recurrent Glioblastoma", "disease_state": "first or second recurrence", "histology_inclusion": "epithelioid Glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Recurrent Glioblastoma", "histology_inclusion": "Glioblastoma"}, {"cohort": "Recurrent Glioblastoma", "histology_inclusion": "Gliosarcoma"}, {"cohort": "Recurrent Glioblastoma", "histology_inclusion": "Giant Cell Glioblastoma"}, {"cohort": "Recurrent Glioblastoma", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT04924608", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Neurofibromatosis 1", "biomarker_inclusion": [], "histology_exclusion": ["malignant glioma", "MPNST"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_exclusion": ["Malignant Peripheral Nerve Sheath Tumor", "Malignant Glioma"]}]}
{"NCT_id": "NCT05119933", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "solid tumor malignancies", "biomarker_inclusion": ["KRAS G12C"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "non-small cell lung cancer (NSCLC)", "biomarker_inclusion": ["KRAS G12C"], "histology_exclusion": ["central nervous system (CNS) involvement with tumor"], "biomarker_exclusion": ["prior treatment with KRAS G12C targeted agents", "prior treatment with pan-KRAS inhibitors"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]], "biomarker_exclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT03844750", "json": [{"cohort": "", "disease_state": "Stage IV Colorectal Cancer", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["MSS", "pMMR"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT04989946", "json": [{"cohort": "", "disease_state": "newly diagnosed, high-risk", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": ["small cell or other variant (non-adenocarcinoma) prostate cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly diagnosed, high-risk", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["Gleason score 7", "baseline serum prostate specific antigen (PSA) > 20 ng/mL"], "histology_exclusion": ["small cell or other variant (non-adenocarcinoma) prostate cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly diagnosed, high-risk", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["Gleason score > 7"], "histology_exclusion": ["small cell or other variant (non-adenocarcinoma) prostate cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "histology_exclusion": ["Prostate Neoplasm", "Prostate Carcinoma"]}, {"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "histology_exclusion": ["Prostate Neoplasm", "Prostate Carcinoma"]}, {"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "histology_exclusion": ["Prostate Neoplasm", "Prostate Carcinoma"]}]}
{"NCT_id": "NCT03128034", "json": [{"cohort": "", "disease_state": "first remission with measurable residual disease", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Active central nervous system leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "first remission with measurable residual disease", "histology_inclusion": "Acute Lymphoblastic Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Active central nervous system leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "first remission with measurable residual disease", "histology_inclusion": "Mixed-Phenotype Acute Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Active central nervous system leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "beyond first remission", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Active central nervous system leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "beyond first remission", "histology_inclusion": "Acute Lymphoblastic Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Active central nervous system leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "beyond first remission", "histology_inclusion": "Mixed-Phenotype Acute Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Active central nervous system leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "primary refractory disease", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Active central nervous system leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "primary refractory disease", "histology_inclusion": "Acute Lymphoblastic Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Active central nervous system leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "primary refractory disease", "histology_inclusion": "Mixed-Phenotype Acute Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Active central nervous system leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Acute Myeloid Leukemia evolved from myelodysplastic or myeloproliferative syndromes", "biomarker_inclusion": [], "histology_exclusion": ["Active central nervous system leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Myelodysplastic Syndrome expressed as refractory anemia with excess blasts", "biomarker_inclusion": [], "histology_exclusion": ["Active central nervous system leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Active central nervous system leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "", "histology_inclusion": "Mixed Phenotype Acute Leukemia", "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "", "histology_inclusion": "Mixed Phenotype Acute Leukemia", "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "", "histology_inclusion": "Mixed Phenotype Acute Leukemia", "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome with Excess Blasts", "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "histology_exclusion": ["Central Nervous System Leukemia"]}]}
{"NCT_id": "NCT03844815", "json": [{"cohort": "Phase 1: Dose Escalation Phase", "disease_state": "High risk AML", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["TP53 mutant AML"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": ["HIV positive", "CNS involvement with AML"]}, {"cohort": "Phase 2: Dose Expansion Phase", "disease_state": "Previously untreated AML", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["TP53 mutation"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": ["HIV positive", "CNS involvement with AML"]}], "json_norm": [{"cohort": "Phase 1: Dose Escalation Phase", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Phase 2: Dose Expansion Phase", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT04040231", "json": [{"cohort": "Malignant Pleural Mesothelioma (MPM)", "disease_state": "previously treated", "histology_inclusion": "malignant pleural mesothelioma", "biomarker_inclusion": ["WT-1 positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Malignant Pleural Mesothelioma (MPM)", "histology_inclusion": "Pleural Malignant Mesothelioma", "biomarker_inclusion": [["WT1-High", "WT1-High", "expression"]]}]}
{"NCT_id": "NCT04105270", "json": [{"cohort": "", "disease_state": "unresectable stage IIIB/C or stage IV", "histology_inclusion": "adenocarcinoma of the lung", "biomarker_inclusion": [], "histology_exclusion": ["squamous cell", "large cell", "NSCLC NOS", "mixed tumors"], "biomarker_exclusion": ["EGFR sensitizing (activating) mutation", "ALK translocation", "ROS1 translocation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Lung Adenocarcinoma", "histology_exclusion": ["Non-Small Cell Lung Carcinoma"], "biomarker_exclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT04859777", "json": [{"cohort": "Part A", "disease_state": "advanced or metastatic refractory", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) tumors", "brain metastasis", "leptomeningeal metastasis"], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "advanced or metastatic refractory", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) tumors", "brain metastasis", "leptomeningeal metastasis"], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "advanced or metastatic refractory", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) tumors", "brain metastasis", "leptomeningeal metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part B", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part C", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT05250362", "json": [{"cohort": "", "disease_state": "acute myeloid leukemia (AML) first complete remission with high-risk features", "histology_inclusion": "acute myeloid leukemia (AML)", "biomarker_inclusion": ["FLT3 mutations", "internal tandem duplication", "DNMT3A", "TET2"], "histology_exclusion": ["central nervous system (CNS) involvement within three months"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "acute myeloid leukemia (AML) second or more significant remission", "histology_inclusion": "acute myeloid leukemia (AML)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) involvement within three months"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "acute myeloid leukemia (AML) primary induction failure with partial response", "histology_inclusion": "acute myeloid leukemia (AML)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) involvement within three months"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "myelodysplastic syndromes (MDS) de novo with intermediate or high-risk IPSS scores", "histology_inclusion": "myelodysplastic syndromes (MDS)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) involvement within three months"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "myelodysplastic syndromes (MDS) treatment-related", "histology_inclusion": "myelodysplastic syndromes (MDS)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) involvement within three months"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "chronic myeloid leukemia (CML) failed to achieve cytogenetic remission or cytogenetic relapse", "histology_inclusion": "chronic myeloid leukemia (CML)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) involvement within three months"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "chronic myeloid leukemia (CML) accelerated phase or blast phase", "histology_inclusion": "chronic myeloid leukemia (CML)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) involvement within three months"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "lymphoma refractory to or released from 1st line therapy, salvaged by 2nd line therapy", "histology_inclusion": "lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) involvement within three months"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high-risk lymphoma with CR to 1st line therapy", "histology_inclusion": "lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) involvement within three months"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive"}, {"cohort": "", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive"}, {"cohort": "", "histology_inclusion": "Lymphoma"}, {"cohort": "", "histology_inclusion": "Lymphoma"}]}
{"NCT_id": "NCT03193281", "json": [{"cohort": "", "disease_state": "chronic phase", "histology_inclusion": "Chronic Myeloid Leukemia", "biomarker_inclusion": ["Ph+", "variants of (9;22) translocations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "biomarker_inclusion": [["PAH-High", "PAH-High", "expression"]]}]}
{"NCT_id": "NCT03454035", "json": [{"cohort": "Dose escalation cohorts", "disease_state": "advanced solid tumor refractory", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion cohort (at RP2D)", "disease_state": "metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion cohort (at RP2D)", "disease_state": "metastatic", "histology_inclusion": "malign melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion cohort (at RP2D) for histologically confirmed unresectable stage III or stage IV melanoma", "disease_state": "unresectable stage III or stage IV", "histology_inclusion": "melanoma", "biomarker_inclusion": ["NRASG12/G13/Q61", "KRASG12/G13", "HRASG12/G13", "NRAS amplification", "KRAS amplification", "HRAS amplification", "NF1 loss-of-function mutation"], "histology_exclusion": [], "biomarker_exclusion": ["BRAFV600 mutation"]}], "json_norm": [{"cohort": "Dose escalation cohorts", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Expansion cohort (at RP2D)", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "Expansion cohort (at RP2D)", "histology_inclusion": "Melanoma"}, {"cohort": "Expansion cohort (at RP2D) for histologically confirmed unresectable stage III or stage IV melanoma", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["NRAS-High", "NRAS-High", "expression"], ["NF1 Mutation", "NF1-Mutation", "gene"], ["HRAS-High", "HRAS-High", "expression"], ["KRAS-High", "KRAS-High", "expression"], ["NF1-Low", "NF1-Low", "expression"]]}]}
{"NCT_id": "NCT03975231", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Anaplastic Thyroid Cancer", "biomarker_inclusion": ["BRAF V600E", "BRAF V600K"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Thyroid Gland Undifferentiated (Anaplastic) Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}]}
{"NCT_id": "NCT04170556", "json": [{"cohort": "Cohort A", "disease_state": "", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "Cohort B", "histology_inclusion": "Hepatocellular Carcinoma"}]}
{"NCT_id": "NCT04300790", "json": [{"cohort": "CohortA", "disease_state": "advanced", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["ER+", "PgR+", "HER2-", "PIK3CA-mut"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "CohortB", "disease_state": "advanced", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["ER+", "PgR+", "HER2-", "PIK3CA-mut"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "CohortA", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PIK3CA - MMUT", "PIK3CA - MMUT", "coordinate"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "CohortB", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PIK3CA - MMUT", "PIK3CA - MMUT", "coordinate"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"], ["PGR-High", "PGR-High", "expression"]]}]}
{"NCT_id": "NCT04534205", "json": [{"cohort": "", "disease_state": "unresectable recurrent or metastatic", "histology_inclusion": "HPV16+ HNSCC", "biomarker_inclusion": ["PD-L1 CPS \u22651"], "histology_exclusion": ["nasopharynx"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT04534283", "json": [{"cohort": "", "disease_state": "advanced unresectable or metastatic cancer", "histology_inclusion": "", "biomarker_inclusion": ["BRAF gain-of-function mutation", "RAF1 gain-of-function mutation", "MEK1 gain-of-function mutation", "MEK2 gain-of-function mutation", "ERK1 gain-of-function mutation", "ERK2 gain-of-function mutation", "RAF1 amplification >6 copies", "BRAF fusion", "RAF1 fusion", "MEK1 fusion", "MEK2 fusion", "ERK1 fusion", "ERK2 fusion", "NF1 loss-of-function mutation"], "histology_exclusion": ["hematologic malignancies", "acute or chronic leukemia"], "biomarker_exclusion": ["NSCLC with BRAF V600E treated with prior RAF and/or MEK inhibition therapy"]}, {"cohort": "", "disease_state": "advanced unresectable or metastatic cancer", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["BRAF V600E"], "histology_exclusion": ["hematologic malignancies", "acute or chronic leukemia", "untreated central nervous system (CNS) malignancy or metastasis"], "biomarker_exclusion": ["prior ERK1/2 inhibitor therapy"]}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["MAPK3 Fusion", "MAPK3", "fusion"], ["MAP2K1 Fusion", "MAP2K1", "fusion"], ["MAP2K1 Mutation", "MAP2K1-Mutation", "gene"], ["NF1 Mutation", "NF1-Mutation", "gene"], ["RAF1 Fusion", "RAF1", "fusion"], ["BRAF Fusion", "BRAF", "fusion"], ["RNASE3 Fusion", "RNASE3", "fusion"], ["MAP2K2 Fusion", "MAP2K2", "fusion"], ["NF1-Low", "NF1-Low", "expression"], ["MAPK1 Mutation", "MAPK1-Mutation", "gene"], ["MAPK3 Mutation", "MAPK3-Mutation", "gene"], ["RAF1-High", "RAF1-High", "expression"], ["RAF1 Mutation", "RAF1-Mutation", "gene"], ["MAPK1 Fusion", "MAPK1", "fusion"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["RNASE3-High", "RNASE3-High", "expression"], ["RNASE3 Mutation", "RNASE3-Mutation", "gene"], ["MAP2K2 Mutation", "MAP2K2-Mutation", "gene"]], "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm", "Chronic Leukemia"]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]], "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm", "Chronic Leukemia"]}]}
{"NCT_id": "NCT04729608", "json": [{"cohort": "", "disease_state": "platinum-resistant recurrent", "histology_inclusion": "high-grade serous adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["tumors in the breast", "tumors in the bone", "central nervous system (CNS) metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Adenocarcinoma"}]}
{"NCT_id": "NCT05055232", "json": [{"cohort": "", "disease_state": "Stage IV NSCLC or Stage IIIB and IIIC NSCLC that cannot be treated with radical radiotherapy", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["ALK rearrangement", "ROS1 rearrangement"], "histology_exclusion": ["small cell lung cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage IV NSCLC or Stage IIIB and IIIC NSCLC that cannot be treated with radical radiotherapy", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["ALK rearrangement"], "histology_exclusion": ["small cell lung cancer", "primary CNS tumors", "brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["ALK Fusion", "ALK", "fusion"]], "histology_exclusion": ["Small Cell Lung Carcinoma"]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK Fusion", "ALK", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm", "Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT05120271", "json": [{"cohort": "GPC3 positive solid tumors", "disease_state": "advanced unresectable or metastatic", "histology_inclusion": "hepatocellular carcinoma (HCC)", "biomarker_inclusion": ["GPC3 overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "GPC3 positive solid tumors", "disease_state": "advanced unresectable or metastatic", "histology_inclusion": "squamous cell carcinoma (SCC) of the lung", "biomarker_inclusion": ["GPC3 overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "GPC3 positive solid tumors", "disease_state": "advanced unresectable or metastatic", "histology_inclusion": "myxoid/round cell liposarcoma (MRCLS)", "biomarker_inclusion": ["GPC3 overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "GPC3 positive solid tumors", "disease_state": "advanced unresectable or metastatic", "histology_inclusion": "Merkel cell carcinoma (MCC)", "biomarker_inclusion": ["GPC3 overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "GPC3 positive solid tumors", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [["GPC3-High", "GPC3-High", "expression"]]}, {"cohort": "GPC3 positive solid tumors", "histology_inclusion": "Squamous Cell Carcinoma", "biomarker_inclusion": [["GPC3-High", "GPC3-High", "expression"]]}, {"cohort": "GPC3 positive solid tumors", "histology_inclusion": "Myxoid Liposarcoma", "biomarker_inclusion": [["GPC3-High", "GPC3-High", "expression"]]}, {"cohort": "GPC3 positive solid tumors", "histology_inclusion": "Merkel Cell Carcinoma", "biomarker_inclusion": [["GPC3-High", "GPC3-High", "expression"]]}]}
{"NCT_id": "NCT05120349", "json": [{"cohort": "", "disease_state": "Stage IA2 or IA3", "histology_inclusion": "Non-Small Cell Lung Cancer, non-squamous histology", "biomarker_inclusion": ["EGFR Ex19del", "EGFR L858R"], "histology_exclusion": ["Mixed small cell and non-small cell cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT02661035", "json": [{"cohort": "", "disease_state": "CR1, CR2+", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "CR1, CR2+", "histology_inclusion": "Acute Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "excluding refractory blast crisis", "histology_inclusion": "Chronic Myelogenous Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "after initial therapy, at least a partial remission", "histology_inclusion": "Plasma Cell Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "requiring transplant", "histology_inclusion": "Myelodysplasia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "after initial therapy", "histology_inclusion": "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "after initial therapy", "histology_inclusion": "Lymphoplasmacytic Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "after initial therapy", "histology_inclusion": "Mantle-Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "after initial therapy", "histology_inclusion": "Prolymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "after initial therapy", "histology_inclusion": "Lymphoblastic Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "after initial therapy", "histology_inclusion": "Burkitt's Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "beyond PR2", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Myeloproliferative Syndromes", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive"}, {"cohort": "", "histology_inclusion": "Plasma Cell Leukemia"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma"}, {"cohort": "", "histology_inclusion": "Small Lymphocytic Lymphoma"}, {"cohort": "", "histology_inclusion": "Lymphoplasmacytic Lymphoma"}, {"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Prolymphocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Lymphoblastic Lymphoma"}, {"cohort": "", "histology_inclusion": "Burkitt Lymphoma"}, {"cohort": "", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": ""}]}
{"NCT_id": "NCT03258567", "json": [{"cohort": "", "disease_state": "EBV-positive LPD (previously untreated or relapsed)", "histology_inclusion": "Lymphomatoid granulomatosis (LYG) grades I-II", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "EBV-positive LPD (previously untreated or relapsed)", "histology_inclusion": "Chronic active EBV disease (CAEBV) of B-cells or T-cells", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "EBV-positive LPD (previously untreated or relapsed)", "histology_inclusion": "EBV-positive post-transplantation lymphoproliferative disorder (PTLD)", "biomarker_inclusion": [], "histology_exclusion": ["PTLD after solid organ transplantation"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "EBV-positive B-cell NHL (relapsed)", "histology_inclusion": "Lymphomatoid granulomatosis (LYG) grade III", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "EBV-positive B-cell NHL (relapsed)", "histology_inclusion": "EBV-positive DLBCL", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Lymphomatoid Granulomatosis"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Post-Transplant Lymphoproliferative Disorder", "histology_exclusion": ["Post-Transplant Lymphoproliferative Disorder"]}, {"cohort": "", "histology_inclusion": "Lymphoproliferative Disorder", "histology_exclusion": ["Post-Transplant Lymphoproliferative Disorder"]}, {"cohort": "", "histology_inclusion": "Lymphomatoid Granulomatosis"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}]}
{"NCT_id": "NCT03519412", "json": [{"cohort": "MMRp", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["RAS extended mutations", "MMR-proficient", "MGMT IHC-negative", "MGMT promoter methylation-positive", "TMB > 20 mutations/MB"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "MMRd", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["MMR-deficient"], "histology_exclusion": [], "biomarker_exclusion": ["prior therapy with anti-PD-1, anti-PD-L1, or anti-PD-L2 agent or with an agent directed to another stimulatory or co-inhibitory T-cell receptor (eg, CTLA-4, OX-40, CD137)"]}], "json_norm": [{"cohort": "MMRp", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["TMB-High", "TMB-High", "coordinate"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["TMB", "TMB", "coordinate"], ["MB Mutation", "MB-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["MGMT-Low", "MGMT-Low", "expression"]]}, {"cohort": "MMRd", "histology_inclusion": "Colorectal Carcinoma"}]}
{"NCT_id": "NCT03975387", "json": [{"cohort": "", "disease_state": "advanced solid tumors that are metastatic or unresectable and are refractory or have relapsed", "histology_inclusion": "any tumor type", "biomarker_inclusion": ["wild-type TP53"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1", "disease_state": "advanced solid tumors that are metastatic or unresectable and are refractory or have relapsed", "histology_inclusion": "malignant pleural mesothelioma (MPM)", "biomarker_inclusion": ["wild-type TP53"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "advanced solid tumors that are metastatic or unresectable and are refractory or have relapsed", "histology_inclusion": "Liposarcoma (well-differentiated (WD), de-differentiated (DD), or mix), intimal sarcoma, and other sarcomas with human murine double minute 2 (MDM2) amplification", "biomarker_inclusion": ["wild-type TP53"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "advanced solid tumors that are metastatic or unresectable and are refractory or have relapsed", "histology_inclusion": "Glioblastoma multiforme (GBM) and tumors with CDNK2A loss of function (LOF) excluding malignant pleural mesothelioma (MPM), liposarcoma, intimal sarcoma, and uveal melanoma (UVM)", "biomarker_inclusion": ["wild-type TP53"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 4", "disease_state": "advanced solid tumors that are metastatic or unresectable and are refractory or have relapsed", "histology_inclusion": "any solid tumors with molecular feature that may confer sensitivity to ASTX295", "biomarker_inclusion": ["wild-type TP53"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 5", "disease_state": "advanced solid tumors that are metastatic or unresectable and are refractory or have relapsed", "histology_inclusion": "Uveal melanoma", "biomarker_inclusion": ["wild-type TP53"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 6", "disease_state": "advanced solid tumors that are metastatic or unresectable and are refractory or have relapsed", "histology_inclusion": "Any cancer type with MDM2 amplification excluding malignant pleural mesothelioma (MPM), sarcoma, and uveal melanoma (UVM)", "biomarker_inclusion": ["wild-type TP53"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "Cohort 1", "histology_inclusion": "Pleural Malignant Mesothelioma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Intimal Sarcoma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Liposarcoma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Sarcoma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Pleural Malignant Mesothelioma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Intraocular Melanoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Intimal Sarcoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Liposarcoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "Cohort 4", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "Cohort 5", "histology_inclusion": "Intraocular Melanoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "Cohort 6", "histology_inclusion": "Pleural Malignant Mesothelioma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "Cohort 6", "histology_inclusion": "Intraocular Melanoma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "Cohort 6", "histology_inclusion": "Sarcoma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT05315700", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["EGFR exon 20 insertion mutation", "HER2 exon 20 insertion mutation", "HER2 amplification", "HER2 overexpression"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR T790M mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"]]}]}
{"NCT_id": "NCT05445791", "json": [{"cohort": "", "disease_state": "stage IIIB-IV", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR sensitizing mutation"], "histology_exclusion": [], "biomarker_exclusion": ["previous EGFR-TKI treatment"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT05445843", "json": [{"cohort": "Cohort A", "disease_state": "locally advanced (stage IIIb/IIIc) or metastatic (stage IV)", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["KRAS G12C mutation", "PD-L1 expression < 1%"], "histology_exclusion": ["central nervous system metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["EGFR-sensitizing mutation", "ALK rearrangement"]}, {"cohort": "Cohort B", "disease_state": "locally advanced (stage IIIb/IIIc) or metastatic (stage IV)", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["KRAS G12C mutation", "PD-L1 expression \u2265 1%", "STK11 co-mutation"], "histology_exclusion": ["central nervous system metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["EGFR-sensitizing mutation", "ALK rearrangement"]}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Cohort B", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"], ["STK11 Mutation", "STK11-Mutation", "gene"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT02465268", "json": [{"cohort": "", "disease_state": "newly-diagnosed", "histology_inclusion": "Glioblastoma Multiforme (GBM)", "biomarker_inclusion": [], "histology_exclusion": ["Recurrent or multifocal malignant gliomas"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype"}, {"cohort": "", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT02726568", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR Ex19del", "EGFR 21L858R"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT03975647", "json": [{"cohort": "", "disease_state": "unresectable locally advanced/metastatic", "histology_inclusion": "HER2+ breast carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04729959", "json": [{"cohort": "", "disease_state": "Recurrent Glioblastoma", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["EGFR amplification", "whole chromosome 7 gain", "whole chromosome 10 loss", "TERT promoter mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Recurrent Glioblastoma", "histology_inclusion": "Diffuse Astrocytic Glioma, IDH-Wildtype", "biomarker_inclusion": ["EGFR amplification", "whole chromosome 7 gain", "whole chromosome 10 loss", "TERT promoter mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["TERT-Promoter", "TERT-Promoter", "coordinate"], ["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["TERT-Promoter", "TERT-Promoter", "coordinate"], ["EGFR-High", "EGFR-High", "expression"]]}]}
{"NCT_id": "NCT03258931", "json": [{"cohort": "", "disease_state": "Newly Diagnosed", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["FLT3-ITD", "FLT3-D835"], "histology_exclusion": ["Acute Promyelocytic Leukemia"], "biomarker_exclusion": ["CNS leukemia"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT03975829", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Diffuse Astrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Anaplastic Astrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Oligodendroglioma, Childhood", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Anaplastic Oligodendroglioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Pilocytic Astrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Giant Cell Astrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Pleomorphic Xanthoastrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Anaplastic Pleomorphic Xanthoastrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Angiocentric Glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Chordoid Glioma of Third Ventricle", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Gangliocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Ganglioglioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Anaplastic Ganglioglioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Dysplastic Gangliocytoma of Cerebrellum", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Desmoplastic Infantile Astrocytoma and Ganglioglioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Papillary Glioneuronal Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Rosette-forming Glioneurona Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Central Neurocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Extraventricular Neurocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Cerebellar Liponeurocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Neurofibromatosis Type 1", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Astrocytoma"}, {"cohort": "", "histology_inclusion": "Anaplastic Astrocytoma"}, {"cohort": "", "histology_inclusion": "Astrocytoma"}, {"cohort": "", "histology_inclusion": "Oligodendroglioma"}, {"cohort": "", "histology_inclusion": "Anaplastic Oligodendroglioma"}, {"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Pilocytic Astrocytoma"}, {"cohort": "", "histology_inclusion": "Astrocytoma"}, {"cohort": "", "histology_inclusion": "Pleomorphic Xanthoastrocytoma"}, {"cohort": "", "histology_inclusion": "Anaplastic Pleomorphic Xanthoastrocytoma"}, {"cohort": "", "histology_inclusion": "Angiocentric Glioma"}, {"cohort": "", "histology_inclusion": "Chordoid Glioma"}, {"cohort": "", "histology_inclusion": "Gangliocytoma"}, {"cohort": "", "histology_inclusion": "Ganglioglioma"}, {"cohort": "", "histology_inclusion": "Anaplastic Ganglioglioma"}, {"cohort": "", "histology_inclusion": "Gangliocytoma"}, {"cohort": "", "histology_inclusion": "Ganglioglioma"}, {"cohort": "", "histology_inclusion": "Desmoplastic Infantile Astrocytoma"}, {"cohort": "", "histology_inclusion": "Papillary Glioneuronal Tumor"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Central Neurocytoma"}, {"cohort": "", "histology_inclusion": "Extraventricular Neurocytoma"}, {"cohort": "", "histology_inclusion": "Cerebellar Liponeurocytoma"}, {"cohort": ""}]}
{"NCT_id": "NCT04990739", "json": [{"cohort": "", "disease_state": "locally advanced, unresectable and/or metastatic solid tumor(s)", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04339400", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Primary Myelofibrosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Polycythemia Vera", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Essential Thrombocythemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Post-Polycythemia Vera Myelofibrosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Post-Essential Thrombocythemia Myelofibrosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Primary Myelofibrosis"}, {"cohort": "", "histology_inclusion": "Polycythemia Vera"}, {"cohort": "", "histology_inclusion": "Essential Thrombocythemia"}, {"cohort": "", "histology_inclusion": "Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase"}, {"cohort": "", "histology_inclusion": "Myelofibrosis Transformation in Essential Thrombocythemia"}]}
{"NCT_id": "NCT04469764", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "ovarian epithelial cancer", "biomarker_inclusion": ["CDK4/6 activation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": ["CDK4/6 activation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": ["CDK4/6 activation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["endometrioid histology", "positive hormone receptor expression"], "histology_exclusion": [], "biomarker_exclusion": ["Cyclin E gene (CCNE) amplification", "retinoblastoma susceptibility gene product (RB) loss"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Tumor"}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"]], "biomarker_exclusion": [["CCNE1-High", "CCNE1-High", "expression"], ["RB1-Low", "RB1-Low", "expression"]]}]}
{"NCT_id": "NCT04665206", "json": [{"cohort": "Cohort 1", "disease_state": "advanced", "histology_inclusion": "malignant pleural mesothelioma", "biomarker_inclusion": ["NF2 mutation"], "histology_exclusion": ["brain metastases", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["NF2 mutation"], "histology_exclusion": ["brain metastases", "leptomeningeal metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Pleural Malignant Mesothelioma", "biomarker_inclusion": [["NF2 Mutation", "NF2-Mutation", "gene"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NF2 Mutation", "NF2-Mutation", "gene"]]}]}
{"NCT_id": "NCT05120960", "json": [{"cohort": "Group A", "disease_state": "", "histology_inclusion": "primary cancer or brain metastasis", "biomarker_inclusion": ["MET alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group B", "disease_state": "first, second or third recurrence", "histology_inclusion": "WHO grade IV glioma (glioblastoma or gliosarcoma)", "biomarker_inclusion": ["MET alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group B", "disease_state": "first, second or third recurrence", "histology_inclusion": "IDH wildtype grade III anaplastic astrocytoma (1p19q intact)", "biomarker_inclusion": ["MET alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group C", "disease_state": "", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["EGFR mutation", "T790M status", "MET alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b, Group A", "disease_state": "", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["METexon14-skipping mutations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Group A", "histology_inclusion": "Metastatic Malignant Neoplasm to the Brain", "biomarker_inclusion": [["MET Mutation", "MET-Mutation", "gene"], ["SLTM Mutation", "SLTM-Mutation", "gene"]]}, {"cohort": "Group B", "histology_inclusion": "Gliosarcoma", "biomarker_inclusion": [["SLTM Mutation", "SLTM-Mutation", "gene"], ["MET Mutation", "MET-Mutation", "gene"]]}, {"cohort": "Group B", "histology_inclusion": "Glioma", "biomarker_inclusion": [["SLTM Mutation", "SLTM-Mutation", "gene"], ["MET Mutation", "MET-Mutation", "gene"]]}, {"cohort": "Group B", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["MET Mutation", "MET-Mutation", "gene"], ["SLTM Mutation", "SLTM-Mutation", "gene"]]}, {"cohort": "Group B", "histology_inclusion": "Anaplastic Astrocytoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["SLTM Mutation", "SLTM-Mutation", "gene"], ["MET Mutation", "MET-Mutation", "gene"]]}, {"cohort": "Group B", "histology_inclusion": "Anaplastic Astrocytoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["MET Mutation", "MET-Mutation", "gene"], ["SLTM Mutation", "SLTM-Mutation", "gene"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Group C", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MET Mutation", "MET-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["SLTM Mutation", "SLTM-Mutation", "gene"]]}, {"cohort": "Phase 1b, Group A", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT05316129", "json": [{"cohort": "", "disease_state": "recurrent or persistent", "histology_inclusion": "high-grade (grade 2-3) epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube carcinoma", "biomarker_inclusion": ["FSHR antigen"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma"}]}
{"NCT_id": "NCT05316155", "json": [{"cohort": "", "disease_state": "non-muscle-invasive or muscle-invasive", "histology_inclusion": "urothelial carcinoma of the Bladder", "biomarker_inclusion": ["activating tumor pan-fibroblast growth factor receptor (FGFR) mutation", "fusion"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with an pan-fibroblast growth factor receptor (FGFR) inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Bladder Urothelial Carcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"]]}]}
{"NCT_id": "NCT03520075", "json": [{"cohort": "", "disease_state": "advanced solid tumors that are metastatic or unresectable, refractory or relapsed", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1 Part B and Phase 2", "disease_state": "advanced solid tumors that are metastatic or unresectable, refractory or relapsed", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["gene alterations in the MAPK pathway"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "advanced solid tumors that are metastatic or unresectable, refractory or relapsed", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["measurable disease according to RECIST v1.1"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["extracellular signal-regulated kinase (ERK) inhibitors"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase 1 Part B and Phase 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MAPK/ERK pathway", null, "pathway"]]}, {"cohort": "Phase 2", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": ""}]}
{"NCT_id": "NCT04301557", "json": [{"cohort": "PD1 Antibody and Chemoradiotherapy for dMMR/MSI-H LACRC", "disease_state": "locally advanced", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["dMMR", "MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "PD1 Antibody and Chemoradiotherapy for dMMR/MSI-H LACRC", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT05056116", "json": [{"cohort": "Biliary Tract Cancer", "disease_state": "Advanced (unresectable) or metastatic", "histology_inclusion": "adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS disease", "brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Biliary Tract Cancer", "histology_inclusion": "Adenocarcinoma"}]}
{"NCT_id": "NCT05121038", "json": [{"cohort": "Cohort 1 Pancreatic Cancer", "disease_state": "Resectable or Borderline Resectable", "histology_inclusion": "Pancreatic ductal adenocarcinomas", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2 Peritoneal Mets", "disease_state": "Peritoneal Metastases", "histology_inclusion": "Colorectal adenocarcinomas", "biomarker_inclusion": ["RAS positive", "BRAF positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2 Peritoneal Mets", "disease_state": "Peritoneal Metastases", "histology_inclusion": "Appendiceal adenocarcinomas", "biomarker_inclusion": ["RAS positive", "BRAF positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3 Oligomets Colon Cancer", "disease_state": "Oligometastatic", "histology_inclusion": "Colorectal adenocarcinomas", "biomarker_inclusion": ["RAS positive", "BRAF positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1 Pancreatic Cancer"}, {"cohort": "Cohort 2 Peritoneal Mets", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["BRAF-High", "BRAF-High", "expression"], ["HRAS Mutation", "HRAS-Mutation", "gene"]]}, {"cohort": "Cohort 2 Peritoneal Mets", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["BRAF-High", "BRAF-High", "expression"], ["HRAS Mutation", "HRAS-Mutation", "gene"]]}, {"cohort": "Cohort 3 Oligomets Colon Cancer", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["BRAF-High", "BRAF-High", "expression"], ["HRAS Mutation", "HRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04106362", "json": [{"cohort": "", "disease_state": "Stage III-IV", "histology_inclusion": "HPV-positive Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": ["KRAS-Variant", "p16-positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}]}
{"NCT_id": "NCT04470024", "json": [{"cohort": "Arm 1", "disease_state": "recurrent or metastatic", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm 2", "disease_state": "recurrent or metastatic", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm 1", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Arm 2", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT04730544", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["dMMR", "MSI"], "histology_exclusion": ["brain metastases", "leptomeningeal metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04795661", "json": [{"cohort": "Cohort Colorectal cancer (CRC)", "disease_state": "localized non-metastatic", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["MSI/dMMR"], "histology_exclusion": [], "biomarker_exclusion": ["MSS/pMMR"]}, {"cohort": "Cohort Oesogastric cancer", "disease_state": "localized non-metastatic", "histology_inclusion": "Oesogastric (gastric, gastro-oesophageal or oesophageal) cancer", "biomarker_inclusion": ["MSI/dMMR"], "histology_exclusion": [], "biomarker_exclusion": ["MSS/pMMR"]}, {"cohort": "Cohort Endometrial cancer", "disease_state": "localized non-metastatic", "histology_inclusion": "Endometrial carcinoma", "biomarker_inclusion": ["MSI/dMMR"], "histology_exclusion": [], "biomarker_exclusion": ["MSS/pMMR"]}, {"cohort": "Cohort Other cancer", "disease_state": "localized non-metastatic", "histology_inclusion": "biliary tract or pancreas adenocarcinoma, small bowel adenocarcinoma (duodenum, jejunum, ileum), peritoneum adenocarcinoma", "biomarker_inclusion": ["MSI/dMMR"], "histology_exclusion": [], "biomarker_exclusion": ["MSS/pMMR"]}], "json_norm": [{"cohort": "Cohort Colorectal cancer (CRC)", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "biomarker_exclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Cohort Oesogastric cancer", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "biomarker_exclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Cohort Endometrial cancer", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "biomarker_exclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Cohort Other cancer", "histology_inclusion": "Small Intestinal Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "biomarker_exclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Cohort Other cancer", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "biomarker_exclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Cohort Other cancer", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "biomarker_exclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT02933736", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "World Health Organization (WHO) Grade III or IV glioma", "biomarker_inclusion": ["RB positivity", "Chromosome 9p21.3 deletion", "CDKN2A/B/C loss", "CDK4/6 amplification", "CCND1/2 amplification"], "histology_exclusion": [], "biomarker_exclusion": ["Rb-negative status"]}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "World Health Organization (WHO) Grade II or III meningioma", "biomarker_inclusion": ["RB positivity"], "histology_exclusion": [], "biomarker_exclusion": ["Rb-negative status"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioma", "biomarker_exclusion": [["RB1-Low", "RB1-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Meningioma", "biomarker_exclusion": [["RB1-Low", "RB1-Low", "expression"]]}]}
{"NCT_id": "NCT05641831", "json": [{"cohort": "", "disease_state": "high-risk CCUS", "histology_inclusion": "", "biomarker_inclusion": ["somatic spliceosome mutation (SRSF2, SF3B1, U2AF1, or ZRSR2)", "TP53 mutation > 5% VAF", "TET2 mutation", "DMNT3A mutation", "ASXL1 mutation", "pathogenic germline mutation predisposing to myeloid malignancy"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["ASXL1 Mutation", "ASXL1-Mutation", "gene"], ["SF3B2 Mutation", "SF3B2-Mutation", "gene"], ["TET2 Mutation", "TET2-Mutation", "gene"], ["U2AF1 Mutation", "U2AF1-Mutation", "gene"], ["ZRSR2 Mutation", "ZRSR2-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["SRSF2 Mutation", "SRSF2-Mutation", "gene"], ["SF3B1 Mutation", "SF3B1-Mutation", "gene"]]}]}
{"NCT_id": "NCT03976375", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer (NSCLC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR-activating mutations", "ALK gene rearrangements", "ROS1 gene rearrangements", "K-ras mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04171700", "json": [{"cohort": "Cohort A", "disease_state": "unresectable, locally advanced or metastatic solid tumor and relapsed/progressive disease", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation", "PALB2 mutation", "RAD51C mutation", "RAD51D mutation"], "histology_exclusion": ["primary CNS tumor"], "biomarker_exclusion": ["HER2 negative breast cancer with germline BRCA1 or BRCA2 mutations", "epithelial ovarian cancer with BRCA1 or BRCA2 mutations", "fallopian tube cancer with BRCA1 or BRCA2 mutations", "primary peritoneal cancer with BRCA1 or BRCA2 mutations", "metastatic castration-resistant prostate cancer with BRCA1 or BRCA2 mutations"]}, {"cohort": "Cohort B", "disease_state": "unresectable, locally advanced or metastatic solid tumor and relapsed/progressive disease", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["BARD1 mutation", "BRIP1 mutation", "FANCA mutation", "NBN mutation", "RAD51 mutation", "RAD51B mutation"], "histology_exclusion": ["primary CNS tumor"], "biomarker_exclusion": ["HER2 negative breast cancer with germline BRCA1 or BRCA2 mutations", "epithelial ovarian cancer with BRCA1 or BRCA2 mutations", "fallopian tube cancer with BRCA1 or BRCA2 mutations", "primary peritoneal cancer with BRCA1 or BRCA2 mutations", "metastatic castration-resistant prostate cancer with BRCA1 or BRCA2 mutations"]}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["PALB2 Mutation", "PALB2-Mutation", "gene"], ["RAD51C Mutation", "RAD51C-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["RAD51D Mutation", "RAD51D-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"], "biomarker_exclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "Cohort B", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ARTN Mutation", "ARTN-Mutation", "gene"], ["RAD51B Mutation", "RAD51B-Mutation", "gene"], ["NBN Mutation", "NBN-Mutation", "gene"], ["BARD1 Mutation", "BARD1-Mutation", "gene"], ["FANCA Mutation", "FANCA-Mutation", "gene"], ["RAD51 Mutation", "RAD51-Mutation", "gene"], ["BRIP1 Mutation", "BRIP1-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"], "biomarker_exclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04926181", "json": [{"cohort": "", "disease_state": "metastatic castration-resistant", "histology_inclusion": "prostate adenocarcinoma with neuroendocrine features", "biomarker_inclusion": [], "histology_exclusion": ["de novo small cell carcinoma of the prostate"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic castration-resistant", "histology_inclusion": "small cell neuroendocrine prostate cancer", "biomarker_inclusion": ["loss-of-function mutation or deletion of Retinoblastoma (RB1) gene"], "histology_exclusion": ["de novo small cell carcinoma of the prostate"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "histology_exclusion": ["Prostate Small Cell Neuroendocrine Carcinoma"]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["RB1 Mutation", "RB1-Mutation", "gene"]], "histology_exclusion": ["Prostate Small Cell Neuroendocrine Carcinoma"]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["RB1 Mutation", "RB1-Mutation", "gene"]], "histology_exclusion": ["Prostate Small Cell Neuroendocrine Carcinoma"]}]}
{"NCT_id": "NCT05316701", "json": [{"cohort": "", "disease_state": "Acute myeloid, lymphoid or mixed phenotype leukemia in complete remission (CR) or CR with incomplete hematologic recovery (CRi)", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Acute myeloid, lymphoid or mixed phenotype leukemia in complete remission (CR) or CR with incomplete hematologic recovery (CRi)", "histology_inclusion": "Acute Lymphoid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Acute myeloid, lymphoid or mixed phenotype leukemia in complete remission (CR) or CR with incomplete hematologic recovery (CRi)", "histology_inclusion": "Mixed Phenotype Acute Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Myelodysplastic syndromes (MDS) that are indicated for alloHSCT per 2017 International Expert Panel recommendations and/or have therapy-related/secondary MDS, with \u2264 10% blast burden in the bone marrow", "histology_inclusion": "High-risk Myelodysplastic Syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Myelodysplastic syndromes (MDS) that are indicated for alloHSCT per 2017 International Expert Panel recommendations and/or have therapy-related/secondary MDS, with \u2264 10% blast burden in the bone marrow", "histology_inclusion": "Therapy-Related Myelodysplastic Syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Myelodysplastic syndromes (MDS) that are indicated for alloHSCT per 2017 International Expert Panel recommendations and/or have therapy-related/secondary MDS, with \u2264 10% blast burden in the bone marrow", "histology_inclusion": "MDS", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Mixed Phenotype Acute Leukemia"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Therapy-Related Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}]}
{"NCT_id": "NCT05576896", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT03585686", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Langerhans Cell Histiocytosis", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Langerhans Cell Histiocytosis", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT03650894", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced unresectable", "histology_inclusion": "HER2-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with an anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CD137, or anti-CTLA-4 antibody in the metastatic setting", "prior treatment with bicalutamide, enzalutamide, or any other androgen receptor blocker"]}, {"cohort": "", "disease_state": "metastatic or locally advanced unresectable", "histology_inclusion": "Triple Negative Breast Cancer", "biomarker_inclusion": ["androgen-receptor (AR) positivity"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with an anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CD137, or anti-CTLA-4 antibody in the metastatic setting", "prior treatment with bicalutamide, enzalutamide, or any other androgen receptor blocker"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}]}
{"NCT_id": "NCT04302025", "json": [{"cohort": "ALK Cohort", "disease_state": "Stage IB, IIA, IIB, IIIA, or selected IIIB", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["ALK fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "ROS 1 Cohort", "disease_state": "Stage IB, IIA, IIB, IIIA, or selected IIIB", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["ROS1 fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "NTRK Cohort", "disease_state": "Stage IB, IIA, IIB, IIIA, or selected IIIB", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["NTRK1 fusion", "NTRK2 fusion", "NTRK3 fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "BRAF Cohort", "disease_state": "Stage IB, IIA, IIB, IIIA, or selected IIIB", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "RET Cohort", "disease_state": "Stage IB, IIA, IIB, IIIA, or selected IIIB", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["RET fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "PD-L1 Cohort", "disease_state": "Stage IB, IIA, IIB, IIIA, or selected IIIB", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["PD-L1 expression in \u2265 1% tumor cells"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "ALK Cohort", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "ROS 1 Cohort", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"]]}, {"cohort": "NTRK Cohort", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}, {"cohort": "BRAF Cohort", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "RET Cohort", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"]]}, {"cohort": "PD-L1 Cohort", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04340141", "json": [{"cohort": "", "disease_state": "Resectable", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Resectable", "histology_inclusion": "Pancreatic Adenosquamous Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Adenosquamous Carcinoma"}]}
{"NCT_id": "NCT04991480", "json": [{"cohort": "Part A1", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": [], "histology_exclusion": ["Brain Metastases"], "biomarker_exclusion": []}, {"cohort": "Part A2", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": [], "histology_exclusion": ["Brain Metastases"], "biomarker_exclusion": []}, {"cohort": "Part B1", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": ["PARP inhibitor"], "histology_exclusion": ["Brain Metastases"], "biomarker_exclusion": []}, {"cohort": "Part B2", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": ["Pol Theta Inhibition"], "histology_exclusion": ["Brain Metastases"], "biomarker_exclusion": ["PARP inhibitor"]}, {"cohort": "Part B3", "disease_state": "Locally Advanced or Metastatic", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["HER2-negative", "BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": ["Brain Metastases"], "biomarker_exclusion": []}, {"cohort": "Part A3", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": ["PARP inhibitor"], "histology_exclusion": ["Brain Metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A1", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part A2", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part B1", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part B2", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part B3", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "Part A3", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT03911557", "json": [{"cohort": "Patients with moderate to high tumor mutational burden", "disease_state": "relapsed/refractory", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["TMB high (>20 mutations/MB)", "moderate TMB (10-20 mutations/MB)"], "histology_exclusion": [], "biomarker_exclusion": ["MSS tumor"]}], "json_norm": [{"cohort": "Patients with moderate to high tumor mutational burden", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"], ["MB Mutation", "MB-Mutation", "gene"]], "biomarker_exclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT04796194", "json": [{"cohort": "", "disease_state": "Stage III B, C, D or Stage IVm1a, m1b (without liver mets), unresectable metastatic melanoma", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": ["primary ocular melanoma", "mucosal melanoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "histology_exclusion": ["Mucosal Melanoma", "Ocular Melanoma"]}]}
{"NCT_id": "NCT05512208", "json": [{"cohort": "VS-6766 + Defactinib", "disease_state": "recurrent", "histology_inclusion": "endometrioid cancer", "biomarker_inclusion": ["RAS mutation", "BRAF (type I, II, and/or III) mutation", "NF-1 loss of function", "RAS activation"], "histology_exclusion": ["low grade serous ovarian cancer"], "biomarker_exclusion": ["prior MEKi or RAFi exposure"]}, {"cohort": "VS-6766 + Defactinib", "disease_state": "recurrent", "histology_inclusion": "mucinous ovarian cancer", "biomarker_inclusion": ["RAS mutation", "BRAF (type I, II, and/or III) mutation", "NF-1 loss of function", "RAS activation"], "histology_exclusion": ["low grade serous ovarian cancer"], "biomarker_exclusion": ["prior MEKi or RAFi exposure"]}, {"cohort": "VS-6766 + Defactinib", "disease_state": "recurrent", "histology_inclusion": "high grade serous ovarian cancer", "biomarker_inclusion": ["RAS mutation", "BRAF (type I, II, and/or III) mutation", "NF-1 loss of function", "RAS activation"], "histology_exclusion": ["low grade serous ovarian cancer"], "biomarker_exclusion": ["prior MEKi or RAFi exposure"]}, {"cohort": "VS-6766 + Defactinib", "disease_state": "recurrent", "histology_inclusion": "cervical cancer", "biomarker_inclusion": ["RAS mutation", "BRAF (type I, II, and/or III) mutation", "NF-1 loss of function", "RAS activation"], "histology_exclusion": ["low grade serous ovarian cancer"], "biomarker_exclusion": ["prior MEKi or RAFi exposure"]}], "json_norm": [{"cohort": "VS-6766 + Defactinib", "histology_inclusion": "Endometrioid Adenocarcinoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"], ["GCNT2 Mutation", "GCNT2-Mutation", "gene"], ["NF1-Low", "NF1-Low", "expression"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"]], "histology_exclusion": ["Invasive Ovarian Micropapillary Serous Carcinoma"]}, {"cohort": "VS-6766 + Defactinib", "histology_inclusion": "Ovarian Mucinous Tumor", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"], ["GCNT2 Mutation", "GCNT2-Mutation", "gene"], ["NF1-Low", "NF1-Low", "expression"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"]], "histology_exclusion": ["Invasive Ovarian Micropapillary Serous Carcinoma"]}, {"cohort": "VS-6766 + Defactinib", "histology_inclusion": "Ovarian Serous Adenocarcinoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"], ["GCNT2 Mutation", "GCNT2-Mutation", "gene"], ["NF1-Low", "NF1-Low", "expression"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"]], "histology_exclusion": ["Invasive Ovarian Micropapillary Serous Carcinoma"]}, {"cohort": "VS-6766 + Defactinib", "histology_inclusion": "Cervical Carcinoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"], ["GCNT2 Mutation", "GCNT2-Mutation", "gene"], ["NF1-Low", "NF1-Low", "expression"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"]], "histology_exclusion": ["Invasive Ovarian Micropapillary Serous Carcinoma"]}]}
{"NCT_id": "NCT02074839", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "hematologic malignancy", "biomarker_inclusion": ["IDH1 R132 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Hematopoietic and Lymphoid Cell Neoplasm"}]}
{"NCT_id": "NCT02140242", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "acute myeloid leukemia (AML)", "biomarker_inclusion": [], "histology_exclusion": ["acute promyelocytic leukemia (APL)", "central nervous system manifestation of AML", "relapsed AML", "primary refractory AML"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Acute Myeloid Leukemia (AML)"]}]}
{"NCT_id": "NCT02335944", "json": [{"cohort": "Phase Ib and Phase II Groups 1 to 4", "disease_state": "locally advanced or recurrent (stage IIIB not eligible for combined modality treatment) or metastatic (Stage IV) NSCLC", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutation L858R", "ex19del", "de novo EGFR T790M mutation", "L861Q", "G719X", "S768I"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II Group 5", "disease_state": "stage IIIB/IIIC (not amenable to curative surgery, chemoradiation or radiation) or stage IV NSCLC", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR activating mutation", "T790M negative", "MET gene amplification (GCN \u2265 5)"], "histology_exclusion": ["squamous cell carcinoma", "small cell lung cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase Ib and Phase II Groups 1 to 4", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR T790M", "T790M", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Phase II Group 5", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["MET-High", "MET-High", "expression"]], "histology_exclusion": ["Squamous Cell Carcinoma", "Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT02727803", "json": [{"cohort": "", "disease_state": "induction failure, high-risk for relapse first remission, secondary leukemia from prior chemotherapy and/or arising from myelodysplastic syndromes (MDS), any disease beyond first remission", "histology_inclusion": "Acute Myelogenous Leukemia (AML)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Primary or therapy related, revised International Prognostic Scoring System (IPSS) intermediate and high risk groups, malondialdehyde (MDA) with transfusion dependency, failure to respond or progression of disease on hypomethylating agents, refractory anemia with excess of blasts, transformation to acute leukemia, chronic myelomonocytic leukemia, atypical MDS/myeloproliferative syndromes", "histology_inclusion": "Myelodysplastic Syndrome (MDS)", "biomarker_inclusion": ["complex karyotype", "abn(3g)", "-5/5g-", "-7/7g-", "abn(12p)", "abn(17p)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Induction failure, primary refractory to treatment, beyond first remission including second or greater remission or active disease, high risk", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": ["translocations 9;22", "translocations 4;11", "hypodiploidy", "complex karyotype", "secondary leukemia developing after cytotoxic drug exposure", "minimal residual disease", "acute biphenotypic leukemia", "double hit non-Hodgkin's lymphoma"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "second or third complete remission, or relapse", "histology_inclusion": "Non-Hodgkin's Lymphoma (NHL)", "biomarker_inclusion": ["relapsed double hit lymphomas"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "progressive disease following a minimum of two lines of standard therapy", "histology_inclusion": "Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "second chronic phase or accelerated phase", "histology_inclusion": "Chronic Myeloid Leukemia (CML)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Induction failures, after first complete remission, or relapse, or active disease", "histology_inclusion": "Hodgkin's Disease (HD)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "stage II or III, symptomatic, secretory multiple myeloma requiring treatment", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Non-Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Small Lymphocytic Lymphoma"}, {"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive"}, {"cohort": "", "histology_inclusion": "Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Plasma Cell Myeloma"}]}
{"NCT_id": "NCT04340427", "json": [{"cohort": "", "disease_state": "Advanced/metastatic solid tumors", "histology_inclusion": "", "biomarker_inclusion": ["IDH2 gene mutation"], "histology_exclusion": ["central nervous system metastasis", "central nervous system leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory/recurrent acute myeloid leukemia", "histology_inclusion": "", "biomarker_inclusion": ["IDH2 gene mutation"], "histology_exclusion": ["central nervous system leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]], "histology_exclusion": ["Central Nervous System Leukemia"]}, {"cohort": "", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]], "histology_exclusion": ["Central Nervous System Leukemia"]}]}
{"NCT_id": "NCT02401347", "json": [{"cohort": "Cohort A - Triple-negative Breast Cancer", "disease_state": "metastatic or recurrent", "histology_inclusion": "triple-negative breast cancer", "biomarker_inclusion": ["homologous recombination deficiency (HRD)"], "histology_exclusion": ["hormone receptor positive breast cancer", "HER2 positive breast cancer", "brain or central nervous system (CNS) metastases"], "biomarker_exclusion": ["deleterious mutation in BRCA1 or BRCA2"]}, {"cohort": "Cohort B - HER2-negative solid tumor", "disease_state": "metastatic or recurrent", "histology_inclusion": "HER2-negative breast cancer", "biomarker_inclusion": ["deleterious germline or somatic mutation in homologous recombination (HR) pathway"], "histology_exclusion": ["HER2 positive breast cancer", "brain or central nervous system (CNS) metastases"], "biomarker_exclusion": ["deleterious mutation in BRCA1 or BRCA2"]}, {"cohort": "Cohort B - HER2-negative solid tumor", "disease_state": "metastatic or recurrent", "histology_inclusion": "other solid tumor", "biomarker_inclusion": ["deleterious germline or somatic mutation in homologous recombination (HR) pathway"], "histology_exclusion": ["HER2 positive breast cancer", "brain or central nervous system (CNS) metastases"], "biomarker_exclusion": ["deleterious mutation in BRCA1 or BRCA2"]}], "json_norm": [{"cohort": "Cohort A - Triple-negative Breast Cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["Homologous Recombination Pathway", null, "pathway"]], "histology_exclusion": ["Breast Carcinoma"], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["PGR-High", "PGR-High", "expression"], ["ESR1-High", "ESR1-High", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "Cohort B - HER2-negative solid tumor", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR Mutation", "HR-Mutation", "gene"]], "histology_exclusion": ["Breast Carcinoma"], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "Cohort B - HER2-negative solid tumor", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"], ["HR Mutation", "HR-Mutation", "gene"]], "histology_exclusion": ["Breast Carcinoma"], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT03390504", "json": [{"cohort": "Cohort 1", "disease_state": "Metastatic or surgically unresectable urothelial cancer", "histology_inclusion": "Transitional cell carcinoma of the urothelium", "biomarker_inclusion": ["Selected FGFR gene aberrations"], "histology_exclusion": ["Symptomatic central nervous system metastases"], "biomarker_exclusion": ["Prior FGFR inhibitor treatment"]}, {"cohort": "Cohort 2", "disease_state": "Metastatic or surgically unresectable urothelial cancer", "histology_inclusion": "Transitional cell carcinoma of the urothelium", "biomarker_inclusion": ["Selected FGFR gene aberrations"], "histology_exclusion": ["Symptomatic central nervous system metastases"], "biomarker_exclusion": ["Prior FGFR inhibitor treatment"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Transitional Cell Carcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Transitional Cell Carcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}]}
{"NCT_id": "NCT03520946", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["RAS", "BRAF V600E"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["RAS"], "histology_exclusion": [], "biomarker_exclusion": ["BRAF V600E"]}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["BRAF V600E"], "histology_exclusion": [], "biomarker_exclusion": ["RAS"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT04042116", "json": [{"cohort": "Phase 2: Expansion Cohort - Endometrial Cancer", "disease_state": "Recurrent", "histology_inclusion": "Endometrial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2: Expansion Cohort - Ovarian Cancer", "disease_state": "Recurrent", "histology_inclusion": "High grade epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["Clear cell carcinoma"], "biomarker_exclusion": []}, {"cohort": "Phase 2: Expansion Cohort - Ovarian Cancer", "disease_state": "Recurrent", "histology_inclusion": "Fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": ["Clear cell carcinoma"], "biomarker_exclusion": []}, {"cohort": "Phase 2: Expansion Cohort - Ovarian Cancer", "disease_state": "Recurrent", "histology_inclusion": "Primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": ["Clear cell carcinoma"], "biomarker_exclusion": []}, {"cohort": "Phase 2: Expansion Cohort - Clear Cell Cancer", "disease_state": "Recurrent, metastatic", "histology_inclusion": "Clear cell carcinoma of ovarian origin", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2: Expansion Cohort - Clear Cell Cancer", "disease_state": "Recurrent, metastatic", "histology_inclusion": "Clear cell carcinoma of fallopian tube origin", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2: Expansion Cohort - Clear Cell Cancer", "disease_state": "Recurrent, metastatic", "histology_inclusion": "Clear cell carcinoma of primary peritoneal origin", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2: Expansion Cohort - Clear Cell Cancer", "disease_state": "Recurrent, metastatic", "histology_inclusion": "Clear cell carcinoma of endometrial origin", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2: Expansion Cohort - Cervical Cancer", "disease_state": "Persistent or recurrent", "histology_inclusion": "Squamous carcinoma of cervix", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2: Expansion Cohort - Cervical Cancer", "disease_state": "Persistent or recurrent", "histology_inclusion": "Adenocarcinoma of cervix", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2: Expansion Cohort - Cervical Cancer", "disease_state": "Persistent or recurrent", "histology_inclusion": "Adenosquamous carcinoma of cervix", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 2: Expansion Cohort - Endometrial Cancer", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "Phase 2: Expansion Cohort - Ovarian Cancer", "histology_inclusion": "Ovarian Epithelial Cancer", "histology_exclusion": ["Endometrial Clear Cell Adenocarcinoma"]}, {"cohort": "Phase 2: Expansion Cohort - Ovarian Cancer", "histology_inclusion": "Fallopian Tube Carcinoma", "histology_exclusion": ["Endometrial Clear Cell Adenocarcinoma"]}, {"cohort": "Phase 2: Expansion Cohort - Ovarian Cancer", "histology_inclusion": "Primary Peritoneal Carcinoma", "histology_exclusion": ["Endometrial Clear Cell Adenocarcinoma"]}, {"cohort": "Phase 2: Expansion Cohort - Clear Cell Cancer", "histology_inclusion": "Ovarian Clear Cell Tumor"}, {"cohort": "Phase 2: Expansion Cohort - Clear Cell Cancer", "histology_inclusion": "Fallopian Tube Clear Cell Adenocarcinoma"}, {"cohort": "Phase 2: Expansion Cohort - Clear Cell Cancer", "histology_inclusion": "Endometrial Clear Cell Adenocarcinoma"}, {"cohort": "Phase 2: Expansion Cohort - Clear Cell Cancer", "histology_inclusion": "Endometrial Clear Cell Adenocarcinoma"}, {"cohort": "Phase 2: Expansion Cohort - Cervical Cancer", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "Phase 2: Expansion Cohort - Cervical Cancer", "histology_inclusion": "Endocervical Carcinoma"}, {"cohort": "Phase 2: Expansion Cohort - Cervical Cancer", "histology_inclusion": "Cervical Adenocarcinoma"}, {"cohort": "Phase 2: Expansion Cohort - Cervical Cancer", "histology_inclusion": "Cervical Adenosquamous Carcinoma"}]}
{"NCT_id": "NCT04405674", "json": [{"cohort": "", "disease_state": "locally advanced (Stage IIIB/C) not amenable to curative surgery or radiotherapy, or metastatic (Stage IV)", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": ["EGFR sensitizing mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR T790M mutation after 1st or 2nd generation EGFR TKI"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"]]}]}
{"NCT_id": "NCT05121948", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "Squamous Cell Carcinoma of Head and Neck (SCCHN)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Colorectal Cancer (CRC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Non-Small Cell Lung Cancer (NSCLC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Transitional Cell Carcinoma of the Bladder (TCC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Other Solid Tumors", "biomarker_inclusion": [], "histology_exclusion": ["rapidly progressing neoplasms", "pancreatic cancer", "glioblastoma", "hepatocellular carcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Urothelial Carcinoma"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Hepatocellular Carcinoma", "Glioblastoma", "Pancreatic Carcinoma"]}]}
{"NCT_id": "NCT05512377", "json": [{"cohort": "Cohort 1", "disease_state": "Locally advanced or metastatic", "histology_inclusion": "Biliary tract adenocarcinoma", "biomarker_inclusion": ["MDM2 amplification", "TP53 wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["BI 907828 treatment", "MDM2-p53 antagonist", "MDMX-p53 antagonist"]}, {"cohort": "Cohort 2", "disease_state": "Locally advanced or metastatic", "histology_inclusion": "Pancreatic ductal adenocarcinoma", "biomarker_inclusion": ["MDM2 amplification", "TP53 wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["BI 907828 treatment", "MDM2-p53 antagonist", "MDMX-p53 antagonist"]}, {"cohort": "Cohort 3", "disease_state": "Locally advanced or metastatic", "histology_inclusion": "Lung adenocarcinoma", "biomarker_inclusion": ["MDM2 amplification", "TP53 wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["BI 907828 treatment", "MDM2-p53 antagonist", "MDMX-p53 antagonist"]}, {"cohort": "Cohort 4", "disease_state": "Locally advanced or metastatic", "histology_inclusion": "Urothelial bladder cancer", "biomarker_inclusion": ["MDM2 amplification", "TP53 wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["BI 907828 treatment", "MDM2-p53 antagonist", "MDMX-p53 antagonist"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]], "biomarker_exclusion": [["MDM4 - TP53", "MDM4 - TP53", "coordinate"], ["MDM2 - TP53", "MDM2 - TP53", "coordinate"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]], "biomarker_exclusion": [["MDM4 - TP53", "MDM4 - TP53", "coordinate"], ["MDM2 - TP53", "MDM2 - TP53", "coordinate"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]], "biomarker_exclusion": [["MDM4 - TP53", "MDM4 - TP53", "coordinate"], ["MDM2 - TP53", "MDM2 - TP53", "coordinate"]]}, {"cohort": "Cohort 4", "histology_inclusion": "Bladder Carcinoma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]], "biomarker_exclusion": [["MDM2 - TP53", "MDM2 - TP53", "coordinate"], ["MDM4 - TP53", "MDM4 - TP53", "coordinate"]]}, {"cohort": "Cohort 4", "histology_inclusion": "Bladder Neoplasm", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]], "biomarker_exclusion": [["MDM4 - TP53", "MDM4 - TP53", "coordinate"], ["MDM2 - TP53", "MDM2 - TP53", "coordinate"]]}]}
{"NCT_id": "NCT05577416", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Low Grade Glioma", "biomarker_inclusion": ["IDH1 mutated"], "histology_exclusion": ["cerebellum tumor", "brainstem tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Low Grade Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}]}
{"NCT_id": "NCT02205762", "json": [{"cohort": "Stratum I", "disease_state": "", "histology_inclusion": "Langerhans Cell Histiocytosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum II", "disease_state": "", "histology_inclusion": "Langerhans Cell Histiocytosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum III", "disease_state": "", "histology_inclusion": "Langerhans Cell Histiocytosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum IV", "disease_state": "", "histology_inclusion": "Langerhans Cell Histiocytosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum V", "disease_state": "", "histology_inclusion": "Langerhans Cell Histiocytosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum VI", "disease_state": "", "histology_inclusion": "Langerhans Cell Histiocytosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Stratum I", "histology_inclusion": "Langerhans Cell Histiocytosis"}, {"cohort": "Stratum II", "histology_inclusion": "Langerhans Cell Histiocytosis"}, {"cohort": "Stratum III", "histology_inclusion": "Langerhans Cell Histiocytosis"}, {"cohort": "Stratum IV", "histology_inclusion": "Langerhans Cell Histiocytosis"}, {"cohort": "Stratum V", "histology_inclusion": "Langerhans Cell Histiocytosis"}, {"cohort": "Stratum VI", "histology_inclusion": "Langerhans Cell Histiocytosis"}]}
{"NCT_id": "NCT04926831", "json": [{"cohort": "Cohort A", "disease_state": "stage IB-IIIA, N2 and selected IIIB (T3N2 or T4N2)", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["MET exon 14 skipping mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "stage IB-IIIA, N2 and selected IIIB (T3N2 or T4N2)", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["high level MET amplification"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]]}, {"cohort": "Cohort B", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}]}
{"NCT_id": "NCT04992013", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["BRCA1", "BRCA2", "PARP metabolism", "DNA repair pathways", "HRD", "ATM", "BAP1", "BARD1", "BRIP1", "MRE11A", "NBN", "PALB2", "RAD50", "RAD51B", "RAD51C", "RAD51D", "RAD54B", "RAD54L", "ATR", "XRCC2", "XRCC3"], "histology_exclusion": ["central nervous system cancer"], "biomarker_exclusion": ["prior treatment with PARP inhibitor"]}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system cancer"], "biomarker_exclusion": ["prior treatment with PARP inhibitor"]}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system cancer"], "biomarker_exclusion": ["prior treatment with PARP inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT03521154", "json": [{"cohort": "", "disease_state": "Stage III", "histology_inclusion": "Non-small Cell Lung Cancer (NSCLC) of predominantly non-squamous Pathology", "biomarker_inclusion": ["EGFR Ex19del", "EGFR L858R"], "histology_exclusion": ["Mixed small cell and non-small cell lung cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]], "histology_exclusion": ["Non-Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT05252390", "json": [{"cohort": "Phase 1 (Monotherapy Study; Advanced Solid Tumors)", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["active or symptomatic central nervous system (CNS) disease"], "biomarker_exclusion": []}, {"cohort": "Phase 1b (Combination Study with Enzalutamide or Olaparib)", "disease_state": "relapsed", "histology_inclusion": "high grade serous ovarian, fallopian, or primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": ["active or symptomatic central nervous system (CNS) disease"], "biomarker_exclusion": ["BRCA mutation", "homologous recombination deficiency", "PARP inhibitor"]}, {"cohort": "Phase 1b (Combination Study with Enzalutamide or Olaparib)", "disease_state": "advanced", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": ["active or symptomatic central nervous system (CNS) disease"], "biomarker_exclusion": ["BRCA mutation", "PARP inhibitor"]}, {"cohort": "Phase 1b (Combination Study with Enzalutamide or Olaparib)", "disease_state": "mCRPC", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": ["active or symptomatic central nervous system (CNS) disease"], "biomarker_exclusion": ["HRR gene mutation", "PARP inhibitor"]}, {"cohort": "Phase 1b (Combination Study with Enzalutamide or Olaparib)", "disease_state": "advanced", "histology_inclusion": "triple-negative breast cancer (TNBC)", "biomarker_inclusion": [], "histology_exclusion": ["active or symptomatic central nervous system (CNS) disease"], "biomarker_exclusion": ["BRCA mutation", "PARP inhibitor"]}, {"cohort": "Phase 2 (Monotherapy Study) and Phase 2b (Combination Study with Enzalutamide or Olaparib)", "disease_state": "relapsed", "histology_inclusion": "high grade serous ovarian, fallopian, or primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": ["active or symptomatic central nervous system (CNS) disease"], "biomarker_exclusion": ["BRCA mutation", "homologous recombination deficiency", "PARP inhibitor"]}, {"cohort": "Phase 2 (Monotherapy Study) and Phase 2b (Combination Study with Enzalutamide or Olaparib)", "disease_state": "advanced", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": ["active or symptomatic central nervous system (CNS) disease"], "biomarker_exclusion": ["BRCA mutation", "PARP inhibitor"]}, {"cohort": "Phase 2 Monotherapy Only", "disease_state": "mCRPC", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": ["active or symptomatic central nervous system (CNS) disease"], "biomarker_exclusion": ["androgen receptor (AR)-directed therapy", "taxane chemotherapy"]}, {"cohort": "Phase 2b Combination Only", "disease_state": "mCRPC", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": ["active or symptomatic central nervous system (CNS) disease"], "biomarker_exclusion": ["deleterious or suspected deleterious germline or somatic HRR gene mutation", "PARP inhibitor"]}, {"cohort": "Phase 2 (Monotherapy Study) and Phase 2b (Combination Study with Enzalutamide or Olaparib)", "disease_state": "advanced", "histology_inclusion": "triple-negative breast cancer (TNBC)", "biomarker_inclusion": [], "histology_exclusion": ["active or symptomatic central nervous system (CNS) disease"], "biomarker_exclusion": ["BRCA mutation", "PARP inhibitor"]}], "json_norm": [{"cohort": "Phase 1 (Monotherapy Study; Advanced Solid Tumors)", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase 1b (Combination Study with Enzalutamide or Olaparib)", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_exclusion": [["Homologous Recombination Pathway", null, "pathway"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "Phase 1b (Combination Study with Enzalutamide or Olaparib)", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_exclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "Phase 1b (Combination Study with Enzalutamide or Olaparib)", "histology_inclusion": "Prostate Neoplasm", "biomarker_exclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Phase 1b (Combination Study with Enzalutamide or Olaparib)", "histology_inclusion": "Prostate Carcinoma", "biomarker_exclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Phase 1b (Combination Study with Enzalutamide or Olaparib)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]], "biomarker_exclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "Phase 2 (Monotherapy Study) and Phase 2b (Combination Study with Enzalutamide or Olaparib)", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_exclusion": [["Homologous Recombination Pathway", null, "pathway"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "Phase 2 (Monotherapy Study) and Phase 2b (Combination Study with Enzalutamide or Olaparib)", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_exclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "Phase 2 Monotherapy Only", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Phase 2 Monotherapy Only", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Phase 2b Combination Only", "histology_inclusion": "Prostate Neoplasm", "biomarker_exclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Phase 2b Combination Only", "histology_inclusion": "Prostate Carcinoma", "biomarker_exclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Phase 2 (Monotherapy Study) and Phase 2b (Combination Study with Enzalutamide or Olaparib)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]], "biomarker_exclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT05252416", "json": [{"cohort": "", "disease_state": "Advanced solid tumors", "histology_inclusion": "Advanced Solid Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "ER+ HER2- BC progressed following treatment with a CDK4/6 inhibitor", "histology_inclusion": "ER+ Breast Cancer", "biomarker_inclusion": ["HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Endometrial and gastric cancer progressed after at least 2 prior therapies (including one prior platinum therapy)", "histology_inclusion": "Endometrial Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Endometrial and gastric cancer progressed after at least 2 prior therapies (including one prior platinum therapy)", "histology_inclusion": "Gastric Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Platinum refractory or platinum resistant ovarian cancer CCNE1 amplified tumors progressed beyond standard of care", "histology_inclusion": "Ovarian Cancer", "biomarker_inclusion": ["CCNE1 Amplification"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["CCNE1-High", "CCNE1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["CCNE1-High", "CCNE1-High", "expression"]]}]}
{"NCT_id": "NCT03065062", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "squamous cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["symptomatic brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": ["symptomatic brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "head & neck cancer (non-oropharynx squamous cell carcinoma or HPV-negative oropharynx squamous cell carcinoma)", "biomarker_inclusion": [], "histology_exclusion": ["symptomatic brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "any tumor with suspected PI3K-pathway dependence", "biomarker_inclusion": ["PIK3CA-mutant hotspot mutation", "PIK3CA copy number gain", "PTEN loss"], "histology_exclusion": ["symptomatic brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Squamous Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma"}, {"cohort": "", "biomarker_inclusion": [["PTEN-Low", "PTEN-Low", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}]}
{"NCT_id": "NCT03260491", "json": [{"cohort": "Dose Escalation", "disease_state": "metastatic or unresectable", "histology_inclusion": "adenocarcinoma NSCLC", "biomarker_inclusion": ["EGFR activating mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR T790M mutation"]}, {"cohort": "Dose Expansion: Cohort 1, EGFR mutant", "disease_state": "metastatic or unresectable", "histology_inclusion": "adenocarcinoma NSCLC", "biomarker_inclusion": ["EGFR activating mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion: Cohort 2, EGFR wild-type", "disease_state": "metastatic or unresectable", "histology_inclusion": "squamous or non-squamous NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR-activating mutations"]}, {"cohort": "Dose Expansion: Cohort 3a, EGFR mutant", "disease_state": "metastatic or unresectable", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["EGFR activating mutation"], "histology_exclusion": ["small-cell", "combined small cell and non-small cell"], "biomarker_exclusion": []}, {"cohort": "Dose Expansion: Cohort 3b, EGFR mutant", "disease_state": "metastatic or unresectable", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["EGFR activating mutation"], "histology_exclusion": ["small-cell", "combined small cell and non-small cell"], "biomarker_exclusion": []}, {"cohort": "Dose Expansion: Cohort 4, EGFR mutant", "disease_state": "metastatic or unresectable", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["EGFR activating mutation"], "histology_exclusion": ["small-cell", "combined small cell and non-small cell"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Escalation", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"]]}, {"cohort": "Dose Expansion: Cohort 1, EGFR mutant", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Dose Expansion: Cohort 2, EGFR wild-type", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Dose Expansion: Cohort 3a, EGFR mutant", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Dose Expansion: Cohort 3b, EGFR mutant", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Dose Expansion: Cohort 4, EGFR mutant", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT03260504", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "RCC with a clear cell component", "biomarker_inclusion": [], "histology_exclusion": ["active central nervous system (CNS) metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}]}
{"NCT_id": "NCT03586453", "json": [{"cohort": "", "disease_state": "stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR L858R", "EGFR exon 19 deletion"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT04172597", "json": [{"cohort": "Cohort 1", "disease_state": "advanced or metastatic", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["HER2 activating mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR T790 mutation"]}, {"cohort": "Cohort 2", "disease_state": "advanced or metastatic", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["HER2 activating mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR T790 mutation"]}, {"cohort": "Cohort 3", "disease_state": "advanced or metastatic", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["HER2 activating mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR T790 mutation"]}, {"cohort": "Cohort 4", "disease_state": "advanced or metastatic", "histology_inclusion": "Glioblastome Multiforme", "biomarker_inclusion": ["EGFR activating mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR T790 mutation", "vascular endothelial growth factor (VEGF) inhibitor therapy"]}, {"cohort": "Cohort 5", "disease_state": "advanced or metastatic", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["EGFR activating mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR T790 mutation"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "Cohort 4", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Cohort 5", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04172675", "json": [{"cohort": "Cohort 1", "disease_state": "high-risk non-muscle-invasive bladder cancer (NMIBC) with disease recurrence after BCG therapy", "histology_inclusion": "urothelial carcinoma of the bladder", "biomarker_inclusion": ["FGFR mutations", "FGFR fusions"], "histology_exclusion": ["small cell component", "pure adenocarcinoma", "pure squamous cell carcinoma", "pure squamous CIS of the bladder"], "biomarker_exclusion": ["prior treatment with an FGFR inhibitor"]}, {"cohort": "Cohort 2", "disease_state": "high-risk, BCG-unresponsive NMIBC with or without concurrent papillary tumor", "histology_inclusion": "urothelial carcinoma of the bladder", "biomarker_inclusion": ["FGFR mutations", "FGFR fusions"], "histology_exclusion": ["small cell component", "pure adenocarcinoma", "pure squamous cell carcinoma", "pure squamous CIS of the bladder"], "biomarker_exclusion": ["prior treatment with an FGFR inhibitor"]}, {"cohort": "Cohort 3", "disease_state": "intermediate-risk NMIBC presenting as papillary disease only", "histology_inclusion": "urothelial carcinoma of the bladder", "biomarker_inclusion": ["FGFR mutations", "FGFR fusions"], "histology_exclusion": ["small cell component", "pure adenocarcinoma", "pure squamous cell carcinoma", "pure squamous CIS of the bladder"], "biomarker_exclusion": ["prior treatment with an FGFR inhibitor"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Bladder Urothelial Carcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR1 Fusion", "FGFR1", "fusion"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR4 Fusion", "FGFR4", "fusion"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"], ["FGFR3 Fusion", "FGFR3", "fusion"]], "histology_exclusion": ["Squamous Cell Carcinoma", "Adenocarcinoma"]}, {"cohort": "Cohort 2", "histology_inclusion": "Bladder Urothelial Carcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR1 Fusion", "FGFR1", "fusion"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR4 Fusion", "FGFR4", "fusion"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"], ["FGFR3 Fusion", "FGFR3", "fusion"]], "histology_exclusion": ["Squamous Cell Carcinoma", "Adenocarcinoma"]}, {"cohort": "Cohort 3", "histology_inclusion": "Bladder Urothelial Carcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR1 Fusion", "FGFR1", "fusion"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR4 Fusion", "FGFR4", "fusion"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"], ["FGFR3 Fusion", "FGFR3", "fusion"]], "histology_exclusion": ["Squamous Cell Carcinoma", "Adenocarcinoma"]}]}
{"NCT_id": "NCT04666649", "json": [{"cohort": "", "disease_state": "Relapsed or Refractory Acute Myeloid Leukemia", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["Complex Karyotype AML", "TP53-mutated AML"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT03586661", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "endometrial adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["carcinosarcoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "high-grade serous ovarian carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "primary peritoneal high-grade serous adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "fallopian tube carcinoma", "biomarker_inclusion": ["deleterious BRCA1 gene mutation", "deleterious BRCA2 gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "dose escalation", "disease_state": "recurrent, platinum resistant", "histology_inclusion": "ovarian carcinoma", "biomarker_inclusion": ["deleterious BRCA1 gene mutation", "deleterious BRCA2 gene mutation"], "histology_exclusion": [], "biomarker_exclusion": ["PARP inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Endometrial Adenocarcinoma", "histology_exclusion": ["Carcinosarcoma"]}, {"cohort": "", "histology_inclusion": "Ovarian Serous Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Primary Peritoneal High Grade Serous Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "dose escalation", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "dose escalation", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04042558", "json": [{"cohort": "", "disease_state": "Stage IIIB/IV", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage IIIB/IV", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["ALK rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage IIIB/IV", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["ROS1 fusion"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"]]}]}
{"NCT_id": "NCT04237805", "json": [{"cohort": "Phase I dose escalation", "disease_state": "advanced", "histology_inclusion": "ALK-positive malignant solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase I study", "disease_state": "locally advanced ALK-positive and/or metastatic stage IIIB/IV", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["ALK-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II Study Part I", "disease_state": "locally-advanced and/or metastatic stage IIIb ~IV", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["ALK-positive", "ROS1-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II Study Part II - Cohort 1", "disease_state": "locally advanced and/or metastatic stage IIIB~IV", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["ROS1-positive"], "histology_exclusion": [], "biomarker_exclusion": ["prior systemic therapy", "prior non-ROS1-inhibitor treatment"]}, {"cohort": "Phase II Study Part II - Cohort 2", "disease_state": "locally advanced and/or metastatic stage IIIb ~IV", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["ROS1-positive"], "histology_exclusion": [], "biomarker_exclusion": ["prior crizotinib as a ROS1 inhibitor", "more than 3 overall previous treatment lines"]}], "json_norm": [{"cohort": "Phase I dose escalation", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"]]}, {"cohort": "Phase I study", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"]]}, {"cohort": "Phase II Study Part I", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"], ["ROS1-High", "ROS1-High", "expression"]]}, {"cohort": "Phase II Study Part II - Cohort 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1-High", "ROS1-High", "expression"]]}, {"cohort": "Phase II Study Part II - Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1-High", "ROS1-High", "expression"]]}]}
{"NCT_id": "NCT04406272", "json": [{"cohort": "", "disease_state": "Recurrent or Progressive", "histology_inclusion": "Glioblastoma or Gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["Tumor primarily localized to the brainstem or spinal cord"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gliosarcoma"}, {"cohort": "", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT04666740", "json": [{"cohort": "Cohort A: Core HRD", "disease_state": "metastatic", "histology_inclusion": "pancreatic ductal adenocarcinoma", "biomarker_inclusion": ["BRCA1", "BRCA2", "PALB2"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B: Non core HRD", "disease_state": "metastatic", "histology_inclusion": "pancreatic ductal adenocarcinoma", "biomarker_inclusion": ["ATM", "BAP1", "BARD1", "BLM", "BRIP1", "CHEK2", "FAM175A", "FANCA", "FANCC", "NBN", "RAD50", "RAD51", "RAD51C", "RTEL1"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort C: Platinum sensitive", "disease_state": "metastatic", "histology_inclusion": "pancreatic ductal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["BRCA1", "BRCA2", "PALB2", "ATM", "BAP1", "BARD1", "BLM", "BRIP1", "CHEK2", "FAM175A", "FANCA", "FANCC", "NBN", "RAD50", "RAD51", "RAD51C", "RTEL1"]}], "json_norm": [{"cohort": "Cohort A: Core HRD", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma"}, {"cohort": "Cohort B: Non core HRD", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma"}, {"cohort": "Cohort C: Platinum sensitive", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma"}]}
{"NCT_id": "NCT04862143", "json": [{"cohort": "single arm", "disease_state": "Advanced Breast Cancer", "histology_inclusion": "ER-positive and/or PR-positive breast cancer", "biomarker_inclusion": ["PIK3CA mutant"], "histology_exclusion": ["HER2-negative ABC"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "single arm", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "biomarker_exclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "single arm", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "biomarker_exclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "single arm", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "biomarker_exclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "single arm", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["PGR-High", "PGR-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"]], "biomarker_exclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT05122546", "json": [{"cohort": "", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Clear Cell Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Papillary Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Sarcomatoid Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Papillary Renal Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Sarcomatoid Renal Cell Carcinoma"}]}
{"NCT_id": "NCT05187624", "json": [{"cohort": "All Participants", "disease_state": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["EGFRvIII-positive"], "histology_exclusion": ["infratentorial tumors", "tumors primarily located in or close to critical structures (e.g., brain stem)"], "biomarker_exclusion": []}, {"cohort": "Part I and Part II", "disease_state": "newly diagnosed", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["EGFRvIII-positive", "unmethylated MGMT promotor status"], "histology_exclusion": ["infratentorial tumors", "tumors primarily located in or close to critical structures (e.g., brain stem)"], "biomarker_exclusion": []}, {"cohort": "Part I", "disease_state": "newly diagnosed", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["EGFRvIII-positive", "methylated MGMT promotor status"], "histology_exclusion": ["infratentorial tumors", "tumors primarily located in or close to critical structures (e.g., brain stem)"], "biomarker_exclusion": []}, {"cohort": "Part III and Part IV A", "disease_state": "first or second recurrence", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["EGFRvIII-positive"], "histology_exclusion": ["infratentorial tumors", "tumors primarily located in or close to critical structures (e.g., brain stem)"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "All Participants", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["EGFR exon 8 indel", "V30_R297delinsG", "exon"], ["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "Part I and Part II", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["EGFR exon 8 indel", "V30_R297delinsG", "exon"], ["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "Part I", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["EGFR exon 8 indel", "V30_R297delinsG", "exon"], ["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "Part III and Part IV A", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["EGFR exon 8 indel", "V30_R297delinsG", "exon"], ["EGFR-High", "EGFR-High", "expression"]]}]}
{"NCT_id": "NCT03065387", "json": [{"cohort": "", "disease_state": "advanced or metastatic solid tumors, refractory", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["EGFR mutation", "EGFR amplification", "HER2 mutation", "HER2 amplification", "HER3 mutation", "HER4 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic solid tumors, refractory", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB3 Mutation", "ERBB3-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"], ["ERBB4 Mutation", "ERBB4-Mutation", "gene"], ["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04471415", "json": [{"cohort": "Part 2", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KEAP1 mutation", "NFE2L2 mutation", "STK11 mutation"], "histology_exclusion": ["primary CNS tumors", "hepatocellular carcinoma"], "biomarker_exclusion": []}, {"cohort": "Part 3 and 4", "disease_state": "advanced", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": ["prior exposure to checkpoint inhibitor"], "histology_exclusion": ["primary CNS tumors", "hepatocellular carcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["STK11 Mutation", "STK11-Mutation", "gene"], ["KEAP1 Mutation", "KEAP1-Mutation", "gene"], ["NFE2L2 Mutation", "NFE2L2-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm", "Hepatocellular Carcinoma"]}, {"cohort": "Part 3 and 4", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm", "Hepatocellular Carcinoma"]}]}
{"NCT_id": "NCT05317858", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR negative", "ALK negative"], "histology_exclusion": ["metastatic melanoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK-Low", "ALK-Low", "expression"], ["EGFR-Low", "EGFR-Low", "expression"]]}]}
{"NCT_id": "NCT05578092", "json": [{"cohort": "MRTX0902 monotherapy", "disease_state": "unresectable or metastatic", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": ["KRAS mutations", "SOS1 mutation", "PTPN11 mutation", "EGFR mutation", "NF1 mutation"], "histology_exclusion": ["brain metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "MRTX0902 and adagrasib combination therapy", "disease_state": "unresectable or metastatic", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": ["brain metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["prior treatment with a KRAS G12C inhibitor"]}], "json_norm": [{"cohort": "MRTX0902 monotherapy", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NF1 Mutation", "NF1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["SOS1 Mutation", "SOS1-Mutation", "gene"], ["PTPN11 Mutation", "PTPN11-Mutation", "gene"]]}, {"cohort": "MRTX0902 and adagrasib combination therapy", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT04042831", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the biliary tract", "biomarker_inclusion": ["ATM gene mutation", "ATR gene mutation", "CHEK2 gene mutation", "BRCA1 gene mutation", "BRCA2 gene mutation", "RAD51 gene mutation", "BRIP1 gene mutation", "PALB2 gene mutation", "PTEN gene deletion", "FANC gene mutation", "NBN gene mutation", "EMSY gene mutation", "MRE11 gene mutation", "ARID1A gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["CHEK2 Mutation", "CHEK2-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["ARTN Mutation", "ARTN-Mutation", "gene"], ["MRE11 Mutation", "MRE11-Mutation", "gene"], ["NBN Mutation", "NBN-Mutation", "gene"], ["SERPINA2 Mutation", "SERPINA2-Mutation", "gene"], ["RAD51 Mutation", "RAD51-Mutation", "gene"], ["ANTXR1 Mutation", "ANTXR1-Mutation", "gene"], ["ATR Mutation", "ATR-Mutation", "gene"], ["BRIP1 Mutation", "BRIP1-Mutation", "gene"], ["ARID1A Mutation", "ARID1A-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["EMSY Mutation", "EMSY-Mutation", "gene"]]}]}
{"NCT_id": "NCT04601857", "json": [{"cohort": "Cohort A", "disease_state": "advanced or metastatic", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": ["FGFR3 mutation", "FGFR1-4 fusion/rearrangement"], "histology_exclusion": [], "biomarker_exclusion": ["prior therapy with anti-PD-1", "prior therapy with anti-PD-L1/L2 agent", "prior therapy with FGFR inhibitor"]}, {"cohort": "Cohort B", "disease_state": "advanced or metastatic", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior therapy with anti-PD-1", "prior therapy with anti-PD-L1/L2 agent", "prior therapy with FGFR inhibitor"]}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["FGFR1 Fusion", "FGFR1", "fusion"], ["FGFR4 Fusion", "FGFR4", "fusion"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"]]}, {"cohort": "Cohort B", "histology_inclusion": "Urothelial Carcinoma"}]}
{"NCT_id": "NCT04732065", "json": [{"cohort": "Arm A", "disease_state": "Diffuse Midline Glioma (DMG) with prior therapy", "histology_inclusion": "DMG H3K27M mutant, WHO grade III and IV H3 wildtype gliomas", "biomarker_inclusion": [], "histology_exclusion": ["WHO grade II diffuse astrocytomas", "low grade gliomas without H3K27M mutation"], "biomarker_exclusion": []}, {"cohort": "Arm B", "disease_state": "Newly diagnosed Diffuse Midline Glioma (DMG)", "histology_inclusion": "DMG H3K27M mutant, WHO grade III and IV H3 wildtype gliomas", "biomarker_inclusion": [], "histology_exclusion": ["WHO grade II diffuse astrocytomas", "low grade gliomas without H3K27M mutation"], "biomarker_exclusion": []}, {"cohort": "Arm C", "disease_state": "Diffuse Midline Gliomas (DMGs) with first progression but previously untreated", "histology_inclusion": "DMG H3K27M mutant, WHO grade III and IV H3 wildtype gliomas", "biomarker_inclusion": [], "histology_exclusion": ["WHO grade II diffuse astrocytomas", "low grade gliomas without H3K27M mutation"], "biomarker_exclusion": []}, {"cohort": "Arm D", "disease_state": "Recurrent primary malignant CNS tumors with progression", "histology_inclusion": "Recurrent primary malignant CNS tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm D", "disease_state": "Recurrent primary malignant CNS tumors with progression", "histology_inclusion": "Recurrent Ependymoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm A", "biomarker_inclusion": [["RLN3 RLN3-wild_type", "RLN3-wild_type", "wild_type"], ["H3C14 H3C14-wild_type", "H3C14-wild_type", "wild_type"], ["H3-3A K28M", "K28M", "coordinate"]], "biomarker_exclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Arm A", "biomarker_inclusion": [["RLN3 RLN3-wild_type", "RLN3-wild_type", "wild_type"], ["H3C14 H3C14-wild_type", "H3C14-wild_type", "wild_type"], ["H3-3A K28M", "K28M", "coordinate"]], "biomarker_exclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Arm A", "biomarker_inclusion": [["RLN3 RLN3-wild_type", "RLN3-wild_type", "wild_type"], ["H3C14 H3C14-wild_type", "H3C14-wild_type", "wild_type"], ["H3-3A K28M", "K28M", "coordinate"]], "biomarker_exclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Arm B", "biomarker_inclusion": [["RLN3 RLN3-wild_type", "RLN3-wild_type", "wild_type"], ["H3C14 H3C14-wild_type", "H3C14-wild_type", "wild_type"], ["H3-3A K28M", "K28M", "coordinate"]], "biomarker_exclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Arm B", "biomarker_inclusion": [["RLN3 RLN3-wild_type", "RLN3-wild_type", "wild_type"], ["H3C14 H3C14-wild_type", "H3C14-wild_type", "wild_type"], ["H3-3A K28M", "K28M", "coordinate"]], "biomarker_exclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Arm B", "biomarker_inclusion": [["RLN3 RLN3-wild_type", "RLN3-wild_type", "wild_type"], ["H3C14 H3C14-wild_type", "H3C14-wild_type", "wild_type"], ["H3-3A K28M", "K28M", "coordinate"]], "biomarker_exclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Arm C", "biomarker_inclusion": [["RLN3 RLN3-wild_type", "RLN3-wild_type", "wild_type"], ["H3C14 H3C14-wild_type", "H3C14-wild_type", "wild_type"], ["H3-3A K28M", "K28M", "coordinate"]], "biomarker_exclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Arm C", "biomarker_inclusion": [["RLN3 RLN3-wild_type", "RLN3-wild_type", "wild_type"], ["H3C14 H3C14-wild_type", "H3C14-wild_type", "wild_type"], ["H3-3A K28M", "K28M", "coordinate"]], "biomarker_exclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Arm C", "biomarker_inclusion": [["RLN3 RLN3-wild_type", "RLN3-wild_type", "wild_type"], ["H3C14 H3C14-wild_type", "H3C14-wild_type", "wild_type"], ["H3-3A K28M", "K28M", "coordinate"]], "biomarker_exclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Arm D", "histology_inclusion": "Malignant Central Nervous System Neoplasm"}, {"cohort": "Arm D", "histology_inclusion": "Ependymoma"}]}
{"NCT_id": "NCT04862455", "json": [{"cohort": "", "disease_state": "Recurrent or Metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Recurrent or Metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["PD-1 refractory"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "PD-1/L1 naive", "disease_state": "Recurrent or Metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["1% \u2264 CPS < 20"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "PD-1/L1 refractory", "disease_state": "Recurrent or Metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["All CPS levels allowed"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "PD-1/L1 naive", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "PD-1/L1 refractory", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT04303403", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "RAS mutant colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04471727", "json": [{"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "Small-cell Lung Cancer", "biomarker_inclusion": ["DLL3 expression"], "histology_exclusion": ["glioma", "primary CNS malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "Neuroendocrine Prostate Cancer", "biomarker_inclusion": ["DLL3 expression"], "histology_exclusion": ["glioma", "primary CNS malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "High-grade neuroendocrine tumor", "biomarker_inclusion": ["DLL3 expression"], "histology_exclusion": ["glioma", "primary CNS malignancy", "Small-cell Lung Cancer", "Neuroendocrine Prostate Cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm", "Glioma"]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "histology_exclusion": ["Glioma", "Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm", "Glioma"]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Carcinoma", "histology_exclusion": ["Glioma", "Primary Brain Neoplasm", "Small Cell Lung Carcinoma", "Prostate Neoplasm", "Prostate Carcinoma"]}, {"cohort": "", "histology_inclusion": "Lung Neuroendocrine Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm", "Prostate Neoplasm", "Prostate Carcinoma", "Glioma", "Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT04992780", "json": [{"cohort": "", "disease_state": "Stage IIIA or IIIB", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT05513365", "json": [{"cohort": "Cohort A", "disease_state": "recurrent and/or metastatic", "histology_inclusion": "salivary duct carcinoma", "biomarker_inclusion": ["AR positive (strong expression in at least 1% of nuclei of neoplastic cells)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "recurrent and/or metastatic", "histology_inclusion": "salivary duct carcinoma", "biomarker_inclusion": ["AR positive (strong expression in at least 1% of nuclei of neoplastic cells)", "ADT-resistant"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Salivary Duct Carcinoma", "biomarker_inclusion": [["AKR1B1-High", "AKR1B1-High", "expression"], ["AR-High", "AR-High", "expression"]]}, {"cohort": "Cohort B", "histology_inclusion": "Salivary Duct Carcinoma", "biomarker_inclusion": [["AKR1B1-High", "AKR1B1-High", "expression"], ["AR-High", "AR-High", "expression"]]}]}
{"NCT_id": "NCT03456843", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT04471844", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Glioblastoma Multiforme", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype"}, {"cohort": "", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT04602117", "json": [{"cohort": "Cohort A (de-escalation)", "disease_state": "advanced", "histology_inclusion": "HER2-positive breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A (de-escalation)", "disease_state": "advanced", "histology_inclusion": "gastroesophageal adenocarcinoma", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A (de-escalation)", "disease_state": "advanced", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A (de-escalation)", "disease_state": "advanced", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A (de-escalation)", "disease_state": "advanced", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A (de-escalation)", "disease_state": "advanced", "histology_inclusion": "urothelial cancer", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A (de-escalation)", "disease_state": "advanced", "histology_inclusion": "HER2-low breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B (expansion)", "disease_state": "advanced", "histology_inclusion": "HER2-positive breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B (expansion)", "disease_state": "advanced", "histology_inclusion": "HER2-low breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A (de-escalation)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort A (de-escalation)", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort A (de-escalation)", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort A (de-escalation)", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort A (de-escalation)", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort A (de-escalation)", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort A (de-escalation)", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort A (de-escalation)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Cohort B (expansion)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort B (expansion)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT04862650", "json": [{"cohort": "", "disease_state": "Recurrent/Metastatic", "histology_inclusion": "Squamous Cell Carcinoma of the Head and Neck", "biomarker_inclusion": [], "histology_exclusion": ["Nasopharyngeal Carcinoma", "Salivary Gland Carcinoma", "Lip Carcinoma", "Sinonasal Carcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Recurrent/Metastatic", "histology_inclusion": "Squamous Cell Carcinoma of Unknown Primary", "biomarker_inclusion": ["p16 Positive"], "histology_exclusion": ["Nasopharyngeal Carcinoma", "Salivary Gland Carcinoma", "Lip Carcinoma", "Sinonasal Carcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Nasal Cavity and Paranasal Sinus Carcinoma", "Nasopharyngeal Carcinoma", "Malignant Salivary Gland Neoplasm", "Salivary Gland Carcinoma"]}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma of Unknown Primary Origin", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]], "histology_exclusion": ["Nasal Cavity and Paranasal Sinus Carcinoma", "Nasopharyngeal Carcinoma", "Malignant Salivary Gland Neoplasm", "Salivary Gland Carcinoma"]}]}
{"NCT_id": "NCT03522142", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "gastric or GEJ adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "HCC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "RCC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "soft-tissue sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "SCCHN", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "TNBC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1", "disease_state": "advanced or metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "advanced or metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "recurrent or metastatic", "histology_inclusion": "SCCHN", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 4", "disease_state": "advanced or metastatic", "histology_inclusion": "soft-tissue sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1C", "disease_state": "relapsed/refractory", "histology_inclusion": "AML", "biomarker_inclusion": ["FLT3-ITD", "IDH1/2"], "histology_exclusion": ["acute promyelocytic leukemia (M3)", "therapy-related AML"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "", "histology_inclusion": "Melanoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Refractory Cytopenia of Childhood"}, {"cohort": "", "histology_inclusion": "Soft Tissue Sarcoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "Cohort 1", "histology_inclusion": "Melanoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 3", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Cohort 4", "histology_inclusion": "Soft Tissue Sarcoma"}, {"cohort": "Part 1C", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Acute Myeloid Leukemia (AML)"]}]}
{"NCT_id": "NCT03913026", "json": [{"cohort": "High-risk Acute Leukemia/Myelodysplasia", "disease_state": "Acute Myeloid Leukemia", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "High-risk Acute Leukemia/Myelodysplasia", "disease_state": "Acute Lymphoid Leukemia", "histology_inclusion": "Acute Lymphoid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "High-risk Acute Leukemia/Myelodysplasia", "disease_state": "Myelodysplastic Syndrome", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": ["TP53 mutation", "RAS mutation", "JAK2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "High-risk Acute Leukemia/Myelodysplasia", "disease_state": "Chronic Myelomonocytic Leukemia", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "High-risk Acute Leukemia/Myelodysplasia", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "High-risk Acute Leukemia/Myelodysplasia", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "High-risk Acute Leukemia/Myelodysplasia", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["JAK2 Mutation", "JAK2-Mutation", "gene"]]}, {"cohort": "High-risk Acute Leukemia/Myelodysplasia", "histology_inclusion": "Chronic Myelomonocytic Leukemia"}]}
{"NCT_id": "NCT04471974", "json": [{"cohort": "Safety Cohort", "disease_state": "metastatic castration-resistant", "histology_inclusion": "prostate adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["de novo small cell prostate cancer"], "biomarker_exclusion": []}, {"cohort": "Cohort A: Transdifferentiated mCRPC", "disease_state": "metastatic castration-resistant", "histology_inclusion": "small cell neuroendocrine prostate cancer", "biomarker_inclusion": ["loss-of-function mutation or deletion of RB1"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B: mCRPC without evidence of transdifferentiation", "disease_state": "metastatic castration-resistant", "histology_inclusion": "prostate adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["small cell neuroendocrine prostate cancer"], "biomarker_exclusion": ["loss-of-function mutation or deletion of RB1"]}], "json_norm": [{"cohort": "Safety Cohort", "histology_inclusion": "Prostate Adenocarcinoma", "histology_exclusion": ["Prostate Neoplasm", "Prostate Carcinoma"]}, {"cohort": "Cohort A: Transdifferentiated mCRPC", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["RB1 Mutation", "RB1-Mutation", "gene"]]}, {"cohort": "Cohort A: Transdifferentiated mCRPC", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["RB1 Mutation", "RB1-Mutation", "gene"]]}, {"cohort": "Cohort B: mCRPC without evidence of transdifferentiation", "histology_inclusion": "Prostate Adenocarcinoma", "histology_exclusion": ["Prostate Neoplasm", "Prostate Carcinoma"], "biomarker_exclusion": [["RB1 Mutation", "RB1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04862780", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR T790M", "EGFR C797S"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR exon 20 insertion", "KRAS", "BRAF V600E", "NTRK1/2/3", "HER2", "ALK", "ROS1", "MET", "RET"]}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR T790M"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR exon 20 insertion", "KRAS", "BRAF V600E", "NTRK1/2/3", "HER2", "ALK", "ROS1", "MET", "RET"]}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR C797S"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR exon 20 insertion", "KRAS", "BRAF V600E", "NTRK1/2/3", "HER2", "ALK", "ROS1", "MET", "RET"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR T790M", "T790M", "coordinate"], ["EGFR C797S", "C797S", "coordinate"]], "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR T790M", "T790M", "coordinate"]], "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR C797S", "C797S", "coordinate"]], "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT02206984", "json": [{"cohort": "", "disease_state": "clinical stages I-III", "histology_inclusion": "invasive lobular breast cancer", "biomarker_inclusion": ["ER-positive", "HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": ["HER-2 positivity"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Invasive Lobular Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}]}
{"NCT_id": "NCT02468024", "json": [{"cohort": "", "disease_state": "Stage I", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT03652545", "json": [{"cohort": "Group A", "disease_state": "newly diagnosed", "histology_inclusion": "diffuse intrinsic pontine gliomas (DIPGs)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group B", "disease_state": "recurrent, progressive, or refractory", "histology_inclusion": "high-risk CNS tumors", "biomarker_inclusion": [], "histology_exclusion": ["bulky tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Group A"}, {"cohort": "Group B", "histology_inclusion": "Central Nervous System Neoplasm"}, {"cohort": "Group B", "histology_inclusion": "Malignant Central Nervous System Neoplasm"}]}
{"NCT_id": "NCT04108481", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["pMMR", "MSS"], "histology_exclusion": ["central nervous system metastatic disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT04173585", "json": [{"cohort": "", "disease_state": "refractory or relapsed", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": ["central nervous system manifestation of AML", "acute myeloid leukemia previously treated with gemtuzumab ozogamicin"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT04238624", "json": [{"cohort": "BRAF-mutant ATC", "disease_state": "metastatic or locoregional not resectable for cure", "histology_inclusion": "Anaplastic Thyroid Cancer", "biomarker_inclusion": ["BRAF-V600E"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "BRAF-mutant ATC", "histology_inclusion": "Thyroid Gland Undifferentiated (Anaplastic) Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT03066206", "json": [{"cohort": "Cohort 1", "disease_state": "stage IV or recurrent", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["EGFR exon 20 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR T790M mutation"]}, {"cohort": "Cohort 2", "disease_state": "stage IV or recurrent", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["HER2 exon 20 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "stage IV or recurrent", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["EGFR exon 20 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR T790M mutation"]}, {"cohort": "Cohort 4", "disease_state": "stage IV or recurrent", "histology_inclusion": "solid tumor (excluding NSCLC)", "biomarker_inclusion": ["EGFR exon 20 mutation", "HER2 exon 20 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 5", "disease_state": "stage IV or recurrent", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["HER2 exon 19 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 3", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"]]}, {"cohort": "Cohort 4", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Cohort 4", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 5", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT03391869", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["small cell lung cancer", "carcinoid tumors"], "biomarker_exclusion": ["EGFR sensitizing", "ALK fusion"]}, {"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "lung adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["small cell lung cancer", "carcinoid tumors"], "biomarker_exclusion": ["EGFR sensitizing", "ALK fusion"]}, {"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "lung non-small cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["small cell lung cancer", "carcinoid tumors"], "biomarker_exclusion": ["EGFR sensitizing", "ALK fusion"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma"], "biomarker_exclusion": [["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "", "histology_inclusion": "Lung Adenocarcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma"], "biomarker_exclusion": [["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma"], "biomarker_exclusion": [["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT04238715", "json": [{"cohort": "", "disease_state": "unresectable advanced or metastatic", "histology_inclusion": "intrahepatic or perihilar cholangiocarcinoma", "biomarker_inclusion": ["FGFR2 gene fusion"], "histology_exclusion": ["brain or subdural metastases"], "biomarker_exclusion": ["prior therapy targeting FGFR2"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["FGFR2 Fusion", "FGFR2", "fusion"]]}]}
{"NCT_id": "NCT05188508", "json": [{"cohort": "Cohort A", "disease_state": "recurrent", "histology_inclusion": "grade II or III IDH-mutated glioma (absence of known CDKN2A/B deletion)", "biomarker_inclusion": [], "histology_exclusion": ["significant intracranial hemorrhage"], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "recurrent", "histology_inclusion": "IDH-wildtype glioma", "biomarker_inclusion": ["deleterious mutations in at least 1 of the specified 15 genes involved in homologous recombination repair (BRCA1, BRCA2, ATM, BARD1, BRIP1, CDK12, CHEK1, CHEK2, FANCL, PALB2, PPP2R2A, RAD51B, RAD51C, RAD51D, and RAD54L)"], "histology_exclusion": ["significant intracranial hemorrhage"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["CDKN2A Mutation", "CDKN2A-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"], ["GCNT2 Mutation", "GCNT2-Mutation", "gene"]]}, {"cohort": "Cohort A", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["CDKN2A Mutation", "CDKN2A-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"], ["GCNT2 Mutation", "GCNT2-Mutation", "gene"]]}, {"cohort": "Cohort A", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["CDKN2A Mutation", "CDKN2A-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"], ["GCNT2 Mutation", "GCNT2-Mutation", "gene"]]}, {"cohort": "Cohort A", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["CDKN2A Mutation", "CDKN2A-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"], ["GCNT2 Mutation", "GCNT2-Mutation", "gene"]]}, {"cohort": "Cohort B", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Cohort B", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT05318573", "json": [{"cohort": "Safety Run-in Phase", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Safety Run-in Phase", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT03391973", "json": [{"cohort": "", "disease_state": "metastatic carcinoma with no primary site identified", "histology_inclusion": "adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic carcinoma with no primary site identified", "histology_inclusion": "poorly differentiated carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic carcinoma with no primary site identified", "histology_inclusion": "squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["lymphomas", "malignant melanoma", "extragonadal germ cell neoplasms", "sarcomas", "neuroendocrine tumors", "prostatic adenocarcinomas in men"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Adenocarcinoma"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma", "histology_exclusion": ["Neuroendocrine Tumor", "Extragonadal Germ Cell Tumor", "Lung Neuroendocrine Neoplasm", "Neuroendocrine Carcinoma", "Melanoma", "Sarcoma"]}]}
{"NCT_id": "NCT03587662", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Renal Medullary Carcinoma", "biomarker_inclusion": ["SMARCB1 Negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Unclassified Renal Cell Carcinoma with Medullary Phenotype", "biomarker_inclusion": ["SMARCB1 Negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Adult-Onset Malignant Rhabdoid Tumors", "biomarker_inclusion": ["SMARCB1 Negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Kidney Medullary Carcinoma", "biomarker_inclusion": [["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Unclassified Renal Cell Carcinoma", "biomarker_inclusion": [["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Rhabdoid Tumor", "biomarker_inclusion": [["SMARCB1-Low", "SMARCB1-Low", "expression"]]}]}
{"NCT_id": "NCT03978689", "json": [{"cohort": "", "disease_state": "Recurrent/Metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["HPV16+", "HLA A*0201", "p16INK4A"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT04108858", "json": [{"cohort": "", "disease_state": "stage IV", "histology_inclusion": "HER2 Positive Breast Cancer", "biomarker_inclusion": ["PIK3CA mutation", "PTEN mutation"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}]}
{"NCT_id": "NCT05253807", "json": [{"cohort": "Cohort A: Squamous NSCLC", "disease_state": "advanced or metastatic NSCLC (Stage IIIB/C or IV)", "histology_inclusion": "squamous NSCLC", "biomarker_inclusion": ["FGFR1-3 mutations outside the kinase domain", "FGFR1-3 fusions/rearrangements"], "histology_exclusion": [], "biomarker_exclusion": ["prior receipt of a selective FGFR inhibitor"]}, {"cohort": "Cohort B: Non-squamous NSCLC", "disease_state": "advanced or metastatic NSCLC (Stage IIIB/C or IV)", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": ["FGFR1-3 mutations outside the kinase domain", "FGFR1-3 fusions/rearrangements"], "histology_exclusion": [], "biomarker_exclusion": ["prior receipt of a selective FGFR inhibitor"]}], "json_norm": [{"cohort": "Cohort A: Squamous NSCLC", "histology_inclusion": "Squamous Cell Lung Carcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"], ["FGFR1 Fusion", "FGFR1", "fusion"]]}, {"cohort": "Cohort B: Non-squamous NSCLC", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"], ["FGFR1 Fusion", "FGFR1", "fusion"]]}]}
{"NCT_id": "NCT03327064", "json": [{"cohort": "Renal Transplant subjects receiving UAB30", "disease_state": "", "histology_inclusion": "Non-melanoma Skin Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Renal Transplant subjects receiving placebo", "disease_state": "", "histology_inclusion": "Non-melanoma Skin Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Renal Transplant subjects receiving UAB30", "histology_inclusion": "Skin Carcinoma"}, {"cohort": "Renal Transplant subjects receiving placebo", "histology_inclusion": "Skin Carcinoma"}]}
{"NCT_id": "NCT03392246", "json": [{"cohort": "", "disease_state": "stage IV", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR L858R", "EGFR exon 19 deletion"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT05319028", "json": [{"cohort": "", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Non-GCB/ABC Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["DLBCL with central nervous system (CNS) involvement with active brain or leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Non-GCB/ABC Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": ["MyD88 mutation"], "histology_exclusion": ["DLBCL with central nervous system (CNS) involvement with active brain or leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Non-GCB/ABC Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": ["CD79B mutation"], "histology_exclusion": ["DLBCL with central nervous system (CNS) involvement with active brain or leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Diffuse Large B-Cell Lymphoma"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MYD88 Mutation", "MYD88-Mutation", "gene"]], "histology_exclusion": ["Diffuse Large B-Cell Lymphoma"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["CD79B Mutation", "CD79B-Mutation", "gene"]], "histology_exclusion": ["Diffuse Large B-Cell Lymphoma"]}]}
{"NCT_id": "NCT05384119", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "hormone receptor-positive (HR+) and human epithelial receptor 2-negative (HER2-) breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["retinoblastoma tumor suppressor gene (Rb) loss", "estrogen receptor 1 (ESR1) activating mutation", "human epithelial receptor 2 (HER2) overexpression"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["HR-High", "HR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]], "biomarker_exclusion": [["RB1-Low", "RB1-Low", "expression"], ["ESR1 Mutation", "ESR1-Mutation", "gene"], ["ESR1 Mutation", "ESR1-Mutation", "gene"], ["ESR1 Mutation", "ESR1-Mutation", "gene"], ["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["HR-High", "HR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]], "biomarker_exclusion": [["RB1-Low", "RB1-Low", "expression"], ["ESR1 Mutation", "ESR1-Mutation", "gene"], ["ESR1 Mutation", "ESR1-Mutation", "gene"], ["ESR1 Mutation", "ESR1-Mutation", "gene"], ["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["HR-High", "HR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]], "biomarker_exclusion": [["RB1-Low", "RB1-Low", "expression"], ["ESR1 Mutation", "ESR1-Mutation", "gene"], ["ESR1 Mutation", "ESR1-Mutation", "gene"], ["ESR1 Mutation", "ESR1-Mutation", "gene"], ["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["HR-High", "HR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]], "biomarker_exclusion": [["ESR1 Mutation", "ESR1-Mutation", "gene"], ["RB1-Low", "RB1-Low", "expression"], ["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04603001", "json": [{"cohort": "Cohort 1", "disease_state": "relapsed/refractory AML", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH1 R132 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior IDH inhibitor"]}, {"cohort": "Cohort 2", "disease_state": "relapsed/refractory AML", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH1 R132 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "relapsed/refractory", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": ["IDH1 R132 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "relapsed/refractory", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": ["IDH1 R132 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 4", "disease_state": "relapsed/refractory", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 4", "disease_state": "relapsed/refractory", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": ["IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 4", "disease_state": "relapsed/refractory", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": ["IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 5", "disease_state": "newly diagnosed AML", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH1 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior venetoclax therapy"]}, {"cohort": "Cohort 5", "disease_state": "newly diagnosed AML", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior venetoclax therapy"]}, {"cohort": "Cohort 5", "disease_state": "relapsed/refractory AML", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH1 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior venetoclax therapy"]}, {"cohort": "Cohort 5", "disease_state": "relapsed/refractory AML", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior venetoclax therapy"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "Cohort 2", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "Cohort 3", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "Cohort 3", "histology_inclusion": "Chronic Myelomonocytic Leukemia"}, {"cohort": "Cohort 4", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Cohort 4", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Cohort 4", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Cohort 5", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "Cohort 5", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Cohort 5", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "Cohort 5", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04603040", "json": [{"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "gastric or gastroesophageal junction adenocarcinoma", "biomarker_inclusion": ["PD-L1 positive (\u22655% tumor cells or \u226510% immune cells)"], "histology_exclusion": ["squamous cell carcinoma", "sarcoma", "undifferentiated carcinoma of the stomach or gastroesophageal junction"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "gastric or gastroesophageal junction adenocarcinoma", "biomarker_inclusion": ["EBV positive (EBER-ISH)"], "histology_exclusion": ["squamous cell carcinoma", "sarcoma", "undifferentiated carcinoma of the stomach or gastroesophageal junction"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "gastric or gastroesophageal junction adenocarcinoma", "biomarker_inclusion": ["TMB-H (\u226512 Muts/Mb)"], "histology_exclusion": ["squamous cell carcinoma", "sarcoma", "undifferentiated carcinoma of the stomach or gastroesophageal junction"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "gastric or gastroesophageal junction adenocarcinoma", "biomarker_inclusion": ["MSI-H"], "histology_exclusion": ["squamous cell carcinoma", "sarcoma", "undifferentiated carcinoma of the stomach or gastroesophageal junction"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"]], "histology_exclusion": ["Squamous Cell Carcinoma", "Undifferentiated Gastric Carcinoma", "Sarcoma"]}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "histology_exclusion": ["Squamous Cell Carcinoma", "Undifferentiated Gastric Carcinoma", "Sarcoma"]}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["TMB-High", "TMB-High", "coordinate"]], "histology_exclusion": ["Squamous Cell Carcinoma", "Undifferentiated Gastric Carcinoma", "Sarcoma"]}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Squamous Cell Carcinoma", "Undifferentiated Gastric Carcinoma", "Sarcoma"]}]}
{"NCT_id": "NCT05579366", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["active CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": ["active CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": ["active CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": ["active CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["active CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "mesothelioma", "biomarker_inclusion": [], "histology_exclusion": ["active CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["active CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "HER2-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["active CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "hormone receptor-positive breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["active CNS metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Mesothelioma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"]]}]}
{"NCT_id": "NCT04174352", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "ER\u03b1+ Breast Cancer", "biomarker_inclusion": ["ESR1 mutation"], "histology_exclusion": ["HER2 positive"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1 Mutation", "ESR1-Mutation", "gene"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04407741", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer (adenocarcinoma or squamous cell carcinoma)", "biomarker_inclusion": ["EGFR negative", "ALK negative", "ROS1 negative", "BRAF negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "gastrointestinal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "triple-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases", "active central nervous system (CNS)"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma", "biomarker_inclusion": [["EGFR-Low", "EGFR-Low", "expression"], ["ALK-Low", "ALK-Low", "expression"], ["ALK-Low", "ALK-Low", "expression"], ["ROS1-Low", "ROS1-Low", "expression"], ["ROS1-Low", "ROS1-Low", "expression"], ["BRAF-Low", "BRAF-Low", "expression"], ["BRAF-Low", "BRAF-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["EGFR-Low", "EGFR-Low", "expression"], ["ALK-Low", "ALK-Low", "expression"], ["ALK-Low", "ALK-Low", "expression"], ["ROS1-Low", "ROS1-Low", "expression"], ["ROS1-Low", "ROS1-Low", "expression"], ["BRAF-Low", "BRAF-Low", "expression"], ["BRAF-Low", "BRAF-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1-Low", "ROS1-Low", "expression"], ["ALK-Low", "ALK-Low", "expression"], ["EGFR-Low", "EGFR-Low", "expression"], ["BRAF-Low", "BRAF-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Cholangiocarcinoma"}, {"cohort": "", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma"}, {"cohort": ""}]}
{"NCT_id": "NCT05189197", "json": [{"cohort": "Experimental: Zanubrutinib + R-CHOP", "disease_state": "Stage II (not candidates for local X-ray therapy), III, or IV", "histology_inclusion": "non-GCB subtype Diffuse Large B-cell Lymphoma (DLBCL)", "biomarker_inclusion": ["MYC+\u226540%", "BCL2+\u226550%"], "histology_exclusion": ["Primary mediastinal lymphoma", "Central nervous system involvement lymphoma", "Histologically transformed lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Experimental: Zanubrutinib + R-CHOP", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MYC-High", "MYC-High", "expression"], ["BCL2-High", "BCL2-High", "expression"]], "histology_exclusion": ["Mediastinal Lymphoma"]}]}
{"NCT_id": "NCT05254184", "json": [{"cohort": "Patients With NSCLC", "disease_state": "Stage III/IV unresectable", "histology_inclusion": "adenocarcinoma of the lung", "biomarker_inclusion": ["KRAS G12C", "KRAS G12V", "KRAS G12D", "KRAS G12A", "KRAS G13D", "KRAS G12R"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Patients With NSCLC", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"], ["KRAS G12A", "G12A", "coordinate"], ["KRAS G13D", "G13D", "coordinate"], ["KRAS G12V", "G12V", "coordinate"], ["KRAS G12R", "G12R", "coordinate"], ["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT05514496", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "EGFR-mutant cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["C797X EGFR mutations", "known second driver of disease"]}, {"cohort": "Expansion Cohort 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "EGFR mutant NSCLC", "biomarker_inclusion": ["CNS lesion(s)", "asymptomatic leptomeningeal disease"], "histology_exclusion": ["ex20ins mutations"], "biomarker_exclusion": ["C797X EGFR mutations", "known second driver of disease"]}, {"cohort": "Expansion Cohort 2", "disease_state": "locally advanced or metastatic", "histology_inclusion": "EGFR ex20ins-mutant NSCLC", "biomarker_inclusion": ["CNS lesion(s)", "asymptomatic leptomeningeal disease"], "histology_exclusion": [], "biomarker_exclusion": ["C797X EGFR mutations", "known second driver of disease"]}, {"cohort": "Expansion Cohort 3", "disease_state": "locally advanced or metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["EGFR ex20ins mutations"], "histology_exclusion": [], "biomarker_exclusion": ["C797X EGFR mutations", "known second driver of disease", "prior ex20ins mutation targeted therapy"]}, {"cohort": "Expansion Cohort 4", "disease_state": "locally advanced or metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["rare EGFR mutations"], "histology_exclusion": [], "biomarker_exclusion": ["C797X EGFR mutations", "known second driver of disease", "exon 19", "exon 21 L858R or L861Q", "ex20ins mutations", "current targeted therapy"]}, {"cohort": "Expansion Cohort 5", "disease_state": "locally advanced or metastatic", "histology_inclusion": "EGFR mutant NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["C797X EGFR mutations", "known second driver of disease", "specific requirements for Expansion Cohorts 1 through 4"]}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Expansion Cohort 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Expansion Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Expansion Cohort 3", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Expansion Cohort 4", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Expansion Cohort 5", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04603287", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "epithelial malignancies", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Epithelial Neoplasm"}]}
{"NCT_id": "NCT03718767", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "diffuse glioma", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04109456", "json": [{"cohort": "Metastatic Melanoma", "disease_state": "metastatic", "histology_inclusion": "uveal melanoma", "biomarker_inclusion": [], "histology_exclusion": ["active central nervous system (CNS) metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "Metastatic Melanoma", "disease_state": "metastatic", "histology_inclusion": "NRAS-mutant melanoma", "biomarker_inclusion": ["NRAS activating mutations of Q61", "NRAS activating mutations of G12", "NRAS activating mutations of G13"], "histology_exclusion": ["active central nervous system (CNS) metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Metastatic Melanoma", "histology_inclusion": "Intraocular Melanoma"}, {"cohort": "Metastatic Melanoma", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["GNA13 Mutation", "GNA13-Mutation", "gene"], ["ATF6B Mutation", "ATF6B-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04407988", "json": [{"cohort": "Pyrotinib plus Letrozole", "disease_state": "metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["HER2+", "ER+"], "histology_exclusion": ["central nervous system metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Pyrotinib plus Letrozole", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-High", "EREG-High", "expression"]]}]}
{"NCT_id": "NCT04603365", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "renal cell carcinoma with morphologic features consistent with hereditary leiomyomatosis and renal cell cancer (HLRCC)", "biomarker_inclusion": ["germline fumarate hydratase (FH) alteration"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with a PARP inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Hereditary Leiomyomatosis and Renal Cell Cancer", "biomarker_inclusion": [["FH Mutation", "FH-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [["FH Mutation", "FH-Mutation", "gene"]]}]}
{"NCT_id": "NCT04798781", "json": [{"cohort": "Advanced Stomach and Gastroesophageal Junction Cancer", "disease_state": "recurrent, locally advanced or metastatic, PD-L1-positive", "histology_inclusion": "gastric/esophagealgastric adenocarcinoma", "biomarker_inclusion": ["PD-L1 CPS \u22651"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Hepatocellular Carcinoma", "disease_state": "unresectable, not amenable to locoregional therapy, disease progression after at least one prior line of systemic therapy or discontinued first line therapy for intolerance", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["Child-Pugh Score B or C liver cirrhosis"]}], "json_norm": [{"cohort": "Advanced Stomach and Gastroesophageal Junction Cancer", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "Hepatocellular Carcinoma", "histology_inclusion": "Hepatocellular Carcinoma"}]}
{"NCT_id": "NCT05384626", "json": [{"cohort": "Phase 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["ALK rearrangement", "activating ALK mutation"], "histology_exclusion": [], "biomarker_exclusion": ["oncogenic driver alteration other than ALK"]}, {"cohort": "Cohort 2a", "disease_state": "locally advanced or metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["ALK rearrangement"], "histology_exclusion": [], "biomarker_exclusion": ["oncogenic driver alteration other than ALK"]}, {"cohort": "Cohort 2b", "disease_state": "locally advanced or metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["ALK rearrangement"], "histology_exclusion": [], "biomarker_exclusion": ["oncogenic driver alteration other than ALK"]}, {"cohort": "Cohort 2c", "disease_state": "locally advanced or metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["ALK rearrangement"], "histology_exclusion": [], "biomarker_exclusion": ["oncogenic driver alteration other than ALK"]}, {"cohort": "Cohort 2d", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["ALK rearrangement", "activating ALK mutation"], "histology_exclusion": [], "biomarker_exclusion": ["oncogenic driver alteration other than ALK"]}], "json_norm": [{"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ALK Mutation", "ALK-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Cohort 2a", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Cohort 2b", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Cohort 2c", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Cohort 2d", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ALK Mutation", "ALK-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT05514717", "json": [{"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["HER2 expression"], "histology_exclusion": ["CNS metastases", "leptomeningeal metastasis", "carcinomatous meningitis"], "biomarker_exclusion": ["prior treatment targeting STING pathway"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT01750567", "json": [{"cohort": "", "disease_state": "Relapsed Chronic Lymphocytic Leukemia", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Untreated Chronic Lymphocytic Leukemia with Genomic Deletion 11q", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": ["del11q"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia"}]}
{"NCT_id": "NCT03067181", "json": [{"cohort": "Low Risk Stage I Immature Teratoma", "disease_state": "Stage I", "histology_inclusion": "Ovarian Immature Teratoma (Grade 2 or 3)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Low Risk Stage I Non-Seminoma MGCT", "disease_state": "Stage I", "histology_inclusion": "Ovarian, Testicular, or Extragonadal Non-Seminoma Malignant Germ Cell Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Low Risk Stage I Seminoma-MGCT", "disease_state": "Stage I", "histology_inclusion": "Testicular Seminoma Malignant Germ Cell Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Standard Risk 1", "disease_state": "Stage II-IV", "histology_inclusion": "Ovarian, Testicular, or Extragonadal Malignant Germ Cell Tumor (Yolk Sac Tumor, Embryonal Carcinoma, or Choriocarcinoma)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Standard Risk 2 - Ovarian", "disease_state": "Stage II-III", "histology_inclusion": "Ovarian Malignant Germ Cell Tumor (Yolk Sac Tumor, Embryonal Carcinoma, or Choriocarcinoma)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Standard Risk 2 - Testicular", "disease_state": "Stage II-IV", "histology_inclusion": "Testicular Malignant Germ Cell Tumor (Yolk Sac Tumor, Embryonal Carcinoma, or Choriocarcinoma)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Standard Risk 2 - Extragonadal", "disease_state": "Stage II", "histology_inclusion": "Extragonadal Malignant Germ Cell Tumor (Yolk Sac Tumor, Embryonal Carcinoma, or Choriocarcinoma)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Low Risk Stage I Immature Teratoma", "histology_inclusion": "Immature Ovarian Teratoma"}, {"cohort": "Low Risk Stage I Non-Seminoma MGCT", "histology_inclusion": "Malignant Germ Cell Tumor"}, {"cohort": "Low Risk Stage I Seminoma-MGCT", "histology_inclusion": "Malignant Germ Cell Tumor"}, {"cohort": "Low Risk Stage I Seminoma-MGCT", "histology_inclusion": "Seminoma"}, {"cohort": "Standard Risk 1", "histology_inclusion": "Malignant Germ Cell Tumor"}, {"cohort": "Standard Risk 1", "histology_inclusion": "Yolk Sac Tumor"}, {"cohort": "Standard Risk 1", "histology_inclusion": "Embryonal Carcinoma"}, {"cohort": "Standard Risk 1", "histology_inclusion": "Choriocarcinoma"}, {"cohort": "Standard Risk 1", "histology_inclusion": "Embryonal Neoplasm"}, {"cohort": "Standard Risk 2 - Ovarian", "histology_inclusion": "Malignant Germ Cell Tumor"}, {"cohort": "Standard Risk 2 - Ovarian", "histology_inclusion": "Yolk Sac Tumor"}, {"cohort": "Standard Risk 2 - Ovarian", "histology_inclusion": "Embryonal Carcinoma"}, {"cohort": "Standard Risk 2 - Ovarian", "histology_inclusion": "Choriocarcinoma"}, {"cohort": "Standard Risk 2 - Ovarian", "histology_inclusion": "Embryonal Neoplasm"}, {"cohort": "Standard Risk 2 - Testicular", "histology_inclusion": "Malignant Germ Cell Tumor"}, {"cohort": "Standard Risk 2 - Testicular", "histology_inclusion": "Yolk Sac Tumor"}, {"cohort": "Standard Risk 2 - Testicular", "histology_inclusion": "Embryonal Carcinoma"}, {"cohort": "Standard Risk 2 - Testicular", "histology_inclusion": "Choriocarcinoma"}, {"cohort": "Standard Risk 2 - Testicular", "histology_inclusion": "Embryonal Neoplasm"}, {"cohort": "Standard Risk 2 - Extragonadal", "histology_inclusion": "Malignant Germ Cell Tumor"}, {"cohort": "Standard Risk 2 - Extragonadal", "histology_inclusion": "Yolk Sac Tumor"}, {"cohort": "Standard Risk 2 - Extragonadal", "histology_inclusion": "Embryonal Carcinoma"}, {"cohort": "Standard Risk 2 - Extragonadal", "histology_inclusion": "Choriocarcinoma"}, {"cohort": "Standard Risk 2 - Extragonadal", "histology_inclusion": "Embryonal Neoplasm"}]}
{"NCT_id": "NCT03197506", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "supratentorial glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "astrocytoma grade IV", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Grade IV IDH-mutant astrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Astrocytoma"}, {"cohort": "", "histology_inclusion": "Gliosarcoma"}, {"cohort": "", "histology_inclusion": "Astrocytoma"}]}
{"NCT_id": "NCT04174716", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": ["Homologous Recombination Repair Gene Mutation"], "histology_exclusion": ["CNS metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["Prior treatment with PARP inhibitors"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}]}
{"NCT_id": "NCT04603495", "json": [{"cohort": "", "disease_state": "Intermediate-1 or higher per Dynamic International Prognostic Scoring System (DIPSS)", "histology_inclusion": "myelofibrosis (primary, post-polycythemia vera, or post essential thrombocythemia)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Essential Thrombocythemia"}, {"cohort": "", "histology_inclusion": "Myelofibrosis"}]}
{"NCT_id": "NCT01553942", "json": [{"cohort": "", "disease_state": "stage IIIA", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT02143050", "json": [{"cohort": "", "disease_state": "Unresectable Stage IIIC and Stage IV", "histology_inclusion": "Melanoma", "biomarker_inclusion": ["BRAFV600E"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT03328078", "json": [{"cohort": "Cohort 1", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Marginal zone lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Burkitt lymphoma", "Lymphoblastic lymphoma or leukemia", "Post-transplantation lymphoproliferative disorder", "Primary mediastinal DLBCL", "Ocular DLBCL", "Epidural DLBCL", "Waldenstr\u00f6m's macroglobulinemia", "Lymphoplasmacytic lymphoma", "Chronic lymphocytic leukemia", "Small lymphocytic lymphoma"], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Relapsed or Refractory", "histology_inclusion": "ABC diffuse large B-cell lymphoma", "biomarker_inclusion": ["MYD88 L265P"], "histology_exclusion": ["Burkitt lymphoma", "Lymphoblastic lymphoma or leukemia", "Post-transplantation lymphoproliferative disorder", "Primary mediastinal DLBCL", "Ocular DLBCL", "Epidural DLBCL", "Waldenstr\u00f6m's macroglobulinemia", "Lymphoplasmacytic lymphoma", "Chronic lymphocytic leukemia", "Small lymphocytic lymphoma"], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Extranodal DLBCL (Leg-type)", "biomarker_inclusion": ["MYD88 L265P"], "histology_exclusion": ["Burkitt lymphoma", "Lymphoblastic lymphoma or leukemia", "Post-transplantation lymphoproliferative disorder", "Primary mediastinal DLBCL", "Ocular DLBCL", "Epidural DLBCL", "Waldenstr\u00f6m's macroglobulinemia", "Lymphoplasmacytic lymphoma", "Chronic lymphocytic leukemia", "Small lymphocytic lymphoma"], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Extranodal DLBCL (Testicular-type)", "biomarker_inclusion": ["MYD88 L265P"], "histology_exclusion": ["Burkitt lymphoma", "Lymphoblastic lymphoma or leukemia", "Post-transplantation lymphoproliferative disorder", "Primary mediastinal DLBCL", "Ocular DLBCL", "Epidural DLBCL", "Waldenstr\u00f6m's macroglobulinemia", "Lymphoplasmacytic lymphoma", "Chronic lymphocytic leukemia", "Small lymphocytic lymphoma"], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Extranodal DLBCL (NOS-type)", "biomarker_inclusion": ["MYD88 L265P"], "histology_exclusion": ["Burkitt lymphoma", "Lymphoblastic lymphoma or leukemia", "Post-transplantation lymphoproliferative disorder", "Primary mediastinal DLBCL", "Ocular DLBCL", "Epidural DLBCL", "Waldenstr\u00f6m's macroglobulinemia", "Lymphoplasmacytic lymphoma", "Chronic lymphocytic leukemia", "Small lymphocytic lymphoma"], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Primary central nervous system lymphoma", "biomarker_inclusion": ["MYD88 L265P"], "histology_exclusion": ["Burkitt lymphoma", "Lymphoblastic lymphoma or leukemia", "Post-transplantation lymphoproliferative disorder", "Primary mediastinal DLBCL", "Ocular DLBCL", "Epidural DLBCL", "Waldenstr\u00f6m's macroglobulinemia", "Lymphoplasmacytic lymphoma", "Chronic lymphocytic leukemia", "Small lymphocytic lymphoma"], "biomarker_exclusion": []}, {"cohort": "Cohort 4", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Non-Hodgkin Lymphoma", "biomarker_inclusion": ["myddosome mutations"], "histology_exclusion": ["Burkitt lymphoma", "Lymphoblastic lymphoma or leukemia", "Post-transplantation lymphoproliferative disorder", "Primary mediastinal DLBCL", "Ocular DLBCL", "Epidural DLBCL", "Waldenstr\u00f6m's macroglobulinemia", "Lymphoplasmacytic lymphoma", "Chronic lymphocytic leukemia", "Small lymphocytic lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Marginal Zone Lymphoma", "histology_exclusion": ["Small Lymphocytic Lymphoma", "Chronic Lymphocytic Leukemia", "Diffuse Large B-Cell Lymphoma", "Lymphoplasmacytic Lymphoma", "Burkitt Lymphoma", "Lymphoproliferative Disorder", "Lymphoblastic Lymphoma"]}, {"cohort": "Cohort 2", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MYD88 L265P", "L265P", "coordinate"]], "histology_exclusion": ["Small Lymphocytic Lymphoma", "Chronic Lymphocytic Leukemia", "Diffuse Large B-Cell Lymphoma", "Lymphoplasmacytic Lymphoma", "Burkitt Lymphoma", "Lymphoproliferative Disorder", "Lymphoblastic Lymphoma"]}, {"cohort": "Cohort 2", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MYD88 L265P", "L265P", "coordinate"]], "histology_exclusion": ["Small Lymphocytic Lymphoma", "Chronic Lymphocytic Leukemia", "Diffuse Large B-Cell Lymphoma", "Lymphoplasmacytic Lymphoma", "Burkitt Lymphoma", "Lymphoproliferative Disorder", "Lymphoblastic Lymphoma"]}, {"cohort": "Cohort 2", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MYD88 L265P", "L265P", "coordinate"]], "histology_exclusion": ["Small Lymphocytic Lymphoma", "Chronic Lymphocytic Leukemia", "Diffuse Large B-Cell Lymphoma", "Lymphoplasmacytic Lymphoma", "Burkitt Lymphoma", "Lymphoproliferative Disorder", "Lymphoblastic Lymphoma"]}, {"cohort": "Cohort 2", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["NOS2 - SGCG", "NOS2 - SGCG", "coordinate"], ["NOS1 - SGCG", "NOS1 - SGCG", "coordinate"], ["MYD88 L265P", "L265P", "coordinate"]], "histology_exclusion": ["Burkitt Lymphoma", "Lymphoblastic Lymphoma", "Lymphoproliferative Disorder", "Diffuse Large B-Cell Lymphoma", "Diffuse Large B-Cell Lymphoma", "Diffuse Large B-Cell Lymphoma", "Lymphoplasmacytic Lymphoma", "Chronic Lymphocytic Leukemia", "Small Lymphocytic Lymphoma"]}, {"cohort": "Cohort 2", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["NOS2 - SGCG", "NOS2 - SGCG", "coordinate"], ["NOS1 - SGCG", "NOS1 - SGCG", "coordinate"], ["MYD88 L265P", "L265P", "coordinate"]], "histology_exclusion": ["Small Lymphocytic Lymphoma", "Chronic Lymphocytic Leukemia", "Diffuse Large B-Cell Lymphoma", "Lymphoplasmacytic Lymphoma", "Burkitt Lymphoma", "Lymphoproliferative Disorder", "Lymphoblastic Lymphoma"]}, {"cohort": "Cohort 3", "histology_inclusion": "Central Nervous System Lymphoma", "biomarker_inclusion": [["MYD88 L265P", "L265P", "coordinate"]], "histology_exclusion": ["Burkitt Lymphoma", "Lymphoblastic Lymphoma", "Lymphoproliferative Disorder", "Diffuse Large B-Cell Lymphoma", "Diffuse Large B-Cell Lymphoma", "Diffuse Large B-Cell Lymphoma", "Lymphoplasmacytic Lymphoma", "Chronic Lymphocytic Leukemia", "Small Lymphocytic Lymphoma"]}, {"cohort": "Cohort 3", "histology_inclusion": "Primary Central Nervous System Lymphoma", "biomarker_inclusion": [["MYD88 L265P", "L265P", "coordinate"]], "histology_exclusion": ["Small Lymphocytic Lymphoma", "Chronic Lymphocytic Leukemia", "Diffuse Large B-Cell Lymphoma", "Lymphoplasmacytic Lymphoma", "Burkitt Lymphoma", "Lymphoproliferative Disorder", "Lymphoblastic Lymphoma"]}, {"cohort": "Cohort 4", "histology_inclusion": "Non-Hodgkin Lymphoma", "histology_exclusion": ["Small Lymphocytic Lymphoma", "Chronic Lymphocytic Leukemia", "Diffuse Large B-Cell Lymphoma", "Lymphoplasmacytic Lymphoma", "Burkitt Lymphoma", "Lymphoproliferative Disorder", "Lymphoblastic Lymphoma"]}]}
{"NCT_id": "NCT03914612", "json": [{"cohort": "", "disease_state": "Stage III, Stage IVA, Stage IVB or Recurrent", "histology_inclusion": "Endometrioid adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III, Stage IVA, Stage IVB or Recurrent", "histology_inclusion": "Serous adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III, Stage IVA, Stage IVB or Recurrent", "histology_inclusion": "Dedifferentiated/undifferentiated carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III, Stage IVA, Stage IVB or Recurrent", "histology_inclusion": "Clear cell adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III, Stage IVA, Stage IVB or Recurrent", "histology_inclusion": "Mixed epithelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III, Stage IVA, Stage IVB or Recurrent", "histology_inclusion": "Adenocarcinoma not otherwise specified (N.O.S.)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1", "anti-CTLA-4"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Endometrioid Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Undifferentiated Carcinoma"}, {"cohort": "", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Epithelial Neoplasm"}, {"cohort": "", "histology_inclusion": "Adenocarcinoma"}]}
{"NCT_id": "NCT03914625", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "B-lymphoblastic leukemia", "biomarker_inclusion": [], "histology_exclusion": ["acute undifferentiated leukemia", "MYC translocation associated with mature (Burkitt) B-cell ALL"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "B-lymphoblastic lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["T-Lymphoblastic Lymphoma", "morphologically unclassifiable lymphoma", "CNS positive disease", "testicular involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_exclusion": ["Acute Undifferentiated Leukemia", "Infant Acute Undifferentiated Leukemia", "B Acute Lymphoblastic Leukemia"], "biomarker_exclusion": [["MYC Fusion", "MYC", "fusion"]]}, {"cohort": "", "histology_inclusion": "B Lymphoblastic Lymphoma"}]}
{"NCT_id": "NCT03979651", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced unresectable", "histology_inclusion": "malignant melanoma", "biomarker_inclusion": ["NRAS mutation"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04109924", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": [], "histology_exclusion": ["untreated brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma"}]}
{"NCT_id": "NCT04240106", "json": [{"cohort": "Cohort A", "disease_state": "metastatic", "histology_inclusion": "HR-positive/HER2-negative breast cancer", "biomarker_inclusion": ["gBRCA1 mutation", "gBRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["HER2-positive"]}, {"cohort": "Exploratory Cohort B", "disease_state": "metastatic", "histology_inclusion": "HR-positive/HER2-negative breast cancer", "biomarker_inclusion": ["gBRCA1 wild-type", "gBRCA2 wild-type", "non-detrimental gBRCAms", "homologous recombination deficiency (HRD)"], "histology_exclusion": [], "biomarker_exclusion": ["HER2-positive"]}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Exploratory Cohort B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["Homologous Recombination Pathway", null, "pathway"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Exploratory Cohort B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04538664", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "nonsquamous non-small cell lung cancer", "biomarker_inclusion": ["EGFR Exon 20ins activating mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04603833", "json": [{"cohort": "", "disease_state": "metastatic castration-resistant", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": ["neuroendocrine carcinoma", "small cell carcinoma", "brain tumor lesions"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Neoplasm", "histology_exclusion": ["Neuroendocrine Carcinoma", "Neuroendocrine Tumor", "Small Cell Carcinoma", "Primary Brain Neoplasm", "Malignant Brain Neoplasm", "Brain Tumor"]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "histology_exclusion": ["Malignant Brain Neoplasm", "Neuroendocrine Tumor", "Small Cell Carcinoma", "Primary Brain Neoplasm", "Neuroendocrine Carcinoma", "Brain Tumor"]}]}
{"NCT_id": "NCT04799249", "json": [{"cohort": "Cohort 1", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "Triple-Negative Breast Cancer", "biomarker_inclusion": ["ER < 1%", "PR < 1%", "HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": ["PD-1/PD-L1 inhibitor treatment"]}, {"cohort": "Cohort 2", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "Triple-Negative Breast Cancer", "biomarker_inclusion": ["ER < 1%", "PR < 1%", "HER2-negative", "PD-L1 positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["CD274-High", "CD274-High", "expression"]]}]}
{"NCT_id": "NCT03914742", "json": [{"cohort": "Phase I", "disease_state": "Recurrent", "histology_inclusion": "WHO grade II-III glioma", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase I", "disease_state": "Recurrent", "histology_inclusion": "Grade IV glioma", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II: Arm A", "disease_state": "Recurrent", "histology_inclusion": "WHO grade II-III glioma", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II: Arm B", "disease_state": "Recurrent", "histology_inclusion": "WHO grade II-III glioma", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "GBM Arm", "disease_state": "Recurrent", "histology_inclusion": "WHO grade IV glioblastoma", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Surgical Arm", "disease_state": "Recurrent", "histology_inclusion": "WHO grade II-IV glioma", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase I", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Phase I", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Phase II: Arm A", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Phase II: Arm B", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "GBM Arm", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Surgical Arm", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04669002", "json": [{"cohort": "Phase 2A Cohort 1", "disease_state": "advanced platinum resistant", "histology_inclusion": "high-grade serous ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["non-epithelial tumor of the ovary", "fallopian tube", "peritoneum", "low malignant potential", "low grade"], "biomarker_exclusion": ["prior treatment with a topoisomerase I inhibitor"]}, {"cohort": "Phase 2A Cohort 1", "disease_state": "advanced platinum resistant", "histology_inclusion": "high-grade endometrioid ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["non-epithelial tumor of the ovary", "fallopian tube", "peritoneum", "low malignant potential", "low grade"], "biomarker_exclusion": ["prior treatment with a topoisomerase I inhibitor"]}, {"cohort": "Phase 2A Cohort 2", "disease_state": "advanced", "histology_inclusion": "high-grade serous ovarian cancer", "biomarker_inclusion": ["received at least 1 prior line of treatment, 1 of which must be platinum-based chemotherapy", "received a PARP inhibitor in the maintenance setting as their most recent treatment"], "histology_exclusion": ["non-epithelial tumor of the ovary", "fallopian tube", "peritoneum", "low malignant potential", "low grade"], "biomarker_exclusion": ["prior treatment with a topoisomerase I inhibitor"]}, {"cohort": "Phase 2A Cohort 2", "disease_state": "advanced", "histology_inclusion": "high-grade endometrioid ovarian cancer", "biomarker_inclusion": ["received at least 1 prior line of treatment, 1 of which must be platinum-based chemotherapy", "received a PARP inhibitor in the maintenance setting as their most recent treatment"], "histology_exclusion": ["non-epithelial tumor of the ovary", "fallopian tube", "peritoneum", "low malignant potential", "low grade"], "biomarker_exclusion": ["prior treatment with a topoisomerase I inhibitor"]}], "json_norm": [{"cohort": "Phase 2A Cohort 1", "histology_inclusion": "Ovarian Serous Adenocarcinoma"}, {"cohort": "Phase 2A Cohort 1", "histology_inclusion": "Ovarian Endometrioid Adenocarcinoma"}, {"cohort": "Phase 2A Cohort 2", "histology_inclusion": "Ovarian Serous Adenocarcinoma"}, {"cohort": "Phase 2A Cohort 2", "histology_inclusion": "Ovarian Endometrioid Adenocarcinoma"}]}
{"NCT_id": "NCT04669067", "json": [{"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["TP53 wildtype", "FLT3 mutation (FLT3-TKD or FLT3-ITD)"], "histology_exclusion": ["AML subtype 3"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["FLT3 Mutation", "FLT3-Mutation", "gene"]], "histology_exclusion": ["Acute Myeloid Leukemia (AML)"]}]}
{"NCT_id": "NCT04799275", "json": [{"cohort": "", "disease_state": "Ann Arbor Stage IIX (bulky), III or IV", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma transformed from Follicular Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma transformed from Marginal Zone Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma transformed from Lymphoplasmacytic Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma transformed from Nodular Lymphocyte-Predominant Hodgkin Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Grade IIIB Follicular Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "High-Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Marginal Zone Lymphoma"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Lymphoplasmacytic Lymphoma"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Nodular Lymphocyte Predominant Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"]]}]}
{"NCT_id": "NCT02796261", "json": [{"cohort": "", "disease_state": "Recurrent Anaplastic Astrocytoma", "histology_inclusion": "Anaplastic Astrocytoma (WHO grade 3)", "biomarker_inclusion": [], "histology_exclusion": ["glioblastoma", "radiation necrosis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Anaplastic Astrocytoma", "histology_exclusion": ["Glioblastoma"]}]}
{"NCT_id": "NCT03458728", "json": [{"cohort": "Phase I", "disease_state": "relapsed/refractory", "histology_inclusion": "solid tumor or lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system malignancies"], "biomarker_exclusion": []}, {"cohort": "Phase II - Neuroblastoma", "disease_state": "", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system malignancies"], "biomarker_exclusion": []}, {"cohort": "Phase II - Osteosarcoma", "disease_state": "", "histology_inclusion": "osteosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system malignancies"], "biomarker_exclusion": []}, {"cohort": "Phase II - Rhabdomyosarcoma", "disease_state": "", "histology_inclusion": "rhabdomyosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system malignancies"], "biomarker_exclusion": []}, {"cohort": "Phase II - Ewing sarcoma", "disease_state": "", "histology_inclusion": "Ewing sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system malignancies"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase I", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Phase II - Neuroblastoma", "histology_inclusion": "Neuroblastoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Phase II - Osteosarcoma", "histology_inclusion": "Osteosarcoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Phase II - Rhabdomyosarcoma", "histology_inclusion": "Rhabdomyosarcoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Phase II - Ewing sarcoma", "histology_inclusion": "Ewing Sarcoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT03784599", "json": [{"cohort": "", "disease_state": "stage IV", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": ["EGFR mutation", "HER2-overexpression"], "histology_exclusion": [], "biomarker_exclusion": ["T790M"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT03849651", "json": [{"cohort": "", "disease_state": "High risk ALL in CR1", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": ["t(9;22)", "MLL fusion", "t(4;11)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "ALL in High risk CR2", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": ["t(9;22)", "T-ALL"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "ALL in CR3 or subsequent", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "AML in high risk CR1", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": ["FLT3-ITD", "NUP98-NSD1 fusion", "WT1 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "AML in CR2 or subsequent", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Myelodysplastic Syndromes (MDS)", "histology_inclusion": "Myelodysplastic Syndromes (MDS)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "NK-Cell Leukemia", "histology_inclusion": "NK-Cell Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "CML in accelerated phase", "histology_inclusion": "Chronic Myeloid Leukemia (CML)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Hodgkin lymphoma in CR2 or subsequent", "histology_inclusion": "Hodgkin Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Non-Hodgkin lymphoma in CR2 or subsequent", "histology_inclusion": "Non Hodgkin Lymphoma (NHL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Juvenile Myelomonocytic Leukemia (JMML)", "histology_inclusion": "Juvenile Myelomonocytic Leukemia (JMML)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["KMT2A Fusion", "KMT2A", "fusion"]]}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["TBXT - BCR", "TBXT - BCR", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["NUP98 Fusion", "NUP98", "fusion"], ["NUP98 - NSD1", "NUP98 - NSD1", "coordinate"], ["NSD1 Fusion", "NSD1", "fusion"], ["WT1 Mutation", "WT1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Aggressive NK-Cell Leukemia"}, {"cohort": "", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive"}, {"cohort": "", "histology_inclusion": "Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Non-Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Juvenile Myelomonocytic Leukemia"}]}
{"NCT_id": "NCT03914794", "json": [{"cohort": "", "disease_state": "recurrent low- or intermediate-risk non-muscle invasive bladder cancer", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["high grade urothelial carcinoma", "upper urinary tract non-invasive urothelial carcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Urothelial Carcinoma", "histology_exclusion": ["Urothelial Carcinoma"]}]}
{"NCT_id": "NCT04175301", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Malignant Glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Glioma"}]}
{"NCT_id": "NCT04604067", "json": [{"cohort": "", "disease_state": "Ann Arbor stage I-IV", "histology_inclusion": "Diffuse Large B-cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS lymphoma", "high grade B-cell lymphoma", "primary mediastinal large B-cell lymphoma", "primary central nervous system lymphoma", "T-cell/histiocyte-rich large B-cell lymphoma", "intravascular large B-cell lymphoma", "plasmablastic lymphoma", "lymphomatoid granulomatosis", "primary effusion lymphoma"], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "Ann Arbor stage I-IV", "histology_inclusion": "Diffuse Large B-cell Lymphoma", "biomarker_inclusion": ["MYD88 L265P", "CD79A/B mutations"], "histology_exclusion": ["CNS lymphoma", "high grade B-cell lymphoma", "primary mediastinal large B-cell lymphoma", "primary central nervous system lymphoma", "T-cell/histiocyte-rich large B-cell lymphoma", "intravascular large B-cell lymphoma", "plasmablastic lymphoma", "lymphomatoid granulomatosis", "primary effusion lymphoma"], "biomarker_exclusion": []}, {"cohort": "Cohort B, C, D", "disease_state": "Ann Arbor stage I-IV", "histology_inclusion": "Diffuse Large B-cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS lymphoma", "high grade B-cell lymphoma", "primary mediastinal large B-cell lymphoma", "primary central nervous system lymphoma", "T-cell/histiocyte-rich large B-cell lymphoma", "intravascular large B-cell lymphoma", "plasmablastic lymphoma", "lymphomatoid granulomatosis", "primary effusion lymphoma"], "biomarker_exclusion": ["MYD88 L265P", "CD79A/B mutations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Primary Effusion Lymphoma", "Lymphomatoid Granulomatosis", "T-Cell/Histiocyte-Rich Large B-Cell Lymphoma", "Central Nervous System Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Plasmablastic Lymphoma", "Intravascular Large B-Cell Lymphoma", "Primary Central Nervous System Lymphoma", "High Grade B-Cell Lymphoma"]}, {"cohort": "Cohort A", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["CD79A Mutation", "CD79A-Mutation", "gene"], ["MYD88 L265P", "L265P", "coordinate"]], "histology_exclusion": ["Primary Effusion Lymphoma", "Lymphomatoid Granulomatosis", "T-Cell/Histiocyte-Rich Large B-Cell Lymphoma", "Central Nervous System Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Plasmablastic Lymphoma", "Intravascular Large B-Cell Lymphoma", "Primary Central Nervous System Lymphoma", "High Grade B-Cell Lymphoma"]}, {"cohort": "Cohort B, C, D", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Primary Effusion Lymphoma", "Lymphomatoid Granulomatosis", "T-Cell/Histiocyte-Rich Large B-Cell Lymphoma", "Central Nervous System Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Plasmablastic Lymphoma", "Intravascular Large B-Cell Lymphoma", "Primary Central Nervous System Lymphoma", "High Grade B-Cell Lymphoma"], "biomarker_exclusion": [["CD79A Mutation", "CD79A-Mutation", "gene"], ["MYD88 L265P", "L265P", "coordinate"]]}]}
{"NCT_id": "NCT04604132", "json": [{"cohort": "", "disease_state": "inoperable recurrent, locally advanced adenocarcinoma or progressing stage IV adenocarcinoma", "histology_inclusion": "adenocarcinoma of the gastro-esophageal junction or stomach", "biomarker_inclusion": ["HER2-negative", "FGFR2 fusions", "FGFR2 rearrangements", "FGFR2 amplifications", "FGFR1 mutations", "FGFR2 mutations", "FGFR3 mutations", "FGFR1 short variants", "FGFR2 short variants", "FGFR3 short variants"], "histology_exclusion": [], "biomarker_exclusion": ["CNS metastases"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["FGFR2-High", "FGFR2-High", "expression"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04994977", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Atypical Choroid Plexus Papilloma", "biomarker_inclusion": [], "histology_exclusion": ["Choroid Plexus Papilloma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Choroid Plexus Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Choroid Plexus Papilloma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Atypical Choroid Plexus Papilloma", "histology_exclusion": ["Choroid Plexus Papilloma"]}, {"cohort": "", "histology_inclusion": "Choroid Plexus Neoplasm", "histology_exclusion": ["Choroid Plexus Papilloma"]}, {"cohort": "", "histology_inclusion": "Choroid Plexus Carcinoma", "histology_exclusion": ["Choroid Plexus Papilloma"]}]}
{"NCT_id": "NCT05190172", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "IDH-mutated astrocytoma grade II", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["CDKN2A/B homozygous deletion"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "IDH-mutated astrocytoma grade III", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["CDKN2A/B homozygous deletion"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "oligodendroglioma grade II", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["CDKN2A/B homozygous deletion"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "oligodendroglioma grade III", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["CDKN2A/B homozygous deletion"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"], ["GCNT2 Mutation", "GCNT2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"], ["GCNT2 Mutation", "GCNT2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"], ["GCNT2 Mutation", "GCNT2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Oligodendroglioma"}, {"cohort": "", "histology_inclusion": "Oligodendroglioma"}]}
{"NCT_id": "NCT05515575", "json": [{"cohort": "Niraparib", "disease_state": "unresectable or metastatic", "histology_inclusion": "soft tissue sarcoma", "biomarker_inclusion": ["DDR pathway gene alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Niraparib", "disease_state": "unresectable or metastatic", "histology_inclusion": "uterine sarcoma", "biomarker_inclusion": ["DDR pathway gene alteration"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Niraparib", "histology_inclusion": "Soft Tissue Sarcoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "Niraparib", "histology_inclusion": "Uterine Corpus Sarcoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}]}
{"NCT_id": "NCT05580562", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "H3 K27M-mutant diffuse glioma", "biomarker_inclusion": [], "histology_exclusion": ["Primary spinal tumor", "Diffuse intrinsic pontine glioma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]], "histology_exclusion": ["Diffuse Intrinsic Pontine Glioma"]}]}
{"NCT_id": "NCT03589339", "json": [{"cohort": "Escalation Cohort 1", "disease_state": "inoperable LRR or R/M HNSCC", "histology_inclusion": "Squamous Cell Carcinoma of Head and Neck", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Escalation Cohort 2", "disease_state": "metastasized to the lung", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Escalation Cohort 3", "disease_state": "metastasized to the liver", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohorts 1 and 2", "disease_state": "inoperable LRR or R/M HNSCC", "histology_inclusion": "Squamous Cell Carcinoma of Head and Neck", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort 3", "disease_state": "inoperable metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort 3", "disease_state": "inoperable metastatic", "histology_inclusion": "malignant melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort 3", "disease_state": "inoperable metastatic", "histology_inclusion": "HCC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort 3", "disease_state": "inoperable metastatic", "histology_inclusion": "RCC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort 3", "disease_state": "inoperable metastatic", "histology_inclusion": "urothelial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort 3", "disease_state": "inoperable metastatic", "histology_inclusion": "cervical cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort 3", "disease_state": "inoperable metastatic", "histology_inclusion": "TNBC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Escalation Cohort 1", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Escalation Cohort 2"}, {"cohort": "Escalation Cohort 3"}, {"cohort": "Expansion Cohorts 1 and 2", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Expansion Cohort 3", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Expansion Cohort 3", "histology_inclusion": "Melanoma"}, {"cohort": "Expansion Cohort 3", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "Expansion Cohort 3", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "Expansion Cohort 3", "histology_inclusion": "Refractory Cytopenia of Childhood"}, {"cohort": "Expansion Cohort 3", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "Expansion Cohort 3", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "Expansion Cohort 3", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}]}
{"NCT_id": "NCT03719690", "json": [{"cohort": "AIM-HN", "disease_state": "", "histology_inclusion": "head and neck cancer (oral cavity, pharynx, larynx, sinonasal, nasopharyngeal, or unknown primary) of squamous histology", "biomarker_inclusion": ["HRAS mutation"], "histology_exclusion": ["salivary gland", "thyroid", "primary cutaneous squamous", "nonsquamous histologies (e.g. mucosal melanoma)"], "biomarker_exclusion": []}, {"cohort": "SEQ-HN", "disease_state": "", "histology_inclusion": "head and neck cancer (oral cavity, pharynx, larynx, sinonasal, nasopharyngeal, or unknown primary) of squamous histology", "biomarker_inclusion": ["HRAS wildtype"], "histology_exclusion": ["salivary gland", "thyroid", "primary cutaneous squamous", "nonsquamous histologies (e.g. mucosal melanoma)"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "AIM-HN", "histology_inclusion": "Malignant Head and Neck Neoplasm", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"]], "histology_exclusion": ["Mucosal Melanoma"]}, {"cohort": "AIM-HN", "histology_inclusion": "Head and Neck Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"]], "histology_exclusion": ["Mucosal Melanoma"]}, {"cohort": "SEQ-HN", "histology_inclusion": "Malignant Head and Neck Neoplasm", "biomarker_inclusion": [["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"]], "histology_exclusion": ["Mucosal Melanoma"]}, {"cohort": "SEQ-HN", "histology_inclusion": "Head and Neck Carcinoma", "biomarker_inclusion": [["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"]], "histology_exclusion": ["Mucosal Melanoma"]}]}
{"NCT_id": "NCT04995094", "json": [{"cohort": "", "disease_state": "Stage IIIB, IIIC, IIID", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": [], "histology_exclusion": ["uveal melanoma", "mucosal melanoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Cutaneous Melanoma", "histology_exclusion": ["Mucosal Melanoma", "Intraocular Melanoma"]}]}
{"NCT_id": "NCT05190315", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["recurrent high-grade glioma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "diffuse midline glioma", "biomarker_inclusion": [], "histology_exclusion": ["recurrent high-grade glioma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Gliosarcoma", "histology_exclusion": ["Malignant Glioma"]}, {"cohort": "", "histology_inclusion": "Glioma", "histology_exclusion": ["Malignant Glioma"]}]}
{"NCT_id": "NCT05385549", "json": [{"cohort": "", "disease_state": "High risk GIST according to Modified NIH criteria", "histology_inclusion": "Gastrointestinal Stromal Tumors (GIST) with CD117(+), DOG-1(+), or mutation in KIT or PDGFR\u03b1 gene", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PDGFR\u03b1 D842V mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["ANO1-High", "ANO1-High", "expression"], ["ANO1 Mutation", "ANO1-Mutation", "gene"], ["KIT-High", "KIT-High", "expression"], ["KIT Mutation", "KIT-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["ANO1-High", "ANO1-High", "expression"], ["ANO1 Mutation", "ANO1-Mutation", "gene"], ["KIT-High", "KIT-High", "expression"], ["KIT Mutation", "KIT-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["ANO1-High", "ANO1-High", "expression"], ["ANO1 Mutation", "ANO1-Mutation", "gene"], ["KIT-High", "KIT-High", "expression"], ["KIT Mutation", "KIT-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["ANO1-High", "ANO1-High", "expression"], ["ANO1 Mutation", "ANO1-Mutation", "gene"], ["KIT-High", "KIT-High", "expression"], ["KIT Mutation", "KIT-Mutation", "gene"]]}]}
{"NCT_id": "NCT05580770", "json": [{"cohort": "Phase 2 Dose Expansion A", "disease_state": "Advanced, metastatic or unresectable solid cancer", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["NRAS mutation"], "histology_exclusion": ["Central Nervous System metastases"], "biomarker_exclusion": []}, {"cohort": "Phase 2 Dose Expansion B", "disease_state": "Advanced, metastatic or unresectable solid cancer", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": ["Central Nervous System metastases"], "biomarker_exclusion": []}, {"cohort": "Phase 2 Dose Expansion C", "disease_state": "Advanced, metastatic or unresectable solid cancer", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["BRAF Class II mutation", "BRAF Class III mutation", "BRAF Fusion mutation"], "histology_exclusion": ["Central Nervous System metastases"], "biomarker_exclusion": []}, {"cohort": "Phase 2 Dose Expansion C", "disease_state": "Advanced, metastatic or unresectable solid cancer", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["BRAF Class II mutation", "BRAF Class III mutation", "BRAF Fusion mutation"], "histology_exclusion": ["Central Nervous System metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 2 Dose Expansion A", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"]]}, {"cohort": "Phase 2 Dose Expansion B", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "Phase 2 Dose Expansion C", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["BRAF Fusion", "BRAF", "fusion"], ["BRAF Class 3", "BRAF Class 3", "coordinate"], ["BRAF Class 2", "BRAF Class 2", "coordinate"]]}, {"cohort": "Phase 2 Dose Expansion C", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["BRAF Fusion", "BRAF", "fusion"], ["BRAF Class 3", "BRAF Class 3", "coordinate"], ["BRAF Class 2", "BRAF Class 2", "coordinate"]]}]}
{"NCT_id": "NCT02339571", "json": [{"cohort": "", "disease_state": "unresectable stage III or stage IV", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF wild-type", "BRAF mutated"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT02861898", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "glioblastoma multiforme (GBM)", "biomarker_inclusion": ["EGFR overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["EGFR-High", "EGFR-High", "expression"]]}]}
{"NCT_id": "NCT03263572", "json": [{"cohort": ">= 60 years of age with previously untreated Ph-positive ALL or lymphoid accelerated or blast phase CML", "disease_state": "untreated, relapsed, or refractory", "histology_inclusion": "Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia", "biomarker_inclusion": ["BCR-ABL positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": ">= 18 years of age with relapsed / refractory Ph-positive ALL or previously treated lymphoid accelerated or blast phase CML", "disease_state": "relapsed, refractory", "histology_inclusion": "Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia", "biomarker_inclusion": ["BCR-ABL positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": ">= 60 years of age with previously untreated Ph-positive ALL or lymphoid accelerated or blast phase CML", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["BCR - MTTP", "BCR - MTTP", "coordinate"], ["BCR - ABL1", "BCR - ABL1", "coordinate"], ["MTTP-High", "MTTP-High", "expression"]]}, {"cohort": ">= 18 years of age with relapsed / refractory Ph-positive ALL or previously treated lymphoid accelerated or blast phase CML", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["BCR - MTTP", "BCR - MTTP", "coordinate"], ["BCR - ABL1", "BCR - ABL1", "coordinate"], ["MTTP-High", "MTTP-High", "expression"]]}]}
{"NCT_id": "NCT03654833", "json": [{"cohort": "", "disease_state": "relapsed", "histology_inclusion": "malignant mesothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Mesothelioma"}]}
{"NCT_id": "NCT04345913", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": ["ER negative (less than 10%)", "PR negative (less than 10%)", "HER2 negative/unamplified"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with eribulin", "prior treatment with PI3K/mTOR/AKT pathway inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["PRH2-Low", "PRH2-Low", "expression"], ["TMEM37-Low", "TMEM37-Low", "expression"]]}]}
{"NCT_id": "NCT04541277", "json": [{"cohort": "", "disease_state": "relapsed or refractory AML", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": ["PD-L1 expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "elderly, unfit AML", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": ["PD-L1 expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "AML with positive minimal residual disease", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": ["PD-L1 expression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}]}
{"NCT_id": "NCT04606381", "json": [{"cohort": "Part 1 and Part 2", "disease_state": "metastatic or unresectable", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 1 and Part 2", "disease_state": "metastatic or unresectable", "histology_inclusion": "squamous cell carcinoma of the head and neck", "biomarker_inclusion": [], "histology_exclusion": ["leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 1 and Part 2", "disease_state": "metastatic or unresectable", "histology_inclusion": "hepatocellular cancer", "biomarker_inclusion": [], "histology_exclusion": ["leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 1 and Part 2", "disease_state": "metastatic or unresectable", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": ["leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 1 and Part 2", "disease_state": "metastatic or unresectable", "histology_inclusion": "renal cell cancer", "biomarker_inclusion": [], "histology_exclusion": ["leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 1 and Part 2", "disease_state": "metastatic or unresectable", "histology_inclusion": "medullary thyroid cancer", "biomarker_inclusion": [], "histology_exclusion": ["leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 1 and Part 2", "disease_state": "metastatic or unresectable", "histology_inclusion": "gastroesophageal cancer", "biomarker_inclusion": [], "histology_exclusion": ["leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 1 and Part 2", "disease_state": "metastatic or unresectable", "histology_inclusion": "mesothelioma", "biomarker_inclusion": [], "histology_exclusion": ["leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 1 and Part 2", "disease_state": "metastatic or unresectable", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 1 and Part 2", "disease_state": "metastatic or unresectable", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 3", "disease_state": "metastatic or unresectable", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": ["leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 1 and Part 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part 1 and Part 2", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Part 1 and Part 2", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "Part 1 and Part 2", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Part 1 and Part 2", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "Part 1 and Part 2", "histology_inclusion": "Thyroid Gland Medullary Carcinoma"}, {"cohort": "Part 1 and Part 2", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "Part 1 and Part 2", "histology_inclusion": "Mesothelioma"}, {"cohort": "Part 1 and Part 2", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "Part 1 and Part 2", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Part 1 and Part 2", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "Part 3", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04606446", "json": [{"cohort": "Part 1A (Monotherapy Dose Escalation)", "disease_state": "locally advanced or metastatic", "histology_inclusion": "ER+HER2- breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1A (Monotherapy Dose Escalation)", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Castration-resistant Prostate Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1A (Monotherapy Dose Escalation)", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1B, Part 1C and Part 1D (Combination Dose Escalation)", "disease_state": "locally advanced or metastatic", "histology_inclusion": "ER+HER2- breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2A (ER+HER2- breast cancer 2L+, monotherapy)", "disease_state": "locally advanced or metastatic", "histology_inclusion": "ER+HER2- breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2B (ER+HER2- breast cancer 2-4L, combination with fulvestrant)", "disease_state": "advanced or metastatic", "histology_inclusion": "ER+HER2- breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2D (ER+HER2- breast cancer 2-4L, combination with PF-07220060 (CDK4i) and fulvestrant)", "disease_state": "advanced or metastatic", "histology_inclusion": "ER+HER2- breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 1A (Monotherapy Dose Escalation)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 1A (Monotherapy Dose Escalation)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 1A (Monotherapy Dose Escalation)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 1A (Monotherapy Dose Escalation)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 1A (Monotherapy Dose Escalation)", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Part 1A (Monotherapy Dose Escalation)", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Part 1A (Monotherapy Dose Escalation)", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part 1B, Part 1C and Part 1D (Combination Dose Escalation)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 1B, Part 1C and Part 1D (Combination Dose Escalation)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 1B, Part 1C and Part 1D (Combination Dose Escalation)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 1B, Part 1C and Part 1D (Combination Dose Escalation)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 2A (ER+HER2- breast cancer 2L+, monotherapy)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 2A (ER+HER2- breast cancer 2L+, monotherapy)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 2A (ER+HER2- breast cancer 2L+, monotherapy)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 2A (ER+HER2- breast cancer 2L+, monotherapy)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 2B (ER+HER2- breast cancer 2-4L, combination with fulvestrant)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 2B (ER+HER2- breast cancer 2-4L, combination with fulvestrant)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 2B (ER+HER2- breast cancer 2-4L, combination with fulvestrant)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 2B (ER+HER2- breast cancer 2-4L, combination with fulvestrant)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 2D (ER+HER2- breast cancer 2-4L, combination with PF-07220060 (CDK4i) and fulvestrant)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 2D (ER+HER2- breast cancer 2-4L, combination with PF-07220060 (CDK4i) and fulvestrant)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 2D (ER+HER2- breast cancer 2-4L, combination with PF-07220060 (CDK4i) and fulvestrant)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Part 2D (ER+HER2- breast cancer 2-4L, combination with PF-07220060 (CDK4i) and fulvestrant)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}]}
{"NCT_id": "NCT03656718", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["ocular melanoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["ocular melanoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": ["ocular melanoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["ocular melanoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["MSI-H", "dMMR"], "histology_exclusion": ["ocular melanoma"], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "advanced or metastatic", "histology_inclusion": "other solid tumor types", "biomarker_inclusion": [], "histology_exclusion": ["ocular melanoma"], "biomarker_exclusion": []}, {"cohort": "Part E", "disease_state": "metastatic", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["ocular melanoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Ocular Melanoma"]}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Ocular Melanoma"]}, {"cohort": "", "histology_inclusion": "Melanoma", "histology_exclusion": ["Ocular Melanoma"]}, {"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma", "histology_exclusion": ["Ocular Melanoma"]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Ocular Melanoma"]}, {"cohort": "Part B", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Ocular Melanoma"]}, {"cohort": "Part E", "histology_inclusion": "Urothelial Carcinoma", "histology_exclusion": ["Ocular Melanoma"]}]}
{"NCT_id": "NCT04671849", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["NTRK fusion", "ROS1 fusion", "ALK fusion"], "histology_exclusion": ["primary central-nervous-system tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["ALK Fusion", "ALK", "fusion"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["ROS1 Fusion", "ROS1", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}]}
{"NCT_id": "NCT03396185", "json": [{"cohort": "", "disease_state": "stage IIIA-IIIB", "histology_inclusion": "lung adenocarcinoma", "biomarker_inclusion": ["EGFR 19 del", "EGFR 21 L858R"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"]]}]}
{"NCT_id": "NCT04606771", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "EGFRm+ NSCLC", "biomarker_inclusion": ["EGFR mutation", "MET amplification"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["MET-High", "MET-High", "expression"], ["EGFR-High", "EGFR-High", "expression"]]}]}
{"NCT_id": "NCT04737109", "json": [{"cohort": "Phase I de-escalation cohort", "disease_state": "castration resistant prostate cancer", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": ["small cell carcinoma prostate cancer"], "biomarker_exclusion": []}, {"cohort": "Phase II neoadjuvant cohort", "disease_state": "high risk localized or locally advanced prostate cancer", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["PI3K pathway activation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase I de-escalation cohort", "histology_inclusion": "Prostate Neoplasm", "histology_exclusion": ["Prostate Small Cell Neuroendocrine Carcinoma"]}, {"cohort": "Phase I de-escalation cohort", "histology_inclusion": "Prostate Carcinoma", "histology_exclusion": ["Prostate Small Cell Neuroendocrine Carcinoma"]}, {"cohort": "Phase II neoadjuvant cohort", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Phase II neoadjuvant cohort", "histology_inclusion": "Prostate Carcinoma"}]}
{"NCT_id": "NCT04802161", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "therapy-related", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "originating from prior hematologic malignancy", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["MDS", "CMML", "MPN"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "with myelodysplasia-related cytogenetic abnormalities", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["Complex karyotype", "-7/del(7q)", "Del(5q)/t(5q)/add(5q)", "+8", "i(17q)", "-17/add(17p) or del(17p)", "Del(20q)", "-13/del(13q)", "Del(11q)", "Del(12p)/t(12p)/add(12p)", "idicX(q13)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "with myelodysplasia-related mutations", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["ASXL1", "BCOR", "EZH2", "RUNX1", "SF3B1", "SRSF2", "STAG2", "U2AF1", "ZRSR2"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}]}
{"NCT_id": "NCT03526835", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases", "leptomeningeal involvement"], "biomarker_exclusion": []}, {"cohort": "HNSCC patients", "disease_state": "metastatic or locally advanced", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases", "leptomeningeal involvement"], "biomarker_exclusion": []}, {"cohort": "Gastric/gastroesophageal junction adenocarcinoma", "disease_state": "metastatic or locally advanced", "histology_inclusion": "gastric/gastroesophageal junction adenocarcinoma", "biomarker_inclusion": ["EGFR amplification (FISH score EGFR/CEP7 ratio \u22652.0, or NGS EGFR copy \u22658, or cfDNA >2.14, or EGFR IHC H-score \u2265200)"], "histology_exclusion": ["central nervous system metastases", "leptomeningeal involvement"], "biomarker_exclusion": []}, {"cohort": "NSCLC SCC patients", "disease_state": "metastatic or locally advanced", "histology_inclusion": "non-small cell lung cancer squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases", "leptomeningeal involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "HNSCC patients", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Gastric/gastroesophageal junction adenocarcinoma", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "NSCLC SCC patients", "histology_inclusion": "Squamous Cell Lung Carcinoma"}]}
{"NCT_id": "NCT03852511", "json": [{"cohort": "", "disease_state": "metastatic or advanced", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or advanced", "histology_inclusion": "squamous cell carcinoma of the head and neck", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or advanced", "histology_inclusion": "MSI high/dMMR cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or advanced", "histology_inclusion": "uterine/endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or advanced", "histology_inclusion": "cervical cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or advanced", "histology_inclusion": "oesophageal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or advanced", "histology_inclusion": "gastric cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or advanced", "histology_inclusion": "cutaneous squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or advanced", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or advanced", "histology_inclusion": "triple-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "", "histology_inclusion": "Esophageal Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "", "histology_inclusion": "Skin Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}]}
{"NCT_id": "NCT04047862", "json": [{"cohort": "Phase 1b Cohort 1", "disease_state": "metastatic", "histology_inclusion": "squamous NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort 2", "disease_state": "metastatic", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutation", "ALK fusion", "ROS1 fusion"]}, {"cohort": "Phase 1b Cohort 3", "disease_state": "metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["PD-L1 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort 4", "disease_state": "extensive-stage", "histology_inclusion": "SCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort 5", "disease_state": "stage IIIB, IIIC or IV", "histology_inclusion": "NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort 6", "disease_state": "metastatic", "histology_inclusion": "ESCC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort 7", "disease_state": "metastatic", "histology_inclusion": "EAC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort 8", "disease_state": "recurrent or metastatic", "histology_inclusion": "HNSCC", "biomarker_inclusion": ["PD-L1 positive, vCPS\u2265 1%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort 9", "disease_state": "metastatic", "histology_inclusion": "G/GEJ adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["squamous", "HER2 positive"], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort 10", "disease_state": "metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["PD-L1 positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1b Cohort 1", "histology_inclusion": "Squamous Cell Lung Carcinoma"}, {"cohort": "Phase 1b Cohort 2", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Phase 1b Cohort 3", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"]]}, {"cohort": "Phase 1b Cohort 4", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Phase 1b Cohort 5", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Phase 1b Cohort 6", "histology_inclusion": "Esophageal Squamous Cell Carcinoma"}, {"cohort": "Phase 1b Cohort 7"}, {"cohort": "Phase 1b Cohort 8", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"]]}, {"cohort": "Phase 1b Cohort 9", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Phase 1b Cohort 10", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"]]}]}
{"NCT_id": "NCT04737187", "json": [{"cohort": "", "disease_state": "Refractory Metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma"}]}
{"NCT_id": "NCT05323045", "json": [{"cohort": "Part 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["c-MET positive membrane staining", "MET amplification", "MET mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "renal cell carcinoma (PRCC + CCRCC)", "biomarker_inclusion": ["c-MET positive membrane staining", "MET amplification"], "histology_exclusion": [], "biomarker_exclusion": ["MET exon14m"]}, {"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "renal cell carcinoma (PRCC + CCRCC)", "biomarker_inclusion": ["c-MET positive membrane staining", "MET mutation"], "histology_exclusion": [], "biomarker_exclusion": ["MET exon14m"]}, {"cohort": "Cohort B", "disease_state": "locally advanced or metastatic", "histology_inclusion": "uveal melanoma (UM)", "biomarker_inclusion": ["c-MET positive membrane staining", "MET amplification"], "histology_exclusion": [], "biomarker_exclusion": ["MET exon14m"]}, {"cohort": "Cohort B", "disease_state": "locally advanced or metastatic", "histology_inclusion": "uveal melanoma (UM)", "biomarker_inclusion": ["c-MET positive membrane staining", "MET mutation"], "histology_exclusion": [], "biomarker_exclusion": ["MET exon14m"]}, {"cohort": "Cohort C", "disease_state": "locally advanced or metastatic", "histology_inclusion": "head and neck squamous cell carcinoma (HNSCC)", "biomarker_inclusion": ["c-MET positive membrane staining", "MET amplification"], "histology_exclusion": [], "biomarker_exclusion": ["MET exon14m"]}, {"cohort": "Cohort C", "disease_state": "locally advanced or metastatic", "histology_inclusion": "head and neck squamous cell carcinoma (HNSCC)", "biomarker_inclusion": ["c-MET positive membrane staining", "MET mutation"], "histology_exclusion": [], "biomarker_exclusion": ["MET exon14m"]}, {"cohort": "Cohort D", "disease_state": "locally advanced or metastatic", "histology_inclusion": "other cancers (non-RCC, non-UM and non-HNSCC)", "biomarker_inclusion": ["c-MET positive membrane staining", "MET amplification"], "histology_exclusion": [], "biomarker_exclusion": ["MET exon14m"]}, {"cohort": "Cohort D", "disease_state": "locally advanced or metastatic", "histology_inclusion": "other cancers (non-RCC, non-UM and non-HNSCC)", "biomarker_inclusion": ["c-MET positive membrane staining", "MET mutation"], "histology_exclusion": [], "biomarker_exclusion": ["MET exon14m"]}], "json_norm": [{"cohort": "Part 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MET Mutation", "MET-Mutation", "gene"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["SLTM Mutation", "SLTM-Mutation", "gene"]]}, {"cohort": "Cohort A", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [["PRCC-High", "PRCC-High", "expression"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}, {"cohort": "Cohort A", "histology_inclusion": "Papillary Renal Cell Carcinoma", "biomarker_inclusion": [["PRCC-High", "PRCC-High", "expression"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}, {"cohort": "Cohort A", "histology_inclusion": "Clear Cell Renal Cell Carcinoma", "biomarker_inclusion": [["PRCC-High", "PRCC-High", "expression"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}, {"cohort": "Cohort A", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [["PRCC-High", "PRCC-High", "expression"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["SLTM Mutation", "SLTM-Mutation", "gene"], ["MET Mutation", "MET-Mutation", "gene"]]}, {"cohort": "Cohort A", "histology_inclusion": "Papillary Renal Cell Carcinoma", "biomarker_inclusion": [["PRCC-High", "PRCC-High", "expression"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["SLTM Mutation", "SLTM-Mutation", "gene"], ["MET Mutation", "MET-Mutation", "gene"]]}, {"cohort": "Cohort A", "histology_inclusion": "Clear Cell Renal Cell Carcinoma", "biomarker_inclusion": [["PRCC-High", "PRCC-High", "expression"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["MET Mutation", "MET-Mutation", "gene"], ["SLTM Mutation", "SLTM-Mutation", "gene"]]}, {"cohort": "Cohort B", "histology_inclusion": "Intraocular Melanoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}, {"cohort": "Cohort B", "histology_inclusion": "Intraocular Melanoma", "biomarker_inclusion": [["MET Mutation", "MET-Mutation", "gene"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["SLTM Mutation", "SLTM-Mutation", "gene"]]}, {"cohort": "Cohort C", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}, {"cohort": "Cohort C", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["MET Mutation", "MET-Mutation", "gene"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["SLTM Mutation", "SLTM-Mutation", "gene"]]}, {"cohort": "Cohort D", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}, {"cohort": "Cohort D", "biomarker_inclusion": [["MET Mutation", "MET-Mutation", "gene"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["SLTM Mutation", "SLTM-Mutation", "gene"]]}]}
{"NCT_id": "NCT05388123", "json": [{"cohort": "Low dose Vemurafenib and Rituximab", "disease_state": "", "histology_inclusion": "Hairy Cell Leukemia", "biomarker_inclusion": ["BRAF V600E positive"], "histology_exclusion": [], "biomarker_exclusion": ["BRAF V600E mutation negative"]}], "json_norm": [{"cohort": "Low dose Vemurafenib and Rituximab", "histology_inclusion": "Hairy Cell Leukemia", "biomarker_inclusion": [["BRAF-High", "BRAF-High", "expression"], ["BRAF V600E", "V600E", "coordinate"]], "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT02407405", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Neurofibromatosis Type 1 (NF1)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Plexiform Neurofibromas (PN)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}, {"cohort": ""}]}
{"NCT_id": "NCT03787602", "json": [{"cohort": "Cohort 1, 3, 4", "disease_state": "metastatic", "histology_inclusion": "Merkel Cell Carcinoma", "biomarker_inclusion": ["p53 Wild-Type"], "histology_exclusion": ["Central Nervous System metastases"], "biomarker_exclusion": ["MDM2 antagonist therapies", "p53-directed therapies"]}, {"cohort": "Cohort 2", "disease_state": "metastatic", "histology_inclusion": "Merkel Cell Carcinoma", "biomarker_inclusion": ["p53 Wild-Type", "Anti-PD-1 treatment naive", "Anti-PD-L1 treatment naive"], "histology_exclusion": ["Central Nervous System metastases"], "biomarker_exclusion": ["MDM2 antagonist therapies", "p53-directed therapies"]}], "json_norm": [{"cohort": "Cohort 1, 3, 4", "histology_inclusion": "Merkel Cell Carcinoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Merkel Cell Carcinoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04997902", "json": [{"cohort": "PIK3CA-dependent (Cohort 1)", "disease_state": "Recurrent/Metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["PIK3CA mutation", "PIK3CA amplification"], "histology_exclusion": ["salivary gland", "thyroid", "primary cutaneous squamous", "mucosal melanoma"], "biomarker_exclusion": []}, {"cohort": "HRAS-dependent (Cohort 2)", "disease_state": "Recurrent/Metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["HRAS overexpression"], "histology_exclusion": ["salivary gland", "thyroid", "primary cutaneous squamous", "mucosal melanoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "PIK3CA-dependent (Cohort 1)", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["PIK3CA-High", "PIK3CA-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Mucosal Melanoma"]}, {"cohort": "HRAS-dependent (Cohort 2)", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["HRAS-High", "HRAS-High", "expression"]], "histology_exclusion": ["Mucosal Melanoma"]}]}
{"NCT_id": "NCT05453292", "json": [{"cohort": "EUS guided RFA", "disease_state": "resectable GISTs", "histology_inclusion": "Gastrointestinal Stromal Tumor (GIST)", "biomarker_inclusion": [], "histology_exclusion": ["Rectal GISTs"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "EUS guided RFA", "histology_inclusion": "Gastrointestinal Stromal Tumor"}]}
{"NCT_id": "NCT02407509", "json": [{"cohort": "Part IIA (COMPLETED)", "disease_state": "refractory", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["BRAF mutation", "KRAS mutation", "NRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part IIB", "disease_state": "refractory", "histology_inclusion": "multiple myeloma", "biomarker_inclusion": ["KRAS mutation", "NRAS mutation", "BRAF mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part IIC (COMPLETED)", "disease_state": "refractory", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["BRAF mutation", "KRAS mutation", "NRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part IID - Dose expansion", "disease_state": "refractory", "histology_inclusion": "lung cancer", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part IIA (COMPLETED)", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"]]}, {"cohort": "Part IIB", "histology_inclusion": "Plasma Cell Myeloma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"]]}, {"cohort": "Part IIC (COMPLETED)", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"]]}, {"cohort": "Part IID - Dose expansion", "histology_inclusion": "Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04802590", "json": [{"cohort": "", "disease_state": "Stage II-IV", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System Lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}]}
{"NCT_id": "NCT04997993", "json": [{"cohort": "", "disease_state": "Advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["PTEN-null"], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT03136146", "json": [{"cohort": "", "disease_state": "Relapsed/refractory", "histology_inclusion": "Acute Lymphoblastic Leukemia", "biomarker_inclusion": ["Philadelphia negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/refractory", "histology_inclusion": "Lymphoblastic Lymphoma", "biomarker_inclusion": ["Philadelphia negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/refractory", "histology_inclusion": "Acute Lymphoblastic Leukemia", "biomarker_inclusion": ["Philadelphia positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/refractory", "histology_inclusion": "Lymphoblastic Lymphoma", "biomarker_inclusion": ["Philadelphia positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/refractory", "histology_inclusion": "Burkitt Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/refractory", "histology_inclusion": "Burkitt Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/refractory", "histology_inclusion": "Double-Hit Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/refractory", "histology_inclusion": "Double-Hit Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Lymphoblastic Lymphoma"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Lymphoblastic Lymphoma"}, {"cohort": "", "histology_inclusion": "Burkitt Leukemia"}, {"cohort": "", "histology_inclusion": "Burkitt Lymphoma"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Double-Hit Lymphoma"}]}
{"NCT_id": "NCT04178460", "json": [{"cohort": "EXP-1 gastric cancer", "disease_state": "locally advanced or metastatic", "histology_inclusion": "gastric adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "EXP-1 gastric cancer", "disease_state": "locally advanced or metastatic", "histology_inclusion": "gastroesophageal junction adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "EXP-2 triple negative breast cancer", "disease_state": "metastatic or inoperable locally advanced", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": ["LAG-3 expression moderate or high"], "histology_exclusion": [], "biomarker_exclusion": ["HER2", "ER", "PR"]}, {"cohort": "EXP-3 biliary tract carcinoma", "disease_state": "", "histology_inclusion": "biliary tract carcinoma", "biomarker_inclusion": ["LAG-3 expression moderate or high"], "histology_exclusion": [], "biomarker_exclusion": ["IDH-1 mutations", "FGFR2 fusions"]}, {"cohort": "EXP-4 endometrial carcinoma", "disease_state": "advanced or metastatic", "histology_inclusion": "endometrial carcinoma", "biomarker_inclusion": ["LAG-3 expression moderate or high"], "histology_exclusion": ["carcinosarcomas", "endometrial leiomyosarcomas", "high-grade sarcomas", "endometrial stromal sarcomas"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "EXP-1 gastric cancer", "histology_inclusion": "Gastric Adenocarcinoma"}, {"cohort": "EXP-1 gastric cancer", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "EXP-2 triple negative breast cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "EXP-3 biliary tract carcinoma", "histology_inclusion": "Liver Cancer", "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["FGFR2 Fusion", "FGFR2", "fusion"]]}, {"cohort": "EXP-3 biliary tract carcinoma", "histology_inclusion": "Biliary Tract Carcinoma", "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["FGFR2 Fusion", "FGFR2", "fusion"]]}, {"cohort": "EXP-4 endometrial carcinoma", "histology_inclusion": "Endometrial Carcinoma", "histology_exclusion": ["Sarcoma"]}]}
{"NCT_id": "NCT04243616", "json": [{"cohort": "", "disease_state": "cT1-T3, cN0-N3, cM0", "histology_inclusion": "Invasive Breast Cancer", "biomarker_inclusion": ["HR+ (ER+ and/or PR+) HER2 negative", "PD-L1 and/or PD-L2 expression \u2265 1%"], "histology_exclusion": [], "biomarker_exclusion": ["HER2 positive"]}, {"cohort": "", "disease_state": "cT1-T3, cN0-N3, cM0", "histology_inclusion": "Invasive Breast Cancer", "biomarker_inclusion": ["HR- (ER- and PR-) HER2 negative/triple negative", "PD-L1 and/or PD-L2 expression \u2265 1%"], "histology_exclusion": [], "biomarker_exclusion": ["HER2 positive"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["PRH2-High", "PRH2-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["HR-High", "HR-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-Low", "HR-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["TMEM37-Low", "TMEM37-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04672434", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Squamous cell carcinoma of the head and neck", "biomarker_inclusion": [], "histology_exclusion": ["Central nervous system (CNS) malignancies"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-small-cell lung carcinoma-adenocarcinoma histology subtype", "biomarker_inclusion": [], "histology_exclusion": ["Central nervous system (CNS) malignancies"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Pancreatic ductal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Central nervous system (CNS) malignancies"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Central nervous system (CNS) malignancies"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Colorectal carcinoma", "biomarker_inclusion": ["microsatellite stable (MSS)", "microsatellite instability-high (MSI-H)"], "histology_exclusion": ["Central nervous system (CNS) malignancies"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Gastric carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Central nervous system (CNS) malignancies"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Esophageal carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Central nervous system (CNS) malignancies"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Mesothelioma", "biomarker_inclusion": [], "histology_exclusion": ["Central nervous system (CNS) malignancies"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Cervical carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Central nervous system (CNS) malignancies"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Cholangiocarcinoma"}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "", "histology_inclusion": "Esophageal Carcinoma"}, {"cohort": "", "histology_inclusion": "Mesothelioma"}, {"cohort": "", "histology_inclusion": "Cervical Carcinoma"}]}
{"NCT_id": "NCT04477200", "json": [{"cohort": "Phase 0 - Recurrent glioblastoma (GBM) / gliosarcoma (GS)", "disease_state": "recurrent", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [], "histology_exclusion": ["Gliomatosis cerebri pattern", "Leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Phase 0 - Recurrent glioblastoma (GBM) / gliosarcoma (GS)", "disease_state": "recurrent", "histology_inclusion": "Gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["Gliomatosis cerebri pattern", "Leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Phase 1 - Recurrent GBM / GS", "disease_state": "recurrent", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [], "histology_exclusion": ["Gliomatosis cerebri pattern", "Leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Phase 1 - Recurrent GBM / GS", "disease_state": "recurrent", "histology_inclusion": "Gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["Gliomatosis cerebri pattern", "Leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Phase 1 - Newly Diagnosed GBM / GS", "disease_state": "newly diagnosed", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [], "histology_exclusion": ["Gliomatosis cerebri pattern", "Leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Phase 1 - Newly Diagnosed GBM / GS", "disease_state": "newly diagnosed", "histology_inclusion": "Gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["Gliomatosis cerebri pattern", "Leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 0 - Recurrent glioblastoma (GBM) / gliosarcoma (GS)", "histology_inclusion": "Glioblastoma"}, {"cohort": "Phase 0 - Recurrent glioblastoma (GBM) / gliosarcoma (GS)", "histology_inclusion": "Gliosarcoma"}, {"cohort": "Phase 1 - Recurrent GBM / GS", "histology_inclusion": "Glioblastoma"}, {"cohort": "Phase 1 - Recurrent GBM / GS", "histology_inclusion": "Gliosarcoma"}, {"cohort": "Phase 1 - Newly Diagnosed GBM / GS", "histology_inclusion": "Glioblastoma"}, {"cohort": "Phase 1 - Newly Diagnosed GBM / GS", "histology_inclusion": "Gliosarcoma"}]}
{"NCT_id": "NCT04607421", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["MSI-H", "dMMR"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04802876", "json": [{"cohort": "cohort 1", "disease_state": "metastatic", "histology_inclusion": "PD1 mRNA high-expression", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD1", "anti-PDL1", "anti-PDL2"]}, {"cohort": "cohort 2", "disease_state": "metastatic", "histology_inclusion": "PD1 mRNA low-expression", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD1", "anti-PDL1", "anti-PDL2"]}], "json_norm": [{"cohort": "cohort 1", "biomarker_inclusion": [["PDCD1-High", "PDCD1-High", "expression"], ["SPATA2-High", "SPATA2-High", "expression"], ["SNCA-High", "SNCA-High", "expression"]]}, {"cohort": "cohort 1", "biomarker_inclusion": [["PDCD1-High", "PDCD1-High", "expression"], ["SPATA2-High", "SPATA2-High", "expression"], ["SNCA-High", "SNCA-High", "expression"]]}, {"cohort": "cohort 1", "biomarker_inclusion": [["PDCD1-High", "PDCD1-High", "expression"], ["SPATA2-High", "SPATA2-High", "expression"], ["SNCA-High", "SNCA-High", "expression"]]}, {"cohort": "cohort 2", "biomarker_inclusion": [["PDCD1-Low", "PDCD1-Low", "expression"], ["SPATA2-Low", "SPATA2-Low", "expression"], ["SNCA-Low", "SNCA-Low", "expression"]]}, {"cohort": "cohort 2", "biomarker_inclusion": [["PDCD1-Low", "PDCD1-Low", "expression"], ["SPATA2-Low", "SPATA2-Low", "expression"], ["SNCA-Low", "SNCA-Low", "expression"]]}, {"cohort": "cohort 2", "biomarker_inclusion": [["PDCD1-Low", "PDCD1-Low", "expression"], ["SPATA2-Low", "SPATA2-Low", "expression"], ["SNCA-Low", "SNCA-Low", "expression"]]}]}
{"NCT_id": "NCT05388669", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR Exon 19 deletion", "EGFR Exon 21 L858R mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT02146924", "json": [{"cohort": "", "disease_state": "relapsed, refractory, residual", "histology_inclusion": "acute lymphoblastic leukemia", "biomarker_inclusion": ["CD19+"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["CD19-High", "CD19-High", "expression"]]}]}
{"NCT_id": "NCT02734537", "json": [{"cohort": "", "disease_state": "Stage III or IVA", "histology_inclusion": "Squamous Cell Carcinoma of the Head and Neck", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III or IVA", "histology_inclusion": "Hypopharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III or IVA", "histology_inclusion": "Laryngeal Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III or IVA", "histology_inclusion": "Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III or IVA", "histology_inclusion": "Lip and Oral Cavity Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III or IVA", "histology_inclusion": "p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": ["p16 negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Hypopharyngeal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Laryngeal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Laryngeal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-Low", "H3P10-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]]}]}
{"NCT_id": "NCT03006172", "json": [{"cohort": "Stage I Arm A", "disease_state": "locally advanced, recurrent, or metastatic", "histology_inclusion": "PIK3CA mutant solid tumor malignancy, including breast cancer", "biomarker_inclusion": ["PIK3CA mutant"], "histology_exclusion": ["metaplastic breast cancer"], "biomarker_exclusion": []}, {"cohort": "Stages I and II, Arms B and C", "disease_state": "locally advanced or metastatic", "histology_inclusion": "PIK3CA-mutant HR+/HER2- breast cancer", "biomarker_inclusion": ["PIK3CA mutant", "HR+", "HER2-"], "histology_exclusion": ["metaplastic breast cancer"], "biomarker_exclusion": []}, {"cohort": "Stage II, Arms D, E, or F", "disease_state": "locally advanced or metastatic", "histology_inclusion": "PIK3CA-mutant HR+/HER2- breast cancer", "biomarker_inclusion": ["PIK3CA mutant", "HR+", "HER2-"], "histology_exclusion": ["metaplastic breast cancer"], "biomarker_exclusion": []}, {"cohort": "Stage II Arm G", "disease_state": "locally advanced or metastatic", "histology_inclusion": "PIK3CA-mutant HER2+ breast cancer", "biomarker_inclusion": ["PIK3CA mutant", "HER2+"], "histology_exclusion": ["metaplastic breast cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Stage I Arm A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}, {"cohort": "Stage I Arm A", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}, {"cohort": "Stages I and II, Arms B and C", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["HR Mutation", "HR-Mutation", "gene"], ["PIK3CA-High", "PIK3CA-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}, {"cohort": "Stages I and II, Arms B and C", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["HR Mutation", "HR-Mutation", "gene"], ["PIK3CA-High", "PIK3CA-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}, {"cohort": "Stages I and II, Arms B and C", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["HR Mutation", "HR-Mutation", "gene"], ["PIK3CA-High", "PIK3CA-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}, {"cohort": "Stages I and II, Arms B and C", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["HR Mutation", "HR-Mutation", "gene"], ["PIK3CA-High", "PIK3CA-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}, {"cohort": "Stages I and II, Arms B and C", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["HR Mutation", "HR-Mutation", "gene"], ["PIK3CA-High", "PIK3CA-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}, {"cohort": "Stages I and II, Arms B and C", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["HR Mutation", "HR-Mutation", "gene"], ["PIK3CA-High", "PIK3CA-High", "expression"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}, {"cohort": "Stage II, Arms D, E, or F", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["HR Mutation", "HR-Mutation", "gene"], ["PIK3CA-High", "PIK3CA-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}, {"cohort": "Stage II, Arms D, E, or F", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["HR Mutation", "HR-Mutation", "gene"], ["PIK3CA-High", "PIK3CA-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}, {"cohort": "Stage II, Arms D, E, or F", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["HR Mutation", "HR-Mutation", "gene"], ["PIK3CA-High", "PIK3CA-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}, {"cohort": "Stage II, Arms D, E, or F", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["HR Mutation", "HR-Mutation", "gene"], ["PIK3CA-High", "PIK3CA-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}, {"cohort": "Stage II, Arms D, E, or F", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["HR Mutation", "HR-Mutation", "gene"], ["PIK3CA-High", "PIK3CA-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}, {"cohort": "Stage II, Arms D, E, or F", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["HR Mutation", "HR-Mutation", "gene"], ["PIK3CA-High", "PIK3CA-High", "expression"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}, {"cohort": "Stage II Arm G", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["PIK3CA-High", "PIK3CA-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["ERBB2-High", "ERBB2-High", "expression"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}, {"cohort": "Stage II Arm G", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["PIK3CA-High", "PIK3CA-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["ERBB2-High", "ERBB2-High", "expression"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}, {"cohort": "Stage II Arm G", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["PIK3CA-High", "PIK3CA-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["ERBB2-High", "ERBB2-High", "expression"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}, {"cohort": "Stage II Arm G", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["PIK3CA-High", "PIK3CA-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}]}
{"NCT_id": "NCT03396926", "json": [{"cohort": "", "disease_state": "locally advanced unresectable or metastatic (stage IV)", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["MSS", "pMMR"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_exclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT03918278", "json": [{"cohort": "Part 2: Cohort A", "disease_state": "metastatic", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": ["PD-L1 CPS \u22651"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2: Cohort B", "disease_state": "recurrent non-operable", "histology_inclusion": "glioblastoma", "biomarker_inclusion": [], "histology_exclusion": ["carcinomatous meningitis", "tumor primarily localized to the brainstem or spinal cord"], "biomarker_exclusion": []}, {"cohort": "Part 2: Cohort C", "disease_state": "metastatic", "histology_inclusion": "pancreatic ductal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2: Cohort D", "disease_state": "metastatic", "histology_inclusion": "soft tissue sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2: Cohort E", "disease_state": "metastatic", "histology_inclusion": "non-squamous non-small cell lung carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["small cell lung cancer"], "biomarker_exclusion": ["EGFR", "ALK", "ROS1"]}], "json_norm": [{"cohort": "Part 2: Cohort A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Part 2: Cohort B", "histology_inclusion": "Glioblastoma"}, {"cohort": "Part 2: Cohort C", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma"}, {"cohort": "Part 2: Cohort D", "histology_inclusion": "Soft Tissue Sarcoma"}, {"cohort": "Part 2: Cohort E", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT04113616", "json": [{"cohort": "Part A", "disease_state": "relapsed or refractory AML, or newly-diagnosed AML secondary to MPN", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["TP53 mutation positive"]}, {"cohort": "Part B", "disease_state": "relapsed or refractory AML secondary to MPN (myelofibrosis [MF], polycythemia vera [PV], or essential thrombocythemia [ET])", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["acute promyelocytic leukemia (APL)"], "biomarker_exclusion": ["TP53 mutation positive"]}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Part B", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT04178798", "json": [{"cohort": "", "disease_state": "Early Stage CLL", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia"}]}
{"NCT_id": "NCT05453903", "json": [{"cohort": "Arm A", "disease_state": "relapsed/refractory", "histology_inclusion": "AML", "biomarker_inclusion": ["NPM1", "KMT2A"], "histology_exclusion": ["Acute promyelocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm A", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT03462342", "json": [{"cohort": "A", "disease_state": "Recurrent platinum-sensitive ovarian cancer", "histology_inclusion": "High grade serous ovarian, primary peritoneal, and/or fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "B", "disease_state": "Recurrent platinum-resistant ovarian cancer", "histology_inclusion": "High grade serous ovarian, primary peritoneal, and/or fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "C", "disease_state": "PARP inhibitor resistant, platinum-sensitive", "histology_inclusion": "High grade serous ovarian, primary peritoneal, and/or fallopian tube cancer", "biomarker_inclusion": ["Germline or somatic BRCA mutation", "HRD mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "D Part I", "disease_state": "Platinum sensitive/platinum resistant ovarian cancer", "histology_inclusion": "Non-mucinous epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "D Part II", "disease_state": "PARP inhibitor resistant, platinum-sensitive", "histology_inclusion": "Ovarian cancer", "biomarker_inclusion": ["Germline or somatic BRCA mutation", "HRD mutation"], "histology_exclusion": ["Brain metastases diagnosed within one year"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "A", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "B", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "C", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"], ["TBCE Mutation", "TBCE-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "D Part I", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "D Part II", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["Homologous Recombination Pathway", null, "pathway"], ["TBCE Mutation", "TBCE-Mutation", "gene"]]}, {"cohort": "D Part II", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"], ["TBCE Mutation", "TBCE-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04607668", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["pMMR", "MSS"], "histology_exclusion": ["central nervous system metastases", "leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT05063552", "json": [{"cohort": "", "disease_state": "metastatic or recurrent", "histology_inclusion": "squamous cell carcinoma of the head and neck (excluding SCC of salivary glands, and skin)", "biomarker_inclusion": ["PD-L1 expression >= 1% by CPS"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT03592888", "json": [{"cohort": "All subjects", "disease_state": "high risk of relapse and have no evidence of disease", "histology_inclusion": "pancreatic ductal adenocarcinoma", "biomarker_inclusion": ["KRAS(G12D-)", "KRAS(G12V-)", "KRAS(G12R-)", "KRAS(G12C-mutated)", "HLA-A02", "HLA-A03", "HLA-A11", "HLA-B07", "HLA-C08"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "All subjects", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"], ["KRAS-Low", "KRAS-Low", "expression"], ["KRAS G12V", "G12V", "coordinate"], ["KRAS G12R", "G12R", "coordinate"], ["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT04998669", "json": [{"cohort": "Relapsed or Refractory Follicular Lymphoma", "disease_state": "relapsed or refractory", "histology_inclusion": "Follicular Lymphoma (grade 1, 2 and 3A)", "biomarker_inclusion": ["CD19-positive", "CD20-positive"], "histology_exclusion": ["FL grade 3B", "transformed FL"], "biomarker_exclusion": ["central nervous system involvement of lymphoma"]}], "json_norm": [{"cohort": "Relapsed or Refractory Follicular Lymphoma", "histology_inclusion": "Follicular Lymphoma", "biomarker_inclusion": [["CD19-High", "CD19-High", "expression"], ["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Grade 3b Follicular Lymphoma"]}]}
{"NCT_id": "NCT05063786", "json": [{"cohort": "Cohort 1 (HER2+/HR-)", "disease_state": "Advanced", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["HER2+", "PIK3CA mutated", "HR-"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2 (HER2+/HR+)", "disease_state": "Advanced", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["HER2+", "PIK3CA mutated", "HR+"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1 (HER2+/HR-)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "Cohort 2 (HER2+/HR+)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-High", "HR-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}]}
{"NCT_id": "NCT05128773", "json": [{"cohort": "", "disease_state": "Stage IIB or Stage III", "histology_inclusion": "adenocarcinoma of the breast", "biomarker_inclusion": ["hormone receptor-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage IIB or Stage III", "histology_inclusion": "adenocarcinoma of the breast", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT05128825", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "high-grade serous ovarian, fallopian tube, or primary peritoneal cancer", "biomarker_inclusion": ["CCNE1 gene copy number amplification"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma"}]}
{"NCT_id": "NCT04412616", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["EGFR positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["EGFR-High", "EGFR-High", "expression"]]}]}
{"NCT_id": "NCT04412629", "json": [{"cohort": "", "disease_state": "progressed on first line therapy", "histology_inclusion": "high-grade neuroendocrine tumor", "biomarker_inclusion": ["Ki-67 >= 20%", "mitotic count > 20 mitoses per high power field", "poorly differentiated neoplasm", "necrosis", "p53 mutation", "RB mutation"], "histology_exclusion": ["small cell lung cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "progressed on first line therapy", "histology_inclusion": "high grade well differentiated neuroendocrine neoplasms", "biomarker_inclusion": [], "histology_exclusion": ["small cell lung cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "progressed on first line therapy", "histology_inclusion": "transformed NENs from a lower to a higher grade", "biomarker_inclusion": [], "histology_exclusion": ["small cell lung cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "progressed on first line therapy", "histology_inclusion": "high grade neoplasms with significant expression of neuroendocrine markers", "biomarker_inclusion": ["synaptophysin", "chromogranin", "INSM-1"], "histology_exclusion": ["small cell lung cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "progressed on first line therapy", "histology_inclusion": "unknown origin neoplasms with gene expression signatures consistent with neuroendocrine lineage", "biomarker_inclusion": ["CancerType ID"], "histology_exclusion": ["small cell lung cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "progressed on first line therapy", "histology_inclusion": "mixed neuroendocrine and non-neuroendocrine neoplasms (MiNEN)", "biomarker_inclusion": [], "histology_exclusion": ["small cell lung cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Neuroendocrine Carcinoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["RB1 Mutation", "RB1-Mutation", "gene"]], "histology_exclusion": ["Small Cell Lung Carcinoma"]}, {"cohort": "", "histology_inclusion": "Lung Neuroendocrine Neoplasm", "biomarker_inclusion": [["RB1 Mutation", "RB1-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"]], "histology_exclusion": ["Small Cell Lung Carcinoma"]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Tumor", "histology_exclusion": ["Small Cell Lung Carcinoma"]}, {"cohort": "", "histology_exclusion": ["Small Cell Lung Carcinoma"]}, {"cohort": "", "histology_exclusion": ["Small Cell Lung Carcinoma"]}, {"cohort": "", "histology_exclusion": ["Small Cell Lung Carcinoma"]}, {"cohort": "", "histology_exclusion": ["Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT03983993", "json": [{"cohort": "", "disease_state": "advanced, metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["RAS wildtype"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["MSI high"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["MSS"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT04933669", "json": [{"cohort": "", "disease_state": "High risk GIST", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": ["c-Kit (CD117) positive", "DOG-1 positive"], "histology_exclusion": [], "biomarker_exclusion": ["Asp842Val (D842V) mutation in Exon 18 of PDGFRA gene", "wild type (c-kit exon 9,11,13,17, and PDGFRA Exon 12,18)", "c-kit exon 9 mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["ANO1-High", "ANO1-High", "expression"], ["KIT-High", "KIT-High", "expression"]], "biomarker_exclusion": [["PDGFRA D842V", "D842V", "coordinate"]]}]}
{"NCT_id": "NCT04933695", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["KRAS G12C mutation", "PD-L1 TPS < 1%", "STK11 co-mutation"], "histology_exclusion": ["Mixed small-cell lung cancer and NSCLC"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"], ["STK11 Mutation", "STK11-Mutation", "gene"]], "histology_exclusion": ["Small Cell Lung Carcinoma", "Non-Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT05194072", "json": [{"cohort": "", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "High-grade serous epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "HER2-negative, HR positive breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "Triple-negative breast cancer (TNBC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "Endometrial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "Non-small cell lung cancer (Squamous cell carcinoma [SqCC], Adenocarcinoma [AC])", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "Cholangiocarcinoma or gallbladder carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "Adenoid cystic carcinoma (ACC) of the head and neck", "biomarker_inclusion": [], "histology_exclusion": ["Carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Cholangiocarcinoma"}, {"cohort": "", "histology_inclusion": "Gallbladder Carcinoma"}, {"cohort": "", "histology_inclusion": "Adenoid Cystic Carcinoma"}]}
{"NCT_id": "NCT01951469", "json": [{"cohort": "", "disease_state": "stage IV", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR activating mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04244552", "json": [{"cohort": "Monotherapy Cohorts", "disease_state": "Inoperable, locally advanced or metastatic, refractory to standard therapy or no standard therapy exists", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Monotherapy Cohorts", "disease_state": "Inoperable, locally advanced or metastatic, refractory to standard therapy or no standard therapy exists", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Monotherapy Cohorts", "disease_state": "Inoperable, locally advanced or metastatic, refractory to standard therapy or no standard therapy exists", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Monotherapy Cohorts", "disease_state": "Inoperable, locally advanced or metastatic, refractory to standard therapy or no standard therapy exists", "histology_inclusion": "Ovarian Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Monotherapy Cohorts", "disease_state": "Inoperable, locally advanced or metastatic, refractory to standard therapy or no standard therapy exists", "histology_inclusion": "Acral Lentiginous Melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Pembrolizumab Combination Therapy Cohort", "disease_state": "Inoperable, locally advanced or metastatic, prior or ongoing anti-PD-1 or anti-PD-L1 treatment", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["MSI-H", "dMMR"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Pembrolizumab Combination Therapy Cohort", "disease_state": "Inoperable, locally advanced or metastatic, prior or ongoing anti-PD-1 or anti-PD-L1 treatment", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["MSI-H", "dMMR"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Pembrolizumab Combination Therapy Cohort", "disease_state": "Inoperable, locally advanced or metastatic, prior or ongoing anti-PD-1 or anti-PD-L1 treatment", "histology_inclusion": "Melanoma", "biomarker_inclusion": ["BRAF mutant"], "histology_exclusion": ["Uveal Melanoma"], "biomarker_exclusion": []}, {"cohort": "Pembrolizumab Combination Therapy Cohort", "disease_state": "Inoperable, locally advanced or metastatic, prior or ongoing anti-PD-1 or anti-PD-L1 treatment", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Pembrolizumab Combination Therapy Cohort", "disease_state": "Inoperable, locally advanced or metastatic, prior or ongoing anti-PD-1 or anti-PD-L1 treatment", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Pembrolizumab Combination Therapy Cohort", "disease_state": "Inoperable, locally advanced or metastatic, prior or ongoing anti-PD-1 or anti-PD-L1 treatment", "histology_inclusion": "Esophageal Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Pembrolizumab Combination Therapy Cohort", "disease_state": "Inoperable, locally advanced or metastatic, prior or ongoing anti-PD-1 or anti-PD-L1 treatment", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Pembrolizumab Combination Therapy Cohort", "disease_state": "Inoperable, locally advanced or metastatic, prior or ongoing anti-PD-1 or anti-PD-L1 treatment", "histology_inclusion": "Triple Negative Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "PLD Combination Therapy Cohort", "disease_state": "Inoperable, locally advanced or metastatic, platinum-resistant", "histology_inclusion": "High-grade serous epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "PLD Combination Therapy Cohort", "disease_state": "Inoperable, locally advanced or metastatic, platinum-resistant", "histology_inclusion": "Fallopian tube carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "PLD Combination Therapy Cohort", "disease_state": "Inoperable, locally advanced or metastatic, platinum-resistant", "histology_inclusion": "Primary peritoneal carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "PLD Combination Therapy Cohort", "disease_state": "Inoperable, locally advanced or metastatic, refractory to other standard therapies", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Monotherapy Cohorts", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "Monotherapy Cohorts", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Monotherapy Cohorts", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Monotherapy Cohorts", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Monotherapy Cohorts", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "Monotherapy Cohorts", "histology_inclusion": "Acral Lentiginous Melanoma"}, {"cohort": "Pembrolizumab Combination Therapy Cohort", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Pembrolizumab Combination Therapy Cohort", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Pembrolizumab Combination Therapy Cohort", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"]], "histology_exclusion": ["Intraocular Melanoma"]}, {"cohort": "Pembrolizumab Combination Therapy Cohort", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "Pembrolizumab Combination Therapy Cohort", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Pembrolizumab Combination Therapy Cohort", "histology_inclusion": "Esophageal Squamous Cell Carcinoma"}, {"cohort": "Pembrolizumab Combination Therapy Cohort", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "Pembrolizumab Combination Therapy Cohort", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "PLD Combination Therapy Cohort", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "PLD Combination Therapy Cohort", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "PLD Combination Therapy Cohort", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "PLD Combination Therapy Cohort", "histology_inclusion": "Breast Carcinoma"}]}
{"NCT_id": "NCT05389462", "json": [{"cohort": "Part 1: Dose Escalation, ADCT-601 Combination Therapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Soft tissue sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 1: Dose Escalation, ADCT-601 Combination Therapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Bone sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 1: Dose Escalation, ADCT-601 Monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 1: Dose Escalation, ADCT-601 Monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 1: Dose Escalation, ADCT-601 Monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Solid tumors", "biomarker_inclusion": ["AXL gene amplification"], "histology_exclusion": ["CNS metastases", "leptomeningeal disease", "lymphomas"], "biomarker_exclusion": []}, {"cohort": "Part 2: Dose Expansion, ADCT-601 Monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Sarcoma", "biomarker_inclusion": ["AXL gene amplification"], "histology_exclusion": ["CNS metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 2: Dose Expansion, ADCT-601 Monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Ovarian/fallopian tube cancer/primary peritoneal cancer", "biomarker_inclusion": ["AXL gene amplification"], "histology_exclusion": ["CNS metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 2: Dose Expansion, ADCT-601 Monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Pancreatic cancer", "biomarker_inclusion": ["AXL gene amplification"], "histology_exclusion": ["CNS metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 2: Dose Expansion, ADCT-601 Monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Bladder cancer", "biomarker_inclusion": ["AXL gene amplification"], "histology_exclusion": ["CNS metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 2: Dose Expansion, ADCT-601 Monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Cervical cancer", "biomarker_inclusion": ["AXL gene amplification"], "histology_exclusion": ["CNS metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 2: Dose Expansion, ADCT-601 Monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Endometrial cancer", "biomarker_inclusion": ["AXL gene amplification"], "histology_exclusion": ["CNS metastases", "leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 1: Dose Escalation, ADCT-601 Combination Therapy", "histology_inclusion": "Soft Tissue Sarcoma"}, {"cohort": "Part 1: Dose Escalation, ADCT-601 Combination Therapy", "histology_inclusion": "Bone Sarcoma"}, {"cohort": "Part 1: Dose Escalation, ADCT-601 Monotherapy", "histology_inclusion": "Sarcoma"}, {"cohort": "Part 1: Dose Escalation, ADCT-601 Monotherapy", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part 1: Dose Escalation, ADCT-601 Monotherapy", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["AXL-High", "AXL-High", "expression"]]}, {"cohort": "Part 2: Dose Expansion, ADCT-601 Monotherapy", "histology_inclusion": "Sarcoma", "biomarker_inclusion": [["AXL-High", "AXL-High", "expression"]]}, {"cohort": "Part 2: Dose Expansion, ADCT-601 Monotherapy", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["AXL-High", "AXL-High", "expression"]]}, {"cohort": "Part 2: Dose Expansion, ADCT-601 Monotherapy", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [["AXL-High", "AXL-High", "expression"]]}, {"cohort": "Part 2: Dose Expansion, ADCT-601 Monotherapy", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["AXL-High", "AXL-High", "expression"]]}, {"cohort": "Part 2: Dose Expansion, ADCT-601 Monotherapy", "histology_inclusion": "Bladder Carcinoma", "biomarker_inclusion": [["AXL-High", "AXL-High", "expression"]]}, {"cohort": "Part 2: Dose Expansion, ADCT-601 Monotherapy", "histology_inclusion": "Bladder Neoplasm", "biomarker_inclusion": [["AXL-High", "AXL-High", "expression"]]}, {"cohort": "Part 2: Dose Expansion, ADCT-601 Monotherapy", "histology_inclusion": "Cervical Carcinoma", "biomarker_inclusion": [["AXL-High", "AXL-High", "expression"]]}, {"cohort": "Part 2: Dose Expansion, ADCT-601 Monotherapy", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["AXL-High", "AXL-High", "expression"]]}]}
{"NCT_id": "NCT05584670", "json": [{"cohort": "Cohort A", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "advanced unresectable or metastatic", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases", "leptomeningeal metastases"], "biomarker_exclusion": ["Child Pugh Class B or C liver score"]}, {"cohort": "Cohort C", "disease_state": "advanced unresectable or metastatic", "histology_inclusion": "gastric cancer", "biomarker_inclusion": ["CPS < 1", "non-MSI-H", "proficient MMR (pMMR)", "HER2/neu negative"], "histology_exclusion": ["brain metastases", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Cohort C", "disease_state": "advanced unresectable or metastatic", "histology_inclusion": "Siewert Type 2 & 3 gastro esophageal junction adenocarcinoma", "biomarker_inclusion": ["CPS < 1", "non-MSI-H", "proficient MMR (pMMR)", "HER2/neu negative"], "histology_exclusion": ["brain metastases", "leptomeningeal metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort B", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "Cohort C", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort C", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT02800486", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "glioblastoma multiforme (GBM)", "biomarker_inclusion": ["EGFR overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "anaplastic astrocytoma (AA)", "biomarker_inclusion": ["EGFR overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "anaplastic oligoastrocytoma (AOA)", "biomarker_inclusion": ["EGFR overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Anaplastic Astrocytoma", "biomarker_inclusion": [["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Anaplastic Oligoastrocytoma", "biomarker_inclusion": [["EGFR-High", "EGFR-High", "expression"]]}]}
{"NCT_id": "NCT03267433", "json": [{"cohort": "", "disease_state": "Minimal Residual Disease-Negative First Complete Remission", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["CD20 Positive", "Cyclin D1 Positive", "t(11;14)"], "histology_exclusion": ["Central Nervous System Involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Minimal Residual Disease-Negative First Complete Remission", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["CD20 Positive", "Cyclin D1 Negative", "SOX11+"], "histology_exclusion": ["Central Nervous System Involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"], ["CCND1-High", "CCND1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"], ["CCND1-Low", "CCND1-Low", "expression"], ["SOX11-High", "SOX11-High", "expression"]]}]}
{"NCT_id": "NCT03919071", "json": [{"cohort": "", "disease_state": "newly-diagnosed", "histology_inclusion": "high-grade glioma", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": ["intrinsic brainstem tumor", "primary spinal cord tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly-diagnosed", "histology_inclusion": "anaplastic astrocytoma", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": ["intrinsic brainstem tumor", "primary spinal cord tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly-diagnosed", "histology_inclusion": "anaplastic pleomorphic xanthoastrocytoma", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": ["intrinsic brainstem tumor", "primary spinal cord tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly-diagnosed", "histology_inclusion": "anaplastic ganglioglioma", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": ["intrinsic brainstem tumor", "primary spinal cord tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly-diagnosed", "histology_inclusion": "glioblastoma", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": ["intrinsic brainstem tumor", "primary spinal cord tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly-diagnosed", "histology_inclusion": "high-grade astrocytoma, not otherwise specified", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": ["intrinsic brainstem tumor", "primary spinal cord tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Glioma", "histology_exclusion": ["Spinal Cord Neoplasm"]}, {"cohort": "", "histology_inclusion": "Anaplastic Astrocytoma", "histology_exclusion": ["Spinal Cord Neoplasm"]}, {"cohort": "", "histology_inclusion": "Anaplastic Pleomorphic Xanthoastrocytoma", "histology_exclusion": ["Spinal Cord Neoplasm"]}, {"cohort": "", "histology_inclusion": "Anaplastic Ganglioglioma", "histology_exclusion": ["Spinal Cord Neoplasm"]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "histology_exclusion": ["Spinal Cord Neoplasm"]}, {"cohort": "", "histology_inclusion": "Anaplastic Astrocytoma", "histology_exclusion": ["Spinal Cord Neoplasm"]}]}
{"NCT_id": "NCT04543188", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Cohort 1", "disease_state": "advanced/metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "advanced/metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "advanced/metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Cohort 4", "disease_state": "advanced/metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Cohort 5", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Optional Cohort 6", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Optional Cohort 7", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort 1", "histology_inclusion": "Melanoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort 2", "histology_inclusion": "Melanoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort 3", "histology_inclusion": "Melanoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort 4", "histology_inclusion": "Melanoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort 5", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Optional Cohort 6", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Optional Cohort 7", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT04673448", "json": [{"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "pancreas cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "ovary cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT02408861", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": [], "histology_exclusion": ["pancreas", "prostate", "microsatellite stable colorectal cancer"], "biomarker_exclusion": []}, {"cohort": "relapsed refractory HIV-cHL expansion cohort", "disease_state": "relapsed/refractory", "histology_inclusion": "HIV-associated classical Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Kaposi sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Colorectal Carcinoma"], "biomarker_exclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "relapsed refractory HIV-cHL expansion cohort", "histology_inclusion": "Classic Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Sarcoma"}]}
{"NCT_id": "NCT04310007", "json": [{"cohort": "Step 1", "disease_state": "metastatic Stage IVA or IVB", "histology_inclusion": "non-squamous non-small cell lung carcinoma (NSCLC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR tyrosine kinase inhibitor (TKI) sensitizing mutations", "ALK gene rearrangements"]}], "json_norm": [{"cohort": "Step 1", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma"}, {"cohort": "Step 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04348045", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["histology other than PDAC"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma", "histology_exclusion": ["Pancreatic Ductal Adenocarcinoma"]}]}
{"NCT_id": "NCT04478279", "json": [{"cohort": "Dose Escalation", "disease_state": "locally advanced or metastatic", "histology_inclusion": "melanoma, carcinoma, or sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion HR+ Breast", "disease_state": "HR positive locally advanced or metastatic breast cancer", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["HR positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Melanoma", "disease_state": "advanced or metastatic melanoma", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion GBM", "disease_state": "recurrent or progressed primary glioblastoma", "histology_inclusion": "glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion CRPC", "disease_state": "castration-resistant prostate cancer", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Recurrent Glioblastoma", "disease_state": "recurrent glioblastoma", "histology_inclusion": "glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Newly Diagnosed Glioblastoma", "disease_state": "newly diagnosed glioblastoma", "histology_inclusion": "glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Escalation", "histology_inclusion": "Melanoma"}, {"cohort": "Dose Escalation", "histology_inclusion": "Sarcoma"}, {"cohort": "Dose Expansion HR+ Breast", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["HR-High", "HR-High", "expression"]]}, {"cohort": "Dose Expansion Melanoma", "histology_inclusion": "Melanoma"}, {"cohort": "Dose Expansion GBM", "histology_inclusion": "Glioblastoma"}, {"cohort": "Dose Expansion CRPC", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Dose Expansion CRPC", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Dose Expansion Recurrent Glioblastoma", "histology_inclusion": "Glioblastoma"}, {"cohort": "Newly Diagnosed Glioblastoma", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT05259696", "json": [{"cohort": "", "disease_state": "advanced or relapsed/refractory", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": ["untreated brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or relapsed/refractory", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["untreated brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or relapsed/refractory", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["prior anti-PD-(L)1 pathway therapy resistant"], "histology_exclusion": ["untreated brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or relapsed/refractory", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["mMSI-H", "dMMR", "prior anti-PD-(L)1 pathway therapy resistant"], "histology_exclusion": ["untreated brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or relapsed/refractory", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": ["untreated brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or relapsed/refractory", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["untreated brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or relapsed/refractory", "histology_inclusion": "gastric cancer", "biomarker_inclusion": [], "histology_exclusion": ["untreated brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or relapsed/refractory", "histology_inclusion": "esophagogastric junction cancer", "biomarker_inclusion": [], "histology_exclusion": ["untreated brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or relapsed/refractory", "histology_inclusion": "head and neck cancer", "biomarker_inclusion": ["prior anti-PD-(L)1 pathway therapy resistant"], "histology_exclusion": ["untreated brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or relapsed/refractory", "histology_inclusion": "urothelial cancer", "biomarker_inclusion": ["prior anti-PD-(L)1 pathway therapy resistant"], "histology_exclusion": ["untreated brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Malignant Head and Neck Neoplasm"}, {"cohort": "", "histology_inclusion": "Head and Neck Carcinoma"}, {"cohort": "", "histology_inclusion": "Urothelial Carcinoma"}]}
{"NCT_id": "NCT04310176", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["RAS mutations"], "histology_exclusion": [], "biomarker_exclusion": ["RAS wild type"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]], "biomarker_exclusion": [["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04608812", "json": [{"cohort": "", "disease_state": "recurrent/progressive", "histology_inclusion": "High-grade Glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent/progressive", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent/progressive", "histology_inclusion": "Glioblastoma Multiforme", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent/progressive", "histology_inclusion": "Anaplastic Astrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Glioma"}, {"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype"}, {"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Anaplastic Astrocytoma"}]}
{"NCT_id": "NCT04673942", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "malignant solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT05194735", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["active CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": ["active CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": ["active CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": ["active CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["active CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["active CNS metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Cholangiocarcinoma"}]}
{"NCT_id": "NCT04348292", "json": [{"cohort": "", "disease_state": "Stage I, II, IIIa", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04869475", "json": [{"cohort": "Refractory Solid Tumors", "disease_state": "refractory", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["rescuable p53 mutation"], "histology_exclusion": ["brain or meningeal metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Refractory Solid Tumors", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT05585320", "json": [{"cohort": "Phase 1", "disease_state": "advanced and unresectable, or metastatic", "histology_inclusion": "RAS-mutated solid tumor malignancy", "biomarker_inclusion": ["KRAS", "NRAS", "HRAS"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2a", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "NRAS-mutant melanoma", "biomarker_inclusion": ["NRAS"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2a", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "KRAS-mutant pancreatic ductal adenocarcinoma (PDAC)", "biomarker_inclusion": ["KRAS"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2a", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "KRAS-mutant non-small cell lung cancer (NSCLC)", "biomarker_inclusion": ["KRAS"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2a", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "KRAS-mutant and APC-wild-type colorectal cancer (CRC)", "biomarker_inclusion": ["KRAS", "APC-wild-type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "Phase 2a", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"]]}, {"cohort": "Phase 2a", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "Phase 2a", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "Phase 2a", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["APC APC-wild_type", "APC-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["APC APC-wild_type", "APC-wild_type", "wild_type"]]}, {"cohort": "Phase 2a", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["APC APC-wild_type", "APC-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["APC APC-wild_type", "APC-wild_type", "wild_type"]]}, {"cohort": "Phase 2a", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["APC APC-wild_type", "APC-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT00887146", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "World Health Organization (WHO) grade III anaplastic glioma", "biomarker_inclusion": ["1p/19q co-deletion", "IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "World Health Organization (WHO) grade II low grade glioma", "biomarker_inclusion": ["1p/19q co-deletion", "IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "WHO Grade III Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Low Grade Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT02670707", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Langerhans Cell Histiocytosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Langerhans Cell Histiocytosis"}]}
{"NCT_id": "NCT04115059", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Waldenstrom's Macroglobulinemia", "biomarker_inclusion": ["MYD88 mutation", "BTKCys481 mutation", "PLC\u03b32 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Waldenstrom Macroglobulinemia", "biomarker_inclusion": [["MYD88 Mutation", "MYD88-Mutation", "gene"], ["PLCG2 Mutation", "PLCG2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04180215", "json": [{"cohort": "All Patients", "disease_state": "Recurrent/Metastatic", "histology_inclusion": "HPV 16+ Cancer", "biomarker_inclusion": [], "histology_exclusion": ["Untreated and/or symptomatic metastatic central nervous system disease"], "biomarker_exclusion": []}, {"cohort": "Treatment Group 1, Group 3, Group 5, Group 6, Group A, or Group D", "disease_state": "Recurrent/Metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["HPV 16+"], "histology_exclusion": ["Untreated and/or symptomatic metastatic central nervous system disease"], "biomarker_exclusion": []}, {"cohort": "Treatment Group 2, Group 4, Group C, or Group F", "disease_state": "Recurrent/Metastatic", "histology_inclusion": "HPV 16+ Cancer", "biomarker_inclusion": [], "histology_exclusion": ["Untreated and/or symptomatic metastatic central nervous system disease"], "biomarker_exclusion": []}, {"cohort": "Treatment Group B or Group E", "disease_state": "Recurrent/Metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["HPV 16+"], "histology_exclusion": ["Untreated and/or symptomatic metastatic central nervous system disease"], "biomarker_exclusion": []}, {"cohort": "Anal Cancer Cohort", "disease_state": "Locally Advanced or Metastatic", "histology_inclusion": "HPV 16+ Squamous Cell Carcinoma of Anal Canal", "biomarker_inclusion": [], "histology_exclusion": ["Untreated and/or symptomatic metastatic central nervous system disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "All Patients"}, {"cohort": "Treatment Group 1, Group 3, Group 5, Group 6, Group A, or Group D", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Treatment Group 2, Group 4, Group C, or Group F"}, {"cohort": "Treatment Group B or Group E", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Anal Cancer Cohort", "histology_inclusion": "Anal Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT04739202", "json": [{"cohort": "Group 1", "disease_state": "advanced/metastatic", "histology_inclusion": "gastric or gastroesophageal junction adenocarcinomas", "biomarker_inclusion": ["EBV positive", "MSI-high"], "histology_exclusion": [], "biomarker_exclusion": ["HER2 overexpression"]}, {"cohort": "Group 2", "disease_state": "advanced/metastatic", "histology_inclusion": "gastric or gastroesophageal junction adenocarcinomas", "biomarker_inclusion": ["genomically stable tumors"], "histology_exclusion": [], "biomarker_exclusion": ["HER2 overexpression"]}, {"cohort": "Group 3", "disease_state": "advanced/metastatic", "histology_inclusion": "gastric or gastroesophageal junction adenocarcinomas", "biomarker_inclusion": ["chromosomal instability"], "histology_exclusion": [], "biomarker_exclusion": ["HER2 overexpression"]}], "json_norm": [{"cohort": "Group 1", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Group 2", "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Group 3", "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04999761", "json": [{"cohort": "Cohort A-1 and A-2", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B-1", "disease_state": "advanced or metastatic", "histology_inclusion": "pancreatic ductal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B-2", "disease_state": "unresectable metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["MSS", "pMMR"], "histology_exclusion": ["liver metastases"], "biomarker_exclusion": []}, {"cohort": "Cohort B-3", "disease_state": "unresectable metastatic", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR gene mutation", "ALK fusion gene", "ROS1 fusion gene", "BRAF gene mutation", "MET exon 14 skipping", "NTRK fusion gene", "RET fusion gene", "KRAS gene mutation"]}, {"cohort": "Cohort D-1", "disease_state": "unresectable metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["PD-L1 (\u2265 50% tumor proportion score)"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR gene mutation", "ALK fusion gene", "ROS1 fusion gene", "BRAF gene mutation", "MET exon 14 skipping", "NTRK fusion gene", "RET fusion gene", "KRAS gene mutation"]}, {"cohort": "Cohort E-1", "disease_state": "unresectable metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["PD-L1 (\u2265 50% tumor proportion score)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort E-2", "disease_state": "unresectable metastatic", "histology_inclusion": "alveolar soft part sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A-1 and A-2", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Cohort B-1", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma"}, {"cohort": "Cohort B-2", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Cohort B-3", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["RET Fusion", "RET", "fusion"], ["NTRK1 Fusion", "NTRK1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["MET exon 14 del", "exon 14 del", "exon"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}, {"cohort": "Cohort D-1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["RET Fusion", "RET", "fusion"], ["NTRK1 Fusion", "NTRK1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["MET exon 14 del", "exon 14 del", "exon"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}, {"cohort": "Cohort E-1", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort E-2", "histology_inclusion": "Alveolar Soft Part Sarcoma"}]}
{"NCT_id": "NCT04180371", "json": [{"cohort": "Phase I (dose escalation phase, with BT5528 alone or in combination with nivolumab)", "disease_state": "metastatic recurrent", "histology_inclusion": "malignant solid tumors historically known for high EphA2 tumor expression", "biomarker_inclusion": [], "histology_exclusion": ["untreated CNS metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Phase II (dose expansion phase, with BT5528 alone)", "disease_state": "metastatic recurrent", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["untreated CNS metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Phase II (dose expansion phase, with BT5528 alone)", "disease_state": "metastatic recurrent", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["untreated CNS metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Phase II (dose expansion phase, with BT5528 alone)", "disease_state": "metastatic recurrent", "histology_inclusion": "triple-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["untreated CNS metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Phase II (dose expansion phase, with BT5528 alone)", "disease_state": "metastatic recurrent", "histology_inclusion": "gastric/upper gastrointestinal cancer", "biomarker_inclusion": [], "histology_exclusion": ["untreated CNS metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Phase II (dose expansion phase, with BT5528 alone)", "disease_state": "metastatic recurrent", "histology_inclusion": "head and neck cancer", "biomarker_inclusion": [], "histology_exclusion": ["untreated CNS metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Phase II (dose expansion phase, with BT5528 alone)", "disease_state": "metastatic recurrent", "histology_inclusion": "urothelial cancer", "biomarker_inclusion": [], "histology_exclusion": ["untreated CNS metastases", "leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase I (dose escalation phase, with BT5528 alone or in combination with nivolumab)", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["EPHA2-High", "EPHA2-High", "expression"]]}, {"cohort": "Phase II (dose expansion phase, with BT5528 alone)", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Phase II (dose expansion phase, with BT5528 alone)", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Phase II (dose expansion phase, with BT5528 alone)", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "Phase II (dose expansion phase, with BT5528 alone)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Phase II (dose expansion phase, with BT5528 alone)", "histology_inclusion": "Digestive System Neoplasm"}, {"cohort": "Phase II (dose expansion phase, with BT5528 alone)", "histology_inclusion": "Malignant Head and Neck Neoplasm"}, {"cohort": "Phase II (dose expansion phase, with BT5528 alone)", "histology_inclusion": "Head and Neck Carcinoma"}, {"cohort": "Phase II (dose expansion phase, with BT5528 alone)", "histology_inclusion": "Urothelial Carcinoma"}]}
{"NCT_id": "NCT04310592", "json": [{"cohort": "", "disease_state": "Primary or Secondary acute myeloid leukemia (AML) in first or second Morphological Complete Remission (CR), Morphological Complete Remission with incomplete hematologic recovery (CRi), or Morphologic Leukemia-free State (MLFS)", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": ["bi-phenotypic acute leukemia", "acute promyelocytic leukemia (APL)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/Refractory (R/R) AML", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": ["bi-phenotypic acute leukemia", "acute promyelocytic leukemia (APL)"], "biomarker_exclusion": []}, {"cohort": "MRD positive population only", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": ["minimal residual disease (MRD) positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Acute Leukemia"]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Acute Leukemia"]}, {"cohort": "MRD positive population only"}]}
{"NCT_id": "NCT04739358", "json": [{"cohort": "Monotherapy", "disease_state": "metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["MET Exon 14 skipping mutation", "MET amplifications (MET/CEP7 \u2265 4 using FISH)", "MET fusions"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Combination Therapy", "disease_state": "metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["EGFR alterations", "ALK alterations", "MET-driven acquired resistance"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Monotherapy", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["SLTM Fusion", "SLTM", "fusion"], ["MET exon 14 del", "exon 14 del", "exon"], ["MET Fusion", "MET", "fusion"]]}, {"cohort": "Combination Therapy", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK Mutation", "ALK-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT05130060", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma originating from the colon or the rectal", "biomarker_inclusion": ["microsatellite stable"], "histology_exclusion": [], "biomarker_exclusion": ["high microsatellite instability (MSI H)", "central nervous system (CNS) metastases"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04348747", "json": [{"cohort": "", "disease_state": "Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Malignant Neoplasm in the Brain, Prognostic Stage IV Breast Cancer AJCC v8", "histology_inclusion": "Triple-Negative Breast Carcinoma", "biomarker_inclusion": ["HER2 Negative", "ER <= 1%", "PR <= 1%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Malignant Neoplasm in the Brain, Prognostic Stage IV Breast Cancer AJCC v8", "histology_inclusion": "HER2+ Breast Cancer", "biomarker_inclusion": ["HER2 Positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04544111", "json": [{"cohort": "Cohort A-BRAF WT tumors", "disease_state": "Radioiodine-Refractory", "histology_inclusion": "differentiated thyroid cancer of follicular origin", "biomarker_inclusion": ["non-V600- BRAF mutations", "BRAF translocations"], "histology_exclusion": ["Symptomatic metastatic brain or leptomeningeal tumors"], "biomarker_exclusion": ["BRAFV600- mutation"]}, {"cohort": "Cohort B-BRAF Mutant", "disease_state": "Radioiodine-Refractory", "histology_inclusion": "differentiated thyroid cancer of follicular origin", "biomarker_inclusion": ["BRAFV600- mutation"], "histology_exclusion": ["Symptomatic metastatic brain or leptomeningeal tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A-BRAF WT tumors", "histology_inclusion": "Differentiated Thyroid Gland Carcinoma", "biomarker_inclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"], ["BRAF Fusion", "BRAF", "fusion"], ["BRAF-Low", "BRAF-Low", "expression"]]}, {"cohort": "Cohort B-BRAF Mutant", "histology_inclusion": "Differentiated Thyroid Gland Carcinoma"}]}
{"NCT_id": "NCT04544189", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "ER+ and/or PgR+ breast cancer", "biomarker_inclusion": ["PIK3CA mutation"], "histology_exclusion": ["HER2-negative breast cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["EREG-High", "EREG-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Breast Carcinoma"], "biomarker_exclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["EREG-High", "EREG-High", "expression"], ["PGR-High", "PGR-High", "expression"]], "histology_exclusion": ["Breast Carcinoma"], "biomarker_exclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT05520567", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": ["FLT3 mutation (ITD or TKD [D835/I836])"], "histology_exclusion": ["Acute promyelocytic leukemia (APL)", "central nervous system (CNS) involvement with AML", "myeloproliferative neoplasm (MPN)", "myelofibrosis", "essential thrombocythemia", "polycythemia vera", "chronic myeloid leukemia (CML) with or without BCR-ABL1 translocation", "AML with BCR-ABL1 translocation"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]], "histology_exclusion": ["Myeloproliferative Neoplasm", "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Myelofibrosis", "Acute Promyelocytic Leukemia with PML-RARA", "Essential Thrombocythemia", "Polycythemia Vera", "Acute Myeloid Leukemia (AML)", "Myelodysplastic/Myeloproliferative Disease"], "biomarker_exclusion": [["ABL1 Fusion", "ABL1", "fusion"], ["BCR Fusion", "BCR", "fusion"], ["BCR - ABL1", "BCR - ABL1", "coordinate"]]}]}
{"NCT_id": "NCT04245722", "json": [{"cohort": "FT596 Monotherapy, Lymphoma", "disease_state": "relapsed/refractory", "histology_inclusion": "B-cell Lymphoma", "biomarker_inclusion": ["CD19", "CD20"], "histology_exclusion": ["CNS involvement by malignancy"], "biomarker_exclusion": []}, {"cohort": "FT596 in Combination with Rituximab, Lymphoma", "disease_state": "relapsed/refractory", "histology_inclusion": "B-cell Lymphoma", "biomarker_inclusion": ["CD19", "CD20"], "histology_exclusion": ["CNS involvement by malignancy"], "biomarker_exclusion": []}, {"cohort": "FT596 in Combination with Obinutuzumab, Lymphoma", "disease_state": "relapsed/refractory", "histology_inclusion": "B-cell Lymphoma", "biomarker_inclusion": ["CD19", "CD20"], "histology_exclusion": ["CNS involvement by malignancy"], "biomarker_exclusion": []}, {"cohort": "FT596 Monotherapy, CLL", "disease_state": "relapsed/refractory", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement by malignancy"], "biomarker_exclusion": []}, {"cohort": "FT596 in Combination with Obinutuzumab, CLL", "disease_state": "relapsed/refractory", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement by malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "FT596 Monotherapy, Lymphoma", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma"}, {"cohort": "FT596 in Combination with Rituximab, Lymphoma", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma"}, {"cohort": "FT596 in Combination with Obinutuzumab, Lymphoma", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma"}, {"cohort": "FT596 Monotherapy, CLL", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "FT596 in Combination with Obinutuzumab, CLL", "histology_inclusion": "Chronic Lymphocytic Leukemia"}]}
{"NCT_id": "NCT04869943", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["AR+", "ER+", "HER2-"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["AKR1B1-High", "AKR1B1-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["AR-High", "AR-High", "expression"], ["EREG-High", "EREG-High", "expression"]]}]}
{"NCT_id": "NCT04870034", "json": [{"cohort": "", "disease_state": "operable", "histology_inclusion": "lung adenocarcinoma", "biomarker_inclusion": ["KRAS-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "operable", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["KRAS-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "operable", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["KRAS-positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["KRAS-High", "KRAS-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS-High", "KRAS-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["KRAS-High", "KRAS-High", "expression"]]}]}
{"NCT_id": "NCT03203525", "json": [{"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "malignancies with predominant hepatic metastasis", "biomarker_inclusion": ["PI3K pathway aberration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm A", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer with predominant hepatic metastases", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B", "disease_state": "predominant hepatic metastases", "histology_inclusion": "malignancies with predominant hepatic metastasis", "biomarker_inclusion": ["PI3K pathway aberration"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["PI3K/AKT/mTOR pathway", null, "pathway"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "Arm A", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Arm B", "biomarker_inclusion": [["PI3K/AKT/mTOR pathway", null, "pathway"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}]}
{"NCT_id": "NCT04115631", "json": [{"cohort": "", "disease_state": "untreated", "histology_inclusion": "mantle cell lymphoma", "biomarker_inclusion": ["cyclin D1 (BCL1) expression", "t(11;14)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma"}]}
{"NCT_id": "NCT04245839", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "follicular lymphoma (FL) (Grade 1, 2 or 3a)", "biomarker_inclusion": [], "histology_exclusion": ["composite Diffuse large B-cell lymphoma (DLBCL) and FL", "transformed FL", "WHO subclassification of duodenal-type FL"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "marginal zone lymphoma (MZL)", "biomarker_inclusion": [], "histology_exclusion": ["composite Diffuse large B-cell lymphoma (DLBCL) and FL", "transformed FL", "WHO subclassification of duodenal-type FL"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Follicular Lymphoma", "histology_exclusion": ["Diffuse Large B-Cell Lymphoma"]}, {"cohort": "", "histology_inclusion": "Marginal Zone Lymphoma", "histology_exclusion": ["Diffuse Large B-Cell Lymphoma"]}]}
{"NCT_id": "NCT04479306", "json": [{"cohort": "", "disease_state": "Stage IIIB/IV or recurrent", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR exon 21 L858R", "EGFR exon 19 deletion", "EGFR T790M"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR T790M", "T790M", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT04739800", "json": [{"cohort": "", "disease_state": "recurrent platinum-resistant", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent platinum-resistant", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent platinum-resistant", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent platinum-resistant", "histology_inclusion": "high grade serous carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent platinum-resistant", "histology_inclusion": "grade 3 endometrioid carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent platinum-resistant", "histology_inclusion": "clear cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent platinum-resistant", "histology_inclusion": "low grade serous carcinoma", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent platinum-resistant", "histology_inclusion": "grade 1 or 2 endometrioid carcinoma", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent platinum-resistant", "histology_inclusion": "mixed epithelial carcinoma", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent platinum-resistant", "histology_inclusion": "undifferentiated carcinoma", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent platinum-resistant", "histology_inclusion": "mucinous carcinoma", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Ovarian Serous Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Endometrioid Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Endometrial Clear Cell Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Serous Adenocarcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Endometrioid Adenocarcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Epithelial Neoplasm", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Undifferentiated Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Mucinous Adenocarcinoma", "biomarker_inclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Ovarian Mucinous Adenocarcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT05000294", "json": [{"cohort": "", "disease_state": "advanced and unresectable, or metastatic", "histology_inclusion": "bile duct or gallbladder cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H", "dMMR"]}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "breast cancer, HR-negative HER2-positive", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H", "dMMR"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "neuroendocrine cancer, grade 2 or 3; well- or moderately- differentiated", "biomarker_inclusion": [], "histology_exclusion": ["Grades 1, 4, and poorly differentiated neuroendocrine pathologies"], "biomarker_exclusion": ["MSI-H", "dMMR"]}, {"cohort": "", "disease_state": "FIGO stage IV or metastatic", "histology_inclusion": "high grade serious or high grade endometrioid ovarian cancer, primary peritoneal cancer and / or fallopian-tube cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H", "dMMR"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H", "dMMR"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "soft tissue sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H", "dMMR"]}, {"cohort": "", "disease_state": "castrate-resistant", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H", "dMMR"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "vulvar cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H", "dMMR"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Gallbladder Carcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Carcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Tumor", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Ovarian Endometrioid Adenocarcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Soft Tissue Sarcoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Vulvar Carcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Vulvar Neoplasm", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT05390710", "json": [{"cohort": "Phase I", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II", "disease_state": "locally advanced or metastatic", "histology_inclusion": "TNBC", "biomarker_inclusion": ["HER2 negative", "ER negative", "PR negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase I", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase II", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["PRH2-Low", "PRH2-Low", "expression"], ["TMEM37-Low", "TMEM37-Low", "expression"]]}]}
{"NCT_id": "NCT03008187", "json": [{"cohort": "", "disease_state": "Relapsed AML unsuitable for intensive chemotherapy and not eligible for any approved targeted therapy", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Primary refractory AML unsuitable for intensive chemotherapy and not eligible for any approved targeted therapy", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT03725059", "json": [{"cohort": "", "disease_state": "localized invasive breast ductal adenocarcinoma, T1c-T2 (tumor size \u22652 cm), cN1-cN2, or T3-T4, cN0-cN2", "histology_inclusion": "ER+/HER2-, Grade 3 breast cancer of ductal histology", "biomarker_inclusion": [], "histology_exclusion": ["breast cancer with lobular histology"], "biomarker_exclusion": ["ER-, progesterone receptor positive breast cancer"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Ductal Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]], "histology_exclusion": ["Breast Carcinoma"], "biomarker_exclusion": [["EREG-Low", "EREG-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Ductal Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]], "histology_exclusion": ["Breast Carcinoma"], "biomarker_exclusion": [["EREG-Low", "EREG-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}]}
{"NCT_id": "NCT04674813", "json": [{"cohort": "", "disease_state": "relapsed and/or refractory", "histology_inclusion": "multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system involvement of MM", "plasma cell leukemia", "Waldenstrom's macroglobulinemia", "POEMS syndrome", "clinically significant amyloidosis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Plasma Cell Leukemia", "Amyloidosis", "Waldenstrom Macroglobulinemia"]}]}
{"NCT_id": "NCT05000450", "json": [{"cohort": "ALLO-605, ALLO-647", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System involvement", "leptomeningeal involvement", "plasma cell leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "ALLO-605, ALLO-647", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Plasma Cell Leukemia"]}]}
{"NCT_id": "NCT05521048", "json": [{"cohort": "Single Arm Open Label", "disease_state": "", "histology_inclusion": "Neurofibromatosis Type 2", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Single Arm Open Label"}]}
{"NCT_id": "NCT03855371", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "myelodysplastic syndromes", "biomarker_inclusion": ["p53 mutants predicted to respond to ATO+DAC"], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["AADAC-High", "AADAC-High", "expression"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["AADAC Mutation", "AADAC-Mutation", "gene"]]}]}
{"NCT_id": "NCT04246086", "json": [{"cohort": "", "disease_state": "R/R", "histology_inclusion": "Follicular Lymphoma Grade 1, 2, or 3a", "biomarker_inclusion": ["CD20 positive"], "histology_exclusion": ["Grade 3b FL", "Transformation and/or diffuse large B-cell lymphoma (DLBCL)", "Central nervous system (CNS) lymphoma or leptomeningeal infiltration"], "biomarker_exclusion": ["HIV positive"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Follicular Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Grade 3b Follicular Lymphoma", "Diffuse Large B-Cell Lymphoma"]}]}
{"NCT_id": "NCT03008408", "json": [{"cohort": "", "disease_state": "advanced or recurrent", "histology_inclusion": "endometrial carcinoma (endometrioid and mixed endometrioid tumors, any grade)", "biomarker_inclusion": [], "histology_exclusion": ["uterine sarcomas", "carcinosarcomas", "serous tumors (any component)", "pure clear cell carcinomas"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "histology_exclusion": ["Sarcoma", "Ovarian Serous Adenocarcinoma"]}, {"cohort": "", "histology_inclusion": "Endometrioid Adenocarcinoma", "histology_exclusion": ["Sarcoma", "Ovarian Serous Adenocarcinoma"]}]}
{"NCT_id": "NCT04181060", "json": [{"cohort": "", "disease_state": "stage IIIB, stage IV, recurrent stage I-III", "histology_inclusion": "non-squamous, non-small cell lung cancer (NSCLC)", "biomarker_inclusion": ["EGFR Exon 19 deletion", "EGFR L858R", "EGFR E709X", "EGFR G719X", "EGFR exon 19 insertions", "EGFR L861Q", "EGFR S768I"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR exon 20 insertions"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR exon 19 del", "exon 19 del", "exon"], ["EGFR L858R", "L858R", "coordinate"], ["EGFR L861Q", "L861Q", "coordinate"], ["EGFR S768I", "S768I", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"], ["EGFR S768I", "S768I", "coordinate"], ["EGFR L861Q", "L861Q", "coordinate"]]}]}
{"NCT_id": "NCT04675060", "json": [{"cohort": "Cohort 1", "disease_state": "Advanced", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": ["ALK fusion", "ROS1 fusion", "MET mutation", "MET amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Advanced", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": ["ALK fusion", "ROS1 fusion", "MET mutation", "MET amplification"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["MET Mutation", "MET-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"], ["SLTM Mutation", "SLTM-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["MET Mutation", "MET-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"], ["SLTM Mutation", "SLTM-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"]]}]}
{"NCT_id": "NCT04740190", "json": [{"cohort": "interventional arm", "disease_state": "recurrent", "histology_inclusion": "WHO grade 3-4 glioma", "biomarker_inclusion": ["IDH mutation", "PTEN mutation"], "histology_exclusion": [], "biomarker_exclusion": ["Prior therapy with PARP inhibitor"]}, {"cohort": "interventional arm", "disease_state": "recurrent", "histology_inclusion": "WHO grade 3-4 glioma", "biomarker_inclusion": ["BRCAness signature (ATM, ATR, BAP1, BRCA1, BRCA2, CDK12, CHEK1, CHEK2, FANCA, FANCC, FANCD2, FANCE, FANCF, PALB2, NGS1, WRN, RAD50, RAD51B, RAD51C, RAD51D, MRE11A, BLM, BRIP1)"], "histology_exclusion": [], "biomarker_exclusion": ["Prior therapy with PARP inhibitor"]}], "json_norm": [{"cohort": "interventional arm", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"]]}, {"cohort": "interventional arm", "histology_inclusion": "Glioma"}]}
{"NCT_id": "NCT05130866", "json": [{"cohort": "", "disease_state": "Progressive", "histology_inclusion": "NF2 mutated meningioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Meningioma", "biomarker_inclusion": [["NF2 Mutation", "NF2-Mutation", "gene"]]}]}
{"NCT_id": "NCT05456256", "json": [{"cohort": "", "disease_state": "advanced (Stage III or IV)", "histology_inclusion": "primary adenocarcinoma of the lung", "biomarker_inclusion": ["MET exon14 skipping mutations", "ALK", "EGFR", "NTRK fusions"], "histology_exclusion": ["small cell", "squamous cell", "large cell", "undifferentiated", "mesothelioma", "mixed histopathological diagnosis of primary lung cancer", "metastatic adenocarcinoma arising from any primary site other than the lung"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"], ["NTRK1 Fusion", "NTRK1", "fusion"]], "histology_exclusion": ["Mesothelioma", "Lung Carcinoma"]}]}
{"NCT_id": "NCT04116073", "json": [{"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "adenosquamous carcinoma of the pancreas", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "adenosquamous carcinoma of the ampulla", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Adenosquamous Carcinoma"}, {"cohort": "", "histology_inclusion": "Cervical Adenosquamous Carcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Adenosquamous Carcinoma"}]}
{"NCT_id": "NCT05000801", "json": [{"cohort": "", "disease_state": "AML with persistent MRD", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["WT1", "hTERT", "survivin"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "AML with molecular relapse after induction and consolidation chemotherapy", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["WT1", "hTERT", "survivin"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "AML with molecular relapse after allogeneic stem cell transplant", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["WT1", "hTERT", "survivin"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}]}
{"NCT_id": "NCT02867592", "json": [{"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "Ewing Sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "Rhabdomyosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "Non-rhabdomyosarcoma Soft Tissue Sarcomas", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "Osteosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "Wilms Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "Medullary Thyroid Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "Hepatoblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "Adrenal Cortex Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "Pediatric Solid Tumors", "biomarker_inclusion": ["MET amplification", "overexpression", "activating mutation", "MET translocation", "MET exon skipping mutations", "activating RET mutations", "RET rearrangement", "overexpression or activation of AXL"], "histology_exclusion": ["Central Nervous System tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ewing Sarcoma"}, {"cohort": "", "histology_inclusion": "Rhabdomyosarcoma"}, {"cohort": "", "histology_inclusion": "Sarcoma"}, {"cohort": "", "histology_inclusion": "Osteosarcoma"}, {"cohort": "", "histology_inclusion": "Wilms Tumor"}, {"cohort": "", "histology_inclusion": "Thyroid Gland Medullary Carcinoma"}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "", "histology_inclusion": "Hepatoblastoma"}, {"cohort": "", "histology_inclusion": "Adrenal Cortex Carcinoma"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"], ["RET Fusion", "RET", "fusion"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["MET Mutation", "MET-Mutation", "gene"], ["SLTM Fusion", "SLTM", "fusion"], ["SLTM Mutation", "SLTM-Mutation", "gene"], ["MET Fusion", "MET", "fusion"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT04544995", "json": [{"cohort": "Part 1", "disease_state": "recurrent or refractory", "histology_inclusion": "osteosarcoma", "biomarker_inclusion": ["BRCAness mutational signature 3"], "histology_exclusion": ["central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "recurrent or refractory", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": ["BRCAness mutational signature 3"], "histology_exclusion": ["central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "recurrent or refractory", "histology_inclusion": "adrenocortical carcinoma", "biomarker_inclusion": ["BRCAness mutational signature 3"], "histology_exclusion": ["central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "recurrent or refractory", "histology_inclusion": "Ewing sarcoma", "biomarker_inclusion": ["BRCAness mutational signature 3"], "histology_exclusion": ["central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "recurrent or refractory", "histology_inclusion": "rhabdomyosarcoma", "biomarker_inclusion": ["BRCAness mutational signature 3"], "histology_exclusion": ["central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part 2A", "disease_state": "recurrent or refractory", "histology_inclusion": "osteosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2B", "disease_state": "recurrent or refractory", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 1", "histology_inclusion": "Osteosarcoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Part 1", "histology_inclusion": "Neuroblastoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Part 1", "histology_inclusion": "Adrenal Cortex Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Part 1", "histology_inclusion": "Ewing Sarcoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Part 1", "histology_inclusion": "Rhabdomyosarcoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Part 2A", "histology_inclusion": "Osteosarcoma"}, {"cohort": "Part 2B", "histology_inclusion": "Neuroblastoma"}]}
{"NCT_id": "NCT05261269", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "HER2-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Dose Expansion (DAN-222)", "disease_state": "metastatic", "histology_inclusion": "HER2-negative breast cancer", "biomarker_inclusion": ["HRD-positive"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Dose Expansion (DAN-222)", "disease_state": "metastatic", "histology_inclusion": "HER2-negative breast cancer", "biomarker_inclusion": ["HRD-negative"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Dose Expansion (DAN-222 + niraparib, HRD-positive)", "disease_state": "metastatic", "histology_inclusion": "HER2-negative breast cancer", "biomarker_inclusion": ["HRD-positive"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Dose Expansion (DAN-222 + niraparib, HRD-negative)", "disease_state": "metastatic", "histology_inclusion": "HER2-negative breast cancer", "biomarker_inclusion": ["HRD-negative"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Dose Expansion (DAN-222)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["TBCE-High", "TBCE-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Dose Expansion (DAN-222)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["TBCE-Low", "TBCE-Low", "expression"]]}, {"cohort": "Dose Expansion (DAN-222 + niraparib, HRD-positive)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["TBCE-High", "TBCE-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Dose Expansion (DAN-222 + niraparib, HRD-negative)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["TBCE-Low", "TBCE-Low", "expression"]]}]}
{"NCT_id": "NCT03921021", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "gastroesophageal adenocarcinoma", "biomarker_inclusion": ["PD-L1 positive"], "histology_exclusion": ["active central nervous system metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"]]}]}
{"NCT_id": "NCT04116320", "json": [{"cohort": "Cohort 1", "disease_state": "Advanced", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": ["Uveal Melanoma"], "biomarker_exclusion": []}, {"cohort": "Cohort 1", "disease_state": "Advanced", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1", "disease_state": "Advanced", "histology_inclusion": "Merkel Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1", "disease_state": "Advanced", "histology_inclusion": "Squamous Cell Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1", "disease_state": "Advanced", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1", "disease_state": "Advanced", "histology_inclusion": "Cervical Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1", "disease_state": "Advanced", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1", "disease_state": "Advanced", "histology_inclusion": "Ovarian Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1", "disease_state": "Advanced", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1", "disease_state": "Advanced", "histology_inclusion": "Small-cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1", "disease_state": "Advanced", "histology_inclusion": "Microsatellite Instability High", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1", "disease_state": "Advanced", "histology_inclusion": "Gastric Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1", "disease_state": "Advanced", "histology_inclusion": "Esophageal Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Advanced", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Advanced", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Advanced", "histology_inclusion": "Merkel Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Advanced", "histology_inclusion": "Squamous Cell Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Advanced", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Advanced", "histology_inclusion": "Cervical Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Advanced", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Advanced", "histology_inclusion": "Ovarian Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Advanced", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Advanced", "histology_inclusion": "Small-cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Advanced", "histology_inclusion": "Microsatellite Instability High", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Advanced", "histology_inclusion": "Gastric Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Advanced", "histology_inclusion": "Esophageal Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Melanoma", "histology_exclusion": ["Intraocular Melanoma"]}, {"cohort": "Cohort 1", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "Cohort 1", "histology_inclusion": "Merkel Cell Carcinoma"}, {"cohort": "Cohort 1", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "Cohort 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 1", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "Cohort 1", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "Cohort 1", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Cohort 1", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "Cohort 1", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "Cohort 1", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Cohort 1", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort 1", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort 1", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "Cohort 1", "histology_inclusion": "Esophageal Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Melanoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Merkel Cell Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Cohort 2", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "Cohort 2", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Cohort 2", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort 2", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Esophageal Carcinoma"}]}
{"NCT_id": "NCT04870840", "json": [{"cohort": "", "disease_state": "locally advanced unresectable", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": ["HPV-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced unresectable", "histology_inclusion": "hypopharyngeal squamous cell carcinoma", "biomarker_inclusion": ["HPV-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced unresectable", "histology_inclusion": "laryngeal squamous cell carcinoma", "biomarker_inclusion": ["HPV-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced unresectable", "histology_inclusion": "nasopharyngeal squamous cell carcinoma", "biomarker_inclusion": ["HPV-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced unresectable", "histology_inclusion": "oral cavity squamous cell carcinoma", "biomarker_inclusion": ["HPV-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced unresectable", "histology_inclusion": "oropharyngeal squamous cell carcinoma", "biomarker_inclusion": ["HPV-negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Hypopharyngeal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Laryngeal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Nasopharyngeal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT05261399", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR exon19 deletion", "EGFR L858R mutation", "EGFR T790M"], "histology_exclusion": ["predominant squamous NSCLC", "small cell lung cancer"], "biomarker_exclusion": ["MET inhibitors treatment", "third-generation EGFR-TKI other than Osimertinib"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR T790M", "T790M", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]], "histology_exclusion": ["Squamous Cell Lung Carcinoma", "Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT05326425", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation (L858R, Exon 19 deletion, G719X, L861Q)"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with lazertinib"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR L861Q", "L861Q", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT05326464", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["MGMT unmethylated", "IDH wild type", "EGFR gene amplification"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with EGFR inhibitor", "prior treatment with JAK inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["EGFR-High", "EGFR-High", "expression"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04116541", "json": [{"cohort": "HDM201-Ribociclib", "disease_state": "metastatic or unresectable locally advanced", "histology_inclusion": "malignancy", "biomarker_inclusion": ["CDK6 amplification", "CDK4 amplification", "CDKN2A homozygous deletion", "CCND1 amplification", "CCND3 amplification", "RB1 no deletion/losses more than single copy", "P53 wild-type"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cabozantinib", "disease_state": "metastatic or unresectable locally advanced", "histology_inclusion": "malignancy", "biomarker_inclusion": ["AXL activating mutations or amplification", "MET activating mutations or amplification", "VEGFR activating mutations or amplification", "VEGF activating mutations or amplification", "KIT activating mutations or amplification", "RET activating mutations or amplification", "ROS1 activating mutations or amplification", "MER activating mutations or amplification", "TRKB activating mutations or amplification", "FLT3 activating mutations or amplification", "TIE-2 activating mutations or amplification", "Tyro3 activating mutations or amplification", "NTRK translocation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Alectinib", "disease_state": "metastatic or unresectable locally advanced", "histology_inclusion": "malignancy", "biomarker_inclusion": ["ALK translocation", "ALK mutation", "ALK amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Regorafenib", "disease_state": "metastatic or unresectable locally advanced", "histology_inclusion": "malignancy", "biomarker_inclusion": ["VEGFR1-3 activating mutations or amplification", "TIE-2 activating mutations or amplification", "KIT activating mutations or amplification", "RET activating mutations or amplification", "RAF1 activating mutations or amplification", "BRAF activating mutations or amplification (other than V600 mutations)", "CRAF activating mutations or amplification", "HRAS activating mutations or amplification", "KRAS activating mutations or amplification", "PDGFR activating mutations or amplification", "FGFR1-2 activating mutations or amplification", "FLT3 activating mutations or amplification", "CSF1R activating mutations or amplification", "ligands amplification", "SMAD4 biallelic inactivation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Trametinib", "disease_state": "metastatic or unresectable locally advanced", "histology_inclusion": "malignancy", "biomarker_inclusion": ["KRAS activating mutations or amplification", "NRAS activating mutations or amplification", "HRAS activating mutations or amplification", "MAP2K activating mutations or amplification", "NF1 biallelic inactivation", "PTPN11 activating mutation", "BRAF amplification or translocation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Trametinib + Dabrafenib", "disease_state": "metastatic or unresectable locally advanced", "histology_inclusion": "malignancy", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "HDM201-Ribociclib", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["CCND3-High", "CCND3-High", "expression"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["CDK6-High", "CDK6-High", "expression"], ["CCND1-High", "CCND1-High", "expression"], ["CDK4-High", "CDK4-High", "expression"]]}, {"cohort": "Cabozantinib", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"], ["TYRO3 Mutation", "TYRO3-Mutation", "gene"], ["NTRK1 Fusion", "NTRK1", "fusion"], ["VEGFA Mutation", "VEGFA-Mutation", "gene"], ["MERTK Mutation", "MERTK-Mutation", "gene"], ["KDR Mutation", "KDR-Mutation", "gene"], ["MET Mutation", "MET-Mutation", "gene"], ["TEK Mutation", "TEK-Mutation", "gene"], ["FLT3 Mutation", "FLT3-Mutation", "gene"], ["NTRK2 Mutation", "NTRK2-Mutation", "gene"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["AXL Mutation", "AXL-Mutation", "gene"], ["SLTM Mutation", "SLTM-Mutation", "gene"], ["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"], ["NTRK2 Fusion", "NTRK2", "fusion"], ["KIT Mutation", "KIT-Mutation", "gene"]]}, {"cohort": "Alectinib", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"], ["ALK Mutation", "ALK-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Regorafenib", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"], ["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["PDGFRB Mutation", "PDGFRB-Mutation", "gene"], ["TEK Mutation", "TEK-Mutation", "gene"], ["FLT3 Mutation", "FLT3-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["CSF1R Mutation", "CSF1R-Mutation", "gene"], ["RAF1 Mutation", "RAF1-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["FLT1 Mutation", "FLT1-Mutation", "gene"], ["RNASE3 Mutation", "RNASE3-Mutation", "gene"], ["KIT Mutation", "KIT-Mutation", "gene"]]}, {"cohort": "Trametinib", "biomarker_inclusion": [["BRAF-High", "BRAF-High", "expression"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["PTPN11 Mutation", "PTPN11-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"]]}, {"cohort": "Trametinib + Dabrafenib"}]}
{"NCT_id": "NCT04181684", "json": [{"cohort": "", "disease_state": "recurrent or progressive", "histology_inclusion": "WHO Grade II-IV glioma", "biomarker_inclusion": [], "histology_exclusion": ["infratentorial tumor", "leptomeningeal spread"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioma"}]}
{"NCT_id": "NCT04246671", "json": [{"cohort": "Stage 2: Chordoma Cancer Cohort", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Chordoma", "biomarker_inclusion": ["Brachyury"], "histology_exclusion": ["Central Nervous System"], "biomarker_exclusion": []}, {"cohort": "Stage 2: HER2-positive Breast Cancer Cohort (Trastuzumab + TAEK-VAC-HerBy)", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "HER2-positive Breast Cancer", "biomarker_inclusion": ["HER2"], "histology_exclusion": ["Central Nervous System"], "biomarker_exclusion": []}, {"cohort": "Stage 2: HER2-positive Breast Cancer Cohort (Trastuzumab + Pertuzumab + TAEK-VAC-HerBy)", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "HER2-positive Breast Cancer", "biomarker_inclusion": ["HER2"], "histology_exclusion": ["Central Nervous System"], "biomarker_exclusion": []}, {"cohort": "Stage 2: HER2-positive Gastric/GEJ cancer cohort (Trastuzumab + TAEK-VAC-HerBy)", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "HER2-positive Gastric/Gastroesophageal Junction Cancer", "biomarker_inclusion": ["HER2"], "histology_exclusion": ["Central Nervous System"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Stage 2: Chordoma Cancer Cohort", "histology_inclusion": "Chordoma"}, {"cohort": "Stage 2: HER2-positive Breast Cancer Cohort (Trastuzumab + TAEK-VAC-HerBy)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Stage 2: HER2-positive Breast Cancer Cohort (Trastuzumab + Pertuzumab + TAEK-VAC-HerBy)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Stage 2: HER2-positive Gastric/GEJ cancer cohort (Trastuzumab + TAEK-VAC-HerBy)", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04415008", "json": [{"cohort": "Newly-diagnosed CEBPA Double Mutated Acute Myeloid Leukemia", "disease_state": "", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["CEBPA double mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Newly-diagnosed CEBPA Double Mutated Acute Myeloid Leukemia", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["CEBPA Mutation", "CEBPA-Mutation", "gene"]]}]}
{"NCT_id": "NCT05001282", "json": [{"cohort": "", "disease_state": "advanced, recurrent or refractory", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["FR\u03b1 overexpressing"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, recurrent or refractory", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["FR\u03b1 overexpressing"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, recurrent or refractory", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["FR\u03b1 overexpressing"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, recurrent or refractory", "histology_inclusion": "gastric cancer", "biomarker_inclusion": ["FR\u03b1 overexpressing"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, recurrent or refractory", "histology_inclusion": "gastroesophageal junction cancer", "biomarker_inclusion": ["FR\u03b1 overexpressing"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, recurrent or refractory", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": ["FR\u03b1 overexpressing"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, recurrent or refractory", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["FR\u03b1 overexpressing"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, recurrent or refractory", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": ["FR\u03b1 overexpressing"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["FOLR1-High", "FOLR1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["FOLR1-High", "FOLR1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["FOLR1-High", "FOLR1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["FOLR1-High", "FOLR1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["FOLR1-High", "FOLR1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["FOLR1-High", "FOLR1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["FOLR1-High", "FOLR1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["FOLR1-High", "FOLR1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["FOLR1-High", "FOLR1-High", "expression"]]}]}
{"NCT_id": "NCT05261490", "json": [{"cohort": "", "disease_state": "Platinum-resistant recurrent", "histology_inclusion": "Epithelial Ovarian Cancer", "biomarker_inclusion": [], "histology_exclusion": ["Non-epithelial histology", "Malignant mixed Mullerian tumors", "Ovarian tumors with low malignant potential (borderline tumors)", "Low grade serous ovarian cancer", "Carcinosarcoma", "Central Nervous System (CNS) metastases", "Carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Platinum-resistant recurrent", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Non-epithelial histology", "Malignant mixed Mullerian tumors", "Ovarian tumors with low malignant potential (borderline tumors)", "Low grade serous ovarian cancer", "Carcinosarcoma", "Central Nervous System (CNS) metastases", "Carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Platinum-resistant recurrent", "histology_inclusion": "Primary Peritoneal Carcinomas", "biomarker_inclusion": [], "histology_exclusion": ["Non-epithelial histology", "Malignant mixed Mullerian tumors", "Ovarian tumors with low malignant potential (borderline tumors)", "Low grade serous ovarian cancer", "Carcinosarcoma", "Central Nervous System (CNS) metastases", "Carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "histology_exclusion": ["Carcinosarcoma", "Invasive Ovarian Micropapillary Serous Carcinoma", "Malignant Ovarian Neoplasm", "Ovarian Epithelial Cancer", "Malignant Mixed Mesodermal (Mullerian) Tumor"]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "histology_exclusion": ["Carcinosarcoma", "Invasive Ovarian Micropapillary Serous Carcinoma", "Malignant Ovarian Neoplasm", "Ovarian Epithelial Cancer", "Malignant Mixed Mesodermal (Mullerian) Tumor"]}, {"cohort": "", "histology_exclusion": ["Carcinosarcoma", "Invasive Ovarian Micropapillary Serous Carcinoma", "Malignant Ovarian Neoplasm", "Ovarian Epithelial Cancer", "Malignant Mixed Mesodermal (Mullerian) Tumor"]}]}
{"NCT_id": "NCT05326516", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "AML", "biomarker_inclusion": ["KMT2A rearrangement", "KMT2A amplification", "NPM1c", "NUP98"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "ALL", "biomarker_inclusion": ["KMT2A rearrangement", "KMT2A amplification", "NPM1c", "NUP98"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "acute leukemias of ambiguous lineage", "biomarker_inclusion": ["KMT2A rearrangement", "KMT2A amplification", "NPM1c", "NUP98"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "MPAL", "biomarker_inclusion": ["KMT2A rearrangement", "KMT2A amplification", "NPM1c", "NUP98"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "acute undifferentiated leukemia", "biomarker_inclusion": ["KMT2A rearrangement", "KMT2A amplification", "NPM1c", "NUP98"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["KMT2A-High", "KMT2A-High", "expression"], ["KMT2A Fusion", "KMT2A", "fusion"]]}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["KMT2A-High", "KMT2A-High", "expression"], ["KMT2A Fusion", "KMT2A", "fusion"]]}, {"cohort": "", "histology_inclusion": "Acute Leukemia of Ambiguous Lineage", "biomarker_inclusion": [["KMT2A-High", "KMT2A-High", "expression"], ["KMT2A Fusion", "KMT2A", "fusion"]]}, {"cohort": "", "histology_inclusion": "Mixed Phenotype Acute Leukemia", "biomarker_inclusion": [["KMT2A-High", "KMT2A-High", "expression"], ["KMT2A Fusion", "KMT2A", "fusion"]]}, {"cohort": "", "histology_inclusion": "Acute Undifferentiated Leukemia", "biomarker_inclusion": [["KMT2A Fusion", "KMT2A", "fusion"], ["KMT2A-High", "KMT2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Infant Acute Undifferentiated Leukemia", "biomarker_inclusion": [["KMT2A-High", "KMT2A-High", "expression"], ["KMT2A Fusion", "KMT2A", "fusion"]]}]}
{"NCT_id": "NCT03660826", "json": [{"cohort": "", "disease_state": "recurrent or persistent endometrial carcinoma, refractory to curative therapy or established treatments", "histology_inclusion": "endometrioid adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["clear cell histology"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or persistent endometrial carcinoma, refractory to curative therapy or established treatments", "histology_inclusion": "serous adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["clear cell histology"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or persistent endometrial carcinoma, refractory to curative therapy or established treatments", "histology_inclusion": "undifferentiated carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["clear cell histology"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or persistent endometrial carcinoma, refractory to curative therapy or established treatments", "histology_inclusion": "mixed epithelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["clear cell histology"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or persistent endometrial carcinoma, refractory to curative therapy or established treatments", "histology_inclusion": "adenocarcinoma not otherwise specified (N.O.S.)", "biomarker_inclusion": [], "histology_exclusion": ["clear cell histology"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Endometrioid Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Undifferentiated Carcinoma"}, {"cohort": "", "histology_inclusion": "Epithelial Neoplasm"}, {"cohort": "", "histology_inclusion": "Adenocarcinoma"}]}
{"NCT_id": "NCT04610528", "json": [{"cohort": "", "disease_state": "non-metastatic primary invasive adenocarcinoma of the breast", "histology_inclusion": "HR-positive/HER2-negative early breast cancer", "biomarker_inclusion": ["ER-positive", "PgR-positive", "HER2-negative", "Ki67% \u2265 10%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "non-metastatic primary invasive adenocarcinoma of the breast", "histology_inclusion": "triple-negative breast cancer (TNBC)", "biomarker_inclusion": ["ER-negative", "PgR-negative", "HER2-negative", "Ki67% \u2265 10%"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["EREG-High", "EREG-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["HR-High", "HR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"]]}]}
{"NCT_id": "NCT04675710", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Anaplastic Thyroid Carcinoma", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": ["Brain Metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Undifferentiated Carcinoma", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": ["Brain Metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Squamous Carcinoma", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": ["Brain Metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Carcinoma with Spindled, Giant Cell, or Epithelial Features", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": ["Brain Metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Poorly Differentiated Carcinoma with Pleomorphism, Extensive Necrosis with Tumor Cells Present", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": ["Brain Metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Thyroid Gland Undifferentiated (Anaplastic) Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Undifferentiated Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT01953926", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": ["HER2 mutation", "EGFR exon 18 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["ineligible somatic HER2 mutations"]}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}]}
{"NCT_id": "NCT03986606", "json": [{"cohort": "Part 2", "disease_state": "advanced", "histology_inclusion": "squamous non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "advanced", "histology_inclusion": "squamous cell carcinoma of the head and neck", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "locally advanced or metastatic", "histology_inclusion": "gastric or gastroesophageal carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "advanced or metastatic", "histology_inclusion": "renal cell carcinoma", "biomarker_inclusion": ["clear cell", "papillary", "other"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "", "histology_inclusion": "MSI-high colon carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "advanced", "histology_inclusion": "urothelial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "advanced", "histology_inclusion": "soft-tissue or bone sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 2", "histology_inclusion": "Squamous Cell Lung Carcinoma"}, {"cohort": "Part 2", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Part 2", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "Part 2", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "Part 2", "histology_inclusion": "Colon Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Part 2", "histology_inclusion": "Colon Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Part 2", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Part 2", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "Part 2", "histology_inclusion": "Melanoma"}, {"cohort": "Part 2", "histology_inclusion": "Bone Sarcoma"}]}
{"NCT_id": "NCT04936295", "json": [{"cohort": "Fulvestrant plus Anlotinib", "disease_state": "metastatic", "histology_inclusion": "HR+/HER2- breast cancer", "biomarker_inclusion": ["FGFR mutation"], "histology_exclusion": ["brain or meningeal metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Fulvestrant plus Anlotinib", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}, {"cohort": "Fulvestrant plus Anlotinib", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["HR-High", "HR-High", "expression"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}]}
{"NCT_id": "NCT05001451", "json": [{"cohort": "", "disease_state": "MRD positive", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}]}
{"NCT_id": "NCT03530696", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "HER2-positive breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["HER2-negative breast cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "histology_exclusion": ["Breast Carcinoma"], "biomarker_exclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT04247126", "json": [{"cohort": "Group 1", "disease_state": "Advanced Solid Tumor", "histology_inclusion": "Advanced Solid Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group 2", "disease_state": "Advanced or Metastatic Breast Cancer", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["HR-positive", "HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group 3", "disease_state": "Pancreatic Ductal Adenocarcinoma", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group 4", "disease_state": "Pancreatic Ductal Adenocarcinoma", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Group 1", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Group 2", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Group 3", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma"}, {"cohort": "Group 4", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma"}]}
{"NCT_id": "NCT04545710", "json": [{"cohort": "", "disease_state": "Stage IV, recurrent or metastatic", "histology_inclusion": "NSCLC-lung adenocarcinoma", "biomarker_inclusion": ["EGFR Exon 21 L858R", "EGFR Exon 19 deletion", "EGFR Exon 18 G719X", "EGFR Exon 21 L861Q"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR L861Q", "L861Q", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT05327010", "json": [{"cohort": "Cohort 1", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["BARD1 mutation", "FANCA mutation", "BRIP1 mutation", "PALB2 mutation", "RAD51 mutation", "RAD51C mutation", "RAD51D mutation"], "histology_exclusion": [], "biomarker_exclusion": ["BRCA1 mutation", "BRCA2 mutation"]}, {"cohort": "Cohort 3", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["BRCA1 mutation", "BRCA2 mutation", "BARD1 mutation", "FANCA mutation", "BRIP1 mutation", "PALB2 mutation", "RAD51 mutation", "RAD51C mutation", "RAD51D mutation"]}, {"cohort": "Cohort 4", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["RAD51C Mutation", "RAD51C-Mutation", "gene"], ["BARD1 Mutation", "BARD1-Mutation", "gene"], ["FANCA Mutation", "FANCA-Mutation", "gene"], ["RAD51 Mutation", "RAD51-Mutation", "gene"], ["BRIP1 Mutation", "BRIP1-Mutation", "gene"], ["RAD51D Mutation", "RAD51D-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"]], "biomarker_exclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_exclusion": [["RAD51C Mutation", "RAD51C-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BARD1 Mutation", "BARD1-Mutation", "gene"], ["FANCA Mutation", "FANCA-Mutation", "gene"], ["RAD51 Mutation", "RAD51-Mutation", "gene"], ["BRIP1 Mutation", "BRIP1-Mutation", "gene"], ["RAD51D Mutation", "RAD51D-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "Cohort 4", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT03270007", "json": [{"cohort": "", "disease_state": "lymph node positive", "histology_inclusion": "estrogen receptor <10% and progesterone receptor <10% and human epidermal growth factor receptor-2 negative primary breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["EGFR-Low", "EGFR-Low", "expression"], ["EGF-Low", "EGF-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["EGFR-Low", "EGFR-Low", "expression"], ["EGF-Low", "EGF-Low", "expression"]]}]}
{"NCT_id": "NCT03596086", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "anaplastic astrocytoma", "biomarker_inclusion": [], "histology_exclusion": ["multifocal tumor", "leptomeningeal metastatic disease", "brainstem involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "glioblastoma multiforme", "biomarker_inclusion": [], "histology_exclusion": ["multifocal tumor", "leptomeningeal metastatic disease", "brainstem involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Anaplastic Astrocytoma"}, {"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype"}, {"cohort": "", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT04117087", "json": [{"cohort": "", "disease_state": "Resected PDAC", "histology_inclusion": "Pancreatic Cancer", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Metastatic MSS CRC", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04936529", "json": [{"cohort": "", "disease_state": "high-risk neuroblastoma in complete remission", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Neuroblastoma"}]}
{"NCT_id": "NCT05522309", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04676477", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR exon 19 deletion", "L858R mutation"], "histology_exclusion": ["small cell", "combined small cell/non-small cell disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT05262400", "json": [{"cohort": "Part 1", "disease_state": "Breast Cancer", "histology_inclusion": "HR+, HER2- BC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "Breast Cancer", "histology_inclusion": "Refractory HR-positive/HER2-positive BC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "Solid Tumors", "histology_inclusion": "Solid Tumors other than BC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "Breast Cancer", "histology_inclusion": "HR-positive/HER2-negative BC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 1", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Part 1", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Part 1", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Part 1", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Part 1", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part 2", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Part 2", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT05652868", "json": [{"cohort": "Part 2 Cohort A", "disease_state": "locally advanced, recurrent or metastatic", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": ["high cMET expression"], "histology_exclusion": [], "biomarker_exclusion": ["actionable EGFR mutation"]}, {"cohort": "Part 2 Cohort B", "disease_state": "locally advanced, recurrent or metastatic", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": ["intermediate cMET expression"], "histology_exclusion": [], "biomarker_exclusion": ["actionable EGFR mutation"]}, {"cohort": "Part 2 Cohort C", "disease_state": "locally advanced, recurrent or metastatic", "histology_inclusion": "squamous NSCLC", "biomarker_inclusion": ["cMET overexpression"], "histology_exclusion": [], "biomarker_exclusion": ["actionable EGFR mutation"]}, {"cohort": "Part 2 Cohort D", "disease_state": "locally advanced, recurrent or metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["MET amplification", "MET exon 14 skipping mutations"], "histology_exclusion": [], "biomarker_exclusion": ["actionable EGFR mutation", "cMET IHC entry criteria for Cohorts A-C"]}, {"cohort": "Part 2 Cohort E", "disease_state": "locally advanced, recurrent or metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["cMET expression"], "histology_exclusion": [], "biomarker_exclusion": ["actionable EGFR mutation", "more than 3 prior lines of systemic therapy including prior cMET targeted ADC or antibody"]}], "json_norm": [{"cohort": "Part 2 Cohort A", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Part 2 Cohort B", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Part 2 Cohort C", "histology_inclusion": "Squamous Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Part 2 Cohort D", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Part 2 Cohort E", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT03596866", "json": [{"cohort": "", "disease_state": "stage IIIB (locally advanced or recurrent) or stage IV", "histology_inclusion": "Non-Small-Cell Lung Cancer", "biomarker_inclusion": ["ALK rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT04313881", "json": [{"cohort": "", "disease_state": "intermediate/high/very high risk", "histology_inclusion": "Myelodysplastic Syndrome (MDS)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}]}
{"NCT_id": "NCT04417192", "json": [{"cohort": "", "disease_state": "Stage III or IV", "histology_inclusion": "high-grade serous or Grade 3 endometrioid ovarian, fallopian tube, or primary peritoneal cancer", "biomarker_inclusion": ["HRD-positive"], "histology_exclusion": ["brain metastasis", "tumor causing spinal cord compression"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [["TBCE-High", "TBCE-High", "expression"]]}]}
{"NCT_id": "NCT04807881", "json": [{"cohort": "Cohort 1", "disease_state": "relapsed or refractory", "histology_inclusion": "Primary central nervous system lymphoma (PCNSL)", "biomarker_inclusion": [], "histology_exclusion": ["T-cell lymphoma"], "biomarker_exclusion": ["BCR inhibitors (such as BTK, phosphoinositide kinase 3 kinase [PI3K] or SYK inhibitors)", "BCL-2 inhibitors (such as ABT-199)", "Chimeric Antigen Receptor T-Cell Immunotherapy (CAR-T)", "bispecific antibody drug"]}, {"cohort": "Cohort 2", "disease_state": "refractory or relapsed", "histology_inclusion": "CLL/SLL", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "failed in \u2264 3 different chemotherapies and / or targeted drugs treatment", "histology_inclusion": "Mantle cell lymphoma", "biomarker_inclusion": ["t (11; 14) (q13; q32) positive", "cyclin D1 highly expressed"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Central Nervous System Lymphoma", "histology_exclusion": ["T-Cell Non-Hodgkin Lymphoma"]}, {"cohort": "Cohort 1", "histology_inclusion": "Primary Central Nervous System Lymphoma", "histology_exclusion": ["T-Cell Non-Hodgkin Lymphoma"]}, {"cohort": "Cohort 2", "histology_inclusion": "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma"}, {"cohort": "Cohort 3", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["CCND1-High", "CCND1-High", "expression"]]}]}
{"NCT_id": "NCT01220583", "json": [{"cohort": "", "disease_state": "T3-4 or N1-3 or T1-2, N0 with a close (\u2264 1mm) or microscopically positive surgical margin; free of distant metastases", "histology_inclusion": "malignant major salivary gland tumor or malignant minor salivary gland tumor of the head and neck", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Intermediate-grade adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Intermediate-grade mucoepidermoid carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "High-grade acinic cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "High-grade (>30% solid component) adenoid cystic carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Salivary Gland Neoplasm"}, {"cohort": "", "histology_inclusion": "Salivary Gland Carcinoma"}, {"cohort": "", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Mucoepidermoid Carcinoma"}, {"cohort": "", "histology_inclusion": "Acinar Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Adenoid Cystic Carcinoma"}]}
{"NCT_id": "NCT03206671", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "aggressive mature B-cell Non-Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["lack of CD20 expression"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "Burkitt lymphoma (BL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["lack of CD20 expression"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "Burkitt leukemia (B-AL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["lack of CD20 expression"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "diffuse large B-cell lymphoma (DLBCL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["lack of CD20 expression"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "mature B-cell NHL not further classified", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["lack of CD20 expression"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Mature B-Cell Non-Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Burkitt Lymphoma"}, {"cohort": "", "histology_inclusion": "Burkitt Leukemia"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Non-Hodgkin Lymphoma"}]}
{"NCT_id": "NCT03793140", "json": [{"cohort": "", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Burkitt Lymphoma/Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed or Refractory", "histology_inclusion": "High-grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Plasmablastic lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed or Refractory", "histology_inclusion": "High-grade B-cell lymphoma with rearrangements of MYC without bcl-2", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System (CNS) parenchymal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Burkitt Leukemia"}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Plasmablastic Lymphoma"}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma"}]}
{"NCT_id": "NCT03793166", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "renal cell carcinoma with clear cell component", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "renal cell carcinoma with sarcomatoid features", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "renal cell carcinoma with rhabdoid features", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Sarcomatoid Renal Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma"}]}
{"NCT_id": "NCT04053673", "json": [{"cohort": "Dose Escalation Phase", "disease_state": "Metastatic or advanced-stage solid malignant tumor", "histology_inclusion": "Solid Tumor, Adult", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Phase - SCCL", "disease_state": "Locally advanced or metastatic solid tumors", "histology_inclusion": "Non-Small Cell Lung Cancer (NSCLC) of predominantly squamous cell histology", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Phase - HNSCC", "disease_state": "Locally advanced or metastatic solid tumors", "histology_inclusion": "Squamous cell carcinoma of the head and neck (either HPV-positive or -negative)", "biomarker_inclusion": [], "histology_exclusion": ["Nasopharyngeal carcinoma", "Skin squamous cell carcinoma", "Salivary gland carcinomas"], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Phase - HR+ breast cancer", "disease_state": "Locally advanced or metastatic solid tumors", "histology_inclusion": "Estrogen receptor (ER) and/or progesterone receptor (PR) positive, HER2-negative adenocarcinoma of breast", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Phase - PARP7 amplified", "disease_state": "Locally advanced or metastatic solid tumors", "histology_inclusion": "Solid Tumor, Adult", "biomarker_inclusion": ["PARP7 (or TIPARP) gene copy amplification"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Escalation Phase", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Dose Expansion Phase - SCCL", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Dose Expansion Phase - HNSCC", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Skin Squamous Cell Carcinoma", "Nasopharyngeal Carcinoma"]}, {"cohort": "Dose Expansion Phase - HR+ breast cancer", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "Dose Expansion Phase - HR+ breast cancer", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "Dose Expansion Phase - HR+ breast cancer", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "Dose Expansion Phase - HR+ breast cancer", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "Dose Expansion Phase - PARP7 amplified", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT03337087", "json": [{"cohort": "Phase I", "disease_state": "metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase I", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase I", "disease_state": "metastatic", "histology_inclusion": "gastroesophageal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase I", "disease_state": "metastatic", "histology_inclusion": "biliary tract adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase Ib", "disease_state": "metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II", "disease_state": "metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation", "PALB2 mutation", "homologous recombination deficiency (HRD)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase I", "histology_inclusion": "Pancreatic Adenocarcinoma"}, {"cohort": "Phase I", "histology_inclusion": "Colorectal Adenocarcinoma"}, {"cohort": "Phase I", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "Phase I", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "Phase Ib", "histology_inclusion": "Pancreatic Adenocarcinoma"}, {"cohort": "Phase II", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04417465", "json": [{"cohort": "Combination Dose Expansion", "disease_state": "relapsed or refractory", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": ["PD-L1 (CPS \u2265 1)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Combination Dose Expansion", "disease_state": "relapsed or refractory", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["PD-L1 (TPS \u2265 1%)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Combination Dose Expansion", "disease_state": "relapsed or refractory", "histology_inclusion": "clear cell renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Combination Dose Expansion", "disease_state": "refractory", "histology_inclusion": "microsatellite instability-high tumors", "biomarker_inclusion": ["MSI-H status by PCR or NGS tests", "dMMR by IHC tests"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Combination Dose Expansion", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Combination Dose Expansion", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Combination Dose Expansion", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}, {"cohort": "Combination Dose Expansion", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Combination Dose Expansion", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04873362", "json": [{"cohort": "", "disease_state": "cT4/anyN/M0, any cT/N2-3/M0, or cT1-3/N0-1/M0", "histology_inclusion": "HER2-positive invasive breast cancer", "biomarker_inclusion": ["PD-L1", "hormone receptor status"], "histology_exclusion": ["Stage IV breast cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "histology_exclusion": ["Breast Carcinoma"]}]}
{"NCT_id": "NCT05003622", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF V600E"], "histology_exclusion": ["NSCLC with ALK fusion oncogene", "NSCLC with ROS1 rearrangement", "NSCLC with EGFR sensitizing or driver mutation"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["BRAF V600E"], "histology_exclusion": ["NSCLC with ALK fusion oncogene", "NSCLC with ROS1 rearrangement", "NSCLC with EGFR sensitizing or driver mutation"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]], "histology_exclusion": ["Non-Small Cell Lung Carcinoma"], "biomarker_exclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]], "histology_exclusion": ["Non-Small Cell Lung Carcinoma"], "biomarker_exclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT05068752", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["KRAS G12D"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"]]}]}
{"NCT_id": "NCT05198804", "json": [{"cohort": "", "disease_state": "platinum-resistant", "histology_inclusion": "high grade epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "platinum-resistant", "histology_inclusion": "primary peritoneal carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "platinum-resistant", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II", "disease_state": "platinum-resistant", "histology_inclusion": "high grade epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II", "disease_state": "platinum-resistant", "histology_inclusion": "primary peritoneal carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II", "disease_state": "platinum-resistant", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "Phase II", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Phase II", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "Phase II", "histology_inclusion": "Fallopian Tube Carcinoma"}]}
{"NCT_id": "NCT05459129", "json": [{"cohort": "", "disease_state": "resectable Stage III-IVA", "histology_inclusion": "Squamous Cell Carcinoma of the Head and Neck", "biomarker_inclusion": ["PD-L1 CPS >= 1", "HPV-negative"], "histology_exclusion": ["HPV-positive oropharyngeal cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Oropharyngeal Carcinoma"]}]}
{"NCT_id": "NCT03728335", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04119024", "json": [{"cohort": "", "disease_state": "Stage IIIC or IV Melanoma", "histology_inclusion": "Melanoma", "biomarker_inclusion": ["IL13Ralpha2 Positive (>= 20%, 1+)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma"}]}
{"NCT_id": "NCT04184050", "json": [{"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": ["Plasma cell leukemia", "Non-secretory myeloma (e.g., solitary plasmacytoma)"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Plasmacytoma", "Plasma Cell Leukemia"]}]}
{"NCT_id": "NCT04678102", "json": [{"cohort": "", "disease_state": "Platinum-resistant or Platinum-refractory", "histology_inclusion": "Ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["Low-grade serous carcinoma", "Mucinous carcinoma of the ovary", "Malignant mixed Mullerian tumor (carcinosarcoma)", "Ovarian borderline epithelial tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Platinum-resistant or Platinum-refractory", "histology_inclusion": "Fallopian tube carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Low-grade serous carcinoma", "Mucinous carcinoma of the ovary", "Malignant mixed Mullerian tumor (carcinosarcoma)", "Ovarian borderline epithelial tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Platinum-resistant or Platinum-refractory", "histology_inclusion": "Primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": ["Low-grade serous carcinoma", "Mucinous carcinoma of the ovary", "Malignant mixed Mullerian tumor (carcinosarcoma)", "Ovarian borderline epithelial tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "histology_exclusion": ["Ovarian Serous Adenocarcinoma", "Ovarian Mucinous Adenocarcinoma", "Carcinosarcoma", "Malignant Mixed Mesodermal (Mullerian) Tumor", "Epithelial Neoplasm"]}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm", "histology_exclusion": ["Carcinosarcoma", "Ovarian Mucinous Adenocarcinoma", "Ovarian Serous Adenocarcinoma", "Malignant Mixed Mesodermal (Mullerian) Tumor", "Epithelial Neoplasm"]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "histology_exclusion": ["Carcinosarcoma", "Ovarian Mucinous Adenocarcinoma", "Ovarian Serous Adenocarcinoma", "Malignant Mixed Mesodermal (Mullerian) Tumor", "Epithelial Neoplasm"]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "histology_exclusion": ["Carcinosarcoma", "Ovarian Mucinous Adenocarcinoma", "Ovarian Serous Adenocarcinoma", "Malignant Mixed Mesodermal (Mullerian) Tumor", "Epithelial Neoplasm"]}]}
{"NCT_id": "NCT04808362", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["KRAS-mutated"], "histology_exclusion": ["CNS primary tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "TNBC", "biomarker_inclusion": [], "histology_exclusion": ["CNS primary tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "CRC", "biomarker_inclusion": ["RAS mutated"], "histology_exclusion": ["CNS primary tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04938609", "json": [{"cohort": "", "disease_state": "stage III-IVA", "histology_inclusion": "HPV-negative HNSCC", "biomarker_inclusion": [], "histology_exclusion": ["T1 larynx cancer", "T2 larynx cancer", "T3 larynx cancer"], "biomarker_exclusion": ["prior therapy with anti-PD-1, anti-PD-L1, or anti-PD-L2 agent", "prior radiotherapy to the head and neck region", "active TB (Bacillus Tuberculosis)", "grade 2 or higher peripheral neuropathy"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Laryngeal Carcinoma"]}]}
{"NCT_id": "NCT05198934", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["KRAS p.G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": ["active brain metastases", "hematological malignancies", "leptomeningeal disease", "previous treatment with a KRAS G12C inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT03467789", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Basal Cell Carcinoma", "biomarker_inclusion": ["PTCH1 gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Basal Cell Carcinoma", "biomarker_inclusion": [["PTCH1 Mutation", "PTCH1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Experimental Organism Basal Cell Carcinoma", "biomarker_inclusion": [["PTCH1 Mutation", "PTCH1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Skin Basal Cell Carcinoma", "biomarker_inclusion": [["PTCH1 Mutation", "PTCH1-Mutation", "gene"]]}]}
{"NCT_id": "NCT03793517", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "acute leukemia", "biomarker_inclusion": ["MLL-r", "TLS-ERG", "SIL-TAL1"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Leukemia", "biomarker_inclusion": [["PMEL - TAL1", "PMEL - TAL1", "coordinate"], ["FUS - ERG", "FUS - ERG", "coordinate"], ["STIL - TAL1", "STIL - TAL1", "coordinate"]]}]}
{"NCT_id": "NCT04417621", "json": [{"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["NRAS mutation"], "histology_exclusion": ["primary central nervous system (CNS) tumors", "symptomatic CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["BRAFV600 mutant"], "histology_exclusion": ["primary central nervous system (CNS) tumors", "symptomatic CNS metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Cutaneous Melanoma"}]}
{"NCT_id": "NCT04417699", "json": [{"cohort": "", "disease_state": "Stage II/III", "histology_inclusion": "Rectal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Rectal Adenocarcinoma"}]}
{"NCT_id": "NCT05003895", "json": [{"cohort": "", "disease_state": "Advanced", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": ["GPC3 positive (>= 25%)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [["GPC3-High", "GPC3-High", "expression"]]}]}
{"NCT_id": "NCT03011671", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "IDH wildtype glioblastoma", "biomarker_inclusion": ["MGMT promoter-methylated"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "grade III or IV astrocytoma", "biomarker_inclusion": ["MGMT promoter-methylated"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Astrocytoma"}]}
{"NCT_id": "NCT03598257", "json": [{"cohort": "", "disease_state": "inflammatory breast cancer without distant metastases", "histology_inclusion": "Breast Inflammatory Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Inflammatory Breast Carcinoma"}]}
{"NCT_id": "NCT05004025", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "uveal melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Intraocular Melanoma"}]}
{"NCT_id": "NCT02413736", "json": [{"cohort": "", "disease_state": "high risk of GIST recurrence", "histology_inclusion": "gastrointestinal stromal tumor (GIST)", "biomarker_inclusion": ["KIT mutation", "PDGFRA mutation", "DOG-1 positive"], "histology_exclusion": [], "biomarker_exclusion": ["PDGFRA D842V mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["ANO1-High", "ANO1-High", "expression"], ["PDGFRA Mutation", "PDGFRA-Mutation", "gene"], ["KIT Mutation", "KIT-Mutation", "gene"]], "biomarker_exclusion": [["PDGFRA D842V", "D842V", "coordinate"]]}]}
{"NCT_id": "NCT03207256", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Non Hodgkin Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Non-Hodgkin Lymphoma"}]}
{"NCT_id": "NCT04249622", "json": [{"cohort": "", "disease_state": "Stage I-III", "histology_inclusion": "HER2 Positive Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04743505", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT05199272", "json": [{"cohort": "1B", "disease_state": "locally advanced (unresectable) or metastatic", "histology_inclusion": "Clear Cell Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "2B", "disease_state": "locally advanced (unresectable) or metastatic, platinum-resistant", "histology_inclusion": "Epithelial Ovarian Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "2B", "disease_state": "locally advanced (unresectable) or metastatic, platinum-resistant", "histology_inclusion": "Fallopian Tube Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "2B", "disease_state": "locally advanced (unresectable) or metastatic, platinum-resistant", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "3B", "disease_state": "locally advanced (unresectable) or metastatic", "histology_inclusion": "Merkel Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "3B", "disease_state": "locally advanced (unresectable) or metastatic", "histology_inclusion": "Well-differentiated Grade 3 neuroendocrine cancers with unfavorable biology", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "3B", "disease_state": "locally advanced (unresectable) or metastatic", "histology_inclusion": "Poorly differentiated neuroendocrine carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "4B", "disease_state": "locally advanced (unresectable) or metastatic", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": ["TMB-H", "MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "5B", "disease_state": "locally advanced (unresectable) or metastatic", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "6B", "disease_state": "locally advanced (unresectable) or metastatic", "histology_inclusion": "Extensive-stage Small-cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "1B", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}, {"cohort": "2B", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "2B", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "2B", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "3B", "histology_inclusion": "Merkel Cell Carcinoma"}, {"cohort": "3B", "histology_inclusion": "Neuroendocrine Carcinoma"}, {"cohort": "3B", "histology_inclusion": "Neuroendocrine Tumor"}, {"cohort": "3B", "histology_inclusion": "Pancreatic Neuroendocrine Carcinoma"}, {"cohort": "4B", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"], ["MSI", "MSI", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "5B", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "6B", "histology_inclusion": "Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT02609776", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "C, E, MET-1", "disease_state": "metastatic or unresectable", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR Exon 19 deletion", "EGFR L858R"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "C, D, MET-1", "disease_state": "metastatic or unresectable", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR Exon 20 insertion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "MET-2", "disease_state": "metastatic or unresectable", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["cMet Exon 14 skipping mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "WT-Ad", "disease_state": "metastatic or unresectable", "histology_inclusion": "non-small cell lung cancer, adenocarcinoma", "biomarker_inclusion": ["EGFR positive", "MET positive"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR wild-type", "ALK wild-type", "MET Exon 14 skipping mutation"]}, {"cohort": "WT-Sq", "disease_state": "metastatic or unresectable", "histology_inclusion": "non-small cell lung cancer, squamous cell carcinoma", "biomarker_inclusion": ["EGFR positive", "MET positive"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR wild-type", "ALK wild-type", "MET Exon 14 skipping mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "C, E, MET-1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}, {"cohort": "C, D, MET-1", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "MET-2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "WT-Ad", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["EGFR-High", "EGFR-High", "expression"]], "biomarker_exclusion": [["MET exon 14 del", "exon 14 del", "exon"], ["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["ALK ALK-wild_type", "ALK-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "WT-Sq", "histology_inclusion": "Squamous Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["EGFR-High", "EGFR-High", "expression"]], "biomarker_exclusion": [["MET exon 14 del", "exon 14 del", "exon"], ["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["ALK ALK-wild_type", "ALK-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT03924245", "json": [{"cohort": "", "disease_state": "Recurrent, Platinum-Refractory, Resistant", "histology_inclusion": "High-grade carcinomas of the ovary, fallopian tube, or peritoneum", "biomarker_inclusion": ["HR-proficient (HRD score < 42)"], "histology_exclusion": ["Low grade or borderline epithelial ovarian, fallopian tube, or peritoneal cancers", "Sex-cord stromal tumors of the ovary", "Germ cell tumors of the ovary"], "biomarker_exclusion": ["BRCA1 mutation", "BRCA2 mutation", "RAD51 mutation", "BRIP1 mutation", "ATM mutation", "FANCL mutation", "PALB2 mutation", "Other FA/BRCA pathway gene mutations", "HR-deficient"]}], "json_norm": [{"cohort": "", "histology_exclusion": ["Germ Cell Tumor", "Sex Cord-Stromal Tumor", "Primary Peritoneal Carcinoma"], "biomarker_exclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["HR-Low", "HR-Low", "expression"], ["RAD51 Mutation", "RAD51-Mutation", "gene"], ["BRIP1 Mutation", "BRIP1-Mutation", "gene"], ["FANCL Mutation", "FANCL-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["FXN Mutation", "FXN-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04678583", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Colorectal cancer", "biomarker_inclusion": ["RAS mutation (KRAS or NRAS)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT05329545", "json": [{"cohort": "", "disease_state": "metastatic or recurrent", "histology_inclusion": "high grade serous ovarian cancer", "biomarker_inclusion": ["NaPi2b-H/positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or recurrent", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": ["NaPi2b-H/positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or recurrent", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": ["NaPi2b-H/positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Serous Adenocarcinoma", "biomarker_inclusion": [["FUT1-High", "FUT1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["FUT1-High", "FUT1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [["FUT1-High", "FUT1-High", "expression"]]}]}
{"NCT_id": "NCT01760655", "json": [{"cohort": "", "disease_state": "high-risk", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["FLT3/ITD mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high-risk", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["Inv(3) (q21.3;q26.2); GATA2, MECOM"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high-risk", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["t(6;9) (p23;q34.1); DEK-NUP214"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["DEK - NUP214", "DEK - NUP214", "coordinate"]]}]}
{"NCT_id": "NCT03207529", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["Androgen Receptor Positive", "PTEN Positive"], "histology_exclusion": [], "biomarker_exclusion": ["HER2/Neu Negative", "primary CNS tumor", "CNS tumor involvement", "active leptomeningeal disease"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PTEN-High", "PTEN-High", "expression"], ["AR-High", "AR-High", "expression"]], "biomarker_exclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["NEU1-Low", "NEU1-Low", "expression"]]}]}
{"NCT_id": "NCT04249843", "json": [{"cohort": "Phase 1a", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["BRAF Class II mutation", "BRAF Class III mutation", "BRAF fusion", "NRAS mutation", "KRAS mutation"], "histology_exclusion": ["colorectal cancer", "pancreatic cancer"], "biomarker_exclusion": []}, {"cohort": "Phase 1b, Group 1", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": ["colorectal cancer"], "biomarker_exclusion": []}, {"cohort": "Phase 1b, Group 2", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["BRAF Class II mutation", "BRAF fusion mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b, Group 3", "disease_state": "advanced", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["NRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b, Group 4", "disease_state": "advanced", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["NRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1a", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRAF Fusion", "BRAF", "fusion"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["BRAF Class 3", "BRAF Class 3", "coordinate"], ["BRAF Class 2", "BRAF Class 2", "coordinate"]], "histology_exclusion": ["Colorectal Carcinoma", "Pancreatic Carcinoma"]}, {"cohort": "Phase 1b, Group 1", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Colorectal Carcinoma"]}, {"cohort": "Phase 1b, Group 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRAF Fusion", "BRAF", "fusion"], ["BRAF Class 2", "BRAF Class 2", "coordinate"]]}, {"cohort": "Phase 1b, Group 3", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"]]}, {"cohort": "Phase 1b, Group 4", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04418167", "json": [{"cohort": "Part A: JSI-1187 Monotherapy Dose Escalation", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": ["MAPK pathway mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B: JSI-1187 Plus Dabrafenib Combination Dose Escalation", "disease_state": "unresectable or metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF V600E/K mutation"], "histology_exclusion": ["colorectal cancer"], "biomarker_exclusion": []}, {"cohort": "Part B: JSI-1187 Plus Dabrafenib Combination Dose Escalation", "disease_state": "metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": ["colorectal cancer"], "biomarker_exclusion": []}, {"cohort": "Part B: JSI-1187 Plus Dabrafenib Combination Dose Escalation", "disease_state": "locally advanced or metastatic", "histology_inclusion": "anaplastic thyroid cancer", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": ["colorectal cancer"], "biomarker_exclusion": []}, {"cohort": "Part C: JSI-1187 Plus Dabrafenib Expansion - Cohort 1", "disease_state": "unresectable or metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF V600E/K mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part C: JSI-1187 Plus Dabrafenib Expansion - Cohort 2", "disease_state": "unresectable or metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF V600E/K mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part C: JSI-1187 Plus Dabrafenib Expansion - Cohort 3", "disease_state": "metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A: JSI-1187 Monotherapy Dose Escalation", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MAPK/ERK pathway", null, "pathway"]]}, {"cohort": "Part B: JSI-1187 Plus Dabrafenib Combination Dose Escalation", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]], "histology_exclusion": ["Colorectal Carcinoma"]}, {"cohort": "Part B: JSI-1187 Plus Dabrafenib Combination Dose Escalation", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]], "histology_exclusion": ["Colorectal Carcinoma"]}, {"cohort": "Part B: JSI-1187 Plus Dabrafenib Combination Dose Escalation", "histology_inclusion": "Thyroid Gland Undifferentiated (Anaplastic) Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]], "histology_exclusion": ["Colorectal Carcinoma"]}, {"cohort": "Part C: JSI-1187 Plus Dabrafenib Expansion - Cohort 1", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}, {"cohort": "Part C: JSI-1187 Plus Dabrafenib Expansion - Cohort 2", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}, {"cohort": "Part C: JSI-1187 Plus Dabrafenib Expansion - Cohort 3", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT04613596", "json": [{"cohort": "Phase 2 Cohort 1a: PD-L1 TPS <1%", "disease_state": "unresectable or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS G12C mutation", "PD-L1 TPS <1%"], "histology_exclusion": [], "biomarker_exclusion": ["Active brain metastases"]}, {"cohort": "Phase 2 Cohort 1b: PD-L1 TPS <1%", "disease_state": "unresectable or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS G12C mutation", "PD-L1 TPS <1%"], "histology_exclusion": [], "biomarker_exclusion": ["Active brain metastases"]}, {"cohort": "Phase 2 Cohort 2: PD-L1 TPS \u22651%", "disease_state": "unresectable or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS G12C mutation", "PD-L1 TPS \u22651%"], "histology_exclusion": [], "biomarker_exclusion": ["Active brain metastases"]}, {"cohort": "Phase 3 Cohort 3: PD-L1 TPS<50% randomized 1:1 with comparator arm", "disease_state": "unresectable or metastatic", "histology_inclusion": "nonsquamous Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS G12C mutation", "PD-L1 TPS <50%"], "histology_exclusion": ["brainstem lesions"], "biomarker_exclusion": ["untreated brain lesions > 1.0 cm", "ongoing use of systemic corticosteroids for control of symptoms of brain lesions at a total daily dose of > 10 mg of prednisone (or equivalent) prior to randomization", "poorly controlled (> 1/week) generalized or complex partial seizures, or manifest neurologic progression due to brain lesions notwithstanding CNS-directed therapy"]}, {"cohort": "Phase 3 Cohort 4: PD-L1 TPS <50% randomized 1:1 with experimental arm", "disease_state": "unresectable or metastatic", "histology_inclusion": "nonsquamous Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS G12C mutation", "PD-L1 TPS <50%"], "histology_exclusion": ["brainstem lesions"], "biomarker_exclusion": ["untreated brain lesions > 1.0 cm", "ongoing use of systemic corticosteroids for control of symptoms of brain lesions at a total daily dose of > 10 mg of prednisone (or equivalent) prior to randomization", "poorly controlled (> 1/week) generalized or complex partial seizures, or manifest neurologic progression due to brain lesions notwithstanding CNS-directed therapy"]}], "json_norm": [{"cohort": "Phase 2 Cohort 1a: PD-L1 TPS <1%", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "Phase 2 Cohort 1b: PD-L1 TPS <1%", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "Phase 2 Cohort 2: PD-L1 TPS \u22651%", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "Phase 3 Cohort 3: PD-L1 TPS<50% randomized 1:1 with comparator arm", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "Phase 3 Cohort 4: PD-L1 TPS <50% randomized 1:1 with experimental arm", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT04678648", "json": [{"cohort": "RSC-1255 Treatment", "disease_state": "advanced or metastatic", "histology_inclusion": "advanced or metastatic malignancy", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "RSC-1255 Treatment"}]}
{"NCT_id": "NCT04874194", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": ["RUNX1 mutation"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "biphenotypic leukemia", "biomarker_inclusion": ["RUNX1 mutation"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "bilineage leukemia", "biomarker_inclusion": ["RUNX1 mutation"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "myelodysplastic syndrome", "biomarker_inclusion": ["RUNX1 mutation"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["RUNX1 Mutation", "RUNX1-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "biomarker_inclusion": [["RUNX1 Mutation", "RUNX1-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "biomarker_inclusion": [["RUNX1 Mutation", "RUNX1-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["RUNX1 Mutation", "RUNX1-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT05004350", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["BRAF V600E"], "histology_exclusion": [], "biomarker_exclusion": ["RAS mutant", "anti-EGFR treatment", "RAF inhibitor", "cetuximab", "panitumumab", "EGFR inhibitors", "symptomatic brain metastasis", "leptomeningeal disease"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]], "biomarker_exclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT05199584", "json": [{"cohort": "", "disease_state": "refractory advanced solid tumors", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["PTCH1 loss of function mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["PTCH1 Mutation", "PTCH1-Mutation", "gene"], ["PTCH1-Low", "PTCH1-Low", "expression"]]}]}
{"NCT_id": "NCT05394831", "json": [{"cohort": "Part A and Part B", "disease_state": "advanced and/or metastatic", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutant C797S", "EGFR mutant T790M"], "histology_exclusion": ["mixed squamous cell histology", "tumor with histological transformation"], "biomarker_exclusion": []}, {"cohort": "Part C Cohort 1", "disease_state": "advanced and/or metastatic", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutations C797S", "EGFR mutations T790M"], "histology_exclusion": ["mixed squamous cell histology", "tumor with histological transformation"], "biomarker_exclusion": []}, {"cohort": "Part C Cohort 2", "disease_state": "advanced and/or metastatic", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutations C797S"], "histology_exclusion": ["mixed squamous cell histology", "tumor with histological transformation"], "biomarker_exclusion": ["EGFR mutations T790M"]}, {"cohort": "Part C Cohort 3", "disease_state": "advanced and/or metastatic", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutations T790M"], "histology_exclusion": ["mixed squamous cell histology", "tumor with histological transformation"], "biomarker_exclusion": ["EGFR mutations C797S"]}, {"cohort": "Part C Cohort 4", "disease_state": "advanced and/or metastatic", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["any EGFR mutations"], "histology_exclusion": ["mixed squamous cell histology", "tumor with histological transformation", "Central Nervous System (CNS) metastasis"], "biomarker_exclusion": []}, {"cohort": "Part C Cohort 5", "disease_state": "advanced and/or metastatic", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["any EGFR dependent mutations"], "histology_exclusion": ["mixed squamous cell histology", "tumor with histological transformation"], "biomarker_exclusion": ["EGFR mutations C797S", "EGFR mutations T790M"]}], "json_norm": [{"cohort": "Part A and Part B", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR T790M", "T790M", "coordinate"], ["EGFR C797S", "C797S", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Part C Cohort 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR T790M", "T790M", "coordinate"], ["EGFR C797S", "C797S", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Part C Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR C797S", "C797S", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"]], "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Part C Cohort 3", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR T790M", "T790M", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"]], "biomarker_exclusion": [["EGFR C797S", "C797S", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Part C Cohort 4", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Part C Cohort 5", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"], ["EGFR C797S", "C797S", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT03663933", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Lymphoproliferative Disorders", "biomarker_inclusion": ["germline T-cell activating mutation in the PI3k pathway", "ADA2 deficiency (biallelic mutations in CECR1 (ADA2) and/or phenotypically with low ADA2 level)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Autoimmune Lymphoproliferative", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Primary T-cell Immunodeficiency Disorders", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Immune System Diseases", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Common Variable Immunodeficiency", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["PI3K/AKT/mTOR pathway", null, "pathway"], ["ADA2-Low", "ADA2-Low", "expression"], ["ADA2 Mutation", "ADA2-Mutation", "gene"], ["TADA2A-Low", "TADA2A-Low", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["TADA2A Mutation", "TADA2A-Mutation", "gene"], ["TBXT Mutation", "TBXT-Mutation", "gene"]]}, {"cohort": ""}, {"cohort": "", "biomarker_inclusion": [["TBXT-Low", "TBXT-Low", "expression"]]}, {"cohort": ""}, {"cohort": ""}]}
{"NCT_id": "NCT04184869", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": [], "histology_exclusion": ["Hematological Malignancies"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm"]}]}
{"NCT_id": "NCT04874207", "json": [{"cohort": "Patients", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["RAS wild-type", "MSI-H", "BRAF V600E"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Patients", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["MSI", "MSI", "coordinate"], ["BRAF V600E", "V600E", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04939363", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Richter's transformation into diffuse large B-cell lymphoma (DLBCL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Richter Syndrome"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}]}
{"NCT_id": "NCT05004441", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["RAS activating mutation", "RAS wild type", "BRAF wild type"], "histology_exclusion": [], "biomarker_exclusion": ["BRAF activating mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]], "biomarker_exclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"]]}]}
{"NCT_id": "NCT03012321", "json": [{"cohort": "", "disease_state": "metastatic castration-resistant", "histology_inclusion": "prostate adenocarcinoma", "biomarker_inclusion": ["ATM", "BRCA1", "BRCA2"], "histology_exclusion": ["small-cell carcinoma of the prostate"], "biomarker_exclusion": []}, {"cohort": "Arm IV", "disease_state": "metastatic castration-resistant", "histology_inclusion": "prostate adenocarcinoma", "biomarker_inclusion": ["FANCA", "PALB2", "RAD51", "ERCC3", "MRE11", "NBN", "MLH3", "CDK12", "CHEK2", "HDAC2", "ATR", "PMS2", "GEN1", "MSH2", "MSH6", "BRIP1", "FAM175A"], "histology_exclusion": ["small-cell carcinoma of the prostate"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "histology_exclusion": ["Prostate Small Cell Neuroendocrine Carcinoma"]}, {"cohort": "Arm IV", "histology_inclusion": "Prostate Adenocarcinoma", "histology_exclusion": ["Prostate Small Cell Neuroendocrine Carcinoma"]}]}
{"NCT_id": "NCT03989713", "json": [{"cohort": "", "disease_state": "refractory to induction therapy or relapsed after first line treatment", "histology_inclusion": "acute myeloid leukemia (except acute promyelocytic leukemia)", "biomarker_inclusion": ["FLT3-ITD (ratio of mutant to wild-type alleles of at least 0.05)"], "histology_exclusion": ["acute promyelocytic leukemia (AML FAB M3 with t(15;17)(q22;q12) / PML-RARA)", "CNS leukemia", "isolated extramedullary manifestation of AML"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Promyelocytic Leukemia with PML-RARA", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["FLT3 Mutation", "FLT3-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Acute Myeloid Leukemia (AML)", "Central Nervous System Leukemia", "Acute Myeloid Leukemia (AML)"], "biomarker_exclusion": [["PML - RARA", "PML - RARA", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Central Nervous System Leukemia", "Acute Myeloid Leukemia (AML)"], "biomarker_exclusion": [["PML - RARA", "PML - RARA", "coordinate"]]}]}
{"NCT_id": "NCT04054752", "json": [{"cohort": "", "disease_state": "Stage I-III", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II or III", "histology_inclusion": "Gastrointestinal Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II or III", "histology_inclusion": "Bladder Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Gastrointestinal Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Prostate Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "", "histology_inclusion": "Digestive System Neoplasm"}, {"cohort": "", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "", "histology_inclusion": "Digestive System Neoplasm"}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma"}]}
{"NCT_id": "NCT04548752", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": ["germline BRCA1 mutation", "germline BRCA2 mutation"], "histology_exclusion": ["neuroendocrine tumors", "acinar cell", "adenosquamous carcinomas"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]], "histology_exclusion": ["Neuroendocrine Carcinoma", "Lung Neuroendocrine Neoplasm", "Neuroendocrine Tumor"]}]}
{"NCT_id": "NCT03207867", "json": [{"cohort": "Part 1", "disease_state": "advanced or metastatic", "histology_inclusion": "renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "advanced or metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "advanced or metastatic", "histology_inclusion": "urothelial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "advanced or metastatic", "histology_inclusion": "head and neck cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "advanced or metastatic", "histology_inclusion": "diffuse large B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "advanced or metastatic", "histology_inclusion": "microsatellite stable colon cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "advanced or metastatic", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "advanced or metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "advanced or metastatic", "histology_inclusion": "metastatic castration resistant prostate cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 3", "disease_state": "advanced or metastatic", "histology_inclusion": "selected advanced/metastatic malignancies", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Japanese safety run-in part", "disease_state": "advanced or metastatic", "histology_inclusion": "any tumor type included in part 1, 2 and 3", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 1", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "Part 1", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "Part 1", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "Part 1", "histology_inclusion": "Malignant Head and Neck Neoplasm"}, {"cohort": "Part 1", "histology_inclusion": "Head and Neck Carcinoma"}, {"cohort": "Part 1", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "Part 1", "histology_inclusion": "Colon Carcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Part 1", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Part 1", "histology_inclusion": "Melanoma"}, {"cohort": "Part 1", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Part 1", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Part 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part 3"}, {"cohort": "Japanese safety run-in part"}]}
{"NCT_id": "NCT04939662", "json": [{"cohort": "Relapsed Small Cell Lung Cancer Subjects", "disease_state": "relapsed", "histology_inclusion": "Small Cell Lung Cancer", "biomarker_inclusion": ["ATM deficiency", "SLFN11 positive", "POU2F3 positive", "BRCA 1/2", "MRE11A", "BLM", "NBN", "RAD50", "RAD52", "RAD54L", "RAD51", "RAD51B", "RAD51C", "RAD51D", "RECQL", "RECQL4", "RECQL5", "RPA1", "WRN"], "histology_exclusion": [], "biomarker_exclusion": ["PARP inhibitor"]}], "json_norm": [{"cohort": "Relapsed Small Cell Lung Cancer Subjects", "histology_inclusion": "Small Cell Lung Carcinoma", "biomarker_inclusion": [["POU2F3-High", "POU2F3-High", "expression"], ["SLFN11-High", "SLFN11-High", "expression"], ["ATM-Low", "ATM-Low", "expression"]]}]}
{"NCT_id": "NCT05204927", "json": [{"cohort": "", "disease_state": "Metastatic Castration-Resistant", "histology_inclusion": "prostate adenocarcinoma without predominant small cell component", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT05400122", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": ["active, untreated malignant involvement of the central nervous system (CNS)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "myelodysplastic syndrome", "biomarker_inclusion": [], "histology_exclusion": ["active, untreated malignant involvement of the central nervous system (CNS)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "acute lymphoblastic leukemia", "biomarker_inclusion": [], "histology_exclusion": ["active, untreated malignant involvement of the central nervous system (CNS)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "chronic myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": ["active, untreated malignant involvement of the central nervous system (CNS)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "chronic lymphocytic leukemia", "biomarker_inclusion": [], "histology_exclusion": ["active, untreated malignant involvement of the central nervous system (CNS)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "non Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["active, untreated malignant involvement of the central nervous system (CNS)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["active, untreated malignant involvement of the central nervous system (CNS)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "myeloproliferative syndromes", "biomarker_inclusion": [], "histology_exclusion": ["active, untreated malignant involvement of the central nervous system (CNS)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "plasma cell myeloma", "biomarker_inclusion": [], "histology_exclusion": ["active, untreated malignant involvement of the central nervous system (CNS)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "colon and/or rectal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive"}, {"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Non-Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Hodgkin Lymphoma"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "", "histology_inclusion": "Rectal Adenocarcinoma"}]}
{"NCT_id": "NCT03213041", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": ["CTC >= 5"], "histology_exclusion": [], "biomarker_exclusion": ["HER2-positive"]}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "HER2-negative metastatic breast cancer", "biomarker_inclusion": ["CTC >= 5"], "histology_exclusion": [], "biomarker_exclusion": ["HER2-positive"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04488783", "json": [{"cohort": "Glioblastoma patients", "disease_state": "newly diagnosed", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [], "histology_exclusion": ["brain tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Glioblastoma patients", "histology_inclusion": "Glioblastoma", "histology_exclusion": ["Primary Brain Neoplasm", "Malignant Brain Neoplasm", "Brain Tumor"]}]}
{"NCT_id": "NCT04619004", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR exon 19 deletion", "EGFR L858R"], "histology_exclusion": ["small cell", "combined small cell/non-small cell disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT05009836", "json": [{"cohort": "", "disease_state": "unresectable locally advanced (stage \u2162B/\u2162C), metastatic or recurrent (stage IV)", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR exon 19 deletion", "EGFR L858R", "c-MET overexpression"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR inhibitors", "MET inhibitors", "active brain metastasis"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT05270044", "json": [{"cohort": "", "disease_state": "Stage II (pT3b-pT4bN0)", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["BRAF V600E", "BRAF V600K"], "histology_exclusion": ["uveal melanoma", "mucosal melanoma"], "biomarker_exclusion": ["RAS mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]], "histology_exclusion": ["Mucosal Melanoma", "Intraocular Melanoma"], "biomarker_exclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT05595473", "json": [{"cohort": "", "disease_state": "BCLC stage B or C", "histology_inclusion": "Hepatocellular carcinoma", "biomarker_inclusion": ["hTERT positive expression"], "histology_exclusion": ["Carcinomas other than HCC"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma", "histology_exclusion": ["Hepatocellular Carcinoma"]}]}
{"NCT_id": "NCT03929965", "json": [{"cohort": "advanced solid tumors with FGFR alteration", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["FGFR mutation", "FGFR fusion", "FGFR rearrangements"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "advanced solid tumors with FGFR alteration", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR1 Fusion", "FGFR1", "fusion"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR4 Fusion", "FGFR4", "fusion"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"], ["FGFR3 Fusion", "FGFR3", "fusion"]]}]}
{"NCT_id": "NCT03995017", "json": [{"cohort": "", "disease_state": "Advanced stage 4 or locally unresectable stage 3", "histology_inclusion": "Gastric or gastroesophageal junction adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["MSI high", "MMR deficient"]}, {"cohort": "", "disease_state": "Advanced stage 4 or locally unresectable stage 3", "histology_inclusion": "Esophageal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["MSI high", "MMR deficient"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT05009927", "json": [{"cohort": "", "disease_state": "locally advanced/metastatic", "histology_inclusion": "Gastrointestinal Stromal Tumor (GIST)", "biomarker_inclusion": ["c-kit (CD117) expression"], "histology_exclusion": [], "biomarker_exclusion": ["D842V mutation in PDGFRA"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_exclusion": [["PDGFRA D842V", "D842V", "coordinate"]]}]}
{"NCT_id": "NCT05009992", "json": [{"cohort": "Cohort 1A and 1B", "disease_state": "New diagnosis of DMG", "histology_inclusion": "Diffuse Midline Glioma, H3 K27M-Mutant; WHO grade III and IV H3 wildtype gliomas", "biomarker_inclusion": [], "histology_exclusion": ["Thalamic H3K27M DMG"], "biomarker_exclusion": []}, {"cohort": "Cohort 2A and 2B", "disease_state": "Diagnosis of DMG post-radiation therapy", "histology_inclusion": "Diffuse Midline Glioma, H3 K27M-Mutant; WHO grade III and IV H3 wildtype gliomas", "biomarker_inclusion": [], "histology_exclusion": ["Thalamic H3K27M DMG"], "biomarker_exclusion": []}, {"cohort": "Cohort 3A and 3B", "disease_state": "Recurrent DMG", "histology_inclusion": "Diffuse Midline Glioma, H3 K27M-Mutant; WHO grade III and IV H3 wildtype gliomas", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1A and 1B", "histology_inclusion": "Diffuse Midline Glioma, H3 K27M-Mutant", "biomarker_inclusion": [["RLN3 RLN3-wild_type", "RLN3-wild_type", "wild_type"], ["H3C14 H3C14-wild_type", "H3C14-wild_type", "wild_type"], ["H3-3A K28M", "K28M", "coordinate"]], "biomarker_exclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Cohort 1A and 1B", "histology_inclusion": "Diffuse Midline Glioma, H3 K27M-Mutant", "biomarker_inclusion": [["RLN3 RLN3-wild_type", "RLN3-wild_type", "wild_type"], ["H3C14 H3C14-wild_type", "H3C14-wild_type", "wild_type"], ["H3-3A K28M", "K28M", "coordinate"]], "biomarker_exclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Cohort 1A and 1B", "histology_inclusion": "Diffuse Midline Glioma, H3 K27M-Mutant", "biomarker_inclusion": [["RLN3 RLN3-wild_type", "RLN3-wild_type", "wild_type"], ["H3C14 H3C14-wild_type", "H3C14-wild_type", "wild_type"], ["H3-3A K28M", "K28M", "coordinate"]], "biomarker_exclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Cohort 2A and 2B", "histology_inclusion": "Diffuse Midline Glioma, H3 K27M-Mutant", "biomarker_inclusion": [["RLN3 RLN3-wild_type", "RLN3-wild_type", "wild_type"], ["H3C14 H3C14-wild_type", "H3C14-wild_type", "wild_type"], ["H3-3A K28M", "K28M", "coordinate"]], "biomarker_exclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Cohort 2A and 2B", "histology_inclusion": "Diffuse Midline Glioma, H3 K27M-Mutant", "biomarker_inclusion": [["RLN3 RLN3-wild_type", "RLN3-wild_type", "wild_type"], ["H3C14 H3C14-wild_type", "H3C14-wild_type", "wild_type"], ["H3-3A K28M", "K28M", "coordinate"]], "biomarker_exclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Cohort 2A and 2B", "histology_inclusion": "Diffuse Midline Glioma, H3 K27M-Mutant", "biomarker_inclusion": [["RLN3 RLN3-wild_type", "RLN3-wild_type", "wild_type"], ["H3C14 H3C14-wild_type", "H3C14-wild_type", "wild_type"], ["H3-3A K28M", "K28M", "coordinate"]], "biomarker_exclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Cohort 3A and 3B", "histology_inclusion": "Diffuse Midline Glioma, H3 K27M-Mutant", "biomarker_inclusion": [["RLN3 RLN3-wild_type", "RLN3-wild_type", "wild_type"], ["H3C14 H3C14-wild_type", "H3C14-wild_type", "wild_type"], ["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Cohort 3A and 3B", "histology_inclusion": "Diffuse Midline Glioma, H3 K27M-Mutant", "biomarker_inclusion": [["RLN3 RLN3-wild_type", "RLN3-wild_type", "wild_type"], ["H3C14 H3C14-wild_type", "H3C14-wild_type", "wild_type"], ["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Cohort 3A and 3B", "histology_inclusion": "Diffuse Midline Glioma, H3 K27M-Mutant", "biomarker_inclusion": [["RLN3 RLN3-wild_type", "RLN3-wild_type", "wild_type"], ["H3C14 H3C14-wild_type", "H3C14-wild_type", "wild_type"], ["H3-3A K28M", "K28M", "coordinate"]]}]}
{"NCT_id": "NCT05205161", "json": [{"cohort": "Cohort B1 (R/R MCL)", "disease_state": "relapsed or refractory", "histology_inclusion": "mantle cell lymphoma", "biomarker_inclusion": ["t(11;14)(q13;q32)", "cyclin D1 overexpression"], "histology_exclusion": ["post-transplant lymphoproliferative disease", "Richter's transformation", "Burkitt's lymphoma", "Burkitt-like lymphoma", "lymphoblastic lymphoma/leukaemia", "chronic lymphocytic leukaemia", "small lymphocytic lymphoma", "central nervous system involvement"], "biomarker_exclusion": []}, {"cohort": "Cohort B2 (R/R FL or MZL)", "disease_state": "relapsed or refractory", "histology_inclusion": "follicular lymphoma Grade 1, 2, or 3a", "biomarker_inclusion": [], "histology_exclusion": ["post-transplant lymphoproliferative disease", "Richter's transformation", "Burkitt's lymphoma", "Burkitt-like lymphoma", "lymphoblastic lymphoma/leukaemia", "chronic lymphocytic leukaemia", "small lymphocytic lymphoma", "central nervous system involvement"], "biomarker_exclusion": []}, {"cohort": "Cohort B2 (R/R FL or MZL)", "disease_state": "relapsed or refractory", "histology_inclusion": "marginal zone lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["post-transplant lymphoproliferative disease", "Richter's transformation", "Burkitt's lymphoma", "Burkitt-like lymphoma", "lymphoblastic lymphoma/leukaemia", "chronic lymphocytic leukaemia", "small lymphocytic lymphoma", "central nervous system involvement"], "biomarker_exclusion": []}, {"cohort": "Cohort B3 (R/R DLBCL)", "disease_state": "relapsed or refractory", "histology_inclusion": "diffuse large B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["post-transplant lymphoproliferative disease", "Richter's transformation", "Burkitt's lymphoma", "Burkitt-like lymphoma", "lymphoblastic lymphoma/leukaemia", "chronic lymphocytic leukaemia", "small lymphocytic lymphoma", "central nervous system involvement"], "biomarker_exclusion": []}, {"cohort": "Cohort B3 (R/R DLBCL)", "disease_state": "relapsed or refractory", "histology_inclusion": "follicular lymphoma Grade 3b", "biomarker_inclusion": [], "histology_exclusion": ["post-transplant lymphoproliferative disease", "Richter's transformation", "Burkitt's lymphoma", "Burkitt-like lymphoma", "lymphoblastic lymphoma/leukaemia", "chronic lymphocytic leukaemia", "small lymphocytic lymphoma", "central nervous system involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort B1 (R/R MCL)", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["CCND1-High", "CCND1-High", "expression"]], "histology_exclusion": ["Atypical Burkitt/Burkitt-Like Lymphoma", "Small Lymphocytic Lymphoma", "Richter Syndrome", "Burkitt Lymphoma", "Lymphoblastic Lymphoma"]}, {"cohort": "Cohort B2 (R/R FL or MZL)", "histology_inclusion": "Follicular Lymphoma", "histology_exclusion": ["Atypical Burkitt/Burkitt-Like Lymphoma", "Small Lymphocytic Lymphoma", "Richter Syndrome", "Burkitt Lymphoma", "Lymphoblastic Lymphoma"]}, {"cohort": "Cohort B2 (R/R FL or MZL)", "histology_inclusion": "Marginal Zone Lymphoma", "histology_exclusion": ["Atypical Burkitt/Burkitt-Like Lymphoma", "Small Lymphocytic Lymphoma", "Richter Syndrome", "Burkitt Lymphoma", "Lymphoblastic Lymphoma"]}, {"cohort": "Cohort B3 (R/R DLBCL)", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Atypical Burkitt/Burkitt-Like Lymphoma", "Small Lymphocytic Lymphoma", "Richter Syndrome", "Burkitt Lymphoma", "Lymphoblastic Lymphoma"]}, {"cohort": "Cohort B3 (R/R DLBCL)", "histology_inclusion": "Grade 3b Follicular Lymphoma", "histology_exclusion": ["Atypical Burkitt/Burkitt-Like Lymphoma", "Small Lymphocytic Lymphoma", "Richter Syndrome", "Burkitt Lymphoma", "Lymphoblastic Lymphoma"]}]}
{"NCT_id": "NCT04619316", "json": [{"cohort": "BRAF wild type", "disease_state": "metastatic", "histology_inclusion": "thyroid carcinoma of follicular origin (including papillary and its respective variants)", "biomarker_inclusion": ["BRAF wild type"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "BRAF V600E Mutation", "disease_state": "metastatic", "histology_inclusion": "thyroid carcinoma of follicular origin (including papillary and its respective variants)", "biomarker_inclusion": ["BRAF V600E Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "BRAF wild type", "histology_inclusion": "Thyroid Gland Follicular Carcinoma", "biomarker_inclusion": [["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]]}, {"cohort": "BRAF V600E Mutation", "histology_inclusion": "Thyroid Gland Follicular Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT04879849", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Non-small-cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastasis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Triple-negative Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastasis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Squamous-cell Carcinoma of the Head and Neck", "biomarker_inclusion": [], "histology_exclusion": ["brain metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT05010031", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "", "biomarker_inclusion": ["ATM mutation"], "histology_exclusion": ["CNS disease"], "biomarker_exclusion": ["p53 mutation"]}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"]], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT05010122", "json": [{"cohort": "Phase I", "disease_state": "relapsed/refractory", "histology_inclusion": "FLT3-mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome", "biomarker_inclusion": ["FLT3-ITD", "FLT3 D835"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II Cohort A", "disease_state": "newly diagnosed", "histology_inclusion": "FLT3-mutated Acute Myeloid Leukemia", "biomarker_inclusion": ["FLT3-ITD", "FLT3 D835"], "histology_exclusion": [], "biomarker_exclusion": ["prior therapy for AML"]}, {"cohort": "Phase II Cohort B", "disease_state": "relapsed/refractory", "histology_inclusion": "FLT3-mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome", "biomarker_inclusion": ["FLT3-ITD", "FLT3 D835"], "histology_exclusion": [], "biomarker_exclusion": [">= 3 prior lines of therapy"]}], "json_norm": [{"cohort": "Phase I", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]]}, {"cohort": "Phase I", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]]}, {"cohort": "Phase II Cohort A", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]]}, {"cohort": "Phase II Cohort B", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]]}, {"cohort": "Phase II Cohort B", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]]}]}
{"NCT_id": "NCT05205252", "json": [{"cohort": "Arm 1-Tazemetostat plus tafasitamab-cxix (CD19 Ab)/lenalidomide in subjects with R/R DLBCL", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["T-cell lymphoblastic lymphoma", "T-cell acute lymphoblastic leukemia"], "biomarker_exclusion": []}, {"cohort": "Arm 2-Tazemetostat plus lenalidomide in subjects with R/R DLBCL", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["T-cell lymphoblastic lymphoma", "T-cell acute lymphoblastic leukemia"], "biomarker_exclusion": []}, {"cohort": "Arm 3-Tazemetostat plus acalabrutinib in subjects with R/R mantle cell lymphoma", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["T-cell lymphoblastic lymphoma", "T-cell acute lymphoblastic leukemia"], "biomarker_exclusion": []}, {"cohort": "Arm 4-Tazemetostat plus daratumumab/pomalidomide/dexamethasone in subjects with R/R multiple myeloma", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": ["T-cell lymphoblastic lymphoma", "T-cell acute lymphoblastic leukemia"], "biomarker_exclusion": []}, {"cohort": "Arm 5-Tazemetostat plus mosunetuzumab (CD20/CD3 BsAb) in subjects with R/R follicular lymphoma", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Follicular Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Grade 3b Follicular Lymphoma", "Mixed Histology Follicular Lymphoma", "Follicular Lymphoma transformed to Diffuse Large B-Cell Lymphoma", "T-cell lymphoblastic lymphoma", "T-cell acute lymphoblastic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm 1-Tazemetostat plus tafasitamab-cxix (CD19 Ab)/lenalidomide in subjects with R/R DLBCL", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Infant T Acute Lymphoblastic Leukemia", "T cell acute lymphoblastic leukemia", "Lymphoblastic Lymphoma"]}, {"cohort": "Arm 2-Tazemetostat plus lenalidomide in subjects with R/R DLBCL", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Infant T Acute Lymphoblastic Leukemia", "T cell acute lymphoblastic leukemia", "Lymphoblastic Lymphoma"]}, {"cohort": "Arm 3-Tazemetostat plus acalabrutinib in subjects with R/R mantle cell lymphoma", "histology_inclusion": "Mantle Cell Lymphoma", "histology_exclusion": ["Infant T Acute Lymphoblastic Leukemia", "T cell acute lymphoblastic leukemia", "Lymphoblastic Lymphoma"]}, {"cohort": "Arm 4-Tazemetostat plus daratumumab/pomalidomide/dexamethasone in subjects with R/R multiple myeloma", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Infant T Acute Lymphoblastic Leukemia", "T cell acute lymphoblastic leukemia", "Lymphoblastic Lymphoma"]}, {"cohort": "Arm 5-Tazemetostat plus mosunetuzumab (CD20/CD3 BsAb) in subjects with R/R follicular lymphoma", "histology_inclusion": "Follicular Lymphoma", "histology_exclusion": ["Follicular Lymphoma", "Infant T Acute Lymphoblastic Leukemia", "Diffuse Large B-Cell Lymphoma", "T cell acute lymphoblastic leukemia", "Lymphoblastic Lymphoma", "Grade 3b Follicular Lymphoma"]}]}
{"NCT_id": "NCT03669718", "json": [{"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "HPV16 positive Oropharyngeal Cancer", "biomarker_inclusion": ["PD-L1 (CPS \u2265 1)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "HPV16 positive Oropharyngeal Cancer", "biomarker_inclusion": ["disease progression on or after platinum containing chemotherapy"], "histology_exclusion": ["brain metastases", "leptomeningeal metastases"], "biomarker_exclusion": ["PD-L1 (CPS < 1)", "prior treatment with anti-PD-1 antibody", "prior treatment with anti-PD-L1", "prior treatment with anti-PD-L2", "prior treatment with anti-CTLA-4 antibody", "prior treatment with T-cell co-stimulation or immune checkpoint pathways", "prior treatment with more than one chemotherapy regimen for metastatic OPC", "prior treatment with therapeutic anti-HPV vaccines including ISA101 or ISA101b"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Oropharyngeal Carcinoma"}, {"cohort": "", "histology_inclusion": "Oropharyngeal Carcinoma"}]}
{"NCT_id": "NCT04060394", "json": [{"cohort": "", "disease_state": "metastatic castration-resistant prostate cancer", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": ["neuroendocrine differentiation", "small cell histology"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT04190550", "json": [{"cohort": "", "disease_state": "Newly diagnosed and previously untreated", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["wild-type p53"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": ["p53 mutation", "chromosome 17p deletion"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT04190628", "json": [{"cohort": "Part A", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["BRAF V600E mutation", "BRAF V600 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["BRAF mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "C-1", "disease_state": "", "histology_inclusion": "central nervous system (CNS) tumors", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "C-2", "disease_state": "melanoma with brain metastasis", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "C-3", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["BRAF mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "C-4", "disease_state": "melanoma with brain metastasis", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "Part B", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "C-1"}, {"cohort": "C-2", "histology_inclusion": "Melanoma"}, {"cohort": "C-3", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "C-4", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"]]}]}
{"NCT_id": "NCT04749641", "json": [{"cohort": "", "disease_state": "newly-diagnosed", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma", "biomarker_inclusion": ["H3.3K27M mutation", "HLA-A2 subtype"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}]}
{"NCT_id": "NCT05400577", "json": [{"cohort": "", "disease_state": "Stage Ib, IIa, IIb, IIIa", "histology_inclusion": "Non-squamous Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT02158858", "json": [{"cohort": "Arm 1 and 2", "disease_state": "Myelofibrosis", "histology_inclusion": "Myelofibrosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm 3", "disease_state": "Myelofibrosis", "histology_inclusion": "Myelofibrosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["Prior treatment with JAKi"]}, {"cohort": "Arm 4", "disease_state": "Essential Thrombocythemia", "histology_inclusion": "Essential Thrombocythemia", "biomarker_inclusion": ["High-risk disease"], "histology_exclusion": [], "biomarker_exclusion": ["Resistant or intolerant to HU"]}], "json_norm": [{"cohort": "Arm 1 and 2", "histology_inclusion": "Myelofibrosis"}, {"cohort": "Arm 3", "histology_inclusion": "Myelofibrosis"}, {"cohort": "Arm 4", "histology_inclusion": "Essential Thrombocythemia"}]}
{"NCT_id": "NCT04619537", "json": [{"cohort": "", "disease_state": "local advanced and/or metastatic NSCLC (phase IIIB, IIIC or IV) or recurrent non-squamous non-small cell lung cancer", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation-negative", "ALK mutation-negative"], "histology_exclusion": ["squamous carcinoma of lung", "adenosquamous carcinoma", "small cell lung cancer", "lung cancer mixed with small cell lung cancer and non-small cell lung cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Cervical Adenosquamous Carcinoma", "Squamous Cell Carcinoma", "Pancreatic Adenosquamous Carcinoma", "Lung Carcinoma", "Small Cell Lung Carcinoma", "Non-Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT04619563", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation-positive", "ALK mutation-negative"], "histology_exclusion": ["squamous carcinoma of lung", "small cell lung cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "histology_exclusion": ["Squamous Cell Carcinoma", "Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT05075512", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "HR-positive and HER2-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT03213652", "json": [{"cohort": "", "disease_state": "relapsed or refractory advanced", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["ALK genomic alterations", "ROS1 genomic alterations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory advanced", "histology_inclusion": "non-Hodgkin lymphoma", "biomarker_inclusion": ["ALK genomic alterations", "ROS1 genomic alterations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory advanced", "histology_inclusion": "histiocytic disorders", "biomarker_inclusion": ["ALK genomic alterations", "ROS1 genomic alterations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Non-Hodgkin Lymphoma", "biomarker_inclusion": [["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"]]}, {"cohort": "", "biomarker_inclusion": [["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"]]}]}
{"NCT_id": "NCT03213678", "json": [{"cohort": "", "disease_state": "metastatic, recurrent, refractory", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["TSC1 loss of function mutation", "TSC2 loss of function mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic, recurrent, refractory", "histology_inclusion": "non-Hodgkin lymphoma", "biomarker_inclusion": ["TSC1 loss of function mutation", "TSC2 loss of function mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic, recurrent, refractory", "histology_inclusion": "histiocytic disorders", "biomarker_inclusion": ["TSC1 loss of function mutation", "TSC2 loss of function mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic, recurrent, refractory", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["PI3K/MTOR pathway mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic, recurrent, refractory", "histology_inclusion": "non-Hodgkin lymphoma", "biomarker_inclusion": ["PI3K/MTOR pathway mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic, recurrent, refractory", "histology_inclusion": "histiocytic disorders", "biomarker_inclusion": ["PI3K/MTOR pathway mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TSC2-Low", "TSC2-Low", "expression"], ["TSC1-Low", "TSC1-Low", "expression"], ["TSC1 Mutation", "TSC1-Mutation", "gene"], ["TSC2 Mutation", "TSC2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Non-Hodgkin Lymphoma", "biomarker_inclusion": [["TSC2-Low", "TSC2-Low", "expression"], ["TSC1-Low", "TSC1-Low", "expression"], ["TSC1 Mutation", "TSC1-Mutation", "gene"], ["TSC2 Mutation", "TSC2-Mutation", "gene"]]}, {"cohort": "", "biomarker_inclusion": [["TSC2-Low", "TSC2-Low", "expression"], ["TSC1-Low", "TSC1-Low", "expression"], ["TSC1 Mutation", "TSC1-Mutation", "gene"], ["TSC2 Mutation", "TSC2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["PI3K/AKT/mTOR pathway", null, "pathway"], ["MTOR Mutation", "MTOR-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Non-Hodgkin Lymphoma", "biomarker_inclusion": [["PI3K/AKT/mTOR pathway", null, "pathway"], ["MTOR Mutation", "MTOR-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "", "biomarker_inclusion": [["PI3K/AKT/mTOR pathway", null, "pathway"], ["MTOR Mutation", "MTOR-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}]}
{"NCT_id": "NCT03539536", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["c-Met+"], "histology_exclusion": ["adenosquamous"], "biomarker_exclusion": ["EGFR mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT03670069", "json": [{"cohort": "Cohort 1", "disease_state": "Refractory Metastatic/Advanced", "histology_inclusion": "Leiomyosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System (CNS) metastases"], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Refractory Metastatic/Advanced", "histology_inclusion": "Undifferentiated Pleomorphic Sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System (CNS) metastases"], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "Refractory Metastatic/Advanced", "histology_inclusion": "Synovial Sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System (CNS) metastases"], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "Refractory Metastatic/Advanced", "histology_inclusion": "Myxoid/Round Cell Liposarcoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System (CNS) metastases"], "biomarker_exclusion": []}, {"cohort": "Cohort 4", "disease_state": "Refractory Metastatic/Advanced", "histology_inclusion": "Chondrosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System (CNS) metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Leiomyosarcoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Undifferentiated Pleomorphic Sarcoma"}, {"cohort": "Cohort 3", "histology_inclusion": "Synovial Sarcoma"}, {"cohort": "Cohort 3", "histology_inclusion": "Myxoid Liposarcoma"}, {"cohort": "Cohort 4", "histology_inclusion": "Chondrosarcoma"}]}
{"NCT_id": "NCT04554680", "json": [{"cohort": "Treatment Group", "disease_state": "RAI-refractory", "histology_inclusion": "Papillary thyroid carcinoma", "biomarker_inclusion": ["BRAFV600E mutation", "RAS mutation"], "histology_exclusion": ["Anaplastic thyroid carcinoma"], "biomarker_exclusion": []}, {"cohort": "Treatment Group", "disease_state": "RAI-refractory", "histology_inclusion": "Follicular thyroid carcinoma", "biomarker_inclusion": ["BRAFV600E mutation", "RAS mutation"], "histology_exclusion": ["Anaplastic thyroid carcinoma"], "biomarker_exclusion": []}, {"cohort": "Treatment Group", "disease_state": "RAI-refractory", "histology_inclusion": "Hurthle cell carcinoma", "biomarker_inclusion": ["BRAFV600E mutation", "RAS mutation"], "histology_exclusion": ["Anaplastic thyroid carcinoma"], "biomarker_exclusion": []}, {"cohort": "Treatment Group", "disease_state": "RAI-refractory", "histology_inclusion": "Poorly differentiated thyroid carcinoma", "biomarker_inclusion": ["BRAFV600E mutation", "RAS mutation"], "histology_exclusion": ["Anaplastic thyroid carcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Treatment Group", "histology_inclusion": "Thyroid Gland Papillary Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["BRAF V600E", "V600E", "coordinate"], ["KRAS Mutation", "KRAS-Mutation", "gene"]], "histology_exclusion": ["Thyroid Gland Undifferentiated (Anaplastic) Carcinoma"]}, {"cohort": "Treatment Group", "histology_inclusion": "Thyroid Gland Follicular Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["BRAF V600E", "V600E", "coordinate"], ["KRAS Mutation", "KRAS-Mutation", "gene"]], "histology_exclusion": ["Thyroid Gland Undifferentiated (Anaplastic) Carcinoma"]}, {"cohort": "Treatment Group", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["BRAF V600E", "V600E", "coordinate"], ["KRAS Mutation", "KRAS-Mutation", "gene"]], "histology_exclusion": ["Thyroid Gland Undifferentiated (Anaplastic) Carcinoma"]}, {"cohort": "Treatment Group", "histology_inclusion": "Poorly Differentiated Thyroid Gland Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["BRAF V600E", "V600E", "coordinate"], ["KRAS Mutation", "KRAS-Mutation", "gene"]], "histology_exclusion": ["Thyroid Gland Undifferentiated (Anaplastic) Carcinoma"]}]}
{"NCT_id": "NCT04684979", "json": [{"cohort": "HLA-compatible Related Donor", "disease_state": "relapsed", "histology_inclusion": "CD20+ aggressive B cell NHL (DLBCL, large cell transformation of indolent NHL/CLL, or mantle cell)", "biomarker_inclusion": [], "histology_exclusion": ["mantle cell or DLBCL NHL with progressive disease"], "biomarker_exclusion": ["known negativity for CD20 pre-allograft"]}, {"cohort": "HLA-compatible Related Donor", "disease_state": "relapsed", "histology_inclusion": "CD20+ indolent NHL/CLL", "biomarker_inclusion": [], "histology_exclusion": ["mantle cell or DLBCL NHL with progressive disease"], "biomarker_exclusion": ["known negativity for CD20 pre-allograft"]}, {"cohort": "Unrelated Donor", "disease_state": "relapsed", "histology_inclusion": "CD20+ aggressive B cell NHL (DLBCL, large cell transformation of indolent NHL/CLL, or mantle cell)", "biomarker_inclusion": [], "histology_exclusion": ["mantle cell or DLBCL NHL with progressive disease"], "biomarker_exclusion": ["known negativity for CD20 pre-allograft"]}, {"cohort": "Unrelated Donor", "disease_state": "relapsed", "histology_inclusion": "CD20+ indolent NHL/CLL", "biomarker_inclusion": [], "histology_exclusion": ["mantle cell or DLBCL NHL with progressive disease"], "biomarker_exclusion": ["known negativity for CD20 pre-allograft"]}], "json_norm": [{"cohort": "HLA-compatible Related Donor", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Non-Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma"]}, {"cohort": "HLA-compatible Related Donor", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Non-Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma"]}, {"cohort": "HLA-compatible Related Donor", "histology_inclusion": "Non-Hodgkin Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Diffuse Large B-Cell Lymphoma", "Non-Hodgkin Lymphoma"]}, {"cohort": "HLA-compatible Related Donor", "histology_inclusion": "Non-Hodgkin Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Non-Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma"]}, {"cohort": "HLA-compatible Related Donor", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Diffuse Large B-Cell Lymphoma", "Non-Hodgkin Lymphoma"]}, {"cohort": "Unrelated Donor", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Non-Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma"]}, {"cohort": "Unrelated Donor", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Non-Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma"]}, {"cohort": "Unrelated Donor", "histology_inclusion": "Non-Hodgkin Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Diffuse Large B-Cell Lymphoma", "Non-Hodgkin Lymphoma"]}, {"cohort": "Unrelated Donor", "histology_inclusion": "Non-Hodgkin Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Non-Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma"]}, {"cohort": "Unrelated Donor", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Diffuse Large B-Cell Lymphoma", "Non-Hodgkin Lymphoma"]}]}
{"NCT_id": "NCT03083678", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "chordoma", "biomarker_inclusion": ["EGFR expressing"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Chordoma", "biomarker_inclusion": [["EGFR-High", "EGFR-High", "expression"]]}]}
{"NCT_id": "NCT03539822", "json": [{"cohort": "Gastric & esophageal cancer cohort", "disease_state": "advanced (stage 4) or locally unresectable (stage III)", "histology_inclusion": "Gastric or gastroesophageal junction adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PD1 or PD-L1 inhibitor", "MET or Dual MET/HGF monoclonal antibodies or MET/HGF tyrosine kinase inhibitors"]}, {"cohort": "Gastric & esophageal cancer cohort", "disease_state": "advanced (stage 4) or locally unresectable (stage III)", "histology_inclusion": "Esophageal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PD1 or PD-L1 inhibitor", "MET or Dual MET/HGF monoclonal antibodies or MET/HGF tyrosine kinase inhibitors"]}, {"cohort": "Colorectal cancer cohort", "disease_state": "advanced (stage 4) or locally unresectable (stage III)", "histology_inclusion": "Colorectal adenocarcinoma", "biomarker_inclusion": ["Ras wild type"], "histology_exclusion": [], "biomarker_exclusion": ["PD1 or PD-L1 inhibitor", "MET or Dual MET/HGF monoclonal antibodies or MET/HGF tyrosine kinase inhibitors"]}, {"cohort": "Hepatocellular carcinoma cohort", "disease_state": "advanced (stage 4) or locally unresectable (stage III)", "histology_inclusion": "Hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PD1 or PD-L1 inhibitor", "MET or Dual MET/HGF monoclonal antibodies or MET/HGF tyrosine kinase inhibitors"]}], "json_norm": [{"cohort": "Gastric & esophageal cancer cohort", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "Gastric & esophageal cancer cohort", "histology_inclusion": "Esophageal Adenocarcinoma"}, {"cohort": "Colorectal cancer cohort", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}, {"cohort": "Hepatocellular carcinoma cohort", "histology_inclusion": "Hepatocellular Carcinoma"}]}
{"NCT_id": "NCT03604991", "json": [{"cohort": "", "disease_state": "Clinical Stage II Esophageal Adenocarcinoma AJCC v8", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Clinical Stage III Esophageal Adenocarcinoma AJCC v8", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Esophageal Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Esophageal Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Esophageal Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}]}
{"NCT_id": "NCT04685135", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["Prior treatment with an agent targeting KRAS G12C (e.g., AMG 510, Sotorasib)"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]], "biomarker_exclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT04945642", "json": [{"cohort": "", "disease_state": "Stage IIB, Stage IIC, Stage III, Stage IIIA, Stage IIIB, Stage IIIC, Stage IVA", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": ["PSA > 10", "Gleason score >= 7"], "histology_exclusion": ["Neuroendocrine carcinoma of the prostate", "Small cell carcinoma of the prostate"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "histology_exclusion": ["Prostate Neuroendocrine Neoplasm", "Prostate Small Cell Neuroendocrine Carcinoma", "Prostate Neuroendocrine Carcinoma"]}]}
{"NCT_id": "NCT05010694", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT05401110", "json": [{"cohort": "", "disease_state": "Stage IV or recurrent/metastatic", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": ["EGFR Exon 21 L858R", "EGFR Exon 19 deletion", "EGFR Exon 18 G719X", "EGFR Exon 21 L861Q"], "histology_exclusion": ["Small cell lung cancer"], "biomarker_exclusion": []}, {"cohort": "Part II, Cohort 1", "disease_state": "Progressive disease on osimertinib or other prior EGFR TKIs", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": ["EGFR Exon 21 L858R", "EGFR Exon 19 deletion", "EGFR Exon 18 G719X", "EGFR Exon 21 L861Q"], "histology_exclusion": ["Small cell lung cancer"], "biomarker_exclusion": []}, {"cohort": "Part II, Cohort 2", "disease_state": "Receiving osimertinib as front line treatment for less than 12 weeks", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": ["EGFR Exon 21 L858R", "EGFR Exon 19 deletion", "EGFR Exon 18 G719X", "EGFR Exon 21 L861Q", "Persistent ctDNA with EGFR mutation between weeks 6-12 from the start of osimertinib treatment"], "histology_exclusion": ["Small cell lung cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR L861Q", "L861Q", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]], "histology_exclusion": ["Small Cell Lung Carcinoma"]}, {"cohort": "Part II, Cohort 1", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR L861Q", "L861Q", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]], "histology_exclusion": ["Small Cell Lung Carcinoma"]}, {"cohort": "Part II, Cohort 2", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR L861Q", "L861Q", "coordinate"]], "histology_exclusion": ["Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT04945733", "json": [{"cohort": "Gastric Cancer (GC) Cohorts", "disease_state": "locally advanced, unresectable, or metastatic", "histology_inclusion": "gastric (including gastroesophageal junction [GEJ])", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior epidermal growth factor receptor (EGFR) or tyrosine-protein kinase mesenchymal-epithelial transition (cMet)-directed therapies"]}, {"cohort": "Esophageal Cancer (EC) Cohorts", "disease_state": "locally advanced, unresectable, or metastatic", "histology_inclusion": "esophageal cancer (EC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior epidermal growth factor receptor (EGFR) or tyrosine-protein kinase mesenchymal-epithelial transition (cMet)-directed therapies"]}], "json_norm": [{"cohort": "Gastric Cancer (GC) Cohorts"}, {"cohort": "Esophageal Cancer (EC) Cohorts", "histology_inclusion": "Esophageal Carcinoma"}]}
{"NCT_id": "NCT05075980", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "non-human papillomavirus (HPV) associated malignant epithelial cancer in the head and/or neck", "biomarker_inclusion": ["p16 negative", "HPV DNA negative"], "histology_exclusion": ["HPV-associated squamous cell carcinoma", "germ cell tumors", "hematologic malignancies", "neuroendocrine malignancies", "adenoid cystic carcinoma", "sarcomas of bone", "benign tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "skin cancer", "biomarker_inclusion": ["p16 positive"], "histology_exclusion": ["HPV-associated squamous cell carcinoma", "germ cell tumors", "hematologic malignancies", "neuroendocrine malignancies", "adenoid cystic carcinoma", "sarcomas of bone", "benign tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Epithelial Neoplasm", "biomarker_inclusion": [["H3P10-Low", "H3P10-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]], "histology_exclusion": ["Germ Cell Tumor", "Neuroendocrine Tumor", "Squamous Cell Carcinoma", "Adenoid Cystic Carcinoma", "Neuroendocrine Carcinoma", "Sarcoma", "Hematopoietic and Lymphoid Cell Neoplasm"]}, {"cohort": "", "histology_inclusion": "Malignant Skin Neoplasm", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]], "histology_exclusion": ["Squamous Cell Carcinoma", "Germ Cell Tumor", "Hematopoietic and Lymphoid Cell Neoplasm", "Neuroendocrine Carcinoma", "Neuroendocrine Tumor", "Adenoid Cystic Carcinoma", "Sarcoma"]}, {"cohort": "", "histology_inclusion": "Skin Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]], "histology_exclusion": ["Germ Cell Tumor", "Neuroendocrine Tumor", "Squamous Cell Carcinoma", "Adenoid Cystic Carcinoma", "Neuroendocrine Carcinoma", "Sarcoma", "Hematopoietic and Lymphoid Cell Neoplasm"]}]}
{"NCT_id": "NCT04620187", "json": [{"cohort": "Standard of Care + T-DM1 in HER2-Positive Salivary Gland Cancer", "disease_state": "stage II (with positive margins), III, IVA, or IVB locoregionally advanced", "histology_inclusion": "salivary gland carcinoma", "biomarker_inclusion": ["HER2 expression staining intensity of 2 or 3+ by IHC", "HER2 amplification by FISH (HER2/CEP 17 ratio >= 2.0 or HER2 mean copy number >= 4.0)", "HER2 or ERBB2 mutated on tumor genomic sequencing assay"], "histology_exclusion": [], "biomarker_exclusion": ["AJCC 2017 8th edition stage I or stage IVC (metastatic) disease", "prior HER2 directed therapy"]}], "json_norm": [{"cohort": "Standard of Care + T-DM1 in HER2-Positive Salivary Gland Cancer", "histology_inclusion": "Malignant Salivary Gland Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "Standard of Care + T-DM1 in HER2-Positive Salivary Gland Cancer", "histology_inclusion": "Salivary Gland Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}]}
{"NCT_id": "NCT05011019", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Type I Neurofibromatosis", "biomarker_inclusion": ["NF1 germline mutation"], "histology_exclusion": ["Malignant Peripheral Nerve Sheath Tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["NF1 Mutation", "NF1-Mutation", "gene"]], "histology_exclusion": ["Malignant Peripheral Nerve Sheath Tumor"]}]}
{"NCT_id": "NCT05271240", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "Glioblastoma, IDH-wildtype", "biomarker_inclusion": ["TERT promoter mutations", "EGFR gene amplification", "combined gain of entire chromosome 7 and loss of entire chromosome 10"], "histology_exclusion": ["IDH mutant astrocytoma", "non GBM brain tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["TERT-Promoter", "TERT-Promoter", "coordinate"], ["EGFR-High", "EGFR-High", "expression"]], "histology_exclusion": ["Astrocytoma", "Primary Brain Neoplasm", "Malignant Brain Neoplasm", "Brain Tumor", "Glioblastoma"], "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["TERT-Promoter", "TERT-Promoter", "coordinate"], ["EGFR-High", "EGFR-High", "expression"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "histology_exclusion": ["Malignant Brain Neoplasm", "Primary Brain Neoplasm", "Astrocytoma", "Glioblastoma", "Brain Tumor"], "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT02290145", "json": [{"cohort": "", "disease_state": "Clinical stage III/IVA (T1-2, N2, M0 or T3-4, N2, M0)", "histology_inclusion": "squamous cell carcinoma of the oral cavity (tongue, gingiva, buccal mucosa, floor of mouth, palate, and retromolar region)", "biomarker_inclusion": ["Cyclin D1 high expression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma", "biomarker_inclusion": [["CCND1-High", "CCND1-High", "expression"]]}]}
{"NCT_id": "NCT03996239", "json": [{"cohort": "Cohort 1: CH", "disease_state": "", "histology_inclusion": "clonal hematopoiesis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2: Solid Tumor", "disease_state": "stage III", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2: Solid Tumor", "disease_state": "stage III", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2: Solid Tumor", "disease_state": "metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3: Active Surveillance", "disease_state": "localized", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 4: Lynch Syndrome", "disease_state": "", "histology_inclusion": "Lynch syndrome", "biomarker_inclusion": ["MLH1", "MSH2", "MSH6", "PMS2", "EPCAM"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1: CH"}, {"cohort": "Cohort 2: Solid Tumor", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Cohort 2: Solid Tumor", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "Cohort 2: Solid Tumor", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "Cohort 3: Active Surveillance", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Cohort 3: Active Surveillance", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Cohort 4: Lynch Syndrome", "histology_inclusion": "Lynch Syndrome"}]}
{"NCT_id": "NCT04191499", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "HR+/HER2- breast cancer", "biomarker_inclusion": ["PIK3CA mutation"], "histology_exclusion": ["metaplastic breast cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]], "histology_exclusion": ["Breast Metaplastic Carcinoma"]}]}
{"NCT_id": "NCT04424966", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "high-grade glioma", "biomarker_inclusion": ["FGFR1 K656E", "FGFR3 K650E", "FGFR3-TACC3 translocation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Glioma", "biomarker_inclusion": [["FGFR3 K650E", "K650E", "coordinate"], ["TACC3 Fusion", "TACC3", "fusion"], ["FGFR3 - TACC3", "FGFR3 - TACC3", "coordinate"], ["FGFR1 K656E", "K656E", "coordinate"], ["FGFR3 Fusion", "FGFR3", "fusion"]]}]}
{"NCT_id": "NCT04620330", "json": [{"cohort": "Arm 1: avutometinib (VS-6766) monotherapy", "disease_state": "Recurrent", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": ["KRAS G12V"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm 2: avutometinib (VS-6766) in combination with defactinib", "disease_state": "Recurrent", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": ["KRAS G12V"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm 3: avutometinib (VS-6766) in combination with defactinib", "disease_state": "Recurrent", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": ["KRAS non-G12V"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm 4: avutometinib (VS-6766) in combination with defactinib", "disease_state": "Recurrent", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": ["BRAF V600E"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm 5: avutometinib (VS-6766) in combination with defactinib", "disease_state": "Recurrent", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": ["BRAF non-V600E"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm 1: avutometinib (VS-6766) monotherapy", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12V", "G12V", "coordinate"]]}, {"cohort": "Arm 2: avutometinib (VS-6766) in combination with defactinib", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12V", "G12V", "coordinate"]]}, {"cohort": "Arm 3: avutometinib (VS-6766) in combination with defactinib", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12V", "G12V", "coordinate"]]}, {"cohort": "Arm 4: avutometinib (VS-6766) in combination with defactinib", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "Arm 5: avutometinib (VS-6766) in combination with defactinib", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT04815720", "json": [{"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "Squamous Cell Carcinoma of the Head and Neck (HNSCC)", "biomarker_inclusion": ["PD-L1 IHC"], "histology_exclusion": ["SCC of the nasopharynx"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Squamous Cell Carcinoma"]}]}
{"NCT_id": "NCT05011058", "json": [{"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "EBV+ DLBCL, NOS", "biomarker_inclusion": ["EBV+"], "histology_exclusion": ["CNS involvement by lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "PTLD", "biomarker_inclusion": ["EBV+"], "histology_exclusion": ["CNS involvement by lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "Hodgkin lymphoma", "biomarker_inclusion": ["EBV+"], "histology_exclusion": ["CNS involvement by lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "ENKTL", "biomarker_inclusion": ["EBV+"], "histology_exclusion": ["CNS involvement by lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "PTCL, NOS", "biomarker_inclusion": ["EBV+"], "histology_exclusion": ["CNS involvement by lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Post-Transplant Lymphoproliferative Disorder"}, {"cohort": "", "histology_inclusion": "Hodgkin Lymphoma"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma"}]}
{"NCT_id": "NCT05336409", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "CD19-positive B-cell Non-Hodgkin's Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Central nervous system (CNS)-only involvement by malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma", "biomarker_inclusion": [["CD19-High", "CD19-High", "expression"], ["PPIB-High", "PPIB-High", "expression"]]}, {"cohort": "", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma", "biomarker_inclusion": [["CD19-High", "CD19-High", "expression"], ["PPIB-High", "PPIB-High", "expression"]]}]}
{"NCT_id": "NCT05076396", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion phase", "disease_state": "advanced", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion phase", "disease_state": "advanced", "histology_inclusion": "gastric cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion phase", "disease_state": "advanced", "histology_inclusion": "liposarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion phase", "disease_state": "advanced", "histology_inclusion": "leiomyosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion phase", "disease_state": "advanced", "histology_inclusion": "synovial sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion phase", "disease_state": "advanced", "histology_inclusion": "Ewing's sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion phase", "disease_state": "advanced", "histology_inclusion": "epithelial ovarian cancer", "biomarker_inclusion": ["deleterious germline BRCA mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion phase", "disease_state": "advanced", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["deleterious germline BRCA mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion phase", "disease_state": "advanced", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["deleterious germline BRCA mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion phase", "disease_state": "advanced", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["deleterious germline BRCA mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion phase", "disease_state": "advanced", "histology_inclusion": "epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["deleterious germline BRCA mutation"]}, {"cohort": "Expansion phase", "disease_state": "advanced", "histology_inclusion": "adrenocortical carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Expansion phase", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Expansion phase", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "Expansion phase", "histology_inclusion": "Liposarcoma"}, {"cohort": "Expansion phase", "histology_inclusion": "Leiomyosarcoma"}, {"cohort": "Expansion phase", "histology_inclusion": "Synovial Sarcoma"}, {"cohort": "Expansion phase", "histology_inclusion": "Ewing Sarcoma"}, {"cohort": "Expansion phase", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "Expansion phase", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "Expansion phase", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "Expansion phase", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "Expansion phase", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "Expansion phase", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_exclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "Expansion phase", "histology_inclusion": "Adrenal Cortex Carcinoma"}]}
{"NCT_id": "NCT05726864", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": ["KRAS G12D", "KRAS G12R", "KRAS G12V", "KRAS G12A", "KRAS G12C", "KRAS G12S", "KRAS G13D", "NRAS G12D", "NRAS G12R", "NRAS G12V", "NRAS G12C", "NRAS G12S"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["KRAS G12D", "KRAS G12R", "KRAS G12V", "KRAS G12A", "KRAS G12C", "KRAS G12S", "KRAS G13D", "NRAS G12D", "NRAS G12R", "NRAS G12V", "NRAS G12C", "NRAS G12S"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["KRAS G12D", "KRAS G12R", "KRAS G12V", "KRAS G12A", "KRAS G12C", "KRAS G12S", "KRAS G13D", "NRAS G12D", "NRAS G12R", "NRAS G12V", "NRAS G12C", "NRAS G12S"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"], ["NRAS G12S", "G12S", "coordinate"], ["NRAS G12C", "G12C", "coordinate"], ["KRAS G13D", "G13D", "coordinate"], ["KRAS G12A", "G12A", "coordinate"], ["NRAS G12V", "G12V", "coordinate"], ["KRAS G12V", "G12V", "coordinate"], ["KRAS G12R", "G12R", "coordinate"], ["KRAS G12S", "G12S", "coordinate"], ["NRAS G12R", "G12R", "coordinate"], ["KRAS G12C", "G12C", "coordinate"], ["NRAS G12D", "G12D", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"], ["NRAS G12S", "G12S", "coordinate"], ["NRAS G12C", "G12C", "coordinate"], ["KRAS G13D", "G13D", "coordinate"], ["KRAS G12A", "G12A", "coordinate"], ["NRAS G12V", "G12V", "coordinate"], ["KRAS G12V", "G12V", "coordinate"], ["KRAS G12R", "G12R", "coordinate"], ["KRAS G12S", "G12S", "coordinate"], ["NRAS G12R", "G12R", "coordinate"], ["KRAS G12C", "G12C", "coordinate"], ["NRAS G12D", "G12D", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"], ["NRAS G12S", "G12S", "coordinate"], ["NRAS G12C", "G12C", "coordinate"], ["KRAS G13D", "G13D", "coordinate"], ["KRAS G12A", "G12A", "coordinate"], ["NRAS G12V", "G12V", "coordinate"], ["KRAS G12V", "G12V", "coordinate"], ["KRAS G12R", "G12R", "coordinate"], ["KRAS G12S", "G12S", "coordinate"], ["NRAS G12R", "G12R", "coordinate"], ["KRAS G12C", "G12C", "coordinate"], ["NRAS G12D", "G12D", "coordinate"]]}]}
{"NCT_id": "NCT02616965", "json": [{"cohort": "", "disease_state": "stage IB, IIA, IIB, III or IV", "histology_inclusion": "mycosis fungoides (MF), Sezary syndrome (SS)", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "multifocal symptomatic or extensive lesions requiring systemic treatment", "histology_inclusion": "primary cutaneous CD30-positive lymphoproliferative disorder, including lymphomatoid papulosis and primary cutaneous ALCL (pc-ALCL)", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Synovial Sarcoma"}, {"cohort": "", "histology_inclusion": "Mycosis Fungoides"}, {"cohort": "", "histology_inclusion": "Sezary Syndrome"}, {"cohort": "", "histology_inclusion": "Lymphoproliferative Disorder", "biomarker_inclusion": [["TNFRSF8-High", "TNFRSF8-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Anaplastic Large Cell Lymphoma", "biomarker_inclusion": [["TNFRSF8-High", "TNFRSF8-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Lymphomatoid Papulosis", "biomarker_inclusion": [["TNFRSF8-High", "TNFRSF8-High", "expression"]]}]}
{"NCT_id": "NCT03410043", "json": [{"cohort": "", "disease_state": "Stage IIIB/IV or recurrent non-small cell lung cancer", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR exon 19 deletion", "EGFR L858R mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage IIIB/IV or recurrent non-small cell lung cancer", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR T790M mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior third generation TKI"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR T790M", "T790M", "coordinate"]]}]}
{"NCT_id": "NCT04256941", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "HR positive breast cancer", "biomarker_inclusion": ["ESR1 activating mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1 Mutation", "ESR1-Mutation", "gene"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT05011383", "json": [{"cohort": "ATM", "disease_state": "metastatic castration-resistant", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["ATM inactivating mutations"], "histology_exclusion": ["small cell carcinoma", "parenchymal brain metastasis", "liver metastases"], "biomarker_exclusion": []}, {"cohort": "CDK12", "disease_state": "metastatic castration-resistant", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["CDK12 inactivating mutations"], "histology_exclusion": ["small cell carcinoma", "parenchymal brain metastasis", "liver metastases"], "biomarker_exclusion": []}, {"cohort": "CHEK2", "disease_state": "metastatic castration-resistant", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["CHEK2 inactivating mutations"], "histology_exclusion": ["small cell carcinoma", "parenchymal brain metastasis", "liver metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "ATM", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"]], "histology_exclusion": ["Small Cell Carcinoma"]}, {"cohort": "CDK12", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["CDK12 Mutation", "CDK12-Mutation", "gene"]], "histology_exclusion": ["Small Cell Carcinoma"]}, {"cohort": "CHEK2", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["CHEK2 Mutation", "CHEK2-Mutation", "gene"]], "histology_exclusion": ["Small Cell Carcinoma"]}]}
{"NCT_id": "NCT05076513", "json": [{"cohort": "Arm A: Presumed Newly-Diagnosed glioblastoma", "disease_state": "newly diagnosed", "histology_inclusion": "glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B: Recurrent Glioma (Grades II-IV)", "disease_state": "recurrent", "histology_inclusion": "glioma", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation", "ATRX loss"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm A: Presumed Newly-Diagnosed glioblastoma", "histology_inclusion": "Glioblastoma"}, {"cohort": "Arm B: Recurrent Glioma (Grades II-IV)", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["ATRX-Low", "ATRX-Low", "expression"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT03344965", "json": [{"cohort": "Cohorts 1 and 2", "disease_state": "metastatic", "histology_inclusion": "invasive breast cancer", "biomarker_inclusion": ["ATM", "ATR", "BARD1", "BRIP1 (FANCJ)", "CHEK2", "FANCA", "FANCC", "FANCD2", "FANCE", "FANCF", "FANCM", "MRE11A", "NBN", "PALB2", "RAD50", "RAD51C", "RAD51D"], "histology_exclusion": [], "biomarker_exclusion": ["germline BRCA1", "germline BRCA2"]}, {"cohort": "Cohort 1a", "disease_state": "metastatic", "histology_inclusion": "invasive breast cancer", "biomarker_inclusion": ["germline PALB2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2a", "disease_state": "metastatic", "histology_inclusion": "invasive breast cancer", "biomarker_inclusion": ["somatic mutation of BRCA 1", "somatic mutation of BRCA 2"], "histology_exclusion": [], "biomarker_exclusion": ["germline mutation in BRCA 1/2"]}], "json_norm": [{"cohort": "Cohorts 1 and 2", "histology_inclusion": "Invasive Breast Carcinoma"}, {"cohort": "Cohort 1a", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["PALB2 Mutation", "PALB2-Mutation", "gene"]]}, {"cohort": "Cohort 2a", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]], "biomarker_exclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04555577", "json": [{"cohort": "", "disease_state": "Newly Diagnosed", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["MGMT Unmethylated", "IDH Wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["MGMT Methylated"]}, {"cohort": "", "disease_state": "Newly Diagnosed", "histology_inclusion": "Gliosarcoma", "biomarker_inclusion": ["MGMT Unmethylated", "IDH Wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["MGMT Methylated"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Gliosarcoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04620681", "json": [{"cohort": "Myelodysplastic Syndrome (MDS) having failed hypomethylating agent (HMA) therapy cohort", "disease_state": "", "histology_inclusion": "Myelodysplastic Syndrome (MDS)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Myelodysplastic Syndrome (MDS) having failed hypomethylating agent (HMA) therapy cohort", "disease_state": "", "histology_inclusion": "myelodysplastic/myeloproliferative overlap (MDS/MPN)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Secondary Acute Myeloid Leukemia (sAML)", "disease_state": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [], "histology_exclusion": ["Acute promyelocytic leukemia", "t(15;17)", "blastic transformation of chronic myelogenous leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Myelodysplastic Syndrome (MDS) having failed hypomethylating agent (HMA) therapy cohort", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "Myelodysplastic Syndrome (MDS) having failed hypomethylating agent (HMA) therapy cohort", "histology_inclusion": "Myelodysplastic/Myeloproliferative Disease"}, {"cohort": "Secondary Acute Myeloid Leukemia (sAML)", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT04750928", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Neurofibromatosis Type 1 (NF1) Related Atypical Neurofibromas", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}]}
{"NCT_id": "NCT04750941", "json": [{"cohort": "Follicular Lymphoma (FL)", "disease_state": "relapsed or refractory", "histology_inclusion": "follicular lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Endometrial Cancer (EC)", "disease_state": "recurrent or advanced", "histology_inclusion": "endometrioid endometrial cancer", "biomarker_inclusion": ["activating mutation in PIK3CA", "loss of PTEN"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Endometrial Cancer (EC)", "disease_state": "recurrent or advanced", "histology_inclusion": "serous endometrial cancer", "biomarker_inclusion": ["activating mutation in PIK3CA", "loss of PTEN"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Endometrial Cancer (EC)", "disease_state": "recurrent or advanced", "histology_inclusion": "clear cell endometrial cancer", "biomarker_inclusion": ["activating mutation in PIK3CA", "loss of PTEN"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Endometrial Cancer (EC)", "disease_state": "recurrent or advanced", "histology_inclusion": "undifferentiated endometrial cancer", "biomarker_inclusion": ["activating mutation in PIK3CA", "loss of PTEN"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Endometrial Cancer (EC)", "disease_state": "recurrent or advanced", "histology_inclusion": "dedifferentiated endometrial cancer", "biomarker_inclusion": ["activating mutation in PIK3CA", "loss of PTEN"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Endometrial Cancer (EC)", "disease_state": "recurrent or advanced", "histology_inclusion": "mucinous endometrial cancer", "biomarker_inclusion": ["activating mutation in PIK3CA", "loss of PTEN"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Endometrial Cancer (EC)", "disease_state": "recurrent or advanced", "histology_inclusion": "squamous endometrial cancer", "biomarker_inclusion": ["activating mutation in PIK3CA", "loss of PTEN"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Endometrial Cancer (EC)", "disease_state": "recurrent or advanced", "histology_inclusion": "transitional endometrial cancer", "biomarker_inclusion": ["activating mutation in PIK3CA", "loss of PTEN"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Endometrial Cancer (EC)", "disease_state": "recurrent or advanced", "histology_inclusion": "not-otherwise specified endometrial cancer", "biomarker_inclusion": ["activating mutation in PIK3CA", "loss of PTEN"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Endometrial Cancer (EC)", "disease_state": "recurrent or advanced", "histology_inclusion": "mixed celltype endometrial cancer", "biomarker_inclusion": ["activating mutation in PIK3CA", "loss of PTEN"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Follicular Lymphoma (FL)", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "Endometrial Cancer (EC)", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["PTEN-Low", "PTEN-Low", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "Endometrial Cancer (EC)", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["PTEN-Low", "PTEN-Low", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "Endometrial Cancer (EC)", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["PTEN-Low", "PTEN-Low", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "Endometrial Cancer (EC)", "histology_inclusion": "Endometrial Undifferentiated Carcinoma", "biomarker_inclusion": [["PTEN-Low", "PTEN-Low", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "Endometrial Cancer (EC)", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["PTEN-Low", "PTEN-Low", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "Endometrial Cancer (EC)", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["PTEN-Low", "PTEN-Low", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "Endometrial Cancer (EC)", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["PTEN-Low", "PTEN-Low", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "Endometrial Cancer (EC)", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["PTEN-Low", "PTEN-Low", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "Endometrial Cancer (EC)", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["PTEN-Low", "PTEN-Low", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "Endometrial Cancer (EC)", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["PTEN-Low", "PTEN-Low", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}]}
{"NCT_id": "NCT04946370", "json": [{"cohort": "", "disease_state": "progressive metastatic CRPC", "histology_inclusion": "prostate adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1", "anti-PD-L2", "CTLA-4", "OX 40", "CD137"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT05011487", "json": [{"cohort": "", "disease_state": "Stage IIIA or T3-4N2 IIIB", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["EGFR Ex19del", "EGFR L858R"], "histology_exclusion": ["mixed small cell and NSCLC"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]], "histology_exclusion": ["Non-Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT03801369", "json": [{"cohort": "", "disease_state": "Metastatic", "histology_inclusion": "Triple-Negative Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}]}
{"NCT_id": "NCT04257110", "json": [{"cohort": "Part 2: Cohort 1", "disease_state": "locally advanced/metastatic", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["HER2 overexpressing", "HER2 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2: Cohort 2", "disease_state": "locally advanced/metastatic", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["HER2 low expressing"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2 Cohort 3", "disease_state": "locally advanced/metastatic", "histology_inclusion": "Gastric Cancer", "biomarker_inclusion": ["HER2 overexpressing", "HER2 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2 Cohort 3", "disease_state": "locally advanced/metastatic", "histology_inclusion": "gastroesophageal junction cancer", "biomarker_inclusion": ["HER2 overexpressing", "HER2 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2 Cohort 4", "disease_state": "locally advanced/metastatic", "histology_inclusion": "Solid Tumors other than Breast Cancer and Gastric Cancer", "biomarker_inclusion": ["HER2 overexpressing", "HER2 positive"], "histology_exclusion": ["Breast Cancer", "Gastric Cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 2: Cohort 1", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part 2: Cohort 2", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Part 2 Cohort 3", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part 2 Cohort 3", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part 2 Cohort 4", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-High", "ERBB2-High", "expression"]], "histology_exclusion": ["Breast Carcinoma", "Gastric Carcinoma", "Gastric Carcinoma"]}, {"cohort": "Part 2 Cohort 4", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-High", "ERBB2-High", "expression"]], "histology_exclusion": ["Breast Carcinoma", "Gastric Carcinoma", "Gastric Carcinoma"]}, {"cohort": "Part 2 Cohort 4", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "histology_exclusion": ["Breast Carcinoma", "Gastric Carcinoma"]}]}
{"NCT_id": "NCT04816214", "json": [{"cohort": "", "disease_state": "Stage IIIB/IIIC or IV", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutation", "T790M negative", "MET gene amplification"], "histology_exclusion": [], "biomarker_exclusion": ["Prior treatment with any MET inhibitor", "HGF-targeting therapy", "known druggable molecular alterations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["MET-High", "MET-High", "expression"]]}]}
{"NCT_id": "NCT05076760", "json": [{"cohort": "", "disease_state": "Advanced/metastatic", "histology_inclusion": "Non-small cell lung cancer (NSCLC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Advanced/metastatic", "histology_inclusion": "Cutaneous squamous-cell carcinoma (cSCC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Advanced/metastatic", "histology_inclusion": "Merkel cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Advanced/metastatic", "histology_inclusion": "Melanoma", "biomarker_inclusion": ["BRAF V600E"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Advanced/metastatic", "histology_inclusion": "Pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Advanced/metastatic", "histology_inclusion": "Triple negative breast cancer (TNBC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Advanced/metastatic", "histology_inclusion": "Head and Neck Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Merkel Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Malignant Head and Neck Neoplasm"}, {"cohort": "", "histology_inclusion": "Head and Neck Carcinoma"}]}
{"NCT_id": "NCT01505569", "json": [{"cohort": "Arm A: Solid Tumor", "disease_state": "metastatic or relapsed", "histology_inclusion": "Ewing's Family Tumors", "biomarker_inclusion": [], "histology_exclusion": ["Primary Malignant Brain Neoplasms"], "biomarker_exclusion": []}, {"cohort": "Arm A: Solid Tumor", "disease_state": "relapsed", "histology_inclusion": "Renal Tumors", "biomarker_inclusion": [], "histology_exclusion": ["Primary Malignant Brain Neoplasms"], "biomarker_exclusion": []}, {"cohort": "Arm A: Solid Tumor", "disease_state": "metastatic or relapsed", "histology_inclusion": "Hepatoblastoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary Malignant Brain Neoplasms"], "biomarker_exclusion": []}, {"cohort": "Arm A: Solid Tumor", "disease_state": "metastatic or relapsed", "histology_inclusion": "Rhabdomyosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary Malignant Brain Neoplasms"], "biomarker_exclusion": []}, {"cohort": "Arm A: Solid Tumor", "disease_state": "chemotherapy responsive metastatic or relapsed", "histology_inclusion": "Soft Tissue Sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary Malignant Brain Neoplasms"], "biomarker_exclusion": []}, {"cohort": "Arm A: Solid Tumor", "disease_state": "at diagnosis or relapse", "histology_inclusion": "Primary Malignant Brain Neoplasms", "biomarker_inclusion": [], "histology_exclusion": ["Primary Malignant Brain Neoplasms"], "biomarker_exclusion": []}, {"cohort": "Arm A: Solid Tumor", "disease_state": "disseminated at diagnosis or relapsed", "histology_inclusion": "Retinoblastoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary Malignant Brain Neoplasms"], "biomarker_exclusion": []}, {"cohort": "Arm A: Solid Tumor", "disease_state": "", "histology_inclusion": "CNS Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary Malignant Brain Neoplasms"], "biomarker_exclusion": []}, {"cohort": "Arm B: Certain CNS tumors", "disease_state": "high risk", "histology_inclusion": "Medulloblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B: Certain CNS tumors", "disease_state": "", "histology_inclusion": "Anaplastic Histologic Variant Medulloblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B: Certain CNS tumors", "disease_state": "", "histology_inclusion": "Infant Medulloblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B: Certain CNS tumors", "disease_state": "", "histology_inclusion": "Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B: Certain CNS tumors", "disease_state": "", "histology_inclusion": "Atypical Teratoid/Rhabdoid Tumor (AT/RT)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm C: Germ Cell Tumors", "disease_state": "", "histology_inclusion": "Germ Cell Tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm D: Certain CNS Tumor patients who can only undergo one transplant", "disease_state": "high risk", "histology_inclusion": "Medulloblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm D: Certain CNS Tumor patients who can only undergo one transplant", "disease_state": "", "histology_inclusion": "Anaplastic Histologic Variant Medulloblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm D: Certain CNS Tumor patients who can only undergo one transplant", "disease_state": "", "histology_inclusion": "Infant Medulloblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm D: Certain CNS Tumor patients who can only undergo one transplant", "disease_state": "", "histology_inclusion": "Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm D: Certain CNS Tumor patients who can only undergo one transplant", "disease_state": "", "histology_inclusion": "Atypical Teratoid/Rhabdoid Tumor (AT/RT)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm D: Certain CNS Tumor patients who can only undergo one transplant", "disease_state": "", "histology_inclusion": "Choroid Plexus Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm E: Neuroblastoma", "disease_state": "", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm E: Neuroblastoma", "disease_state": "", "histology_inclusion": "Ganglioneuroblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm A: Solid Tumor", "histology_inclusion": "Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor", "histology_exclusion": ["Malignant Brain Neoplasm"]}, {"cohort": "Arm A: Solid Tumor", "histology_inclusion": "Kidney Cancer", "histology_exclusion": ["Malignant Brain Neoplasm"]}, {"cohort": "Arm A: Solid Tumor", "histology_inclusion": "Hepatoblastoma", "histology_exclusion": ["Malignant Brain Neoplasm"]}, {"cohort": "Arm A: Solid Tumor", "histology_inclusion": "Rhabdomyosarcoma", "histology_exclusion": ["Malignant Brain Neoplasm"]}, {"cohort": "Arm A: Solid Tumor", "histology_inclusion": "Soft Tissue Sarcoma", "histology_exclusion": ["Malignant Brain Neoplasm"]}, {"cohort": "Arm A: Solid Tumor", "histology_inclusion": "Malignant Brain Neoplasm", "histology_exclusion": ["Malignant Brain Neoplasm"]}, {"cohort": "Arm A: Solid Tumor", "histology_inclusion": "Retinoblastoma", "histology_exclusion": ["Malignant Brain Neoplasm"]}, {"cohort": "Arm A: Solid Tumor", "histology_inclusion": "Central Nervous System Lymphoma", "histology_exclusion": ["Malignant Brain Neoplasm"]}, {"cohort": "Arm A: Solid Tumor", "histology_inclusion": "Primary Central Nervous System Lymphoma", "histology_exclusion": ["Malignant Brain Neoplasm"]}, {"cohort": "Arm B: Certain CNS tumors", "histology_inclusion": "Medulloblastoma"}, {"cohort": "Arm B: Certain CNS tumors", "histology_inclusion": "Medulloblastoma"}, {"cohort": "Arm B: Certain CNS tumors", "histology_inclusion": "Medulloblastoma"}, {"cohort": "Arm B: Certain CNS tumors", "histology_inclusion": "Primitive Neuroectodermal Tumor"}, {"cohort": "Arm B: Certain CNS tumors", "histology_inclusion": "Atypical Teratoid/Rhabdoid Tumor"}, {"cohort": "Arm C: Germ Cell Tumors", "histology_inclusion": "Germ Cell Tumor"}, {"cohort": "Arm D: Certain CNS Tumor patients who can only undergo one transplant", "histology_inclusion": "Medulloblastoma"}, {"cohort": "Arm D: Certain CNS Tumor patients who can only undergo one transplant", "histology_inclusion": "Medulloblastoma"}, {"cohort": "Arm D: Certain CNS Tumor patients who can only undergo one transplant", "histology_inclusion": "Medulloblastoma"}, {"cohort": "Arm D: Certain CNS Tumor patients who can only undergo one transplant", "histology_inclusion": "Primitive Neuroectodermal Tumor"}, {"cohort": "Arm D: Certain CNS Tumor patients who can only undergo one transplant", "histology_inclusion": "Atypical Teratoid/Rhabdoid Tumor"}, {"cohort": "Arm D: Certain CNS Tumor patients who can only undergo one transplant", "histology_inclusion": "Choroid Plexus Neoplasm"}, {"cohort": "Arm D: Certain CNS Tumor patients who can only undergo one transplant", "histology_inclusion": "Choroid Plexus Carcinoma"}, {"cohort": "Arm E: Neuroblastoma", "histology_inclusion": "Neuroblastoma"}, {"cohort": "Arm E: Neuroblastoma", "histology_inclusion": "Ganglioneuroblastoma"}]}
{"NCT_id": "NCT02356159", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Hodgkin's Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Non-Hodgkin's Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Acute Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Non-Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Acute Leukemia"}, {"cohort": "", "histology_inclusion": "Plasma Cell Myeloma"}]}
{"NCT_id": "NCT03345303", "json": [{"cohort": "", "disease_state": "stage IV", "histology_inclusion": "intrahepatic cholangiocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases", "brain metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Intrahepatic Cholangiocarcinoma"}]}
{"NCT_id": "NCT03801434", "json": [{"cohort": "Idiopathic Hypereosinophilic Syndrome", "disease_state": "Dependent, intolerant or refractory to corticosteroids OR has relapsed/refractory disease to other therapy besides corticosteroids", "histology_inclusion": "Idiopathic Hypereosinophilic Syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Lymphocyte-Variant Hypereosinophilia", "disease_state": "Dependent, intolerant or refractory to corticosteroids OR has relapsed/refractory disease to other therapy besides corticosteroids", "histology_inclusion": "Lymphocyte-Variant Hypereosinophilia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Chronic Eosinophilic Leukemia, Not Otherwise Specified (CEL, NOS)", "disease_state": "Newly-diagnosed OR receiving corticosteroids OR has relapsed/refractory disease to any therapy besides corticosteroids", "histology_inclusion": "Chronic Eosinophilic Leukemia, Not Otherwise Specified (CEL, NOS)", "biomarker_inclusion": ["JAK2 Gene Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "JAK2-Rearranged Eosinophilic Neoplasm", "disease_state": "Newly-diagnosed OR receiving corticosteroids OR has relapsed/refractory disease to any therapy besides corticosteroids", "histology_inclusion": "JAK2-Rearranged Eosinophilic Neoplasm", "biomarker_inclusion": ["PCM1-JAK2", "BCR-JAK2", "ETV6-JAK2", "JAK2 rearrangements"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Idiopathic Hypereosinophilic Syndrome"}, {"cohort": "Lymphocyte-Variant Hypereosinophilia"}, {"cohort": "Chronic Eosinophilic Leukemia, Not Otherwise Specified (CEL, NOS)", "histology_inclusion": "Chronic Eosinophilic Leukemia", "biomarker_inclusion": [["JAK2 Mutation", "JAK2-Mutation", "gene"]]}, {"cohort": "JAK2-Rearranged Eosinophilic Neoplasm", "biomarker_inclusion": [["PCM1 - JAK2", "PCM1 - JAK2", "coordinate"], ["JAK2 Fusion", "JAK2", "fusion"], ["BCR - JAK2", "BCR - JAK2", "coordinate"], ["ETV6 - JAK2", "ETV6 - JAK2", "coordinate"], ["MBD1 - JAK2", "MBD1 - JAK2", "coordinate"]]}]}
{"NCT_id": "NCT03801525", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Small Lymphocytic Lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia", "histology_exclusion": ["Small Lymphocytic Lymphoma"]}]}
{"NCT_id": "NCT04555837", "json": [{"cohort": "Phase II", "disease_state": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["Rb-deficient"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with anti-PD-1 antibody", "prior treatment with anti-PD-L1", "prior treatment with anti-PD-L2", "prior treatment with anti-CTLA-4 antibody", "prior treatment with drugs targeting T-cell co-stimulation or immune checkpoint pathways"]}, {"cohort": "Phase II", "disease_state": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["HPV positive"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with anti-PD-1 antibody", "prior treatment with anti-PD-L1", "prior treatment with anti-PD-L2", "prior treatment with anti-CTLA-4 antibody", "prior treatment with drugs targeting T-cell co-stimulation or immune checkpoint pathways"]}, {"cohort": "Phase I", "disease_state": "", "histology_inclusion": "invasive solid tumor malignancy", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase II", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["RB1-Low", "RB1-Low", "expression"]]}, {"cohort": "Phase II", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Phase I", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04322539", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colon adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Colon Adenocarcinoma"}]}
{"NCT_id": "NCT04686305", "json": [{"cohort": "", "disease_state": "unresectable locally advanced/metastatic", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["HER2+ (IHC 3+ or IHC 2+)"], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": ["HER2 mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "biomarker_exclusion": [["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04751370", "json": [{"cohort": "", "disease_state": "Stage II or III", "histology_inclusion": "Adenocarcinoma of the rectal", "biomarker_inclusion": ["MSI-H", "dMMR"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Rectal Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04946864", "json": [{"cohort": "single arm", "disease_state": "metastatic", "histology_inclusion": "ER positive breast cancer", "biomarker_inclusion": ["HER2 negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "combination arm", "disease_state": "metastatic", "histology_inclusion": "ER positive breast cancer", "biomarker_inclusion": ["HER2 negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "single arm", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "combination arm", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}]}
{"NCT_id": "NCT03736616", "json": [{"cohort": "Cohort A", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Diffuse Large B Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["Prior exposure to a BTK inhibitor"]}, {"cohort": "Cohort B", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Diffuse Large B Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["Prior exposure to a BTK inhibitor"]}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "Cohort B", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}]}
{"NCT_id": "NCT04556071", "json": [{"cohort": "", "disease_state": "platinum refractory/resistant recurrent", "histology_inclusion": "ovarian cancer, fallopian tube cancer, primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "platinum refractory/resistant recurrent", "histology_inclusion": "high-grade serous", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "platinum refractory/resistant recurrent", "histology_inclusion": "endometrioid", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": ""}, {"cohort": ""}]}
{"NCT_id": "NCT05142241", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "rare solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04816838", "json": [{"cohort": "N/A(Single Arm)", "disease_state": "stage I to IIIa", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutation (Exon 19 deletion)", "EGFR mutation (L858R)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "N/A(Single Arm)", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT03671720", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["tumor mutation burden higher than 9 Muts/MB"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"], ["MB Mutation", "MB-Mutation", "gene"]]}]}
{"NCT_id": "NCT03736889", "json": [{"cohort": "", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["MSI-H", "dMMR"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT03932253", "json": [{"cohort": "", "disease_state": "advanced melanoma stage III or IV", "histology_inclusion": "melanoma", "biomarker_inclusion": ["NRAS-aberrant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced melanoma stage III or IV", "histology_inclusion": "melanoma", "biomarker_inclusion": ["NRAS-mutant"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT03932331", "json": [{"cohort": "Phase II Cohort A", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system involvement of lymphoma/leukemia", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Phase II Cohort B", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system involvement of lymphoma/leukemia", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Phase I", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Other B-cell Malignancies", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system involvement of lymphoma/leukemia", "leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase II Cohort A", "histology_inclusion": "Mantle Cell Lymphoma"}, {"cohort": "Phase II Cohort B", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "Phase I", "histology_inclusion": "B-Cell Neoplasm"}]}
{"NCT_id": "NCT04947254", "json": [{"cohort": "", "disease_state": "Localized or regional high-risk", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma"}]}
{"NCT_id": "NCT05597917", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Dedifferentiated liposarcoma", "biomarker_inclusion": ["CD13 positivity (score \u2265 1)"], "histology_exclusion": ["Gastrointestinal stromal tumors (GIST)", "Epitheloid sarcoma", "Alveolar soft part sarcoma", "Desmoplastic small round cell tumor", "Chondrosarcoma", "Osteosarcoma", "Ewing sarcoma (including CIC-rearranged sarcoma and Sarcoma with BCOR alterations)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Myxoid liposarcoma (high grade)", "biomarker_inclusion": ["CD13 positivity (score \u2265 1)"], "histology_exclusion": ["Gastrointestinal stromal tumors (GIST)", "Epitheloid sarcoma", "Alveolar soft part sarcoma", "Desmoplastic small round cell tumor", "Chondrosarcoma", "Osteosarcoma", "Ewing sarcoma (including CIC-rearranged sarcoma and Sarcoma with BCOR alterations)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Pleomorphic liposarcoma", "biomarker_inclusion": ["CD13 positivity (score \u2265 1)"], "histology_exclusion": ["Gastrointestinal stromal tumors (GIST)", "Epitheloid sarcoma", "Alveolar soft part sarcoma", "Desmoplastic small round cell tumor", "Chondrosarcoma", "Osteosarcoma", "Ewing sarcoma (including CIC-rearranged sarcoma and Sarcoma with BCOR alterations)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Adult fibrosarcoma", "biomarker_inclusion": ["CD13 positivity (score \u2265 1)"], "histology_exclusion": ["Gastrointestinal stromal tumors (GIST)", "Epitheloid sarcoma", "Alveolar soft part sarcoma", "Desmoplastic small round cell tumor", "Chondrosarcoma", "Osteosarcoma", "Ewing sarcoma (including CIC-rearranged sarcoma and Sarcoma with BCOR alterations)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Myxofibrosarcoma (high-grade)", "biomarker_inclusion": ["CD13 positivity (score \u2265 1)"], "histology_exclusion": ["Gastrointestinal stromal tumors (GIST)", "Epitheloid sarcoma", "Alveolar soft part sarcoma", "Desmoplastic small round cell tumor", "Chondrosarcoma", "Osteosarcoma", "Ewing sarcoma (including CIC-rearranged sarcoma and Sarcoma with BCOR alterations)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Leiomyosarcoma", "biomarker_inclusion": ["CD13 positivity (score \u2265 1)"], "histology_exclusion": ["Gastrointestinal stromal tumors (GIST)", "Epitheloid sarcoma", "Alveolar soft part sarcoma", "Desmoplastic small round cell tumor", "Chondrosarcoma", "Osteosarcoma", "Ewing sarcoma (including CIC-rearranged sarcoma and Sarcoma with BCOR alterations)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Rhabdomyosarcoma (alveolar, pleomorphic)", "biomarker_inclusion": ["CD13 positivity (score \u2265 1)"], "histology_exclusion": ["Gastrointestinal stromal tumors (GIST)", "Epitheloid sarcoma", "Alveolar soft part sarcoma", "Desmoplastic small round cell tumor", "Chondrosarcoma", "Osteosarcoma", "Ewing sarcoma (including CIC-rearranged sarcoma and Sarcoma with BCOR alterations)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Angiosarcoma", "biomarker_inclusion": ["CD13 positivity (score \u2265 1)"], "histology_exclusion": ["Gastrointestinal stromal tumors (GIST)", "Epitheloid sarcoma", "Alveolar soft part sarcoma", "Desmoplastic small round cell tumor", "Chondrosarcoma", "Osteosarcoma", "Ewing sarcoma (including CIC-rearranged sarcoma and Sarcoma with BCOR alterations)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Synovial sarcoma", "biomarker_inclusion": ["CD13 positivity (score \u2265 1)"], "histology_exclusion": ["Gastrointestinal stromal tumors (GIST)", "Epitheloid sarcoma", "Alveolar soft part sarcoma", "Desmoplastic small round cell tumor", "Chondrosarcoma", "Osteosarcoma", "Ewing sarcoma (including CIC-rearranged sarcoma and Sarcoma with BCOR alterations)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Undifferentiated sarcoma", "biomarker_inclusion": ["CD13 positivity (score \u2265 1)"], "histology_exclusion": ["Gastrointestinal stromal tumors (GIST)", "Epitheloid sarcoma", "Alveolar soft part sarcoma", "Desmoplastic small round cell tumor", "Chondrosarcoma", "Osteosarcoma", "Ewing sarcoma (including CIC-rearranged sarcoma and Sarcoma with BCOR alterations)"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Dedifferentiated Liposarcoma", "histology_exclusion": ["Alveolar Soft Part Sarcoma", "Desmoplastic Small Round Cell Tumor", "Chondrosarcoma", "Gastrointestinal Stromal Tumor", "Sarcoma", "Ewing Sarcoma", "Osteosarcoma"], "biomarker_exclusion": [["CIC Mutation", "CIC-Mutation", "gene"], ["BCOR Mutation", "BCOR-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Myxoid Liposarcoma", "histology_exclusion": ["Alveolar Soft Part Sarcoma", "Desmoplastic Small Round Cell Tumor", "Chondrosarcoma", "Gastrointestinal Stromal Tumor", "Sarcoma", "Ewing Sarcoma", "Osteosarcoma"], "biomarker_exclusion": [["CIC Mutation", "CIC-Mutation", "gene"], ["BCOR Mutation", "BCOR-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Pleomorphic Liposarcoma", "histology_exclusion": ["Alveolar Soft Part Sarcoma", "Desmoplastic Small Round Cell Tumor", "Chondrosarcoma", "Gastrointestinal Stromal Tumor", "Sarcoma", "Ewing Sarcoma", "Osteosarcoma"], "biomarker_exclusion": [["CIC Mutation", "CIC-Mutation", "gene"], ["BCOR Mutation", "BCOR-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Fibrosarcoma", "histology_exclusion": ["Alveolar Soft Part Sarcoma", "Desmoplastic Small Round Cell Tumor", "Chondrosarcoma", "Gastrointestinal Stromal Tumor", "Sarcoma", "Ewing Sarcoma", "Osteosarcoma"], "biomarker_exclusion": [["CIC Mutation", "CIC-Mutation", "gene"], ["BCOR Mutation", "BCOR-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Myxofibrosarcoma", "histology_exclusion": ["Alveolar Soft Part Sarcoma", "Desmoplastic Small Round Cell Tumor", "Chondrosarcoma", "Gastrointestinal Stromal Tumor", "Sarcoma", "Ewing Sarcoma", "Osteosarcoma"], "biomarker_exclusion": [["CIC Mutation", "CIC-Mutation", "gene"], ["BCOR Mutation", "BCOR-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Leiomyosarcoma", "histology_exclusion": ["Alveolar Soft Part Sarcoma", "Desmoplastic Small Round Cell Tumor", "Chondrosarcoma", "Gastrointestinal Stromal Tumor", "Sarcoma", "Ewing Sarcoma", "Osteosarcoma"], "biomarker_exclusion": [["CIC Mutation", "CIC-Mutation", "gene"], ["BCOR Mutation", "BCOR-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Rhabdomyosarcoma", "histology_exclusion": ["Alveolar Soft Part Sarcoma", "Desmoplastic Small Round Cell Tumor", "Chondrosarcoma", "Gastrointestinal Stromal Tumor", "Sarcoma", "Ewing Sarcoma", "Osteosarcoma"], "biomarker_exclusion": [["CIC Mutation", "CIC-Mutation", "gene"], ["BCOR Mutation", "BCOR-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Angiosarcoma", "histology_exclusion": ["Alveolar Soft Part Sarcoma", "Desmoplastic Small Round Cell Tumor", "Chondrosarcoma", "Gastrointestinal Stromal Tumor", "Sarcoma", "Ewing Sarcoma", "Osteosarcoma"], "biomarker_exclusion": [["CIC Mutation", "CIC-Mutation", "gene"], ["BCOR Mutation", "BCOR-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Synovial Sarcoma", "histology_exclusion": ["Alveolar Soft Part Sarcoma", "Desmoplastic Small Round Cell Tumor", "Chondrosarcoma", "Gastrointestinal Stromal Tumor", "Sarcoma", "Ewing Sarcoma", "Osteosarcoma"], "biomarker_exclusion": [["CIC Mutation", "CIC-Mutation", "gene"], ["BCOR Mutation", "BCOR-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Liver Embryonal Sarcoma", "histology_exclusion": ["Alveolar Soft Part Sarcoma", "Desmoplastic Small Round Cell Tumor", "Chondrosarcoma", "Gastrointestinal Stromal Tumor", "Sarcoma", "Ewing Sarcoma", "Osteosarcoma"], "biomarker_exclusion": [["CIC Mutation", "CIC-Mutation", "gene"], ["BCOR Mutation", "BCOR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04751929", "json": [{"cohort": "", "disease_state": "metastatic castration resistant prostate cancer", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": ["small cell carcinoma"], "biomarker_exclusion": []}, {"cohort": "CDK12 Mutation Cohort", "disease_state": "metastatic castration resistant prostate cancer", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["CDK12 loss of function"], "histology_exclusion": ["small cell carcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "histology_exclusion": ["Small Cell Carcinoma"]}, {"cohort": "CDK12 Mutation Cohort", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["CDK12-Low", "CDK12-Low", "expression"]], "histology_exclusion": ["Small Cell Carcinoma"]}]}
{"NCT_id": "NCT04882176", "json": [{"cohort": "Dose Escalation", "disease_state": "advanced", "histology_inclusion": "malignant tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Extension", "disease_state": "advanced", "histology_inclusion": "EGFR-TKI-resistant non-small cell lung cancer", "biomarker_inclusion": ["c-Met abnormality"], "histology_exclusion": ["head and neck squamous cell carcinoma", "lung squamous cell carcinoma", "central nervous system metastasis", "meningeal metastasis"], "biomarker_exclusion": []}, {"cohort": "Dose Extension", "disease_state": "advanced", "histology_inclusion": "pulmonary sarcomatoid adenocarcinoma", "biomarker_inclusion": ["c-Met abnormality"], "histology_exclusion": ["head and neck squamous cell carcinoma", "lung squamous cell carcinoma", "central nervous system metastasis", "meningeal metastasis"], "biomarker_exclusion": []}, {"cohort": "Dose Extension", "disease_state": "advanced", "histology_inclusion": "papillary renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["head and neck squamous cell carcinoma", "lung squamous cell carcinoma", "central nervous system metastasis", "meningeal metastasis"], "biomarker_exclusion": []}, {"cohort": "Dose Extension", "disease_state": "metastatic or locally advanced unresectable", "histology_inclusion": "gastric adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["head and neck squamous cell carcinoma", "lung squamous cell carcinoma", "central nervous system metastasis", "meningeal metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Escalation", "histology_inclusion": "Malignant Neoplasm"}, {"cohort": "Dose Extension", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MET Mutation", "MET-Mutation", "gene"], ["SLTM Mutation", "SLTM-Mutation", "gene"]], "histology_exclusion": ["Head and Neck Squamous Cell Carcinoma", "Squamous Cell Lung Carcinoma"]}, {"cohort": "Dose Extension", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["MET Mutation", "MET-Mutation", "gene"], ["SLTM Mutation", "SLTM-Mutation", "gene"]], "histology_exclusion": ["Head and Neck Squamous Cell Carcinoma", "Squamous Cell Lung Carcinoma"]}, {"cohort": "Dose Extension", "histology_inclusion": "Papillary Renal Cell Carcinoma", "histology_exclusion": ["Head and Neck Squamous Cell Carcinoma", "Squamous Cell Lung Carcinoma"]}, {"cohort": "Dose Extension", "histology_inclusion": "Gastric Adenocarcinoma", "histology_exclusion": ["Head and Neck Squamous Cell Carcinoma", "Squamous Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT04947319", "json": [{"cohort": "Part A", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Primary Central Nervous System Lymphoma (PCNSL)", "biomarker_inclusion": [], "histology_exclusion": ["non-B cell PCNSL"], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "Newly Diagnosed, Treatment na\u00efve", "histology_inclusion": "Primary Central Nervous System Lymphoma (PCNSL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Central Nervous System Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma"]}, {"cohort": "Part A", "histology_inclusion": "Primary Central Nervous System Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma"]}, {"cohort": "Part B", "histology_inclusion": "Central Nervous System Lymphoma"}, {"cohort": "Part B", "histology_inclusion": "Primary Central Nervous System Lymphoma"}]}
{"NCT_id": "NCT05012397", "json": [{"cohort": "", "disease_state": "advanced or metastatic solid tumor", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["WT TP53", "MDM2 gene amplification (CN \u2265 8)"], "histology_exclusion": ["well-differentiated/dedifferentiated liposarcoma", "intimal sarcoma/cardiac sarcoma", "primary malignant brain tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]], "histology_exclusion": ["Intimal Sarcoma", "Malignant Brain Neoplasm", "Sarcoma", "Dedifferentiated Liposarcoma"]}]}
{"NCT_id": "NCT05142592", "json": [{"cohort": "", "disease_state": "advanced or recurrent, metastatic or unresectable", "histology_inclusion": "all solid tumor types", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2 Dose Expansion", "disease_state": "advanced or recurrent, metastatic or unresectable", "histology_inclusion": "renal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2 Dose Expansion", "disease_state": "advanced or recurrent, metastatic or unresectable", "histology_inclusion": "triple-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2 Dose Expansion", "disease_state": "advanced or recurrent, metastatic or unresectable", "histology_inclusion": "head and neck cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2 Dose Expansion", "disease_state": "advanced or recurrent, metastatic or unresectable", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part 2 Dose Expansion", "histology_inclusion": "Kidney Cancer"}, {"cohort": "Part 2 Dose Expansion", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Part 2 Dose Expansion", "histology_inclusion": "Malignant Head and Neck Neoplasm"}, {"cohort": "Part 2 Dose Expansion", "histology_inclusion": "Head and Neck Carcinoma"}, {"cohort": "Part 2 Dose Expansion", "histology_inclusion": "Melanoma"}]}
{"NCT_id": "NCT05272709", "json": [{"cohort": "Cohort 1M", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": ["brain or leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Cohort 2M: mCRPC", "disease_state": "mCRPC", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["predominant neuroendocrine", "small cell features", "brain or leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Cohort 2M: MSI/MMR defective tumours", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": ["MSI-H", "dMMR"], "histology_exclusion": ["brain or leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Cohort 2M: TNBC", "disease_state": "TNBC", "histology_inclusion": "", "biomarker_inclusion": ["HER2 negative", "ER negative", "PR negative"], "histology_exclusion": ["brain or leptomeningeal metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1M"}, {"cohort": "Cohort 2M: mCRPC", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "Cohort 2M: MSI/MMR defective tumours", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort 2M: TNBC", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"], ["TMEM37-Low", "TMEM37-Low", "expression"]]}]}
{"NCT_id": "NCT03802240", "json": [{"cohort": "", "disease_state": "stage IIIB/IIIC (unresectable and not fit for radical concurrent chemoradiotherapy) or metastatic / recurrent", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": ["squamous cell > 10%", "small cell types"], "biomarker_exclusion": ["EGFR-TKI resistance"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04192981", "json": [{"cohort": "", "disease_state": "Brain Metastases or Leptomeningeal Metastases", "histology_inclusion": "Solid Tumor Malignancies", "biomarker_inclusion": ["PIK3CA mutation", "PIK3CB mutation", "PIK3CD mutation", "PIK3CG mutation", "PIK3R1 mutation", "PIK3R2 mutation", "PIK3R3 mutation", "PIK3C2G mutation", "PIK3C3 mutation", "INPP4A mutation", "INPP4B mutation", "INPPL1 mutation", "INPP5D mutation", "PTEN mutation", "AKT1 mutation", "AKT2 mutation", "AKT3 mutation", "MTOR mutation"], "histology_exclusion": ["Primary Brain Tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["AKT1 Mutation", "AKT1-Mutation", "gene"], ["PIK3CD Mutation", "PIK3CD-Mutation", "gene"], ["PIK3CG Mutation", "PIK3CG-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["PIK3R1 Mutation", "PIK3R1-Mutation", "gene"], ["PIK3R2 Mutation", "PIK3R2-Mutation", "gene"], ["PIK3R3 Mutation", "PIK3R3-Mutation", "gene"], ["PIK3C3 Mutation", "PIK3C3-Mutation", "gene"], ["INPP4A Mutation", "INPP4A-Mutation", "gene"], ["PIK3C2G Mutation", "PIK3C2G-Mutation", "gene"], ["AKT2 Mutation", "AKT2-Mutation", "gene"], ["AKT3 Mutation", "AKT3-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["MTOR Mutation", "MTOR-Mutation", "gene"], ["INPP5D Mutation", "INPP5D-Mutation", "gene"], ["INPP4B Mutation", "INPP4B-Mutation", "gene"], ["INPPL1 Mutation", "INPPL1-Mutation", "gene"], ["PIK3CB Mutation", "PIK3CB-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT04817254", "json": [{"cohort": "Arm 1", "disease_state": "newly diagnosed", "histology_inclusion": "glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm 1", "disease_state": "newly diagnosed", "histology_inclusion": "gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm 2", "disease_state": "newly diagnosed", "histology_inclusion": "glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm 2", "disease_state": "newly diagnosed", "histology_inclusion": "gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm 1", "histology_inclusion": "Glioblastoma"}, {"cohort": "Arm 1", "histology_inclusion": "Gliosarcoma"}, {"cohort": "Arm 2", "histology_inclusion": "Glioblastoma"}, {"cohort": "Arm 2", "histology_inclusion": "Gliosarcoma"}]}
{"NCT_id": "NCT04947501", "json": [{"cohort": "Participants with newly-diagnosed HR-Neuroblastoma", "disease_state": "MYCN-amplified stage 2/3/4/4S at any age and stage 4 in patients >18 months old", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": ["MYCN-amplified"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Participants with newly-diagnosed HR-Neuroblastoma", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]]}]}
{"NCT_id": "NCT05207722", "json": [{"cohort": "", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "HER2-Positive Gastric or Gastroesophageal junction (G/GEJ) adenocarcinoma", "biomarker_inclusion": ["HER2 IHC 3+", "HER2 IHC 2+ with positive FISH", "HER2 FISH+"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["SH3PXD2A-High", "SH3PXD2A-High", "expression"]]}]}
{"NCT_id": "NCT05207787", "json": [{"cohort": "HS-10365", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["RET gene alteration"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "HS-10365", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}]}
{"NCT_id": "NCT03150810", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior exposure to a poly adenosine diphosphate-ribose polymerase (PARP) inhibitor", "refractory to platinum-based therapy"]}, {"cohort": "dose expansion", "disease_state": "", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["homologous recombination deficiency (HRD+)", "known BRCA mutant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "dose expansion", "disease_state": "", "histology_inclusion": "triple-negative breast cancer", "biomarker_inclusion": ["homologous recombination deficiency (HRD+)", "known breast cancer susceptibility gene (BRCA) mutant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "dose expansion", "disease_state": "", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["homologous recombination deficiency (HRD+)", "known BRCA mutant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "dose expansion", "disease_state": "", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "dose expansion", "disease_state": "", "histology_inclusion": "gastric cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "dose expansion", "disease_state": "", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["homologous recombination deficiency (HRD+)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "dose expansion", "disease_state": "", "histology_inclusion": "head and neck cancer", "biomarker_inclusion": ["homologous recombination deficiency (HRD+)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "dose expansion", "disease_state": "", "histology_inclusion": "esophageal cancer", "biomarker_inclusion": ["homologous recombination deficiency (HRD+)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "dose expansion", "disease_state": "", "histology_inclusion": "soft tissue sarcomas", "biomarker_inclusion": ["homologous recombination deficiency (HRD+)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "dose expansion", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["TBCE-High", "TBCE-High", "expression"], ["Homologous Recombination Pathway", null, "pathway"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "dose expansion", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["TBCE-High", "TBCE-High", "expression"], ["Homologous Recombination Pathway", null, "pathway"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "dose expansion", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["TBCE-High", "TBCE-High", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "dose expansion", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["TBCE-High", "TBCE-High", "expression"], ["Homologous Recombination Pathway", null, "pathway"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "dose expansion", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["TBCE-High", "TBCE-High", "expression"], ["Homologous Recombination Pathway", null, "pathway"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "dose expansion", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "dose expansion", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "dose expansion", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["TBCE-High", "TBCE-High", "expression"], ["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "dose expansion", "histology_inclusion": "Malignant Head and Neck Neoplasm", "biomarker_inclusion": [["TBCE-High", "TBCE-High", "expression"], ["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "dose expansion", "histology_inclusion": "Head and Neck Carcinoma", "biomarker_inclusion": [["TBCE-High", "TBCE-High", "expression"], ["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "dose expansion", "histology_inclusion": "Esophageal Carcinoma", "biomarker_inclusion": [["TBCE-High", "TBCE-High", "expression"], ["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "dose expansion", "histology_inclusion": "Sarcoma", "biomarker_inclusion": [["TBCE-High", "TBCE-High", "expression"], ["Homologous Recombination Pathway", null, "pathway"]]}]}
{"NCT_id": "NCT03932643", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["TP53 mutation", "RUNX1 mutation", "ASXL1 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Myelodysplastic Syndromes", "biomarker_inclusion": ["TP53 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["ASXL1 Mutation", "ASXL1-Mutation", "gene"], ["RUNX1 Mutation", "RUNX1-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT05012618", "json": [{"cohort": "", "disease_state": "locally advanced, recurrent, or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["RAS alterations positive"], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT05077735", "json": [{"cohort": "SPORT-DMG", "disease_state": "", "histology_inclusion": "Diffuse Midline Glioma, H3 K27M-Mutant", "biomarker_inclusion": [], "histology_exclusion": ["neurofibromatosis type 1", "neurofibromatosis type 2"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "SPORT-DMG", "histology_inclusion": "Diffuse Midline Glioma, H3 K27M-Mutant", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}]}
{"NCT_id": "NCT03476681", "json": [{"cohort": "NSCLC", "disease_state": "advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["NEO-201 antigen expression (\u226510% tumor cells)", "PD-L1 (TSP > 1%)", "MSI-H", "TMB-H (\u226510 mut/Mb)"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR", "ALK1", "ROS1", "BRAF V600E"]}, {"cohort": "Cervical Cancer", "disease_state": "advanced", "histology_inclusion": "cervical cancer", "biomarker_inclusion": ["NEO-201 antigen expression (\u226510% tumor cells)", "CPS > 1", "MSI-H", "TMB-H (\u226510 mut/Mb)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "HNSCC", "disease_state": "advanced", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": ["NEO-201 antigen expression (\u226510% tumor cells)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Uterine Carcinoma", "disease_state": "advanced", "histology_inclusion": "uterine cancer", "biomarker_inclusion": ["NEO-201 antigen expression (\u226510% tumor cells)"], "histology_exclusion": [], "biomarker_exclusion": ["MSI", "dMMR"]}], "json_norm": [{"cohort": "NSCLC", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]], "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "Cervical Cancer", "histology_inclusion": "Cervical Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "HNSCC", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Uterine Carcinoma", "histology_inclusion": "Malignant Uterine Neoplasm", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT03997968", "json": [{"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "B-cell non-Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "chronic lymphocytic leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/progressive", "histology_inclusion": "multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "squamous cell carcinoma of the head and neck", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "progressive", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "soft tissue sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent metastatic or locally advanced", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "small-cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["mixed histology"], "biomarker_exclusion": []}, {"cohort": "DLBCL Cohort", "disease_state": "progressing", "histology_inclusion": "diffuse large B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "DLBCL Cohort", "disease_state": "progressing", "histology_inclusion": "double hit lymphoma", "biomarker_inclusion": ["BCL2", "MYC"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "", "histology_inclusion": "Soft Tissue Sarcoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "DLBCL Cohort", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "DLBCL Cohort", "histology_inclusion": "Double-Hit Lymphoma"}]}
{"NCT_id": "NCT05533463", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["KRAS G12D mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"]]}]}
{"NCT_id": "NCT04361708", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "gastroesophageal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "gallbladder adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "ampullary carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "adenocarcinoma of unclear primary (with upper GI primary suspected)", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "other primary GI malignancy", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Cholangiocarcinoma"}, {"cohort": "", "histology_inclusion": "Gallbladder Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Ampulla of Vater Carcinoma"}, {"cohort": "", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Digestive System Neoplasm"}]}
{"NCT_id": "NCT04492033", "json": [{"cohort": "P1b", "disease_state": "metastatic or unresectable advanced solid tumors", "histology_inclusion": "advanced solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastasis"], "biomarker_exclusion": []}, {"cohort": "P2", "disease_state": "unresectable advanced, metastatic, or recurrent biliary tract cancers", "histology_inclusion": "biliary tract cancers", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastasis"], "biomarker_exclusion": []}, {"cohort": "P2", "disease_state": "unresectable advanced, metastatic, or recurrent biliary tract cancers", "histology_inclusion": "intrahepatic cholangiocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastasis"], "biomarker_exclusion": []}, {"cohort": "P2", "disease_state": "unresectable advanced, metastatic, or recurrent biliary tract cancers", "histology_inclusion": "extrahepatic cholangiocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastasis"], "biomarker_exclusion": []}, {"cohort": "P2", "disease_state": "unresectable advanced, metastatic, or recurrent biliary tract cancers", "histology_inclusion": "gallbladder cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastasis"], "biomarker_exclusion": []}, {"cohort": "P2", "disease_state": "unresectable advanced, metastatic, or recurrent biliary tract cancers", "histology_inclusion": "ampullary carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "P1b", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "P2", "histology_inclusion": "Liver Cancer"}, {"cohort": "P2", "histology_inclusion": "Biliary Tract Carcinoma"}, {"cohort": "P2", "histology_inclusion": "Intrahepatic Cholangiocarcinoma"}, {"cohort": "P2", "histology_inclusion": "Cholangiocarcinoma"}, {"cohort": "P2", "histology_inclusion": "Gallbladder Carcinoma"}, {"cohort": "P2", "histology_inclusion": "Ampulla of Vater Carcinoma"}]}
{"NCT_id": "NCT04427072", "json": [{"cohort": "", "disease_state": "Stage IIIB/IIIC (not amenable to surgery, radiation or multi modality therapy) or IV NSCLC", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR wt", "ALK negative", "MET\u0394ex14 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["MET inhibitor", "HGF-targeting therapy", "ROS1 rearrangement", "RET rearrangement", "BRAF mutation", "KRAS mutation", "NTRK fusion"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["ALK-Low", "ALK-Low", "expression"]], "biomarker_exclusion": [["RET Fusion", "RET", "fusion"], ["NTRK1 Fusion", "NTRK1", "fusion"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}]}
{"NCT_id": "NCT05533697", "json": [{"cohort": "Arm 1a", "disease_state": "locally advanced or metastatic", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system tumors or metastases"], "biomarker_exclusion": []}, {"cohort": "Arm 1a", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small-cell lung carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system tumors or metastases"], "biomarker_exclusion": []}, {"cohort": "Arm 1a", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-muscle invasive bladder cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system tumors or metastases"], "biomarker_exclusion": []}, {"cohort": "Arm 1a", "disease_state": "locally advanced or metastatic", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system tumors or metastases"], "biomarker_exclusion": []}, {"cohort": "Arm 1a", "disease_state": "locally advanced or metastatic", "histology_inclusion": "microsatellite stable colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system tumors or metastases"], "biomarker_exclusion": []}, {"cohort": "Arm 1a", "disease_state": "locally advanced or metastatic", "histology_inclusion": "basal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system tumors or metastases"], "biomarker_exclusion": []}, {"cohort": "Arm 1a", "disease_state": "locally advanced or metastatic", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system tumors or metastases"], "biomarker_exclusion": []}, {"cohort": "Arm 1b", "disease_state": "locally advanced or metastatic, checkpoint inhibitor refractory", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system tumors or metastases"], "biomarker_exclusion": []}, {"cohort": "Arm 1b", "disease_state": "locally advanced or metastatic, checkpoint inhibitor refractory", "histology_inclusion": "non-small-cell lung carcinoma", "biomarker_inclusion": ["epidermal growth factor receptor", "anaplastic lymphoma kinase", "proto-oncogen tyrosine-protein kinase reactive oxygen species"], "histology_exclusion": ["central nervous system tumors or metastases"], "biomarker_exclusion": []}, {"cohort": "Arm 2", "disease_state": "locally advanced, metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system tumors or metastases"], "biomarker_exclusion": []}, {"cohort": "Arm 2", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small-cell lung carcinoma", "biomarker_inclusion": ["PD-L1 TPS \u22651%"], "histology_exclusion": ["central nervous system tumors or metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm 1a", "histology_inclusion": "Cutaneous Melanoma"}, {"cohort": "Arm 1a", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Arm 1a", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "Arm 1a", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": "Arm 1a", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Arm 1a", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Arm 1a", "histology_inclusion": "Basal Cell Carcinoma"}, {"cohort": "Arm 1a", "histology_inclusion": "Experimental Organism Basal Cell Carcinoma"}, {"cohort": "Arm 1a", "histology_inclusion": "Skin Basal Cell Carcinoma"}, {"cohort": "Arm 1a", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Arm 1b", "histology_inclusion": "Melanoma"}, {"cohort": "Arm 1b", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Arm 2", "histology_inclusion": "Melanoma"}, {"cohort": "Arm 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04362072", "json": [{"cohort": "", "disease_state": "metastatic NSCLC (Stage IV, AJCC v7.0)", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["ALK rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT04492293", "json": [{"cohort": "ICP-192", "disease_state": "unresectable or metastatic", "histology_inclusion": "bladder urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "ICP-192", "histology_inclusion": "Bladder Urothelial Carcinoma"}]}
{"NCT_id": "NCT04557449", "json": [{"cohort": "Part 1: Breast Cancer", "disease_state": "Refractory Hormone Receptor Positive (HR+), Human Epidermal Growth Factor Receptor 2 Negative (HER2-) BC", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["HR+", "HER2-"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1: Breast Cancer", "disease_state": "Refractory HR-positive/HER2-positive BC", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["HR+", "HER2+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1: Tumors other than BC", "disease_state": "", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["CDK4", "CCND1"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1: Tumors other than BC", "disease_state": "", "histology_inclusion": "Prostate Cancer", "biomarker_inclusion": ["CDK4", "CCND1"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1: Tumors other than BC", "disease_state": "", "histology_inclusion": "CRC", "biomarker_inclusion": ["CDK4", "CCND1"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1: Tumors other than BC", "disease_state": "", "histology_inclusion": "Liposarcoma", "biomarker_inclusion": ["CDK4", "CCND1"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1F: Prostate Cancer", "disease_state": "", "histology_inclusion": "Prostate Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2A, 2B and 2C", "disease_state": "HR-positive/HER2-negative BC", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["HR+", "HER2-"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1D", "disease_state": "Metastatic Castration Resistant Prostate Cancer", "histology_inclusion": "Prostate Cancer", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 1: Breast Cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Part 1: Breast Cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Part 1: Tumors other than BC", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part 1: Tumors other than BC", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Part 1: Tumors other than BC", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Part 1: Tumors other than BC", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Part 1: Tumors other than BC", "histology_inclusion": "Liposarcoma"}, {"cohort": "Part 1F: Prostate Cancer", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Part 1F: Prostate Cancer", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Part 2A, 2B and 2C", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Part 1D", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Part 1D", "histology_inclusion": "Prostate Carcinoma"}]}
{"NCT_id": "NCT04258956", "json": [{"cohort": "", "disease_state": "unresectable/metastatic", "histology_inclusion": "Gastrointestinal Stromal Tumor (GIST)", "biomarker_inclusion": ["C-Kit (CD117) positive", "KIT mutation", "PDGFRA mutation"], "histology_exclusion": [], "biomarker_exclusion": ["PDGFRA D842V mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["PDGFRA Mutation", "PDGFRA-Mutation", "gene"], ["KIT-High", "KIT-High", "expression"], ["KIT Mutation", "KIT-Mutation", "gene"]], "biomarker_exclusion": [["PDGFRA D842V", "D842V", "coordinate"]]}]}
{"NCT_id": "NCT04948333", "json": [{"cohort": "", "disease_state": "CML-CP", "histology_inclusion": "Chronic Myelogenous Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["AP/BC"], "biomarker_exclusion": ["BCR-ABL1 T315I mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "biomarker_exclusion": [["ABL1 T315I", "T315I", "coordinate"], ["BCR - ABL1", "BCR - ABL1", "coordinate"]]}]}
{"NCT_id": "NCT05469022", "json": [{"cohort": "", "disease_state": "stage I-IIIB, stage IVA with single metastasis", "histology_inclusion": "lung adenocarcinoma", "biomarker_inclusion": ["EGFR E19Del", "EGFR L858R"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR-TKIs treatment"]}, {"cohort": "", "disease_state": "stage I-IIIB, stage IVA with single metastasis", "histology_inclusion": "lung adenocarcinoma", "biomarker_inclusion": ["EGFR T790M"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR-TKIs treatment"]}, {"cohort": "", "disease_state": "stage I-IIIB, stage IVA with single metastasis", "histology_inclusion": "lung adenocarcinoma", "biomarker_inclusion": ["EGFR G719X"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR-TKIs treatment"]}, {"cohort": "", "disease_state": "stage I-IIIB, stage IVA with single metastasis", "histology_inclusion": "lung adenocarcinoma", "biomarker_inclusion": ["EGFR exon 20 insertion"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR-TKIs treatment"]}, {"cohort": "", "disease_state": "stage I-IIIB, stage IVA with single metastasis", "histology_inclusion": "lung adenocarcinoma", "biomarker_inclusion": ["EGFR S768I"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR-TKIs treatment"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}, {"cohort": "", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["EGFR T790M", "T790M", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Lung Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Lung Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["EGFR S768I", "S768I", "coordinate"]]}]}
{"NCT_id": "NCT00703105", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}]}
{"NCT_id": "NCT05013554", "json": [{"cohort": "Dose Escalation", "disease_state": "metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["HER2 expressing"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "metastatic", "histology_inclusion": "breast cancers", "biomarker_inclusion": ["HER2 high expression", "HER2 amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "metastatic", "histology_inclusion": "breast cancers", "biomarker_inclusion": ["HER2 low expression", "HER2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["HER2 amplification"]}, {"cohort": "Cohort C", "disease_state": "metastatic", "histology_inclusion": "gastric cancers", "biomarker_inclusion": ["HER2 low expression", "HER2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["HER2 amplification"]}, {"cohort": "Cohort D", "disease_state": "metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["HER2 low expression", "HER2 high expression", "HER2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Escalation", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort C", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort D", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}]}
{"NCT_id": "NCT03803553", "json": [{"cohort": "", "disease_state": "Stage III", "histology_inclusion": "adenocarcinoma of colorectal", "biomarker_inclusion": ["dMMR"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-high", "BRAF V600E mutation"]}, {"cohort": "ctDNA-POSITIVE MSI-H: NIVOLUMAB", "disease_state": "Stage III", "histology_inclusion": "adenocarcinoma of colorectal", "biomarker_inclusion": ["dMMR", "MSI-high", "ctDNA positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "ctDNA-POSITIVE BRAF Mutant: ENCORAFENIB/BINIMETINIB/CETUXIMAB", "disease_state": "Stage III", "histology_inclusion": "adenocarcinoma of colorectal", "biomarker_inclusion": ["dMMR", "BRAF V600E mutation", "ctDNA positive"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-high"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]], "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "ctDNA-POSITIVE MSI-H: NIVOLUMAB", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "ctDNA-POSITIVE BRAF Mutant: ENCORAFENIB/BINIMETINIB/CETUXIMAB", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04557956", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAFV600E", "BRAFV600K"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAFV600E", "BRAFV600K", "EZH2 alteration"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}, {"cohort": "Phase 2", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["EZH2 Mutation", "EZH2-Mutation", "gene"], ["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}]}
{"NCT_id": "NCT05339321", "json": [{"cohort": "SCG101", "disease_state": "advanced", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": ["HLA-A *02", "HBsAg positive"], "histology_exclusion": ["Central nervous system metastasis"], "biomarker_exclusion": []}, {"cohort": "SCG101 + PD1/PD-L1 checkpoint inhibitor", "disease_state": "advanced", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": ["HLA-A *02", "HBsAg positive"], "histology_exclusion": ["Central nervous system metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "SCG101", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "SCG101 + PD1/PD-L1 checkpoint inhibitor", "histology_inclusion": "Hepatocellular Carcinoma"}]}
{"NCT_id": "NCT03087071", "json": [{"cohort": "Cohort 1", "disease_state": "Stage IV", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["EGFR S492R or other ectodomain mutation"], "histology_exclusion": ["brain metastasis"], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Stage IV", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["KRAS exon 2, 3, or 4 mutation", "NRAS exon 2, 3, or 4 mutation", "BRAF codon 600 mutation", "MEK (MAP2K1) mutation"], "histology_exclusion": ["brain metastasis"], "biomarker_exclusion": ["EGFR ectodomain mutation with over 5-fold higher allele frequency than the most prevalent KRAS/NRAS/BRAF mutation"]}, {"cohort": "Cohort 3", "disease_state": "Stage IV", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastasis"], "biomarker_exclusion": ["EGFR ectodomain mutation", "KRAS mutation", "NRAS mutation", "BRAF mutation"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["EGFR S492R", "S492R", "coordinate"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["MAP2K1 Mutation", "MAP2K1-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"]], "biomarker_exclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_exclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}]}
{"NCT_id": "NCT04689100", "json": [{"cohort": "Dose Escalation Cohort", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["RAS wild type"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Cohort", "disease_state": "locally advanced / metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["RAS wild type", "BRAF V600E wild type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Escalation Cohort", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}, {"cohort": "Dose Expansion Cohort", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["BRAF V600E", "V600E", "coordinate"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04819399", "json": [{"cohort": "", "disease_state": "non-muscle invasive urothelial carcinoma of the bladder", "histology_inclusion": "pT1", "biomarker_inclusion": [], "histology_exclusion": ["Low risk or intermediate risk tumors according to EAU guidelines"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "non-muscle invasive urothelial carcinoma of the bladder", "histology_inclusion": "G3 HG tumors", "biomarker_inclusion": [], "histology_exclusion": ["Low risk or intermediate risk tumors according to EAU guidelines"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "non-muscle invasive urothelial carcinoma of the bladder", "histology_inclusion": "CIS", "biomarker_inclusion": [], "histology_exclusion": ["Low risk or intermediate risk tumors according to EAU guidelines"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "non-muscle invasive urothelial carcinoma of the bladder", "histology_inclusion": "Multiple, recurrent and large (>3cm) pTa G1-G2 LG tumors", "biomarker_inclusion": [], "histology_exclusion": ["Low risk or intermediate risk tumors according to EAU guidelines"], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}, {"cohort": ""}, {"cohort": ""}, {"cohort": ""}]}
{"NCT_id": "NCT03609216", "json": [{"cohort": "", "disease_state": "Stage T2-T4aN0/xM0", "histology_inclusion": "Muscle-invasive urothelial carcinoma of the bladder", "biomarker_inclusion": ["DDR gene alteration"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Bladder Urothelial Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}]}
{"NCT_id": "NCT04493853", "json": [{"cohort": "", "disease_state": "metastatic hormone-sensitive", "histology_inclusion": "prostate adenocarcinoma without small-cell tumours", "biomarker_inclusion": ["PTEN deficiency"], "histology_exclusion": ["tissue from bone metastases", "brain metastases", "spinal cord compression"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["PTEN-Low", "PTEN-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Small Cell Carcinoma", "biomarker_inclusion": [["PTEN-Low", "PTEN-Low", "expression"]]}]}
{"NCT_id": "NCT04754425", "json": [{"cohort": "", "disease_state": "castration-resistant", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "castration-resistant", "histology_inclusion": "small cell of the prostate", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}, {"cohort": ""}]}
{"NCT_id": "NCT05405309", "json": [{"cohort": "", "disease_state": "Relapsed or Refractory Chronic Lymphocytic Leukemia", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": ["TP53 mutation", "ATM mutation", "SF3B1 mutation", "XPO1 mutation", "POT1 mutation", "deletion 17p13", "deletion 11q22.3"], "histology_exclusion": [], "biomarker_exclusion": ["t(11;14)(IgH/CCND1)", "cyclin D1 positive"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["SF3B2 Mutation", "SF3B2-Mutation", "gene"], ["POT1 Mutation", "POT1-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["XPO1 Mutation", "XPO1-Mutation", "gene"], ["SF3B1 Mutation", "SF3B1-Mutation", "gene"]], "biomarker_exclusion": [["CCND1-High", "CCND1-High", "expression"]]}]}
{"NCT_id": "NCT04065269", "json": [{"cohort": "1A", "disease_state": "relapsed", "histology_inclusion": "ovarian clear cell carcinoma", "biomarker_inclusion": ["loss of ARID1A expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "1A", "disease_state": "relapsed", "histology_inclusion": "endometrial clear cell carcinoma", "biomarker_inclusion": ["loss of ARID1A expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "1B", "disease_state": "relapsed", "histology_inclusion": "ovarian clear cell carcinoma", "biomarker_inclusion": ["loss of ARID1A expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "1B", "disease_state": "relapsed", "histology_inclusion": "endometrial clear cell carcinoma", "biomarker_inclusion": ["loss of ARID1A expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "2", "disease_state": "relapsed", "histology_inclusion": "ovarian clear cell carcinoma", "biomarker_inclusion": ["no loss of ARID1A expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "2", "disease_state": "relapsed", "histology_inclusion": "endometrial clear cell carcinoma", "biomarker_inclusion": ["no loss of ARID1A expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "3", "disease_state": "relapsed", "histology_inclusion": "endometrioid ovarian carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "3", "disease_state": "relapsed", "histology_inclusion": "endometrioid endometrial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "3", "disease_state": "relapsed", "histology_inclusion": "cervical adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "3", "disease_state": "relapsed", "histology_inclusion": "cervical squamous", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "3", "disease_state": "relapsed", "histology_inclusion": "ovarian carcinosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "3", "disease_state": "relapsed", "histology_inclusion": "endometrial carcinosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "1A", "histology_inclusion": "Ovarian Clear Cell Tumor", "biomarker_inclusion": [["ARID1A-Low", "ARID1A-Low", "expression"]]}, {"cohort": "1A", "histology_inclusion": "Endometrial Clear Cell Adenocarcinoma", "biomarker_inclusion": [["ARID1A-Low", "ARID1A-Low", "expression"]]}, {"cohort": "1B", "histology_inclusion": "Ovarian Clear Cell Tumor", "biomarker_inclusion": [["ARID1A-Low", "ARID1A-Low", "expression"]]}, {"cohort": "1B", "histology_inclusion": "Endometrial Clear Cell Adenocarcinoma", "biomarker_inclusion": [["ARID1A-Low", "ARID1A-Low", "expression"]]}, {"cohort": "2", "histology_inclusion": "Ovarian Clear Cell Tumor", "biomarker_inclusion": [["ARID1A-Low", "ARID1A-Low", "expression"]]}, {"cohort": "2", "histology_inclusion": "Endometrial Clear Cell Adenocarcinoma", "biomarker_inclusion": [["ARID1A-Low", "ARID1A-Low", "expression"]]}, {"cohort": "3", "histology_inclusion": "Ovarian Endometrioid Adenocarcinoma"}, {"cohort": "3", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "3", "histology_inclusion": "Endocervical Carcinoma"}, {"cohort": "3", "histology_inclusion": "Cervical Adenocarcinoma"}, {"cohort": "3"}, {"cohort": "3", "histology_inclusion": "Ovarian Carcinosarcoma"}, {"cohort": "3", "histology_inclusion": "Carcinosarcoma"}]}
{"NCT_id": "NCT04559139", "json": [{"cohort": "", "disease_state": "Stage II-III Gallbladder Cancer", "histology_inclusion": "Gallbladder Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gallbladder Carcinoma"}]}
{"NCT_id": "NCT04624204", "json": [{"cohort": "", "disease_state": "Limited-Stage (Stage I-III)", "histology_inclusion": "Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["mixed tumor with small cell and non-small cell elements"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT02359565", "json": [{"cohort": "Stratum A (closed)", "disease_state": "recurrent, progressive, or refractory", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum B", "disease_state": "recurrent, progressive, or refractory", "histology_inclusion": "Non-Brainstem High-Grade Glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum D", "disease_state": "recurrent, progressive, or refractory", "histology_inclusion": "Ependymoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum E", "disease_state": "recurrent, progressive, or refractory", "histology_inclusion": "Medulloblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Stratum A (closed)", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma"}, {"cohort": "Stratum B", "histology_inclusion": "Malignant Glioma"}, {"cohort": "Stratum D", "histology_inclusion": "Ependymoma"}, {"cohort": "Stratum E", "histology_inclusion": "Medulloblastoma"}]}
{"NCT_id": "NCT03088059", "json": [{"cohort": "Patient Cohort B1", "disease_state": "recurrent or metastatic", "histology_inclusion": "Squamous Cell Carcinoma of the Head and Neck", "biomarker_inclusion": ["p16 negative", "EGFR amplification", "EGFR mutation", "PTEN high", "HER2 mutation", "HER2 amplification"], "histology_exclusion": ["Nasopharynx tumor", "sino-nasal tumor"], "biomarker_exclusion": ["untreated and uncontrolled brain metastases", "leptomeningeal carcinomatosis"]}, {"cohort": "Patient Cohort B2", "disease_state": "recurrent or metastatic", "histology_inclusion": "Squamous Cell Carcinoma of the Head and Neck", "biomarker_inclusion": ["p16 negative", "cetuximab na\u00efve"], "histology_exclusion": ["Nasopharynx tumor", "sino-nasal tumor"], "biomarker_exclusion": ["untreated and uncontrolled brain metastases", "leptomeningeal carcinomatosis"]}, {"cohort": "Patient Cohort B3", "disease_state": "recurrent or metastatic", "histology_inclusion": "Squamous Cell Carcinoma of the Head and Neck", "biomarker_inclusion": ["p16 negative", "CCND1 amplification"], "histology_exclusion": ["Nasopharynx tumor", "sino-nasal tumor"], "biomarker_exclusion": ["untreated and uncontrolled brain metastases", "leptomeningeal carcinomatosis"]}, {"cohort": "Patient Cohort B4", "disease_state": "recurrent or metastatic", "histology_inclusion": "Squamous Cell Carcinoma of the Head and Neck", "biomarker_inclusion": ["p16 negative", "platinum sensitive"], "histology_exclusion": ["Nasopharynx tumor", "sino-nasal tumor"], "biomarker_exclusion": ["untreated and uncontrolled brain metastases", "leptomeningeal carcinomatosis"]}, {"cohort": "Patient Cohort B5", "disease_state": "recurrent or metastatic", "histology_inclusion": "Oropharyngeal cancer", "biomarker_inclusion": ["p16 positive"], "histology_exclusion": ["Nasopharynx tumor", "sino-nasal tumor"], "biomarker_exclusion": ["untreated and uncontrolled brain metastases", "leptomeningeal carcinomatosis"]}, {"cohort": "Patient Cohort I1", "disease_state": "recurrent or metastatic", "histology_inclusion": "Squamous Cell Carcinoma of the Head and Neck", "biomarker_inclusion": ["anti-PD(L)1-na\u00efeve", "anti-PD(L)1-resistant"], "histology_exclusion": ["Nasopharynx tumor", "sino-nasal tumor"], "biomarker_exclusion": ["untreated and uncontrolled brain metastases", "leptomeningeal carcinomatosis"]}, {"cohort": "Patient Cohort I2", "disease_state": "recurrent or metastatic", "histology_inclusion": "Squamous Cell Carcinoma of the Head and Neck", "biomarker_inclusion": ["PD(L)1 pretreated"], "histology_exclusion": ["Nasopharynx tumor", "sino-nasal tumor"], "biomarker_exclusion": ["untreated and uncontrolled brain metastases", "leptomeningeal carcinomatosis"]}, {"cohort": "Patient Cohort I3", "disease_state": "recurrent or metastatic", "histology_inclusion": "Squamous Cell Carcinoma of the Head and Neck", "biomarker_inclusion": ["progressing prior PD(L)1"], "histology_exclusion": ["Nasopharynx tumor", "sino-nasal tumor"], "biomarker_exclusion": ["untreated and uncontrolled brain metastases", "leptomeningeal carcinomatosis"]}], "json_norm": [{"cohort": "Patient Cohort B1", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"], ["H3P10-Low", "H3P10-Low", "expression"], ["PTEN-High", "PTEN-High", "expression"], ["EGFR-High", "EGFR-High", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]], "histology_exclusion": ["Nasopharyngeal Carcinoma", "Nasal Cavity and Paranasal Sinus Carcinoma"]}, {"cohort": "Patient Cohort B2", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-Low", "H3P10-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]], "histology_exclusion": ["Nasopharyngeal Carcinoma", "Nasal Cavity and Paranasal Sinus Carcinoma"]}, {"cohort": "Patient Cohort B3", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-Low", "H3P10-Low", "expression"], ["CCND1-High", "CCND1-High", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]], "histology_exclusion": ["Nasopharyngeal Carcinoma", "Nasal Cavity and Paranasal Sinus Carcinoma"]}, {"cohort": "Patient Cohort B4", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-Low", "H3P10-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]], "histology_exclusion": ["Nasopharyngeal Carcinoma", "Nasal Cavity and Paranasal Sinus Carcinoma"]}, {"cohort": "Patient Cohort B5", "histology_inclusion": "Oropharyngeal Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]], "histology_exclusion": ["Nasopharyngeal Carcinoma", "Nasal Cavity and Paranasal Sinus Carcinoma"]}, {"cohort": "Patient Cohort I1", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Nasopharyngeal Carcinoma", "Nasal Cavity and Paranasal Sinus Carcinoma"]}, {"cohort": "Patient Cohort I2", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Nasopharyngeal Carcinoma", "Nasal Cavity and Paranasal Sinus Carcinoma"]}, {"cohort": "Patient Cohort I3", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Nasopharyngeal Carcinoma", "Nasal Cavity and Paranasal Sinus Carcinoma"]}]}
{"NCT_id": "NCT03348631", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "ovarian endometrioid carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "ovarian clear cell carcinoma", "biomarker_inclusion": ["ARID1A pathologic variant", "ARID1A likely pathologic variant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "endometrioid endometrial adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["mismatch repair deficient"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Endometrioid Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Endometrioid Tumor"}, {"cohort": "", "histology_inclusion": "Ovarian Clear Cell Tumor"}, {"cohort": "", "histology_inclusion": "Endometrial Endometrioid Adenocarcinoma"}]}
{"NCT_id": "NCT03609424", "json": [{"cohort": "PDR001 plus Imatinib", "disease_state": "metastatic or unresectable", "histology_inclusion": "GIST with CD117(+), DOG-1(+)", "biomarker_inclusion": ["mutation in KIT", "mutation in PDGFR\u03b1"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "PDR001 plus Imatinib", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["ANO1-High", "ANO1-High", "expression"], ["KIT-High", "KIT-High", "expression"], ["KIT Mutation", "KIT-Mutation", "gene"]]}, {"cohort": "PDR001 plus Imatinib", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["ANO1-High", "ANO1-High", "expression"], ["KIT-High", "KIT-High", "expression"], ["KIT Mutation", "KIT-Mutation", "gene"]]}]}
{"NCT_id": "NCT03739710", "json": [{"cohort": "", "disease_state": "relapsed/refractory advanced", "histology_inclusion": "Non-small Cell Lung Cancer (NSCLC)", "biomarker_inclusion": [], "histology_exclusion": ["Carcinomatous meningitis"], "biomarker_exclusion": ["BRAF molecular alterations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"]]}]}
{"NCT_id": "NCT05275426", "json": [{"cohort": "Main cohort", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Ewing sarcoma", "biomarker_inclusion": ["EWSR1 fusion with an ETS-transcription factor family member including FLI1, ERG, ETV1, ETV4, and FEV"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Pilot cohort", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Ewing-like sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["CNS metastases"]}], "json_norm": [{"cohort": "Main cohort", "histology_inclusion": "Ewing Sarcoma", "biomarker_inclusion": [["EWSR1 Fusion", "EWSR1", "fusion"]]}, {"cohort": "Pilot cohort", "histology_inclusion": "Sarcoma"}]}
{"NCT_id": "NCT05275439", "json": [{"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["TP53 mutation/deletion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "intermediate, high or very high risk", "histology_inclusion": "Myelodysplastic Syndromes", "biomarker_inclusion": ["TP53 mutation/deletion"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT05275478", "json": [{"cohort": "Dose Escalation", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["MTAP deletion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion in NSCLC", "disease_state": "advanced or metastatic", "histology_inclusion": "NSCLC (squamous and non squamous)", "biomarker_inclusion": ["MTAP deletion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion in Mesothelioma", "disease_state": "advanced or metastatic", "histology_inclusion": "mesothelioma", "biomarker_inclusion": ["MTAP deletion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion in Cholangiocarcinoma", "disease_state": "advanced or metastatic", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": ["MTAP deletion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion in MPNST", "disease_state": "advanced or metastatic", "histology_inclusion": "malignant peripheral nerve sheath tumor (MPNST)", "biomarker_inclusion": ["MTAP deletion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion in solid tumors", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["MTAP deletion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion in Glioblastoma", "disease_state": "relapsed/refractory", "histology_inclusion": "glioblastoma", "biomarker_inclusion": ["MTAP deletion"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Escalation", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Dose Expansion in NSCLC", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Dose Expansion in Mesothelioma", "histology_inclusion": "Mesothelioma"}, {"cohort": "Dose Expansion in Cholangiocarcinoma", "histology_inclusion": "Cholangiocarcinoma"}, {"cohort": "Dose Expansion in MPNST", "histology_inclusion": "Malignant Peripheral Nerve Sheath Tumor"}, {"cohort": "Dose Expansion in solid tumors", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Dose Expansion in Glioblastoma", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT04364048", "json": [{"cohort": "", "disease_state": "Stage III", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["small cell lung cancer"], "biomarker_exclusion": ["prior exposure to anti-PD-1 or anti-PD-L1 antibodies"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT04429087", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Small cell lung carcinoma (SCLC)", "biomarker_inclusion": ["DLL3 positive"], "histology_exclusion": [], "biomarker_exclusion": ["T cell Engager (TcE) or cell therapies targeting Delta-Like Ligand 3 (DLL3)"]}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Large cells neuroendocrine lung carcinoma (LCNEC)", "biomarker_inclusion": ["DLL3 positive"], "histology_exclusion": [], "biomarker_exclusion": ["T cell Engager (TcE) or cell therapies targeting Delta-Like Ligand 3 (DLL3)"]}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Neuroendocrine carcinoma (NEC) or small cell carcinoma of any other origin", "biomarker_inclusion": ["DLL3 positive"], "histology_exclusion": [], "biomarker_exclusion": ["T cell Engager (TcE) or cell therapies targeting Delta-Like Ligand 3 (DLL3)"]}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Tumours with mixed histologies for any above type", "biomarker_inclusion": ["DLL3 positive", "neuroendocrine carcinoma/small tumor cells component is predominant and represent at least 50% of the overall tumour tissue"], "histology_exclusion": [], "biomarker_exclusion": ["T cell Engager (TcE) or cell therapies targeting Delta-Like Ligand 3 (DLL3)"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma", "biomarker_inclusion": [["DLL3-High", "DLL3-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Large Cell Neuroendocrine Carcinoma", "biomarker_inclusion": [["DLL3-High", "DLL3-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Lung Carcinoma", "biomarker_inclusion": [["DLL3-High", "DLL3-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Carcinoma", "biomarker_inclusion": [["DLL3-High", "DLL3-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Tumor", "biomarker_inclusion": [["DLL3-High", "DLL3-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Small Cell Carcinoma", "biomarker_inclusion": [["DLL3-High", "DLL3-High", "expression"]]}, {"cohort": "", "biomarker_inclusion": [["DLL3-High", "DLL3-High", "expression"]]}]}
{"NCT_id": "NCT04820023", "json": [{"cohort": "BBT-176", "disease_state": "advanced and/or metastatic stage IIIB/IV", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "BBT-176", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT05340621", "json": [{"cohort": "Phase 1b", "disease_state": "Solid tumor refractory", "histology_inclusion": "Solid tumor", "biomarker_inclusion": ["RAS mutation", "BRAF mutation", "NF1 mutation", "GNAQ/11 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["Untreated or symptomatic brain metastasis", "Known hypersensitivity to binimetinib or other MEK inhibitors"]}, {"cohort": "Phase 2", "disease_state": "Metastatic melanoma", "histology_inclusion": "Melanoma", "biomarker_inclusion": ["NRAS mutation"], "histology_exclusion": ["Uveal melanoma"], "biomarker_exclusion": ["Untreated or symptomatic brain metastasis", "Known hypersensitivity to binimetinib or other MEK inhibitors"]}], "json_norm": [{"cohort": "Phase 1b", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NF1 Mutation", "NF1-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["GNAQ Mutation", "GNAQ-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "Phase 2", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"]], "histology_exclusion": ["Intraocular Melanoma"]}]}
{"NCT_id": "NCT04000529", "json": [{"cohort": "TNO155 plus spartalizumab", "disease_state": "advanced", "histology_inclusion": "Non-small Cell Lung Carcinoma", "biomarker_inclusion": ["EGFR WT", "ALK WT"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "TNO155 plus spartalizumab", "disease_state": "advanced", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "TNO155 plus spartalizumab", "disease_state": "advanced", "histology_inclusion": "Esophageal SCC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "TNO155 plus spartalizumab", "disease_state": "advanced", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "TNO155 plus ribociclib", "disease_state": "advanced", "histology_inclusion": "Non-small Cell Lung Carcinoma", "biomarker_inclusion": ["EGFR WT", "ALK WT"], "histology_exclusion": ["Colorectal Cancer", "Gastrointestinal Stromal Tumors"], "biomarker_exclusion": []}, {"cohort": "TNO155 plus ribociclib", "disease_state": "advanced", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Colorectal Cancer", "Gastrointestinal Stromal Tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "TNO155 plus spartalizumab", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["ALK ALK-wild_type", "ALK-wild_type", "wild_type"]]}, {"cohort": "TNO155 plus spartalizumab", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "TNO155 plus spartalizumab", "histology_inclusion": "Esophageal Squamous Cell Carcinoma"}, {"cohort": "TNO155 plus spartalizumab", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "TNO155 plus ribociclib", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["ALK ALK-wild_type", "ALK-wild_type", "wild_type"]], "histology_exclusion": ["Colorectal Carcinoma", "Gastrointestinal Stromal Tumor"]}, {"cohort": "TNO155 plus ribociclib", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Colorectal Carcinoma", "Gastrointestinal Stromal Tumor"]}]}
{"NCT_id": "NCT04494425", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["HER2-low", "HR+"], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": ["HER2-positive"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04689815", "json": [{"cohort": "Oral arsenic trioxide-Azacitidine", "disease_state": "", "histology_inclusion": "AML with NPM1 mutation", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Oral arsenic trioxide-Azacitidine", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["NPM1 Mutation", "NPM1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04689828", "json": [{"cohort": "", "disease_state": "metastatic castrate resistant", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT05275673", "json": [{"cohort": "Group A - NFE2L2 Mutation", "disease_state": "Stage IV", "histology_inclusion": "Squamous Non-Small Cell Lung Cancer", "biomarker_inclusion": ["NFE2L2 mutation"], "histology_exclusion": ["Non-squamous cell histology", "mixed histology tumors with any small-cell/neuroendocrine component", "active/untreated central nervous system metastasis", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Group B - NFE2L2 Wild-Type", "disease_state": "Stage IV", "histology_inclusion": "Squamous Non-Small Cell Lung Cancer", "biomarker_inclusion": ["NFE2L2 wild-type"], "histology_exclusion": ["Non-squamous cell histology", "mixed histology tumors with any small-cell/neuroendocrine component", "active/untreated central nervous system metastasis", "leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Group A - NFE2L2 Mutation", "histology_inclusion": "Squamous Cell Lung Carcinoma", "biomarker_inclusion": [["NFE2L2 Mutation", "NFE2L2-Mutation", "gene"]]}, {"cohort": "Group B - NFE2L2 Wild-Type", "histology_inclusion": "Squamous Cell Lung Carcinoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["NFE2L2 NFE2L2-wild_type", "NFE2L2-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT03544723", "json": [{"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": ["wild type p53", "p53 gene mutations that will not inhibit normal p53 function"], "histology_exclusion": [], "biomarker_exclusion": ["p53 positive tumor cells > 20%"]}, {"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["wild type p53", "p53 gene mutations that will not inhibit normal p53 function"], "histology_exclusion": [], "biomarker_exclusion": ["p53 positive tumor cells > 20%"]}, {"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "lymphoma", "biomarker_inclusion": ["wild type p53", "p53 gene mutations that will not inhibit normal p53 function"], "histology_exclusion": [], "biomarker_exclusion": ["p53 positive tumor cells > 20%"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]], "biomarker_exclusion": [["TP53-High", "TP53-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]], "biomarker_exclusion": [["TP53-High", "TP53-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Lymphoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]], "biomarker_exclusion": [["TP53-High", "TP53-High", "expression"]]}]}
{"NCT_id": "NCT05210790", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "polycythemia vera", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Polycythemia Vera"}]}
{"NCT_id": "NCT05275868", "json": [{"cohort": "Dose escalation", "disease_state": "advanced (metastatic or unresectable)", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["NFE2L2 mutation", "KEAP1 mutation", "CUL3 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose expansion group 1", "disease_state": "advanced (metastatic or unresectable)", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["NFE2L2 mutation", "KEAP1 mutation", "CUL3 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose expansion group 2", "disease_state": "advanced (metastatic or unresectable)", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose escalation", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["CUL3 Mutation", "CUL3-Mutation", "gene"], ["KEAP1 Mutation", "KEAP1-Mutation", "gene"], ["NFE2L2 Mutation", "NFE2L2-Mutation", "gene"]]}, {"cohort": "Dose expansion group 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["CUL3 Mutation", "CUL3-Mutation", "gene"], ["KEAP1 Mutation", "KEAP1-Mutation", "gene"], ["NFE2L2 Mutation", "NFE2L2-Mutation", "gene"]]}, {"cohort": "Dose expansion group 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT03740256", "json": [{"cohort": "", "disease_state": "advanced refractory", "histology_inclusion": "HER2 positive solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced refractory", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": ["HER2 positivity"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced refractory", "histology_inclusion": "cancer of the salivary glands", "biomarker_inclusion": ["HER2 positivity"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced refractory", "histology_inclusion": "lung cancer", "biomarker_inclusion": ["HER2 positivity"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced refractory", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["HER2 positivity"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced refractory", "histology_inclusion": "bladder cancer", "biomarker_inclusion": ["HER2 positivity"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced refractory", "histology_inclusion": "gastric cancer", "biomarker_inclusion": ["HER2 positivity"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced refractory", "histology_inclusion": "esophageal cancer", "biomarker_inclusion": ["HER2 positivity"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced refractory", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["HER2 positivity"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced refractory", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": ["HER2 positivity"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Salivary Gland Carcinoma"}, {"cohort": "", "histology_inclusion": "Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "", "histology_inclusion": "Esophageal Carcinoma"}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma"}]}
{"NCT_id": "NCT04429542", "json": [{"cohort": "Expansion Cohort 1", "disease_state": "Cutaneous Squamous Cell Carcinoma", "histology_inclusion": "Cutaneous Squamous Cell Carcinoma", "biomarker_inclusion": ["EGFR-driven"], "histology_exclusion": [], "biomarker_exclusion": ["prior anti-EGFR antibodies in unresectable/metastatic setting"]}, {"cohort": "Expansion Cohort 2", "disease_state": "Head and Neck Squamous Cell Carcinoma", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["EGFR-driven", "PD-L1 CPS \u2265 1", "HPV status"], "histology_exclusion": ["nasopharynx"], "biomarker_exclusion": ["prior systemic therapy in recurrent or metastatic setting", "prior immune checkpoint inhibitors", "prior anti-EGFR antibodies"]}, {"cohort": "Expansion Cohort 3", "disease_state": "Squamous Carcinoma of the Anal Canal", "histology_inclusion": "Squamous Carcinoma of the Anal Canal", "biomarker_inclusion": ["EGFR-driven"], "histology_exclusion": [], "biomarker_exclusion": ["prior immune checkpoint inhibitors"]}], "json_norm": [{"cohort": "Expansion Cohort 1", "histology_inclusion": "Skin Squamous Cell Carcinoma"}, {"cohort": "Expansion Cohort 2", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Expansion Cohort 3", "histology_inclusion": "Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT05015608", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic (stage IIIB, IIIC or IV)", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR sensitive mutations", "MET amplification"], "histology_exclusion": [], "biomarker_exclusion": ["T790M mutations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["MET-High", "MET-High", "expression"]]}]}
{"NCT_id": "NCT02099058", "json": [{"cohort": "Monotherapy Expansion Cohort", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-squamous, EGFR wild type, c-Met+ NSCLC", "biomarker_inclusion": [], "histology_exclusion": ["adenosquamous"], "biomarker_exclusion": []}, {"cohort": "Arm E", "disease_state": "metastatic/locally advanced nonsquamous NSCLC", "histology_inclusion": "", "biomarker_inclusion": ["EGFR mutation(s) del19", "L858R", "T790M"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutations known to be resistant to osimertinib"]}], "json_norm": [{"cohort": "Monotherapy Expansion Cohort", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}, {"cohort": "Monotherapy Expansion Cohort", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}, {"cohort": "Monotherapy Expansion Cohort", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}, {"cohort": "Arm E", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR exon 19 del", "exon 19 del", "exon"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT05210946", "json": [{"cohort": "Pemigatinib in Advanced Non-Small Cell Lung Cancer Patients with FGFR Gene Alterations", "disease_state": "unresectable stage IIIB-IIIC or stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["FGFR 1-3 alterations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Pemigatinib in Advanced Non-Small Cell Lung Cancer Patients with FGFR Gene Alterations", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}]}
{"NCT_id": "NCT03740529", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Small Lymphocytic Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Waldenstrom Macroglobulinemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Marginal Zone Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "B-cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Small Lymphocytic Lymphoma"}, {"cohort": "", "histology_inclusion": "Waldenstrom Macroglobulinemia"}, {"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Marginal Zone Lymphoma"}, {"cohort": "", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma"}]}
{"NCT_id": "NCT03935893", "json": [{"cohort": "", "disease_state": "locally advanced, recurrent, or metastatic", "histology_inclusion": "gastric/esophagogastric cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced, recurrent, or metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced, recurrent, or metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced, recurrent, or metastatic", "histology_inclusion": "sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced, recurrent, or metastatic", "histology_inclusion": "mesothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced, recurrent, or metastatic", "histology_inclusion": "neuroendocrine tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced, recurrent, or metastatic", "histology_inclusion": "squamous cell cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced, recurrent, or metastatic", "histology_inclusion": "Merkel cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced, recurrent, or metastatic", "histology_inclusion": "mismatch repair deficient cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced, recurrent, or metastatic", "histology_inclusion": "microsatellite unstable cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Esophagogastric Cancer"}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "", "histology_inclusion": "Sarcoma"}, {"cohort": "", "histology_inclusion": "Mesothelioma"}, {"cohort": "", "histology_inclusion": "Neuroendocrine Carcinoma"}, {"cohort": "", "histology_inclusion": "Neuroendocrine Tumor"}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Merkel Cell Carcinoma"}, {"cohort": ""}, {"cohort": "", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT03870919", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "adenocarcinoma of the breast", "biomarker_inclusion": ["ER-positive", "HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}]}
{"NCT_id": "NCT04196413", "json": [{"cohort": "", "disease_state": "H3K27M-mutated Diffuse Intrinsic Pontine Glioma (DIPG) with radiographically evident tumor restricted to the brainstem", "histology_inclusion": "H3K27M-mutated Diffuse Intrinsic Pontine Glioma (DIPG)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "H3K27M-mutated Diffuse Midline Glioma (DMG) of the spinal cord", "histology_inclusion": "H3K27M-mutated Diffuse Midline Glioma (DMG) of the spinal cord", "biomarker_inclusion": [], "histology_exclusion": ["cerebellar vermis or hemispheres (pontocerebellar peduncle involvement is allowed)", "thalamic lesions", "supratentorial lesions"], "biomarker_exclusion": ["Prior CAR therapy", "Prior GD2-antibody therapy"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}]}
{"NCT_id": "NCT04625270", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Low-Grade Serous Ovarian Cancer", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": ["high-grade ovarian cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Low-Grade Serous Ovarian Cancer", "biomarker_inclusion": ["KRAS wild-type"], "histology_exclusion": ["high-grade ovarian cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Invasive Ovarian Micropapillary Serous Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]], "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm"]}, {"cohort": "", "histology_inclusion": "Invasive Ovarian Micropapillary Serous Carcinoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"]], "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm"]}]}
{"NCT_id": "NCT05081180", "json": [{"cohort": "", "disease_state": "high-grade primary CNS tumors, progressed after at least 1 prior systemic therapy", "histology_inclusion": "primary CNS malignancy", "biomarker_inclusion": [], "histology_exclusion": ["low-grade gliomas", "subependymal giant cell astrocytoma", "pilocytic astrocytoma", "World Health organization (WHO) Grade 1 tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "diffuse midline glioma with or without the H3 K27M mutation, no more than 1 prior systemic therapy", "histology_inclusion": "diffuse midline glioma", "biomarker_inclusion": ["H3 K27M mutation"], "histology_exclusion": ["low-grade gliomas", "subependymal giant cell astrocytoma", "pilocytic astrocytoma", "World Health organization (WHO) Grade 1 tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "diffuse midline glioma with or without the H3 K27M mutation, no prior systemic therapy, prior radiotherapy only", "histology_inclusion": "diffuse midline glioma", "biomarker_inclusion": ["H3 K27M mutation"], "histology_exclusion": ["low-grade gliomas", "subependymal giant cell astrocytoma", "pilocytic astrocytoma", "World Health organization (WHO) Grade 1 tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Primary Brain Neoplasm", "histology_exclusion": ["Pilocytic Astrocytoma", "Astrocytoma"]}, {"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]], "histology_exclusion": ["Pilocytic Astrocytoma", "Astrocytoma"]}, {"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]], "histology_exclusion": ["Pilocytic Astrocytoma", "Astrocytoma"]}]}
{"NCT_id": "NCT05601700", "json": [{"cohort": "", "disease_state": "Stage III-IV", "histology_inclusion": "Low-grade serous carcinoma of the ovary, fallopian tube, and peritoneum", "biomarker_inclusion": ["ER positive (\u2265 10%)", "PgR positive (\u2265 10%)"], "histology_exclusion": ["Central nervous system metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Serous Adenocarcinoma", "biomarker_inclusion": [["EREG-High", "EREG-High", "expression"], ["PGR-High", "PGR-High", "expression"]]}]}
{"NCT_id": "NCT03284502", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumors with RAS- or RAF-mutation", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion cohort I", "disease_state": "locally advanced or metastatic", "histology_inclusion": "KRAS-mutant NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion cohort I", "disease_state": "locally advanced or metastatic", "histology_inclusion": "KRAS-mutant Pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion cohort I", "disease_state": "locally advanced or metastatic", "histology_inclusion": "RAS-mutant CRC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion cohort II", "disease_state": "locally advanced or metastatic", "histology_inclusion": "KRAS G13D-mutant CRC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion cohort II", "disease_state": "locally advanced or metastatic", "histology_inclusion": "BRAF V600-mutant CRC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion cohort II", "disease_state": "locally advanced or metastatic", "histology_inclusion": "NRAS-mutant Melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stage 1b and Expansion cohort III", "disease_state": "locally advanced or metastatic", "histology_inclusion": "BRAF V600-mutant CRC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Expansion cohort I", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "Expansion cohort I", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "Expansion cohort I", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Expansion cohort II", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS G13D", "G13D", "coordinate"]]}, {"cohort": "Expansion cohort II", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Expansion cohort II", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"]]}, {"cohort": "Stage 1b and Expansion cohort III", "histology_inclusion": "Colorectal Carcinoma"}]}
{"NCT_id": "NCT04951115", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["Limited-Stage SCLC treated with concurrent chemo-radiation"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Mixed-histology (NSCLC and SCLC)", "biomarker_inclusion": [], "histology_exclusion": ["Limited-Stage SCLC treated with concurrent chemo-radiation"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma"]}, {"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma"]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT05406700", "json": [{"cohort": "", "disease_state": "progressive", "histology_inclusion": "IDH1 mutant glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "progressive", "histology_inclusion": "IDH2 mutant glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04131621", "json": [{"cohort": "", "disease_state": "relapsed or refractory to platinum-based chemotherapy", "histology_inclusion": "Adenocarcinoma of unknown primary site (ACUP)", "biomarker_inclusion": [], "histology_exclusion": ["Non-epithelial cancer", "Extragonadal germ-cell tumor", "Poorly differentiated carcinoma with midline distribution", "Women with papillary adenocarcinoma of the peritoneal cavity", "Women with adenocarcinoma involving only the axillary lymph nodes", "Squamous cell carcinoma restricted to cervical lymph nodes", "Poorly and well differentiated neuroendocrine tumors", "Men with blastic bone metastases and elevated PSA", "Subjects with a single, small tumor potentially resectable and/or amenable to radiotherapy with curative intent", "Colon cancer-type CUP"], "biomarker_exclusion": ["brain or spinal cord metastasis", "leptomeningeal disease"]}, {"cohort": "", "disease_state": "relapsed or refractory to platinum-based chemotherapy", "histology_inclusion": "Poorly differentiated adenocarcinoma of unknown primary site", "biomarker_inclusion": [], "histology_exclusion": ["Non-epithelial cancer", "Extragonadal germ-cell tumor", "Poorly differentiated carcinoma with midline distribution", "Women with papillary adenocarcinoma of the peritoneal cavity", "Women with adenocarcinoma involving only the axillary lymph nodes", "Squamous cell carcinoma restricted to cervical lymph nodes", "Poorly and well differentiated neuroendocrine tumors", "Men with blastic bone metastases and elevated PSA", "Subjects with a single, small tumor potentially resectable and/or amenable to radiotherapy with curative intent", "Colon cancer-type CUP"], "biomarker_exclusion": ["brain or spinal cord metastasis", "leptomeningeal disease"]}, {"cohort": "", "disease_state": "relapsed or refractory to platinum-based chemotherapy", "histology_inclusion": "Poorly differentiated carcinoma of unknown primary site", "biomarker_inclusion": [], "histology_exclusion": ["Non-epithelial cancer", "Extragonadal germ-cell tumor", "Poorly differentiated carcinoma with midline distribution", "Women with papillary adenocarcinoma of the peritoneal cavity", "Women with adenocarcinoma involving only the axillary lymph nodes", "Squamous cell carcinoma restricted to cervical lymph nodes", "Poorly and well differentiated neuroendocrine tumors", "Men with blastic bone metastases and elevated PSA", "Subjects with a single, small tumor potentially resectable and/or amenable to radiotherapy with curative intent", "Colon cancer-type CUP"], "biomarker_exclusion": ["brain or spinal cord metastasis", "leptomeningeal disease"]}, {"cohort": "", "disease_state": "relapsed or refractory to platinum-based chemotherapy", "histology_inclusion": "Squamous cell carcinoma of unknown primary site (SCUP)", "biomarker_inclusion": [], "histology_exclusion": ["Non-epithelial cancer", "Extragonadal germ-cell tumor", "Poorly differentiated carcinoma with midline distribution", "Women with papillary adenocarcinoma of the peritoneal cavity", "Women with adenocarcinoma involving only the axillary lymph nodes", "Squamous cell carcinoma restricted to cervical lymph nodes", "Poorly and well differentiated neuroendocrine tumors", "Men with blastic bone metastases and elevated PSA", "Subjects with a single, small tumor potentially resectable and/or amenable to radiotherapy with curative intent", "Colon cancer-type CUP"], "biomarker_exclusion": ["brain or spinal cord metastasis", "leptomeningeal disease"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Adenocarcinoma of Unknown Primary", "histology_exclusion": ["Germ Cell Tumor", "Carcinoma of Unknown Primary Origin", "Neuroendocrine Tumor", "Squamous Cell Carcinoma", "Gastric Papillary Adenocarcinoma", "Adenocarcinoma"]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma of Unknown Primary", "histology_exclusion": ["Germ Cell Tumor", "Carcinoma of Unknown Primary Origin", "Neuroendocrine Tumor", "Squamous Cell Carcinoma", "Gastric Papillary Adenocarcinoma", "Adenocarcinoma"]}, {"cohort": "", "histology_inclusion": "Carcinoma of Unknown Primary Origin", "histology_exclusion": ["Germ Cell Tumor", "Carcinoma of Unknown Primary Origin", "Neuroendocrine Tumor", "Squamous Cell Carcinoma", "Gastric Papillary Adenocarcinoma", "Adenocarcinoma"]}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma of Unknown Primary Origin", "histology_exclusion": ["Germ Cell Tumor", "Carcinoma of Unknown Primary Origin", "Neuroendocrine Tumor", "Squamous Cell Carcinoma", "Gastric Papillary Adenocarcinoma", "Adenocarcinoma"]}]}
{"NCT_id": "NCT05081492", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["ER > 10%", "PR > 10%", "HER2 positive"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT03871257", "json": [{"cohort": "", "disease_state": "newly diagnosed or previously untreated", "histology_inclusion": "Neurofibromatosis Type 1 associated Low-Grade Glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly diagnosed or previously untreated", "histology_inclusion": "Optic Pathway Glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Low Grade Glioma"}, {"cohort": "", "histology_inclusion": "Glioma"}]}
{"NCT_id": "NCT03936465", "json": [{"cohort": "Arm 1 Cohort A", "disease_state": "relapsed or refractory", "histology_inclusion": "non-CNS primary solid tumors or lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm 1 Cohort B", "disease_state": "relapsed or refractory", "histology_inclusion": "solid tumors or lymphoma", "biomarker_inclusion": ["MYCN amplification", "MYC amplification", "Translocation involving MYC", "Translocation involving MYCN", "Translocation involving BRD4", "Translocation involving BRD3", "BRD4 amplification", "NUT midline carcinoma"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm 2 Cohort A", "disease_state": "relapsed or refractory", "histology_inclusion": "primary CNS tumors or untreated CNS metastases", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm 2 Cohort B", "disease_state": "relapsed or refractory", "histology_inclusion": "primary CNS tumors or untreated CNS metastases", "biomarker_inclusion": ["MYCN amplification", "MYC amplification", "Translocation involving MYC", "Translocation involving MYCN", "Translocation involving BRD4", "Translocation involving BRD3", "BRD4 amplification", "NUT midline carcinoma"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm 1 Cohort A", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Arm 1 Cohort B", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRD4-High", "BRD4-High", "expression"], ["MYCN-High", "MYCN-High", "expression"], ["MYC-High", "MYC-High", "expression"]]}, {"cohort": "Arm 2 Cohort A", "histology_inclusion": "Primary Brain Neoplasm"}, {"cohort": "Arm 2 Cohort B", "histology_inclusion": "Primary Brain Neoplasm", "biomarker_inclusion": [["BRD4-High", "BRD4-High", "expression"], ["MYCN-High", "MYCN-High", "expression"], ["MYC-High", "MYC-High", "expression"]]}]}
{"NCT_id": "NCT04001569", "json": [{"cohort": "Phase 1b", "disease_state": "metastatic solid tumor", "histology_inclusion": "metastatic solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PI3K inhibitor", "Akt inhibitor", "mTOR inhibitor"]}, {"cohort": "Phase 2b", "disease_state": "locally advanced or metastatic gastric cancer", "histology_inclusion": "gastric cancer", "biomarker_inclusion": ["PTEN loss by IHC", "PTEN gene deletion", "PTEN loss of function mutation", "PIK3CB gene amplification", "PIK3CB gain of function mutation"], "histology_exclusion": [], "biomarker_exclusion": ["PI3K inhibitor", "Akt inhibitor", "mTOR inhibitor"]}], "json_norm": [{"cohort": "Phase 1b", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase 2b", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["PTEN-Low", "PTEN-Low", "expression"], ["PIK3CB Mutation", "PIK3CB-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["PIK3CB-High", "PIK3CB-High", "expression"]]}]}
{"NCT_id": "NCT04625647", "json": [{"cohort": "S1900E", "disease_state": "stage IV or recurrent", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR sensitizing mutations", "EGFR T790M mutation", "ALK gene fusion", "ROS1 gene rearrangement", "BRAF V600E mutation", "prior AMG 510", "other KRAS G12C specific inhibitor"]}], "json_norm": [{"cohort": "S1900E", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]], "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"], ["BRAF V600E", "V600E", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT05276726", "json": [{"cohort": "", "disease_state": "locally-advanced or metastatic", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["KRAS p.G12C mutation", "STK11 co-mutation", "KEAP1 Wild-Type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KEAP1 KEAP1-wild_type", "KEAP1-wild_type", "wild_type"], ["KRAS G12C", "G12C", "coordinate"], ["STK11 Mutation", "STK11-Mutation", "gene"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04951492", "json": [{"cohort": "", "disease_state": "castration resistant", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["positive LOH score on prior UW OncoPlex testing"], "histology_exclusion": [], "biomarker_exclusion": ["previous treatment with PARP inhibitor", "previous treatment with platinum chemotherapy in the metastatic castration-resistant setting"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT05016544", "json": [{"cohort": "Inetetamab+Pyrotinib", "disease_state": "stage IIIB-IV", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["HER2 activation amplification", "HER2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Inetetamab+Pyrotinib", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}]}
{"NCT_id": "NCT05406999", "json": [{"cohort": "", "disease_state": "high-risk or locally advanced", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": ["neuroendocrine", "small cell", "sarcoma-like"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Neoplasm", "histology_exclusion": ["Sarcoma"]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "histology_exclusion": ["Sarcoma"]}]}
{"NCT_id": "NCT03024489", "json": [{"cohort": "Palbociclib-Cetuximab-IMRT", "disease_state": "Locally Advanced", "histology_inclusion": "squamous cell carcinoma of oral cavity, oropharynx, larynx, and hypopharynx", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["p16 by IHC (only in expansion cohort)"]}], "json_norm": [{"cohort": "Palbociclib-Cetuximab-IMRT", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT03480672", "json": [{"cohort": "", "disease_state": "stage III, IVA/B", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT03806426", "json": [{"cohort": "", "disease_state": "FAP stage 1-3", "histology_inclusion": "Familial Adenomatous Polyposis", "biomarker_inclusion": [], "histology_exclusion": ["invasive carcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}]}
{"NCT_id": "NCT04262154", "json": [{"cohort": "Metastatic Prostate Cancer", "disease_state": "metastatic hormone-sensitive", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": ["small cell carcinoma of the prostate"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Metastatic Prostate Cancer", "histology_inclusion": "Prostate Adenocarcinoma", "histology_exclusion": ["Prostate Small Cell Neuroendocrine Carcinoma"]}]}
{"NCT_id": "NCT04495621", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["N-K-RAS wild-type", "BRAF wild-type", "PIK3CA mutated"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}]}
{"NCT_id": "NCT05276973", "json": [{"cohort": "", "disease_state": "Stage III or Stage IV", "histology_inclusion": "High grade serous", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["Prior treatment with agent(s) targeting PI3K/AKT/mTor pathway"]}, {"cohort": "", "disease_state": "Stage III or Stage IV", "histology_inclusion": "Endometrioid adenocarcinoma, grade 3", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["Prior treatment with agent(s) targeting PI3K/AKT/mTor pathway"]}], "json_norm": [{"cohort": ""}, {"cohort": "", "histology_inclusion": "Endometrioid Adenocarcinoma"}]}
{"NCT_id": "NCT04067115", "json": [{"cohort": "Ewing Sarcoma Patients", "disease_state": "relapsed and refractory", "histology_inclusion": "Ewing sarcoma", "biomarker_inclusion": ["EWS-FLI1 fusion"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Ewing Sarcoma Patients", "histology_inclusion": "Ewing Sarcoma", "biomarker_inclusion": [["FLII Fusion", "FLII", "fusion"], ["FLI1 Fusion", "FLI1", "fusion"], ["EWSR1 Fusion", "EWSR1", "fusion"], ["EWSR1 - FLII", "EWSR1 - FLII", "coordinate"], ["EWSR1 - FLI1", "EWSR1 - FLI1", "coordinate"]]}]}
{"NCT_id": "NCT04430738", "json": [{"cohort": "Cohort 1A, 1B, 1C, 1D", "disease_state": "unresectable or metastatic", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": ["HER2+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1A, 1B, 1C, 1D", "disease_state": "unresectable or metastatic", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": ["HER2+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1A, 1B, 1C, 1D", "disease_state": "unresectable or metastatic", "histology_inclusion": "GEJ Adenocarcinoma", "biomarker_inclusion": ["HER2+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1A, 1B, 1C, 1D", "disease_state": "unresectable or metastatic", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_inclusion": ["HER2+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1A, 1B, 1C, 1D", "disease_state": "unresectable or metastatic", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": ["HER2+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1A, 1B, 1C, 1D", "disease_state": "unresectable or metastatic", "histology_inclusion": "Gallbladder Carcinoma", "biomarker_inclusion": ["HER2+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1E, 1F, 1G, 2A", "disease_state": "unresectable or metastatic", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": ["HER2+"], "histology_exclusion": [], "biomarker_exclusion": ["Prior anti-PD-1, anti-PD-L1, or anti PD L2 agent"]}, {"cohort": "Cohort 1E, 1F, 1G, 2A", "disease_state": "unresectable or metastatic", "histology_inclusion": "GEJ Adenocarcinoma", "biomarker_inclusion": ["HER2+"], "histology_exclusion": [], "biomarker_exclusion": ["Prior anti-PD-1, anti-PD-L1, or anti PD L2 agent"]}, {"cohort": "Cohort 1E, 1F, 1G, 2A", "disease_state": "unresectable or metastatic", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_inclusion": ["HER2+"], "histology_exclusion": [], "biomarker_exclusion": ["Prior anti-PD-1, anti-PD-L1, or anti PD L2 agent"]}, {"cohort": "Cohort 2B", "disease_state": "unresectable or metastatic", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": ["HER2+"], "histology_exclusion": [], "biomarker_exclusion": ["prior anti-HER2 therapies"]}], "json_norm": [{"cohort": "Cohort 1A, 1B, 1C, 1D", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort 1A, 1B, 1C, 1D", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort 1A, 1B, 1C, 1D", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort 1A, 1B, 1C, 1D", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort 1A, 1B, 1C, 1D", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort 1A, 1B, 1C, 1D", "histology_inclusion": "Gallbladder Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort 1E, 1F, 1G, 2A", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort 1E, 1F, 1G, 2A", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort 1E, 1F, 1G, 2A", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort 2B", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04951778", "json": [{"cohort": "Part A and Part B", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Acute Promyelocytic Leukemia"], "biomarker_exclusion": []}, {"cohort": "Part A and Part B", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Higher-Risk Myelodysplastic Syndromes", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A and Part B", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Part A and Part B", "histology_inclusion": "Myelodysplastic Syndrome"}]}
{"NCT_id": "NCT02959619", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["ALK positive"], "histology_exclusion": ["primary CNS tumors", "meningeal metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT04691375", "json": [{"cohort": "Part A: Escalation Cohorts", "disease_state": "locally advanced (unresectable) and/or metastatic", "histology_inclusion": "Gynecological cancers", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A: Escalation Cohorts", "disease_state": "locally advanced (unresectable) and/or metastatic", "histology_inclusion": "gastric adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A: Escalation Cohorts", "disease_state": "locally advanced (unresectable) and/or metastatic", "histology_inclusion": "Colorectal", "biomarker_inclusion": ["MSIlow", "CPI refractory MSIhigh"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A: Escalation Cohorts", "disease_state": "locally advanced (unresectable) and/or metastatic", "histology_inclusion": "non-small cell lung adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A: Escalation Cohorts", "disease_state": "locally advanced (unresectable) and/or metastatic", "histology_inclusion": "lung squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A: Escalation Cohorts", "disease_state": "locally advanced (unresectable) and/or metastatic", "histology_inclusion": "renal clear cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A: Escalation Cohorts", "disease_state": "locally advanced (unresectable) and/or metastatic", "histology_inclusion": "renal non-clear cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A: Escalation Cohorts", "disease_state": "locally advanced (unresectable) and/or metastatic", "histology_inclusion": "Triple Negative Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A: Escalation Cohorts", "disease_state": "locally advanced (unresectable) and/or metastatic", "histology_inclusion": "Hormone Receptor/Growth Factor Receptor-Negative Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B: Expansion Cohorts", "disease_state": "locally advanced (unresectable) and/or metastatic", "histology_inclusion": "advanced solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["EGFR", "VEGF", "ALK", "ROS-1", "NTRK", "MET", "RET", "BRAF V600E", "HER2"]}], "json_norm": [{"cohort": "Part A: Escalation Cohorts"}, {"cohort": "Part A: Escalation Cohorts", "histology_inclusion": "Gastric Adenocarcinoma"}, {"cohort": "Part A: Escalation Cohorts", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Part A: Escalation Cohorts", "histology_inclusion": "Lung Adenocarcinoma"}, {"cohort": "Part A: Escalation Cohorts", "histology_inclusion": "Squamous Cell Lung Carcinoma"}, {"cohort": "Part A: Escalation Cohorts", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}, {"cohort": "Part A: Escalation Cohorts"}, {"cohort": "Part A: Escalation Cohorts", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Part A: Escalation Cohorts", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "Part B: Expansion Cohorts", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT04756505", "json": [{"cohort": "REINA Trial", "disease_state": "Metastatic", "histology_inclusion": "Hormone Receptor Positive Breast Adenocarcinoma", "biomarker_inclusion": ["HER2 Negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "REINA Trial", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "REINA Trial", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}]}
{"NCT_id": "NCT04821622", "json": [{"cohort": "", "disease_state": "metastatic castration-sensitive prostate cancer", "histology_inclusion": "adenocarcinoma of the prostate without neuroendocrine differentiation, small cell or signet cell features", "biomarker_inclusion": ["DDR gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}]}
{"NCT_id": "NCT04886804", "json": [{"cohort": "Phase Ia", "disease_state": "advanced, unresectable and/or metastatic", "histology_inclusion": "non-haematologic malignancy", "biomarker_inclusion": ["HER2 overexpression", "HER2 gene amplification", "HER2 non-synonymous somatic mutation", "HER2 gene rearrangement", "NRG1 gene rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase Ib - Cohort 1", "disease_state": "advanced/metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["HER2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase Ib - Cohort 2", "disease_state": "treatment na\u00efve", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["HER2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase Ib - Cohort 3", "disease_state": "advanced/metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["HER2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase Ia", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "Phase Ib - Cohort 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "Phase Ib - Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "Phase Ib - Cohort 3", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}]}
{"NCT_id": "NCT05017025", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["EGFR Exon 19 deletion"], "histology_exclusion": [], "biomarker_exclusion": ["previous treatment with other aurora kinase inhibitors"]}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["EGFR L858R mutation"], "histology_exclusion": [], "biomarker_exclusion": ["previous treatment with other aurora kinase inhibitors"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR exon 19 del", "exon 19 del", "exon"]]}, {"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"]]}]}
{"NCT_id": "NCT05082025", "json": [{"cohort": "Cohort 1", "disease_state": "advanced or metastatic", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["ER+", "PR+", "PIK3CA gain of function mutations", "PIK3R1 loss of function mutations", "PTEN loss of function mutations", "PTEN deletions"], "histology_exclusion": ["central nervous system involvement"], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "advanced or metastatic", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["ER+", "PR+", "PIK3CA gain of function mutations", "PIK3R1 loss of function mutations", "PTEN loss of function mutations", "PTEN deletions"], "histology_exclusion": ["central nervous system involvement"], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "advanced or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["ER+", "PR+", "PIK3CA gain of function mutations", "PIK3R1 loss of function mutations", "PTEN loss of function mutations", "PTEN deletions"], "histology_exclusion": ["central nervous system involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["EREG-High", "EREG-High", "expression"], ["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["PIK3R1-Low", "PIK3R1-Low", "expression"], ["PIK3R1 Mutation", "PIK3R1-Mutation", "gene"], ["PTEN-Low", "PTEN-Low", "expression"], ["PTEN Mutation", "PTEN-Mutation", "gene"]]}, {"cohort": "Cohort 1", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["PTEN Mutation", "PTEN-Mutation", "gene"], ["PIK3R1 Mutation", "PIK3R1-Mutation", "gene"], ["PRH2-High", "PRH2-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["PIK3R1-Low", "PIK3R1-Low", "expression"], ["PTEN-Low", "PTEN-Low", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["PTEN Mutation", "PTEN-Mutation", "gene"], ["PIK3R1 Mutation", "PIK3R1-Mutation", "gene"], ["PRH2-High", "PRH2-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["PIK3R1-Low", "PIK3R1-Low", "expression"], ["PTEN-Low", "PTEN-Low", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PTEN Mutation", "PTEN-Mutation", "gene"], ["PIK3R1 Mutation", "PIK3R1-Mutation", "gene"], ["PRH2-High", "PRH2-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["PIK3R1-Low", "PIK3R1-Low", "expression"], ["PTEN-Low", "PTEN-Low", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"]]}]}
{"NCT_id": "NCT03871959", "json": [{"cohort": "", "disease_state": "Stage III or IV", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma (PDAC)", "biomarker_inclusion": [], "histology_exclusion": ["pancreatic endocrine tumors"], "biomarker_exclusion": ["MSI-high", "MMR-deficient"]}, {"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Colorectal Cancer (CRC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["MSI-high", "MMR-deficient"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "histology_exclusion": ["Pancreatic Neuroendocrine Carcinoma", "Pancreatic Neuroendocrine Neoplasm"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04002297", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system involvement by lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma"}]}
{"NCT_id": "NCT04067336", "json": [{"cohort": "Phase 1b - Cohort 1", "disease_state": "relapsed or refractory", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["KMT2A-r"], "histology_exclusion": ["acute promyelocytic leukemia", "chronic myelogenous leukemia in blast crisis"], "biomarker_exclusion": []}, {"cohort": "Phase 1b - Cohort 2", "disease_state": "relapsed or refractory", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["NPM1-m"], "histology_exclusion": ["acute promyelocytic leukemia", "chronic myelogenous leukemia in blast crisis"], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "relapsed or refractory", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["NPM1-m"], "histology_exclusion": ["acute promyelocytic leukemia", "chronic myelogenous leukemia in blast crisis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1b - Cohort 1", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Phase 1b - Cohort 2", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Phase 2", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT03090165", "json": [{"cohort": "Phase I", "disease_state": "Metastatic or unresectable", "histology_inclusion": "Triple-negative breast cancer (TNBC)", "biomarker_inclusion": ["AR+ (IHC staining > 0% of tumor nuclei)", "ER < 10%", "PR < 10%", "HER2 negative"], "histology_exclusion": [], "biomarker_exclusion": ["Prior therapy with AR antagonists", "Prior therapy with CDK 4/6 inhibitors"]}, {"cohort": "Phase II", "disease_state": "Metastatic or unresectable", "histology_inclusion": "Triple-negative breast cancer (TNBC)", "biomarker_inclusion": ["AR+ (IHC staining \u2265 10% of tumor nuclei)", "ER < 10%", "PR < 10%", "HER2 negative"], "histology_exclusion": [], "biomarker_exclusion": ["Prior therapy with AR antagonists", "Prior therapy with CDK 4/6 inhibitors"]}], "json_norm": [{"cohort": "Phase I", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["AKR1B1-High", "AKR1B1-High", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["AR-High", "AR-High", "expression"]]}, {"cohort": "Phase II", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["AKR1B1-High", "AKR1B1-High", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["AR-High", "AR-High", "expression"]]}]}
{"NCT_id": "NCT04132505", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04197687", "json": [{"cohort": "", "disease_state": "Stage II-III", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": ["HER2 Positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04262687", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["MSS", "pMMR"], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": ["dMMR", "MSI"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT05407675", "json": [{"cohort": "", "disease_state": "advanced, unresectable/metastatic", "histology_inclusion": "solid malignancy", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastases", "leptomeningeal metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}]}
{"NCT_id": "NCT03872180", "json": [{"cohort": "", "disease_state": "untreated", "histology_inclusion": "mantle cell lymphoma", "biomarker_inclusion": ["t(11;14)", "CCND1 positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["CCND1-High", "CCND1-High", "expression"]]}]}
{"NCT_id": "NCT03546686", "json": [{"cohort": "Treatment Arm", "disease_state": "Early Stage/Resectable", "histology_inclusion": "invasive carcinoma of the breast", "biomarker_inclusion": ["ER negative", "PR negative", "HER2 negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Treatment Arm", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"], ["TMEM37-Low", "TMEM37-Low", "expression"]]}]}
{"NCT_id": "NCT03416335", "json": [{"cohort": "Monotherapy Part A (Dose Escalation)", "disease_state": "metastatic or unresectable and recurrent and/or refractory", "histology_inclusion": "advanced solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["CNS primary tumors"], "biomarker_exclusion": ["prior therapy with a TLR agonist"]}, {"cohort": "Combination Part B (Dose Escalation)", "disease_state": "metastatic or unresectable and recurrent and/or refractory", "histology_inclusion": "advanced solid tumor", "biomarker_inclusion": ["pembrolizumab approved treatment", "primary or acquired resistance to ICIs"], "histology_exclusion": ["CNS primary tumors"], "biomarker_exclusion": ["prior therapy with a TLR agonist"]}, {"cohort": "Combination Arm C (Dose Expansion)", "disease_state": "metastatic or unresectable, and recurrent and/or refractory", "histology_inclusion": "Advanced HNSCC tumors of the oropharynx, oral cavity, hypopharynx, larynx, lip, or sinus", "biomarker_inclusion": ["treated with pembrolizumab or other PD-1 or PD-L1 inhibitors", "primary or acquired resistance to ICIs", "platinum refractory", "PD-1 or PD-L1 exposed", "known status of PD-L1 CPS", "known HPV status"], "histology_exclusion": ["CNS primary tumors"], "biomarker_exclusion": ["prior therapy with a TLR agonist"]}], "json_norm": [{"cohort": "Monotherapy Part A (Dose Escalation)", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Combination Part B (Dose Escalation)", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Combination Arm C (Dose Expansion)", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Combination Arm C (Dose Expansion)", "histology_inclusion": "Oropharyngeal Carcinoma"}]}
{"NCT_id": "NCT03611868", "json": [{"cohort": "Cohort A", "disease_state": "unresectable or metastatic melanoma, refractory or relapse after PD-1 antibody treatment", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": ["uveal melanoma"], "biomarker_exclusion": ["prior systemic MDM2-p53 inhibitor treatment"]}, {"cohort": "Cohort F", "disease_state": "metastatic or unresectable MPNST", "histology_inclusion": "malignant peripheral nerve sheath tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior systemic MDM2-p53 inhibitor treatment"]}, {"cohort": "Cohort E", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["known FGFR translocation mutation"]}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Melanoma", "histology_exclusion": ["Intraocular Melanoma"]}, {"cohort": "Cohort F", "histology_inclusion": "Malignant Peripheral Nerve Sheath Tumor"}, {"cohort": "Cohort E", "biomarker_exclusion": [["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"], ["FGFR4 Fusion", "FGFR4", "fusion"], ["FGFR1 Fusion", "FGFR1", "fusion"]]}]}
{"NCT_id": "NCT03937635", "json": [{"cohort": "", "disease_state": "high-risk smoldering multiple myeloma", "histology_inclusion": "smoldering plasma cell myeloma", "biomarker_inclusion": ["abnormal serum free light chain ratio >20", "serum M-protein level >= 2 gm/dL", "t(4;14)", "del 17p", "del 13q", "1q gain", ">20% plasma cells on biopsy or aspirate"], "histology_exclusion": [], "biomarker_exclusion": ["more than one focal marrow lesion on MRI", "grade 2 or higher peripheral neuropathy", "monoclonal gammopathy of undetermined significance"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Smoldering Plasma Cell Myeloma"}]}
{"NCT_id": "NCT04263090", "json": [{"cohort": "Rigosertib + Nivolumab", "disease_state": "Stage IV metastatic", "histology_inclusion": "lung adenocarcinoma", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR sensitizing (activating) mutation", "ALK translocation"]}], "json_norm": [{"cohort": "Rigosertib + Nivolumab", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT04952584", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Hodgkin lymphoma", "biomarker_inclusion": ["CD30-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Aggressive non-Hodgkin lymphoma", "biomarker_inclusion": ["CD30-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "ALK-negative anaplastic T cell lymphoma", "biomarker_inclusion": ["CD30-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "other peripheral T-cell lymphoma", "biomarker_inclusion": ["CD30-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "ALK-positive anaplastic T cell lymphoma", "biomarker_inclusion": ["CD30-positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Hodgkin Lymphoma", "biomarker_inclusion": [["TNFRSF8-High", "TNFRSF8-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Aggressive Non-Hodgkin Lymphoma", "biomarker_inclusion": [["TNFRSF8-High", "TNFRSF8-High", "expression"]]}, {"cohort": "", "histology_inclusion": "T-Cell Non-Hodgkin Lymphoma", "biomarker_inclusion": [["ALK-Low", "ALK-Low", "expression"], ["TNFRSF8-High", "TNFRSF8-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma", "biomarker_inclusion": [["TNFRSF8-High", "TNFRSF8-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Peripheral T-Cell Lymphoma", "biomarker_inclusion": [["TNFRSF8-High", "TNFRSF8-High", "expression"]]}, {"cohort": "", "histology_inclusion": "T-Cell Non-Hodgkin Lymphoma", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"], ["TNFRSF8-High", "TNFRSF8-High", "expression"]]}]}
{"NCT_id": "NCT04952597", "json": [{"cohort": "", "disease_state": "Limited-stage (stage Tx, T1-T4, N0-3, M0; AJCC staging, 8th edition)", "histology_inclusion": "Small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["Mixed small cell lung cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT05017610", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Gliosarcoma"}]}
{"NCT_id": "NCT05538130", "json": [{"cohort": "Monotherapy Phase 1a Dose Escalation", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Substudy A and B", "disease_state": "advanced/metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Substudy A", "disease_state": "advanced/metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Substudy B", "disease_state": "advanced/metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Substudy B", "disease_state": "advanced/metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF Class II alteration"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Monotherapy Phase 1a Dose Escalation", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Substudy A and B", "histology_inclusion": "Melanoma"}, {"cohort": "Substudy A", "histology_inclusion": "Melanoma"}, {"cohort": "Substudy B", "histology_inclusion": "Melanoma"}, {"cohort": "Substudy B", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF Class 2", "BRAF Class 2", "coordinate"]]}]}
{"NCT_id": "NCT04002947", "json": [{"cohort": "", "disease_state": "Stage II, III, or IV", "histology_inclusion": "Diffuse Large B-Cell Lymphoma, NOS, Activated B-cell type (ABC)", "biomarker_inclusion": [], "histology_exclusion": ["Primary DLBCL of the central nervous system (PCNSL)", "Primary mediastinal B-cell lymphoma (PMBL)", "Plasmablastic lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II, III, or IV", "histology_inclusion": "Diffuse Large B-Cell Lymphoma, NOS, Germinal center B-cell type (GCB)", "biomarker_inclusion": [], "histology_exclusion": ["Primary DLBCL of the central nervous system (PCNSL)", "Primary mediastinal B-cell lymphoma (PMBL)", "Plasmablastic lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II, III, or IV", "histology_inclusion": "T-cell/histiocyte-rich large B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary DLBCL of the central nervous system (PCNSL)", "Primary mediastinal B-cell lymphoma (PMBL)", "Plasmablastic lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II, III, or IV", "histology_inclusion": "Primary cutaneous DLBCL, leg-type", "biomarker_inclusion": [], "histology_exclusion": ["Primary DLBCL of the central nervous system (PCNSL)", "Primary mediastinal B-cell lymphoma (PMBL)", "Plasmablastic lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II, III, or IV", "histology_inclusion": "EBV+ DLBCL, NOS", "biomarker_inclusion": [], "histology_exclusion": ["Primary DLBCL of the central nervous system (PCNSL)", "Primary mediastinal B-cell lymphoma (PMBL)", "Plasmablastic lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II, III, or IV", "histology_inclusion": "DLBCL associated with chronic inflammation", "biomarker_inclusion": [], "histology_exclusion": ["Primary DLBCL of the central nervous system (PCNSL)", "Primary mediastinal B-cell lymphoma (PMBL)", "Plasmablastic lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II, III, or IV", "histology_inclusion": "ALK+ large B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary DLBCL of the central nervous system (PCNSL)", "Primary mediastinal B-cell lymphoma (PMBL)", "Plasmablastic lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II, III, or IV", "histology_inclusion": "High-grade B-cell lymphoma, NOS", "biomarker_inclusion": [], "histology_exclusion": ["Primary DLBCL of the central nervous system (PCNSL)", "Primary mediastinal B-cell lymphoma (PMBL)", "Plasmablastic lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II, III, or IV", "histology_inclusion": "High-grade B-cell lymphoma, with MYC and BCL2 and/or BCL6 rearrangements", "biomarker_inclusion": [], "histology_exclusion": ["Primary DLBCL of the central nervous system (PCNSL)", "Primary mediastinal B-cell lymphoma (PMBL)", "Plasmablastic lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma Activated B-Cell Type", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Plasmablastic Lymphoma"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Plasmablastic Lymphoma"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Plasmablastic Lymphoma"]}, {"cohort": "", "histology_inclusion": "T-Cell/Histiocyte-Rich Large B-Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Plasmablastic Lymphoma"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Plasmablastic Lymphoma"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Plasmablastic Lymphoma"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Plasmablastic Lymphoma"]}, {"cohort": "", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"]], "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Plasmablastic Lymphoma"]}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma, Not Otherwise Specified", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Plasmablastic Lymphoma"]}, {"cohort": "", "histology_inclusion": "High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"]], "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Plasmablastic Lymphoma"]}]}
{"NCT_id": "NCT04692155", "json": [{"cohort": "", "disease_state": "Stage II, III, IV", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["cyclin D1 overexpression", "t(11;14) by FISH"], "histology_exclusion": ["CNS involvement by MCL"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["CCND1-High", "CCND1-High", "expression"]], "histology_exclusion": ["Mantle Cell Lymphoma"]}]}
{"NCT_id": "NCT05212987", "json": [{"cohort": "Dose-escalation stage", "disease_state": "advanced solid malignancies, stage III or IV", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["NTRK gene fusion positive", "mutations in TRK kinase region"], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "Dose expansion stage", "disease_state": "advanced solid malignant tumors, stage III or IV", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["NTRK gene fusion positive", "TRK kinase region mutation"], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose-escalation stage", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["TPM3 Mutation", "TPM3-Mutation", "gene"], ["NTRK1 Mutation", "NTRK1-Mutation", "gene"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Dose expansion stage", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["TPM3 Mutation", "TPM3-Mutation", "gene"], ["NTRK1 Mutation", "NTRK1-Mutation", "gene"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT02231775", "json": [{"cohort": "", "disease_state": "Stage IIIB-C", "histology_inclusion": "Melanoma", "biomarker_inclusion": ["BRAF V600E", "BRAF V600K"], "histology_exclusion": ["Brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}]}
{"NCT_id": "NCT03416530", "json": [{"cohort": "Arm A and G", "disease_state": "recurrent/refractory", "histology_inclusion": "H3 K27M glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B", "disease_state": "newly diagnosed", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma (DIPG)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm C", "disease_state": "", "histology_inclusion": "midline gliomas", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm D", "disease_state": "recurrent", "histology_inclusion": "H3 K27M glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm E", "disease_state": "recurrent/refractory", "histology_inclusion": "H3 K27M glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm E", "disease_state": "", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma (DIPG)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm F", "disease_state": "recurrent", "histology_inclusion": "high-grade glioma", "biomarker_inclusion": ["H3 K27M mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm G", "disease_state": "recurrent/refractory", "histology_inclusion": "H3 K27M glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm A and G", "histology_inclusion": "Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Arm B", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma"}, {"cohort": "Arm C"}, {"cohort": "Arm D", "histology_inclusion": "Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Arm E", "histology_inclusion": "Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Arm E", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma"}, {"cohort": "Arm F", "histology_inclusion": "Malignant Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Arm G", "histology_inclusion": "Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}]}
{"NCT_id": "NCT04068103", "json": [{"cohort": "", "disease_state": "Stage IIA", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["neuroendocrine carcinoma", "sarcoma", "lymphoma", "squamous cell carcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "histology_exclusion": ["Lymphoma", "Neuroendocrine Tumor", "Squamous Cell Carcinoma", "Neuroendocrine Carcinoma", "Sarcoma"]}]}
{"NCT_id": "NCT04627142", "json": [{"cohort": "", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": ["RAS targeting agent", "MAPK targeting agent", "SOS1 targeting agent"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT03547115", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Follicular Lymphoma (FL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Mantle Cell Lymphoma (MCL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Marginal Zone Lymphoma (MZL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Small Lymphocytic Lymphoma (SLL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Chronic Lymphocytic Leukemia (CLL)", "biomarker_inclusion": [], "histology_exclusion": ["aggressive lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Diffuse Large B-cell Lymphoma (DLBCL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [], "histology_exclusion": ["Acute promyelocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Marginal Zone Lymphoma"}, {"cohort": "", "histology_inclusion": "Small Lymphocytic Lymphoma"}, {"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia", "histology_exclusion": ["Aggressive Non-Hodgkin Lymphoma"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT05148195", "json": [{"cohort": "A", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastasis"], "biomarker_exclusion": []}, {"cohort": "B", "disease_state": "advanced", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastasis", "cholangiocarcinoma", "mixed cell carcinoma", "fibroblastic layer cell carcinoma"], "biomarker_exclusion": []}, {"cohort": "C1", "disease_state": "advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR", "ALK", "ROS1"], "histology_exclusion": ["central nervous system metastasis", "central and cavernous lung squamous cell carcinoma"], "biomarker_exclusion": ["T790M", "osimertinib treatment failure"]}, {"cohort": "C2", "disease_state": "advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR", "ALK", "ROS1"], "histology_exclusion": ["central nervous system metastasis", "central and cavernous lung squamous cell carcinoma"], "biomarker_exclusion": ["T790M", "osimertinib treatment failure"]}, {"cohort": "D", "disease_state": "advanced", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["pMMR", "MSI-L", "MSS"], "histology_exclusion": ["central nervous system metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "A", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "B", "histology_inclusion": "Hepatocellular Carcinoma", "histology_exclusion": ["Cholangiocarcinoma"]}, {"cohort": "C1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Squamous Cell Lung Carcinoma"]}, {"cohort": "C2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Squamous Cell Lung Carcinoma"]}, {"cohort": "D", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT05538572", "json": [{"cohort": "", "disease_state": "advanced, recurrent, or metastatic", "histology_inclusion": "HR+ and HER2-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, recurrent, or metastatic", "histology_inclusion": "HR+ and HER2+ breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, recurrent, or metastatic", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["IDH wild type"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, recurrent, or metastatic", "histology_inclusion": "IDH-mutant astrocytoma", "biomarker_inclusion": ["CDKN2A/B homozygous deleted"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, recurrent, or metastatic", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["KRAS-mutant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, recurrent, or metastatic", "histology_inclusion": "malignant mesothelioma", "biomarker_inclusion": ["CDK pathway alternation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, recurrent, or metastatic", "histology_inclusion": "HPV-negative Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["CDK pathway alternation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, recurrent, or metastatic", "histology_inclusion": "sarcoma", "biomarker_inclusion": ["CDK pathway alternation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, recurrent, or metastatic", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["CDK pathway alternation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Astrocytoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Malignant Mesothelioma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Sarcoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT05538624", "json": [{"cohort": "", "disease_state": "metastatic or unresectable, platinum-resistant", "histology_inclusion": "high-grade serous adenocarcinoma of the ovary", "biomarker_inclusion": [], "histology_exclusion": ["low-grade serous", "mucinous", "clear cell", "endometrioid adenocarcinoma of the ovary", "carcinosarcoma", "mixed histology tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable, platinum-resistant", "histology_inclusion": "high-grade serous adenocarcinoma of the primary peritoneum", "biomarker_inclusion": [], "histology_exclusion": ["low-grade serous", "mucinous", "clear cell", "endometrioid adenocarcinoma of the primary peritoneum", "carcinosarcoma", "mixed histology tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable, platinum-resistant", "histology_inclusion": "high-grade serous adenocarcinoma of the fallopian tube", "biomarker_inclusion": [], "histology_exclusion": ["low-grade serous", "mucinous", "clear cell", "endometrioid adenocarcinoma of the fallopian tube", "carcinosarcoma", "mixed histology tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Serous Adenocarcinoma", "histology_exclusion": ["Carcinosarcoma", "Ovarian Endometrioid Adenocarcinoma"]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "histology_exclusion": ["Carcinosarcoma", "Endometrioid Adenocarcinoma"]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "histology_exclusion": ["Carcinosarcoma", "Fallopian Tube Endometrioid Adenocarcinoma"]}]}
{"NCT_id": "NCT04953104", "json": [{"cohort": "", "disease_state": "metastatic or surgically unresectable", "histology_inclusion": "urothelial cell carcinoma of the urothelial involving the bladder, urethra, ureter, or renal pelvis", "biomarker_inclusion": ["ARID1A mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["ARID1A Mutation", "ARID1A-Mutation", "gene"]]}]}
{"NCT_id": "NCT05278364", "json": [{"cohort": "Phase I Dose-escalation", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["RET alteration (fusion or mutation)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase I Dose-expansion", "disease_state": "advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["RET fusion"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR", "ALK", "ROS1", "KRAS", "selective RET inhibitor"]}, {"cohort": "Phase I Dose-expansion", "disease_state": "advanced", "histology_inclusion": "medullary thyroid cancer", "biomarker_inclusion": ["RET mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR", "ALK", "ROS1", "KRAS", "selective RET inhibitor"]}, {"cohort": "Phase I Dose-expansion", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["RET alteration"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR", "ALK", "ROS1", "KRAS", "selective RET inhibitor"]}, {"cohort": "Phase II", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["RET fusion"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR", "ALK", "ROS1", "KRAS", "selective RET inhibitor"]}], "json_norm": [{"cohort": "Phase I Dose-escalation", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "Phase I Dose-expansion", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"]]}, {"cohort": "Phase I Dose-expansion", "histology_inclusion": "Thyroid Gland Medullary Carcinoma", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "Phase I Dose-expansion", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "Phase II", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"]]}]}
{"NCT_id": "NCT03026062", "json": [{"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "high grade epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastasis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastasis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastasis"], "biomarker_exclusion": []}, {"cohort": "molecularly defined expansion cohort", "disease_state": "recurrent", "histology_inclusion": "uterine serous carcinoma", "biomarker_inclusion": ["nonsynonymous PPP2R1A mutation"], "histology_exclusion": ["brain metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "molecularly defined expansion cohort", "histology_inclusion": "Endometrial Serous Adenocarcinoma", "biomarker_inclusion": [["PPP2R1A Mutation", "PPP2R1A-Mutation", "gene"]]}]}
{"NCT_id": "NCT03091257", "json": [{"cohort": "Dabrafenib", "disease_state": "Relapsed and/or Refractory", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": ["BRAF V600 mutated"], "histology_exclusion": ["Primary amyloidosis (AL)", "Myeloma complicated by amyloidosis", "Nonsecretory multiple myeloma"], "biomarker_exclusion": []}, {"cohort": "Dabrafenib and Trametinib", "disease_state": "Relapsed and/or Refractory", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": ["BRAF V600 mutated"], "histology_exclusion": ["Primary amyloidosis (AL)", "Myeloma complicated by amyloidosis", "Nonsecretory multiple myeloma"], "biomarker_exclusion": []}, {"cohort": "Dabrafenib and Trametinib", "disease_state": "Relapsed and/or Refractory", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": ["BRAF/KRAS mutated"], "histology_exclusion": ["Primary amyloidosis (AL)", "Myeloma complicated by amyloidosis", "Nonsecretory multiple myeloma"], "biomarker_exclusion": []}, {"cohort": "Dabrafenib and Trametinib", "disease_state": "Relapsed and/or Refractory", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": ["BRAF/NRAS mutated"], "histology_exclusion": ["Primary amyloidosis (AL)", "Myeloma complicated by amyloidosis", "Nonsecretory multiple myeloma"], "biomarker_exclusion": []}, {"cohort": "Dabrafenib and Trametinib", "disease_state": "Relapsed and/or Refractory", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": ["BRAF non-V600 mutated"], "histology_exclusion": ["Primary amyloidosis (AL)", "Myeloma complicated by amyloidosis", "Nonsecretory multiple myeloma"], "biomarker_exclusion": []}, {"cohort": "Trametinib", "disease_state": "Relapsed and/or Refractory", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": ["KRAS mutated"], "histology_exclusion": ["Primary amyloidosis (AL)", "Myeloma complicated by amyloidosis", "Nonsecretory multiple myeloma"], "biomarker_exclusion": []}, {"cohort": "Trametinib", "disease_state": "Relapsed and/or Refractory", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": ["NRAS mutated"], "histology_exclusion": ["Primary amyloidosis (AL)", "Myeloma complicated by amyloidosis", "Nonsecretory multiple myeloma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dabrafenib", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Primary Amyloidosis", "Non-Secretory Plasma Cell Myeloma", "Amyloidosis"]}, {"cohort": "Dabrafenib and Trametinib", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Primary Amyloidosis", "Non-Secretory Plasma Cell Myeloma", "Amyloidosis"]}, {"cohort": "Dabrafenib and Trametinib", "histology_inclusion": "Plasma Cell Myeloma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]], "histology_exclusion": ["Primary Amyloidosis", "Non-Secretory Plasma Cell Myeloma", "Amyloidosis"]}, {"cohort": "Dabrafenib and Trametinib", "histology_inclusion": "Plasma Cell Myeloma", "biomarker_inclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"]], "histology_exclusion": ["Primary Amyloidosis", "Non-Secretory Plasma Cell Myeloma", "Amyloidosis"]}, {"cohort": "Dabrafenib and Trametinib", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Primary Amyloidosis", "Non-Secretory Plasma Cell Myeloma", "Amyloidosis"]}, {"cohort": "Trametinib", "histology_inclusion": "Plasma Cell Myeloma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]], "histology_exclusion": ["Primary Amyloidosis", "Non-Secretory Plasma Cell Myeloma", "Amyloidosis"]}, {"cohort": "Trametinib", "histology_inclusion": "Plasma Cell Myeloma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"]], "histology_exclusion": ["Primary Amyloidosis", "Non-Secretory Plasma Cell Myeloma", "Amyloidosis"]}]}
{"NCT_id": "NCT03742895", "json": [{"cohort": "", "disease_state": "advanced (metastatic and/or unresectable) solid tumor (except ovarian cancer with germline or somatic BRCA mutation and breast cancer with germline BRCA mutation)", "histology_inclusion": "", "biomarker_inclusion": ["HRRm", "HRD"], "histology_exclusion": ["primary cancer of unknown origin"], "biomarker_exclusion": []}, {"cohort": "somatic BRCAm breast cancer", "disease_state": "metastatic breast cancer", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["somatic BRCA1 mutation", "somatic BRCA2 mutation"], "histology_exclusion": ["primary cancer of unknown origin"], "biomarker_exclusion": ["germline BRCA1 mutation", "germline BRCA2 mutation"]}], "json_norm": [{"cohort": ""}, {"cohort": "somatic BRCAm breast cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]], "biomarker_exclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04328844", "json": [{"cohort": "Group 1: Cutaneous Melanoma", "disease_state": "advanced or metastatic", "histology_inclusion": "cutaneous and mucosal melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group 2: Uveal Melanoma", "disease_state": "metastatic", "histology_inclusion": "ocular/uveal melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group 4: Mesothelioma", "disease_state": "advanced or metastatic", "histology_inclusion": "mesothelioma (any subtype)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group 7: NHL-FL", "disease_state": "relapsed, refractory, or PD", "histology_inclusion": "Indolent Non-Hodgkin Lymphoma, type Follicular Lymphoma (FL), Grade 1-3A", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group 7: NHL-PTCL", "disease_state": "advanced or metastatic", "histology_inclusion": "Non-Hodgkin Lymphoma, type Peripheral T cell lymphoma (PTCL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group 5: NSCLC 1st line", "disease_state": "locally advanced (primary or recurrent)", "histology_inclusion": "Non-Small Cell Lung Cancer (NSCLC) non-squamous", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["activating EGFR mutations", "ALK or ROS1 translocations/rearrangements"]}], "json_norm": [{"cohort": "Group 1: Cutaneous Melanoma", "histology_inclusion": "Mucosal Melanoma"}, {"cohort": "Group 2: Uveal Melanoma", "histology_inclusion": "Intraocular Melanoma"}, {"cohort": "Group 4: Mesothelioma", "histology_inclusion": "Mesothelioma"}, {"cohort": "Group 7: NHL-FL", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "Group 7: NHL-FL", "histology_inclusion": "Indolent Non-Hodgkin Lymphoma"}, {"cohort": "Group 7: NHL-PTCL", "histology_inclusion": "Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma"}, {"cohort": "Group 7: NHL-PTCL", "histology_inclusion": "Peripheral T-Cell Lymphoma"}, {"cohort": "Group 7: NHL-PTCL", "histology_inclusion": "Non-Hodgkin Lymphoma"}, {"cohort": "Group 5: NSCLC 1st line", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"]]}, {"cohort": "Group 5: NSCLC 1st line", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04198766", "json": [{"cohort": "Part 2 and Part 4", "disease_state": "locally advanced or metastatic, non-resectable", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system tumors", "leptomeningeal disease"], "biomarker_exclusion": ["tumor activating EGFR mutations", "ALK gene rearrangements"]}, {"cohort": "Part 2 and Part 4", "disease_state": "locally advanced or metastatic, non-resectable", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system tumors", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 2 and Part 4", "disease_state": "locally advanced or metastatic, non-resectable", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system tumors", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 2 and Part 4", "disease_state": "locally advanced or metastatic, non-resectable", "histology_inclusion": "gastric cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system tumors", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 2 and Part 4", "disease_state": "locally advanced or metastatic, non-resectable", "histology_inclusion": "renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system tumors", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 2 and Part 4", "disease_state": "locally advanced or metastatic, non-resectable", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system tumors", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Part 4", "disease_state": "locally advanced or metastatic, non-resectable", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["MSI-high", "TMB-high", "MMR-deficient"], "histology_exclusion": ["primary central nervous system tumors", "leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 2 and Part 4", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm"], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Part 2 and Part 4", "histology_inclusion": "Melanoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "Part 2 and Part 4", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "Part 2 and Part 4", "histology_inclusion": "Gastric Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "Part 2 and Part 4", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "Part 2 and Part 4", "histology_inclusion": "Urothelial Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "Part 4", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT04198818", "json": [{"cohort": "Cohort 1", "disease_state": "unresectable/metastatic", "histology_inclusion": "Melanoma", "biomarker_inclusion": ["BRAF V600", "NRAS G13V", "NRAS Q61", "BRAF G469A", "BRAF L485W", "BRAF L597Q", "BRAF T599dup"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "unresectable/metastatic", "histology_inclusion": "Non-Small-Cell Lung Cancer", "biomarker_inclusion": ["BRAF V600", "NRAS G13V", "NRAS Q61", "BRAF G469A", "BRAF L485W", "BRAF L597Q", "BRAF T599dup"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "unresectable/metastatic", "histology_inclusion": "Langerhans Cell Histiocytosis Syndrome (LCH)/ Erdheim-Chester disease (ECD)", "biomarker_inclusion": ["BRAF V600"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 4", "disease_state": "unresectable/metastatic", "histology_inclusion": "Other RAS/RAF/MEK/ERK Mutated Tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF L597Q", "L597Q", "coordinate"], ["NRAS G13V", "G13V", "coordinate"], ["BRAF L485W", "L485W", "coordinate"], ["BRAF G469A", "G469A", "coordinate"], ["BRAF exon 15 indel", "T599dup", "exon"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["BRAF L597Q", "L597Q", "coordinate"], ["NRAS G13V", "G13V", "coordinate"], ["BRAF L485W", "L485W", "coordinate"], ["BRAF G469A", "G469A", "coordinate"], ["BRAF exon 15 indel", "T599dup", "exon"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Langerhans Cell Histiocytosis"}, {"cohort": "Cohort 3", "histology_inclusion": "Erdheim-Chester Disease"}, {"cohort": "Cohort 4", "biomarker_inclusion": [["EPHB2 Mutation", "EPHB2-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["MAPK1 Mutation", "MAPK1-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"]]}, {"cohort": "Cohort 4", "biomarker_inclusion": [["EPHB2 Mutation", "EPHB2-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["MAPK1 Mutation", "MAPK1-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"]]}, {"cohort": "Cohort 4", "biomarker_inclusion": [["EPHB2 Mutation", "EPHB2-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["MAPK1 Mutation", "MAPK1-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"]]}, {"cohort": "Cohort 4", "biomarker_inclusion": [["EPHB2 Mutation", "EPHB2-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["MAPK1 Mutation", "MAPK1-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"]]}, {"cohort": "Cohort 4", "biomarker_inclusion": [["EPHB2 Mutation", "EPHB2-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["MAPK1 Mutation", "MAPK1-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04692740", "json": [{"cohort": "Cohort A", "disease_state": "Stage IV", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": ["gBRCA1 mutation", "gBRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["MMR", "MSI-H", "high TMB"]}, {"cohort": "Cohort B", "disease_state": "Stage IV", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": ["BRCA1 VUS", "BRCA2 VUS"], "histology_exclusion": [], "biomarker_exclusion": ["MMR", "MSI-H", "high TMB"]}, {"cohort": "Cohort C", "disease_state": "Stage IV", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": ["other HRD-associated genetic aberrations"], "histology_exclusion": [], "biomarker_exclusion": ["MMR", "MSI-H", "high TMB"]}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_exclusion": [["TMB", "TMB", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Cohort B", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_exclusion": [["TMB", "TMB", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Cohort C", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"], ["TBCE Mutation", "TBCE-Mutation", "gene"]], "biomarker_exclusion": [["TMB", "TMB", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}]}
{"NCT_id": "NCT05083481", "json": [{"cohort": "All", "disease_state": "locally-advanced (unresectable) or metastatic", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "NSCLC monotherapy expansion", "disease_state": "locally-advanced (unresectable) or metastatic", "histology_inclusion": "non-small cell lung carcinoma", "biomarker_inclusion": ["PD-L1 expression positive (TPS \u2265 50% measured by 22C3 assay)", "no actionable driver mutation (e.g., EGFR, ALK, NTRK)"], "histology_exclusion": [], "biomarker_exclusion": ["prior checkpoint inhibitor as first-line therapy in advanced setting"]}, {"cohort": "Melanoma monotherapy expansion", "disease_state": "locally-advanced (unresectable) or metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "All", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "NSCLC monotherapy expansion", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"]]}, {"cohort": "Melanoma monotherapy expansion", "histology_inclusion": "Melanoma"}]}
{"NCT_id": "NCT05473910", "json": [{"cohort": "TSC-100 Treatment Arm", "disease_state": "", "histology_inclusion": "AML", "biomarker_inclusion": ["HLA-A*0201", "HA1+/-", "HA-1+/+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "TSC-100 Treatment Arm", "disease_state": "", "histology_inclusion": "MDS", "biomarker_inclusion": ["HLA-A*0201", "HA1+/-", "HA-1+/+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "TSC-100 Treatment Arm", "disease_state": "", "histology_inclusion": "ALL", "biomarker_inclusion": ["HLA-A*0201", "HA1+/-", "HA-1+/+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "TSC-101 Treatment Arm", "disease_state": "", "histology_inclusion": "AML", "biomarker_inclusion": ["HA2+/-", "HA-2+/+"], "histology_exclusion": [], "biomarker_exclusion": ["HLA-A*02:07"]}, {"cohort": "TSC-101 Treatment Arm", "disease_state": "", "histology_inclusion": "MDS", "biomarker_inclusion": ["HA2+/-", "HA-2+/+"], "histology_exclusion": [], "biomarker_exclusion": ["HLA-A*02:07"]}, {"cohort": "TSC-101 Treatment Arm", "disease_state": "", "histology_inclusion": "ALL", "biomarker_inclusion": ["HA2+/-", "HA-2+/+"], "histology_exclusion": [], "biomarker_exclusion": ["HLA-A*02:07"]}], "json_norm": [{"cohort": "TSC-100 Treatment Arm", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["ARHGAP45-High", "ARHGAP45-High", "expression"], ["KRT31-High", "KRT31-High", "expression"]]}, {"cohort": "TSC-100 Treatment Arm", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["ARHGAP45-High", "ARHGAP45-High", "expression"], ["KRT31-High", "KRT31-High", "expression"]]}, {"cohort": "TSC-100 Treatment Arm", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["ARHGAP45-High", "ARHGAP45-High", "expression"], ["KRT31-High", "KRT31-High", "expression"]]}, {"cohort": "TSC-101 Treatment Arm", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["MYO1G-High", "MYO1G-High", "expression"], ["KRT32-High", "KRT32-High", "expression"]]}, {"cohort": "TSC-101 Treatment Arm", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["MYO1G-High", "MYO1G-High", "expression"], ["KRT32-High", "KRT32-High", "expression"]]}, {"cohort": "TSC-101 Treatment Arm", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["MYO1G-High", "MYO1G-High", "expression"], ["KRT32-High", "KRT32-High", "expression"]]}]}
{"NCT_id": "NCT02689427", "json": [{"cohort": "", "disease_state": "Stage I-III", "histology_inclusion": "Triple-Negative Breast Cancer", "biomarker_inclusion": ["Androgen Receptor-Positive (AR >= 10%)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["AR-High", "AR-High", "expression"]]}]}
{"NCT_id": "NCT02820116", "json": [{"cohort": "", "disease_state": "IIIA-IIIB", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR exon 19 deletion", "EGFR exon 21 L858 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT03808441", "json": [{"cohort": "", "disease_state": "Stage III un-resectable/ IV", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["BRAF p.V600E", "BRAF p.V600K", "BRAF p.V600R"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["BRAF V600R", "V600R", "coordinate"], ["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}]}
{"NCT_id": "NCT04068831", "json": [{"cohort": "Cohort 1 (Closed to Accrual)", "disease_state": "metastatic", "histology_inclusion": "renal cell carcinoma", "biomarker_inclusion": ["VHL alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1 (Closed to Accrual)", "disease_state": "metastatic", "histology_inclusion": "renal medullary carcinoma", "biomarker_inclusion": ["VHL alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "metastatic", "histology_inclusion": "renal cell carcinoma", "biomarker_inclusion": ["FH expression-loss", "SDH expression-loss"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "metastatic", "histology_inclusion": "renal medullary carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1 (Closed to Accrual)", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [["VHL Mutation", "VHL-Mutation", "gene"]]}, {"cohort": "Cohort 1 (Closed to Accrual)", "histology_inclusion": "Kidney Medullary Carcinoma", "biomarker_inclusion": [["VHL Mutation", "VHL-Mutation", "gene"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [["SDHB-Low", "SDHB-Low", "expression"], ["SARDH-Low", "SARDH-Low", "expression"], ["FH-Low", "FH-Low", "expression"], ["SDS-Low", "SDS-Low", "expression"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Kidney Medullary Carcinoma"}]}
{"NCT_id": "NCT04199104", "json": [{"cohort": "", "disease_state": "Recurrent or Metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["PD-L1"], "histology_exclusion": ["Nasopharynx", "Unknown primary tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT03026517", "json": [{"cohort": "", "disease_state": "stage IV melanoma or stage III melanoma not curable by surgery and progressing", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF V600E mutation", "BRAF V600K mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}]}
{"NCT_id": "NCT03808558", "json": [{"cohort": "TVB-2640", "disease_state": "metastatic or advanced stage, refractory, relapsed", "histology_inclusion": "Non-small Cell Lung Carcinoma", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutation", "ALK gene rearrangement"]}], "json_norm": [{"cohort": "TVB-2640", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04003896", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "biliary tract cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor", "brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor", "brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "ampullary carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor", "brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "gallbladder carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor", "brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Liver Cancer", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Biliary Tract Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Cholangiocarcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Ampulla of Vater Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Gallbladder Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT02896335", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["CDK4 alteration", "CDK6 alteration", "CCND1 alteration", "CCND2 alteration", "CCND3 alteration", "CCNE1 alteration", "CDKN2A loss"], "histology_exclusion": ["leptomeningeal involvement"], "biomarker_exclusion": ["prior CDK4/6 inhibitor treatment"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["CCND1 Mutation", "CCND1-Mutation", "gene"], ["CCND2 Mutation", "CCND2-Mutation", "gene"], ["CDK6 Mutation", "CDK6-Mutation", "gene"], ["CDK4 Mutation", "CDK4-Mutation", "gene"], ["CCNE1 Mutation", "CCNE1-Mutation", "gene"], ["CCND3 Mutation", "CCND3-Mutation", "gene"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]]}]}
{"NCT_id": "NCT04497844", "json": [{"cohort": "", "disease_state": "Metastatic Castration-Sensitive Prostate Cancer", "histology_inclusion": "prostate adenocarcinoma", "biomarker_inclusion": ["deleterious homologous recombination repair (HRR) gene alteration"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with a poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitor", "history or current diagnosis of myelodysplastic syndrome (MDS)/ acute myeloid leukemia (AML)"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}]}
{"NCT_id": "NCT05214183", "json": [{"cohort": "Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma", "disease_state": "Stage II-IV", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["t(11;14)(q13;q32)", "cyclin D1 overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["CCND1-High", "CCND1-High", "expression"]]}]}
{"NCT_id": "NCT02428712", "json": [{"cohort": "Cohort 1", "disease_state": "advanced unresectable", "histology_inclusion": "glioma", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": ["colorectal cancer", "pancreatic cancer"], "biomarker_exclusion": ["RAS-related mutations", "RTK activation"]}, {"cohort": "Cohort 2", "disease_state": "advanced unresectable", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["BRAF non-V600 mutation"], "histology_exclusion": ["colorectal cancer", "pancreatic cancer"], "biomarker_exclusion": ["RAS-related mutations", "RTK activation"]}, {"cohort": "Cohort 3", "disease_state": "advanced unresectable", "histology_inclusion": "glioma", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": ["colorectal cancer", "pancreatic cancer"], "biomarker_exclusion": ["RAS-related mutations", "RTK activation"]}, {"cohort": "Cohort 4", "disease_state": "advanced unresectable", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["BRAF non-V600 mutation"], "histology_exclusion": ["colorectal cancer", "pancreatic cancer"], "biomarker_exclusion": ["RAS-related mutations", "RTK activation"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Glioma", "histology_exclusion": ["Colorectal Carcinoma", "Pancreatic Carcinoma"]}, {"cohort": "Cohort 2", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Colorectal Carcinoma", "Pancreatic Carcinoma"]}, {"cohort": "Cohort 3", "histology_inclusion": "Glioma", "histology_exclusion": ["Colorectal Carcinoma", "Pancreatic Carcinoma"]}, {"cohort": "Cohort 4", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Colorectal Carcinoma", "Pancreatic Carcinoma"]}]}
{"NCT_id": "NCT03157128", "json": [{"cohort": "Phase 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2 Cohort 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["RET gene alteration"], "histology_exclusion": [], "biomarker_exclusion": ["additional known oncogenic driver", "prior treatment with a selective RET inhibitor"]}, {"cohort": "Phase 2 Cohort 2", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["RET gene alteration"], "histology_exclusion": [], "biomarker_exclusion": ["additional known oncogenic driver", "prior treatment with a selective RET inhibitor"]}, {"cohort": "Phase 2 Cohort 5", "disease_state": "", "histology_inclusion": "MCT", "biomarker_inclusion": ["RET gene alteration"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with a selective RET inhibitor"]}, {"cohort": "Phase 2 Cohort 5", "disease_state": "", "histology_inclusion": "MTC syndrome spectrum cancers", "biomarker_inclusion": ["RET gene alteration"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with a selective RET inhibitor"]}, {"cohort": "Phase 2 Cohort 5", "disease_state": "", "histology_inclusion": "cancers with neuroendocrine features/differentiation", "biomarker_inclusion": ["RET gene alteration"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with a selective RET inhibitor"]}, {"cohort": "Phase 2 Cohort 5", "disease_state": "", "histology_inclusion": "poorly differentiated thyroid cancers", "biomarker_inclusion": ["RET gene alteration"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with a selective RET inhibitor"]}, {"cohort": "Phase 2 Cohort 6", "disease_state": "", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["RET gene alteration"], "histology_exclusion": [], "biomarker_exclusion": ["additional known oncogenic driver"]}, {"cohort": "Phase 2 Cohort 7", "disease_state": "", "histology_inclusion": "NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior systemic therapy for NSCLC"]}], "json_norm": [{"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase 2 Cohort 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "Phase 2 Cohort 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "Phase 2 Cohort 5", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "Phase 2 Cohort 5", "histology_inclusion": "Thyroid Gland Medullary Carcinoma", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "Phase 2 Cohort 5", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "Phase 2 Cohort 5", "histology_inclusion": "Poorly Differentiated Thyroid Gland Carcinoma", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "Phase 2 Cohort 6", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "Phase 2 Cohort 7", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04628494", "json": [{"cohort": "", "disease_state": "Relapsed or refractory", "histology_inclusion": "DLBCL, NOS", "biomarker_inclusion": ["CD20-positive"], "histology_exclusion": ["Primary Central Nervous System (CNS) tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed or refractory", "histology_inclusion": "Double-hit DLBCL", "biomarker_inclusion": ["CD20-positive"], "histology_exclusion": ["Primary Central Nervous System (CNS) tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed or refractory", "histology_inclusion": "Triple-hit DLBCL", "biomarker_inclusion": ["CD20-positive"], "histology_exclusion": ["Primary Central Nervous System (CNS) tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed or refractory", "histology_inclusion": "FL Grade 3B", "biomarker_inclusion": ["CD20-positive"], "histology_exclusion": ["Primary Central Nervous System (CNS) tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed or refractory", "histology_inclusion": "T-cell/histiocyte-rich large B-cell lymphoma", "biomarker_inclusion": ["CD20-positive"], "histology_exclusion": ["Primary Central Nervous System (CNS) tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Grade 3b Follicular Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "T-Cell/Histiocyte-Rich Large B-Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]]}]}
{"NCT_id": "NCT03744468", "json": [{"cohort": "Phase 1 Dose Escalation + Phase 2 Safety Lead-In", "disease_state": "advanced, metastatic, unresectable solid tumors", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2 Dose-Expansion HNSCC Cohort 1,4,6 (PD-L1 positive)", "disease_state": "recurrent/metastatic", "histology_inclusion": "head and neck squamous cell cancer", "biomarker_inclusion": ["PD-L1 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2 Dose-Expansion NSCLC Cohort 2,5,7 (PD-L1 positive)", "disease_state": "locally recurrent Stage IIIB, stage IIIC or Stage IV", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["PD-L1 positive"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutation", "BRAF mutation", "ALK fusion", "ROS1 fusion"]}, {"cohort": "Phase 2 Dose-Expansion RCC Cohort 3", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "renal cell carcinoma with a clear cell histology", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1 Dose Escalation + Phase 2 Safety Lead-In", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase 2 Dose-Expansion HNSCC Cohort 1,4,6 (PD-L1 positive)", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"]]}, {"cohort": "Phase 2 Dose-Expansion NSCLC Cohort 2,5,7 (PD-L1 positive)", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"]], "biomarker_exclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Phase 2 Dose-Expansion RCC Cohort 3", "histology_inclusion": "Renal Cell Carcinoma"}]}
{"NCT_id": "NCT03809624", "json": [{"cohort": "Parts 1 and 3 (escalation cohorts)", "disease_state": "locally advanced or metastatic non-resectable solid tumors", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": ["hematologic malignancies"], "biomarker_exclusion": ["prior exposure to 4-1BB agonists"]}, {"cohort": "Part 2 (expansion cohorts)", "disease_state": "locally advanced or metastatic, non-resectable", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["hematologic malignancies"], "biomarker_exclusion": ["prior exposure to 4-1BB agonists"]}, {"cohort": "Part 2 (expansion cohorts)", "disease_state": "locally advanced or metastatic, non-resectable", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": [], "histology_exclusion": ["hematologic malignancies"], "biomarker_exclusion": ["prior exposure to 4-1BB agonists"]}, {"cohort": "Part 2 (expansion cohorts)", "disease_state": "locally advanced or metastatic, non-resectable", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["hematologic malignancies"], "biomarker_exclusion": ["prior exposure to 4-1BB agonists"]}, {"cohort": "Part 4 relapsed or refractory to CPI cohorts", "disease_state": "locally advanced or metastatic, non-resectable", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["PD-L1 positivity by immunohistochemistry (IHC)"], "histology_exclusion": ["hematologic malignancies"], "biomarker_exclusion": ["prior exposure to 4-1BB agonists"]}, {"cohort": "Part 4 relapsed or refractory to CPI cohorts", "disease_state": "locally advanced or metastatic, non-resectable", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["PD-L1 positivity by immunohistochemistry (IHC)"], "histology_exclusion": ["hematologic malignancies"], "biomarker_exclusion": ["prior exposure to 4-1BB agonists"]}, {"cohort": "Part 4 relapsed or refractory to CPI cohorts", "disease_state": "locally advanced or metastatic, non-resectable", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": ["PD-L1 positivity by immunohistochemistry (IHC)"], "histology_exclusion": ["hematologic malignancies"], "biomarker_exclusion": ["prior exposure to 4-1BB agonists"]}, {"cohort": "Part 4 CPI naive cohorts", "disease_state": "locally advanced or metastatic, non-resectable", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["PD-L1 positivity by immunohistochemistry (IHC)"], "histology_exclusion": ["hematologic malignancies"], "biomarker_exclusion": ["prior exposure to 4-1BB agonists"]}, {"cohort": "Part 4 CPI naive cohorts", "disease_state": "locally advanced or metastatic, non-resectable", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": ["PD-L1 positivity by immunohistochemistry (IHC)"], "histology_exclusion": ["hematologic malignancies", "primary central nervous system (CNS) tumors"], "biomarker_exclusion": ["prior exposure to 4-1BB agonists"]}], "json_norm": [{"cohort": "Parts 1 and 3 (escalation cohorts)", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm"]}, {"cohort": "Part 2 (expansion cohorts)", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm"]}, {"cohort": "Part 2 (expansion cohorts)", "histology_inclusion": "Cutaneous Melanoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm"]}, {"cohort": "Part 2 (expansion cohorts)", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm"]}, {"cohort": "Part 4 relapsed or refractory to CPI cohorts", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm"]}, {"cohort": "Part 4 relapsed or refractory to CPI cohorts", "histology_inclusion": "Cutaneous Melanoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm"]}, {"cohort": "Part 4 relapsed or refractory to CPI cohorts", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm"]}, {"cohort": "Part 4 CPI naive cohorts", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm"]}, {"cohort": "Part 4 CPI naive cohorts", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm"]}]}
{"NCT_id": "NCT03223155", "json": [{"cohort": "", "disease_state": "stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["exon 19 deletion or exon 21 L858R EGFR mutation without progression or intolerance to EGFR TKI", "ALK translocation without progression or intolerance to ALK inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT03939897", "json": [{"cohort": "", "disease_state": "stage IV", "histology_inclusion": "ER and/or PR positive, HER2 negative or non-amplified breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}]}
{"NCT_id": "NCT04330625", "json": [{"cohort": "", "disease_state": "locally advanced (not amenable to curative surgery) or metastatic", "histology_inclusion": "invasive breast cancer", "biomarker_inclusion": ["ER+", "PgR+", "HER2-negative", "PIK3CA mutations"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"], ["PGR-High", "PGR-High", "expression"]]}]}
{"NCT_id": "NCT05410418", "json": [{"cohort": "Mosunetuzumab and Polatuzumab Vedotin", "disease_state": "untreated follicular lymphoma grade 1-3A, stage II-IV", "histology_inclusion": "follicular lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["aggressive B cell lymphoma such as diffuse large B cell lymphoma or high-grade B cell lymphoma", "CNS lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Mosunetuzumab and Polatuzumab Vedotin", "histology_inclusion": "Follicular Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Diffuse Large B-Cell Lymphoma", "B-Cell Non-Hodgkin Lymphoma", "High Grade B-Cell Lymphoma", "Primary Central Nervous System Lymphoma"]}]}
{"NCT_id": "NCT05020119", "json": [{"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "gastric cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "esophageal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "liver cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "gastrointestinal stromal tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "biliary tract cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "kidney cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "bladder cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "head and neck cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "nasopharyngeal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "skin cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "malignant sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "cervical cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, refractory", "histology_inclusion": "brain cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "", "histology_inclusion": "Esophageal Carcinoma"}, {"cohort": "", "histology_inclusion": "Liver Cancer"}, {"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor"}, {"cohort": "", "histology_inclusion": "Liver Cancer"}, {"cohort": "", "histology_inclusion": "Biliary Tract Carcinoma"}, {"cohort": "", "histology_inclusion": "Kidney Cancer"}, {"cohort": "", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "", "histology_inclusion": "Malignant Head and Neck Neoplasm"}, {"cohort": "", "histology_inclusion": "Head and Neck Carcinoma"}, {"cohort": "", "histology_inclusion": "Nasopharyngeal Carcinoma"}, {"cohort": "", "histology_inclusion": "Malignant Skin Neoplasm"}, {"cohort": "", "histology_inclusion": "Skin Carcinoma"}, {"cohort": "", "histology_inclusion": "Melanoma"}, {"cohort": "", "histology_inclusion": "Sarcoma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "", "histology_inclusion": "Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Primary Brain Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Brain Neoplasm"}, {"cohort": "", "histology_inclusion": "Brain Tumor"}]}
{"NCT_id": "NCT05215340", "json": [{"cohort": "", "disease_state": "Stage IIIB, IIIC, or IV", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["PD-L1 TPS \u226550%"], "histology_exclusion": ["Central Nervous System metastases"], "biomarker_exclusion": ["EGFR", "ALK", "ROS1", "NTRK", "BRAF", "RET", "MET"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT03093116", "json": [{"cohort": "Phase 1", "disease_state": "locally advanced or metastatic solid tumor (Stage IV)", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["ALK gene rearrangement", "ROS1 gene rearrangement", "NTRK1 gene rearrangement", "NTRK2 gene rearrangement", "NTRK3 gene rearrangement"], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "locally advanced or metastatic solid tumor", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["ROS1 gene fusion", "NTRK1 gene fusion", "NTRK2 gene fusion", "NTRK3 gene fusion"], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK1 Fusion", "NTRK1", "fusion"], ["ROS1 Fusion", "ROS1", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT03810105", "json": [{"cohort": "Castration Sensitive Biochemically Recurrent Prostate Cancer", "disease_state": "Non-Metastatic", "histology_inclusion": "Prostate Cancer", "biomarker_inclusion": ["BRCA1", "BRCA2", "ATM", "CHEK2", "FANCA", "RAD51C", "RAD51D", "PALB2", "BRIP1", "BARD1", "CDK12"], "histology_exclusion": [], "biomarker_exclusion": ["PARP inhibitor"]}], "json_norm": [{"cohort": "Castration Sensitive Biochemically Recurrent Prostate Cancer", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Castration Sensitive Biochemically Recurrent Prostate Cancer", "histology_inclusion": "Prostate Carcinoma"}]}
{"NCT_id": "NCT04759911", "json": [{"cohort": "", "disease_state": "locally advanced primary tumor (T3 or T4) or recurrent/residual invasive/bulky nodal disease", "histology_inclusion": "medullary thyroid carcinoma", "biomarker_inclusion": ["RET gene alteration"], "histology_exclusion": [], "biomarker_exclusion": ["additional validated oncogenic driver"]}, {"cohort": "", "disease_state": "locally advanced primary tumor (T3 or T4) or recurrent/residual invasive/bulky nodal disease", "histology_inclusion": "papillary thyroid carcinoma", "biomarker_inclusion": ["RET gene alteration"], "histology_exclusion": [], "biomarker_exclusion": ["additional validated oncogenic driver"]}, {"cohort": "", "disease_state": "locally advanced primary tumor (T3 or T4) or recurrent/residual invasive/bulky nodal disease", "histology_inclusion": "poorly differentiated thyroid carcinoma", "biomarker_inclusion": ["RET gene alteration"], "histology_exclusion": [], "biomarker_exclusion": ["additional validated oncogenic driver"]}, {"cohort": "", "disease_state": "locally advanced primary tumor (T3 or T4) or recurrent/residual invasive/bulky nodal disease", "histology_inclusion": "anaplastic thyroid carcinoma", "biomarker_inclusion": ["RET gene alteration"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Thyroid Gland Medullary Carcinoma", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Thyroid Gland Papillary Carcinoma", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Poorly Differentiated Thyroid Gland Carcinoma", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Thyroid Gland Undifferentiated (Anaplastic) Carcinoma", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}]}
{"NCT_id": "NCT04890236", "json": [{"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "diffuse large B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}]}
{"NCT_id": "NCT04005690", "json": [{"cohort": "", "disease_state": "resectable, borderline resectable, locally advanced, or metastatic", "histology_inclusion": "adenocarcinoma of the pancreas", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma"}]}
{"NCT_id": "NCT04825288", "json": [{"cohort": "", "disease_state": "metastatic, unresectable, or recurrent", "histology_inclusion": "pancreatic adenocarcinoma of exocrine pancreas", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma"}]}
{"NCT_id": "NCT05020665", "json": [{"cohort": "", "disease_state": "previously untreated", "histology_inclusion": "acute myeloid leukemia (AML)", "biomarker_inclusion": ["Nucleophosmin-1 (NPM1)-mutated"], "histology_exclusion": ["acute promyelocytic leukemia", "central nervous system (CNS) involvement with leukemia"], "biomarker_exclusion": ["FLT3 mutation (either tyrosine kinase domain or internal tandem duplication)"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["NPM1 Mutation", "NPM1-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"], "biomarker_exclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]]}]}
{"NCT_id": "NCT02756897", "json": [{"cohort": "Cohort 1", "disease_state": "Refractory or Relapsed", "histology_inclusion": "Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Untreated", "histology_inclusion": "Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)", "biomarker_inclusion": ["del(17p)", "mutated TP53", "del(11q)", "unmutated IGHV"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Small Lymphocytic Lymphoma"}, {"cohort": "Cohort 1", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "Cohort 2", "histology_inclusion": "Small Lymphocytic Lymphoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT02756962", "json": [{"cohort": "Cohort A: HiDAC", "disease_state": "Intermediate-I or Intermediate-II", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["non-M3 AML", "mutated NPM1 without FLT3-ITD"], "histology_exclusion": ["acute promyelocytic leukemia (APL) with t(15;17)(q22;q12); PML-RARA"], "biomarker_exclusion": ["therapy-related AML", "secondary AML", "Monoallelic CEBPA mutations"]}, {"cohort": "Cohort B: Investigator's choice (HiDAC, AlloSCT)", "disease_state": "Intermediate-I or Intermediate-II", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["non-M3 AML", "mutated NPM1 without FLT3-ITD"], "histology_exclusion": ["acute promyelocytic leukemia (APL) with t(15;17)(q22;q12); PML-RARA"], "biomarker_exclusion": ["therapy-related AML", "secondary AML", "Monoallelic CEBPA mutations"]}], "json_norm": [{"cohort": "Cohort A: HiDAC", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"], "biomarker_exclusion": [["CEBPA Mutation", "CEBPA-Mutation", "gene"], ["PML - RARA", "PML - RARA", "coordinate"]]}, {"cohort": "Cohort B: Investigator's choice (HiDAC, AlloSCT)", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"], "biomarker_exclusion": [["CEBPA Mutation", "CEBPA-Mutation", "gene"], ["PML - RARA", "PML - RARA", "coordinate"]]}]}
{"NCT_id": "NCT03224000", "json": [{"cohort": "", "disease_state": "T1-3, N0-2 (AJCC, 8th ed.)", "histology_inclusion": "squamous cell carcinoma of the oropharynx (tonsil, base of tongue, soft palate, or oropharyngeal walls)", "biomarker_inclusion": ["HPV positive by p16 IHC or ISH"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT03940703", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-small Cell Lung Cancer (NSCLC)", "biomarker_inclusion": ["activating Epidermal Growth Factor Receptor (EGFR) mutation", "MET amplification"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["MET-High", "MET-High", "expression"]]}]}
{"NCT_id": "NCT05215951", "json": [{"cohort": "", "disease_state": "locally advanced (clinical stage IIIB, IIIC) or metastatic NSCLC (clinical stage IVA or IVB) or recurrent NSCLC", "histology_inclusion": "nonsquamous NSCLC", "biomarker_inclusion": ["EGFR G719X", "EGFR L861Q", "EGFR S768I", "EGFR T790M"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR ex19del", "EGFR L858R"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR T790M", "T790M", "coordinate"], ["EGFR S768I", "S768I", "coordinate"], ["EGFR L861Q", "L861Q", "coordinate"]], "biomarker_exclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT03354390", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "clear cell renal cell carcinoma", "biomarker_inclusion": ["HLA-A*11:01 positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}]}
{"NCT_id": "NCT04890613", "json": [{"cohort": "Main Study Cohort", "disease_state": "Advanced", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["BRCA2", "PALB2"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Main Study Cohort", "disease_state": "Advanced", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["BRCA2", "PALB2"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Main Study Cohort", "disease_state": "Advanced", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["BRCA2", "PALB2"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Main Study Cohort", "disease_state": "Advanced", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["BRCA2", "PALB2"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Exploratory Cohort", "disease_state": "Advanced", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["BRCA1"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Exploratory Cohort", "disease_state": "Advanced", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["HRD-associated mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Exploratory Cohort", "disease_state": "Advanced", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": ["BRCA1"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Exploratory Cohort", "disease_state": "Advanced", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": ["HRD-associated mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Exploratory Cohort", "disease_state": "Advanced", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": ["BRCA1"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Exploratory Cohort", "disease_state": "Advanced", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": ["HRD-associated mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Main Study Cohort", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "Main Study Cohort", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Main Study Cohort", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Main Study Cohort", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "Main Study Cohort", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Main Study Cohort", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "Exploratory Cohort", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Exploratory Cohort", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "Exploratory Cohort", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"], ["TBCE Mutation", "TBCE-Mutation", "gene"]]}, {"cohort": "Exploratory Cohort", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"], ["TBCE Mutation", "TBCE-Mutation", "gene"]]}, {"cohort": "Exploratory Cohort", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "Exploratory Cohort", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"], ["TBCE Mutation", "TBCE-Mutation", "gene"]]}, {"cohort": "Exploratory Cohort", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "Exploratory Cohort", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"], ["TBCE Mutation", "TBCE-Mutation", "gene"]]}]}
{"NCT_id": "NCT04955743", "json": [{"cohort": "Cohort 1: Melanoma", "disease_state": "metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["PD-1/PD-L1 experienced"], "histology_exclusion": ["leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Cohort 2: Renal Cell Carcinoma", "disease_state": "metastatic", "histology_inclusion": "renal cell carcinoma", "biomarker_inclusion": ["PD-1/PD-L1 experienced"], "histology_exclusion": ["leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1: Melanoma", "histology_inclusion": "Melanoma"}, {"cohort": "Cohort 2: Renal Cell Carcinoma", "histology_inclusion": "Renal Cell Carcinoma"}]}
{"NCT_id": "NCT03746080", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Glioblastoma with Primitive Neuronal Component", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Malignant Glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Glioblastoma with Oligodendroglial Features", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Glioblastoma with Primitive Neuroectodermal Tumor (PNET) Features", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Gliosarcoma"}, {"cohort": "", "histology_inclusion": "Malignant Glioma"}, {"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Primitive Neuroectodermal Tumor"}, {"cohort": "", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT04695847", "json": [{"cohort": "Part 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumors expressing or likely to expressing EGFR and MUC1", "biomarker_inclusion": ["EGFR", "MUC1"], "histology_exclusion": ["brain metastasis"], "biomarker_exclusion": []}, {"cohort": "Part 2: Cohort A", "disease_state": "metastatic", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR", "MUC1"], "histology_exclusion": ["brain metastasis"], "biomarker_exclusion": []}, {"cohort": "Part 2: Cohort B", "disease_state": "metastatic", "histology_inclusion": "esophageal squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastasis"], "biomarker_exclusion": ["MSI-H"]}], "json_norm": [{"cohort": "Part 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "Part 2: Cohort A", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part 2: Cohort B", "histology_inclusion": "Esophageal Squamous Cell Carcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT05086692", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Clear Cell Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Triple Negative Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer Squamous", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer Non-squamous", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Gastric Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Biliary Tract Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Gallbladder Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Cervical Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Basal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Bladder Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Merkel Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Squamous Cell Carcinoma of Head and Neck", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Cutaneous Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Pleural Mesothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Esophageal Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Solid Tumor, Adult", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma"}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Squamous Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "", "histology_inclusion": "Liver Cancer"}, {"cohort": "", "histology_inclusion": "Biliary Tract Carcinoma"}, {"cohort": "", "histology_inclusion": "Gallbladder Carcinoma"}, {"cohort": "", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "", "histology_inclusion": "Basal Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Experimental Organism Basal Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Skin Basal Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": "", "histology_inclusion": "Merkel Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Skin Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Pleural Malignant Mesothelioma"}, {"cohort": "", "histology_inclusion": "Esophageal Carcinoma"}, {"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT03941626", "json": [{"cohort": "Glioblastoma", "disease_state": "First disease progression or disease recurrence (\u2265 1 cm and \u2264 5 cm) of a supratentorial WHO grade IV malignant glioma (GBM or gliosarcoma)", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["EGFRvIII"], "histology_exclusion": [], "biomarker_exclusion": ["malignant tumor cells with T cell origin"]}, {"cohort": "Liver Cancer", "disease_state": "Untreatable by surgery; Or postoperative recurrence; Or no effective treatment", "histology_inclusion": "Hepatoma", "biomarker_inclusion": ["DR5"], "histology_exclusion": [], "biomarker_exclusion": ["malignant tumor cells with T cell origin"]}, {"cohort": "Liver Cancer", "disease_state": "Untreatable by surgery; Or postoperative recurrence; Or no effective treatment", "histology_inclusion": "Hepatoma", "biomarker_inclusion": ["EGFRvIII"], "histology_exclusion": [], "biomarker_exclusion": ["malignant tumor cells with T cell origin"]}, {"cohort": "Gastric Cancer", "disease_state": "Pathological stage: IIIA\uff5eIV", "histology_inclusion": "Gastric Cancer", "biomarker_inclusion": ["Mesothelin"], "histology_exclusion": [], "biomarker_exclusion": ["malignant tumor cells with T cell origin"]}, {"cohort": "Esophageal Cancer", "disease_state": "Postoperative recurrence or chemoradiotherapy failure", "histology_inclusion": "Esophagus Cancer", "biomarker_inclusion": ["NY-ESO-1", "HLA-A*0201"], "histology_exclusion": [], "biomarker_exclusion": ["malignant tumor cells with T cell origin"]}], "json_norm": [{"cohort": "Glioblastoma", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["EGFR exon 8 indel", "V30_R297delinsG", "exon"]]}, {"cohort": "Liver Cancer"}, {"cohort": "Liver Cancer", "biomarker_inclusion": [["EGFR exon 8 indel", "V30_R297delinsG", "exon"]]}, {"cohort": "Gastric Cancer", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "Esophageal Cancer", "histology_inclusion": "Esophageal Carcinoma"}]}
{"NCT_id": "NCT04267120", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "papillary RCC", "biomarker_inclusion": [], "histology_exclusion": ["predominant clear cell renal cell carcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "chromophobe RCC", "biomarker_inclusion": [], "histology_exclusion": ["predominant clear cell renal cell carcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "TFE-3/B translocation RCC", "biomarker_inclusion": [], "histology_exclusion": ["predominant clear cell renal cell carcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "SDHB-loss RCC", "biomarker_inclusion": [], "histology_exclusion": ["predominant clear cell renal cell carcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "TSC1-loss RCC", "biomarker_inclusion": [], "histology_exclusion": ["predominant clear cell renal cell carcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "sarcomatoid RCC without clear cell component", "biomarker_inclusion": [], "histology_exclusion": ["predominant clear cell renal cell carcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "unclassified RCC", "biomarker_inclusion": [], "histology_exclusion": ["predominant clear cell renal cell carcinoma"], "biomarker_exclusion": ["uncontrolled or untreated brain metastasis"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Clear Cell Renal Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Refractory Cytopenia of Childhood", "histology_exclusion": ["Clear Cell Renal Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Clear Cell Renal Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Refractory Cytopenia of Childhood", "histology_exclusion": ["Clear Cell Renal Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Clear Cell Renal Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Refractory Cytopenia of Childhood", "histology_exclusion": ["Clear Cell Renal Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [["SDHB-Low", "SDHB-Low", "expression"], ["XRCC1-Low", "XRCC1-Low", "expression"]], "histology_exclusion": ["Clear Cell Renal Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [["SDHB-Low", "SDHB-Low", "expression"], ["XRCC1-Low", "XRCC1-Low", "expression"]], "histology_exclusion": ["Clear Cell Renal Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Refractory Cytopenia of Childhood", "biomarker_inclusion": [["SDHB-Low", "SDHB-Low", "expression"], ["XRCC1-Low", "XRCC1-Low", "expression"]], "histology_exclusion": ["Clear Cell Renal Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Refractory Cytopenia of Childhood", "biomarker_inclusion": [["SDHB-Low", "SDHB-Low", "expression"], ["XRCC1-Low", "XRCC1-Low", "expression"]], "histology_exclusion": ["Clear Cell Renal Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [["TSC1-Low", "TSC1-Low", "expression"], ["XRCC1-Low", "XRCC1-Low", "expression"]], "histology_exclusion": ["Clear Cell Renal Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [["TSC1-Low", "TSC1-Low", "expression"], ["XRCC1-Low", "XRCC1-Low", "expression"]], "histology_exclusion": ["Clear Cell Renal Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Refractory Cytopenia of Childhood", "biomarker_inclusion": [["TSC1-Low", "TSC1-Low", "expression"], ["XRCC1-Low", "XRCC1-Low", "expression"]], "histology_exclusion": ["Clear Cell Renal Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Refractory Cytopenia of Childhood", "biomarker_inclusion": [["TSC1-Low", "TSC1-Low", "expression"], ["XRCC1-Low", "XRCC1-Low", "expression"]], "histology_exclusion": ["Clear Cell Renal Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Clear Cell Renal Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Refractory Cytopenia of Childhood", "histology_exclusion": ["Clear Cell Renal Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Clear Cell Renal Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Refractory Cytopenia of Childhood", "histology_exclusion": ["Clear Cell Renal Cell Carcinoma"]}]}
{"NCT_id": "NCT04267146", "json": [{"cohort": "newly diagnosed high-grade glioma", "disease_state": "", "histology_inclusion": "non-brainstem WHO grade III and IV High-grade Glioma", "biomarker_inclusion": [], "histology_exclusion": ["Diffuse midline gliomas with H3K27M mutation", "Anaplastic ganglioglioma", "Anaplastic ple\u00efomorphic astrocytoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "newly diagnosed high-grade glioma", "histology_inclusion": "Malignant Glioma", "biomarker_exclusion": [["H3-3A K28M", "K28M", "coordinate"]], "histology_exclusion": ["Anaplastic Ganglioglioma", "Astrocytoma"]}]}
{"NCT_id": "NCT04696029", "json": [{"cohort": "Cohort 1 - Molecular High Risk", "disease_state": "", "histology_inclusion": "Medulloblastoma", "biomarker_inclusion": ["Metastatic non-MYC amplified Group 3", "Metastatic Group 4", "Metastatic non-WNT/non-SHH (Must be non-MYC amplified)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2 - Molecular Very High Risk", "disease_state": "", "histology_inclusion": "Medulloblastoma", "biomarker_inclusion": ["Metastatic OR MYCN amplified OR TP53 mutant non-infant (>3 yrs) SHH", "MYC amplified Group 3", "Non-WNT, non-SHH infant (< 3 yrs)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3: Relapsed/Refractory Medulloblastoma", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Medulloblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1 - Molecular High Risk", "histology_inclusion": "Medulloblastoma", "biomarker_inclusion": [["MYC-High", "MYC-High", "expression"]]}, {"cohort": "Cohort 2 - Molecular Very High Risk", "histology_inclusion": "Medulloblastoma", "biomarker_inclusion": [["MYCN Mutation", "MYCN-Mutation", "gene"], ["SHH Mutation", "SHH-Mutation", "gene"], ["MYCN-High", "MYCN-High", "expression"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["MYC-High", "MYC-High", "expression"]]}, {"cohort": "Cohort 3: Relapsed/Refractory Medulloblastoma", "histology_inclusion": "Medulloblastoma"}]}
{"NCT_id": "NCT04826341", "json": [{"cohort": "Phase I", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II HRD Cohort", "disease_state": "resistant to PARP inhibitors", "histology_inclusion": "HRD cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation", "ATM mutation", "BRIP1 mutation", "BARD1 mutation", "CDK12 mutation", "CHEK1 mutation", "CHEK2 mutation", "FANCL mutation", "PALB2 mutation", "PPP2R2A mutation", "RAD51B mutation", "RAD51C mutation", "RAD51D mutation", "RAD54L mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II SCLC and EP-SCNC", "disease_state": "recurrent", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II SCLC and EP-SCNC", "disease_state": "recurrent", "histology_inclusion": "extra-pulmonary small cell neuroendocrine cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase I", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase II HRD Cohort", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["CHEK2 Mutation", "CHEK2-Mutation", "gene"], ["CDK12 Mutation", "CDK12-Mutation", "gene"], ["RAD54L Mutation", "RAD54L-Mutation", "gene"], ["RAD51C Mutation", "RAD51C-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["RAD51B Mutation", "RAD51B-Mutation", "gene"], ["BARD1 Mutation", "BARD1-Mutation", "gene"], ["BRIP1 Mutation", "BRIP1-Mutation", "gene"], ["FANCL Mutation", "FANCL-Mutation", "gene"], ["RAD51D Mutation", "RAD51D-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["CHEK1 Mutation", "CHEK1-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["PPP2R2A Mutation", "PPP2R2A-Mutation", "gene"]]}, {"cohort": "Phase II SCLC and EP-SCNC", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Phase II SCLC and EP-SCNC", "histology_inclusion": "Small Cell Carcinoma"}]}
{"NCT_id": "NCT04826393", "json": [{"cohort": "Cohort 1", "disease_state": "Recurrent", "histology_inclusion": "WHO grade IV GBM or its variants", "biomarker_inclusion": [], "histology_exclusion": ["WHO grade III recurrent malignant glioma"], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Recurrent", "histology_inclusion": "WHO grade IV GBM or its variants", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Glioblastoma", "histology_exclusion": ["Malignant Glioma"]}, {"cohort": "Cohort 2", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT04956640", "json": [{"cohort": "", "disease_state": "locally advanced, unresectable, and/or metastatic", "histology_inclusion": "Non-Small-Cell Lung Carcinoma", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": ["central nervous system malignancy", "carcinomatous meningitis"], "biomarker_exclusion": ["prior treatment with any KRAS G12C small molecule inhibitor"]}, {"cohort": "", "disease_state": "locally advanced, unresectable, and/or metastatic", "histology_inclusion": "Colorectal Neoplasms", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": ["central nervous system malignancy", "carcinomatous meningitis"], "biomarker_exclusion": ["prior treatment with any KRAS G12C small molecule inhibitor"]}, {"cohort": "", "disease_state": "locally advanced, unresectable, and/or metastatic", "histology_inclusion": "Endometrial Neoplasms", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": ["central nervous system malignancy", "carcinomatous meningitis"], "biomarker_exclusion": ["prior treatment with any KRAS G12C small molecule inhibitor"]}, {"cohort": "", "disease_state": "locally advanced, unresectable, and/or metastatic", "histology_inclusion": "Ovarian Neoplasms", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": ["central nervous system malignancy", "carcinomatous meningitis"], "biomarker_exclusion": ["prior treatment with any KRAS G12C small molecule inhibitor"]}, {"cohort": "", "disease_state": "locally advanced, unresectable, and/or metastatic", "histology_inclusion": "Pancreatic Neoplasms", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": ["central nervous system malignancy", "carcinomatous meningitis"], "biomarker_exclusion": ["prior treatment with any KRAS G12C small molecule inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT04435691", "json": [{"cohort": "Phase Ib dose finding cohort", "disease_state": "relapsed/refractory AML", "histology_inclusion": "Acute Myeloid Leukemia (excluding acute promyelocytic leukemia [APL])", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II (frontline cohort)", "disease_state": "newly diagnosed AML", "histology_inclusion": "Acute Myeloid Leukemia (excluding acute promyelocytic leukemia [APL])", "biomarker_inclusion": ["poor risk karyotype", "complex karyotype", "TP53 deletions/mutations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase Ib dose finding cohort", "histology_inclusion": "Acute Promyelocytic Leukemia with PML-RARA"}, {"cohort": "Phase Ib dose finding cohort", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "Phase II (frontline cohort)", "histology_inclusion": "Acute Promyelocytic Leukemia with PML-RARA", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Phase II (frontline cohort)", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT04956692", "json": [{"cohort": "", "disease_state": "Stage IV (T any, N any, M1a, M1b, or M1c - American Joint Committee on Cancer 8th Edition)", "histology_inclusion": "squamous non-small cell lung cancer (NSCLC)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage IV (T any, N any, M1a, M1b, or M1c - American Joint Committee on Cancer 8th Edition)", "histology_inclusion": "nonsquamous non-small cell lung cancer (NSCLC)", "biomarker_inclusion": ["EGFR not indicated", "ALK not indicated", "ROS1 not indicated"], "histology_exclusion": ["central nervous system (CNS) metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Squamous Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT05021900", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["HER-2 positive breast cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "histology_exclusion": ["Breast Carcinoma"], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT05347212", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "renal medullary carcinoma", "biomarker_inclusion": ["SMARCB1 negative"], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD1", "anti-PD-L1", "anti-CTLA-4", "anti-LAG-3"]}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "unclassified renal cell carcinoma with medullary phenotype", "biomarker_inclusion": ["SMARCB1 negative"], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD1", "anti-PD-L1", "anti-CTLA-4", "anti-LAG-3"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Kidney Medullary Carcinoma", "biomarker_inclusion": [["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Unclassified Renal Cell Carcinoma", "biomarker_inclusion": [["SMARCB1-Low", "SMARCB1-Low", "expression"]]}]}
{"NCT_id": "NCT05672524", "json": [{"cohort": "Participant with Rectal Adenocarcinoma", "disease_state": "locally advanced", "histology_inclusion": "rectal adenocarcinoma", "biomarker_inclusion": ["HER2 3+ IHC", "HER2 2+ IHC with FISH or CISH amplification", "HER2 (ERBB2) amplification by NGS"], "histology_exclusion": [], "biomarker_exclusion": ["RAS mutation", "dMMR", "MSI"]}], "json_norm": [{"cohort": "Participant with Rectal Adenocarcinoma", "histology_inclusion": "Rectal Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["CISH-High", "CISH-High", "expression"]], "biomarker_exclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["MSI", "MSI", "coordinate"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT03486067", "json": [{"cohort": "", "disease_state": "relapsed and refractory", "histology_inclusion": "multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Plasma Cell Myeloma"}]}
{"NCT_id": "NCT03681535", "json": [{"cohort": "", "disease_state": "stage I-IV", "histology_inclusion": "diffuse large B-cell lymphoma, not otherwise specified (DLBCL NOS)", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system lymphoma", "primary cutaneous DLBCL, leg type", "T-cell/histiocyte-rich large B-cell lymphoma", "primary mediastinal (thymic) large B-cell lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "stage I-IV", "histology_inclusion": "high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system lymphoma", "primary cutaneous DLBCL, leg type", "T-cell/histiocyte-rich large B-cell lymphoma", "primary mediastinal (thymic) large B-cell lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "stage I-IV", "histology_inclusion": "high-grade B-cell lymphoma, NOS", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system lymphoma", "primary cutaneous DLBCL, leg type", "T-cell/histiocyte-rich large B-cell lymphoma", "primary mediastinal (thymic) large B-cell lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma, Not Otherwise Specified", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "T-Cell/Histiocyte-Rich Large B-Cell Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["T-Cell/Histiocyte-Rich Large B-Cell Lymphoma", "Central Nervous System Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "Primary Central Nervous System Lymphoma"]}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"]], "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "T-Cell/Histiocyte-Rich Large B-Cell Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma"]}, {"cohort": "", "histology_inclusion": "High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"]], "histology_exclusion": ["T-Cell/Histiocyte-Rich Large B-Cell Lymphoma", "Central Nervous System Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "Primary Central Nervous System Lymphoma"]}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma, Not Otherwise Specified", "histology_exclusion": ["T-Cell/Histiocyte-Rich Large B-Cell Lymphoma", "Central Nervous System Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "Primary Central Nervous System Lymphoma"]}]}
{"NCT_id": "NCT04072198", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["RAS mutated", "BRAF mutated"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}]}
{"NCT_id": "NCT04566133", "json": [{"cohort": "", "disease_state": "refractory", "histology_inclusion": "biliary tract carcinoma", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory", "histology_inclusion": "intrahepatic cholangiocarcinoma", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory", "histology_inclusion": "extrahepatic cholangiocarcinoma", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory", "histology_inclusion": "gallbladder cancer", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory", "histology_inclusion": "ampullary cancer", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Liver Cancer", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Biliary Tract Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Intrahepatic Cholangiocarcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Gallbladder Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Ampulla of Vater Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT05152147", "json": [{"cohort": "", "disease_state": "unresectable locally advanced, recurrent or metastatic", "histology_inclusion": "gastroesophageal adenocarcinoma", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": ["central nervous system metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable locally advanced, recurrent or metastatic", "histology_inclusion": "esophageal adenocarcinoma", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": ["central nervous system metastases", "leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT05737706", "json": [{"cohort": "Phase 1/2", "disease_state": "Unresectable or metastatic", "histology_inclusion": "Solid tumor malignancy", "biomarker_inclusion": ["KRAS G12D mutation"], "histology_exclusion": ["Active brain metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1/2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"]]}]}
{"NCT_id": "NCT04892017", "json": [{"cohort": "Dose Escalation Phase (Part 1)", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["RAS mutation", "NF1 mutation", "RAF mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Escalation Phase (Part 1, Cohort D)", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Phase (Part 2, Cohort 1)", "disease_state": "advanced or metastatic", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Phase (Part 2, Cohort 2)", "disease_state": "advanced or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS mutation", "NRAS mutation", "NF1 mutation", "BRAF mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Phase (Part 2, Cohort 3)", "disease_state": "advanced or metastatic", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["KRAS mutation", "NRAS mutation", "NF1 mutation", "BRAF mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Phase (Part 2, Cohort 4)", "disease_state": "advanced or metastatic", "histology_inclusion": "Melanoma", "biomarker_inclusion": ["NRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior MEK inhibitor therapy"]}, {"cohort": "Dose Expansion Phase (Part 2, Cohort 5)", "disease_state": "advanced or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior sotorasib therapy", "prior KRAS G12C inhibitor therapy"]}], "json_norm": [{"cohort": "Dose Escalation Phase (Part 1)", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NF1 Mutation", "NF1-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"]]}, {"cohort": "Dose Escalation Phase (Part 1, Cohort D)", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "Dose Expansion Phase (Part 2, Cohort 1)", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "Dose Expansion Phase (Part 2, Cohort 2)", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["NF1 Mutation", "NF1-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "Dose Expansion Phase (Part 2, Cohort 3)", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["NF1 Mutation", "NF1-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "Dose Expansion Phase (Part 2, Cohort 4)", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"]]}, {"cohort": "Dose Expansion Phase (Part 2, Cohort 5)", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT05217446", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal carcinoma", "biomarker_inclusion": ["MSI-H", "dMMR", "BRAF V600E"], "histology_exclusion": ["RAS mutant colorectal adenocarcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal carcinoma", "biomarker_inclusion": ["MSI-H", "dMMR", "BRAF V600E"], "histology_exclusion": ["colorectal adenocarcinoma with unknown RAS mutation status"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal carcinoma", "biomarker_inclusion": ["MSI-H", "dMMR", "BRAF V600E"], "histology_exclusion": ["active central nervous system metastases", "carcinomatous meningitis", "leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Colorectal Adenocarcinoma"], "biomarker_exclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Colorectal Adenocarcinoma"]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT03095248", "json": [{"cohort": "Stratum 2: other NF2 related tumors (meningiomas and ependymoma)", "disease_state": "", "histology_inclusion": "Neurofibromatosis 2", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 2: other NF2 related tumors (meningiomas and ependymoma)", "disease_state": "", "histology_inclusion": "Vestibular Schwannoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 2: other NF2 related tumors (meningiomas and ependymoma)", "disease_state": "", "histology_inclusion": "Meningioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 2: other NF2 related tumors (meningiomas and ependymoma)", "disease_state": "", "histology_inclusion": "Ependymoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 2: other NF2 related tumors (meningiomas and ependymoma)", "disease_state": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Stratum 2: other NF2 related tumors (meningiomas and ependymoma)"}, {"cohort": "Stratum 2: other NF2 related tumors (meningiomas and ependymoma)", "histology_inclusion": "Acoustic Schwannoma"}, {"cohort": "Stratum 2: other NF2 related tumors (meningiomas and ependymoma)", "histology_inclusion": "Meningioma"}, {"cohort": "Stratum 2: other NF2 related tumors (meningiomas and ependymoma)", "histology_inclusion": "Ependymoma"}, {"cohort": "Stratum 2: other NF2 related tumors (meningiomas and ependymoma)", "histology_inclusion": "Glioma"}]}
{"NCT_id": "NCT04267848", "json": [{"cohort": "", "disease_state": "stage IIA, IIB IIIA or IIIB", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR exon 19 deletion", "EGFR L858 R mutation", "ALK rearrangement"]}, {"cohort": "", "disease_state": "stage IIA, IIB IIIA or IIIB", "histology_inclusion": "non-small cell lung cancer (squamous)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR L858R", "L858R", "coordinate"], ["ALK Fusion", "ALK", "fusion"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04696731", "json": [{"cohort": "ALLO-647, ALLO-316", "disease_state": "Advanced/Metastatic", "histology_inclusion": "renal cell carcinoma with a predominant clear cell component", "biomarker_inclusion": [], "histology_exclusion": ["Central nervous system (CNS) metastatic disease (unless controlled and stable for at least 4 weeks)", "leptomeningeal disease", "cord compression"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "ALLO-647, ALLO-316", "histology_inclusion": "Renal Cell Carcinoma"}]}
{"NCT_id": "NCT04761744", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colon cancer", "biomarker_inclusion": ["DDR gene alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "stomach cancer", "biomarker_inclusion": ["DDR gene alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "biliary tract cancer", "biomarker_inclusion": ["DDR gene alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["DDR gene alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "bladder cancer", "biomarker_inclusion": ["DDR gene alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "upper urinary tract cancer", "biomarker_inclusion": ["DDR gene alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["DDR gene alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["DDR gene alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["DDR gene alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "other cancers", "biomarker_inclusion": ["DDR gene alteration"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Liver Cancer", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Biliary Tract Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Bladder Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Bladder Neoplasm", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Renal Pelvis and Ureter Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}]}
{"NCT_id": "NCT04957290", "json": [{"cohort": "Part 2: Arm 1: Patients with mCRPC (RP2D NOX66)", "disease_state": "metastatic castration-resistant", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2: Arm 2: Patients with BC or NSCLC (RP2D NOX66)", "disease_state": "", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["estrogen receptors/progesterone receptors", "estrogen receptors alone"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2: Arm 2: Patients with BC or NSCLC (RP2D NOX66)", "disease_state": "", "histology_inclusion": "non-small-cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "metastatic", "histology_inclusion": "any other solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 2: Arm 1: Patients with mCRPC (RP2D NOX66)", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Part 2: Arm 1: Patients with mCRPC (RP2D NOX66)", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Part 2: Arm 2: Patients with BC or NSCLC (RP2D NOX66)", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "Part 2: Arm 2: Patients with BC or NSCLC (RP2D NOX66)", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part 1", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT02628067", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "Anal Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Biliary Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Ampulla of Vater cancers"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Neuroendocrine Tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["sarcomas", "mesenchymal tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Cervical Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Vulvar Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Small Cell Lung Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Mesothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Thyroid Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Salivary Gland Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["sarcomas", "mesenchymal tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Any advanced solid tumor", "biomarker_inclusion": ["MSI-H"], "histology_exclusion": ["colorectal carcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Any advanced solid tumor", "biomarker_inclusion": ["dMMR", "MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": ["dMMR", "MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Pembrolizumab 400 mg", "disease_state": "advanced", "histology_inclusion": "Any advanced solid tumor", "biomarker_inclusion": ["TMB-H"], "histology_exclusion": [], "biomarker_exclusion": ["dMMR", "MSI-H"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Anal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "histology_exclusion": ["Ampulla of Vater Carcinoma"]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Carcinoma"}, {"cohort": "", "histology_inclusion": "Lung Neuroendocrine Neoplasm"}, {"cohort": "", "histology_inclusion": "Neuroendocrine Tumor"}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "histology_exclusion": ["Sarcoma"]}, {"cohort": "", "histology_inclusion": "Cervical Squamous Cell Carcinoma, Not Otherwise Specified"}, {"cohort": "", "histology_inclusion": "Cervical Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Vulvar Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Mesothelioma"}, {"cohort": "", "histology_inclusion": "Thyroid Gland Carcinoma"}, {"cohort": "", "histology_inclusion": "Malignant Salivary Gland Neoplasm", "histology_exclusion": ["Sarcoma"]}, {"cohort": "", "histology_inclusion": "Salivary Gland Carcinoma", "histology_exclusion": ["Sarcoma"]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Colorectal Carcinoma"]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Pembrolizumab 400 mg", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TMB-High", "TMB-High", "coordinate"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT03616782", "json": [{"cohort": "Ixazomib", "disease_state": "Stage II, III, or IV", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["cyclin D1", "t(11;14) translocation"], "histology_exclusion": ["Central Nervous System involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Ixazomib", "histology_inclusion": "Mantle Cell Lymphoma"}]}
{"NCT_id": "NCT04892173", "json": [{"cohort": "", "disease_state": "Locally Advanced", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["HPV p16"], "histology_exclusion": ["SCC originating in the nasopharynx or paranasal sinus", "SCC from the salivary gland", "SCC from the thyroid gland", "non-squamous histology (e.g., melanoma or neuroendocrine carcinoma)", "SCC of unknown primary origin"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Squamous Cell Carcinoma", "Melanoma", "Neuroendocrine Carcinoma", "Neuroendocrine Tumor"]}]}
{"NCT_id": "NCT05608044", "json": [{"cohort": "", "disease_state": "refractory metastatic", "histology_inclusion": "colorectal cancer adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H", "dMMR"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT02693535", "json": [{"cohort": "Group 3 (ALK, ROS1, MET)", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "", "biomarker_inclusion": ["ALK fusion", "ALK mutation", "ROS1 fusion", "MET amplification", "MET mutation", "MET exon 14 alteration", "RON amplification", "RON mutation"], "histology_exclusion": ["primary brain tumors", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Group 4 (CDKN2A, CDK4, CDK6)", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "", "biomarker_inclusion": ["CDKN2A loss", "CDKN2A mutation", "CDK4 amplification", "CDK6 amplification"], "histology_exclusion": ["primary brain tumors", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Group 5 (CSF1R,PDGFR,VEGFR)", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "", "biomarker_inclusion": ["CSF1R", "PDGFR", "VEGFR1", "VEGFR2", "VEGFR3", "KIT", "FLT-3", "RET", "FGFR1", "FGFR2", "FGFR3", "VHL"], "histology_exclusion": ["primary brain tumors", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Group 6 (mTOR, TSC)", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "", "biomarker_inclusion": ["mTOR", "TSC1", "TSC2", "AKT1"], "histology_exclusion": ["primary brain tumors", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Group 8 (ERBB2)", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "", "biomarker_inclusion": ["ERBB2 amplification", "ERBB2 overexpression", "specific ERBB2 mutations"], "histology_exclusion": ["primary brain tumors", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Group 9 (BRAF V600E/D/K/R)", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "", "biomarker_inclusion": ["BRAF V600E", "BRAF V600D", "BRAF V600K", "BRAF V600R"], "histology_exclusion": ["primary brain tumors", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Group 13 (RET,VEGFR1/2/3,KIT,PDGFR\u03b2,RAF-1,BRAF)", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "", "biomarker_inclusion": ["RET", "VEGFR1", "VEGFR2", "VEGFR3", "KIT", "PDGFR\u03b2", "RAF-1", "BRAF"], "histology_exclusion": ["primary brain tumors", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Group 14 (BRCA1/2; ATM)", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "", "biomarker_inclusion": ["germline BRCA1/2", "somatic BRCA1/2", "ATM mutations", "ATM deletions"], "histology_exclusion": ["primary brain tumors", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Group 15 (POLE, POLD1)", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "", "biomarker_inclusion": ["specific POLE mutations", "specific POLD1 mutations"], "histology_exclusion": ["primary brain tumors", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Group 16 (MSI-H, high mutational load and others)", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "", "biomarker_inclusion": ["MSI high status", "high tumor mutational burden", "MLH1", "MSH2", "MSH6", "PMS2", "EPCAM", "specific POLE mutations", "specific POLD1 mutations", "BRCA1/2", "ATM", "MSH3", "PMS1", "MLH3", "EXO1", "RFC1", "RFC2", "RFC3", "RFC4", "RFC5", "PCNA", "RPA1", "RPA2", "RPA3", "RPA4", "SSBP1"], "histology_exclusion": ["primary brain tumors", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Group 17 (CDKN2A, CDK4, CDK6)", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "", "biomarker_inclusion": ["CDKN2A loss", "CDKN2A mutation", "CDK4 amplification", "CDK6 amplification"], "histology_exclusion": ["primary brain tumors", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Group 18 (NRG1)", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "", "biomarker_inclusion": ["NRG1 fusions"], "histology_exclusion": ["primary brain tumors", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Group 19 (BRCA1/2, PALB2)", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "", "biomarker_inclusion": ["germline BRCA1/2", "somatic BRCA1/2", "PALB2 mutations"], "histology_exclusion": ["primary brain tumors", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Group 20 (ERBB2)", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "", "biomarker_inclusion": ["ERBB2 amplification", "ERBB2 overexpression"], "histology_exclusion": ["primary brain tumors", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Group 21 (BRCA1/2, PALB2, ATM, and others)", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "", "biomarker_inclusion": ["germline BRCA1/2", "somatic BRCA1/2", "PALB2", "ATM", "ATR", "CHEK2", "FANCA", "RAD51C", "NBN", "MLH1", "MRE11A", "CDK12", "Myriad MyChoice CDx test", "FoundationOne CDx test"], "histology_exclusion": ["primary brain tumors", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Group 22 (ROS1 fusion)", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "", "biomarker_inclusion": ["ROS1 fusion"], "histology_exclusion": ["primary brain tumors", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Group 23 (NTRK amplification)", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "", "biomarker_inclusion": ["NTRK1 amplification", "NTRK2 amplification", "NTRK3 amplification"], "histology_exclusion": ["primary brain tumors", "leptomeningeal metastases"], "biomarker_exclusion": []}, {"cohort": "Group 24 (ERBB2)", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "", "biomarker_inclusion": ["ERBB2 amplification", "ERBB2 overexpression", "specific ERBB2 mutations"], "histology_exclusion": ["primary brain tumors", "leptomeningeal metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Group 3 (ALK, ROS1, MET)", "biomarker_inclusion": [["MST1R-High", "MST1R-High", "expression"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["MET Mutation", "MET-Mutation", "gene"], ["MST1R Mutation", "MST1R-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"], ["SLTM Mutation", "SLTM-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 4 (CDKN2A, CDK4, CDK6)", "biomarker_inclusion": [["CDKN2A Mutation", "CDKN2A-Mutation", "gene"], ["CDK4-High", "CDK4-High", "expression"], ["CDK6-High", "CDK6-High", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 5 (CSF1R,PDGFR,VEGFR)", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 6 (mTOR, TSC)", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 8 (ERBB2)", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 9 (BRAF V600E/D/K/R)", "biomarker_inclusion": [["BRAF V600R", "V600R", "coordinate"], ["BRAF V600E", "V600E", "coordinate"], ["BRAF V600D", "V600D", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 13 (RET,VEGFR1/2/3,KIT,PDGFR\u03b2,RAF-1,BRAF)", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 14 (BRCA1/2; ATM)", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 15 (POLE, POLD1)", "biomarker_inclusion": [["POLE Mutation", "POLE-Mutation", "gene"], ["POLD1 Mutation", "POLD1-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 16 (MSI-H, high mutational load and others)", "biomarker_inclusion": [["TMB-High", "TMB-High", "coordinate"], ["POLE Mutation", "POLE-Mutation", "gene"], ["TMB", "TMB", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["POLD1 Mutation", "POLD1-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 17 (CDKN2A, CDK4, CDK6)", "biomarker_inclusion": [["CDKN2A Mutation", "CDKN2A-Mutation", "gene"], ["CDK4-High", "CDK4-High", "expression"], ["CDK6-High", "CDK6-High", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 18 (NRG1)", "biomarker_inclusion": [["NRG1 Fusion", "NRG1", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 19 (BRCA1/2, PALB2)", "biomarker_inclusion": [["PALB2 Mutation", "PALB2-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 20 (ERBB2)", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 21 (BRCA1/2, PALB2, ATM, and others)", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 22 (ROS1 fusion)", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 23 (NTRK amplification)", "biomarker_inclusion": [["NTRK1-High", "NTRK1-High", "expression"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 24 (ERBB2)", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT03747120", "json": [{"cohort": "", "disease_state": "non-metastatic", "histology_inclusion": "invasive HER2-positive breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1", "anti-PD-L2", "CTLA-4", "OX 40", "CD137"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04631744", "json": [{"cohort": "Cabozantinib Arm", "disease_state": "metastatic castrate resistant prostate cancer", "histology_inclusion": "prostate carcinoma", "biomarker_inclusion": ["MET amplification or activating mutation", "KIT amplification or activating mutation", "RET amplification or activating mutation", "VEGFR-1 amplification or activating mutation", "VEGFR-2 amplification or activating mutation", "VEGFR-3 amplification or activating mutation", "FLT3 amplification or activating mutation", "AXL amplification or activating mutation", "TRKB amplification or activating mutation", "TIE2 amplification or activating mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with cabozantinib"]}], "json_norm": [{"cohort": "Cabozantinib Arm", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["SLTM Mutation", "SLTM-Mutation", "gene"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["MET Mutation", "MET-Mutation", "gene"], ["KIT Mutation", "KIT-Mutation", "gene"], ["KIT-High", "KIT-High", "expression"], ["RET Mutation", "RET-Mutation", "gene"], ["RET-High", "RET-High", "expression"], ["KDR-High", "KDR-High", "expression"], ["KDR Mutation", "KDR-Mutation", "gene"], ["KDR-High", "KDR-High", "expression"], ["KDR Mutation", "KDR-Mutation", "gene"], ["FLT4-High", "FLT4-High", "expression"], ["FLT4 Mutation", "FLT4-Mutation", "gene"], ["FLT3 Mutation", "FLT3-Mutation", "gene"], ["FLT3-High", "FLT3-High", "expression"], ["AXL-High", "AXL-High", "expression"], ["AXL Mutation", "AXL-Mutation", "gene"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK2 Mutation", "NTRK2-Mutation", "gene"], ["TEK Mutation", "TEK-Mutation", "gene"], ["TEK-High", "TEK-High", "expression"]]}, {"cohort": "Cabozantinib Arm", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["KIT-High", "KIT-High", "expression"], ["NTRK2-High", "NTRK2-High", "expression"], ["TEK-High", "TEK-High", "expression"], ["TEK Mutation", "TEK-Mutation", "gene"], ["AXL Mutation", "AXL-Mutation", "gene"], ["SLTM Mutation", "SLTM-Mutation", "gene"], ["FLT3-High", "FLT3-High", "expression"], ["FLT4-High", "FLT4-High", "expression"], ["NTRK2 Mutation", "NTRK2-Mutation", "gene"], ["FLT4 Mutation", "FLT4-Mutation", "gene"], ["RET Mutation", "RET-Mutation", "gene"], ["KDR Mutation", "KDR-Mutation", "gene"], ["FLT3 Mutation", "FLT3-Mutation", "gene"], ["AXL-High", "AXL-High", "expression"], ["RET-High", "RET-High", "expression"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["MET Mutation", "MET-Mutation", "gene"], ["KDR-High", "KDR-High", "expression"], ["KIT Mutation", "KIT-Mutation", "gene"]]}]}
{"NCT_id": "NCT04631835", "json": [{"cohort": "HS-10352", "disease_state": "locally advanced or metastatic", "histology_inclusion": "HR+ HER2- breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "HS-10352", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "HS-10352", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "HS-10352", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "HS-10352", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT04762069", "json": [{"cohort": "", "disease_state": "Recurrent", "histology_inclusion": "Glioblastoma Multiforme", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["IDH mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT01582191", "json": [{"cohort": "", "disease_state": "advanced or metastatic cancer that is refractory to standard therapy, relapsed after standard therapy, or who have no standard therapy available that improves survival by at least three months", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}]}
{"NCT_id": "NCT03095612", "json": [{"cohort": "Selinexor Monotherapy and in Combination with Docetaxel", "disease_state": "advanced", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["KRAS mutation (codons 12, 13, or 61)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Selinexor Monotherapy and in Combination with Docetaxel", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT03356223", "json": [{"cohort": "", "disease_state": "locally advanced/metastatic", "histology_inclusion": "head and neck squamous cell carcinoma (HNSCC)", "biomarker_inclusion": ["CDKN2A homozygous deletion"], "histology_exclusion": ["nasopharynx cancer"], "biomarker_exclusion": ["HPV positive", "RB1 deletion/losses more than single copy"]}, {"cohort": "", "disease_state": "locally advanced/metastatic", "histology_inclusion": "head and neck squamous cell carcinoma (HNSCC)", "biomarker_inclusion": ["CCND1 amplification"], "histology_exclusion": ["nasopharynx cancer"], "biomarker_exclusion": ["HPV positive", "RB1 deletion/losses more than single copy"]}, {"cohort": "", "disease_state": "locally advanced/metastatic", "histology_inclusion": "head and neck squamous cell carcinoma (HNSCC)", "biomarker_inclusion": ["CDK6 amplification"], "histology_exclusion": ["nasopharynx cancer"], "biomarker_exclusion": ["HPV positive", "RB1 deletion/losses more than single copy"]}, {"cohort": "", "disease_state": "locally advanced/metastatic", "histology_inclusion": "head and neck squamous cell carcinoma (HNSCC)", "biomarker_inclusion": ["CDK4 amplification"], "histology_exclusion": ["nasopharynx cancer"], "biomarker_exclusion": ["HPV positive", "RB1 deletion/losses more than single copy"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Nasopharyngeal Carcinoma"]}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["CCND1-High", "CCND1-High", "expression"]], "histology_exclusion": ["Nasopharyngeal Carcinoma"]}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["CDK6-High", "CDK6-High", "expression"]], "histology_exclusion": ["Nasopharyngeal Carcinoma"]}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["CDK4-High", "CDK4-High", "expression"]], "histology_exclusion": ["Nasopharyngeal Carcinoma"]}]}
{"NCT_id": "NCT03942653", "json": [{"cohort": "", "disease_state": "locally advanced, recurrent, or metastatic", "histology_inclusion": "androgen receptor-positive salivary gland carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent", "prior androgen deprivation therapy"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Salivary Gland Neoplasm", "biomarker_inclusion": [["AR-High", "AR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Salivary Gland Carcinoma", "biomarker_inclusion": [["AR-High", "AR-High", "expression"]]}]}
{"NCT_id": "NCT04072900", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": [], "histology_exclusion": ["uveal melanoma", "mucosal melanoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Cutaneous Melanoma", "histology_exclusion": ["Mucosal Melanoma", "Intraocular Melanoma"]}]}
{"NCT_id": "NCT04762160", "json": [{"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Follicular Lymphoma Grade 1 to 3a", "biomarker_inclusion": [], "histology_exclusion": ["Grade 2b", "mixed histology", "transformed FL"], "biomarker_exclusion": ["Prior exposure to Tazemetostat or other inhibitor(s) of EZH2"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Follicular Lymphoma"}]}
{"NCT_id": "NCT04762199", "json": [{"cohort": "Dose Escalation Cohort", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Cohort A (Treatment naive)", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR TKI treatment"]}, {"cohort": "Dose Expansion Cohort B (EGFR TKI resistant)", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation", "EGFR-T790M negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Backfill Cohort C", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": ["untreated brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Escalation Cohort", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Dose Expansion Cohort A (Treatment naive)", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Dose Expansion Cohort B (EGFR TKI resistant)", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR T790M", "T790M", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR-Low", "EGFR-Low", "expression"]]}, {"cohort": "Backfill Cohort C", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04762225", "json": [{"cohort": "", "disease_state": "relapsed/refractory, metastatic or locally advanced", "histology_inclusion": "Malignant melanoma", "biomarker_inclusion": ["PRAME positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory, metastatic or locally advanced", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["HPV-16 E6/E7 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory, metastatic or locally advanced", "histology_inclusion": "Cervical Cancer", "biomarker_inclusion": ["HPV-16 E6/E7 positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["PRAME-High", "PRAME-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Cervical Carcinoma"}]}
{"NCT_id": "NCT04957615", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["ARID1A mutation", "CXCL13 expression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ARID1A Mutation", "ARID1A-Mutation", "gene"]]}]}
{"NCT_id": "NCT03682289", "json": [{"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Renal cell carcinoma with predominant clear cell histology", "biomarker_inclusion": [], "histology_exclusion": ["clear cell ovarian cancer", "endometrial cancer"], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["clear cell ovarian cancer", "endometrial cancer"], "biomarker_exclusion": []}, {"cohort": "Cohort C", "disease_state": "locally advanced or metastatic", "histology_inclusion": "All pancreatic cancers", "biomarker_inclusion": [], "histology_exclusion": ["clear cell ovarian cancer", "endometrial cancer"], "biomarker_exclusion": []}, {"cohort": "Cohort D", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Other solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["clear cell ovarian cancer", "endometrial cancer"], "biomarker_exclusion": []}, {"cohort": "Cohort E", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Endometrial and ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["clear cell ovarian cancer"], "biomarker_exclusion": []}, {"cohort": "ATM Loss Subgroup", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Metastatic castration resistant prostate cancer", "biomarker_inclusion": ["ATM loss"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "ATM Loss Subgroup", "disease_state": "locally advanced or metastatic", "histology_inclusion": "All other solid tumor malignancies", "biomarker_inclusion": ["ATM loss"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "ATM Endometrial Cancer Cohort", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Endometrial cancer", "biomarker_inclusion": ["pathogenic ARID1A alteration", "microsatellite stable"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Ovarian Clear Cell Tumor", "Endometrial Carcinoma"]}, {"cohort": "Cohort B", "histology_inclusion": "Urothelial Carcinoma", "histology_exclusion": ["Ovarian Clear Cell Tumor", "Endometrial Carcinoma"]}, {"cohort": "Cohort C", "histology_inclusion": "Pancreatic Carcinoma", "histology_exclusion": ["Ovarian Clear Cell Tumor", "Endometrial Carcinoma"]}, {"cohort": "Cohort D", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Ovarian Clear Cell Tumor", "Endometrial Carcinoma"]}, {"cohort": "Cohort E", "histology_inclusion": "Ovarian Epithelial Cancer", "histology_exclusion": ["Ovarian Clear Cell Tumor"]}, {"cohort": "Cohort E", "histology_inclusion": "Malignant Ovarian Neoplasm", "histology_exclusion": ["Ovarian Clear Cell Tumor"]}, {"cohort": "ATM Loss Subgroup", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["ATM-Low", "ATM-Low", "expression"]]}, {"cohort": "ATM Loss Subgroup", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["ATM-Low", "ATM-Low", "expression"]]}, {"cohort": "ATM Loss Subgroup", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ATM-Low", "ATM-Low", "expression"]]}, {"cohort": "ATM Endometrial Cancer Cohort", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["ARID1A Mutation", "ARID1A-Mutation", "gene"], ["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT03747484", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "Merkel cell polyomavirus (MCPyV)-associated Merkel cell carcinoma (VP-MCC)", "biomarker_inclusion": [], "histology_exclusion": ["untreated brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Merkel Cell Carcinoma", "biomarker_inclusion": [["PPOX - MCC", "PPOX - MCC", "coordinate"]]}]}
{"NCT_id": "NCT04008030", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["MSI-H", "dMMR"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04566952", "json": [{"cohort": "", "disease_state": "Platinum-sensitive recurrent", "histology_inclusion": "FIGO III/IV ovarian cancer, fallopian tube cancer, or primary peritoneal cancer; high-grade serous or endometrioid histology", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma"}]}
{"NCT_id": "NCT04827576", "json": [{"cohort": "Safety Run-in Cohort 1", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Safety Run-in Cohort 1", "disease_state": "metastatic", "histology_inclusion": "urothelial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Safety Run-in Cohort 1", "disease_state": "metastatic", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2 Cohort 1a", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR", "ROS1", "ALK", "NTRK", "MET exon 14"]}, {"cohort": "Phase 2 Cohort 1b", "disease_state": "metastatic", "histology_inclusion": "urothelial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2 Cohort 1c", "disease_state": "metastatic", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Safety Run-in Cohort 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Safety Run-in Cohort 1", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "Safety Run-in Cohort 1", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Phase 2 Cohort 1a", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Phase 2 Cohort 1b", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "Phase 2 Cohort 1c", "histology_inclusion": "Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT02824458", "json": [{"cohort": "", "disease_state": "stage IIIB (unsuitable for radiotherapy) or IV or recurrent", "histology_inclusion": "non-squamous non-small-cell lung cancer", "biomarker_inclusion": ["EGFR mutation (Example 19 del and L858R)"], "histology_exclusion": ["squamous cell carcinoma", "adenosquamous carcinoma", "undifferentiated carcinoma", "small cell lung cancer", "small cell and non-small cell mixed lung cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"]], "histology_exclusion": ["Cervical Adenosquamous Carcinoma", "Pancreatic Undifferentiated Carcinoma", "Squamous Cell Carcinoma", "Pancreatic Adenosquamous Carcinoma", "Lung Carcinoma", "Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT03486873", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["active central nervous system metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "hematologic malignancies", "biomarker_inclusion": [], "histology_exclusion": ["active central nervous system metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Hematopoietic and Lymphoid Cell Neoplasm"}]}
{"NCT_id": "NCT04892693", "json": [{"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment PARP inhibitor"]}, {"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["HRR genes mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment PARP inhibitor"]}, {"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["HRD detected through RAD51 foci formation functional assay"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment PARP inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma"}]}
{"NCT_id": "NCT05088070", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["c-Met abnormalities"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MET Mutation", "MET-Mutation", "gene"], ["SLTM Mutation", "SLTM-Mutation", "gene"]]}]}
{"NCT_id": "NCT01371630", "json": [{"cohort": "", "disease_state": "previously untreated", "histology_inclusion": "pre-B ALL", "biomarker_inclusion": ["Philadelphia chromosome negative", "Philadelphia chromosome positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "first remission", "histology_inclusion": "pre-B ALL", "biomarker_inclusion": ["Philadelphia chromosome negative", "Philadelphia chromosome positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory-relapsed", "histology_inclusion": "ALL", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory-relapsed", "histology_inclusion": "Burkitt lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory-relapsed", "histology_inclusion": "Burkitt-like lymphoma with 11q aberration", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory-relapsed", "histology_inclusion": "high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory-relapsed", "histology_inclusion": "high-grade B-cell lymphoma not otherwise specified", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Burkitt Lymphoma"}, {"cohort": "", "histology_inclusion": "MYC-Negative B-Cell Lymphoma with 11q Aberration Resembling Burkitt Lymphoma"}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"]]}, {"cohort": "", "histology_inclusion": "High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"]]}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma"}]}
{"NCT_id": "NCT03096054", "json": [{"cohort": "", "disease_state": "advanced or metastatic, refractory", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic, refractory", "histology_inclusion": "High Grade Serous Ovarian Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic, refractory", "histology_inclusion": "Non Small-cell Lung Cancer (Squamous Cell Variant)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic, refractory", "histology_inclusion": "Squamous Carcinoma of the Oesophagus", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic, refractory", "histology_inclusion": "Squamous Carcinoma of the Head and Neck (HPV Negative)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic, refractory", "histology_inclusion": "Urothelial Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic, refractory", "histology_inclusion": "Breast Cancer (Triple Negative Type)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic, refractory", "histology_inclusion": "Pancreatic Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Serous Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["SGCG-Low", "SGCG-Low", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["SGCG-Low", "SGCG-Low", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma"}]}
{"NCT_id": "NCT03291444", "json": [{"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": ["CD19", "CD20", "CD22", "CD10", "CD33", "CD38", "CD56", "CD117", "CD123", "CD34", "Muc1", "EPS8", "WT1"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": ["CD19", "CD20", "CD22", "CD10", "CD33", "CD38", "CD56", "CD117", "CD123", "CD34", "Muc1", "EPS8", "WT1"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Refractory Anemia with Excess Blasts (RAEB)", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": ["CD19", "CD20", "CD22", "CD10", "CD33", "CD38", "CD56", "CD117", "CD123", "CD34", "Muc1", "EPS8", "WT1"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}]}
{"NCT_id": "NCT03943043", "json": [{"cohort": "", "disease_state": "advanced (unresectable or metastatic)", "histology_inclusion": "biliary tract cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced (unresectable or metastatic)", "histology_inclusion": "gallbladder cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced (unresectable or metastatic)", "histology_inclusion": "cancer of the extrahepatic bile duct", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced (unresectable or metastatic)", "histology_inclusion": "intrahepatic cholangiocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced (unresectable or metastatic)", "histology_inclusion": "ampullary carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Liver Cancer"}, {"cohort": "", "histology_inclusion": "Biliary Tract Carcinoma"}, {"cohort": "", "histology_inclusion": "Gallbladder Carcinoma"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Intrahepatic Cholangiocarcinoma"}, {"cohort": "", "histology_inclusion": "Ampulla of Vater Carcinoma"}]}
{"NCT_id": "NCT04138381", "json": [{"cohort": "", "disease_state": "metastatic and/or unresectable", "histology_inclusion": "GIST", "biomarker_inclusion": ["KIT mutation", "PDGFRA mutation"], "histology_exclusion": ["brain or central nervous system metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["PDGFRA Mutation", "PDGFRA-Mutation", "gene"], ["KIT Mutation", "KIT-Mutation", "gene"]]}]}
{"NCT_id": "NCT04268550", "json": [{"cohort": "", "disease_state": "Stage IV or Recurrent", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["RET fusion-positive"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR sensitizing mutations", "EGFR T790M", "ALK gene fusion", "ROS1 gene fusion", "KRAS activating mutation", "BRAF V600E mutation", "MET exon 14 skipping mutation or high-level amplification and expression"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"], ["RET-High", "RET-High", "expression"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"], ["ALK Fusion", "ALK", "fusion"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["MET exon 14 del", "exon 14 del", "exon"], ["EGFR T790M", "T790M", "coordinate"], ["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT04762602", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "solid malignancy", "biomarker_inclusion": ["IDH mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT03878095", "json": [{"cohort": "", "disease_state": "progressed", "histology_inclusion": "solid malignant tumor", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": ["cholangiocarcinoma", "primary central nervous system tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Neoplasm", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]], "histology_exclusion": ["Cholangiocarcinoma", "Primary Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT03943173", "json": [{"cohort": "", "disease_state": "Stage III or IV", "histology_inclusion": "High-grade epithelial non-mucinous ovarian, primary peritoneal, or fallopian tube cancer", "biomarker_inclusion": ["BRCA pathway mutations"], "histology_exclusion": ["Mucinous or low grade epithelial carcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]], "histology_exclusion": ["Epithelial Neoplasm"]}]}
{"NCT_id": "NCT04892953", "json": [{"cohort": "Cohort A", "disease_state": "Stage III", "histology_inclusion": "NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR sensitizing mutations", "ALK fusion", "ROS1 rearrangements", "RET fusions", "MET exon 14 skipping mutations"]}, {"cohort": "Cohort B", "disease_state": "Stage III", "histology_inclusion": "NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR sensitizing mutations", "ALK fusion", "ROS1 rearrangements", "RET fusions", "MET exon 14 skipping mutations"]}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["RET Fusion", "RET", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"], ["MET exon 14 del", "exon 14 del", "exon"], ["ROS1 Fusion", "ROS1", "fusion"]]}, {"cohort": "Cohort B", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["RET Fusion", "RET", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"], ["MET exon 14 del", "exon 14 del", "exon"], ["ROS1 Fusion", "ROS1", "fusion"]]}]}
{"NCT_id": "NCT05088356", "json": [{"cohort": "", "disease_state": "complete remission (CR) or CR with incomplete hematologic recovery (CRi) or beyond first complete remission (CR1) without the presence of minimal residual disease", "histology_inclusion": "Acute myeloid, lymphoid, or mixed phenotype leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "not in morphologic CR with bone marrow infiltration by leukemic blasts of \u226410%", "histology_inclusion": "Acute myeloid, leukemia, or mixed phenotype leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "in morphologic CR with evidence of minimal residual disease positivity by either multiparametric flow cytometric analysis or by a nucleic acid-based technique", "histology_inclusion": "Acute myeloid, leukemia, or mixed phenotype leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "primary refractory", "histology_inclusion": "Acute myeloid, lymphoid, or mixed phenotype leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "accelerated, blast or second chronic phase", "histology_inclusion": "Chronic myelogenous leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Myelodysplastic syndromes", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "transplant-eligible", "histology_inclusion": "Myelofibrosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Myeloproliferative syndromes", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Blastic plasmacytoid dendritic cell neoplasm", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "poor risk features not suitable for autologous HCT", "histology_inclusion": "Non-Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}, {"cohort": "", "histology_inclusion": "Myeloid Leukemia"}, {"cohort": "", "histology_inclusion": "Myeloid Leukemia"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Myelofibrosis"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Blastic Plasmacytoid Dendritic Cell Neoplasm"}, {"cohort": "", "histology_inclusion": "Non-Hodgkin Lymphoma"}]}
{"NCT_id": "NCT05153330", "json": [{"cohort": "Cohort 1", "disease_state": "Refractory or relapsed", "histology_inclusion": "Acute leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Acute promyelocytic leukemia (APL)", "chronic myeloid leukemia (CML) in blast crisis", "Central Nervous System (CNS) leukemia"], "biomarker_exclusion": ["Prior menin inhibitor therapy"]}, {"cohort": "Cohort 2", "disease_state": "Previously treated", "histology_inclusion": "Diffuse Large B-cell Lymphoma (DLBCL)", "biomarker_inclusion": [], "histology_exclusion": ["Primary mediastinal B-cell lymphoma (PMBCL)", "DLBCL transformed from diseases other than indolent non-Hodgkin's Lymphoma (NHL)", "Active CNS lymphoma", "meningeal involvement"], "biomarker_exclusion": ["Prior menin inhibitor therapy"]}, {"cohort": "Cohort 3", "disease_state": "Measurable", "histology_inclusion": "Multiple Myeloma (MM)", "biomarker_inclusion": [], "histology_exclusion": ["Active plasma cell leukemia", "myeloma with amyloidosis", "systemic light chain amyloidosis", "Active CNS MM"], "biomarker_exclusion": ["Prior menin inhibitor therapy"]}, {"cohort": "Cohort 4", "disease_state": "Previously treated", "histology_inclusion": "Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)", "biomarker_inclusion": [], "histology_exclusion": ["Known or suspected history of Richter's transformation", "Active CNS leukemia"], "biomarker_exclusion": ["Prior menin inhibitor therapy"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Acute Leukemia", "histology_exclusion": ["Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Cohort 2", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Diffuse Large B-Cell Lymphoma", "Non-Hodgkin Lymphoma", "Primary Central Nervous System Lymphoma", "Indolent Non-Hodgkin Lymphoma"]}, {"cohort": "Cohort 3", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Plasma Cell Leukemia", "Amyloidosis"]}, {"cohort": "Cohort 4", "histology_inclusion": "Small Lymphocytic Lymphoma", "histology_exclusion": ["Richter Syndrome", "Central Nervous System Leukemia"]}, {"cohort": "Cohort 4", "histology_inclusion": "Chronic Lymphocytic Leukemia", "histology_exclusion": ["Richter Syndrome", "Central Nervous System Leukemia"]}]}
{"NCT_id": "NCT05153408", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR Ex19Del", "EGFR L858R"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR T790M", "EGFR exon 20 insertions", "KRAS", "BRAF V600E", "NTRK1/2/3", "HER2", "ALK", "ROS1", "MET", "RET"]}, {"cohort": "Part 2A", "disease_state": "metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR C797X"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR T790M", "EGFR exon 20 insertions", "KRAS", "BRAF V600E", "NTRK1/2/3", "HER2", "ALK", "ROS1", "MET", "RET"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]], "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"], ["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "Part 2A", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"], ["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT05218408", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "IDH1 wild-type glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT05348577", "json": [{"cohort": "", "disease_state": "metastatic castration resistant", "histology_inclusion": "prostate adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["neuroendocrine", "small cell cancers"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "histology_exclusion": ["Small Cell Carcinoma"]}]}
{"NCT_id": "NCT02965950", "json": [{"cohort": "TP53 mutated, LABC", "disease_state": "Locally Advanced Breast Cancer", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["TP53 mutated"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "TP53 mutated, MBC, first line", "disease_state": "Metastatic Breast Cancer", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["TP53 mutated"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "TP53 wt, LABC", "disease_state": "Locally Advanced Breast Cancer", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["TP53 wt"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "TP53 wt, MBC", "disease_state": "Metastatic Breast Cancer", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["TP53 wt"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "TP53 mutated, MBC", "disease_state": "Metastatic Breast Cancer", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["TP53 mutated"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "TP53 mutated, LABC", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "TP53 mutated, MBC, first line", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "TP53 wt, LABC", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "TP53 wt, MBC", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "TP53 mutated, MBC", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT03356782", "json": [{"cohort": "", "disease_state": "Stage \u2162, \u2163 or recurrent", "histology_inclusion": "Sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS sarcoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Sarcoma", "histology_exclusion": ["Central Nervous System Sarcoma"]}]}
{"NCT_id": "NCT04567420", "json": [{"cohort": "", "disease_state": "Stage II or III", "histology_inclusion": "HER2 negative, ER positive invasive breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["HER2 positive", "triple negative synchronous breast cancer"], "biomarker_exclusion": ["PR positive but ER negative"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-High", "PGR-High", "expression"]], "histology_exclusion": ["Breast Carcinoma"]}, {"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["PRH2-High", "PRH2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-High", "PGR-High", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["TMEM37-High", "TMEM37-High", "expression"]], "histology_exclusion": ["Breast Carcinoma"]}]}
{"NCT_id": "NCT04958226", "json": [{"cohort": "", "disease_state": "locally advanced inoperable or metastatic", "histology_inclusion": "solid tumours", "biomarker_inclusion": [], "histology_exclusion": ["spinal cord compression", "brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT05218499", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic, unresectable, progressive or recurrent", "histology_inclusion": "dedifferentiated liposarcoma", "biomarker_inclusion": ["MDM2 positive"], "histology_exclusion": [], "biomarker_exclusion": ["TP53 mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Dedifferentiated Liposarcoma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"]], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT01910610", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the colon and/or rectal", "biomarker_inclusion": ["Wild-type RAS", "no mutation in exon 2 [codon 12/13], exon 3 [codon 59/61] and exon 4 [codon 117/146] of both KRAS and NRAS genes"], "histology_exclusion": ["Exclusive bone metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT02824952", "json": [{"cohort": "", "disease_state": "Stage IIIA/B", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutation", "T790M"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR TKI-resistant EGFR mutations (e.g., insertion in exon 20)"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04502394", "json": [{"cohort": "Cohort 1 (R/R DLBCL)", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": ["TP53wt"], "histology_exclusion": [], "biomarker_exclusion": ["MDM2 inhibitor", "BTK inhibitor"]}, {"cohort": "Cohort 2 (R/R CLL)", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": ["TP53wt"], "histology_exclusion": [], "biomarker_exclusion": ["MDM2 inhibitor", "BTK inhibitor"]}], "json_norm": [{"cohort": "Cohort 1 (R/R DLBCL)", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "Cohort 2 (R/R CLL)", "histology_inclusion": "Chronic Lymphocytic Leukemia"}]}
{"NCT_id": "NCT04502407", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "HPV Positive Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": ["p16-positive"], "histology_exclusion": [], "biomarker_exclusion": ["AJCC 8th edition pT4", "cN3 disease"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}]}
{"NCT_id": "NCT04762979", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "Hormone Receptor Positive Breast Carcinoma", "biomarker_inclusion": ["HER2-negative", "PIK3CA mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["PGR-High", "PGR-High", "expression"]]}]}
{"NCT_id": "NCT04958434", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "metastatic", "histology_inclusion": "HPV+ malignancies", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part B"}]}
{"NCT_id": "NCT05023486", "json": [{"cohort": "NP-G2-044 Monotherapy", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "NP-G2-044 Monotherapy Expansion", "disease_state": "advanced or metastatic", "histology_inclusion": "gynecologic malignancy", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "NP-G2-044 Monotherapy Expansion", "disease_state": "advanced or metastatic", "histology_inclusion": "triple-negative breast cancer", "biomarker_inclusion": ["EGFR-high (2+ or 3+ staining per DAKO criteria or genomic sequencing data showing 3 or more copies of the EGFR gene)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "NP-G2-044 Combination Therapy", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": [], "histology_exclusion": ["untreated brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "NP-G2-044 Monotherapy", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "NP-G2-044 Monotherapy Expansion", "histology_inclusion": "Malignant Female Reproductive System Neoplasm"}, {"cohort": "NP-G2-044 Monotherapy Expansion", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "NP-G2-044 Combination Therapy", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04008797", "json": [{"cohort": "HCC", "disease_state": "unresectable", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["fibrolamellar", "sarcomatoid", "mixed cholangio-HCC"], "biomarker_exclusion": []}, {"cohort": "ST (except for HCC)", "disease_state": "", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["hepatocellular carcinoma"], "biomarker_exclusion": []}, {"cohort": "CRC", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "EC", "disease_state": "", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "HCC", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "ST (except for HCC)", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Hepatocellular Carcinoma"]}, {"cohort": "CRC", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "EC", "histology_inclusion": "Endometrial Carcinoma"}]}
{"NCT_id": "NCT04502602", "json": [{"cohort": "Phase 1", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS tumor", "prostate tumor"], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "platinum-resistant", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["BRCA germline mutation"]}], "json_norm": [{"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm", "Prostate Neoplasm", "Prostate Carcinoma"]}, {"cohort": "Phase 1b", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_exclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "Phase 1b", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_exclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04958486", "json": [{"cohort": "", "disease_state": "recurrent or residual", "histology_inclusion": "ependymoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ependymoma"}]}
{"NCT_id": "NCT05023655", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["ARID1A mutation"], "histology_exclusion": ["epithelioid sarcoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ARID1A Mutation", "ARID1A-Mutation", "gene"]], "histology_exclusion": ["Epithelioid Sarcoma"]}]}
{"NCT_id": "NCT03878524", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable locally-advanced", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, relapsed, or refractory", "histology_inclusion": "hematological malignancy", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Hematopoietic and Lymphoid Cell Neoplasm"}]}
{"NCT_id": "NCT04632992", "json": [{"cohort": "Arm A: Entrectinib", "disease_state": "advanced unresectable or metastatic solid malignancy", "histology_inclusion": "", "biomarker_inclusion": ["ROS1 gene fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B: Inavolisib", "disease_state": "advanced unresectable or metastatic solid malignancy", "histology_inclusion": "", "biomarker_inclusion": ["PI3KCA activating mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm C: Alectinib", "disease_state": "advanced unresectable or metastatic solid malignancy", "histology_inclusion": "", "biomarker_inclusion": ["ALK rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm D: Ipatasertib", "disease_state": "advanced unresectable or metastatic solid malignancy", "histology_inclusion": "", "biomarker_inclusion": ["AKT1/2/3 activating mutation"], "histology_exclusion": [], "biomarker_exclusion": ["PTEN loss/loss of function"]}, {"cohort": "Arm E: Atezolizumab + Investigator's Choice of Chemotherapy", "disease_state": "advanced unresectable or metastatic solid malignancy", "histology_inclusion": "", "biomarker_inclusion": ["TMB high"], "histology_exclusion": [], "biomarker_exclusion": ["MSI high", "dMMR"]}, {"cohort": "Arm F: Trastuzumab Emtansine + Atezolizumab", "disease_state": "advanced unresectable or metastatic solid malignancy", "histology_inclusion": "", "biomarker_inclusion": ["ERBB2 mutations", "ERBB2 amplification"], "histology_exclusion": [], "biomarker_exclusion": ["TMB high", "MSI high", "dMMR"]}, {"cohort": "Arm J: Trastuzumab Emtansine + Atezolizumab", "disease_state": "advanced unresectable or metastatic solid malignancy", "histology_inclusion": "", "biomarker_inclusion": ["ERBB2 mutation", "ERBB2 amplification", "TMB high"], "histology_exclusion": [], "biomarker_exclusion": ["MSI high", "dMMR"]}, {"cohort": "Arm K: Ipatasertib + Atezolizumab", "disease_state": "advanced unresectable or metastatic solid malignancy", "histology_inclusion": "", "biomarker_inclusion": ["PI3KCA activating mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm L: Ipatasertib + Atezolizumab", "disease_state": "advanced unresectable or metastatic solid malignancy", "histology_inclusion": "", "biomarker_inclusion": ["AKT1/2/3 activating mutation"], "histology_exclusion": [], "biomarker_exclusion": ["PTEN loss/loss of function"]}, {"cohort": "Arm M: Ipatasertib + Paclitaxel", "disease_state": "advanced unresectable or metastatic solid malignancy", "histology_inclusion": "", "biomarker_inclusion": ["PI3KCA activating mutations", "AKT1/2/3 activating mutation"], "histology_exclusion": [], "biomarker_exclusion": ["PTEN loss/loss of function"]}, {"cohort": "Arm N: Atezolizumab + Tiragolumab", "disease_state": "advanced unresectable or metastatic solid malignancy", "histology_inclusion": "", "biomarker_inclusion": ["TMB high"], "histology_exclusion": [], "biomarker_exclusion": ["MSI high", "dMMR"]}, {"cohort": "Arm O: Pralsetinib", "disease_state": "advanced unresectable or metastatic solid malignancy", "histology_inclusion": "", "biomarker_inclusion": ["RET fusion"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm A: Entrectinib", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"]]}, {"cohort": "Arm B: Inavolisib"}, {"cohort": "Arm C: Alectinib", "biomarker_inclusion": [["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Arm D: Ipatasertib", "biomarker_inclusion": [["AKT1 Mutation", "AKT1-Mutation", "gene"]], "biomarker_exclusion": [["PTEN-Low", "PTEN-Low", "expression"]]}, {"cohort": "Arm E: Atezolizumab + Investigator's Choice of Chemotherapy", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Arm F: Trastuzumab Emtansine + Atezolizumab", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]], "biomarker_exclusion": [["TMB", "TMB", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Arm J: Trastuzumab Emtansine + Atezolizumab", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Arm K: Ipatasertib + Atezolizumab"}, {"cohort": "Arm L: Ipatasertib + Atezolizumab", "biomarker_inclusion": [["AKT1 Mutation", "AKT1-Mutation", "gene"]], "biomarker_exclusion": [["PTEN-Low", "PTEN-Low", "expression"]]}, {"cohort": "Arm M: Ipatasertib + Paclitaxel", "biomarker_inclusion": [["AKT1 Mutation", "AKT1-Mutation", "gene"]], "biomarker_exclusion": [["PTEN-Low", "PTEN-Low", "expression"]]}, {"cohort": "Arm N: Atezolizumab + Tiragolumab", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Arm O: Pralsetinib", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"]]}]}
{"NCT_id": "NCT04828486", "json": [{"cohort": "", "disease_state": "Advanced or Metastatic BCLC Stage A, B, or C", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": ["FGF19 positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [["FGF19-High", "FGF19-High", "expression"]]}]}
{"NCT_id": "NCT03422679", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": ["NOTCH1-4 activating mutation"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "ER+/- breast cancer", "biomarker_inclusion": ["NOTCH1-4 activating mutation"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "HER2+/- breast cancer", "biomarker_inclusion": ["NOTCH1-4 activating mutation"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "resistant to oxaliplatin or irinotecan-based therapy", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["NOTCH1-4 activating mutation"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "osteosarcoma", "biomarker_inclusion": ["NOTCH1-4 activating mutation"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "adenoid cystic carcinoma", "biomarker_inclusion": ["NOTCH1-4 activating mutation"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "malignant glomus tumour", "biomarker_inclusion": ["NOTCH1-4 activating mutation"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "T-cell acute lymphoblastic leukaemia", "biomarker_inclusion": ["NOTCH pathway activation"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "T-cell lymphoblastic lymphoma", "biomarker_inclusion": ["NOTCH pathway activation"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["NOTCH1 Mutation", "NOTCH1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["EREG-High", "EREG-High", "expression"], ["NOTCH1 Mutation", "NOTCH1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["NOTCH1 Mutation", "NOTCH1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["NOTCH1 Mutation", "NOTCH1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Osteosarcoma", "biomarker_inclusion": [["NOTCH1 Mutation", "NOTCH1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Adenoid Cystic Carcinoma", "biomarker_inclusion": [["NOTCH1 Mutation", "NOTCH1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Malignant Glomus Tumor", "biomarker_inclusion": [["NOTCH1 Mutation", "NOTCH1-Mutation", "gene"]]}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Lymphoblastic Lymphoma"}]}
{"NCT_id": "NCT03553004", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the exocrine pancreas", "biomarker_inclusion": ["germline or somatic mutation in genes involved in DNA repair"], "histology_exclusion": [], "biomarker_exclusion": ["known history of myelodysplastic syndrome (MDS)", "acute myeloid leukemia (AML)"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}]}
{"NCT_id": "NCT03878719", "json": [{"cohort": "", "disease_state": "Unresectable or Metastatic", "histology_inclusion": "cutaneous melanoma or unknown primary melanoma American Joint Committee on Cancer Stage IIIB, IIIC, or IV", "biomarker_inclusion": ["BRAF V600E", "BRAF V600K"], "histology_exclusion": ["uveal melanoma", "mucosal melanoma"], "biomarker_exclusion": ["BRAF\u02b7\u036d", "indeterminate melanoma"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]], "histology_exclusion": ["Intraocular Melanoma", "Mucosal Melanoma"]}, {"cohort": "", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]], "histology_exclusion": ["Mucosal Melanoma", "Intraocular Melanoma"]}]}
{"NCT_id": "NCT04633122", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "Gastrointestinal Stromal Tumor (GIST)", "biomarker_inclusion": ["KIT mutation", "PDGFRA mutation"], "histology_exclusion": ["active central nervous system metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["PDGFRA Mutation", "PDGFRA-Mutation", "gene"], ["KIT Mutation", "KIT-Mutation", "gene"]]}]}
{"NCT_id": "NCT04958811", "json": [{"cohort": "A", "disease_state": "advanced", "histology_inclusion": "non-squamous non-small-cell lung cancer", "biomarker_inclusion": ["PD-L1 TPS \u2265 1%", "EGFR wild-type", "ALK wild-type", "ROS1 wild-type"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "B", "disease_state": "advanced", "histology_inclusion": "non-squamous non-small-cell lung cancer", "biomarker_inclusion": ["EGFR activating alteration"], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD(L)1 therapeutic antibodies"]}], "json_norm": [{"cohort": "A", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["ROS1 ROS1-wild_type", "ROS1-wild_type", "wild_type"], ["ALK ALK-wild_type", "ALK-wild_type", "wild_type"], ["ROS 1 ROS 1-wild_type", "ROS 1-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "B", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT03031730", "json": [{"cohort": "", "disease_state": "relapsed and/or refractory multiple myeloma", "histology_inclusion": "multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["TP53 mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Plasma Cell Myeloma", "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT03683433", "json": [{"cohort": "", "disease_state": "Recurrent or Refractory Acute Myeloid Leukemia", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH2 gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Recurrent or Refractory Acute Myeloid Leukemia", "histology_inclusion": "Biphenotypic Leukemia", "biomarker_inclusion": ["IDH2 gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Recurrent or Refractory Acute Myeloid Leukemia", "histology_inclusion": "Bilineage Leukemia", "biomarker_inclusion": ["IDH2 gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Newly Diagnosed Acute Myeloid Leukemia", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH2 gene mutation", "Age > 60 years"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Acute Myeloid Leukemia with prior history of Myelodysplastic Syndrome", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH2 gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Acute Myeloid Leukemia with prior history of Chronic Myelomonocytic Leukemia", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH2 gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04372706", "json": [{"cohort": "Part 2: RTX-240 Solid Tumor Expansion", "disease_state": "relapsed/refractory or locally advanced", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system malignancy"], "biomarker_exclusion": []}, {"cohort": "Part 2: RTX-240 Solid Tumor Expansion", "disease_state": "relapsed/refractory or locally advanced", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system malignancy"], "biomarker_exclusion": []}, {"cohort": "Part 2: RTX-240 Solid Tumor Expansion", "disease_state": "relapsed/refractory or locally advanced", "histology_inclusion": "anal cancers", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system malignancy"], "biomarker_exclusion": []}, {"cohort": "Part 4: RTX-240 Plus Pembrolizumab Dose Escalation", "disease_state": "relapsed/refractory or locally advanced", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system malignancy"], "biomarker_exclusion": []}, {"cohort": "Part 4: RTX-240 Plus Pembrolizumab Dose Escalation", "disease_state": "relapsed/refractory or locally advanced", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 2: RTX-240 Solid Tumor Expansion", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "Part 2: RTX-240 Solid Tumor Expansion", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "Part 2: RTX-240 Solid Tumor Expansion", "histology_inclusion": "Anal Neoplasm", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "Part 2: RTX-240 Solid Tumor Expansion", "histology_inclusion": "Anal Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "Part 4: RTX-240 Plus Pembrolizumab Dose Escalation", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "Part 4: RTX-240 Plus Pembrolizumab Dose Escalation", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT04633278", "json": [{"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["PD-L1 CPS \u2265 1"], "histology_exclusion": ["Nasopharynx"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT05544552", "json": [{"cohort": "Phase 1 Part A and Part B", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1 Part B", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["FGFR3 gene mutation", "FGFR3 gene fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "locally advanced/metastatic", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": ["FGFR3 gene mutation", "FGFR3 gene rearrangement", "resistance mutation", "kinase domain mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior FGFR inhibitor"]}, {"cohort": "Phase 2", "disease_state": "locally advanced/metastatic", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": ["FGFR3 gene mutation", "FGFR3 gene rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "locally advanced/metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["FGFR3 gene mutation", "FGFR3 gene rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1 Part A and Part B", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase 1 Part B", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR3 Fusion", "FGFR3", "fusion"]]}, {"cohort": "Phase 2", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["FGFR3 Mutation", "FGFR3-Mutation", "gene"]]}, {"cohort": "Phase 2", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["FGFR3 Mutation", "FGFR3-Mutation", "gene"]]}, {"cohort": "Phase 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGFR3 Mutation", "FGFR3-Mutation", "gene"]]}]}
{"NCT_id": "NCT04438005", "json": [{"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Diffuse Large B Cell Lymphoma", "biomarker_inclusion": ["MyD88 L265P", "CD79B positive"], "histology_exclusion": ["Richter's syndrome", "lymphoma involved central nervous system"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["CD79B-High", "CD79B-High", "expression"], ["MYD88 L265P", "L265P", "coordinate"]], "histology_exclusion": ["Richter Syndrome"]}]}
{"NCT_id": "NCT05479578", "json": [{"cohort": "", "disease_state": "Metastatic Castration Resistant", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT04373031", "json": [{"cohort": "", "disease_state": "locally advanced non-metastatic (M0) TNBC", "histology_inclusion": "Triple Negative Breast Cancer (TNBC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent", "agent directed to another co-inhibitory T-cell receptor (e.g., CTLA-4, OX 40, CD137)", "participation in MK-3475 clinical trials"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}]}
{"NCT_id": "NCT04959175", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Acute myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "B-cell acute lymphoblastic leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "T-cell acute lymphoblastic leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Myelodysplastic syndrome", "biomarker_inclusion": ["Intermediate or higher score by the Revised International Prognostic Scoring System (IPSS-R)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Primary myelofibrosis", "biomarker_inclusion": ["Intermediate-2 or higher risk by the DIPSS"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Chronic myelomonocytic leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Chronic myelogenous leukemia", "biomarker_inclusion": ["Resistant to or intolerant of >=3 tyrosine kinase inhibitors", "History of accelerated phase or blast crisis"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "B-cell lymphoma", "biomarker_inclusion": ["Relapsed within 1 year of completion of primary treatment", "After autologous transplantation", "Progressed through at least 2 lines of therapy"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Hodgkin lymphoma", "biomarker_inclusion": ["Relapsed within 1 year of completion of primary treatment", "After autologous transplantation", "Progressed through at least 2 lines of therapy"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Chronic lymphocytic leukemia", "biomarker_inclusion": ["17p deletion", "Unmutated IgHV", "Refractory or intolerant of both BTK and PI3K inhibitors"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Mature T or NK neoplasms", "biomarker_inclusion": ["Sufficient type and severity for allogeneic HCT based on the Prognostic Index for T-cell lymphoma (PIT) score of low-intermediate risk or higher"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Hematologic malignancy of dendritic cell or histiocytic cell type", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Multiple myeloma", "biomarker_inclusion": ["Stage III", "Relapsing after therapy with both a proteasome inhibitor and an immunomodulatory drug (IMiD)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "B Acute Lymphoblastic Leukemia"}, {"cohort": "", "histology_inclusion": "T cell acute lymphoblastic leukemia"}, {"cohort": "", "histology_inclusion": "Infant T Acute Lymphoblastic Leukemia"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Primary Myelofibrosis"}, {"cohort": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive"}, {"cohort": "", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Hematopoietic and Lymphoid Cell Neoplasm"}, {"cohort": "", "histology_inclusion": "Plasma Cell Myeloma"}]}
{"NCT_id": "NCT05219500", "json": [{"cohort": "", "disease_state": "Metastatic Castration Resistant", "histology_inclusion": "Adenocarcinoma of Prostate", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT05479812", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT05674825", "json": [{"cohort": "Group 1", "disease_state": "localized", "histology_inclusion": "aggressive solid malignancy", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group 2", "disease_state": "metastatic", "histology_inclusion": "aggressive solid malignancy", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group 3", "disease_state": "metastatic or unresectable", "histology_inclusion": "aggressive solid malignancy", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Group 1"}, {"cohort": "Group 2"}, {"cohort": "Group 3"}]}
{"NCT_id": "NCT00044304", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Eosinophilic Myeloid Neoplasm", "biomarker_inclusion": ["PDGFRA rearrangement", "PDGFRB rearrangement"], "histology_exclusion": [], "biomarker_exclusion": ["D816V KIT-positive systemic mastocytosis"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "Hypereosinophilic Syndrome", "biomarker_inclusion": ["PDGFRA rearrangement", "PDGFRB rearrangement"], "histology_exclusion": [], "biomarker_exclusion": ["D816V KIT-positive systemic mastocytosis"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Myeloid Neoplasm", "biomarker_inclusion": [["PDGFRA Fusion", "PDGFRA", "fusion"], ["PDGFRB Fusion", "PDGFRB", "fusion"]], "biomarker_exclusion": [["KIT D816V", "D816V", "coordinate"], ["KIT-High", "KIT-High", "expression"]]}, {"cohort": "", "biomarker_inclusion": [["PDGFRA Fusion", "PDGFRA", "fusion"], ["PDGFRB Fusion", "PDGFRB", "fusion"]], "biomarker_exclusion": [["KIT D816V", "D816V", "coordinate"], ["KIT-High", "KIT-High", "expression"]]}]}
{"NCT_id": "NCT03618667", "json": [{"cohort": "single group", "disease_state": "recurrent", "histology_inclusion": "glioblastoma", "biomarker_inclusion": ["high EGFR amplification"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "single group", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["EGFR-High", "EGFR-High", "expression"]]}]}
{"NCT_id": "NCT03749018", "json": [{"cohort": "", "disease_state": "Ann Arbor stage II-IV", "histology_inclusion": "Aggressive B-cell Non-Hodgkin Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["active Central Nervous System (CNS) lymphoma", "Richter's transformation from chronic lymphocytic leukemia (CLL)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Ann Arbor stage I", "histology_inclusion": "Primary Mediastinal B-cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["active Central Nervous System (CNS) lymphoma", "Richter's transformation from chronic lymphocytic leukemia (CLL)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Mediastinal B-cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["active Central Nervous System (CNS) lymphoma", "Richter's transformation from chronic lymphocytic leukemia (CLL)"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma", "histology_exclusion": ["Richter Syndrome", "Chronic Lymphocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "histology_exclusion": ["Richter Syndrome", "Chronic Lymphocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma", "histology_exclusion": ["Richter Syndrome", "Chronic Lymphocytic Leukemia"]}]}
{"NCT_id": "NCT04269902", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Small Lymphocytic Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Small Lymphocytic Lymphoma"}]}
{"NCT_id": "NCT05219578", "json": [{"cohort": "", "disease_state": "relapsed or refractory, or locally advanced", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory, or locally advanced", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory, or locally advanced", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory, or locally advanced", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory, or locally advanced", "histology_inclusion": "Triple-Negative Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Cutaneous Melanoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}]}
{"NCT_id": "NCT03162627", "json": [{"cohort": "Dose Escalation Phase", "disease_state": "advanced or recurrent", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["Ras pathway alterations"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Ovarian Cancer with RPA", "disease_state": "advanced or recurrent", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["Ras pathway alterations"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Endometrial Cancer with RPA", "disease_state": "advanced or recurrent", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["Ras pathway alterations"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Ovarian Cancer-Progression-prior PARP Treatment", "disease_state": "advanced or recurrent", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["PARP resistance"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Solid Tumors that Harbor Somatic RPA", "disease_state": "advanced or recurrent", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["Ras pathway alterations"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Escalation Phase", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["MAPK/ERK pathway", null, "pathway"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"]]}, {"cohort": "Ovarian Cancer with RPA", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["MAPK/ERK pathway", null, "pathway"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"]]}, {"cohort": "Ovarian Cancer with RPA", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["MAPK/ERK pathway", null, "pathway"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"]]}, {"cohort": "Endometrial Cancer with RPA", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["MAPK/ERK pathway", null, "pathway"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"]]}, {"cohort": "Ovarian Cancer-Progression-prior PARP Treatment", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Ovarian Cancer-Progression-prior PARP Treatment", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "Solid Tumors that Harbor Somatic RPA", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["MAPK/ERK pathway", null, "pathway"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT03749187", "json": [{"cohort": "Arm A", "disease_state": "newly diagnosed", "histology_inclusion": "World Health Organization (WHO) grade III-IV IDH1/2-mutant glioma", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B", "disease_state": "recurrent", "histology_inclusion": "World Health Organization (WHO) grades I-IV IDH1/2 mutant glioma", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["PARP inhibitor"]}], "json_norm": [{"cohort": "Arm A", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Arm B", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04698915", "json": [{"cohort": "", "disease_state": "non-metastatic", "histology_inclusion": "adenocarcinoma of the pancreas", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma"}]}
{"NCT_id": "NCT05024552", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": ["FLT3-ITD", "FLT3-TKD"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}]}
{"NCT_id": "NCT05479994", "json": [{"cohort": "", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Richter's syndrome"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Small Lymphocytic Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Richter's syndrome"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia", "histology_exclusion": ["Richter Syndrome"]}, {"cohort": "", "histology_inclusion": "Small Lymphocytic Lymphoma", "histology_exclusion": ["Richter Syndrome"]}]}
{"NCT_id": "NCT05610163", "json": [{"cohort": "", "disease_state": "Stage II or III", "histology_inclusion": "Rectal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Mismatch repair deficient rectal adenocarcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Rectal Adenocarcinoma", "histology_exclusion": ["Rectal Adenocarcinoma"]}]}
{"NCT_id": "NCT04633902", "json": [{"cohort": "Olaparib + Pembrolizumab", "disease_state": "unresectable or metastatic stage III or IV melanoma", "histology_inclusion": "melanoma", "biomarker_inclusion": ["ARID1A mutation", "ARID1B mutation", "ARID2 mutation", "ATM mutation", "ATR mutation", "BARD1 mutation", "BRCA1 mutation", "BRCA2 mutation", "BAP1 mutation", "BRIP1 mutation", "CHEK2 mutation", "FANCA mutation", "FANCD2 mutation", "MRN11A mutation", "PALB2 mutation", "RAD50 mutation", "RAD51 mutation", "RAD54B mutation"], "histology_exclusion": [], "biomarker_exclusion": ["PARP inhibitor treatment"]}], "json_norm": [{"cohort": "Olaparib + Pembrolizumab", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["RAD50 Mutation", "RAD50-Mutation", "gene"], ["BARD1 Mutation", "BARD1-Mutation", "gene"], ["RAD54B Mutation", "RAD54B-Mutation", "gene"], ["BRIP1 Mutation", "BRIP1-Mutation", "gene"], ["FANCD2 Mutation", "FANCD2-Mutation", "gene"], ["MAGI1 Mutation", "MAGI1-Mutation", "gene"], ["CHEK2 Mutation", "CHEK2-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["SERPINA2 Mutation", "SERPINA2-Mutation", "gene"], ["RAD51 Mutation", "RAD51-Mutation", "gene"], ["ATR Mutation", "ATR-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["RNF2 Mutation", "RNF2-Mutation", "gene"], ["ANTXR1 Mutation", "ANTXR1-Mutation", "gene"], ["ARID1A Mutation", "ARID1A-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["ARID2 Mutation", "ARID2-Mutation", "gene"], ["ARID1B Mutation", "ARID1B-Mutation", "gene"], ["FANCA Mutation", "FANCA-Mutation", "gene"], ["BAP1 Mutation", "BAP1-Mutation", "gene"]]}]}
{"NCT_id": "NCT05089734", "json": [{"cohort": "", "disease_state": "Stage 4", "histology_inclusion": "non-small cell lung cancer (NSCLC)", "biomarker_inclusion": ["EGFR", "ALK", "PD-1", "PD-L1"], "histology_exclusion": ["mixed small-cell lung cancer and NSCLC"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma", "Non-Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT05415072", "json": [{"cohort": "Dose Escalation", "disease_state": "metastatic", "histology_inclusion": "uveal melanoma", "biomarker_inclusion": ["GNAQ mutation", "GNA11 mutation"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Phase II: Tebe naive group", "disease_state": "metastatic", "histology_inclusion": "uveal melanoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Phase II: Tebe pre-treated", "disease_state": "metastatic", "histology_inclusion": "uveal melanoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Phase II: Non-uveal melanoma", "disease_state": "metastatic", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["GNAQ mutation", "GNA11 mutation"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Phase II: Non-uveal melanoma", "disease_state": "metastatic", "histology_inclusion": "mucosal melanoma", "biomarker_inclusion": ["GNAQ mutation", "GNA11 mutation"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Escalation", "histology_inclusion": "Intraocular Melanoma", "biomarker_inclusion": [["GNA11 Mutation", "GNA11-Mutation", "gene"], ["GNAQ Mutation", "GNAQ-Mutation", "gene"]]}, {"cohort": "Phase II: Tebe naive group", "histology_inclusion": "Intraocular Melanoma"}, {"cohort": "Phase II: Tebe pre-treated", "histology_inclusion": "Intraocular Melanoma"}, {"cohort": "Phase II: Non-uveal melanoma", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["GNA11 Mutation", "GNA11-Mutation", "gene"], ["GNAQ Mutation", "GNAQ-Mutation", "gene"]]}, {"cohort": "Phase II: Non-uveal melanoma", "histology_inclusion": "Mucosal Melanoma", "biomarker_inclusion": [["GNA11 Mutation", "GNA11-Mutation", "gene"], ["GNAQ Mutation", "GNAQ-Mutation", "gene"]]}]}
{"NCT_id": "NCT05415098", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic solid tumors or relapsed or refractory Non-Hodgkin's Lymphoma", "histology_inclusion": "nasopharyngeal carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic solid tumors or relapsed or refractory Non-Hodgkin's Lymphoma", "histology_inclusion": "castration-resistant prostate cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic solid tumors or relapsed or refractory Non-Hodgkin's Lymphoma", "histology_inclusion": "gastric cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic solid tumors or relapsed or refractory Non-Hodgkin's Lymphoma", "histology_inclusion": "ovarian clear cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic solid tumors or relapsed or refractory Non-Hodgkin's Lymphoma", "histology_inclusion": "mesothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic solid tumors or relapsed or refractory Non-Hodgkin's Lymphoma", "histology_inclusion": "sarcoma", "biomarker_inclusion": ["aberrant SMARCB1 status"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic solid tumors or relapsed or refractory Non-Hodgkin's Lymphoma", "histology_inclusion": "epithelioid sarcoma", "biomarker_inclusion": ["aberrant SMARCB1 status"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory Non-Hodgkin's Lymphoma", "histology_inclusion": "B cell lymphoma", "biomarker_inclusion": ["EZH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Nasopharyngeal Carcinoma"}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Clear Cell Tumor"}, {"cohort": "", "histology_inclusion": "Mesothelioma"}, {"cohort": "", "histology_inclusion": "Sarcoma", "biomarker_inclusion": [["SMARCB1 Mutation", "SMARCB1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Epithelioid Sarcoma", "biomarker_inclusion": [["SMARCB1 Mutation", "SMARCB1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma", "biomarker_inclusion": [["EZH2 Mutation", "EZH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT03293173", "json": [{"cohort": "", "disease_state": "stage II with age adjusted IPI score of 2 or 3", "histology_inclusion": "CD20+ Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Posttransplantation lymphoma (PTLD)", "discordant lymphoma", "transformed lymphoma", "Primary mediastinal B-cell lymphoma"], "biomarker_exclusion": ["Known HIV positivity"]}, {"cohort": "", "disease_state": "stage III /IV and elevated LDH", "histology_inclusion": "CD20+ Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Posttransplantation lymphoma (PTLD)", "discordant lymphoma", "transformed lymphoma", "Primary mediastinal B-cell lymphoma"], "biomarker_exclusion": ["Known HIV positivity"]}, {"cohort": "", "disease_state": "stage IIE and higher", "histology_inclusion": "Testicular lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Posttransplantation lymphoma (PTLD)", "discordant lymphoma", "transformed lymphoma", "Primary mediastinal B-cell lymphoma"], "biomarker_exclusion": ["Known HIV positivity"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "Paranasal sinus and orbital lymphoma with destruction of bone", "biomarker_inclusion": [], "histology_exclusion": ["Posttransplantation lymphoma (PTLD)", "discordant lymphoma", "transformed lymphoma", "Primary mediastinal B-cell lymphoma"], "biomarker_exclusion": ["Known HIV positivity"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "Large cell lymphoma infiltration of the bone marrow", "biomarker_inclusion": [], "histology_exclusion": ["Posttransplantation lymphoma (PTLD)", "discordant lymphoma", "transformed lymphoma", "Primary mediastinal B-cell lymphoma"], "biomarker_exclusion": ["Known HIV positivity"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Post-Transplant Lymphoproliferative Disorder"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Post-Transplant Lymphoproliferative Disorder"]}, {"cohort": "", "histology_inclusion": "Testicular Lymphoma", "histology_exclusion": ["Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Post-Transplant Lymphoproliferative Disorder"]}, {"cohort": "", "histology_exclusion": ["Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Post-Transplant Lymphoproliferative Disorder"]}, {"cohort": "", "histology_exclusion": ["Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Post-Transplant Lymphoproliferative Disorder"]}]}
{"NCT_id": "NCT03488693", "json": [{"cohort": "", "disease_state": "T3N0", "histology_inclusion": "invasive carcinoma of the breast", "biomarker_inclusion": ["ER \u2265 1%", "HER2 negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT03944772", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "adenocarcinoma of the lung", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Module 7", "disease_state": "advanced", "histology_inclusion": "adenocarcinoma of the lung with neuroendocrine transformation to SCLC or large cell NEC", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Module 7", "histology_inclusion": "Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Module 7", "histology_inclusion": "Large Cell Neuroendocrine Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Module 7", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04699123", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic (i.e., Stage IIIB not eligible for definitive chemoradiotherapy, Stage IV, or recurrent) NSCLC", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["leptomeningeal carcinomatosis"], "biomarker_exclusion": []}, {"cohort": "Arm 1a and 1b", "disease_state": "locally advanced or metastatic (i.e., Stage IIIB not eligible for definitive chemoradiotherapy, Stage IV, or recurrent) NSCLC", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["Prior PD-1 axis inhibitor therapy (anti-PD-1 or anti-PD-L1, e.g. nivolumab, pembrolizumab, atezolizumab, durvalumab, avelumab) either alone or in combination with other systemic agents, with documented progressive disease"], "histology_exclusion": ["leptomeningeal carcinomatosis"], "biomarker_exclusion": []}, {"cohort": "Arm 2", "disease_state": "locally advanced or metastatic (i.e., Stage IIIB not eligible for definitive chemoradiotherapy, Stage IV, or recurrent) NSCLC", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["PD-L1 expression of less than 50 percent (PD-1 axis inhibitor therapy na\u00efve)"], "histology_exclusion": ["leptomeningeal carcinomatosis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Arm 1a and 1b", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Arm 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04699188", "json": [{"cohort": "", "disease_state": "advanced (metastatic or unresectable)", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["KRAS G12C mutant"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT05154994", "json": [{"cohort": "", "disease_state": "metastatic or unresectable, locally advanced", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": ["ARID1A loss of function"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable, locally advanced", "histology_inclusion": "urothelial carcinoma, sarcomatoid variant", "biomarker_inclusion": ["ARID1A loss of function"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["ARID1A-Low", "ARID1A-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["ARID1A-Low", "ARID1A-Low", "expression"]]}]}
{"NCT_id": "NCT05284994", "json": [{"cohort": "Dose Escalation Phase", "disease_state": "Stage IIIB-IV", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": ["EGFR sensitive mutations"], "histology_exclusion": [], "biomarker_exclusion": ["T790M mutation"]}, {"cohort": "Cohort 1", "disease_state": "Stage IIIB-IV", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": ["EGFR sensitive mutations", "PI3K signaling pathway gene abnormality"], "histology_exclusion": [], "biomarker_exclusion": ["T790M mutation"]}, {"cohort": "Cohort 2", "disease_state": "Stage IIIB-IV", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": ["EGFR sensitive mutations"], "histology_exclusion": [], "biomarker_exclusion": ["T790M mutation", "PI3K signaling pathway gene abnormality"]}, {"cohort": "Cohort 3", "disease_state": "Stage IIIB-IV", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": ["EGFR sensitive mutations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Escalation Phase", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Cohort 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["PI3K/AKT/mTOR pathway", null, "pathway"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "biomarker_exclusion": [["PI3K/AKT/mTOR pathway", null, "pathway"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT02761070", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "glioblastoma", "biomarker_inclusion": [], "histology_exclusion": ["meningeal dissemination", "gliomatosis cerebri"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "giant cell glioblastoma", "biomarker_inclusion": [], "histology_exclusion": ["meningeal dissemination", "gliomatosis cerebri"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["meningeal dissemination", "gliomatosis cerebri"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Giant Cell Glioblastoma"}, {"cohort": "", "histology_inclusion": "Gliosarcoma"}]}
{"NCT_id": "NCT03423628", "json": [{"cohort": "Arm A", "disease_state": "recurrent/relapsed or progressive", "histology_inclusion": "Glioblastoma Multiforme", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B", "disease_state": "", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": [], "histology_exclusion": ["Arm B has now closed to recruitment"], "biomarker_exclusion": []}, {"cohort": "Arm C", "disease_state": "primary", "histology_inclusion": "Glioblastoma Multiforme with unmethylated O6-methylguanine-DNA methyltransferase (MGMT)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["methylated MGMT"]}, {"cohort": "Arm C", "disease_state": "primary", "histology_inclusion": "Grade 4 astrocytoma with unmethylated O6-methylguanine-DNA methyltransferase (MGMT)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["methylated MGMT"]}, {"cohort": "Arm C", "disease_state": "primary", "histology_inclusion": "histology with molecular features of GBM with unmethylated O6-methylguanine-DNA methyltransferase (MGMT)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["methylated MGMT"]}], "json_norm": [{"cohort": "Arm A", "histology_inclusion": "Glioblastoma, IDH-Wildtype"}, {"cohort": "Arm A", "histology_inclusion": "Glioblastoma"}, {"cohort": "Arm B", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Arm C", "histology_inclusion": "Glioblastoma, IDH-Wildtype"}, {"cohort": "Arm C", "histology_inclusion": "Glioblastoma"}, {"cohort": "Arm C", "histology_inclusion": "Astrocytoma"}, {"cohort": "Arm C", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT03554083", "json": [{"cohort": "", "disease_state": "High-risk stage III melanoma", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS lesion"], "biomarker_exclusion": []}, {"cohort": "Arm C", "disease_state": "High-risk stage III melanoma", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": ["BRAF wild-type"], "histology_exclusion": ["CNS lesion"], "biomarker_exclusion": []}, {"cohort": "Arm C", "disease_state": "High-risk stage III melanoma", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": ["BRAF mutant"], "histology_exclusion": ["CNS lesion"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Cutaneous Melanoma"}, {"cohort": "Arm C", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]]}, {"cohort": "Arm C", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"]]}]}
{"NCT_id": "NCT04010071", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "ampullary carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "gallbladder carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "mixed carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "", "histology_inclusion": "Cholangiocarcinoma"}, {"cohort": "", "histology_inclusion": "Ampulla of Vater Carcinoma"}, {"cohort": "", "histology_inclusion": "Gallbladder Carcinoma"}, {"cohort": ""}]}
{"NCT_id": "NCT05024968", "json": [{"cohort": "Cancer of Unknown Primary", "disease_state": "unresectable, locally advanced, recurrent or metastatic", "histology_inclusion": "Cancer of Unknown Primary", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cancer of Unknown Primary", "histology_inclusion": "Carcinoma of Unknown Primary Origin"}]}
{"NCT_id": "NCT05024994", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["SF3B1 mutation", "SRSF2 mutation", "U2AF1 mutation", "U2AF2 mutation", "ZRSR2 mutation"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Myelodysplastic Syndromes", "biomarker_inclusion": ["SF3B1 mutation", "SRSF2 mutation", "U2AF1 mutation", "U2AF2 mutation", "ZRSR2 mutation"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": ["SF3B1 mutation", "SRSF2 mutation", "U2AF1 mutation", "U2AF2 mutation", "ZRSR2 mutation"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["SF3B2 Mutation", "SF3B2-Mutation", "gene"], ["U2AF1 Mutation", "U2AF1-Mutation", "gene"], ["ZRSR2 Mutation", "ZRSR2-Mutation", "gene"], ["U2AF2 Mutation", "U2AF2-Mutation", "gene"], ["SRSF2 Mutation", "SRSF2-Mutation", "gene"], ["SF3B1 Mutation", "SF3B1-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["SF3B2 Mutation", "SF3B2-Mutation", "gene"], ["U2AF1 Mutation", "U2AF1-Mutation", "gene"], ["ZRSR2 Mutation", "ZRSR2-Mutation", "gene"], ["U2AF2 Mutation", "U2AF2-Mutation", "gene"], ["SRSF2 Mutation", "SRSF2-Mutation", "gene"], ["SF3B1 Mutation", "SF3B1-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": [["SF3B2 Mutation", "SF3B2-Mutation", "gene"], ["U2AF1 Mutation", "U2AF1-Mutation", "gene"], ["ZRSR2 Mutation", "ZRSR2-Mutation", "gene"], ["U2AF2 Mutation", "U2AF2-Mutation", "gene"], ["SRSF2 Mutation", "SRSF2-Mutation", "gene"], ["SF3B1 Mutation", "SF3B1-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT04504071", "json": [{"cohort": "", "disease_state": "stage IIIB/IV or recurrent", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR G719X", "EGFR 18del", "EGFR E709X", "EGFR V689M", "EGFR S720P/F", "EGFR P699S", "EGFR N700D", "EGFR E709Q", "EGFR G721A", "EGFR V740A", "EGFR L718P", "EGFR I744_K745insKIPVAI", "EGFR K745_E746insIPVAIK", "EGFR K745_E746insVPVAIK", "EGFR K745_E746insTPVAIK", "EGFR S768I", "EGFR V765A", "EGFR T783A", "EGFR V774A", "EGFR S784P", "EGFR R776C", "EGFR R776H", "EGFR V765M", "EGFR G779C", "EGFR G779F", "EGFR G779S", "EGFR T783I", "EGFR L798F", "EGFR L798H", "EGFR K806E", "EGFR Q812R", "EGFR L814P", "EGFR L861Q", "EGFR R831H", "EGFR V834I", "EGFR L838P", "EGFR L861R", "EGFR 18G719A+20S768I", "EGFR 18 E709X+21L861Q"], "histology_exclusion": ["Small cell lung cancer"], "biomarker_exclusion": ["EGFR 19del", "EGFR 21L858R", "EGFR 20 insertion", "EGFR 20T790M", "EGFR L747S", "EGFR L747P", "EGFR D761Y", "EGFR T854A"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR V765M", "V765M", "coordinate"], ["EGFR L861Q", "L861Q", "coordinate"], ["EGFR L861R", "L861R", "coordinate"], ["EGFR G779F", "G779F", "coordinate"], ["EGFR-High", "EGFR-High", "expression"], ["EGFR exon 19 indel", "K745_E746insVPVAIK", "exon"], ["EGFR R831H", "R831H", "coordinate"], ["EGFR R776H", "R776H", "coordinate"], ["EGFR S768I", "S768I", "coordinate"], ["EGFR T783I", "T783I", "coordinate"], ["EGFR R776C", "R776C", "coordinate"], ["EGFR S720F", "S720F", "coordinate"]], "histology_exclusion": ["Small Cell Lung Carcinoma"], "biomarker_exclusion": [["EGFR D761Y", "D761Y", "coordinate"], ["EGFR L747S", "L747S", "coordinate"], ["EGFR L747P", "L747P", "coordinate"]]}]}
{"NCT_id": "NCT05155332", "json": [{"cohort": "", "disease_state": "advanced, unresectable and/or metastatic or relapsed/refractory", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["brain tumors", "brain metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm", "Malignant Brain Neoplasm", "Brain Tumor"]}]}
{"NCT_id": "NCT03424005", "json": [{"cohort": "1L PD-L1+ cohort", "disease_state": "metastatic or inoperable locally advanced", "histology_inclusion": "Triple-Negative Breast Cancer", "biomarker_inclusion": ["PD-L1 expression >= 1%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "2L CIT-naive cohort", "disease_state": "metastatic or inoperable locally advanced", "histology_inclusion": "Triple-Negative Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "1L PD-L1+ cohort", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "2L CIT-naive cohort", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}]}
{"NCT_id": "NCT03554473", "json": [{"cohort": "All", "disease_state": "relapsed", "histology_inclusion": "Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "All", "disease_state": "relapsed", "histology_inclusion": "Extrapulmonary Small Cell Cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "All", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "All", "histology_inclusion": "Small Cell Carcinoma"}]}
{"NCT_id": "NCT04699630", "json": [{"cohort": "Part A and B (HER2-negative, ER-positive)", "disease_state": "locally advanced or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["HR+"], "histology_exclusion": [], "biomarker_exclusion": ["HER2-positive", "HER3 targeting agent"]}, {"cohort": "Part Z (HER2-positive)", "disease_state": "metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": [], "biomarker_exclusion": ["HER3 targeting agent", "T-DXd"]}], "json_norm": [{"cohort": "Part A and B (HER2-negative, ER-positive)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["HR-High", "HR-High", "expression"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part Z (HER2-positive)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04699643", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["FGF19 positive"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": ["FGF19-FGFR4 targeted therapy", "pan-FGFR inhibitor", "PD-1 inhibitors", "PD-L1/2 inhibitors"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGF19-High", "FGF19-High", "expression"]]}]}
{"NCT_id": "NCT04895046", "json": [{"cohort": "Investigational Group", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the biliary tract", "biomarker_inclusion": ["BRCA1", "BRCA2", "PALB2", "MRE", "CHEK1", "CHEK2", "PTEN", "ATM", "ATR", "BER", "RPA1", "RAD51", "BARD1", "BRIP1", "FAAP20", "FANCM", "FAN1", "NBN", "EMSY", "MRE11", "ARID1A", "BAP-1"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Investigational Group", "histology_inclusion": "Adenocarcinoma"}]}
{"NCT_id": "NCT05090358", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "HR-positive, HER2-negative breast cancer", "biomarker_inclusion": ["PIK3CA mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT04010552", "json": [{"cohort": "NALIRINOX treatment", "disease_state": "Resectable", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "NALIRINOX treatment", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma"}]}
{"NCT_id": "NCT01716806", "json": [{"cohort": "Parts A, B, C, D, and E", "disease_state": "", "histology_inclusion": "classical Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part F", "disease_state": "", "histology_inclusion": "CD30-expressing Peripheral T-cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Parts D, E, and F", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": ["cerebral/meningeal disease related to the underlying malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Parts A, B, C, D, and E", "histology_inclusion": "Classic Hodgkin Lymphoma"}, {"cohort": "Part F", "histology_inclusion": "Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma", "biomarker_inclusion": [["TNFRSF8-High", "TNFRSF8-High", "expression"]]}, {"cohort": "Part F", "histology_inclusion": "Peripheral T-Cell Lymphoma", "biomarker_inclusion": [["TNFRSF8-High", "TNFRSF8-High", "expression"]]}, {"cohort": "Parts D, E, and F"}]}
{"NCT_id": "NCT02968303", "json": [{"cohort": "", "disease_state": "Stage IV, or unresectable stage III", "histology_inclusion": "BRAF V600E/K mutated melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}]}
{"NCT_id": "NCT04634877", "json": [{"cohort": "", "disease_state": "FIGO 2009 surgical stage I/II with myometrial invasion of non-endometrioid histology; FIGO 2009 surgical stage I/II with myometrial invasion of any histology with known aberrant p53 expression or p53 mutation; or FIGO (2009) surgical stage III or IVA of any histology", "histology_inclusion": "Endometrial Carcinoma or Carcinosarcoma (Mixed Mullerian Tumor)", "biomarker_inclusion": [], "histology_exclusion": ["uterine mesenchymal tumor", "endometrial stromal sarcoma", "leiomyosarcoma", "pure sarcomas", "adenosarcomas"], "biomarker_exclusion": ["POLE mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Carcinosarcoma", "histology_exclusion": ["Endometrioid Stromal Sarcoma", "Leiomyosarcoma", "Sarcoma"], "biomarker_exclusion": [["POLE Mutation", "POLE-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "histology_exclusion": ["Leiomyosarcoma", "Endometrioid Stromal Sarcoma", "Sarcoma"], "biomarker_exclusion": [["POLE Mutation", "POLE-Mutation", "gene"]]}]}
{"NCT_id": "NCT04374630", "json": [{"cohort": "", "disease_state": "Platinum-resistant", "histology_inclusion": "high grade serous OC", "biomarker_inclusion": [], "histology_exclusion": ["carcinosarcoma", "sarcoma", "mucinous OC", "low-grade serous OC"], "biomarker_exclusion": ["AKT or PI3K pathway or mTOR inhibitors"]}, {"cohort": "", "disease_state": "Platinum-resistant", "histology_inclusion": "endometroid OC", "biomarker_inclusion": [], "histology_exclusion": ["carcinosarcoma", "sarcoma", "mucinous OC", "low-grade serous OC"], "biomarker_exclusion": ["AKT or PI3K pathway or mTOR inhibitors"]}, {"cohort": "", "disease_state": "Platinum-resistant", "histology_inclusion": "ovarian clear cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["carcinosarcoma", "sarcoma", "mucinous OC", "low-grade serous OC"], "biomarker_exclusion": ["AKT or PI3K pathway or mTOR inhibitors"]}], "json_norm": [{"cohort": "", "histology_exclusion": ["Carcinosarcoma", "Sarcoma"]}, {"cohort": "", "histology_exclusion": ["Carcinosarcoma", "Sarcoma"]}, {"cohort": "", "histology_inclusion": "Ovarian Clear Cell Tumor", "histology_exclusion": ["Carcinosarcoma", "Sarcoma"]}]}
{"NCT_id": "NCT03425292", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "high grade glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Glioma"}]}
{"NCT_id": "NCT03295396", "json": [{"cohort": "Arm A", "disease_state": "recurrent", "histology_inclusion": "high-grade glioma", "biomarker_inclusion": ["H3 K27M mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B", "disease_state": "recurrent", "histology_inclusion": "high-grade glioma", "biomarker_inclusion": ["H3 K27M mutation"], "histology_exclusion": ["primary malignant lesion located in the pons or spinal cord", "ependymoma", "ganglioma", "pleomorphic xanthoastrocytoma", "pilocytic astrocytoma", "subependymal giant cell astrocytoma (SEGA)"], "biomarker_exclusion": ["prior bevacizumab treatment of >4 doses of >7.5 mg/Kg", "1p/19q co-deletion"]}], "json_norm": [{"cohort": "Arm A", "histology_inclusion": "Malignant Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Arm B", "histology_inclusion": "Malignant Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]], "histology_exclusion": ["Pleomorphic Xanthoastrocytoma", "Pilocytic Astrocytoma", "Astrocytoma", "Ependymoma"]}]}
{"NCT_id": "NCT04961996", "json": [{"cohort": "", "disease_state": "Stage I-III", "histology_inclusion": "Estrogen Receptor-positive, HER2-negative Early Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": ["Stage IV breast cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]], "histology_exclusion": ["Breast Carcinoma"]}]}
{"NCT_id": "NCT05287386", "json": [{"cohort": "", "disease_state": "unresectable stage IIIB-IIIC or stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["FGFR 1-3 alterations"], "histology_exclusion": [], "biomarker_exclusion": ["selective FGFR inhibitors"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}]}
{"NCT_id": "NCT05417594", "json": [{"cohort": "Module 1 Part A", "disease_state": "relapsed advanced", "histology_inclusion": "ovarian, fallopian tube or primary peritoneal cancer", "biomarker_inclusion": ["BRCA1", "BRCA2", "PALB2", "RAD51C", "RAD51D"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Module 1 Part A", "disease_state": "recurrent locally advanced or metastatic", "histology_inclusion": "HER2-negative carcinoma of the breast", "biomarker_inclusion": ["BRCA1", "BRCA2", "PALB2", "RAD51C", "RAD51D"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Module 1 Part A", "disease_state": "advanced/metastatic castration-resistant", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["BRCA1", "BRCA2", "PALB2", "RAD51C", "RAD51D"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Module 1 Part A", "disease_state": "advanced/metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["BRCA1", "BRCA2", "PALB2", "RAD51C", "RAD51D"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Module 1 Part B", "disease_state": "metastatic or recurrent locally advanced", "histology_inclusion": "HER2-negative carcinoma of the breast", "biomarker_inclusion": ["predicted loss of function germline or tumour mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Module 2", "disease_state": "IDH1/2-mutant glioma", "histology_inclusion": "glioma", "biomarker_inclusion": ["IDH1", "IDH2"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Module 1 Part A", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "Module 1 Part A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Module 1 Part A", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Module 1 Part A", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Module 1 Part A", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "Module 1 Part B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Module 2", "histology_inclusion": "Glioma"}]}
{"NCT_id": "NCT04077463", "json": [{"cohort": "Phase 1 and Phase 1b lazertinib+Amivantamab combination cohorts", "disease_state": "metastatic or unresectable", "histology_inclusion": "non-small cell lung cancer (NSCLC)", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b LACP combination cohort", "disease_state": "advanced or metastatic", "histology_inclusion": "EGFR-mutated NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort A", "disease_state": "advanced or metastatic", "histology_inclusion": "EGFR-mutated non-small cell lung cancer (NSCLC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort B", "disease_state": "previously treated, advanced or metastatic", "histology_inclusion": "NSCLC with documented primary EGFR Exon 20ins activating mutation", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort C", "disease_state": "advanced or metastatic", "histology_inclusion": "NSCLC with uncommon EGFR mutations", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort D, E, and F", "disease_state": "advanced or metastatic", "histology_inclusion": "EGFR-mutated NSCLC (EGFR Exon19 deletion or L858R)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1 and Phase 1b lazertinib+Amivantamab combination cohorts", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Phase 1b LACP combination cohort", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Expansion Cohort A", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Expansion Cohort B", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Expansion Cohort C", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Expansion Cohort D, E, and F", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}, {"cohort": "Expansion Cohort D, E, and F", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}, {"cohort": "Expansion Cohort D, E, and F", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT05222438", "json": [{"cohort": "", "disease_state": "relapsed refractory", "histology_inclusion": "Diffuse Large B-cell Lymphoma", "biomarker_inclusion": ["Double hit lymphoma", "Triple hit lymphoma", "Double expressor lymphoma", "CMYC rearranged"], "histology_exclusion": ["Grade 3b follicular lymphoma", "Burkitt's lymphoma", "brain involvement", "spinal involvement", "CSF involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Grade 3b Follicular Lymphoma", "Burkitt Lymphoma"]}]}
{"NCT_id": "NCT03947385", "json": [{"cohort": "MUM", "disease_state": "metastatic", "histology_inclusion": "uveal melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H/dMMR"]}, {"cohort": "Non-MUM", "disease_state": "advanced", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["GNAQ/11 hotspot mutation"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H/dMMR"]}, {"cohort": "Non-MUM", "disease_state": "advanced", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["GNAQ/11 hotspot mutation"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H/dMMR"]}, {"cohort": "Non-MUM", "disease_state": "advanced", "histology_inclusion": "other solid tumors", "biomarker_inclusion": ["GNAQ/11 hotspot mutation"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H/dMMR"]}], "json_norm": [{"cohort": "MUM", "histology_inclusion": "Intraocular Melanoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Non-MUM", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["GNAQ Mutation", "GNAQ-Mutation", "gene"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Non-MUM", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["GNAQ Mutation", "GNAQ-Mutation", "gene"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Non-MUM", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["GNAQ Mutation", "GNAQ-Mutation", "gene"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04272957", "json": [{"cohort": "HMPL-306", "disease_state": "relapsed/refractory", "histology_inclusion": "Acute myeloid leukemia", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior IDH1 inhibitor", "prior IDH2 inhibitor", "prior IDH1/IDH2 double-targeted therapy"]}, {"cohort": "HMPL-306", "disease_state": "relapsed/refractory", "histology_inclusion": "myelodysplastic syndrome", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior IDH1 inhibitor", "prior IDH2 inhibitor", "prior IDH1/IDH2 double-targeted therapy"]}, {"cohort": "HMPL-306", "disease_state": "relapsed/refractory", "histology_inclusion": "chronic myelomonocytic leukemia", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior IDH1 inhibitor", "prior IDH2 inhibitor", "prior IDH1/IDH2 double-targeted therapy"]}, {"cohort": "HMPL-306", "disease_state": "relapsed/refractory", "histology_inclusion": "other myeloid neoplasm", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior IDH1 inhibitor", "prior IDH2 inhibitor", "prior IDH1/IDH2 double-targeted therapy"]}], "json_norm": [{"cohort": "HMPL-306", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "HMPL-306", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "HMPL-306", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "HMPL-306", "histology_inclusion": "Myeloid Neoplasm", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT05222802", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Glioblastoma, IDH WT", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT03621982", "json": [{"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "head and neck cancer squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "gastric cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "esophageal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "bladder cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "triple-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "disease_state": "locally advanced or metastatic", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1 Dose-escalation camidanlumab tesirine in combination with pembrolizumab", "disease_state": "locally advanced or metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1 Dose-escalation camidanlumab tesirine in combination with pembrolizumab", "disease_state": "locally advanced or metastatic", "histology_inclusion": "gastric-esophageal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1 Dose-escalation camidanlumab tesirine in combination with pembrolizumab", "disease_state": "locally advanced or metastatic", "histology_inclusion": "ovarian/fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1 Dose-escalation camidanlumab tesirine in combination with pembrolizumab", "disease_state": "locally advanced or metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1 Dose-escalation camidanlumab tesirine in combination with pembrolizumab", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1 Dose-escalation camidanlumab tesirine in combination with pembrolizumab", "disease_state": "locally advanced or metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2 Dose expansion camidanlumab tesirine in combination with pembrolizumab - Group 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "One of the indications identified in Part 1", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2 Dose expansion camidanlumab tesirine in combination with pembrolizumab - Group 2", "disease_state": "advanced/metastatic", "histology_inclusion": "advanced solid tumors", "biomarker_inclusion": ["MSI-H", "dMMR"], "histology_exclusion": [], "biomarker_exclusion": ["PD-1 inhibitor", "PD-L1 inhibitor"]}], "json_norm": [{"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "histology_inclusion": "Malignant Head and Neck Neoplasm"}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "histology_inclusion": "Head and Neck Carcinoma"}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "histology_inclusion": "Esophageal Carcinoma"}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "histology_inclusion": "Melanoma"}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "Part 1 Dose escalation camidanlumab tesirine as monotherapy", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "Part 1 Dose-escalation camidanlumab tesirine in combination with pembrolizumab", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Part 1 Dose-escalation camidanlumab tesirine in combination with pembrolizumab"}, {"cohort": "Part 1 Dose-escalation camidanlumab tesirine in combination with pembrolizumab", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "Part 1 Dose-escalation camidanlumab tesirine in combination with pembrolizumab", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "Part 1 Dose-escalation camidanlumab tesirine in combination with pembrolizumab", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part 1 Dose-escalation camidanlumab tesirine in combination with pembrolizumab", "histology_inclusion": "Melanoma"}, {"cohort": "Part 2 Dose expansion camidanlumab tesirine in combination with pembrolizumab - Group 1"}, {"cohort": "Part 2 Dose expansion camidanlumab tesirine in combination with pembrolizumab - Group 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04506567", "json": [{"cohort": "", "disease_state": "progressive metastatic CRPC", "histology_inclusion": "adenocarcinoma of prostate", "biomarker_inclusion": [], "histology_exclusion": ["active brain metastases", "leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT03752333", "json": [{"cohort": "Cohort 1", "disease_state": "Cancer of unknown primary", "histology_inclusion": "Cancer of unknown primary", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Cancer of unknown primary", "histology_inclusion": "Cancer of unknown primary", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Carcinoma of Unknown Primary Origin"}, {"cohort": "Cohort 2", "histology_inclusion": "Carcinoma of Unknown Primary Origin"}]}
{"NCT_id": "NCT03752398", "json": [{"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "Melanoma (excluding uveal melanoma)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "Cervical carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "Pancreatic carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "Breast carcinoma", "biomarker_inclusion": ["Estrogen Receptor negative", "Progesterone Receptor negative", "Her2 negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "Hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "Urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "Squamous cell carcinoma of the head and neck", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "Nasopharyngeal carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "Renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "Colorectal carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "Endometrial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "Non-small Cell Lung Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "Gastric or Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "Sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "advanced", "histology_inclusion": "Non-squamous Non-small Cell Lung Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "advanced", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "advanced", "histology_inclusion": "Squamous Cell Carcinoma of the Head and Neck", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "advanced", "histology_inclusion": "Nasopharyngeal Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "advanced", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "advanced", "histology_inclusion": "Undifferentiated Pleomorphic Sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "advanced", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": ["clear cell histology"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "advanced", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": ["Microsatellite Stable", "proficient Mismatch Repair"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Melanoma"}, {"cohort": "Part A", "histology_inclusion": "Intraocular Melanoma"}, {"cohort": "Part A", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "Part A", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "Part A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"]]}, {"cohort": "Part A", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "Part A", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "Part A", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Part A", "histology_inclusion": "Nasopharyngeal Carcinoma"}, {"cohort": "Part A", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "Part A", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Part A", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "Part A", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part A", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Part A", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "Part A", "histology_inclusion": "Sarcoma"}, {"cohort": "Part B", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma"}, {"cohort": "Part B", "histology_inclusion": "Melanoma"}, {"cohort": "Part B", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Part B", "histology_inclusion": "Nasopharyngeal Carcinoma"}, {"cohort": "Part B", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Part B", "histology_inclusion": "Undifferentiated Pleomorphic Sarcoma"}, {"cohort": "Part B", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "Part C", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT04208178", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "HER2-positive breast cancer", "biomarker_inclusion": ["PIK3CA mutation"], "histology_exclusion": ["inflammatory breast cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Inflammatory Breast Carcinoma"]}]}
{"NCT_id": "NCT05027867", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Small Cell Lung Cancer", "biomarker_inclusion": ["TP53WT"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04965753", "json": [{"cohort": "Advanced Synovial Sarcoma", "disease_state": "advanced", "histology_inclusion": "synovial sarcoma", "biomarker_inclusion": ["SS18-SSX rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Advanced SMARCB1-Loss Tumors", "disease_state": "advanced", "histology_inclusion": "malignant rhabdoid tumors", "biomarker_inclusion": ["biallelic SMARCB1 alterations", "SMARCB1 protein loss"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Advanced SMARCB1-Loss Tumors", "disease_state": "advanced", "histology_inclusion": "epithelioid sarcoma", "biomarker_inclusion": ["biallelic SMARCB1 alterations", "SMARCB1 protein loss"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Advanced SMARCB1-Loss Tumors", "disease_state": "advanced", "histology_inclusion": "poorly differentiated chordoma", "biomarker_inclusion": ["biallelic SMARCB1 alterations", "SMARCB1 protein loss"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Advanced SMARCB1-Loss Tumors", "disease_state": "advanced", "histology_inclusion": "other solid tumors with SMARCB1 loss", "biomarker_inclusion": ["biallelic SMARCB1 alterations", "SMARCB1 protein loss"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Advanced Synovial Sarcoma", "histology_inclusion": "Synovial Sarcoma", "biomarker_inclusion": [["SS18 - SSX2", "SS18 - SSX2", "coordinate"], ["SSX2 Fusion", "SSX2", "fusion"], ["SS18 Fusion", "SS18", "fusion"]]}, {"cohort": "Advanced SMARCB1-Loss Tumors", "histology_inclusion": "Rhabdoid Tumor", "biomarker_inclusion": [["SMARCB1 Mutation", "SMARCB1-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "Advanced SMARCB1-Loss Tumors", "histology_inclusion": "Epithelioid Sarcoma", "biomarker_inclusion": [["SMARCB1 Mutation", "SMARCB1-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "Advanced SMARCB1-Loss Tumors", "histology_inclusion": "Chordoma", "biomarker_inclusion": [["SMARCB1 Mutation", "SMARCB1-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "Advanced SMARCB1-Loss Tumors", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["SMARCB1 Mutation", "SMARCB1-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"]]}]}
{"NCT_id": "NCT04965766", "json": [{"cohort": "", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["HER3-high (75% or more tumor cells express HER3)", "HER2 negative", "HR+"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB3-High", "ERBB3-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT05160896", "json": [{"cohort": "MSS or MSI-L/pMMR, RAS and BRAF are both wild type", "disease_state": "advanced metastatic colorectal cancer", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["MSS", "MSI-L", "pMMR", "RAS wild type", "BRAF wild type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "MSS or MSI-L/pMMR, RAS and BRAF are both wild type", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["MSI-Low", "MSI-Low", "coordinate"], ["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["MSI", "MSI", "coordinate"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04211337", "json": [{"cohort": "", "disease_state": "unresectable, locally advanced and/or metastatic MTC", "histology_inclusion": "Medullary Thyroid Cancer", "biomarker_inclusion": ["RET gene alteration"], "histology_exclusion": [], "biomarker_exclusion": ["RAS gene mutation", "BRAF gene mutation", "NTRK gene fusion"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Thyroid Gland Medullary Carcinoma", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]], "biomarker_exclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}]}
{"NCT_id": "NCT04276376", "json": [{"cohort": "Cohort 1A", "disease_state": "metastatic or recurrent", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["ATM", "BARD1", "BRCA1", "BRCA2", "BRIP1", "CDK12", "CHEK2", "PALB2", "RAD51C", "RAD51D", "FANCA", "NBN", "RAD51", "RAD54L"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1B", "disease_state": "metastatic or recurrent", "histology_inclusion": "Urothelial Bladder Cancer", "biomarker_inclusion": ["ATM", "BARD1", "BRCA1", "BRCA2", "BRIP1", "CDK12", "CHEK2", "PALB2", "RAD51C", "RAD51D", "FANCA", "NBN", "RAD51", "RAD54L"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1C", "disease_state": "metastatic Castration Resistant Prostate Cancer", "histology_inclusion": "Prostate Cancer", "biomarker_inclusion": ["ATM", "BARD1", "BRCA1", "BRCA2", "BRIP1", "CDK12", "CHEK2", "PALB2", "RAD51C", "RAD51D", "FANCA", "NBN", "RAD51", "RAD54L"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1D", "disease_state": "metastatic or recurrent", "histology_inclusion": "any histology, excepted breast cancer or serous ovarian cancer", "biomarker_inclusion": ["ATM", "BARD1", "BRCA1", "BRCA2", "BRIP1", "CDK12", "CHEK2", "PALB2", "RAD51C", "RAD51D", "FANCA", "NBN", "RAD51", "RAD54L"], "histology_exclusion": ["breast cancer", "serous ovarian cancer"], "biomarker_exclusion": []}, {"cohort": "Cohort 2A", "disease_state": "Platinum-sensitive", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2B", "disease_state": "Platinum-sensitive", "histology_inclusion": "Urothelial Bladder Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2C", "disease_state": "Platinum-sensitive", "histology_inclusion": "Gastric or gastro-esophageal junction adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "Metastatic Castration Resistant Prostate Cancer", "histology_inclusion": "Prostate Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 4", "disease_state": "", "histology_inclusion": "Clear Cell Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1A", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 1B", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "Cohort 1B", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": "Cohort 1C", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Cohort 1C", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Cohort 1D", "histology_inclusion": "Breast Carcinoma", "histology_exclusion": ["Breast Carcinoma", "Ovarian Serous Adenocarcinoma"]}, {"cohort": "Cohort 1D", "histology_inclusion": "Ovarian Serous Adenocarcinoma", "histology_exclusion": ["Breast Carcinoma", "Ovarian Serous Adenocarcinoma"]}, {"cohort": "Cohort 2A", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 2B", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "Cohort 2B", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": "Cohort 2C", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "Cohort 3", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Cohort 3", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Cohort 4", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}]}
{"NCT_id": "NCT04379596", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "adenocarcinoma of the stomach, gastroesophageal junction (GEJ) or esophagus", "biomarker_inclusion": ["HER2 overexpression (IHC 3+ or IHC 2+/ISH+)"], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04965818", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT05356182", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "solid tumor malignancies", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT03103971", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "B-cell Non-Hodgkin Lymphoma", "biomarker_inclusion": ["CD19"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": ["CD19"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "biomarker_inclusion": ["CD19"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Transformed Non-Hodgkin Lymphoma", "biomarker_inclusion": ["CD19"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements", "biomarker_inclusion": ["CD19"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "B Acute Lymphoblastic Leukemia", "biomarker_inclusion": ["CD19"], "histology_exclusion": ["Burkitt's lymphoma/leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Diffuse Large B-Cell Lymphoma, Not Otherwise Specified", "biomarker_inclusion": ["CD19"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements", "biomarker_inclusion": ["CD19"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Primary Mediastinal (Thymic) Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Transformed Non-Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"]]}, {"cohort": "", "histology_inclusion": "B Acute Lymphoblastic Leukemia", "histology_exclusion": ["Burkitt Lymphoma"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"}, {"cohort": "", "histology_inclusion": "Double-Hit Lymphoma", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"]]}]}
{"NCT_id": "NCT03299309", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "medulloblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Grade III glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Grade IV glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Medulloblastoma"}, {"cohort": "", "histology_inclusion": "Glioma"}, {"cohort": "", "histology_inclusion": "Glioma"}]}
{"NCT_id": "NCT04146298", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["KRAS G12V", "HLA-A*11:01"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["KRAS G12V", "HLA-A*11:01"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["KRAS G12V", "HLA-A*11:01"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["KRAS G12V", "G12V", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["KRAS G12V", "G12V", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["KRAS G12V", "G12V", "coordinate"]]}]}
{"NCT_id": "NCT04444921", "json": [{"cohort": "", "disease_state": "inoperable, recurrent, or metastatic", "histology_inclusion": "anal squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior immunotherapy"]}, {"cohort": "", "disease_state": "inoperable, recurrent, or metastatic", "histology_inclusion": "anal basaloid carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior immunotherapy"]}, {"cohort": "", "disease_state": "inoperable, recurrent, or metastatic", "histology_inclusion": "anal canal cloacogenic carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior immunotherapy"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Anal Squamous Cell Carcinoma"}, {"cohort": ""}, {"cohort": ""}]}
{"NCT_id": "NCT04835714", "json": [{"cohort": "", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04510064", "json": [{"cohort": "", "disease_state": "unresectable locally advanced or limited metastatic", "histology_inclusion": "adenocarcinoma of the stomach (including adenocarcinoma of the gastroesophageal junction)", "biomarker_inclusion": [], "histology_exclusion": ["brain or meningeal metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastric Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}]}
{"NCT_id": "NCT04770688", "json": [{"cohort": "", "disease_state": "locally advanced/metastasis", "histology_inclusion": "adenocarcinoma of the lung (AJCC Eighth Edition TNM Stage \u2162B to stage \u2163)", "biomarker_inclusion": ["EGFR exon 19 deletion", "EGFR L858R"], "histology_exclusion": ["non-lung adenocarcinoma", "lung squamous carcinoma", "mixed histology"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]], "histology_exclusion": ["Squamous Cell Carcinoma", "Adenocarcinoma"]}]}
{"NCT_id": "NCT04835805", "json": [{"cohort": "", "disease_state": "metastatic (recurrent or de novo Stage IV) or unresectable locally advanced (Stage III)", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["NRAS mutation-positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04510285", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "HER2+ esophageal, GEJ, or gastric adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["active central nervous system (CNS) metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1", "anti-CTLA-4 agent"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04705649", "json": [{"cohort": "", "disease_state": "Early Stage", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": ["POLE mutation", "p53 wildtype"], "histology_exclusion": [], "biomarker_exclusion": ["Abnormal p53", "Mismatch Repair Deficiency"]}, {"cohort": "", "disease_state": "Early Stage", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": ["p53 wildtype", "Non-specific Mismatch Repair Proficient"], "histology_exclusion": ["MELF pattern of invasion"], "biomarker_exclusion": ["Abnormal p53", "Mismatch Repair Deficiency", "POLE mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["POLE Mutation", "POLE-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]], "biomarker_exclusion": [["POLE Mutation", "POLE-Mutation", "gene"]]}]}
{"NCT_id": "NCT03690921", "json": [{"cohort": "", "disease_state": "Stage I, II, III", "histology_inclusion": "Anal Canal Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Anal Canal Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT04081688", "json": [{"cohort": "", "disease_state": "advanced, unresectable NSCLC", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["untreated central nervous system (CNS) metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04705818", "json": [{"cohort": "Cohort A", "disease_state": "Advanced", "histology_inclusion": "Pancreatic Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR/ALK/ROS mutated NSCLC"]}, {"cohort": "Cohort B", "disease_state": "Advanced", "histology_inclusion": "Non MSI-H or MMR-deficient Colorectal Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR/ALK/ROS mutated NSCLC"]}, {"cohort": "Cohort C", "disease_state": "Metastatic", "histology_inclusion": "Solid Tumor with positive IFNG gene expression signature and/or tertiary lymphoid structure positive", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR/ALK/ROS mutated NSCLC"]}, {"cohort": "Cohort D", "disease_state": "Advanced", "histology_inclusion": "Soft-tissue Sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR/ALK/ROS mutated NSCLC"]}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_exclusion": [["ALK Mutation", "ALK-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Cohort B", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"]]}, {"cohort": "Cohort B", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "biomarker_exclusion": [["ALK Mutation", "ALK-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Cohort C", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["IFNG-High", "IFNG-High", "expression"]], "biomarker_exclusion": [["ALK Mutation", "ALK-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Cohort D", "histology_inclusion": "Soft Tissue Sarcoma", "biomarker_exclusion": [["ALK Mutation", "ALK-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT05551936", "json": [{"cohort": "Investigational Group", "disease_state": "Stage II, III, or IV", "histology_inclusion": "Low grade follicular lymphoma (grade 1-2 or 3A)", "biomarker_inclusion": [], "histology_exclusion": ["grade 3B", "FLBL", "transformed lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Investigational Group", "histology_inclusion": "Follicular Lymphoma", "histology_exclusion": ["Grade 3b Follicular Lymphoma"]}]}
{"NCT_id": "NCT03104439", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "adenocarcinoma of colorectal origin", "biomarker_inclusion": ["Microsatellite Stable"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "adenocarcinoma of pancreatic origin", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "adenocarcinoma of colorectal origin", "biomarker_inclusion": ["MSI High"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT03104491", "json": [{"cohort": "Phase 1 Acute Lymphoblastic Leukemia", "disease_state": "", "histology_inclusion": "CD22-positive Acute Lymphoblastic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1 Non-Hodgkin's Lymphoma", "disease_state": "", "histology_inclusion": "CD22-positive B-cell Non-Hodgkin's Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2 Acute Lymphoblastic Leukemia", "disease_state": "", "histology_inclusion": "CD22-positive Acute Lymphoblastic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1 Acute Lymphoblastic Leukemia", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["CD22-High", "CD22-High", "expression"]]}, {"cohort": "Phase 1 Non-Hodgkin's Lymphoma", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma", "biomarker_inclusion": [["PPIB-High", "PPIB-High", "expression"], ["CD22-High", "CD22-High", "expression"]]}, {"cohort": "Phase 1 Non-Hodgkin's Lymphoma", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma", "biomarker_inclusion": [["PPIB-High", "PPIB-High", "expression"], ["CD22-High", "CD22-High", "expression"]]}, {"cohort": "Phase 2 Acute Lymphoblastic Leukemia", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["CD22-High", "CD22-High", "expression"]]}]}
{"NCT_id": "NCT03886415", "json": [{"cohort": "", "disease_state": "Intermediate-risk and High-risk Myelofibrosis", "histology_inclusion": "Primary Myelofibrosis", "biomarker_inclusion": ["JAK2 mutation", "JAK2 wild"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Intermediate-risk and High-risk Myelofibrosis", "histology_inclusion": "Post-Polycythemia Vera Myelofibrosis", "biomarker_inclusion": ["JAK2 mutation", "JAK2 wild"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Intermediate-risk and High-risk Myelofibrosis", "histology_inclusion": "Post-Essential Thrombocythemia Myelofibrosis", "biomarker_inclusion": ["JAK2 mutation", "JAK2 wild"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Primary Myelofibrosis", "biomarker_inclusion": [["JAK2 Mutation", "JAK2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase", "biomarker_inclusion": [["JAK2 Mutation", "JAK2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Myelofibrosis Transformation in Essential Thrombocythemia", "biomarker_inclusion": [["JAK2 Mutation", "JAK2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04966481", "json": [{"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "HPV-unrelated Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["CDKN2A loss-of-function (LOF) alteration"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["CDKN2A Mutation", "CDKN2A-Mutation", "gene"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]]}]}
{"NCT_id": "NCT05422027", "json": [{"cohort": "", "disease_state": "newly diagnosed high risk", "histology_inclusion": "multiple myeloma", "biomarker_inclusion": ["t(4;14)", "t(14;16)", "t(14;20)", "Del 17p", "p53 mutation", "Gain 1q", "R-ISS Stage 3", "High Plasma Cell S-phase", "GEP: High risk signature"], "histology_exclusion": ["plasma cell leukemia", "active amyloidosis", "CNS involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Plasma Cell Myeloma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]], "histology_exclusion": ["Plasma Cell Leukemia", "Amyloidosis"]}]}
{"NCT_id": "NCT03560882", "json": [{"cohort": "", "disease_state": "relapsed", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["TP53 IHC-positive"], "histology_exclusion": ["squamous cell cancer of the oropharynx"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": ["TP53 IHC-positive"], "histology_exclusion": ["squamous cell cancer of the oropharynx"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["TP53 IHC-negative", "TP53 wild type", "TP53 null"], "histology_exclusion": ["squamous cell cancer of the oropharynx"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": ["TP53 IHC-negative", "TP53 wild type", "TP53 null"], "histology_exclusion": ["squamous cell cancer of the oropharynx"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["TP53-High", "TP53-High", "expression"]], "histology_exclusion": ["Oropharyngeal Squamous Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TP53-High", "TP53-High", "expression"]], "histology_exclusion": ["Oropharyngeal Squamous Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["TP53-Low", "TP53-Low", "expression"]], "histology_exclusion": ["Oropharyngeal Squamous Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["TP53-Low", "TP53-Low", "expression"]], "histology_exclusion": ["Oropharyngeal Squamous Cell Carcinoma"]}]}
{"NCT_id": "NCT04510584", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "high grade serous ovarian cancer", "biomarker_inclusion": ["TP53-mutant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "high grade endometrioid ovarian cancer", "biomarker_inclusion": ["TP53-mutant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "high grade serous fallopian tube cancer", "biomarker_inclusion": ["TP53-mutant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "high grade endometrioid fallopian tube cancer", "biomarker_inclusion": ["TP53-mutant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "high grade serous primary peritoneal cancer", "biomarker_inclusion": ["TP53-mutant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "high grade endometrioid primary peritoneal cancer", "biomarker_inclusion": ["TP53-mutant"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Serous Adenocarcinoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Ovarian Endometrioid Adenocarcinoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT02115295", "json": [{"cohort": "Frontline Cohorts 1 or 4", "disease_state": "untreated", "histology_inclusion": "Acute Myeloid Leukemia, Acute Biphenotypic Leukemia, High-Risk Myelodysplastic Syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Frontline Cohorts 1 or 4", "disease_state": "untreated", "histology_inclusion": "Chronic Myeloid Leukemia", "biomarker_inclusion": ["Myeloid Blast Phase"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Secondary AML Cohort", "disease_state": "treated", "histology_inclusion": "Secondary Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Salvage Cohort", "disease_state": "previously treated, relapsed or refractory", "histology_inclusion": "Acute Myeloid Leukemia, Acute Biphenotypic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Salvage Cohort", "disease_state": "previously treated, relapsed or refractory", "histology_inclusion": "Chronic Myeloid Leukemia", "biomarker_inclusion": ["Myeloid Blast Phase"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Frontline Cohorts 1 or 4", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "Frontline Cohorts 1 or 4", "histology_inclusion": "Infant Acute Biphenotypic Leukemia"}, {"cohort": "Frontline Cohorts 1 or 4", "histology_inclusion": "Acute Biphenotypic Leukemia"}, {"cohort": "Frontline Cohorts 1 or 4", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "Frontline Cohorts 1 or 4", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive"}, {"cohort": "Secondary AML Cohort", "histology_inclusion": "Secondary Acute Myeloid Leukemia"}, {"cohort": "Salvage Cohort", "histology_inclusion": "Infant Acute Biphenotypic Leukemia"}, {"cohort": "Salvage Cohort", "histology_inclusion": "Acute Biphenotypic Leukemia"}, {"cohort": "Salvage Cohort", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "Salvage Cohort", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive"}]}
{"NCT_id": "NCT04380636", "json": [{"cohort": "", "disease_state": "Stage IIIA, IIIB, or IIIC", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["small cell lung cancer", "mixed tumor with presence of small cell elements"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT04576091", "json": [{"cohort": "", "disease_state": "recurrent, unresectable", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": ["PD-L1 (CPS >= 1)"], "histology_exclusion": ["cutaneous", "nasopharynx", "paranasal sinus", "salivary gland cancers"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Malignant Salivary Gland Neoplasm", "Salivary Gland Carcinoma"]}]}
{"NCT_id": "NCT04836663", "json": [{"cohort": "Endometrial Cancer", "disease_state": "recurrent/metastatic advanced", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["PIK3CA gene-altered", "PIK3R1/2 gene-altered"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cervical Cancer", "disease_state": "recurrent/metastatic advanced", "histology_inclusion": "cervical cancer", "biomarker_inclusion": ["PIK3CA gene-altered", "PIK3R1/2 gene-altered"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Ovarian Cancer", "disease_state": "recurrent/metastatic advanced", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["PIK3CA gene-altered", "PIK3R1/2 gene-altered"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Endometrial Cancer", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "Cervical Cancer", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "Ovarian Cancer", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Ovarian Cancer", "histology_inclusion": "Malignant Ovarian Neoplasm"}]}
{"NCT_id": "NCT04901702", "json": [{"cohort": "Phase I", "disease_state": "refractory or recurrent non-CNS solid tumors", "histology_inclusion": "non-CNS solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) solid tumors"], "biomarker_exclusion": []}, {"cohort": "Phase I - Expansion Cohort A2", "disease_state": "refractory or recurrent non-CNS solid tumors", "histology_inclusion": "non-CNS solid tumors", "biomarker_inclusion": ["deleterious alteration in germline or somatic genes involved in HR repair and DSBs signaling"], "histology_exclusion": ["central nervous system (CNS) solid tumors", "Ewing sarcoma"], "biomarker_exclusion": []}, {"cohort": "Phase II", "disease_state": "refractory or recurrent Ewing sarcoma", "histology_inclusion": "Ewing sarcoma", "biomarker_inclusion": ["EWSR1-FLI1 translocation", "other EWS rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase I", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Malignant Solid Neoplasm"]}, {"cohort": "Phase I - Expansion Cohort A2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["HR Mutation", "HR-Mutation", "gene"]], "histology_exclusion": ["Malignant Solid Neoplasm", "Ewing Sarcoma"]}, {"cohort": "Phase II", "histology_inclusion": "Ewing Sarcoma", "biomarker_inclusion": [["FLII Fusion", "FLII", "fusion"], ["FLI1 Fusion", "FLI1", "fusion"], ["EWSR1 Fusion", "EWSR1", "fusion"], ["EWSR1 - FLII", "EWSR1 - FLII", "coordinate"], ["EWSR1 - FLI1", "EWSR1 - FLI1", "coordinate"]]}]}
{"NCT_id": "NCT02245997", "json": [{"cohort": "patients with high-risk neuroblastoma", "disease_state": "INSS stage 4", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": ["MYCN amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "patients with high-risk neuroblastoma", "disease_state": "INSS stage 4", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": ["Age > 18 months"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "patients with high-risk neuroblastoma", "disease_state": "INSS stage 3", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": ["MYCN amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "patients with high-risk neuroblastoma", "disease_state": "INSS stage 3", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": ["Age > 18 months", "unfavorable pathology"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "patients with high-risk neuroblastoma", "disease_state": "INSS stage 2a or 2b", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": ["MYCN amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "patients with high-risk neuroblastoma", "disease_state": "INSS stage 4s", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": ["MYCN amplification"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "patients with high-risk neuroblastoma", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]]}, {"cohort": "patients with high-risk neuroblastoma", "histology_inclusion": "Neuroblastoma"}, {"cohort": "patients with high-risk neuroblastoma", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]]}, {"cohort": "patients with high-risk neuroblastoma", "histology_inclusion": "Neuroblastoma"}, {"cohort": "patients with high-risk neuroblastoma", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]]}, {"cohort": "patients with high-risk neuroblastoma", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]]}]}
{"NCT_id": "NCT02974725", "json": [{"cohort": "LXH254+LTT462", "disease_state": "advanced or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS mutation", "BRAF mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "LXH254+LTT462", "disease_state": "advanced or metastatic", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["NRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "LXH254+Trametinib", "disease_state": "advanced or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS mutation", "BRAF mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "LXH254+Trametinib", "disease_state": "advanced or metastatic", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["NRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "LXH254+Ribociclib", "disease_state": "advanced or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS mutation", "BRAF mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "LXH254+Ribociclib", "disease_state": "advanced or metastatic", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["NRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "LXH254+LTT462", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "LXH254+LTT462", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"]]}, {"cohort": "LXH254+Trametinib", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "LXH254+Trametinib", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"]]}, {"cohort": "LXH254+Ribociclib", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "LXH254+Ribociclib", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT03170206", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT03235245", "json": [{"cohort": "", "disease_state": "Unresectable Stage III or IV", "histology_inclusion": "cutaneous or mucosal melanoma", "biomarker_inclusion": ["BRAF V600E", "BRAF V600K"], "histology_exclusion": ["Uveal melanoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Mucosal Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]], "histology_exclusion": ["Intraocular Melanoma"]}]}
{"NCT_id": "NCT04147351", "json": [{"cohort": "", "disease_state": "Stage IIIB~IV", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR exon19 deletion", "EGFR L858R", "EGFR G719X", "EGFR L861Q", "EGFR S768I"], "histology_exclusion": ["Leptomeningeal disease"], "biomarker_exclusion": ["EGFR T790M", "EGFR exon20 insertion"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"], ["EGFR S768I", "S768I", "coordinate"], ["EGFR L861Q", "L861Q", "coordinate"]], "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"]]}]}
{"NCT_id": "NCT04511013", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF-V600"], "histology_exclusion": ["uveal primary"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma"}]}
{"NCT_id": "NCT04771520", "json": [{"cohort": "Cohort 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "malignant solid tumor", "biomarker_inclusion": ["CKIT activating mutation"], "histology_exclusion": ["gastrointestinal stromal tumor"], "biomarker_exclusion": ["CKIT mutation V654A", "CKIT mutation T670I"]}, {"cohort": "Cohort 2", "disease_state": "locally advanced or metastatic", "histology_inclusion": "malignant solid tumor", "biomarker_inclusion": ["PDGFRA activating mutation"], "histology_exclusion": ["gastrointestinal stromal tumor"], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "locally advanced or metastatic", "histology_inclusion": "malignant solid tumor", "biomarker_inclusion": ["CKIT activating mutation", "PDGFRA activating mutation"], "histology_exclusion": ["gastrointestinal stromal tumor"], "biomarker_exclusion": ["CKIT mutation V654A", "CKIT mutation T670I"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Gastrointestinal Stromal Tumor"]}, {"cohort": "Cohort 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["PDGFRA Mutation", "PDGFRA-Mutation", "gene"]], "histology_exclusion": ["Gastrointestinal Stromal Tumor"]}, {"cohort": "Cohort 3", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["PDGFRA Mutation", "PDGFRA-Mutation", "gene"]], "histology_exclusion": ["Gastrointestinal Stromal Tumor"]}]}
{"NCT_id": "NCT04901806", "json": [{"cohort": "Phase 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "NTRK-fusion-positive solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "NTRK-gene amplified solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "EWSR1-WT1-positive DSRCT", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "measurable disease", "histology_inclusion": "NTRK-fusion-positive non-brain primary tumor", "biomarker_inclusion": ["TRK inhibitor resistance mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "measurable disease", "histology_inclusion": "NTRK-fusion-positive primary brain tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"], ["NTRK1-High", "NTRK1-High", "expression"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"], ["NTRK1-High", "NTRK1-High", "expression"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"], ["NTRK1-High", "NTRK1-High", "expression"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"], ["NTRK1-High", "NTRK1-High", "expression"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"], ["NTRK1-High", "NTRK1-High", "expression"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"], ["NTRK1-High", "NTRK1-High", "expression"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK1-High", "NTRK1-High", "expression"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"]]}, {"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK1-High", "NTRK1-High", "expression"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"]]}, {"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK1-High", "NTRK1-High", "expression"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"]]}, {"cohort": "Phase 1", "histology_inclusion": "Desmoplastic Small Round Cell Tumor", "biomarker_inclusion": [["EWSR1-High", "EWSR1-High", "expression"], ["WT1-High", "WT1-High", "expression"]]}, {"cohort": "Phase 1", "histology_inclusion": "Desmoplastic Small Round Cell Tumor", "biomarker_inclusion": [["EWSR1-High", "EWSR1-High", "expression"], ["WT1-High", "WT1-High", "expression"]]}, {"cohort": "Phase 2", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"], ["NTRK1-High", "NTRK1-High", "expression"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"], ["TPM3 Mutation", "TPM3-Mutation", "gene"], ["NTRK1 Mutation", "NTRK1-Mutation", "gene"]]}, {"cohort": "Phase 2", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"], ["NTRK1-High", "NTRK1-High", "expression"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"], ["TPM3 Mutation", "TPM3-Mutation", "gene"], ["NTRK1 Mutation", "NTRK1-Mutation", "gene"]]}, {"cohort": "Phase 2", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"], ["NTRK1-High", "NTRK1-High", "expression"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"], ["TPM3 Mutation", "TPM3-Mutation", "gene"], ["NTRK1 Mutation", "NTRK1-Mutation", "gene"]]}, {"cohort": "Phase 2", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"], ["NTRK1-High", "NTRK1-High", "expression"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"], ["TPM3 Mutation", "TPM3-Mutation", "gene"], ["NTRK1 Mutation", "NTRK1-Mutation", "gene"]]}, {"cohort": "Phase 2", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"], ["NTRK1-High", "NTRK1-High", "expression"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"], ["TPM3 Mutation", "TPM3-Mutation", "gene"], ["NTRK1 Mutation", "NTRK1-Mutation", "gene"]]}, {"cohort": "Phase 2", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"], ["TPM3 Mutation", "TPM3-Mutation", "gene"], ["NTRK1-High", "NTRK1-High", "expression"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK1 Mutation", "NTRK1-Mutation", "gene"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}, {"cohort": "Phase 2", "histology_inclusion": "Primary Brain Neoplasm", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"], ["NTRK1-High", "NTRK1-High", "expression"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}, {"cohort": "Phase 2", "histology_inclusion": "Primary Brain Neoplasm", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"], ["NTRK1-High", "NTRK1-High", "expression"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}, {"cohort": "Phase 2", "histology_inclusion": "Primary Brain Neoplasm", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"], ["NTRK1-High", "NTRK1-High", "expression"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}, {"cohort": "Phase 2", "histology_inclusion": "Primary Brain Neoplasm", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"], ["NTRK1-High", "NTRK1-High", "expression"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}, {"cohort": "Phase 2", "histology_inclusion": "Primary Brain Neoplasm", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"], ["NTRK1-High", "NTRK1-High", "expression"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}, {"cohort": "Phase 2", "histology_inclusion": "Primary Brain Neoplasm", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"], ["NTRK1-High", "NTRK1-High", "expression"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}]}
{"NCT_id": "NCT05032040", "json": [{"cohort": "", "disease_state": "persistent or recurrent", "histology_inclusion": "clear cell carcinoma of the ovary, peritoneum, or endometrium", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "persistent or recurrent", "histology_inclusion": "high-grade serous carcinoma of the ovary, fallopian tube, or peritoneum", "biomarker_inclusion": [], "histology_exclusion": ["carcinosarcoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "cervical carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "endometrial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H", "dMMR"]}, {"cohort": "", "disease_state": "high-risk metastatic castration-resistant", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Endometrial Clear Cell Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Serous Adenocarcinoma", "histology_exclusion": ["Carcinosarcoma"]}, {"cohort": "", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma"}]}
{"NCT_id": "NCT04901988", "json": [{"cohort": "", "disease_state": "Stage IIB or IIC melanoma", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["BRAF (p.V600E/p.V600K/p.V600R)", "NRAS (p.Q61R/p.Q61K, p.Q61L/p.G12D)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["NRAS Q61R", "Q61R", "coordinate"], ["BRAF V600R", "V600R", "coordinate"], ["NRAS Q61L", "Q61L", "coordinate"], ["BRAF V600K", "V600K", "coordinate"], ["NRAS Q61K", "Q61K", "coordinate"], ["BRAF V600E", "V600E", "coordinate"], ["NRAS G12D", "G12D", "coordinate"]]}]}
{"NCT_id": "NCT04902040", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "renal cell cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "bladder cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Merkle cell cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "microsatellite instability high (MSI-H) cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": ""}, {"cohort": "", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Melanoma"}]}
{"NCT_id": "NCT04967196", "json": [{"cohort": "", "disease_state": "Stage III-IV Unresectable Metastatic", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": ["Metastatic uveal melanoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma"}]}
{"NCT_id": "NCT05552755", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Familial Adenomatous Polyposis", "biomarker_inclusion": ["APC gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["APC Mutation", "APC-Mutation", "gene"]]}]}
{"NCT_id": "NCT05552781", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR exon 20 insertion mutations"]}, {"cohort": "Part B", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR C797S mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR exon 20 insertion mutations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Part B", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR C797S", "C797S", "coordinate"]]}]}
{"NCT_id": "NCT02637934", "json": [{"cohort": "Dynamic", "disease_state": "", "histology_inclusion": "epithelial ovarian, fallopian tube, or primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dynamic", "histology_inclusion": "Primary Peritoneal Carcinoma"}]}
{"NCT_id": "NCT02909777", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["CNS tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "CNS tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "relapsed or refractory", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": ["MYCN amplification", "Mycn protein expression > 1+", "Myc expression > 1+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "relapsed or refractory", "histology_inclusion": "diffuse large B cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "relapsed or refractory", "histology_inclusion": "Burkitt lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "", "histology_inclusion": "Central Nervous System Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Central Nervous System Neoplasm"}, {"cohort": "", "histology_inclusion": "Lymphoma"}, {"cohort": "Part B", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]]}, {"cohort": "Part B", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "Part B", "histology_inclusion": "Burkitt Lymphoma"}]}
{"NCT_id": "NCT03365882", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced and unresectable", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["HER2 amplification"], "histology_exclusion": [], "biomarker_exclusion": ["KRAS exon 2 (codons 12 and 13), exon 3 (codons 59 and 61), exon 4 (codons 117 and 146) activating mutations", "NRAS exon 2 (codons 12 and 13), exon 3 (codons 59 and 61), exon 4 (codons 117 and 146) activating mutations", "BRAF exon 15 (V600E) mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT04082572", "json": [{"cohort": "", "disease_state": "locally advanced", "histology_inclusion": "solid cancer", "biomarker_inclusion": ["dMMR", "MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04771897", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma", "biomarker_inclusion": [], "histology_exclusion": ["low-grade glioma (Grade II or less)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "Diffuse Midline Glioma, H3 K27M-Mutant", "biomarker_inclusion": [], "histology_exclusion": ["low-grade glioma (Grade II or less)"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma", "histology_exclusion": ["Low Grade Glioma"]}, {"cohort": "", "histology_inclusion": "Diffuse Midline Glioma, H3 K27M-Mutant", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]], "histology_exclusion": ["Low Grade Glioma"]}]}
{"NCT_id": "NCT05097443", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "aggressive B-cell non-Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["indolent B-cell lymphoma transformation"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma", "histology_exclusion": ["B-Cell Non-Hodgkin Lymphoma"]}]}
{"NCT_id": "NCT05422794", "json": [{"cohort": "", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Triple-Negative Breast Cancer", "biomarker_inclusion": ["ER < 10%", "PR < 10%", "HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT01985087", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "glioblastoma/gliosarcoma", "biomarker_inclusion": ["o6-methylguanine-DNA-methyltransferase promoter methylation status"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gliosarcoma"}, {"cohort": "", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT04017650", "json": [{"cohort": "Cohort A", "disease_state": "unresectable or metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["BRAFV600E", "MSS"], "histology_exclusion": [], "biomarker_exclusion": ["prior BRAF inhibitor", "prior MEK inhibitor", "prior ERK inhibitor", "prior anti-EGFR therapies"]}, {"cohort": "Cohort B", "disease_state": "unresectable or metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["BRAFV600E", "MSS"], "histology_exclusion": [], "biomarker_exclusion": ["unacceptable toxicity to prior BRAF, EGFR, MEK, or ERK inhibitor therapy"]}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Cohort B", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT04446260", "json": [{"cohort": "", "disease_state": "Advanced/unresectable or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["HER2 expression", "HER2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}]}
{"NCT_id": "NCT03952585", "json": [{"cohort": "", "disease_state": "Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "histology_inclusion": "Squamous Cell Carcinoma, Papillary Squamous Cell Carcinoma, Basaloid Squamous Cell Carcinoma", "biomarker_inclusion": ["p16-positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}]}
{"NCT_id": "NCT04278144", "json": [{"cohort": "Single agent BDC-1001", "disease_state": "advanced", "histology_inclusion": "HER2 Positive Solid Tumors", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system tumor", "epidural tumor", "brain metastasis"], "biomarker_exclusion": []}, {"cohort": "Combination BDC-1001 plus nivolumab", "disease_state": "advanced", "histology_inclusion": "HER2 Positive Solid Tumors", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system tumor", "epidural tumor", "brain metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Single agent BDC-1001", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Combination BDC-1001 plus nivolumab", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT04706949", "json": [{"cohort": "", "disease_state": "Phase IIIB or IV", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": ["HER2 mutation", "HER2 amplification"], "histology_exclusion": [], "biomarker_exclusion": ["Previous therapy with other HER2 inhibitors"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}]}
{"NCT_id": "NCT05162755", "json": [{"cohort": "Dose escalation", "disease_state": "unresectable, locally advanced or metastatic", "histology_inclusion": "solid tumor malignancies", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort expansion part 2a", "disease_state": "metastatic", "histology_inclusion": "HER2+ gastric cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort expansion part 2b", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of colorectal cancer", "biomarker_inclusion": ["wild-type KRAS (exons 2, 3, 4)", "wild-type NRAS (exons 2, 3, 4)", "BRAF (absence of V600E mutation)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose escalation", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Cohort expansion part 2a", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort expansion part 2b", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04148066", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": ["EGFR exon 19 deletion", "EGFR exon 21 L858R mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT04772235", "json": [{"cohort": "Advanced and/or metastatic EGFR mutant NSCLC", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-squamous cell lung carcinoma", "biomarker_inclusion": ["EGFR activating mutation (including exon 18, exon 19, exon 21 and mutation T790M)"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR exon 20 insertion mutation"]}], "json_norm": [{"cohort": "Advanced and/or metastatic EGFR mutant NSCLC", "histology_inclusion": "Lung Carcinoma", "biomarker_inclusion": [["EGFR T790M", "T790M", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT03170960", "json": [{"cohort": "Dose-Escalation Stage", "disease_state": "inoperable, locally advanced, metastatic, or recurrent", "histology_inclusion": "Urothelial Carcinoma (including renal pelvis, ureter, bladder, urethra)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose-Escalation Stage", "disease_state": "inoperable, locally advanced, metastatic, or recurrent", "histology_inclusion": "Renal Cell Carcinoma (clear cell, non-clear cell histology)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Stage", "disease_state": "inoperable locally advanced or metastatic solid tumor", "histology_inclusion": "Urothelial Carcinoma, Renal Cell Carcinoma, Castration-resistant Prostate Cancer, Non-Small Cell Lung Cancer, Triple Negative Breast Cancer, Ovarian Cancer, Endometrial Cancer, Hepatocellular Carcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Colorectal Cancer, Head and Neck Cancer, Differentiated Thyroid Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-CTLA-4", "anti-PD-1", "anti-PD-L1", "anti-PD-L2"]}], "json_norm": [{"cohort": "Dose-Escalation Stage", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "Dose-Escalation Stage", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "Expansion Stage", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Expansion Stage", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Expansion Stage", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Expansion Stage", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Expansion Stage", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Expansion Stage", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Expansion Stage", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Expansion Stage", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Expansion Stage", "histology_inclusion": "Head and Neck Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Expansion Stage", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Expansion Stage", "histology_inclusion": "Malignant Head and Neck Neoplasm", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Expansion Stage", "histology_inclusion": "Differentiated Thyroid Gland Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Expansion Stage", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Expansion Stage", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Expansion Stage", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Expansion Stage", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}]}
{"NCT_id": "NCT04381650", "json": [{"cohort": "Cohort A: Non-squamous NSCLC", "disease_state": "advanced or metastatic", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR", "BRAF V600E", "ROS1", "NRTK", "ALK"]}, {"cohort": "Cohort B: Cervical Cancer", "disease_state": "recurrent or Stage IVB", "histology_inclusion": "squamous cell carcinoma, adenosquamous carcinoma or adenocarcinoma of the cervix", "biomarker_inclusion": [], "histology_exclusion": ["minimal deviation/adenoma malignum", "gastric-type adenocarcinoma", "clear-cell carcinoma", "mesonephric carcinoma"], "biomarker_exclusion": []}, {"cohort": "Cohort C: MSS-CRC", "disease_state": "advanced or metastatic", "histology_inclusion": "microsatellite stable-colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort D: Cutaneous Melanoma", "disease_state": "unresectable Stage III or Stage IV", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort E: Squamous NSCLC", "disease_state": "advanced or metastatic", "histology_inclusion": "squamous non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort F: Small Cell Lung Cancer", "disease_state": "advanced or metastatic", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort G: HNSCC", "disease_state": "advanced or metastatic", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort H: MSI-H/dMMR CRC", "disease_state": "advanced or metastatic", "histology_inclusion": "microsatellite instability, high levels/ mismatch-repair-deficient colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A: Non-squamous NSCLC", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "Cohort B: Cervical Cancer", "histology_inclusion": "Cervical Adenosquamous Carcinoma", "histology_exclusion": ["Adenocarcinoma", "Endometrial Clear Cell Adenocarcinoma", "Endometrial Clear Cell Adenocarcinoma", "Endometrial Clear Cell Adenocarcinoma", "Endometrial Clear Cell Adenocarcinoma"]}, {"cohort": "Cohort B: Cervical Cancer", "histology_inclusion": "Squamous Cell Carcinoma", "histology_exclusion": ["Adenocarcinoma", "Endometrial Clear Cell Adenocarcinoma", "Endometrial Clear Cell Adenocarcinoma", "Endometrial Clear Cell Adenocarcinoma", "Endometrial Clear Cell Adenocarcinoma"]}, {"cohort": "Cohort B: Cervical Cancer", "histology_inclusion": "Cervical Adenocarcinoma", "histology_exclusion": ["Adenocarcinoma", "Endometrial Clear Cell Adenocarcinoma", "Endometrial Clear Cell Adenocarcinoma", "Endometrial Clear Cell Adenocarcinoma", "Endometrial Clear Cell Adenocarcinoma"]}, {"cohort": "Cohort B: Cervical Cancer", "histology_inclusion": "Pancreatic Adenosquamous Carcinoma", "histology_exclusion": ["Adenocarcinoma", "Endometrial Clear Cell Adenocarcinoma", "Endometrial Clear Cell Adenocarcinoma", "Endometrial Clear Cell Adenocarcinoma", "Endometrial Clear Cell Adenocarcinoma"]}, {"cohort": "Cohort B: Cervical Cancer", "histology_inclusion": "Endocervical Carcinoma", "histology_exclusion": ["Adenocarcinoma", "Endometrial Clear Cell Adenocarcinoma"]}, {"cohort": "Cohort C: MSS-CRC", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Cohort D: Cutaneous Melanoma", "histology_inclusion": "Cutaneous Melanoma"}, {"cohort": "Cohort E: Squamous NSCLC", "histology_inclusion": "Squamous Cell Lung Carcinoma"}, {"cohort": "Cohort F: Small Cell Lung Cancer", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Cohort G: HNSCC", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Cohort H: MSI-H/dMMR CRC", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"]]}]}
{"NCT_id": "NCT04511845", "json": [{"cohort": "Part I", "disease_state": "locally advanced, recurrent, or metastatic solid tumor", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["MAPK pathway alterations positive"], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "Part II - NSCLC cohort", "disease_state": "locally advanced, recurrent, or metastatic solid tumor", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["KRAS mutated"], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "Part II - Ovarian Cancer cohort", "disease_state": "locally advanced, recurrent, or metastatic solid tumor", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["KRAS mutated"], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "Part II - Biopsy cohort", "disease_state": "locally advanced, recurrent, or metastatic solid tumor", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["RAS mutated"], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part I", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MAPK/ERK pathway", null, "pathway"]]}, {"cohort": "Part II - NSCLC cohort", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "Part II - Ovarian Cancer cohort", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "Part II - Ovarian Cancer cohort", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "Part II - Biopsy cohort", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04511871", "json": [{"cohort": "CCT303-406", "disease_state": "stage IV metastatic", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": ["HER2 IHC 3+"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "CCT303-406", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT05097911", "json": [{"cohort": "Advanced HCC patients", "disease_state": "advanced", "histology_inclusion": "Hepatocellular Carcinoma with cirrhosis resulting from hepatitis B, hepatitis C, alcohol-related liver disease or any other aetiology", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Advanced HCC patients", "disease_state": "advanced", "histology_inclusion": "Hepatocellular Carcinoma with or without cirrhosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Advanced HCC patients", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "Advanced HCC patients", "histology_inclusion": "Hepatocellular Carcinoma"}]}
{"NCT_id": "NCT05163028", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS mutation", "EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["KRAS mutation", "EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Pancreatic Cancer", "biomarker_inclusion": ["KRAS mutation", "EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": ["KRAS mutation", "EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT05228015", "json": [{"cohort": "Dose escalation cohort", "disease_state": "advanced, unresectable, locally recurrent, or metastatic", "histology_inclusion": "MPM", "biomarker_inclusion": ["NF2 deficiency"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose escalation cohort", "disease_state": "advanced, unresectable, locally recurrent, or metastatic", "histology_inclusion": "EHE", "biomarker_inclusion": ["TAZ-CAMTA1 fusion", "YAP1-TFE3 fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose escalation cohort", "disease_state": "advanced, unresectable, locally recurrent, or metastatic", "histology_inclusion": "Solid tumors", "biomarker_inclusion": ["YAP1/TAZ gene fusions"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1", "disease_state": "", "histology_inclusion": "MPM", "biomarker_inclusion": ["NF2 deficiency"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "", "histology_inclusion": "NF2-deficient solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "", "histology_inclusion": "EHE", "biomarker_inclusion": ["TAZ-CAMTA1 fusion", "YAP1-TFE3 fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 4", "disease_state": "", "histology_inclusion": "Solid tumors", "biomarker_inclusion": ["YAP1/TAZ gene fusions"], "histology_exclusion": [], "biomarker_exclusion": ["primary CNS tumors"]}], "json_norm": [{"cohort": "Dose escalation cohort", "biomarker_inclusion": [["NF2-Low", "NF2-Low", "expression"]]}, {"cohort": "Dose escalation cohort", "biomarker_inclusion": [["WWTR1 Fusion", "WWTR1", "fusion"], ["YAP1 - TFE3", "YAP1 - TFE3", "coordinate"], ["TFE3 Fusion", "TFE3", "fusion"], ["YAP1 Fusion", "YAP1", "fusion"], ["TAFAZZIN - CAMTA1", "TAFAZZIN - CAMTA1", "coordinate"], ["CAMTA1 Fusion", "CAMTA1", "fusion"], ["TAFAZZIN Fusion", "TAFAZZIN", "fusion"], ["WWTR1 - CAMTA1", "WWTR1 - CAMTA1", "coordinate"]]}, {"cohort": "Dose escalation cohort", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["WWTR1 Fusion", "WWTR1", "fusion"], ["TAFAZZIN Fusion", "TAFAZZIN", "fusion"]]}, {"cohort": "Cohort 1", "biomarker_inclusion": [["NF2-Low", "NF2-Low", "expression"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NF2-Low", "NF2-Low", "expression"]]}, {"cohort": "Cohort 3", "biomarker_inclusion": [["WWTR1 Fusion", "WWTR1", "fusion"], ["YAP1 - TFE3", "YAP1 - TFE3", "coordinate"], ["TFE3 Fusion", "TFE3", "fusion"], ["YAP1 Fusion", "YAP1", "fusion"], ["TAFAZZIN - CAMTA1", "TAFAZZIN - CAMTA1", "coordinate"], ["CAMTA1 Fusion", "CAMTA1", "fusion"], ["TAFAZZIN Fusion", "TAFAZZIN", "fusion"], ["WWTR1 - CAMTA1", "WWTR1 - CAMTA1", "coordinate"]]}, {"cohort": "Cohort 4", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["WWTR1 Fusion", "WWTR1", "fusion"], ["TAFAZZIN Fusion", "TAFAZZIN", "fusion"]]}]}
{"NCT_id": "NCT05488314", "json": [{"cohort": "", "disease_state": "Stage IV (metastatic)", "histology_inclusion": "non-small cell lung cancer (NSCLC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT05488366", "json": [{"cohort": "", "disease_state": "advanced, progressive, recurrent, or metastatic", "histology_inclusion": "soft-tissue sarcoma", "biomarker_inclusion": ["tumor mutational burden \u226510 mut/Mb"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, progressive, recurrent, or metastatic", "histology_inclusion": "undifferentiated pleomorphic sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, progressive, recurrent, or metastatic", "histology_inclusion": "undifferentiated sarcoma (unclassified histology)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Soft Tissue Sarcoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Undifferentiated Pleomorphic Sarcoma"}, {"cohort": "", "histology_inclusion": "Liver Embryonal Sarcoma"}]}
{"NCT_id": "NCT04083170", "json": [{"cohort": "", "disease_state": "High risk in first complete remission (CR1), >= 2 cycles to obtain complete remission (CR), erythroblastic or megakaryocytic leukemia; >= in second complete remission (CR2)", "histology_inclusion": "Acute myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "High risk CR1 (for example, but not limited to: t(9;22), t(1;19), t(4;11) or other mixed-lineage leukemia [MLL] rearrangements, hypodiploid); greater than 1 cycle to obtain CR; >= CR2", "histology_inclusion": "Acute lymphoblastic leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "excluding refractory blast crisis. To be eligible in first chronic phase (CP1) patient must have failed or be intolerant to imatinib mesylate", "histology_inclusion": "Chronic myelogenous leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Myelodysplasia (MDS) International Prognostic Scoring System (IPSS) intermediate (Int)-2 or high risk (i.e., refractory anemia with excess blasts [RAEB], refractory anemia with excess blasts in transformation [RAEBt]) or refractory anemia with severe pancytopenia or high-risk cytogenetics. Blasts must be < 10% by a representative bone marrow aspirate morphology", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Non-Hodgkin Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Non-Hodgkin Lymphoma"}]}
{"NCT_id": "NCT04837716", "json": [{"cohort": "", "disease_state": "Stage IIIC or IV or Recurrent", "histology_inclusion": "ALK-Positive Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"]]}]}
{"NCT_id": "NCT05098132", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Malignant Melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Cervical Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Gastric Cancer", "biomarker_inclusion": ["Microsatellite Instability High"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "GastroEsophageal Cancer", "biomarker_inclusion": ["Microsatellite Instability High"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": ["Microsatellite Instability High"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "", "biomarker_inclusion": ["Mismatch Repair Deficiency"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Melanoma"}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": ""}]}
{"NCT_id": "NCT05163080", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "glioblastoma of the cerebrum", "biomarker_inclusion": [], "histology_exclusion": ["gliosarcoma", "anaplastic astrocytoma", "oligodendroglioma", "ependymoma", "low grade glioma"], "biomarker_exclusion": ["recurrent or progressive glioblastoma"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma", "histology_exclusion": ["Low Grade Glioma", "Ependymoma", "Oligodendroglioma", "Gliosarcoma", "Anaplastic Astrocytoma"]}]}
{"NCT_id": "NCT02638766", "json": [{"cohort": "Unique arm", "disease_state": "metastatic and/or unresectable", "histology_inclusion": "Gastrointestinal Stromal Tumors (GIST)", "biomarker_inclusion": ["KIT wild-type", "PDGFR wild-type"], "histology_exclusion": [], "biomarker_exclusion": ["Imatinib as first line of advanced KIT/PDGFRa wild type GIST"]}], "json_norm": [{"cohort": "Unique arm", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["PDGFRB PDGFRB-wild_type", "PDGFRB-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["KIT KIT-wild_type", "KIT-wild_type", "wild_type"]], "biomarker_exclusion": [["KIT KIT-wild_type", "KIT-wild_type", "wild_type"], ["PDGFRA PDGFRA-wild_type", "PDGFRA-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT03627403", "json": [{"cohort": "Selinexor, all patients", "disease_state": "refractory or intolerant to JAK1/2 inhibitors", "histology_inclusion": "primary myelofibrosis (PMF)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Selinexor, all patients", "disease_state": "refractory or intolerant to JAK1/2 inhibitors", "histology_inclusion": "post-essential thrombocytosis (PET-MF)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Selinexor, all patients", "disease_state": "refractory or intolerant to JAK1/2 inhibitors", "histology_inclusion": "post-polycythemia vera (PPV-MF)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Selinexor, all patients", "histology_inclusion": "Primary Myelofibrosis"}, {"cohort": "Selinexor, all patients"}, {"cohort": "Selinexor, all patients"}]}
{"NCT_id": "NCT04018248", "json": [{"cohort": "Phase Ia", "disease_state": "relapsed/refractory", "histology_inclusion": "B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "Phase Ia", "disease_state": "relapsed/refractory", "histology_inclusion": "CLL/SLL", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "Phase Ia", "disease_state": "relapsed/refractory", "histology_inclusion": "PTCL", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "Phase Ib", "disease_state": "relapsed/refractory", "histology_inclusion": "PTCL NOS", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "Phase Ib", "disease_state": "relapsed/refractory", "histology_inclusion": "PTCL AITL", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "Phase Ib", "disease_state": "relapsed/refractory", "histology_inclusion": "Nodal PTCL with TFH", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "Phase Ib", "disease_state": "relapsed/refractory", "histology_inclusion": "PTCL FTCL", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase Ia", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma"}, {"cohort": "Phase Ia", "histology_inclusion": "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma"}, {"cohort": "Phase Ia", "histology_inclusion": "Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma"}, {"cohort": "Phase Ib", "histology_inclusion": "Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma"}, {"cohort": "Phase Ib", "histology_inclusion": "Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma"}, {"cohort": "Phase Ib", "histology_inclusion": "Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma"}, {"cohort": "Phase Ib", "histology_inclusion": "Follicular T-Cell Lymphoma"}, {"cohort": "Phase Ib", "histology_inclusion": "Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma"}]}
{"NCT_id": "NCT02975934", "json": [{"cohort": "", "disease_state": "metastatic castration-resistant", "histology_inclusion": "adenocarcinoma or poorly differentiated carcinoma of the prostate", "biomarker_inclusion": ["BRCA1/2 mutation", "ATM mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with any PARP inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["ATM Mutation", "ATM-Mutation", "gene"], ["ATM Mutation", "ATM-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["ATM Mutation", "ATM-Mutation", "gene"], ["ATM Mutation", "ATM-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}]}
{"NCT_id": "NCT03953235", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Microsatellite-stable colorectal cancer (MSS-CRC)", "biomarker_inclusion": ["BRAF_G466V", "CTNNB1_S37F", "CTNNB1_S45F", "CTNNB1_S45P", "CTNNB1_T41A", "ERBB2_Y772_A775dup", "KRAS_G12C", "NRAS_G12C", "KRAS_G12D", "NRAS_G12D", "KRAS_G12V", "KRAS_G13D", "KRAS_Q61H", "NRAS_Q61H", "KRAS_Q61K", "NRAS_Q61K", "KRAS_Q61L", "NRAS_Q61L", "KRAS_Q61R", "NRAS_Q61R", "TP53_K132E", "TP53_K132N", "TP53_R213L", "TP53_R249M", "TP53_S127Y"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-high"]}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Non-small cell lung cancer (NSCLC)", "biomarker_inclusion": ["BRAF_G466V", "CTNNB1_S37F", "CTNNB1_S45F", "CTNNB1_S45P", "CTNNB1_T41A", "ERBB2_Y772_A775dup", "KRAS_G12C", "NRAS_G12C", "KRAS_G12D", "NRAS_G12D", "KRAS_G12V", "KRAS_G13D", "KRAS_Q61H", "NRAS_Q61H", "KRAS_Q61K", "NRAS_Q61K", "KRAS_Q61L", "NRAS_Q61L", "KRAS_Q61R", "NRAS_Q61R", "TP53_K132E", "TP53_K132N", "TP53_R213L", "TP53_R249M", "TP53_S127Y"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR", "ALK", "ROS1", "RET", "TRK", "MSI-high"]}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Pancreatic ductal adenocarcinoma (PDA)", "biomarker_inclusion": ["BRAF_G466V", "CTNNB1_S37F", "CTNNB1_S45F", "CTNNB1_S45P", "CTNNB1_T41A", "ERBB2_Y772_A775dup", "KRAS_G12C", "NRAS_G12C", "KRAS_G12D", "NRAS_G12D", "KRAS_G12V", "KRAS_G13D", "KRAS_Q61H", "NRAS_Q61H", "KRAS_Q61K", "NRAS_Q61K", "KRAS_Q61L", "NRAS_Q61L", "KRAS_Q61R", "NRAS_Q61R", "TP53_K132E", "TP53_K132N", "TP53_R213L", "TP53_R249M", "TP53_S127Y"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-high"]}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Shared Neoantigen-Positive Solid Tumors", "biomarker_inclusion": ["BRAF_G466V", "CTNNB1_S37F", "CTNNB1_S45F", "CTNNB1_S45P", "CTNNB1_T41A", "ERBB2_Y772_A775dup", "KRAS_G12C", "NRAS_G12C", "KRAS_G12D", "NRAS_G12D", "KRAS_G12V", "KRAS_G13D", "KRAS_Q61H", "NRAS_Q61H", "KRAS_Q61K", "NRAS_Q61K", "KRAS_Q61L", "NRAS_Q61L", "KRAS_Q61R", "NRAS_Q61R", "TP53_K132E", "TP53_K132N", "TP53_R213L", "TP53_R249M", "TP53_S127Y"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-high"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["NRAS Q61L", "Q61L", "coordinate"], ["KRAS Q61R", "Q61R", "coordinate"], ["TP53 R213L", "R213L", "coordinate"], ["KRAS Q61H", "Q61H", "coordinate"], ["KRAS G12V", "G12V", "coordinate"], ["CTNNB1 S45P", "S45P", "coordinate"], ["KRAS Q61K", "Q61K", "coordinate"], ["NRAS Q61H", "Q61H", "coordinate"], ["KRAS G13D", "G13D", "coordinate"], ["TP53 K132E", "K132E", "coordinate"], ["NRAS G12D", "G12D", "coordinate"], ["CTNNB1 S37F", "S37F", "coordinate"], ["NRAS Q61K", "Q61K", "coordinate"], ["ERBB2 exon 20 indel", "Y772_A775dup", "exon"], ["CTNNB1 S45F", "S45F", "coordinate"], ["NRAS Q61R", "Q61R", "coordinate"], ["BRAF G466V", "G466V", "coordinate"], ["KRAS G12D", "G12D", "coordinate"], ["NRAS G12C", "G12C", "coordinate"], ["TP53 K132N", "K132N", "coordinate"], ["CTNNB1 T41A", "T41A", "coordinate"], ["TP53 R249M", "R249M", "coordinate"], ["KRAS Q61L", "Q61L", "coordinate"], ["TP53 S127Y", "S127Y", "coordinate"], ["KRAS G12C", "G12C", "coordinate"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["NRAS Q61L", "Q61L", "coordinate"], ["KRAS Q61R", "Q61R", "coordinate"], ["TP53 R213L", "R213L", "coordinate"], ["KRAS Q61H", "Q61H", "coordinate"], ["KRAS G12V", "G12V", "coordinate"], ["CTNNB1 S45P", "S45P", "coordinate"], ["KRAS Q61K", "Q61K", "coordinate"], ["NRAS Q61H", "Q61H", "coordinate"], ["KRAS G13D", "G13D", "coordinate"], ["TP53 K132E", "K132E", "coordinate"], ["NRAS G12D", "G12D", "coordinate"], ["CTNNB1 S37F", "S37F", "coordinate"], ["NRAS Q61K", "Q61K", "coordinate"], ["ERBB2 exon 20 indel", "Y772_A775dup", "exon"], ["CTNNB1 S45F", "S45F", "coordinate"], ["NRAS Q61R", "Q61R", "coordinate"], ["BRAF G466V", "G466V", "coordinate"], ["KRAS G12D", "G12D", "coordinate"], ["NRAS G12C", "G12C", "coordinate"], ["TP53 K132N", "K132N", "coordinate"], ["CTNNB1 T41A", "T41A", "coordinate"], ["TP53 R249M", "R249M", "coordinate"], ["KRAS Q61L", "Q61L", "coordinate"], ["TP53 S127Y", "S127Y", "coordinate"], ["KRAS G12C", "G12C", "coordinate"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": [["NRAS Q61L", "Q61L", "coordinate"], ["KRAS Q61R", "Q61R", "coordinate"], ["TP53 R213L", "R213L", "coordinate"], ["KRAS Q61H", "Q61H", "coordinate"], ["KRAS G12V", "G12V", "coordinate"], ["CTNNB1 S45P", "S45P", "coordinate"], ["KRAS Q61K", "Q61K", "coordinate"], ["NRAS Q61H", "Q61H", "coordinate"], ["KRAS G13D", "G13D", "coordinate"], ["TP53 K132E", "K132E", "coordinate"], ["NRAS G12D", "G12D", "coordinate"], ["CTNNB1 S37F", "S37F", "coordinate"], ["NRAS Q61K", "Q61K", "coordinate"], ["ERBB2 exon 20 indel", "Y772_A775dup", "exon"], ["CTNNB1 S45F", "S45F", "coordinate"], ["NRAS Q61R", "Q61R", "coordinate"], ["BRAF G466V", "G466V", "coordinate"], ["KRAS G12D", "G12D", "coordinate"], ["NRAS G12C", "G12C", "coordinate"], ["TP53 K132N", "K132N", "coordinate"], ["CTNNB1 T41A", "T41A", "coordinate"], ["TP53 R249M", "R249M", "coordinate"], ["KRAS Q61L", "Q61L", "coordinate"], ["TP53 S127Y", "S127Y", "coordinate"], ["KRAS G12C", "G12C", "coordinate"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NRAS Q61L", "Q61L", "coordinate"], ["KRAS Q61R", "Q61R", "coordinate"], ["TP53 R213L", "R213L", "coordinate"], ["KRAS Q61H", "Q61H", "coordinate"], ["KRAS G12V", "G12V", "coordinate"], ["CTNNB1 S45P", "S45P", "coordinate"], ["KRAS Q61K", "Q61K", "coordinate"], ["NRAS Q61H", "Q61H", "coordinate"], ["KRAS G13D", "G13D", "coordinate"], ["TP53 K132E", "K132E", "coordinate"], ["NRAS G12D", "G12D", "coordinate"], ["CTNNB1 S37F", "S37F", "coordinate"], ["NRAS Q61K", "Q61K", "coordinate"], ["ERBB2 exon 20 indel", "Y772_A775dup", "exon"], ["CTNNB1 S45F", "S45F", "coordinate"], ["NRAS Q61R", "Q61R", "coordinate"], ["BRAF G466V", "G466V", "coordinate"], ["KRAS G12D", "G12D", "coordinate"], ["NRAS G12C", "G12C", "coordinate"], ["TP53 K132N", "K132N", "coordinate"], ["CTNNB1 T41A", "T41A", "coordinate"], ["TP53 R249M", "R249M", "coordinate"], ["KRAS Q61L", "Q61L", "coordinate"], ["TP53 S127Y", "S127Y", "coordinate"], ["KRAS G12C", "G12C", "coordinate"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04278768", "json": [{"cohort": "Phase 1 Dose Escalation (Monotherapy)", "disease_state": "AML (primary or secondary, including treatment-related) after failing at least 1 standard treatment", "histology_inclusion": "Acute Myelogenous Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1 Dose Escalation (Monotherapy)", "disease_state": "High-risk R/R MDS resistant/refractory following at least 2 to 3 cycles of HMA or evidence of early progression", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b (Combination Therapy) Doublet Arm: emavusertib + AZA", "disease_state": "IPSS-R High, high risk myelodysplastic syndrome (hrMDS) ineligible for intensive chemotherapy", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b (Combination Therapy) Doublet Arm: emavusertib + Venetoclax", "disease_state": "R/R AML or hrMDS, after first line therapy", "histology_inclusion": "Acute Myelogenous Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2a Dose Expansion (Monotherapy)", "disease_state": "R/R AML with FLT3 mutations, R/R including a FLT3 inhibitor", "histology_inclusion": "Acute Myelogenous Leukemia", "biomarker_inclusion": ["FLT3 mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2a Dose Expansion (Monotherapy)", "disease_state": "R/R AML with spliceosome mutations of SF3B1 or U2AF1", "histology_inclusion": "Acute Myelogenous Leukemia", "biomarker_inclusion": ["SF3B1 mutations", "U2AF1 mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2a Dose Expansion (Monotherapy)", "disease_state": "R/R hrMDS with spliceosome mutations of SF3B1 or U2AF1; bone marrow blast count >= 8%; ineligible for intensive chemotherapy", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": ["SF3B1 mutations", "U2AF1 mutations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1 Dose Escalation (Monotherapy)", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "Phase 1 Dose Escalation (Monotherapy)", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "Phase 1b (Combination Therapy) Doublet Arm: emavusertib + AZA", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "Phase 1b (Combination Therapy) Doublet Arm: emavusertib + Venetoclax", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "Phase 2a Dose Expansion (Monotherapy)", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]]}, {"cohort": "Phase 2a Dose Expansion (Monotherapy)", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["SF3B2 Mutation", "SF3B2-Mutation", "gene"], ["U2AF1 Mutation", "U2AF1-Mutation", "gene"], ["SF3B1 Mutation", "SF3B1-Mutation", "gene"]]}, {"cohort": "Phase 2a Dose Expansion (Monotherapy)", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["SF3B2 Mutation", "SF3B2-Mutation", "gene"], ["U2AF1 Mutation", "U2AF1-Mutation", "gene"], ["SF3B1 Mutation", "SF3B1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04278781", "json": [{"cohort": "Chondrosarcoma", "disease_state": "advanced/metastatic or recurrent", "histology_inclusion": "Chondrosarcoma, Grade 2", "biomarker_inclusion": ["IDH1 mutation"], "histology_exclusion": ["Chondrosarcoma, Grade 1", "dedifferentiated chondrosarcoma"], "biomarker_exclusion": []}, {"cohort": "Chondrosarcoma", "disease_state": "advanced/metastatic or recurrent", "histology_inclusion": "Chondrosarcoma, Grade 3", "biomarker_inclusion": ["IDH1 mutation"], "histology_exclusion": ["Chondrosarcoma, Grade 1", "dedifferentiated chondrosarcoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Chondrosarcoma", "histology_inclusion": "Chondrosarcoma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]], "histology_exclusion": ["Dedifferentiated Chondrosarcoma", "Chondrosarcoma"]}, {"cohort": "Chondrosarcoma", "histology_inclusion": "Chondrosarcoma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]], "histology_exclusion": ["Dedifferentiated Chondrosarcoma", "Chondrosarcoma"]}]}
{"NCT_id": "NCT04447118", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": ["HER2 Exon 20 Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04903119", "json": [{"cohort": "", "disease_state": "metastatic or unresectable melanoma", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma"}]}
{"NCT_id": "NCT05098405", "json": [{"cohort": "", "disease_state": "relapsed/refractory advanced", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory advanced", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory advanced", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory advanced", "histology_inclusion": "gastric cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory advanced", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory advanced", "histology_inclusion": "anal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory advanced", "histology_inclusion": "cervical cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory advanced", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory advanced", "histology_inclusion": "mesothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory advanced", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory advanced", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory advanced", "histology_inclusion": "urothelial/bladder cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory advanced", "histology_inclusion": "microsatellite instability high cancer", "biomarker_inclusion": ["MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory advanced", "histology_inclusion": "cutaneous squamous cell cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory advanced", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "", "histology_inclusion": "Anal Neoplasm"}, {"cohort": "", "histology_inclusion": "Anal Carcinoma"}, {"cohort": "", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Mesothelioma"}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Melanoma"}, {"cohort": "", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": "", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Skin Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma"}]}
{"NCT_id": "NCT05488821", "json": [{"cohort": "", "disease_state": "metastatic or unresectable advanced solid tumors", "histology_inclusion": "solid tumors with MAPK signaling pathway alteration", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04382300", "json": [{"cohort": "", "disease_state": "advanced (IIIB or IV)", "histology_inclusion": "non-small-cell lung cancer", "biomarker_inclusion": ["HER2 exon 20 insertions"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutations", "T790M resistance mutations", "ALK fusions", "ROS1 fusions", "RET rearrangements", "BRAF V600E mutations", "NTRK fusions", "MET exon 14 skipping"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["RET Fusion", "RET", "fusion"], ["NTRK1 Fusion", "NTRK1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"], ["MET exon 14 del", "exon 14 del", "exon"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["BRAF V600E", "V600E", "coordinate"], ["ROS1 Fusion", "ROS1", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}]}
{"NCT_id": "NCT04512430", "json": [{"cohort": "", "disease_state": "stage IIIA", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutation (Del Exon 19)", "EGFR mutation (ins Exon 21)"], "histology_exclusion": [], "biomarker_exclusion": ["other EGFR mutations", "ALK fusion oncogene", "STK11 ligand alteration", "ROS1 translocations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR exon 19 del", "exon 19 del", "exon"]], "biomarker_exclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["STK11 Mutation", "STK11-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT02835222", "json": [{"cohort": "", "disease_state": "newly diagnosed de novo Acute Myeloid Leukemia (non-APL)", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["core binding factor acute myeloid leukemia (AML) (ie AML with t(8;21) or t(16;16) or i16)", "Acute Promyelocytic Leukemia"], "biomarker_exclusion": ["FLT3 mutation (either ITD OR TKD mutations) for patients \u226460 years of age", "partial or total monosomy 5", "partial or total monosomy 7", "i(17q)", "t(17p)"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Acute Myeloid Leukemia (AML)"], "biomarker_exclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]]}]}
{"NCT_id": "NCT04214067", "json": [{"cohort": "", "disease_state": "Stage I", "histology_inclusion": "Endometrioid Endometrial Cancer", "biomarker_inclusion": ["dMMR"], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1", "anti-CTLA-4"]}, {"cohort": "", "disease_state": "Stage II", "histology_inclusion": "Endometrioid Endometrial Cancer", "biomarker_inclusion": ["dMMR"], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1", "anti-CTLA-4"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04708054", "json": [{"cohort": "", "disease_state": "high-risk", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": ["ELN17 adverse risk", "measurable residual disease positive", "not in complete remission", "AML secondary to MDS or MPD"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": ["HIV positive", "active CNS involvement with AML"]}, {"cohort": "", "disease_state": "high-risk", "histology_inclusion": "myelodysplastic syndrome", "biomarker_inclusion": ["poor or very poor cytogenetic risk group as per IPSS-R", "mutated P53", "Ras pathway genes (CBL, NRAS, KRAS, NF1, PTPN1)", "DNMT 3a", "ASXL1", "RUNX1", "maximum IPSS-R >3.5", "\u2265 5% BM blasts at transplant"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": ["HIV positive", "active CNS involvement with AML"]}, {"cohort": "", "disease_state": "high-risk", "histology_inclusion": "chronic myelomonocytic leukemia", "biomarker_inclusion": ["poor or very poor cytogenetic risk group as per IPSS-R", "mutated P53", "Ras pathway genes (CBL, NRAS, KRAS, NF1, PTPN1)", "DNMT 3a", "ASXL1", "RUNX1", "maximum IPSS-R >3.5", "\u2265 5% BM blasts at transplant"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": ["HIV positive", "active CNS involvement with AML"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT05033691", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": ["leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT05424016", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Hemangioblastoma of CNS", "biomarker_inclusion": ["Von Hippel-Lindau Disease"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Hemangioblastoma"}]}
{"NCT_id": "NCT02704858", "json": [{"cohort": "", "disease_state": "recurrent or progressive", "histology_inclusion": "Grade IV glioma", "biomarker_inclusion": ["IDH1 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}]}
{"NCT_id": "NCT02769962", "json": [{"cohort": "Phase I", "disease_state": "advanced solid tumor", "histology_inclusion": "advanced solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II SCLC", "disease_state": "relapsed or progressive", "histology_inclusion": "Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase I", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase II SCLC", "histology_inclusion": "Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT03497767", "json": [{"cohort": "First-line metastatic cancer", "disease_state": "Metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR exon 19 del", "EGFR L858R", "EGFR G719X", "EGFR L861G", "EGFR S768I", "EGFR T790M"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Second-line metastatic cancer (T790M+)", "disease_state": "Metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR T790M"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Second-line metastatic cancer (T790M-)", "disease_state": "Metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR T790M"]}], "json_norm": [{"cohort": "First-line metastatic cancer", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR T790M", "T790M", "coordinate"], ["EGFR S768I", "S768I", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}, {"cohort": "Second-line metastatic cancer (T790M+)", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR T790M", "T790M", "coordinate"]]}, {"cohort": "Second-line metastatic cancer (T790M-)", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"]]}]}
{"NCT_id": "NCT04018872", "json": [{"cohort": "", "disease_state": "localized (locoregional)", "histology_inclusion": "esophageal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "localized (locoregional)", "histology_inclusion": "gastroesophageal junction cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Esophageal Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}]}
{"NCT_id": "NCT04083976", "json": [{"cohort": "", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": ["FGFR mutation", "FGFR gene fusion"], "histology_exclusion": ["urothelial carcinoma", "hematologic malignancy"], "biomarker_exclusion": ["FGFR gatekeeper mutation", "FGFR resistance mutation", "EGFR mutation", "ALK gene fusion", "ROS1 gene fusion", "NTRK gene fusion", "BRAF V600E mutation", "KRAS mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR1 Fusion", "FGFR1", "fusion"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR4 Fusion", "FGFR4", "fusion"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"], ["FGFR3 Fusion", "FGFR3", "fusion"]], "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm", "Urothelial Carcinoma"], "biomarker_exclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["NTRK1 Fusion", "NTRK1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"], ["BRAF V600E", "V600E", "coordinate"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}]}
{"NCT_id": "NCT04643041", "json": [{"cohort": "", "disease_state": "TxNxM0", "histology_inclusion": "rectal adenocarcinoma", "biomarker_inclusion": ["dMMR", "MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Rectal Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT05489237", "json": [{"cohort": "Phase 1", "disease_state": "metastatic and/or surgically unresectable", "histology_inclusion": "Gastrointestinal Stromal Tumor (GIST)", "biomarker_inclusion": ["KIT mutation", "PDGFRA mutation (excluding exon 18 mutations)"], "histology_exclusion": ["primary CNS malignancy"], "biomarker_exclusion": ["KIT and PDGFRA wild-type"]}, {"cohort": "Phase 1b Cohort 1", "disease_state": "metastatic and/or surgically unresectable", "histology_inclusion": "Gastrointestinal Stromal Tumor (GIST)", "biomarker_inclusion": ["KIT mutation", "PDGFRA mutation (excluding exon 18 mutations)"], "histology_exclusion": ["primary CNS malignancy"], "biomarker_exclusion": ["KIT and PDGFRA wild-type"]}, {"cohort": "Phase 1b Cohort 2", "disease_state": "metastatic and/or surgically unresectable", "histology_inclusion": "Gastrointestinal Stromal Tumor (GIST)", "biomarker_inclusion": ["KIT mutation", "PDGFRA mutation (excluding exon 18 mutations)"], "histology_exclusion": ["primary CNS malignancy"], "biomarker_exclusion": ["KIT and PDGFRA wild-type"]}, {"cohort": "Phase 1b Cohort 3", "disease_state": "metastatic and/or surgically unresectable", "histology_inclusion": "Gastrointestinal Stromal Tumor (GIST)", "biomarker_inclusion": ["KIT mutation", "PDGFRA mutation (excluding exon 18 mutations)"], "histology_exclusion": ["primary CNS malignancy"], "biomarker_exclusion": ["KIT and PDGFRA wild-type"]}], "json_norm": [{"cohort": "Phase 1", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["PDGFRA Mutation", "PDGFRA-Mutation", "gene"], ["KIT Mutation", "KIT-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"], "biomarker_exclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["PDGFRA PDGFRA-wild_type", "PDGFRA-wild_type", "wild_type"], ["KIT KIT-wild_type", "KIT-wild_type", "wild_type"]]}, {"cohort": "Phase 1b Cohort 1", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["PDGFRA Mutation", "PDGFRA-Mutation", "gene"], ["KIT Mutation", "KIT-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"], "biomarker_exclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["PDGFRA PDGFRA-wild_type", "PDGFRA-wild_type", "wild_type"], ["KIT KIT-wild_type", "KIT-wild_type", "wild_type"]]}, {"cohort": "Phase 1b Cohort 2", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["PDGFRA Mutation", "PDGFRA-Mutation", "gene"], ["KIT Mutation", "KIT-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"], "biomarker_exclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["PDGFRA PDGFRA-wild_type", "PDGFRA-wild_type", "wild_type"], ["KIT KIT-wild_type", "KIT-wild_type", "wild_type"]]}, {"cohort": "Phase 1b Cohort 3", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["PDGFRA Mutation", "PDGFRA-Mutation", "gene"], ["KIT Mutation", "KIT-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"], "biomarker_exclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["PDGFRA PDGFRA-wild_type", "PDGFRA-wild_type", "wild_type"], ["KIT KIT-wild_type", "KIT-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT05554328", "json": [{"cohort": "Cohort 1", "disease_state": "recurrent or persistent", "histology_inclusion": "ovarian, primary peritoneal, or fallopian tube cancer", "biomarker_inclusion": ["KRAS mutation", "NRAS mutation", "HRAS mutation", "BRAF mutation", "MEK1 mutation", "MEK2 mutation", "NF1 inactivating mutation"], "histology_exclusion": [], "biomarker_exclusion": ["progressed while receiving a PARP inhibitor", "received any MEK inhibitors"]}, {"cohort": "Cohort 2", "disease_state": "recurrent or persistent", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["KRAS mutation", "NRAS mutation", "HRAS mutation", "BRAF mutation", "MEK1 mutation", "MEK2 mutation", "NF1 inactivating mutation"], "histology_exclusion": [], "biomarker_exclusion": ["progressed while receiving a PARP inhibitor", "received any MEK inhibitors"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["MAP2K1 Mutation", "MAP2K1-Mutation", "gene"], ["NF1 Mutation", "NF1-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["MAP2K2 Mutation", "MAP2K2-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["MAP2K1 Mutation", "MAP2K1-Mutation", "gene"], ["NF1 Mutation", "NF1-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["MAP2K2 Mutation", "MAP2K2-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}]}
{"NCT_id": "NCT05554354", "json": [{"cohort": "Cohort I (Arm I) (fulvestrant, binimetinib)", "disease_state": "Metastatic", "histology_inclusion": "Hormone Receptor-Positive Breast Carcinoma", "biomarker_inclusion": ["NF1 nonsense mutation", "NF1 frameshift mutation", "NF1 whole gene deletion"], "histology_exclusion": ["HER2-positive"], "biomarker_exclusion": []}, {"cohort": "Cohort I (Arm II)", "disease_state": "Metastatic", "histology_inclusion": "Hormone Receptor-Positive Breast Carcinoma", "biomarker_inclusion": ["NF1 nonsense mutation", "NF1 frameshift mutation", "NF1 whole gene deletion"], "histology_exclusion": ["HER2-positive"], "biomarker_exclusion": []}, {"cohort": "Cohort II (fulvestrant, binimetinib)", "disease_state": "Metastatic", "histology_inclusion": "Hormone Receptor-Positive Breast Carcinoma", "biomarker_inclusion": ["NF1 nonsense mutation", "NF1 frameshift mutation", "NF1 whole gene deletion"], "histology_exclusion": ["HER2-positive"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort I (Arm I) (fulvestrant, binimetinib)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["NF1 Mutation", "NF1-Mutation", "gene"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort I (Arm I) (fulvestrant, binimetinib)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["NF1 Mutation", "NF1-Mutation", "gene"], ["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort I (Arm II)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["NF1 Mutation", "NF1-Mutation", "gene"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort I (Arm II)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["NF1 Mutation", "NF1-Mutation", "gene"], ["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort II (fulvestrant, binimetinib)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["NF1 Mutation", "NF1-Mutation", "gene"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort II (fulvestrant, binimetinib)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["NF1 Mutation", "NF1-Mutation", "gene"], ["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT05554380", "json": [{"cohort": "", "disease_state": "locally advanced, unresectable, or metastatic", "histology_inclusion": "non-breast solid malignancy", "biomarker_inclusion": ["AKT1 mutation", "AKT2 mutation", "AKT3 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["KRAS mutation", "NRAS mutation", "HRAS mutation", "BRAF mutation"]}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["AKT1 Mutation", "AKT1-Mutation", "gene"], ["AKT2 Mutation", "AKT2-Mutation", "gene"], ["AKT3 Mutation", "AKT3-Mutation", "gene"]], "biomarker_exclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT03693339", "json": [{"cohort": "", "disease_state": "unresectable stage IIIB/IV", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["MET exon 14 skipping alteration"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]]}]}
{"NCT_id": "NCT03953898", "json": [{"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH1 R132V", "IDH1 R132G", "IDH1 R132S", "IDH1 R132L", "IDH1 R132C", "IDH1 R132H"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH2 R140W", "IDH2 R140L", "IDH2 R140Q", "IDH2 R172W", "IDH2 R172G", "IDH2 R172S", "IDH2 R172M", "IDH2 R172K"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": ["IDH1 R132V", "IDH1 R132G", "IDH1 R132S", "IDH1 R132L", "IDH1 R132C", "IDH1 R132H"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": ["IDH2 R140W", "IDH2 R140L", "IDH2 R140Q", "IDH2 R172W", "IDH2 R172G", "IDH2 R172S", "IDH2 R172M", "IDH2 R172K"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH1 R132C", "R132C", "coordinate"], ["IDH1 R132S", "R132S", "coordinate"], ["IDH1 R132L", "R132L", "coordinate"], ["IDH1 R132H", "R132H", "coordinate"], ["IDH1 R132G", "R132G", "coordinate"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH2 R140L", "R140L", "coordinate"], ["IDH2 R172W", "R172W", "coordinate"], ["IDH2 R172S", "R172S", "coordinate"], ["IDH2 R172M", "R172M", "coordinate"], ["IDH2 R172G", "R172G", "coordinate"], ["IDH2 R140Q", "R140Q", "coordinate"], ["IDH2 R140W", "R140W", "coordinate"], ["IDH2 R172K", "R172K", "coordinate"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["IDH1 R132C", "R132C", "coordinate"], ["IDH1 R132S", "R132S", "coordinate"], ["IDH1 R132L", "R132L", "coordinate"], ["IDH1 R132H", "R132H", "coordinate"], ["IDH1 R132G", "R132G", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["IDH2 R140L", "R140L", "coordinate"], ["IDH2 R172W", "R172W", "coordinate"], ["IDH2 R172S", "R172S", "coordinate"], ["IDH2 R172M", "R172M", "coordinate"], ["IDH2 R172G", "R172G", "coordinate"], ["IDH2 R140Q", "R140Q", "coordinate"], ["IDH2 R140W", "R140W", "coordinate"], ["IDH2 R172K", "R172K", "coordinate"]]}]}
{"NCT_id": "NCT04214249", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["FLT3-mutated AML"]}, {"cohort": "", "disease_state": "secondary", "histology_inclusion": "Acute Myeloid Leukemia arising from prior myelodysplastic syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["FLT3-mutated AML"]}, {"cohort": "", "disease_state": "therapy-related", "histology_inclusion": "Therapy-Related Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["FLT3-mutated AML"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_exclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_exclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_exclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Therapy-Related Acute Myeloid Leukemia", "biomarker_exclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]]}]}
{"NCT_id": "NCT04214262", "json": [{"cohort": "", "disease_state": "stage I-IIA or limited T3N0M0", "histology_inclusion": "non-small cell lung cancer (NSCLC)", "biomarker_inclusion": [], "histology_exclusion": ["clinically significant interstitial lung disease", "active pneumonitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04382664", "json": [{"cohort": "", "disease_state": "unresectable stage IIIB D, or unresectable stage IV", "histology_inclusion": "malignant melanoma", "biomarker_inclusion": [], "histology_exclusion": ["uveal or ocular melanoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "histology_exclusion": ["Ocular Melanoma"]}]}
{"NCT_id": "NCT05099003", "json": [{"cohort": "Stratum DIPG", "disease_state": "newly-diagnosed", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum DIPG", "disease_state": "newly-diagnosed", "histology_inclusion": "Anaplastic Astrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum DIPG", "disease_state": "newly-diagnosed", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum DIPG", "disease_state": "newly-diagnosed", "histology_inclusion": "High-Grade Glioma Not Otherwise Specified", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum DMG", "disease_state": "newly-diagnosed", "histology_inclusion": "Diffuse Midline Glioma", "biomarker_inclusion": ["H3 K27M-mutant"], "histology_exclusion": [], "biomarker_exclusion": ["BRAF V600", "IDH1"]}, {"cohort": "Stratum HGG", "disease_state": "newly-diagnosed", "histology_inclusion": "High-Grade Glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["H3 K27M", "BRAF V600", "IDH1"]}], "json_norm": [{"cohort": "Stratum DIPG", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma"}, {"cohort": "Stratum DIPG", "histology_inclusion": "Anaplastic Astrocytoma"}, {"cohort": "Stratum DIPG", "histology_inclusion": "Glioblastoma"}, {"cohort": "Stratum DIPG", "histology_inclusion": "Malignant Glioma"}, {"cohort": "Stratum DMG", "histology_inclusion": "Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "Stratum HGG", "histology_inclusion": "Malignant Glioma", "biomarker_exclusion": [["H3-3A K28M", "K28M", "coordinate"]]}]}
{"NCT_id": "NCT03758664", "json": [{"cohort": "", "disease_state": "unresectable or metastatic advanced malignant solid tumor", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastasis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable, recurrent or metastatic (AJCC version 8 TNM staging IV (2017), biliary tract malignant tumor", "histology_inclusion": "biliary tract malignant tumor", "biomarker_inclusion": ["FGFR2 translocation/fusion"], "histology_exclusion": ["central nervous system metastasis"], "biomarker_exclusion": ["previous treatment with FGFR small molecule inhibitors or antibody drugs"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Neoplasm", "biomarker_inclusion": [["FGFR2 Fusion", "FGFR2", "fusion"]]}]}
{"NCT_id": "NCT04214392", "json": [{"cohort": "", "disease_state": "Recurrent or Progressive", "histology_inclusion": "Grade IV Glioblastoma", "biomarker_inclusion": ["MMP2+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Recurrent or Progressive", "histology_inclusion": "Grade II or III Malignant Brain Tumor", "biomarker_inclusion": ["MMP2+"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["MMP2-High", "MMP2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Malignant Brain Neoplasm", "biomarker_inclusion": [["MMP2-High", "MMP2-High", "expression"]]}]}
{"NCT_id": "NCT04214418", "json": [{"cohort": "Phase 2: Cohort 1", "disease_state": "Advanced", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": ["KRAS-activating mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2: Cohort 2", "disease_state": "Advanced", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": ["KRAS-activating mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2: Cohort 3", "disease_state": "Advanced", "histology_inclusion": "Histology Agnostic Adenocarcinoma", "biomarker_inclusion": ["KRAS-activating mutation"], "histology_exclusion": ["Pancreatic Adenocarcinoma", "Colorectal Adenocarcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 2: Cohort 1", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "Phase 2: Cohort 2", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "Phase 2: Cohort 3", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]], "histology_exclusion": ["Pancreatic Adenocarcinoma", "Colorectal Adenocarcinoma"]}]}
{"NCT_id": "NCT04903873", "json": [{"cohort": "Dose Expansion Cohort 1", "disease_state": "metastatic or locally advanced", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["MSI-H", "MSS"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Cohort 2", "disease_state": "metastatic or locally advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR", "ALK", "ROS1"]}], "json_norm": [{"cohort": "Dose Expansion Cohort 1", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Dose Expansion Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04968990", "json": [{"cohort": "Favorable Histology Stage I & II and FH Stage III/IV", "disease_state": "Stage I, II, III, IV", "histology_inclusion": "Wilms Tumor", "biomarker_inclusion": [], "histology_exclusion": ["anaplastic", "non-Wilms histology"], "biomarker_exclusion": []}, {"cohort": "Stage III & IV Adjuvant RT and Stage V", "disease_state": "Stage III, IV, V", "histology_inclusion": "Wilms Tumor", "biomarker_inclusion": [], "histology_exclusion": ["anaplastic", "non-Wilms histology"], "biomarker_exclusion": []}, {"cohort": "Stage V Adjuvant RT", "disease_state": "Stage V", "histology_inclusion": "Wilms Tumor", "biomarker_inclusion": [], "histology_exclusion": ["anaplastic", "non-Wilms histology"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Favorable Histology Stage I & II and FH Stage III/IV", "histology_inclusion": "Wilms Tumor"}, {"cohort": "Stage III & IV Adjuvant RT and Stage V", "histology_inclusion": "Wilms Tumor"}, {"cohort": "Stage V Adjuvant RT", "histology_inclusion": "Wilms Tumor"}]}
{"NCT_id": "NCT04969029", "json": [{"cohort": "", "disease_state": "T4NX/TXN+ colon cancer", "histology_inclusion": "Colonic adenocarcinoma", "biomarker_inclusion": ["MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "T4NX/TXN+ colon cancer", "histology_inclusion": "Colonic adenocarcinoma", "biomarker_inclusion": ["POLE mutation", "POLD1 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["POLE Mutation", "POLE-Mutation", "gene"], ["POLD1 Mutation", "POLD1-Mutation", "gene"]]}]}
{"NCT_id": "NCT05099172", "json": [{"cohort": "", "disease_state": "locally advanced, recurrent or metastatic", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutation", "HER2 mutation"], "histology_exclusion": ["small cell or mixed histologies"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}]}
{"NCT_id": "NCT03367702", "json": [{"cohort": "", "disease_state": "Stage IIA-B", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": ["Gleason 7(3+4) with PSA < 20 ng/mL", "Gleason 6(3+3) with PSA > 10 ng/mL and < 20 ng/mL", "Group Grade 1 with PSA > 10 ng/mL and < 20 ng/mL", "Group Grade 2 with PSA < 20 ng/mL"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT04019327", "json": [{"cohort": "Metastatic Castration Resistant Prostate Cancer", "disease_state": "metastatic castration resistant", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["pathogenic or likely pathogenic germline or somatic mutation in BRCA 1", "pathogenic or likely pathogenic germline or somatic mutation in BRCA 2", "pathogenic or likely pathogenic germline or somatic mutation in ATM", "pathogenic or likely pathogenic germline or somatic mutation in FANCA", "pathogenic or likely pathogenic germline or somatic mutation in CHECK2", "pathogenic or likely pathogenic germline or somatic mutation in PALB2", "pathogenic or likely pathogenic germline or somatic mutation in MRE11A", "pathogenic or likely pathogenic germline or somatic mutation in NBN", "pathogenic or likely pathogenic germline or somatic mutation in RAD51C", "pathogenic or likely pathogenic germline or somatic mutation in ATR", "pathogenic or likely pathogenic germline or somatic mutation in MLH1", "pathogenic or likely pathogenic germline or somatic mutation in CDK12", "brain metastasis", "active leptomeningeal disease"]}], "json_norm": [{"cohort": "Metastatic Castration Resistant Prostate Cancer", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_exclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["MLH1 Mutation", "MLH1-Mutation", "gene"], ["CDK12 Mutation", "CDK12-Mutation", "gene"], ["RAD51C Mutation", "RAD51C-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["ARTN Mutation", "ARTN-Mutation", "gene"], ["MRE11 Mutation", "MRE11-Mutation", "gene"], ["NBN Mutation", "NBN-Mutation", "gene"], ["SERPINA2 Mutation", "SERPINA2-Mutation", "gene"], ["FANCA Mutation", "FANCA-Mutation", "gene"], ["ANTXR1 Mutation", "ANTXR1-Mutation", "gene"], ["ATR Mutation", "ATR-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT05554744", "json": [{"cohort": "MEN1-1-related pNETs", "disease_state": "", "histology_inclusion": "Multiple Endocrine Neoplasia Type 1-related Pancreatic Neuroendocrine Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "MEN1-1-related pNETs", "histology_inclusion": "Pancreatic Neuroendocrine Neoplasm"}, {"cohort": "MEN1-1-related pNETs", "histology_inclusion": "Pancreatic Neuroendocrine Carcinoma"}, {"cohort": "MEN1-1-related pNETs", "histology_inclusion": "Pancreatic Neuroendocrine Tumor"}]}
{"NCT_id": "NCT02444000", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Anaplastic Gliomas", "biomarker_inclusion": ["1p/19q Codeletion"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}]}
{"NCT_id": "NCT04773782", "json": [{"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["KIT mutation", "PDGFRA mutation"], "histology_exclusion": ["CNS tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "failed standard therapy", "histology_inclusion": "H3K27M mutant glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["PDGFRA Mutation", "PDGFRA-Mutation", "gene"], ["KIT Mutation", "KIT-Mutation", "gene"]], "histology_exclusion": ["Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}]}
{"NCT_id": "NCT04149691", "json": [{"cohort": "Part 1", "disease_state": "advanced, refractory", "histology_inclusion": "gastric cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "advanced, refractory", "histology_inclusion": "bladder cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "advanced, refractory", "histology_inclusion": "squamous lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "advanced, refractory", "histology_inclusion": "non-small cell lung cancer with squamous immunophenotype", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "advanced, refractory", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "advanced, refractory", "histology_inclusion": "sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "advanced, refractory", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2 and 3", "disease_state": "advanced, refractory", "histology_inclusion": "gastric cancer", "biomarker_inclusion": ["FGFR 1", "FGFR 2", "FGFR 3"], "histology_exclusion": [], "biomarker_exclusion": ["another FGFR inhibitor"]}, {"cohort": "Part 2 and 3", "disease_state": "advanced, refractory", "histology_inclusion": "bladder cancer", "biomarker_inclusion": ["FGFR 1", "FGFR 2", "FGFR 3"], "histology_exclusion": [], "biomarker_exclusion": ["another FGFR inhibitor"]}, {"cohort": "Part 2 and 3", "disease_state": "advanced, refractory", "histology_inclusion": "squamous lung cancer", "biomarker_inclusion": ["FGFR 1", "FGFR 2", "FGFR 3"], "histology_exclusion": [], "biomarker_exclusion": ["another FGFR inhibitor"]}, {"cohort": "Part 2 and 3", "disease_state": "advanced, refractory", "histology_inclusion": "non-small cell lung cancer with squamous immunophenotype", "biomarker_inclusion": ["FGFR 1", "FGFR 2", "FGFR 3"], "histology_exclusion": [], "biomarker_exclusion": ["another FGFR inhibitor"]}], "json_norm": [{"cohort": "Part 1", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "Part 1", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "Part 1", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": "Part 1", "histology_inclusion": "Lung Carcinoma"}, {"cohort": "Part 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part 1", "histology_inclusion": "Cholangiocarcinoma"}, {"cohort": "Part 1", "histology_inclusion": "Sarcoma"}, {"cohort": "Part 1", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "Part 2 and 3", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "Part 2 and 3", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "Part 2 and 3", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": "Part 2 and 3", "histology_inclusion": "Lung Carcinoma"}, {"cohort": "Part 2 and 3", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04383210", "json": [{"cohort": "Cohort 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["NRG1 gene fusion"], "histology_exclusion": [], "biomarker_exclusion": ["actionable oncogenic driver mutation other than NRG1 fusion", "prior ERBB3/HER3 directed therapy", "prior pan-ERBB or any ERBB/HER2/HER3 directed therapy"]}, {"cohort": "Cohort 2", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["NRG1 gene fusion"], "histology_exclusion": [], "biomarker_exclusion": ["actionable oncogenic driver mutation other than NRG1 fusion"]}, {"cohort": "Cohort 3", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["NRG1 gene fusion lacking an EGF-like domain"], "histology_exclusion": [], "biomarker_exclusion": ["actionable oncogenic driver mutation other than NRG1 fusion"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NRG1 Fusion", "NRG1", "fusion"]], "biomarker_exclusion": [["NRG1 Fusion", "NRG1", "fusion"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NRG1 Fusion", "NRG1", "fusion"]], "biomarker_exclusion": [["NRG1 Fusion", "NRG1", "fusion"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NRG1 Fusion", "NRG1", "fusion"]], "biomarker_exclusion": [["NRG1 Fusion", "NRG1", "fusion"]]}]}
{"NCT_id": "NCT05229588", "json": [{"cohort": "", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "cancer of the exocrine pancreas", "biomarker_inclusion": ["ATM mutation", "ATR mutation", "CHEK2 mutation", "BRCA1 mutation", "BRCA2 mutation", "RAD51 mutation", "BRIP1 mutation", "PALB2 mutation", "PTEN mutation", "FANC mutation", "NBN mutation", "EMSY mutation", "MRE11 mutation", "ARID1A mutation"], "histology_exclusion": ["neuroendocrine differentiation", "mucinous subtype"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["CHEK2 Mutation", "CHEK2-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["ARTN Mutation", "ARTN-Mutation", "gene"], ["MRE11 Mutation", "MRE11-Mutation", "gene"], ["NBN Mutation", "NBN-Mutation", "gene"], ["SERPINA2 Mutation", "SERPINA2-Mutation", "gene"], ["RAD51 Mutation", "RAD51-Mutation", "gene"], ["ANTXR1 Mutation", "ANTXR1-Mutation", "gene"], ["ATR Mutation", "ATR-Mutation", "gene"], ["BRIP1 Mutation", "BRIP1-Mutation", "gene"], ["ARID1A Mutation", "ARID1A-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["EMSY Mutation", "EMSY-Mutation", "gene"]]}]}
{"NCT_id": "NCT03694002", "json": [{"cohort": "", "disease_state": "unresectable locally advanced, recurrent, or metastatic", "histology_inclusion": "thymic carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Thymus Neoplasm"}, {"cohort": "", "histology_inclusion": "Thymic Carcinoma"}]}
{"NCT_id": "NCT04513665", "json": [{"cohort": "Stage 1", "disease_state": "recurrent", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["HER2 overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stage 1", "disease_state": "recurrent", "histology_inclusion": "endometrial carcinosarcoma", "biomarker_inclusion": ["HER2 overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stage 2", "disease_state": "recurrent", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["HER2 overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stage 2", "disease_state": "recurrent", "histology_inclusion": "endometrial carcinosarcoma", "biomarker_inclusion": ["HER2 overexpression"], "histology_exclusion": ["central nervous system metastases", "leptomeningeal carcinomatosis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Stage 1", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Stage 1", "histology_inclusion": "Carcinosarcoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Stage 2", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Stage 2", "histology_inclusion": "Carcinosarcoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT03824483", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Chronic Lymphocytic Leukemia (CLL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Small Lymphocytic Leukemia (SLL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "TP53 Mutant MCL", "disease_state": "untreated stage II-IV", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["TP53 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "TP53 Mutant MCL", "disease_state": "untreated stage II-IV", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["p53 overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Transplant Ineligible MCL", "disease_state": "untreated stage II-IV", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma"}, {"cohort": "", "histology_inclusion": "Small Lymphocytic Lymphoma"}, {"cohort": "TP53 Mutant MCL", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "TP53 Mutant MCL", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["TP53-High", "TP53-High", "expression"]]}, {"cohort": "Transplant Ineligible MCL", "histology_inclusion": "Mantle Cell Lymphoma"}]}
{"NCT_id": "NCT04019964", "json": [{"cohort": "Nivolumab in biochemically recurrent prostate cancer", "disease_state": "biochemically recurrent", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["MSI-high"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Nivolumab in biochemically recurrent prostate cancer", "disease_state": "biochemically recurrent", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["MMR protein loss (MSH2, MSH6, MLH1, PMS2)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Nivolumab in biochemically recurrent prostate cancer", "disease_state": "biochemically recurrent", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["Inactivating mutation of MSH2, MSH6, MLH1 or PSM2"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Nivolumab in biochemically recurrent prostate cancer", "disease_state": "biochemically recurrent", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["TMB >= 20 muts/Mb"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Nivolumab in biochemically recurrent prostate cancer", "disease_state": "biochemically recurrent", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["Inactivating mutation (at least monoallelic) of CDK12"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Nivolumab in biochemically recurrent prostate cancer", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Nivolumab in biochemically recurrent prostate cancer", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Nivolumab in biochemically recurrent prostate cancer", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Nivolumab in biochemically recurrent prostate cancer", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Nivolumab in biochemically recurrent prostate cancer", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["MSH6 Mutation", "MSH6-Mutation", "gene"], ["MLH1 Mutation", "MLH1-Mutation", "gene"], ["MSH2 Mutation", "MSH2-Mutation", "gene"]]}, {"cohort": "Nivolumab in biochemically recurrent prostate cancer", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["MSH2 Mutation", "MSH2-Mutation", "gene"], ["MLH1 Mutation", "MLH1-Mutation", "gene"], ["MSH6 Mutation", "MSH6-Mutation", "gene"]]}, {"cohort": "Nivolumab in biochemically recurrent prostate cancer", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Nivolumab in biochemically recurrent prostate cancer", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Nivolumab in biochemically recurrent prostate cancer", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["CDK12 Mutation", "CDK12-Mutation", "gene"]]}, {"cohort": "Nivolumab in biochemically recurrent prostate cancer", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["CDK12 Mutation", "CDK12-Mutation", "gene"]]}]}
{"NCT_id": "NCT04084951", "json": [{"cohort": "", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "HPV16+ solid tumors", "biomarker_inclusion": ["HLA-A*02+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 8", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "HPV16+ head and neck cancer", "biomarker_inclusion": ["HLA-A*02+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 9", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "HPV16+ cervical cancer", "biomarker_inclusion": ["HLA-A*02+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 10", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "HPV16+ anal cancer", "biomarker_inclusion": ["HLA-A*02+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 11", "disease_state": "recurrent, locally advanced or metastatic", "histology_inclusion": "other HPV16+ cancer", "biomarker_inclusion": ["HLA-A*02+"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Cohort 8", "histology_inclusion": "Malignant Head and Neck Neoplasm"}, {"cohort": "Cohort 8", "histology_inclusion": "Head and Neck Carcinoma"}, {"cohort": "Cohort 9", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "Cohort 10", "histology_inclusion": "Anal Neoplasm"}, {"cohort": "Cohort 10", "histology_inclusion": "Anal Carcinoma"}, {"cohort": "Cohort 11"}]}
{"NCT_id": "NCT04839510", "json": [{"cohort": "", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "urothelium cancer", "biomarker_inclusion": ["HER2 positive (IHC 3+)", "HER2 positive (IHC 2+)"], "histology_exclusion": ["central nervous system (CNS) metastasis", "neoplastic meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT05555342", "json": [{"cohort": "IRE ablation and radiation therapy", "disease_state": "stage IV, progressive, recurrent, or metastatic", "histology_inclusion": "metastatic cancer of any histology", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "IRE ablation and radiation therapy"}]}
{"NCT_id": "NCT04644211", "json": [{"cohort": "Cohort 1", "disease_state": "Very low, Low, and Intermediate-risk Essential Thrombocythemia", "histology_inclusion": "Essential Thrombocythemia", "biomarker_inclusion": ["JAK2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["JAK2 V617F mutation", "history of thrombosis", ">5% blasts"]}, {"cohort": "Cohort 1", "disease_state": "Very low, Low, and Intermediate-risk Essential Thrombocythemia", "histology_inclusion": "Essential Thrombocythemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["JAK2 V617F mutation", "history of thrombosis", ">5% blasts"]}, {"cohort": "Cohort 2", "disease_state": "Low-risk Polycythemia Vera", "histology_inclusion": "Polycythemia Vera", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["history of thrombosis", ">5% blasts"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Essential Thrombocythemia", "biomarker_inclusion": [["JAK2 Mutation", "JAK2-Mutation", "gene"]], "biomarker_exclusion": [["JAK2 V617F", "V617F", "coordinate"]]}, {"cohort": "Cohort 1", "histology_inclusion": "Essential Thrombocythemia", "biomarker_exclusion": [["JAK2 V617F", "V617F", "coordinate"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Polycythemia Vera"}]}
{"NCT_id": "NCT04709276", "json": [{"cohort": "Neuroendocrine Prostate Cancer (NEPC) or Aggressive Variant Prostate Cancer (AVPC)", "disease_state": "metastatic", "histology_inclusion": "Neuroendocrine-like prostate cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Neuroendocrine Prostate Cancer (NEPC) or Aggressive Variant Prostate Cancer (AVPC)", "disease_state": "metastatic", "histology_inclusion": "Primary small cell carcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Neuroendocrine Prostate Cancer (NEPC) or Aggressive Variant Prostate Cancer (AVPC)", "disease_state": "metastatic", "histology_inclusion": "Intermediate atypical carcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Neuroendocrine Prostate Cancer (NEPC) or Aggressive Variant Prostate Cancer (AVPC)", "disease_state": "metastatic", "histology_inclusion": "Mixed histology tumors of the prostate", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Neuroendocrine Prostate Cancer (NEPC) or Aggressive Variant Prostate Cancer (AVPC)", "disease_state": "metastatic", "histology_inclusion": "Adenocarcinoma of the prostate", "biomarker_inclusion": ["TP53 alteration", "RB1 alteration", "PTEN alteration"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Neuroendocrine Prostate Cancer (NEPC) or Aggressive Variant Prostate Cancer (AVPC)", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Neuroendocrine Prostate Cancer (NEPC) or Aggressive Variant Prostate Cancer (AVPC)", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Neuroendocrine Prostate Cancer (NEPC) or Aggressive Variant Prostate Cancer (AVPC)", "histology_inclusion": "Prostate Small Cell Neuroendocrine Carcinoma"}, {"cohort": "Neuroendocrine Prostate Cancer (NEPC) or Aggressive Variant Prostate Cancer (AVPC)", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Neuroendocrine Prostate Cancer (NEPC) or Aggressive Variant Prostate Cancer (AVPC)", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Neuroendocrine Prostate Cancer (NEPC) or Aggressive Variant Prostate Cancer (AVPC)", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Neuroendocrine Prostate Cancer (NEPC) or Aggressive Variant Prostate Cancer (AVPC)", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Neuroendocrine Prostate Cancer (NEPC) or Aggressive Variant Prostate Cancer (AVPC)", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["RB1 Mutation", "RB1-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"]]}]}
{"NCT_id": "NCT04774393", "json": [{"cohort": "", "disease_state": "relapsed or refractory acute myeloid leukemia", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly diagnosed acute myeloid leukemia not eligible for intensive chemotherapy", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT04774419", "json": [{"cohort": "Radiation and Dostarlimab", "disease_state": "stage III/IVA", "histology_inclusion": "Endometrial cancer", "biomarker_inclusion": ["MMR-D", "MSI-H", "hypermethylation of MMR gene promoters (MLH1, MSH2, MSH6 or PMS2)", "POLE-mutated"], "histology_exclusion": [], "biomarker_exclusion": ["prior therapy with anti-PD-1, anti-PD-L1, or anti-CTLA-4 agent for endometrial cancer"]}], "json_norm": [{"cohort": "Radiation and Dostarlimab", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["POLE Mutation", "POLE-Mutation", "gene"]]}]}
{"NCT_id": "NCT04969835", "json": [{"cohort": "", "disease_state": "locally advanced (unresectable) and/or metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced (unresectable) and/or metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced (unresectable) and/or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced (unresectable) and/or metastatic", "histology_inclusion": "squamous cell carcinoma of the head and neck", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced (unresectable) and/or metastatic", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced (unresectable) and/or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced (unresectable) and/or metastatic", "histology_inclusion": "soft tissue sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced (unresectable) and/or metastatic", "histology_inclusion": "bladder cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "", "histology_inclusion": "Soft Tissue Sarcoma"}, {"cohort": "", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "", "histology_inclusion": "Bladder Neoplasm"}]}
{"NCT_id": "NCT05490472", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT02912559", "json": [{"cohort": "", "disease_state": "Stage III", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": ["dMMR"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT03107988", "json": [{"cohort": "Cohort A1 (Dose-finding)", "disease_state": "relapsed/refractory high-risk neuroblastoma", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": ["ALK activating mutation", "ALK amplification", "ALK fusion protein"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A2 (Adult and large BSA)", "disease_state": "relapsed/refractory high-risk neuroblastoma", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": ["ALK activating mutation", "ALK amplification", "ALK fusion protein"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B1 (Expansion)", "disease_state": "relapsed/refractory high-risk neuroblastoma", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": ["ALK activating mutation", "ALK amplification", "ALK fusion protein"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B2 (Combined w/ chemotherapy)", "disease_state": "relapsed/refractory high-risk neuroblastoma", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": ["ALK activating mutation", "ALK amplification", "ALK fusion protein"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A1 (Dose-finding)", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"], ["ALK Mutation", "ALK-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Cohort A2 (Adult and large BSA)", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"], ["ALK Mutation", "ALK-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Cohort B1 (Expansion)", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"], ["ALK Mutation", "ALK-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Cohort B2 (Combined w/ chemotherapy)", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"], ["ALK Mutation", "ALK-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT03433781", "json": [{"cohort": "", "disease_state": "Intermediate or High Risk Myelodysplastic Syndrome", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": ["TET2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["TET2 Mutation", "TET2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04085315", "json": [{"cohort": "Cohort A", "disease_state": "stage IV", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "stage IV", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Cohort B", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04644315", "json": [{"cohort": "ALK-positive Solid Tumors", "disease_state": "locally-advanced or metastatic", "histology_inclusion": "solid tumor excluding lung cancer", "biomarker_inclusion": ["ALK-positive"], "histology_exclusion": ["Lung Cancer", "primary CNS tumors"], "biomarker_exclusion": ["ALK point mutations: I1171X", "ALK point mutations: G1202R", "ALK point mutations: V1180L"]}], "json_norm": [{"cohort": "ALK-positive Solid Tumors", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"]], "histology_exclusion": ["Lung Carcinoma", "Primary Brain Neoplasm"], "biomarker_exclusion": [["ALK Mutation", "ALK-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"], ["ALK G1202R", "G1202R", "coordinate"], ["ALK Mutation", "ALK-Mutation", "gene"]]}, {"cohort": "ALK-positive Solid Tumors", "histology_inclusion": "Lung Carcinoma", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm", "Lung Carcinoma"], "biomarker_exclusion": [["ALK Mutation", "ALK-Mutation", "gene"], ["ALK G1202R", "G1202R", "coordinate"]]}]}
{"NCT_id": "NCT05620693", "json": [{"cohort": "Treatment group", "disease_state": "Late recurrent or metastatic", "histology_inclusion": "Soft tissue sarcoma", "biomarker_inclusion": ["NY-ESO-1 expression", "HLA-A 02/01"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Treatment group", "histology_inclusion": "Soft Tissue Sarcoma"}]}
{"NCT_id": "NCT02183883", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutation", "HER2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}]}
{"NCT_id": "NCT02912572", "json": [{"cohort": "MSI/POLE cohort", "disease_state": "recurrent or persistent endometrial cancer", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["MSI-H"], "histology_exclusion": [], "biomarker_exclusion": ["PD-1/PD-L1 pathway targeted drugs"]}, {"cohort": "MSI/POLE cohort", "disease_state": "recurrent or persistent endometrial cancer", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["POLE-mutated"], "histology_exclusion": [], "biomarker_exclusion": ["PD-1/PD-L1 pathway targeted drugs"]}, {"cohort": "MSS cohort", "disease_state": "recurrent or persistent endometrial cancer", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["MSS"], "histology_exclusion": [], "biomarker_exclusion": ["PD-1/PD-L1 pathway targeted drugs", "PARP inhibitor therapy"]}, {"cohort": "MSS Avelumab/Axitinib Combination Arm", "disease_state": "recurrent or persistent endometrial cancer", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["MSS"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["PD-1/PD-L1 pathway targeted drugs", "axitinib"]}], "json_norm": [{"cohort": "MSI/POLE cohort", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "MSI/POLE cohort", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["POLE Mutation", "POLE-Mutation", "gene"]]}, {"cohort": "MSS cohort", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "MSS Avelumab/Axitinib Combination Arm", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT03368729", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "HER2-positive breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["germline BRCA 1 mutation", "germline BRCA 2 mutation", "prior treatment with a known poly(ADP-ribose) polymerase (PARP) inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "biomarker_exclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04514159", "json": [{"cohort": "ZN-c5 + abemaciclib combination therapy", "disease_state": "advanced", "histology_inclusion": "adenocarcinoma of the breast", "biomarker_inclusion": ["Estrogen receptor positive", "Human Epidermal Growth Factor Receptor 2 negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "ZN-c5 + abemaciclib combination therapy", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT04579380", "json": [{"cohort": "", "disease_state": "locally-advanced unresectable or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["HER2 overexpression/amplification", "HER2 activating mutations"], "histology_exclusion": ["breast cancer", "gastric or gastroesophageal junction adenocarcinoma", "CRC"], "biomarker_exclusion": ["HER2 amplification/overexpression"]}, {"cohort": "", "disease_state": "locally-advanced unresectable or metastatic", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": ["HER2 overexpression/amplification", "HER2 activating mutations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]], "histology_exclusion": ["Breast Carcinoma", "Colorectal Carcinoma", "Gastroesophageal Junction Adenocarcinoma"], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04644432", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "non-clear cell renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "100% sarcomatoid tumor arising from the kidney", "biomarker_inclusion": [], "histology_exclusion": ["clear cell RCC"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Sarcomatoid Carcinoma", "histology_exclusion": ["Clear Cell Renal Cell Carcinoma"]}]}
{"NCT_id": "NCT05100251", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["C-myc overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["C-myc overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MYC-High", "MYC-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["MYC-High", "MYC-High", "expression"]]}]}
{"NCT_id": "NCT04150640", "json": [{"cohort": "Cohort 1: HER2 Negative", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_inclusion": ["HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": ["DPD deficiency"]}, {"cohort": "Cohort 1: HER2 Negative", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": ["HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": ["DPD deficiency"]}, {"cohort": "Cohort 2: HER2 Positive", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": [], "biomarker_exclusion": ["DPD deficiency"]}, {"cohort": "Cohort 2: HER2 Positive", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": [], "biomarker_exclusion": ["DPD deficiency"]}, {"cohort": "Cohort 3: HER2 Negative", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_inclusion": ["HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": ["DPD deficiency", "contraindications to immune checkpoint inhibitors", "prior immune mediated adverse events related to immunotherapy"]}, {"cohort": "Cohort 3: HER2 Negative", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": ["HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": ["DPD deficiency", "contraindications to immune checkpoint inhibitors", "prior immune mediated adverse events related to immunotherapy"]}, {"cohort": "Cohort 4: HER2 Positive", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": [], "biomarker_exclusion": ["DPD deficiency", "contraindications to immune checkpoint inhibitors", "prior immune mediated adverse events related to immunotherapy"]}, {"cohort": "Cohort 4: HER2 Positive", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": [], "biomarker_exclusion": ["DPD deficiency", "contraindications to immune checkpoint inhibitors", "prior immune mediated adverse events related to immunotherapy"]}], "json_norm": [{"cohort": "Cohort 1: HER2 Negative", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]], "biomarker_exclusion": [["DPYD-Low", "DPYD-Low", "expression"]]}, {"cohort": "Cohort 1: HER2 Negative", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]], "biomarker_exclusion": [["DPYD-Low", "DPYD-Low", "expression"]]}, {"cohort": "Cohort 2: HER2 Positive", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "biomarker_exclusion": [["DPYD-Low", "DPYD-Low", "expression"]]}, {"cohort": "Cohort 2: HER2 Positive", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "biomarker_exclusion": [["DPYD-Low", "DPYD-Low", "expression"]]}, {"cohort": "Cohort 3: HER2 Negative", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]], "biomarker_exclusion": [["DPYD-Low", "DPYD-Low", "expression"]]}, {"cohort": "Cohort 3: HER2 Negative", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]], "biomarker_exclusion": [["DPYD-Low", "DPYD-Low", "expression"]]}, {"cohort": "Cohort 4: HER2 Positive", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "biomarker_exclusion": [["DPYD-Low", "DPYD-Low", "expression"]]}, {"cohort": "Cohort 4: HER2 Positive", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "biomarker_exclusion": [["DPYD-Low", "DPYD-Low", "expression"]]}]}
{"NCT_id": "NCT03564691", "json": [{"cohort": "Dose Expansion, Arm A: Pancreatic Adenocarcinoma", "disease_state": "metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion, Arm B: Glioblastoma (GBM)", "disease_state": "unresectable", "histology_inclusion": "glioblastoma multiforme", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion, Arm C: R/M HNSCC", "disease_state": "recurrent or metastatic", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion, Arm D: PD-L1 positive HNSCC, Dose A", "disease_state": "advanced or metastatic", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": ["PD-L1 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion, Arms E and F: First-Line Advanced NSCLC", "disease_state": "advanced (Stage IIIB) or Stage IV metastatic", "histology_inclusion": "non-small-cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion, Arm G: NSCLC, +Carboplatin/Pemetrexed", "disease_state": "advanced (Stage IIIB) or Stage IV metastatic", "histology_inclusion": "nonsquamous non-small-cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion, Arm H: RCC, +Lenvatinib", "disease_state": "locally advanced/metastatic or recurrent", "histology_inclusion": "renal cell cancer", "biomarker_inclusion": ["clear cell component"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion, Arm I: R/M Gastric/GE Junction Adenocarcinoma", "disease_state": "recurrent or metastatic", "histology_inclusion": "gastric or gastroesophageal junction adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion, Arm J: Ovarian Cancer", "disease_state": "", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion, Arm K: Triple negative Breast Cancer (TNBC)", "disease_state": "", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion, Arm L: Mesothelioma", "disease_state": "advanced", "histology_inclusion": "mesothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion, Arm M: Advanced Solid Tumor in Chinese Participants In China", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Coformulation Phase, Arm N: MK-4830A (Coformulation of MK-4830 + pembrolizumab)", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Expansion, Arm A: Pancreatic Adenocarcinoma", "histology_inclusion": "Pancreatic Adenocarcinoma"}, {"cohort": "Dose Expansion, Arm B: Glioblastoma (GBM)", "histology_inclusion": "Glioblastoma, IDH-Wildtype"}, {"cohort": "Dose Expansion, Arm B: Glioblastoma (GBM)", "histology_inclusion": "Glioblastoma"}, {"cohort": "Dose Expansion, Arm C: R/M HNSCC", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Dose Expansion, Arm D: PD-L1 positive HNSCC, Dose A", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"]]}, {"cohort": "Dose Expansion, Arms E and F: First-Line Advanced NSCLC", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Dose Expansion, Arm G: NSCLC, +Carboplatin/Pemetrexed", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Dose Expansion, Arm H: RCC, +Lenvatinib", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "Dose Expansion, Arm I: R/M Gastric/GE Junction Adenocarcinoma", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "Dose Expansion, Arm J: Ovarian Cancer", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Dose Expansion, Arm J: Ovarian Cancer", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "Dose Expansion, Arm K: Triple negative Breast Cancer (TNBC)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Dose Expansion, Arm L: Mesothelioma", "histology_inclusion": "Mesothelioma"}, {"cohort": "Dose Expansion, Arm M: Advanced Solid Tumor in Chinese Participants In China", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Coformulation Phase, Arm N: MK-4830A (Coformulation of MK-4830 + pembrolizumab)", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04215978", "json": [{"cohort": "Phase 1a", "disease_state": "advanced, metastatic, unresectable solid tumors", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["leptomeningeal disease", "uncontrolled brain metastasis"], "biomarker_exclusion": ["prior therapy targeting OX40", "prior T cell agonist therapy"]}, {"cohort": "Phase 1b Cohort 1 (NSCLC)", "disease_state": "stage IIIB, IIIC, or IV", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["leptomeningeal disease", "uncontrolled brain metastasis"], "biomarker_exclusion": ["prior therapy targeting OX40", "prior T cell agonist therapy"]}, {"cohort": "Phase 1b Cohort 2 (HNSCC)", "disease_state": "recurrent or metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["leptomeningeal disease", "uncontrolled brain metastasis"], "biomarker_exclusion": ["prior therapy targeting OX40", "prior T cell agonist therapy"]}], "json_norm": [{"cohort": "Phase 1a", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase 1b Cohort 1 (NSCLC)", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Phase 1b Cohort 2 (HNSCC)", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT04514497", "json": [{"cohort": "Dose Escalation Cohorts", "disease_state": "metastatic or unresectable", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Cohorts", "disease_state": "metastatic or unresectable", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Cohorts", "disease_state": "metastatic or unresectable", "histology_inclusion": "poorly differentiated neuroendocrine carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Cohorts", "disease_state": "metastatic or unresectable", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Escalation Cohorts", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Dose Expansion Cohorts", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Dose Expansion Cohorts", "histology_inclusion": "Pancreatic Neuroendocrine Carcinoma"}, {"cohort": "Dose Expansion Cohorts", "histology_inclusion": "Pancreatic Adenocarcinoma"}]}
{"NCT_id": "NCT04579757", "json": [{"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["microsatellite stable"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "progressive, low or intermediate grade (grade 1 or grade 2)", "histology_inclusion": "NETs of thoracic or GEP origins", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort C", "disease_state": "progressed on standard first line chemotherapy treatment", "histology_inclusion": "Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort D", "disease_state": "progressed on at least 2 prior lines of therapy", "histology_inclusion": "adenocarcinoma of the stomach or gastroesophageal junction", "biomarker_inclusion": ["PD-L1 CPS \u22655%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort E", "disease_state": "progressed on at least one line of standard therapy or refused standard frontline cytotoxic chemotherapy", "histology_inclusion": "Alveolar Soft Part Sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort E", "disease_state": "progressed on at least one line of standard therapy or refused standard frontline cytotoxic chemotherapy", "histology_inclusion": "Undifferentiated Pleomorphic Sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort F", "disease_state": "not curable by resection", "histology_inclusion": "Anaplastic Thyroid Cancer", "biomarker_inclusion": ["BRAFV600E mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Cohort B"}, {"cohort": "Cohort C", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Cohort D", "histology_inclusion": "Gastric Adenocarcinoma"}, {"cohort": "Cohort E", "histology_inclusion": "Alveolar Soft Part Sarcoma"}, {"cohort": "Cohort E", "histology_inclusion": "Undifferentiated Pleomorphic Sarcoma"}, {"cohort": "Cohort F", "histology_inclusion": "Thyroid Gland Undifferentiated (Anaplastic) Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT05230810", "json": [{"cohort": "Ib Safety Cohort /II Expansion Cohort", "disease_state": "metastatic", "histology_inclusion": "HER2-positive breast cancer", "biomarker_inclusion": ["PIK3CA mutation"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Ib Safety Cohort /II Expansion Cohort", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}]}
{"NCT_id": "NCT03304080", "json": [{"cohort": "HR-positive, HER2-positive Metastatic Breast Cancer", "disease_state": "metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["ER-positive", "PR-positive", "HER2-positive"], "histology_exclusion": [], "biomarker_exclusion": ["HER2-negative"]}], "json_norm": [{"cohort": "HR-positive, HER2-positive Metastatic Breast Cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["PRH2-High", "PRH2-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"]], "biomarker_exclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT04384484", "json": [{"cohort": "", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": ["CD19 expression"], "histology_exclusion": ["Burkitt lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed or Refractory", "histology_inclusion": "High-grade B-cell lymphoma", "biomarker_inclusion": ["MYC rearrangement", "BCL2 rearrangement", "BCL6 rearrangement"], "histology_exclusion": ["Burkitt lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Burkitt Lymphoma"]}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma", "biomarker_inclusion": [["MYC Fusion", "MYC", "fusion"], ["BCL6 Fusion", "BCL6", "fusion"], ["BCL2 Fusion", "BCL2", "fusion"]], "histology_exclusion": ["Burkitt Lymphoma"]}]}
{"NCT_id": "NCT03173950", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Ependymoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Medulloblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Parenchymal Pineal Region Tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Choroid Plexus Tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Malignant/Atypical Meningioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Primary CNS Sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Pleomorphic Xanthoastrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Anaplastic Pleomorphic Xanthoastrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Primitive Neuro-Ectodermal Tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ependymoma"}, {"cohort": "", "histology_inclusion": "Medulloblastoma"}, {"cohort": "", "histology_inclusion": "Pineal Region Neoplasm"}, {"cohort": "", "histology_inclusion": "Choroid Plexus Neoplasm"}, {"cohort": "", "histology_inclusion": "Choroid Plexus Carcinoma"}, {"cohort": "", "histology_inclusion": "Atypical Meningioma"}, {"cohort": "", "histology_inclusion": "Gliosarcoma"}, {"cohort": "", "histology_inclusion": "Central Nervous System Sarcoma"}, {"cohort": "", "histology_inclusion": "Pleomorphic Xanthoastrocytoma"}, {"cohort": "", "histology_inclusion": "Anaplastic Pleomorphic Xanthoastrocytoma"}, {"cohort": "", "histology_inclusion": "Primitive Neuroectodermal Tumor"}]}
{"NCT_id": "NCT04216316", "json": [{"cohort": "", "disease_state": "stage IV", "histology_inclusion": "squamous cell non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Squamous Cell Lung Carcinoma"}]}
{"NCT_id": "NCT03175224", "json": [{"cohort": "Cohort A-1", "disease_state": "NSCLC EXON 14 skip mutation (c-Met na\u00efve) for first line treatment", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["c-Met EXON 14 Skip Mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A-2", "disease_state": "NSCLC EXON 14 skip mutation (c-Met na\u00efve) pretreated subjects with no more than 3 lines of prior therapy", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["c-Met EXON 14 Skip Mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "NSCLC EXON 14 skip mutation (c-Met experienced; radiographic progression on prior c-Met inhibitor)", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["c-Met EXON 14 Skip Mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort C", "disease_state": "basket of tumor types with c-Met high level amplification (except Primary CNS tumors)", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": ["c-Met high level amplification"], "histology_exclusion": ["Primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "Cohort C-1", "disease_state": "NSCLC harboring MET amplification and wild-type epidermal growth factor receptor (EGFR) with no more than 3 lines of prior therapy (MET Naive)", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["MET amplification", "wild-type EGFR"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort D", "disease_state": "basket of tumor types except for primary CNS tumors harboring MET gene fusions (e.g., NSCLC, upper GI, colorectal, hepatobiliary cancer). Previously treated; or previously untreated but refused standard treatment, or if treatment was unavailable or unfeasible (\u2264 3 prior lines in unresectable or metastatic setting). Met naive", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": ["MET gene fusions"], "histology_exclusion": ["Primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "Cohort E", "disease_state": "Primary CNS tumors with MET alterations (single or co-occurred MET fusion including PTPRZ1-MET [ZM] fusion, MET Exon 14 skipping mutation, or MET amplification).Previously treated or previously untreated but refused standard treatment, or if treatment was unavailable or unfeasible (\u2264 3 prior lines), Met naive", "histology_inclusion": "Primary CNS tumors", "biomarker_inclusion": ["MET alterations", "PTPRZ1-MET fusion", "MET Exon 14 skipping mutation", "MET amplification"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A-1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]]}, {"cohort": "Cohort A-2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]]}, {"cohort": "Cohort B", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]]}, {"cohort": "Cohort C", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort C-1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "Cohort D", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["SLTM Fusion", "SLTM", "fusion"], ["MET Fusion", "MET", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort E", "histology_inclusion": "Primary Brain Neoplasm", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["MET Mutation", "MET-Mutation", "gene"], ["PTPRZ1 - MET", "PTPRZ1 - MET", "coordinate"], ["SLTM Fusion", "SLTM", "fusion"], ["MET exon 14 del", "exon 14 del", "exon"], ["PTPRZ1 - SLTM", "PTPRZ1 - SLTM", "coordinate"], ["PTPRZ1 Fusion", "PTPRZ1", "fusion"], ["SLTM Mutation", "SLTM-Mutation", "gene"], ["MET Fusion", "MET", "fusion"]]}]}
{"NCT_id": "NCT04152499", "json": [{"cohort": "Phase II: Triple Negative Breast cancer", "disease_state": "locally advanced unresectable/metastatic", "histology_inclusion": "Triple negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II: Epithelial ovarian cancer", "disease_state": "locally advanced unresectable/metastatic", "histology_inclusion": "Epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II: Non-Small Cell Lung Cancer", "disease_state": "locally advanced unresectable/metastatic", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II: Gastric Adenocarcinoma or gastroesophageal junction adenocarcinoma", "disease_state": "locally advanced unresectable/metastatic", "histology_inclusion": "Gastric adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II: Gastric Adenocarcinoma or gastroesophageal junction adenocarcinoma", "disease_state": "locally advanced unresectable/metastatic", "histology_inclusion": "Gastroesophageal junction adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II: Extensive-stage small Cell Lung Cancer", "disease_state": "locally advanced unresectable/metastatic", "histology_inclusion": "Small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II: HR+/ HER2- breast cancer", "disease_state": "locally advanced unresectable/metastatic", "histology_inclusion": "HR+/ HER2- breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II: Head and neck squamous cell carcinoma", "disease_state": "locally advanced unresectable/metastatic", "histology_inclusion": "Head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II: Endometrial carcinoma", "disease_state": "locally advanced unresectable/metastatic", "histology_inclusion": "Endometrial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II: Urothelial carcinoma", "disease_state": "locally advanced unresectable/metastatic", "histology_inclusion": "Urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase II: Triple Negative Breast cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Phase II: Epithelial ovarian cancer", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Phase II: Non-Small Cell Lung Cancer", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Phase II: Gastric Adenocarcinoma or gastroesophageal junction adenocarcinoma", "histology_inclusion": "Gastric Adenocarcinoma"}, {"cohort": "Phase II: Gastric Adenocarcinoma or gastroesophageal junction adenocarcinoma", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "Phase II: Extensive-stage small Cell Lung Cancer", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Phase II: HR+/ HER2- breast cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Phase II: HR+/ HER2- breast cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Phase II: Head and neck squamous cell carcinoma", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Phase II: Endometrial carcinoma", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "Phase II: Urothelial carcinoma", "histology_inclusion": "Urothelial Carcinoma"}]}
{"NCT_id": "NCT04776655", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["RAS wild type", "BRAF wild type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04972110", "json": [{"cohort": "", "disease_state": "advanced solid tumors resistant or refractory to standard treatment", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT02979977", "json": [{"cohort": "All subjects", "disease_state": "metastatic, recurrent or locally advanced", "histology_inclusion": "squamous cell carcinoma of the head and neck", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "All subjects", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT04972253", "json": [{"cohort": "", "disease_state": "cT2-T4a N0 M0", "histology_inclusion": "bladder transitional cell carcinoma", "biomarker_inclusion": ["FGFR3 exon 7 R248C", "FGFR3 exon 7 S249C", "FGFR3 exon 10 G372C", "FGFR3 exon 10 A393E", "FGFR3 exon 10 Y375C", "FGFR3 exon 15 K652M", "FGFR3 exon 15 K652T", "FGFR3 exon 15 K652E", "FGFR3 exon 15 K652Q", "FGFR2 exon 7 R248C", "FGFR2 exon 7 S249C", "FGFR2 exon 10 G372C", "FGFR2 exon 10 A393E", "FGFR2 exon 10 Y375C", "FGFR2 exon 15 K652M", "FGFR2 exon 15 K652T", "FGFR2 exon 15 K652E", "FGFR2 exon 15 K652Q", "FGFR3/2 gene fusion"], "histology_exclusion": ["small cell histology", "primary TCC of the ureter", "primary TCC of the urethra", "primary TCC of the renal pelvis without TCC of the bladder"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Bladder Urothelial Carcinoma", "biomarker_inclusion": [["FGFR3 R248C", "R248C", "coordinate"], ["FGFR3 S249C", "S249C", "coordinate"], ["FGFR2 Y375C", "Y375C", "coordinate"], ["FGFR3 Y375C", "Y375C", "coordinate"]]}]}
{"NCT_id": "NCT03175432", "json": [{"cohort": "", "disease_state": "untreated melanoma brain metastases", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF V600 wild-type"], "histology_exclusion": ["leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT05037461", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Pancreatic Neuroendocrine Tumours in MEN1 Patients", "biomarker_inclusion": [], "histology_exclusion": ["Suspected malignant pNET"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Neoplasm", "histology_exclusion": ["Primitive Neuroectodermal Tumor"]}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Carcinoma", "histology_exclusion": ["Primitive Neuroectodermal Tumor"]}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Tumor", "histology_exclusion": ["Primitive Neuroectodermal Tumor"]}]}
{"NCT_id": "NCT05037500", "json": [{"cohort": "", "disease_state": "metastatic castrate resistant prostate cancer", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) involvement"], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort", "disease_state": "metastatic castrate resistant prostate cancer", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["RB1 alteration", "TP53 alteration"], "histology_exclusion": ["central nervous system (CNS) involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "Expansion Cohort", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["RB1 Mutation", "RB1-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Expansion Cohort", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["RB1 Mutation", "RB1-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT04217993", "json": [{"cohort": "", "disease_state": "Intermediate-risk and High-risk Myelofibrosis", "histology_inclusion": "Primary Myelofibrosis", "biomarker_inclusion": ["JAK2 mutation", "JAK2 wild"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Intermediate-risk and High-risk Myelofibrosis", "histology_inclusion": "Post-Polycythemia Vera Myelofibrosis", "biomarker_inclusion": ["JAK2 mutation", "JAK2 wild"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Intermediate-risk and High-risk Myelofibrosis", "histology_inclusion": "Post-Essential Thrombocythemia Myelofibrosis", "biomarker_inclusion": ["JAK2 mutation", "JAK2 wild"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Primary Myelofibrosis", "biomarker_inclusion": [["JAK2 Mutation", "JAK2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase", "biomarker_inclusion": [["JAK2 Mutation", "JAK2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Myelofibrosis Transformation in Essential Thrombocythemia", "biomarker_inclusion": [["JAK2 Mutation", "JAK2-Mutation", "gene"]]}]}
{"NCT_id": "NCT03436485", "json": [{"cohort": "", "disease_state": "metastatic castration-resistant", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases", "active leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT05232851", "json": [{"cohort": "", "disease_state": "Locally Advanced", "histology_inclusion": "HPV-OPSCC", "biomarker_inclusion": ["p16-Positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}]}
{"NCT_id": "NCT05297864", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Oligodendroglioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Glioma WHO Grade III", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Glioma WHO Grade IV", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Astrocytoma"}, {"cohort": "", "histology_inclusion": "Oligodendroglioma"}, {"cohort": "", "histology_inclusion": "Glioma"}, {"cohort": "", "histology_inclusion": "Glioma"}]}
{"NCT_id": "NCT05297903", "json": [{"cohort": "XmAb20717", "disease_state": "advanced", "histology_inclusion": "biliary tract cancers", "biomarker_inclusion": ["FGFR2 fusion", "NTRK fusion", "IDH1 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["PD-1 inhibitor", "PD-L1 inhibitor", "CTLA-4 inhibitor"]}], "json_norm": [{"cohort": "XmAb20717", "histology_inclusion": "Liver Cancer", "biomarker_inclusion": [["FGFR2 Fusion", "FGFR2", "fusion"], ["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"], ["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "XmAb20717", "histology_inclusion": "Biliary Tract Carcinoma", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["IDH1 Mutation", "IDH1-Mutation", "gene"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}]}
{"NCT_id": "NCT02980510", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["K-Ras wild-type", "N-Ras wild-type", "B-Raf wild-type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT03110744", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "chordoma", "biomarker_inclusion": ["Loss of p16", "presence of CDK4/6", "presence of RB1"], "histology_exclusion": ["uncontrolled central nervous system (CNS) involvement"], "biomarker_exclusion": ["Prior treatment with palbociclib", "Prior treatment with other CDK4/6 inhibitors"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Chordoma", "biomarker_inclusion": [["H3P10-Low", "H3P10-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]]}]}
{"NCT_id": "NCT04022876", "json": [{"cohort": "Part 2 NSCLC", "disease_state": "Stage IV", "histology_inclusion": "adenocarcinoma", "biomarker_inclusion": ["p53 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutation", "ALK re-arrangement"]}, {"cohort": "Part 1 SCLC", "disease_state": "ED", "histology_inclusion": "SCLC", "biomarker_inclusion": ["p53 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 2 NSCLC", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Part 1 SCLC", "histology_inclusion": "Small Cell Lung Carcinoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT04907539", "json": [{"cohort": "", "disease_state": "metastatic (Stage IV)", "histology_inclusion": "Colorectal cancer (CRC)", "biomarker_inclusion": ["RNF43 aberration", "RSPO aberration", "MSS status"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["RNF43 Mutation", "RNF43-Mutation", "gene"], ["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT04907643", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "biliary tract cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "colon cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "liver cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "pancreas cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "rectal cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "small intestine cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "stomach cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "neuroendocrine tumors", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "tumors of mesenchymal origin", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Liver Cancer"}, {"cohort": "", "histology_inclusion": "Biliary Tract Carcinoma"}, {"cohort": "", "histology_inclusion": "Colon Carcinoma"}, {"cohort": "", "histology_inclusion": "Liver Cancer"}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "", "histology_inclusion": "Rectal Carcinoma"}, {"cohort": "", "histology_inclusion": "Small Intestinal Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Neuroendocrine Carcinoma"}, {"cohort": "", "histology_inclusion": "Lung Neuroendocrine Neoplasm"}, {"cohort": "", "histology_inclusion": "Neuroendocrine Tumor"}, {"cohort": ""}]}
{"NCT_id": "NCT05233033", "json": [{"cohort": "Phase 1a", "disease_state": "Relapsed or Refractory", "histology_inclusion": "B-cell NHL", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1a", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Diffuse Large B-cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1a", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Waldenstr\u00f6m's Macroglobulinemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Diffuse Large B-cell Lymphoma", "biomarker_inclusion": ["MYD88 mutant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "Relapsed or Refractory", "histology_inclusion": "Diffuse Large B-cell Lymphoma", "biomarker_inclusion": ["MYD88 wild type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1a", "histology_inclusion": "Non-Hodgkin Lymphoma"}, {"cohort": "Phase 1a", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "Phase 1a"}, {"cohort": "Phase 1b", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MYD88 Mutation", "MYD88-Mutation", "gene"]]}, {"cohort": "Phase 1b", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MYD88 MYD88-wild_type", "MYD88-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT01990521", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Prostate Cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04023071", "json": [{"cohort": "FT516 Monotherapy", "disease_state": "Primary Refractory AML", "histology_inclusion": "Acute Myelogenous Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["t(15:17) translocation"]}, {"cohort": "FT516 Monotherapy", "disease_state": "Relapsed AML", "histology_inclusion": "Acute Myelogenous Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["t(15:17) translocation"]}, {"cohort": "FT516 + rituximab or obinutuzumab", "disease_state": "Relapsed or Refractory B-cell Lymphoma", "histology_inclusion": "B-cell Lymphoma", "biomarker_inclusion": ["CD20"], "histology_exclusion": ["Waldenstrom macroglobulinemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "FT516 Monotherapy", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "FT516 Monotherapy", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "FT516 + rituximab or obinutuzumab", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma", "histology_exclusion": ["Waldenstrom Macroglobulinemia"]}]}
{"NCT_id": "NCT04088188", "json": [{"cohort": "", "disease_state": "Unresectable or Metastatic Cholangiocarcinoma", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": ["IDH1 gene mutation (R132C/L/G/H/S mutation)"], "histology_exclusion": [], "biomarker_exclusion": ["Prior therapy with IDH inhibitor"]}, {"cohort": "", "disease_state": "Unresectable or Metastatic Cholangiocarcinoma", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": ["FGFR2 gene alteration"], "histology_exclusion": [], "biomarker_exclusion": ["Prior therapy with selective FGFR inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["IDH1 R132C", "R132C", "coordinate"], ["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH1 R132S", "R132S", "coordinate"], ["IDH1 R132L", "R132L", "coordinate"], ["IDH1 R132H", "R132H", "coordinate"], ["IDH1 R132G", "R132G", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}]}
{"NCT_id": "NCT05493501", "json": [{"cohort": "", "disease_state": "Stage IIIB, metastatic (Stage IVA or IVB), or recurrent", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["EGFR ex19del", "EGFR L858R"], "histology_exclusion": ["mixed small-cell and non-small-cell pathology"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT02382549", "json": [{"cohort": "Cohort 1 (Advanced)", "disease_state": "Measurable stage IIIB, IIIC, IIID or IV melanoma", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2 (Neo-adjuvant)", "disease_state": "Resectable stage IIIB, IIIC, IIID, or IV melanoma", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3 (Adjuvant)", "disease_state": "Stage IIIA, IIIB, IIIC, IIID or IV melanoma resected to no evidence of disease", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1 (Advanced)", "histology_inclusion": "Melanoma"}, {"cohort": "Cohort 2 (Neo-adjuvant)", "histology_inclusion": "Melanoma"}, {"cohort": "Cohort 3 (Adjuvant)", "histology_inclusion": "Melanoma"}]}
{"NCT_id": "NCT02578368", "json": [{"cohort": "", "disease_state": "limited metastatic", "histology_inclusion": "adenocarcinoma of the stomach or esophagogastric junction", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastric Adenocarcinoma"}]}
{"NCT_id": "NCT03827850", "json": [{"cohort": "Cohort 1 FGFR trans", "disease_state": "Stage IIIB/IV", "histology_inclusion": "Squamous Non Small Cell Lung Carcinoma", "biomarker_inclusion": ["Activating FGFR translocations"], "histology_exclusion": ["Symptomatic central nervous system metastases"], "biomarker_exclusion": ["EGFR", "BRAF", "ALK", "ROS1", "NTRK", "Prior FGFR inhibitor treatment"]}, {"cohort": "Cohort 2 FGFR mut", "disease_state": "Stage IIIB/IV", "histology_inclusion": "Squamous Non Small Cell Lung Carcinoma", "biomarker_inclusion": ["Activating hotspot FGFR mutations"], "histology_exclusion": ["Symptomatic central nervous system metastases"], "biomarker_exclusion": ["EGFR", "BRAF", "ALK", "ROS1", "NTRK", "Prior FGFR inhibitor treatment"]}, {"cohort": "Cohort 3 FGFR other", "disease_state": "Stage IIIB/IV", "histology_inclusion": "Squamous Non Small Cell Lung Carcinoma", "biomarker_inclusion": ["Activating low confidence FGFR alteration"], "histology_exclusion": ["Symptomatic central nervous system metastases"], "biomarker_exclusion": ["EGFR", "BRAF", "ALK", "ROS1", "NTRK", "Prior FGFR inhibitor treatment"]}], "json_norm": [{"cohort": "Cohort 1 FGFR trans", "histology_inclusion": "Squamous Cell Lung Carcinoma", "biomarker_inclusion": [["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"], ["FGFR4 Fusion", "FGFR4", "fusion"], ["FGFR1 Fusion", "FGFR1", "fusion"]]}, {"cohort": "Cohort 2 FGFR mut", "histology_inclusion": "Squamous Cell Lung Carcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"]]}, {"cohort": "Cohort 3 FGFR other", "histology_inclusion": "Squamous Cell Lung Carcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"]]}]}
{"NCT_id": "NCT04907851", "json": [{"cohort": "Module 1 - RNF43 Mutated Advanced (unresectable)/Metastatic Pancreatic Cancer (Stage III/IV)", "disease_state": "Stage III/IV", "histology_inclusion": "Pancreatic Cancer", "biomarker_inclusion": ["RNF43 loss of function mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Module 2 - Advanced (unresectable)/Metastatic Biliary Tract Cancer (Stage III/IV)", "disease_state": "Stage III/IV", "histology_inclusion": "Biliary Tract Cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Module 3 - Advanced (unresectable)/Metastatic Biliary Tract Cancer (Stage Ill/IV) Combination Therapy", "disease_state": "Stage III/IV", "histology_inclusion": "Biliary Tract Cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Module 1 - RNF43 Mutated Advanced (unresectable)/Metastatic Pancreatic Cancer (Stage III/IV)", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["RNF43 Mutation", "RNF43-Mutation", "gene"], ["RNF43-Low", "RNF43-Low", "expression"]]}, {"cohort": "Module 2 - Advanced (unresectable)/Metastatic Biliary Tract Cancer (Stage III/IV)", "histology_inclusion": "Liver Cancer"}, {"cohort": "Module 2 - Advanced (unresectable)/Metastatic Biliary Tract Cancer (Stage III/IV)", "histology_inclusion": "Biliary Tract Carcinoma"}, {"cohort": "Module 3 - Advanced (unresectable)/Metastatic Biliary Tract Cancer (Stage Ill/IV) Combination Therapy", "histology_inclusion": "Liver Cancer"}, {"cohort": "Module 3 - Advanced (unresectable)/Metastatic Biliary Tract Cancer (Stage Ill/IV) Combination Therapy", "histology_inclusion": "Biliary Tract Carcinoma"}]}
{"NCT_id": "NCT02709226", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Gliosarcoma"}]}
{"NCT_id": "NCT03306472", "json": [{"cohort": "Cohort A", "disease_state": "operable", "histology_inclusion": "breast adenocarcinoma", "biomarker_inclusion": ["ER positive (Allred\u22653)", "HER2 negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "early or locoregionally advanced", "histology_inclusion": "breast adenocarcinoma", "biomarker_inclusion": ["ER positive (Allred\u22653)", "HER2 negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Cohort B", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}]}
{"NCT_id": "NCT04842877", "json": [{"cohort": "Aggressive B-cell Lymphoma", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Diffuse Large B-cell Lymphoma, Primary Mediastinal B-cell Lymphoma, High Grade B-cell Lymphoma, Transformed Indolent Lymphoma, Grade 3b Follicular Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System Lymphoma"], "biomarker_exclusion": ["EZH2 Inhibitor"]}, {"cohort": "Follicular Lymphoma", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Follicular Lymphoma Grade 1, 2, 3a", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System Lymphoma"], "biomarker_exclusion": ["EZH2 Inhibitor"]}, {"cohort": "Mantle Cell Lymphoma", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System Lymphoma"], "biomarker_exclusion": ["EZH2 Inhibitor"]}, {"cohort": "Other Indolent Lymphomas", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Marginal Zone Lymphoma, Waldenstr\u00f6m Macroglobulinemia", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System Lymphoma"], "biomarker_exclusion": ["EZH2 Inhibitor"]}, {"cohort": "Hodgkin Lymphoma", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Hodgkin Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System Lymphoma"], "biomarker_exclusion": ["EZH2 Inhibitor"]}], "json_norm": [{"cohort": "Aggressive B-cell Lymphoma", "histology_inclusion": "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}, {"cohort": "Aggressive B-cell Lymphoma", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}, {"cohort": "Aggressive B-cell Lymphoma", "histology_inclusion": "High Grade B-Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}, {"cohort": "Aggressive B-cell Lymphoma", "histology_inclusion": "Grade 3b Follicular Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}, {"cohort": "Aggressive B-cell Lymphoma", "histology_inclusion": "Indolent Non-Hodgkin Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}, {"cohort": "Follicular Lymphoma", "histology_inclusion": "Follicular Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}, {"cohort": "Mantle Cell Lymphoma", "histology_inclusion": "Mantle Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}, {"cohort": "Other Indolent Lymphomas", "histology_inclusion": "Marginal Zone Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}, {"cohort": "Other Indolent Lymphomas", "histology_inclusion": "Waldenstrom Macroglobulinemia", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}, {"cohort": "Hodgkin Lymphoma", "histology_inclusion": "Hodgkin Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}]}
{"NCT_id": "NCT04973163", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "adenocarcinoma of the lung", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer (NSCLC) with mixed histology", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT05558722", "json": [{"cohort": "", "disease_state": "Stage IIB-IIIA", "histology_inclusion": "HER2-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["HER2 positive"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT03502330", "json": [{"cohort": "Advanced Melanoma", "disease_state": "Unresectable stage III or stage IV", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": ["Untreated brain metastases", "Leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Renal Cell Carcinoma", "disease_state": "Locally advanced unresectable or metastatic", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Untreated brain metastases", "Leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "NSCLC", "disease_state": "Locally advanced or metastatic (Stage IIIB not eligible for definitive chemoradiotherapy, stage IV, or recurrent)", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["ALK rearrangement", "EGFR mutation"], "histology_exclusion": ["Untreated brain metastases", "Leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Advanced Melanoma", "histology_inclusion": "Melanoma"}, {"cohort": "Renal Cell Carcinoma", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "NSCLC", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT04387071", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Melanoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Locally Advanced Unresectable", "histology_inclusion": "Solid Tumor Malignancies", "biomarker_inclusion": [], "histology_exclusion": ["Melanoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma", "histology_exclusion": ["Melanoma"]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Melanoma"]}]}
{"NCT_id": "NCT04647526", "json": [{"cohort": "", "disease_state": "metastatic castration-resistant prostate cancer", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": ["prostate cancer with significant sarcomatoid or spindle cell or neuroendocrine components", "small cell component in the cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "histology_exclusion": ["Prostate Neoplasm", "Prostate Carcinoma"]}]}
{"NCT_id": "NCT05103358", "json": [{"cohort": "Arm A: Pathogenic inactivating TSC1 alterations", "disease_state": "metastatic or locally advanced", "histology_inclusion": "malignant solid tumor", "biomarker_inclusion": ["TSC1 pathogenic inactivating alteration"], "histology_exclusion": ["primary brain tumor", "PEComa"], "biomarker_exclusion": ["prior treatment with mTOR inhibitor"]}, {"cohort": "Arm B: Pathogenic inactivating TSC2 alterations", "disease_state": "metastatic or locally advanced", "histology_inclusion": "malignant solid tumor", "biomarker_inclusion": ["TSC2 pathogenic inactivating alteration"], "histology_exclusion": ["primary brain tumor", "PEComa"], "biomarker_exclusion": ["prior treatment with mTOR inhibitor"]}], "json_norm": [{"cohort": "Arm A: Pathogenic inactivating TSC1 alterations", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TSC1 Mutation", "TSC1-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm", "PEComa"]}, {"cohort": "Arm B: Pathogenic inactivating TSC2 alterations", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TSC2 Mutation", "TSC2-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm", "PEComa"]}]}
{"NCT_id": "NCT05168423", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Glioblastoma, IDH-wildtype", "biomarker_inclusion": ["EGFR amplification"], "histology_exclusion": ["brain stem tumor", "spinal cord tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["EGFR-High", "EGFR-High", "expression"]], "histology_exclusion": ["Spinal Cord Neoplasm"]}, {"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["EGFR-High", "EGFR-High", "expression"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "histology_exclusion": ["Spinal Cord Neoplasm"]}]}
{"NCT_id": "NCT05363605", "json": [{"cohort": "", "disease_state": "locally advanced, inoperable, or metastatic", "histology_inclusion": "solid tumours", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT03567642", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation", "P53 alteration", "RB1 alteration"], "histology_exclusion": ["pure small cell histology"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RB1 Mutation", "RB1-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04452292", "json": [{"cohort": "", "disease_state": "metastatic and/or not resectable", "histology_inclusion": "high grade neuroendocrine carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["small cell carcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Neuroendocrine Carcinoma", "histology_exclusion": ["Small Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Tumor", "histology_exclusion": ["Small Cell Carcinoma"]}]}
{"NCT_id": "NCT04777994", "json": [{"cohort": "Monotherapy Dose Expansion", "disease_state": "locally advanced or metastatic, relapsed or refractory", "histology_inclusion": "head and neck squamous cell carcinoma (HNSCC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Monotherapy Dose Expansion", "disease_state": "locally advanced or metastatic, relapsed or refractory", "histology_inclusion": "non-small cell lung cancer (NSCLC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Monotherapy Dose Expansion", "disease_state": "advanced", "histology_inclusion": "clear cell renal cell carcinoma (ccRCC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "PD-1 Targeting Agent Combination Dose Expansion", "disease_state": "locally advanced or metastatic, relapsed", "histology_inclusion": "head and neck squamous cell carcinoma (HNSCC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "PD-1 Targeting Agent Combination Dose Expansion", "disease_state": "locally advanced or metastatic, relapsed", "histology_inclusion": "non-small cell lung cancer (NSCLC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "PD-1 Targeting Agent Combination Dose Expansion", "disease_state": "locally advanced or metastatic, relapsed", "histology_inclusion": "clear cell renal cell carcinoma (ccRCC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "PD-1 Targeting Agent Combination Dose Expansion", "disease_state": "locally advanced or metastatic", "histology_inclusion": "MSI-H tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "VEGFR TKI Combination Dose Expansion", "disease_state": "locally advanced or metastatic, relapsed", "histology_inclusion": "clear cell renal cell carcinoma (ccRCC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Monotherapy Dose Expansion", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Monotherapy Dose Expansion", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Monotherapy Dose Expansion", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}, {"cohort": "PD-1 Targeting Agent Combination Dose Expansion", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "PD-1 Targeting Agent Combination Dose Expansion", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "PD-1 Targeting Agent Combination Dose Expansion", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}, {"cohort": "PD-1 Targeting Agent Combination Dose Expansion", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "PD-1 Targeting Agent Combination Dose Expansion", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "VEGFR TKI Combination Dose Expansion", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}]}
{"NCT_id": "NCT05233696", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced unresectable", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": ["PD-L1 CPS > 10%"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}]}
{"NCT_id": "NCT03241745", "json": [{"cohort": "", "disease_state": "metastatic or recurrent", "histology_inclusion": "uterine cancer", "biomarker_inclusion": ["MSI-high"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or recurrent", "histology_inclusion": "endometrial carcinoma", "biomarker_inclusion": ["MMR-deficient"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or recurrent", "histology_inclusion": "carcinosarcoma", "biomarker_inclusion": ["Hypermutated (\u226520 somatic mutations)"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or recurrent", "histology_inclusion": "clear cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or recurrent", "histology_inclusion": "leiomyosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or recurrent", "histology_inclusion": "undifferentiated sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or recurrent", "histology_inclusion": "high grade endometrial stromal sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Uterine Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "", "histology_inclusion": "Carcinosarcoma", "biomarker_inclusion": [["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Endometrial Clear Cell Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Leiomyosarcoma"}, {"cohort": "", "histology_inclusion": "Liver Embryonal Sarcoma"}, {"cohort": "", "histology_inclusion": "Endometrioid Stromal Sarcoma"}]}
{"NCT_id": "NCT03698019", "json": [{"cohort": "", "disease_state": "Stage III-IV", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": ["Uveal Melanoma", "Primary Brain Tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III-IV", "histology_inclusion": "Acral Lentiginous Melanoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary Brain Tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III-IV", "histology_inclusion": "Mucosal Melanoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary Brain Tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "histology_exclusion": ["Primary Brain Neoplasm", "Intraocular Melanoma"]}, {"cohort": "", "histology_inclusion": "Acral Lentiginous Melanoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Mucosal Melanoma", "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT04647838", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["MET exon 14 skipping mutation", "c-MET copy number gain (\u22656.0)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "gastric cancer", "biomarker_inclusion": ["MET exon 14 skipping mutation", "c-MET copy number gain (\u22656.0)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["MET exon 14 skipping mutation", "c-MET copy number gain (\u22656.0)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["MET exon 14 skipping mutation", "c-MET copy number gain (\u22656.0)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "hepatocellular cancer", "biomarker_inclusion": ["MET exon 14 skipping mutation", "c-MET copy number gain (\u22656.0)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "head and neck cancer", "biomarker_inclusion": ["MET exon 14 skipping mutation", "c-MET copy number gain (\u22656.0)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "RCC", "biomarker_inclusion": ["MET exon 14 skipping mutation", "c-MET copy number gain (\u22656.0)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "other solid cancers", "biomarker_inclusion": ["MET exon 14 skipping mutation", "c-MET copy number gain (\u22656.0)"], "histology_exclusion": ["central nervous system (CNS) or brain metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]]}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]]}, {"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]]}, {"cohort": "", "histology_inclusion": "Malignant Head and Neck Neoplasm", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]]}, {"cohort": "", "histology_inclusion": "Head and Neck Carcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]]}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]]}, {"cohort": "", "histology_inclusion": "Refractory Cytopenia of Childhood", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]]}, {"cohort": "", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]]}]}
{"NCT_id": "NCT02448420", "json": [{"cohort": "Cohorts A and B (Recruitment Closed)", "disease_state": "metastatic or locally advanced", "histology_inclusion": "adenocarcinoma of the breast", "biomarker_inclusion": ["HER2 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohorts C", "disease_state": "metastatic or locally advanced", "histology_inclusion": "adenocarcinoma of the breast", "biomarker_inclusion": ["HER2 positive", "Hormone receptor positive", "Luminal intrinsic subtype (Luminal A or Luminal B)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohorts A and B (Recruitment Closed)", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohorts C", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"]]}]}
{"NCT_id": "NCT04284228", "json": [{"cohort": "", "disease_state": "relapsed", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": ["HLA-A*0201"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed", "histology_inclusion": "Myelodysplastic Syndrome (MDS)", "biomarker_inclusion": ["HLA-A*0201"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}]}
{"NCT_id": "NCT04387500", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "FH-deficient RCC", "biomarker_inclusion": ["germline FH gene mutation", "somatic FH gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Fumarate Hydratase-Deficient Renal Cell Carcinoma", "biomarker_inclusion": [["FH-Low", "FH-Low", "expression"], ["XRCC1-Low", "XRCC1-Low", "expression"], ["FH Mutation", "FH-Mutation", "gene"], ["FH Mutation", "FH-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Fumarate Hydratase-Deficient Renal Cell Carcinoma", "biomarker_inclusion": [["FH Mutation", "FH-Mutation", "gene"], ["FH-Low", "FH-Low", "expression"], ["XRCC1-Low", "XRCC1-Low", "expression"]]}]}
{"NCT_id": "NCT04973683", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "adenoid cystic carcinoma", "biomarker_inclusion": ["NOTCH1 pathway activation (NICD1 IHC nuclear staining in >= 70% of tumor cells)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Adenoid Cystic Carcinoma"}]}
{"NCT_id": "NCT05038696", "json": [{"cohort": "Single arm", "disease_state": "Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia", "histology_inclusion": "B-cell acute lymphoblastic leukemia/lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["Positive HIV test"]}, {"cohort": "Single arm", "disease_state": "Induction failure B-lineage Acute Lymphoblastic Leukemia", "histology_inclusion": "B-cell acute lymphoblastic leukemia/lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["Positive HIV test"]}, {"cohort": "Single arm", "disease_state": "High risk B-lineage Acute Lymphoblastic Leukemia", "histology_inclusion": "B-cell acute lymphoblastic leukemia/lymphoma", "biomarker_inclusion": ["BCR-ABL1", "BCR-ABL1-like", "ABL1-r", "PDGFRB-r", "TCF3-HLF", "MLL-r", "hypodiploid ALL (< 45 chromosomes)", "p53 pathogenic mutation"], "histology_exclusion": [], "biomarker_exclusion": ["Positive HIV test"]}], "json_norm": [{"cohort": "Single arm", "histology_inclusion": "B Acute Lymphoblastic Leukemia"}, {"cohort": "Single arm", "histology_inclusion": "B Acute Lymphoblastic Leukemia"}, {"cohort": "Single arm", "histology_inclusion": "B Acute Lymphoblastic Leukemia", "biomarker_inclusion": [["TCF3 - EPAS1", "TCF3 - EPAS1", "coordinate"], ["BCR - ABL1", "BCR - ABL1", "coordinate"], ["TCF3 - HLF", "TCF3 - HLF", "coordinate"], ["TCF7L1 - EPAS1", "TCF7L1 - EPAS1", "coordinate"], ["TCF7L1 - HLF", "TCF7L1 - HLF", "coordinate"], ["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT05038735", "json": [{"cohort": "", "disease_state": "Advanced", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["HR+", "HER2-", "PIK3CA mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT05364073", "json": [{"cohort": "Stage 1 Dose Escalation and Backfill Cohorts", "disease_state": "Stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer (NSCLC)", "biomarker_inclusion": ["EGFR Exon 20 insertion mutation", "HER2 Exon 20 insertion mutation", "EGFR activating mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stage 2 Expansion Cohort 1", "disease_state": "Stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer (NSCLC)", "biomarker_inclusion": ["EGFR Exon 20 insertion mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stage 2 Expansion Cohort 2", "disease_state": "Stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer (NSCLC)", "biomarker_inclusion": ["HER2 Exon 20 insertion mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stage 2 Expansion Cohort 3", "disease_state": "Stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer (NSCLC)", "biomarker_inclusion": ["EGFR activating mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR Exon 20 insertion mutation", "EGFR Uncommon mutation"]}, {"cohort": "Stage 2 Expansion Cohort 4", "disease_state": "Stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer (NSCLC)", "biomarker_inclusion": ["EGFR Uncommon mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Stage 1 Dose Escalation and Backfill Cohorts", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Stage 2 Expansion Cohort 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Stage 2 Expansion Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Stage 2 Expansion Cohort 3", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Stage 2 Expansion Cohort 4", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT02122172", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "urothelial tract carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}]}
{"NCT_id": "NCT04219254", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1 (Non-small cell lung cancer)", "disease_state": "", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["PD-L1 \u2265 50%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1 (Non-small cell lung cancer)", "disease_state": "", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["unknown PD-L1", "PD-L1 < 50%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1 (Non-small cell lung cancer)", "disease_state": "", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["anaplastic lymphoma kinase", "ROS1", "epidermal growth factor receptor"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2 (Metastatic Melanoma)", "disease_state": "metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2 (Metastatic Melanoma)", "disease_state": "metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF V600-activating mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3 (Other Tumor Types)", "disease_state": "", "histology_inclusion": "other tumor types", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Cohort 1 (Non-small cell lung cancer)", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 1 (Non-small cell lung cancer)", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 1 (Non-small cell lung cancer)", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 2 (Metastatic Melanoma)", "histology_inclusion": "Melanoma"}, {"cohort": "Cohort 2 (Metastatic Melanoma)", "histology_inclusion": "Melanoma"}, {"cohort": "Cohort 3 (Other Tumor Types)"}]}
{"NCT_id": "NCT04517851", "json": [{"cohort": "", "disease_state": "intermediate or higher risk", "histology_inclusion": "JAK2 V617F+ primary myelofibrosis (PMF) or post-polycythemia vera (PV)/essential thrombocythemia myelofibrosis (ET-MF)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Primary Myelofibrosis", "biomarker_inclusion": [["JAK2 V617F", "V617F", "coordinate"], ["JAK2-High", "JAK2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Primary Myelofibrosis", "biomarker_inclusion": [["JAK2 V617F", "V617F", "coordinate"], ["JAK2-High", "JAK2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Myelofibrosis Transformation in Essential Thrombocythemia", "biomarker_inclusion": [["JAK2 V617F", "V617F", "coordinate"], ["JAK2-High", "JAK2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Myelofibrosis Transformation in Essential Thrombocythemia", "biomarker_inclusion": [["JAK2 V617F", "V617F", "coordinate"], ["JAK2-High", "JAK2-High", "expression"]]}]}
{"NCT_id": "NCT04778410", "json": [{"cohort": "Safety Run-in Cohort 1 and Phase 2 Cohort 1 [Ineligible (1L) Unfit AML Mag+Ven+Aza)]", "disease_state": "newly diagnosed, previously untreated", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Safety Run-in Cohort 2 and Phase 2 Cohort 2 [Relapsed/refractory (R/R) AML Mag+MEC)]", "disease_state": "refractory or first relapse", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Safety Run-in Cohort 3 and Phase 2 Cohort 3 (Post-chemo Maintenance Mag+CC-486)", "disease_state": "complete remission or complete remission with incomplete hematologic recovery with minimal residual disease positivity", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Safety Run-in Cohort 1 and Phase 2 Cohort 1 [Ineligible (1L) Unfit AML Mag+Ven+Aza)]", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "Safety Run-in Cohort 2 and Phase 2 Cohort 2 [Relapsed/refractory (R/R) AML Mag+MEC)]", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "Safety Run-in Cohort 3 and Phase 2 Cohort 3 (Post-chemo Maintenance Mag+CC-486)", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}]}
{"NCT_id": "NCT05038839", "json": [{"cohort": "", "disease_state": "advanced or refractory solid tumors", "histology_inclusion": "", "biomarker_inclusion": ["deleterious BRCA1 mutation", "deleterious BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or refractory solid tumors", "histology_inclusion": "", "biomarker_inclusion": ["deleterious mutation or deletion of MRE11", "deleterious mutation or deletion of RAD50", "deleterious mutation or deletion of NBS1", "deleterious mutation or deletion of ATM", "deleterious mutation or deletion of ATR", "deleterious mutation or deletion of CHEK1", "deleterious mutation or deletion of CHEK2", "deleterious mutation or deletion of PALB2", "deleterious mutation or deletion of ARID1A", "deleterious mutation or deletion of Fanconi anemia genes", "deleterious mutation or deletion of PTEN", "loss of PTEN by IHC", "amplification of EMSY"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "biomarker_inclusion": [["NLRP2 Mutation", "NLRP2-Mutation", "gene"], ["RAD50 Mutation", "RAD50-Mutation", "gene"], ["ATM Mutation", "ATM-Mutation", "gene"], ["CHEK2 Mutation", "CHEK2-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["MRE11 Mutation", "MRE11-Mutation", "gene"], ["NBN Mutation", "NBN-Mutation", "gene"], ["SERPINA2 Mutation", "SERPINA2-Mutation", "gene"], ["ANTXR1 Mutation", "ANTXR1-Mutation", "gene"], ["ATR Mutation", "ATR-Mutation", "gene"], ["ARID1A Mutation", "ARID1A-Mutation", "gene"], ["EMSY-High", "EMSY-High", "expression"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["PTEN-Low", "PTEN-Low", "expression"], ["CHEK1 Mutation", "CHEK1-Mutation", "gene"]]}]}
{"NCT_id": "NCT03698383", "json": [{"cohort": "", "disease_state": "Metastatic", "histology_inclusion": "HER2-positive breast cancer", "biomarker_inclusion": ["PIK3CA-mutant hotspot mutation", "PIK3CA copy number gain", "mTOR hotspot mutation", "PTEN loss"], "histology_exclusion": [], "biomarker_exclusion": ["previous treatment with mTOR inhibitor", "previous treatment with PI3K inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["PTEN-Low", "PTEN-Low", "expression"], ["MTOR Mutation", "MTOR-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}]}
{"NCT_id": "NCT04089189", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "non-mucinous ovarian epithelial cancer, fallopian tube cancer, primary peritoneal cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Tumor", "biomarker_inclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04452877", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["BRAF V600E mutation-positive"], "histology_exclusion": [], "biomarker_exclusion": ["brain or leptomeningeal metastases >1 cm", "previous treatment with BRAF inhibitor", "previous treatment with MEK inhibitor", "history of another malignancy with confirmed activating RAS-mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]], "biomarker_exclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04648254", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04908787", "json": [{"cohort": "", "disease_state": "platinum-resistant", "histology_inclusion": "epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["non-epithelial tumors", "ovarian tumors with low malignant potential"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "platinum-resistant", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": ["non-epithelial tumors", "ovarian tumors with low malignant potential"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "platinum-resistant", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": ["non-epithelial tumors", "ovarian tumors with low malignant potential"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm"]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm"]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm"]}]}
{"NCT_id": "NCT01190930", "json": [{"cohort": "", "disease_state": "newly diagnosed standard-risk acute lymphoblastic leukemia or localized B-lineage lymphoblastic lymphoma", "histology_inclusion": "B-ALL", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system 3 leukemia", "testicular leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly diagnosed standard-risk acute lymphoblastic leukemia or localized B-lineage lymphoblastic lymphoma", "histology_inclusion": "B-LLy Murphy stages I or II", "biomarker_inclusion": [], "histology_exclusion": ["T-lymphoblastic lymphoma", "morphologically unclassifiable lymphoma", "central nervous system 3 leukemia", "testicular involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly diagnosed standard-risk acute lymphoblastic leukemia or localized B-lineage lymphoblastic lymphoma", "histology_inclusion": "Down syndrome", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system 3 leukemia", "testicular leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "B Acute Lymphoblastic Leukemia", "biomarker_inclusion": [["PPIB - BCR", "PPIB - BCR", "coordinate"]]}, {"cohort": ""}, {"cohort": ""}]}
{"NCT_id": "NCT03242382", "json": [{"cohort": "Cohort 1: STS and osteosarcoma", "disease_state": "metastasis or locally advanced, unresectable", "histology_inclusion": "soft tissue sarcoma", "biomarker_inclusion": ["CDK4 overexpression", "low-to-normal p16 expression"], "histology_exclusion": ["Ewing sarcoma", "rhabdomyosarcoma", "well differentiated/dedifferentiated liposarcoma"], "biomarker_exclusion": ["anti CDK4 treatment", "immune checkpoint inhibitor treatment"]}, {"cohort": "Cohort 1: STS and osteosarcoma", "disease_state": "metastasis or locally advanced, unresectable", "histology_inclusion": "osteosarcoma", "biomarker_inclusion": ["CDK4 overexpression", "low-to-normal p16 expression"], "histology_exclusion": ["Ewing sarcoma", "rhabdomyosarcoma", "well differentiated/dedifferentiated liposarcoma"], "biomarker_exclusion": ["anti CDK4 treatment", "immune checkpoint inhibitor treatment"]}, {"cohort": "Cohort 2: Chordomas", "disease_state": "", "histology_inclusion": "chordoma", "biomarker_inclusion": ["CDKN2A mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1: STS and osteosarcoma", "histology_inclusion": "Soft Tissue Sarcoma", "biomarker_inclusion": [["CDK4-High", "CDK4-High", "expression"]], "histology_exclusion": ["Rhabdomyosarcoma", "Ewing Sarcoma", "Dedifferentiated Liposarcoma"]}, {"cohort": "Cohort 1: STS and osteosarcoma", "histology_inclusion": "Osteosarcoma", "biomarker_inclusion": [["CDK4-High", "CDK4-High", "expression"]], "histology_exclusion": ["Rhabdomyosarcoma", "Ewing Sarcoma", "Dedifferentiated Liposarcoma"]}, {"cohort": "Cohort 2: Chordomas", "histology_inclusion": "Chordoma", "biomarker_inclusion": [["CDKN2A Mutation", "CDKN2A-Mutation", "gene"]]}]}
{"NCT_id": "NCT03893903", "json": [{"cohort": "IDH1 peptide vaccine", "disease_state": "first, second or third recurrence of a histologically confirmed IDH1R132H-mutated glioma WHO grade II, III or IV progressive after radiotherapy and chemotherapy", "histology_inclusion": "IDH1R132H-mutated glioma", "biomarker_inclusion": ["Absence of chromosomal 1p/19q co-deletion", "Loss of nuclear ATRX expression (partial loss allowed)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "combination", "disease_state": "first, second or third recurrence of a histologically confirmed IDH1R132H-mutated glioma WHO grade II, III or IV progressive after radiotherapy and chemotherapy", "histology_inclusion": "IDH1R132H-mutated glioma", "biomarker_inclusion": ["Absence of chromosomal 1p/19q co-deletion", "Loss of nuclear ATRX expression (partial loss allowed)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Avelumab", "disease_state": "first, second or third recurrence of a histologically confirmed IDH1R132H-mutated glioma WHO grade II, III or IV progressive after radiotherapy and chemotherapy", "histology_inclusion": "IDH1R132H-mutated glioma", "biomarker_inclusion": ["Absence of chromosomal 1p/19q co-deletion", "Loss of nuclear ATRX expression (partial loss allowed)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "IDH1 peptide vaccine", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 R132H", "R132H", "coordinate"]]}, {"cohort": "combination", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 R132H", "R132H", "coordinate"]]}, {"cohort": "Avelumab", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 R132H", "R132H", "coordinate"]]}]}
{"NCT_id": "NCT03959085", "json": [{"cohort": "B-ALL and MPAL", "disease_state": "", "histology_inclusion": "B-cell Acute Lymphoblastic Leukemia (B-ALL), Mixed Phenotype Acute Leukemia (MPAL)", "biomarker_inclusion": [], "histology_exclusion": ["Down syndrome", "acute undifferentiated leukemia (AUL)", "MYC translocation associated with mature (Burkitt) B-cell ALL"], "biomarker_exclusion": []}, {"cohort": "B-LLy", "disease_state": "", "histology_inclusion": "B-lymphoblastic lymphoma (B-LLy)", "biomarker_inclusion": [], "histology_exclusion": ["T-lymphoblastic lymphoma", "morphologically unclassifiable lymphoma", "absence of both B-cell and T-cell phenotype markers in a case submitted as lymphoblastic lymphoma", "Down syndrome"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "B-ALL and MPAL", "histology_inclusion": "B Acute Lymphoblastic Leukemia", "biomarker_inclusion": [["PPIB - BCR", "PPIB - BCR", "coordinate"]], "histology_exclusion": ["Acute Undifferentiated Leukemia", "Infant Acute Undifferentiated Leukemia", "B Acute Lymphoblastic Leukemia"], "biomarker_exclusion": [["MYC Fusion", "MYC", "fusion"]]}, {"cohort": "B-ALL and MPAL", "histology_inclusion": "Mixed Phenotype Acute Leukemia", "biomarker_inclusion": [["PPIB - BCR", "PPIB - BCR", "coordinate"]], "histology_exclusion": ["Acute Undifferentiated Leukemia", "Infant Acute Undifferentiated Leukemia", "B Acute Lymphoblastic Leukemia"], "biomarker_exclusion": [["MYC Fusion", "MYC", "fusion"]]}, {"cohort": "B-LLy", "histology_inclusion": "B Lymphoblastic Lymphoma", "histology_exclusion": ["Lymphoblastic Lymphoma"]}]}
{"NCT_id": "NCT05039177", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["BRAF V600E", "KRAS mutation", "NRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": ["RAS inhibitor", "MEK inhibitor", "ERK inhibitor"]}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": ["KRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": ["RAS inhibitor", "MEK inhibitor", "ERK inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["BRAF V600E", "V600E", "coordinate"], ["NRAS Mutation", "NRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT01861093", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Aplastic Anemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Myelodysplastic Syndrome (MDS)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}, {"cohort": "", "histology_inclusion": "Leukemia"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Lymphoma"}]}
{"NCT_id": "NCT02981940", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "glioblastoma, IDH-wildtype; glioblastoma variants; or astrocytoma, IDH-mutant, WHO grade 4", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04089449", "json": [{"cohort": "", "disease_state": "refractory", "histology_inclusion": "Advanced Solid Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "High-Grade Glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "GBM", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Glioma"}, {"cohort": "", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT04284787", "json": [{"cohort": "", "disease_state": "Newly diagnosed and previously untreated", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Acute Promyelocytic Leukemia"], "biomarker_exclusion": ["core binding factor (CBF)-AML"]}, {"cohort": "", "disease_state": "Secondary AML arising from prior myelodysplastic syndrome (MDS)", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Acute Promyelocytic Leukemia"], "biomarker_exclusion": ["core binding factor (CBF)-AML"]}, {"cohort": "", "disease_state": "Therapy-related Acute Myeloid Leukemia", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Acute Promyelocytic Leukemia"], "biomarker_exclusion": ["core binding factor (CBF)-AML"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT04518137", "json": [{"cohort": "", "disease_state": "advanced or metastatic solid tumors", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["NFE2L2 mutations"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic solid tumors", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["STK11 mutations"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic solid tumors", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["RICTOR amplifications"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NFE2L2 Mutation", "NFE2L2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["STK11 Mutation", "STK11-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["RICTOR-High", "RICTOR-High", "expression"]]}]}
{"NCT_id": "NCT04974216", "json": [{"cohort": "", "disease_state": "Previously untreated high-grade B-cell lymphoma", "histology_inclusion": "CD20+ diffuse large B-cell lymphoma (DLBCL)", "biomarker_inclusion": [], "histology_exclusion": ["Any other histological type of lymphoma, Burkitt included", "Any history of treated or non-treated Small-B cell lymphoma prior Aggressive B Cell lymphoma diagnosis", "Central nervous system or meningeal involvement by lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Previously untreated high-grade B-cell lymphoma", "histology_inclusion": "De Novo transformed DLBCL from low grade lymphoma (Follicular, other...) and DLBCL associated with some small cell infiltration in bone marrow or lymph node", "biomarker_inclusion": [], "histology_exclusion": ["Any other histological type of lymphoma, Burkitt included", "Any history of treated or non-treated Small-B cell lymphoma prior Aggressive B Cell lymphoma diagnosis", "Central nervous system or meningeal involvement by lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Previously untreated high-grade B-cell lymphoma", "histology_inclusion": "High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements", "biomarker_inclusion": [], "histology_exclusion": ["Any other histological type of lymphoma, Burkitt included", "Any history of treated or non-treated Small-B cell lymphoma prior Aggressive B Cell lymphoma diagnosis", "Central nervous system or meningeal involvement by lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Previously untreated high-grade B-cell lymphoma", "histology_inclusion": "High-grade B-cell lymphoma, Not Otherwise Specified (NOS)", "biomarker_inclusion": [], "histology_exclusion": ["Any other histological type of lymphoma, Burkitt included", "Any history of treated or non-treated Small-B cell lymphoma prior Aggressive B Cell lymphoma diagnosis", "Central nervous system or meningeal involvement by lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Previously untreated high-grade B-cell lymphoma", "histology_inclusion": "Follicular lymphoma grade 3B", "biomarker_inclusion": [], "histology_exclusion": ["Any other histological type of lymphoma, Burkitt included", "Any history of treated or non-treated Small-B cell lymphoma prior Aggressive B Cell lymphoma diagnosis", "Central nervous system or meningeal involvement by lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["B-Cell Non-Hodgkin Lymphoma", "Burkitt Lymphoma"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["B-Cell Non-Hodgkin Lymphoma", "Burkitt Lymphoma"]}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"]], "histology_exclusion": ["Burkitt Lymphoma", "B-Cell Non-Hodgkin Lymphoma"]}, {"cohort": "", "histology_inclusion": "High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"]], "histology_exclusion": ["B-Cell Non-Hodgkin Lymphoma", "Burkitt Lymphoma"]}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma, Not Otherwise Specified", "histology_exclusion": ["B-Cell Non-Hodgkin Lymphoma", "Burkitt Lymphoma"]}, {"cohort": "", "histology_inclusion": "Grade 3b Follicular Lymphoma", "histology_exclusion": ["B-Cell Non-Hodgkin Lymphoma", "Burkitt Lymphoma"]}]}
{"NCT_id": "NCT05104281", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR Exon 18-21 mutation"], "histology_exclusion": ["squamous"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT05364645", "json": [{"cohort": "", "disease_state": "stage IV or recurrent", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["RET fusion-positive"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR sensitizing mutations", "EGFR T790M mutations", "ALK gene fusions", "ROS1 gene fusion", "KRAS activating mutations", "BRAF V600E mutation", "MET exon 14 skipping mutations or high-level amplification and expression"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"], ["RET-High", "RET-High", "expression"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"], ["ALK Fusion", "ALK", "fusion"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["MET exon 14 del", "exon 14 del", "exon"], ["EGFR T790M", "T790M", "coordinate"], ["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT05429684", "json": [{"cohort": "", "disease_state": "refractory advanced", "histology_inclusion": "HER2 positive breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT03047135", "json": [{"cohort": "", "disease_state": "biochemically-recurrent", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with PARP inhibitor, including olaparib"]}, {"cohort": "enrichment stage", "disease_state": "biochemically-recurrent", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["deleterious mutation in ATM", "deleterious mutation in BARD1", "deleterious mutation in BRCA1", "deleterious mutation in BRCA2", "deleterious mutation in BRIP1", "deleterious mutation in CDK12", "deleterious mutation in CHEK1", "deleterious mutation in CHEK2", "deleterious mutation in FANCL", "deleterious mutation in PALB2", "deleterious mutation in PPP2R2A", "deleterious mutation in RAD51B", "deleterious mutation in RAD51C", "deleterious mutation in RAD51D", "deleterious mutation in other DNA repair genes"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with PARP inhibitor, including olaparib"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}, {"cohort": "enrichment stage", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["CHEK2 Mutation", "CHEK2-Mutation", "gene"], ["CDK12 Mutation", "CDK12-Mutation", "gene"], ["RAD51C Mutation", "RAD51C-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["RAD51B Mutation", "RAD51B-Mutation", "gene"], ["BARD1 Mutation", "BARD1-Mutation", "gene"], ["DNA Damage Repair (DDR) pathways", null, "pathway"], ["BRIP1 Mutation", "BRIP1-Mutation", "gene"], ["FANCL Mutation", "FANCL-Mutation", "gene"], ["RAD51D Mutation", "RAD51D-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["CHEK1 Mutation", "CHEK1-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["PPP2R2A Mutation", "PPP2R2A-Mutation", "gene"]]}]}
{"NCT_id": "NCT03503409", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Myelodysplastic syndrome", "biomarker_inclusion": ["IDH1 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04024436", "json": [{"cohort": "Cohort 1", "disease_state": "metastatic", "histology_inclusion": "HR+ HER2- breast cancer", "biomarker_inclusion": ["FGFR2 gene amplification"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with FGFR inhibitor"]}, {"cohort": "Cohort 2", "disease_state": "metastatic", "histology_inclusion": "TNBC", "biomarker_inclusion": ["FGFR2 gene amplification"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with FGFR inhibitor"]}, {"cohort": "Cohort 3", "disease_state": "metastatic", "histology_inclusion": "TNBC or HR+ HER2- breast cancer", "biomarker_inclusion": ["FGFR2 gene amplification"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with FGFR inhibitor"]}, {"cohort": "Cohort 4", "disease_state": "metastatic", "histology_inclusion": "HR+ HER2- breast cancer", "biomarker_inclusion": ["FGFR1 high-level gene amplification"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with FGFR inhibitor", "prior treatment with fulvestrant"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["FGFR2-High", "FGFR2-High", "expression"]]}, {"cohort": "Cohort 1", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["FGFR2-High", "FGFR2-High", "expression"]]}, {"cohort": "Cohort 1", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["FGFR2-High", "FGFR2-High", "expression"]]}, {"cohort": "Cohort 1", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["FGFR2-High", "FGFR2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Cohort 2", "biomarker_inclusion": [["FGFR2-High", "FGFR2-High", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-Low", "HR-Low", "expression"], ["HR-High", "HR-High", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["FGFR2-High", "FGFR2-High", "expression"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-Low", "HR-Low", "expression"], ["HR-High", "HR-High", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["FGFR2-High", "FGFR2-High", "expression"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-Low", "HR-Low", "expression"], ["HR-High", "HR-High", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["FGFR2-High", "FGFR2-High", "expression"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-Low", "HR-Low", "expression"], ["HR-High", "HR-High", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["FGFR2-High", "FGFR2-High", "expression"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["FGFR2-High", "FGFR2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["HR-High", "HR-High", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Cohort 4", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["FGFR1-High", "FGFR1-High", "expression"]]}, {"cohort": "Cohort 4", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["FGFR1-High", "FGFR1-High", "expression"]]}, {"cohort": "Cohort 4", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["FGFR1-High", "FGFR1-High", "expression"]]}, {"cohort": "Cohort 4", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-Low", "HR-Low", "expression"], ["HR-High", "HR-High", "expression"], ["FGFR1-High", "FGFR1-High", "expression"]]}]}
{"NCT_id": "NCT04518345", "json": [{"cohort": "", "disease_state": "FLT3-ITD mutated", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["FLT3-ITD mutation"], "histology_exclusion": ["acute promyelocytic leukemia", "advanced malignant solid tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "FLT3-ITD mutated", "histology_inclusion": "Secondary Acute Myeloid Leukemia", "biomarker_inclusion": ["FLT3-ITD mutation"], "histology_exclusion": ["acute promyelocytic leukemia", "advanced malignant solid tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "FLT3-ITD mutated", "histology_inclusion": "Therapy-Related Acute Myeloid Leukemia", "biomarker_inclusion": ["FLT3-ITD mutation"], "histology_exclusion": ["acute promyelocytic leukemia", "advanced malignant solid tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Malignant Solid Neoplasm", "Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "histology_inclusion": "Secondary Acute Myeloid Leukemia", "histology_exclusion": ["Malignant Solid Neoplasm", "Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "histology_inclusion": "Therapy-Related Acute Myeloid Leukemia", "histology_exclusion": ["Malignant Solid Neoplasm", "Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT04844073", "json": [{"cohort": "", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "cancers expressing epidermal growth factor receptor (EGFR)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort Expansion Phase: NSCLC", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer (NSCLC)", "biomarker_inclusion": ["EGFR mutation", "ALK rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort Expansion Phase: HNSCC", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "head and neck squamous cell carcinoma (HNSCC)", "biomarker_inclusion": ["human papillomavirus (HPV) positive"], "histology_exclusion": ["upper esophageal tumors", "salivary gland tumors"], "biomarker_exclusion": []}, {"cohort": "Cohort Expansion Phase: CRC", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "colorectal cancer (CRC)", "biomarker_inclusion": ["K-Ras WT"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort Expansion Phase: CRC", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "colorectal cancer (CRC)", "biomarker_inclusion": ["K-Ras mutant"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "Cohort Expansion Phase: NSCLC", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Cohort Expansion Phase: HNSCC", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Esophageal Carcinoma", "Malignant Salivary Gland Neoplasm", "Salivary Gland Carcinoma"]}, {"cohort": "Cohort Expansion Phase: CRC", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Cohort Expansion Phase: CRC", "histology_inclusion": "Colorectal Carcinoma"}]}
{"NCT_id": "NCT05169437", "json": [{"cohort": "Niraparib in Locally Advanced or Metastatic Solid Tumor Patients with PALB2 Mutations", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["tPALB2 mutation"], "histology_exclusion": ["ovarian cancer", "prostate cancer"], "biomarker_exclusion": ["BRCA1 mutation", "BRCA2 mutation"]}], "json_norm": [{"cohort": "Niraparib in Locally Advanced or Metastatic Solid Tumor Patients with PALB2 Mutations", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Prostate Neoplasm", "Prostate Carcinoma"], "biomarker_exclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT02645149", "json": [{"cohort": "A1", "disease_state": "unresectable Stage IIIB, IIIC or Stage IV metastatic melanoma", "histology_inclusion": "melanoma", "biomarker_inclusion": ["Non-V600 BRAF", "BRAF wildtype", "NRAS wildtype", "Actionable gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "A2", "disease_state": "unresectable Stage IIIB, IIIC or Stage IV metastatic melanoma", "histology_inclusion": "melanoma", "biomarker_inclusion": ["Non-V600 BRAF", "BRAF wildtype", "NRAS wildtype", "Actionable gene mutation"], "histology_exclusion": [], "biomarker_exclusion": ["matched drug available"]}, {"cohort": "A3", "disease_state": "unresectable Stage IIIB, IIIC or Stage IV metastatic melanoma", "histology_inclusion": "melanoma", "biomarker_inclusion": ["Non-V600 BRAF", "BRAF wildtype", "NRAS wildtype"], "histology_exclusion": [], "biomarker_exclusion": ["actionable genetic aberration"]}, {"cohort": "B", "disease_state": "unresectable Stage IIIB, IIIC or Stage IV metastatic melanoma", "histology_inclusion": "mucosal melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "C", "disease_state": "unresectable Stage IIIB, IIIC or Stage IV metastatic melanoma", "histology_inclusion": "melanoma", "biomarker_inclusion": ["NRAS mutant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "D", "disease_state": "unresectable Stage IIIB, IIIC or Stage IV metastatic melanoma", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAF V600 mutant"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "A1", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]]}, {"cohort": "A2", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]]}, {"cohort": "A3", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]]}, {"cohort": "B", "histology_inclusion": "Mucosal Melanoma"}, {"cohort": "C", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"]]}, {"cohort": "D", "histology_inclusion": "Melanoma"}]}
{"NCT_id": "NCT03568656", "json": [{"cohort": "mCRPC", "disease_state": "metastatic castration-resistant prostate cancer", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor", "brain metastases"], "biomarker_exclusion": []}, {"cohort": "metastatic breast cancer", "disease_state": "metastatic breast cancer", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor", "brain metastases"], "biomarker_exclusion": []}, {"cohort": "non-small cell lung cancer", "disease_state": "non-small cell lung cancer", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor", "brain metastases"], "biomarker_exclusion": []}, {"cohort": "advanced solid tumors", "disease_state": "advanced solid tumors", "histology_inclusion": "advanced solid tumors", "biomarker_inclusion": ["loss of function mutations in CREBBP", "loss of function mutations in EP300", "loss of function mutations in ARID1A", "MYC gene amplifications", "MYC gene rearrangements", "androgen receptor (AR) gene amplifications", "androgen receptor (AR) over-expression"], "histology_exclusion": ["primary brain tumor", "brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "mCRPC", "histology_inclusion": "Prostate Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "mCRPC", "histology_inclusion": "Prostate Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "metastatic breast cancer", "histology_inclusion": "Breast Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "non-small cell lung cancer", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "advanced solid tumors", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["AR-High", "AR-High", "expression"], ["ARID1A Mutation", "ARID1A-Mutation", "gene"], ["AKR1B1-High", "AKR1B1-High", "expression"], ["EP300 Mutation", "EP300-Mutation", "gene"], ["CREBBP Mutation", "CREBBP-Mutation", "gene"], ["MYC-High", "MYC-High", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT04285086", "json": [{"cohort": "", "disease_state": "high-risk", "histology_inclusion": "Essential Thrombocythemia", "biomarker_inclusion": ["JAK2V617-positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Essential Thrombocythemia", "biomarker_inclusion": [["JAK2-High", "JAK2-High", "expression"]]}]}
{"NCT_id": "NCT05104567", "json": [{"cohort": "Cohort A (Sub-study 01)", "disease_state": "advanced unresectable or metastatic", "histology_inclusion": "esophageal squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases", "leptomeningeal disease"], "biomarker_exclusion": ["prior IL2-based anticancer treatment"]}, {"cohort": "Cohort B1 (Sub-study 02)", "disease_state": "advanced unresectable or metastatic", "histology_inclusion": "gastric cancer or gastro-esophageal junction adenocarcinoma", "biomarker_inclusion": ["PD1/PD-L1 naive", "non-MSI-H", "CPS \u22651"], "histology_exclusion": ["brain metastases", "leptomeningeal disease"], "biomarker_exclusion": ["prior IL2-based anticancer treatment", "prior PD-1/PD-L1 pathway treatment"]}, {"cohort": "Cohort B2 (Sub-study 02)", "disease_state": "advanced unresectable or metastatic", "histology_inclusion": "gastric cancer or gastro-esophageal junction adenocarcinoma", "biomarker_inclusion": ["PD1/PD-L1 naive", "non-MSI-H", "CPS < 1"], "histology_exclusion": ["brain metastases", "leptomeningeal disease"], "biomarker_exclusion": ["prior IL2-based anticancer treatment", "prior PD-1/PD-L1 pathway treatment"]}, {"cohort": "Cohort B3 (Sub-study 02)", "disease_state": "advanced unresectable or metastatic", "histology_inclusion": "gastric cancer or gastro-esophageal junction adenocarcinoma", "biomarker_inclusion": ["post PD1/PD-L1", "non-MSI-H"], "histology_exclusion": ["brain metastases", "leptomeningeal disease"], "biomarker_exclusion": ["prior IL2-based anticancer treatment"]}, {"cohort": "Cohort C (Sub-study 03)", "disease_state": "advanced unresectable or metastatic", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": ["post PD-1/PD-L1"], "histology_exclusion": ["brain metastases", "leptomeningeal disease"], "biomarker_exclusion": ["prior IL2-based anticancer treatment"]}, {"cohort": "Cohort D1 (Sub-study 04)", "disease_state": "advanced unresectable or metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["non-MSI-H", "any RAS"], "histology_exclusion": ["brain metastases", "leptomeningeal disease"], "biomarker_exclusion": ["prior IL2-based anticancer treatment", "prior PD-1/PD-L1 pathway treatment"]}, {"cohort": "Cohort D2 (Sub-study 04)", "disease_state": "advanced unresectable or metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["non-MSI-H", "RAS wild type"], "histology_exclusion": ["brain metastases", "leptomeningeal disease"], "biomarker_exclusion": ["prior IL2-based anticancer treatment"]}], "json_norm": [{"cohort": "Cohort A (Sub-study 01)", "histology_inclusion": "Esophageal Squamous Cell Carcinoma"}, {"cohort": "Cohort B1 (Sub-study 02)", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort B1 (Sub-study 02)", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort B2 (Sub-study 02)", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort B2 (Sub-study 02)", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort B3 (Sub-study 02)", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort B3 (Sub-study 02)", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort C (Sub-study 03)", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "Cohort D1 (Sub-study 04)", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort D2 (Sub-study 04)", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT05169658", "json": [{"cohort": "", "disease_state": "untreated", "histology_inclusion": "Follicular lymphoma (grade 1-2 or 3a)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Marginal zone lymphoma (MALT subtype)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "untreated", "histology_inclusion": "Marginal zone lymphoma (non-MALT subtype)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "", "histology_inclusion": "Marginal Zone Lymphoma"}, {"cohort": "", "histology_inclusion": "Marginal Zone Lymphoma"}]}
{"NCT_id": "NCT05755087", "json": [{"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Germinal Center B-cell-like (GCB) and non-GCB Diffuse Large B Cell Lymphoma (DLBCL)", "biomarker_inclusion": ["Increased expression of MYC (>= 40%)", "Increased expression of BCL2 (>= 50%)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Germinal Center B-cell-like (GCB) and non-GCB Diffuse Large B Cell Lymphoma (DLBCL)", "biomarker_inclusion": ["Presence of isolated MYC translocation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "High-Grade B-cell Lymphoma (HGBCL) (double hit [DH] and triple hit [TH])", "biomarker_inclusion": ["Translocations of MYC and BCL2 and/or BCL6"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Histologic transformation of indolent non-Hodgkin's lymphoma (NHL) to DLBCL", "histology_inclusion": "Diffuse Large B Cell Lymphoma (DLBCL)", "biomarker_inclusion": ["Increased expression of MYC (>= 40%)", "Increased expression of BCL2 (>= 50%)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Histologic transformation of indolent non-Hodgkin's lymphoma (NHL) to DLBCL", "histology_inclusion": "Diffuse Large B Cell Lymphoma (DLBCL)", "biomarker_inclusion": ["Presence of MYC and BCL2 translocation"], "histology_exclusion": ["Active Central Nervous System (CNS) lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MYC Fusion", "MYC", "fusion"]]}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["BCL2 Fusion", "BCL2", "fusion"]]}]}
{"NCT_id": "NCT02579967", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Primary T-cell Immunodeficiency Disorders", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Common Variable Immunodeficiency", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Immune System Diseases", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Autoimmune Lymphoproliferative", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Lymphoproliferative Disorders", "biomarker_inclusion": [], "histology_exclusion": ["Central Nervous System involvement by malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["TBXT-Low", "TBXT-Low", "expression"]]}, {"cohort": ""}, {"cohort": ""}, {"cohort": ""}, {"cohort": ""}]}
{"NCT_id": "NCT03373097", "json": [{"cohort": "Phase I", "disease_state": "High Risk and/or Relapsed/Refractory", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": ["GD2-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II", "disease_state": "High Risk and/or Relapsed/Refractory", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": ["GD2-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II", "disease_state": "Extremely High Risk", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": ["Stage III", "Stage IV", "Myc-N amplification", "GD2-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II", "disease_state": "Incurable", "histology_inclusion": "GD2-positive tumors other than Neuroblastoma", "biomarker_inclusion": ["GD2-positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase I", "histology_inclusion": "Neuroblastoma"}, {"cohort": "Phase II", "histology_inclusion": "Neuroblastoma"}, {"cohort": "Phase II", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["MYC-High", "MYC-High", "expression"]]}, {"cohort": "Phase II", "histology_inclusion": "Neuroblastoma"}]}
{"NCT_id": "NCT03829410", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["Kras mutation"], "histology_exclusion": [], "biomarker_exclusion": ["concomitant Kras and BRAF-V600 mutations", "MSI-H/dMMR"]}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": ["untreated or symptomatic brain metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}]}
{"NCT_id": "NCT04089904", "json": [{"cohort": "", "disease_state": "cT1b-T2N0M0", "histology_inclusion": "Esophageal Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1", "anti-PD-L2", "CTLA-4", "OX 40", "CD137"]}, {"cohort": "", "disease_state": "cT1b-T2N0M0", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma (Siewert type I and II)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1", "anti-PD-L2", "CTLA-4", "OX 40", "CD137"]}, {"cohort": "", "disease_state": "cT1b-T2N0M0", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1", "anti-PD-L2", "CTLA-4", "OX 40", "CD137"]}, {"cohort": "", "disease_state": "cT1b-T2N0M0", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma (Siewert type III)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1", "anti-PD-L2", "CTLA-4", "OX 40", "CD137"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Esophageal Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}]}
{"NCT_id": "NCT04779151", "json": [{"cohort": "1.A - Urothelial Bladder Cancer", "disease_state": "metastatic or recurrent", "histology_inclusion": "Urothelial Bladder Cancer", "biomarker_inclusion": ["DNA repair deficiency"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "1.B - Gastric or gastro-esophageal junction adenocarcinoma", "disease_state": "metastatic or recurrent", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": ["DNA repair deficiency"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "1.C - Head and Neck Cancer", "disease_state": "metastatic or recurrent", "histology_inclusion": "Head and Neck Cancer", "biomarker_inclusion": ["DNA repair deficiency"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "1.D - Biliary Tract Cancer and pancreatic ductal adenocarcinoma (PDAC)", "disease_state": "metastatic or recurrent", "histology_inclusion": "Biliary Tract Cancer", "biomarker_inclusion": ["DNA repair deficiency"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "1.D - Biliary Tract Cancer and pancreatic ductal adenocarcinoma (PDAC)", "disease_state": "metastatic or recurrent", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": ["DNA repair deficiency"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "1.E - Others: any histology, excepted breast cancer, prostate cancer or serous ovarian cancer", "disease_state": "metastatic or recurrent", "histology_inclusion": "any histology, excepted breast cancer, prostate cancer or serous ovarian cancer", "biomarker_inclusion": ["DNA repair deficiency"], "histology_exclusion": ["breast cancer", "prostate cancer", "serous ovarian cancer"], "biomarker_exclusion": []}, {"cohort": "Cohort 2 - Platinum-sensitive urothelial bladder cancer", "disease_state": "metastatic or recurrent", "histology_inclusion": "Urothelial Bladder Cancer", "biomarker_inclusion": ["Platinum-sensitive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3 - Clear Cell Renal Cell Carcinoma", "disease_state": "metastatic or recurrent", "histology_inclusion": "Clear Cell Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "1.A - Urothelial Bladder Cancer", "histology_inclusion": "Bladder Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "1.A - Urothelial Bladder Cancer", "histology_inclusion": "Bladder Neoplasm", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "1.B - Gastric or gastro-esophageal junction adenocarcinoma", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "1.C - Head and Neck Cancer", "histology_inclusion": "Malignant Head and Neck Neoplasm", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "1.C - Head and Neck Cancer", "histology_inclusion": "Head and Neck Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "1.D - Biliary Tract Cancer and pancreatic ductal adenocarcinoma (PDAC)", "histology_inclusion": "Liver Cancer", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "1.D - Biliary Tract Cancer and pancreatic ductal adenocarcinoma (PDAC)", "histology_inclusion": "Biliary Tract Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "1.D - Biliary Tract Cancer and pancreatic ductal adenocarcinoma (PDAC)", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "1.E - Others: any histology, excepted breast cancer, prostate cancer or serous ovarian cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]], "histology_exclusion": ["Breast Carcinoma", "Prostate Neoplasm", "Prostate Carcinoma", "Prostate Neoplasm", "Prostate Carcinoma", "Prostate Neoplasm", "Prostate Carcinoma", "Ovarian Serous Adenocarcinoma", "Ovarian Serous Adenocarcinoma", "Ovarian Serous Adenocarcinoma"]}, {"cohort": "1.E - Others: any histology, excepted breast cancer, prostate cancer or serous ovarian cancer", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]], "histology_exclusion": ["Breast Carcinoma", "Prostate Neoplasm", "Prostate Carcinoma", "Prostate Neoplasm", "Prostate Carcinoma", "Prostate Neoplasm", "Prostate Carcinoma", "Ovarian Serous Adenocarcinoma", "Ovarian Serous Adenocarcinoma", "Ovarian Serous Adenocarcinoma"]}, {"cohort": "1.E - Others: any histology, excepted breast cancer, prostate cancer or serous ovarian cancer", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]], "histology_exclusion": ["Breast Carcinoma", "Prostate Neoplasm", "Prostate Carcinoma", "Prostate Neoplasm", "Prostate Carcinoma", "Prostate Neoplasm", "Prostate Carcinoma", "Ovarian Serous Adenocarcinoma", "Ovarian Serous Adenocarcinoma", "Ovarian Serous Adenocarcinoma"]}, {"cohort": "1.E - Others: any histology, excepted breast cancer, prostate cancer or serous ovarian cancer", "histology_inclusion": "Ovarian Serous Adenocarcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]], "histology_exclusion": ["Breast Carcinoma", "Prostate Neoplasm", "Prostate Carcinoma", "Ovarian Serous Adenocarcinoma"]}, {"cohort": "Cohort 2 - Platinum-sensitive urothelial bladder cancer", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "Cohort 2 - Platinum-sensitive urothelial bladder cancer", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": "Cohort 3 - Clear Cell Renal Cell Carcinoma", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}]}
{"NCT_id": "NCT03829462", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["A/A CCND1 genotype of rs603965 CCND1"], "histology_exclusion": [], "biomarker_exclusion": ["A/G CCND1 genotype of rs603965 CCND1", "G/G CCND1 genotype of rs603965 CCND1"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma"}]}
{"NCT_id": "NCT04388475", "json": [{"cohort": "All patients", "disease_state": "Recurrent", "histology_inclusion": "Glioblastoma (WHO Grade IV)", "biomarker_inclusion": ["MGMT promoter methylation status"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "All patients", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT04714190", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "gastric or gastroesophageal adenocarcinoma", "biomarker_inclusion": ["HER2 IHC 2+", "HER2 IHC 3+"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}]}
{"NCT_id": "NCT05039801", "json": [{"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["KEAP1 mutation", "NFE2L2 mutation", "STK11 mutation", "NF1 mutation", "low ASNS expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "immunotherapy melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "post-platinum Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "chondrosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced", "histology_inclusion": "ARID1A mutant clear cell ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "recurrent", "histology_inclusion": "high-grade non-mucinous ovarian cancer", "biomarker_inclusion": ["platinum-resistant", "low ASNS expression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NF1 Mutation", "NF1-Mutation", "gene"], ["NFE2L2 Mutation", "NFE2L2-Mutation", "gene"], ["KEAP1 Mutation", "KEAP1-Mutation", "gene"], ["STK11 Mutation", "STK11-Mutation", "gene"]]}, {"cohort": "Part A", "histology_inclusion": "Melanoma"}, {"cohort": "Part A", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Part A", "histology_inclusion": "Chondrosarcoma"}, {"cohort": "Part A", "histology_inclusion": "Ovarian Clear Cell Tumor", "biomarker_inclusion": [["ARID1A Mutation", "ARID1A-Mutation", "gene"]]}, {"cohort": "Part B", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Part B", "histology_inclusion": "Malignant Ovarian Neoplasm"}]}
{"NCT_id": "NCT05300048", "json": [{"cohort": "Cohort 1a", "disease_state": "advanced/metastatic", "histology_inclusion": "any extracranial solid tumor", "biomarker_inclusion": ["PIK3CA mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": ["serabelisib", "alpelisib", "other PI3K inhibitor"]}, {"cohort": "Cohort 1b", "disease_state": "recurrent or persistent", "histology_inclusion": "endometrial adenocarcinoma", "biomarker_inclusion": ["PIK3CA mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": ["serabelisib", "alpelisib", "other PI3K inhibitor"]}, {"cohort": "Cohort 1b", "disease_state": "recurrent or persistent", "histology_inclusion": "ovarian clear cell or ovarian endometrioid carcinoma", "biomarker_inclusion": ["PIK3CA mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": ["serabelisib", "alpelisib", "other PI3K inhibitor"]}, {"cohort": "Cohort 2", "disease_state": "advanced/metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["PIK3CA mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": ["serabelisib", "alpelisib", "other PI3K inhibitor"]}, {"cohort": "Cohort 3", "disease_state": "recurrent or persistent", "histology_inclusion": "endometrial adenocarcinoma", "biomarker_inclusion": ["PIK3CA mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": ["serabelisib", "alpelisib", "other PI3K inhibitor"]}, {"cohort": "Cohort 4", "disease_state": "recurrent or persistent", "histology_inclusion": "ovarian clear cell or ovarian endometrioid carcinoma", "biomarker_inclusion": ["PIK3CA mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": ["serabelisib", "alpelisib", "other PI3K inhibitor"]}], "json_norm": [{"cohort": "Cohort 1a", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort 1b", "histology_inclusion": "Endometrial Adenocarcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort 1b", "histology_inclusion": "Ovarian Endometrioid Adenocarcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort 1b", "histology_inclusion": "Ovarian Endometrioid Tumor", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort 2", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort 3", "histology_inclusion": "Endometrial Adenocarcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort 4", "histology_inclusion": "Ovarian Endometrioid Adenocarcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort 4", "histology_inclusion": "Ovarian Endometrioid Tumor", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT03634228", "json": [{"cohort": "Arm A", "disease_state": "newly diagnosed", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["TP53 wild-type"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": ["t(15;17) karyotypic abnormality", "non-synonymous mutation in TP53 gene", "insertion in TP53 gene", "deletion in TP53 gene", "prior treatment with MDM2 inhibitor", "central nervous system involvement of leukemia"]}, {"cohort": "Arm B", "disease_state": "refractory or relapsed", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["TP53 wild-type"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": ["t(15;17) karyotypic abnormality", "non-synonymous mutation in TP53 gene", "insertion in TP53 gene", "deletion in TP53 gene", "prior treatment with MDM2 inhibitor", "central nervous system involvement of leukemia"]}], "json_norm": [{"cohort": "Arm A", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Arm B", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT03764540", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "prostate adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT04518852", "json": [{"cohort": "", "disease_state": "BCLC stage B or stage C", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["fibrolamellar carcinoma", "sarcomatoid carcinoma", "cholangiocarcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma", "histology_exclusion": ["Fibrolamellar Carcinoma", "Cholangiocarcinoma", "Sarcomatoid Carcinoma"]}]}
{"NCT_id": "NCT04974879", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "nonsquamous non-small cell lung cancer", "biomarker_inclusion": ["EGFR Exon 20ins activating mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT05235074", "json": [{"cohort": "Phase I", "disease_state": "recurrent", "histology_inclusion": "anaplastic astrocytoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase I", "disease_state": "recurrent", "histology_inclusion": "anaplastic oligoastrocytoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase I", "disease_state": "recurrent", "histology_inclusion": "glioblastoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase I", "disease_state": "recurrent", "histology_inclusion": "gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase I", "disease_state": "recurrent", "histology_inclusion": "anaplastic ependymoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase I", "disease_state": "recurrent", "histology_inclusion": "medulloblastoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase I", "disease_state": "recurrent", "histology_inclusion": "malignant meningioma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase I", "disease_state": "recurrent", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase IIa", "disease_state": "recurrent", "histology_inclusion": "glioblastoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase I", "histology_inclusion": "Anaplastic Astrocytoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase I", "histology_inclusion": "Anaplastic Oligoastrocytoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase I", "histology_inclusion": "Glioblastoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase I", "histology_inclusion": "Gliosarcoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase I", "histology_inclusion": "Anaplastic Ependymoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase I", "histology_inclusion": "Medulloblastoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase I", "histology_inclusion": "Anaplastic (Malignant) Meningioma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase I", "histology_inclusion": "Melanoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase IIa", "histology_inclusion": "Glioblastoma", "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT02841540", "json": [{"cohort": "MDS Expansion", "disease_state": "lower-risk MDS", "histology_inclusion": "Myelodysplastic Syndromes", "biomarker_inclusion": ["missense SF3B1 mutation"], "histology_exclusion": ["core binding factor leukemia", "acute promyelocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "Dose Optimization", "disease_state": "transfusion-dependent, lower-risk MDS", "histology_inclusion": "Myelodysplastic Syndromes", "biomarker_inclusion": ["missense SF3B1 mutation"], "histology_exclusion": ["core binding factor leukemia", "acute promyelocytic leukemia"], "biomarker_exclusion": ["prior HMA", "prior lenalidomide"]}, {"cohort": "Dose Escalation", "disease_state": "higher-risk MDS/CMML", "histology_inclusion": "Myelodysplastic Syndromes", "biomarker_inclusion": [], "histology_exclusion": ["core binding factor leukemia", "acute promyelocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "Dose Escalation", "disease_state": "lower-risk MDS/CMML", "histology_inclusion": "Myelodysplastic Syndromes", "biomarker_inclusion": [], "histology_exclusion": ["core binding factor leukemia", "acute promyelocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "Dose Escalation", "disease_state": "Acute Myeloid Leukemia", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["core binding factor leukemia", "acute promyelocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "Dose Escalation", "disease_state": "Chronic Myelomonocytic Leukemia", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["core binding factor leukemia", "acute promyelocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "MDS Expansion", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["SF3B2 Mutation", "SF3B2-Mutation", "gene"], ["SF3B1 Mutation", "SF3B1-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Dose Optimization", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["SF3B2 Mutation", "SF3B2-Mutation", "gene"], ["SF3B1 Mutation", "SF3B1-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Dose Escalation", "histology_inclusion": "Myelodysplastic Syndrome", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Dose Escalation", "histology_inclusion": "Myelodysplastic Syndrome", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Dose Escalation", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Dose Escalation", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT04779489", "json": [{"cohort": "Cohort 1", "disease_state": "bulky cN+", "histology_inclusion": "Bladder cancer (Pure urothelial, variant urothelial, or any proportion of squamous cell carcinoma)", "biomarker_inclusion": [], "histology_exclusion": ["Non-urothelial histology (other than pure squamous cell, which is permitted) including pure adenocarcinoma, pure small cell carcinoma, sarcoma, lymphoma, non-genitourinary primary (e.g. colorectal)"], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "bulky cN+", "histology_inclusion": "Bladder cancer (Pure urothelial, variant urothelial, or any proportion of squamous cell carcinoma)", "biomarker_inclusion": [], "histology_exclusion": ["Non-urothelial histology (other than pure squamous cell, which is permitted) including pure adenocarcinoma, pure small cell carcinoma, sarcoma, lymphoma, non-genitourinary primary (e.g. colorectal)"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Squamous Cell Carcinoma", "histology_exclusion": ["Sarcoma", "Adenocarcinoma", "Small Cell Carcinoma"]}, {"cohort": "Cohort 1", "histology_inclusion": "Bladder Carcinoma", "histology_exclusion": ["Sarcoma", "Adenocarcinoma", "Small Cell Carcinoma"]}, {"cohort": "Cohort 1", "histology_inclusion": "Bladder Neoplasm", "histology_exclusion": ["Adenocarcinoma", "Sarcoma", "Small Cell Carcinoma"]}, {"cohort": "Cohort 2", "histology_inclusion": "Squamous Cell Carcinoma", "histology_exclusion": ["Sarcoma", "Adenocarcinoma", "Small Cell Carcinoma"]}, {"cohort": "Cohort 2", "histology_inclusion": "Bladder Carcinoma", "histology_exclusion": ["Sarcoma", "Adenocarcinoma", "Small Cell Carcinoma"]}, {"cohort": "Cohort 2", "histology_inclusion": "Bladder Neoplasm", "histology_exclusion": ["Adenocarcinoma", "Sarcoma", "Small Cell Carcinoma"]}]}
{"NCT_id": "NCT05170204", "json": [{"cohort": "Cohort A1", "disease_state": "Stage III", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["ALK fusion positive"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutation"]}, {"cohort": "Cohort A2", "disease_state": "Stage III", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["ROS1 fusion positive"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutation"]}, {"cohort": "Cohort A3", "disease_state": "Stage III", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["RET fusion positive"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutation"]}], "json_norm": [{"cohort": "Cohort A1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"], ["ALK Fusion", "ALK", "fusion"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Cohort A2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["ROS1-High", "ROS1-High", "expression"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Cohort A3", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"], ["RET-High", "RET-High", "expression"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT05495464", "json": [{"cohort": "", "disease_state": "Previously untreated high-risk", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["CD20 positivity", "t(11;14) (q13;q32)", "cyclin D1 overexpression", "Blastoid/pleomorphic histology", "Ki-67 (\u226550%)", "TP53 mutated", "NOTCH1 mutated", "NOTCH2 mutated", "NSD2 mutated", "UBR5 mutated", "FAT1 mutated", "POT1 mutated", "SMARCA4 mutated", "KMT2D mutated", "BIRC3 mutated", "complex karyotype", "Bulky disease > 5 cm", "FISH positive for TP53", "FISH positive for MYC", "high risk MIPI score (with Ki-67%)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["KMT2D Mutation", "KMT2D-Mutation", "gene"], ["POT1 Mutation", "POT1-Mutation", "gene"], ["TP53-High", "TP53-High", "expression"], ["UBR5 Mutation", "UBR5-Mutation", "gene"], ["NSD2 Mutation", "NSD2-Mutation", "gene"], ["NOTCH2 Mutation", "NOTCH2-Mutation", "gene"], ["NOTCH1 Mutation", "NOTCH1-Mutation", "gene"], ["SH3PXD2A-High", "SH3PXD2A-High", "expression"], ["SMARCA4 Mutation", "SMARCA4-Mutation", "gene"], ["BIRC3 Mutation", "BIRC3-Mutation", "gene"], ["CCND1-High", "CCND1-High", "expression"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["FAT1 Mutation", "FAT1-Mutation", "gene"], ["MYC-High", "MYC-High", "expression"]]}]}
{"NCT_id": "NCT03634540", "json": [{"cohort": "Cohort 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Clear Cell Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["untreated brain metastases", "leptomeningeal disease", "spinal cord compression"], "biomarker_exclusion": ["prior treatment with belzutifan or other HIF2\u03b1 inhibitors", "prior treatment with cabozantinib"]}, {"cohort": "Cohort 2", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Clear Cell Renal Cell Carcinoma", "biomarker_inclusion": ["prior immunotherapy"], "histology_exclusion": ["untreated brain metastases", "leptomeningeal disease", "spinal cord compression"], "biomarker_exclusion": ["prior treatment with belzutifan or other HIF2\u03b1 inhibitors", "prior treatment with cabozantinib"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}]}
{"NCT_id": "NCT04090398", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["HER2 negative", "ER positive", "PR positive", "ER negative", "PR negative"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["PRH2-High", "PRH2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["PGR-High", "PGR-High", "expression"], ["PRH2-Low", "PRH2-Low", "expression"], ["TMEM37-Low", "TMEM37-Low", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"]]}]}
{"NCT_id": "NCT04285671", "json": [{"cohort": "", "disease_state": "Refractory Stage IV", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": ["Small cell lung cancer", "Small cell transformation"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "histology_exclusion": ["Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT04388839", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "fusion positive rhabdomyosarcoma", "biomarker_inclusion": ["PAX/FOXO1 fusion"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Rhabdomyosarcoma", "biomarker_inclusion": [["FOXO1 Fusion", "FOXO1", "fusion"]]}]}
{"NCT_id": "NCT04388852", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "prostate carcinoma", "biomarker_inclusion": ["Tp53 loss or mutation", "RB1 loss or mutation", "PTEN loss or mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "small cell carcinoma", "biomarker_inclusion": ["Tp53 loss or mutation", "RB1 loss or mutation", "PTEN loss or mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "neuroendocrine carcinoma", "biomarker_inclusion": ["Tp53 loss or mutation", "RB1 loss or mutation", "PTEN loss or mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "clear cell renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["TP53-Low", "TP53-Low", "expression"], ["RB1 Mutation", "RB1-Mutation", "gene"], ["RB1-Low", "RB1-Low", "expression"], ["PTEN-Low", "PTEN-Low", "expression"], ["PTEN Mutation", "PTEN-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["PTEN Mutation", "PTEN-Mutation", "gene"], ["RB1-Low", "RB1-Low", "expression"], ["TP53-Low", "TP53-Low", "expression"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["RB1 Mutation", "RB1-Mutation", "gene"], ["PTEN-Low", "PTEN-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Small Cell Carcinoma", "biomarker_inclusion": [["PTEN Mutation", "PTEN-Mutation", "gene"], ["RB1-Low", "RB1-Low", "expression"], ["TP53-Low", "TP53-Low", "expression"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["RB1 Mutation", "RB1-Mutation", "gene"], ["PTEN-Low", "PTEN-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Carcinoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["TP53-Low", "TP53-Low", "expression"], ["RB1 Mutation", "RB1-Mutation", "gene"], ["RB1-Low", "RB1-Low", "expression"], ["PTEN-Low", "PTEN-Low", "expression"], ["PTEN Mutation", "PTEN-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Tumor", "biomarker_inclusion": [["PTEN Mutation", "PTEN-Mutation", "gene"], ["RB1-Low", "RB1-Low", "expression"], ["TP53-Low", "TP53-Low", "expression"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["RB1 Mutation", "RB1-Mutation", "gene"], ["PTEN-Low", "PTEN-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}]}
{"NCT_id": "NCT04584255", "json": [{"cohort": "Arm A Triple Negative Breast Cancer (TNBC)", "disease_state": "Stage I to III", "histology_inclusion": "invasive breast cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation", "PALB2 mutation", "ER negative", "PR negative", "HER2 negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B TNBC", "disease_state": "Stage I to III", "histology_inclusion": "invasive breast cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation", "PALB2 mutation", "ER negative", "PR negative", "HER2 negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm C ER+/HER2-", "disease_state": "Stage I to III", "histology_inclusion": "invasive breast cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation", "PALB2 mutation", "ER positive", "PR positive", "HER2 negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm A Triple Negative Breast Cancer (TNBC)", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["TMEM37-Low", "TMEM37-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "Arm B TNBC", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["TMEM37-Low", "TMEM37-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "Arm C ER+/HER2-", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["PRH2-High", "PRH2-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT05300438", "json": [{"cohort": "Phase Ia", "disease_state": "locally advanced, relapsed, or metastatic", "histology_inclusion": "malignancies", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase Ib", "disease_state": "locally advanced, relapsed, or metastatic", "histology_inclusion": "malignancies", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase Ia"}, {"cohort": "Phase Ib"}]}
{"NCT_id": "NCT03048084", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "diffuse astrocytoma (IDH-1 wildtype)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "diffuse astrocytoma (IDH-1 mutated)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "diffuse oligodendroglioma (IDH-1 mutated and 1p/19q co-deleted)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "anaplastic astrocytoma (IDH-1 wildtype)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "anaplastic astrocytoma (IDH-1 mutated)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "anaplastic oligodendroglioma (IDH-1 mutated and 1p/19q co-deleted)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "glioblastoma (IDH-1 wild-type)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "glioblastoma (IDH-1 mutated)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "diffuse astrocytoma not otherwise specified (NOS)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "anaplastic astrocytoma NOS", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "oligodendroglioma NOS", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "oligoastrocytoma NOS", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "anaplastic oligoastrocytoma NOS", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "anaplastic oligodendroglioma NOS", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "glioblastoma NOS", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Astrocytoma", "biomarker_inclusion": [["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Diffuse Astrocytoma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Oligodendroglioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["AQP1 Mutation", "AQP1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Oligodendroglioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["AQP1 Mutation", "AQP1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Anaplastic Astrocytoma", "biomarker_inclusion": [["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Anaplastic Astrocytoma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Anaplastic Oligodendroglioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["AQP1 Mutation", "AQP1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Anaplastic Oligodendroglioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["AQP1 Mutation", "AQP1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Diffuse Astrocytoma"}, {"cohort": "", "histology_inclusion": "Anaplastic Astrocytoma"}, {"cohort": "", "histology_inclusion": "Oligodendroglioma"}, {"cohort": "", "histology_inclusion": "Oligoastrocytoma"}, {"cohort": "", "histology_inclusion": "Anaplastic Oligoastrocytoma"}, {"cohort": "", "histology_inclusion": "Anaplastic Oligodendroglioma"}, {"cohort": "", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT04090528", "json": [{"cohort": "", "disease_state": "Castration-resistant, Metastatic", "histology_inclusion": "Adenocarcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": ["Small cell or other variant (non-adenocarcinoma) prostate cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "histology_exclusion": ["Prostate Neoplasm", "Prostate Carcinoma"]}]}
{"NCT_id": "NCT04220749", "json": [{"cohort": "", "disease_state": "early-stage", "histology_inclusion": "HPV-negative oropharyngeal squamous cell carcinoma", "biomarker_inclusion": ["negative p16 status"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "early-stage", "histology_inclusion": "HPV-negative oropharyngeal squamous cell carcinoma", "biomarker_inclusion": ["real time PCR"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "early-stage", "histology_inclusion": "HPV-negative oropharyngeal squamous cell carcinoma", "biomarker_inclusion": ["in-situ hybridization"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-Low", "H3P10-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT04975152", "json": [{"cohort": "", "disease_state": "Stage I-II", "histology_inclusion": "Merkel Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["hematologic malignancies (eg, chronic lymphocytic leukemia [CLL])"], "biomarker_exclusion": ["prior systemic anti-cancer immunotherapy for MCC"]}, {"cohort": "", "disease_state": "Stage III to Stage IV (M0)", "histology_inclusion": "Cutaneous Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["hematologic malignancies (eg, chronic lymphocytic leukemia [CLL])"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II (\u22653 cm longest diameter lesion in an aesthetically-sensitive region)", "histology_inclusion": "Cutaneous Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["hematologic malignancies (eg, chronic lymphocytic leukemia [CLL])"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Merkel Cell Carcinoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm", "Chronic Lymphocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "Skin Squamous Cell Carcinoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm", "Chronic Lymphocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "Skin Squamous Cell Carcinoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm", "Chronic Lymphocytic Leukemia"]}]}
{"NCT_id": "NCT04975256", "json": [{"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "phase 1b", "disease_state": "unresectable or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "phase 1b", "disease_state": "unresectable or metastatic", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "phase 1b", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "phase 1b", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT05040360", "json": [{"cohort": "", "disease_state": "Stage I Pancreatic Neuroendocrine Tumor AJCC v8", "histology_inclusion": "well-differentiated pancreatic neuroendocrine tumor", "biomarker_inclusion": ["Ki-67 >= 3%", "Ki-67 <= 55%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II Pancreatic Neuroendocrine Tumor AJCC v8", "histology_inclusion": "well-differentiated pancreatic neuroendocrine tumor", "biomarker_inclusion": ["Ki-67 >= 3%", "Ki-67 <= 55%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III Pancreatic Neuroendocrine Tumor AJCC v8", "histology_inclusion": "well-differentiated pancreatic neuroendocrine tumor", "biomarker_inclusion": ["Ki-67 >= 3%", "Ki-67 <= 55%"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Neoplasm"}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Carcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Tumor"}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Neoplasm"}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Carcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Tumor"}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Neoplasm"}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Carcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Tumor"}]}
{"NCT_id": "NCT05365581", "json": [{"cohort": "Gastric/GEJ Cancer", "disease_state": "metastatic or locally advanced unresectable", "histology_inclusion": "gastric or gastroesophageal junction (GEJ) adenocarcinoma", "biomarker_inclusion": ["claudin (CLDN)18.2 expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Pancreatic Cancer", "disease_state": "metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": ["claudin (CLDN)18.2 expression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Gastric/GEJ Cancer", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "Pancreatic Cancer", "histology_inclusion": "Pancreatic Adenocarcinoma"}]}
{"NCT_id": "NCT04090567", "json": [{"cohort": "", "disease_state": "Advanced/metastatic", "histology_inclusion": "HER2 negative, BRCA germline positive breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["untreated brain metastases", "spinal cord compression", "symptomatic brain metastases", "leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT04975308", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "ER+ HER2- breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["visceral crisis", "lymphangitic spread within the lung", "leptomeningeal disease", "symptomatic or untreated brain metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}]}
{"NCT_id": "NCT04975399", "json": [{"cohort": "", "disease_state": "relapsed and/or refractory", "histology_inclusion": "multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Plasma Cell Myeloma"}]}
{"NCT_id": "NCT03113487", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "epithelial ovarian cancer", "biomarker_inclusion": ["p53 mutation", "p53 overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": ["p53 mutation", "p53 overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": ["p53 mutation", "p53 overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["TP53-High", "TP53-High", "expression"], ["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [["TP53-High", "TP53-High", "expression"], ["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["TP53-High", "TP53-High", "expression"], ["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT03178552", "json": [{"cohort": "A", "disease_state": "unresectable Stage IIIb or Stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["ALK positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "B", "disease_state": "unresectable Stage IIIb or Stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["RET positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "C", "disease_state": "unresectable Stage IIIb or Stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["bTMB positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "D", "disease_state": "unresectable Stage IIIb or Stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["ROS1+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "E", "disease_state": "unresectable Stage IIIb or Stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["BRAF V600 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "F", "disease_state": "unresectable Stage IIIb or Stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR exon 20+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "G", "disease_state": "unresectable Stage IIIb or Stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "A", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"]]}, {"cohort": "B", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET-High", "RET-High", "expression"]]}, {"cohort": "C", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"]]}, {"cohort": "D", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1-High", "ROS1-High", "expression"]]}, {"cohort": "E", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "F", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "G", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT03634982", "json": [{"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) tumors"], "biomarker_exclusion": []}, {"cohort": "Dose-Expansion Component", "disease_state": "relapsed/refractory", "histology_inclusion": "non-small cell lung cancer (NSCLC)", "biomarker_inclusion": ["KRASG12C"], "histology_exclusion": ["primary central nervous system (CNS) tumors"], "biomarker_exclusion": []}, {"cohort": "Dose-Expansion Component", "disease_state": "relapsed/refractory", "histology_inclusion": "gynecological cancers", "biomarker_inclusion": ["NF1 LOF"], "histology_exclusion": ["primary central nervous system (CNS) tumors"], "biomarker_exclusion": []}, {"cohort": "Dose-Expansion Component", "disease_state": "relapsed/refractory", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["KRAS amplifications", "BRAF Class 3"], "histology_exclusion": ["primary central nervous system (CNS) tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Dose-Expansion Component", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "Dose-Expansion Component"}, {"cohort": "Dose-Expansion Component", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRAF Class 3", "BRAF Class 3", "coordinate"], ["KRAS-High", "KRAS-High", "expression"]]}]}
{"NCT_id": "NCT03635021", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the left colon or rectal (originate in the splenic flexure, descending colon, sigmoid colon, or rectal)", "biomarker_inclusion": ["wild-type RAS"], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT03700099", "json": [{"cohort": "Study cohort", "disease_state": "metastatic castration-resistant prostate cancer", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Study cohort", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Study cohort", "histology_inclusion": "Prostate Carcinoma"}]}
{"NCT_id": "NCT04221035", "json": [{"cohort": "High-Risk Neuroblastoma", "disease_state": "Stage M neuroblastoma above 365 days of age at diagnosis (no upper age limit) and Ms neuroblastoma 12-18 months old, any MYCN status; L2, M or Ms neuroblastoma any age with MYCN amplification or focal high level MYC or MYCL amplification", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": ["MYCN amplification", "MYC amplification", "MYCL amplification"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "High-Risk Neuroblastoma", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"], ["MYCL-High", "MYCL-High", "expression"], ["MYC-High", "MYC-High", "expression"]]}]}
{"NCT_id": "NCT04975555", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Diffuse large B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Mantle cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Follicular lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Primary mediastinal large B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "High grade B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "DLBCL arising from follicular lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "B-cell precursor acute lymphoblastic leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "", "histology_inclusion": "Primary Mediastinal (Thymic) Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}]}
{"NCT_id": "NCT04584853", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["ER positive", "HER2 negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}]}
{"NCT_id": "NCT05236036", "json": [{"cohort": "Groups 1-3", "disease_state": "Newly diagnosed", "histology_inclusion": "Glioblastoma, IDH wild-type", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Groups 1-3", "disease_state": "Newly diagnosed", "histology_inclusion": "Astrocytoma with molecular features of GBM", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group 2", "disease_state": "Newly diagnosed", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["Unmethylated"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group S", "disease_state": "Newly suspected or recurrent", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Groups 1-3", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Groups 1-3", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Groups 1-3", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Groups 1-3", "histology_inclusion": "Astrocytoma"}, {"cohort": "Groups 1-3", "histology_inclusion": "Glioblastoma"}, {"cohort": "Group 2", "histology_inclusion": "Glioblastoma"}, {"cohort": "Group S", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT04519879", "json": [{"cohort": "Cohort 1", "disease_state": "Biochemically Recurrent Prostate Cancer", "histology_inclusion": "Adenocarcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Therapy Naive Favorable Risk Prostate Cancer", "histology_inclusion": "Adenocarcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Prostate Adenocarcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT05366816", "json": [{"cohort": "Group A: KIT Exon 13 receiving Sunitinib", "disease_state": "metastatic or unresectable", "histology_inclusion": "Gastrointestinal Stromal Tumors", "biomarker_inclusion": ["KIT exon 13 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["KIT wild type"]}, {"cohort": "Group B: KIT Exon 17 receiving Regorafenib", "disease_state": "metastatic or unresectable", "histology_inclusion": "Gastrointestinal Stromal Tumors", "biomarker_inclusion": ["KIT exon 17 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["KIT wild type"]}], "json_norm": [{"cohort": "Group A: KIT Exon 13 receiving Sunitinib", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_exclusion": [["KIT KIT-wild_type", "KIT-wild_type", "wild_type"]]}, {"cohort": "Group B: KIT Exon 17 receiving Regorafenib", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_exclusion": [["KIT KIT-wild_type", "KIT-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04976634", "json": [{"cohort": "", "disease_state": "advanced (unresectable and/or metastatic)", "histology_inclusion": "Hepatocellular carcinoma (HCC)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced (unresectable and/or metastatic)", "histology_inclusion": "Colorectal cancer (CRC)", "biomarker_inclusion": ["non-microsatellite instability-high (non-MSI-H)", "deficient mismatch repair (dMMR)"], "histology_exclusion": ["central nervous system (CNS) metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced (unresectable and/or metastatic)", "histology_inclusion": "Pancreatic ductal adenocarcinoma (PDAC)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced (unresectable and/or metastatic)", "histology_inclusion": "Biliary tract cancer (BTC)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced (unresectable and/or metastatic)", "histology_inclusion": "Endometrial cancer (EC)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastases", "carcinomatous meningitis", "carcinosarcoma", "endometrial leiomyosarcoma", "high-grade sarcomas", "endometrial stromal sarcomas"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced (unresectable and/or metastatic)", "histology_inclusion": "Esophageal squamous cell carcinoma (ESCC)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastases", "carcinomatous meningitis", "clinically apparent ascites", "pleural effusion"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Liver Cancer"}, {"cohort": "", "histology_inclusion": "Biliary Tract Carcinoma"}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "histology_exclusion": ["Carcinosarcoma", "Leiomyosarcoma", "Sarcoma"]}, {"cohort": "", "histology_inclusion": "Esophageal Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT03179904", "json": [{"cohort": "Cohort A", "disease_state": "Metastatic", "histology_inclusion": "HER2 Positive Breast Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "Metastatic", "histology_inclusion": "HER2 Positive Breast Carcinoma", "biomarker_inclusion": ["ERalpha positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04585958", "json": [{"cohort": "Dose Escalation Phase", "disease_state": "metastatic or unresectable", "histology_inclusion": "", "biomarker_inclusion": ["HER2 1-3+ expression", "HER2 amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Phase", "disease_state": "", "histology_inclusion": "uterine serous carcinoma", "biomarker_inclusion": ["HER2 1-3+ expression", "HER2 amplification"], "histology_exclusion": [], "biomarker_exclusion": ["unknown or negative HER2 testing"]}], "json_norm": [{"cohort": "Dose Escalation Phase", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Dose Expansion Phase", "histology_inclusion": "Endometrial Serous Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "biomarker_exclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT04781374", "json": [{"cohort": "", "disease_state": "metastatic castration-resistant", "histology_inclusion": "prostate adenocarcinoma", "biomarker_inclusion": ["pHER2 positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT03114865", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Pre-B Acute Lymphoblastic Leukemia", "biomarker_inclusion": ["CD19+"], "histology_exclusion": ["Central Nervous System"], "biomarker_exclusion": ["Ph-positive ALL with TKI sensitivity"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "B-cell Non-Hodgkin Lymphoma", "biomarker_inclusion": ["CD19+"], "histology_exclusion": ["Central Nervous System"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["CD19-High", "CD19-High", "expression"]], "biomarker_exclusion": [["PAH-High", "PAH-High", "expression"]]}, {"cohort": "", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma", "biomarker_inclusion": [["CD19-High", "CD19-High", "expression"]]}]}
{"NCT_id": "NCT04390737", "json": [{"cohort": "Relapsed/Refractory FL", "disease_state": "relapsed/refractory", "histology_inclusion": "Follicular lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Epithelioid sarcoma", "disease_state": "advanced", "histology_inclusion": "Epithelioid sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Relapsed/Refractory PTCL", "disease_state": "relapsed/refractory", "histology_inclusion": "Peripheral T-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Other relapsed/refractory Non-Hodgkin's lymphomas with EZH2 mutation", "disease_state": "relapsed/refractory", "histology_inclusion": "Non-Hodgkin's lymphoma", "biomarker_inclusion": ["EZH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Advanced solid tumors with specific genetic alterations", "disease_state": "advanced", "histology_inclusion": "Solid tumor", "biomarker_inclusion": ["EZH2 mutation", "INI1 deficiency", "BAP1 deficiency", "ARID1A mutation", "SMARCA4 mutation"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Relapsed/Refractory FL", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "Epithelioid sarcoma", "histology_inclusion": "Epithelioid Sarcoma"}, {"cohort": "Relapsed/Refractory PTCL", "histology_inclusion": "Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma"}, {"cohort": "Relapsed/Refractory PTCL", "histology_inclusion": "Peripheral T-Cell Lymphoma"}, {"cohort": "Other relapsed/refractory Non-Hodgkin's lymphomas with EZH2 mutation", "histology_inclusion": "Non-Hodgkin Lymphoma", "biomarker_inclusion": [["EZH2 Mutation", "EZH2-Mutation", "gene"]]}, {"cohort": "Advanced solid tumors with specific genetic alterations", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["RNF2-Low", "RNF2-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["MAGI1-Low", "MAGI1-Low", "expression"], ["SMARCA4 Mutation", "SMARCA4-Mutation", "gene"], ["ARID1A Mutation", "ARID1A-Mutation", "gene"], ["EZH2 Mutation", "EZH2-Mutation", "gene"], ["BAP1-Low", "BAP1-Low", "expression"]]}]}
{"NCT_id": "NCT04455750", "json": [{"cohort": "", "disease_state": "metastatic castration-resistant", "histology_inclusion": "prostate adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT05497453", "json": [{"cohort": "", "disease_state": "metastatic, advanced (non-resectable), or recurrent solid tumor", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["mixed histology cholangiocarcinoma and HCC", "fibrolamellar variant HCC"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "BCLC Stage B (intermediate stage) or C (advanced stage), Child-Pugh A hepatocellular carcinoma", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["mixed histology cholangiocarcinoma and HCC", "fibrolamellar variant HCC", "hepatocellular carcinoma with \u2265 50% liver occupation", "clear invasion into the bile duct", "portal vein invasion with Vp4"], "biomarker_exclusion": ["active/untreated CNS metastases", "carcinomatous meningitis"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma", "histology_exclusion": ["Cholangiocarcinoma", "Hepatocellular Carcinoma"]}, {"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma", "histology_exclusion": ["Cholangiocarcinoma", "Hepatocellular Carcinoma"]}]}
{"NCT_id": "NCT01470716", "json": [{"cohort": "Study arm", "disease_state": "Stage II & IIIA", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR exon 19", "EGFR exon 21"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Study arm", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04521075", "json": [{"cohort": "", "disease_state": "metastatic or inoperable", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "MSI-H/dMMR metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "MSI-H/dMMR metastatic", "histology_inclusion": "gastric adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "MSI-H/dMMR metastatic", "histology_inclusion": "esophageal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "MSI-H/dMMR metastatic", "histology_inclusion": "endometrial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "MSI-H/dMMR metastatic", "histology_inclusion": "ovarian carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "MSI-H/dMMR metastatic", "histology_inclusion": "pancreatic ductal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "MSI-H/dMMR metastatic", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Esophageal Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Urothelial Carcinoma"}]}
{"NCT_id": "NCT04586231", "json": [{"cohort": "", "disease_state": "unresectable, locally advanced or metastatic", "histology_inclusion": "clear cell renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}]}
{"NCT_id": "NCT04586270", "json": [{"cohort": "Dose Escalation", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "HER2 negative Breast Cancer", "biomarker_inclusion": ["NF1 mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "locally advanced or metastatic", "histology_inclusion": "HR+/HER2 negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Cohort C", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["PTEN loss", "PTEN mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Cohort D", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Cohort E", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["KRAS G12D mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Escalation", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["NF1 Mutation", "NF1-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort C", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["PTEN-Low", "PTEN-Low", "expression"], ["PTEN Mutation", "PTEN-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort D", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort E", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"]], "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT05172245", "json": [{"cohort": "", "disease_state": "Stage III-IVB", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Nasopharynx", "Salivary", "Thyroid", "Parathyroid glands", "Skin"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III-IVB", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": ["p16-Negative"], "histology_exclusion": ["Nasopharynx", "Salivary", "Thyroid", "Parathyroid glands", "Skin"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III-IVB", "histology_inclusion": "Unknown Primary Head and Neck Carcinoma", "biomarker_inclusion": ["p16-Negative"], "histology_exclusion": ["Nasopharynx", "Salivary", "Thyroid", "Parathyroid glands", "Skin"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-Low", "H3P10-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Malignant Head and Neck Neoplasm", "biomarker_inclusion": [["H3P10-Low", "H3P10-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Head and Neck Carcinoma", "biomarker_inclusion": [["H3P10-Low", "H3P10-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]]}]}
{"NCT_id": "NCT05172258", "json": [{"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["PD-L1 CPS >= 1"], "histology_exclusion": ["Nasopharynx"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "Hypopharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": ["PD-L1 CPS >= 1"], "histology_exclusion": ["Nasopharynx"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "Laryngeal Squamous Cell Carcinoma", "biomarker_inclusion": ["PD-L1 CPS >= 1"], "histology_exclusion": ["Nasopharynx"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma", "biomarker_inclusion": ["PD-L1 CPS >= 1"], "histology_exclusion": ["Nasopharynx"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": ["PD-L1 CPS >= 1", "HPV p16"], "histology_exclusion": ["Nasopharynx"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Hypopharyngeal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Laryngeal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT05302336", "json": [{"cohort": "", "disease_state": "Early", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["HR-positive", "HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT02713269", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["lymphoma", "multiple myeloma", "small cell carcinoma", "germ cell tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["lymphoma", "multiple myeloma", "small cell carcinoma", "germ cell tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "prostate carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["lymphoma", "multiple myeloma", "small cell carcinoma", "germ cell tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["lymphoma", "multiple myeloma", "small cell carcinoma", "germ cell tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": ["lymphoma", "multiple myeloma", "small cell carcinoma", "germ cell tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "gastrointestinal cancer", "biomarker_inclusion": [], "histology_exclusion": ["lymphoma", "multiple myeloma", "small cell carcinoma", "germ cell tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["lymphoma", "multiple myeloma", "small cell carcinoma", "germ cell tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "thyroid carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["lymphoma", "multiple myeloma", "small cell carcinoma", "germ cell tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "head and neck carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["lymphoma", "multiple myeloma", "small cell carcinoma", "germ cell tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "unknown primary tumor", "biomarker_inclusion": [], "histology_exclusion": ["lymphoma", "multiple myeloma", "small cell carcinoma", "germ cell tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Germ Cell Tumor", "Plasma Cell Myeloma", "Lymphoma", "Small Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "histology_exclusion": ["Germ Cell Tumor", "Plasma Cell Myeloma", "Lymphoma", "Small Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "histology_exclusion": ["Lymphoma", "Plasma Cell Myeloma", "Small Cell Carcinoma", "Germ Cell Tumor"]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "histology_exclusion": ["Germ Cell Tumor", "Plasma Cell Myeloma", "Lymphoma", "Small Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Germ Cell Tumor", "Plasma Cell Myeloma", "Lymphoma", "Small Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Melanoma", "histology_exclusion": ["Germ Cell Tumor", "Plasma Cell Myeloma", "Lymphoma", "Small Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Digestive System Neoplasm", "histology_exclusion": ["Germ Cell Tumor", "Plasma Cell Myeloma", "Lymphoma", "Small Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Sarcoma", "histology_exclusion": ["Germ Cell Tumor", "Plasma Cell Myeloma", "Lymphoma", "Small Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Thyroid Gland Carcinoma", "histology_exclusion": ["Germ Cell Tumor", "Plasma Cell Myeloma", "Lymphoma", "Small Cell Carcinoma"]}, {"cohort": "", "histology_inclusion": "Malignant Head and Neck Neoplasm", "histology_exclusion": ["Lymphoma", "Plasma Cell Myeloma", "Small Cell Carcinoma", "Germ Cell Tumor"]}, {"cohort": "", "histology_inclusion": "Head and Neck Carcinoma", "histology_exclusion": ["Germ Cell Tumor", "Plasma Cell Myeloma", "Lymphoma", "Small Cell Carcinoma"]}, {"cohort": "", "histology_exclusion": ["Germ Cell Tumor", "Plasma Cell Myeloma", "Lymphoma", "Small Cell Carcinoma"]}]}
{"NCT_id": "NCT03310619", "json": [{"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Diffuse large B-cell lymphoma (DLBCL) Not otherwise specified (NOS) including transformed indolent Non-Hodgkin lymphoma (NHL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Follicular lymphoma Grade 3B", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "T cell/histiocyte-rich large B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Epstein-Barr virus (EBV) positive DLBCL, NOS", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Primary mediastinal (thymic) large B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with DLBCL histology (double/triple-hit lymphoma)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Indolent Non-Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Non-Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Grade 3b Follicular Lymphoma"}, {"cohort": "", "histology_inclusion": "T-Cell/Histiocyte-Rich Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Primary Mediastinal (Thymic) Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"]]}, {"cohort": "", "histology_inclusion": "High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"]]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"]]}]}
{"NCT_id": "NCT03571438", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "clear cell renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}]}
{"NCT_id": "NCT03831932", "json": [{"cohort": "", "disease_state": "stage IV", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation (L858R or exon 19 deletion)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "expansion", "disease_state": "stage IV", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation (L858R or exon 19 deletion)", "prior first line EGFR inhibitor therapy with osimertinib"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}, {"cohort": "expansion", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT04586335", "json": [{"cohort": "Part 1 dose escalation", "disease_state": "Advanced solid tumors", "histology_inclusion": "Advanced recurrent or metastatic solid tumor", "biomarker_inclusion": ["DDR gene mutation", "PIK3CA mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2 dose expansion - Cohort 1", "disease_state": "Advanced solid tumors", "histology_inclusion": "Advanced recurrent or metastatic solid tumor", "biomarker_inclusion": ["selected DDR gene mutation"], "histology_exclusion": [], "biomarker_exclusion": ["acquired PARP inhibitor resistance"]}, {"cohort": "Part 2 dose expansion - Cohort 2", "disease_state": "Advanced solid tumors", "histology_inclusion": "Advanced recurrent or metastatic solid tumor", "biomarker_inclusion": ["PIK3CA hotspot mutation"], "histology_exclusion": [], "biomarker_exclusion": ["acquired PARP inhibitor resistance"]}, {"cohort": "Part 2 dose expansion - Cohort 3", "disease_state": "Advanced high grade serous ovarian, fallopian tube or primary peritoneal cancer", "histology_inclusion": "Advanced recurrent or metastatic solid tumor", "biomarker_inclusion": ["acquired PARP inhibitor resistance"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2 dose expansion - Cohort 4", "disease_state": "Advanced solid tumors", "histology_inclusion": "Advanced recurrent or metastatic solid tumor", "biomarker_inclusion": ["selected DDR gene mutation", "acquired PARP inhibitor resistance"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2 dose expansion - Cohort 5", "disease_state": "Platinum resistant/refractory recurrent high grade serous ovarian, fallopian tube, or primary peritoneal cancer", "histology_inclusion": "Advanced recurrent or metastatic solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 1 dose escalation", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "Part 2 dose expansion - Cohort 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "Part 2 dose expansion - Cohort 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "Part 2 dose expansion - Cohort 3", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part 2 dose expansion - Cohort 4", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "Part 2 dose expansion - Cohort 5", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04846920", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "clear cell renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain or meningeal metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}]}
{"NCT_id": "NCT02321501", "json": [{"cohort": "Dose Escalation Cohort", "disease_state": "Locally Advanced or Metastatic Solid Tumors", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Cohort", "disease_state": "Stage IIIB or IV Non-small Cell Lung Cancer", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["ALK Positive", "ROS1 Gene Rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Escalation Cohort", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Dose Expansion Cohort", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"]]}]}
{"NCT_id": "NCT04716686", "json": [{"cohort": "Cohort 1", "disease_state": "FIGO stage III-IV", "histology_inclusion": "serous endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PARP inhibitor treatment"]}, {"cohort": "Cohort 1", "disease_state": "FIGO stage III-IV", "histology_inclusion": "other types of endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PARP inhibitor treatment"]}, {"cohort": "Cohort 2", "disease_state": "relapsed", "histology_inclusion": "serous endometrial cancer", "biomarker_inclusion": [">2 lines of platinum containing chemotherapy"], "histology_exclusion": [], "biomarker_exclusion": ["PARP inhibitor treatment"]}, {"cohort": "Cohort 2", "disease_state": "relapsed", "histology_inclusion": "other types of endometrial cancer", "biomarker_inclusion": [">2 lines of platinum containing chemotherapy", "BRCA mutation", "HRD positive"], "histology_exclusion": [], "biomarker_exclusion": ["PARP inhibitor treatment"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "Cohort 1", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["TBCE-High", "TBCE-High", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}]}
{"NCT_id": "NCT05627960", "json": [{"cohort": "Phase 1A", "disease_state": "relapsed/refractory", "histology_inclusion": "advanced solid tumor malignancies", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1B Triple Negative Breast Cancer", "disease_state": "metastatic", "histology_inclusion": "Triple Negative Breast Cancer", "biomarker_inclusion": ["GP88 1+", "GP88 2+", "GP88 3+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1B Hormone-resistant Breast Cancer", "disease_state": "metastatic", "histology_inclusion": "Hormone-Resistant Breast Cancer", "biomarker_inclusion": ["GP88 1+", "GP88 2+", "GP88 3+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1B NSCLC", "disease_state": "metastatic/recurrent", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": ["GP88 1+", "GP88 2+", "GP88 3+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1B Mesothelioma", "disease_state": "metastatic/recurrent", "histology_inclusion": "Mesothelioma", "biomarker_inclusion": ["GP88 1+", "GP88 2+", "GP88 3+"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1A", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase 1B Triple Negative Breast Cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Phase 1B Hormone-resistant Breast Cancer", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "Phase 1B NSCLC", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Phase 1B Mesothelioma", "histology_inclusion": "Mesothelioma"}]}
{"NCT_id": "NCT03310879", "json": [{"cohort": "Participants with CCND1, CCND2, or CCND3", "disease_state": "advanced solid tumor of a non-breast origin", "histology_inclusion": "", "biomarker_inclusion": ["CCND1 high-level amplification", "CCND2 high-level amplification", "CCND3 high-level amplification", "CCND1 mutation", "CCND1 splice variant"], "histology_exclusion": ["hematologic lymphoma"], "biomarker_exclusion": ["prior treatment with a CDK4/6 inhibitor"]}, {"cohort": "Participants with CDK4 or CDK6", "disease_state": "advanced solid tumor of a non-breast origin", "histology_inclusion": "", "biomarker_inclusion": ["CDK4 high-level amplification", "CDK6 high-level amplification"], "histology_exclusion": ["hematologic lymphoma"], "biomarker_exclusion": ["prior treatment with a CDK4/6 inhibitor"]}], "json_norm": [{"cohort": "Participants with CCND1, CCND2, or CCND3", "biomarker_inclusion": [["CCND1-High", "CCND1-High", "expression"], ["CCND3-High", "CCND3-High", "expression"], ["CCND1 Mutation", "CCND1-Mutation", "gene"], ["CCND2-High", "CCND2-High", "expression"]]}, {"cohort": "Participants with CDK4 or CDK6", "biomarker_inclusion": [["CDK4-High", "CDK4-High", "expression"], ["CDK6-High", "CDK6-High", "expression"]]}]}
{"NCT_id": "NCT03767075", "json": [{"cohort": "Module 1 Arm 1A", "disease_state": "Advanced Solid Tumor", "histology_inclusion": "", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": ["brain metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Module 1 Arm 1B", "disease_state": "Advanced Solid Tumor", "histology_inclusion": "", "biomarker_inclusion": ["MLH1 mutation", "MSH2 mutation", "MSH6 mutation", "PMS2 mutation"], "histology_exclusion": ["brain metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Module 1 Arm 1C", "disease_state": "Advanced Solid Tumor", "histology_inclusion": "", "biomarker_inclusion": ["POLE mutation", "POLD1 mutation"], "histology_exclusion": ["brain metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Module 1 Arm 1D", "disease_state": "Advanced Solid Tumor", "histology_inclusion": "", "biomarker_inclusion": ["hypermutated tumors"], "histology_exclusion": ["brain metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Module 1 Arm 1E", "disease_state": "Advanced Solid Tumor", "histology_inclusion": "", "biomarker_inclusion": ["other mutations in DNA-repair genes"], "histology_exclusion": ["brain metastases", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Module 1 Arm 1F", "disease_state": "Advanced Solid Tumor", "histology_inclusion": "", "biomarker_inclusion": ["tumors with amplified PDL1"], "histology_exclusion": ["brain metastases", "leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Module 1 Arm 1A", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "Module 1 Arm 1B", "biomarker_inclusion": [["MSH2 Mutation", "MSH2-Mutation", "gene"], ["MLH1 Mutation", "MLH1-Mutation", "gene"], ["PMS2 Mutation", "PMS2-Mutation", "gene"], ["MSH6 Mutation", "MSH6-Mutation", "gene"]]}, {"cohort": "Module 1 Arm 1C", "biomarker_inclusion": [["POLE Mutation", "POLE-Mutation", "gene"], ["POLD1 Mutation", "POLD1-Mutation", "gene"]]}, {"cohort": "Module 1 Arm 1D", "biomarker_inclusion": [["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Module 1 Arm 1E"}, {"cohort": "Module 1 Arm 1F", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"]]}]}
{"NCT_id": "NCT04027647", "json": [{"cohort": "", "disease_state": "stage IIIB/IIIC/IV or recurrent", "histology_inclusion": "adenocarcinoma NSCLC", "biomarker_inclusion": ["EGFR activating mutation (exon 19 deletion)", "EGFR activating mutation (L858R mutation in exon 21)"], "histology_exclusion": ["small cell lung cancer", "carcinoid lung cancer", "squamous element"], "biomarker_exclusion": ["EGFR exon 20 T790M", "EGFR exon 20 insertion mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR exon 19 del", "exon 19 del", "exon"]], "histology_exclusion": ["Lung Carcinoid Tumor", "Small Cell Lung Carcinoma"], "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"]]}]}
{"NCT_id": "NCT04092673", "json": [{"cohort": "Cohort EMNK", "disease_state": "metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer (NSCLC)", "biomarker_inclusion": ["KRAS-activating mutation (non-G12C)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort EMBF", "disease_state": "advanced/metastatic", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["ER+", "FGFR amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort EMBH", "disease_state": "advanced/metastatic", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["ER+", "HER2+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort ECNS", "disease_state": "stage IIIB (pleural or pericardial effusion) or stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer (NSCLC)", "biomarker_inclusion": ["G12C KRAS-activating mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior KRAS-specific therapy"]}, {"cohort": "Cohort ECBF", "disease_state": "advanced/metastatic", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["ER+"], "histology_exclusion": [], "biomarker_exclusion": ["prior CDK4/6 inhibitor"]}, {"cohort": "Cohort ECBF+A", "disease_state": "advanced/metastatic", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["ER+"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort EMNK", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "Cohort EMBF", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["FGFR4-High", "FGFR4-High", "expression"], ["FGFR3-High", "FGFR3-High", "expression"], ["FGFR2-High", "FGFR2-High", "expression"], ["FGFR1-High", "FGFR1-High", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Cohort EMBH", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Cohort ECNS", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}, {"cohort": "Cohort ECBF", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Cohort ECBF+A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["EREG-High", "EREG-High", "expression"]]}]}
{"NCT_id": "NCT04456322", "json": [{"cohort": "", "disease_state": "clinical stage II-IVa (except N3)", "histology_inclusion": "non-keratinizing nasopharyngeal carcinoma, type of WHO II or III", "biomarker_inclusion": ["pre-treatment plasma EBV DNA < 1500 copies/mL", "plasma EBV DNA = 0 copy/mL after two cycle induction chemotherapy"], "histology_exclusion": ["keratinizing squamous cell carcinoma (WHO I)"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Nasopharyngeal Carcinoma", "histology_exclusion": ["Squamous Cell Carcinoma"]}]}
{"NCT_id": "NCT04977375", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Glioblastoma Multiforme", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype"}, {"cohort": "", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT05042531", "json": [{"cohort": "", "disease_state": "intermediate and high-risk", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["malignant tumors of other organs"], "biomarker_exclusion": ["HCV positive", "HIV positive", "HBsAg positive", "HBsAg negative, HBcAb positive and HBV DNA titer positive"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Malignant Neoplasm"]}]}
{"NCT_id": "NCT03832361", "json": [{"cohort": "", "disease_state": "persistent or recurrent", "histology_inclusion": "Uterine serous carcinoma (Pure or Mixed)", "biomarker_inclusion": ["FR\u03b1-positive"], "histology_exclusion": ["Carcinomatous meningitis", "untreated central nervous system (CNS) disease", "symptomatic CNS metastasis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "persistent or recurrent", "histology_inclusion": "Grade 2 endometrial adenocarcinoma", "biomarker_inclusion": ["FR\u03b1-positive"], "histology_exclusion": ["Carcinomatous meningitis", "untreated central nervous system (CNS) disease", "symptomatic CNS metastasis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "persistent or recurrent", "histology_inclusion": "Grade 3 endometrial adenocarcinoma", "biomarker_inclusion": ["FR\u03b1-positive"], "histology_exclusion": ["Carcinomatous meningitis", "untreated central nervous system (CNS) disease", "symptomatic CNS metastasis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "persistent or recurrent", "histology_inclusion": "Carcinosarcoma with high grade serous", "biomarker_inclusion": ["FR\u03b1-positive"], "histology_exclusion": ["Carcinomatous meningitis", "untreated central nervous system (CNS) disease", "symptomatic CNS metastasis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "persistent or recurrent", "histology_inclusion": "Carcinosarcoma with Grade 2 endometrioid components", "biomarker_inclusion": ["FR\u03b1-positive"], "histology_exclusion": ["Carcinomatous meningitis", "untreated central nervous system (CNS) disease", "symptomatic CNS metastasis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "persistent or recurrent", "histology_inclusion": "Carcinosarcoma with Grade 3 endometrioid components", "biomarker_inclusion": ["FR\u03b1-positive"], "histology_exclusion": ["Carcinomatous meningitis", "untreated central nervous system (CNS) disease", "symptomatic CNS metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Endometrial Serous Adenocarcinoma", "biomarker_inclusion": [["FOLR1-High", "FOLR1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Endometrial Adenocarcinoma", "biomarker_inclusion": [["FOLR1-High", "FOLR1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Endometrial Adenocarcinoma", "biomarker_inclusion": [["FOLR1-High", "FOLR1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Carcinosarcoma", "biomarker_inclusion": [["FOLR1-High", "FOLR1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Carcinosarcoma", "biomarker_inclusion": [["FOLR1-High", "FOLR1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Carcinosarcoma", "biomarker_inclusion": [["FOLR1-High", "FOLR1-High", "expression"]]}]}
{"NCT_id": "NCT03962647", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Estrogen Receptor-positive Breast Cancer", "biomarker_inclusion": ["HER2 negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT04222972", "json": [{"cohort": "", "disease_state": "locally advanced (not able to be treated with surgery or radiotherapy) or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["RET-fusion"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR", "ALK", "ROS1", "MET", "BRAF", "selective RET inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"]]}]}
{"NCT_id": "NCT04521621", "json": [{"cohort": "Part 1, Cohort A: Triple-Negative Breast Cancer", "disease_state": "Locally-advanced, inoperable, metastatic", "histology_inclusion": "Triple-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1, Cohort B: Head and Neck Squamous Cell Carcinoma", "disease_state": "Advanced or metastatic", "histology_inclusion": "Head and neck squamous cell carcinoma", "biomarker_inclusion": ["PD-L1+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1, Cohort C: Cutaneous Squamous Cell Carcinoma", "disease_state": "Recurrent/metastatic", "histology_inclusion": "Cutaneous squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2, Solid Tumors+Liver Metastases Dose Level 1-3 arms", "disease_state": "Advanced/metastatic", "histology_inclusion": "Solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2, Cohort D: Hepatocellular Carcinoma (HCC)", "disease_state": "Advanced", "histology_inclusion": "Hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2, Cohort E: Gastric Carcinoma", "disease_state": "Locally advanced, unresectable, metastatic", "histology_inclusion": "Gastric or gastroesophageal junction adenocarcinoma", "biomarker_inclusion": ["HER2 negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 1, Cohort A: Triple-Negative Breast Cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Part 1, Cohort B: Head and Neck Squamous Cell Carcinoma", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"]]}, {"cohort": "Part 1, Cohort C: Cutaneous Squamous Cell Carcinoma", "histology_inclusion": "Skin Squamous Cell Carcinoma"}, {"cohort": "Part 2, Solid Tumors+Liver Metastases Dose Level 1-3 arms", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part 2, Cohort D: Hepatocellular Carcinoma (HCC)", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "Part 2, Cohort E: Gastric Carcinoma", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT05498155", "json": [{"cohort": "Cohort A", "disease_state": "Early Stage", "histology_inclusion": "HER2-negative ER-negative or ER-low Breast Cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "Early Stage", "histology_inclusion": "HER2-negative ER-negative or ER-low Breast Cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["Prior exposure to anti-PD1", "Prior exposure to anti-PD-L1", "Prior exposure to anti-CTLA4 agents"]}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "Cohort A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "Cohort B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "Cohort B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["EREG-Low", "EREG-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04027946", "json": [{"cohort": "", "disease_state": "non-squamous non-small cell lung cancer not amenable to potentially curative treatments", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutations", "ALK gene rearrangement", "ROS1 gene rearrangement", "KRAS mutations", "mesothelin expression (>=25%)"], "histology_exclusion": ["neuroendocrine tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"]], "histology_exclusion": ["Neuroendocrine Carcinoma", "Lung Neuroendocrine Neoplasm", "Neuroendocrine Tumor"]}]}
{"NCT_id": "NCT04521686", "json": [{"cohort": "Monotherapy Dose Escalation", "disease_state": "locally advanced or metastatic solid tumor", "histology_inclusion": "any solid tumor", "biomarker_inclusion": ["IDH1 R132 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Monotherapy Dose Escalation", "disease_state": "locally advanced or metastatic solid tumor", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": ["IDH2 R140 mutation", "IDH2 R172 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Monotherapy Dose Expansion Cohort 1", "disease_state": "advanced or metastatic cholangiocarcinoma", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": ["IDH1 R132 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior IDH1 inhibitor treatment"]}, {"cohort": "Monotherapy Dose Expansion Cohort 2", "disease_state": "locally advanced or metastatic solid tumor", "histology_inclusion": "any solid tumor", "biomarker_inclusion": ["IDH1 R132 mutation"], "histology_exclusion": ["cholangiocarcinoma"], "biomarker_exclusion": []}, {"cohort": "Monotherapy Dose Expansion Cohort 3", "disease_state": "locally advanced or metastatic solid tumor", "histology_inclusion": "any solid tumor", "biomarker_inclusion": ["IDH1 R132 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Combination Dose Expansion Cohort 4", "disease_state": "advanced or metastatic cholangiocarcinoma", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": ["IDH1 R132 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Combination Dose Expansion Cohort 5", "disease_state": "advanced or metastatic cholangiocarcinoma", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": ["IDH1 R132 mutation", "IDH2 R140 mutation", "IDH2 R172 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Monotherapy Dose Escalation", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Monotherapy Dose Escalation", "histology_inclusion": "Cholangiocarcinoma"}, {"cohort": "Monotherapy Dose Expansion Cohort 1", "histology_inclusion": "Cholangiocarcinoma"}, {"cohort": "Monotherapy Dose Expansion Cohort 2", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Cholangiocarcinoma"]}, {"cohort": "Monotherapy Dose Expansion Cohort 3", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Combination Dose Expansion Cohort 4", "histology_inclusion": "Cholangiocarcinoma"}, {"cohort": "Combination Dose Expansion Cohort 5", "histology_inclusion": "Cholangiocarcinoma"}]}
{"NCT_id": "NCT04717154", "json": [{"cohort": "", "disease_state": "metastatic castration-resistant prostate cancer", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["mismatch repair deficiency", "high mutational burden >7 mutations per Mb"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic castration-resistant prostate cancer", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["BRCA2 inactivation", "BRCAness signature"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic castration-resistant prostate cancer", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["tandem duplication signature", "CDK12 biallelic inactivation"], "histology_exclusion": ["brain or leptomeningeal involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"], ["MB Mutation", "MB-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT03832569", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": ["MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04158141", "json": [{"cohort": "", "disease_state": "Stage I-IIIA", "histology_inclusion": "Malignant Pleural Mesothelioma (Epithelioid or Biphasic)", "biomarker_inclusion": [], "histology_exclusion": ["Sarcomatoid Mesothelioma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pleural Malignant Mesothelioma", "histology_exclusion": ["Mesothelioma"]}]}
{"NCT_id": "NCT04391595", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "glioblastoma", "biomarker_inclusion": ["RB positivity (\u226520%)", "CDKN2A/B/C loss", "CDK4/6 amplification", "pERK positivity (>30%)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT04456699", "json": [{"cohort": "", "disease_state": "metastatic or unresectable (Stage IV)", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["myelodysplastic syndrome/acute myeloid leukemia (MDS/AML)"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma"}]}
{"NCT_id": "NCT05498428", "json": [{"cohort": "Cohort 1, 3, 5, 6", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR Exon19del", "EGFR Exon 21 L858R"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR Exon 20ins"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1, 3, 5, 6", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT02714010", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutant type (19 and/or 21 exon mutation)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT03181100", "json": [{"cohort": "", "disease_state": "unresectable locoregional or metastatic", "histology_inclusion": "anaplastic thyroid carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1"]}, {"cohort": "", "disease_state": "unresectable locoregional or metastatic", "histology_inclusion": "poorly differentiated thyroid carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1"]}, {"cohort": "Cohort 1", "disease_state": "unresectable locoregional or metastatic", "histology_inclusion": "anaplastic thyroid carcinoma", "biomarker_inclusion": ["BRAFV600E mutation"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1"]}, {"cohort": "Cohort 1", "disease_state": "unresectable locoregional or metastatic", "histology_inclusion": "poorly differentiated thyroid carcinoma", "biomarker_inclusion": ["BRAFV600E mutation"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Thyroid Gland Undifferentiated (Anaplastic) Carcinoma"}, {"cohort": "", "histology_inclusion": "Poorly Differentiated Thyroid Gland Carcinoma"}, {"cohort": "Cohort 1", "histology_inclusion": "Thyroid Gland Undifferentiated (Anaplastic) Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "Cohort 1", "histology_inclusion": "Poorly Differentiated Thyroid Gland Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT03311334", "json": [{"cohort": "Phase 1b Dose Search Part", "disease_state": "metastatic", "histology_inclusion": "unresectable or metastatic melanoma", "biomarker_inclusion": ["HLA-A*02:01", "HLA-A*02:06", "HLA-A*24:02", "HLA-A*03:01", "HLA-B*15:01"], "histology_exclusion": ["untreated brain metastases", "multifocal glioblastoma"], "biomarker_exclusion": []}, {"cohort": "Phase 1b Dose Search Part", "disease_state": "metastatic", "histology_inclusion": "metastatic NSCLC", "biomarker_inclusion": ["HLA-A*02:01", "HLA-A*02:06", "HLA-A*24:02", "HLA-A*03:01", "HLA-B*15:01"], "histology_exclusion": ["untreated brain metastases", "multifocal glioblastoma"], "biomarker_exclusion": []}, {"cohort": "Phase 1b Dose Search Part", "disease_state": "advanced", "histology_inclusion": "RCC", "biomarker_inclusion": ["HLA-A*02:01", "HLA-A*02:06", "HLA-A*24:02", "HLA-A*03:01", "HLA-B*15:01"], "histology_exclusion": ["untreated brain metastases", "multifocal glioblastoma"], "biomarker_exclusion": []}, {"cohort": "Phase 1b Dose Search Part", "disease_state": "recurrent or metastatic", "histology_inclusion": "squamous cell carcinoma of the head and neck", "biomarker_inclusion": ["HLA-A*02:01", "HLA-A*02:06", "HLA-A*24:02", "HLA-A*03:01", "HLA-B*15:01"], "histology_exclusion": ["untreated brain metastases", "multifocal glioblastoma"], "biomarker_exclusion": []}, {"cohort": "Phase 1b Dose Search Part", "disease_state": "locally advanced or metastatic", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": ["HLA-A*02:01", "HLA-A*02:06", "HLA-A*24:02", "HLA-A*03:01", "HLA-B*15:01"], "histology_exclusion": ["untreated brain metastases", "multifocal glioblastoma"], "biomarker_exclusion": []}, {"cohort": "Phase 1b Dose Search Part", "disease_state": "", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": ["HLA-A*02:01", "HLA-A*02:06", "HLA-A*24:02", "HLA-A*03:01", "HLA-B*15:01"], "histology_exclusion": ["untreated brain metastases", "multifocal glioblastoma"], "biomarker_exclusion": []}, {"cohort": "Phase 1b Dose Search Part", "disease_state": "", "histology_inclusion": "MSI-H/dMMR colorectal cancer", "biomarker_inclusion": ["HLA-A*02:01", "HLA-A*02:06", "HLA-A*24:02", "HLA-A*03:01", "HLA-B*15:01"], "histology_exclusion": ["untreated brain metastases", "multifocal glioblastoma"], "biomarker_exclusion": []}, {"cohort": "Phase 1b Dose Search Part", "disease_state": "unresectable or metastatic", "histology_inclusion": "MSI-H/dMMR solid tumors", "biomarker_inclusion": ["HLA-A*02:01", "HLA-A*02:06", "HLA-A*24:02", "HLA-A*03:01", "HLA-B*15:01"], "histology_exclusion": ["untreated brain metastases", "multifocal glioblastoma"], "biomarker_exclusion": []}, {"cohort": "Phase 1b Dose Search Part", "disease_state": "recurrent locally advanced or metastatic", "histology_inclusion": "gastric cancer or gastroesophageal junction adenocarcinoma", "biomarker_inclusion": ["HLA-A*02:01", "HLA-A*02:06", "HLA-A*24:02", "HLA-A*03:01", "HLA-B*15:01"], "histology_exclusion": ["untreated brain metastases", "multifocal glioblastoma"], "biomarker_exclusion": []}, {"cohort": "Phase 1b Dose Search Part", "disease_state": "recurrent or metastatic", "histology_inclusion": "cervical cancer", "biomarker_inclusion": ["HLA-A*02:01", "HLA-A*02:06", "HLA-A*24:02", "HLA-A*03:01", "HLA-B*15:01"], "histology_exclusion": ["untreated brain metastases", "multifocal glioblastoma"], "biomarker_exclusion": []}, {"cohort": "Phase 1b Enrichment Cohort", "disease_state": "locally advanced or metastatic", "histology_inclusion": "RCC or urothelial carcinoma", "biomarker_inclusion": ["HLA-A*02:01", "HLA-A*02:06", "HLA-A*24:02", "HLA-A*03:01", "HLA-B*15:01"], "histology_exclusion": ["untreated brain metastases", "multifocal glioblastoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1b Dose Search Part", "histology_inclusion": "Melanoma", "histology_exclusion": ["Glioblastoma"]}, {"cohort": "Phase 1b Dose Search Part", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Glioblastoma"]}, {"cohort": "Phase 1b Dose Search Part", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Glioblastoma"]}, {"cohort": "Phase 1b Dose Search Part", "histology_inclusion": "Refractory Cytopenia of Childhood", "histology_exclusion": ["Glioblastoma"]}, {"cohort": "Phase 1b Dose Search Part", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Glioblastoma"]}, {"cohort": "Phase 1b Dose Search Part", "histology_inclusion": "Urothelial Carcinoma", "histology_exclusion": ["Glioblastoma"]}, {"cohort": "Phase 1b Dose Search Part", "histology_inclusion": "Hepatocellular Carcinoma", "histology_exclusion": ["Glioblastoma"]}, {"cohort": "Phase 1b Dose Search Part", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Glioblastoma"]}, {"cohort": "Phase 1b Dose Search Part", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Glioblastoma"]}, {"cohort": "Phase 1b Dose Search Part", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Glioblastoma"]}, {"cohort": "Phase 1b Dose Search Part", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Glioblastoma"]}, {"cohort": "Phase 1b Dose Search Part", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "histology_exclusion": ["Glioblastoma"]}, {"cohort": "Phase 1b Dose Search Part", "histology_inclusion": "Gastric Carcinoma", "histology_exclusion": ["Glioblastoma"]}, {"cohort": "Phase 1b Dose Search Part", "histology_inclusion": "Cervical Carcinoma", "histology_exclusion": ["Glioblastoma"]}, {"cohort": "Phase 1b Enrichment Cohort", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Glioblastoma"]}, {"cohort": "Phase 1b Enrichment Cohort", "histology_inclusion": "Urothelial Carcinoma", "histology_exclusion": ["Glioblastoma"]}, {"cohort": "Phase 1b Enrichment Cohort", "histology_inclusion": "Refractory Cytopenia of Childhood", "histology_exclusion": ["Glioblastoma"]}]}
{"NCT_id": "NCT03506997", "json": [{"cohort": "", "disease_state": "metastatic castrate resistant", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["high mutational load (11 or more mutations per targeted panel)", "DNA repair defect", "MMR deficiency", "high MSI"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"], ["DNA Damage Repair (DDR) pathways", null, "pathway"]]}]}
{"NCT_id": "NCT04093167", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutation-negative", "ALK mutation-negative", "PD-L1 TPS \u2265 1%"], "histology_exclusion": ["Large Cell Neuroendocrine Carcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "stage III", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutation-negative", "ALK mutation-negative", "PD-L1 TPS \u2265 1%"], "histology_exclusion": ["Large Cell Neuroendocrine Carcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Large Cell Neuroendocrine Carcinoma"]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Large Cell Neuroendocrine Carcinoma"]}]}
{"NCT_id": "NCT04717414", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Primary Myelofibrosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Post-Polycythemia Vera Myelofibrosis", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Primary Myelofibrosis"}, {"cohort": "", "histology_inclusion": "Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase"}]}
{"NCT_id": "NCT05173142", "json": [{"cohort": "dose escalation phase", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) metastases"], "biomarker_exclusion": ["selective FGFR targeting therapy"]}, {"cohort": "dose expansion phase", "disease_state": "", "histology_inclusion": "urothelial carcinoma (UC)", "biomarker_inclusion": ["specific FGFR gene alterations"], "histology_exclusion": ["central nervous system (CNS) metastases"], "biomarker_exclusion": ["selective FGFR targeting therapy"]}, {"cohort": "dose expansion phase", "disease_state": "", "histology_inclusion": "gastric cancer (GC)", "biomarker_inclusion": ["specific FGFR gene alterations"], "histology_exclusion": ["central nervous system (CNS) metastases"], "biomarker_exclusion": ["selective FGFR targeting therapy"]}, {"cohort": "dose expansion phase", "disease_state": "", "histology_inclusion": "gastroesophageal junction (GEJ) cancer", "biomarker_inclusion": ["specific FGFR gene alterations"], "histology_exclusion": ["central nervous system (CNS) metastases"], "biomarker_exclusion": ["selective FGFR targeting therapy"]}, {"cohort": "dose expansion phase", "disease_state": "", "histology_inclusion": "intrahepatic cholangiocarcinoma (IHCC)", "biomarker_inclusion": ["specific FGFR gene alterations"], "histology_exclusion": ["central nervous system (CNS) metastases"], "biomarker_exclusion": ["selective FGFR targeting therapy"]}], "json_norm": [{"cohort": "dose escalation phase", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "dose expansion phase", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}, {"cohort": "dose expansion phase", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}, {"cohort": "dose expansion phase", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}, {"cohort": "dose expansion phase", "histology_inclusion": "Intrahepatic Cholangiocarcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}]}
{"NCT_id": "NCT05498519", "json": [{"cohort": "Escalation Part", "disease_state": "advanced solid tumor, refractory or inappropriate at this stage to standard therapies or for which no standard therapy exists", "histology_inclusion": "hepatocellular carcinoma (HCC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Part", "disease_state": "advanced solid tumor, refractory or inappropriate at this stage to standard therapies or for which no standard therapy exists", "histology_inclusion": "FGF19 IHC+ advanced solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Escalation Part", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "Expansion Part", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGF19-High", "FGF19-High", "expression"]]}]}
{"NCT_id": "NCT04093362", "json": [{"cohort": "", "disease_state": "locally advanced, metastatic, or recurrent unresectable", "histology_inclusion": "intrahepatic cholangiocarcinoma (iCCA)", "biomarker_inclusion": ["FGFR2 gene rearrangements"], "histology_exclusion": ["mixed hepatocellular carcinoma - iCCA"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Intrahepatic Cholangiocarcinoma", "histology_exclusion": ["Intrahepatic Cholangiocarcinoma", "Hepatocellular Carcinoma"]}]}
{"NCT_id": "NCT04288687", "json": [{"cohort": "Niraparib Arm (only arm)", "disease_state": "metastatic castration-resistant", "histology_inclusion": "prostate adenocarcinoma", "biomarker_inclusion": ["BRCA1/2", "ATM", "FANCA", "PALB2", "CHEK2", "HDAC2", "BRIP1"], "histology_exclusion": ["pure small cell histology"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Niraparib Arm (only arm)", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT04782609", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "IDH wildtype glioblastoma", "biomarker_inclusion": [], "histology_exclusion": ["tumor localized primarily to the brainstem or spinal cord"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "grade 3 or 4 IDH mutant astrocytoma", "biomarker_inclusion": [], "histology_exclusion": ["tumor localized primarily to the brainstem or spinal cord"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04093466", "json": [{"cohort": "", "disease_state": "relapsed advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["stage IB or lower grade cervical cancer", "noninvasive basal cell or squamous cell cancer", "breast cancer with complete remission (CR) > 10 years", "melanoma with CR > 10 years", "other malignant tumors with CR > 5 years"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Breast Carcinoma", "Squamous Cell Carcinoma", "Malignant Solid Neoplasm", "Cervical Carcinoma", "Melanoma"]}]}
{"NCT_id": "NCT03833167", "json": [{"cohort": "", "disease_state": "locally advanced", "histology_inclusion": "cutaneous squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["basal cell carcinoma", "Bowen's disease", "Merkel cell carcinoma", "melanoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Skin Squamous Cell Carcinoma", "histology_exclusion": ["Basal Cell Carcinoma", "Experimental Organism Basal Cell Carcinoma", "Skin Basal Cell Carcinoma", "Merkel Cell Carcinoma", "Melanoma"]}]}
{"NCT_id": "NCT03833180", "json": [{"cohort": "", "disease_state": "previously treated and progressed or relapsed", "histology_inclusion": "chronic lymphocytic leukemia/small lymphocytic lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["malignancy involving the central nervous system"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "previously treated and progressed or relapsed", "histology_inclusion": "mantle cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["malignancy involving the central nervous system"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "previously treated and progressed or relapsed", "histology_inclusion": "follicular lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["malignancy involving the central nervous system"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "previously treated and progressed or relapsed", "histology_inclusion": "marginal zone lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["malignancy involving the central nervous system"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "previously treated and progressed or relapsed", "histology_inclusion": "diffuse large B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["malignancy involving the central nervous system"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "previously treated and progressed or relapsed", "histology_inclusion": "Richter transformation lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["malignancy involving the central nervous system"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "previously treated and progressed or relapsed", "histology_inclusion": "Burkitt lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["malignancy involving the central nervous system"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "previously treated and progressed or relapsed", "histology_inclusion": "lymphoplasmacytoid lymphoma/Waldenstr\u00f6m macroglobulinemia", "biomarker_inclusion": [], "histology_exclusion": ["malignancy involving the central nervous system"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "previously treated and progressed or relapsed", "histology_inclusion": "T-cell non-Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["malignancy involving the central nervous system"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "previously treated and progressed or relapsed", "histology_inclusion": "acute lymphoid leukemia", "biomarker_inclusion": [], "histology_exclusion": ["malignancy involving the central nervous system"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "previously treated and progressed or relapsed", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": ["malignancy involving the central nervous system"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma"}, {"cohort": "", "histology_inclusion": "Small Lymphocytic Lymphoma"}, {"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "", "histology_inclusion": "Marginal Zone Lymphoma"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Richter Syndrome"}, {"cohort": "", "histology_inclusion": "Burkitt Lymphoma"}, {"cohort": "", "histology_inclusion": "Lymphoplasmacytic Lymphoma"}, {"cohort": "", "histology_inclusion": "Waldenstrom Macroglobulinemia"}, {"cohort": "", "histology_inclusion": "T-Cell Non-Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}]}
{"NCT_id": "NCT04457284", "json": [{"cohort": "", "disease_state": "locally advanced unresectable or metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["MSS", "MMR proficient", "BRAF wild type", "POLE wild type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["POLE POLE-wild_type", "POLE-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"], ["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT04848116", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": ["HPV(-)", "HPV(+) with \u226520 pack year smoking history"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT04913285", "json": [{"cohort": "", "disease_state": "metastatic or advanced stage", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["BRAF Class I", "BRAF Class II", "BRAF Class III"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or advanced stage", "histology_inclusion": "melanoma", "biomarker_inclusion": ["NRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": ["BRAF Class I"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRAF Class 1", "BRAF Class 1", "coordinate"], ["BRAF Class 3", "BRAF Class 3", "coordinate"], ["BRAF Class 2", "BRAF Class 2", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"]], "biomarker_exclusion": [["BRAF Class 1", "BRAF Class 1", "coordinate"]]}]}
{"NCT_id": "NCT05108623", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases", "leptomeningeal metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT03051516", "json": [{"cohort": "", "disease_state": "initial or recurrent", "histology_inclusion": "anal high-grade squamous intraepithelial lesion (AIN2/3)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior HPV vaccination"]}, {"cohort": "", "disease_state": "initial or recurrent", "histology_inclusion": "vulvar high-grade squamous intraepithelial lesion (VIN2/3)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior HPV vaccination"]}], "json_norm": [{"cohort": ""}, {"cohort": ""}]}
{"NCT_id": "NCT03246906", "json": [{"cohort": "", "disease_state": "relapsed", "histology_inclusion": "Acute Lymphoblastic Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["< 5% marrow blasts"], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "biomarker_inclusion": ["< 5% marrow blasts"], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed", "histology_inclusion": "Hodgkin Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed", "histology_inclusion": "Plasma Cell Myeloma", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed", "histology_inclusion": "Small Lymphocytic Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed", "histology_inclusion": "Waldenstrom Macroglobulinemia", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Aggressive Non-Hodgkin Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": ["< 5% marrow blasts"], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Myelodysplastic/Myeloproliferative Neoplasm", "biomarker_inclusion": ["< 5% marrow blasts"], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Prolymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Blastic Plasmacytoid Dendritic Cell Neoplasm", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "biomarker_inclusion": [["BCR - ABL1", "BCR - ABL1", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "", "histology_inclusion": "Small Lymphocytic Lymphoma"}, {"cohort": "", "histology_inclusion": "Waldenstrom Macroglobulinemia"}, {"cohort": "", "histology_inclusion": "Aggressive Non-Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Myelodysplastic/Myeloproliferative Disease"}, {"cohort": "", "histology_inclusion": "Prolymphocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Blastic Plasmacytoid Dendritic Cell Neoplasm"}]}
{"NCT_id": "NCT03311958", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Diffuse Large B Cell Lymphoma", "biomarker_inclusion": ["High risk IPI", "ABC-subtype DLBCL", "Double hit DLBCL", "Triple hit DLBCL", "Ki67>90%", "MYC translocation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MYC Fusion", "MYC", "fusion"]]}]}
{"NCT_id": "NCT04028778", "json": [{"cohort": "", "disease_state": "locally advanced and/or metastatic stage IIIB (unsuitable for radiotherapy) or IV or recurrent", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": ["EGFR exon19 del", "EGFR L858R"], "histology_exclusion": ["small cell lung cancer", "small cell and non-small cell mixed lung cancer"], "biomarker_exclusion": ["T790M mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]], "histology_exclusion": ["Lung Carcinoma", "Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT04978584", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "non-GCB DLBCL subtype", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system involvement with lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}]}
{"NCT_id": "NCT05238883", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "Gastric cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "Renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "Melanoma", "biomarker_inclusion": ["BRAF V600E mutant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "Melanoma", "biomarker_inclusion": ["BRAF V600E wild type"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "Sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "Testicular germ cell tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "Cervical cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "Mesothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "Head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Sarcoma"}, {"cohort": "", "histology_inclusion": "Germ Cell Tumor"}, {"cohort": "", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "", "histology_inclusion": "Mesothelioma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT05238922", "json": [{"cohort": "Disease Group 1", "disease_state": "advanced or metastatic", "histology_inclusion": "gynecologic tumors (epithelial ovarian/fallopian/primary peritoneal carcinoma or clear cell ovarian cancer, or endometrial adenocarcinoma, uterine carcinosarcoma, or uterine papillary serous carcinoma)", "biomarker_inclusion": [], "histology_exclusion": ["untreated brain or central nervous system (CNS) metastases"], "biomarker_exclusion": []}, {"cohort": "Disease Group 2", "disease_state": "advanced or metastatic", "histology_inclusion": "gastrointestinal tumors (gastric, GEJ, and esophageal adenocarcinomas)", "biomarker_inclusion": [], "histology_exclusion": ["untreated brain or central nervous system (CNS) metastases"], "biomarker_exclusion": []}, {"cohort": "Disease Group 3", "disease_state": "advanced or metastatic", "histology_inclusion": "breast cancer (HR-positive/HER2-negative breast cancer with disease progression on or intolerant of therapies known to confer clinical benefit, including a CDK4/6 inhibitor)", "biomarker_inclusion": [], "histology_exclusion": ["untreated brain or central nervous system (CNS) metastases"], "biomarker_exclusion": []}, {"cohort": "Disease Group 4", "disease_state": "advanced or metastatic", "histology_inclusion": "other tumor indications", "biomarker_inclusion": [], "histology_exclusion": ["untreated brain or central nervous system (CNS) metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Disease Group 1", "histology_inclusion": "Ovarian Clear Cell Tumor"}, {"cohort": "Disease Group 1", "histology_inclusion": "Endometrial Serous Adenocarcinoma"}, {"cohort": "Disease Group 1", "histology_inclusion": "Uterine Carcinosarcoma"}, {"cohort": "Disease Group 1", "histology_inclusion": "Malignant Female Reproductive System Neoplasm"}, {"cohort": "Disease Group 1", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "Disease Group 1", "histology_inclusion": "Uterine Corpus Carcinosarcoma"}, {"cohort": "Disease Group 1", "histology_inclusion": "Endometrial Adenocarcinoma"}, {"cohort": "Disease Group 2", "histology_inclusion": "Digestive System Neoplasm"}, {"cohort": "Disease Group 3", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Disease Group 3", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Disease Group 4"}]}
{"NCT_id": "NCT03442556", "json": [{"cohort": "", "disease_state": "Metastatic Castration Resistant Prostate Cancer", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["Homologous Recombination DNA Repair Deficiency"], "histology_exclusion": ["predominant small cell histology"], "biomarker_exclusion": ["prior therapy with a PARP inhibitor", "prior therapy with platinum chemotherapy in the castration resistant setting"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"], ["DNA Damage Repair (DDR) pathways", null, "pathway"]]}]}
{"NCT_id": "NCT03638167", "json": [{"cohort": "", "disease_state": "refractory or recurrent", "histology_inclusion": "EGFR positive Central Nervous System (CNS) tumor", "biomarker_inclusion": [], "histology_exclusion": ["classic diffuse intrinsic pontine glioma (DIPG)"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["EGFR-High", "EGFR-High", "expression"]], "histology_exclusion": ["Diffuse Intrinsic Pontine Glioma"]}]}
{"NCT_id": "NCT04159155", "json": [{"cohort": "Early Stage Cohort", "disease_state": "stage I, II", "histology_inclusion": "pure serous endometrial carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["mixed serous tumors", "endometrial carcinosarcoma", "tumors with subclonal mutant-type p53 staining"], "biomarker_exclusion": []}, {"cohort": "Early Stage Cohort", "disease_state": "stage I, II", "histology_inclusion": "endometrioid with abnormal/mutant-type p53", "biomarker_inclusion": [], "histology_exclusion": ["mixed serous tumors", "endometrial carcinosarcoma", "tumors with subclonal mutant-type p53 staining"], "biomarker_exclusion": []}, {"cohort": "Early Stage Cohort", "disease_state": "stage I, II", "histology_inclusion": "clear cell with abnormal/mutant-type p53", "biomarker_inclusion": [], "histology_exclusion": ["mixed serous tumors", "endometrial carcinosarcoma", "tumors with subclonal mutant-type p53 staining"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Early Stage Cohort", "histology_inclusion": "Endometrial Carcinoma", "histology_exclusion": ["Carcinosarcoma", "Ovarian Serous Adenocarcinoma"], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["SGCG Mutation", "SGCG-Mutation", "gene"]]}, {"cohort": "Early Stage Cohort", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["SGCG Mutation", "SGCG-Mutation", "gene"]], "histology_exclusion": ["Ovarian Serous Adenocarcinoma", "Carcinosarcoma"], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["SGCG Mutation", "SGCG-Mutation", "gene"]]}, {"cohort": "Early Stage Cohort", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["SGCG Mutation", "SGCG-Mutation", "gene"]], "histology_exclusion": ["Carcinosarcoma", "Ovarian Serous Adenocarcinoma"], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["SGCG Mutation", "SGCG-Mutation", "gene"]]}, {"cohort": "Early Stage Cohort", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["SGCG Mutation", "SGCG-Mutation", "gene"]], "histology_exclusion": ["Ovarian Serous Adenocarcinoma", "Carcinosarcoma"], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["SGCG Mutation", "SGCG-Mutation", "gene"]]}, {"cohort": "Early Stage Cohort", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["SGCG Mutation", "SGCG-Mutation", "gene"]], "histology_exclusion": ["Carcinosarcoma", "Ovarian Serous Adenocarcinoma"], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["SGCG Mutation", "SGCG-Mutation", "gene"]]}]}
{"NCT_id": "NCT04457596", "json": [{"cohort": "", "disease_state": "Stage I-III", "histology_inclusion": "HER2 Positive Breast Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage I-III", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": ["HER2 Positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage I-III", "histology_inclusion": "Multifocal Breast Carcinoma", "biomarker_inclusion": ["HER2 Positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage I-III", "histology_inclusion": "Synchronous Bilateral Breast Carcinoma", "biomarker_inclusion": ["HER2 Positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Bilateral Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04978779", "json": [{"cohort": "", "disease_state": "refractory", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed", "histology_inclusion": "Richter Syndrome", "biomarker_inclusion": ["MYC overexpression", "MYC amplification", "MYC translocation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Richter Syndrome", "biomarker_inclusion": [["MYC Fusion", "MYC", "fusion"], ["MYC-High", "MYC-High", "expression"]]}]}
{"NCT_id": "NCT05173987", "json": [{"cohort": "", "disease_state": "inoperable, Stage III or IV or recurrent", "histology_inclusion": "Endometrial Carcinoma (EC) or carcinosarcoma (mixed Mullerian tumor)", "biomarker_inclusion": ["dMMR"], "histology_exclusion": ["uterine mesenchymal tumor", "endometrial stromal sarcoma", "leiomyosarcoma", "pure sarcomas", "adenosarcomas", "neuroendocrine tumors"], "biomarker_exclusion": ["pMMR"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Carcinosarcoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Endometrioid Stromal Sarcoma", "Leiomyosarcoma", "Sarcoma", "Neuroendocrine Carcinoma", "Lung Neuroendocrine Neoplasm", "Neuroendocrine Tumor"]}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Neuroendocrine Tumor", "Lung Neuroendocrine Neoplasm", "Endometrioid Stromal Sarcoma", "Neuroendocrine Carcinoma", "Sarcoma", "Leiomyosarcoma"]}]}
{"NCT_id": "NCT05629429", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "ER(+)Her2(-) breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "triple-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["EREG-High", "EREG-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}]}
{"NCT_id": "NCT02780128", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Neuroblastoma"}]}
{"NCT_id": "NCT03638297", "json": [{"cohort": "", "disease_state": "metastatic or primary", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["dMMR", "MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or primary", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["TMB > 1000"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}]}
{"NCT_id": "NCT03768505", "json": [{"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "Follicular Lymphoma (FL) Grade 1, 2, or 3a", "biomarker_inclusion": [], "histology_exclusion": ["FL Grade 3b transformation from FL to an aggressive lymphoma", "lymphomatous involvement of the central nervous system"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "Marginal Zone Lymphoma (MZL) including nodal, extranodal, and splenic MZL", "biomarker_inclusion": [], "histology_exclusion": ["lymphomatous involvement of the central nervous system"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Follicular Lymphoma", "histology_exclusion": ["Grade 3b Follicular Lymphoma", "Aggressive Non-Hodgkin Lymphoma"]}, {"cohort": "", "histology_inclusion": "Marginal Zone Lymphoma"}]}
{"NCT_id": "NCT04522895", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH2 R172 mutation", "IDH2 R140 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Myelodysplastic Syndromes", "biomarker_inclusion": ["IDH2 R172 mutation", "IDH2 R140 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": ["IDH2 R172 mutation", "IDH2 R140 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia"}]}
{"NCT_id": "NCT04783415", "json": [{"cohort": "", "disease_state": "Previously Untreated", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["CD20+", "t(11;14)(q13;q32)", "Cyclin D1 overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"], ["CCND1-High", "CCND1-High", "expression"]]}]}
{"NCT_id": "NCT04848597", "json": [{"cohort": "Single Arm", "disease_state": "Cancer of Unknown Primary", "histology_inclusion": "adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Single Arm", "disease_state": "Cancer of Unknown Primary", "histology_inclusion": "squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Single Arm", "disease_state": "Cancer of Unknown Primary", "histology_inclusion": "poorly differentiated carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Single Arm", "disease_state": "Cancer of Unknown Primary", "histology_inclusion": "poorly differentiated malignant tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Single Arm", "disease_state": "Cancer of Unknown Primary", "histology_inclusion": "neuroendocrine carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain or meningeal metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Single Arm", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "Single Arm", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "Single Arm"}, {"cohort": "Single Arm", "histology_inclusion": "Malignant Neoplasm"}, {"cohort": "Single Arm", "histology_inclusion": "Neuroendocrine Carcinoma"}, {"cohort": "Single Arm", "histology_inclusion": "Neuroendocrine Tumor"}]}
{"NCT_id": "NCT05564416", "json": [{"cohort": "", "disease_state": "T2-T4, N0-1", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": ["FGFR3 R248C", "FGFR3 S249C", "FGFR3 G370C", "FGFR3 Y373C", "FGFR3-TACC3", "FGFR3-BAIAP2L1", "FGFR2-BICC1", "FGFR2-CASP7"], "histology_exclusion": ["neuroendocrine carcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["FGFR3 S249C", "S249C", "coordinate"], ["FGFR2 - BICC1", "FGFR2 - BICC1", "coordinate"], ["FGFR3 - BAIAP2L1", "FGFR3 - BAIAP2L1", "coordinate"], ["FGFR3 R248C", "R248C", "coordinate"], ["FGFR3 Y373C", "Y373C", "coordinate"], ["FGFR3 G370C", "G370C", "coordinate"], ["FGFR2 - CASP7", "FGFR2 - CASP7", "coordinate"], ["FGFR3 - TACC3", "FGFR3 - TACC3", "coordinate"]], "histology_exclusion": ["Neuroendocrine Carcinoma", "Neuroendocrine Tumor"]}]}
{"NCT_id": "NCT04224441", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "Glioblastoma Multiforme", "biomarker_inclusion": ["MGMT-Unmethylated"], "histology_exclusion": [], "biomarker_exclusion": ["MGMT-Methylated"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype"}, {"cohort": "", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT05174169", "json": [{"cohort": "Cohort A", "disease_state": "Stage IIIA or IIIB", "histology_inclusion": "colon adenocarcinoma (T1-3, N1/N1c)", "biomarker_inclusion": ["ctDNA-ve"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H", "dMMR"]}, {"cohort": "Cohort B", "disease_state": "Stage II or IIIC", "histology_inclusion": "colon adenocarcinoma", "biomarker_inclusion": ["ctDNA+ve"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H", "dMMR"]}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort B", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT03964233", "json": [{"cohort": "Phase Ia (dose escalation part)", "disease_state": "unresectable, advanced and/or metastatic solid tumors", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase Ia (Expansion Cohort)", "disease_state": "MDM2 amplified tumors and TP53 wild type", "histology_inclusion": "MDM2 amplified tumors", "biomarker_inclusion": ["TP53 wild type"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase Ib (dose expansion part) - Cohort 1", "disease_state": "unresectable, advanced and/or metastatic TP53 wt", "histology_inclusion": "Liposarcoma excluding dedifferentiated liposarcoma", "biomarker_inclusion": ["TP53 wild type"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["TP53 mutation"]}, {"cohort": "Phase Ib (dose expansion part) - Cohort 1", "disease_state": "unresectable, advanced and/or metastatic TP53 wt", "histology_inclusion": "Undifferentiated pleomorphic sarcoma", "biomarker_inclusion": ["TP53 wild type"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["TP53 mutation"]}, {"cohort": "Phase Ib (dose expansion part) - Cohort 1", "disease_state": "unresectable, advanced and/or metastatic TP53 wt", "histology_inclusion": "Myxofibrosarcoma", "biomarker_inclusion": ["TP53 wild type"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["TP53 mutation"]}, {"cohort": "Phase Ib (dose expansion part) - Cohort 1", "disease_state": "unresectable, advanced and/or metastatic TP53 wt", "histology_inclusion": "Synovial sarcoma", "biomarker_inclusion": ["TP53 wild type"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["TP53 mutation"]}, {"cohort": "Phase Ib (dose expansion part) - Cohort 1", "disease_state": "unresectable, advanced and/or metastatic TP53 wt", "histology_inclusion": "Leiomyosarcoma", "biomarker_inclusion": ["TP53 wild type"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["TP53 mutation"]}, {"cohort": "Phase Ib (dose expansion part) - Cohort 2", "disease_state": "unresectable, advanced and/or metastatic TP53 wt MDM2-amplified tumors", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["TP53 wild type", "MDM2-amplified"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["TP53 mutation"]}, {"cohort": "Phase Ib (dose expansion part) - Cohort 2", "disease_state": "unresectable, advanced and/or metastatic TP53 wt MDM2-amplified tumors", "histology_inclusion": "Gastric adenocarcinoma", "biomarker_inclusion": ["TP53 wild type", "MDM2-amplified"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["TP53 mutation"]}, {"cohort": "Phase Ib (dose expansion part) - Cohort 2", "disease_state": "unresectable, advanced and/or metastatic TP53 wt MDM2-amplified tumors", "histology_inclusion": "Urothelial carcinoma", "biomarker_inclusion": ["TP53 wild type", "MDM2-amplified"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["TP53 mutation"]}, {"cohort": "Phase Ib (dose expansion part) - Cohort 2", "disease_state": "unresectable, advanced and/or metastatic TP53 wt MDM2-amplified tumors", "histology_inclusion": "Biliary tract carcinoma", "biomarker_inclusion": ["TP53 wild type", "MDM2-amplified"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["TP53 mutation"]}], "json_norm": [{"cohort": "Phase Ia (dose escalation part)", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase Ia (Expansion Cohort)", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Phase Ib (dose expansion part) - Cohort 1", "histology_inclusion": "Liposarcoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Phase Ib (dose expansion part) - Cohort 1", "histology_inclusion": "Dedifferentiated Liposarcoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Phase Ib (dose expansion part) - Cohort 1", "histology_inclusion": "Undifferentiated Pleomorphic Sarcoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Phase Ib (dose expansion part) - Cohort 1", "histology_inclusion": "Myxofibrosarcoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Phase Ib (dose expansion part) - Cohort 1", "histology_inclusion": "Synovial Sarcoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Phase Ib (dose expansion part) - Cohort 1", "histology_inclusion": "Leiomyosarcoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Phase Ib (dose expansion part) - Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Phase Ib (dose expansion part) - Cohort 2", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Phase Ib (dose expansion part) - Cohort 2", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Phase Ib (dose expansion part) - Cohort 2", "histology_inclusion": "Liver Cancer", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["MDM2-High", "MDM2-High", "expression"]], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Phase Ib (dose expansion part) - Cohort 2", "histology_inclusion": "Biliary Tract Carcinoma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT04653480", "json": [{"cohort": "Surufatinib, Toripalimab and Chemotherapy", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["RAS mutant", "BRAF mutant", "MSS"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Surufatinib, Toripalimab and Chemotherapy", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}]}
{"NCT_id": "NCT02715284", "json": [{"cohort": "Cohort A1", "disease_state": "recurrent or advanced (Stage >= IIIB)", "histology_inclusion": "dMMR/MSI-H endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": ["endometrial sarcoma", "carcinosarcoma"], "biomarker_exclusion": []}, {"cohort": "Cohort A2", "disease_state": "recurrent or advanced (Stage >= IIIB)", "histology_inclusion": "MMR-proficient/MSS endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": ["endometrial sarcoma", "carcinosarcoma"], "biomarker_exclusion": []}, {"cohort": "Cohort E", "disease_state": "recurrent or advanced", "histology_inclusion": "non-small cell lung cancer (NSCLC)", "biomarker_inclusion": ["EGFR mutation", "ALK translocation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort F", "disease_state": "recurrent or advanced", "histology_inclusion": "dMMR/MSI-H solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["endometrial cancers", "gastrointestinal cancers"], "biomarker_exclusion": []}, {"cohort": "Cohort G", "disease_state": "advanced, relapsed", "histology_inclusion": "high-grade serous, endometrioid, or clear cell ovarian, fallopian tube, or primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["known BRCA mutation"]}], "json_norm": [{"cohort": "Cohort A1", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Sarcoma", "Carcinosarcoma"]}, {"cohort": "Cohort A1", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Carcinosarcoma", "Sarcoma"]}, {"cohort": "Cohort A2", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]], "histology_exclusion": ["Carcinosarcoma", "Sarcoma"]}, {"cohort": "Cohort E", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Cohort F", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Endometrial Carcinoma", "Digestive System Neoplasm"]}, {"cohort": "Cohort F", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Digestive System Neoplasm", "Endometrial Carcinoma"]}, {"cohort": "Cohort G", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_exclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04718675", "json": [{"cohort": "Part 1", "disease_state": "relapsed/refractory", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "relapsed/refractory", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "relapsed/refractory", "histology_inclusion": "epithelial ovarian cancer", "biomarker_inclusion": ["MYC copy number gain", "MYC overexpression"], "histology_exclusion": ["central nervous system"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "relapsed/refractory", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["MYC copy number gain", "MYC overexpression"], "histology_exclusion": ["central nervous system"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "relapsed/refractory", "histology_inclusion": "diffuse large B-cell lymphoma", "biomarker_inclusion": ["MYC translocation"], "histology_exclusion": ["central nervous system"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "relapsed/refractory", "histology_inclusion": "Burkitt's lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "relapsed/refractory", "histology_inclusion": "sarcoma", "biomarker_inclusion": ["transcription factor fusion"], "histology_exclusion": ["central nervous system"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "relapsed/refractory", "histology_inclusion": "chordoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "relapsed/refractory", "histology_inclusion": "NUT midline carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "relapsed/refractory", "histology_inclusion": "adenoid cystic carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system"], "biomarker_exclusion": []}, {"cohort": "Part 2A", "disease_state": "relapsed/refractory", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["MYC copy number gain", "MYC overexpression"], "histology_exclusion": ["central nervous system"], "biomarker_exclusion": []}, {"cohort": "Part 2B", "disease_state": "relapsed/refractory", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": ["transcription factor oncogenic drivers"], "histology_exclusion": ["central nervous system"], "biomarker_exclusion": []}, {"cohort": "Part 2B", "disease_state": "relapsed/refractory", "histology_inclusion": "soft tissue sarcoma", "biomarker_inclusion": ["transcription factor oncogenic drivers"], "histology_exclusion": ["central nervous system"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 1", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part 1", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Part 1", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["MYC-High", "MYC-High", "expression"]]}, {"cohort": "Part 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MYC-High", "MYC-High", "expression"]]}, {"cohort": "Part 1", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MYC Fusion", "MYC", "fusion"]]}, {"cohort": "Part 1", "histology_inclusion": "Burkitt Lymphoma"}, {"cohort": "Part 1", "histology_inclusion": "Sarcoma"}, {"cohort": "Part 1", "histology_inclusion": "Chordoma"}, {"cohort": "Part 1", "histology_inclusion": "NUT Carcinoma"}, {"cohort": "Part 1", "histology_inclusion": "Adenoid Cystic Carcinoma"}, {"cohort": "Part 2A", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MYC-High", "MYC-High", "expression"]]}, {"cohort": "Part 2B", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Part 2B", "histology_inclusion": "Soft Tissue Sarcoma"}]}
{"NCT_id": "NCT05109442", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "EGFR-positive non-small cell lung cancer (NSCLC)", "biomarker_inclusion": ["EGFR WT"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, unresectable, or metastatic", "histology_inclusion": "gastric/GEJ adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "hepatocellular carcinoma (HCC)", "biomarker_inclusion": ["BCLC C", "BCLC B not amenable or refractory to locoregional therapy"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "hepatobiliary adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma"}]}
{"NCT_id": "NCT05304585", "json": [{"cohort": "Very Low-Risk Stratum (Regimen VA)", "disease_state": "Stage 1, CG I", "histology_inclusion": "Embryonal Rhabdomyosarcoma (ERMS), Spindle Cell/Sclerosing RMS, FOXO1 Fusion Negative Alveolar Rhabdomyosarcoma (ARMS)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Low-Risk Stratum (Regimen VAC/VA)", "disease_state": "Stage 1, CG II; Stage 2, CG I or II; Stage 1, CG III (orbit only)", "histology_inclusion": "Embryonal Rhabdomyosarcoma (ERMS), Spindle Cell/Sclerosing RMS, FOXO1 Fusion Negative Alveolar Rhabdomyosarcoma (ARMS)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Very Low-Risk Stratum (Regimen VA)", "histology_inclusion": "Alveolar Rhabdomyosarcoma", "biomarker_inclusion": [["FOXO1-Low", "FOXO1-Low", "expression"], ["FOXO1 Fusion", "FOXO1", "fusion"]]}, {"cohort": "Very Low-Risk Stratum (Regimen VA)", "histology_inclusion": "Alveolar Rhabdomyosarcoma", "biomarker_inclusion": [["FOXO1-Low", "FOXO1-Low", "expression"], ["FOXO1 Fusion", "FOXO1", "fusion"]]}, {"cohort": "Very Low-Risk Stratum (Regimen VA)", "histology_inclusion": "Embryonal Rhabdomyosarcoma", "biomarker_inclusion": [["FOXO1-Low", "FOXO1-Low", "expression"], ["FOXO1 Fusion", "FOXO1", "fusion"]]}, {"cohort": "Very Low-Risk Stratum (Regimen VA)", "histology_inclusion": "Embryonal Rhabdomyosarcoma", "biomarker_inclusion": [["FOXO1-Low", "FOXO1-Low", "expression"], ["FOXO1 Fusion", "FOXO1", "fusion"]]}, {"cohort": "Low-Risk Stratum (Regimen VAC/VA)", "histology_inclusion": "Alveolar Rhabdomyosarcoma", "biomarker_inclusion": [["FOXO1-Low", "FOXO1-Low", "expression"], ["FOXO1 Fusion", "FOXO1", "fusion"]]}, {"cohort": "Low-Risk Stratum (Regimen VAC/VA)", "histology_inclusion": "Alveolar Rhabdomyosarcoma", "biomarker_inclusion": [["FOXO1-Low", "FOXO1-Low", "expression"], ["FOXO1 Fusion", "FOXO1", "fusion"]]}, {"cohort": "Low-Risk Stratum (Regimen VAC/VA)", "histology_inclusion": "Embryonal Rhabdomyosarcoma", "biomarker_inclusion": [["FOXO1-Low", "FOXO1-Low", "expression"], ["FOXO1 Fusion", "FOXO1", "fusion"]]}, {"cohort": "Low-Risk Stratum (Regimen VAC/VA)", "histology_inclusion": "Embryonal Rhabdomyosarcoma", "biomarker_inclusion": [["FOXO1-Low", "FOXO1-Low", "expression"], ["FOXO1 Fusion", "FOXO1", "fusion"]]}]}
{"NCT_id": "NCT03769103", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR exon 19 deletions", "EGFR exon 21 (L858R) substitution mutations"], "histology_exclusion": ["Leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT04094610", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["ALK alteration", "ROS1 alteration", "NTRK1-3 alteration"], "histology_exclusion": ["neuroblastoma with only bone marrow disease evaluable by bone marrow aspiration only"], "biomarker_exclusion": []}, {"cohort": "Cohort 1", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["NTRK fusion gene positive", "TRK TKI naive"], "histology_exclusion": ["neuroblastoma with only bone marrow disease evaluable by bone marrow aspiration only"], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["NTRK fusion gene positive", "TRK TKI pre-treated"], "histology_exclusion": ["neuroblastoma with only bone marrow disease evaluable by bone marrow aspiration only"], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "advanced or metastatic", "histology_inclusion": "tumors or ALCL", "biomarker_inclusion": ["ALK alteration", "ROS1 alteration", "NTRK alteration", "NTRK fusion"], "histology_exclusion": ["neuroblastoma with only bone marrow disease evaluable by bone marrow aspiration only"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["NTRK1 Mutation", "NTRK1-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"]], "histology_exclusion": ["Neuroblastoma"]}, {"cohort": "Cohort 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]], "histology_exclusion": ["Neuroblastoma"]}, {"cohort": "Cohort 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]], "histology_exclusion": ["Neuroblastoma"]}, {"cohort": "Cohort 3", "histology_inclusion": "Anaplastic Large Cell Lymphoma", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["ALK Mutation", "ALK-Mutation", "gene"], ["NTRK3 Mutation", "NTRK3-Mutation", "gene"], ["NTRK2 Mutation", "NTRK2-Mutation", "gene"], ["NTRK1 Mutation", "NTRK1-Mutation", "gene"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"], ["NTRK2 Fusion", "NTRK2", "fusion"]], "histology_exclusion": ["Neuroblastoma"]}]}
{"NCT_id": "NCT04094688", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["dMMR", "MSI-H"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04458259", "json": [{"cohort": "Part 4, Cohort 1", "disease_state": "metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["METex14-skipping alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 4, Cohort 2", "disease_state": "metastatic", "histology_inclusion": "CRC", "biomarker_inclusion": ["MSS", "intermediate TMB"], "histology_exclusion": [], "biomarker_exclusion": ["prior anti-PD-(L)1 therapy"]}, {"cohort": "Part 4, Cohort 3", "disease_state": "metastatic", "histology_inclusion": "gastric or GEJ adenocarcinoma", "biomarker_inclusion": ["PD-L1 positive"], "histology_exclusion": [], "biomarker_exclusion": ["prior anti-PD-(L)1 therapy"]}, {"cohort": "Part 4, Cohort 4", "disease_state": "metastatic", "histology_inclusion": "RCC", "biomarker_inclusion": ["clear cell component", "IMDC intermediate or poor risk"], "histology_exclusion": [], "biomarker_exclusion": ["prior systemic therapy for metastatic disease"]}], "json_norm": [{"cohort": "Part 4, Cohort 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part 4, Cohort 2", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Part 4, Cohort 3", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"]]}, {"cohort": "Part 4, Cohort 4", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "Part 4, Cohort 4", "histology_inclusion": "Refractory Cytopenia of Childhood"}]}
{"NCT_id": "NCT04979442", "json": [{"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "Dedifferentiated Liposarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Dedifferentiated Liposarcoma"}]}
{"NCT_id": "NCT02193282", "json": [{"cohort": "", "disease_state": "Stage IB (>= 4 cm), II, IIIA", "histology_inclusion": "Non-squamous Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR exon 19 deletion", "EGFR L858R mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR T790M mutation", "EGFR TK domain resistant mutations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]], "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04225039", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV", "biomarker_inclusion": ["EGFR amplification", "whole chromosome 7 gain", "whole chromosome 10 loss", "TERT promoter mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Gliosarcoma"}, {"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["EGFR-High", "EGFR-High", "expression"], ["TERT-Promoter", "TERT-Promoter", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["EGFR-High", "EGFR-High", "expression"], ["TERT-Promoter", "TERT-Promoter", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["EGFR-High", "EGFR-High", "expression"], ["TERT-Promoter", "TERT-Promoter", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["TERT-Promoter", "TERT-Promoter", "coordinate"], ["EGFR-High", "EGFR-High", "expression"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT05174650", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "intrahepatic cholangiocarcinoma", "biomarker_inclusion": ["FGFR2 fusion", "FGFR2 rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Intrahepatic Cholangiocarcinoma", "biomarker_inclusion": [["FGFR2 Fusion", "FGFR2", "fusion"]]}]}
{"NCT_id": "NCT03769311", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Nasopharyngeal Carcinoma", "Advanced Cutaneous Squamous Cell Carcinoma of the Head & Neck", "Salivary Gland Tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Skin Squamous Cell Carcinoma", "Nasopharyngeal Carcinoma", "Malignant Salivary Gland Neoplasm", "Salivary Gland Carcinoma"]}]}
{"NCT_id": "NCT04225117", "json": [{"cohort": "Cohort 1: HR+/HER2- breast cancer", "disease_state": "locally advanced or metastatic", "histology_inclusion": "HR+/HER2- breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2: Triple negative breast cancer (TNBC)", "disease_state": "locally advanced or metastatic", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3: Squamous non-small cell lung cancer", "disease_state": "locally advanced or metastatic", "histology_inclusion": "squamous non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["neuroendocrine histology"], "biomarker_exclusion": ["EGFR", "ALK", "ROS", "BRAF"]}], "json_norm": [{"cohort": "Cohort 1: HR+/HER2- breast cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Cohort 1: HR+/HER2- breast cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Cohort 2: Triple negative breast cancer (TNBC)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Cohort 3: Squamous non-small cell lung cancer", "histology_inclusion": "Squamous Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04393454", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["dMMR"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04849364", "json": [{"cohort": "", "disease_state": "Stage I-III", "histology_inclusion": "Triple Negative Breast Cancer (ER-/PR-/HER2-)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["TMEM37-Low", "TMEM37-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["TMEM37-Low", "TMEM37-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["TMEM37-Low", "TMEM37-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["TMEM37-Low", "TMEM37-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["TMEM37-Low", "TMEM37-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["TMEM37-Low", "TMEM37-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"]]}]}
{"NCT_id": "NCT03769532", "json": [{"cohort": "Pembrolizumab + Azacitidine", "disease_state": "NPM1mut AML in complete morphologic remission", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["NPM1 mutation", "MRD ratio > 1%"], "histology_exclusion": ["malignant liver tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Pembrolizumab + Azacitidine", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["NPM1 Mutation", "NPM1-Mutation", "gene"]], "histology_exclusion": ["Liver Cancer"]}]}
{"NCT_id": "NCT03834688", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["Cyclin D1 (BCL1) expression", "t(11;14)"], "histology_exclusion": ["Central Nervous System Lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}]}
{"NCT_id": "NCT03834740", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "WHO Grade III glioma", "biomarker_inclusion": ["RB positivity (\u226520%)", "CDKN2A/B/C loss", "CDK4/6 amplification", "CCND1/2 amplification", "mTOR+: PTEN loss", "PIK3C2B amplification", "AKT3 amplification", "PIK3CA mutation", "PIK3R1 mutation", "mTOR mutation", "PTEN mutation", "pS6 positivity (\u226510%)"], "histology_exclusion": ["primary CNS tumor"], "biomarker_exclusion": ["RB mutations"]}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "WHO Grade IV glioma", "biomarker_inclusion": ["RB positivity (\u226520%)", "CDKN2A/B/C loss", "CDK4/6 amplification", "CCND1/2 amplification", "mTOR+: PTEN loss", "PIK3C2B amplification", "AKT3 amplification", "PIK3CA mutation", "PIK3R1 mutation", "mTOR mutation", "PTEN mutation", "pS6 positivity (\u226510%)"], "histology_exclusion": ["primary CNS tumor"], "biomarker_exclusion": ["RB mutations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "WHO Grade III Glioma", "biomarker_inclusion": [["PTEN Mutation", "PTEN-Mutation", "gene"], ["PIK3R1 Mutation", "PIK3R1-Mutation", "gene"], ["PIK3C2B-High", "PIK3C2B-High", "expression"], ["MTOR Mutation", "MTOR-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["AKT3-High", "AKT3-High", "expression"], ["MTOR-High", "MTOR-High", "expression"], ["PTEN-Low", "PTEN-Low", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"], "biomarker_exclusion": [["RB1 Mutation", "RB1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["PTEN Mutation", "PTEN-Mutation", "gene"], ["PIK3R1 Mutation", "PIK3R1-Mutation", "gene"], ["PIK3C2B-High", "PIK3C2B-High", "expression"], ["MTOR Mutation", "MTOR-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["AKT3-High", "AKT3-High", "expression"], ["MTOR-High", "MTOR-High", "expression"], ["PTEN-Low", "PTEN-Low", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"], "biomarker_exclusion": [["RB1 Mutation", "RB1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04290546", "json": [{"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "squamous cell carcinoma of the head neck (including oral cavity, oropharynx, larynx, hypopharynx, paranasal sinuses)", "biomarker_inclusion": [], "histology_exclusion": ["nasopharyngeal carcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or metastatic", "histology_inclusion": "salivary gland carcinoma (including adenoid cystic carcinoma and non-adenoid cystic carcinoma histologies)", "biomarker_inclusion": [], "histology_exclusion": ["nasopharyngeal carcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma", "histology_exclusion": ["Nasopharyngeal Carcinoma"]}, {"cohort": "", "histology_inclusion": "Adenoid Cystic Carcinoma", "histology_exclusion": ["Nasopharyngeal Carcinoma"]}, {"cohort": "", "histology_inclusion": "Malignant Salivary Gland Neoplasm", "histology_exclusion": ["Nasopharyngeal Carcinoma"]}, {"cohort": "", "histology_inclusion": "Salivary Gland Carcinoma", "histology_exclusion": ["Nasopharyngeal Carcinoma"]}]}
{"NCT_id": "NCT05500508", "json": [{"cohort": "", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "ovarian cancer (including primary peritoneal cancer and fallopian tube cancer)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "papillary thyroid cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "head and neck cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "gastric cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "non-small cell lung cancer (NSCLC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "mesothelioma: pleural and peritoneal", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "esophageal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "cervical cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "colorectal cancers (colon, rectal)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "grade 4 gliomas (including both IDH WT and IDH-mutant astrocytoma)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory or progressive", "histology_inclusion": "DIPG or DMG", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory or progressive", "histology_inclusion": "high-grade gliomas (such as anaplastic astrocytoma, glioblastoma, H3 K27M-mutant DMG)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "", "histology_inclusion": "Thyroid Gland Papillary Carcinoma"}, {"cohort": "", "histology_inclusion": "Malignant Head and Neck Neoplasm"}, {"cohort": "", "histology_inclusion": "Head and Neck Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Mesothelioma"}, {"cohort": "", "histology_inclusion": "Esophageal Carcinoma"}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "", "histology_inclusion": "Melanoma"}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma"}, {"cohort": "", "histology_inclusion": "Anaplastic Astrocytoma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}]}
{"NCT_id": "NCT02716116", "json": [{"cohort": "General", "disease_state": "locally advanced (Stage IIIB) or metastatic (Stage IV) NSCLC", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort 1", "disease_state": "locally advanced or metastatic NSCLC", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR exon 20 insertion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort 2", "disease_state": "locally advanced or metastatic NSCLC", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["HER2 exon 20 insertion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort 2", "disease_state": "locally advanced or metastatic NSCLC", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["HER2 activating point mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort 3", "disease_state": "locally advanced or metastatic NSCLC with active, measurable CNS metastases", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR exon 20 insertion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort 3", "disease_state": "locally advanced or metastatic NSCLC with active, measurable CNS metastases", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["HER2 exon 20 insertion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort 3", "disease_state": "locally advanced or metastatic NSCLC with active, measurable CNS metastases", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["HER2 activating point mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort 4", "disease_state": "locally advanced or metastatic NSCLC", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR activating mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort 5", "disease_state": "locally advanced or metastatic NSCLC without active CNS metastases", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR exon 20 insertion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort 7", "disease_state": "locally advanced or metastatic solid tumors other than NSCLC without active CNS metastases", "histology_inclusion": "Solid tumors other than Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR/HER2 mutations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "General", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Expansion Cohort 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Expansion Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Expansion Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "Expansion Cohort 3", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Expansion Cohort 3", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Expansion Cohort 3", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "Expansion Cohort 4", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Expansion Cohort 5", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Expansion Cohort 7", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "Expansion Cohort 7", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04095273", "json": [{"cohort": "Dose expansion cohort 1a of Elimusertib", "disease_state": "advanced", "histology_inclusion": "hormone-receptor-positive, HER2-negative breast cancer", "biomarker_inclusion": ["ATM loss", "ATM deleterious alterations"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H"]}, {"cohort": "Dose expansion cohort 1b of Elimusertib", "disease_state": "advanced", "histology_inclusion": "hormone-receptor-positive, HER2-negative breast cancer", "biomarker_inclusion": ["DDR deficiency biomarker-positive"], "histology_exclusion": [], "biomarker_exclusion": ["ATM loss", "ATM mutation", "MSI-H"]}, {"cohort": "Dose expansion cohort 2a of Elimusertib", "disease_state": "advanced", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["ATM loss", "ATM deleterious alterations"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H"]}, {"cohort": "Dose expansion cohort 2b of Elimusertib", "disease_state": "advanced", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["DDR deficiency biomarker-positive"], "histology_exclusion": [], "biomarker_exclusion": ["ATM loss", "ATM mutation", "MSI-H"]}, {"cohort": "Dose expansion cohort 3 of Elimusertib", "disease_state": "advanced", "histology_inclusion": "gastric/gastroesophageal junction cancer", "biomarker_inclusion": ["DDR deficiency biomarker-positive", "ATM mutation", "ATM loss"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose expansion cohort 3a of Elimusertib", "disease_state": "advanced", "histology_inclusion": "gastric/gastroesophageal junction cancer", "biomarker_inclusion": ["variants of unknown significance of DDR gene alterations"], "histology_exclusion": [], "biomarker_exclusion": ["DDR deficiency alterations"]}, {"cohort": "Dose expansion cohort 4 of Elimusertib", "disease_state": "advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["DDR deficiency biomarker-positive", "ATM mutation", "ATM loss"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose expansion cohort 4a of Elimusertib", "disease_state": "advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["variants of unknown significance of DDR gene alterations"], "histology_exclusion": [], "biomarker_exclusion": ["DDR deficiency alterations"]}, {"cohort": "Dose expansion cohort 5 of Elimusertib", "disease_state": "advanced", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["DDR deficiency biomarker-positive", "ATM mutation", "ATM loss"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H"]}, {"cohort": "Dose expansion cohort 5a of Elimusertib", "disease_state": "advanced", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["variants of unknown significance of DDR gene alterations"], "histology_exclusion": [], "biomarker_exclusion": ["DDR deficiency alterations", "MSI-H"]}, {"cohort": "Dose expansion cohort 6 of Elimusertib", "disease_state": "advanced", "histology_inclusion": "metastatic castration-resistant prostate cancer", "biomarker_inclusion": ["DDR deficiency biomarker-positive", "ATM mutation", "ATM loss"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H"]}, {"cohort": "Dose expansion cohort 6a of Elimusertib", "disease_state": "advanced", "histology_inclusion": "metastatic castration-resistant prostate cancer", "biomarker_inclusion": ["variants of unknown significance of DDR gene alterations"], "histology_exclusion": [], "biomarker_exclusion": ["DDR deficiency alterations", "MSI-H"]}], "json_norm": [{"cohort": "Dose expansion cohort 1a of Elimusertib", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"], ["ATM-Low", "ATM-Low", "expression"], ["ATM Mutation", "ATM-Mutation", "gene"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Dose expansion cohort 1a of Elimusertib", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"], ["ATM-Low", "ATM-Low", "expression"], ["ATM Mutation", "ATM-Mutation", "gene"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Dose expansion cohort 1a of Elimusertib", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"], ["ESR1-High", "ESR1-High", "expression"], ["ATM-Low", "ATM-Low", "expression"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Dose expansion cohort 1b of Elimusertib", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"], ["DNA Damage Repair (DDR) pathways", null, "pathway"]], "biomarker_exclusion": [["ATM-Low", "ATM-Low", "expression"], ["ATM Mutation", "ATM-Mutation", "gene"], ["ATM Mutation", "ATM-Mutation", "gene"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Dose expansion cohort 1b of Elimusertib", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"], ["DNA Damage Repair (DDR) pathways", null, "pathway"]], "biomarker_exclusion": [["ATM-Low", "ATM-Low", "expression"], ["ATM Mutation", "ATM-Mutation", "gene"], ["ATM Mutation", "ATM-Mutation", "gene"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Dose expansion cohort 1b of Elimusertib", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"], ["ESR1-High", "ESR1-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]], "biomarker_exclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["ATM-Low", "ATM-Low", "expression"]]}, {"cohort": "Dose expansion cohort 2a of Elimusertib", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["ATM-Low", "ATM-Low", "expression"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Dose expansion cohort 2b of Elimusertib", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]], "biomarker_exclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["ATM-Low", "ATM-Low", "expression"]]}, {"cohort": "Dose expansion cohort 3 of Elimusertib", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["DNA Damage Repair (DDR) pathways", null, "pathway"], ["ATM-Low", "ATM-Low", "expression"]]}, {"cohort": "Dose expansion cohort 3a of Elimusertib", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]], "biomarker_exclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "Dose expansion cohort 4 of Elimusertib", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["DNA Damage Repair (DDR) pathways", null, "pathway"], ["ATM-Low", "ATM-Low", "expression"]]}, {"cohort": "Dose expansion cohort 4a of Elimusertib", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]], "biomarker_exclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "Dose expansion cohort 5 of Elimusertib", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["DNA Damage Repair (DDR) pathways", null, "pathway"], ["ATM-Low", "ATM-Low", "expression"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Dose expansion cohort 5a of Elimusertib", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "Dose expansion cohort 6 of Elimusertib", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"], ["ATM Mutation", "ATM-Mutation", "gene"], ["ATM-Low", "ATM-Low", "expression"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Dose expansion cohort 6 of Elimusertib", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["DNA Damage Repair (DDR) pathways", null, "pathway"], ["ATM-Low", "ATM-Low", "expression"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Dose expansion cohort 6a of Elimusertib", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]], "biomarker_exclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Dose expansion cohort 6a of Elimusertib", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["DNA Damage Repair (DDR) pathways", null, "pathway"]]}]}
{"NCT_id": "NCT04095364", "json": [{"cohort": "", "disease_state": "Stage II-IV", "histology_inclusion": "Low-grade serous ovarian cancer", "biomarker_inclusion": ["Nonaberrant p53 expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II-IV", "histology_inclusion": "Low-grade serous fallopian tube cancer", "biomarker_inclusion": ["Nonaberrant p53 expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II-IV", "histology_inclusion": "Low-grade serous primary peritoneal cancer", "biomarker_inclusion": ["Nonaberrant p53 expression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Invasive Ovarian Micropapillary Serous Carcinoma"}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma"}]}
{"NCT_id": "NCT04458922", "json": [{"cohort": "", "disease_state": "newly diagnosed, unresectable, metastatic", "histology_inclusion": "clear cell sarcoma", "biomarker_inclusion": ["EWSR1/ATF1 translocation", "EWSR1/CREB1 translocation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly diagnosed, unresectable, metastatic", "histology_inclusion": "grade 2 conventional chondrosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly diagnosed, unresectable, metastatic", "histology_inclusion": "grade 3 conventional chondrosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly diagnosed, unresectable, metastatic", "histology_inclusion": "dedifferentiated chondrosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Clear Cell Sarcoma of Soft Tissue", "biomarker_inclusion": [["CREB1 Fusion", "CREB1", "fusion"], ["GDNF Fusion", "GDNF", "fusion"], ["ATF1 Fusion", "ATF1", "fusion"]]}, {"cohort": "", "histology_inclusion": "Chondrosarcoma"}, {"cohort": "", "histology_inclusion": "Chondrosarcoma"}, {"cohort": "", "histology_inclusion": "Dedifferentiated Chondrosarcoma"}]}
{"NCT_id": "NCT04524000", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "ER+ and/or PgR+ breast cancer", "biomarker_inclusion": ["PIK3CA mutation"], "histology_exclusion": ["HER2-negative breast cancer", "inflammatory breast cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["EREG-High", "EREG-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Breast Carcinoma", "Inflammatory Breast Carcinoma"], "biomarker_exclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["EREG-High", "EREG-High", "expression"], ["PGR-High", "PGR-High", "expression"]], "histology_exclusion": ["Breast Carcinoma", "Inflammatory Breast Carcinoma"], "biomarker_exclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT05110196", "json": [{"cohort": "", "disease_state": "Stage IIIB/IIIC (not amenable to surgery, radiation or multi-modality therapy) or Stage IV", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": ["EGFR wild-type", "ALK rearrangement negative", "MET exon 14 skipping mutation positive"], "histology_exclusion": [], "biomarker_exclusion": ["ROS1 translocation", "BRAF mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["ALK Fusion", "ALK", "fusion"], ["MET exon 14 del", "exon 14 del", "exon"], ["ALK-Low", "ALK-Low", "expression"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]], "biomarker_exclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"]]}]}
{"NCT_id": "NCT04980222", "json": [{"cohort": "", "disease_state": "untreated", "histology_inclusion": "CD20-positive Diffuse Large B-Cell Lymphoma (DLBCL)", "biomarker_inclusion": [], "histology_exclusion": ["B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classic Hodgkin lymphoma (gray-zone lymphoma)", "primary mediastinal (thymic) large B-cell lymphoma", "Burkitt lymphoma", "central nervous system (CNS) lymphoma", "primary effusion DLBCL", "primary cutaneous DLBCL"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "untreated", "histology_inclusion": "High-grade B-cell lymphoma (HGBCL) with MYC and BCL2 and/or BCL6 translocations", "biomarker_inclusion": [], "histology_exclusion": ["B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classic Hodgkin lymphoma (gray-zone lymphoma)", "primary mediastinal (thymic) large B-cell lymphoma", "Burkitt lymphoma", "central nervous system (CNS) lymphoma", "primary effusion DLBCL", "primary cutaneous DLBCL"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "untreated", "histology_inclusion": "de novo transformed follicular lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classic Hodgkin lymphoma (gray-zone lymphoma)", "primary mediastinal (thymic) large B-cell lymphoma", "Burkitt lymphoma", "central nervous system (CNS) lymphoma", "primary effusion DLBCL", "primary cutaneous DLBCL"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma", "Burkitt Lymphoma", "B-Cell Non-Hodgkin Lymphoma", "Classic Hodgkin Lymphoma"]}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"]], "histology_exclusion": ["Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma", "Burkitt Lymphoma", "B-Cell Non-Hodgkin Lymphoma", "Classic Hodgkin Lymphoma"]}, {"cohort": "", "histology_inclusion": "Follicular Lymphoma", "histology_exclusion": ["Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma", "Burkitt Lymphoma", "B-Cell Non-Hodgkin Lymphoma", "Classic Hodgkin Lymphoma"]}]}
{"NCT_id": "NCT02455141", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "adenocarcinoma of the breast", "biomarker_inclusion": ["ER <10% positivity", "PgR <10% positivity", "Her2 negative (IHC 0-1+ or FISH negative)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["SH3PXD2A-Low", "SH3PXD2A-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT02922764", "json": [{"cohort": "Recurrent NSCLC (2nd/3rd Line Lung Cancer). Expansion", "disease_state": "advanced", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Newly dignosed NSCLC Cohort Expansion", "disease_state": "advanced", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR not indicated", "ALK-directed therapy not indicated", "PD-L1 TPS <1%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Recurrent/Relapsed Small Cell Lung Cancer (SCLC) Expansion", "disease_state": "advanced", "histology_inclusion": "Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Recurrent/Relapsed Endometrial Cancer Expansion", "disease_state": "Stage III, Stage IV, or recurrent", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": ["ApoE E2 allele heterozygous or homozygous", "ApoE E4 allele heterozygous or homozygous"], "histology_exclusion": [], "biomarker_exclusion": ["prior checkpoint inhibitor therapy"]}], "json_norm": [{"cohort": "Recurrent NSCLC (2nd/3rd Line Lung Cancer). Expansion", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Newly dignosed NSCLC Cohort Expansion", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Recurrent/Relapsed Small Cell Lung Cancer (SCLC) Expansion", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Recurrent/Relapsed Endometrial Cancer Expansion", "histology_inclusion": "Endometrial Carcinoma"}]}
{"NCT_id": "NCT03313778", "json": [{"cohort": "Part A", "disease_state": "resected", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "resected", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "resected", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "resected", "histology_inclusion": "bladder urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "resected", "histology_inclusion": "human papillomavirus-negative head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "resected", "histology_inclusion": "solid malignancy", "biomarker_inclusion": ["microsatellite instable high", "mismatch repair deficient"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "resected", "histology_inclusion": "solid malignancy", "biomarker_inclusion": ["high tumor mutational load", "high tumor mutational burden"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "unresectable", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["epidermal growth factor receptor sensitizing mutation", "anaplastic lymphoma kinase translocation"]}, {"cohort": "Part B", "disease_state": "unresectable", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "unresectable", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "unresectable", "histology_inclusion": "bladder urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "unresectable", "histology_inclusion": "human papillomavirus-negative head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "unresectable", "histology_inclusion": "solid malignancy", "biomarker_inclusion": ["microsatellite instable high", "mismatch repair deficient"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "unresectable", "histology_inclusion": "solid malignancy", "biomarker_inclusion": ["high tumor mutational load", "high tumor mutational burden"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "unresectable", "histology_inclusion": "microsatellite stable colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior anti-programmed cell death protein 1", "prior anti-programmed death-ligand 1"]}, {"cohort": "Part C", "disease_state": "unresectable", "histology_inclusion": "human papillomavirus-negative metastatic or recurrent head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior anti-programmed cell death protein 1", "prior anti-programmed death-ligand 1"]}, {"cohort": "Part C", "disease_state": "unresectable", "histology_inclusion": "bladder urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior anti-programmed cell death protein 1", "prior anti-programmed death-ligand 1"]}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part A", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Part A", "histology_inclusion": "Melanoma"}, {"cohort": "Part A", "histology_inclusion": "Bladder Urothelial Carcinoma"}, {"cohort": "Part A", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Part A"}, {"cohort": "Part A", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Part B", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Part B", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Part B", "histology_inclusion": "Melanoma"}, {"cohort": "Part B", "histology_inclusion": "Bladder Urothelial Carcinoma"}, {"cohort": "Part B", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Part B"}, {"cohort": "Part B", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Part C", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Part C", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Part C", "histology_inclusion": "Bladder Urothelial Carcinoma"}]}
{"NCT_id": "NCT05435846", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["MET exon 14 skipping mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR activating mutations", "KRAS g12c", "ALK oncogenic fusions", "ROS1 oncogenic fusions", "NTRK oncogenic fusions", "BRAF V600E", "RET oncogenic fusions"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]], "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT02128906", "json": [{"cohort": "", "disease_state": "Stage III, IVa, IVb", "histology_inclusion": "Squamous Cell Carcinoma, Undifferentiated Carcinoma, Poorly Differentiated Carcinoma of the Oropharynx, Larynx, or Hypopharynx", "biomarker_inclusion": ["ERCC1", "p16(+) or p16(-)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Undifferentiated Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Oropharyngeal Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}]}
{"NCT_id": "NCT04030559", "json": [{"cohort": "", "disease_state": "high or very high risk localized prostate cancer", "histology_inclusion": "prostate carcinoma", "biomarker_inclusion": ["ATM gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high or very high risk localized prostate cancer", "histology_inclusion": "prostate carcinoma", "biomarker_inclusion": ["BRCA1 gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high or very high risk localized prostate cancer", "histology_inclusion": "prostate carcinoma", "biomarker_inclusion": ["BRCA2 gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high or very high risk localized prostate cancer", "histology_inclusion": "prostate carcinoma", "biomarker_inclusion": ["BRIP1 gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high or very high risk localized prostate cancer", "histology_inclusion": "prostate carcinoma", "biomarker_inclusion": ["CDK12 gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high or very high risk localized prostate cancer", "histology_inclusion": "prostate carcinoma", "biomarker_inclusion": ["CHEK1 gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high or very high risk localized prostate cancer", "histology_inclusion": "prostate carcinoma", "biomarker_inclusion": ["CHEK2 gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high or very high risk localized prostate cancer", "histology_inclusion": "prostate carcinoma", "biomarker_inclusion": ["FANCA gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high or very high risk localized prostate cancer", "histology_inclusion": "prostate carcinoma", "biomarker_inclusion": ["FANCD2 gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high or very high risk localized prostate cancer", "histology_inclusion": "prostate carcinoma", "biomarker_inclusion": ["FANCL gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high or very high risk localized prostate cancer", "histology_inclusion": "prostate carcinoma", "biomarker_inclusion": ["GEN1 gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high or very high risk localized prostate cancer", "histology_inclusion": "prostate carcinoma", "biomarker_inclusion": ["NBN gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high or very high risk localized prostate cancer", "histology_inclusion": "prostate carcinoma", "biomarker_inclusion": ["RAD51 gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "high or very high risk localized prostate cancer", "histology_inclusion": "prostate carcinoma", "biomarker_inclusion": ["RAD51C gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["BRIP1 Mutation", "BRIP1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["BRIP1 Mutation", "BRIP1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["CDK12 Mutation", "CDK12-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["CDK12 Mutation", "CDK12-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["CHEK1 Mutation", "CHEK1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["CHEK1 Mutation", "CHEK1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["CHEK2 Mutation", "CHEK2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["CHEK2 Mutation", "CHEK2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["FANCA Mutation", "FANCA-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["FANCA Mutation", "FANCA-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["FANCD2 Mutation", "FANCD2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["FANCD2 Mutation", "FANCD2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["FANCL Mutation", "FANCL-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["FANCL Mutation", "FANCL-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["GEN1 Mutation", "GEN1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["GEN1 Mutation", "GEN1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["ARTN Mutation", "ARTN-Mutation", "gene"], ["NBN Mutation", "NBN-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["ARTN Mutation", "ARTN-Mutation", "gene"], ["NBN Mutation", "NBN-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["RAD51 Mutation", "RAD51-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["RAD51 Mutation", "RAD51-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["RAD51C Mutation", "RAD51C-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["RAD51C Mutation", "RAD51C-Mutation", "gene"]]}]}
{"NCT_id": "NCT04291079", "json": [{"cohort": "Part B Cohort NSCLC", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B Cohort UC", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B Cohort MEL", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Cutaneous melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B Cohort ccRCC", "disease_state": "locally advanced or metastatic", "histology_inclusion": "clear cell Renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B Cohort Any Other", "disease_state": "locally advanced or metastatic", "histology_inclusion": "any other solid tumor type that is not NSCLC, UC, MEL, or ccRCC", "biomarker_inclusion": [], "histology_exclusion": ["Non-small cell lung cancer", "Urothelial Carcinoma", "Cutaneous melanoma", "clear cell Renal cell carcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part B Cohort NSCLC", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part B Cohort UC", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "Part B Cohort MEL", "histology_inclusion": "Cutaneous Melanoma"}, {"cohort": "Part B Cohort ccRCC", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}, {"cohort": "Part B Cohort Any Other", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Non-Small Cell Lung Carcinoma", "Urothelial Carcinoma", "Urothelial Carcinoma", "Cutaneous Melanoma", "Cutaneous Melanoma", "Clear Cell Renal Cell Carcinoma", "Clear Cell Renal Cell Carcinoma"]}, {"cohort": "Part B Cohort Any Other", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Non-Small Cell Lung Carcinoma", "Urothelial Carcinoma", "Urothelial Carcinoma", "Cutaneous Melanoma", "Cutaneous Melanoma", "Clear Cell Renal Cell Carcinoma", "Clear Cell Renal Cell Carcinoma"]}, {"cohort": "Part B Cohort Any Other", "histology_inclusion": "Clear Cell Renal Cell Carcinoma", "histology_exclusion": ["Urothelial Carcinoma", "Cutaneous Melanoma", "Non-Small Cell Lung Carcinoma", "Clear Cell Renal Cell Carcinoma"]}]}
{"NCT_id": "NCT04980404", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "myelodysplastic syndrome (MDS)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "chronic myelomonocytic leukemia (CMML)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia"}]}
{"NCT_id": "NCT03574779", "json": [{"cohort": "Cohort A", "disease_state": "recurrent", "histology_inclusion": "high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer or carcinosarcoma of the ovary", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior therapy with a PARP inhibitor"]}, {"cohort": "Cohort C", "disease_state": "newly diagnosed Stage III or IV", "histology_inclusion": "ovarian, fallopian tube, or primary peritoneal cancer", "biomarker_inclusion": ["HRd tumor"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "Cohort A", "histology_inclusion": "Ovarian Carcinosarcoma"}, {"cohort": "Cohort C", "histology_inclusion": "Primary Peritoneal Carcinoma"}]}
{"NCT_id": "NCT04291105", "json": [{"cohort": "Head and Neck Squamous Cell Carcinoma", "disease_state": "advanced and/or metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["PD-L1 status \u2265 10% CPS"], "histology_exclusion": ["nasopharynx"], "biomarker_exclusion": []}, {"cohort": "Melanoma", "disease_state": "advanced and/or metastatic", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["uPR, SD or PD to an anti-PD-(L)1-containing regimen", "BRAF V600-positive"], "histology_exclusion": ["ocular melanoma", "mucosal melanoma", "acral melanoma"], "biomarker_exclusion": []}, {"cohort": "Colo-rectal Cancer", "disease_state": "advanced and/or metastatic", "histology_inclusion": "Colo-rectal Cancer", "biomarker_inclusion": ["non-MSI high"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Head and Neck Squamous Cell Carcinoma", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Melanoma", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["BRAF-High", "BRAF-High", "expression"]], "histology_exclusion": ["Mucosal Melanoma", "Ocular Melanoma", "Acral Lentiginous Melanoma"]}, {"cohort": "Colo-rectal Cancer", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04785196", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "liposarcoma", "biomarker_inclusion": ["TP53 wide-type", "MDM2 Amplification"], "histology_exclusion": [], "biomarker_exclusion": ["MDM2-p53 inhibitor"]}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["MDM2-p53 inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Liposarcoma", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT03770429", "json": [{"cohort": "", "disease_state": "progressive", "histology_inclusion": "myelodysplastic syndrome (MDS)", "biomarker_inclusion": [], "histology_exclusion": ["acute myeloid leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "progressive", "histology_inclusion": "chronic myelomonocytic leukemia (CMML)", "biomarker_inclusion": [], "histology_exclusion": ["acute myeloid leukemia"], "biomarker_exclusion": []}, {"cohort": "Part 2 - splicing factor mutated arm", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": ["SF3B1: E622", "SF3B1: Y623", "SF3B1: R625", "SF3B1: N626", "SF3B1: H662", "SF3B1: T663", "SF3B1: K666", "SF3B1: K700", "SF3B1: V701", "SF3B1: I704", "SF3B1: G740", "SF3B1: K741", "SF3B1: G742", "SF3B1: A774", "SF3B1: D781", "U2AF1: S34", "U2AF1: R156", "U2AF1: Q157", "SRSF2: P95", "SRSF2: Deletion including amino acid P95", "ZRSR2: Any frameshift or nonsense mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2 - splicing factor wildtype arm", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["SF3B1: E622", "SF3B1: Y623", "SF3B1: R625", "SF3B1: N626", "SF3B1: H662", "SF3B1: T663", "SF3B1: K666", "SF3B1: K700", "SF3B1: V701", "SF3B1: I704", "SF3B1: G740", "SF3B1: K741", "SF3B1: G742", "SF3B1: A774", "SF3B1: D781", "U2AF1: S34", "U2AF1: R156", "U2AF1: Q157", "SRSF2: P95", "SRSF2: Deletion including amino acid P95", "ZRSR2: Any frameshift or nonsense mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "histology_exclusion": ["Acute Myeloid Leukemia (AML)"]}, {"cohort": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "histology_exclusion": ["Acute Myeloid Leukemia (AML)"]}, {"cohort": "Part 2 - splicing factor mutated arm"}, {"cohort": "Part 2 - splicing factor wildtype arm"}]}
{"NCT_id": "NCT04589845", "json": [{"cohort": "Cohort A", "disease_state": "unresectable, locally advanced or metastatic solid tumors", "histology_inclusion": "solid malignancy", "biomarker_inclusion": ["ROS1 fusion-positive"], "histology_exclusion": ["NSCLC"], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "unresectable, locally advanced or metastatic solid tumors", "histology_inclusion": "solid malignancy", "biomarker_inclusion": ["NTRK1 fusion-positive", "NTRK2 fusion-positive", "NTRK3 fusion-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort C", "disease_state": "unresectable, locally advanced or metastatic solid tumors", "histology_inclusion": "solid malignancy", "biomarker_inclusion": ["ALK fusion-positive"], "histology_exclusion": ["NSCLC"], "biomarker_exclusion": []}, {"cohort": "Cohort D", "disease_state": "unresectable, locally advanced or metastatic solid tumors", "histology_inclusion": "solid malignancy", "biomarker_inclusion": ["TMB-high"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort E", "disease_state": "unresectable, locally advanced or metastatic solid tumors", "histology_inclusion": "solid malignancy", "biomarker_inclusion": ["AKT1 mutant-positive", "AKT2 mutant-positive", "AKT3 mutant-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort F", "disease_state": "unresectable, locally advanced or metastatic solid tumors", "histology_inclusion": "solid malignancy", "biomarker_inclusion": ["HER2 mutant-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort H", "disease_state": "unresectable, locally advanced or metastatic solid tumors", "histology_inclusion": "solid malignancy", "biomarker_inclusion": ["PIK3CA multiple mutant-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort I", "disease_state": "unresectable, locally advanced or metastatic solid tumors", "histology_inclusion": "solid malignancy", "biomarker_inclusion": ["BRAF class II mutant-positive", "BRAF fusion-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort J", "disease_state": "unresectable, locally advanced or metastatic solid tumors", "histology_inclusion": "solid malignancy", "biomarker_inclusion": ["BRAF class III mutant-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort K", "disease_state": "unresectable, locally advanced or metastatic solid tumors", "histology_inclusion": "solid malignancy", "biomarker_inclusion": ["RET fusion-positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["ROS1-High", "ROS1-High", "expression"]], "histology_exclusion": ["Non-Small Cell Lung Carcinoma"]}, {"cohort": "Cohort B", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK2-High", "NTRK2-High", "expression"], ["NTRK3-High", "NTRK3-High", "expression"], ["NTRK1-High", "NTRK1-High", "expression"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]]}, {"cohort": "Cohort C", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"], ["ALK Fusion", "ALK", "fusion"]], "histology_exclusion": ["Non-Small Cell Lung Carcinoma"]}, {"cohort": "Cohort D", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Cohort E", "biomarker_inclusion": [["AKT1 Mutation", "AKT1-Mutation", "gene"], ["AKT3 Mutation", "AKT3-Mutation", "gene"], ["AKT2 Mutation", "AKT2-Mutation", "gene"], ["AKT2-High", "AKT2-High", "expression"], ["AKT3-High", "AKT3-High", "expression"], ["AKT1-High", "AKT1-High", "expression"]]}, {"cohort": "Cohort F", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "Cohort H", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "Cohort I", "biomarker_inclusion": [["BRAF-High", "BRAF-High", "expression"], ["GCNT2-High", "GCNT2-High", "expression"], ["BRAF Fusion", "BRAF", "fusion"], ["BRAF Class 2", "BRAF Class 2", "coordinate"]]}, {"cohort": "Cohort J", "biomarker_inclusion": [["BRAF Class 3", "BRAF Class 3", "coordinate"]]}, {"cohort": "Cohort K", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"], ["RET-High", "RET-High", "expression"]]}]}
{"NCT_id": "NCT04720157", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT01066663", "json": [{"cohort": "", "disease_state": "Relapsed", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement with CLL"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed", "histology_inclusion": "Small Lymphocytic Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement with CLL"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia", "histology_exclusion": ["Chronic Lymphocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "Small Lymphocytic Lymphoma", "histology_exclusion": ["Chronic Lymphocytic Leukemia"]}]}
{"NCT_id": "NCT03379428", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "HER2-amplified breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04655157", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": ["BRAFV600E", "BRAFV600K"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}]}
{"NCT_id": "NCT05241132", "json": [{"cohort": "BMCUP treated with Tislelizumab and chemotherapy", "disease_state": "bone metastases from cancer of unknown primary", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": ["unknown primary lesion of squamous cells", "lymphoma", "malignant melanoma", "gonads germ cell tumor", "sarcoma", "neuroendocrine tumor", "male prostate cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "BMCUP treated with Tislelizumab and chemotherapy", "histology_exclusion": ["Germ Cell Tumor", "Lymphoma", "Neuroendocrine Tumor", "Prostate Neoplasm", "Neuroendocrine Carcinoma", "Melanoma", "Sarcoma", "Prostate Carcinoma"]}]}
{"NCT_id": "NCT02521051", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "non-squamous, non-small cell lung cancer", "biomarker_inclusion": ["ALK rearrangement"], "histology_exclusion": ["squamous cell histology", "mixed, predominantly squamous adenosquamous carcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK Fusion", "ALK", "fusion"]], "histology_exclusion": ["Cervical Adenosquamous Carcinoma", "Pancreatic Adenosquamous Carcinoma"]}]}
{"NCT_id": "NCT03705507", "json": [{"cohort": "Group A (18 years and above)", "disease_state": "relapsed/refractory or progressive", "histology_inclusion": "B cell precursor or T-Acute Lymphoblastic Leukaemia (ALL)", "biomarker_inclusion": ["RAS pathway activating mutations (NRAS, KRAS, FLT3, PTPN11, cCBL, NF1, BRAF, IKZF2, IKZF3, IL7R\u03b1, JAK1)"], "histology_exclusion": ["Mature B-cell leukaemia", "Philadelphia positive ALL"], "biomarker_exclusion": ["Prior exposure to MEK, RAS or RAF inhibitors"]}, {"cohort": "Group P (under 18 years)", "disease_state": "relapsed/refractory or progressive", "histology_inclusion": "B cell precursor or T-Acute Lymphoblastic Leukaemia (ALL)", "biomarker_inclusion": ["RAS pathway activating mutations (NRAS, KRAS, FLT3, PTPN11, cCBL, NF1, BRAF, IKZF2, IKZF3, IL7R\u03b1, JAK1)"], "histology_exclusion": ["Mature B-cell leukaemia", "Philadelphia positive ALL"], "biomarker_exclusion": ["Prior exposure to MEK, RAS or RAF inhibitors"]}], "json_norm": [{"cohort": "Group A (18 years and above)", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"], ["FLT3 Mutation", "FLT3-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["PTPN11 Mutation", "PTPN11-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["MAPK/ERK pathway", null, "pathway"]], "histology_exclusion": ["Acute Lymphoblastic Leukemia (ALL)"]}, {"cohort": "Group P (under 18 years)", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"], ["FLT3 Mutation", "FLT3-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["PTPN11 Mutation", "PTPN11-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["MAPK/ERK pathway", null, "pathway"]], "histology_exclusion": ["Acute Lymphoblastic Leukemia (ALL)"]}]}
{"NCT_id": "NCT04915755", "json": [{"cohort": "Cohort 1: Participants with tBRCAmut HER2- breast cancer (Independent of HR status, including HR+ and TNBC)", "disease_state": "Stage I to III", "histology_inclusion": "HER2- breast cancer", "biomarker_inclusion": ["tBRCA mutation"], "histology_exclusion": [], "biomarker_exclusion": ["Prior treatment with PARP inhibitor", "Current treatment with CDK4/6 inhibitor or endocrine therapy other than anastrozole, letrozole, exemestane, and tamoxifen with or without ovarian suppression", "Known history of MDS or AML"]}, {"cohort": "Cohort 1: Participants with tBRCAmut HER2- breast cancer (Independent of HR status, including HR+ and TNBC)", "disease_state": "Stage I to III", "histology_inclusion": "TNBC", "biomarker_inclusion": ["tBRCA mutation"], "histology_exclusion": [], "biomarker_exclusion": ["Prior treatment with PARP inhibitor", "Current treatment with CDK4/6 inhibitor or endocrine therapy other than anastrozole, letrozole, exemestane, and tamoxifen with or without ovarian suppression", "Known history of MDS or AML"]}, {"cohort": "Cohort 2: Participants with tBRCAwt TNBC", "disease_state": "Stage I to III", "histology_inclusion": "TNBC", "biomarker_inclusion": ["tBRCA wild type"], "histology_exclusion": [], "biomarker_exclusion": ["Prior treatment with PARP inhibitor", "Current treatment with CDK4/6 inhibitor or endocrine therapy other than anastrozole, letrozole, exemestane, and tamoxifen with or without ovarian suppression", "Known history of MDS or AML"]}], "json_norm": [{"cohort": "Cohort 1: Participants with tBRCAmut HER2- breast cancer (Independent of HR status, including HR+ and TNBC)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Cohort 1: Participants with tBRCAmut HER2- breast cancer (Independent of HR status, including HR+ and TNBC)", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Cohort 2: Participants with tBRCAwt TNBC", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}]}
{"NCT_id": "NCT05566574", "json": [{"cohort": "RP-3500 in Combination With Standard Radiation Therapy", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["ATM mutation (deleterious or VUS; somatic or germline; monoallelic or biallelic)"], "histology_exclusion": [], "biomarker_exclusion": ["germline homozygous ATM mutations"]}], "json_norm": [{"cohort": "RP-3500 in Combination With Standard Radiation Therapy", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"]], "biomarker_exclusion": [["ATM Mutation", "ATM-Mutation", "gene"]]}]}
{"NCT_id": "NCT03835819", "json": [{"cohort": "", "disease_state": "advanced or recurrent", "histology_inclusion": "serous endometrial cancer", "biomarker_inclusion": ["microsatellite stable (MSS)", "FR\u03b1 positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["FOLR1-High", "FOLR1-High", "expression"], ["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT03900949", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["CD33 positive", "FLT3 ITD mutation", "FLT3 TKD mutation"], "histology_exclusion": ["Acute promyelocytic leukemia"], "biomarker_exclusion": ["active CNS involvement by AML"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"], ["CD33-High", "CD33-High", "expression"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT04161391", "json": [{"cohort": "Cohort I", "disease_state": "advanced/metastatic", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": ["RET fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort II", "disease_state": "advanced/metastatic", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": ["RET fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort III", "disease_state": "advanced/metastatic", "histology_inclusion": "Medullary Thyroid Cancer", "biomarker_inclusion": ["RET mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort IV", "disease_state": "advanced/metastatic", "histology_inclusion": "Medullary Thyroid Cancer", "biomarker_inclusion": ["RET mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort V", "disease_state": "advanced/metastatic", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": ["RET fusion", "RET mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort VI", "disease_state": "advanced/metastatic", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": ["RET fusion", "RET mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort I", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"]]}, {"cohort": "Cohort II", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"]]}, {"cohort": "Cohort III", "histology_inclusion": "Thyroid Gland Medullary Carcinoma", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "Cohort IV", "histology_inclusion": "Thyroid Gland Medullary Carcinoma", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "Cohort V", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"], ["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "Cohort VI", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"], ["RET Mutation", "RET-Mutation", "gene"]]}]}
{"NCT_id": "NCT04394858", "json": [{"cohort": "", "disease_state": "Advanced (metastatic or unresectable primary)", "histology_inclusion": "Pheochromocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Advanced (metastatic or unresectable primary)", "histology_inclusion": "Paraganglioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}, {"cohort": "", "histology_inclusion": "Paraganglioma"}]}
{"NCT_id": "NCT04590248", "json": [{"cohort": "", "disease_state": "recurrent or persistent", "histology_inclusion": "Uterine Serous Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["carcinosarcomas"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Endometrial Serous Adenocarcinoma"}]}
{"NCT_id": "NCT02390752", "json": [{"cohort": "", "disease_state": "refractory", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory", "histology_inclusion": "acute leukemia", "biomarker_inclusion": ["AML", "ALL"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed", "histology_inclusion": "acute leukemia", "biomarker_inclusion": ["AML", "ALL"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory", "histology_inclusion": "Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed", "histology_inclusion": "Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory", "histology_inclusion": "malignant peripheral nerve sheath tumor (MPNST)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed", "histology_inclusion": "malignant peripheral nerve sheath tumor (MPNST)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Acute Leukemia"}, {"cohort": "", "histology_inclusion": "Acute Leukemia"}, {"cohort": ""}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Malignant Peripheral Nerve Sheath Tumor"}, {"cohort": "", "histology_inclusion": "Malignant Peripheral Nerve Sheath Tumor"}]}
{"NCT_id": "NCT03054038", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04096417", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["FGFR1 gain of function mutations", "FGFR1 translocations", "FGFR1 amplifications", "FGFR2 gain of function mutations", "FGFR2 translocations", "FGFR2 amplifications", "FGFR3 gain of function mutations", "FGFR3 translocations", "FGFR3 amplifications"], "histology_exclusion": ["brain metastases", "central nervous system metastases", "leptomeningeal disease", "spinal cord compression"], "biomarker_exclusion": ["prior treatment with pemigatinib", "prior treatment with a selective FGFR inhibitor <= 180 days"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR1 Fusion", "FGFR1", "fusion"], ["FGFR2-High", "FGFR2-High", "expression"], ["FGFR3-High", "FGFR3-High", "expression"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR1-High", "FGFR1-High", "expression"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"], ["FGFR3 Fusion", "FGFR3", "fusion"]]}]}
{"NCT_id": "NCT05631795", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["HR-positive", "HER2-negative", "PIK3CA mutant"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT05631886", "json": [{"cohort": "", "disease_state": "Local advanced/metastatic solid tumors or relapsed/refractory lymphomas", "histology_inclusion": "", "biomarker_inclusion": ["EphA2 positive (\u226520%)", "TP53 R273H"], "histology_exclusion": [], "biomarker_exclusion": ["TP53 R273H germline mutation"]}, {"cohort": "", "disease_state": "Local advanced/metastatic solid tumors or relapsed/refractory lymphomas", "histology_inclusion": "", "biomarker_inclusion": ["EphA2 positive (\u226520%)", "TP53 R175H"], "histology_exclusion": [], "biomarker_exclusion": ["TP53 R175H germline mutation"]}, {"cohort": "", "disease_state": "Local advanced/metastatic solid tumors or relapsed/refractory lymphomas", "histology_inclusion": "", "biomarker_inclusion": ["EphA2 positive (\u226520%)", "TP53 R248Q"], "histology_exclusion": [], "biomarker_exclusion": ["TP53 R248Q germline mutation"]}, {"cohort": "", "disease_state": "Local advanced/metastatic solid tumors or relapsed/refractory lymphomas", "histology_inclusion": "", "biomarker_inclusion": ["EphA2 positive (\u226520%)", "TP53 R249S"], "histology_exclusion": [], "biomarker_exclusion": ["TP53 R249S germline mutation"]}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["EPHA2-High", "EPHA2-High", "expression"], ["TP53 R273H", "R273H", "coordinate"]], "biomarker_exclusion": [["TP53 R273H", "R273H", "coordinate"]]}, {"cohort": "", "biomarker_inclusion": [["TP53 R175H", "R175H", "coordinate"], ["EPHA2-High", "EPHA2-High", "expression"]], "biomarker_exclusion": [["TP53 R175H", "R175H", "coordinate"]]}, {"cohort": "", "biomarker_inclusion": [["EPHA2-High", "EPHA2-High", "expression"], ["TP53 R248Q", "R248Q", "coordinate"]], "biomarker_exclusion": [["TP53 R248Q", "R248Q", "coordinate"]]}, {"cohort": "", "biomarker_inclusion": [["EPHA2-High", "EPHA2-High", "expression"], ["TP53 R249S", "R249S", "coordinate"]], "biomarker_exclusion": [["TP53 R249S", "R249S", "coordinate"]]}]}
{"NCT_id": "NCT05631899", "json": [{"cohort": "", "disease_state": "local advanced/metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["EphA2 positive (\u226520%)", "KRAS G12V"], "histology_exclusion": [], "biomarker_exclusion": ["KRAS G12V germline mutation"]}, {"cohort": "", "disease_state": "local advanced/metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["EphA2 positive (\u226520%)", "KRAS G12D"], "histology_exclusion": [], "biomarker_exclusion": ["KRAS G12D germline mutation"]}, {"cohort": "", "disease_state": "local advanced/metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["EphA2 positive (\u226520%)", "KRAS G12C"], "histology_exclusion": ["central nervous system disease"], "biomarker_exclusion": ["KRAS G12C germline mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["EPHA2-High", "EPHA2-High", "expression"], ["KRAS G12V", "G12V", "coordinate"]], "biomarker_exclusion": [["KRAS G12V", "G12V", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["EPHA2-High", "EPHA2-High", "expression"], ["KRAS G12D", "G12D", "coordinate"]], "biomarker_exclusion": [["KRAS G12D", "G12D", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["EPHA2-High", "EPHA2-High", "expression"], ["KRAS G12C", "G12C", "coordinate"]], "biomarker_exclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT02521493", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "myelodysplastic syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "history of transient myeloproliferative disorder", "histology_inclusion": "myeloproliferative neoplasm", "biomarker_inclusion": [], "histology_exclusion": ["promyelocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Myeloproliferative Neoplasm", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "histology_inclusion": "Myelodysplastic/Myeloproliferative Disease", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT04851119", "json": [{"cohort": "Part A", "disease_state": "recurrent or refractory", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "recurrent or refractory", "histology_inclusion": "non-Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "recurrent or refractory", "histology_inclusion": "desmoid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "recurrent or refractory", "histology_inclusion": "Ewing sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "recurrent or refractory", "histology_inclusion": "desmoid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "recurrent or refractory", "histology_inclusion": "osteosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "recurrent or refractory", "histology_inclusion": "liver tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "recurrent or refractory", "histology_inclusion": "Wilms tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "recurrent or refractory", "histology_inclusion": "tumors with Wnt pathway aberrations", "biomarker_inclusion": ["CTNNB1 mutations (S37F, S45F, T41A, S45P, S33C, S37C, D32Y, S33F, T41I, G34R, G34V, D32N, S33P, G34E, D32G)", "loss of function mutations in APC, Axin2FBXW7, TCF7L2, RNF43", "gain-of-function mutations in GSK3B, LRP6, LGR5"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part A", "histology_inclusion": "Non-Hodgkin Lymphoma"}, {"cohort": "Part A", "histology_inclusion": "Deep Fibromatosis/Desmoid Tumor"}, {"cohort": "Part B", "histology_inclusion": "Ewing Sarcoma"}, {"cohort": "Part B", "histology_inclusion": "Deep Fibromatosis/Desmoid Tumor"}, {"cohort": "Part B", "histology_inclusion": "Osteosarcoma"}, {"cohort": "Part B", "histology_inclusion": "Liver Cancer"}, {"cohort": "Part B", "histology_inclusion": "Wilms Tumor"}, {"cohort": "Part B", "biomarker_inclusion": [["WNT Pathway", null, "pathway"], ["FZD1 Mutation", "FZD1-Mutation", "gene"], ["CTNNB1 D32Y", "D32Y", "coordinate"], ["CTNNB1 S33C", "S33C", "coordinate"], ["CTNNB1 D32N", "D32N", "coordinate"], ["CTNNB1 S37C", "S37C", "coordinate"], ["CTNNB1 S37F", "S37F", "coordinate"], ["CTNNB1 G34R", "G34R", "coordinate"], ["CTNNB1 D32G", "D32G", "coordinate"], ["CTNNB1 T41A", "T41A", "coordinate"], ["CTNNB1 S33P", "S33P", "coordinate"], ["CTNNB1 G34E", "G34E", "coordinate"], ["CTNNB1 G34V", "G34V", "coordinate"], ["CTNNB1 T41I", "T41I", "coordinate"], ["CTNNB1 S45P", "S45P", "coordinate"], ["CTNNB1 S33F", "S33F", "coordinate"], ["CTNNB1 Mutation", "CTNNB1-Mutation", "gene"], ["CTNNB1 S45F", "S45F", "coordinate"], ["RNF43 Mutation", "RNF43-Mutation", "gene"], ["APC Mutation", "APC-Mutation", "gene"], ["TCF7L2 Mutation", "TCF7L2-Mutation", "gene"], ["LRP6 Mutation", "LRP6-Mutation", "gene"], ["LGR5 Mutation", "LGR5-Mutation", "gene"], ["GSK3B Mutation", "GSK3B-Mutation", "gene"]]}, {"cohort": "Part B", "biomarker_inclusion": [["CTNNB1 S33C", "S33C", "coordinate"], ["CTNNB1 D32G", "D32G", "coordinate"], ["APC Mutation", "APC-Mutation", "gene"], ["CTNNB1 S45P", "S45P", "coordinate"], ["FZD1 Mutation", "FZD1-Mutation", "gene"], ["GSK3B Mutation", "GSK3B-Mutation", "gene"], ["CTNNB1 D32Y", "D32Y", "coordinate"], ["CTNNB1 D32N", "D32N", "coordinate"], ["LRP6 Mutation", "LRP6-Mutation", "gene"], ["WNT Pathway", null, "pathway"], ["CTNNB1 S33F", "S33F", "coordinate"], ["CTNNB1 S37F", "S37F", "coordinate"], ["CTNNB1 G34R", "G34R", "coordinate"], ["CTNNB1 T41I", "T41I", "coordinate"], ["CTNNB1 Mutation", "CTNNB1-Mutation", "gene"], ["LGR5 Mutation", "LGR5-Mutation", "gene"], ["CTNNB1 S45F", "S45F", "coordinate"], ["CTNNB1 S37C", "S37C", "coordinate"], ["CTNNB1 T41A", "T41A", "coordinate"], ["CTNNB1 S33P", "S33P", "coordinate"], ["CTNNB1 G34E", "G34E", "coordinate"], ["CTNNB1 G34V", "G34V", "coordinate"], ["TCF7L2 Mutation", "TCF7L2-Mutation", "gene"], ["RNF43 Mutation", "RNF43-Mutation", "gene"]]}]}
{"NCT_id": "NCT05176470", "json": [{"cohort": "", "disease_state": "Stage IIIB-D locally advanced or Stage IV melanoma", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": ["ocular/uveal melanoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "histology_exclusion": ["Intraocular Melanoma"]}]}
{"NCT_id": "NCT05501886", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "HR+/HER2- breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PIK3CA mutation"]}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "HR+/HER2- breast cancer", "biomarker_inclusion": ["PIK3CA mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]], "biomarker_exclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]], "biomarker_exclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT03184571", "json": [{"cohort": "Cohort A", "disease_state": "Stage IV", "histology_inclusion": "adenocarcinoma non-small cell lung cancer (NSCLC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "Stage IV", "histology_inclusion": "adenocarcinoma non-small cell lung cancer (NSCLC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort C", "disease_state": "Stage IV", "histology_inclusion": "adenocarcinoma non-small cell lung cancer (NSCLC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort A", "histology_inclusion": "Lung Adenocarcinoma"}, {"cohort": "Cohort B", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort B", "histology_inclusion": "Lung Adenocarcinoma"}, {"cohort": "Cohort C", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort C", "histology_inclusion": "Lung Adenocarcinoma"}]}
{"NCT_id": "NCT03836209", "json": [{"cohort": "", "disease_state": "previously untreated", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["FLT3 mutated"], "histology_exclusion": ["M3 AML", "Core Binding Factor -t(8;21)", "inv(16)", "t(16;16)", "active Central Nervous System leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Central Nervous System Leukemia", "Acute Myeloid Leukemia (AML)"]}]}
{"NCT_id": "NCT04031677", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Leiomyosarcoma (LMS)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Liposarcoma (LPS)", "biomarker_inclusion": ["MDM2 expression", "CDK4 expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "DDLPS grade 2", "biomarker_inclusion": ["FNCLCC score=5", "CINSARC-high"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Leiomyosarcoma"}, {"cohort": "", "histology_inclusion": "Liposarcoma"}, {"cohort": "", "histology_inclusion": "Dedifferentiated Liposarcoma"}]}
{"NCT_id": "NCT04226950", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Essential Thrombocythemia", "biomarker_inclusion": ["JAK2 V617F", "CALR", "MPL gene mutation"], "histology_exclusion": ["Primary Myelofibrosis", "Polycythemia Vera", "Secondary Thrombocytosis", "Familial Thrombocytosis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Essential Thrombocythemia", "biomarker_inclusion": [["JAK2 V617F", "V617F", "coordinate"], ["MPL Mutation", "MPL-Mutation", "gene"]], "histology_exclusion": ["Polycythemia Vera", "Primary Myelofibrosis"]}]}
{"NCT_id": "NCT04292119", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer (Stage IV, AJCC v7.0)", "biomarker_inclusion": ["ALK rearrangement", "ROS1 rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT04395222", "json": [{"cohort": "", "disease_state": "relapsed or refractory acute leukemia", "histology_inclusion": "acute leukemia (myeloid or lymphoid)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "acute leukemia in first remission at high-risk for recurrence", "histology_inclusion": "acute leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "chronic, accelerated phase or blast-crisis", "histology_inclusion": "chronic myelogenous leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "myelodysplastic syndromes", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "chronic myeloproliferative disease", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent, refractory or high-risk", "histology_inclusion": "malignant lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or with poor prognostic features", "histology_inclusion": "chronic lymphocytic leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "other hematological disorder in need of allogeneic transplant (e.g. blastoid dendritic cell neoplasm)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["uncontrolled HIV disease"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Leukemia"}, {"cohort": "", "histology_inclusion": "Acute Leukemia"}, {"cohort": "", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Myeloproliferative Neoplasm"}, {"cohort": "", "histology_inclusion": "Lymphoma"}, {"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "", "histology_inclusion": "Hematologic and Lymphocytic Disorder"}]}
{"NCT_id": "NCT04590664", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "glioblastoma", "biomarker_inclusion": ["EGFR mutant", "EGFR amplified"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR-High", "EGFR-High", "expression"]]}]}
{"NCT_id": "NCT04981509", "json": [{"cohort": "Cohort 1", "disease_state": "Advanced", "histology_inclusion": "Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Associated Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Advanced", "histology_inclusion": "Sporadic Papillary Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Hereditary Leiomyomatosis and Renal Cell Cancer"}, {"cohort": "Cohort 1", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Papillary Renal Cell Carcinoma"}]}
{"NCT_id": "NCT05111561", "json": [{"cohort": "", "disease_state": "advanced/metastatic or unresectable solid tumor that is refractory to standard therapy or has relapsed after standard therapy", "histology_inclusion": "Triple negative breast cancer (TNBC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["estrogen receptor <= 1%", "progesterone receptor <= 1%", "human epidermal growth factor receptor 2 0-1+ or non-amplified"]}, {"cohort": "", "disease_state": "advanced/metastatic or unresectable solid tumor that is refractory to standard therapy or has relapsed after standard therapy", "histology_inclusion": "Solid tumor with genomic alteration(s) activating RAS signaling", "biomarker_inclusion": ["activating KRAS", "activating NRAS", "activating HRAS", "activating BRAF", "inactivating NF1", "BRAF fusions"], "histology_exclusion": [], "biomarker_exclusion": ["PI3K pathway activating genomic alterations", "inactivating mutations/deletions in PTEN", "PIK3R1", "amplifications in PIK3CA", "activating mutations in PIK3CA", "Akt", "mTOR"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["BRAF Fusion", "BRAF", "fusion"]], "biomarker_exclusion": [["PI3K/AKT/mTOR pathway", null, "pathway"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["PIK3CA-High", "PIK3CA-High", "expression"], ["PIK3CA-High", "PIK3CA-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["BRAF Fusion", "BRAF", "fusion"]], "biomarker_exclusion": [["PI3K/AKT/mTOR pathway", null, "pathway"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["PIK3CA-High", "PIK3CA-High", "expression"], ["PIK3CA-High", "PIK3CA-High", "expression"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["BRAF Fusion", "BRAF", "fusion"]], "biomarker_exclusion": [["PIK3CA-High", "PIK3CA-High", "expression"], ["PI3K/AKT/mTOR pathway", null, "pathway"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}]}
{"NCT_id": "NCT05111626", "json": [{"cohort": "Part 1 and Part 2", "disease_state": "unresectable, locally advanced or metastatic", "histology_inclusion": "gastric or gastroesophageal junction adenocarcinoma", "biomarker_inclusion": ["FGFR2b overexpression"], "histology_exclusion": [], "biomarker_exclusion": ["HER2 positive"]}], "json_norm": [{"cohort": "Part 1 and Part 2", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT05176665", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "gastric cancer", "biomarker_inclusion": ["cMET amplification", "cMET overexpression", "EGFR overexpression", "EGFR or cMET gene alteration in ctDNA"], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "hepatocellular cancer", "biomarker_inclusion": ["cMET amplification", "cMET overexpression", "EGFR overexpression", "EGFR or cMET gene alteration in ctDNA"], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": ["cMET amplification", "cMET overexpression", "EGFR overexpression", "EGFR or cMET gene alteration in ctDNA"], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["cMET amplification", "cMET overexpression", "EGFR overexpression", "EGFR or cMET gene alteration in ctDNA"], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR-High", "EGFR-High", "expression"]]}]}
{"NCT_id": "NCT03314974", "json": [{"cohort": "", "disease_state": "Acute Myeloid Leukemia (AML) and related precursor neoplasms: 2nd or greater complete remission (CR); first complete remission (CR1) in patients > 60 years old; CR1 in \u2264 60 years old that is NOT considered as favorable-risk.", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Acute lymphoblastic leukemia (ALL)/lymphoma: second or greater CR; CR1 unable to tolerate consolidation chemotherapy due to chemotherapy-related toxicities; CR1 high-risk ALL.", "histology_inclusion": "Acute Lymphoblastic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Chronic Myelogenous Leukemia excluding refractory blast crisis: To be eligible in first chronic phase (CP1) patient must have failed or be intolerant to one or more tyrosine kinase inhibitors.", "histology_inclusion": "Chronic Myelogenous Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Plasma Cell Leukemia after initial therapy, in patients who have achieved at least a partial remission", "histology_inclusion": "Plasma Cell Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Myeloproliferative Neoplasms/Myelofibrosis, either primary as a result of polycythemia vera or essential thrombocythemia, with disease risk of intermediate or high-risk according to DIPSS criteria. Blasts must be <10% by bone marrow aspirate morphology.", "histology_inclusion": "Myeloproliferative Neoplasms", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Myelodysplasia (MDS) IPSS INT-2 or High Risk (i.e. RAEB, RAEBt) or Refractory Anemia with severe pancytopenia, transfusion dependence, or high risk cytogenetics or molecular features. Blasts must be < 10% by a representative bone marrow aspirate morphology.", "histology_inclusion": "Myelodysplasia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Marginal Zone B-Cell Lymphoma or Follicular Lymphoma are eligible if there was disease progression/relapse within 12 of achieving a partial or complete remission. Patients who had remissions lasting > 12 months, are eligible after at least two prior therapies. Patients with bulky disease (nodal mass greater than 5 cm) should be considered for debulking chemotherapy before transplant.", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Lymphoplasmacytic Lymphoma, Mantle-Cell Lymphoma, Prolymphocytic Leukemia are eligible after initial therapy in CR1+ or PR1+.", "histology_inclusion": "Lymphoplasmacytic Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Diffuse large Cell NHL > CR/> PR: Patients in CR/PR with initial short remission (<6 months) are eligible, or those who have failed/or are not eligible for autologous transplant.", "histology_inclusion": "Diffuse Large Cell Non Hodgkins Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Lymphoblastic Lymphoma, Burkitt's Lymphoma, and other high-grade NHL after initial therapy if stage III/IV in CR1/PR1 or after progression if stage I/II < 1 year.", "histology_inclusion": "Lymphoblastic Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive"}, {"cohort": "", "histology_inclusion": "Plasma Cell Leukemia"}, {"cohort": "", "histology_inclusion": "Myeloproliferative Neoplasm"}, {"cohort": "", "histology_inclusion": "Myelodysplastic/Myeloproliferative Disease"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Lymphoplasmacytic Lymphoma"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Lymphoblastic Lymphoma"}]}
{"NCT_id": "NCT03836352", "json": [{"cohort": "All cohorts", "disease_state": "advanced or metastatic", "histology_inclusion": "Epithelial ovarian, fallopian tube, or peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["Known EGFR mutations or ALK rearrangements"]}, {"cohort": "All cohorts", "disease_state": "advanced or metastatic", "histology_inclusion": "Hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["Known EGFR mutations or ALK rearrangements"]}, {"cohort": "All cohorts", "disease_state": "advanced or metastatic", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["Known EGFR mutations or ALK rearrangements"]}, {"cohort": "All cohorts", "disease_state": "advanced or metastatic", "histology_inclusion": "Urothelial cancer", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["Known EGFR mutations or ALK rearrangements"]}, {"cohort": "All cohorts", "disease_state": "advanced or metastatic", "histology_inclusion": "Microsatellite instability high solid tumours", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["Known EGFR mutations or ALK rearrangements"]}], "json_norm": [{"cohort": "All cohorts", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "All cohorts", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "All cohorts", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "All cohorts", "histology_inclusion": "Urothelial Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "All cohorts", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "biomarker_exclusion": [["ALK Mutation", "ALK-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "All cohorts", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT05241834", "json": [{"cohort": "", "disease_state": "locally advanced, unresectable and/or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["RET fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced, unresectable and/or metastatic", "histology_inclusion": "Medullary Thyroid Cancer", "biomarker_inclusion": ["RET mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced, unresectable and/or metastatic", "histology_inclusion": "MEN2-associated cancers", "biomarker_inclusion": ["RET mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"]]}, {"cohort": "", "histology_inclusion": "Thyroid Gland Medullary Carcinoma", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}]}
{"NCT_id": "NCT05241873", "json": [{"cohort": "All participants", "disease_state": "metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": ["ROS", "BRAF V600E", "ALK", "RET", "HER2", "MET", "KRAS", "NTRK1/2/3", "EGFR C797X", "EGFR T790M"]}, {"cohort": "Phase II - Cohort 2F", "disease_state": "metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR atypical mutations (e.g., G719X, L861Q)"], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": ["ROS", "BRAF V600E", "ALK", "RET", "HER2", "MET", "KRAS", "NTRK1/2/3", "EGFR C797X", "EGFR T790M"]}, {"cohort": "Phase II - Cohort 2G", "disease_state": "metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR atypical mutations (e.g., G719X, L861Q)"], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": ["ROS", "BRAF V600E", "ALK", "RET", "HER2", "MET", "KRAS", "NTRK1/2/3", "EGFR C797X", "EGFR T790M"]}], "json_norm": [{"cohort": "All participants", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"], "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"], ["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "Phase II - Cohort 2F", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR L861Q", "L861Q", "coordinate"]], "histology_exclusion": ["Primary Brain Neoplasm"], "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"], ["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "Phase II - Cohort 2G", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR L861Q", "L861Q", "coordinate"]], "histology_exclusion": ["Primary Brain Neoplasm"], "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"], ["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT03706287", "json": [{"cohort": "", "disease_state": "stage IV", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation (19 exon deletion)", "EGFR mutation (L858R)"], "histology_exclusion": ["Small Cell Lung Cancer mixed", "squamous mixed"], "biomarker_exclusion": ["T790M mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR Mutation", "EGFR-Mutation", "gene"]], "histology_exclusion": ["Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT03901573", "json": [{"cohort": "Checkpoint Inhibitor-Naive cSCC, MCC Pts", "disease_state": "naive", "histology_inclusion": "cutaneous Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "Checkpoint Inhibitor-Naive cSCC, MCC Pts", "disease_state": "naive", "histology_inclusion": "Merkel Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "Checkpoint Inhibitor-Relapsed/Refractory cSCC MCC Melanoma Pts", "disease_state": "relapsed/refractory", "histology_inclusion": "cutaneous Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "Checkpoint Inhibitor-Relapsed/Refractory cSCC MCC Melanoma Pts", "disease_state": "relapsed/refractory", "histology_inclusion": "Merkel Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "Checkpoint Inhibitor-Relapsed/Refractory cSCC MCC Melanoma Pts", "disease_state": "relapsed/refractory", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Checkpoint Inhibitor-Naive cSCC, MCC Pts", "histology_inclusion": "Skin Squamous Cell Carcinoma"}, {"cohort": "Checkpoint Inhibitor-Naive cSCC, MCC Pts", "histology_inclusion": "Merkel Cell Carcinoma"}, {"cohort": "Checkpoint Inhibitor-Relapsed/Refractory cSCC MCC Melanoma Pts", "histology_inclusion": "Skin Squamous Cell Carcinoma"}, {"cohort": "Checkpoint Inhibitor-Relapsed/Refractory cSCC MCC Melanoma Pts", "histology_inclusion": "Merkel Cell Carcinoma"}, {"cohort": "Checkpoint Inhibitor-Relapsed/Refractory cSCC MCC Melanoma Pts", "histology_inclusion": "Melanoma"}]}
{"NCT_id": "NCT05372120", "json": [{"cohort": "head and neck cancer cohort", "disease_state": "advanced", "histology_inclusion": "head and neck cancer", "biomarker_inclusion": ["FGF gene alteration", "FGFR gene alteration"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with selective FGFR inhibitors", "prior treatment with FGFR antibodies"]}, {"cohort": "other solid tumor cohorts", "disease_state": "advanced", "histology_inclusion": "other solid tumor", "biomarker_inclusion": ["FGF gene alteration", "FGFR gene alteration"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with selective FGFR inhibitors", "prior treatment with FGFR antibodies"]}], "json_norm": [{"cohort": "head and neck cancer cohort", "histology_inclusion": "Malignant Head and Neck Neoplasm", "biomarker_inclusion": [["FGF11 Mutation", "FGF11-Mutation", "gene"], ["FGF21 Mutation", "FGF21-Mutation", "gene"], ["FGF8 Mutation", "FGF8-Mutation", "gene"], ["FGF13 Mutation", "FGF13-Mutation", "gene"], ["FGF12 Mutation", "FGF12-Mutation", "gene"], ["FGF7 Mutation", "FGF7-Mutation", "gene"], ["FGF3 Mutation", "FGF3-Mutation", "gene"], ["FGF16 Mutation", "FGF16-Mutation", "gene"], ["FGF2 Mutation", "FGF2-Mutation", "gene"], ["FGF22 Mutation", "FGF22-Mutation", "gene"], ["FGF10 Mutation", "FGF10-Mutation", "gene"], ["FGF1 Mutation", "FGF1-Mutation", "gene"], ["FGF4 Mutation", "FGF4-Mutation", "gene"], ["FGF6 Mutation", "FGF6-Mutation", "gene"], ["FGF19 Mutation", "FGF19-Mutation", "gene"], ["FGF20 Mutation", "FGF20-Mutation", "gene"], ["FGF18 Mutation", "FGF18-Mutation", "gene"], ["FGF14 Mutation", "FGF14-Mutation", "gene"], ["FGF23 Mutation", "FGF23-Mutation", "gene"], ["FGF17 Mutation", "FGF17-Mutation", "gene"], ["FGF9 Mutation", "FGF9-Mutation", "gene"], ["FGF5 Mutation", "FGF5-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}, {"cohort": "head and neck cancer cohort", "histology_inclusion": "Head and Neck Carcinoma", "biomarker_inclusion": [["FGF21 Mutation", "FGF21-Mutation", "gene"], ["FGF11 Mutation", "FGF11-Mutation", "gene"], ["FGF8 Mutation", "FGF8-Mutation", "gene"], ["FGF13 Mutation", "FGF13-Mutation", "gene"], ["FGF16 Mutation", "FGF16-Mutation", "gene"], ["FGF7 Mutation", "FGF7-Mutation", "gene"], ["FGF12 Mutation", "FGF12-Mutation", "gene"], ["FGF3 Mutation", "FGF3-Mutation", "gene"], ["FGF2 Mutation", "FGF2-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"], ["FGF22 Mutation", "FGF22-Mutation", "gene"], ["FGF10 Mutation", "FGF10-Mutation", "gene"], ["FGF1 Mutation", "FGF1-Mutation", "gene"], ["FGF4 Mutation", "FGF4-Mutation", "gene"], ["FGF6 Mutation", "FGF6-Mutation", "gene"], ["FGF19 Mutation", "FGF19-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGF20 Mutation", "FGF20-Mutation", "gene"], ["FGF18 Mutation", "FGF18-Mutation", "gene"], ["FGF14 Mutation", "FGF14-Mutation", "gene"], ["FGF23 Mutation", "FGF23-Mutation", "gene"], ["FGF17 Mutation", "FGF17-Mutation", "gene"], ["FGF9 Mutation", "FGF9-Mutation", "gene"], ["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGF5 Mutation", "FGF5-Mutation", "gene"]]}, {"cohort": "other solid tumor cohorts", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGF21 Mutation", "FGF21-Mutation", "gene"], ["FGF11 Mutation", "FGF11-Mutation", "gene"], ["FGF8 Mutation", "FGF8-Mutation", "gene"], ["FGF13 Mutation", "FGF13-Mutation", "gene"], ["FGF16 Mutation", "FGF16-Mutation", "gene"], ["FGF7 Mutation", "FGF7-Mutation", "gene"], ["FGF12 Mutation", "FGF12-Mutation", "gene"], ["FGF3 Mutation", "FGF3-Mutation", "gene"], ["FGF2 Mutation", "FGF2-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"], ["FGF22 Mutation", "FGF22-Mutation", "gene"], ["FGF10 Mutation", "FGF10-Mutation", "gene"], ["FGF1 Mutation", "FGF1-Mutation", "gene"], ["FGF4 Mutation", "FGF4-Mutation", "gene"], ["FGF6 Mutation", "FGF6-Mutation", "gene"], ["FGF19 Mutation", "FGF19-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGF20 Mutation", "FGF20-Mutation", "gene"], ["FGF18 Mutation", "FGF18-Mutation", "gene"], ["FGF14 Mutation", "FGF14-Mutation", "gene"], ["FGF23 Mutation", "FGF23-Mutation", "gene"], ["FGF17 Mutation", "FGF17-Mutation", "gene"], ["FGF9 Mutation", "FGF9-Mutation", "gene"], ["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGF5 Mutation", "FGF5-Mutation", "gene"]]}]}
{"NCT_id": "NCT05502237", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "NSCLC", "biomarker_inclusion": [], "histology_exclusion": ["mixed small-cell lung cancer (SCLC) and NSCLC"], "biomarker_exclusion": ["EGFR mutation", "ALK mutation", "ROS1 mutation", "NTRK mutation", "BRAF mutation", "RET mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma", "Non-Small Cell Lung Carcinoma"], "biomarker_exclusion": [["RET Mutation", "RET-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["NTRK3 Mutation", "NTRK3-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"], ["NTRK2 Mutation", "NTRK2-Mutation", "gene"], ["NTRK1 Mutation", "NTRK1-Mutation", "gene"], ["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"]]}]}
{"NCT_id": "NCT05502315", "json": [{"cohort": "Experimental Group", "disease_state": "metastatic castration-resistant prostate cancer", "histology_inclusion": "prostate adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["small cell or neuroendocrine component or histology"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Experimental Group", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT02924402", "json": [{"cohort": "Non-CLL B cell malignancy", "disease_state": "relapsed or refractory", "histology_inclusion": "B-cell Non-Hodgkins Lymphoma", "biomarker_inclusion": ["CD20-expressing"], "histology_exclusion": ["Multiple myeloma", "plasma cell leukemia", "B cell acute lymphoblastic leukemia", "primary central nervous system lymphoma"], "biomarker_exclusion": []}, {"cohort": "CLL/SLL", "disease_state": "relapsed or refractory", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": ["CD20-expressing"], "histology_exclusion": ["Multiple myeloma", "plasma cell leukemia", "B cell acute lymphoblastic leukemia", "primary central nervous system lymphoma"], "biomarker_exclusion": []}, {"cohort": "DLBCL Cohort (Expansion Phase)", "disease_state": "relapsed or refractory", "histology_inclusion": "Diffuse Large B-cell Lymphoma", "biomarker_inclusion": ["CD20-expressing"], "histology_exclusion": ["Multiple myeloma", "plasma cell leukemia", "B cell acute lymphoblastic leukemia", "primary central nervous system lymphoma"], "biomarker_exclusion": []}, {"cohort": "Follicular Lymphoma Cohort (Expansion Phase)", "disease_state": "relapsed or refractory", "histology_inclusion": "Follicular Lymphoma Grades 1-3a", "biomarker_inclusion": ["CD20-expressing"], "histology_exclusion": ["Multiple myeloma", "plasma cell leukemia", "B cell acute lymphoblastic leukemia", "primary central nervous system lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Non-CLL B cell malignancy", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Plasma Cell Myeloma", "Central Nervous System Lymphoma", "B Acute Lymphoblastic Leukemia", "Primary Central Nervous System Lymphoma", "Plasma Cell Leukemia"]}, {"cohort": "CLL/SLL", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Plasma Cell Myeloma", "Central Nervous System Lymphoma", "B Acute Lymphoblastic Leukemia", "Primary Central Nervous System Lymphoma", "Plasma Cell Leukemia"]}, {"cohort": "DLBCL Cohort (Expansion Phase)", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Plasma Cell Myeloma", "Central Nervous System Lymphoma", "B Acute Lymphoblastic Leukemia", "Primary Central Nervous System Lymphoma", "Plasma Cell Leukemia"]}, {"cohort": "Follicular Lymphoma Cohort (Expansion Phase)", "histology_inclusion": "Follicular Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Plasma Cell Myeloma", "Central Nervous System Lymphoma", "B Acute Lymphoblastic Leukemia", "Primary Central Nervous System Lymphoma", "Plasma Cell Leukemia"]}]}
{"NCT_id": "NCT03641313", "json": [{"cohort": "", "disease_state": "progressive metastatic or unresectable", "histology_inclusion": "gastric or gastroesophageal junction adenocarcinoma", "biomarker_inclusion": ["TP53 mutation (exon 2 or exons 4-11)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT04460807", "json": [{"cohort": "", "disease_state": "stage IIB to IV", "histology_inclusion": "high grade serous epithelial ovarian cancer", "biomarker_inclusion": ["Progesterone receptor positive (\u2265 10%)", "Estrogen receptor positive (\u2265 10%)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "stage IIB to IV", "histology_inclusion": "high grade endometrial epithelial ovarian cancer", "biomarker_inclusion": ["Progesterone receptor positive (\u2265 10%)", "Estrogen receptor positive (\u2265 10%)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["PGR-High", "PGR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["PGR-High", "PGR-High", "expression"]]}]}
{"NCT_id": "NCT04851613", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "HR+/HER2- breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT01738139", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "gastrointestinal stromal tumor (GIST)", "biomarker_inclusion": ["c-KIT mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "melanoma", "biomarker_inclusion": ["c-KIT mutations"], "histology_exclusion": [], "biomarker_exclusion": ["exon 13 V654X", "exon 14 T6701", "exon 17 D816X", "exon 18 mutations"]}, {"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "uncategorized tumors", "biomarker_inclusion": ["c-KIT mutations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["KIT Mutation", "KIT-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["KIT Mutation", "KIT-Mutation", "gene"]]}, {"cohort": "", "biomarker_inclusion": [["KIT Mutation", "KIT-Mutation", "gene"]]}]}
{"NCT_id": "NCT02783300", "json": [{"cohort": "Part 2: Disease-Specific Expansion cohort", "disease_state": "advanced or recurrent", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Part 2: Disease-Specific Expansion cohort", "disease_state": "advanced or recurrent", "histology_inclusion": "non-Hodgkin's lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 2: Disease-Specific Expansion cohort", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part 2: Disease-Specific Expansion cohort", "histology_inclusion": "Non-Hodgkin Lymphoma"}]}
{"NCT_id": "NCT04786600", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H", "dMMR", "BRAF (V600E) mutated"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT05177133", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "HER2 negative adenocarcinoma of the stomach or gastroesophageal junction (Siewert II and III)", "biomarker_inclusion": ["dMMR"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "adenocarcinoma of the stomach or oesophagus", "biomarker_inclusion": ["dMMR"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT03250338", "json": [{"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": ["FLT3-ITD", "FLT3-D835"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}]}
{"NCT_id": "NCT04097444", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colon or rectal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["appendix cancer", "anal canal cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases", "spinal cord compression", "primary brain tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Rectal Adenocarcinoma", "histology_exclusion": ["Appendix Carcinoma"]}, {"cohort": "", "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT04395989", "json": [{"cohort": "LAR-HER2+", "disease_state": "metastatic", "histology_inclusion": "Triple-Negative Breast Cancer", "biomarker_inclusion": ["HER2 gene activated mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "LAR-PAM+", "disease_state": "metastatic", "histology_inclusion": "Triple-Negative Breast Cancer", "biomarker_inclusion": ["PI3K/AKT/mTOR pathway mutation"], "histology_exclusion": [], "biomarker_exclusion": ["HER2 gene activated mutation"]}, {"cohort": "IM", "disease_state": "metastatic", "histology_inclusion": "Triple-Negative Breast Cancer", "biomarker_inclusion": ["CD8 positive T cell more than 20%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "BLIS", "disease_state": "metastatic", "histology_inclusion": "Triple-Negative Breast Cancer", "biomarker_inclusion": ["BLIS subtype", "MES subtype"], "histology_exclusion": [], "biomarker_exclusion": ["PI3K/AKT/mTOR pathway activation"]}, {"cohort": "MES-PAM+", "disease_state": "metastatic", "histology_inclusion": "Triple-Negative Breast Cancer", "biomarker_inclusion": ["PI3K/AKT/mTOR pathway activation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "LAR-HER2+", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "LAR-PAM+", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["AKT1 Mutation", "AKT1-Mutation", "gene"], ["PI3K/AKT/mTOR pathway", null, "pathway"], ["MTOR Mutation", "MTOR-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["Triple-Negative", "Triple-Negative", "coordinate"]], "biomarker_exclusion": [["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "IM", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["CD8A-High", "CD8A-High", "expression"]]}, {"cohort": "BLIS", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "MES-PAM+", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}]}
{"NCT_id": "NCT04526106", "json": [{"cohort": "Part 2: Dose Expansion - Cholangiocarcinoma", "disease_state": "unresectable or metastatic", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": ["FGFR2 fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2: Dose Expansion - Cholangiocarcinoma", "disease_state": "unresectable or metastatic", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": ["FGFR2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2: Dose Expansion - Cholangiocarcinoma", "disease_state": "unresectable or metastatic", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": ["FGFR2 amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2: Dose Expansion - Other Solid Tumors", "disease_state": "unresectable or metastatic", "histology_inclusion": "Other Solid Tumors", "biomarker_inclusion": ["FGFR2 fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2: Dose Expansion - Other Solid Tumors", "disease_state": "unresectable or metastatic", "histology_inclusion": "Other Solid Tumors", "biomarker_inclusion": ["FGFR2 amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2: Dose Expansion - Other Solid Tumors", "disease_state": "unresectable or metastatic", "histology_inclusion": "Other Solid Tumors", "biomarker_inclusion": ["FGFR2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 3: Extension", "disease_state": "unresectable or metastatic", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": ["FGFR2 fusion"], "histology_exclusion": ["CNS metastases", "primary CNS tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 2: Dose Expansion - Cholangiocarcinoma", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["FGFR2 Fusion", "FGFR2", "fusion"]]}, {"cohort": "Part 2: Dose Expansion - Cholangiocarcinoma", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}, {"cohort": "Part 2: Dose Expansion - Cholangiocarcinoma", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["FGFR2-High", "FGFR2-High", "expression"]]}, {"cohort": "Part 2: Dose Expansion - Other Solid Tumors", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGFR2 Fusion", "FGFR2", "fusion"]]}, {"cohort": "Part 2: Dose Expansion - Other Solid Tumors", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGFR2-High", "FGFR2-High", "expression"]]}, {"cohort": "Part 2: Dose Expansion - Other Solid Tumors", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}, {"cohort": "Part 3: Extension", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["FGFR2 Fusion", "FGFR2", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT04851834", "json": [{"cohort": "NTX-301 Monotherapy Dose Escalation", "disease_state": "Locally advanced or metastatic cancer", "histology_inclusion": "all solid tumours", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "NTX-301 platinum-based doublet therapy Dose Escalation", "disease_state": "Locally advanced or metastatic cancer", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "NTX-301 platinum-based doublet therapy Dose Escalation", "disease_state": "Locally advanced or metastatic cancer", "histology_inclusion": "bladder cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "NTX-301 Temozolomide doublet therapy Dose Escalation", "disease_state": "High-grade glioma", "histology_inclusion": "glioblastoma multiforme (GBM)", "biomarker_inclusion": ["IDH1 mutated"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "NTX-301 Monotherapy Dose Escalation"}, {"cohort": "NTX-301 platinum-based doublet therapy Dose Escalation", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "NTX-301 platinum-based doublet therapy Dose Escalation", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "NTX-301 platinum-based doublet therapy Dose Escalation", "histology_inclusion": "Bladder Carcinoma"}, {"cohort": "NTX-301 platinum-based doublet therapy Dose Escalation", "histology_inclusion": "Bladder Neoplasm"}, {"cohort": "NTX-301 Temozolomide doublet therapy Dose Escalation", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "NTX-301 Temozolomide doublet therapy Dose Escalation", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04526288", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Myelodysplastic Syndrome With Excess Blasts-2", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Myeloid Neoplasm", "biomarker_inclusion": ["Abnormal cells identified by multiparameter flow cytometry", "Abnormal karyotype", "Abnormal fluorescence in-situ hybridization", "CBL (CDS)", "CSF3R (exons 14, 15, 17)", "EZH2 (exons 15-20)", "FBXW7 (CDS)", "FGFR1 (exons 4, 11-17, partial 18)", "FLT3 (p.D835H)", "GATA1 (exons 2-3)", "GATA2 (exons 3-5)", "HRAS (exon 1-2)", "IDH1(p.R132)", "IDH2 (exon 4)", "JAK2 (exon 12, 14, 16)", "KIT (8-18)", "KMT2A (CDS)", "KRAS (CDS)", "MAP2K1 (exons 2, 3, 6)", "MPL (exon 10)", "MYD88 (exon 3-5)", "NOTCH1 (exons 20, 26, 27)", "NPM1 (exon 12)", "NRAS (CDS)", "PDGFRA (exons 12-18)", "PHF6 (CDS)", "PTEN (CDS)", "RB1 (CDS)", "RUNX1 (exon 4-8)", "SF3B1 (exon 14-16)", "SRSF2 (exon 1)", "STAG2 (CDS)", "STAT3 (exons 20-21)", "TP53 (CDS)", "U2AF1 (exons 2, 6)", "WT1 (CDS)", "ZRSR2 (CDS)"], "histology_exclusion": [], "biomarker_exclusion": ["DNMT3A", "TET2", "ASXL1"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome with Excess Blasts-2"}, {"cohort": "", "histology_inclusion": "Myeloid Neoplasm", "biomarker_inclusion": [["FLT3 D835H", "D835H", "coordinate"]]}]}
{"NCT_id": "NCT04982224", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["MET overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}]}
{"NCT_id": "NCT05372614", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["HER2 overexpression", "HER2 amplification", "HER2 activating mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}]}
{"NCT_id": "NCT03250676", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "Estrogen Receptor-positive, HER2 Negative Breast Cancer", "biomarker_inclusion": ["ESR1 Y537S mutation"], "histology_exclusion": ["inflammatory breast cancer"], "biomarker_exclusion": ["ESR1 D538G mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1 Y537S", "Y537S", "coordinate"], ["ERBB2-Low", "ERBB2-Low", "expression"]], "histology_exclusion": ["Inflammatory Breast Carcinoma"], "biomarker_exclusion": [["ESR1 D538G", "D538G", "coordinate"]]}]}
{"NCT_id": "NCT03446157", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["KRAS wild-type", "NRAS wild-type", "BRAF wild-type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04526470", "json": [{"cohort": "Phase IB", "disease_state": "advanced/recurrent", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PI3K or AKT inhibitor treatment"]}, {"cohort": "Phase II", "disease_state": "locally advanced or metastatic", "histology_inclusion": "gastric cancer", "biomarker_inclusion": ["PIK3CA gene alterations"], "histology_exclusion": [], "biomarker_exclusion": ["PI3K or AKT inhibitor treatment"]}], "json_norm": [{"cohort": "Phase IB", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase II", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}]}
{"NCT_id": "NCT04656652", "json": [{"cohort": "", "disease_state": "Stage IIIB, IIIC, or stage IV", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["Mixed small-cell lung cancer (SCLC) and NSCLC histology"], "biomarker_exclusion": ["EGFR", "ALK", "ROS1", "NTRK", "BRAF", "MET exon 14 skipping", "RET"]}, {"cohort": "", "disease_state": "Stage IIIB, IIIC, or stage IV", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR", "ALK", "ROS1", "NTRK", "BRAF", "MET exon 14 skipping", "RET"], "histology_exclusion": ["Mixed small-cell lung cancer (SCLC) and NSCLC histology"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma", "Non-Small Cell Lung Carcinoma"], "biomarker_exclusion": [["MET exon 14 del", "exon 14 del", "exon"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"]], "histology_exclusion": ["Small Cell Lung Carcinoma", "Non-Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT04982354", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["FLT3 mutated"], "histology_exclusion": ["Central Nervous System"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]]}]}
{"NCT_id": "NCT05307705", "json": [{"cohort": "Phase 1A", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["PIK3CA H1047R mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1B: Part A", "disease_state": "ER+/HER2- advanced", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["PIK3CA H1047R mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1B: Part B", "disease_state": "ER+/HER2- advanced", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["PIK3CA H1047R mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1B: Part C", "disease_state": "ER+/HER2- advanced", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["PIK3CA H1047R mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1B: Part D", "disease_state": "advanced", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["PIK3CA H1047R mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1B: Part E", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["PIK3CA H1047R mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1B: Part F", "disease_state": "ER+/HER2- advanced", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["PIK3CA H1047R mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1A", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["PIK3CA H1047R", "H1047R", "coordinate"]]}, {"cohort": "Phase 1B: Part A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PIK3CA H1047R", "H1047R", "coordinate"]]}, {"cohort": "Phase 1B: Part B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PIK3CA H1047R", "H1047R", "coordinate"]]}, {"cohort": "Phase 1B: Part C", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PIK3CA H1047R", "H1047R", "coordinate"]]}, {"cohort": "Phase 1B: Part D", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PIK3CA H1047R", "H1047R", "coordinate"]]}, {"cohort": "Phase 1B: Part E", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["PIK3CA H1047R", "H1047R", "coordinate"]]}, {"cohort": "Phase 1B: Part F", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PIK3CA H1047R", "H1047R", "coordinate"]]}]}
{"NCT_id": "NCT03641976", "json": [{"cohort": "", "disease_state": "unresectable metastatic right-sided colon cancer, stage IV", "histology_inclusion": "right-sided colon cancer (cecum~splenic flexure)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Carcinoma"}]}
{"NCT_id": "NCT03837353", "json": [{"cohort": "Cohort 1A, 1B", "disease_state": "metastatic castration-resistant", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["DKK1 positive"], "histology_exclusion": ["pure neuroendocrine carcinoma with prior taxane-based chemotherapy for castration-sensitive disease"], "biomarker_exclusion": []}, {"cohort": "Cohort 2A, 2B", "disease_state": "metastatic castration-resistant", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["DKK1 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1A, 1B, 2A, 2B", "disease_state": "metastatic castration-resistant", "histology_inclusion": "pure neuroendocrine carcinoma", "biomarker_inclusion": ["DKK1 positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1A, 1B", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["DKK1-High", "DKK1-High", "expression"]], "histology_exclusion": ["Neuroendocrine Carcinoma", "Neuroendocrine Tumor"]}, {"cohort": "Cohort 1A, 1B", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["DKK1-High", "DKK1-High", "expression"]], "histology_exclusion": ["Neuroendocrine Carcinoma", "Neuroendocrine Tumor"]}, {"cohort": "Cohort 2A, 2B", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["DKK1-High", "DKK1-High", "expression"]]}, {"cohort": "Cohort 2A, 2B", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["DKK1-High", "DKK1-High", "expression"]]}, {"cohort": "Cohort 1A, 1B, 2A, 2B", "histology_inclusion": "Neuroendocrine Carcinoma", "biomarker_inclusion": [["DKK1-High", "DKK1-High", "expression"]]}, {"cohort": "Cohort 1A, 1B, 2A, 2B", "histology_inclusion": "Neuroendocrine Tumor", "biomarker_inclusion": [["DKK1-High", "DKK1-High", "expression"]]}]}
{"NCT_id": "NCT04032704", "json": [{"cohort": "Cohort 1: SCLC (Parts A and B)", "disease_state": "extensive stage", "histology_inclusion": "Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2: NSCLC-squamous (Parts A and B)", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Non-small Cell Lung Cancer, Squamous", "biomarker_inclusion": ["anti-PD(L)1 therapy"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR", "ALK", "ROS", "BRAF", "other actionable mutations"]}, {"cohort": "Cohort 3: NSCLC-nonsquamous (Parts A and B)", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Non-small Cell Lung Cancer, Non-squamous", "biomarker_inclusion": ["anti-PD(L)1 therapy"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR", "ALK", "ROS", "BRAF", "TRK", "other actionable mutations"]}, {"cohort": "Cohort 4: HNSCC (Parts A and B)", "disease_state": "unresectable locally recurrent or metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["anti-PD(L)1 therapy"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 5: esophageal-squamous (Parts A and B)", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Esophageal Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 6: gastric and GEJ adenocarcinoma (Parts A and B)", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 6: gastric and GEJ adenocarcinoma (Parts A and B)", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1: SCLC (Parts A and B)", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Cohort 2: NSCLC-squamous (Parts A and B)", "histology_inclusion": "Squamous Cell Lung Carcinoma"}, {"cohort": "Cohort 3: NSCLC-nonsquamous (Parts A and B)", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 4: HNSCC (Parts A and B)", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Cohort 5: esophageal-squamous (Parts A and B)", "histology_inclusion": "Esophageal Squamous Cell Carcinoma"}, {"cohort": "Cohort 6: gastric and GEJ adenocarcinoma (Parts A and B)", "histology_inclusion": "Gastric Adenocarcinoma"}, {"cohort": "Cohort 6: gastric and GEJ adenocarcinoma (Parts A and B)", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}]}
{"NCT_id": "NCT04162873", "json": [{"cohort": "", "disease_state": "Advanced-stage (overall stage III and IV)", "histology_inclusion": "Head and neck cancers (sinonasal oral cavity, oropharynx, larynx, and hypopharynx)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Head and Neck Neoplasm"}, {"cohort": "", "histology_inclusion": "Head and Neck Carcinoma"}]}
{"NCT_id": "NCT04526509", "json": [{"cohort": "Substudy 1: Cohort 1 - GSK3901961 in previously treated metastatic NSCLC", "disease_state": "Stage IV", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["NY-ESO-1 positive", "LAGE-1a positive", "HLA-A*02:01", "HLA-A*02:05", "HLA-A*02:06"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "Substudy 1: Cohort 2 - GSK3901961 in previously treated advanced SS or MRCLS", "disease_state": "advanced (metastatic or unresectable)", "histology_inclusion": "synovial sarcoma", "biomarker_inclusion": ["NY-ESO-1 positive", "LAGE-1a positive", "HLA-A*02:01", "HLA-A*02:05", "HLA-A*02:06"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Substudy 1: Cohort 2 - GSK3901961 in previously treated advanced SS or MRCLS", "disease_state": "advanced (metastatic or unresectable)", "histology_inclusion": "myxoid/round cell liposarcoma", "biomarker_inclusion": ["NY-ESO-1 positive", "LAGE-1a positive", "HLA-A*02:01", "HLA-A*02:05", "HLA-A*02:06"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Substudy 2: GSK3845097 in previously treated advanced SS or MRCLS", "disease_state": "advanced (metastatic or unresectable)", "histology_inclusion": "synovial sarcoma", "biomarker_inclusion": ["NY-ESO-1 positive", "LAGE-1a positive", "HLA-A*02:01", "HLA-A*02:05", "HLA-A*02:06"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Substudy 2: GSK3845097 in previously treated advanced SS or MRCLS", "disease_state": "advanced (metastatic or unresectable)", "histology_inclusion": "myxoid/round cell liposarcoma", "biomarker_inclusion": ["NY-ESO-1 positive", "LAGE-1a positive", "HLA-A*02:01", "HLA-A*02:05", "HLA-A*02:06"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Substudy 3: GSK4427296 in previously treated advanced SS or MRCLS", "disease_state": "advanced (metastatic or unresectable)", "histology_inclusion": "synovial sarcoma", "biomarker_inclusion": ["NY-ESO-1 positive", "LAGE-1a positive", "HLA-A*02:01", "HLA-A*02:05", "HLA-A*02:06"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Substudy 3: GSK4427296 in previously treated advanced SS or MRCLS", "disease_state": "advanced (metastatic or unresectable)", "histology_inclusion": "myxoid/round cell liposarcoma", "biomarker_inclusion": ["NY-ESO-1 positive", "LAGE-1a positive", "HLA-A*02:01", "HLA-A*02:05", "HLA-A*02:06"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Substudy 1: Cohort 1 - GSK3901961 in previously treated metastatic NSCLC", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["CTAG1B-High", "CTAG1B-High", "expression"], ["CTAG2-High", "CTAG2-High", "expression"]]}, {"cohort": "Substudy 1: Cohort 2 - GSK3901961 in previously treated advanced SS or MRCLS", "histology_inclusion": "Synovial Sarcoma", "biomarker_inclusion": [["CTAG1B-High", "CTAG1B-High", "expression"], ["CTAG2-High", "CTAG2-High", "expression"]]}, {"cohort": "Substudy 1: Cohort 2 - GSK3901961 in previously treated advanced SS or MRCLS", "histology_inclusion": "Myxoid Liposarcoma", "biomarker_inclusion": [["CTAG1B-High", "CTAG1B-High", "expression"], ["CTAG2-High", "CTAG2-High", "expression"]]}, {"cohort": "Substudy 2: GSK3845097 in previously treated advanced SS or MRCLS", "histology_inclusion": "Synovial Sarcoma", "biomarker_inclusion": [["CTAG1B-High", "CTAG1B-High", "expression"], ["CTAG2-High", "CTAG2-High", "expression"]]}, {"cohort": "Substudy 2: GSK3845097 in previously treated advanced SS or MRCLS", "histology_inclusion": "Myxoid Liposarcoma", "biomarker_inclusion": [["CTAG1B-High", "CTAG1B-High", "expression"], ["CTAG2-High", "CTAG2-High", "expression"]]}, {"cohort": "Substudy 3: GSK4427296 in previously treated advanced SS or MRCLS", "histology_inclusion": "Synovial Sarcoma", "biomarker_inclusion": [["CTAG1B-High", "CTAG1B-High", "expression"], ["CTAG2-High", "CTAG2-High", "expression"]]}, {"cohort": "Substudy 3: GSK4427296 in previously treated advanced SS or MRCLS", "histology_inclusion": "Myxoid Liposarcoma", "biomarker_inclusion": [["CTAG1B-High", "CTAG1B-High", "expression"], ["CTAG2-High", "CTAG2-High", "expression"]]}]}
{"NCT_id": "NCT04787042", "json": [{"cohort": "Phase 1a", "disease_state": "advanced/metastatic", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1a", "disease_state": "advanced/metastatic", "histology_inclusion": "Merkel cell", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1a", "disease_state": "advanced/metastatic", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1a", "disease_state": "advanced/metastatic", "histology_inclusion": "Urothelial", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1a", "disease_state": "advanced/metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1a", "disease_state": "advanced/metastatic", "histology_inclusion": "Triple-negative Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1a", "disease_state": "advanced/metastatic", "histology_inclusion": "Squamous Cell Carcinoma of the Head and Neck", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1a", "disease_state": "advanced/metastatic", "histology_inclusion": "Microsatellite Instability High", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1a", "disease_state": "advanced/metastatic", "histology_inclusion": "High Tumor Mutation Burden", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1a", "disease_state": "advanced/metastatic", "histology_inclusion": "Mismatch Repair Deficient", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "advanced/metastatic", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "advanced/metastatic", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "advanced/metastatic", "histology_inclusion": "Triple-negative Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "advanced/metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "advanced/metastatic", "histology_inclusion": "Squamous Cell Carcinoma of the Head and Neck", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "advanced/metastatic", "histology_inclusion": "Microsatellite Instability High", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1a", "histology_inclusion": "Melanoma"}, {"cohort": "Phase 1a"}, {"cohort": "Phase 1a", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "Phase 1a"}, {"cohort": "Phase 1a", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Phase 1a", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Phase 1a", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Phase 1a", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Phase 1a", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Phase 1a", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Phase 1a", "biomarker_inclusion": [["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"]]}, {"cohort": "Phase 1a"}, {"cohort": "Phase 2", "histology_inclusion": "Melanoma"}, {"cohort": "Phase 2", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "Phase 2", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Phase 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Phase 2", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Phase 2", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Phase 2", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT05112601", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Endometrial Adenocarcinoma", "biomarker_inclusion": ["dMMR"], "histology_exclusion": ["Endometrial Serous Carcinoma", "Carcinosarcoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": ["dMMR"], "histology_exclusion": ["Endometrial Serous Carcinoma", "Carcinosarcoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Endometrial Clear Cell Adenocarcinoma", "biomarker_inclusion": ["dMMR"], "histology_exclusion": ["Endometrial Serous Carcinoma", "Carcinosarcoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Endometrial Dedifferentiated Carcinoma", "biomarker_inclusion": ["dMMR"], "histology_exclusion": ["Endometrial Serous Carcinoma", "Carcinosarcoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Endometrial Endometrioid Adenocarcinoma", "biomarker_inclusion": ["dMMR"], "histology_exclusion": ["Endometrial Serous Carcinoma", "Carcinosarcoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Endometrial Mixed Cell Adenocarcinoma", "biomarker_inclusion": ["dMMR"], "histology_exclusion": ["Endometrial Serous Carcinoma", "Carcinosarcoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Endometrial Mucinous Adenocarcinoma", "biomarker_inclusion": ["dMMR"], "histology_exclusion": ["Endometrial Serous Carcinoma", "Carcinosarcoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Endometrial Undifferentiated Carcinoma", "biomarker_inclusion": ["dMMR"], "histology_exclusion": ["Endometrial Serous Carcinoma", "Carcinosarcoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Endometrioid Adenocarcinoma", "biomarker_inclusion": ["dMMR"], "histology_exclusion": ["Endometrial Serous Carcinoma", "Carcinosarcoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Endometrial Adenocarcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Carcinosarcoma", "Ovarian Serous Adenocarcinoma"]}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Carcinosarcoma", "Ovarian Serous Adenocarcinoma"]}, {"cohort": "", "histology_inclusion": "Endometrial Clear Cell Adenocarcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Carcinosarcoma", "Ovarian Serous Adenocarcinoma"]}, {"cohort": "", "histology_inclusion": "Endometrial Dedifferentiated Carcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Carcinosarcoma", "Ovarian Serous Adenocarcinoma"]}, {"cohort": "", "histology_inclusion": "Endometrial Endometrioid Adenocarcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Carcinosarcoma", "Ovarian Serous Adenocarcinoma"]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Carcinosarcoma", "Ovarian Serous Adenocarcinoma"]}, {"cohort": "", "histology_inclusion": "Endometrial Mucinous Adenocarcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Carcinosarcoma", "Ovarian Serous Adenocarcinoma"]}, {"cohort": "", "histology_inclusion": "Endometrial Undifferentiated Carcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Carcinosarcoma", "Ovarian Serous Adenocarcinoma"]}, {"cohort": "", "histology_inclusion": "Endometrioid Adenocarcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Carcinosarcoma", "Ovarian Serous Adenocarcinoma"]}]}
{"NCT_id": "NCT05242822", "json": [{"cohort": "", "disease_state": "Advanced stage", "histology_inclusion": "Solid Tumor, Adult", "biomarker_inclusion": ["FGFR2 gene alteration", "FGFR3 gene alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Advanced stage", "histology_inclusion": "Intrahepatic Cholangiocarcinoma", "biomarker_inclusion": ["FGFR2 gene alteration", "FGFR3 gene alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Advanced stage", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": ["FGFR2 gene alteration", "FGFR3 gene alteration"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Intrahepatic Cholangiocarcinoma", "biomarker_inclusion": [["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}]}
{"NCT_id": "NCT03120624", "json": [{"cohort": "", "disease_state": "stage IVA, stage IVB or recurrent endometrial carcinoma", "histology_inclusion": "Endometrioid adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "stage IVA, stage IVB or recurrent endometrial carcinoma", "histology_inclusion": "serous adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "stage IVA, stage IVB or recurrent endometrial carcinoma", "histology_inclusion": "undifferentiated carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "stage IVA, stage IVB or recurrent endometrial carcinoma", "histology_inclusion": "clear cell adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "stage IVA, stage IVB or recurrent endometrial carcinoma", "histology_inclusion": "mixed epithelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "stage IVA, stage IVB or recurrent endometrial carcinoma", "histology_inclusion": "carcinosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "stage IVA, stage IVB or recurrent endometrial carcinoma", "histology_inclusion": "adenocarcinoma not otherwise specified (NOS)", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Endometrioid Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Undifferentiated Carcinoma"}, {"cohort": "", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Epithelial Neoplasm"}, {"cohort": "", "histology_inclusion": "Carcinosarcoma"}, {"cohort": "", "histology_inclusion": "Adenocarcinoma"}]}
{"NCT_id": "NCT03446417", "json": [{"cohort": "Phase 1", "disease_state": "metastatic or advanced inoperable", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2, Cohort 1", "disease_state": "metastatic or advanced inoperable", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR T790M mutation"], "histology_exclusion": [], "biomarker_exclusion": ["osimertinib"]}, {"cohort": "Phase 2, Cohort 2", "disease_state": "metastatic or advanced inoperable", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR G719X", "EGFR exon 19 deletion", "EGFR exon 21 L858R", "EGFR L861Q"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR inhibitor"]}], "json_norm": [{"cohort": "Phase 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Phase 2, Cohort 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR T790M", "T790M", "coordinate"]]}, {"cohort": "Phase 2, Cohort 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR L861Q", "L861Q", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT04228042", "json": [{"cohort": "", "disease_state": "low grade UTUC or high grade UTUC not eligible for cis-platin neoadjuvant chemotherapy", "histology_inclusion": "Renal Pelvis and Ureter Urothelial Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Renal Pelvis and Ureter Urothelial Carcinoma"}]}
{"NCT_id": "NCT04526691", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["actionable EGFR genomic alterations", "actionable ALK genomic alterations"]}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": ["KRAS mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": ["non-actionable EGFR genomic alterations", "non-actionable ALK genomic alterations", "non-actionable ROS1 genomic alterations", "non-actionable NTRK genomic alterations", "non-actionable BRAF genomic alterations", "non-actionable RET genomic alterations", "non-actionable MET genomic alterations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["ALK Mutation", "ALK-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["MET Mutation", "MET-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"], ["NTRK3 Mutation", "NTRK3-Mutation", "gene"], ["NTRK2 Mutation", "NTRK2-Mutation", "gene"], ["NTRK1 Mutation", "NTRK1-Mutation", "gene"], ["SLTM Mutation", "SLTM-Mutation", "gene"], ["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04722133", "json": [{"cohort": "", "disease_state": "Advanced/Metastatic/Nonresectable", "histology_inclusion": "Biliary Tract Cancer", "biomarker_inclusion": ["HER2 Positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Liver Cancer", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Biliary Tract Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04787263", "json": [{"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "CD19+ Acute Lymphoblastic Leukemia", "biomarker_inclusion": ["CD19 expressing"], "histology_exclusion": ["testicular involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed", "histology_inclusion": "Diffuse Large B Cell Lymphoma", "biomarker_inclusion": ["CD19 expressing"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed", "histology_inclusion": "Primary Mediastinal Lymphoma", "biomarker_inclusion": ["CD19 expressing"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["CD19-High", "CD19-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["CD19-High", "CD19-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Mediastinal Lymphoma", "biomarker_inclusion": [["CD19-High", "CD19-High", "expression"]]}]}
{"NCT_id": "NCT04852328", "json": [{"cohort": "", "disease_state": "Stage I-III (AJCC 8th Edition) [except clinical stages T1N0 and T2N0]", "histology_inclusion": "squamous-cell carcinoma of the oropharynx or of an upper (levels 2-3) neck mass without a known primary site", "biomarker_inclusion": ["HLA-A*0201", "HPV16", "p16INK4A expression (>70% staining in tumor cells)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT05242965", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT03251027", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "low or high grade glioma (grade II-IV)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Glioma"}]}
{"NCT_id": "NCT04526782", "json": [{"cohort": "Cohort 1 (1st line)", "disease_state": "Stage IV (M1a, M1b, M1c AJCC 8th edition)", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["BRAFV600E"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutation", "ALK fusion oncogene", "ROS1 rearrangement"]}, {"cohort": "Cohort 2 (2nd line)", "disease_state": "Stage IV (M1a, M1b, M1c AJCC 8th edition)", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["BRAFV600E"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutation", "ALK fusion oncogene", "ROS1 rearrangement"]}], "json_norm": [{"cohort": "Cohort 1 (1st line)", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]], "biomarker_exclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Cohort 2 (2nd line)", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]], "biomarker_exclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT04657068", "json": [{"cohort": "Part A1", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A2", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A3", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B1", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": ["ATM gene alterations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B2", "disease_state": "Platinum-resistant", "histology_inclusion": "High Grade Serous Carcinoma", "biomarker_inclusion": ["germline BRCA mutation", "somatic BRCA mutation", "HRD positive"], "histology_exclusion": [], "biomarker_exclusion": ["primary platinum-refractory disease"]}], "json_norm": [{"cohort": "Part A1", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part A2", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part A3", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part B1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"]]}, {"cohort": "Part B2", "histology_inclusion": "Ovarian Serous Adenocarcinoma", "biomarker_inclusion": [["TBCE-High", "TBCE-High", "expression"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04787341", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["RAS wt", "BRAF wt"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]], "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT05243082", "json": [{"cohort": "", "disease_state": "WHO Grade 1-2", "histology_inclusion": "Pancreatic Neuroendocrine Tumor", "biomarker_inclusion": ["Ki-67 <5%"], "histology_exclusion": [], "biomarker_exclusion": ["Metastatic disease", "local lymph node metastases"]}, {"cohort": "", "disease_state": "WHO Grade 1-2", "histology_inclusion": "Pancreatic Neuroendocrine Tumor", "biomarker_inclusion": ["Ki-67 <10%", "PNET < 2cm", "progression during surveillance"], "histology_exclusion": [], "biomarker_exclusion": ["Metastatic disease", "local lymph node metastases"]}, {"cohort": "", "disease_state": "WHO Grade 1-2", "histology_inclusion": "Pancreatic Neuroendocrine Tumor", "biomarker_inclusion": ["Ki-67 <10%", "PNET 1.5-2 cm", "age < 60 years"], "histology_exclusion": [], "biomarker_exclusion": ["Metastatic disease", "local lymph node metastases"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Carcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Neoplasm"}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Tumor"}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Carcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Neoplasm"}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Tumor"}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Carcinoma"}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Neoplasm"}, {"cohort": "", "histology_inclusion": "Pancreatic Neuroendocrine Tumor"}]}
{"NCT_id": "NCT02523014", "json": [{"cohort": "", "disease_state": "progressive", "histology_inclusion": "intracranial meningioma", "biomarker_inclusion": ["SMO mutation", "PTCH1 mutation", "NF2 mutation", "CDKN2A mutation", "AKT1 mutation", "PIK3CA mutation", "PTEN mutation", "CDKN2A copy number loss", "CDK4 copy number gain", "CDK6 copy number gain", "CCND1 copy number gain", "CCND2 copy number gain", "CCND3 copy number gain", "CCNE1 copy number gain"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Meningioma", "biomarker_inclusion": [["CDKN2A Mutation", "CDKN2A-Mutation", "gene"], ["PTCH1 Mutation", "PTCH1-Mutation", "gene"], ["AKT1 Mutation", "AKT1-Mutation", "gene"], ["NF2 Mutation", "NF2-Mutation", "gene"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["SMO Mutation", "SMO-Mutation", "gene"], ["PIK3CA Mutation", "PIK3CA-Mutation", "gene"], ["SMOX Mutation", "SMOX-Mutation", "gene"]]}]}
{"NCT_id": "NCT04982926", "json": [{"cohort": "Dose Escalation", "disease_state": "locally advanced and metastatic", "histology_inclusion": "solid cancer", "biomarker_inclusion": ["EGFR aberration", "HER2 aberration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "locally advanced and metastatic", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "locally advanced and metastatic", "histology_inclusion": "HER2 positive breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Cohort C", "disease_state": "recurrent or refractory", "histology_inclusion": "glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort D", "disease_state": "locally advanced and metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["EGFR aberration", "HER2 aberration"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Escalation", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "Cohort A", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort C", "histology_inclusion": "Glioblastoma"}, {"cohort": "Cohort D", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT05048017", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma"}]}
{"NCT_id": "NCT03186118", "json": [{"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "CD19+ leukemia", "biomarker_inclusion": [], "histology_exclusion": ["active malignancy other than CD19+ malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["CD19-High", "CD19-High", "expression"]], "biomarker_exclusion": [["CD19-High", "CD19-High", "expression"]]}]}
{"NCT_id": "NCT03837808", "json": [{"cohort": "", "disease_state": "Stage II-III", "histology_inclusion": "non-keratinizing nasopharyngeal carcinoma, WHO II or III", "biomarker_inclusion": ["positive EGFR expression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Nasopharyngeal Carcinoma", "biomarker_inclusion": [["EGFR-High", "EGFR-High", "expression"]]}]}
{"NCT_id": "NCT03837821", "json": [{"cohort": "All Subjects", "disease_state": "MIBC (T2-T4)", "histology_inclusion": "Urothelial carcinoma (dominant >50% histology)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "All Subjects", "histology_inclusion": "Urothelial Carcinoma"}]}
{"NCT_id": "NCT04396821", "json": [{"cohort": "Part B Cohort A", "disease_state": "locally advanced or metastatic", "histology_inclusion": "GC/GEJ adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["symptomatic central nervous system metastases"], "biomarker_exclusion": ["prior treatment with any CLDN18.2 target agents"]}, {"cohort": "Part B Cohort B", "disease_state": "locally advanced or metastatic", "histology_inclusion": "GC/GEJ adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["symptomatic central nervous system metastases"], "biomarker_exclusion": ["prior treatment with any CLDN18.2 target agents"]}, {"cohort": "Part B Cohort C", "disease_state": "locally advanced or metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["symptomatic central nervous system metastases"], "biomarker_exclusion": ["prior treatment with any CLDN18.2 target agents"]}], "json_norm": [{"cohort": "Part B Cohort A", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "Part B Cohort B", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "Part B Cohort C", "histology_inclusion": "Pancreatic Adenocarcinoma"}]}
{"NCT_id": "NCT04592237", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "prostate carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "small cell (neuroendocrine) prostate carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "prostate carcinoma", "biomarker_inclusion": ["Tp53 loss or mutation", "RB1 loss or mutation", "PTEN loss or mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["TP53-Low", "TP53-Low", "expression"], ["RB1 Mutation", "RB1-Mutation", "gene"], ["RB1-Low", "RB1-Low", "expression"], ["PTEN-Low", "PTEN-Low", "expression"], ["PTEN Mutation", "PTEN-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["PTEN Mutation", "PTEN-Mutation", "gene"], ["RB1-Low", "RB1-Low", "expression"], ["TP53-Low", "TP53-Low", "expression"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["RB1 Mutation", "RB1-Mutation", "gene"], ["PTEN-Low", "PTEN-Low", "expression"]]}]}
{"NCT_id": "NCT04228601", "json": [{"cohort": "", "disease_state": "local advanced/metastatic", "histology_inclusion": "pancreas adenocarcinoma", "biomarker_inclusion": ["germline BRCA1 mutation", "germline BRCA2 mutation", "germline PALB2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["brain metastasis"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": [["PALB2 Mutation", "PALB2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04722575", "json": [{"cohort": "", "disease_state": "Stage IIIB/C/D or oligometastatic stage IV1 resectable melanoma", "histology_inclusion": "Melanoma", "biomarker_inclusion": ["BRAF V600E/K mutation"], "histology_exclusion": [], "biomarker_exclusion": ["Prior BRAF or MEK directed therapy", "Prior anti-PD-1, anti-PD-L1, anti-PD-L2, or anti-CTLA-4 antibody"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}]}
{"NCT_id": "NCT04852887", "json": [{"cohort": "", "disease_state": "Stage I", "histology_inclusion": "invasive adenocarcinoma of the breast", "biomarker_inclusion": ["ER positive", "PgR positive", "HER2-negative", "Oncotype DX Recurrence Score <= 18"], "histology_exclusion": ["non-epithelial breast malignancies", "Paget's disease of the nipple"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"], ["PGR-High", "PGR-High", "expression"]], "histology_exclusion": ["Nipple Paget Disease", "Breast Carcinoma"]}]}
{"NCT_id": "NCT05308446", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["BRAFV600E mutated"], "histology_exclusion": [], "biomarker_exclusion": ["pMMR", "MSS"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]], "biomarker_exclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT05438667", "json": [{"cohort": "", "disease_state": "recurrent/metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["KRAS G12V", "KRAS G12D", "HLA-A*11:01"], "histology_exclusion": ["intracranial metastasis", "central nervous metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent/metastatic", "histology_inclusion": "other solid tumors", "biomarker_inclusion": ["KRAS G12V", "KRAS G12D", "HLA-A*11:01"], "histology_exclusion": ["intracranial metastasis", "central nervous metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"], ["KRAS G12V", "G12V", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"], ["KRAS G12V", "G12V", "coordinate"]]}]}
{"NCT_id": "NCT03838042", "json": [{"cohort": "", "disease_state": "refractory/relapsed/progressive", "histology_inclusion": "CNS tumors: medulloblastoma", "biomarker_inclusion": [], "histology_exclusion": ["low-grade gliomas", "tumors of unknown malignant potential"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory/relapsed/progressive", "histology_inclusion": "CNS tumors: ependymoma", "biomarker_inclusion": [], "histology_exclusion": ["low-grade gliomas", "tumors of unknown malignant potential"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory/relapsed/progressive", "histology_inclusion": "CNS tumors: ATRT", "biomarker_inclusion": [], "histology_exclusion": ["low-grade gliomas", "tumors of unknown malignant potential"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory/relapsed/progressive", "histology_inclusion": "CNS tumors: ETMR", "biomarker_inclusion": [], "histology_exclusion": ["low-grade gliomas", "tumors of unknown malignant potential"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory/relapsed/progressive", "histology_inclusion": "CNS tumors: pediatric high grade glioma (including DIPG)", "biomarker_inclusion": [], "histology_exclusion": ["low-grade gliomas", "tumors of unknown malignant potential"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory/relapsed/progressive", "histology_inclusion": "CNS tumors: other pediatric embryonal CNS tumors", "biomarker_inclusion": [], "histology_exclusion": ["low-grade gliomas", "tumors of unknown malignant potential"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory/relapsed/progressive", "histology_inclusion": "solid tumors: neuroblastoma", "biomarker_inclusion": [], "histology_exclusion": ["low-grade gliomas", "tumors of unknown malignant potential"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory/relapsed/progressive", "histology_inclusion": "solid tumors: nephroblastoma", "biomarker_inclusion": [], "histology_exclusion": ["low-grade gliomas", "tumors of unknown malignant potential"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory/relapsed/progressive", "histology_inclusion": "solid tumors: rhabdoid tumor", "biomarker_inclusion": [], "histology_exclusion": ["low-grade gliomas", "tumors of unknown malignant potential"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory/relapsed/progressive", "histology_inclusion": "solid tumors: embryonal or alveolar rhabdomyosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["low-grade gliomas", "tumors of unknown malignant potential"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory/relapsed/progressive", "histology_inclusion": "solid tumors: other embryonal small round blue cell tumors including pediatric type (bone) sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["low-grade gliomas", "tumors of unknown malignant potential"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "refractory/relapsed/progressive", "histology_inclusion": "solid tumors: other pediatric type solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["low-grade gliomas", "tumors of unknown malignant potential"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "high grade glioma (HGG) in the context of a constitutional mismatch repair deficiency syndrome", "biomarker_inclusion": [], "histology_exclusion": ["low-grade gliomas", "tumors of unknown malignant potential"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Central Nervous System Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Central Nervous System Neoplasm"}, {"cohort": "", "histology_inclusion": "Medulloblastoma"}, {"cohort": "", "histology_inclusion": "Central Nervous System Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Central Nervous System Neoplasm"}, {"cohort": "", "histology_inclusion": "Ependymoma"}, {"cohort": "", "histology_inclusion": "Central Nervous System Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Central Nervous System Neoplasm"}, {"cohort": "", "histology_inclusion": "Central Nervous System Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Central Nervous System Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Central Nervous System Neoplasm"}, {"cohort": "", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma"}, {"cohort": "", "histology_inclusion": "Central Nervous System Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Glioma"}, {"cohort": "", "histology_inclusion": "Malignant Central Nervous System Neoplasm"}, {"cohort": "", "histology_inclusion": "Central Nervous System Neoplasm"}, {"cohort": "", "histology_inclusion": "Neuroblastoma"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Rhabdoid Tumor"}, {"cohort": "", "histology_inclusion": "Alveolar Rhabdomyosarcoma"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Sarcoma"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Glioma"}]}
{"NCT_id": "NCT05503797", "json": [{"cohort": "Group A", "disease_state": "locally advanced or metastatic solid tumors or primary CNS tumors", "histology_inclusion": "solid tumor or primary CNS tumor", "biomarker_inclusion": ["BRAF gene fusion"], "histology_exclusion": [], "biomarker_exclusion": ["NF1 alteration", "RAS-related mutations", "co-occurring activating RAS mutation(s)"]}, {"cohort": "Group B", "disease_state": "recurrent primary CNS tumors", "histology_inclusion": "grade 3 or 4 glioma or glioneuronal tumor", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group B", "disease_state": "recurrent high-grade glioma", "histology_inclusion": "grade 2 glioma with radiographic or histopathological findings consistent with HGG (WHO grade 3 or 4)", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Group A", "histology_inclusion": "Primary Brain Neoplasm", "biomarker_inclusion": [["BRAF Fusion", "BRAF", "fusion"]], "biomarker_exclusion": [["NF1 Mutation", "NF1-Mutation", "gene"], ["AQP1 Mutation", "AQP1-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"]]}, {"cohort": "Group A", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRAF Fusion", "BRAF", "fusion"]], "biomarker_exclusion": [["NF1 Mutation", "NF1-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["AQP1 Mutation", "AQP1-Mutation", "gene"]]}, {"cohort": "Group B", "histology_inclusion": "Glioma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "Group B", "histology_inclusion": "Grade II Glioma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT04163900", "json": [{"cohort": "", "disease_state": "locally advanced, unresectable or metastatic", "histology_inclusion": "adenocarcinoma of the biliary tract (including gallbladder, intra and extra-hepatic biliary ducts and ampullary cancers)", "biomarker_inclusion": [], "histology_exclusion": ["combined or mixed hepatocellular/cholangiocarcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ampulla of Vater Carcinoma", "histology_exclusion": ["Cholangiocarcinoma"]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "histology_exclusion": ["Cholangiocarcinoma"]}]}
{"NCT_id": "NCT05308901", "json": [{"cohort": "Pembrolizumab + Lenvatinib", "disease_state": "metastatic", "histology_inclusion": "uveal melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Pembrolizumab + Lenvatinib", "histology_inclusion": "Intraocular Melanoma"}]}
{"NCT_id": "NCT04983745", "json": [{"cohort": "", "disease_state": "metastatic, recurrent, or unresectable", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["somatic HRD gene mutation"], "histology_exclusion": ["prostate cancer", "ovarian cancer", "breast cancer", "pancreatic cancer", "CNS tumor"], "biomarker_exclusion": ["germline BRCA1 mutation", "germline BRCA2 mutation", "platinum sensitive ovarian cancer"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"], ["TBCE Mutation", "TBCE-Mutation", "gene"]], "histology_exclusion": ["Breast Carcinoma", "Central Nervous System Neoplasm", "Malignant Ovarian Neoplasm", "Prostate Neoplasm", "Malignant Central Nervous System Neoplasm", "Prostate Carcinoma", "Pancreatic Carcinoma", "Ovarian Epithelial Cancer"], "biomarker_exclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04983810", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "Solid Tumor, Adult", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Lymphoma"}]}
{"NCT_id": "NCT03317392", "json": [{"cohort": "", "disease_state": "metastatic castration-resistant", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": ["small cell carcinoma of the prostate"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "histology_exclusion": ["Prostate Small Cell Neuroendocrine Carcinoma"]}]}
{"NCT_id": "NCT03903835", "json": [{"cohort": "", "disease_state": "metastatic castrate resistant prostate cancer", "histology_inclusion": "prostate adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT04294628", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "HER2-positive or HER2-expressing tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04332653", "json": [{"cohort": "Phase 1b", "disease_state": "Relapsed/Refractory Advanced Solid Tumors", "histology_inclusion": "Advanced or Metastatic Solid Tumors", "biomarker_inclusion": [], "histology_exclusion": ["CNS Metastases", "Carcinomatous Meningitis"], "biomarker_exclusion": []}, {"cohort": "Phase 2a: CPI Treated Triple Negative Breast Cancer", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Triple Negative Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": ["CNS Metastases", "Carcinomatous Meningitis"], "biomarker_exclusion": ["Anti-PD-1", "Anti-PD-L1", "Anti-PD-L2", "CTLA-4", "OX-40", "CD137"]}, {"cohort": "Phase 2a: CPI Treated Non-small Cell Lung Cancer", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["CNS Metastases", "Carcinomatous Meningitis"], "biomarker_exclusion": ["Anti-PD-1", "Anti-PD-L1", "Anti-PD-L2", "CTLA-4", "OX-40", "CD137"]}, {"cohort": "Phase 2a: CPI Treated Small Cell Lung Cancer", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["CNS Metastases", "Carcinomatous Meningitis"], "biomarker_exclusion": ["Anti-PD-1", "Anti-PD-L1", "Anti-PD-L2", "CTLA-4", "OX-40", "CD137"]}, {"cohort": "Phase 2a: CPI Na\u00efve Microsatellite Stable Colorectal Cancer", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Microsatellite Stable Colorectal Cancer", "biomarker_inclusion": [], "histology_exclusion": ["CNS Metastases", "Carcinomatous Meningitis"], "biomarker_exclusion": ["CPI"]}, {"cohort": "Phase 2a: CPI Na\u00efve Pancreatic Cancer", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Pancreatic Cancer", "biomarker_inclusion": [], "histology_exclusion": ["CNS Metastases", "Carcinomatous Meningitis"], "biomarker_exclusion": ["CPI"]}, {"cohort": "Biomarker Cohort: CPI Na\u00efve Ovarian Cancer", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Ovarian Cancer", "biomarker_inclusion": [], "histology_exclusion": ["CNS Metastases", "Carcinomatous Meningitis"], "biomarker_exclusion": ["CPI"]}], "json_norm": [{"cohort": "Phase 1b", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase 2a: CPI Treated Triple Negative Breast Cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Phase 2a: CPI Treated Non-small Cell Lung Cancer", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Phase 2a: CPI Treated Small Cell Lung Cancer", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Phase 2a: CPI Na\u00efve Microsatellite Stable Colorectal Cancer", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]]}, {"cohort": "Phase 2a: CPI Na\u00efve Pancreatic Cancer", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "Biomarker Cohort: CPI Na\u00efve Ovarian Cancer", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Biomarker Cohort: CPI Na\u00efve Ovarian Cancer", "histology_inclusion": "Malignant Ovarian Neoplasm"}]}
{"NCT_id": "NCT02654964", "json": [{"cohort": "Treatment Arm", "disease_state": "recurred or progressed", "histology_inclusion": "Glioblastoma Multiforme (GBM) [WHO grade IV]", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Treatment Arm", "histology_inclusion": "Glioblastoma, IDH-Wildtype"}, {"cohort": "Treatment Arm", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT03448042", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "HER2-expressing breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "inoperable locally advanced or recurrent and/or metastatic", "histology_inclusion": "adenocarcinoma of the stomach or gastroesophageal (GEJ) cancer", "biomarker_inclusion": ["HER2-expressing tumor"], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "HER2-positive solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["primary central nervous system (CNS) malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04332822", "json": [{"cohort": "", "disease_state": "Stage II-IV", "histology_inclusion": "diffuse large B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II-IV", "histology_inclusion": "follicular lymphoma grade 3B", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II-IV", "histology_inclusion": "T-cell/histiocyte-rich LBCL", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II-IV", "histology_inclusion": "primary cutaneous DLBCL, leg type", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II-IV", "histology_inclusion": "EBV-positive DLBCL, NOS", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II-IV", "histology_inclusion": "primary mediastinal LBCL", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II-IV", "histology_inclusion": "high grade B-cell lymphoma with MYC/BCL2 rearrangement", "biomarker_inclusion": [], "histology_exclusion": ["CNS involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Grade 3b Follicular Lymphoma"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"}, {"cohort": "", "histology_inclusion": "Epstein-Barr Virus Positive Diffuse Large B-Cell Lymphoma of the Elderly"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "High Grade B-Cell Lymphoma", "biomarker_inclusion": [["BCL2 Fusion", "BCL2", "fusion"]]}]}
{"NCT_id": "NCT05179447", "json": [{"cohort": "", "disease_state": "Stage I", "histology_inclusion": "Endometrioid type endometrial carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Serous carcinoma", "Clear cell carcinoma", "Undifferentiated carcinoma", "Neuroendocrine carcinoma", "Uterine sarcoma (including carcinosarcoma)"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage II", "histology_inclusion": "Endometrioid type endometrial carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Serous carcinoma", "Clear cell carcinoma", "Undifferentiated carcinoma", "Neuroendocrine carcinoma", "Uterine sarcoma (including carcinosarcoma)"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "histology_exclusion": ["Carcinosarcoma", "Ovarian Serous Adenocarcinoma", "Neuroendocrine Tumor", "Pancreatic Undifferentiated Carcinoma", "Endometrial Clear Cell Adenocarcinoma", "Neuroendocrine Carcinoma", "Uterine Corpus Sarcoma"]}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "histology_exclusion": ["Carcinosarcoma", "Ovarian Serous Adenocarcinoma", "Neuroendocrine Tumor", "Pancreatic Undifferentiated Carcinoma", "Endometrial Clear Cell Adenocarcinoma", "Neuroendocrine Carcinoma", "Uterine Corpus Sarcoma"]}]}
{"NCT_id": "NCT02926911", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Ductal Carcinoma in Situ (DCIS)", "biomarker_inclusion": ["ER(+)", "PR(+)"], "histology_exclusion": ["Grade III DCIS", "invasive breast cancer", "microinvasive breast cancer"], "biomarker_exclusion": ["HER2 3+"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "DCIS + LCIS", "biomarker_inclusion": ["ER(+)", "PR(+)"], "histology_exclusion": ["Grade III DCIS", "invasive breast cancer", "microinvasive breast cancer"], "biomarker_exclusion": ["HER2 3+"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "atypia verging on DCIS", "biomarker_inclusion": [], "histology_exclusion": ["Grade III DCIS", "invasive breast cancer", "microinvasive breast cancer"], "biomarker_exclusion": ["HER2 3+"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Ductal Breast Carcinoma In Situ", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"], ["PGR-High", "PGR-High", "expression"]], "histology_exclusion": ["Invasive Breast Carcinoma", "Breast Carcinoma", "Ductal Breast Carcinoma In Situ"], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Lobular Breast Carcinoma In Situ", "biomarker_inclusion": [["EREG-High", "EREG-High", "expression"], ["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["PGR-High", "PGR-High", "expression"]], "histology_exclusion": ["Ductal Breast Carcinoma In Situ", "Invasive Breast Carcinoma", "Breast Carcinoma"], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Ductal Breast Carcinoma In Situ", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"], ["PGR-High", "PGR-High", "expression"]], "histology_exclusion": ["Invasive Breast Carcinoma", "Breast Carcinoma", "Ductal Breast Carcinoma In Situ"], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Ductal Breast Carcinoma In Situ", "histology_exclusion": ["Invasive Breast Carcinoma", "Breast Carcinoma", "Ductal Breast Carcinoma In Situ"], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04984369", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["BRAF V600E"], "histology_exclusion": ["brain metastases", "meningeal metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT05114421", "json": [{"cohort": "", "disease_state": "platinum-resistant", "histology_inclusion": "high grade serous ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "platinum-resistant", "histology_inclusion": "high grade serous peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "platinum-resistant", "histology_inclusion": "high grade serous fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Serous Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma"}]}
{"NCT_id": "NCT05244551", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "expansion", "disease_state": "progressed or intolerant of standard therapy", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": ["FGFR2 fusions", "FGFR3 fusions", "FGFR3 activating mutations"], "histology_exclusion": [], "biomarker_exclusion": ["FGFR pathway inhibitors", "multi-kinase inhibitors targeting FGFR inhibition"]}, {"cohort": "expansion", "disease_state": "progressed or intolerant of standard therapy", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": ["FGFR2 fusions", "FGFR2 arrangements"], "histology_exclusion": [], "biomarker_exclusion": ["FGFR pathway inhibitors", "multi-kinase inhibitors targeting FGFR inhibition"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "expansion", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"]]}, {"cohort": "expansion", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["FGFR2 Fusion", "FGFR2", "fusion"]]}]}
{"NCT_id": "NCT03513484", "json": [{"cohort": "Escalation Cohort", "disease_state": "Relapsed or Refractory Acute Myeloid Leukemia", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["11q23 translocation", "MLL gene PTD", "FLT3-ITD", "Increased Fgf2 in serum", "HOX(A9/A10) over-expression in bone marrow"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort", "disease_state": "Newly Diagnosed Acute Myeloid Leukemia", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["11q23 translocation", "MLL gene PTD", "FLT3-ITD", "Increased Fgf2 in serum", "HOX(A9/A10) over-expression in bone marrow"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Escalation Cohort", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "Expansion Cohort", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}]}
{"NCT_id": "NCT04229979", "json": [{"cohort": "", "disease_state": "CR2/CRp2", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Acute promyelocytic leukemia", "central nervous system leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Central Nervous System Leukemia"]}]}
{"NCT_id": "NCT05439993", "json": [{"cohort": "Phase 1b", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["c-MET inhibitor"]}, {"cohort": "Phase 2b", "disease_state": "locally advanced or metastatic", "histology_inclusion": "gastric and gastroesophageal carcinoma", "biomarker_inclusion": ["MET amplified (copy number gain \u22653)", "MET exon 14 skipping mutation"], "histology_exclusion": [], "biomarker_exclusion": ["c-MET inhibitor"]}], "json_norm": [{"cohort": "Phase 1b", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase 2b", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["MET exon 14 del", "exon 14 del", "exon"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}]}
{"NCT_id": "NCT03709147", "json": [{"cohort": "FAME arm", "disease_state": "unresectable, locally advanced (stage IIIB) or metastatic (stage IV)", "histology_inclusion": "LKB1-inactive lung adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutations", "ALK rearrangements", "ROS-1 rearrangements", "high expression of PD-L1 (\u2265 50% in immunohistochemistry)"]}], "json_norm": [{"cohort": "FAME arm", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_exclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT03839342", "json": [{"cohort": "", "disease_state": "advanced and/or metastatic solid tumors", "histology_inclusion": "solid malignancy", "biomarker_inclusion": ["BRAF mutation affecting codon: 241, 257, 367, 462, 463, 464, 466, 467, 469, 485, 581, 586, 594, 595, 596, 597 598, 599, 601", "V600 BRAF mutations: V600K (for any malignancy except melanoma), V600D, V600M, V600R", "BRAF deletions ie. V600_K601delinsE or 1799_1801 del TGA", "BRAF insertions ie. T599dup", "BRAF fusions ie. KIAA1549:BRAF"], "histology_exclusion": [], "biomarker_exclusion": ["BRAF V600E mutation", "BRAF V600K mutation in melanoma"]}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["BRAF V600R", "V600R", "coordinate"], ["BRAF V600K", "V600K", "coordinate"], ["BRAF Fusion", "BRAF", "fusion"], ["BRAF exon 15 indel", "V600_K601delinsE", "exon"], ["BRAF V600D", "V600D", "coordinate"], ["BRAF V600M", "V600M", "coordinate"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["BRAF exon 15 indel", "T599dup", "exon"]], "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}]}
{"NCT_id": "NCT04099797", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma", "biomarker_inclusion": ["GD2-expressing", "H3K27M mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "High Grade Glioma", "biomarker_inclusion": ["GD2-expressing", "H3K27M mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "intracranial embryonal tumor", "biomarker_inclusion": ["GD2-expressing"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "High Grade Glioma", "biomarker_inclusion": ["GD2-expressing", "H3K27M mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "ependymal tumor", "biomarker_inclusion": ["GD2-expressing"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Malignant Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Embryonal Neoplasm"}, {"cohort": "", "histology_inclusion": "Embryonal Carcinoma"}, {"cohort": "", "histology_inclusion": "Malignant Glioma", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Ependymal Tumor"}]}
{"NCT_id": "NCT04164979", "json": [{"cohort": "Cabozantinib and Pembrolizumab", "disease_state": "locally advanced, recurrent, or metastatic", "histology_inclusion": "gastric or gastroesophageal adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases", "cranial epidural disease"], "biomarker_exclusion": []}, {"cohort": "Cabozantinib and Pembrolizumab", "disease_state": "progressed after at least one line of immunotherapy", "histology_inclusion": "gastric or gastroesophageal adenocarcinoma", "biomarker_inclusion": ["MSI-High", "dMMR"], "histology_exclusion": ["brain metastases", "cranial epidural disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cabozantinib and Pembrolizumab", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "Cabozantinib and Pembrolizumab", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04528680", "json": [{"cohort": "", "disease_state": "Recurrent", "histology_inclusion": "Glioblastoma, IDH-wildtype", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT03839498", "json": [{"cohort": "Axitinib (AG-013736)", "disease_state": "metastatic, recurrent or primary unresectable", "histology_inclusion": "pheochromocytoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Axitinib (AG-013736)", "disease_state": "metastatic, recurrent or primary unresectable", "histology_inclusion": "paraganglioma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Axitinib (AG-013736)"}, {"cohort": "Axitinib (AG-013736)", "histology_inclusion": "Paraganglioma"}]}
{"NCT_id": "NCT04398524", "json": [{"cohort": "single arm", "disease_state": "recurrent or metastatic", "histology_inclusion": "HPV16 positive Oropharyngeal Cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor", "central nervous system metastases", "leptomeningeal disease", "spinal cord compression"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "single arm", "histology_inclusion": "Oropharyngeal Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT04659044", "json": [{"cohort": "", "disease_state": "relapsed or primary refractory", "histology_inclusion": "mantle cell lymphoma", "biomarker_inclusion": ["cyclin D1 positive", "t(11;14) positive"], "histology_exclusion": ["central nervous system lymphoma", "leptomeningeal infiltration"], "biomarker_exclusion": ["CD20-negative status"]}, {"cohort": "Safety Portion", "disease_state": "relapsed or progressed", "histology_inclusion": "indolent B cell non-Hodgkin lymphoma", "biomarker_inclusion": ["follicular lymphoma grades I-IIIa", "marginal zone lymphoma", "small lymphocytic lymphoma"], "histology_exclusion": ["central nervous system lymphoma", "leptomeningeal infiltration"], "biomarker_exclusion": ["CD20-negative status"]}, {"cohort": "Expansion Portion", "disease_state": "relapsed or progressed", "histology_inclusion": "mantle cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system lymphoma", "leptomeningeal infiltration"], "biomarker_exclusion": ["CD20-negative status"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["CCND1-High", "CCND1-High", "expression"]], "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"], "biomarker_exclusion": [["MS4A1-Low", "MS4A1-Low", "expression"]]}, {"cohort": "Safety Portion", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"], "biomarker_exclusion": [["MS4A1-Low", "MS4A1-Low", "expression"]]}, {"cohort": "Expansion Portion", "histology_inclusion": "Mantle Cell Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"], "biomarker_exclusion": [["MS4A1-Low", "MS4A1-Low", "expression"]]}]}
{"NCT_id": "NCT04854434", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["RAS mutation"], "histology_exclusion": [], "biomarker_exclusion": ["MSI-H", "dMMR"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT02927340", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer (NSCLC)", "biomarker_inclusion": ["ALK rearrangement", "ROS1 rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT04463771", "json": [{"cohort": "Group A", "disease_state": "advanced or metastatic endometrial cancer", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["MSI-High"], "histology_exclusion": ["carcinosarcoma of the uterus", "sarcoma of the uterus"], "biomarker_exclusion": []}, {"cohort": "Group B", "disease_state": "advanced or metastatic endometrial cancer", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["deficient MMR", "ultra-mutated POLE tumor"], "histology_exclusion": ["carcinosarcoma of the uterus", "sarcoma of the uterus"], "biomarker_exclusion": []}, {"cohort": "Group D", "disease_state": "advanced or metastatic endometrial cancer", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["FGFR 1,2,3 mutation or alteration"], "histology_exclusion": ["sarcoma of the uterus"], "biomarker_exclusion": []}, {"cohort": "Group E", "disease_state": "advanced or metastatic endometrial cancer", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["MSS", "PD-L1 positive"], "histology_exclusion": ["carcinosarcoma of the uterus", "sarcoma of the uterus"], "biomarker_exclusion": []}, {"cohort": "Group F", "disease_state": "advanced or metastatic endometrial cancer", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["MSI-H"], "histology_exclusion": ["sarcoma of the uterus"], "biomarker_exclusion": ["LAG-#", "TIM-3 therapy", "lenvatinib"]}], "json_norm": [{"cohort": "Group A", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Uterine Corpus Carcinosarcoma", "Uterine Carcinosarcoma", "Uterine Corpus Sarcoma"]}, {"cohort": "Group B", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["POLE Mutation", "POLE-Mutation", "gene"]], "histology_exclusion": ["Uterine Corpus Carcinosarcoma", "Uterine Carcinosarcoma", "Uterine Corpus Sarcoma"]}, {"cohort": "Group D", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]], "histology_exclusion": ["Uterine Corpus Sarcoma"]}, {"cohort": "Group E", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"], ["MSI-Low", "MSI-Low", "coordinate"]], "histology_exclusion": ["Uterine Corpus Carcinosarcoma", "Uterine Carcinosarcoma", "Uterine Corpus Sarcoma"]}, {"cohort": "Group F", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]], "histology_exclusion": ["Uterine Corpus Sarcoma"], "biomarker_exclusion": [["STMN1-Low", "STMN1-Low", "expression"]]}]}
{"NCT_id": "NCT04528836", "json": [{"cohort": "Cohort A", "disease_state": "Advanced or metastatic", "histology_inclusion": "KRAS mutant solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["CNS tumors", "active CNS metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["SHP2 inhibitor"]}, {"cohort": "Cohort B", "disease_state": "Advanced or metastatic", "histology_inclusion": "solid tumor with NF1 loss-of-function", "biomarker_inclusion": [], "histology_exclusion": ["CNS tumors", "active CNS metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["SHP2 inhibitor"]}, {"cohort": "Cohort B", "disease_state": "Advanced or metastatic", "histology_inclusion": "BRAF class II/III mutant solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["CNS tumors", "active CNS metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["SHP2 inhibitor"]}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]], "histology_exclusion": ["Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Cohort B", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NF1-Low", "NF1-Low", "expression"]], "histology_exclusion": ["Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Cohort B", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRAF Class 2", "BRAF Class 2", "coordinate"]], "histology_exclusion": ["Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT04594005", "json": [{"cohort": "abemaciclib+paclitaxel", "disease_state": "locally advanced or metastatic solid tumors", "histology_inclusion": "", "biomarker_inclusion": ["CCND1 high-level amplification", "CCND2 high-level amplification", "CCND3 high-level amplification", "CCND1 mutation", "CCND1 splice variant", "CDK4 high-level amplification", "CDK6 high-level amplification"], "histology_exclusion": ["symptomatic central nervous system (CNS) metastases"], "biomarker_exclusion": ["abemaciclib-exposed patients"]}], "json_norm": [{"cohort": "abemaciclib+paclitaxel", "biomarker_inclusion": [["CCND1 Mutation", "CCND1-Mutation", "gene"], ["CCND3-High", "CCND3-High", "expression"], ["CDK6-High", "CDK6-High", "expression"], ["CCND1-High", "CCND1-High", "expression"], ["CDK4-High", "CDK4-High", "expression"], ["CCND2-High", "CCND2-High", "expression"]]}]}
{"NCT_id": "NCT04919642", "json": [{"cohort": "Cohort A1", "disease_state": "advanced/metastatic or surgically unresectable cholangiocarcinoma", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": ["FGFR2 fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A2", "disease_state": "advanced/metastatic or surgically unresectable cholangiocarcinoma", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": ["FGFR2 fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "advanced/metastatic or surgically unresectable cholangiocarcinoma", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": ["FGFR2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "advanced/metastatic or surgically unresectable cholangiocarcinoma", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": ["FGFR1 alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "advanced/metastatic or surgically unresectable cholangiocarcinoma", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": ["FGFR3 alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort C", "disease_state": "advanced/metastatic or surgically unresectable cholangiocarcinoma", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": ["FGFR wild-type"], "histology_exclusion": ["brain or central nervous system (CNS) metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A1", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["FGFR2 Fusion", "FGFR2", "fusion"]]}, {"cohort": "Cohort A2", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["FGFR2 Fusion", "FGFR2", "fusion"]]}, {"cohort": "Cohort B", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}, {"cohort": "Cohort B", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"]]}, {"cohort": "Cohort B", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["FGFR3 Mutation", "FGFR3-Mutation", "gene"]]}, {"cohort": "Cohort C", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["FGFR4 FGFR4-wild_type", "FGFR4-wild_type", "wild_type"], ["FGFR2 FGFR2-wild_type", "FGFR2-wild_type", "wild_type"], ["FGFR3 FGFR3-wild_type", "FGFR3-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["FGFR1 FGFR1-wild_type", "FGFR1-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT03253289", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma"}]}
{"NCT_id": "NCT03383575", "json": [{"cohort": "", "disease_state": "high-risk MDS", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": ["IDH2 gene mutation"], "histology_exclusion": ["central nervous system disease", "leptomeningeal involvement"], "biomarker_exclusion": ["prior targeted IDH2 inhibitor"]}, {"cohort": "", "disease_state": "refractory anemia with excess blasts in transformation", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH2 gene mutation", "blasts 20-30 percent of bone marrow nucleated cells"], "histology_exclusion": ["central nervous system disease", "leptomeningeal involvement"], "biomarker_exclusion": ["prior targeted IDH2 inhibitor"]}, {"cohort": "", "disease_state": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": ["IDH2 gene mutation"], "histology_exclusion": ["central nervous system disease", "leptomeningeal involvement"], "biomarker_exclusion": ["prior targeted IDH2 inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT03514017", "json": [{"cohort": "", "disease_state": "high risk", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Richter's transformation", "pro-lymphocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia", "histology_exclusion": ["Richter Syndrome", "Prolymphocytic Leukemia"]}]}
{"NCT_id": "NCT03839771", "json": [{"cohort": "", "disease_state": "Newly diagnosed", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["Dual IDH1 and IDH2 mutations", "FLT3 and IDH1 or IDH2 mutations"]}, {"cohort": "", "disease_state": "Newly diagnosed", "histology_inclusion": "Myelodysplastic Syndrome With Excess Blasts-2", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["Dual IDH1 and IDH2 mutations", "FLT3 and IDH1 or IDH2 mutations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]], "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"], ["FLT3 Mutation", "FLT3-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome with Excess Blasts-2", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]], "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"], ["FLT3 Mutation", "FLT3-Mutation", "gene"]]}]}
{"NCT_id": "NCT04333537", "json": [{"cohort": "", "disease_state": "T1-2N0M0", "histology_inclusion": "Buccal Mucosa Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "T1-2N0M0", "histology_inclusion": "Floor of Mouth Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "T1-2N0M0", "histology_inclusion": "Gingival Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "T1-2N0M0", "histology_inclusion": "Hard Palate Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "T1-2N0M0", "histology_inclusion": "Lip Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "T1-2N0M0", "histology_inclusion": "Lower Alveolar Ridge Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "T1-2N0M0", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "T1-2N0M0", "histology_inclusion": "Retromolar Trigone Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "T1-2N0M0", "histology_inclusion": "Tongue Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "T1-2N0M0", "histology_inclusion": "Upper Alveolar Ridge Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Tongue Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT04919811", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": ["ROS1 fusion"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"]]}]}
{"NCT_id": "NCT03579316", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "ceralasertib arm", "disease_state": "platinum-sensitive", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["germline BRCA mutant", "somatic BRCA mutant", "HRD positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "ceralasertib arm", "disease_state": "platinum-sensitive", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": ["germline BRCA mutant", "somatic BRCA mutant", "HRD positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "ceralasertib arm", "disease_state": "platinum-sensitive", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": ["germline BRCA mutant", "somatic BRCA mutant", "HRD positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "ceralasertib arm", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["TBCE-High", "TBCE-High", "expression"]]}, {"cohort": "ceralasertib arm", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["TBCE-High", "TBCE-High", "expression"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "ceralasertib arm", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [["TBCE-High", "TBCE-High", "expression"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "ceralasertib arm", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["TBCE-High", "TBCE-High", "expression"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT03709680", "json": [{"cohort": "Phase 1 and tumor specific cohorts", "disease_state": "relapsed or refractory solid tumor", "histology_inclusion": "solid tumor (including CNS tumors but not lymphomas)", "biomarker_inclusion": [], "histology_exclusion": ["lymphomas"], "biomarker_exclusion": ["prior treatment with a CDK4/6 inhibitor", "progression while on treatment with an IRN-containing regimen that includes TMZ"]}, {"cohort": "Phase 1 and tumor specific cohorts", "disease_state": "relapsed or refractory solid tumor", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with a CDK4/6 inhibitor", "progression while on treatment with an IRN-containing regimen that includes TMZ"]}, {"cohort": "Phase 1 and tumor specific cohorts", "disease_state": "relapsed or refractory solid tumor", "histology_inclusion": "EWS, rhabdoid tumor, rhabdomyosarcoma, neuroblastoma, and medulloblastoma", "biomarker_inclusion": [], "histology_exclusion": ["EWS for TOPO and CTX tumor-specific cohorts"], "biomarker_exclusion": ["prior treatment with a CDK4/6 inhibitor", "progression while on treatment with an IRN-containing regimen that includes TMZ"]}, {"cohort": "Phase 2", "disease_state": "relapsed or refractory Ewing sarcoma", "histology_inclusion": "Ewing sarcoma", "biomarker_inclusion": ["EWSR1-ETS rearrangement", "FUS-ETS rearrangement"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with a CDK4/6 inhibitor", "progression while on treatment with an IRN-containing or TMZ-containing regimen"]}, {"cohort": "All", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": ["brain tumors or brain metastases requiring steroids"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1 and tumor specific cohorts", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase 1 and tumor specific cohorts", "histology_inclusion": "Malignant Central Nervous System Neoplasm"}, {"cohort": "Phase 1 and tumor specific cohorts", "histology_inclusion": "Central Nervous System Neoplasm"}, {"cohort": "Phase 1 and tumor specific cohorts", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma"}, {"cohort": "Phase 1 and tumor specific cohorts", "histology_inclusion": "Rhabdomyosarcoma"}, {"cohort": "Phase 1 and tumor specific cohorts", "histology_inclusion": "Rhabdoid Tumor"}, {"cohort": "Phase 1 and tumor specific cohorts", "histology_inclusion": "Neuroblastoma"}, {"cohort": "Phase 1 and tumor specific cohorts", "histology_inclusion": "Medulloblastoma"}, {"cohort": "Phase 2", "histology_inclusion": "Ewing Sarcoma", "biomarker_inclusion": [["FUS Fusion", "FUS", "fusion"], ["EWSR1 Fusion", "EWSR1", "fusion"]]}, {"cohort": "All"}]}
{"NCT_id": "NCT04789668", "json": [{"cohort": "", "disease_state": "brain metastases", "histology_inclusion": "melanoma", "biomarker_inclusion": ["PD-1"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "brain metastases", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["PD-1"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "brain metastases", "histology_inclusion": "triple-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "brain metastases", "histology_inclusion": "hormone receptor positive breast adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"]]}]}
{"NCT_id": "NCT05050162", "json": [{"cohort": "Non-OPC/p16-negative OPC Cohort", "disease_state": "Advanced", "histology_inclusion": "Laryngeal Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Non-OPC/p16-negative OPC Cohort", "disease_state": "Advanced", "histology_inclusion": "Hypopharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Non-OPC/p16-negative OPC Cohort", "disease_state": "Advanced", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": ["p16-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "p16-positive OPC/CUP Cohort", "disease_state": "Advanced", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": ["p16-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "p16-positive OPC/CUP Cohort", "disease_state": "Advanced", "histology_inclusion": "Squamous Cell Carcinoma of Unknown Primary", "biomarker_inclusion": ["p16-positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Non-OPC/p16-negative OPC Cohort", "histology_inclusion": "Laryngeal Squamous Cell Carcinoma"}, {"cohort": "Non-OPC/p16-negative OPC Cohort", "histology_inclusion": "Hypopharyngeal Squamous Cell Carcinoma"}, {"cohort": "Non-OPC/p16-negative OPC Cohort", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-Low", "H3P10-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]]}, {"cohort": "p16-positive OPC/CUP Cohort", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "p16-positive OPC/CUP Cohort", "histology_inclusion": "Squamous Cell Carcinoma of Unknown Primary Origin", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}]}
{"NCT_id": "NCT05375461", "json": [{"cohort": "", "disease_state": "Advanced", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["HR-positive", "HER2-negative"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT02264210", "json": [{"cohort": "", "disease_state": "Stage IB", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR activating mutation in exon 19", "EGFR activating mutation in exon 21"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT03905148", "json": [{"cohort": "Part A", "disease_state": "advanced or metastatic, unresectable", "histology_inclusion": "NSCLC", "biomarker_inclusion": [], "histology_exclusion": ["brain or central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced or metastatic, unresectable", "histology_inclusion": "CRC", "biomarker_inclusion": [], "histology_exclusion": ["brain or central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced or metastatic, unresectable", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain or central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced or metastatic, unresectable", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain or central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced or metastatic, unresectable", "histology_inclusion": "thyroid cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain or central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced or metastatic, unresectable", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": ["brain or central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "advanced or metastatic, unresectable", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain or central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part B: Group 1", "disease_state": "advanced or metastatic, unresectable", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["K-RAS mutations"], "histology_exclusion": ["brain or central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part B: Group 2", "disease_state": "advanced or metastatic, unresectable", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["K-RAS mutations"], "histology_exclusion": ["brain or central nervous system tumors"], "biomarker_exclusion": []}, {"cohort": "Part B: Group 3", "disease_state": "advanced or metastatic, unresectable", "histology_inclusion": "Tumor types of interest based on preliminary anti-tumor activities observed in Part A", "biomarker_inclusion": [], "histology_exclusion": ["brain or central nervous system tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Part A", "histology_inclusion": "Colorectal Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Part A", "histology_inclusion": "Ovarian Epithelial Cancer", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "Part A", "histology_inclusion": "Malignant Ovarian Neoplasm", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Part A", "histology_inclusion": "Endometrial Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Part A", "histology_inclusion": "Thyroid Gland Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Part A", "histology_inclusion": "Melanoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Part A", "histology_inclusion": "Pancreatic Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Part B: Group 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Part B: Group 2", "histology_inclusion": "Endometrial Carcinoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Part B: Group 3", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT04035434", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "B-cell malignancies", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system involvement by malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "B-Cell Neoplasm"}]}
{"NCT_id": "NCT04985266", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "ER+ (Allred score 6/8 or greater, or stain in \u226510% of cancer cells) and HER2- (immunohistochemistry 0/1+ and/or negative by in situ hybridization) breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}]}
{"NCT_id": "NCT05245500", "json": [{"cohort": "Phase 1/1B", "disease_state": "unresectable or metastatic", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": ["MTAP homozygous deletion"], "histology_exclusion": ["brain metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "unresectable or metastatic", "histology_inclusion": "mesothelioma", "biomarker_inclusion": ["MTAP homozygous deletion"], "histology_exclusion": ["brain metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["PRMT5 inhibitor therapy", "MAT2A inhibitor therapy"]}, {"cohort": "Phase 2", "disease_state": "unresectable or metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": ["MTAP homozygous deletion"], "histology_exclusion": ["brain metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["PRMT5 inhibitor therapy", "MAT2A inhibitor therapy"]}, {"cohort": "Phase 2", "disease_state": "unresectable or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["MTAP homozygous deletion"], "histology_exclusion": ["brain metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["PRMT5 inhibitor therapy", "MAT2A inhibitor therapy"]}, {"cohort": "Phase 2", "disease_state": "unresectable or metastatic", "histology_inclusion": "malignant peripheral nerve sheath tumor", "biomarker_inclusion": ["MTAP homozygous deletion"], "histology_exclusion": ["brain metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["PRMT5 inhibitor therapy", "MAT2A inhibitor therapy"]}, {"cohort": "Phase 2", "disease_state": "unresectable or metastatic", "histology_inclusion": "other solid tumors", "biomarker_inclusion": ["MTAP homozygous deletion"], "histology_exclusion": ["brain metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["PRMT5 inhibitor therapy", "MAT2A inhibitor therapy"]}], "json_norm": [{"cohort": "Phase 1/1B", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase 2", "histology_inclusion": "Mesothelioma"}, {"cohort": "Phase 2", "histology_inclusion": "Pancreatic Adenocarcinoma"}, {"cohort": "Phase 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Phase 2", "histology_inclusion": "Malignant Peripheral Nerve Sheath Tumor"}, {"cohort": "Phase 2", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT05570825", "json": [{"cohort": "", "disease_state": "Metastatic or Recurrent Stage IIIC or IV", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["PD-L1 expression >= 1%", "No known oncogenic EGFR mutation", "No known ALK rearrangement", "No known ROS1 rearrangement", "No known RET fusions"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"], ["ROS1 Fusion", "ROS1", "fusion"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT03970447", "json": [{"cohort": "Newly Diagnosed", "disease_state": "Newly Diagnosed", "histology_inclusion": "Grade IV Glioblastoma", "biomarker_inclusion": ["IDH wild-type"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Recurrent", "disease_state": "Recurrent", "histology_inclusion": "Grade IV Glioblastoma", "biomarker_inclusion": ["IDH wild-type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Newly Diagnosed", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Recurrent", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04659616", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": ["t(6;9)(p23;q34.1); DEK-NUP214", "t(v;11q23.3); KMT2A rearranged", "t(9;22)(q34.1;q11.2); BCR-ABL1", "inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2,MECOM(EVI1)", "-5 or del(5q); -7; -17/abn(17p)", "complex karyotype", "monosomal karyotype", "mutated RUNX1", "mutated ASXL1", "mutated TP53"], "histology_exclusion": ["acute promyelocytic leukemia (APL, or AML M3 subtype)"], "biomarker_exclusion": ["FLT3 mutations with allelic ratio >0.05", "inv(16)", "t(8;21)", "NPM1 mutations without FLT3 ITD mutations"]}, {"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": ["wild-type or NPM1", "t(9;11)(p21.3;q23.3); MLLT3-KMT2A", "cytogenetic abnormalities not classified as favorable or adverse"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["ASXL1 Mutation", "ASXL1-Mutation", "gene"], ["BCR - ABL1", "BCR - ABL1", "coordinate"], ["RUNX1 Mutation", "RUNX1-Mutation", "gene"], ["DEK - NUP214", "DEK - NUP214", "coordinate"], ["TP53 Mutation", "TP53-Mutation", "gene"]], "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA", "Acute Myeloid Leukemia (AML)"], "biomarker_exclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["MLLT3 - KMT2A", "MLLT3 - KMT2A", "coordinate"]]}]}
{"NCT_id": "NCT03188965", "json": [{"cohort": "Part A", "disease_state": "Advanced Solid Tumor or Non-Hodgkin's Lymphoma", "histology_inclusion": "Solid Tumors or Non-Hodgkin's Lymphoma", "biomarker_inclusion": ["ATM deleterious mutation", "low ATM expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "J-arm of Part A", "disease_state": "Advanced Solid Tumor", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": ["ATM deleterious mutation", "low ATM expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A.1", "disease_state": "Advanced Solid Tumor or Non-Hodgkin's Lymphoma", "histology_inclusion": "Solid Tumors or Non-Hodgkin's Lymphoma", "biomarker_inclusion": ["ATM loss", "ATM deleterious mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "Advanced Solid Tumor", "histology_inclusion": "Castration-Resistant Prostate Cancer", "biomarker_inclusion": ["DDR deficiency"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "Advanced Solid Tumor", "histology_inclusion": "HER2-negative Breast Cancer", "biomarker_inclusion": ["DDR deficiency", "hormone-receptor positive", "TNBC"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "Advanced Solid Tumor", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["DDR deficiency"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "Advanced Solid Tumor", "histology_inclusion": "Gynecological Tumors", "biomarker_inclusion": ["DDR deficiency"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "Advanced Solid Cancer or Non-Hodgkin's Lymphoma", "histology_inclusion": "Advanced Solid Cancer or Non-Hodgkin's Lymphoma", "biomarker_inclusion": ["ATM loss"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B.1", "disease_state": "Relapsed or Refractory Mantle Cell Lymphoma", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"]]}, {"cohort": "Part A", "histology_inclusion": "Non-Hodgkin Lymphoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"]]}, {"cohort": "J-arm of Part A", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"]]}, {"cohort": "Part A.1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ATM-Low", "ATM-Low", "expression"], ["ATM Mutation", "ATM-Mutation", "gene"]]}, {"cohort": "Part A.1", "histology_inclusion": "Non-Hodgkin Lymphoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["ATM-Low", "ATM-Low", "expression"]]}, {"cohort": "Part B", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "Part B", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "Part B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["DNA Damage Repair (DDR) pathways", null, "pathway"], ["PGR-High", "PGR-High", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["ESR1-High", "ESR1-High", "expression"]]}, {"cohort": "Part B", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "Part B", "biomarker_inclusion": [["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "Part B", "histology_inclusion": "Non-Hodgkin Lymphoma", "biomarker_inclusion": [["ATM-Low", "ATM-Low", "expression"]]}, {"cohort": "Part B.1", "histology_inclusion": "Mantle Cell Lymphoma"}]}
{"NCT_id": "NCT04036682", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR Exon 20 Insertion Mutation"], "histology_exclusion": ["esophageal carcinoma", "gastric carcinoma", "pancreatic carcinoma", "hepatobiliary carcinoma", "small bowel carcinoma"], "biomarker_exclusion": []}, {"cohort": "Module A", "disease_state": "", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["esophageal carcinoma", "gastric carcinoma", "pancreatic carcinoma", "hepatobiliary carcinoma", "small bowel carcinoma", "history of gastric resection"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Small Intestinal Carcinoma", "Esophageal Carcinoma", "Pancreatic Carcinoma", "Hepatobiliary Neoplasm", "Gastric Carcinoma"]}, {"cohort": "Module A", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Small Intestinal Carcinoma", "Esophageal Carcinoma", "Pancreatic Carcinoma", "Hepatobiliary Neoplasm", "Gastric Carcinoma"]}]}
{"NCT_id": "NCT04530565", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "B-ALL", "biomarker_inclusion": ["BCR-ABL1 positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "B Acute Lymphoblastic Leukemia", "biomarker_inclusion": [["BCR - ABL1", "BCR - ABL1", "coordinate"], ["PPIB - BCR", "PPIB - BCR", "coordinate"]]}]}
{"NCT_id": "NCT04595747", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "sarcoma", "biomarker_inclusion": ["FGFR alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "SDH-deficient GIST", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Sarcoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["SDHB-Low", "SDHB-Low", "expression"], ["SARDH-Low", "SARDH-Low", "expression"], ["SDS-Low", "SDS-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["SDHB-Low", "SDHB-Low", "expression"], ["SARDH-Low", "SARDH-Low", "expression"], ["SDS-Low", "SDS-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["SDHB-Low", "SDHB-Low", "expression"], ["SARDH-Low", "SARDH-Low", "expression"], ["SDS-Low", "SDS-Low", "expression"]]}]}
{"NCT_id": "NCT04335292", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR Exon 20 insertions"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT05117476", "json": [{"cohort": "Module A Monotherapy Dose Escalation Cohort and Module B Combination Therapy Dose Escalation Cohorts", "disease_state": "metastatic or locally advanced, unresectable", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Module A Cohort Expansion A1", "disease_state": "metastatic or locally advanced, unresectable", "histology_inclusion": "non-small cell lung cancer (NSCLC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Module A Cohort Expansion A2", "disease_state": "metastatic or locally advanced, unresectable", "histology_inclusion": "cervical cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Module B Cohort Expansion B1", "disease_state": "metastatic or locally-advanced, unresectable", "histology_inclusion": "non-small cell lung cancer (NSCLC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Module B Cohort Expansion B2", "disease_state": "metastatic or locally-advanced, unresectable", "histology_inclusion": "head and neck squamous cell carcinoma (HNSCC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Module B Cohort Expansion B3", "disease_state": "metastatic or locally-advanced, unresectable", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Module A Monotherapy Dose Escalation Cohort and Module B Combination Therapy Dose Escalation Cohorts", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Module A Cohort Expansion A1", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Module A Cohort Expansion A2", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "Module B Cohort Expansion B1", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Module B Cohort Expansion B2", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Module B Cohort Expansion B3", "histology_inclusion": "Urothelial Carcinoma"}]}
{"NCT_id": "NCT03842228", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "malignancy", "biomarker_inclusion": ["BARD1 mutation", "BRCA1 mutation", "BRCA2 mutation", "BRIP1 mutation", "FANCA mutation", "NBN mutation", "PALB2 mutation", "RAD51 mutation", "RAD51B mutation", "RAD51C mutation", "RAD51D mutation", "PTEN mutation", "PIK3CA E542 mutation", "PIK3CA E545 mutation", "PIK3CA H1047 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["PTEN Mutation", "PTEN-Mutation", "gene"], ["RAD51C Mutation", "RAD51C-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["ARTN Mutation", "ARTN-Mutation", "gene"], ["RAD51B Mutation", "RAD51B-Mutation", "gene"], ["NBN Mutation", "NBN-Mutation", "gene"], ["BARD1 Mutation", "BARD1-Mutation", "gene"], ["FANCA Mutation", "FANCA-Mutation", "gene"], ["RAD51 Mutation", "RAD51-Mutation", "gene"], ["BRIP1 Mutation", "BRIP1-Mutation", "gene"], ["RAD51D Mutation", "RAD51D-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT03907488", "json": [{"cohort": "", "disease_state": "Stage III or IV", "histology_inclusion": "Classic Hodgkin Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Nodular Lymphocyte Predominant Hodgkin Lymphoma", "Central Nervous System Lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Classic Hodgkin Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma", "Nodular Lymphocyte Predominant Hodgkin Lymphoma"]}]}
{"NCT_id": "NCT04857372", "json": [{"cohort": "Group 1", "disease_state": "Advanced (unresectable or metastatic)", "histology_inclusion": "Malignant pleural mesothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group 2", "disease_state": "Advanced (unresectable or metastatic)", "histology_inclusion": "Solid tumors", "biomarker_inclusion": ["NF2 truncating mutations", "NF2 deletions"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group 3", "disease_state": "Advanced (unresectable or metastatic)", "histology_inclusion": "Solid tumors", "biomarker_inclusion": ["Functional YAP/TAZ fusions"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group 3", "disease_state": "Advanced (unresectable or metastatic)", "histology_inclusion": "Epithelioid hemangioendothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Group 1", "histology_inclusion": "Pleural Malignant Mesothelioma"}, {"cohort": "Group 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NF2 Mutation", "NF2-Mutation", "gene"]]}, {"cohort": "Group 3", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["WWTR1 Fusion", "WWTR1", "fusion"], ["TAFAZZIN Fusion", "TAFAZZIN", "fusion"]]}, {"cohort": "Group 3", "histology_inclusion": "Epithelioid Hemangioendothelioma"}]}
{"NCT_id": "NCT03190941", "json": [{"cohort": "", "disease_state": "metastatic unresectable", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["G12V mutated KRAS", "HLA-A*11:01 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic unresectable", "histology_inclusion": "gastric cancer", "biomarker_inclusion": ["G12V mutated KRAS", "HLA-A*11:01 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic unresectable", "histology_inclusion": "gastrointestinal cancer", "biomarker_inclusion": ["G12V mutated KRAS", "HLA-A*11:01 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic unresectable", "histology_inclusion": "colon cancer", "biomarker_inclusion": ["G12V mutated KRAS", "HLA-A*11:01 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic unresectable", "histology_inclusion": "rectal cancer", "biomarker_inclusion": ["G12V mutated KRAS", "HLA-A*11:01 positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["KRAS G12V", "G12V", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["KRAS G12V", "G12V", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Digestive System Neoplasm", "biomarker_inclusion": [["KRAS G12V", "G12V", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colon Carcinoma", "biomarker_inclusion": [["KRAS G12V", "G12V", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Rectal Carcinoma", "biomarker_inclusion": [["KRAS G12V", "G12V", "coordinate"]]}]}
{"NCT_id": "NCT03972943", "json": [{"cohort": "Cohort I (observation)", "disease_state": "", "histology_inclusion": "Essential Thrombocythemia", "biomarker_inclusion": ["CALR Gene Mutation", "JAK2 Gene Mutation", "MPL Gene Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort I (observation)", "disease_state": "", "histology_inclusion": "Polycythemia Vera", "biomarker_inclusion": ["CALR Gene Mutation", "JAK2 Gene Mutation", "MPL Gene Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort II: (CPAP treatment)", "disease_state": "", "histology_inclusion": "Essential Thrombocythemia", "biomarker_inclusion": ["CALR Gene Mutation", "JAK2 Gene Mutation", "MPL Gene Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort II: (CPAP treatment)", "disease_state": "", "histology_inclusion": "Polycythemia Vera", "biomarker_inclusion": ["CALR Gene Mutation", "JAK2 Gene Mutation", "MPL Gene Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort I (observation)", "histology_inclusion": "Essential Thrombocythemia", "biomarker_inclusion": [["CALR Mutation", "CALR-Mutation", "gene"], ["JAK2 Mutation", "JAK2-Mutation", "gene"], ["MPL Mutation", "MPL-Mutation", "gene"]]}, {"cohort": "Cohort I (observation)", "histology_inclusion": "Polycythemia Vera", "biomarker_inclusion": [["CALR Mutation", "CALR-Mutation", "gene"], ["JAK2 Mutation", "JAK2-Mutation", "gene"], ["MPL Mutation", "MPL-Mutation", "gene"]]}, {"cohort": "Cohort II: (CPAP treatment)", "histology_inclusion": "Essential Thrombocythemia", "biomarker_inclusion": [["CALR Mutation", "CALR-Mutation", "gene"], ["JAK2 Mutation", "JAK2-Mutation", "gene"], ["MPL Mutation", "MPL-Mutation", "gene"]]}, {"cohort": "Cohort II: (CPAP treatment)", "histology_inclusion": "Polycythemia Vera", "biomarker_inclusion": [["CALR Mutation", "CALR-Mutation", "gene"], ["JAK2 Mutation", "JAK2-Mutation", "gene"], ["MPL Mutation", "MPL-Mutation", "gene"]]}]}
{"NCT_id": "NCT05313191", "json": [{"cohort": "Cohort 1: Central Nervous System", "disease_state": "", "histology_inclusion": "Glioblastoma (histologic or molecular including IDH wildtype)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1: Central Nervous System", "disease_state": "", "histology_inclusion": "Astrocytoma (molecular IDH1 mutant)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1: Central Nervous System", "disease_state": "", "histology_inclusion": "Oligodendroglioma (molecular 1p19q co deleted)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1: Central Nervous System", "disease_state": "", "histology_inclusion": "Meningioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1: Central Nervous System", "disease_state": "", "histology_inclusion": "Ependymoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1: Central Nervous System", "disease_state": "", "histology_inclusion": "Chordoma/chondrosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1: Central Nervous System", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Cohort 1: Central Nervous System", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Cohort 1: Central Nervous System", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "Cohort 1: Central Nervous System", "histology_inclusion": "Oligodendroglioma"}, {"cohort": "Cohort 1: Central Nervous System", "histology_inclusion": "Meningioma"}, {"cohort": "Cohort 1: Central Nervous System", "histology_inclusion": "Ependymoma"}, {"cohort": "Cohort 1: Central Nervous System", "histology_inclusion": "Chordoma"}, {"cohort": "Cohort 1: Central Nervous System", "histology_inclusion": "Chondrosarcoma"}]}
{"NCT_id": "NCT03191149", "json": [{"cohort": "", "disease_state": "Stage IIIB-IV or Recurrent", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR Exon 20 Insertion Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT03516981", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutations", "B-Raf mutations", "ALK gene rearrangements", "ROS1 gene rearrangements"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04233567", "json": [{"cohort": "Cohort 1", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["FGFR1-3 fusion/translocation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["FGFR1-3 fusion/translocation"], "histology_exclusion": ["cholangiocarcinoma"], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["FGFR genetic alterations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"], ["FGFR1 Fusion", "FGFR1", "fusion"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"], ["FGFR1 Fusion", "FGFR1", "fusion"]], "histology_exclusion": ["Cholangiocarcinoma"]}, {"cohort": "Cohort 3", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}]}
{"NCT_id": "NCT02332668", "json": [{"cohort": "Melanoma", "disease_state": "advanced", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases", "carcinomatous meningitis", "brain stem tumor"], "biomarker_exclusion": []}, {"cohort": "Solid Tumors and Other Lymphomas", "disease_state": "advanced, relapsed, or refractory", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": ["PD-L1-positive"], "histology_exclusion": ["CNS metastases", "carcinomatous meningitis", "brain stem tumor"], "biomarker_exclusion": []}, {"cohort": "rrcHL", "disease_state": "relapsed or refractory", "histology_inclusion": "Classical Hodgkin Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases", "carcinomatous meningitis", "brain stem tumor"], "biomarker_exclusion": []}, {"cohort": "MSI-H", "disease_state": "advanced, relapsed, or refractory", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": ["MSI-H"], "histology_exclusion": ["CNS metastases", "carcinomatous meningitis", "brain stem tumor"], "biomarker_exclusion": []}, {"cohort": "TMB-H", "disease_state": "advanced, relapsed, or refractory", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": ["TMB-H \u226510 mutation/Mb"], "histology_exclusion": ["CNS metastases", "carcinomatous meningitis", "brain stem tumor"], "biomarker_exclusion": []}, {"cohort": "Adjuvant Melanoma", "disease_state": "resected high-risk Stage IIB, IIC, III, or IV", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases", "carcinomatous meningitis", "brain stem tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Melanoma", "histology_inclusion": "Melanoma"}, {"cohort": "Solid Tumors and Other Lymphomas", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"]]}, {"cohort": "rrcHL", "histology_inclusion": "Classic Hodgkin Lymphoma"}, {"cohort": "MSI-H", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "TMB-H", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["FUT1 Mutation", "FUT1-Mutation", "gene"], ["TMB-High", "TMB-High", "coordinate"], ["MB Mutation", "MB-Mutation", "gene"]]}, {"cohort": "Adjuvant Melanoma", "histology_inclusion": "Melanoma"}]}
{"NCT_id": "NCT03778229", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "EGFRm+ NSCLC", "biomarker_inclusion": ["EGFR mutation", "MET amplification", "MET overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["EGFR-High", "EGFR-High", "expression"]]}]}
{"NCT_id": "NCT04728230", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT05118841", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["untreated or uncontrolled central nervous system (CNS) involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "urothelial cancer", "biomarker_inclusion": [], "histology_exclusion": ["untreated or uncontrolled central nervous system (CNS) involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["untreated or uncontrolled central nervous system (CNS) involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": ["untreated or uncontrolled central nervous system (CNS) involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "non-small cell lung cancer (NSCLC)", "biomarker_inclusion": [], "histology_exclusion": ["untreated or uncontrolled central nervous system (CNS) involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["untreated or uncontrolled central nervous system (CNS) involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "squamous cell cancer of the head and neck", "biomarker_inclusion": [], "histology_exclusion": ["untreated or uncontrolled central nervous system (CNS) involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": ["untreated or uncontrolled central nervous system (CNS) involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["untreated or uncontrolled central nervous system (CNS) involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "", "histology_inclusion": "Melanoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma"}]}
{"NCT_id": "NCT03126916", "json": [{"cohort": "", "disease_state": "newly-diagnosed high-risk", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": ["MYCN amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly-diagnosed high-risk", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": ["age > 547 days"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly-diagnosed high-risk", "histology_inclusion": "ganglioneuroblastoma (nodular)", "biomarker_inclusion": ["MYCN amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly-diagnosed high-risk", "histology_inclusion": "ganglioneuroblastoma (nodular)", "biomarker_inclusion": ["age > 547 days"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Neuroblastoma"}, {"cohort": "", "histology_inclusion": "Ganglioneuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Ganglioneuroblastoma"}]}
{"NCT_id": "NCT03974022", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutation", "HER2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A Dose expansion cohort 5", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR Exon20ins"], "histology_exclusion": [], "biomarker_exclusion": ["prior systemic therapy"]}, {"cohort": "Part B Dose extension", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR Exon20ins"], "histology_exclusion": [], "biomarker_exclusion": ["Poziotinib", "TAK788", "other EGFR/HER2 exon20 insertion inhibitors"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "Part A Dose expansion cohort 5", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part B Dose extension", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04467801", "json": [{"cohort": "", "disease_state": "advanced/metastatic NSCLC", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["mixed small cell and non-small cell lung cancer"], "biomarker_exclusion": ["EGFR mutation", "BRAF mutation", "ALK mutation", "ROS1 mutation", "NTRAK mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Non-Small Cell Lung Carcinoma"], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"], ["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"]]}]}
{"NCT_id": "NCT05249114", "json": [{"cohort": "", "disease_state": "unresectable, progressive", "histology_inclusion": "well-differentiated neuroendocrine tumors of the fore-, mid-, or hindgut, including pancreas, or those with an unknown primary", "biomarker_inclusion": ["somatostatin receptor 2 positive (SSTR2)"], "histology_exclusion": ["poorly differentiated", "small cell histology"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Neuroendocrine Tumor", "biomarker_inclusion": [["SSTR2-High", "SSTR2-High", "expression"]]}]}
{"NCT_id": "NCT03843775", "json": [{"cohort": "", "disease_state": "Metastatic or advanced-stage", "histology_inclusion": "malignant tumors", "biomarker_inclusion": ["BRAF mutation (listed in Table 4 or approved by the study Principal Investigator)", "fusion involving the kinase domain of BRAF", "P367L/S", "G464V/E", "G469A/V/R", "L485W", "N486_A489delinsK", "N486_P490del", "E586K", "L597Q/V/S", "T599TT/TS", "T599I/K", "V600_K601delinsE", "K601E/N/T", "K601_S602delinsNT", "BRAF kinase duplication", "Fusions involving BRAF kinase domain"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Neoplasm", "biomarker_inclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"]]}]}
{"NCT_id": "NCT04039230", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "ER negative (ER-), PR negative (PR-), HER2 negative, invasive breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["TMEM37-Low", "TMEM37-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["TMEM37-Low", "TMEM37-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["TMEM37-Low", "TMEM37-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["TMEM37-Low", "TMEM37-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["TMEM37-Low", "TMEM37-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"]]}]}
{"NCT_id": "NCT04598321", "json": [{"cohort": "", "disease_state": "FIGO stage II, III or IV", "histology_inclusion": "epithelial ovarian, primary peritoneal or fallopian tube cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "FIGO stage II, III or IV", "histology_inclusion": "high grade serous carcinoma", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "FIGO stage II, III or IV", "histology_inclusion": "high grade endometrioid carcinoma", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": ["non-gynecologic malignancy", "synchronous primary endometrial cancer", "primary endometrial cancer"], "biomarker_exclusion": ["prior exposure to a PARP inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Ovarian Serous Adenocarcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Endometrioid Adenocarcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]], "histology_exclusion": ["Endometrial Carcinoma"]}]}
{"NCT_id": "NCT05054374", "json": [{"cohort": "Arm 1 (metastatic breast cancer)", "disease_state": "metastatic", "histology_inclusion": "hormone receptor-positive metastatic breast cancer", "biomarker_inclusion": ["ER+", "HER2-negative", "NF1 loss of function", "MAPK-activating genomic alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm 2 (advanced solid cancers)", "disease_state": "advanced, metastatic", "histology_inclusion": "advanced solid tumor cancer", "biomarker_inclusion": ["MEK1 D67N", "MEK1 P124L", "MEK1 P124S", "MEK1 K57N", "MEK1 C121S", "MEK1 F53L", "MEK1 Q56P"], "histology_exclusion": ["colorectal cancer", "anal cancer", "small bowel cancer", "biliary cancer", "ampullary cancer"], "biomarker_exclusion": ["MEK1 L98-I103", "MEK1 I99-K104", "MEK1 E102-I103"]}, {"cohort": "Arm 2 (advanced solid cancers)", "disease_state": "advanced, metastatic", "histology_inclusion": "advanced solid tumor cancer", "biomarker_inclusion": ["MEK2 F57", "MEK2 Q60", "MEK2 K61", "MEK2 V64", "MEK2 D71", "MEK2 C125", "MEK2 P128", "MEK2 Y134", "MEK2 E207"], "histology_exclusion": ["colorectal cancer", "anal cancer", "small bowel cancer", "biliary cancer", "ampullary cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm 1 (metastatic breast cancer)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["EREG-High", "EREG-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["NF1-Low", "NF1-Low", "expression"]]}, {"cohort": "Arm 1 (metastatic breast cancer)", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"], ["NF1-Low", "NF1-Low", "expression"], ["ESR1-High", "ESR1-High", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Arm 2 (advanced solid cancers)", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MAP2K1 C121S", "C121S", "coordinate"], ["MAP2K1 K57N", "K57N", "coordinate"], ["MAP2K1 D67N", "D67N", "coordinate"], ["MAP2K1 F53L", "F53L", "coordinate"], ["MAP2K1 Q56P", "Q56P", "coordinate"], ["MAP2K1 P124L", "P124L", "coordinate"], ["MAP2K1 P124S", "P124S", "coordinate"]], "histology_exclusion": ["Ampulla of Vater Carcinoma", "Anal Neoplasm", "Anal Carcinoma", "Small Intestinal Carcinoma", "Colorectal Carcinoma"]}, {"cohort": "Arm 2 (advanced solid cancers)", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Ampulla of Vater Carcinoma", "Anal Neoplasm", "Anal Carcinoma", "Small Intestinal Carcinoma", "Colorectal Carcinoma"]}]}
{"NCT_id": "NCT01810913", "json": [{"cohort": "", "disease_state": "Stage III-IV", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III-IV", "histology_inclusion": "Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III", "histology_inclusion": "Hypopharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III", "histology_inclusion": "Laryngeal Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Hypopharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Laryngeal Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma", "biomarker_inclusion": [["CDKN2A-Low", "CDKN2A-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Hypopharyngeal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Laryngeal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Hypopharyngeal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Laryngeal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT03909334", "json": [{"cohort": "", "disease_state": "Locally advanced or metastatic", "histology_inclusion": "Non-squamous, non-small cell lung cancer", "biomarker_inclusion": ["EGFR Exon 19 deletion"], "histology_exclusion": [], "biomarker_exclusion": ["Previous treatment with any EGFR TKIs"]}, {"cohort": "", "disease_state": "Locally advanced or metastatic", "histology_inclusion": "Non-squamous, non-small cell lung cancer", "biomarker_inclusion": ["EGFR L858R mutation"], "histology_exclusion": [], "biomarker_exclusion": ["Previous treatment with any EGFR TKIs"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR exon 19 del", "exon 19 del", "exon"]]}, {"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"]]}]}
{"NCT_id": "NCT04169737", "json": [{"cohort": "Cohort 1", "disease_state": "untreated, high-risk or >= 65 years of age", "histology_inclusion": "chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)", "biomarker_inclusion": ["del(17p)", "mutated TP53", "del(11q)", "unmutated IGHV", "complex karyotype"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "relapsed or refractory", "histology_inclusion": "chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with combined BTKi and BCL2i"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Small Lymphocytic Lymphoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Cohort 1", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Small Lymphocytic Lymphoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Chronic Lymphocytic Leukemia"}]}
{"NCT_id": "NCT02997228", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of colon or rectal", "biomarker_inclusion": ["dMMR", "MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT03779191", "json": [{"cohort": "", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Non-squamous Non-small Cell Lung Cancer", "biomarker_inclusion": ["ALK-rearrangement"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": ["EGFR mutations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK Fusion", "ALK", "fusion"]], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT05379972", "json": [{"cohort": "HR deficient cohort", "disease_state": "metastatic", "histology_inclusion": "gastric or GEJ adenocarcinoma", "biomarker_inclusion": ["ARID1A", "ATM", "ATRX", "MRE11A", "NBN", "PTEN", "RAD50", "RAD51", "RAD51B", "BARD1", "BLM", "BRCA1", "BRCA2", "BRIP1", "FANCA", "FANCC", "FANCD2", "FANCE", "FANCF", "FANCG", "FANCL", "PALB2", "WRN", "CHEK2", "CHEK1", "BAP1", "FAM175A", "SLX4", "MLL2", "XRCC"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "HR proficient cohort", "disease_state": "metastatic", "histology_inclusion": "gastric or GEJ adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["ARID1A", "ATM", "ATRX", "MRE11A", "NBN", "PTEN", "RAD50", "RAD51", "RAD51B", "BARD1", "BLM", "BRCA1", "BRCA2", "BRIP1", "FANCA", "FANCC", "FANCD2", "FANCE", "FANCF", "FANCG", "FANCL", "PALB2", "WRN", "CHEK2", "CHEK1", "BAP1", "FAM175A", "SLX4", "MLL2", "XRCC"]}], "json_norm": [{"cohort": "HR deficient cohort", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "HR proficient cohort", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}]}
{"NCT_id": "NCT04104893", "json": [{"cohort": "", "disease_state": "metastatic castration-resistant prostate cancer", "histology_inclusion": "adenocarcinoma or small cell histology", "biomarker_inclusion": ["dMMR", "CDK12-/-"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["CDK12-Low", "CDK12-Low", "expression"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04533750", "json": [{"cohort": "", "disease_state": "Stage III-IV", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III-IV", "histology_inclusion": "Hypopharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III-IV", "histology_inclusion": "Laryngeal Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III-IV", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III-IV", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": ["p16-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage III", "histology_inclusion": "HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Hypopharyngeal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Laryngeal Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Oral Cavity Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-Low", "H3P10-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Oropharyngeal Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Oropharyngeal Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}]}
{"NCT_id": "NCT05184816", "json": [{"cohort": "Phase 1a", "disease_state": "Leptomeningeal Metastasis", "histology_inclusion": "Solid tumor malignancy", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "Leptomeningeal Metastasis", "histology_inclusion": "Non-small cell lung cancer (NSCLC)", "biomarker_inclusion": ["EGFR", "ALK", "ROS1", "KRAS"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1a", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase 1b", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04170153", "json": [{"cohort": "Part A3", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["ARIDIA loss of function mutation", "ATRX loss of function mutation", "DAXX loss of function mutation", "ATM loss of function mutation"], "histology_exclusion": ["meningeal carcinomatosis"], "biomarker_exclusion": []}, {"cohort": "Part B1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["meningeal carcinomatosis", "prostrate cancer"], "biomarker_exclusion": ["acute myeloid leukemia (AML)", "myelodysplastic syndromes (MDS)", "ATR inhibitor", "CHK1 inhibitor"]}], "json_norm": [{"cohort": "Part A3", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["ATRX Mutation", "ATRX-Mutation", "gene"], ["DAXX Mutation", "DAXX-Mutation", "gene"], ["ATRX-Low", "ATRX-Low", "expression"], ["DAXX-Low", "DAXX-Low", "expression"], ["ATM-Low", "ATM-Low", "expression"]]}, {"cohort": "Part B1", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT02530034", "json": [{"cohort": "", "disease_state": "high-risk MDS (refractory anemia with excess blasts [RAEB-1 or RAEB-2], or any WHO subset with IPSS intermediate-2 or high, or any patients that have failed prior therapy with hypomethylating agents)", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": ["HLA-A2"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "chronic myelomonocytic leukemia (CMML)", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": ["HLA-A2"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "acute myeloid leukemia (AML)", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["HLA-A2"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "chronic myeloid leukemia in blast phase (CML-BP)", "histology_inclusion": "Chronic Myeloid Leukemia", "biomarker_inclusion": ["HLA-A2"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "myelofibrosis with high-risk features (accelerated phase disease -10-19% blasts in peripheral blood or bone marrow-, or with DIPSS-plus high risk score)", "histology_inclusion": "Myelofibrosis", "biomarker_inclusion": ["HLA-A2"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive"}, {"cohort": "", "histology_inclusion": "Myelofibrosis"}]}
{"NCT_id": "NCT04300556", "json": [{"cohort": "Dose-Escalation", "disease_state": "metastatic", "histology_inclusion": "triple-negative breast cancer", "biomarker_inclusion": ["ER negative", "PR negative", "HER2 negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose-Escalation", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung carcinoma adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR-targeted therapy failure", "ALK-targeted therapy failure", "BRAF-targeted therapy failure", "ROS1-targeted therapy failure"]}, {"cohort": "Dose-Escalation", "disease_state": "advanced, recurrent or metastatic", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose-Escalation", "disease_state": "platinum-resistant", "histology_inclusion": "high grade serous epithelial ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose-Escalation", "disease_state": "platinum-resistant", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose-Escalation", "disease_state": "platinum-resistant", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose-Confirmation", "disease_state": "platinum-resistant", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose-Confirmation", "disease_state": "platinum-resistant", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose-Confirmation", "disease_state": "platinum-resistant", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose-Confirmation", "disease_state": "advanced, recurrent, or metastatic", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose-Escalation", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["PRH2-Low", "PRH2-Low", "expression"], ["TMEM37-Low", "TMEM37-Low", "expression"]]}, {"cohort": "Dose-Escalation", "histology_inclusion": "Lung Adenocarcinoma"}, {"cohort": "Dose-Escalation", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "Dose-Escalation", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Dose-Escalation", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "Dose-Escalation", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "Dose-Confirmation", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Dose-Confirmation", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "Dose-Confirmation", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "Dose-Confirmation", "histology_inclusion": "Fallopian Tube Carcinoma"}, {"cohort": "Dose-Confirmation", "histology_inclusion": "Endometrial Carcinoma"}]}
{"NCT_id": "NCT04599140", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "adenocarcinoma of the colon or the rectal", "biomarker_inclusion": ["RAS-mutated (KRAS or NRAS)", "microsatellite stable/proficient in mismatch repair"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT04729322", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["dMMR", "MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT02595866", "json": [{"cohort": "", "disease_state": "Metastatic or locally advanced", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Failed standard first-line therapy", "histology_inclusion": "AIDS-related non-Hodgkin lymphoma and other non-Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed or refractory de novo classical Hodgkin lymphoma", "histology_inclusion": "Classical Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Not eligible for curative attempt resection or liver transplant", "histology_inclusion": "Hepatocellular carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Kaposi sarcoma impacting physical and/or psychological wellbeing and not amenable to local therapy", "histology_inclusion": "Kaposi sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["human herpesvirus 8 (KSHV)-associated multicentric Castleman disease", "symptomatic pulmonary Kapsoi sarcoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Unresectable or metastatic", "histology_inclusion": "Melanoma", "biomarker_inclusion": ["BRAF V600 positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Non-Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Classic Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "", "histology_inclusion": "Sarcoma", "histology_exclusion": ["Sarcoma"]}, {"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF-High", "BRAF-High", "expression"]]}]}
{"NCT_id": "NCT03714958", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["RAS mutation", "RAF mutation", "TP53 wild-type"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["KRAS mutation", "NRAS mutation", "HRAS mutation", "BRAF mutation", "TP53 wild-type"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["BRAF translocation", "TP53 wild-type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF Fusion", "BRAF", "fusion"]]}]}
{"NCT_id": "NCT03845166", "json": [{"cohort": "Expansion Cohort A", "disease_state": "advanced", "histology_inclusion": "clear cell renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohorts B and E", "disease_state": "advanced", "histology_inclusion": "non-clear cell renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohorts C and F", "disease_state": "advanced", "histology_inclusion": "hormone receptor positive breast cancer", "biomarker_inclusion": ["ER+", "PR+", "HER-2-"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohorts D and G", "disease_state": "metastatic castration-resistant", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort H", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["KRAS/NRAS wild-type", "NOT MSI-high", "NOT dMMR"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort I", "disease_state": "unresectable, locally advanced or metastatic", "histology_inclusion": "transitional cell carcinoma of the urothelium", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort J", "disease_state": "unresectable, locally advanced or metastatic", "histology_inclusion": "transitional cell carcinoma of the urothelium", "biomarker_inclusion": ["PD-1/PD-L1 targeting ICI therapy"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort K", "disease_state": "unresectable, locally advanced or metastatic", "histology_inclusion": "transitional cell carcinoma of the urothelium", "biomarker_inclusion": ["first-line platinum-based combination therapy"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Expansion Cohort A", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}, {"cohort": "Expansion Cohorts B and E", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "Expansion Cohorts C and F", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["EREG-High", "EREG-High", "expression"], ["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Expansion Cohorts C and F", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["PRH2-High", "PRH2-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["ESR1-High", "ESR1-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Expansion Cohorts D and G", "histology_inclusion": "Prostate Adenocarcinoma"}, {"cohort": "Expansion Cohort H", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["NR4A2-High", "NR4A2-High", "expression"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}, {"cohort": "Expansion Cohort I", "histology_inclusion": "Transitional Cell Carcinoma"}, {"cohort": "Expansion Cohort J", "histology_inclusion": "Transitional Cell Carcinoma"}, {"cohort": "Expansion Cohort K", "histology_inclusion": "Transitional Cell Carcinoma"}]}
{"NCT_id": "NCT04925284", "json": [{"cohort": "B", "disease_state": "Stage IV", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "C", "disease_state": "", "histology_inclusion": "Urothelial Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "D", "disease_state": "Platinum-resistant", "histology_inclusion": "High-grade Serous Ovarian Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "E", "disease_state": "", "histology_inclusion": "Cervical Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "F", "disease_state": "", "histology_inclusion": "Head and Neck Cancer (Squamous Cell Histology)", "biomarker_inclusion": [], "histology_exclusion": ["Nasopharynx"], "biomarker_exclusion": []}, {"cohort": "G", "disease_state": "", "histology_inclusion": "Pancreatic Cancer (Adenocarcinoma Histology)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "H", "disease_state": "", "histology_inclusion": "Esophageal Cancer (Squamous Cell Histology)", "biomarker_inclusion": [], "histology_exclusion": ["Esophageal Adenocarcinoma", "Adenocarcinoma of Gastroesophageal Junction"], "biomarker_exclusion": []}, {"cohort": "I", "disease_state": "Metastatic, Castration Resistant", "histology_inclusion": "Adenocarcinoma of the Prostate", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "J", "disease_state": "", "histology_inclusion": "Triple-negative Breast Cancer", "biomarker_inclusion": ["ER-", "PR-", "HER-2-"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "K", "disease_state": "", "histology_inclusion": "Hormone Receptor-positive Breast Cancer", "biomarker_inclusion": ["ER+", "PR+", "HER-2-"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "B", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "C", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "D", "histology_inclusion": "Ovarian Serous Adenocarcinoma"}, {"cohort": "E", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "F", "histology_inclusion": "Malignant Head and Neck Neoplasm"}, {"cohort": "F", "histology_inclusion": "Head and Neck Carcinoma"}, {"cohort": "G", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "G", "histology_inclusion": "Pancreatic Carcinoma"}, {"cohort": "H", "histology_inclusion": "Esophageal Carcinoma", "histology_exclusion": ["Gastroesophageal Junction Adenocarcinoma", "Esophageal Adenocarcinoma"]}, {"cohort": "I", "histology_inclusion": "Prostate Adenocarcinoma"}, {"cohort": "J", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["PRH2-Low", "PRH2-Low", "expression"], ["TMEM37-Low", "TMEM37-Low", "expression"]]}, {"cohort": "K", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["EREG-High", "EREG-High", "expression"], ["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "K", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["PRH2-High", "PRH2-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["ESR1-High", "ESR1-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"]]}]}
{"NCT_id": "NCT04990479", "json": [{"cohort": "Cohort 1a and 2a", "disease_state": "unresectable stage III or stage IV", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2b", "disease_state": "stage IV", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["PD-L1 \u226550% TPS"], "histology_exclusion": ["EGFR genomic alteration", "ALK/ROS1/RET genomic alteration"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1a and 2a", "histology_inclusion": "Cutaneous Melanoma"}, {"cohort": "Cohort 2b", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["RET Mutation", "RET-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"], ["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"]]}]}
{"NCT_id": "NCT02595931", "json": [{"cohort": "", "disease_state": "metastatic or unresectable malignancy that is refractory to standard therapy or for which no standard therapy exists", "histology_inclusion": "any solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort", "disease_state": "", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["ATM mutation", "PALB2 mutation", "BRCA1/2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort", "disease_state": "", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["ATM mutation", "PALB2 mutation", "BRCA1/2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort", "disease_state": "", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": ["ATM mutation", "PALB2 mutation", "BRCA1/2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Expansion Cohort", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"]]}, {"cohort": "Expansion Cohort", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"]]}, {"cohort": "Expansion Cohort", "histology_inclusion": "Small Cell Lung Carcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"]]}]}
{"NCT_id": "NCT03389230", "json": [{"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "grade III or IV glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent or refractory", "histology_inclusion": "grade II glioma with radiographic progression consistent with a grade III or IV malignant glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioma"}, {"cohort": "", "histology_inclusion": "Grade II Glioma"}, {"cohort": "", "histology_inclusion": "Malignant Glioma"}]}
{"NCT_id": "NCT05446298", "json": [{"cohort": "", "disease_state": "platinum-resistant", "histology_inclusion": "high-grade serous ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["carcinosarcoma", "malignant mixed Mullerian tumor", "clear cell carcinoma", "endometrioid", "low grade serous", "clear cell", "mucinous adenocarcinoma", "ovarian cancer not otherwise specified"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "platinum-resistant", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": ["carcinosarcoma", "malignant mixed Mullerian tumor", "clear cell carcinoma", "endometrioid", "low grade serous", "clear cell", "mucinous adenocarcinoma", "ovarian cancer not otherwise specified"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "platinum-resistant", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": ["carcinosarcoma", "malignant mixed Mullerian tumor", "clear cell carcinoma", "endometrioid", "low grade serous", "clear cell", "mucinous adenocarcinoma", "ovarian cancer not otherwise specified"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Serous Adenocarcinoma", "histology_exclusion": ["Carcinosarcoma", "Mucinous Adenocarcinoma", "Malignant Ovarian Neoplasm", "Endometrial Clear Cell Adenocarcinoma", "Ovarian Epithelial Cancer", "Malignant Mixed Mesodermal (Mullerian) Tumor"]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "histology_exclusion": ["Carcinosarcoma", "Mucinous Adenocarcinoma", "Malignant Ovarian Neoplasm", "Endometrial Clear Cell Adenocarcinoma", "Ovarian Epithelial Cancer", "Malignant Mixed Mesodermal (Mullerian) Tumor"]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "histology_exclusion": ["Carcinosarcoma", "Mucinous Adenocarcinoma", "Malignant Ovarian Neoplasm", "Endometrial Clear Cell Adenocarcinoma", "Ovarian Epithelial Cancer", "Malignant Mixed Mesodermal (Mullerian) Tumor"]}]}
{"NCT_id": "NCT04236414", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "solid or primary CNS tumours", "biomarker_inclusion": ["HRR deficiency/gene mutation"], "histology_exclusion": ["lymphoid malignancies"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "osteosarcoma", "biomarker_inclusion": ["HRR deficiency/gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "rhabdomyosarcoma", "biomarker_inclusion": ["HRR deficiency/gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "non rhabdomyosarcoma soft tissue sarcoma", "biomarker_inclusion": ["HRR deficiency/gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Ewing Sarcoma", "biomarker_inclusion": ["HRR deficiency/gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": ["HRR deficiency/gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "medulloblastoma", "biomarker_inclusion": ["HRR deficiency/gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "glioma", "biomarker_inclusion": ["HRR deficiency/gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Primary Brain Neoplasm", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]], "histology_exclusion": ["Lymphoma", "Lymphocytic Neoplasm"]}, {"cohort": "", "histology_inclusion": "Osteosarcoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Rhabdomyosarcoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Rhabdomyosarcoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Soft Tissue Sarcoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Ewing Sarcoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Medulloblastoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}]}
{"NCT_id": "NCT04991103", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": ["POEMS", "Waldenstrom's macroglobulinemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Waldenstrom Macroglobulinemia"]}]}
{"NCT_id": "NCT02205047", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "gastric or gastroesophageal (GE)-junction adenocarcinoma (Siewert I-III)", "biomarker_inclusion": ["HER-2 overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04535401", "json": [{"cohort": "Dose Escalation", "disease_state": "advanced or metastatic", "histology_inclusion": "gastrointestinal (GI) cancers", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion - Colorectal Cancer", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["mismatch repair deficiency"]}, {"cohort": "Dose Expansion - Gastroesophageal Cancer", "disease_state": "metastatic", "histology_inclusion": "gastroesophageal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["mismatch repair deficiency"]}], "json_norm": [{"cohort": "Dose Escalation"}, {"cohort": "Dose Expansion - Colorectal Cancer", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Dose Expansion - Gastroesophageal Cancer", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}]}
{"NCT_id": "NCT03520686", "json": [{"cohort": "", "disease_state": "stage 3 or 4 advanced or metastatic", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR sensitizing (activating) mutation", "ALK translocation", "BRAF targetable genomic aberration", "ROS1 targetable genomic aberration", "NTRK targetable genomic aberration"]}, {"cohort": "Cohort A", "disease_state": "stage 3 or 4 advanced or metastatic", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": ["PD-L1 expression (TPS \u22651%)"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR sensitizing (activating) mutation", "ALK translocation", "BRAF targetable genomic aberration", "ROS1 targetable genomic aberration", "NTRK targetable genomic aberration"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["NTRK3 Mutation", "NTRK3-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"], ["NTRK2 Mutation", "NTRK2-Mutation", "gene"], ["NTRK1 Mutation", "NTRK1-Mutation", "gene"], ["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"]]}, {"cohort": "Cohort A", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["NTRK3 Mutation", "NTRK3-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"], ["NTRK2 Mutation", "NTRK2-Mutation", "gene"], ["NTRK1 Mutation", "NTRK1-Mutation", "gene"], ["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"]]}]}
{"NCT_id": "NCT05057013", "json": [{"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "disease_state": "advanced or metastatic", "histology_inclusion": "Bladder cancer", "biomarker_inclusion": ["HER3 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "disease_state": "advanced or metastatic", "histology_inclusion": "Triple negative breast cancer", "biomarker_inclusion": ["HER3 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "disease_state": "advanced or metastatic", "histology_inclusion": "Castration resistant prostate cancer", "biomarker_inclusion": ["HER3 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "disease_state": "advanced or metastatic", "histology_inclusion": "Cervical cancer", "biomarker_inclusion": ["HER3 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "disease_state": "advanced or metastatic", "histology_inclusion": "RAS wild type colorectal cancer", "biomarker_inclusion": ["HER3 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "disease_state": "advanced or metastatic", "histology_inclusion": "Endometrial cancer", "biomarker_inclusion": ["HER3 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "disease_state": "advanced or metastatic", "histology_inclusion": "Gastric cancer", "biomarker_inclusion": ["HER3 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "disease_state": "advanced or metastatic", "histology_inclusion": "Hepatocellular carcinoma (HCC)", "biomarker_inclusion": ["HER3 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "disease_state": "advanced or metastatic", "histology_inclusion": "Melanoma", "biomarker_inclusion": ["HER3 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "disease_state": "advanced or metastatic", "histology_inclusion": "Non-small cell lung cancer (NSCLC)", "biomarker_inclusion": ["HER3 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "disease_state": "advanced or metastatic", "histology_inclusion": "Oesophageal cancer", "biomarker_inclusion": ["HER3 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "disease_state": "advanced or metastatic", "histology_inclusion": "Ovarian cancer", "biomarker_inclusion": ["HER3 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "disease_state": "advanced or metastatic", "histology_inclusion": "Pancreatic cancer", "biomarker_inclusion": ["HER3 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "disease_state": "advanced or metastatic", "histology_inclusion": "Squamous cell cancer of the head and neck", "biomarker_inclusion": ["HER3 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B Arm 1 Monotherapy Dose Expansion", "disease_state": "advanced or metastatic", "histology_inclusion": "Castration resistant prostate cancer", "biomarker_inclusion": ["HER3 positive", "NRG1 fusion rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B Arm 1 Monotherapy Dose Expansion", "disease_state": "advanced or metastatic", "histology_inclusion": "RAS wild type colorectal cancer", "biomarker_inclusion": ["HER3 positive", "NRG1 fusion rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B Arm 1 Monotherapy Dose Expansion", "disease_state": "advanced or metastatic", "histology_inclusion": "Triple negative breast cancer", "biomarker_inclusion": ["HER3 positive", "NRG1 fusion rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B Arm 1 Monotherapy Dose Expansion", "disease_state": "advanced or metastatic", "histology_inclusion": "Squamous cell cancer of the head and neck", "biomarker_inclusion": ["HER3 positive", "NRG1 fusion rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "histology_inclusion": "Bladder Carcinoma", "biomarker_inclusion": [["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "histology_inclusion": "Bladder Neoplasm", "biomarker_inclusion": [["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "histology_inclusion": "Cervical Carcinoma", "biomarker_inclusion": [["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"], ["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"], ["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["ERBB3-High", "ERBB3-High", "expression"], ["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "histology_inclusion": "Esophageal Carcinoma", "biomarker_inclusion": [["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part A Arm 1 Monotherapy Dose Escalation", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part B Arm 1 Monotherapy Dose Expansion", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["ERBB3-High", "ERBB3-High", "expression"], ["NRG1 Fusion", "NRG1", "fusion"]]}, {"cohort": "Part B Arm 1 Monotherapy Dose Expansion", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["NRG1 Fusion", "NRG1", "fusion"], ["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part B Arm 1 Monotherapy Dose Expansion", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"], ["ERBB3-High", "ERBB3-High", "expression"], ["NRG1 Fusion", "NRG1", "fusion"]]}, {"cohort": "Part B Arm 1 Monotherapy Dose Expansion", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"], ["ERBB3-High", "ERBB3-High", "expression"], ["NRG1 Fusion", "NRG1", "fusion"]]}, {"cohort": "Part B Arm 1 Monotherapy Dose Expansion", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["NRG1 Fusion", "NRG1", "fusion"], ["ERBB3-High", "ERBB3-High", "expression"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}, {"cohort": "Part B Arm 1 Monotherapy Dose Expansion", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["NRG1 Fusion", "NRG1", "fusion"], ["Triple-Negative", "Triple-Negative", "coordinate"], ["ERBB3-High", "ERBB3-High", "expression"]]}, {"cohort": "Part B Arm 1 Monotherapy Dose Expansion", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["NRG1 Fusion", "NRG1", "fusion"], ["ERBB3-High", "ERBB3-High", "expression"]]}]}
{"NCT_id": "NCT05382559", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": ["KRAS G12D mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "ASP3082 Combination Therapy for CRC", "disease_state": "locally advanced or metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["KRAS G12D mutation"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with a specific KRAS G12D inhibitor/degrader or pan-RAS inhibitor/degrader targeting KRAS G12D"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"]]}, {"cohort": "ASP3082 Combination Therapy for CRC", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"]]}]}
{"NCT_id": "NCT03847519", "json": [{"cohort": "Part A", "disease_state": "metastatic", "histology_inclusion": "squamous NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part A", "disease_state": "metastatic", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "metastatic", "histology_inclusion": "squamous NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "metastatic", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "metastatic", "histology_inclusion": "squamous NSCLC", "biomarker_inclusion": ["PD-L1 expression \u226550%"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR sensitizing mutation", "ALK translocation"]}, {"cohort": "Part C", "disease_state": "metastatic", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": ["PD-L1 expression \u226550%"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR sensitizing mutation", "ALK translocation"]}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Squamous Cell Lung Carcinoma"}, {"cohort": "Part A", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma"}, {"cohort": "Part B", "histology_inclusion": "Squamous Cell Lung Carcinoma"}, {"cohort": "Part B", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma"}, {"cohort": "Part C", "histology_inclusion": "Squamous Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Part C", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT05383482", "json": [{"cohort": "Phase II", "disease_state": "metastatic, recurrent or persistent", "histology_inclusion": "squamous cell carcinoma, adenosquamous carcinoma, adenocarcinoma of the cervix", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II", "disease_state": "metastatic, recurrent or persistent", "histology_inclusion": "Epithelial Endometrial Carcinoma with endometrioid, high grade serous, or clear cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II", "disease_state": "local advanced, recurrent or metastasis", "histology_inclusion": "esophageal squamous cell carcinoma or Her2- adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II", "disease_state": "locally advanced, recurrent, or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer (squamous cell carcinoma or adenocarcinoma, adenosquamous carcinoma)", "biomarker_inclusion": ["EGFR wild type", "KRAS wild type", "ALK-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II", "disease_state": "locally advanced, recurrent, or metastatic", "histology_inclusion": "Her2- gastric adenocarcinoma or gastroesophageal junction adenocarcinoma or squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase II", "histology_inclusion": "Cervical Adenosquamous Carcinoma"}, {"cohort": "Phase II", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "Phase II", "histology_inclusion": "Cervical Adenocarcinoma"}, {"cohort": "Phase II", "histology_inclusion": "Pancreatic Adenosquamous Carcinoma"}, {"cohort": "Phase II", "histology_inclusion": "Endocervical Carcinoma"}, {"cohort": "Phase II", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "Phase II", "histology_inclusion": "Endometrial Clear Cell Adenocarcinoma"}, {"cohort": "Phase II", "histology_inclusion": "Esophageal Squamous Cell Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Phase II", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Phase II", "histology_inclusion": "Cervical Adenosquamous Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["ALK-Low", "ALK-Low", "expression"], ["ALK-Low", "ALK-Low", "expression"], ["ALK-Low", "ALK-Low", "expression"], ["ALK-Low", "ALK-Low", "expression"]]}, {"cohort": "Phase II", "histology_inclusion": "Squamous Cell Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["ALK-Low", "ALK-Low", "expression"], ["ALK-Low", "ALK-Low", "expression"], ["ALK-Low", "ALK-Low", "expression"], ["ALK-Low", "ALK-Low", "expression"]]}, {"cohort": "Phase II", "histology_inclusion": "Pancreatic Adenosquamous Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["ALK-Low", "ALK-Low", "expression"], ["ALK-Low", "ALK-Low", "expression"], ["ALK-Low", "ALK-Low", "expression"], ["ALK-Low", "ALK-Low", "expression"]]}, {"cohort": "Phase II", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["ALK-Low", "ALK-Low", "expression"], ["ALK-Low", "ALK-Low", "expression"], ["ALK-Low", "ALK-Low", "expression"], ["ALK-Low", "ALK-Low", "expression"]]}, {"cohort": "Phase II", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["ALK-Low", "ALK-Low", "expression"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"]]}, {"cohort": "Phase II", "histology_inclusion": "Squamous Cell Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Phase II", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Phase II", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT05059236", "json": [{"cohort": "", "disease_state": "Metastatic Hormone-sensitive Prostate Cancer", "histology_inclusion": "adenocarcinoma of prostate", "biomarker_inclusion": [], "histology_exclusion": ["small cell carcinoma of the prostate", "neuroendocrine carcinoma of the prostate"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "histology_exclusion": ["Prostate Neuroendocrine Neoplasm", "Prostate Small Cell Neuroendocrine Carcinoma", "Prostate Neuroendocrine Carcinoma"]}]}
{"NCT_id": "NCT04929028", "json": [{"cohort": "High-risk stratum", "disease_state": "Stage T3-T4N0M0 OR T2-4N1M0", "histology_inclusion": "Invasive squamous cell carcinoma (SCC) of the anus or anorectum", "biomarker_inclusion": ["HIV-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "High-risk stratum", "disease_state": "Stage T3-T4N0M0 OR T2-4N1M0", "histology_inclusion": "Squamous cell carcinoma of the anal margin with extension into the anal canal", "biomarker_inclusion": ["HIV-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "High-risk stratum", "disease_state": "Stage T3-T4N0M0 OR T2-4N1M0", "histology_inclusion": "Non-keratinizing histology such as basaloid, transitional cell or cloacogenic", "biomarker_inclusion": ["HIV-positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "High-risk stratum", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "High-risk stratum", "histology_inclusion": "Anal Margin Squamous Cell Carcinoma"}, {"cohort": "High-risk stratum"}]}
{"NCT_id": "NCT04929041", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["PD-L1 TPS < 1%"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR actionable mutations (except exon 20 insertion)", "ALK mutations", "ROS1 mutations"]}, {"cohort": "", "disease_state": "Stage IIIB", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["PD-L1 TPS < 1%"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR actionable mutations (except exon 20 insertion)", "ALK mutations", "ROS1 mutations"]}, {"cohort": "", "disease_state": "Stage IIIC", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["PD-L1 TPS < 1%"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR actionable mutations (except exon 20 insertion)", "ALK mutations", "ROS1 mutations"]}, {"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": ["PD-L1 TPS < 1%"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR actionable mutations (except exon 20 insertion)", "ALK mutations", "ROS1 mutations"]}, {"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Lung Adenosquamous Carcinoma", "biomarker_inclusion": ["PD-L1 TPS < 1%"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR actionable mutations (except exon 20 insertion)", "ALK mutations", "ROS1 mutations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_exclusion": [["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Adenosquamous Lung Carcinoma", "biomarker_exclusion": [["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"]]}]}
{"NCT_id": "NCT04538378", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "EGFR-mutated non-small-cell lung carcinoma (NSCLC) transformed to small cell lung cancer (SCLC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "EGFR-mutated non-small-cell lung carcinoma (NSCLC) transformed to neuroendocrine tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Neuroendocrine Tumor", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT03589326", "json": [{"cohort": "", "disease_state": "Newly diagnosed", "histology_inclusion": "Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)", "biomarker_inclusion": ["BCR-ABL1-positive"], "histology_exclusion": ["chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML)"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["BCR - ABL1", "BCR - ABL1", "coordinate"], ["PAH-High", "PAH-High", "expression"]], "histology_exclusion": ["Chronic Myelogenous Leukemia, BCR-ABL1 Positive"]}]}
{"NCT_id": "NCT03393884", "json": [{"cohort": "", "disease_state": "FIGO stage III or IV", "histology_inclusion": "Epithelial Ovarian Cancer", "biomarker_inclusion": [], "histology_exclusion": ["Primary Brain Tumor", "CNS Disease"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "FIGO stage III or IV", "histology_inclusion": "Fallopian Tube Cancer", "biomarker_inclusion": [], "histology_exclusion": ["Primary Brain Tumor", "CNS Disease"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "FIGO stage III or IV", "histology_inclusion": "Primary Peritoneal Cancer", "biomarker_inclusion": [], "histology_exclusion": ["Primary Brain Tumor", "CNS Disease"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "FIGO stage III or IV", "histology_inclusion": "High Grade Serous Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary Brain Tumor", "CNS Disease"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "FIGO stage III or IV", "histology_inclusion": "Endometrioid Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary Brain Tumor", "CNS Disease"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "FIGO stage III or IV", "histology_inclusion": "Undifferentiated Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary Brain Tumor", "CNS Disease"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "FIGO stage III or IV", "histology_inclusion": "Clear Cell Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary Brain Tumor", "CNS Disease"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "FIGO stage III or IV", "histology_inclusion": "Mixed Epithelial Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary Brain Tumor", "CNS Disease"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "FIGO stage III or IV", "histology_inclusion": "Adenocarcinoma N.O.S.", "biomarker_inclusion": [], "histology_exclusion": ["Primary Brain Tumor", "CNS Disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Endometrioid Adenocarcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Pancreatic Undifferentiated Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Epithelial Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT03654716", "json": [{"cohort": "Cohort A", "disease_state": "relapsed or refractory", "histology_inclusion": "non-CNS primary solid tumors or lymphoma", "biomarker_inclusion": ["TP53 wild type"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "relapsed or refractory", "histology_inclusion": "retinoblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "relapsed or refractory", "histology_inclusion": "hepatoblastoma", "biomarker_inclusion": ["WT TP53"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "relapsed or refractory", "histology_inclusion": "malignant rhabdoid tumor", "biomarker_inclusion": ["WT TP53"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "relapsed or refractory", "histology_inclusion": "solid tumor, CNS tumor, or lymphoma", "biomarker_inclusion": ["MDM2 amplification or high-copy gain", "WT TP53"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "relapsed or refractory", "histology_inclusion": "solid tumor, CNS tumor, or lymphoma", "biomarker_inclusion": ["MDMX amplification or high-copy gain", "WT TP53"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "relapsed or refractory", "histology_inclusion": "solid tumor, CNS tumor, or lymphoma", "biomarker_inclusion": ["PPM1D amplification, high-copy gain, or PPM1D activating mutation", "WT TP53"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "relapsed or refractory", "histology_inclusion": "solid tumor or lymphoma", "biomarker_inclusion": ["TET2 loss or loss-of-function mutation", "WT TP53"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort C", "disease_state": "relapsed or refractory", "histology_inclusion": "AML, ALL, mixed lineage leukemia, biphenotypic leukemia, or other undifferentiated acute leukemia", "biomarker_inclusion": ["TP53 wild type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Cohort B", "histology_inclusion": "Retinoblastoma"}, {"cohort": "Cohort B", "histology_inclusion": "Hepatoblastoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Cohort B", "histology_inclusion": "Rhabdoid Tumor", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Cohort B", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Cohort B", "histology_inclusion": "Malignant Central Nervous System Neoplasm", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Cohort B", "histology_inclusion": "Central Nervous System Neoplasm", "biomarker_inclusion": [["MDM2-High", "MDM2-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Cohort B", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MDM4-High", "MDM4-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Cohort B", "histology_inclusion": "Malignant Central Nervous System Neoplasm", "biomarker_inclusion": [["MDM4-High", "MDM4-High", "expression"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Cohort B", "histology_inclusion": "Central Nervous System Neoplasm", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["MDM4-High", "MDM4-High", "expression"]]}, {"cohort": "Cohort B", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["PPM1D-High", "PPM1D-High", "expression"], ["PPM1D Mutation", "PPM1D-Mutation", "gene"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Cohort B", "histology_inclusion": "Malignant Central Nervous System Neoplasm", "biomarker_inclusion": [["PPM1D-High", "PPM1D-High", "expression"], ["PPM1D Mutation", "PPM1D-Mutation", "gene"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Cohort B", "histology_inclusion": "Central Nervous System Neoplasm", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["PPM1D-High", "PPM1D-High", "expression"], ["PPM1D Mutation", "PPM1D-Mutation", "gene"]]}, {"cohort": "Cohort B", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TET2-Low", "TET2-Low", "expression"], ["TET2 Mutation", "TET2-Mutation", "gene"], ["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Cohort C", "histology_inclusion": "Acute Undifferentiated Leukemia", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Cohort C", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Cohort C", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04305795", "json": [{"cohort": "Cohort 1L- HNSCC", "disease_state": "recurrent locally advanced and/or metastatic", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": ["CPS \u2265 1"], "histology_exclusion": [], "biomarker_exclusion": ["prior anti-PD1 or anti-PD-L1 therapy"]}, {"cohort": "Cohort 2- 1LcuSCC", "disease_state": "locally advanced or metastatic", "histology_inclusion": "cutaneous squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior anti-PD1 or anti-PD-L1 therapy"]}, {"cohort": "Cohort 3- 2L CuSCC", "disease_state": "locally advanced or metastatic", "histology_inclusion": "cutaneous squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1L- HNSCC", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Cohort 2- 1LcuSCC", "histology_inclusion": "Skin Squamous Cell Carcinoma"}, {"cohort": "Cohort 3- 2L CuSCC", "histology_inclusion": "Skin Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT04669587", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "adenocarcinoma of the breast", "biomarker_inclusion": ["ER-positive (\u22651% positive stained cells)"], "histology_exclusion": [], "biomarker_exclusion": ["ER-negative metastatic lesions"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["EREG-High", "EREG-High", "expression"]], "biomarker_exclusion": [["EREG-Low", "EREG-Low", "expression"]]}]}
{"NCT_id": "NCT05190445", "json": [{"cohort": "Arm 1", "disease_state": "advanced", "histology_inclusion": "gastric or gastroesophageal junction (GEJ) adenocarcinoma", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": ["squamous", "undifferentiated"], "biomarker_exclusion": []}, {"cohort": "Arm 2", "disease_state": "advanced", "histology_inclusion": "gastric or gastroesophageal junction (GEJ) adenocarcinoma", "biomarker_inclusion": ["HER2 IHC 1+", "HER2 IHC 2+ without HER2/neu amplification"], "histology_exclusion": ["squamous", "undifferentiated"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm 1", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Arm 2", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}]}
{"NCT_id": "NCT05450692", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR wild-type", "ALK wild-type"], "histology_exclusion": ["mixed SCLC and NSCLC"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR EGFR-wild_type", "EGFR-wild_type", "wild_type"], ["ALK ALK-wild_type", "ALK-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]], "histology_exclusion": ["Small Cell Lung Carcinoma", "Non-Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT04045613", "json": [{"cohort": "", "disease_state": "stage IV, recurrent, progressing, surgically unresectable", "histology_inclusion": "transitional cell carcinoma of the urothelium", "biomarker_inclusion": ["FGFR1 genetic aberration", "FGFR2 genetic aberration", "FGFR3 genetic aberration"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Transitional Cell Carcinoma", "biomarker_inclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}]}
{"NCT_id": "NCT05060432", "json": [{"cohort": "Part 1A/1B/1C/1D/1E/1F", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1G", "disease_state": "newly diagnosed stage IV (M1a or M1b- AJCC 8th edition)", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1G", "disease_state": "newly diagnosed stage IV (M1a or M1b- AJCC 8th edition)", "histology_inclusion": "squamous NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2 (lung cancer, H&N)", "disease_state": "recurrent advanced or metastatic", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": ["PD-L1 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2 (melanoma)", "disease_state": "progressed on treatment with an anti-PD-(L)1 monoclonal antibody (mAb)", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 1A/1B/1C/1D/1E/1F", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part 1G", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma"}, {"cohort": "Part 1G", "histology_inclusion": "Squamous Cell Lung Carcinoma"}, {"cohort": "Part 2 (lung cancer, H&N)", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"]]}, {"cohort": "Part 2 (melanoma)", "histology_inclusion": "Melanoma"}]}
{"NCT_id": "NCT05255653", "json": [{"cohort": "p53abn-RED trial", "disease_state": "stage I (with invasion) II or III", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["p53 abnormal"], "histology_exclusion": [], "biomarker_exclusion": ["Pathogenic POLE mutation(s)", "Mismatch repair deficiency", "Previous treatment with a PARP inhibitor, including olaparib"]}, {"cohort": "MMRd-GREEN trial", "disease_state": "", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["Mismatch repair deficient"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "NSMP-ORANGE trial", "disease_state": "", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["No specific molecular profile"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "POLEmut-BLUE trial", "disease_state": "stage I-II or stage III", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["POLE mutant"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "p53abn-RED trial", "histology_inclusion": "Endometrial Carcinoma", "biomarker_exclusion": [["POLE Mutation", "POLE-Mutation", "gene"]]}, {"cohort": "MMRd-GREEN trial", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "NSMP-ORANGE trial", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "POLEmut-BLUE trial", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["POLE Mutation", "POLE-Mutation", "gene"]]}]}
{"NCT_id": "NCT03785249", "json": [{"cohort": "", "disease_state": "unresectable or metastatic", "histology_inclusion": "solid tumor malignancy", "biomarker_inclusion": ["KRAS G12C mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["KRAS G12C", "G12C", "coordinate"]]}]}
{"NCT_id": "NCT04669899", "json": [{"cohort": "Stage 1 and 2", "disease_state": "advanced/metastatic extracranial solid tumor", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Stage 3", "disease_state": "advanced/metastatic PD-1/PD-L1-na\u00efve, platinum-resistant ovarian cancer", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Stage 4 ccRCC", "disease_state": "advanced/metastatic PD-1/PD-L1-experienced clear cell renal cell carcinoma", "histology_inclusion": "clear cell renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Stage 4 TNBC", "disease_state": "advanced/metastatic PD-1/PD-L1-experienced triple negative breast cancer", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Stage 4 HNSCC", "disease_state": "advanced/metastatic PD-1/PD-L1-na\u00efve, PD-L1+ head and neck squamous cell carcinoma", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": ["PD-L1+"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Stage 4 Ovarian", "disease_state": "advanced/metastatic PD-1/PD-L1-na\u00efve, platinum-resistant ovarian cancer", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Stage 4 NSCLC", "disease_state": "advanced/metastatic PD-1/PD-L1-experienced non-small cell lung cancer", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases", "EGFR mutations", "ALK rearrangements"], "biomarker_exclusion": []}, {"cohort": "Stage 4 cSCC", "disease_state": "advanced/metastatic PD-1/PD-L1-experienced cutaneous squamous cell carcinoma", "histology_inclusion": "cutaneous squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Stage 4 UPS & LPS", "disease_state": "advanced/metastatic PD-1/PD-L1-na\u00efve undifferentiated pleomorphic sarcoma and liposarcoma", "histology_inclusion": "undifferentiated pleomorphic sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Stage 4 UPS & LPS", "disease_state": "advanced/metastatic PD-1/PD-L1-na\u00efve undifferentiated pleomorphic sarcoma and liposarcoma", "histology_inclusion": "liposarcoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Stage 4 HNSCC", "disease_state": "PD-1/PD-L1-experienced head and neck squamous cell carcinoma", "histology_inclusion": "head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "Stage 4 BTC", "disease_state": "biliary tract cancer", "histology_inclusion": "biliary tract cancer", "biomarker_inclusion": ["PD-1/PD-L1 inhibitor resistance"], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["FGFR mutations", "IDH1 mutations"]}], "json_norm": [{"cohort": "Stage 1 and 2"}, {"cohort": "Stage 3", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Stage 3", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "Stage 4 ccRCC", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}, {"cohort": "Stage 4 TNBC", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Stage 4 HNSCC", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"]]}, {"cohort": "Stage 4 Ovarian", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "Stage 4 Ovarian", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "Stage 4 NSCLC", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Stage 4 cSCC", "histology_inclusion": "Skin Squamous Cell Carcinoma"}, {"cohort": "Stage 4 UPS & LPS", "histology_inclusion": "Undifferentiated Pleomorphic Sarcoma"}, {"cohort": "Stage 4 UPS & LPS", "histology_inclusion": "Liposarcoma"}, {"cohort": "Stage 4 HNSCC", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Stage 4 BTC", "histology_inclusion": "Liver Cancer", "biomarker_exclusion": [["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"], ["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "Stage 4 BTC", "histology_inclusion": "Biliary Tract Carcinoma", "biomarker_exclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["IDH1 Mutation", "IDH1-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04734990", "json": [{"cohort": "", "disease_state": "MDS with int-1, int-2, or high risk by IPSS, or CMML-1/CMML-2, myeloproliferative CMML (WBC >= 13 x 10^9/L) or CMML-0 with high-risk molecular features", "histology_inclusion": "Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia", "biomarker_inclusion": ["ASXL1 mutation", "SETBP1 mutation", "RUNX1 mutation", "NRAS mutation", "TP53 mutation", "more than 3 mutations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": [["ASXL1 Mutation", "ASXL1-Mutation", "gene"], ["SETBP1 Mutation", "SETBP1-Mutation", "gene"], ["RUNX1 Mutation", "RUNX1-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["ASXL1 Mutation", "ASXL1-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["RUNX1 Mutation", "RUNX1-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["SETBP1 Mutation", "SETBP1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04995536", "json": [{"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Follicular Lymphoma Grade 1", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Follicular Lymphoma Grade 2", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Follicular Lymphoma Grade 3", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Marginal Zone Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Small Lymphocytic Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": ["Non-Germinal Center B-Cell like (GCB) type determined by immunohistochemistry using Han's algorithm"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "", "histology_inclusion": "Grade 3 Follicular Lymphoma"}, {"cohort": "", "histology_inclusion": "Marginal Zone Lymphoma"}, {"cohort": "", "histology_inclusion": "Small Lymphocytic Lymphoma"}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma"}]}
{"NCT_id": "NCT01817192", "json": [{"cohort": "", "disease_state": "Stage I or Stage IIA", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["14-Gene Prognostic Assay"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04735068", "json": [{"cohort": "", "disease_state": "metastatic or incurable", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["KRAS non-synonymous mutation"], "histology_exclusion": ["CNS metastases", "carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT04930432", "json": [{"cohort": "", "disease_state": "metastatic or unresectable advanced", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR positive", "MET positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable advanced", "histology_inclusion": "Head and Neck Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable advanced", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["AS gene mutation", "BRAF gene mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["EGFR-High", "EGFR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Malignant Head and Neck Neoplasm"}, {"cohort": "", "histology_inclusion": "Head and Neck Carcinoma"}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_exclusion": [["HLA Mutation", "HLA-B-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["UBE3A Mutation", "UBE3A-Mutation", "gene"], ["LINC02605 Mutation", "LINC02605-Mutation", "gene"]]}]}
{"NCT_id": "NCT03524820", "json": [{"cohort": "Metastatic colorectal cancer patients", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["RAS wild type"], "histology_exclusion": [], "biomarker_exclusion": ["RAS mutation"]}], "json_norm": [{"cohort": "Metastatic colorectal cancer patients", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]], "biomarker_exclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT03590054", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non-pulmonary squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Solid tumor", "biomarker_inclusion": ["MSI-high"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Gastric and gastro-esophageal junction adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Merkel cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Thymic carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Mesothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "", "histology_inclusion": "Melanoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Merkel Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Thymus Neoplasm"}, {"cohort": "", "histology_inclusion": "Thymic Carcinoma"}, {"cohort": "", "histology_inclusion": "Mesothelioma"}]}
{"NCT_id": "NCT04409639", "json": [{"cohort": "All patients", "disease_state": "Newly diagnosed or HMA-refractory CMML", "histology_inclusion": "Chronic Myelomonocytic Leukemia (CMML -0/-1/-2; 2016 WHO classification)", "biomarker_inclusion": ["NRAS mutation (VAF \u2265 5%)", "KRAS mutation (VAF \u2265 5%)", "PTPN11 mutation (VAF \u2265 5%)", "FLT3 mutation (VAF \u2265 5%)", "CBL mutation (VAF \u2265 5%)", "JAK2 mutation (VAF \u2265 5%)", "BRAF mutation (VAF \u2265 5%)", "NF1 mutation (VAF \u2265 5%)", "FLT3-ITD PCR allelic ratio \u2265 0.05"], "histology_exclusion": ["Central Nervous System (CNS) leukemia"], "biomarker_exclusion": ["Previous exposure to experimental MEK inhibitors for CMML"]}], "json_norm": [{"cohort": "All patients", "histology_inclusion": "Chronic Myelomonocytic Leukemia-0", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["PTPN11 Mutation", "PTPN11-Mutation", "gene"], ["FLT3 Mutation", "FLT3-Mutation", "gene"], ["CBL Mutation", "CBL-Mutation", "gene"], ["JAK2 Mutation", "JAK2-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["NF1 Mutation", "NF1-Mutation", "gene"]]}, {"cohort": "All patients", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": [["NF1 Mutation", "NF1-Mutation", "gene"], ["FLT3 Mutation", "FLT3-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["PTPN11 Mutation", "PTPN11-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"], ["JAK2 Mutation", "JAK2-Mutation", "gene"], ["CBL Mutation", "CBL-Mutation", "gene"]]}]}
{"NCT_id": "NCT02340117", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["hematological malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm"]}]}
{"NCT_id": "NCT02601313", "json": [{"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma"}]}
{"NCT_id": "NCT04046133", "json": [{"cohort": "", "disease_state": "Stage IIIA or IIIB", "histology_inclusion": "Squamous Cell Cancer of Anus (SCCA)", "biomarker_inclusion": [], "histology_exclusion": ["malignant tumor of non-epithelial origin (sarcoma)"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma", "histology_exclusion": ["Sarcoma", "Malignant Neoplasm"]}]}
{"NCT_id": "NCT04539938", "json": [{"cohort": "Single Arm", "disease_state": "Unresectable Locally-Advanced or Metastatic", "histology_inclusion": "HER2+ Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Single Arm", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT05061017", "json": [{"cohort": "Cohort 1 (MSS mCRC)", "disease_state": "metastatic", "histology_inclusion": "colorectal carcinoma", "biomarker_inclusion": ["MSS"], "histology_exclusion": [], "biomarker_exclusion": ["PD-1", "PD-L1", "CTLA-4", "BRAF", "MEK", "EGFR", "KRAS WT"]}, {"cohort": "Cohort 2 (PD-1 R/R melanoma)", "disease_state": "PD-1 relapsed/refractory", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["BRAF", "MEK"]}, {"cohort": "Cohort 3 (PD-1 R/R NSCLC)", "disease_state": "PD-1 relapsed/refractory", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["BRAF", "MEK", "EGFR", "ALK", "ROS", "MET"]}], "json_norm": [{"cohort": "Cohort 1 (MSS mCRC)", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI-Low", "MSI-Low", "coordinate"]], "biomarker_exclusion": [["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"]]}, {"cohort": "Cohort 2 (PD-1 R/R melanoma)", "histology_inclusion": "Cutaneous Melanoma"}, {"cohort": "Cohort 3 (PD-1 R/R NSCLC)", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT05256225", "json": [{"cohort": "", "disease_state": "Stage IA-IVB, non-recurrent, chemotherapy-naive", "histology_inclusion": "Endometrial Serous Carcinoma", "biomarker_inclusion": ["HER2 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage IA-IVB, non-recurrent, chemotherapy-naive", "histology_inclusion": "Endometrial Carcinosarcoma with serous epithelial component", "biomarker_inclusion": ["HER2 positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Serous Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Carcinosarcoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT02797366", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Anaplastic glioma grade III", "biomarker_inclusion": ["LOH 1p/19q", "IDH-1 mutation"], "histology_exclusion": ["Primary Central Nervous System Tumour"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Arteriovenous malformations", "biomarker_inclusion": [], "histology_exclusion": ["Primary Central Nervous System Tumour"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Chordomas", "biomarker_inclusion": [], "histology_exclusion": ["Primary Central Nervous System Tumour"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Chondrosarcomas", "biomarker_inclusion": [], "histology_exclusion": ["Primary Central Nervous System Tumour"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Craniopharyngiomas", "biomarker_inclusion": [], "histology_exclusion": ["Primary Central Nervous System Tumour"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Ependymomas", "biomarker_inclusion": [], "histology_exclusion": ["Primary Central Nervous System Tumour"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Intracranial germ cell tumours", "biomarker_inclusion": [], "histology_exclusion": ["Primary Central Nervous System Tumour"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Low grade gliomas - grade I-II", "biomarker_inclusion": [], "histology_exclusion": ["Primary Central Nervous System Tumour"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Medulloblastoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary Central Nervous System Tumour"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Primitive neuroectodermal tumour", "biomarker_inclusion": [], "histology_exclusion": ["Primary Central Nervous System Tumour"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Meningiomas", "biomarker_inclusion": [], "histology_exclusion": ["Primary Central Nervous System Tumour"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Neurocytoma", "biomarker_inclusion": [], "histology_exclusion": ["Primary Central Nervous System Tumour"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Other grade I-II primary CNS tumour according to WHO classification", "biomarker_inclusion": [], "histology_exclusion": ["Primary Central Nervous System Tumour"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Pituitary adenomas", "biomarker_inclusion": [], "histology_exclusion": ["Primary Central Nervous System Tumour"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Schwannomas", "biomarker_inclusion": [], "histology_exclusion": ["Primary Central Nervous System Tumour"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Spinal tumours", "biomarker_inclusion": [], "histology_exclusion": ["Primary Central Nervous System Tumour"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Whenever craniospinal irradiation is indicated", "biomarker_inclusion": [], "histology_exclusion": ["Primary Central Nervous System Tumour"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Whenever re-irradiation of CNS is considered", "biomarker_inclusion": [], "histology_exclusion": ["Primary Central Nervous System Tumour"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "WHO Grade III Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_inclusion": "Germ Cell Tumor", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_inclusion": "Medulloblastoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_inclusion": "Primitive Neuroectodermal Tumor", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_inclusion": "Primary Brain Neoplasm", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}, {"cohort": "", "histology_exclusion": ["Primary Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT03850795", "json": [{"cohort": "", "disease_state": "metastatic castration-resistant prostate cancer", "histology_inclusion": "adenocarcinoma of the prostate without significant and relevant neuroendocrine differentiation or small cell features", "biomarker_inclusion": [], "histology_exclusion": ["brain metastasis", "active leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT03915951", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["BRAFV600E mutation"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutation", "ALK fusion oncogene", "ROS1 rearrangement"]}, {"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["BRAFV600K mutation"], "histology_exclusion": ["brain metastasis", "leptomeningeal disease", "CNS metastases"], "biomarker_exclusion": ["EGFR mutation", "ALK fusion oncogene", "ROS1 rearrangement"]}, {"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["BRAFV600D mutation"], "histology_exclusion": ["brain metastasis", "leptomeningeal disease", "CNS metastases"], "biomarker_exclusion": ["EGFR mutation", "ALK fusion oncogene", "ROS1 rearrangement"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]], "biomarker_exclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["BRAF V600K", "V600K", "coordinate"]], "biomarker_exclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["BRAF V600D", "V600D", "coordinate"]], "biomarker_exclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT04996004", "json": [{"cohort": "Dose Escalation", "disease_state": "metastatic or locally advanced", "histology_inclusion": "high-grade leiomyosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["anti-CD47 therapy", "anti-SIRP\u03b1 therapy"]}, {"cohort": "Dose Escalation", "disease_state": "metastatic or locally advanced", "histology_inclusion": "undifferentiated pleomorphic sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["anti-CD47 therapy", "anti-SIRP\u03b1 therapy"]}, {"cohort": "Dose Escalation", "disease_state": "metastatic or locally advanced", "histology_inclusion": "myxofibrosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["anti-CD47 therapy", "anti-SIRP\u03b1 therapy"]}, {"cohort": "Dose Escalation", "disease_state": "metastatic or locally advanced", "histology_inclusion": "dedifferentiated liposarcoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["anti-CD47 therapy", "anti-SIRP\u03b1 therapy"]}, {"cohort": "Dose Escalation", "disease_state": "metastatic or locally advanced", "histology_inclusion": "angiosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["anti-CD47 therapy", "anti-SIRP\u03b1 therapy"]}, {"cohort": "Dose Escalation", "disease_state": "metastatic or locally advanced", "histology_inclusion": "epithelioid sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["anti-CD47 therapy", "anti-SIRP\u03b1 therapy"]}, {"cohort": "Dose Expansion Dose Level A (Cohort A)", "disease_state": "metastatic or locally advanced", "histology_inclusion": "high-grade leiomyosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["anti-CD47 therapy", "anti-SIRP\u03b1 therapy"]}, {"cohort": "Dose Expansion Dose Level B (Cohort B)", "disease_state": "metastatic or locally advanced", "histology_inclusion": "high-grade leiomyosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system metastases", "carcinomatous meningitis"], "biomarker_exclusion": ["anti-CD47 therapy", "anti-SIRP\u03b1 therapy"]}], "json_norm": [{"cohort": "Dose Escalation", "histology_inclusion": "Leiomyosarcoma"}, {"cohort": "Dose Escalation", "histology_inclusion": "Undifferentiated Pleomorphic Sarcoma"}, {"cohort": "Dose Escalation", "histology_inclusion": "Myxofibrosarcoma"}, {"cohort": "Dose Escalation", "histology_inclusion": "Dedifferentiated Liposarcoma"}, {"cohort": "Dose Escalation", "histology_inclusion": "Angiosarcoma"}, {"cohort": "Dose Escalation", "histology_inclusion": "Epithelioid Sarcoma"}, {"cohort": "Dose Expansion Dose Level A (Cohort A)", "histology_inclusion": "Leiomyosarcoma"}, {"cohort": "Dose Expansion Dose Level B (Cohort B)", "histology_inclusion": "Leiomyosarcoma"}]}
{"NCT_id": "NCT05256290", "json": [{"cohort": "Dose Escalation Cohorts - Monotherapy", "disease_state": "Advanced/metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR G719X"], "histology_exclusion": [], "biomarker_exclusion": ["T790M"]}, {"cohort": "Dose Escalation Cohorts - Monotherapy", "disease_state": "Advanced/metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR C797S"], "histology_exclusion": [], "biomarker_exclusion": ["T790M"]}, {"cohort": "Dose Escalation Cohorts - Monotherapy", "disease_state": "Recurrent", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["EGFR alterations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Disease-Specific Dose Expansion Cohorts - Monotherapy", "disease_state": "Advanced/metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR C797S"], "histology_exclusion": [], "biomarker_exclusion": ["T790M"]}, {"cohort": "Disease-Specific Dose Expansion Cohorts - Monotherapy", "disease_state": "Advanced/metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR L858R", "EGFR G719X"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Disease-Specific Dose Expansion Cohorts - Monotherapy", "disease_state": "Recurrent", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["EGFR alterations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Disease-Specific Dose Expansion Cohort - Combination Treatment", "disease_state": "Newly diagnosed", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["EGFR mutations", "EGFR variants"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Escalation Cohorts - Monotherapy", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Dose Escalation Cohorts - Monotherapy", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR C797S", "C797S", "coordinate"]]}, {"cohort": "Dose Escalation Cohorts - Monotherapy", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Disease-Specific Dose Expansion Cohorts - Monotherapy", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR C797S", "C797S", "coordinate"]]}, {"cohort": "Disease-Specific Dose Expansion Cohorts - Monotherapy", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"]]}, {"cohort": "Disease-Specific Dose Expansion Cohorts - Monotherapy", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Disease-Specific Dose Expansion Cohort - Combination Treatment", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04344795", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "squamous cell carcinoma of the head and neck", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "urothelial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "gastric or gastroesophageal junction adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "expansion", "disease_state": "", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "expansion", "disease_state": "", "histology_inclusion": "squamous cell carcinoma of the head and neck", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "expansion", "disease_state": "", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "expansion", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": ["activating mutation in PIK3Ca"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "expansion", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "expansion", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "expansion", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "expansion", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]]}]}
{"NCT_id": "NCT04800822", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "ALK-positive non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "ROS1-positive non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "BRAF V600E mutation colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "RAS-mutant solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "NF1-mutant solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "BRAF class 3 mutant solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1-High", "ROS1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NF1 Mutation", "NF1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRAF Class 3", "BRAF Class 3", "coordinate"]]}]}
{"NCT_id": "NCT04996160", "json": [{"cohort": "Cohort 1", "disease_state": "relapsed or refractory", "histology_inclusion": "acute lymphoblastic leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["Ph+", "Ph like mutation"]}, {"cohort": "Cohort 2", "disease_state": "relapsed or refractory", "histology_inclusion": "acute lymphoblastic leukemia", "biomarker_inclusion": ["Ph+", "Ph like mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_exclusion": [["PAH-High", "PAH-High", "expression"], ["PAH Mutation", "PAH-Mutation", "gene"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["PAH-High", "PAH-High", "expression"], ["PAH Mutation", "PAH-Mutation", "gene"]]}]}
{"NCT_id": "NCT05386550", "json": [{"cohort": "LA SCCHN, High Risk, Cisplatin-ineligible", "disease_state": "Resected", "histology_inclusion": "Squamous Cell Carcinoma of the Head and Neck", "biomarker_inclusion": [], "histology_exclusion": ["Nasopharyngeal", "Paranasal sinuses", "Nasal cavity", "Salivary", "Thyroid or parathyroid gland", "Skin", "Unknown primary site"], "biomarker_exclusion": []}, {"cohort": "LA SCCHN, High Risk, Cisplatin-ineligible", "disease_state": "Resected", "histology_inclusion": "Oropharynx", "biomarker_inclusion": ["p16 positive"], "histology_exclusion": ["Nasopharyngeal", "Paranasal sinuses", "Nasal cavity", "Salivary", "Thyroid or parathyroid gland", "Skin", "Unknown primary site"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "LA SCCHN, High Risk, Cisplatin-ineligible", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "LA SCCHN, High Risk, Cisplatin-ineligible", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}]}
{"NCT_id": "NCT05451602", "json": [{"cohort": "Phase 1", "disease_state": "non-resectable advanced solid tumor", "histology_inclusion": "", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases", "primary CNS tumor"], "biomarker_exclusion": ["known primary driver alteration other than RET"]}, {"cohort": "Phase 2", "disease_state": "", "histology_inclusion": "thyroid cancer", "biomarker_inclusion": ["oncogenic RET-rearrangement/fusion", "RET mutation"], "histology_exclusion": ["CNS metastases", "primary CNS tumor"], "biomarker_exclusion": ["known primary driver alteration other than RET"]}, {"cohort": "Phase 2", "disease_state": "", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["oncogenic RET-rearrangement/fusion", "RET mutation"], "histology_exclusion": ["CNS metastases", "primary CNS tumor"], "biomarker_exclusion": ["known primary driver alteration other than RET"]}, {"cohort": "Phase 2", "disease_state": "", "histology_inclusion": "other advanced solid tumors", "biomarker_inclusion": ["oncogenic RET-rearrangement/fusion", "RET mutation"], "histology_exclusion": ["CNS metastases", "primary CNS tumor"], "biomarker_exclusion": ["known primary driver alteration other than RET"]}], "json_norm": [{"cohort": "Phase 1", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 2", "histology_inclusion": "Thyroid Gland Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"], ["RET Mutation", "RET-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"], ["RET Mutation", "RET-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"], ["RET Mutation", "RET-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT04540302", "json": [], "json_norm": []}
{"NCT_id": "NCT05061420", "json": [{"cohort": "Cohort A1", "disease_state": "recurrent and/or metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["PD-L1 CPS \u22651"], "histology_exclusion": ["nasopharynx"], "biomarker_exclusion": []}, {"cohort": "Cohort B1", "disease_state": "recurrent and/or metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["nasopharynx"], "biomarker_exclusion": []}, {"cohort": "Cohort B2", "disease_state": "recurrent and/or metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["nasopharynx"], "biomarker_exclusion": ["prior cetuximab treatment"]}], "json_norm": [{"cohort": "Cohort A1", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Cohort B1", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Cohort B2", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT05126433", "json": [{"cohort": "Urothelial Cancer Cohort", "disease_state": "advanced or metastatic", "histology_inclusion": "urothelial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Poorly Differentiated Neuroendocrine Carcinomas Cohort", "disease_state": "advanced or metastatic", "histology_inclusion": "poorly differentiated neuroendocrine carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "disease_state": "advanced or metastatic", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["homologous recombination deficient-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "disease_state": "advanced or metastatic", "histology_inclusion": "biliary tract cancer", "biomarker_inclusion": ["homologous recombination deficient-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "disease_state": "advanced or metastatic", "histology_inclusion": "urothelial cancer", "biomarker_inclusion": ["homologous recombination deficient-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "disease_state": "advanced or metastatic", "histology_inclusion": "triple-negative breast cancer", "biomarker_inclusion": ["homologous recombination deficient-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "disease_state": "advanced or metastatic", "histology_inclusion": "HR+HER2- breast cancer", "biomarker_inclusion": ["homologous recombination deficient-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "disease_state": "advanced or metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["homologous recombination deficient-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "disease_state": "advanced or metastatic", "histology_inclusion": "gastric cancer", "biomarker_inclusion": ["homologous recombination deficient-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "disease_state": "advanced or metastatic", "histology_inclusion": "esophageal cancer", "biomarker_inclusion": ["homologous recombination deficient-positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Urothelial Cancer Cohort", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "Poorly Differentiated Neuroendocrine Carcinomas Cohort", "histology_inclusion": "Pancreatic Neuroendocrine Carcinoma"}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "histology_inclusion": "Liver Cancer", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "histology_inclusion": "Biliary Tract Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"], ["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-Low", "HR-Low", "expression"], ["HR-High", "HR-High", "expression"], ["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Homologous Recombination Deficient-Positive Malignancies Agnostic Cohort", "histology_inclusion": "Esophageal Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}]}
{"NCT_id": "NCT05647122", "json": [{"cohort": "Module 1", "disease_state": "metastatic or locally advanced", "histology_inclusion": "EGFRmut. NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Module 1", "disease_state": "metastatic", "histology_inclusion": "EGFRwt. NSCLC", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Module 1", "disease_state": "recurrent or metastatic", "histology_inclusion": "HNSCC of the oral cavity", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Module 2", "disease_state": "metastatic", "histology_inclusion": "NSCLC EGFRmut.", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Module 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Module 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Module 1", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Module 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT02079740", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "KRAS or NRAS mutation-positive malignancy", "biomarker_inclusion": ["KRAS mutation", "NRAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"]]}, {"cohort": "", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT02601950", "json": [{"cohort": "Cohort 1", "disease_state": "INI1-Negative Tumors", "histology_inclusion": "Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT), Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT), Malignant Rhabdoid Tumor of the Ovary (MRTO)", "biomarker_inclusion": ["INI1-negative", "SMARCA4-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "Relapsed/Refractory Synovial Sarcoma", "histology_inclusion": "Synovial Sarcoma", "biomarker_inclusion": ["SS18-SSX rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3", "disease_state": "INI1-Negative Tumors or Any Solid Tumor with an EZH2 GOF Mutation", "histology_inclusion": "Epithelioid Malignant Peripheral Nerve Sheath Tumor (EMPNST), Extraskeletal Myxoid Chondrosarcoma (EMC), Myoepithelial Carcinoma, Other INI1-negative Malignant Tumors with Sponsor Approval (e.g., Dedifferentiated Chordoma), Any Solid Tumor with an EZH2 GOF Mutation", "biomarker_inclusion": ["INI1-negative", "EZH2 GOF mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 4", "disease_state": "Renal Medullary Carcinoma", "histology_inclusion": "Renal Medullary Carcinoma", "biomarker_inclusion": ["INI1-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 5", "disease_state": "Epithelioid Sarcoma", "histology_inclusion": "Epithelioid Sarcoma", "biomarker_inclusion": ["INI1-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 7", "disease_state": "Poorly Differentiated Chordoma (or Other Chordoma with Sponsor Approval)", "histology_inclusion": "Poorly Differentiated Chordoma, Other Chordoma with Sponsor Approval", "biomarker_inclusion": ["INI1-negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Rhabdoid Tumor", "biomarker_inclusion": [["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCA4-Low", "SMARCA4-Low", "expression"], ["SMARCA4-Low", "SMARCA4-Low", "expression"]]}, {"cohort": "Cohort 1", "histology_inclusion": "Rhabdoid Tumor of the Kidney", "biomarker_inclusion": [["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCA4-Low", "SMARCA4-Low", "expression"], ["SMARCA4-Low", "SMARCA4-Low", "expression"]]}, {"cohort": "Cohort 1", "histology_inclusion": "Small Cell Carcinoma", "biomarker_inclusion": [["SMARCA4-Low", "SMARCA4-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Synovial Sarcoma", "biomarker_inclusion": [["SS18 - SSX2", "SS18 - SSX2", "coordinate"], ["SSX2 Fusion", "SSX2", "fusion"], ["SS18 Fusion", "SS18", "fusion"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Malignant Myoepithelioma", "biomarker_inclusion": [["EZH2 Mutation", "EZH2-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["EZH2 Mutation", "EZH2-Mutation", "gene"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Malignant Myoepithelioma", "biomarker_inclusion": [["EZH2 Mutation", "EZH2-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["EZH2 Mutation", "EZH2-Mutation", "gene"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Malignant Peripheral Nerve Sheath Tumor", "biomarker_inclusion": [["EZH2 Mutation", "EZH2-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["EZH2 Mutation", "EZH2-Mutation", "gene"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Malignant Peripheral Nerve Sheath Tumor", "biomarker_inclusion": [["EZH2 Mutation", "EZH2-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["EZH2 Mutation", "EZH2-Mutation", "gene"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Dedifferentiated Chordoma", "biomarker_inclusion": [["EZH2 Mutation", "EZH2-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["EZH2 Mutation", "EZH2-Mutation", "gene"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Dedifferentiated Chordoma", "biomarker_inclusion": [["EZH2 Mutation", "EZH2-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["EZH2 Mutation", "EZH2-Mutation", "gene"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["EZH2 Mutation", "EZH2-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["EZH2 Mutation", "EZH2-Mutation", "gene"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["EZH2 Mutation", "EZH2-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["EZH2 Mutation", "EZH2-Mutation", "gene"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Extraskeletal Myxoid Chondrosarcoma", "biomarker_inclusion": [["EZH2 Mutation", "EZH2-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["EZH2 Mutation", "EZH2-Mutation", "gene"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Extraskeletal Myxoid Chondrosarcoma", "biomarker_inclusion": [["EZH2 Mutation", "EZH2-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["EZH2 Mutation", "EZH2-Mutation", "gene"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Malignant Neoplasm", "biomarker_inclusion": [["EZH2 Mutation", "EZH2-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["EZH2 Mutation", "EZH2-Mutation", "gene"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Malignant Neoplasm", "biomarker_inclusion": [["EZH2 Mutation", "EZH2-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "Cohort 4", "histology_inclusion": "Kidney Medullary Carcinoma", "biomarker_inclusion": [["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "Cohort 5", "histology_inclusion": "Epithelioid Sarcoma", "biomarker_inclusion": [["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "Cohort 7", "histology_inclusion": "Chordoma", "biomarker_inclusion": [["SMARCB1-Low", "SMARCB1-Low", "expression"]]}]}
{"NCT_id": "NCT03329950", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "bladder/urothelial carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "gastric cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "esophageal cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "hepatic cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "ovarian, fallopian, or primary peritoneal carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "head and neck cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "advanced", "histology_inclusion": "diffuse large B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "advanced", "histology_inclusion": "mantle cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "Part 1", "disease_state": "advanced", "histology_inclusion": "indolent B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "Part 3", "disease_state": "", "histology_inclusion": "", "biomarker_inclusion": ["anti-PD-1", "anti-PD-L1"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 4", "disease_state": "metastatic", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Urothelial Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Pancreatic Adenocarcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Esophageal Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Malignant Head and Neck Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Head and Neck Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Cholangiocarcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Part 1", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Part 1", "histology_inclusion": "Mantle Cell Lymphoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Part 1", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Part 3"}, {"cohort": "Part 4", "histology_inclusion": "Pancreatic Adenocarcinoma"}]}
{"NCT_id": "NCT03395197", "json": [{"cohort": "", "disease_state": "metastatic castration resistant prostate cancer (mCRPC)", "histology_inclusion": "adenocarcinoma of the prostate without small cell or signet cell features", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT04931342", "json": [{"cohort": "", "disease_state": "persistent or recurrent", "histology_inclusion": "non-high-grade serous, non-high-grade endometrioid epithelial ovarian, fallopian tube, or primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": ["high-grade serous", "high-grade endometrioid ovarian", "fallopian tube", "primary peritoneal cancer", "borderline epithelial ovarian tumor", "non-epithelial ovarian tumors", "synchronous primary endometrial cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "persistent or recurrent", "histology_inclusion": "low-grade serous ovarian carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["high-grade serous", "high-grade endometrioid ovarian", "fallopian tube", "primary peritoneal cancer", "borderline epithelial ovarian tumor", "non-epithelial ovarian tumors", "synchronous primary endometrial cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "persistent or recurrent", "histology_inclusion": "clear cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["high-grade serous", "high-grade endometrioid ovarian", "fallopian tube", "primary peritoneal cancer", "borderline epithelial ovarian tumor", "non-epithelial ovarian tumors", "synchronous primary endometrial cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "persistent or recurrent", "histology_inclusion": "mucinous carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["high-grade serous", "high-grade endometrioid ovarian", "fallopian tube", "primary peritoneal cancer", "borderline epithelial ovarian tumor", "non-epithelial ovarian tumors", "synchronous primary endometrial cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "persistent or recurrent", "histology_inclusion": "carcinosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["high-grade serous", "high-grade endometrioid ovarian", "fallopian tube", "primary peritoneal cancer", "borderline epithelial ovarian tumor", "non-epithelial ovarian tumors", "synchronous primary endometrial cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "persistent or recurrent", "histology_inclusion": "undifferentiated carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["high-grade serous", "high-grade endometrioid ovarian", "fallopian tube", "primary peritoneal cancer", "borderline epithelial ovarian tumor", "non-epithelial ovarian tumors", "synchronous primary endometrial cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "persistent or recurrent", "histology_inclusion": "seromucinous carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["high-grade serous", "high-grade endometrioid ovarian", "fallopian tube", "primary peritoneal cancer", "borderline epithelial ovarian tumor", "non-epithelial ovarian tumors", "synchronous primary endometrial cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "persistent or recurrent", "histology_inclusion": "malignant Brenner tumors", "biomarker_inclusion": [], "histology_exclusion": ["high-grade serous", "high-grade endometrioid ovarian", "fallopian tube", "primary peritoneal cancer", "borderline epithelial ovarian tumor", "non-epithelial ovarian tumors", "synchronous primary endometrial cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "persistent or recurrent", "histology_inclusion": "Grades 1 or 2 endometrioid carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["high-grade serous", "high-grade endometrioid ovarian", "fallopian tube", "primary peritoneal cancer", "borderline epithelial ovarian tumor", "non-epithelial ovarian tumors", "synchronous primary endometrial cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "persistent or recurrent", "histology_inclusion": "mesonephric-like adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["high-grade serous", "high-grade endometrioid ovarian", "fallopian tube", "primary peritoneal cancer", "borderline epithelial ovarian tumor", "non-epithelial ovarian tumors", "synchronous primary endometrial cancer"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "persistent or recurrent", "histology_inclusion": "small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)", "biomarker_inclusion": [], "histology_exclusion": ["high-grade serous", "high-grade endometrioid ovarian", "fallopian tube", "primary peritoneal cancer", "borderline epithelial ovarian tumor", "non-epithelial ovarian tumors", "synchronous primary endometrial cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Endometrial Carcinoma", "Primary Peritoneal Carcinoma"]}, {"cohort": "", "histology_inclusion": "Invasive Ovarian Micropapillary Serous Carcinoma", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Endometrial Carcinoma", "Primary Peritoneal Carcinoma"]}, {"cohort": "", "histology_inclusion": "Endometrial Clear Cell Adenocarcinoma", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Endometrial Carcinoma", "Primary Peritoneal Carcinoma"]}, {"cohort": "", "histology_inclusion": "Mucinous Adenocarcinoma", "histology_exclusion": ["Primary Peritoneal Carcinoma", "Ovarian Epithelial Cancer", "Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Endometrial Carcinoma"]}, {"cohort": "", "histology_inclusion": "Ovarian Mucinous Adenocarcinoma", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Endometrial Carcinoma", "Primary Peritoneal Carcinoma"]}, {"cohort": "", "histology_inclusion": "Carcinosarcoma", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Endometrial Carcinoma", "Primary Peritoneal Carcinoma"]}, {"cohort": "", "histology_inclusion": "Pancreatic Undifferentiated Carcinoma", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Endometrial Carcinoma", "Primary Peritoneal Carcinoma"]}, {"cohort": "", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Endometrial Carcinoma", "Primary Peritoneal Carcinoma"]}, {"cohort": "", "histology_inclusion": "Brenner Tumor", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Endometrial Carcinoma", "Primary Peritoneal Carcinoma"]}, {"cohort": "", "histology_inclusion": "Endometrioid Adenocarcinoma", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Endometrial Carcinoma", "Primary Peritoneal Carcinoma"]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Endometrial Carcinoma", "Primary Peritoneal Carcinoma"]}, {"cohort": "", "histology_inclusion": "Small Cell Carcinoma", "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Endometrial Carcinoma", "Primary Peritoneal Carcinoma"]}]}
{"NCT_id": "NCT03199885", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "HER2-Positive Breast Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally recurrent, unresectable", "histology_inclusion": "HER2-Positive Breast Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally recurrent, unresectable", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Adenocarcinoma"}, {"cohort": "", "histology_inclusion": "Breast Adenocarcinoma"}]}
{"NCT_id": "NCT04242199", "json": [{"cohort": "Cohort 1", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["brain or CNS metastases"], "biomarker_exclusion": ["prior anti-PD-L1 therapy"]}, {"cohort": "Cohort 2", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["MSI-H", "dMMR"], "histology_exclusion": ["brain or CNS metastases"], "biomarker_exclusion": ["prior anti-PD-L1 therapy"]}, {"cohort": "Cohort 3", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["progression after anti-PD-1 monoclonal antibody therapy"], "histology_exclusion": ["brain or CNS metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Cohort 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort 3", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04410445", "json": [{"cohort": "", "disease_state": "Stage IIIA (LN metastasis > 1 mm), IIIB/C/D, or IV (M1a/b/c/d)", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": [], "histology_exclusion": ["ocular/uveal melanoma", "mucosal melanoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Cutaneous Melanoma", "histology_exclusion": ["Mucosal Melanoma", "Intraocular Melanoma"]}]}
{"NCT_id": "NCT04866641", "json": [{"cohort": "", "disease_state": "refractory", "histology_inclusion": "advanced solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04996823", "json": [{"cohort": "", "disease_state": "advanced/unresectable", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": ["uveal melanoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "histology_exclusion": ["Intraocular Melanoma"]}]}
{"NCT_id": "NCT04996875", "json": [{"cohort": "", "disease_state": "Advanced Systemic Mastocytosis", "histology_inclusion": "Aggressive Systemic Mastocytosis (ASM)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["FIP1L1 PDGFRA fusion"]}, {"cohort": "", "disease_state": "Advanced Systemic Mastocytosis", "histology_inclusion": "Systemic Mastocytosis with an Associated Hematologic Neoplasm (SM-AHN)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["FIP1L1 PDGFRA fusion"]}, {"cohort": "", "disease_state": "Advanced Systemic Mastocytosis", "histology_inclusion": "Mast Cell Leukemia (MCL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["FIP1L1 PDGFRA fusion"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Aggressive Systemic Mastocytosis", "biomarker_exclusion": [["PDGFRA Fusion", "PDGFRA", "fusion"]]}, {"cohort": "", "histology_inclusion": "Hematopoietic and Lymphoid Cell Neoplasm", "biomarker_exclusion": [["PDGFRA Fusion", "PDGFRA", "fusion"]]}, {"cohort": "", "histology_inclusion": "Primary Systemic Mastocytosis", "biomarker_exclusion": [["PDGFRA Fusion", "PDGFRA", "fusion"]]}, {"cohort": "", "histology_inclusion": "Systemic Mastocytosis", "biomarker_exclusion": [["PDGFRA Fusion", "PDGFRA", "fusion"]]}, {"cohort": "", "histology_inclusion": "Systemic Mastocytosis with an Associated Hematological Neoplasm", "biomarker_exclusion": [["PDGFRA Fusion", "PDGFRA", "fusion"]]}, {"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_exclusion": [["PDGFRA Fusion", "PDGFRA", "fusion"]]}, {"cohort": "", "histology_inclusion": "Mast Cell Leukemia", "biomarker_exclusion": [["PDGFRA Fusion", "PDGFRA", "fusion"]]}]}
{"NCT_id": "NCT05387265", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced unresectable", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT03395587", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma"}]}
{"NCT_id": "NCT03786692", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation in exon 19", "EGFR mutation in exon 21"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Never smoker wild-types", "disease_state": "Stage IV", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["ALK rearrangement", "ROS1 rearrangement", "EGFR mutation in exon 19", "EGFR mutation in exon 21", "EGFR mutation in exon 20", "rare EGFR mutations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Never smoker wild-types", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT04410796", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT03656536", "json": [{"cohort": "", "disease_state": "Unresectable or Metastatic Cholangiocarcinoma (Stage IV)", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": ["FGFR2 rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["FGFR2 Fusion", "FGFR2", "fusion"]]}]}
{"NCT_id": "NCT03786796", "json": [{"cohort": "", "disease_state": "Metastatic (AJCC Stage IV) renal cell carcinoma", "histology_inclusion": "renal cell carcinoma (both clear cell and non-clear cell allowed)", "biomarker_inclusion": ["BAP-1 mutation", "ATM mutation", "BRCA1 mutation", "BRCA2 mutation", "PALB2 mutation", "CHEK2 mutation", "BRIP1 mutation", "RAD51C mutation", "BARD1 mutation", "CDK12 mutation", "CHEK1 mutation", "FANCL mutation", "PP2R2A mutation", "RAD51B mutation", "RAD51D mutation", "RAD54L mutation"], "histology_exclusion": ["symptomatic uncontrolled brain metastases"], "biomarker_exclusion": ["previous treatment with PARP inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["CHEK2 Mutation", "CHEK2-Mutation", "gene"], ["CDK12 Mutation", "CDK12-Mutation", "gene"], ["RAD54L Mutation", "RAD54L-Mutation", "gene"], ["RAD51C Mutation", "RAD51C-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["RAD51B Mutation", "RAD51B-Mutation", "gene"], ["RNF2 Mutation", "RNF2-Mutation", "gene"], ["BARD1 Mutation", "BARD1-Mutation", "gene"], ["BRIP1 Mutation", "BRIP1-Mutation", "gene"], ["BAP1 Mutation", "BAP1-Mutation", "gene"], ["FANCL Mutation", "FANCL-Mutation", "gene"], ["RAD51D Mutation", "RAD51D-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"], ["CHEK1 Mutation", "CHEK1-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT03917043", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["ALK gene fusion", "ROS1 gene fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "cohort one", "disease_state": "progressed or not tolerated on second-generation ALK TKI therapy or any ROS1 TKI therapy", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["ALK gene fusion", "ROS1 gene fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "cohort two", "disease_state": "ALK/ROS1 fusion gene positive without TKI treatment", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["ALK gene fusion", "ROS1 gene fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "malignant pleural mesothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "esophageal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "cohort one", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "cohort two", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1 Fusion", "ROS1", "fusion"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "", "histology_inclusion": "Pleural Malignant Mesothelioma"}, {"cohort": "", "histology_inclusion": "Esophageal Carcinoma"}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm"}]}
{"NCT_id": "NCT04475939", "json": [{"cohort": "", "disease_state": "Stage IIIB, Stage IIIC, Stage IV", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["mixed small cell lung cancer", "sarcomatoid variant NSCLC"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Small Cell Lung Carcinoma", "Non-Small Cell Lung Carcinoma"]}]}
{"NCT_id": "NCT04541082", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "glioblastoma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "anaplastic astrocytoma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "anaplastic oligodendroglioma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "pilocytic astrocytoma with anaplastic features", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "diffuse astrocytoma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "oligodendroglioma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "gliomatosis cerebri", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "pleomorphic xanthoastrocytoma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "anaplastic pleomorphic xanthoastrocytoma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "diffuse midline glioma, H3 K27M-Mutant", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "ependymoma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "anaplastic ependymoma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "medulloblastoma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "atypical teratoid/rhabdoid tumor", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "primary CNS embryonal/primitive neuroectodermal tumors", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "atypical meningioma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "anaplastic meningioma", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "choroid plexus tumors", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "pineal region tumors", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS neoplasm"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Gliosarcoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Anaplastic Astrocytoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Anaplastic Oligodendroglioma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Pilocytic Astrocytoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Diffuse Astrocytoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Oligodendroglioma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Pleomorphic Xanthoastrocytoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Anaplastic Pleomorphic Xanthoastrocytoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Diffuse Midline Glioma, H3 K27M-Mutant", "biomarker_inclusion": [["H3-3A K28M", "K28M", "coordinate"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Ependymoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Anaplastic Ependymoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Medulloblastoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Atypical Teratoid/Rhabdoid Tumor", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Primitive Neuroectodermal Tumor", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Atypical Meningioma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Anaplastic (Malignant) Meningioma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Choroid Plexus Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Choroid Plexus Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Pineal Region Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT04606316", "json": [{"cohort": "", "disease_state": "first or second relapse", "histology_inclusion": "World Health Organization Grade IV IDH wildtype glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["IDH mutation"]}, {"cohort": "", "disease_state": "first or second relapse", "histology_inclusion": "gliosarcoma", "biomarker_inclusion": ["IDH wildtype"], "histology_exclusion": [], "biomarker_exclusion": ["IDH mutation"]}, {"cohort": "", "disease_state": "first or second relapse", "histology_inclusion": "glioma with molecularly features of glioblastoma", "biomarker_inclusion": ["IDH wildtype"], "histology_exclusion": [], "biomarker_exclusion": ["IDH mutation"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Gliosarcoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04868877", "json": [{"cohort": "Part 2 NSCLC harboring EGFR exon 20 Insertion", "disease_state": "advanced/metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR exon 20 Insertion"], "histology_exclusion": ["Central Nervous System metastases", "leptomeningeal involvement"], "biomarker_exclusion": []}, {"cohort": "Part 2 NSCLC harboring cMet exon 14 skipping mutation", "disease_state": "advanced/metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["cMet exon 14 skipping mutation"], "histology_exclusion": ["Central Nervous System metastases", "leptomeningeal involvement"], "biomarker_exclusion": []}, {"cohort": "Part 2 Select solid tumors harboring an EGFR or cMet driving mutation", "disease_state": "advanced/metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR driving mutation"], "histology_exclusion": ["Central Nervous System metastases", "leptomeningeal involvement"], "biomarker_exclusion": []}, {"cohort": "Part 2 Select solid tumors harboring an EGFR or cMet driving mutation", "disease_state": "advanced/metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["cMet driving mutation"], "histology_exclusion": ["Central Nervous System metastases", "leptomeningeal involvement"], "biomarker_exclusion": []}, {"cohort": "Part 2 Select solid tumors harboring an EGFR or cMet driving mutation", "disease_state": "advanced/metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["EGFR driving mutation"], "histology_exclusion": ["Central Nervous System metastases", "leptomeningeal involvement"], "biomarker_exclusion": []}, {"cohort": "Part 2 Select solid tumors harboring an EGFR or cMet driving mutation", "disease_state": "advanced/metastatic", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": ["cMet driving mutation"], "histology_exclusion": ["Central Nervous System metastases", "leptomeningeal involvement"], "biomarker_exclusion": []}, {"cohort": "Part 2 Select solid tumors harboring an EGFR or cMet driving mutation", "disease_state": "advanced/metastatic", "histology_inclusion": "Gastric Cancer", "biomarker_inclusion": ["EGFR driving mutation"], "histology_exclusion": ["Central Nervous System metastases", "leptomeningeal involvement"], "biomarker_exclusion": []}, {"cohort": "Part 2 Select solid tumors harboring an EGFR or cMet driving mutation", "disease_state": "advanced/metastatic", "histology_inclusion": "Gastric Cancer", "biomarker_inclusion": ["cMet driving mutation"], "histology_exclusion": ["Central Nervous System metastases", "leptomeningeal involvement"], "biomarker_exclusion": []}, {"cohort": "Part 2 Select solid tumors harboring an EGFR or cMet driving mutation", "disease_state": "advanced/metastatic", "histology_inclusion": "Esophageal Squamous Cell Carcinoma", "biomarker_inclusion": ["EGFR driving mutation"], "histology_exclusion": ["Central Nervous System metastases", "leptomeningeal involvement"], "biomarker_exclusion": []}, {"cohort": "Part 2 Select solid tumors harboring an EGFR or cMet driving mutation", "disease_state": "advanced/metastatic", "histology_inclusion": "Esophageal Squamous Cell Carcinoma", "biomarker_inclusion": ["cMet driving mutation"], "histology_exclusion": ["Central Nervous System metastases", "leptomeningeal involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 2 NSCLC harboring EGFR exon 20 Insertion", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part 2 NSCLC harboring cMet exon 14 skipping mutation", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part 2 Select solid tumors harboring an EGFR or cMet driving mutation", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Part 2 Select solid tumors harboring an EGFR or cMet driving mutation", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part 2 Select solid tumors harboring an EGFR or cMet driving mutation", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Part 2 Select solid tumors harboring an EGFR or cMet driving mutation", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Part 2 Select solid tumors harboring an EGFR or cMet driving mutation", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Part 2 Select solid tumors harboring an EGFR or cMet driving mutation", "histology_inclusion": "Gastric Carcinoma"}, {"cohort": "Part 2 Select solid tumors harboring an EGFR or cMet driving mutation", "histology_inclusion": "Esophageal Squamous Cell Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Part 2 Select solid tumors harboring an EGFR or cMet driving mutation", "histology_inclusion": "Esophageal Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT03919292", "json": [{"cohort": "Colon", "disease_state": "advanced", "histology_inclusion": "Colon Cancer", "biomarker_inclusion": ["RAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Glioblastoma (GBM)", "disease_state": "advanced", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["RAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Glioblastoma (GBM)", "disease_state": "advanced", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["EGFR alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Ocular Melanoma (OM)", "disease_state": "advanced", "histology_inclusion": "Ocular Melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Other Cancer", "disease_state": "advanced", "histology_inclusion": "Other Solid Tumor", "biomarker_inclusion": ["RAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Pancreatic Cancer", "disease_state": "advanced", "histology_inclusion": "Pancreatic Cancer", "biomarker_inclusion": ["RAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Colon", "histology_inclusion": "Colon Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "Glioblastoma (GBM)", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "Glioblastoma (GBM)", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Ocular Melanoma (OM)", "histology_inclusion": "Ocular Melanoma"}, {"cohort": "Other Cancer", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "Pancreatic Cancer", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT03007147", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia", "biomarker_inclusion": ["BCR-ABL1 fusion"], "histology_exclusion": [], "biomarker_exclusion": ["chronic myelogenous leukemia", "prior treatment with dasatinib or any TKI other than imatinib"]}, {"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "B Acute Lymphoblastic Leukemia", "biomarker_inclusion": ["ABL-class fusion"], "histology_exclusion": [], "biomarker_exclusion": ["chronic myelogenous leukemia", "prior treatment with dasatinib or any TKI other than imatinib"]}, {"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "Mixed Phenotype Acute Leukemia", "biomarker_inclusion": ["BCR-ABL1 fusion"], "histology_exclusion": [], "biomarker_exclusion": ["chronic myelogenous leukemia", "prior treatment with dasatinib or any TKI other than imatinib"]}, {"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "T Acute Lymphoblastic Leukemia", "biomarker_inclusion": ["BCR-ABL1 fusion"], "histology_exclusion": [], "biomarker_exclusion": ["chronic myelogenous leukemia", "prior treatment with dasatinib or any TKI other than imatinib"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["ABL1 Fusion", "ABL1", "fusion"], ["BCR Fusion", "BCR", "fusion"], ["BCR - ABL1", "BCR - ABL1", "coordinate"]]}, {"cohort": "", "histology_inclusion": "B Acute Lymphoblastic Leukemia", "biomarker_inclusion": [["ABL1 Fusion", "ABL1", "fusion"], ["MTTP Fusion", "MTTP", "fusion"]]}, {"cohort": "", "histology_inclusion": "Mixed Phenotype Acute Leukemia", "biomarker_inclusion": [["ABL1 Fusion", "ABL1", "fusion"], ["BCR Fusion", "BCR", "fusion"], ["BCR - ABL1", "BCR - ABL1", "coordinate"]]}, {"cohort": "", "histology_inclusion": "T cell acute lymphoblastic leukemia", "biomarker_inclusion": [["ABL1 Fusion", "ABL1", "fusion"], ["BCR Fusion", "BCR", "fusion"], ["BCR - ABL1", "BCR - ABL1", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Infant T Acute Lymphoblastic Leukemia", "biomarker_inclusion": [["ABL1 Fusion", "ABL1", "fusion"], ["BCR Fusion", "BCR", "fusion"], ["BCR - ABL1", "BCR - ABL1", "coordinate"]]}]}
{"NCT_id": "NCT04245085", "json": [{"cohort": "Arm A and B", "disease_state": "stage IIIB/C or IV", "histology_inclusion": "non-squamous NSCLC", "biomarker_inclusion": ["EGFR L858R", "EGFR Del19", "EGFR S768I", "EGFR G719X"], "histology_exclusion": ["small-cell lung carcinoma", "high grade neuroendocrine carcinoma", "squamous cell histologic subtype"], "biomarker_exclusion": ["EGFR T790M positive genotype"]}], "json_norm": [{"cohort": "Arm A and B", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR S768I", "S768I", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]], "histology_exclusion": ["Neuroendocrine Carcinoma", "Small Cell Lung Carcinoma", "Neuroendocrine Tumor"], "biomarker_exclusion": [["EGFR T790M", "T790M", "coordinate"], ["EGFR-High", "EGFR-High", "expression"]]}]}
{"NCT_id": "NCT03594422", "json": [{"cohort": "", "disease_state": "Advanced and/or metastatic", "histology_inclusion": "Gastrointestinal Stromal Tumor (GIST)", "biomarker_inclusion": ["SDHB deficient", "NF1 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Advanced and/or metastatic", "histology_inclusion": "Other Solid Tumors", "biomarker_inclusion": [], "histology_exclusion": ["Brain metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["SDHB-Low", "SDHB-Low", "expression"], ["NF1 Mutation", "NF1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT05065411", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["ER+", "HER2-", "AR+ with AR% nuclei staining \u226540%"], "histology_exclusion": ["HER2+ metastatic breast cancer", "central nervous system (CNS) metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["AKR1B1-High", "AKR1B1-High", "expression"], ["AR-High", "AR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}]}
{"NCT_id": "NCT03725436", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["WT TP53"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort A", "disease_state": "metastatic or inoperable locally advanced or locally recurrent", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["ER positive", "HER2 negative", "WT TP53"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Cohort B", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["MDM2 or MDM4 amplifications", "WT TP53"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": ["HPV-positive malignancy"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Expansion Cohort A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Expansion Cohort B", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"], ["MDM4-High", "MDM4-High", "expression"]]}]}
{"NCT_id": "NCT03530683", "json": [{"cohort": "Phase 1a", "disease_state": "relapsed/refractory", "histology_inclusion": "lymphoma (Hodgkin or non-Hodgkin)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system disease"], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort A1 and A2", "disease_state": "newly diagnosed", "histology_inclusion": "TP53-mutated Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system disease"], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort B1 and B2", "disease_state": "newly diagnosed", "histology_inclusion": "TP53-wildtype AML", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system disease"], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohorts C1, C2, C3, E1, E2, F1, F2, F3", "disease_state": "relapsed/refractory", "histology_inclusion": "Multiple Myeloma (MM)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system disease"], "biomarker_exclusion": []}, {"cohort": "Phase 1b Cohort D1 and D2", "disease_state": "relapsed/refractory", "histology_inclusion": "diffuse large B-cell lymphoma (DLBCL)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1a"}, {"cohort": "Phase 1b Cohort A1 and A2", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "Phase 1b Cohort B1 and B2", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["TP53 TP53-wild_type", "TP53-wild_type", "wild_type"]]}, {"cohort": "Phase 1b Cohorts C1, C2, C3, E1, E2, F1, F2, F3", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "Phase 1b Cohort D1 and D2", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}]}
{"NCT_id": "NCT04872166", "json": [{"cohort": "", "disease_state": "incurable or metastatic solid tumor or B cell NHL that is refractory to or intolerant of all standard therapy or for which no standard therapy is available", "histology_inclusion": "Advanced Solid Tumor", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) disease involvement"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "incurable or metastatic solid tumor or B cell NHL that is refractory to or intolerant of all standard therapy or for which no standard therapy is available", "histology_inclusion": "Non-Hodgkin Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system (CNS) disease involvement"], "biomarker_exclusion": []}, {"cohort": "Expansion Phase", "disease_state": "incurable or metastatic solid tumor or B cell NHL that is refractory to or intolerant of all standard therapy or for which no standard therapy is available", "histology_inclusion": "Advanced Solid Tumor", "biomarker_inclusion": ["MYC genomic amplification/overexpression"], "histology_exclusion": ["central nervous system (CNS) disease involvement"], "biomarker_exclusion": []}, {"cohort": "Expansion Phase", "disease_state": "incurable or metastatic solid tumor or B cell NHL that is refractory to or intolerant of all standard therapy or for which no standard therapy is available", "histology_inclusion": "Non-Hodgkin Lymphoma", "biomarker_inclusion": ["MYC genomic amplification/overexpression"], "histology_exclusion": ["central nervous system (CNS) disease involvement"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Non-Hodgkin Lymphoma"}, {"cohort": "Expansion Phase", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MYC-High", "MYC-High", "expression"]]}, {"cohort": "Expansion Phase", "histology_inclusion": "Non-Hodgkin Lymphoma", "biomarker_inclusion": [["MYC-High", "MYC-High", "expression"]]}]}
{"NCT_id": "NCT03401385", "json": [{"cohort": "NSCLC", "disease_state": "unresectable advanced", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "TNBC", "disease_state": "advanced/unresectable or metastatic", "histology_inclusion": "Triple Negative Breast Cancer", "biomarker_inclusion": ["HR-negative", "HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "HR positive, HER2-negative", "disease_state": "unresectable or metastatic", "histology_inclusion": "Hormone Receptor Positive Breast Cancer", "biomarker_inclusion": ["HER2-negative", "estrogen receptor positive", "progesterone receptor positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "SCLC", "disease_state": "unresectable or metastatic, and/or extensive-stage", "histology_inclusion": "Small-cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Endometrial cancer", "disease_state": "recurrent or persistent", "histology_inclusion": "Endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Pancreatic adenocarcinoma", "disease_state": "unresectable or metastatic", "histology_inclusion": "Pancreatic adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "HER2-negative gastroesophageal cancer", "disease_state": "unresectable or metastatic", "histology_inclusion": "adenocarcinoma of the stomach or esophagus, including the gastroesophagel junction (GEJ)", "biomarker_inclusion": ["HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Esophageal cancer", "disease_state": "unresectable or metastatic", "histology_inclusion": "squamous cell carcinoma of the esophagus", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "HNSCC", "disease_state": "unresectable or metastatic", "histology_inclusion": "Head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "NSCLC", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "TNBC", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["HR-Low", "HR-Low", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "HR positive, HER2-negative", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "HR positive, HER2-negative", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "SCLC", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Endometrial cancer", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "Pancreatic adenocarcinoma", "histology_inclusion": "Pancreatic Adenocarcinoma"}, {"cohort": "HER2-negative gastroesophageal cancer", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Esophageal cancer", "histology_inclusion": "Esophageal Squamous Cell Carcinoma"}, {"cohort": "HNSCC", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT04416568", "json": [{"cohort": "Stratum 1", "disease_state": "relapsed or refractory", "histology_inclusion": "Malignant rhabdoid tumor", "biomarker_inclusion": ["Loss of INI1", "bi-allelic SMARCB1 (INI1) loss or mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 1", "disease_state": "relapsed or refractory", "histology_inclusion": "Rhabdoid tumor of the kidney", "biomarker_inclusion": ["Loss of INI1", "bi-allelic SMARCB1 (INI1) loss or mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 1", "disease_state": "relapsed or refractory", "histology_inclusion": "Epithelioid sarcoma", "biomarker_inclusion": ["Loss of INI1", "bi-allelic SMARCB1 (INI1) loss or mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 1", "disease_state": "relapsed or refractory", "histology_inclusion": "Chordoma (poorly differentiated or de-differentiated)", "biomarker_inclusion": ["Loss of INI1", "bi-allelic SMARCB1 (INI1) loss or mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 1", "disease_state": "relapsed or refractory", "histology_inclusion": "Other INI1-negative or SMARCA4-deficient malignant tumors", "biomarker_inclusion": ["Loss of INI1", "bi-allelic SMARCB1 (INI1) loss or mutation", "Loss of SMARCA4", "bi-allelic SMARCA4 loss or mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 2", "disease_state": "relapsed or refractory", "histology_inclusion": "Atypical teratoid rhabdoid tumor", "biomarker_inclusion": ["Loss of INI1", "bi-allelic SMARCB1 (INI1) loss or mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Stratum 2", "disease_state": "relapsed or refractory", "histology_inclusion": "Other INI1-negative or SMARCA4-deficient primary CNS malignant tumors", "biomarker_inclusion": ["Loss of INI1", "bi-allelic SMARCB1 (INI1) loss or mutation", "Loss of SMARCA4", "bi-allelic SMARCA4 loss or mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Stratum 1", "histology_inclusion": "Rhabdoid Tumor", "biomarker_inclusion": [["SMARCB1 Mutation", "SMARCB1-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "Stratum 1", "histology_inclusion": "Rhabdoid Tumor of the Kidney", "biomarker_inclusion": [["SMARCB1 Mutation", "SMARCB1-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "Stratum 1", "histology_inclusion": "Epithelioid Sarcoma", "biomarker_inclusion": [["SMARCB1 Mutation", "SMARCB1-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "Stratum 1", "histology_inclusion": "Chordoma", "biomarker_inclusion": [["SMARCB1 Mutation", "SMARCB1-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "Stratum 1", "histology_inclusion": "Malignant Neoplasm", "biomarker_inclusion": [["SMARCA4-Low", "SMARCA4-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCB1 Mutation", "SMARCB1-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCA4-Low", "SMARCA4-Low", "expression"], ["SMARCA4-Low", "SMARCA4-Low", "expression"], ["SMARCA4 Mutation", "SMARCA4-Mutation", "gene"]]}, {"cohort": "Stratum 1", "histology_inclusion": "Malignant Neoplasm", "biomarker_inclusion": [["SMARCA4-Low", "SMARCA4-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCA4 Mutation", "SMARCA4-Mutation", "gene"], ["SMARCB1 Mutation", "SMARCB1-Mutation", "gene"]]}, {"cohort": "Stratum 2", "histology_inclusion": "Rhabdoid Tumor", "biomarker_inclusion": [["SMARCB1 Mutation", "SMARCB1-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "Stratum 2", "histology_inclusion": "Malignant Central Nervous System Neoplasm", "biomarker_inclusion": [["SMARCA4-Low", "SMARCA4-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCB1 Mutation", "SMARCB1-Mutation", "gene"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCA4-Low", "SMARCA4-Low", "expression"], ["SMARCA4-Low", "SMARCA4-Low", "expression"], ["SMARCA4 Mutation", "SMARCA4-Mutation", "gene"]]}, {"cohort": "Stratum 2", "histology_inclusion": "Malignant Central Nervous System Neoplasm", "biomarker_inclusion": [["SMARCA4-Low", "SMARCA4-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"], ["SMARCA4 Mutation", "SMARCA4-Mutation", "gene"], ["SMARCB1 Mutation", "SMARCB1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04872543", "json": [{"cohort": "", "disease_state": "advanced, unresectable or metastatic", "histology_inclusion": "Malignant Peripheral Nerve Sheath Tumors (MPNST)", "biomarker_inclusion": ["PRC2 loss (e.g. IHC of loss H3K27me2 and/or H3K27me3 immunostaining, and/or inactivating mutations in EED, SUZ12, EZH2)"], "histology_exclusion": ["brain metastasis", "leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Peripheral Nerve Sheath Tumor", "biomarker_inclusion": [["H3C2-Low", "H3C2-Low", "expression"], ["EED Mutation", "EED-Mutation", "gene"], ["H3-3A K28M", "K28M", "coordinate"], ["EZH2 Mutation", "EZH2-Mutation", "gene"], ["SUZ12 Mutation", "SUZ12-Mutation", "gene"], ["H3C3-Low", "H3C3-Low", "expression"]]}]}
{"NCT_id": "NCT04872595", "json": [{"cohort": "", "disease_state": "Acute myeloid leukemia (AML) with intermediate or high-risk features in CR1 or Relapse AML in \u2265 CR2", "histology_inclusion": "Acute myeloid leukemia (AML)", "biomarker_inclusion": ["MRD <5%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Acute leukemias of ambiguous lineage in \u2265 CR1", "histology_inclusion": "Acute leukemias of ambiguous lineage", "biomarker_inclusion": ["MRD <5%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Adult Patients", "disease_state": "Acute lymphoid leukemia (ALL) in CR1 with clinical, flow cytometric, or molecular features indicating a high risk for relapse, or ALL in \u2265 CR2", "histology_inclusion": "Acute lymphoid leukemia (ALL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Pediatric Patients", "disease_state": "Acute lymphoid leukemia (ALL) in CR1 with clinical, flow cytometric, or molecular features indicating a high risk for relapse, or ALL in \u2265 CR2", "histology_inclusion": "Acute lymphoid leukemia (ALL)", "biomarker_inclusion": ["MRD-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Myelodysplastic syndromes (MDS) with least one of the following: Revised International Prognostic Scoring System risk score of intermediate or higher at the time of transplant evaluation, Life-threatening cytopenia, Karyotype or genomic changes that indicate high risk for progression to acute myelogenous leukemia, including abnormalities of chromosome 7 or 3, mutations of TP53, or complex or monosomal karyotype, Therapy related disease or disease evolving from other malignant processes", "histology_inclusion": "Myelodysplastic syndromes (MDS)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Leukemia of Ambiguous Lineage"}, {"cohort": "Adult Patients", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "Pediatric Patients", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}]}
{"NCT_id": "NCT04872634", "json": [{"cohort": "", "disease_state": "Locally advanced or Metastatic", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutation", "ALK mutation", "ROS1 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["HIV", "HBV", "HCV"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"]]}]}
{"NCT_id": "NCT02945579", "json": [{"cohort": "Cohort A", "disease_state": "Stage T1 or T2 (\u2264 5 cm), N0 or N1 (\u2264 4 abnormal axillary nodes), M0", "histology_inclusion": "HER2 Positive Breast Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "Stage T1 or T2 (\u2264 5 cm), N0 or N1 (\u2264 4 abnormal axillary nodes), M0", "histology_inclusion": "Triple-Negative Breast Carcinoma", "biomarker_inclusion": ["ER < 10%", "PR < 10%", "HER2 Negative (IHC 1+ or 2+ FISH non-amplified)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "Stage T1N0M0", "histology_inclusion": "Non-Lobular Breast Cancer", "biomarker_inclusion": ["ER Positive", "PR Positive", "HER2 Negative"], "histology_exclusion": [], "biomarker_exclusion": ["Oncotype > 25 if age \u2265 50 years", "Oncotype > 20 and tumor size > 1.5cm if age 40-49 years"]}, {"cohort": "Cohort C", "disease_state": "Stage T1 or T2 (\u2264 5 cm), N0, M0", "histology_inclusion": "HER2 Positive Breast Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["SH3PXD2A-High", "SH3PXD2A-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Cohort B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["PRH2-High", "PRH2-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Cohort C", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT03532295", "json": [{"cohort": "", "disease_state": "Recurrent", "histology_inclusion": "WHO grade 4 glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1", "anti-PD-L2", "IDO inhibitor"]}, {"cohort": "", "disease_state": "Recurrent", "histology_inclusion": "gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1", "anti-PD-L2", "IDO inhibitor"]}, {"cohort": "", "disease_state": "Recurrent", "histology_inclusion": "WHO grade 4 astrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1", "anti-PD-L2", "IDO inhibitor"]}, {"cohort": "", "disease_state": "Recurrent", "histology_inclusion": "WHO grade high grade glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["anti-PD-1", "anti-PD-L1", "anti-PD-L2", "IDO inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Gliosarcoma"}, {"cohort": "", "histology_inclusion": "Astrocytoma"}, {"cohort": "", "histology_inclusion": "Malignant Glioma"}]}
{"NCT_id": "NCT03597581", "json": [{"cohort": "2nd Line Colorectal Cancer (CRC) KRAS (+)", "disease_state": "advanced, metastatic or locally advanced and unresectable", "histology_inclusion": "adenocarcinoma or poorly differentiated colorectal cancer", "biomarker_inclusion": ["RAS mutant"], "histology_exclusion": ["small cell", "neuroendocrine", "squamous"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "2nd Line Colorectal Cancer (CRC) KRAS (+)", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"]]}, {"cohort": "2nd Line Colorectal Cancer (CRC) KRAS (+)", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT03923270", "json": [{"cohort": "", "disease_state": "Extensive-Stage Disease", "histology_inclusion": "Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["Carcinomatous meningitis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT03793179", "json": [{"cohort": "", "disease_state": "stage IV", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["PD-L1 expression TPS >= 1%"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutations (except exon 20 insertion)", "BRAF mutations (V600)", "ALK translocations", "ROS1 translocations"]}, {"cohort": "", "disease_state": "stage IIIB", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["PD-L1 expression TPS >= 1%"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutations (except exon 20 insertion)", "BRAF mutations (V600)", "ALK translocations", "ROS1 translocations"]}, {"cohort": "", "disease_state": "stage IIIC", "histology_inclusion": "non-squamous non-small cell lung cancer", "biomarker_inclusion": ["PD-L1 expression TPS >= 1%"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR mutations (except exon 20 insertion)", "BRAF mutations (V600)", "ALK translocations", "ROS1 translocations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT03272633", "json": [{"cohort": "Cohort 1", "disease_state": "high-risk", "histology_inclusion": "Diffuse large cell lymphoma or peripheral T cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1", "disease_state": "high-risk", "histology_inclusion": "Mantle cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1", "disease_state": "high-risk", "histology_inclusion": "Multiple myeloma", "biomarker_inclusion": ["High Revised-International Staging System (R-ISS)", "Cytogenetics or fluorescent in situ hybridization (FISH) del17p"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "high-risk", "histology_inclusion": "Acute myeloid leukemia (AML)", "biomarker_inclusion": ["European Leukemia Network (ELN) high risk features", "measurable minimal residual disease (MRD)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "high-risk", "histology_inclusion": "Myelodysplastic syndrome (MDS)", "biomarker_inclusion": ["complex cytogenetics", "17p deletion", "p53 mutation", "JAK2 mutation", "RAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "high-risk", "histology_inclusion": "Treatment-related MDS or AML", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "high-risk", "histology_inclusion": "Acute lymphoblastic leukemia (ALL)", "biomarker_inclusion": ["measurable minimal residual disease (MRD)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "high-risk", "histology_inclusion": "Any hematologic malignancy", "biomarker_inclusion": ["relapsed or persistent disease after allogeneic hematopoietic stem cell transplant"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "high-risk", "histology_inclusion": "Multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "high-risk", "histology_inclusion": "Non-Hodgkin lymphoma (NHL)", "biomarker_inclusion": ["chemoresistant disease at time of transplant"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma"}, {"cohort": "Cohort 1", "histology_inclusion": "Peripheral T-Cell Lymphoma"}, {"cohort": "Cohort 1", "histology_inclusion": "Mantle Cell Lymphoma"}, {"cohort": "Cohort 1", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "Cohort 2", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "Cohort 2", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["JAK2 Mutation", "JAK2-Mutation", "gene"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "Cohort 2", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "Cohort 2", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "Cohort 2", "histology_inclusion": "Hematopoietic and Lymphoid Cell Neoplasm"}, {"cohort": "Cohort 2", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "Cohort 2", "histology_inclusion": "Non-Hodgkin Lymphoma"}]}
{"NCT_id": "NCT03533582", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Childhood Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Childhood Malignant Liver Neoplasm", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Fibrolamellar Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Hepatoblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Hepatocellular Malignant Neoplasm, Not Otherwise Specified", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "", "histology_inclusion": "Liver Cancer"}, {"cohort": "", "histology_inclusion": "Fibrolamellar Carcinoma"}, {"cohort": "", "histology_inclusion": "Hepatoblastoma"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Neoplasm"}]}
{"NCT_id": "NCT03860272", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT05331521", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Histologically confirmed, newly diagnosed WHO grade II or III glioma", "biomarker_inclusion": ["Tumor carries an isocitrate dehydrogenase (IDH) mutation", "Tumor is co-deleted for 1p/19q"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT05721872", "json": [{"cohort": "Phase 1", "disease_state": "advanced/metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["KRAS+", "NRAS+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "advanced/metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["KRAS+", "NRAS+"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["NRAS-High", "NRAS-High", "expression"], ["KRAS-High", "KRAS-High", "expression"]]}, {"cohort": "Phase 2", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["NRAS-High", "NRAS-High", "expression"], ["KRAS-High", "KRAS-High", "expression"]]}]}
{"NCT_id": "NCT03013998", "json": [{"cohort": "Group A", "disease_state": "previously untreated", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "Group B", "disease_state": "relapsed or refractory", "histology_inclusion": "acute myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Group A", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Group B", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT03600649", "json": [{"cohort": "Ewing Sarcoma Combination Treatment Cohort", "disease_state": "relapsed or refractory", "histology_inclusion": "Ewing Sarcoma", "biomarker_inclusion": ["EWSR1 translocation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Single Agent Myxoid Liposarcoma Cohort", "disease_state": "relapsed or refractory", "histology_inclusion": "Myxoid Liposarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Single Agent FET-Translocated Sarcomas", "disease_state": "relapsed or refractory", "histology_inclusion": "Sarcomas with FET-family translocations, including demoplastic small round cell tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Ewing Sarcoma Combination Treatment Cohort", "histology_inclusion": "Ewing Sarcoma", "biomarker_inclusion": [["EWSR1 Fusion", "EWSR1", "fusion"]]}, {"cohort": "Single Agent Myxoid Liposarcoma Cohort", "histology_inclusion": "Myxoid Liposarcoma"}, {"cohort": "Single Agent FET-Translocated Sarcomas", "histology_inclusion": "Sarcoma"}]}
{"NCT_id": "NCT03992456", "json": [{"cohort": "", "disease_state": "metastatic and/or unresectable", "histology_inclusion": "adenocarcinoma of the colon or rectal", "biomarker_inclusion": ["RAS wild-type", "KRAS wild-type", "NRAS wild-type", "BRAF codon 600 wild-type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colon Adenocarcinoma", "biomarker_inclusion": [["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04253262", "json": [{"cohort": "", "disease_state": "metastatic castration-resistant", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": ["de novo small cell carcinoma of the prostate"], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "metastatic castration-resistant", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["BRCA1", "BRCA2", "ATM", "BARD1", "BRIP1", "CDK12", "CHEK1", "FANCL", "FANCA", "PALB2", "PPP2R2A", "RAD51B", "RAD51C", "RAD51D", "RAD54L"], "histology_exclusion": ["de novo small cell carcinoma of the prostate"], "biomarker_exclusion": ["PARP inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Neoplasm", "histology_exclusion": ["Prostate Small Cell Neuroendocrine Carcinoma"]}, {"cohort": "", "histology_inclusion": "Prostate Carcinoma", "histology_exclusion": ["Prostate Small Cell Neuroendocrine Carcinoma"]}, {"cohort": "Phase 2", "histology_inclusion": "Prostate Neoplasm", "histology_exclusion": ["Prostate Small Cell Neuroendocrine Carcinoma"]}, {"cohort": "Phase 2", "histology_inclusion": "Prostate Carcinoma", "histology_exclusion": ["Prostate Small Cell Neuroendocrine Carcinoma"]}]}
{"NCT_id": "NCT05593328", "json": [{"cohort": "", "disease_state": "metastatic and/or unresectable colorectal cancer", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["KRAS mutation in exon 2, 3, or 4", "NRAS mutation in exon 2, 3, or 4"], "histology_exclusion": [], "biomarker_exclusion": ["concomitant KRAS or NRAS and BRAF-V600 mutation", "Microsatellite Instability High/Deficient Mismatch Repair (MSI-H/dMMR)"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04486833", "json": [{"cohort": "", "disease_state": "Stage III or IV or recurrent", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR mutation-positive"], "histology_exclusion": [], "biomarker_exclusion": ["ALK", "ROS", "BRAF V600E mutations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT05007873", "json": [{"cohort": "", "disease_state": "early chronic phase CML (time from diagnosis <= 12 months)", "histology_inclusion": "Philadelphia chromosome-positive CML", "biomarker_inclusion": ["BCR-ABL positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia", "biomarker_inclusion": [["BCR - MTTP", "BCR - MTTP", "coordinate"], ["BCR - ABL1", "BCR - ABL1", "coordinate"], ["MTTP-High", "MTTP-High", "expression"]]}]}
{"NCT_id": "NCT05008055", "json": [{"cohort": "Cohort 1A (R/R FL)", "disease_state": "Relapsed, progressed or refractory", "histology_inclusion": "Follicular Lymphoma Grade 1, 2, or 3a", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system lymphoma", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Cohort 1B (R/R MZL)", "disease_state": "Relapsed, progressed or refractory", "histology_inclusion": "Marginal Zone Lymphoma (splenic, nodal, and extranodal subtypes)", "biomarker_inclusion": [], "histology_exclusion": ["central nervous system lymphoma", "leptomeningeal disease"], "biomarker_exclusion": []}, {"cohort": "Cohort 1C (R/R MCL)", "disease_state": "Relapsed, progressed or refractory", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["t(11;14)(q13;q32)", "cyclin D1 overexpression"], "histology_exclusion": ["central nervous system lymphoma", "leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1A (R/R FL)", "histology_inclusion": "Follicular Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}, {"cohort": "Cohort 1B (R/R MZL)", "histology_inclusion": "Marginal Zone Lymphoma", "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}, {"cohort": "Cohort 1C (R/R MCL)", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["CCND1-High", "CCND1-High", "expression"]], "histology_exclusion": ["Central Nervous System Lymphoma", "Primary Central Nervous System Lymphoma"]}]}
{"NCT_id": "NCT02613650", "json": [{"cohort": "All patients", "disease_state": "metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["RAS positive", "HRAS positive", "NRAS positive", "KRAS positive"], "histology_exclusion": [], "biomarker_exclusion": ["UGT1A1 *28 homozygous"]}], "json_norm": [{"cohort": "All patients", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["NRAS-High", "NRAS-High", "expression"], ["HRAS-High", "HRAS-High", "expression"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS-High", "KRAS-High", "expression"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"]]}]}
{"NCT_id": "NCT03732703", "json": [{"cohort": "Sub-Protocol A1", "disease_state": "Relapsed Refractory Multiple Myeloma", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": ["CDK activating alteration"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Sub-Protocol B1", "disease_state": "Relapsed Refractory Multiple Myeloma", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": ["IDH2 activating mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Sub-Protocol C1", "disease_state": "Relapsed Refractory Multiple Myeloma", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": ["RAF/RAS mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Sub-Protocol D1", "disease_state": "Relapsed Refractory Multiple Myeloma", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": ["FGFR3 activating mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Sub-Protocol E1", "disease_state": "Relapsed Refractory Multiple Myeloma", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": ["t(11;14) translocation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Sub-Protocol Y1", "disease_state": "Relapsed Refractory Multiple Myeloma", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": ["Non-Actionable Genetic Abnormality"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Sub-Protocol Y2", "disease_state": "Relapsed Refractory Multiple Myeloma", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": ["Non-Actionable Genetic Abnormality"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Sub-Protocol Y3", "disease_state": "Relapsed Refractory Multiple Myeloma", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": ["Non-Actionable Genetic Abnormality"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Sub-Protocol A1", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "Sub-Protocol B1", "histology_inclusion": "Plasma Cell Myeloma", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Sub-Protocol C1", "histology_inclusion": "Plasma Cell Myeloma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "Sub-Protocol D1", "histology_inclusion": "Plasma Cell Myeloma", "biomarker_inclusion": [["FGFR3 Mutation", "FGFR3-Mutation", "gene"]]}, {"cohort": "Sub-Protocol E1", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "Sub-Protocol Y1", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "Sub-Protocol Y2", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "Sub-Protocol Y3", "histology_inclusion": "Plasma Cell Myeloma"}]}
{"NCT_id": "NCT04123366", "json": [{"cohort": "", "disease_state": "advanced (metastatic and/or unresectable) solid tumor", "histology_inclusion": "solid tumor (except breast or ovarian cancers whose tumor has a germline or somatic BRCA mutation)", "biomarker_inclusion": ["HRRm", "HRD"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT04683250", "json": [{"cohort": "Phase I Dose-Escalation", "disease_state": "Advanced solid tumors", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": ["RET-gene abnormalities"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase I Dose-Expansion", "disease_state": "Locally advanced or metastatic", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": ["RET gene fusion", "prior exposure to RET selective inhibitors"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II", "disease_state": "Locally advanced or metastatic", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": ["RET gene fusion", "prior exposure to RET selective inhibitors"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR", "KRAS", "ALK", "HER2", "ROS1", "BRAF", "METex14 activating mutations"]}, {"cohort": "Phase II", "disease_state": "Locally advanced or metastatic", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": ["RET gene fusion", "without prior exposure to RET selective inhibitors"], "histology_exclusion": [], "biomarker_exclusion": ["EGFR", "KRAS", "ALK", "HER2", "ROS1", "BRAF", "METex14 activating mutations"]}, {"cohort": "Phase II", "disease_state": "Advanced", "histology_inclusion": "Solid Tumors", "biomarker_inclusion": ["RET gene abnormalities"], "histology_exclusion": ["Non Small Cell Lung Cancer with primary RET gene fusions"], "biomarker_exclusion": ["EGFR", "KRAS", "ALK", "HER2", "ROS1", "BRAF", "METex14 activating mutations"]}], "json_norm": [{"cohort": "Phase I Dose-Escalation", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]]}, {"cohort": "Phase I Dose-Expansion", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"]]}, {"cohort": "Phase II", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"]]}, {"cohort": "Phase II", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["RET Fusion", "RET", "fusion"]]}, {"cohort": "Phase II", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["RET Mutation", "RET-Mutation", "gene"]], "histology_exclusion": ["Non-Small Cell Lung Carcinoma"], "biomarker_exclusion": [["RET Fusion", "RET", "fusion"]]}]}
{"NCT_id": "NCT05139004", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Acute myelogenous leukemia", "biomarker_inclusion": ["CD25"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Acute lymphocytic leukemia", "biomarker_inclusion": ["CD25"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Myelodysplastic syndrome", "biomarker_inclusion": ["CD25"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}]}
{"NCT_id": "NCT03016806", "json": [{"cohort": "", "disease_state": "Refractory to standard induction therapy", "histology_inclusion": "Acute Myelogenous Leukemia", "biomarker_inclusion": ["FLT3 abnormalities"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Recurrent", "histology_inclusion": "Acute Myelogenous Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Treatment-related", "histology_inclusion": "AML or MDS", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Evolved from myelodysplastic syndrome", "histology_inclusion": "Acute Myelogenous Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Refractory to standard induction therapy", "histology_inclusion": "Acute Lymphoblastic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Recurrent", "histology_inclusion": "Acute Lymphoblastic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Age >30 at diagnosis", "histology_inclusion": "Acute Lymphoblastic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Adverse cytogenetics", "histology_inclusion": "Acute Lymphoblastic Leukemia", "biomarker_inclusion": ["t(9:22)", "t(1:19)", "t(4:11)", "MLL rearrangements"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Accelerated phase or blast crisis", "histology_inclusion": "Chronic Myelogenous Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Biphenotypic or undifferentiated leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Burkitt's leukemia or lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Refractory or recurrent, chemo-sensitive, and ineligible for an autologous stem cell transplant or previously treated with autologous SCT", "histology_inclusion": "Large cell, Mantle cell, Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Progressive after at least two prior therapies", "histology_inclusion": "Marginal zone or follicular lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Recurrent following high-dose therapy and autologous SCT or ineligible for an autologous HSCT", "histology_inclusion": "Multiple Myeloma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "With efficacy of allogeneic HSCT demonstrated for the specific disease and disease status", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["FLT3 Mutation", "FLT3-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["KMT2A Fusion", "KMT2A", "fusion"]]}, {"cohort": "", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Burkitt Leukemia"}, {"cohort": "", "histology_inclusion": "Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "", "histology_inclusion": "Plasma Cell Myeloma"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT03212274", "json": [{"cohort": "", "disease_state": "metastatic, refractory", "histology_inclusion": "glioma", "biomarker_inclusion": ["IDH1 R132V", "IDH1 R132G", "IDH1 R132S", "IDH1 R132L", "IDH1 R132C", "IDH1 R132H", "IDH2 R140W", "IDH2 R140L", "IDH2 R140Q", "IDH2 R172W", "IDH2 R172G", "IDH2 R172S", "IDH2 R172M", "IDH2 R172K"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic, refractory", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": ["IDH1 R132V", "IDH1 R132G", "IDH1 R132S", "IDH1 R132L", "IDH1 R132C", "IDH1 R132H", "IDH2 R140W", "IDH2 R140L", "IDH2 R140Q", "IDH2 R172W", "IDH2 R172G", "IDH2 R172S", "IDH2 R172M", "IDH2 R172K"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic, refractory", "histology_inclusion": "solid malignant tumor", "biomarker_inclusion": ["IDH1 R132V", "IDH1 R132G", "IDH1 R132S", "IDH1 R132L", "IDH1 R132C", "IDH1 R132H", "IDH2 R140W", "IDH2 R140L", "IDH2 R140Q", "IDH2 R172W", "IDH2 R172G", "IDH2 R172S", "IDH2 R172M", "IDH2 R172K"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH2 R140L", "R140L", "coordinate"], ["IDH2 R172W", "R172W", "coordinate"], ["IDH2 R172S", "R172S", "coordinate"], ["IDH2 R172M", "R172M", "coordinate"], ["IDH2 R172K", "R172K", "coordinate"], ["IDH1 R132C", "R132C", "coordinate"], ["IDH2 R172G", "R172G", "coordinate"], ["IDH1 R132S", "R132S", "coordinate"], ["IDH1 R132L", "R132L", "coordinate"], ["IDH1 R132H", "R132H", "coordinate"], ["IDH2 R140Q", "R140Q", "coordinate"], ["IDH2 R140W", "R140W", "coordinate"], ["IDH1 R132G", "R132G", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["IDH2 R140L", "R140L", "coordinate"], ["IDH2 R172W", "R172W", "coordinate"], ["IDH2 R172S", "R172S", "coordinate"], ["IDH2 R172M", "R172M", "coordinate"], ["IDH2 R172K", "R172K", "coordinate"], ["IDH1 R132C", "R132C", "coordinate"], ["IDH2 R172G", "R172G", "coordinate"], ["IDH1 R132S", "R132S", "coordinate"], ["IDH1 R132L", "R132L", "coordinate"], ["IDH1 R132H", "R132H", "coordinate"], ["IDH2 R140Q", "R140Q", "coordinate"], ["IDH2 R140W", "R140W", "coordinate"], ["IDH1 R132G", "R132G", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Malignant Neoplasm", "biomarker_inclusion": [["IDH2 R140L", "R140L", "coordinate"], ["IDH2 R172W", "R172W", "coordinate"], ["IDH2 R172S", "R172S", "coordinate"], ["IDH2 R172M", "R172M", "coordinate"], ["IDH2 R172K", "R172K", "coordinate"], ["IDH1 R132C", "R132C", "coordinate"], ["IDH2 R172G", "R172G", "coordinate"], ["IDH1 R132S", "R132S", "coordinate"], ["IDH1 R132L", "R132L", "coordinate"], ["IDH1 R132H", "R132H", "coordinate"], ["IDH2 R140Q", "R140Q", "coordinate"], ["IDH2 R140W", "R140W", "coordinate"], ["IDH1 R132G", "R132G", "coordinate"]]}]}
{"NCT_id": "NCT04059224", "json": [{"cohort": "Arm A: advanced BRAF V600 wild-type/NRAS-mutant melanoma", "disease_state": "Stage III (unresectable) or Stage IV (metastatic)", "histology_inclusion": "advanced melanoma", "biomarker_inclusion": ["BRAF V600 wild-type", "NRAS-mutant"], "histology_exclusion": ["uveal melanoma"], "biomarker_exclusion": []}, {"cohort": "Arm B: advanced BRAF V600 wild-type/NRAS wild-type melanoma", "disease_state": "Stage III (unresectable) or Stage IV (metastatic)", "histology_inclusion": "advanced melanoma", "biomarker_inclusion": ["BRAF V600 wild-type", "NRAS wild-type"], "histology_exclusion": ["uveal melanoma"], "biomarker_exclusion": ["cKIT mutation"]}], "json_norm": [{"cohort": "Arm A: advanced BRAF V600 wild-type/NRAS-mutant melanoma", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["NRAS Mutation", "NRAS-Mutation", "gene"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]], "histology_exclusion": ["Intraocular Melanoma"]}, {"cohort": "Arm B: advanced BRAF V600 wild-type/NRAS wild-type melanoma", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]], "histology_exclusion": ["Intraocular Melanoma"]}]}
{"NCT_id": "NCT02886585", "json": [{"cohort": "Cohort A", "disease_state": "Previously untreated asymptomatic brain metastases", "histology_inclusion": "any solid tumor", "biomarker_inclusion": [], "histology_exclusion": ["HER2-positive breast cancer", "small cell lung cancer"], "biomarker_exclusion": ["NSCLC with targetable genomic tumor aberrations (e.g. EGFR, ALK)"]}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Breast Carcinoma", "Small Cell Lung Carcinoma"], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ALK Mutation", "ALK-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT04813913", "json": [{"cohort": "", "disease_state": "stage IV", "histology_inclusion": "colorectal cancer of the adenocarcinoma type", "biomarker_inclusion": ["mutated RAS", "wild RAS", "mutated BRAF", "wild BRAF"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["HRAS Mutation", "HRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}]}
{"NCT_id": "NCT02484404", "json": [{"cohort": "Phase II - Ovarian Cancer", "disease_state": "persistent or recurrent, platinum resistant or refractory", "histology_inclusion": "ovarian, fallopian tube, or primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase II - Triple Negative Breast Cancer", "disease_state": "persistent or recurrent", "histology_inclusion": "triple-negative breast cancer", "biomarker_inclusion": ["gBRCAm"], "histology_exclusion": ["CNS metastasis", "leptomeningeal disease"], "biomarker_exclusion": ["prior PARPi"]}, {"cohort": "Phase II - Non-Small Cell Lung Cancer", "disease_state": "advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase II - Ovarian Cancer", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "Phase II - Triple Negative Breast Cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Phase II - Non-Small Cell Lung Cancer", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT03994796", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["CDK gene mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["NTRK family gene mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["PI3K gene mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["ROS1 gene mutation"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK1 Mutation", "NTRK1-Mutation", "gene"], ["NTRK3 Mutation", "NTRK3-Mutation", "gene"], ["NTRK2 Mutation", "NTRK2-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["PIK3CA Mutation", "PIK3CA-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ROS 1 Mutation", "ROS 1-Mutation", "gene"], ["ROS1 Mutation", "ROS1-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT03865511", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "adenocarcinoma of the lung", "biomarker_inclusion": ["EGFR Ex19 deletions", "EGFR L858R"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT04126070", "json": [{"cohort": "COHORT 1: DNA damage repair defects (DDRD) +/- Inflamed Tumor", "disease_state": "metastatic hormone-sensitive prostate cancer", "histology_inclusion": "prostate adenocarcinoma", "biomarker_inclusion": ["somatic or germline homozygous deletions and/or deleterious mutations in a DDR gene", "mismatch repair deficient (MMR-d)", "microsatellite instability high (MSI-H)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "COHORT 2: Inflamed Tumor without DNA repair defects (DDRD)", "disease_state": "metastatic hormone-sensitive prostate cancer", "histology_inclusion": "prostate adenocarcinoma", "biomarker_inclusion": ["PD-L1 positive", "CD8+ T cell inflamed"], "histology_exclusion": [], "biomarker_exclusion": ["somatic or germline homozygous deletions and/or deleterious mutations in a DDR gene", "mismatch repair deficient (MMR-d)", "microsatellite instability high (MSI-H)"]}, {"cohort": "COHORT 3: Biomarker Negative", "disease_state": "metastatic hormone-sensitive prostate cancer", "histology_inclusion": "prostate adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["somatic or germline homozygous deletions and/or deleterious mutations in a DDR gene", "mismatch repair deficient (MMR-d)", "microsatellite instability high (MSI-H)", "PD-L1 positive", "CD8+ T cell inflamed"]}], "json_norm": [{"cohort": "COHORT 1: DNA damage repair defects (DDRD) +/- Inflamed Tumor", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "COHORT 2: Inflamed Tumor without DNA repair defects (DDRD)", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["CD8A-High", "CD8A-High", "expression"], ["CD274-High", "CD274-High", "expression"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["DNA Damage Repair (DDR) pathways", null, "pathway"]]}, {"cohort": "COHORT 3: Biomarker Negative", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_exclusion": [["CD8A-High", "CD8A-High", "expression"], ["DNA Damage Repair (DDR) pathways", null, "pathway"], ["CD274-High", "CD274-High", "expression"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04489706", "json": [{"cohort": "P53 mutation arm", "disease_state": "recurrent and metastatic", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": ["P53 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "P53 mutation arm", "disease_state": "recurrent and metastatic", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["P53 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "P53 mutation arm", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "P53 mutation arm", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "P53 mutation arm", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT04061980", "json": [{"cohort": "", "disease_state": "metastatic, radioiodine refractory", "histology_inclusion": "BRAFV600E/M mutant differentiated thyroid cancer", "biomarker_inclusion": ["BRAF V600E", "BRAF V600M"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Differentiated Thyroid Gland Carcinoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600M", "V600M", "coordinate"]]}]}
{"NCT_id": "NCT04322318", "json": [{"cohort": "Newly Diagnosed Diffuse Anaplastic Wilms Tumor", "disease_state": "Stage II-IV", "histology_inclusion": "Diffuse Anaplastic Wilms Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Relapsed Favorable Histology Wilms Tumor", "disease_state": "Relapsed", "histology_inclusion": "Favorable Histology Wilms Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Newly Diagnosed Diffuse Anaplastic Wilms Tumor", "histology_inclusion": "Wilms Tumor"}, {"cohort": "Relapsed Favorable Histology Wilms Tumor", "histology_inclusion": "Wilms Tumor"}]}
{"NCT_id": "NCT04322383", "json": [{"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Hairy Cell Leukemia", "biomarker_inclusion": ["BRAF Wild Type"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Hairy Cell Leukemia Variant", "biomarker_inclusion": ["BRAF Wild Type"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Hairy Cell Leukemia", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Hairy Cell Leukemia Variant", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04622319", "json": [{"cohort": "", "disease_state": "Residual Invasive Breast Cancer", "histology_inclusion": "HER2-positive Breast Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["Stage IV (metastatic) BC", "Prior treatment with T-DXd, T-DM1 or other anti-HER2 antibody-drug conjugate (ADC)"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04687423", "json": [{"cohort": "Phase I", "disease_state": "Advanced Solid Tumor, Stage III or IV", "histology_inclusion": "Inoperable Solid Tumors", "biomarker_inclusion": [], "histology_exclusion": ["Primary CNS tumors"], "biomarker_exclusion": []}, {"cohort": "Phase II", "disease_state": "NTRK Fusion Positive Advanced Solid Tumor", "histology_inclusion": "Inoperable Solid Tumors", "biomarker_inclusion": ["NTRK fusion gene positive"], "histology_exclusion": ["Primary CNS tumors"], "biomarker_exclusion": ["NTRK1 G595R", "NTRK3 G623R", "TRK gene targeted kinase inhibitor progression"]}], "json_norm": [{"cohort": "Phase I", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase II", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm"], "biomarker_exclusion": [["NTRK3 G623R", "G623R", "coordinate"]]}]}
{"NCT_id": "NCT05338346", "json": [{"cohort": "", "disease_state": "Advanced Solid Tumors", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": ["DDR gene defect", "ATM protein loss", "ATM", "ATRX", "ARID1A", "BARD1", "BRCA1", "BRCA2", "BRIP1", "CDK12", "CHEK2", "FANCA", "FANCC", "FANCD2", "FANCE", "FANCF", "FANCM", "MRE11A", "MSH2", "NBN", "PALB2", "RAD51", "RAD51B", "RAD51C", "RAD51D", "p53 pathway mutation", "MYC pathway mutation"], "histology_exclusion": ["Central Nervous System metastatic disease", "leptomeningeal disease", "metastatic cord compression"], "biomarker_exclusion": ["ATR inhibitor treatment"]}, {"cohort": "", "disease_state": "Hematological Malignancies", "histology_inclusion": "DLBCL", "biomarker_inclusion": ["DDR gene defect", "ATM protein loss", "ATM", "ATRX", "ARID1A", "BARD1", "BRCA1", "BRCA2", "BRIP1", "CDK12", "CHEK2", "FANCA", "FANCC", "FANCD2", "FANCE", "FANCF", "FANCM", "MRE11A", "MSH2", "NBN", "PALB2", "RAD51", "RAD51B", "RAD51C", "RAD51D", "p53 pathway mutation", "MYC pathway mutation"], "histology_exclusion": ["Central Nervous System metastatic disease", "leptomeningeal disease", "metastatic cord compression", "MALT lymphoma", "Composite lymphoma", "Primary mediastinal (thymic) large B-cell lymphoma"], "biomarker_exclusion": ["ATR inhibitor treatment"]}, {"cohort": "", "disease_state": "Hematological Malignancies", "histology_inclusion": "B-cell indolent Non-Hodgkin's Lymphoma", "biomarker_inclusion": ["DDR gene defect", "ATM protein loss", "ATM", "ATRX", "ARID1A", "BARD1", "BRCA1", "BRCA2", "BRIP1", "CDK12", "CHEK2", "FANCA", "FANCC", "FANCD2", "FANCE", "FANCF", "FANCM", "MRE11A", "MSH2", "NBN", "PALB2", "RAD51", "RAD51B", "RAD51C", "RAD51D", "p53 pathway mutation", "MYC pathway mutation"], "histology_exclusion": ["Central Nervous System metastatic disease", "leptomeningeal disease", "metastatic cord compression", "MALT lymphoma", "Composite lymphoma", "Primary mediastinal (thymic) large B-cell lymphoma"], "biomarker_exclusion": ["ATR inhibitor treatment"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MYC Mutation", "MYC-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["DNA Damage Repair (DDR) pathways", null, "pathway"], ["ATM-Low", "ATM-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MYC Mutation", "MYC-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["DNA Damage Repair (DDR) pathways", null, "pathway"], ["ATM-Low", "ATM-Low", "expression"]], "histology_exclusion": ["Composite Lymphoma", "Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma"]}, {"cohort": "", "histology_inclusion": "Indolent Non-Hodgkin Lymphoma", "biomarker_inclusion": [["MYC Mutation", "MYC-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["DNA Damage Repair (DDR) pathways", null, "pathway"], ["ATM-Low", "ATM-Low", "expression"]], "histology_exclusion": ["Composite Lymphoma", "Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma"]}]}
{"NCT_id": "NCT03737981", "json": [{"cohort": "", "disease_state": "Untreated, Older Patients", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Untreated, Older Patients", "histology_inclusion": "Small Lymphocytic Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Small Lymphocytic Lymphoma"}]}
{"NCT_id": "NCT04323956", "json": [{"cohort": "", "disease_state": "Ann Arbor stages II (bulky disease, >= 5 cm, or not a candidate for combined modality treatment with R-CHOP plus radiotherapy), III, or IV", "histology_inclusion": "diffuse large B-cell lymphoma expressing the CD20 antigen", "biomarker_inclusion": ["Non-germinal center B-cell (GCB) subtype by Hans algorithm", "Myc expression >= 40% by immunohistochemistry (IHC)", "Bcl-2 expression >= 50% by IHC", "Myc expression >= 40% AND Bcl-2 expression >= 50% by IHC (double expressor)", "MYC rearrangement by fluorescence in situ hybridization (FISH)", "high-grade B-cell lymphoma with MYC rearrangement AND BCL2 and/or BCL6 rearrangement (double-hit or triple-hit lymphoma)"], "histology_exclusion": ["primary central nervous system (CNS) lymphoma", "parenchymal, meningeal or cerebrospinal fluid involvement with malignant lymphoma cells"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "concurrent DLBCL and an indolent lymphoma (previously undiagnosed, such as follicular lymphoma or marginal zone lymphoma)", "biomarker_inclusion": [], "histology_exclusion": ["known prior diagnosis of indolent lymphoma with new transformation to DLBCL (i.e., transformed lymphoma)"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"], ["PPIB-High", "PPIB-High", "expression"], ["MYC Fusion", "MYC", "fusion"], ["MYC Fusion", "MYC", "fusion"], ["BCL6 Fusion", "BCL6", "fusion"]], "histology_exclusion": ["Lymphoma"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"], ["PPIB-High", "PPIB-High", "expression"], ["MYC Fusion", "MYC", "fusion"], ["BCL6 Fusion", "BCL6", "fusion"]], "histology_exclusion": ["Lymphoma"]}, {"cohort": "", "histology_inclusion": "Follicular Lymphoma", "histology_exclusion": ["Diffuse Large B-Cell Lymphoma", "Indolent Non-Hodgkin Lymphoma"]}, {"cohort": "", "histology_inclusion": "Marginal Zone Lymphoma", "histology_exclusion": ["Diffuse Large B-Cell Lymphoma", "Indolent Non-Hodgkin Lymphoma"]}, {"cohort": "", "histology_inclusion": "Indolent Non-Hodgkin Lymphoma", "histology_exclusion": ["Diffuse Large B-Cell Lymphoma", "Indolent Non-Hodgkin Lymphoma"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Indolent Non-Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma"]}]}
{"NCT_id": "NCT05143996", "json": [{"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [], "histology_exclusion": ["acute promyelocytic leukemia (APL)", "central nervous system (CNS) leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "Myelodysplastic Syndrome (MDS)", "biomarker_inclusion": [], "histology_exclusion": ["acute promyelocytic leukemia (APL)", "central nervous system (CNS) leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT03739814", "json": [{"cohort": "Cohort 1 (inotuzumab ozogamicin, blinatumomab)", "disease_state": "Newly Diagnosed, Recurrent, or Refractory", "histology_inclusion": "precursor B-cell acute lymphoblastic leukemia (ALL)", "biomarker_inclusion": ["CD22-positive"], "histology_exclusion": ["Burkitt lymphoma/leukemia"], "biomarker_exclusion": ["Philadelphia chromosome/BCR-ABL1-positive"]}, {"cohort": "Cohort 2 (inotuzumab ozogamicin, blinatumomab)", "disease_state": "Newly Diagnosed, Recurrent, or Refractory", "histology_inclusion": "precursor B-cell acute lymphoblastic leukemia (ALL)", "biomarker_inclusion": ["CD22-positive"], "histology_exclusion": ["Burkitt lymphoma/leukemia"], "biomarker_exclusion": ["Philadelphia chromosome/BCR-ABL1-positive"]}], "json_norm": [{"cohort": "Cohort 1 (inotuzumab ozogamicin, blinatumomab)", "histology_inclusion": "B Acute Lymphoblastic Leukemia", "biomarker_inclusion": [["CD22-High", "CD22-High", "expression"]], "histology_exclusion": ["Burkitt Leukemia"], "biomarker_exclusion": [["BCR - ABL1", "BCR - ABL1", "coordinate"]]}, {"cohort": "Cohort 1 (inotuzumab ozogamicin, blinatumomab)", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["CD22-High", "CD22-High", "expression"]], "histology_exclusion": ["Burkitt Leukemia"], "biomarker_exclusion": [["BCR - ABL1", "BCR - ABL1", "coordinate"]]}, {"cohort": "Cohort 2 (inotuzumab ozogamicin, blinatumomab)", "histology_inclusion": "B Acute Lymphoblastic Leukemia", "biomarker_inclusion": [["CD22-High", "CD22-High", "expression"]], "histology_exclusion": ["Burkitt Leukemia"], "biomarker_exclusion": [["BCR - ABL1", "BCR - ABL1", "coordinate"]]}, {"cohort": "Cohort 2 (inotuzumab ozogamicin, blinatumomab)", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "biomarker_inclusion": [["CD22-High", "CD22-High", "expression"]], "histology_exclusion": ["Burkitt Leukemia"], "biomarker_exclusion": [["BCR - ABL1", "BCR - ABL1", "coordinate"]]}]}
{"NCT_id": "NCT04065399", "json": [{"cohort": "Phase 2 Cohort 2A", "disease_state": "Relapsed/Refractory", "histology_inclusion": "ALL/MPAL", "biomarker_inclusion": ["MLLr translocation"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "Phase 2 Cohort 2B", "disease_state": "Relapsed/Refractory", "histology_inclusion": "AML", "biomarker_inclusion": ["MLLr translocation"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "Phase 2 Cohort 2C", "disease_state": "Relapsed/Refractory", "histology_inclusion": "AML", "biomarker_inclusion": ["NPM1c"], "histology_exclusion": ["acute promyelocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 2 Cohort 2A", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Phase 2 Cohort 2A", "histology_inclusion": "Mixed Phenotype Acute Leukemia", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Phase 2 Cohort 2B", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}, {"cohort": "Phase 2 Cohort 2C", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Acute Promyelocytic Leukemia with PML-RARA"]}]}
{"NCT_id": "NCT04363801", "json": [{"cohort": "Part A & C", "disease_state": "locally advanced or metastatic", "histology_inclusion": "gastric adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["HER2-positive G/GEJ adenocarcinoma", "squamous cell gastric cancer", "undifferentiated gastric cancer"], "biomarker_exclusion": ["prior therapy with anti-PD-1 or anti-PD-L1 antibody"]}, {"cohort": "Part A & C", "disease_state": "locally advanced or metastatic", "histology_inclusion": "GEJ adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["HER2-positive G/GEJ adenocarcinoma", "squamous cell gastric cancer", "undifferentiated gastric cancer"], "biomarker_exclusion": ["prior therapy with anti-PD-1 or anti-PD-L1 antibody"]}, {"cohort": "Part B", "disease_state": "locally advanced or metastatic", "histology_inclusion": "gastric adenocarcinoma", "biomarker_inclusion": ["DKK1-high (H-score \u2265 35)"], "histology_exclusion": ["squamous cell gastric cancer", "undifferentiated gastric cancer"], "biomarker_exclusion": ["prior therapy with anti-PD-L2 or any other antibody or drug specifically targeting T-cell co-stimulation or co-inhibitory checkpoint pathways", "prior therapy with an anti-DKK1 agent"]}, {"cohort": "Part B", "disease_state": "locally advanced or metastatic", "histology_inclusion": "GEJ adenocarcinoma", "biomarker_inclusion": ["DKK1-high (H-score \u2265 35)"], "histology_exclusion": ["squamous cell gastric cancer", "undifferentiated gastric cancer"], "biomarker_exclusion": ["prior therapy with anti-PD-L2 or any other antibody or drug specifically targeting T-cell co-stimulation or co-inhibitory checkpoint pathways", "prior therapy with an anti-DKK1 agent"]}, {"cohort": "Part C", "disease_state": "locally advanced or metastatic", "histology_inclusion": "gastric adenocarcinoma", "biomarker_inclusion": ["PD-L1 CPS", "DKK1 mRNA expression"], "histology_exclusion": ["HER2-positive G/GEJ adenocarcinoma", "squamous cell gastric cancer", "undifferentiated gastric cancer"], "biomarker_exclusion": ["prior therapy with anti-PD-1 or anti-PD-L1 antibody"]}, {"cohort": "Part C", "disease_state": "locally advanced or metastatic", "histology_inclusion": "GEJ adenocarcinoma", "biomarker_inclusion": ["PD-L1 CPS", "DKK1 mRNA expression"], "histology_exclusion": ["HER2-positive G/GEJ adenocarcinoma", "squamous cell gastric cancer", "undifferentiated gastric cancer"], "biomarker_exclusion": ["prior therapy with anti-PD-1 or anti-PD-L1 antibody"]}], "json_norm": [{"cohort": "Part A & C", "histology_inclusion": "Gastric Adenocarcinoma", "histology_exclusion": ["Undifferentiated Gastric Carcinoma", "Gastroesophageal Junction Adenocarcinoma", "Gastric Carcinoma"], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part A & C", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "histology_exclusion": ["Undifferentiated Gastric Carcinoma", "Gastroesophageal Junction Adenocarcinoma", "Gastric Carcinoma"], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part B", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["DKK1-High", "DKK1-High", "expression"]], "histology_exclusion": ["Undifferentiated Gastric Carcinoma", "Gastric Carcinoma"]}, {"cohort": "Part B", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["DKK1-High", "DKK1-High", "expression"]], "histology_exclusion": ["Undifferentiated Gastric Carcinoma", "Gastric Carcinoma"]}, {"cohort": "Part C", "histology_inclusion": "Gastric Adenocarcinoma", "histology_exclusion": ["Undifferentiated Gastric Carcinoma", "Gastroesophageal Junction Adenocarcinoma", "Gastric Carcinoma"], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Part C", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "histology_exclusion": ["Undifferentiated Gastric Carcinoma", "Gastroesophageal Junction Adenocarcinoma", "Gastric Carcinoma"], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT02957968", "json": [{"cohort": "Cohort A", "disease_state": "Locally Advanced", "histology_inclusion": "Invasive Adenocarcinoma of the Breast", "biomarker_inclusion": ["HER2-negative", "ER-negative", "PR-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "Locally Advanced", "histology_inclusion": "Invasive Adenocarcinoma of the Breast", "biomarker_inclusion": ["HER2-negative", "Hormone Receptor-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A2", "disease_state": "Locally Advanced", "histology_inclusion": "Invasive Adenocarcinoma of the Breast", "biomarker_inclusion": ["HER2-negative", "ER-negative", "PR-negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"], ["TMEM37-Low", "TMEM37-Low", "expression"]]}, {"cohort": "Cohort B", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "Cohort A2", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"], ["TMEM37-Low", "TMEM37-Low", "expression"]]}]}
{"NCT_id": "NCT03413995", "json": [{"cohort": "", "disease_state": "metastatic hormone-sensitive", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["BRCA1", "BRCA2", "ATM", "CHEK2", "NBN", "RAD50", "RAD51C", "RAD51D", "PALB2", "MRE11", "FANCA", "FANCB", "FANCC", "FANCD2", "FANCE", "FANCF", "FANCG", "FANCI", "FANCL", "FANCM"], "histology_exclusion": [], "biomarker_exclusion": ["PARP inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma"}]}
{"NCT_id": "NCT03479268", "json": [{"cohort": "Dose escalation cohort", "disease_state": "Relapsed/Refractory", "histology_inclusion": "B-CLL/small lymphocytic lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose escalation cohort", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Mantle cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose escalation cohort", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Follicular lymphoma - grades 1-3a", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose escalation cohort", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Lymphoplasmacytic lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose escalation cohort", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Marginal zone lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose escalation cohort", "disease_state": "Relapsed/Refractory", "histology_inclusion": "CLL in Richter's transformation", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose escalation cohort", "disease_state": "Relapsed/Refractory", "histology_inclusion": "B-cell prolymphocytic leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose escalation cohort", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Diffuse large B-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion cohort", "disease_state": "Relapsed/Refractory", "histology_inclusion": "B-CLL/SLL", "biomarker_inclusion": [], "histology_exclusion": ["Mantle cell lymphoma"], "biomarker_exclusion": ["t(11;14)", "cyclin D1 overexpression"]}], "json_norm": [{"cohort": "Dose escalation cohort", "histology_inclusion": "Small Lymphocytic Lymphoma"}, {"cohort": "Dose escalation cohort", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "Dose escalation cohort", "histology_inclusion": "Mantle Cell Lymphoma"}, {"cohort": "Dose escalation cohort", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "Dose escalation cohort", "histology_inclusion": "Lymphoplasmacytic Lymphoma"}, {"cohort": "Dose escalation cohort", "histology_inclusion": "Marginal Zone Lymphoma"}, {"cohort": "Dose escalation cohort", "histology_inclusion": "Richter Syndrome"}, {"cohort": "Dose escalation cohort", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "Dose escalation cohort", "histology_inclusion": "B-Cell Prolymphocytic Leukemia"}, {"cohort": "Dose escalation cohort", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "Expansion cohort", "histology_inclusion": "Small Lymphocytic Lymphoma", "histology_exclusion": ["Mantle Cell Lymphoma"], "biomarker_exclusion": [["CCND1-High", "CCND1-High", "expression"]]}, {"cohort": "Expansion cohort", "histology_inclusion": "Chronic Lymphocytic Leukemia", "histology_exclusion": ["Mantle Cell Lymphoma"], "biomarker_exclusion": [["CCND1-High", "CCND1-High", "expression"]]}]}
{"NCT_id": "NCT04260802", "json": [{"cohort": "Phase 1b", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Triple Negative Breast Cancer", "biomarker_inclusion": ["ER < 1%", "PR < 1%", "HER2 negative"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Gastric Cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Cervical Cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Ovarian Cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Squamous Cell Carcinoma of Head and Neck", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Bladder Cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Non Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR negative", "ROS1 negative", "ALK negative"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Urothelial Cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Merkel Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Squamous Cell Carcinoma of the Skin", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Phase 2a", "disease_state": "locally advanced or metastatic", "histology_inclusion": "Solid Tumor", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1b", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["ERBB2-Low", "ERBB2-Low", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1b", "histology_inclusion": "Gastric Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1b", "histology_inclusion": "Cervical Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1b", "histology_inclusion": "Ovarian Epithelial Cancer", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1b", "histology_inclusion": "Malignant Ovarian Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1b", "histology_inclusion": "Hepatocellular Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1b", "histology_inclusion": "Sarcoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1b", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1b", "histology_inclusion": "Bladder Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1b", "histology_inclusion": "Bladder Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1b", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["ROS1-Low", "ROS1-Low", "expression"], ["ALK-Low", "ALK-Low", "expression"], ["EGFR-Low", "EGFR-Low", "expression"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1b", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1b", "histology_inclusion": "Urothelial Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1b", "histology_inclusion": "Merkel Cell Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 1b", "histology_inclusion": "Skin Squamous Cell Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Phase 2a", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT03546582", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma (HNSCC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT04197934", "json": [{"cohort": "Dose Escalation Cohort", "disease_state": "", "histology_inclusion": "glioblastoma, IDH wildtype", "biomarker_inclusion": ["EGFR amplification", "activating EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Escalation Cohort", "disease_state": "", "histology_inclusion": "anaplastic astrocytoma, IDH wildtype", "biomarker_inclusion": ["EGFR amplification", "activating EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Escalation Cohort", "disease_state": "", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["activating EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Cohorts - GBM/AA Cohort", "disease_state": "", "histology_inclusion": "glioblastoma, IDH wildtype", "biomarker_inclusion": ["EGFR amplification", "activating EGFRvIII mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Cohorts - GBM/AA Cohort", "disease_state": "", "histology_inclusion": "anaplastic astrocytoma, IDH wildtype", "biomarker_inclusion": ["EGFR amplification", "activating EGFRvIII mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Cohorts - BTP Cohort", "disease_state": "", "histology_inclusion": "glioblastoma, IDH wildtype", "biomarker_inclusion": ["EGFR amplification", "activating EGFRvIII mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Cohorts - BTP Cohort", "disease_state": "", "histology_inclusion": "anaplastic astrocytoma, IDH wildtype", "biomarker_inclusion": ["EGFR amplification", "activating EGFRvIII mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Dose Expansion Cohorts - NSCLC LM Cohort", "disease_state": "", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["activating EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Escalation Cohort", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["EGFR-High", "EGFR-High", "expression"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Dose Escalation Cohort", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR-High", "EGFR-High", "expression"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Dose Escalation Cohort", "histology_inclusion": "Anaplastic Astrocytoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["EGFR-High", "EGFR-High", "expression"], ["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Dose Escalation Cohort", "histology_inclusion": "Anaplastic Astrocytoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["EGFR-High", "EGFR-High", "expression"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Dose Escalation Cohort", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Dose Expansion Cohorts - GBM/AA Cohort", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["EGFR-High", "EGFR-High", "expression"], ["EGFR exon 8 indel", "V30_R297delinsG", "exon"]]}, {"cohort": "Dose Expansion Cohorts - GBM/AA Cohort", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["EGFR exon 8 indel", "V30_R297delinsG", "exon"], ["EGFR-High", "EGFR-High", "expression"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Dose Expansion Cohorts - GBM/AA Cohort", "histology_inclusion": "Anaplastic Astrocytoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["EGFR-High", "EGFR-High", "expression"], ["EGFR exon 8 indel", "V30_R297delinsG", "exon"]]}, {"cohort": "Dose Expansion Cohorts - GBM/AA Cohort", "histology_inclusion": "Anaplastic Astrocytoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["EGFR exon 8 indel", "V30_R297delinsG", "exon"], ["EGFR-High", "EGFR-High", "expression"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Dose Expansion Cohorts - BTP Cohort", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["EGFR-High", "EGFR-High", "expression"], ["EGFR exon 8 indel", "V30_R297delinsG", "exon"]]}, {"cohort": "Dose Expansion Cohorts - BTP Cohort", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["EGFR exon 8 indel", "V30_R297delinsG", "exon"], ["EGFR-High", "EGFR-High", "expression"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Dose Expansion Cohorts - BTP Cohort", "histology_inclusion": "Anaplastic Astrocytoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"], ["EGFR-High", "EGFR-High", "expression"], ["EGFR exon 8 indel", "V30_R297delinsG", "exon"]]}, {"cohort": "Dose Expansion Cohorts - BTP Cohort", "histology_inclusion": "Anaplastic Astrocytoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["EGFR exon 8 indel", "V30_R297delinsG", "exon"], ["EGFR-High", "EGFR-High", "expression"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Dose Expansion Cohorts - NSCLC LM Cohort", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT05342883", "json": [{"cohort": "Newly Diagnosed GBM", "disease_state": "Newly Diagnosed", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["IDH wild type"], "histology_exclusion": [], "biomarker_exclusion": ["IDH mutated"]}], "json_norm": [{"cohort": "Newly Diagnosed GBM", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "biomarker_exclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04197986", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "invasive urothelial carcinoma", "biomarker_inclusion": ["FGFR3 mutation (Exon 7: R248C, S249C; Exon 10: G370C, A391E, Y373C; Exon 15: K650M/T, K650E/Q)", "FGFR3 gene fusion", "FGFR3 rearrangement"], "histology_exclusion": ["neuroendocrine (including small and large cell)", "sarcomatoid", "plasmacytoid"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["FGFR3 K650T", "K650T", "coordinate"], ["FGFR3 K650E", "K650E", "coordinate"], ["FGFR3 S249C", "S249C", "coordinate"], ["FGFR3 R248C", "R248C", "coordinate"], ["FGFR3 Y373C", "Y373C", "coordinate"], ["FGFR3 G370C", "G370C", "coordinate"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR3 K650M", "K650M", "coordinate"], ["FGFR3 Fusion", "FGFR3", "fusion"]]}]}
{"NCT_id": "NCT04693468", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["BRCA1/2", "PALB2", "RAD51C/D"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["MET mutations", "MET amplifications", "high MET expression", "ALK translocations", "ROS1 translocations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "metastatic castration-resistant prostate cancer", "disease_state": "advanced/metastatic", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["MET Mutation", "MET-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"], ["SLTM Mutation", "SLTM-Mutation", "gene"], ["ROS1 Fusion", "ROS1", "fusion"]]}, {"cohort": "metastatic castration-resistant prostate cancer", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "metastatic castration-resistant prostate cancer", "histology_inclusion": "Prostate Carcinoma"}]}
{"NCT_id": "NCT04954001", "json": [{"cohort": "Cohort 1", "disease_state": "Neurofibromatosis Type 1", "histology_inclusion": "Plexiform Neurofibroma", "biomarker_inclusion": ["NF1 germline mutation"], "histology_exclusion": [], "biomarker_exclusion": ["MEK 1/2 inhibitors"]}, {"cohort": "Cohort 1", "disease_state": "Neurofibromatosis Type 1", "histology_inclusion": "Plexiform Neurofibroma", "biomarker_inclusion": ["\u2265 6 cafe-au-lait macules", "Axillary freckling or freckling in inguinal regions", "\u22652 neurofibromas of any type, or \u2265 1 plexiform neurofibroma", "An optic pathway glioma", "\u22652 Lisch nodules (iris hamartomas)", "A distinctive bony lesion such as dysplasia of the sphenoid bone or dysplasia or thinning of long bone cortex", "First-degree relative with NF1"], "histology_exclusion": [], "biomarker_exclusion": ["MEK 1/2 inhibitors"]}, {"cohort": "Cohort 2", "disease_state": "Neurofibromatosis Type 1", "histology_inclusion": "Plexiform Neurofibroma", "biomarker_inclusion": ["NF1 germline mutation"], "histology_exclusion": [], "biomarker_exclusion": ["MEK 1/2 inhibitors"]}, {"cohort": "Cohort 2", "disease_state": "Neurofibromatosis Type 1", "histology_inclusion": "Plexiform Neurofibroma", "biomarker_inclusion": ["\u2265 6 cafe-au-lait macules", "Axillary freckling or freckling in inguinal regions", "\u22652 neurofibromas of any type, or \u2265 1 plexiform neurofibroma", "An optic pathway glioma", "\u22652 Lisch nodules (iris hamartomas)", "A distinctive bony lesion such as dysplasia of the sphenoid bone or dysplasia or thinning of long bone cortex", "First-degree relative with NF1"], "histology_exclusion": [], "biomarker_exclusion": ["MEK 1/2 inhibitors"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Plexiform Neurofibroma", "biomarker_inclusion": [["NF1 Mutation", "NF1-Mutation", "gene"]]}, {"cohort": "Cohort 1", "histology_inclusion": "Plexiform Neurofibroma"}, {"cohort": "Cohort 2", "histology_inclusion": "Plexiform Neurofibroma", "biomarker_inclusion": [["NF1 Mutation", "NF1-Mutation", "gene"]]}, {"cohort": "Cohort 2", "histology_inclusion": "Plexiform Neurofibroma"}]}
{"NCT_id": "NCT01906385", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "Grade III/IV Glioma (following 2021 WHO CNS5 glioma nomenclature, e.g., Astrocytoma, IDH-mutant grade 3 or 4; Glioblastoma, IDH-wildtype grade 4)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT02494167", "json": [{"cohort": "Group A", "disease_state": "Adjuvant therapy for AML/MDS", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group A", "disease_state": "Adjuvant therapy for AML/MDS", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group B", "disease_state": "Refractory/relapsed or minimal residual AML/MDS disease", "histology_inclusion": "Acute Myeloid Leukemia", "biomarker_inclusion": ["WT1", "NY-ESO-1", "PRAME", "Survivin"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group B", "disease_state": "Refractory/relapsed or minimal residual AML/MDS disease", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": ["WT1", "NY-ESO-1", "PRAME", "Survivin"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Group A", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "Group A", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "Group B", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "Group B", "histology_inclusion": "Myelodysplastic Syndrome"}]}
{"NCT_id": "NCT03613532", "json": [{"cohort": "", "disease_state": "High-risk", "histology_inclusion": "Myelodysplastic Syndrome (MDS)", "biomarker_inclusion": ["TP53 mutation", "RAS pathway mutation (NRAS, KRAS, PTPN11, CBL, NF1, RIT1, FLT3, KIT)"], "histology_exclusion": [], "biomarker_exclusion": ["> 10% morphologic blasts"]}, {"cohort": "", "disease_state": "High-risk", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": ["TP53 mutation", "RUNX1 mutation", "ASXL1 mutation", "t(6;9)(p23;q34.1); DEK-NUP214", "t(v;11q23.3); KMT2A rearranged", "t(9;22)(q34.1;q11.2); BCR-ABL1", "inv(3)(q21.3q26.2) or t(3;3)(q21.3;26.2); GATA2,MECOM(EVI1)", "-5 or del(5q)", "-7", "-17/abn(17p)", "Complex karyotype", "Monosomal karyotype", "Wild-type NPM1 and FLT3-ITDhigh", "Secondary AML", "Secondary-type AML (SRSF2, SF3B1, U2AF1, ZRSR2, ASXL1, EZH2, BCOR, STAG2)", "Measurable residual disease by multiparameter flow cytometry (\u2265 0.1%)"], "histology_exclusion": [], "biomarker_exclusion": ["> 5% morphologic blasts"]}, {"cohort": "", "disease_state": "High-risk", "histology_inclusion": "Chronic Myelomonocytic Leukemia (CMML) or MDS/Myeloproliferative Neoplasm-unclassifiable (MDS/MPN-unclassifiable)", "biomarker_inclusion": ["Trisomy 8", "Chromosome 7 abnormalities", "Complex karyotype (3 or more abnormalities)", "ASXL1 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["> 10% morphologic blasts"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["NF1 Mutation", "NF1-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["PTPN11 Mutation", "PTPN11-Mutation", "gene"], ["HRAS Mutation", "HRAS-Mutation", "gene"], ["MAPK/ERK pathway", null, "pathway"], ["CBL Mutation", "CBL-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["ASXL1 Mutation", "ASXL1-Mutation", "gene"], ["BCR - ABL1", "BCR - ABL1", "coordinate"], ["NPM1 NPM1-wild_type", "NPM1-wild_type", "wild_type"], ["RUNX1 Mutation", "RUNX1-Mutation", "gene"], ["DEK - NUP214", "DEK - NUP214", "coordinate"], ["TP53 Mutation", "TP53-Mutation", "gene"], ["FLT3-High", "FLT3-High", "expression"], ["NPM1-High", "NPM1-High", "expression"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": [["ASXL1 Mutation", "ASXL1-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["ASXL1 Mutation", "ASXL1-Mutation", "gene"]]}]}
{"NCT_id": "NCT03418038", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Hodgkin Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm D", "disease_state": "", "histology_inclusion": "Clonal Cytopenia of Undetermined Significance", "biomarker_inclusion": ["TET2 mutations", "TET2 mutations with concurrent splicing genes mutations (SRSF2, U2AF1, SF3B1, and ZRSR2)", "epigenetic regulator mutations (DNMT3A, EZH2, IDH1, IDH2)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "", "histology_inclusion": "Double-Hit Lymphoma", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"]]}, {"cohort": "", "histology_inclusion": "Hodgkin Lymphoma"}, {"cohort": "Arm D", "biomarker_inclusion": [["SF3B2 Mutation", "SF3B2-Mutation", "gene"], ["TET2 Mutation", "TET2-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"], ["U2AF1 Mutation", "U2AF1-Mutation", "gene"], ["ZRSR2 Mutation", "ZRSR2-Mutation", "gene"], ["IDH1 Mutation", "IDH1-Mutation", "gene"], ["EZH2 Mutation", "EZH2-Mutation", "gene"], ["SRSF2 Mutation", "SRSF2-Mutation", "gene"], ["SF3B1 Mutation", "SF3B1-Mutation", "gene"], ["DNMT3A Mutation", "DNMT3A-Mutation", "gene"]]}]}
{"NCT_id": "NCT03548428", "json": [{"cohort": "A", "disease_state": "metastatic", "histology_inclusion": "leiomyosarcomas uterine/extra-uterine", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "A", "disease_state": "metastatic", "histology_inclusion": "liposarcomas", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "A", "disease_state": "metastatic", "histology_inclusion": "undifferentiated sarcomas", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "B", "disease_state": "metastatic", "histology_inclusion": "leiomyosarcomas uterine/extra-uterine", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "B", "disease_state": "metastatic", "histology_inclusion": "liposarcomas", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "B", "disease_state": "metastatic", "histology_inclusion": "undifferentiated sarcomas", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "A"}, {"cohort": "A"}, {"cohort": "A", "histology_inclusion": "Sarcoma"}, {"cohort": "B"}, {"cohort": "B"}, {"cohort": "B", "histology_inclusion": "Sarcoma"}]}
{"NCT_id": "NCT03678883", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "malignancy", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}]}
{"NCT_id": "NCT04824092", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Diffuse Large B-cell Lymphoma (DLBCL)", "biomarker_inclusion": ["CD20-positive"], "histology_exclusion": ["primary mediastinal (thymic) large B-cell lymphoma", "Burkitt's lymphoma", "BCL, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma (grey-zone lymphoma)", "primary effusion lymphoma", "primary cutaneous DLBCL, leg type", "primary DLBCL of the CNS", "DLBCL arising from CLL or indolent lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "DLBCL, NOS including GCB type, ABC type", "biomarker_inclusion": [], "histology_exclusion": ["primary mediastinal (thymic) large B-cell lymphoma", "Burkitt's lymphoma", "BCL, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma (grey-zone lymphoma)", "primary effusion lymphoma", "primary cutaneous DLBCL, leg type", "primary DLBCL of the CNS", "DLBCL arising from CLL or indolent lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "T-cell rich large BCL", "biomarker_inclusion": [], "histology_exclusion": ["primary mediastinal (thymic) large B-cell lymphoma", "Burkitt's lymphoma", "BCL, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma (grey-zone lymphoma)", "primary effusion lymphoma", "primary cutaneous DLBCL, leg type", "primary DLBCL of the CNS", "DLBCL arising from CLL or indolent lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Epstein-Barr virus-positive DLBCL, NOS", "biomarker_inclusion": [], "histology_exclusion": ["primary mediastinal (thymic) large B-cell lymphoma", "Burkitt's lymphoma", "BCL, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma (grey-zone lymphoma)", "primary effusion lymphoma", "primary cutaneous DLBCL, leg type", "primary DLBCL of the CNS", "DLBCL arising from CLL or indolent lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Anaplastic lymphoma kinase (ALK)-positive large BCL", "biomarker_inclusion": [], "histology_exclusion": ["primary mediastinal (thymic) large B-cell lymphoma", "Burkitt's lymphoma", "BCL, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma (grey-zone lymphoma)", "primary effusion lymphoma", "primary cutaneous DLBCL, leg type", "primary DLBCL of the CNS", "DLBCL arising from CLL or indolent lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Human herpes virus-8 (HHV8)-positive DLBCL, NOS", "biomarker_inclusion": [], "histology_exclusion": ["primary mediastinal (thymic) large B-cell lymphoma", "Burkitt's lymphoma", "BCL, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma (grey-zone lymphoma)", "primary effusion lymphoma", "primary cutaneous DLBCL, leg type", "primary DLBCL of the CNS", "DLBCL arising from CLL or indolent lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "High-grade BCL with MYC and B-cell lymphoma 2 (BCL2) and/or B-cell lymphoma 6 (BCL6) rearrangements (double-hit or triple-hit lymphoma)", "biomarker_inclusion": [], "histology_exclusion": ["primary mediastinal (thymic) large B-cell lymphoma", "Burkitt's lymphoma", "BCL, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma (grey-zone lymphoma)", "primary effusion lymphoma", "primary cutaneous DLBCL, leg type", "primary DLBCL of the CNS", "DLBCL arising from CLL or indolent lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "HGBL-NOS", "biomarker_inclusion": [], "histology_exclusion": ["primary mediastinal (thymic) large B-cell lymphoma", "Burkitt's lymphoma", "BCL, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma (grey-zone lymphoma)", "primary effusion lymphoma", "primary cutaneous DLBCL, leg type", "primary DLBCL of the CNS", "DLBCL arising from CLL or indolent lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "DLBCL coexistent with either follicular lymphoma (FL) of any grade, gastric MALT lymphoma or non-gastric MALT lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["primary mediastinal (thymic) large B-cell lymphoma", "Burkitt's lymphoma", "BCL, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma (grey-zone lymphoma)", "primary effusion lymphoma", "primary cutaneous DLBCL, leg type", "primary DLBCL of the CNS", "DLBCL arising from CLL or indolent lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "FL grade 3b", "biomarker_inclusion": [], "histology_exclusion": ["primary mediastinal (thymic) large B-cell lymphoma", "Burkitt's lymphoma", "BCL, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma (grey-zone lymphoma)", "primary effusion lymphoma", "primary cutaneous DLBCL, leg type", "primary DLBCL of the CNS", "DLBCL arising from CLL or indolent lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MS4A1-High", "MS4A1-High", "expression"]], "histology_exclusion": ["Primary Effusion Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Diffuse Large B-Cell Lymphoma", "Chronic Lymphocytic Leukemia", "Burkitt Lymphoma", "Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "Classic Hodgkin Lymphoma", "Indolent Non-Hodgkin Lymphoma"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Primary Effusion Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Diffuse Large B-Cell Lymphoma", "Chronic Lymphocytic Leukemia", "Burkitt Lymphoma", "Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "Classic Hodgkin Lymphoma", "Indolent Non-Hodgkin Lymphoma"]}, {"cohort": "", "histology_exclusion": ["Primary Effusion Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Diffuse Large B-Cell Lymphoma", "Chronic Lymphocytic Leukemia", "Burkitt Lymphoma", "Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "Classic Hodgkin Lymphoma", "Indolent Non-Hodgkin Lymphoma"]}, {"cohort": "", "histology_inclusion": "Epstein-Barr Virus Positive Diffuse Large B-Cell Lymphoma of the Elderly", "biomarker_inclusion": [["CR2-High", "CR2-High", "expression"]], "histology_exclusion": ["Primary Effusion Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Diffuse Large B-Cell Lymphoma", "Chronic Lymphocytic Leukemia", "Burkitt Lymphoma", "Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "Classic Hodgkin Lymphoma", "Indolent Non-Hodgkin Lymphoma"]}, {"cohort": "", "biomarker_inclusion": [["ALK-High", "ALK-High", "expression"]], "histology_exclusion": ["Primary Effusion Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Diffuse Large B-Cell Lymphoma", "Chronic Lymphocytic Leukemia", "Burkitt Lymphoma", "Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "Classic Hodgkin Lymphoma", "Indolent Non-Hodgkin Lymphoma"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Primary Effusion Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Diffuse Large B-Cell Lymphoma", "Chronic Lymphocytic Leukemia", "Burkitt Lymphoma", "Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "Classic Hodgkin Lymphoma", "Indolent Non-Hodgkin Lymphoma"]}, {"cohort": "", "histology_inclusion": "B-Cell Non-Hodgkin Lymphoma", "histology_exclusion": ["Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Burkitt Lymphoma", "Classic Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma", "Primary Effusion Lymphoma", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System", "Indolent Non-Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma", "Chronic Lymphocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "histology_exclusion": ["Primary Effusion Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Diffuse Large B-Cell Lymphoma", "Chronic Lymphocytic Leukemia", "Burkitt Lymphoma", "Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "Classic Hodgkin Lymphoma", "Indolent Non-Hodgkin Lymphoma"]}, {"cohort": "", "histology_exclusion": ["Primary Effusion Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Diffuse Large B-Cell Lymphoma", "Chronic Lymphocytic Leukemia", "Burkitt Lymphoma", "Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "Classic Hodgkin Lymphoma", "Indolent Non-Hodgkin Lymphoma"]}, {"cohort": "", "histology_inclusion": "Follicular Lymphoma", "histology_exclusion": ["Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Burkitt Lymphoma", "Burkitt Lymphoma", "Classic Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma", "Classic Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma", "Primary Effusion Lymphoma", "Primary Effusion Lymphoma", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System", "Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System", "Indolent Non-Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma", "Chronic Lymphocytic Leukemia", "Indolent Non-Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma", "Chronic Lymphocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue", "histology_exclusion": ["Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Burkitt Lymphoma", "Burkitt Lymphoma", "Classic Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma", "Classic Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma", "Primary Effusion Lymphoma", "Primary Effusion Lymphoma", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System", "Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System", "Indolent Non-Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma", "Chronic Lymphocytic Leukemia", "Indolent Non-Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma", "Chronic Lymphocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Primary Effusion Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Diffuse Large B-Cell Lymphoma", "Chronic Lymphocytic Leukemia", "Burkitt Lymphoma", "Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "Classic Hodgkin Lymphoma", "Indolent Non-Hodgkin Lymphoma"]}, {"cohort": "", "histology_inclusion": "Grade 3b Follicular Lymphoma", "histology_exclusion": ["Primary Effusion Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Diffuse Large B-Cell Lymphoma", "Chronic Lymphocytic Leukemia", "Burkitt Lymphoma", "Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System", "Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type", "Classic Hodgkin Lymphoma", "Indolent Non-Hodgkin Lymphoma"]}]}
{"NCT_id": "NCT02559778", "json": [{"cohort": "Part A", "disease_state": "newly diagnosed high-risk neuroblastoma", "histology_inclusion": "neuroblastoma or ganglioneuroblastoma (nodular or intermixed)", "biomarker_inclusion": ["MYCN amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "high-risk neuroblastoma", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]]}, {"cohort": "Part A", "histology_inclusion": "Ganglioneuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]]}, {"cohort": "Part B", "histology_inclusion": "Neuroblastoma"}]}
{"NCT_id": "NCT05084859", "json": [{"cohort": "CRPC", "disease_state": "advanced and/or metastatic", "histology_inclusion": "castration-resistant prostate cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "NSCLC", "disease_state": "advanced and/or metastatic", "histology_inclusion": "non-small cell lung cancer (adenocarcinoma subtype)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR", "ALK", "NTRK"]}, {"cohort": "CRC", "disease_state": "advanced and/or metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "CRPC", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "CRPC", "histology_inclusion": "Prostate Carcinoma"}, {"cohort": "NSCLC", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "NSCLC", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "CRC", "histology_inclusion": "Colorectal Carcinoma"}]}
{"NCT_id": "NCT05345002", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "astrocytoma (grade 2-4)", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "oligodendroglioma (grade 2-3)", "biomarker_inclusion": ["IDH1 mutation", "IDH2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Astrocytoma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Oligodendroglioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT03745326", "json": [{"cohort": "", "disease_state": "metastatic, unresectable", "histology_inclusion": "Gastrointestinal Cancer", "biomarker_inclusion": ["G12D mutated KRAS", "HLA-A*11:01"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic, unresectable", "histology_inclusion": "Pancreatic Cancer", "biomarker_inclusion": ["G12D mutated KRAS", "HLA-A*11:01"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic, unresectable", "histology_inclusion": "Gastric Cancer", "biomarker_inclusion": ["G12D mutated KRAS", "HLA-A*11:01"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic, unresectable", "histology_inclusion": "Colon Cancer", "biomarker_inclusion": ["G12D mutated KRAS", "HLA-A*11:01"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic, unresectable", "histology_inclusion": "Rectal Cancer", "biomarker_inclusion": ["G12D mutated KRAS", "HLA-A*11:01"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Digestive System Neoplasm", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Colon Carcinoma", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Rectal Carcinoma", "biomarker_inclusion": [["KRAS G12D", "G12D", "coordinate"]]}]}
{"NCT_id": "NCT04955938", "json": [{"cohort": "Arm A - Participants with IDH1 Mutations", "disease_state": "advanced-Phase IDH-mutated Ph-neg MPNs (both untreated and relapsed/refractory)", "histology_inclusion": "polycythemia vera with (PV) \u2265 5% blasts", "biomarker_inclusion": ["IDH1 Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm A - Participants with IDH1 Mutations", "disease_state": "advanced-Phase IDH-mutated Ph-neg MPNs (both untreated and relapsed/refractory)", "histology_inclusion": "essential thrombocythemia (ET) with \u2265 5% blasts", "biomarker_inclusion": ["IDH1 Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm A - Participants with IDH1 Mutations", "disease_state": "advanced-Phase IDH-mutated Ph-neg MPNs (both untreated and relapsed/refractory)", "histology_inclusion": "primary myelofibrosis (PMF) with \u2265 5% blasts", "biomarker_inclusion": ["IDH1 Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm A - Participants with IDH1 Mutations", "disease_state": "advanced-Phase IDH-mutated Ph-neg MPNs (both untreated and relapsed/refractory)", "histology_inclusion": "Atypical CML with \u2265 5% blasts", "biomarker_inclusion": ["IDH1 Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm A - Participants with IDH1 Mutations", "disease_state": "advanced-Phase IDH-mutated Ph-neg MPNs (both untreated and relapsed/refractory)", "histology_inclusion": "MPN-NOS with \u2265 5% blasts", "biomarker_inclusion": ["IDH1 Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm A - Participants with IDH1 Mutations", "disease_state": "advanced-Phase IDH-mutated Ph-neg MPNs (both untreated and relapsed/refractory)", "histology_inclusion": "MDS/MPN Overlap Syndromes with \u2265 5% blasts including CMML", "biomarker_inclusion": ["IDH1 Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm A - Participants with IDH1 Mutations", "disease_state": "advanced-Phase IDH-mutated Ph-neg MPNs (both untreated and relapsed/refractory)", "histology_inclusion": "post-PV myelofibrosis with \u2265 5% blasts", "biomarker_inclusion": ["IDH1 Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm A - Participants with IDH1 Mutations", "disease_state": "advanced-Phase IDH-mutated Ph-neg MPNs (both untreated and relapsed/refractory)", "histology_inclusion": "post-ET myelofibrosis with \u2265 5% blasts", "biomarker_inclusion": ["IDH1 Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B - Participants with IDH2 Mutations", "disease_state": "advanced-Phase IDH-mutated Ph-neg MPNs (both untreated and relapsed/refractory)", "histology_inclusion": "polycythemia vera with (PV) \u2265 5% blasts", "biomarker_inclusion": ["IDH2 Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B - Participants with IDH2 Mutations", "disease_state": "advanced-Phase IDH-mutated Ph-neg MPNs (both untreated and relapsed/refractory)", "histology_inclusion": "essential thrombocythemia (ET) with \u2265 5% blasts", "biomarker_inclusion": ["IDH2 Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B - Participants with IDH2 Mutations", "disease_state": "advanced-Phase IDH-mutated Ph-neg MPNs (both untreated and relapsed/refractory)", "histology_inclusion": "primary myelofibrosis (PMF) with \u2265 5% blasts", "biomarker_inclusion": ["IDH2 Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B - Participants with IDH2 Mutations", "disease_state": "advanced-Phase IDH-mutated Ph-neg MPNs (both untreated and relapsed/refractory)", "histology_inclusion": "Atypical CML with \u2265 5% blasts", "biomarker_inclusion": ["IDH2 Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B - Participants with IDH2 Mutations", "disease_state": "advanced-Phase IDH-mutated Ph-neg MPNs (both untreated and relapsed/refractory)", "histology_inclusion": "MPN-NOS with \u2265 5% blasts", "biomarker_inclusion": ["IDH2 Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B - Participants with IDH2 Mutations", "disease_state": "advanced-Phase IDH-mutated Ph-neg MPNs (both untreated and relapsed/refractory)", "histology_inclusion": "MDS/MPN Overlap Syndromes with \u2265 5% blasts including CMML", "biomarker_inclusion": ["IDH2 Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B - Participants with IDH2 Mutations", "disease_state": "advanced-Phase IDH-mutated Ph-neg MPNs (both untreated and relapsed/refractory)", "histology_inclusion": "post-PV myelofibrosis with \u2265 5% blasts", "biomarker_inclusion": ["IDH2 Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm B - Participants with IDH2 Mutations", "disease_state": "advanced-Phase IDH-mutated Ph-neg MPNs (both untreated and relapsed/refractory)", "histology_inclusion": "post-ET myelofibrosis with \u2265 5% blasts", "biomarker_inclusion": ["IDH2 Mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm A - Participants with IDH1 Mutations", "histology_inclusion": "Polycythemia Vera", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "Arm A - Participants with IDH1 Mutations", "histology_inclusion": "Essential Thrombocythemia", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "Arm A - Participants with IDH1 Mutations", "histology_inclusion": "Primary Myelofibrosis", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "Arm A - Participants with IDH1 Mutations", "histology_inclusion": "Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "Arm A - Participants with IDH1 Mutations", "biomarker_inclusion": [["PRSS27 - NOS2", "PRSS27 - NOS2", "coordinate"], ["PRSS27 - NOS1", "PRSS27 - NOS1", "coordinate"], ["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "Arm A - Participants with IDH1 Mutations", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["PRSS27 - NOS2", "PRSS27 - NOS2", "coordinate"], ["PRSS27 - NOS1", "PRSS27 - NOS1", "coordinate"]]}, {"cohort": "Arm A - Participants with IDH1 Mutations", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "Arm A - Participants with IDH1 Mutations", "histology_inclusion": "Myelodysplastic/Myeloproliferative Disease", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "Arm A - Participants with IDH1 Mutations", "histology_inclusion": "Myelofibrosis", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "Arm A - Participants with IDH1 Mutations", "histology_inclusion": "Myelofibrosis Transformation in Essential Thrombocythemia", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"]]}, {"cohort": "Arm B - Participants with IDH2 Mutations", "histology_inclusion": "Polycythemia Vera", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Arm B - Participants with IDH2 Mutations", "histology_inclusion": "Essential Thrombocythemia", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Arm B - Participants with IDH2 Mutations", "histology_inclusion": "Primary Myelofibrosis", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Arm B - Participants with IDH2 Mutations", "histology_inclusion": "Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Arm B - Participants with IDH2 Mutations", "biomarker_inclusion": [["PRSS27 - NOS2", "PRSS27 - NOS2", "coordinate"], ["PRSS27 - NOS1", "PRSS27 - NOS1", "coordinate"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Arm B - Participants with IDH2 Mutations", "biomarker_inclusion": [["PRSS27 - NOS2", "PRSS27 - NOS2", "coordinate"], ["IDH2 Mutation", "IDH2-Mutation", "gene"], ["PRSS27 - NOS1", "PRSS27 - NOS1", "coordinate"]]}, {"cohort": "Arm B - Participants with IDH2 Mutations", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Arm B - Participants with IDH2 Mutations", "histology_inclusion": "Myelodysplastic/Myeloproliferative Disease", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Arm B - Participants with IDH2 Mutations", "histology_inclusion": "Myelofibrosis", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}, {"cohort": "Arm B - Participants with IDH2 Mutations", "histology_inclusion": "Myelofibrosis Transformation in Essential Thrombocythemia", "biomarker_inclusion": [["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT05281406", "json": [{"cohort": "", "disease_state": "Stage IIIB or IV", "histology_inclusion": "NSCLC", "biomarker_inclusion": ["Ex19del EGFR mutation", "L858R EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT05281471", "json": [{"cohort": "", "disease_state": "Platinum-resistant or -refractory", "histology_inclusion": "High-grade serous ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["mucinous ovarian cancer", "low-grade serous ovarian cancer", "squamous cell ovarian cancer", "small cell neuroendocrine ovarian cancer", "non-epithelial ovarian cancers"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Platinum-resistant or -refractory", "histology_inclusion": "Endometrioid ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["mucinous ovarian cancer", "low-grade serous ovarian cancer", "squamous cell ovarian cancer", "small cell neuroendocrine ovarian cancer", "non-epithelial ovarian cancers"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Platinum-resistant or -refractory", "histology_inclusion": "Clear-cell ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["mucinous ovarian cancer", "low-grade serous ovarian cancer", "squamous cell ovarian cancer", "small cell neuroendocrine ovarian cancer", "non-epithelial ovarian cancers"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Platinum-resistant or -refractory", "histology_inclusion": "Fallopian tube cancer", "biomarker_inclusion": [], "histology_exclusion": ["mucinous ovarian cancer", "low-grade serous ovarian cancer", "squamous cell ovarian cancer", "small cell neuroendocrine ovarian cancer", "non-epithelial ovarian cancers"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Platinum-resistant or -refractory", "histology_inclusion": "Primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": ["mucinous ovarian cancer", "low-grade serous ovarian cancer", "squamous cell ovarian cancer", "small cell neuroendocrine ovarian cancer", "non-epithelial ovarian cancers"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Serous Adenocarcinoma", "histology_exclusion": ["Ovarian Mucinous Tumor", "Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Invasive Ovarian Micropapillary Serous Carcinoma"]}, {"cohort": "", "histology_inclusion": "Ovarian Endometrioid Adenocarcinoma", "histology_exclusion": ["Ovarian Mucinous Tumor", "Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Invasive Ovarian Micropapillary Serous Carcinoma"]}, {"cohort": "", "histology_inclusion": "Ovarian Clear Cell Tumor", "histology_exclusion": ["Ovarian Mucinous Tumor", "Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Invasive Ovarian Micropapillary Serous Carcinoma"]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "histology_exclusion": ["Ovarian Mucinous Tumor", "Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Invasive Ovarian Micropapillary Serous Carcinoma"]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "histology_exclusion": ["Ovarian Mucinous Tumor", "Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm", "Invasive Ovarian Micropapillary Serous Carcinoma"]}]}
{"NCT_id": "NCT03485209", "json": [{"cohort": "Parts A, B, and C", "disease_state": "locally-advanced or metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Parts A, B, and C", "disease_state": "locally-advanced or metastatic", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": [], "histology_exclusion": ["exocrine pancreatic adenocarcinoma"], "biomarker_exclusion": []}, {"cohort": "Parts A, B, and C", "disease_state": "locally-advanced or metastatic", "histology_inclusion": "squamous non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Parts A, B, and C", "disease_state": "locally-advanced or metastatic", "histology_inclusion": "squamous cell carcinoma of head and neck", "biomarker_inclusion": [], "histology_exclusion": ["primary site of nasopharynx"], "biomarker_exclusion": []}, {"cohort": "Part D", "disease_state": "recurrent or metastatic", "histology_inclusion": "squamous cell carcinoma of head and neck", "biomarker_inclusion": [], "histology_exclusion": ["primary site of nasopharynx"], "biomarker_exclusion": []}, {"cohort": "Part D", "disease_state": "metastatic", "histology_inclusion": "squamous cell non-small cell lung cancer", "biomarker_inclusion": ["PD-L1 expression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Parts A, B, and C", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "Parts A, B, and C", "histology_inclusion": "Pancreatic Carcinoma", "histology_exclusion": ["Pancreatic Adenocarcinoma"]}, {"cohort": "Parts A, B, and C", "histology_inclusion": "Squamous Cell Lung Carcinoma"}, {"cohort": "Parts A, B, and C", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Part D", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Part D", "histology_inclusion": "Squamous Cell Lung Carcinoma"}]}
{"NCT_id": "NCT03811015", "json": [{"cohort": "", "disease_state": "Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "histology_inclusion": "p16-positive oropharyngeal squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "histology_inclusion": "p16-positive oropharyngeal squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "histology_inclusion": "p16-positive oropharyngeal squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "histology_inclusion": "p16-positive oropharyngeal squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Oropharyngeal Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}]}
{"NCT_id": "NCT04071457", "json": [{"cohort": "S1803", "disease_state": "symptomatic multiple myeloma", "histology_inclusion": "multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": ["smoldering myeloma", "non-secretory MM", "plasma cell leukemia", "central nervous system involvement"], "biomarker_exclusion": ["amyloidosis"]}], "json_norm": [{"cohort": "S1803", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Smoldering Plasma Cell Myeloma", "Plasma Cell Leukemia"]}]}
{"NCT_id": "NCT04369937", "json": [{"cohort": "", "disease_state": "local-regionally advanced, intermediate risk", "histology_inclusion": "HPV-16-associated head and neck squamous cell carcinoma", "biomarker_inclusion": ["p16(+)", "HPV ISH(+)", "\u2265 10 pack-years tobacco exposure"], "histology_exclusion": ["oral cavity", "larynx", "hypopharynx", "nasopharyngeal primary site"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "local-regionally advanced, intermediate risk", "histology_inclusion": "HPV-16-associated head and neck squamous cell carcinoma", "biomarker_inclusion": ["p16(+)", "HPV ISH(+)", "T4", "N2c/N3 disease"], "histology_exclusion": ["oral cavity", "larynx", "hypopharynx", "nasopharyngeal primary site"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "local-regionally advanced, intermediate risk", "histology_inclusion": "HPV-16-associated head and neck squamous cell carcinoma of unknown primary", "biomarker_inclusion": ["p16(+)", "HPV ISH(+)", "\u2265 N2a", "\u2265 10 pack-years tobacco exposure"], "histology_exclusion": ["oral cavity", "larynx", "hypopharynx", "nasopharyngeal primary site"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "local-regionally advanced, intermediate risk", "histology_inclusion": "HPV-16-associated head and neck squamous cell carcinoma of unknown primary", "biomarker_inclusion": ["p16(+)", "HPV ISH(+)", "N2c/N3 disease"], "histology_exclusion": ["oral cavity", "larynx", "hypopharynx", "nasopharyngeal primary site"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}]}
{"NCT_id": "NCT04266912", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["ARID1A", "ATM", "ATR", "ATRX", "BAP1", "BARD1", "BRCA1/2", "BRIP1", "CDK12", "CHEK2", "FANCA", "FANCC", "FANCD2", "FANCE", "FANCF", "FANCM", "MRE11A", "MSH2", "NBN (NBS1)", "PALB2", "RAD51", "RAD51C", "RAD51D", "SMARCB1", "VHL"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT05476939", "json": [{"cohort": "BIOMEDE 2.0", "disease_state": "", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma (DIPG)", "biomarker_inclusion": ["H3K28M mutation", "EZHIP overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "BIOMEDE 2.0", "disease_state": "", "histology_inclusion": "Non-DIPG diffuse midline gliomas, H3K28M mutant (ND-DMG)", "biomarker_inclusion": ["H3K28 trimethylation loss", "EZHIP overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "BIOMEDE 2.0", "histology_inclusion": "Diffuse Intrinsic Pontine Glioma", "biomarker_inclusion": [["EZHIP-High", "EZHIP-High", "expression"]]}, {"cohort": "BIOMEDE 2.0", "biomarker_inclusion": [["EZHIP-High", "EZHIP-High", "expression"]]}]}
{"NCT_id": "NCT03944304", "json": [{"cohort": "", "disease_state": "metastatic or advanced", "histology_inclusion": "Gastrointestinal Stromal Tumor (GIST)", "biomarker_inclusion": ["CD117(+)", "DOG-1(+)", "KIT mutation", "PDGFR\u03b1 mutation", "P-glycoprotein expression H-score \u2264 250"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastrointestinal Stromal Tumor", "biomarker_inclusion": [["ANO1-High", "ANO1-High", "expression"], ["KIT-High", "KIT-High", "expression"], ["KIT Mutation", "KIT-Mutation", "gene"]]}]}
{"NCT_id": "NCT04503265", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "advanced or metastatic malignancy", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}]}
{"NCT_id": "NCT02631044", "json": [{"cohort": "DLBCL cohort", "disease_state": "Relapsed or refractory", "histology_inclusion": "Diffuse Large B Cell Lymphoma", "biomarker_inclusion": ["CD19-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "DLBCL cohort", "disease_state": "Relapsed or refractory", "histology_inclusion": "High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with DLBCL histology", "biomarker_inclusion": ["CD19-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "DLBCL cohort", "disease_state": "Relapsed or refractory", "histology_inclusion": "Primary Mediastinal B-cell Lymphoma", "biomarker_inclusion": ["CD19-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "DLBCL cohort", "disease_state": "Relapsed or refractory", "histology_inclusion": "Follicular Lymphoma Grade 3B", "biomarker_inclusion": ["CD19-positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "MCL cohort", "disease_state": "Relapsed or refractory", "histology_inclusion": "Mantle-cell Lymphoma", "biomarker_inclusion": ["CD19-positive", "Cyclin D1 expression", "t(11;14)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "DLBCL cohort", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["CD19-High", "CD19-High", "expression"]]}, {"cohort": "DLBCL cohort", "histology_inclusion": "High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"], ["CD19-High", "CD19-High", "expression"]]}, {"cohort": "DLBCL cohort", "histology_inclusion": "High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"], ["CD19-High", "CD19-High", "expression"]]}, {"cohort": "DLBCL cohort", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["CD19-High", "CD19-High", "expression"], ["BCL6 Fusion", "BCL6", "fusion"]]}, {"cohort": "DLBCL cohort", "histology_inclusion": "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "biomarker_inclusion": [["CD19-High", "CD19-High", "expression"]]}, {"cohort": "DLBCL cohort", "histology_inclusion": "Grade 3b Follicular Lymphoma", "biomarker_inclusion": [["CD19-High", "CD19-High", "expression"]]}, {"cohort": "MCL cohort", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["CD19-High", "CD19-High", "expression"]]}]}
{"NCT_id": "NCT04830137", "json": [{"cohort": "Phase 1a", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Chronic Lymphocytic Leukemia (CLL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1a", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Small Lymphocytic Lymphoma (SLL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1a", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Waldenstrom Macroglobulinemia (WM)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1a", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Mantle Cell Lymphoma (MCL)", "biomarker_inclusion": [], "histology_exclusion": ["MCL with blastoid histology", "MCL with pleomorphic morphology", "MCL with known TP53 mutation"], "biomarker_exclusion": []}, {"cohort": "Phase 1a", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Marginal Zone Lymphoma (MZL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1a", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Follicular Lymphoma (FL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1a", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Diffuse Large B-cell Lymphoma (DLBCL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1a", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Primary Central Nervous System Lymphoma (PCNSL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Chronic Lymphocytic Leukemia (CLL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["BTK C481 mutation"]}, {"cohort": "Phase 1b", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Small Lymphocytic Lymphoma (SLL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["BTK C481 mutation"]}, {"cohort": "Phase 1b", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Chronic Lymphocytic Leukemia (CLL)", "biomarker_inclusion": ["BTK C481 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Small Lymphocytic Lymphoma (SLL)", "biomarker_inclusion": ["BTK C481 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Mantle Cell Lymphoma (MCL)", "biomarker_inclusion": [], "histology_exclusion": ["MCL with blastoid histology", "MCL with pleomorphic morphology", "MCL with known TP53 mutation"], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Follicular Lymphoma (FL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Marginal Zone Lymphoma (MZL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Primary Central Nervous System Lymphoma (PCNSL)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Diffuse Large B-cell Lymphoma (DLBCL)", "biomarker_inclusion": [], "histology_exclusion": ["GCB DLBCL"], "biomarker_exclusion": []}, {"cohort": "Phase 1b", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Waldenstrom Macroglobulinemia (WM)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1a", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "Phase 1a", "histology_inclusion": "Small Lymphocytic Lymphoma"}, {"cohort": "Phase 1a", "histology_inclusion": "Waldenstrom Macroglobulinemia"}, {"cohort": "Phase 1a", "histology_inclusion": "Mantle Cell Lymphoma", "histology_exclusion": ["Mantle Cell Lymphoma"], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["CLEC4D Mutation", "CLEC4D-Mutation", "gene"]]}, {"cohort": "Phase 1a", "histology_inclusion": "Marginal Zone Lymphoma"}, {"cohort": "Phase 1a", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "Phase 1a", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "Phase 1a", "histology_inclusion": "Central Nervous System Lymphoma"}, {"cohort": "Phase 1a", "histology_inclusion": "Primary Central Nervous System Lymphoma"}, {"cohort": "Phase 1b", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "Phase 1b", "histology_inclusion": "Small Lymphocytic Lymphoma"}, {"cohort": "Phase 1b", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "Phase 1b", "histology_inclusion": "Small Lymphocytic Lymphoma"}, {"cohort": "Phase 1b", "histology_inclusion": "Mantle Cell Lymphoma", "histology_exclusion": ["Mantle Cell Lymphoma"], "biomarker_exclusion": [["TP53 Mutation", "TP53-Mutation", "gene"], ["CLEC4D Mutation", "CLEC4D-Mutation", "gene"]]}, {"cohort": "Phase 1b", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "Phase 1b", "histology_inclusion": "Marginal Zone Lymphoma"}, {"cohort": "Phase 1b", "histology_inclusion": "Central Nervous System Lymphoma"}, {"cohort": "Phase 1b", "histology_inclusion": "Primary Central Nervous System Lymphoma"}, {"cohort": "Phase 1b", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type"]}, {"cohort": "Phase 1b", "histology_inclusion": "Waldenstrom Macroglobulinemia"}]}
{"NCT_id": "NCT05350787", "json": [{"cohort": "", "disease_state": "relapsed and refractory acute B-cell leukemia", "histology_inclusion": "B-ALL", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "B Acute Lymphoblastic Leukemia", "biomarker_inclusion": [["PPIB - BCR", "PPIB - BCR", "coordinate"]]}]}
{"NCT_id": "NCT04374305", "json": [{"cohort": "Master Protocol", "disease_state": "", "histology_inclusion": "Vestibular Schwannoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Master Protocol", "disease_state": "", "histology_inclusion": "Non-vestibular Schwannoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Master Protocol", "disease_state": "", "histology_inclusion": "Meningioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Master Protocol", "disease_state": "", "histology_inclusion": "Ependymoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Master Protocol", "histology_inclusion": "Acoustic Schwannoma"}, {"cohort": "Master Protocol", "histology_inclusion": "Schwannoma"}, {"cohort": "Master Protocol", "histology_inclusion": "Meningioma"}, {"cohort": "Master Protocol", "histology_inclusion": "Ependymoma"}]}
{"NCT_id": "NCT04765111", "json": [{"cohort": "", "disease_state": "Previously Untreated", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["CD20 positivity", "t(11;14) (q13;q32)", "Cyclin D1 positive"], "histology_exclusion": ["Blastoid histology", "Pleomorphic histology"], "biomarker_exclusion": ["Ki-67% > 50%", "TP53 mutation", "TP53 positive by FISH", "Complex karyotype in bone marrow"]}, {"cohort": "", "disease_state": "Previously Untreated", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["CD20 positivity", "Cyclin D1 negative"], "histology_exclusion": ["Blastoid histology", "Pleomorphic histology"], "biomarker_exclusion": ["Ki-67% > 50%", "TP53 mutation", "TP53 positive by FISH", "Complex karyotype in bone marrow"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["CCND1-High", "CCND1-High", "expression"]], "biomarker_exclusion": [["TP53-High", "TP53-High", "expression"], ["TP53 Mutation", "TP53-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["CCND1-Low", "CCND1-Low", "expression"]], "biomarker_exclusion": [["TP53-High", "TP53-High", "expression"], ["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT04895722", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "CRC adenocarcinoma", "biomarker_inclusion": ["dMMR", "MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "Stage IV", "histology_inclusion": "CRC adenocarcinoma", "biomarker_inclusion": ["dMMR", "MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "Stage IV", "histology_inclusion": "CRC adenocarcinoma", "biomarker_inclusion": ["dMMR", "MSI-H"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort A", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort A", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort B", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"], ["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohort B", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04895748", "json": [{"cohort": "Arm 1B", "disease_state": "advanced or metastatic", "histology_inclusion": "malignancies with VHL mutations", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["HIF2\u03b1 inhibitor"]}, {"cohort": "Arm 1B", "disease_state": "advanced or metastatic", "histology_inclusion": "malignancies with FH mutations", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["HIF2\u03b1 inhibitor"]}, {"cohort": "Arm 1B", "disease_state": "advanced or metastatic", "histology_inclusion": "malignancies with SDHD, SDHAF2, SDHC, SDHB, SDHA mutations", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["HIF2\u03b1 inhibitor"]}, {"cohort": "Arm 1B", "disease_state": "advanced or metastatic", "histology_inclusion": "malignancies with EPAS1/HIF2A mutations", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["HIF2\u03b1 inhibitor"]}, {"cohort": "Arm 1B", "disease_state": "advanced or metastatic", "histology_inclusion": "malignancies with ELOC/TCEB1 mutations", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["HIF2\u03b1 inhibitor"]}, {"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "clear cell renal cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["HIF2\u03b1 inhibitor"]}], "json_norm": [{"cohort": "Arm 1B", "biomarker_inclusion": [["VHL Mutation", "VHL-Mutation", "gene"]]}, {"cohort": "Arm 1B", "biomarker_inclusion": [["FH Mutation", "FH-Mutation", "gene"]]}, {"cohort": "Arm 1B", "biomarker_inclusion": [["SDHAF2 Mutation", "SDHAF2-Mutation", "gene"], ["SDHC Mutation", "SDHC-Mutation", "gene"], ["SDHB Mutation", "SDHB-Mutation", "gene"], ["SDHA Mutation", "SDHA-Mutation", "gene"], ["SDHD Mutation", "SDHD-Mutation", "gene"]]}, {"cohort": "Arm 1B", "biomarker_inclusion": [["SDHAF2 Mutation", "SDHAF2-Mutation", "gene"], ["SDHC Mutation", "SDHC-Mutation", "gene"], ["SDHB Mutation", "SDHB-Mutation", "gene"], ["SDHA Mutation", "SDHA-Mutation", "gene"], ["SDHD Mutation", "SDHD-Mutation", "gene"]]}, {"cohort": "Arm 1B", "biomarker_inclusion": [["SDHAF2 Mutation", "SDHAF2-Mutation", "gene"], ["SDHC Mutation", "SDHC-Mutation", "gene"], ["SDHB Mutation", "SDHB-Mutation", "gene"], ["SDHA Mutation", "SDHA-Mutation", "gene"], ["SDHD Mutation", "SDHD-Mutation", "gene"]]}, {"cohort": "Arm 1B", "biomarker_inclusion": [["SDHAF2 Mutation", "SDHAF2-Mutation", "gene"], ["SDHC Mutation", "SDHC-Mutation", "gene"], ["SDHB Mutation", "SDHB-Mutation", "gene"], ["SDHA Mutation", "SDHA-Mutation", "gene"], ["SDHD Mutation", "SDHD-Mutation", "gene"]]}, {"cohort": "Arm 1B", "biomarker_inclusion": [["SDHAF2 Mutation", "SDHAF2-Mutation", "gene"], ["SDHC Mutation", "SDHC-Mutation", "gene"], ["SDHB Mutation", "SDHB-Mutation", "gene"], ["SDHA Mutation", "SDHA-Mutation", "gene"], ["SDHD Mutation", "SDHD-Mutation", "gene"]]}, {"cohort": "Arm 1B", "biomarker_inclusion": [["EPAS1 Mutation", "EPAS1-Mutation", "gene"]]}, {"cohort": "Arm 1B", "biomarker_inclusion": [["ELOC Mutation", "ELOC-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}]}
{"NCT_id": "NCT02566304", "json": [{"cohort": "", "disease_state": "Acute myeloid leukemia in morphologic complete remission", "histology_inclusion": "Acute myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": ["chronic myelomonocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Refractory anemia", "histology_inclusion": "Refractory anemia", "biomarker_inclusion": [], "histology_exclusion": ["chronic myelomonocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Refractory anemia with ring sideroblasts", "histology_inclusion": "Refractory anemia with ring sideroblasts", "biomarker_inclusion": [], "histology_exclusion": ["chronic myelomonocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Hodgkin or Indolent non-Hodgkin's lymphoma", "histology_inclusion": "Hodgkin Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["chronic myelomonocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Hodgkin or Indolent non-Hodgkin's lymphoma", "histology_inclusion": "Indolent Non-Hodgkin Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["chronic myelomonocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Myeloma with < 5% plasma cells in the marrow", "histology_inclusion": "Plasma Cell Myeloma", "biomarker_inclusion": [], "histology_exclusion": ["chronic myelomonocytic leukemia"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Aplastic anemia", "histology_inclusion": "Aplastic Anemia", "biomarker_inclusion": [], "histology_exclusion": ["chronic myelomonocytic leukemia"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Chronic Myelomonocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "Refractory Anemia", "histology_exclusion": ["Chronic Myelomonocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis", "histology_exclusion": ["Chronic Myelomonocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "Hodgkin Lymphoma", "histology_exclusion": ["Chronic Myelomonocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "Indolent Non-Hodgkin Lymphoma", "histology_exclusion": ["Chronic Myelomonocytic Leukemia"]}, {"cohort": "", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Chronic Myelomonocytic Leukemia"]}, {"cohort": "", "histology_exclusion": ["Chronic Myelomonocytic Leukemia"]}]}
{"NCT_id": "NCT04374877", "json": [{"cohort": "Part B", "disease_state": "advanced or metastatic", "histology_inclusion": "Clear Cell Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "unresectable", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "Barcelona Clinic Liver Cancer Stage B or Stage C", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "locally advanced and/or metastatic Stage IV", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "advanced", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "advanced", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "unresectable", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "Barcelona Clinic Liver Cancer Stage B or Stage C", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "metastatic or unresectable", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part B", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}, {"cohort": "Part B", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "Part B", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "Part B", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part C", "histology_inclusion": "Renal Cell Carcinoma"}, {"cohort": "Part C", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "Part C", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "Part C", "histology_inclusion": "Hepatocellular Carcinoma"}, {"cohort": "Part C", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT05091346", "json": [{"cohort": "", "disease_state": "advanced (metastatic and/or unresectable)", "histology_inclusion": "melanoma (excluding uveal melanoma)", "biomarker_inclusion": [], "histology_exclusion": ["uveal melanoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced (metastatic and/or unresectable)", "histology_inclusion": "colorectal cancer (CRC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage B (not amenable to locoregional therapy or refractory to locoregional therapy, and not amenable to a curative treatment) or stage C", "histology_inclusion": "hepatocellular carcinoma (HCC)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "histology_exclusion": ["Intraocular Melanoma"]}, {"cohort": "", "histology_inclusion": "Intraocular Melanoma", "histology_exclusion": ["Intraocular Melanoma"]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma"}, {"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma"}]}
{"NCT_id": "NCT03946358", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "anal cancer", "biomarker_inclusion": ["HPV+", "p16+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "head and neck carcinoma", "biomarker_inclusion": ["HPV+", "p16+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "cervical carcinoma", "biomarker_inclusion": ["HPV+", "p16+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "vulvar carcinoma", "biomarker_inclusion": ["HPV+", "p16+"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Anal Neoplasm", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Anal Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Malignant Head and Neck Neoplasm", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Head and Neck Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Cervical Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Vulvar Carcinoma", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Vulvar Neoplasm", "biomarker_inclusion": [["H3P10-High", "H3P10-High", "expression"], ["CDKN2A-High", "CDKN2A-High", "expression"]]}]}
{"NCT_id": "NCT05286801", "json": [{"cohort": "", "disease_state": "relapsed, refractory", "histology_inclusion": "Renal medullary carcinoma", "biomarker_inclusion": ["SMARCB1 deficient", "SMARCA4 deficient"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed, refractory", "histology_inclusion": "Malignant rhabdoid tumor (extra-CNS)", "biomarker_inclusion": ["SMARCB1 deficient", "SMARCA4 deficient"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed, refractory", "histology_inclusion": "Atypical teratoid rhabdoid tumor (CNS)", "biomarker_inclusion": ["SMARCB1 deficient", "SMARCA4 deficient"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed, refractory", "histology_inclusion": "Poorly differentiated chordoma", "biomarker_inclusion": ["SMARCB1 deficient", "SMARCA4 deficient"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed, refractory", "histology_inclusion": "Epithelioid sarcoma", "biomarker_inclusion": ["SMARCB1 deficient", "SMARCA4 deficient"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed, refractory", "histology_inclusion": "Other SMARCB1 or SMARCA4 deficient tumors", "biomarker_inclusion": ["SMARCB1 deficient", "SMARCA4 deficient"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Kidney Medullary Carcinoma", "biomarker_inclusion": [["SMARCA4-Low", "SMARCA4-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Rhabdoid Tumor", "biomarker_inclusion": [["SMARCA4-Low", "SMARCA4-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Rhabdoid Tumor", "biomarker_inclusion": [["SMARCA4-Low", "SMARCA4-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Chordoma", "biomarker_inclusion": [["SMARCA4-Low", "SMARCA4-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "", "histology_inclusion": "Epithelioid Sarcoma", "biomarker_inclusion": [["SMARCA4-Low", "SMARCA4-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"]]}, {"cohort": "", "biomarker_inclusion": [["SMARCA4-Low", "SMARCA4-Low", "expression"], ["SMARCB1-Low", "SMARCB1-Low", "expression"]]}]}
{"NCT_id": "NCT00980954", "json": [{"cohort": "", "disease_state": "stage IA2, IB, or IIA", "histology_inclusion": "squamous carcinoma of the cervix", "biomarker_inclusion": [], "histology_exclusion": ["neuroendocrine histology"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "stage IA2, IB, or IIA", "histology_inclusion": "adenosquamous carcinoma of the cervix", "biomarker_inclusion": [], "histology_exclusion": ["neuroendocrine histology"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "stage IA2, IB, or IIA", "histology_inclusion": "adenocarcinoma of the cervix", "biomarker_inclusion": [], "histology_exclusion": ["neuroendocrine histology"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "", "histology_inclusion": "Cervical Adenosquamous Carcinoma"}, {"cohort": "", "histology_inclusion": "Endocervical Carcinoma"}, {"cohort": "", "histology_inclusion": "Cervical Adenocarcinoma"}]}
{"NCT_id": "NCT05417321", "json": [{"cohort": "Phase I", "disease_state": "locally advanced, recurrent, or metastatic solid tumors", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor", "CNS tumor"], "biomarker_exclusion": []}, {"cohort": "Phase II - Advanced non-small cell lung cancer", "disease_state": "locally advanced, recurrent or metastatic NSCLC", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["PD-L1 TPS\u22651%"], "histology_exclusion": ["primary brain tumor", "CNS tumor"], "biomarker_exclusion": ["EGFR mutations", "ALK gene fusion mutation"]}, {"cohort": "Phase II - Advanced other cancer", "disease_state": "locally advanced, recurrent or metastatic cancer", "histology_inclusion": "esophageal squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor", "CNS tumor"], "biomarker_exclusion": []}, {"cohort": "Phase II - Advanced other cancer", "disease_state": "locally advanced, recurrent or metastatic cancer", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor", "CNS tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase I", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Phase II - Advanced non-small cell lung cancer", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Phase II - Advanced other cancer", "histology_inclusion": "Esophageal Squamous Cell Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "Phase II - Advanced other cancer", "histology_inclusion": "Melanoma", "histology_exclusion": ["Primary Brain Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT04701307", "json": [{"cohort": "Cohort 1", "disease_state": "unresected or locally advanced", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2", "disease_state": "", "histology_inclusion": "high-grade neuroendocrine carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["high-grade neuroendocrine carcinoma of prostate"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Small Cell Lung Carcinoma"}, {"cohort": "Cohort 2", "histology_inclusion": "Neuroendocrine Carcinoma", "histology_exclusion": ["Prostate Neuroendocrine Neoplasm", "Prostate Neuroendocrine Carcinoma"]}, {"cohort": "Cohort 2", "histology_inclusion": "Neuroendocrine Tumor", "histology_exclusion": ["Prostate Neuroendocrine Neoplasm", "Prostate Neuroendocrine Carcinoma"]}]}
{"NCT_id": "NCT05092815", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Langerhans Cell Histiocytosis", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Erdheim-Chester Disease", "biomarker_inclusion": ["BRAF V600E mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Langerhans Cell Histiocytosis", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Erdheim-Chester Disease", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT05222971", "json": [{"cohort": "", "disease_state": "locally advanced unresectable, recurrence after curative surgery or metastatic", "histology_inclusion": "adenocarcinoma of biliary tract (intrahepatic, extrahepatic cholangiocarcinoma, or gallbladder carcinoma)", "biomarker_inclusion": ["somatic or germline mutation of at least one the DNA damage repair gene including ATM, ATR, BAP1, BARD1, BLM, BRCA1, BRCA2, BRIP1, CHEK1, CHEK2, GEN1, FANCA, FANCD2, POLE, MLH1, MSH2, MSH6, MRE11A, NBN, PALB2, PMS2, RAD50, RAD51, RAD51C, RAD51D, and XRCC2"], "histology_exclusion": ["combined hepatocellular carcinoma/cholangiocarcinoma"], "biomarker_exclusion": ["leptomeningeal carcinomatosis", "symptomatic uncontrolled brain metastases"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["DNA Damage Repair (DDR) pathways", null, "pathway"]], "histology_exclusion": ["Cholangiocarcinoma", "Hepatocellular Carcinoma"]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["DNA Damage Repair (DDR) pathways", null, "pathway"]], "histology_exclusion": ["Cholangiocarcinoma", "Hepatocellular Carcinoma"]}, {"cohort": "", "histology_inclusion": "Gallbladder Carcinoma", "biomarker_inclusion": [["ATM Mutation", "ATM-Mutation", "gene"], ["DNA Damage Repair (DDR) pathways", null, "pathway"]], "histology_exclusion": ["Cholangiocarcinoma", "Hepatocellular Carcinoma"]}]}
{"NCT_id": "NCT01376505", "json": [{"cohort": "EXTENSION HER-2 Vaccine at OBD", "disease_state": "metastatic or unresectable", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "EXTENSION HER-2 Vaccine at OBD", "disease_state": "metastatic or unresectable", "histology_inclusion": "ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "EXTENSION HER-2 Vaccine at OBD", "disease_state": "metastatic or unresectable", "histology_inclusion": "gastrointestinal cancers", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "EXTENSION HER-2 Vaccine at OBD", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "EXTENSION HER-2 Vaccine at OBD", "histology_inclusion": "Ovarian Epithelial Cancer"}, {"cohort": "EXTENSION HER-2 Vaccine at OBD", "histology_inclusion": "Malignant Ovarian Neoplasm"}, {"cohort": "EXTENSION HER-2 Vaccine at OBD", "histology_inclusion": "Digestive System Neoplasm"}]}
{"NCT_id": "NCT04962867", "json": [{"cohort": "Group A", "disease_state": "advanced or recurrent solid tumor", "histology_inclusion": "", "biomarker_inclusion": ["FGFR1-3 fusion"], "histology_exclusion": ["primary CNS tumor located in either cerebellum, brainstem, spinal cord, pituitary gland, optic nerve or olfactory nerve"], "biomarker_exclusion": ["FGFR gatekeeper mutations: FGFR1 V561, FGFR2 V564/565, FGFR3 V555/557, FGFR4 V550", "coexisting driver gene abnormalities: KRAS, NRAS, EGFR, BRAF V600, ALK, ROS1, NTRK"]}, {"cohort": "Group B", "disease_state": "advanced or recurrent solid tumor", "histology_inclusion": "", "biomarker_inclusion": ["FGFR1: P150S, T340M, R445W, N546K, K656E"], "histology_exclusion": ["primary CNS tumor located in either cerebellum, brainstem, spinal cord, pituitary gland, optic nerve or olfactory nerve"], "biomarker_exclusion": ["FGFR gatekeeper mutations: FGFR1 V561, FGFR2 V564/565, FGFR3 V555/557, FGFR4 V550", "coexisting driver gene abnormalities: KRAS, NRAS, EGFR, BRAF V600, ALK, ROS1, NTRK"]}, {"cohort": "Group B", "disease_state": "advanced or recurrent solid tumor", "histology_inclusion": "", "biomarker_inclusion": ["FGFR2: C62Y, A67V, N82K, D101Y, E160K, E163K, M186T, R203H, R210Q, Q212K, R251Q, S252W, P253R, P253L, A264T, W290C, K310R, Y328N, G364E, Y375C, C382R, A389T, V392A, R399Q, H416R, I422V, H544Q, N549H, N549K, N549D, N549S, L560F, K659E, K659N, R664W, E718K, S791T"], "histology_exclusion": ["primary CNS tumor located in either cerebellum, brainstem, spinal cord, pituitary gland, optic nerve or olfactory nerve"], "biomarker_exclusion": ["FGFR gatekeeper mutations: FGFR1 V561, FGFR2 V564/565, FGFR3 V555/557, FGFR4 V550", "coexisting driver gene abnormalities: KRAS, NRAS, EGFR, BRAF V600, ALK, ROS1, NTRK"]}, {"cohort": "Group B", "disease_state": "advanced or recurrent solid tumor", "histology_inclusion": "", "biomarker_inclusion": ["FGFR3: G380E, G380R, A391E, K650T, K650E, K650Q, K650N"], "histology_exclusion": ["primary CNS tumor located in either cerebellum, brainstem, spinal cord, pituitary gland, optic nerve or olfactory nerve"], "biomarker_exclusion": ["FGFR gatekeeper mutations: FGFR1 V561, FGFR2 V564/565, FGFR3 V555/557, FGFR4 V550", "coexisting driver gene abnormalities: KRAS, NRAS, EGFR, BRAF V600, ALK, ROS1, NTRK"]}, {"cohort": "Group C", "disease_state": "advanced or recurrent solid tumor", "histology_inclusion": "", "biomarker_inclusion": ["FGFR1-3 activating mutation not applicable to group B", "FGFR1, 2 gene amplification"], "histology_exclusion": ["primary CNS tumor located in either cerebellum, brainstem, spinal cord, pituitary gland, optic nerve or olfactory nerve"], "biomarker_exclusion": ["FGFR gatekeeper mutations: FGFR1 V561, FGFR2 V564/565, FGFR3 V555/557, FGFR4 V550", "coexisting driver gene abnormalities: KRAS, NRAS, EGFR, BRAF V600, ALK, ROS1, NTRK"]}, {"cohort": "Group D", "disease_state": "cholangiocarcinoma", "histology_inclusion": "", "biomarker_inclusion": ["FGFR2 fusion"], "histology_exclusion": ["primary CNS tumor located in either cerebellum, brainstem, spinal cord, pituitary gland, optic nerve or olfactory nerve"], "biomarker_exclusion": ["FGFR gatekeeper mutations: FGFR1 V561, FGFR2 V564/565, FGFR3 V555/557, FGFR4 V550", "coexisting driver gene abnormalities: KRAS, NRAS, EGFR, BRAF V600, ALK, ROS1, NTRK", "prior selective FGFR inhibitor in the recurrent/metastatic disease setting"]}], "json_norm": [{"cohort": "Group A", "biomarker_inclusion": [["FGFR2 Fusion", "FGFR2", "fusion"], ["FGFR3 Fusion", "FGFR3", "fusion"], ["FGFR1 Fusion", "FGFR1", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm"], "biomarker_exclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "Group B", "biomarker_inclusion": [["FGFR1 N546K", "N546K", "coordinate"], ["FGFR1 K656E", "K656E", "coordinate"], ["FGFR1 R445W", "R445W", "coordinate"]], "histology_exclusion": ["Primary Brain Neoplasm"], "biomarker_exclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "Group B", "biomarker_inclusion": [["FGFR2 L560F", "L560F", "coordinate"], ["FGFR2 C382R", "C382R", "coordinate"], ["FGFR2 K659N", "K659N", "coordinate"], ["FGFR2 W290C", "W290C", "coordinate"], ["FGFR2 R399Q", "R399Q", "coordinate"], ["FGFR2 P253L", "P253L", "coordinate"], ["FGFR2 N549K", "N549K", "coordinate"], ["FGFR2 Y375C", "Y375C", "coordinate"], ["FGFR2 K659E", "K659E", "coordinate"], ["FGFR2 S252W", "S252W", "coordinate"], ["FGFR2 C62Y", "C62Y", "coordinate"], ["FGFR2 R210Q", "R210Q", "coordinate"], ["FGFR2 D101Y", "D101Y", "coordinate"], ["FGFR2 A67V", "A67V", "coordinate"], ["FGFR2 H544Q", "H544Q", "coordinate"], ["FGFR2 P253R", "P253R", "coordinate"], ["FGFR2 E718K", "E718K", "coordinate"], ["FGFR2 R664W", "R664W", "coordinate"], ["FGFR2 R203H", "R203H", "coordinate"]], "histology_exclusion": ["Primary Brain Neoplasm"], "biomarker_exclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "Group B", "biomarker_inclusion": [["FGFR3 K650E", "K650E", "coordinate"], ["FGFR3 K650T", "K650T", "coordinate"], ["FGFR3 G380E", "G380E", "coordinate"], ["FGFR3 G380R", "G380R", "coordinate"]], "histology_exclusion": ["Primary Brain Neoplasm"], "biomarker_exclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "Group C", "histology_exclusion": ["Primary Brain Neoplasm"], "biomarker_exclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}, {"cohort": "Group D", "biomarker_inclusion": [["FGFR2 Fusion", "FGFR2", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm"], "biomarker_exclusion": [["FGFR1 Mutation", "FGFR1-Mutation", "gene"], ["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Mutation", "ALK-Mutation", "gene"], ["FGFR4 Mutation", "FGFR4-Mutation", "gene"], ["NRAS Mutation", "NRAS-Mutation", "gene"], ["KRAS Mutation", "KRAS-Mutation", "gene"], ["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"], ["BRAF Mutation", "BRAF-Mutation", "gene"]]}]}
{"NCT_id": "NCT02568267", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["NTRK1 gene rearrangement", "NTRK2 gene rearrangement", "NTRK3 gene rearrangement", "ROS1 gene rearrangement", "ALK gene rearrangement"], "histology_exclusion": ["primary brain tumors"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT04442022", "json": [{"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "Diffuse Large B-cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["mucosa-associated lymphoid tissue (MALT) lymphoma", "composite lymphoma (Hodgkin's lymphoma + non-Hodgkin's lymphoma [NHL])", "DLBCL transformed from diseases other than indolent NHL", "primary mediastinal (thymic) large B-cell lymphoma (PMBL)", "T-cell rich large B-cell lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Relapsed/Refractory", "histology_inclusion": "DLBCL transformed from previously diagnosed indolent lymphoma (e.g., follicular lymphoma)", "biomarker_inclusion": [], "histology_exclusion": ["mucosa-associated lymphoid tissue (MALT) lymphoma", "composite lymphoma (Hodgkin's lymphoma + non-Hodgkin's lymphoma [NHL])", "DLBCL transformed from diseases other than indolent NHL", "primary mediastinal (thymic) large B-cell lymphoma (PMBL)", "T-cell rich large B-cell lymphoma"], "biomarker_exclusion": []}, {"cohort": "Phase 2", "disease_state": "Relapsed/Refractory", "histology_inclusion": "high-grade lymphoma with c-MYC, Bcl2 and/or Bcl6 rearrangements", "biomarker_inclusion": [], "histology_exclusion": ["mucosa-associated lymphoid tissue (MALT) lymphoma", "composite lymphoma (Hodgkin's lymphoma + non-Hodgkin's lymphoma [NHL])", "DLBCL transformed from diseases other than indolent NHL", "primary mediastinal (thymic) large B-cell lymphoma (PMBL)", "T-cell rich large B-cell lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Hodgkin Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Diffuse Large B-Cell Lymphoma", "Non-Hodgkin Lymphoma", "Composite Lymphoma", "B-Cell Non-Hodgkin Lymphoma"]}, {"cohort": "", "histology_inclusion": "Follicular Lymphoma", "histology_exclusion": ["Composite Lymphoma", "Hodgkin Lymphoma", "Non-Hodgkin Lymphoma", "Non-Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma", "Non-Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "B-Cell Non-Hodgkin Lymphoma", "B-Cell Non-Hodgkin Lymphoma"]}, {"cohort": "", "histology_inclusion": "Indolent Non-Hodgkin Lymphoma", "histology_exclusion": ["Composite Lymphoma", "Hodgkin Lymphoma", "Non-Hodgkin Lymphoma", "Non-Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma", "Non-Hodgkin Lymphoma", "Diffuse Large B-Cell Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "B-Cell Non-Hodgkin Lymphoma", "B-Cell Non-Hodgkin Lymphoma"]}, {"cohort": "", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["Hodgkin Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Diffuse Large B-Cell Lymphoma", "Non-Hodgkin Lymphoma", "Composite Lymphoma", "B-Cell Non-Hodgkin Lymphoma"]}, {"cohort": "Phase 2", "histology_inclusion": "Lymphoma", "biomarker_inclusion": [["BCL6 Fusion", "BCL6", "fusion"]], "histology_exclusion": ["Hodgkin Lymphoma", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Diffuse Large B-Cell Lymphoma", "Non-Hodgkin Lymphoma", "Composite Lymphoma", "B-Cell Non-Hodgkin Lymphoma"]}]}
{"NCT_id": "NCT04572295", "json": [{"cohort": "", "disease_state": "recurrent/metastatic", "histology_inclusion": "ER+ and HER2- breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["inflammatory breast cancer", "bilateral breast cancer of different histologic types"], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "recurrent/metastatic", "histology_inclusion": "ER+ and HER2- breast cancer", "biomarker_inclusion": ["FGFR positive tumor"], "histology_exclusion": ["inflammatory breast cancer", "bilateral breast cancer of different histologic types"], "biomarker_exclusion": ["prior treatment with an FGFR inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]], "histology_exclusion": ["Inflammatory Breast Carcinoma", "Bilateral Breast Carcinoma"]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"]], "histology_exclusion": ["Bilateral Breast Carcinoma", "Inflammatory Breast Carcinoma"]}, {"cohort": "Part 2", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-High", "EREG-High", "expression"], ["FGFR2-High", "FGFR2-High", "expression"], ["FGFR1-High", "FGFR1-High", "expression"], ["FGFR4-High", "FGFR4-High", "expression"], ["FGFR3-High", "FGFR3-High", "expression"]], "histology_exclusion": ["Inflammatory Breast Carcinoma", "Bilateral Breast Carcinoma"]}, {"cohort": "Part 2", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["FGFR4-High", "FGFR4-High", "expression"], ["FGFR3-High", "FGFR3-High", "expression"], ["FGFR2-High", "FGFR2-High", "expression"], ["FGFR1-High", "FGFR1-High", "expression"], ["EREG-High", "EREG-High", "expression"]], "histology_exclusion": ["Bilateral Breast Carcinoma", "Inflammatory Breast Carcinoma"]}]}
{"NCT_id": "NCT04702581", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "low-grade oligodendroglioma", "biomarker_inclusion": ["1p/19q co-deletion", "IDH-mutant (IDH1 or IDH2)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Oligodendroglioma", "biomarker_inclusion": [["IDH1 Mutation", "IDH1-Mutation", "gene"], ["IDH2 Mutation", "IDH2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04963153", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": ["FGFR2 genetic alterations", "FGFR3 genetic alterations"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["FGFR3 Mutation", "FGFR3-Mutation", "gene"], ["FGFR2 Mutation", "FGFR2-Mutation", "gene"]]}]}
{"NCT_id": "NCT05093322", "json": [{"cohort": "Part 1", "disease_state": "recurrent or refractory", "histology_inclusion": "solid tumors or lymphoma", "biomarker_inclusion": ["VEGFR-1 dysfunction", "VEGFR-2 dysfunction", "VEGFR-3 dysfunction", "FGFR-1 dysfunction", "CSF-1R dysfunction"], "histology_exclusion": ["central nervous system"], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "recurrent or refractory", "histology_inclusion": "osteosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "recurrent or refractory", "histology_inclusion": "Ewing sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "recurrent or refractory", "histology_inclusion": "Rhabdomyosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2", "disease_state": "recurrent or refractory", "histology_inclusion": "Non-rhabdomyosarcoma Soft Tissue Sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 1", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Part 2", "histology_inclusion": "Osteosarcoma"}, {"cohort": "Part 2", "histology_inclusion": "Ewing Sarcoma"}, {"cohort": "Part 2", "histology_inclusion": "Rhabdomyosarcoma"}, {"cohort": "Part 2", "histology_inclusion": "Soft Tissue Sarcoma"}]}
{"NCT_id": "NCT02176967", "json": [{"cohort": "Group A", "disease_state": "INRG stage L1", "histology_inclusion": "neuroblastoma/ganglioneuroblastoma", "biomarker_inclusion": ["MYCN non-amplified"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group B", "disease_state": "INRG stage L2", "histology_inclusion": "neuroblastoma/ganglioneuroblastoma", "biomarker_inclusion": ["MYCN non-amplified", "favorable histology", "favorable genomic features"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group C", "disease_state": "INRG stage Ms", "histology_inclusion": "neuroblastoma/ganglioneuroblastoma", "biomarker_inclusion": ["MYCN non-amplified"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Group A", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]]}, {"cohort": "Group A", "histology_inclusion": "Ganglioneuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]]}, {"cohort": "Group B", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]]}, {"cohort": "Group B", "histology_inclusion": "Ganglioneuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]]}, {"cohort": "Group C", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]]}, {"cohort": "Group C", "histology_inclusion": "Ganglioneuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]]}]}
{"NCT_id": "NCT03036098", "json": [{"cohort": "", "disease_state": "metastatic or surgically inoperable", "histology_inclusion": "transitional cell cancer (TCC) of the urothelium involving the renal pelvis, ureter, bladder or urethra", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Transitional Cell Carcinoma"}]}
{"NCT_id": "NCT03818061", "json": [{"cohort": "HPV +", "disease_state": "recurrent or metastatic", "histology_inclusion": "squamous-cell carcinoma of the head and neck (HNSCC)", "biomarker_inclusion": ["HPV positive"], "histology_exclusion": ["cancer of nasopharynx (i.e. cavum cancer)", "central nervous system (CNS) metastases"], "biomarker_exclusion": []}, {"cohort": "HPV -", "disease_state": "recurrent or metastatic", "histology_inclusion": "squamous-cell carcinoma of the head and neck (HNSCC)", "biomarker_inclusion": ["HPV negative"], "histology_exclusion": ["cancer of nasopharynx (i.e. cavum cancer)", "central nervous system (CNS) metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "HPV +", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Nasopharyngeal Carcinoma"]}, {"cohort": "HPV -", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Nasopharyngeal Carcinoma"]}]}
{"NCT_id": "NCT04143607", "json": [{"cohort": "", "disease_state": "Locally Advanced or Metastatic", "histology_inclusion": "adenocarcinoma of the lung", "biomarker_inclusion": ["EGFR Ex19del", "EGFR L858R"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT04833036", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["RAS wild type", "B-RAF wild type"], "histology_exclusion": ["brain metastasis", "meningeal metastasis"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["HRAS HRAS-wild_type", "HRAS-wild_type", "wild_type"], ["BRAF BRAF-wild_type", "BRAF-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"], ["NRAS NRAS-wild_type", "NRAS-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT04963283", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "colorectal adenocarcinoma", "biomarker_inclusion": ["MSS", "MSI-L", "pMMR"], "histology_exclusion": [], "biomarker_exclusion": ["extended RAS and BRAF status"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Colorectal Adenocarcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]]}]}
{"NCT_id": "NCT04143711", "json": [{"cohort": "Dose Escalation", "disease_state": "locally advanced or metastatic solid tumors", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["HER2 expression", "erbb2 amplification", "erbb2 activating mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "3+3 Nivolumab Combination Cohort", "disease_state": "malignancy of epithelial origin", "histology_inclusion": "malignancy of epithelial origin", "biomarker_inclusion": ["HER2 expression", "erbb2 amplification", "erbb2 activating mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "3+3 Nab paclitaxel Combination Cohort", "disease_state": "metastatic breast cancer", "histology_inclusion": "metastatic breast cancer", "biomarker_inclusion": ["HER2 expression", "erbb2 amplification", "erbb2 activating mutations"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Urothelial Bladder Cancer Expansion Cohort(s)", "disease_state": "locally advanced or metastatic transitional cell carcinoma of the urothelium", "histology_inclusion": "transitional cell carcinoma of the urothelium", "biomarker_inclusion": ["HER2 1+ expression"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Breast Cancer (HER2 Low) Expansion Cohort", "disease_state": "metastatic or locally advanced breast cancer", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["HER2 0, 1+, or 2+ expression"], "histology_exclusion": [], "biomarker_exclusion": ["erbb2 amplification"]}], "json_norm": [{"cohort": "Dose Escalation", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "3+3 Nivolumab Combination Cohort", "histology_inclusion": "Epithelial Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "3+3 Nab paclitaxel Combination Cohort", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}, {"cohort": "Urothelial Bladder Cancer Expansion Cohort(s)", "histology_inclusion": "Transitional Cell Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Breast Cancer (HER2 Low) Expansion Cohort", "histology_inclusion": "Breast Carcinoma", "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT03687957", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 2 Expansion Cohort", "disease_state": "", "histology_inclusion": "Glioblastoma Multiforme (WHO grade IV)", "biomarker_inclusion": ["IDH1 wildtype", "MGMT promoter unmethylated"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioma"}, {"cohort": "Phase 2 Expansion Cohort", "histology_inclusion": "Glioblastoma, IDH-Wildtype", "biomarker_inclusion": [["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "Phase 2 Expansion Cohort", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}]}
{"NCT_id": "NCT05028933", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "gastric cancer", "biomarker_inclusion": ["EpCAM positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["EpCAM positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "pancreatic cancer", "biomarker_inclusion": ["EpCAM positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "hepatocellular carcinoma", "biomarker_inclusion": ["EpCAM positive"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastric Carcinoma", "biomarker_inclusion": [["EPCAM-High", "EPCAM-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["EPCAM-High", "EPCAM-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Carcinoma", "biomarker_inclusion": [["EPCAM-High", "EPCAM-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [["EPCAM-High", "EPCAM-High", "expression"]]}]}
{"NCT_id": "NCT01785420", "json": [{"cohort": "Pre Operative Trastuzumab in Operable Breast Cancer", "disease_state": "Stage I, HER2 Positive", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["HER2 Positive (IHC3+ or IHC2+ with FISH or CISH confirmation)"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Pre Operative Trastuzumab in Operable Breast Cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT03427866", "json": [{"cohort": "", "disease_state": "Intermediate-2/ high-risk disease as per Dynamic IPSS (DIPSS) criteria OR Intermediate-1 risk disease with one of the following additional unfavorable features known to impact the survival adversely", "histology_inclusion": "pathologically confirmed primary myelofibrosis according to WHO criteria1 or secondary myelofibrosis as defined by the IWG-MRT criteria.19", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["Hypersensitivity to any JAK inhibitor", "Prior allogeneic transplant for any hematopoietic disorder", "Had accelerated phase or leukemic transformation (\u226510% blasts in PB or BM any time prior to HCT)", "History of another malignancy within 5-years of date of except h/o basal cell or squamous cell carcinoma of skin or Polycythemia Vera or Essential Thrombocythemia", "Have current or a history of congestive heart failure New York Heart Association (NYHA) class 3 or 4, or any history of documented diastolic or systolic dysfunction (LVEF &lt; 40%, as measured by MUGA scan or echocardiogram)"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Myelofibrosis"}, {"cohort": "", "histology_inclusion": "Primary Myelofibrosis"}]}
{"NCT_id": "NCT04209465", "json": [{"cohort": "Phase 1", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["allosteric HER2 mutation", "allosteric HER3 mutation", "EGFR exon 20 insertion mutation", "HER2 exon 20 insertion mutation", "HER2 amplified", "HER2 overexpressing", "EGFR exon 19 deletion", "EGFR L858R mutation"], "histology_exclusion": ["leptomeningeal malignancies", "untreated CNS malignancies", "symptomatic CNS malignancies"], "biomarker_exclusion": ["KRAS mutation", "EGFR T790M mutation", "EGFR C797S mutation", "HER2 C805S mutation"]}, {"cohort": "Phase 2", "disease_state": "locally advanced or metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["allosteric HER2 mutation", "EGFR exon 20 insertion mutation", "HER2 exon 20 insertion mutation"], "histology_exclusion": ["leptomeningeal malignancies", "untreated CNS malignancies", "symptomatic CNS malignancies"], "biomarker_exclusion": ["KRAS mutation", "EGFR T790M mutation", "EGFR C797S mutation", "HER2 C805S mutation"]}], "json_norm": [{"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB3 Mutation", "ERBB3-Mutation", "gene"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"], ["EGFR L858R", "L858R", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]], "histology_exclusion": ["Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"], "biomarker_exclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["EGFR T790M", "T790M", "coordinate"], ["EGFR C797S", "C797S", "coordinate"]]}, {"cohort": "Phase 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2 Mutation", "ERBB2-Mutation", "gene"]], "histology_exclusion": ["Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"], "biomarker_exclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["EGFR T790M", "T790M", "coordinate"], ["EGFR C797S", "C797S", "coordinate"]]}]}
{"NCT_id": "NCT03297606", "json": [{"cohort": "Group 5", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["EGFR"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Group 7", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["BRCA1", "BRCA2", "mutations in HRD"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Group 8", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["CDKN2A", "CDK4", "CCND1", "SMARCA4"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Group 10", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["AKT1", "AKT2", "AKT3", "FBXW7", "FLCN", "mTOR", "NF1", "NF2", "NTRK3", "PIK3CA", "PIK3R1", "PTEN", "RHEB", "STK11", "TSC1", "TSC2"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Group 12", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["BRAFV600"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Group 13", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["PTCH1", "SMO"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Group 14", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["ERBB2"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Group 5", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 7", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"], ["TBCE Mutation", "TBCE-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 8", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 10", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 12", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 13", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Group 14", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT05094336", "json": [{"cohort": "", "disease_state": "metastatic or locally advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["CDKN2A-null", "MTAP-null"], "histology_exclusion": ["primary brain tumor", "lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm", "Lymphoma"]}]}
{"NCT_id": "NCT04209855", "json": [{"cohort": "", "disease_state": "platinum-resistant", "histology_inclusion": "high-grade serious epithelial ovarian cancer", "biomarker_inclusion": ["FR\u03b1 positive"], "histology_exclusion": ["endometrioid", "clear cell", "mucinous", "sarcomatous", "low-grade or borderline ovarian tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "platinum-resistant", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": ["FR\u03b1 positive"], "histology_exclusion": ["endometrioid", "clear cell", "mucinous", "sarcomatous", "low-grade or borderline ovarian tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "platinum-resistant", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": ["FR\u03b1 positive"], "histology_exclusion": ["endometrioid", "clear cell", "mucinous", "sarcomatous", "low-grade or borderline ovarian tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["FOLR1-High", "FOLR1-High", "expression"]], "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm"]}, {"cohort": "", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [["FOLR1-High", "FOLR1-High", "expression"]], "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm"]}, {"cohort": "", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["FOLR1-High", "FOLR1-High", "expression"]], "histology_exclusion": ["Ovarian Epithelial Cancer", "Malignant Ovarian Neoplasm"]}]}
{"NCT_id": "NCT04964479", "json": [{"cohort": "", "disease_state": "locally advanced (stage \u2162B/\u2162C), metastatic or recurrent (Stage IV) NSCLC", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["PD-L1 TPS \u2265 1%"], "histology_exclusion": ["small cell components", "central type, cavity squamous cell carcinoma"], "biomarker_exclusion": ["EGFR mutations", "ALK fusions"]}, {"cohort": "", "disease_state": "locally advanced (stage \u2162B/\u2162C), metastatic or recurrent (Stage IV) NSCLC", "histology_inclusion": "squamous non-small cell lung cancer", "biomarker_inclusion": ["PD-L1 TPS \u2265 1%"], "histology_exclusion": ["small cell components", "central type, cavity squamous cell carcinoma", "brain metastases"], "biomarker_exclusion": ["EGFR mutations", "ALK fusions"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Squamous Cell Carcinoma"], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "", "histology_inclusion": "Squamous Cell Lung Carcinoma", "histology_exclusion": ["Squamous Cell Carcinoma"], "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT05159778", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "ER/PR+/HER2- breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["PRH2-High", "PRH2-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["PGR-High", "PGR-High", "expression"]]}]}
{"NCT_id": "NCT03363217", "json": [{"cohort": "Group 1: NF1 with Progressing/Refractory LGG", "disease_state": "Progressing/Refractory", "histology_inclusion": "Low-grade Glioma", "biomarker_inclusion": ["Neurofibromatosis Type 1 (NF1)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group 2: NF1 with Progressing/Refractory PN", "disease_state": "Progressing/Refractory", "histology_inclusion": "Plexiform Neurofibroma", "biomarker_inclusion": ["Neurofibromatosis Type 1 (NF1)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group 3: Progressing/Refractory LGG with KIAA1549-BRAF fusion", "disease_state": "Progressing/Refractory", "histology_inclusion": "Low-grade Glioma", "biomarker_inclusion": ["KIAA1549-BRAF fusion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Group 4: Progressing/Refractory CNS Glioma with activation of the MAPK/ERK pathway", "disease_state": "Progressing/Refractory", "histology_inclusion": "Central Nervous System Glioma", "biomarker_inclusion": ["MAPK/ERK pathway activation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Group 1: NF1 with Progressing/Refractory LGG", "histology_inclusion": "Low Grade Glioma"}, {"cohort": "Group 2: NF1 with Progressing/Refractory PN", "histology_inclusion": "Plexiform Neurofibroma"}, {"cohort": "Group 3: Progressing/Refractory LGG with KIAA1549-BRAF fusion", "histology_inclusion": "Low Grade Glioma", "biomarker_inclusion": [["KIAA1549 - BRAF", "KIAA1549 - BRAF", "coordinate"], ["KIAA1549 Fusion", "KIAA1549", "fusion"], ["BRAF Fusion", "BRAF", "fusion"]]}, {"cohort": "Group 4: Progressing/Refractory CNS Glioma with activation of the MAPK/ERK pathway", "histology_inclusion": "Glioma"}]}
{"NCT_id": "NCT05094804", "json": [{"cohort": "Part A", "disease_state": "advanced/metastatic", "histology_inclusion": "carcinoma, sarcoma, or melanoma", "biomarker_inclusion": [], "histology_exclusion": ["hematologic malignancy", "malignant primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Part B1", "disease_state": "advanced/metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": [], "histology_exclusion": ["hematologic malignancy", "malignant primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Part B2", "disease_state": "advanced/metastatic", "histology_inclusion": "NSCLC", "biomarker_inclusion": [], "histology_exclusion": ["hematologic malignancy", "malignant primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Part B", "disease_state": "advanced/metastatic", "histology_inclusion": "melanoma", "biomarker_inclusion": [], "histology_exclusion": ["hematologic malignancy", "malignant primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "advanced/metastatic", "histology_inclusion": "carcinoma, sarcoma, or melanoma", "biomarker_inclusion": [], "histology_exclusion": ["hematologic malignancy", "malignant primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "advanced/metastatic", "histology_inclusion": "SCCHN", "biomarker_inclusion": [], "histology_exclusion": ["hematologic malignancy", "malignant primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "advanced/metastatic", "histology_inclusion": "dedifferentiated liposarcoma", "biomarker_inclusion": [], "histology_exclusion": ["hematologic malignancy", "malignant primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Part C", "disease_state": "advanced/metastatic", "histology_inclusion": "leiomyosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["hematologic malignancy", "malignant primary brain tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Melanoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm", "Primary Brain Neoplasm"]}, {"cohort": "Part A", "histology_inclusion": "Sarcoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm", "Primary Brain Neoplasm"]}, {"cohort": "Part B1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm", "Primary Brain Neoplasm"]}, {"cohort": "Part B2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm", "Primary Brain Neoplasm"]}, {"cohort": "Part B", "histology_inclusion": "Melanoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm", "Primary Brain Neoplasm"]}, {"cohort": "Part C", "histology_inclusion": "Melanoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm", "Primary Brain Neoplasm"]}, {"cohort": "Part C", "histology_inclusion": "Sarcoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm", "Primary Brain Neoplasm"]}, {"cohort": "Part C", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm", "Primary Brain Neoplasm"]}, {"cohort": "Part C", "histology_inclusion": "Dedifferentiated Liposarcoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm", "Primary Brain Neoplasm"]}, {"cohort": "Part C", "histology_inclusion": "Leiomyosarcoma", "histology_exclusion": ["Hematopoietic and Lymphoid Cell Neoplasm", "Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT04508803", "json": [{"cohort": "The main research", "disease_state": "metastatic", "histology_inclusion": "HER2-negative breast cancer", "biomarker_inclusion": ["BRCA1/2", "PALB2", "CHEK2"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Ancillary Exploration research 1", "disease_state": "metastatic", "histology_inclusion": "HER2-negative breast cancer", "biomarker_inclusion": ["ATM", "ATR", "BAP1", "BARD1", "BLM", "BRIP1", "CHEK1", "CDK12", "FANCA", "FANCC", "FANCD2", "FANCE", "FANCF", "FANCM", "MRE11A", "NBN", "PTEN", "RAD50", "RAD51C", "RAD51D", "WRN"], "histology_exclusion": [], "biomarker_exclusion": ["BRCA1/2", "PALB2", "CHEK2"]}, {"cohort": "Ancillary Exploration research 2", "disease_state": "metastatic", "histology_inclusion": "HER2-positive breast cancer", "biomarker_inclusion": ["BRCA1/2", "PALB2", "CHEK2", "ATM", "ATR", "BAP1", "BARD1", "BLM", "BRIP1", "CHEK1", "CDK12", "FANCA", "FANCC", "FANCD2", "FANCE", "FANCF", "FANCM", "MRE11A", "NBN", "PTEN", "RAD50", "RAD51C", "RAD51D", "WRN"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Ancillary Exploration research 3", "disease_state": "metastatic", "histology_inclusion": "breast cancer with brain metastases", "biomarker_inclusion": ["BRCA1/2", "PALB2", "CHEK2", "ATM", "ATR", "BAP1", "BARD1", "BLM", "BRIP1", "CHEK1", "CDK12", "FANCA", "FANCC", "FANCD2", "FANCE", "FANCF", "FANCM", "MRE11A", "NBN", "PTEN", "RAD50", "RAD51C", "RAD51D", "WRN"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "The main research", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Ancillary Exploration research 1", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"]]}, {"cohort": "Ancillary Exploration research 2", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Ancillary Exploration research 3", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "Ancillary Exploration research 3", "histology_inclusion": "Metastatic Malignant Neoplasm to the Brain"}]}
{"NCT_id": "NCT05029882", "json": [{"cohort": "Part 2a (wtEGFR Non-Small Cell Lung Cancer [NSCLC])", "disease_state": "advanced", "histology_inclusion": "non-squamous wtEGFR NSCLC", "biomarker_inclusion": ["c-Met intermediate/high"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2b (mutEGFR NSCLC)", "disease_state": "advanced", "histology_inclusion": "non-squamous mutEGFR NSCLC", "biomarker_inclusion": ["c-Met intermediate/high"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2c (wtEGFR NSCLC)", "disease_state": "advanced", "histology_inclusion": "non-squamous wtEGFR NSCLC", "biomarker_inclusion": ["c-Met low"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 2d (Squamous NSCLC)", "disease_state": "advanced", "histology_inclusion": "squamous NSCLC", "biomarker_inclusion": ["c-Met overexpressing"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 3 (Gastric/Gastroesophageal Junction Adenocarcinoma)", "disease_state": "advanced", "histology_inclusion": "gastroesophageal adenocarcinoma", "biomarker_inclusion": ["c-Met overexpressing"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 4 (Colorectal Cancer)", "disease_state": "advanced", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["c-Met unselected", "not BRAF V600E", "not dMMR+/MSI-Hi"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part 2a (wtEGFR Non-Small Cell Lung Cancer [NSCLC])", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part 2b (mutEGFR NSCLC)", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part 2c (wtEGFR NSCLC)", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM-Low", "SLTM-Low", "expression"], ["MET-Low", "MET-Low", "expression"]]}, {"cohort": "Part 2d (Squamous NSCLC)", "histology_inclusion": "Squamous Cell Lung Carcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}, {"cohort": "Part 3 (Gastric/Gastroesophageal Junction Adenocarcinoma)", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"]]}, {"cohort": "Part 4 (Colorectal Cancer)", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI-High", "MSI-High", "coordinate"], ["MSI", "MSI", "coordinate"], ["BRAF V600E", "V600E", "coordinate"]]}]}
{"NCT_id": "NCT03428802", "json": [{"cohort": "Arm 1", "disease_state": "metastatic, recurrent or locally advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["POLE mutation", "POLD1 mutation"], "histology_exclusion": [], "biomarker_exclusion": ["non-hotspot POLE mutation with MSI", "non-hotspot POLD1 mutation with MSI"]}, {"cohort": "Arm 2", "disease_state": "metastatic, recurrent or locally advanced", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm 2", "disease_state": "metastatic, recurrent or locally advanced", "histology_inclusion": "ovarian carcinoma", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["POLE Mutation", "POLE-Mutation", "gene"], ["POLD1 Mutation", "POLD1-Mutation", "gene"]], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["POLE Mutation", "POLE-Mutation", "gene"], ["POLD1 Mutation", "POLD1-Mutation", "gene"]]}, {"cohort": "Arm 2", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}, {"cohort": "Arm 2", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "Arm 2", "histology_inclusion": "Malignant Ovarian Neoplasm", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT03493945", "json": [{"cohort": "Cohort 1", "disease_state": "metastatic or locally advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["microsatellite instability high/mismatch repair deficient", "tumor mutational burden high", "pathogenic homologous recombination repair mutations"]}, {"cohort": "Cohorts 2A, 2D and 2R", "disease_state": "castration-resistant", "histology_inclusion": "prostate cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain/leptomeningeal metastasis"], "biomarker_exclusion": ["microsatellite instability high/mismatch repair deficient", "tumor mutational burden high", "pathogenic homologous recombination repair mutations"]}], "json_norm": [{"cohort": "Cohort 1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_exclusion": [["TMB-High", "TMB-High", "coordinate"], ["MSI", "MSI", "coordinate"], ["TMB", "TMB", "coordinate"], ["Homologous Recombination Pathway", null, "pathway"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Cohorts 2A, 2D and 2R", "histology_inclusion": "Prostate Neoplasm", "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["TMB", "TMB", "coordinate"], ["TMB-High", "TMB-High", "coordinate"], ["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Cohorts 2A, 2D and 2R", "histology_inclusion": "Prostate Carcinoma", "biomarker_exclusion": [["TMB-High", "TMB-High", "coordinate"], ["MSI", "MSI", "coordinate"], ["TMB", "TMB", "coordinate"], ["Homologous Recombination Pathway", null, "pathway"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04145297", "json": [{"cohort": "All patients", "disease_state": "Advanced", "histology_inclusion": "Gastrointestinal Adenocarcinomas", "biomarker_inclusion": ["MAPK-mutated", "KRAS", "NRAS", "HRAS", "BRAFnon-V600", "MEK", "ERK"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "All patients"}]}
{"NCT_id": "NCT04639219", "json": [{"cohort": "", "disease_state": "unresectable and/or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["HER2 activating mutations"], "histology_exclusion": ["HER2 overexpressing breast adenocarcinoma", "HER2 overexpressing gastric adenocarcinoma", "HER2 overexpressing gastroesophageal junction adenocarcinoma", "HER2 mutant NSCLC", "central nervous system metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ERBB2 Mutation", "ERBB2-Mutation", "gene"]], "histology_exclusion": ["Non-Small Cell Lung Carcinoma", "Breast Adenocarcinoma", "Gastric Adenocarcinoma", "Gastroesophageal Junction Adenocarcinoma"], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2 Mutation", "ERBB2-Mutation", "gene"]]}]}
{"NCT_id": "NCT04639245", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "triple negative breast cancer", "biomarker_inclusion": ["MAGE-A1"], "histology_exclusion": [], "biomarker_exclusion": ["HLA B*4901"]}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": ["MAGE-A1"], "histology_exclusion": [], "biomarker_exclusion": ["HLA B*4901"]}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["MAGE-A1"], "histology_exclusion": [], "biomarker_exclusion": ["HLA B*4901"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Urothelial Carcinoma"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04964934", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "adenocarcinoma of the breast", "biomarker_inclusion": ["ESR1 mutation", "HR-positive", "HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locoregionally recurrent", "histology_inclusion": "adenocarcinoma of the breast", "biomarker_inclusion": ["ESR1 mutation", "HR-positive", "HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "adenocarcinoma of the breast", "biomarker_inclusion": ["ESR1 mutation", "HR-positive", "HER2-negative"], "histology_exclusion": ["CNS metastases", "carcinomatous meningitis", "leptomeningeal disease"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ESR1 Mutation", "ESR1-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ESR1 Mutation", "ESR1-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ESR1 Mutation", "ESR1-Mutation", "gene"], ["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT04964960", "json": [{"cohort": "", "disease_state": "untreated asymptomatic brain metastasis", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["oncogenic driver mutations"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT05420454", "json": [{"cohort": "HER2-positive breast cancer", "disease_state": "", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["HER2 positive"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Luminal breast cancer (HER2-, LN+), and triple negative breast cancer", "disease_state": "", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["ER positive", "PR positive", "HER2 negative"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Luminal breast cancer (HER2-, LN+), and triple negative breast cancer", "disease_state": "", "histology_inclusion": "Breast Cancer", "biomarker_inclusion": ["Triple-negative breast cancer"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "HER2-positive breast cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Luminal breast cancer (HER2-, LN+), and triple negative breast cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["PRH2-High", "PRH2-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"]]}, {"cohort": "Luminal breast cancer (HER2-, LN+), and triple negative breast cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}]}
{"NCT_id": "NCT03428958", "json": [{"cohort": "All patients", "disease_state": "locally advanced/unresectable or metastatic", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "All patients", "histology_inclusion": "Colorectal Carcinoma"}]}
{"NCT_id": "NCT04080284", "json": [{"cohort": "Uterine serous carcinoma", "disease_state": "Stage III, Stage IV, or platinum-sensitive recurrent", "histology_inclusion": "Uterine Serous Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Uterine serous carcinoma", "histology_inclusion": "Endometrial Serous Adenocarcinoma"}]}
{"NCT_id": "NCT04834778", "json": [{"cohort": "", "disease_state": "metastatic (Stage IV)", "histology_inclusion": "renal cell carcinoma - clear cell or papillary", "biomarker_inclusion": [], "histology_exclusion": ["pancreatic cancer", "glioblastoma", "hepatocellular carcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic (Stage IV)", "histology_inclusion": "small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["pancreatic cancer", "glioblastoma", "hepatocellular carcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic (Stage IV)", "histology_inclusion": "gastric adenocarcinoma", "biomarker_inclusion": [], "histology_exclusion": ["pancreatic cancer", "glioblastoma", "hepatocellular carcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic (Stage IV)", "histology_inclusion": "metastatic breast cancer", "biomarker_inclusion": ["Human epidermal growth factor receptor positive (HER2+)"], "histology_exclusion": ["pancreatic cancer", "glioblastoma", "hepatocellular carcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic (Stage IV)", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["pancreatic cancer", "glioblastoma", "hepatocellular carcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic (Stage IV)", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": [], "histology_exclusion": ["pancreatic cancer", "glioblastoma", "hepatocellular carcinoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic (Stage IV)", "histology_inclusion": "carcinoma of unknown primary", "biomarker_inclusion": [], "histology_exclusion": ["pancreatic cancer", "glioblastoma", "hepatocellular carcinoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Hepatocellular Carcinoma", "Glioblastoma", "Pancreatic Carcinoma"]}, {"cohort": "", "histology_inclusion": "Small Cell Lung Carcinoma", "histology_exclusion": ["Hepatocellular Carcinoma", "Glioblastoma", "Pancreatic Carcinoma"]}, {"cohort": "", "histology_inclusion": "Gastric Adenocarcinoma", "histology_exclusion": ["Hepatocellular Carcinoma", "Glioblastoma", "Pancreatic Carcinoma"]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["EGFR-High", "EGFR-High", "expression"]], "histology_exclusion": ["Hepatocellular Carcinoma", "Glioblastoma", "Pancreatic Carcinoma"]}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Hepatocellular Carcinoma", "Glioblastoma", "Pancreatic Carcinoma"]}, {"cohort": "", "histology_inclusion": "Colorectal Carcinoma", "histology_exclusion": ["Hepatocellular Carcinoma", "Glioblastoma", "Pancreatic Carcinoma"]}, {"cohort": "", "histology_inclusion": "Carcinoma of Unknown Primary Origin", "histology_exclusion": ["Hepatocellular Carcinoma", "Glioblastoma", "Pancreatic Carcinoma"]}]}
{"NCT_id": "NCT04965090", "json": [{"cohort": "Cohort A", "disease_state": "metastatic or recurrent", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "metastatic or recurrent", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Cohort B", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}]}
{"NCT_id": "NCT05095207", "json": [{"cohort": "Participants with Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer", "disease_state": "metastatic", "histology_inclusion": "HER2-negative breast cancer", "biomarker_inclusion": ["AR-positive (\u22651% staining)"], "histology_exclusion": ["brain metastases", "leptomeningeal carcinomatosis", "spinal cord compression"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Participants with Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["AKR1B1-High", "AKR1B1-High", "expression"], ["AR-High", "AR-High", "expression"], ["ERBB2-Low", "ERBB2-Low", "expression"]]}]}
{"NCT_id": "NCT05290337", "json": [{"cohort": "ZR-CHOP", "disease_state": "newly-diagnosed", "histology_inclusion": "diffuse large B-cell lymphoma", "biomarker_inclusion": ["MYC translocation"], "histology_exclusion": ["primary central nerves lymphoma"], "biomarker_exclusion": []}, {"cohort": "ZR-CHOP", "disease_state": "newly-diagnosed", "histology_inclusion": "diffuse large B-cell lymphoma", "biomarker_inclusion": ["MYD88 mutation"], "histology_exclusion": ["primary central nerves lymphoma"], "biomarker_exclusion": []}, {"cohort": "ZR-CHOP", "disease_state": "newly-diagnosed", "histology_inclusion": "diffuse large B-cell lymphoma", "biomarker_inclusion": ["CD79B mutation"], "histology_exclusion": ["primary central nerves lymphoma"], "biomarker_exclusion": []}, {"cohort": "ZR-CHOP", "disease_state": "newly-diagnosed", "histology_inclusion": "diffuse large B-cell lymphoma", "biomarker_inclusion": ["NOTCH1 mutation"], "histology_exclusion": ["primary central nerves lymphoma"], "biomarker_exclusion": []}, {"cohort": "ZR-CHOP", "disease_state": "newly-diagnosed", "histology_inclusion": "diffuse large B-cell lymphoma", "biomarker_inclusion": ["TP53 mutation"], "histology_exclusion": ["primary central nerves lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "ZR-CHOP", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MYC Fusion", "MYC", "fusion"]]}, {"cohort": "ZR-CHOP", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["MYD88 Mutation", "MYD88-Mutation", "gene"]]}, {"cohort": "ZR-CHOP", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["CD79B Mutation", "CD79B-Mutation", "gene"]]}, {"cohort": "ZR-CHOP", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["NOTCH1 Mutation", "NOTCH1-Mutation", "gene"]]}, {"cohort": "ZR-CHOP", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]]}]}
{"NCT_id": "NCT02972840", "json": [{"cohort": "", "disease_state": "previously untreated", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": ["t(11;14)(q13;q32)", "cyclin D1 overexpression"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [["CCND1-High", "CCND1-High", "expression"]]}]}
{"NCT_id": "NCT03624543", "json": [{"cohort": "Cohort 1: TNBC", "disease_state": "advanced/metastatic/recurrent or unresectable", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["ER-", "PR-", "HER2-"], "histology_exclusion": [], "biomarker_exclusion": ["HER2 positive"]}, {"cohort": "Cohort 2: PTEN-null, ER+ and/or PR+, HER2-", "disease_state": "advanced/metastatic/recurrent or unresectable", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["ER+ or PR+", "HER2-", "PTEN loss or mutation"], "histology_exclusion": [], "biomarker_exclusion": ["HER2 positive"]}, {"cohort": "Cohort 3: Not PTEN-null, ER+ and/or PR+, HER2-", "disease_state": "advanced/metastatic/recurrent or unresectable", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["ER+ or PR+", "HER2-", "No PTEN loss or mutation"], "histology_exclusion": [], "biomarker_exclusion": ["HER2 positive"]}], "json_norm": [{"cohort": "Cohort 1: TNBC", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["EREG-Low", "EREG-Low", "expression"], ["PGR-Low", "PGR-Low", "expression"], ["PRH2-Low", "PRH2-Low", "expression"], ["TMEM37-Low", "TMEM37-Low", "expression"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort 2: PTEN-null, ER+ and/or PR+, HER2-", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["PTEN Mutation", "PTEN-Mutation", "gene"], ["PRH2-High", "PRH2-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["PTEN-Low", "PTEN-Low", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Cohort 3: Not PTEN-null, ER+ and/or PR+, HER2-", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["PRH2-High", "PRH2-High", "expression"], ["PGR-High", "PGR-High", "expression"], ["PTEN-Low", "PTEN-Low", "expression"], ["TMEM37-High", "TMEM37-High", "expression"], ["EREG-High", "EREG-High", "expression"]], "biomarker_exclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04704661", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["HER2"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "A", "disease_state": "advanced/metastatic", "histology_inclusion": "gastroesophageal cancer", "biomarker_inclusion": ["HER2"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "B", "disease_state": "advanced/metastatic", "histology_inclusion": "colorectal cancer", "biomarker_inclusion": ["HER2"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "A", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma"}, {"cohort": "B", "histology_inclusion": "Colorectal Carcinoma"}]}
{"NCT_id": "NCT04965220", "json": [{"cohort": "ATC", "disease_state": "metastatic/recurrent advanced", "histology_inclusion": "BRAF+ solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["BRAF inhibitors", "MEK inhibitors"]}, {"cohort": "Primary brain tumor", "disease_state": "metastatic/recurrent advanced", "histology_inclusion": "BRAF+ solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["brain or meningeal metastases"], "biomarker_exclusion": ["BRAF inhibitors", "MEK inhibitors"]}, {"cohort": "CRC(KRAS mutant)", "disease_state": "metastatic/recurrent advanced", "histology_inclusion": "BRAF+ solid tumors", "biomarker_inclusion": ["KRAS mutant"], "histology_exclusion": [], "biomarker_exclusion": ["BRAF inhibitors", "MEK inhibitors"]}, {"cohort": "other solid tumor", "disease_state": "metastatic/recurrent advanced", "histology_inclusion": "BRAF+ solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["BRAF inhibitors", "MEK inhibitors"]}], "json_norm": [{"cohort": "ATC", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRAF-High", "BRAF-High", "expression"]]}, {"cohort": "Primary brain tumor", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRAF-High", "BRAF-High", "expression"]]}, {"cohort": "CRC(KRAS mutant)", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRAF-High", "BRAF-High", "expression"], ["KRAS Mutation", "KRAS-Mutation", "gene"]]}, {"cohort": "other solid tumor", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["BRAF-High", "BRAF-High", "expression"]]}]}
{"NCT_id": "NCT05095376", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": ["MGMT Methylated", "IDH Wildtype"], "histology_exclusion": ["Gliosarcoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [["IDH2 IDH2-wild_type", "IDH2-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]], "histology_exclusion": ["Gliosarcoma"]}]}
{"NCT_id": "NCT02831959", "json": [{"cohort": "", "disease_state": "", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["Leptomeningeal metastases", "Recurrent brain metastases"], "biomarker_exclusion": ["ALK", "EGFR", "ROS-1", "B-RAF"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT03298763", "json": [{"cohort": "", "disease_state": "Inoperable stage IIIb/IV", "histology_inclusion": "lung adenocarcinoma", "biomarker_inclusion": ["EGFR mutation negative", "EML4-ALK translocation negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["EML4 - ALK", "EML4 - ALK", "coordinate"], ["EML4-Low", "EML4-Low", "expression"], ["ALK Fusion", "ALK", "fusion"], ["EML4 Fusion", "EML4", "fusion"], ["ALK-Low", "ALK-Low", "expression"]]}]}
{"NCT_id": "NCT03363867", "json": [{"cohort": "BEACON - ABC", "disease_state": "Platinum resistant or refractory recurrent", "histology_inclusion": "High grade serous ovarian carcinoma (HGSC) including fallopian tube and primary peritoneal cancers", "biomarker_inclusion": [], "histology_exclusion": ["clear cell", "mucinous", "carcinosarcomas"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "BEACON - ABC", "histology_inclusion": "Ovarian Serous Adenocarcinoma"}, {"cohort": "BEACON - ABC", "histology_inclusion": "Primary Peritoneal Carcinoma"}]}
{"NCT_id": "NCT05355701", "json": [{"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["BRAF V600", "BRAF non-V600 Class II", "BRAF non-V600 Class III"], "histology_exclusion": ["brain metastasis"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced/metastatic", "histology_inclusion": "primary brain tumor", "biomarker_inclusion": ["BRAF V600", "BRAF non-V600 Class II", "BRAF non-V600 Class III"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "", "histology_inclusion": "Primary Brain Neoplasm"}]}
{"NCT_id": "NCT05355753", "json": [{"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "synovial sarcoma", "biomarker_inclusion": ["SMARCB1-perturbed"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "locally advanced or metastatic", "histology_inclusion": "SMARCB1-null solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Synovial Sarcoma"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT03233724", "json": [{"cohort": "Cohort 1 (Dose Escalation)", "disease_state": "inoperable or unresectable, locally advanced, or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1 (Dose Escalation)", "disease_state": "inoperable or unresectable, locally advanced, or metastatic", "histology_inclusion": "Esophageal Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 1 (Dose Escalation)", "disease_state": "inoperable or unresectable, locally advanced, or metastatic", "histology_inclusion": "Malignant Pleural Mesothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 2 (Dose Expansion: NSCLC with high PD-L1)", "disease_state": "inoperable or unresectable, locally advanced, or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["PD-L1 expression >= 50%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 3 (Dose Expansion: NSCLC with low PD-L1)", "disease_state": "inoperable or unresectable, locally advanced, or metastatic", "histology_inclusion": "Non-Small Cell Lung Cancer", "biomarker_inclusion": ["PD-L1 expression 0-49%"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 4 (Dose Expansion: EsC)", "disease_state": "inoperable or unresectable, locally advanced, or metastatic", "histology_inclusion": "Esophageal Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort 5 (Dose Expansion: MPM)", "disease_state": "inoperable or unresectable, locally advanced, or metastatic", "histology_inclusion": "Malignant Pleural Mesothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort 1 (Dose Escalation)", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 1 (Dose Escalation)", "histology_inclusion": "Esophageal Carcinoma"}, {"cohort": "Cohort 1 (Dose Escalation)", "histology_inclusion": "Pleural Malignant Mesothelioma"}, {"cohort": "Cohort 2 (Dose Expansion: NSCLC with high PD-L1)", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 3 (Dose Expansion: NSCLC with low PD-L1)", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Cohort 4 (Dose Expansion: EsC)", "histology_inclusion": "Esophageal Carcinoma"}, {"cohort": "Cohort 5 (Dose Expansion: MPM)", "histology_inclusion": "Pleural Malignant Mesothelioma"}]}
{"NCT_id": "NCT03755102", "json": [{"cohort": "Cohort 1: Participants treated with dacomitinib alone", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR activating mutation"], "histology_exclusion": [], "biomarker_exclusion": ["MET amplification", "ALK fusion", "RET fusion"]}, {"cohort": "Cohort 2: Participants treated with dacomitinib in combination with osimertinib", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["EGFR activating mutation", "EGFR secondary acquired mutation"], "histology_exclusion": [], "biomarker_exclusion": ["MET amplification", "ALK fusion", "RET fusion"]}], "json_norm": [{"cohort": "Cohort 1: Participants treated with dacomitinib alone", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "biomarker_exclusion": [["RET Fusion", "RET", "fusion"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": "Cohort 2: Participants treated with dacomitinib in combination with osimertinib", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]], "biomarker_exclusion": [["RET Fusion", "RET", "fusion"], ["SLTM-High", "SLTM-High", "expression"], ["MET-High", "MET-High", "expression"], ["ALK Fusion", "ALK", "fusion"]]}]}
{"NCT_id": "NCT04704934", "json": [{"cohort": "", "disease_state": "metastatic and/or unresectable", "histology_inclusion": "gastric adenocarcinoma", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic and/or unresectable", "histology_inclusion": "gastro-esophageal junction adenocarcinoma", "biomarker_inclusion": ["HER2-positive"], "histology_exclusion": ["central nervous system metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Gastric Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Gastroesophageal Junction Adenocarcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT04965519", "json": [{"cohort": "Queue one", "disease_state": "recurrent or metastatic cervical cancer", "histology_inclusion": "cervical cancer", "biomarker_inclusion": ["HER2 1+", "HER2 2+", "HER2 3+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Queue two", "disease_state": "ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer", "histology_inclusion": "ovarian epithelial cancer", "biomarker_inclusion": ["HER2 1+", "HER2 2+", "HER2 3+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Queue two", "disease_state": "ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer", "histology_inclusion": "fallopian tube cancer", "biomarker_inclusion": ["HER2 1+", "HER2 2+", "HER2 3+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Queue two", "disease_state": "ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer", "histology_inclusion": "primary peritoneal cancer", "biomarker_inclusion": ["HER2 1+", "HER2 2+", "HER2 3+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Queue three", "disease_state": "recurrent or metastatic endometrial cancer", "histology_inclusion": "endometrial cancer", "biomarker_inclusion": ["HER2 1+", "HER2 2+", "HER2 3+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Queue four", "disease_state": "recurrent or metastatic other gynecological malignancies", "histology_inclusion": "vulvar cancer", "biomarker_inclusion": ["HER2 1+", "HER2 2+", "HER2 3+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Queue four", "disease_state": "recurrent or metastatic other gynecological malignancies", "histology_inclusion": "vaginal cancer", "biomarker_inclusion": ["HER2 1+", "HER2 2+", "HER2 3+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Queue four", "disease_state": "recurrent or metastatic other gynecological malignancies", "histology_inclusion": "primary sarcoma of the gynecological reproductive system", "biomarker_inclusion": ["HER2 1+", "HER2 2+", "HER2 3+"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Queue one", "histology_inclusion": "Cervical Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Queue two", "histology_inclusion": "Ovarian Epithelial Cancer", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Queue two", "histology_inclusion": "Ovarian Epithelial Tumor", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Queue two", "histology_inclusion": "Fallopian Tube Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Queue two", "histology_inclusion": "Primary Peritoneal Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Queue three", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Queue four", "histology_inclusion": "Vulvar Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-High", "ERBB2-High", "expression"], ["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Queue four", "histology_inclusion": "Vulvar Neoplasm", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Queue four", "histology_inclusion": "Vaginal Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Queue four", "histology_inclusion": "Sarcoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}]}
{"NCT_id": "NCT03494569", "json": [{"cohort": "", "disease_state": "active", "histology_inclusion": "Acute myelogenous leukemia", "biomarker_inclusion": ["unfavorable risk group", "poor risk cytogenetics", "monosomal karyotype", "-5", "5q-", "-7", "7q-", "11q23-non t (9;11)", "inv (3)", "t (3;3)", "t (6;9)", "t (9;22)", "complex karyotypes (\u2265 3 unrelated abnormalities)", "intermediate risk groups except FLT3-NPM1+"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "active", "histology_inclusion": "Acute lymphocytic leukemia", "biomarker_inclusion": ["hypoploidy (< 44 chromosomes)", "t (v;11q23): MLL rearranged", "t (9;22) (q34;q11.2)", "complex cytogenetics (5 or more chromosomal abnormalities)", "high white blood cell (WBC) at diagnosis (\u2265 30,000 for B lineage or \u2265 50,000 for T lineage)", "iAMP21loss of 13q", "abnormal 17p"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "", "histology_inclusion": "Myelodysplastic syndrome", "biomarker_inclusion": ["high-intermediate (int-2) and high risk categories"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "biomarker_inclusion": [["FLT3 - NPM1", "FLT3 - NPM1", "coordinate"], ["FLT3-High", "FLT3-High", "expression"], ["NPM1-High", "NPM1-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}]}
{"NCT_id": "NCT03950609", "json": [{"cohort": "", "disease_state": "advanced, unresectable", "histology_inclusion": "well differentiated carcinoid tumors", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, unresectable", "histology_inclusion": "multiple neuroendocrine tumors associated with MEN1 syndrome", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced, unresectable", "histology_inclusion": "gastrointestinal neuroendocrine tumors", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": ""}, {"cohort": "", "histology_inclusion": "Neuroendocrine Carcinoma"}, {"cohort": "", "histology_inclusion": "Neuroendocrine Tumor"}, {"cohort": "", "histology_inclusion": "Digestive System Neuroendocrine Tumor"}, {"cohort": "", "histology_inclusion": "Digestive System Neuroendocrine Neoplasm"}]}
{"NCT_id": "NCT02375204", "json": [{"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Germ Cell Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Teratoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Choriocarcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Germinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Mixed Germ Cell Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Yolk Sac Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Childhood Teratoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Malignant Germ Cell Neoplasm", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Extragonadal Seminoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Non-seminomatous Germ Cell Tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed or refractory", "histology_inclusion": "Seminoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases \u2265 2 cm"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Germ Cell Tumor"}, {"cohort": "", "histology_inclusion": "Teratoma"}, {"cohort": "", "histology_inclusion": "Choriocarcinoma"}, {"cohort": "", "histology_inclusion": "Germinoma"}, {"cohort": "", "histology_inclusion": "Mixed Germ Cell Tumor"}, {"cohort": "", "histology_inclusion": "Yolk Sac Tumor"}, {"cohort": "", "histology_inclusion": "Teratoma"}, {"cohort": "", "histology_inclusion": "Malignant Germ Cell Tumor"}, {"cohort": "", "histology_inclusion": "Seminoma"}, {"cohort": "", "histology_inclusion": "Germ Cell Tumor"}, {"cohort": "", "histology_inclusion": "Seminoma"}]}
{"NCT_id": "NCT03755414", "json": [{"cohort": "", "disease_state": "Acute myelogenous leukemia (AML) in complete morphological remission", "histology_inclusion": "Acute myelogenous leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Acute lymphocytic leukemia (ALL) in complete morphological remission (MRD negative)", "histology_inclusion": "Acute lymphocytic leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Myelodysplastic syndrome with \u2264 5% blasts in bone marrow", "histology_inclusion": "Myelodysplastic syndrome", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD) in 2nd or greater complete or partial remission", "histology_inclusion": "Non-Hodgkin's lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD) in 2nd or greater complete or partial remission", "histology_inclusion": "Hodgkin's disease", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Non-Hodgkin Lymphoma"}, {"cohort": "", "histology_inclusion": "Hodgkin Lymphoma"}]}
{"NCT_id": "NCT04146038", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "acute myelogenous leukemia (AML)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "myelodysplasia", "biomarker_inclusion": [">= 10% myeloblasts in blood or bone marrow"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "chronic myelomonocytic leukemia (CMML)", "biomarker_inclusion": [">= 10% myeloblasts in blood or bone marrow"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "chronic myeloproliferative disease (MPD)", "biomarker_inclusion": [">= 10% myeloblasts in blood or bone marrow"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "de novo", "histology_inclusion": "acute myelogenous leukemia (AML)", "biomarker_inclusion": ["not a candidate for standard induction therapy"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "advanced", "histology_inclusion": "myelodysplastic syndrome (MDS)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "secondary", "histology_inclusion": "acute myelogenous leukemia (AML)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "relapsed/refractory", "histology_inclusion": "acute myelogenous leukemia (AML)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": ""}, {"cohort": "", "histology_inclusion": "Chronic Myelomonocytic Leukemia"}, {"cohort": "", "histology_inclusion": "Myeloproliferative Neoplasm"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Myelodysplastic Syndrome"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}, {"cohort": "", "histology_inclusion": "Acute Myeloid Leukemia (AML)"}]}
{"NCT_id": "NCT04574856", "json": [{"cohort": "Patients with Newly Diagnosed Glioblastoma", "disease_state": "Newly diagnosed", "histology_inclusion": "Glioblastoma (all variants), Gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["Recurrent glioma", "Tumor involving the brainstem or cerebellum"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Patients with Newly Diagnosed Glioblastoma", "histology_inclusion": "Gliosarcoma", "histology_exclusion": ["Glioma"]}, {"cohort": "Patients with Newly Diagnosed Glioblastoma", "histology_inclusion": "Glioblastoma", "histology_exclusion": ["Glioma"]}]}
{"NCT_id": "NCT04770246", "json": [{"cohort": "Part A: Dose Escalation", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}, {"cohort": "Part A: Dose and Regimen Confirmation and Part B: Phase 2", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": ["germline PTEN inactivating mutations"], "histology_exclusion": ["primary brain tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Part A: Dose Escalation", "histology_inclusion": "Malignant Solid Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Part A: Dose and Regimen Confirmation and Part B: Phase 2", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["PTEN Mutation", "PTEN-Mutation", "gene"]], "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT04965714", "json": [{"cohort": "", "disease_state": "Resectable", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["Prior anti-PD-1", "Prior ADI-PEG 20"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma"}]}
{"NCT_id": "NCT02834013", "json": [{"cohort": "1A", "disease_state": "", "histology_inclusion": "Squamous cell carcinoma with variants of nasal cavity, sinuses, and nasopharynx and trachea", "biomarker_inclusion": [], "histology_exclusion": ["laryngeal", "nasopharyngeal cancer", "squamous cell carcinoma of the head and neck"], "biomarker_exclusion": []}, {"cohort": "1B", "disease_state": "", "histology_inclusion": "Adenocarcinoma and variants of nasal cavity, sinuses, and nasopharynx", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "4", "disease_state": "", "histology_inclusion": "Undifferentiated carcinoma of gastrointestinal (GI) tract", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "11", "disease_state": "", "histology_inclusion": "Sarcomatoid carcinoma of lung", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "12", "disease_state": "", "histology_inclusion": "Bronchoalveolar carcinoma lung", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "13A", "disease_state": "", "histology_inclusion": "Germ cell tumor of ovary", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "18", "disease_state": "", "histology_inclusion": "Squamous cell carcinoma variants of the genitourinary (GU) system", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "19", "disease_state": "", "histology_inclusion": "Spindle cell carcinoma of kidney, pelvis, ureter", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "21", "disease_state": "", "histology_inclusion": "Odontogenic malignant tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "27", "disease_state": "", "histology_inclusion": "Desmoid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "29", "disease_state": "", "histology_inclusion": "Malignant giant cell tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "38", "disease_state": "", "histology_inclusion": "Perivascular epithelioid cell tumor (PEComa)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "40", "disease_state": "", "histology_inclusion": "Peritoneal mesothelioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "42", "disease_state": "", "histology_inclusion": "Clear cell cervical cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "45", "disease_state": "", "histology_inclusion": "Clear cell endometrial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "47", "disease_state": "", "histology_inclusion": "Gestational trophoblastic disease (GTD)", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "48", "disease_state": "", "histology_inclusion": "Gallbladder cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "49", "disease_state": "", "histology_inclusion": "Small cell carcinoma of the ovary, hypercalcemic type", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "50", "disease_state": "", "histology_inclusion": "PD-L1 amplified tumors", "biomarker_inclusion": ["PD-L1 amplification"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "51", "disease_state": "", "histology_inclusion": "Angiosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "1A", "histology_inclusion": "Squamous Cell Carcinoma", "histology_exclusion": ["Head and Neck Squamous Cell Carcinoma", "Nasopharyngeal Carcinoma"]}, {"cohort": "1B", "histology_inclusion": "Adenocarcinoma"}, {"cohort": "4", "histology_inclusion": "Pancreatic Undifferentiated Carcinoma"}, {"cohort": "11", "histology_inclusion": "Lung Sarcomatoid Carcinoma"}, {"cohort": "12", "histology_inclusion": "Lung Carcinoma"}, {"cohort": "13A", "histology_inclusion": "Ovarian Germ Cell Tumor"}, {"cohort": "18", "histology_inclusion": "Squamous Cell Carcinoma"}, {"cohort": "19", "histology_inclusion": "Sarcomatoid Carcinoma"}, {"cohort": "21", "histology_inclusion": "Malignant Neoplasm"}, {"cohort": "27", "histology_inclusion": "Deep Fibromatosis/Desmoid Tumor"}, {"cohort": "29"}, {"cohort": "38", "histology_inclusion": "PEComa"}, {"cohort": "40", "histology_inclusion": "Peritoneal Malignant Mesothelioma"}, {"cohort": "42", "histology_inclusion": "Cervical Carcinoma"}, {"cohort": "45", "histology_inclusion": "Endometrial Carcinoma"}, {"cohort": "47", "histology_inclusion": "Gestational Trophoblastic Tumor"}, {"cohort": "48", "histology_inclusion": "Gallbladder Carcinoma"}, {"cohort": "49", "histology_inclusion": "Small Cell Carcinoma"}, {"cohort": "50", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"]]}, {"cohort": "51", "histology_inclusion": "Angiosarcoma"}]}
{"NCT_id": "NCT04969315", "json": [{"cohort": "Cohort A", "disease_state": "advanced", "histology_inclusion": "renal cell cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS malignancy"], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "advanced", "histology_inclusion": "castrate resistant prostate cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS malignancy"], "biomarker_exclusion": []}, {"cohort": "Cohort A", "disease_state": "advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS malignancy"], "biomarker_exclusion": []}, {"cohort": "Cohort B", "disease_state": "advanced", "histology_inclusion": "renal cell cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS malignancy"], "biomarker_exclusion": []}, {"cohort": "Cohort C", "disease_state": "advanced", "histology_inclusion": "castrate resistant prostate cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS malignancy"], "biomarker_exclusion": []}, {"cohort": "Cohort D", "disease_state": "advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS malignancy"], "biomarker_exclusion": []}, {"cohort": "Cohort E", "disease_state": "advanced", "histology_inclusion": "renal cell cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS malignancy"], "biomarker_exclusion": []}, {"cohort": "Cohort E", "disease_state": "advanced", "histology_inclusion": "castrate resistant prostate cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS malignancy"], "biomarker_exclusion": []}, {"cohort": "Cohort E", "disease_state": "advanced", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["primary CNS malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort A", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort A", "histology_inclusion": "Prostate Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort A", "histology_inclusion": "Prostate Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort A", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort B", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort C", "histology_inclusion": "Prostate Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort C", "histology_inclusion": "Prostate Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort D", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort E", "histology_inclusion": "Renal Cell Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort E", "histology_inclusion": "Prostate Neoplasm", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort E", "histology_inclusion": "Prostate Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}, {"cohort": "Cohort E", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT03433469", "json": [{"cohort": "", "disease_state": "Stage I-IIIA", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": ["EGFR Exon 19 deletion", "EGFR T790M", "EGFR L858R"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"], ["EGFR T790M", "T790M", "coordinate"], ["EGFR exon 19 del", "exon 19 del", "exon"]]}]}
{"NCT_id": "NCT04150042", "json": [{"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Pancreatic ductal adenocarcinoma", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation", "PALB2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Pancreatic acinar cell carcinoma", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation", "PALB2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Stage IV", "histology_inclusion": "Adenocarcinoma of the breast", "biomarker_inclusion": ["BRCA1 mutation", "BRCA2 mutation", "PALB2 mutation", "HER2-negative"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": [["PALB2 Mutation", "PALB2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Pancreatic Acinar Cell Cancer", "biomarker_inclusion": [["PALB2 Mutation", "PALB2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"]]}, {"cohort": "", "histology_inclusion": "Breast Adenocarcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"], ["PALB2 Mutation", "PALB2-Mutation", "gene"]]}]}
{"NCT_id": "NCT02978625", "json": [{"cohort": "PART I", "disease_state": "refractory", "histology_inclusion": "T cell and NK cell lymphomas", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "PART I", "disease_state": "advanced or refractory", "histology_inclusion": "non-melanoma skin cancers", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "PART II (MCC-2)", "disease_state": "refractory", "histology_inclusion": "Merkel cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PD-1", "PD-L1"]}, {"cohort": "PART II (SCC-2)", "disease_state": "refractory", "histology_inclusion": "Squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PD-1", "PD-L1"]}], "json_norm": [{"cohort": "PART I"}, {"cohort": "PART I", "histology_inclusion": "Skin Carcinoma"}, {"cohort": "PART II (MCC-2)", "histology_inclusion": "Merkel Cell Carcinoma"}, {"cohort": "PART II (SCC-2)", "histology_inclusion": "Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT04216329", "json": [{"cohort": "", "disease_state": "Newly Diagnosed", "histology_inclusion": "Glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Newly Diagnosed", "histology_inclusion": "Gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Newly Diagnosed", "histology_inclusion": "Astrocytoma, Grade IV", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Gliosarcoma"}, {"cohort": "", "histology_inclusion": "Astrocytoma"}]}
{"NCT_id": "NCT02576431", "json": [{"cohort": "Arm 11_Bone health cohort", "disease_state": "locally-advanced or metastatic", "histology_inclusion": "malignancy", "biomarker_inclusion": ["NTRK1 fusion", "NTRK2 fusion", "NTRK3 fusion"], "histology_exclusion": ["primary CNS tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm 11_Bone health cohort", "biomarker_inclusion": [["NTRK1 Fusion", "NTRK1", "fusion"], ["NTRK3 Fusion", "NTRK3", "fusion"], ["NTRK2 Fusion", "NTRK2", "fusion"]], "histology_exclusion": ["Primary Brain Neoplasm"]}]}
{"NCT_id": "NCT04710641", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "Hepatocellular Carcinoma", "biomarker_inclusion": [], "histology_exclusion": ["fibrolamellar", "mixed hepatocellular/cholangiocarcinoma subtype HCC"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Hepatocellular Carcinoma", "histology_exclusion": ["Cholangiocarcinoma", "Hepatocellular Carcinoma"]}]}
{"NCT_id": "NCT04971187", "json": [{"cohort": "", "disease_state": "Locally Advanced or Metastatic", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR Exon 19 deletion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Locally Advanced or Metastatic", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR L858R mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Locally Advanced or Metastatic", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR G719X", "EGFR S768X", "EGFR L861X", "other activating uncommon mutations in exon 18-21"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Locally Advanced or Metastatic", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR exon20 insertion"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Locally Advanced or Metastatic", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Cancer", "biomarker_inclusion": ["EGFR T790M mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR exon 19 del", "exon 19 del", "exon"]]}, {"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR L858R", "L858R", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma"}, {"cohort": "", "histology_inclusion": "Non-Squamous Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR T790M", "T790M", "coordinate"]]}]}
{"NCT_id": "NCT01858168", "json": [{"cohort": "", "disease_state": "recurrent/metastatic", "histology_inclusion": "Ewing's sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent/metastatic", "histology_inclusion": "Rhabdomyosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Ewing Sarcoma"}, {"cohort": "", "histology_inclusion": "Rhabdomyosarcoma"}]}
{"NCT_id": "NCT03761017", "json": [{"cohort": "Cohort Expansion Phase", "disease_state": "unresectable, locally advanced or metastatic", "histology_inclusion": "Squamous Cell Non Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "Cohort Expansion Phase", "disease_state": "Advanced non-microsatellite instability-high colorectal cancer", "histology_inclusion": "Colorectal Cancer", "biomarker_inclusion": ["EGFR mutation"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "Cohort Expansion Phase", "disease_state": "Checkpoint inhibitor-na\u00efve metastatic castration-resistant prostate cancer", "histology_inclusion": "Prostate Cancer Metastatic", "biomarker_inclusion": ["PSA value of at least 2 ng/mL", "HRR pathway gene alterations"], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}, {"cohort": "Cohort Expansion Phase", "disease_state": "unresectable, locally advanced, or metastatic", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [], "histology_exclusion": ["CNS metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort Expansion Phase", "histology_inclusion": "Squamous Cell Lung Carcinoma"}, {"cohort": "Cohort Expansion Phase", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"]]}, {"cohort": "Cohort Expansion Phase", "histology_inclusion": "Prostate Neoplasm", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Cohort Expansion Phase", "histology_inclusion": "Prostate Carcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}, {"cohort": "Cohort Expansion Phase", "histology_inclusion": "Cutaneous Melanoma"}]}
{"NCT_id": "NCT05361720", "json": [{"cohort": "", "disease_state": "Advanced or Metastatic", "histology_inclusion": "Clear Cell Renal Cell Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Clear Cell Renal Cell Carcinoma"}]}
{"NCT_id": "NCT03435250", "json": [{"cohort": "AG-270 Monotherapy", "disease_state": "advanced", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["homozygous loss of CDKN2A", "homozygous loss of MTAP"], "histology_exclusion": ["lymphoma"], "biomarker_exclusion": []}, {"cohort": "AG-270 Monotherapy", "disease_state": "advanced", "histology_inclusion": "lymphoma", "biomarker_inclusion": ["homozygous loss of CDKN2A", "homozygous loss of MTAP"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "AG-270/docetaxel", "disease_state": "metastatic", "histology_inclusion": "non-small cell lung cancer", "biomarker_inclusion": ["homozygous loss of CDKN2A", "homozygous loss of MTAP"], "histology_exclusion": [], "biomarker_exclusion": ["prior treatment with docetaxel"]}, {"cohort": "AG-270/nab-paclitaxel/gemcitabine", "disease_state": "locally advanced", "histology_inclusion": "pancreatic ductal adenocarcinoma", "biomarker_inclusion": ["homozygous loss of CDKN2A", "homozygous loss of MTAP"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "AG-270/nab-paclitaxel/gemcitabine", "disease_state": "metastatic", "histology_inclusion": "pancreatic ductal adenocarcinoma", "biomarker_inclusion": ["homozygous loss of CDKN2A", "homozygous loss of MTAP"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "AG-270 Monotherapy", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MTAP-Low", "MTAP-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]], "histology_exclusion": ["Lymphoma"]}, {"cohort": "AG-270 Monotherapy", "histology_inclusion": "Lymphoma", "biomarker_inclusion": [["MTAP-Low", "MTAP-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]]}, {"cohort": "AG-270/docetaxel", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["MTAP-Low", "MTAP-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]]}, {"cohort": "AG-270/nab-paclitaxel/gemcitabine", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": [["MTAP-Low", "MTAP-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]]}, {"cohort": "AG-270/nab-paclitaxel/gemcitabine", "histology_inclusion": "Pancreatic Ductal Adenocarcinoma", "biomarker_inclusion": [["MTAP-Low", "MTAP-Low", "expression"], ["CDKN2A-Low", "CDKN2A-Low", "expression"]]}]}
{"NCT_id": "NCT04282018", "json": [{"cohort": "Part A", "disease_state": "relapsed/refractory", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PI3K inhibitor"]}, {"cohort": "Part A", "disease_state": "relapsed/refractory", "histology_inclusion": "Small Lymphocytic Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PI3K inhibitor"]}, {"cohort": "Part A", "disease_state": "relapsed/refractory", "histology_inclusion": "Marginal Zone Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PI3K inhibitor"]}, {"cohort": "Part A", "disease_state": "relapsed/refractory", "histology_inclusion": "Follicular Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PI3K inhibitor"]}, {"cohort": "Part A", "disease_state": "relapsed/refractory", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PI3K inhibitor"]}, {"cohort": "Part A", "disease_state": "relapsed/refractory", "histology_inclusion": "Diffuse Large B Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["T-cell/histiocyte-rich large B-cell lymphoma", "high-grade B-cell lymphoma with MYC and BCL-2 and/or BCL-6 rearrangements", "high grade B-cell lymphoma", "primary mediastinal large B-cell lymphoma", "Epstein-barr virus positive DLBCL", "transformed DLBCL"], "biomarker_exclusion": ["PI3K inhibitor"]}, {"cohort": "Part B", "disease_state": "relapsed/refractory", "histology_inclusion": "Follicular Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PI3K inhibitor", "BTK inhibitor"]}, {"cohort": "Part B", "disease_state": "relapsed/refractory", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PI3K inhibitor", "BTK inhibitor"]}, {"cohort": "Part B", "disease_state": "relapsed/refractory", "histology_inclusion": "Diffuse Large B Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PI3K inhibitor", "BTK inhibitor"]}, {"cohort": "Part C", "disease_state": "relapsed/refractory", "histology_inclusion": "Follicular Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PI3K inhibitor", "BTK inhibitor"]}, {"cohort": "Part C", "disease_state": "relapsed/refractory", "histology_inclusion": "Mantle Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PI3K inhibitor", "BTK inhibitor"]}, {"cohort": "Part C", "disease_state": "relapsed/refractory", "histology_inclusion": "Diffuse Large B Cell Lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PI3K inhibitor", "BTK inhibitor"]}, {"cohort": "Part D", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Advanced Solid Tumor", "biomarker_inclusion": ["MSI-H", "dMMR"], "histology_exclusion": [], "biomarker_exclusion": ["PI3K inhibitor"]}, {"cohort": "Part E", "disease_state": "progressed from PD 1/PD-L1 antibody treatment", "histology_inclusion": "Non-small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PI3K inhibitor"]}, {"cohort": "Part E", "disease_state": "progressed from PD 1/PD-L1 antibody treatment", "histology_inclusion": "Metastatic Melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PI3K inhibitor"]}, {"cohort": "Part E", "disease_state": "no prior PD 1/PD-L1 antibody treatment", "histology_inclusion": "Small Cell Lung Cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["PI3K inhibitor"]}], "json_norm": [{"cohort": "Part A", "histology_inclusion": "Chronic Lymphocytic Leukemia"}, {"cohort": "Part A", "histology_inclusion": "Small Lymphocytic Lymphoma"}, {"cohort": "Part A", "histology_inclusion": "Marginal Zone Lymphoma"}, {"cohort": "Part A", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "Part A", "histology_inclusion": "Mantle Cell Lymphoma"}, {"cohort": "Part A", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "histology_exclusion": ["T-Cell/Histiocyte-Rich Large B-Cell Lymphoma", "High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "Primary Mediastinal (Thymic) Large B-Cell Lymphoma", "Diffuse Large B-Cell Lymphoma", "High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements", "High Grade B-Cell Lymphoma"], "biomarker_exclusion": [["BCL6 Fusion", "BCL6", "fusion"], ["CR2-High", "CR2-High", "expression"]]}, {"cohort": "Part B", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "Part B", "histology_inclusion": "Mantle Cell Lymphoma"}, {"cohort": "Part B", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "Part C", "histology_inclusion": "Follicular Lymphoma"}, {"cohort": "Part C", "histology_inclusion": "Mantle Cell Lymphoma"}, {"cohort": "Part C", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "Part D", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Part E", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}, {"cohort": "Part E", "histology_inclusion": "Melanoma"}, {"cohort": "Part E", "histology_inclusion": "Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04282031", "json": [{"cohort": "Phase 1", "disease_state": "locally advanced, recurrent, or metastatic solid tumors", "histology_inclusion": "advanced solid tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["CDK4/6 inhibitors"]}, {"cohort": "Phase 2a Cohort A", "disease_state": "HR+/HER2- locally advanced, recurrent, or metastatic breast cancer", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["HR+", "HER2-"], "histology_exclusion": [], "biomarker_exclusion": ["CDK4/6 inhibitors"]}, {"cohort": "Phase 2a Cohort B", "disease_state": "HR+/HER2- locally advanced, recurrent, or metastatic breast cancer", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["HR+", "HER2-"], "histology_exclusion": [], "biomarker_exclusion": ["CDK4/6 inhibitors"]}], "json_norm": [{"cohort": "Phase 1", "histology_inclusion": "Malignant Solid Neoplasm"}, {"cohort": "Phase 2a Cohort A", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "Phase 2a Cohort B", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT04385277", "json": [{"cohort": "", "disease_state": "High-Risk", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "High-Risk", "histology_inclusion": "Ganglioneuroblastoma, Nodular", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Neuroblastoma"}, {"cohort": "", "histology_inclusion": "Ganglioneuroblastoma, Nodular"}]}
{"NCT_id": "NCT04841148", "json": [{"cohort": "", "disease_state": "Stage II-III", "histology_inclusion": "ER+/Her2 neg invasive breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Invasive Breast Carcinoma", "biomarker_inclusion": [["EREG-High", "EREG-High", "expression"]]}]}
{"NCT_id": "NCT04906395", "json": [{"cohort": "", "disease_state": "Stage I, II, or III", "histology_inclusion": "HR+, HER2-negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}, {"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ERBB2-Low", "ERBB2-Low", "expression"], ["HR-High", "HR-High", "expression"]]}]}
{"NCT_id": "NCT04711161", "json": [{"cohort": "Part 1 dose-escalation cohorts", "disease_state": "persistent or recurrent, locally non-resectable or metastatic", "histology_inclusion": "ovarian, primary peritoneal or fallopian tube epithelial cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Part 1 dose-expansion cohort / Part 2 dose-escalation cohorts / Part 2 dose-expansion cohort", "disease_state": "persistent or recurrent, locally non-resectable or metastatic", "histology_inclusion": "ovarian, primary peritoneal or fallopian tube epithelial cancer", "biomarker_inclusion": [], "histology_exclusion": ["advanced solid tumors of any other histology"], "biomarker_exclusion": []}, {"cohort": "Part 2 dose-escalation cohorts / Part 2 dose-expansion cohort", "disease_state": "persistent or recurrent, locally non-resectable or metastatic", "histology_inclusion": "ovarian, primary peritoneal or fallopian tube epithelial cancer", "biomarker_inclusion": [], "histology_exclusion": ["advanced solid tumors of any other histology"], "biomarker_exclusion": ["known CNS metastases or leptomeningeal disease"]}], "json_norm": [{"cohort": "Part 1 dose-escalation cohorts", "histology_inclusion": "Epithelial Neoplasm"}, {"cohort": "Part 1 dose-expansion cohort / Part 2 dose-escalation cohorts / Part 2 dose-expansion cohort", "histology_inclusion": "Epithelial Neoplasm", "histology_exclusion": ["Malignant Solid Neoplasm"]}, {"cohort": "Part 2 dose-escalation cohorts / Part 2 dose-expansion cohort", "histology_inclusion": "Epithelial Neoplasm", "histology_exclusion": ["Malignant Solid Neoplasm"]}]}
{"NCT_id": "NCT04515836", "json": [{"cohort": "Treatment Arm", "disease_state": "", "histology_inclusion": "malignant mesothelioma", "biomarker_inclusion": ["BAP1 loss", "mutation in germ cells or somatic cells disrupting protein function in at least one gene"], "histology_exclusion": [], "biomarker_exclusion": ["platinum-resistant disease", "myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML)", "brain metastases"]}], "json_norm": [{"cohort": "Treatment Arm", "histology_inclusion": "Malignant Mesothelioma", "biomarker_inclusion": [["RNF2-Low", "RNF2-Low", "expression"], ["MAGI1-Low", "MAGI1-Low", "expression"], ["BAP1-Low", "BAP1-Low", "expression"]]}]}
{"NCT_id": "NCT01728155", "json": [{"cohort": "Low Risk Study", "disease_state": "", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": ["MYCN non-amplified"], "histology_exclusion": ["ganglioneuroma", "ganglioneuroblastoma intermixed INRG Stage L2"], "biomarker_exclusion": ["MYCN amplification"]}, {"cohort": "Intermediate Risk Study", "disease_state": "", "histology_inclusion": "neuroblastoma", "biomarker_inclusion": ["MYCN amplified"], "histology_exclusion": ["ganglioneuroma", "ganglioneuroblastoma intermixed"], "biomarker_exclusion": ["MYCN non-amplified"]}, {"cohort": "Intermediate Risk Study", "disease_state": "", "histology_inclusion": "neuroblastoma or ganglioneuroblastoma nodular", "biomarker_inclusion": ["MYCN non-amplified"], "histology_exclusion": ["neuroblastoma NOS"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Low Risk Study", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]], "histology_exclusion": ["Ganglioneuroma", "Ganglioneuroblastoma"], "biomarker_exclusion": [["MYCN-High", "MYCN-High", "expression"]]}, {"cohort": "Intermediate Risk Study", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]], "histology_exclusion": ["Ganglioneuroma", "Ganglioneuroblastoma"], "biomarker_exclusion": [["MYCN-High", "MYCN-High", "expression"]]}, {"cohort": "Intermediate Risk Study", "histology_inclusion": "Neuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]], "histology_exclusion": ["Neuroblastoma"]}, {"cohort": "Intermediate Risk Study", "histology_inclusion": "Ganglioneuroblastoma", "biomarker_inclusion": [["MYCN-High", "MYCN-High", "expression"]], "histology_exclusion": ["Neuroblastoma"]}]}
{"NCT_id": "NCT01989585", "json": [{"cohort": "", "disease_state": "metastatic or unresectable", "histology_inclusion": "BRAF-mutant (V600E/K) melanoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["prior navitoclax", "prior BRAF inhibitor", "prior MEK inhibitor"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"], ["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"], ["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}, {"cohort": "", "histology_inclusion": "Melanoma", "biomarker_inclusion": [["BRAF Mutation", "BRAF-Mutation", "gene"], ["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]]}]}
{"NCT_id": "NCT05167175", "json": [{"cohort": "", "disease_state": "metastatic hormone sensitive prostate cancer", "histology_inclusion": "adenocarcinoma of the prostate", "biomarker_inclusion": ["HRR gene mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Prostate Adenocarcinoma", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]]}]}
{"NCT_id": "NCT03375307", "json": [{"cohort": "Cohort I (olaparib)", "disease_state": "advanced or metastatic", "histology_inclusion": "non-prostate genitourinary cancer", "biomarker_inclusion": ["BRCA1", "BRCA2", "ATM", "BAP1", "MSH2", "PALB2", "BRIP1", "ABL1", "ATR", "ATRX", "BARD1", "BRD4", "CCND1", "CHEK1", "CHEK2", "DOT1L", "FANCC", "FANCE", "FANCG", "FANCL", "IKBKE", "MEN1", "MLH1", "MSH2", "MSH6", "MUTYH", "NPM1", "PMS2", "POLD1", "POLE", "RAD51", "SMARCB1", "STK11", "TP53"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort I (olaparib)"}]}
{"NCT_id": "NCT03896568", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "high-grade glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "glioblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "anaplastic astrocytoma", "biomarker_inclusion": ["IDH1 wild-type"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent", "histology_inclusion": "IDH-mutant grade 4 astrocytoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Glioma"}, {"cohort": "", "histology_inclusion": "Glioblastoma"}, {"cohort": "", "histology_inclusion": "Gliosarcoma"}, {"cohort": "", "histology_inclusion": "Anaplastic Astrocytoma", "biomarker_inclusion": [["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["IDH1 IDH1-wild_type", "IDH1-wild_type", "wild_type"]]}, {"cohort": "", "histology_inclusion": "Astrocytoma"}]}
{"NCT_id": "NCT03961672", "json": [{"cohort": "", "disease_state": "Recurrent or Refractory", "histology_inclusion": "Chronic Lymphocytic Leukemia", "biomarker_inclusion": [], "histology_exclusion": ["Mantle Cell Lymphoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Recurrent or Refractory", "histology_inclusion": "Small Lymphocytic Lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["Mantle Cell Lymphoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Chronic Lymphocytic Leukemia", "histology_exclusion": ["Mantle Cell Lymphoma"]}, {"cohort": "", "histology_inclusion": "Small Lymphocytic Lymphoma", "histology_exclusion": ["Mantle Cell Lymphoma"]}]}
{"NCT_id": "NCT03961698", "json": [{"cohort": "Cohort A1", "disease_state": "locally advanced and/or metastatic", "histology_inclusion": "Triple-Negative Breast Cancer", "biomarker_inclusion": ["PD-L1 positive (IC1/2/3)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort A2", "disease_state": "locally advanced and/or metastatic", "histology_inclusion": "Triple-Negative Breast Cancer", "biomarker_inclusion": ["PD-L1 negative (IC0)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B1", "disease_state": "locally advanced and/or metastatic", "histology_inclusion": "Renal Cell Carcinoma with clear-cell histology", "biomarker_inclusion": ["PD-L1 positive (IC1/2/3)"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort B2", "disease_state": "locally advanced and/or metastatic", "histology_inclusion": "Renal Cell Carcinoma with clear-cell histology", "biomarker_inclusion": ["PD-L1 negative (IC0)"], "histology_exclusion": [], "biomarker_exclusion": ["brain or leptomeningeal metastases"]}], "json_norm": [{"cohort": "Cohort A1", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"], ["CD274-High", "CD274-High", "expression"]]}, {"cohort": "Cohort A2", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["CD274-Low", "CD274-Low", "expression"], ["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Cohort B1", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [["CD274-High", "CD274-High", "expression"]]}, {"cohort": "Cohort B2", "histology_inclusion": "Renal Cell Carcinoma", "biomarker_inclusion": [["CD274-Low", "CD274-Low", "expression"]]}]}
{"NCT_id": "NCT04092270", "json": [{"cohort": "Dose Escalation Phase", "disease_state": "recurrent or persistent", "histology_inclusion": "epithelial ovarian, fallopian tube or primary peritoneal cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Phase - LGSOC", "disease_state": "recurrent or persistent", "histology_inclusion": "low grade serous ovarian cancer or grade 1 serous ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Expansion Phase - HGSOC", "disease_state": "recurrent or persistent", "histology_inclusion": "high grade serous ovarian cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Dose Escalation Phase", "histology_inclusion": "Primary Peritoneal Carcinoma"}, {"cohort": "Expansion Phase - LGSOC", "histology_inclusion": "Invasive Ovarian Micropapillary Serous Carcinoma"}, {"cohort": "Expansion Phase - LGSOC", "histology_inclusion": "Ovarian Serous Adenocarcinoma"}, {"cohort": "Expansion Phase - HGSOC", "histology_inclusion": "Ovarian Serous Adenocarcinoma"}]}
{"NCT_id": "NCT02389244", "json": [{"cohort": "", "disease_state": "metastatic", "histology_inclusion": "osteosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "Ewing sarcoma of bone", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "chondrosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "chordoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "metastatic", "histology_inclusion": "CIC-rearranged sarcoma", "biomarker_inclusion": [], "histology_exclusion": ["soft tissue sarcoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Osteosarcoma"}, {"cohort": "", "histology_inclusion": "Ewing Sarcoma"}, {"cohort": "", "histology_inclusion": "Chondrosarcoma"}, {"cohort": "", "histology_inclusion": "Chordoma"}, {"cohort": "", "histology_inclusion": "Sarcoma", "histology_exclusion": ["Soft Tissue Sarcoma"]}]}
{"NCT_id": "NCT03117751", "json": [{"cohort": "B-ALL and B-LLy, Low-risk", "disease_state": "newly diagnosed", "histology_inclusion": "B-acute lymphoblastic leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "B-ALL and B-LLy, Low-risk", "disease_state": "newly diagnosed", "histology_inclusion": "B-lymphoblastic lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "T-ALL and T-LLy, Standard-risk", "disease_state": "newly diagnosed", "histology_inclusion": "T-acute lymphoblastic leukemia", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "T-ALL and T-LLy, Standard-risk", "disease_state": "newly diagnosed", "histology_inclusion": "T-lymphoblastic lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "B-ALL and B-LLy, Low-risk", "histology_inclusion": "B Acute Lymphoblastic Leukemia"}, {"cohort": "B-ALL and B-LLy, Low-risk", "histology_inclusion": "B Lymphoblastic Lymphoma"}, {"cohort": "T-ALL and T-LLy, Standard-risk", "histology_inclusion": "T cell acute lymphoblastic leukemia"}, {"cohort": "T-ALL and T-LLy, Standard-risk", "histology_inclusion": "Infant T Acute Lymphoblastic Leukemia"}, {"cohort": "T-ALL and T-LLy, Standard-risk"}]}
{"NCT_id": "NCT03769506", "json": [{"cohort": "", "disease_state": "locoregional persistent, recurrent or second primary", "histology_inclusion": "squamous cell carcinoma of the head and neck", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}]}
{"NCT_id": "NCT04719273", "json": [{"cohort": "", "disease_state": "Refractory", "histology_inclusion": "Endometrial Adenocarcinoma", "biomarker_inclusion": ["ER expression >= 1%", "PR expression >= 1%"], "histology_exclusion": ["Carcinosarcoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Refractory", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": ["ER expression >= 1%", "PR expression >= 1%"], "histology_exclusion": ["Carcinosarcoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Refractory", "histology_inclusion": "Endometrial Clear Cell Adenocarcinoma", "biomarker_inclusion": ["ER expression >= 1%", "PR expression >= 1%"], "histology_exclusion": ["Carcinosarcoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Refractory", "histology_inclusion": "Endometrial Endometrioid Adenocarcinoma", "biomarker_inclusion": ["ER expression >= 1%", "PR expression >= 1%"], "histology_exclusion": ["Carcinosarcoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Refractory", "histology_inclusion": "Endometrial Mixed Cell Adenocarcinoma", "biomarker_inclusion": ["ER expression >= 1%", "PR expression >= 1%"], "histology_exclusion": ["Carcinosarcoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Refractory", "histology_inclusion": "Endometrial Serous Adenocarcinoma", "biomarker_inclusion": ["ER expression >= 1%", "PR expression >= 1%"], "histology_exclusion": ["Carcinosarcoma"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Refractory", "histology_inclusion": "Endometrial Undifferentiated Carcinoma", "biomarker_inclusion": ["ER expression >= 1%", "PR expression >= 1%"], "histology_exclusion": ["Carcinosarcoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Endometrial Adenocarcinoma", "histology_exclusion": ["Carcinosarcoma"]}, {"cohort": "", "histology_inclusion": "Endometrial Carcinoma", "histology_exclusion": ["Carcinosarcoma"]}, {"cohort": "", "histology_inclusion": "Endometrial Clear Cell Adenocarcinoma", "histology_exclusion": ["Carcinosarcoma"]}, {"cohort": "", "histology_inclusion": "Endometrial Endometrioid Adenocarcinoma", "histology_exclusion": ["Carcinosarcoma"]}, {"cohort": "", "histology_inclusion": "Adenocarcinoma", "histology_exclusion": ["Carcinosarcoma"]}, {"cohort": "", "histology_inclusion": "Endometrial Serous Adenocarcinoma", "histology_exclusion": ["Carcinosarcoma"]}, {"cohort": "", "histology_inclusion": "Endometrial Undifferentiated Carcinoma", "histology_exclusion": ["Carcinosarcoma"]}]}
{"NCT_id": "NCT05044897", "json": [{"cohort": "", "disease_state": "recurrent metastatic", "histology_inclusion": "squamous cell carcinoma of the head and neck", "biomarker_inclusion": [], "histology_exclusion": ["squamous cell carcinoma with primary site of nasopharynx", "squamous cell carcinoma with primary site of skin"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma", "histology_exclusion": ["Squamous Cell Carcinoma"]}]}
{"NCT_id": "NCT05435248", "json": [{"cohort": "Phase 1b and Phase 2", "disease_state": "advanced or metastatic", "histology_inclusion": "Non-Small-Cell Lung Cancer", "biomarker_inclusion": ["EGFR C797S mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1b and Phase 2", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [["EGFR C797S", "C797S", "coordinate"]]}]}
{"NCT_id": "NCT05565417", "json": [{"cohort": "Phase 1", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Non-small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": ["EGFR", "ALK", "ROS", "RET", "BRAFV600E", "Met exon 14 skipping", "KRAS mutation"]}, {"cohort": "Phase 1", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Head and neck squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Triple negative breast cancer", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Cutaneous squamous cell carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Hormone receptor positive breast carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Small bowel carcinoma", "biomarker_inclusion": ["MSI-H", "dMMR"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Esophageal cancer", "biomarker_inclusion": ["HER2 overexpressing"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Colorectal cancer", "biomarker_inclusion": ["MSS", "MSI-H", "dMMR"], "histology_exclusion": [], "biomarker_exclusion": ["BRAF V600E mutation"]}, {"cohort": "Phase 1", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Diffuse large B cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "Burkitt lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Phase 1", "disease_state": "unresectable locally advanced or metastatic", "histology_inclusion": "T cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Phase 1", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["KRAS Mutation", "KRAS-Mutation", "gene"], ["MET exon 14 del", "exon 14 del", "exon"], ["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "Phase 1", "histology_inclusion": "Head and Neck Squamous Cell Carcinoma"}, {"cohort": "Phase 1", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["Triple-Negative", "Triple-Negative", "coordinate"]]}, {"cohort": "Phase 1", "histology_inclusion": "Skin Squamous Cell Carcinoma"}, {"cohort": "Phase 1", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "Phase 1", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["ESR1-High", "ESR1-High", "expression"], ["PGR-High", "PGR-High", "expression"]]}, {"cohort": "Phase 1", "histology_inclusion": "Small Intestinal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}, {"cohort": "Phase 1", "histology_inclusion": "Esophageal Carcinoma", "biomarker_inclusion": [["ERBB2-High", "ERBB2-High", "expression"]]}, {"cohort": "Phase 1", "histology_inclusion": "Colorectal Carcinoma", "biomarker_inclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"], ["MSI-Low", "MSI-Low", "coordinate"]], "biomarker_exclusion": [["BRAF V600E", "V600E", "coordinate"]]}, {"cohort": "Phase 1", "histology_inclusion": "Diffuse Large B-Cell Lymphoma"}, {"cohort": "Phase 1", "histology_inclusion": "Hodgkin Lymphoma"}, {"cohort": "Phase 1", "histology_inclusion": "Burkitt Lymphoma"}, {"cohort": "Phase 1", "histology_inclusion": "T-Cell Non-Hodgkin Lymphoma"}]}
{"NCT_id": "NCT03574402", "json": [{"cohort": "", "disease_state": "unresectable stage IIIB or stage IV", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma"}]}
{"NCT_id": "NCT04160494", "json": [{"cohort": "", "disease_state": "recurrent", "histology_inclusion": "WHO grade IV malignant glioma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Glioma"}]}
{"NCT_id": "NCT04591431", "json": [{"cohort": "", "disease_state": "recurrent/metastatic", "histology_inclusion": "breast cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent/metastatic", "histology_inclusion": "gastrointestinal cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "recurrent/metastatic", "histology_inclusion": "non small cell lung cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": ["EGFR mutation", "ALK translocation"]}, {"cohort": "", "disease_state": "recurrent/metastatic", "histology_inclusion": "other cancer", "biomarker_inclusion": [], "histology_exclusion": ["brain metastases"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma"}, {"cohort": "", "histology_inclusion": "Digestive System Neoplasm"}, {"cohort": "", "histology_inclusion": "Non-Small Cell Lung Carcinoma", "biomarker_exclusion": [["EGFR Mutation", "EGFR-Mutation", "gene"], ["ALK Fusion", "ALK", "fusion"]]}, {"cohort": ""}]}
{"NCT_id": "NCT02849496", "json": [{"cohort": "", "disease_state": "unresectable locally advanced or metastatic non-HER2-positive breast cancer", "histology_inclusion": "breast cancer", "biomarker_inclusion": ["BRCA 1/2 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Breast Carcinoma", "biomarker_inclusion": [["BRCA2 Mutation", "BRCA2-Mutation", "gene"], ["BRCA1 Mutation", "BRCA1-Mutation", "gene"]]}]}
{"NCT_id": "NCT03772561", "json": [{"cohort": "", "disease_state": "advanced or metastatic", "histology_inclusion": "solid tumors", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT03967938", "json": [{"cohort": "", "disease_state": "advanced", "histology_inclusion": "cancer", "biomarker_inclusion": ["germline mutation in homologous recombination genes", "somatic tumor mutation in homologous recombination genes"], "histology_exclusion": ["breast cancer", "pancreas cancer", "prostate cancer", "HRD ovarian cancer"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "biomarker_inclusion": [["Homologous Recombination Pathway", null, "pathway"]], "histology_exclusion": ["Breast Carcinoma", "Malignant Ovarian Neoplasm", "Prostate Neoplasm", "Prostate Carcinoma", "Pancreatic Carcinoma", "Ovarian Epithelial Cancer"]}]}
{"NCT_id": "NCT04917809", "json": [{"cohort": "Participants with FGFR3-mutant or -fusion noninvasive bladder tumors", "disease_state": "Recurrent Non-Muscle Invasive Bladder Cancer", "histology_inclusion": "Bladder Cancer", "biomarker_inclusion": ["FGFR3 mutation"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Participants with FGFR3-mutant or -fusion noninvasive bladder tumors", "histology_inclusion": "Bladder Carcinoma", "biomarker_inclusion": [["FGFR3 Mutation", "FGFR3-Mutation", "gene"]]}, {"cohort": "Participants with FGFR3-mutant or -fusion noninvasive bladder tumors", "histology_inclusion": "Bladder Neoplasm", "biomarker_inclusion": [["FGFR3 Mutation", "FGFR3-Mutation", "gene"]]}]}
{"NCT_id": "NCT01804634", "json": [{"cohort": "", "disease_state": "Refractory and/or Relapsed Metastatic", "histology_inclusion": "Neuroblastoma or ganglioneuroblastoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Refractory and/or Relapsed Metastatic", "histology_inclusion": "Stage 4 rhabdomyosarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Refractory and/or Relapsed Metastatic", "histology_inclusion": "Metastatic Ewing Sarcoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Refractory and/or Relapsed Metastatic", "histology_inclusion": "Osteosarcoma with metastatic disease beyond the lungs and/or with lung metastases not amenable to resection", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Refractory and/or Relapsed Metastatic", "histology_inclusion": "Desmoplastic small round cell tumor", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "Refractory and/or Relapsed Metastatic", "histology_inclusion": "Any other solid tumor and soft tissue sarcoma with an estimated <10% chance of survival", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Neuroblastoma"}, {"cohort": "", "histology_inclusion": "Ganglioneuroblastoma"}, {"cohort": "", "histology_inclusion": "Rhabdomyosarcoma"}, {"cohort": "", "histology_inclusion": "Ewing Sarcoma"}, {"cohort": "", "histology_inclusion": "Osteosarcoma"}, {"cohort": "", "histology_inclusion": "Desmoplastic Small Round Cell Tumor"}, {"cohort": "", "histology_inclusion": "Soft Tissue Sarcoma"}, {"cohort": "", "histology_inclusion": "Malignant Solid Neoplasm"}]}
{"NCT_id": "NCT04098393", "json": [{"cohort": "patients hematologic malignancies other than multiple myeloma", "disease_state": "Acute myeloid leukemia (AML) with intermediate or high-risk features in CR1", "histology_inclusion": "Acute myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": ["active extramedullary disease", "active central nervous system malignancy"], "biomarker_exclusion": []}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "disease_state": "Relapsed AML in \u2265 CR2", "histology_inclusion": "Acute myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": ["active extramedullary disease", "active central nervous system malignancy"], "biomarker_exclusion": []}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "disease_state": "Acute leukemias of ambiguous lineage in \u2265 CR1", "histology_inclusion": "Acute leukemias of ambiguous lineage", "biomarker_inclusion": [], "histology_exclusion": ["active extramedullary disease", "active central nervous system malignancy"], "biomarker_exclusion": []}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "disease_state": "Acute lymphoid leukemia (ALL) in CR1 with clinical, flow cytometric, or molecular features indicating a high risk for relapse, or ALL in \u2265 CR2", "histology_inclusion": "Acute lymphoid leukemia", "biomarker_inclusion": [], "histology_exclusion": ["active extramedullary disease", "active central nervous system malignancy"], "biomarker_exclusion": []}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "disease_state": "CML with failed response to or intolerant to BCR-ABL tyrosine kinase inhibitors (TKIs)", "histology_inclusion": "Chronic myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": ["active extramedullary disease", "active central nervous system malignancy"], "biomarker_exclusion": []}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "disease_state": "CML with BCR-ABL mutation consistent with poor response to TKIs (e.g., T315I mutation)", "histology_inclusion": "Chronic myeloid leukemia", "biomarker_inclusion": ["BCR-ABL mutation"], "histology_exclusion": ["active extramedullary disease", "active central nervous system malignancy"], "biomarker_exclusion": []}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "disease_state": "CML in accelerated phase or blast crisis with <10% blasts after therapy, or in second chronic phase", "histology_inclusion": "Chronic myeloid leukemia", "biomarker_inclusion": [], "histology_exclusion": ["active extramedullary disease", "active central nervous system malignancy"], "biomarker_exclusion": []}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "disease_state": "Myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), or MDS/MPN overlap syndromes with least one of the following: Revised International Prognostic Scoring System risk score of intermediate or higher at the time of transplant evaluation, Life-threatening cytopenias, Karyotype or genomic changes that indicate high risk for progression to acute myelogenous leukemia, including abnormalities of chromosome 7 or 3, mutations of TP53, or complex or monosomal karyotype, Therapy related disease or disease evolving from other malignant processes", "histology_inclusion": "Myelodysplastic syndromes, myeloproliferative neoplasms, MDS/MPN overlap syndromes", "biomarker_inclusion": ["abnormalities of chromosome 7 or 3", "mutations of TP53", "complex or monosomal karyotype"], "histology_exclusion": ["active extramedullary disease", "active central nervous system malignancy"], "biomarker_exclusion": []}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "disease_state": "Chronic myelomonocytic leukemia (CMML-1 or CMML-2)", "histology_inclusion": "Chronic myelomonocytic leukemia", "biomarker_inclusion": [], "histology_exclusion": ["active extramedullary disease", "active central nervous system malignancy"], "biomarker_exclusion": []}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "disease_state": "Severe aplastic anemia", "histology_inclusion": "Severe aplastic anemia", "biomarker_inclusion": [], "histology_exclusion": ["active extramedullary disease", "active central nervous system malignancy"], "biomarker_exclusion": []}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "disease_state": "Relapsed Hodgkin lymphoma responding to therapy prior to enrollment and relapse after autologous HCT or are ineligible for autologous HCT", "histology_inclusion": "Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["active extramedullary disease", "active central nervous system malignancy"], "biomarker_exclusion": []}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "disease_state": "Relapsed non-Hodgkin lymphoma responding to therapy prior to enrollment and relapse after prior autologous HCT or are ineligible for autologous HCT", "histology_inclusion": "non-Hodgkin lymphoma", "biomarker_inclusion": [], "histology_exclusion": ["active extramedullary disease", "active central nervous system malignancy"], "biomarker_exclusion": []}, {"cohort": "patients with multiple myeloma", "disease_state": "High-risk multiple myeloma following autologous HCT or relapsed multiple myeloma following autologous HCT with chemosensitive disease", "histology_inclusion": "multiple myeloma", "biomarker_inclusion": [], "histology_exclusion": ["active extramedullary disease", "active central nervous system malignancy"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "patients hematologic malignancies other than multiple myeloma", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "histology_inclusion": "Acute Myeloid Leukemia (AML)", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "histology_inclusion": "Acute Leukemia of Ambiguous Lineage", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "histology_inclusion": "Acute Lymphoblastic Leukemia (ALL)", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "biomarker_inclusion": [["BCR - MTTP", "BCR - MTTP", "coordinate"], ["BCR - ABL1", "BCR - ABL1", "coordinate"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "histology_inclusion": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "histology_inclusion": "Myeloproliferative Neoplasm", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "histology_inclusion": "Myelodysplastic Syndrome", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm"]}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "histology_inclusion": "Myelodysplastic/Myeloproliferative Disease", "biomarker_inclusion": [["TP53 Mutation", "TP53-Mutation", "gene"]], "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "histology_inclusion": "Chronic Myelomonocytic Leukemia", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "histology_inclusion": "Hodgkin Lymphoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "patients hematologic malignancies other than multiple myeloma", "histology_inclusion": "Non-Hodgkin Lymphoma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}, {"cohort": "patients with multiple myeloma", "histology_inclusion": "Plasma Cell Myeloma", "histology_exclusion": ["Primary Central Nervous System Neoplasm", "Malignant Central Nervous System Neoplasm", "Central Nervous System Neoplasm"]}]}
{"NCT_id": "NCT03773302", "json": [{"cohort": "", "disease_state": "unresectable locally advanced or metastatic cholangiocarcinoma", "histology_inclusion": "cholangiocarcinoma", "biomarker_inclusion": ["FGFR2 fusion", "FGFR2 rearrangement"], "histology_exclusion": ["gallbladder cancer", "ampulla of Vater carcinoma"], "biomarker_exclusion": ["MSI-H"]}], "json_norm": [{"cohort": "", "histology_inclusion": "Cholangiocarcinoma", "biomarker_inclusion": [["FGFR2 Fusion", "FGFR2", "fusion"]], "histology_exclusion": ["Ampulla of Vater Carcinoma", "Gallbladder Carcinoma"], "biomarker_exclusion": [["MSI", "MSI", "coordinate"], ["MSI-High", "MSI-High", "coordinate"]]}]}
{"NCT_id": "NCT04657991", "json": [{"cohort": "", "disease_state": "unresectable (Stage IIIB, IIIC, or IIID) or metastatic (Stage IV)", "histology_inclusion": "cutaneous melanoma", "biomarker_inclusion": ["BRAF V600E", "BRAF V600K"], "histology_exclusion": ["mucosal melanoma", "ocular melanoma"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Cutaneous Melanoma", "biomarker_inclusion": [["BRAF V600E", "V600E", "coordinate"], ["BRAF V600K", "V600K", "coordinate"]], "histology_exclusion": ["Mucosal Melanoma", "Ocular Melanoma"]}]}
{"NCT_id": "NCT04397679", "json": [{"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "grade IV glioma", "biomarker_inclusion": [], "histology_exclusion": ["gliomatosis cerebri", "recurrent glioblastoma", "metastatic glioblastoma", "infratentorial tumor"], "biomarker_exclusion": []}, {"cohort": "", "disease_state": "newly diagnosed", "histology_inclusion": "gliosarcoma", "biomarker_inclusion": [], "histology_exclusion": ["gliomatosis cerebri", "recurrent glioblastoma", "metastatic glioblastoma", "infratentorial tumor"], "biomarker_exclusion": []}], "json_norm": [{"cohort": "", "histology_inclusion": "Glioma", "histology_exclusion": ["Glioblastoma"]}, {"cohort": "", "histology_inclusion": "Gliosarcoma", "histology_exclusion": ["Glioblastoma"]}]}
{"NCT_id": "NCT04104776", "json": [{"cohort": "Cohort M1", "disease_state": "advanced/metastatic", "histology_inclusion": "urothelial carcinoma", "biomarker_inclusion": ["ARID1A mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort M1", "disease_state": "metastatic", "histology_inclusion": "solid tumor", "biomarker_inclusion": ["ARID1A mutation"], "histology_exclusion": ["ovarian clear cell cancer", "endometrial cancer", "pleural or peritoneal mesothelioma"], "biomarker_exclusion": []}, {"cohort": "Cohort M2", "disease_state": "advanced", "histology_inclusion": "ovarian clear cell carcinoma", "biomarker_inclusion": ["ARID1A mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort M3", "disease_state": "recurrent/metastatic/unresectable", "histology_inclusion": "endometrial carcinoma", "biomarker_inclusion": ["ARID1A mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort M4", "disease_state": "refractory/relapsed/progressive", "histology_inclusion": "peripheral T-cell lymphoma", "biomarker_inclusion": [], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort M4", "disease_state": "relapsed/refractory", "histology_inclusion": "diffuse large B-cell lymphoma", "biomarker_inclusion": ["EZH2 hotspot mutation"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort M5", "disease_state": "relapsed/refractory", "histology_inclusion": "malignant pleural or peritoneal mesothelioma", "biomarker_inclusion": ["BAP1 loss"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Cohort M6", "disease_state": "castration-resistant", "histology_inclusion": "prostate cancer", "biomarker_inclusion": ["measurable soft tissue disease"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Cohort M1", "histology_inclusion": "Urothelial Carcinoma", "biomarker_inclusion": [["ARID1A Mutation", "ARID1A-Mutation", "gene"]]}, {"cohort": "Cohort M1", "histology_inclusion": "Malignant Solid Neoplasm", "biomarker_inclusion": [["ARID1A Mutation", "ARID1A-Mutation", "gene"]], "histology_exclusion": ["Ovarian Clear Cell Tumor", "Peritoneal Malignant Mesothelioma", "Endometrial Carcinoma"]}, {"cohort": "Cohort M2", "histology_inclusion": "Ovarian Clear Cell Tumor", "biomarker_inclusion": [["ARID1A Mutation", "ARID1A-Mutation", "gene"]]}, {"cohort": "Cohort M3", "histology_inclusion": "Endometrial Carcinoma", "biomarker_inclusion": [["ARID1A Mutation", "ARID1A-Mutation", "gene"]]}, {"cohort": "Cohort M4", "histology_inclusion": "Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma"}, {"cohort": "Cohort M4", "histology_inclusion": "Peripheral T-Cell Lymphoma"}, {"cohort": "Cohort M4", "histology_inclusion": "Diffuse Large B-Cell Lymphoma", "biomarker_inclusion": [["EZH2 Mutation", "EZH2-Mutation", "gene"]]}, {"cohort": "Cohort M5", "histology_inclusion": "Peritoneal Malignant Mesothelioma", "biomarker_inclusion": [["RNF2-Low", "RNF2-Low", "expression"], ["MAGI1-Low", "MAGI1-Low", "expression"], ["BAP1-Low", "BAP1-Low", "expression"]]}, {"cohort": "Cohort M6", "histology_inclusion": "Prostate Neoplasm"}, {"cohort": "Cohort M6", "histology_inclusion": "Prostate Carcinoma"}]}
{"NCT_id": "NCT04410653", "json": [{"cohort": "Arm 1 (KRASwt PDAC)", "disease_state": "metastatic or locally advanced", "histology_inclusion": "pancreatic adenocarcinoma", "biomarker_inclusion": ["NRG1 rearrangement", "KRAS wild-type"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm 2 (IMA)", "disease_state": "metastatic or locally advanced", "histology_inclusion": "invasive mucinous subtype of lung adenocarcinoma", "biomarker_inclusion": ["NRG1 rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}, {"cohort": "Arm 3 (other)", "disease_state": "metastatic or locally advanced", "histology_inclusion": "NRG1-rearranged malignancy", "biomarker_inclusion": ["NRG1 rearrangement"], "histology_exclusion": [], "biomarker_exclusion": []}], "json_norm": [{"cohort": "Arm 1 (KRASwt PDAC)", "histology_inclusion": "Pancreatic Adenocarcinoma", "biomarker_inclusion": [["NRG1 Fusion", "NRG1", "fusion"], ["SGCG SGCG-wild_type", "SGCG-wild_type", "wild_type"], ["KRAS KRAS-wild_type", "KRAS-wild_type", "wild_type"]]}, {"cohort": "Arm 2 (IMA)", "histology_inclusion": "Lung Adenocarcinoma", "biomarker_inclusion": [["NRG1 Fusion", "NRG1", "fusion"]]}, {"cohort": "Arm 3 (other)", "biomarker_inclusion": [["NRG1 Fusion", "NRG1", "fusion"]]}]}
